PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Shah, R				Shah, Raj			Expanding the reach of breakthroughs	LANCET			English	Editorial Material									US Agcy Int Dev, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Shah, R (corresponding author), US Agcy Int Dev, Washington, DC 20523 USA.	rshah@usaid.gov						[Anonymous], 2008, 4 WHO; Countdown to 2015 Initiative, 2010, CAUS MAT CHILD DEATH; National Institute of Allergy and Infectious Diseases, 2009, HIV VACC REG DEM MOD; National Institute of Allergy and Infectious Diseases, 2010, DAIL DOS HIV DRUG RE; *PRES MAL IN, 2010, LANT HYD US GOV MAL; President's Malaria Initiative, 2010, PMI RES; Shah R, 2011, BARMES GLOBAL HLTH L; Stop TB Partnership, 2010, GLOB PLAN STOP 2011; UN, 2010, LEAD UN EV PLEDG SCA; UNFPA, 2009, ENS EV PREG WANT; USAID, 2010, STAT USAID ADM R SHA; USAID, 2010, MICR STAK M NOV 19; WHO, 2010, WORLD MALARIA REPORT 2010, P1	13	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 18	2012	380	9842					632	634		10.1016/S0140-6736(11)60933-1	http://dx.doi.org/10.1016/S0140-6736(11)60933-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	991SE	21724245				2022-12-28	WOS:000307721000010
J	Aberle, DR; Adams, AM; Berg, CD; Black, WC; Clapp, JD; Fagerstrom, RM; Gareen, IF; Gatsonis, C; Marcus, PM; Sicks, JD				Aberle, Denise R.; Adams, Amanda M.; Berg, Christine D.; Black, William C.; Clapp, Jonathan D.; Fagerstrom, Richard M.; Gareen, Ilana F.; Gatsonis, Constantine; Marcus, Pamela M.; Sicks, JoRean D.		Natl Lung Screening Trial Res Team	Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOMATIC MUTATIONS; CT; TRIAL; VOLUME; RECRUITMENT; PREVALENCE; DESIGN	BACKGROUND The aggressive and heterogeneous nature of lung cancer has thwarted efforts to reduce mortality from this cancer through the use of screening. The advent of low-dose helical computed tomography (CT) altered the landscape of lung-cancer screening, with studies indicating that low-dose CT detects many tumors at early stages. The National Lung Screening Trial (NLST) was conducted to determine whether screening with low-dose CT could reduce mortality from lung cancer. METHODS From August 2002 through April 2004, we enrolled 53,454 persons at high risk for lung cancer at 33 U. S. medical centers. Participants were randomly assigned to undergo three annual screenings with either low-dose CT (26,722 participants) or single-view posteroanterior chest radiography (26,732). Data were collected on cases of lung cancer and deaths from lung cancer that occurred through December 31, 2009. RESULTS The rate of adherence to screening was more than 90%. The rate of positive screening tests was 24.2% with low-dose CT and 6.9% with radiography over all three rounds. A total of 96.4% of the positive screening results in the low-dose CT group and 94.5% in the radiography group were false positive results. The incidence of lung cancer was 645 cases per 100,000 person-years (1060 cancers) in the low-dose CT group, as compared with 572 cases per 100,000 person-years (941 cancers) in the radiography group (rate ratio, 1.13; 95% confidence interval [CI], 1.03 to 1.23). There were 247 deaths from lung cancer per 100,000 person-years in the low-dose CT group and 309 deaths per 100,000 person-years in the radiography group, representing a relative reduction in mortality from lung cancer with low-dose CT screening of 20.0% (95% CI, 6.8 to 26.7; P = 0.004). The rate of death from any cause was reduced in the low-dose CT group, as compared with the radiography group, by 6.7% (95% CI, 1.2 to 13.6; P = 0.02). CONCLUSIONS Screening with the use of low-dose CT reduces mortality from lung cancer.	[Berg, Christine D.] NCI, Canc Prevent Div, Early Detect Res Grp, Bethesda, MD 20892 USA; [Aberle, Denise R.] Univ Calif Los Angeles, Los Angeles, CA USA; [Adams, Amanda M.; Gareen, Ilana F.; Gatsonis, Constantine; Sicks, JoRean D.] Brown Univ, ACRIN Biostat Ctr, Providence, RI 02912 USA; [Black, William C.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Clapp, Jonathan D.] Informat Management Serv Inc, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Los Angeles; Brown University; Dartmouth College; Information Management Services, Inc.	Berg, CD (corresponding author), NCI, Canc Prevent Div, Early Detect Res Grp, 6130 Execut Blvd,Suite 3112, Bethesda, MD 20892 USA.	bergc@mail.nih.gov	Gareen, Ilana/I-2816-2014; Peng, Bo/A-6920-2009; Duan, Fenghai/J-3709-2014; Berg, Christine/K-1047-2014; Aberle, Denise R./D-5699-2014	Gareen, Ilana/0000-0002-0457-5595; Peng, Bo/0000-0001-8225-2284; Duan, Fenghai/0000-0002-5084-0070; Aberle, Denise R./0000-0002-8858-3401; Rendas-Baum, Regina/0000-0003-1772-1819; Blevins, Meridith/0000-0002-3861-9859; Chen, Mei-Hsiu/0000-0003-0566-073X; Edelman, Martin/0000-0002-3752-0726; Clapp, Jonathan/0000-0002-8058-5808; fishman, elliot/0000-0002-2567-1658; Donnelly, Edwin/0000-0003-0740-3075	National Cancer Institute; National Lung Screening [NCT00047385]; Division of Cancer Treatment and Diagnosis [U01-CA-80098, U01-CA-79778]; Early Detection Research Group and Biometry Research Group, Division of Cancer Prevention: University of Colorado Denver [N01-CN-25514]; Georgetown University [N01-CN-25522]; Pacific Health Research and Education Institute [N01-CN-25515]; Henry Ford Health System [N01-CN-25512]; University of Minnesota [N01-CN-25513]; Washington University in St. Louis [N01-CN-25516]; University of Pittsburgh [N01-CN-25511]; University of Utah [N01-CN-25524]; Marshfield Clinic Research Foundation [N01-CN-25518]; University of Alabama at Birmingham [N01-CN-75022]; Westat [N01-CN-25476]; Information Management Services [N02-CN-63300]; Wilex; MELA Sciences; Endocyte; Bayer HealthCare; Radiological Society of North America; MRC [G0902006] Funding Source: UKRI; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN025516, N01CN025515, N01CN025512, N01CN025522, N01CN075022, N01CN025476, N01CN025511, N01CN025518, N01CN025513, N01CN025514, N01CN025524] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [N01CA025512, U10CA079778, N01CA025513, N01CA025514, N01CA025515, U10CA080098, N01CA025518, N01CA025524, N01CA025516, N01CA025511, N01CA025522, U01CA079778, N01CA075022, U01CA080098] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176] Funding Source: NIH RePORTER	National Cancer Institute; National Lung Screening(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Cancer Treatment and Diagnosis(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Treatment & Diagnosis); Early Detection Research Group and Biometry Research Group, Division of Cancer Prevention: University of Colorado Denver; Georgetown University; Pacific Health Research and Education Institute; Henry Ford Health System; University of Minnesota(University of Minnesota System); Washington University in St. Louis; University of Pittsburgh(University of Pittsburgh); University of Utah; Marshfield Clinic Research Foundation; University of Alabama at Birmingham; Westat; Information Management Services; Wilex; MELA Sciences; Endocyte(Novartis); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Radiological Society of North America; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funded by the National Cancer Institute; National Lung Screening Trial ClinicalTrials.gov number, NCT00047385.; The American College of Radiology Imaging Network component of the National Lung Screening Trial (NLST) was funded through grants (U01-CA-80098 and U01-CA-79778) under a cooperative agreement with the Cancer Imaging Program, Division of Cancer Treatment and Diagnosis. The Lung Screening Study sites of the NLST were funded through contracts with the Early Detection Research Group and Biometry Research Group, Division of Cancer Prevention: University of Colorado Denver (N01-CN-25514), Georgetown University (N01-CN-25522), Pacific Health Research and Education Institute (N01-CN-25515), Henry Ford Health System (N01-CN-25512), University of Minnesota (N01-CN-25513), Washington University in St. Louis (N01-CN-25516), University of Pittsburgh (N01-CN-25511), University of Utah (N01-CN-25524), Marshfield Clinic Research Foundation (N01-CN-25518), University of Alabama at Birmingham (N01-CN-75022), Westat (N01-CN-25476), and Information Management Services (N02-CN-63300).; Mr. Clapp reports holding a financial interest in Human Genome Sciences; and Dr. Gatsonis, receiving consulting fees from Wilex, MELA Sciences, and Endocyte, lecture fees from Bayer HealthCare, and support from the Radiological Society of North America for developing educational presentations. No other potential conflict of interest relevant to this article was reported.	Aberle DR, 2010, JNCI-J NATL CANCER I, V102, P1771, DOI 10.1093/jnci/djq434; [Anonymous], 2010, STATEMENT NATL LUNG; [Anonymous], CANC LUNG BRONCHUS I; [Anonymous], 2004, SAS STAT VERS 9 2; Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; Baldwin DR, 2011, THORAX, V66, P308, DOI 10.1136/thx.2010.152066; Becker N, 2008, ONKOLOGIE, V31, pPO320; Cagnon CH, 2006, ACAD RADIOL, V13, P1431, DOI 10.1016/j.acra.2006.08.015; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1227; Church TR, 2003, ACAD RADIOL, V10, P713, DOI 10.1016/S1076-6332(03)80095-8; de Gonzalez AB, 2008, J MED SCREEN, V15, P153, DOI 10.1258/jms.2008.008052; Department of Commerce Census Bureau, 2003, NAT CANC I CDCP COSP; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Doria-Rose VP, 2011, CURR MULTIDISC ONCOL, P53; Fritz APC., 2013, INT CLASSIFICATION D; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Gierada DS, 2009, AM J ROENTGENOL, V193, P419, DOI 10.2214/AJR.08.1995; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Infante M, 2009, AM J RESP CRIT CARE, V180, P445, DOI 10.1164/rccm.200901-0076OC; Izmirlian G, 2011, ESTIMATION RELATIVE; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jennison C, 2000, GROUP SEQUENTIAL MET; Mahesh Mahadevappa, 2009, J Am Coll Radiol, V6, P201, DOI 10.1016/j.jacr.2008.11.027; Marchiano A, 2009, RADIOLOGY, V251, P919, DOI 10.1148/radiol.2513081313; NAIDICH DP, 1990, RADIOLOGY, V175, P729, DOI 10.1148/radiology.175.3.2343122; NCI NLST press conference, 2010, NCI RADIO BROAD 1104; Pedersen JH, 2009, J THORAC ONCOL, V4, P608, DOI 10.1097/JTO.0b013e3181a0d98f; Pegna AL, 2009, LUNG CANCER, V64, P34, DOI 10.1016/j.lungcan.2008.07.003; Pierce JP, 2011, JAMA-J AM MED ASSOC, V305, P1106, DOI 10.1001/jama.2011.334; Pinsky PF, 2007, AM J EPIDEMIOL, V165, P874, DOI 10.1093/aje/kwk075; R Core Team, 2020, R LANG ENV STAT COMP; Sanders HR, 2010, CANCER GENET CYTOGEN, V203, P7, DOI 10.1016/j.cancergencyto.2010.07.134; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099	37	6231	6444	36	529	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2011	365	5					395	409		10.1056/NEJMoa1102873	http://dx.doi.org/10.1056/NEJMoa1102873			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801NW	21714641	Bronze, Green Accepted			2022-12-28	WOS:000293447800004
J	Drake, MJ				Drake, Marcus J.			Managing post-prostatectomy stress urinary incontinence	LANCET			English	Editorial Material									[Drake, Marcus J.] Univ Bristol, Fac Med & Dent, Bristol, Avon, England; [Drake, Marcus J.] Southmead Hosp, Bristol Urol Inst, Bristol BS10 5NB, Avon, England	University of Bristol; Southmead Hospital	Drake, MJ (corresponding author), Univ Bristol, Fac Med & Dent, Bristol, Avon, England.	marcus.drake@bui.ac.uk	Drake, Marcus/C-4542-2014	Drake, Marcus/0000-0002-6230-2552				Abrams P, 2010, NEUROUROL URODYNAM, V29, P213, DOI 10.1002/nau.20870; Glazener C, 2011, LANCET, V378, P328, DOI 10.1016/S0140-6736(11)60751-4; Hay-Smith EJC, 2010, COCHRANE DB SYST REV, V1; Jones R, 2010, NEUROUROL URODYNAM, V29, P40, DOI 10.1002/nau.20851; Liss MA, 2010, J UROLOGY, V183, P1464, DOI 10.1016/j.juro.2009.12.009	5	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 23	2011	378	9788					293	294		10.1016/S0140-6736(11)61034-9	http://dx.doi.org/10.1016/S0140-6736(11)61034-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XL	21741698				2022-12-28	WOS:000293615800005
J	Sarraf, KM				Sarraf, Khaled M.			Radiographic Zebra Lines from Cyclical Pamidronate Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hillingdon Hosp NHS Trust, London, England	Brunel University; Imperial College London	Sarraf, KM (corresponding author), Hillingdon Hosp NHS Trust, London, England.								0	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2011	365	3					E5	E5		10.1056/NEJMicm1014009	http://dx.doi.org/10.1056/NEJMicm1014009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794QI	21774705				2022-12-28	WOS:000292915500010
J	Mayer, KH				Mayer, Kenneth H.			Antiretrovirals for HIV prevention: translating promise into praxis	LANCET			English	Editorial Material									Harvard Univ, Sch Med, Beth Israel Deaconess Hosp, Fenway Hlth, Boston, MA 02115 USA	Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Mayer, KH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Hosp, Fenway Hlth, Boston, MA 02115 USA.	kmayer@fenwayhealth.org						[Anonymous], 18 C RETR OPP INF BO; Family Health International, FHI STAT FEM PREP HI; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; NIH News U. S. Department of Health and Human Services National Institutes of Health, NIH NEWS; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Patterson K. P. H., 2010, 18 INT AIDS C VIENN, P18; UNAIDS, 2010, UNAIDS REP GLOB AIDS; WALENSKY R, 2011, 18 C RETR OPP INF BO	10	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 16	2011	378	9787					206	208		10.1016/S0140-6736(11)61056-8	http://dx.doi.org/10.1016/S0140-6736(11)61056-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798JD	21763922				2022-12-28	WOS:000293201100007
J	Shetty, P				Shetty, Priya			Kamiar and Arash Alaei: championing HIV/AIDS initiatives in Iran	LANCET			English	Editorial Material																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 16	2011	378	9787					219	219		10.1016/S0140-6736(11)61113-6	http://dx.doi.org/10.1016/S0140-6736(11)61113-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798JD	21763927				2022-12-28	WOS:000293201100015
J	Kuhlmann, JB; Blum, HE; Kreisel, W; Fischer, R				Kuhlmann, Jan B.; Blum, Hubert E.; Kreisel, Wolfgang; Fischer, Richard			CASE REPORT A severe case of odynophagia	BRITISH MEDICAL JOURNAL			English	Editorial Material							ESOPHAGEAL CROHNS-DISEASE		[Kuhlmann, Jan B.; Blum, Hubert E.; Kreisel, Wolfgang; Fischer, Richard] Univ Hosp Freiburg, D-79106 Freiburg, Germany	University of Freiburg	Kuhlmann, JB (corresponding author), Univ Hosp Freiburg, Hugstetter Str 55, D-79106 Freiburg, Germany.	jan.kuhlmann@uniklinik-freiburg.de						BECK PL, 1995, DIGEST DIS SCI, V40, P837, DOI 10.1007/BF02064988; Decker GAG, 2001, INFLAMM BOWEL DIS, V7, P113, DOI 10.1097/00054725-200105000-00006; ENG J, 1991, DIGEST DIS SCI, V36, P536, DOI 10.1007/BF01298890; GEBOES K, 1986, J CLIN GASTROENTEROL, V8, P31, DOI 10.1097/00004836-198602000-00007; GHARHREMANI GG, 1982, GASTROINTEST RADIOL, V7, P199; Gheorghe C, 1998, HEPATO-GASTROENTEROL, V45, P738; HOWDEN FM, 1994, AM SURGEON, V60, P656; Naranjo-Rodriguez A, 2003, EUR J GASTROEN HEPAT, V15, P1123, DOI 10.1097/00042737-200310000-00010; PRZEMIOSLO RT, 1994, DIGEST DIS SCI, V39, P1594, DOI 10.1007/BF02088073; Reynolds HL, 2001, SURG CLIN N AM, V81, P117, DOI 10.1016/S0039-6109(05)70276-0; RUUSKA T, 1994, J PEDIATR GASTR NUTR, V19, P181, DOI 10.1097/00005176-199408000-00007; TASKIN V, 1995, AM J GASTROENTEROL, V90, P1000; Wagtmans MJ, 1997, AM J GASTROENTEROL, V92, P1467; Zografos GN, 2009, DIS ESOPHAGUS, V22, P633, DOI 10.1111/j.1442-2050.2009.00972.x	14	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 13	2011	343								d3137	10.1136/bmj.d3137	http://dx.doi.org/10.1136/bmj.d3137			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794OE	21752845				2022-12-28	WOS:000292908900001
J	Wainwright, CE; Vidmar, S; Armstrong, DS; Byrnes, CA; Carlin, JB; Cheney, J; Cooper, PJ; Grimwood, K; Moodie, M; Robertson, CF; Tiddens, HA				Wainwright, Claire E.; Vidmar, Suzanna; Armstrong, David S.; Byrnes, Catherine A.; Carlin, John B.; Cheney, Joyce; Cooper, Peter J.; Grimwood, Keith; Moodie, Marj; Robertson, Colin F.; Tiddens, Harm A.		ACFBAL Study Investigators	Effect of Bronchoalveolar Lavage-Directed Therapy on Pseudomonas aeruginosa Infection and Structural Lung Injury in Children With Cystic Fibrosis A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESOLUTION COMPUTED-TOMOGRAPHY; OROPHARYNGEAL CULTURES; AIRWAY INFLAMMATION; YOUNG-CHILDREN; DORNASE-ALPHA; NEW-ZEALAND; INFANTS; DISEASE; PREVALENCE; MANAGEMENT	Context Early pulmonary infection in children with cystic fibrosis leads to increased morbidity and mortality. Despite wide use of oropharyngeal cultures to identify pulmonary infection, concerns remain over their diagnostic accuracy. While bronchoalveolar lavage (BAL) is an alternative diagnostic tool, evidence for its clinical benefit is lacking. Objective To determine if BAL-directed therapy for pulmonary exacerbations during the first 5 years of life provides better outcomes than current standard practice relying on clinical features and oropharyngeal cultures. Design, Setting, and Participants The Australasian Cystic Fibrosis Bronchoalveolar Lavage (ACFBAL) randomized controlled trial, recruiting infants diagnosed with cystic fibrosis through newborn screening programs in 8 Australasian cystic fibrosis centers. Recruitment occurred between June 1, 1999, and April 30, 2005, with the study ending on December 31, 2009. Interventions BAL-directed (n=84) or standard (n=86) therapy until age 5 years. The BAL-directed therapy group underwent BAL before age 6 months when well, when hospitalized for pulmonary exacerbations, if Pseudomonas aeruginosa was detected in oropharyngeal specimens, and after P aeruginosa eradication therapy. Treatment was prescribed according to BAL or oropharyngeal culture results. Main Outcome Measures Primary outcomes at age 5 years were prevalence of P aeruginosa on BAL cultures and total cystic fibrosis computed tomography (CF-CT) score (as a percentage of the maximum score) on high-resolution chest CT scan. Results Of 267 infants diagnosed with cystic fibrosis following newborn screening, 170 were enrolled and randomized, and 157 completed the study. At age 5 years, 8 of 79 children (10%) in the BAL-directed therapy group and 9 of 76 (12%) in the standard therapy group had P aeruginosa in final BAL cultures (risk difference, -1.7% [95% confidence interval, -11.6% to 8.1%]; P=.73). Mean total CF-CT scores for the BAL-directed therapy and standard therapy groups were 3.0% and 2.8%, respectively (mean difference, 0.19% [95% confidence interval, -0.94% to 1.33%]; P=.74). Conclusion Among infants diagnosed with cystic fibrosis, BAL-directed therapy did not result in a lower prevalence of P aeruginosa infection or lower total CF-CT score when compared with standard therapy at age 5 years.	[Wainwright, Claire E.; Cheney, Joyce] Univ Queensland, Royal Childrens Hosp, Queensland Childrens Resp Ctr, Brisbane, Qld 4029, Australia; [Wainwright, Claire E.; Cheney, Joyce; Grimwood, Keith] Univ Queensland, Royal Childrens Hosp, Queensland Childrens Med Res Inst, Brisbane, Qld 4029, Australia; [Grimwood, Keith] Univ Queensland, Royal Childrens Hosp, Dept Infect Dis, Brisbane, Qld 4029, Australia; [Vidmar, Suzanna; Carlin, John B.] Murdoch Childrens Res Inst, Clin Epidemiol & Biostat Unit, Melbourne, Vic, Australia; [Vidmar, Suzanna; Carlin, John B.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Armstrong, David S.] Monash Univ, Dept Paediat, Melbourne, Vic 3004, Australia; [Byrnes, Catherine A.] Univ Auckland, Dept Paediat, Auckland, New Zealand; [Byrnes, Catherine A.] Starship Childrens Hlth, Paediat Resp Med, Auckland, New Zealand; [Cooper, Peter J.] Childrens Hosp Westmead, Sydney, NSW, Australia; [Moodie, Marj] Deakin Univ, Deakin Hlth Econ, Populat Hlth Strateg Res Ctr, Melbourne, Vic, Australia; [Tiddens, Harm A.] Sophia Childrens Univ Hosp, Dept Pediat Pulmonol, Rotterdam, Netherlands; [Tiddens, Harm A.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands	Royal Children's Hospital Brisbane; University of Queensland; Royal Children's Hospital Brisbane; University of Queensland; Royal Children's Hospital Brisbane; University of Queensland; Murdoch Children's Research Institute; University of Melbourne; Monash University; University of Auckland; Starship Children's Hospital; University of Sydney; Deakin University; Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC	Wainwright, CE (corresponding author), Univ Queensland, Royal Childrens Hosp, Queensland Childrens Resp Ctr, Royal Childrens Hosp Herston Rd, Brisbane, Qld 4029, Australia.	claire_wainwright@health.qld.gov.au	Grimwood, Keith/F-9334-2011; Carlin, John/AAG-4332-2020; Wainwright, Claire E/G-4218-2013; Carlin, John B/B-3492-2012	Carlin, John/0000-0002-2694-9463; Wainwright, Claire E/0000-0001-8389-3809; Carlin, John B/0000-0002-2694-9463; Byrnes, Catherine/0000-0002-3032-3172; Grimwood, Keith/0000-0003-3174-9834; Moodie, Marjory/0000-0001-6890-5250	North American Cystic Fibrosis Foundation; European Cystic Fibrosis Society; Novartis; UK CF Trust; University of Miami; GlaxoSmithKline; Boehringer-Ingelheim; Vertex Pharmaceuticals Inc; Insmed Inc; Novartis Pharma; New Zealand Health Research Council; University of Auckland; Royal Children's Hospital Queensland; Inspire Pharmaceuticals Inc; Gilead Sciences Inc; National Health and Medical Research Council [9937868, 351541]; Roche; Royal Children's Hospital Foundation, Australia; Royal Children's Hospital Foundation; Pathogenesis Corporation; Chiron Corporation	North American Cystic Fibrosis Foundation; European Cystic Fibrosis Society; Novartis(Novartis); UK CF Trust; University of Miami; GlaxoSmithKline(GlaxoSmithKline); Boehringer-Ingelheim(Boehringer Ingelheim); Vertex Pharmaceuticals Inc(Vertex Pharmaceuticals); Insmed Inc; Novartis Pharma; New Zealand Health Research Council(Health Research Council of New Zealand); University of Auckland; Royal Children's Hospital Queensland; Inspire Pharmaceuticals Inc; Gilead Sciences Inc(Gilead Sciences); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Roche(Roche Holding); Royal Children's Hospital Foundation, Australia; Royal Children's Hospital Foundation; Pathogenesis Corporation; Chiron Corporation	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Wainwright reported receiving travel grants from North American Cystic Fibrosis Foundation and from the European Cystic Fibrosis Society, funding from Novartis to cover an extra night at European CF Conference 2010, travel and accommodation expenses from the UK CF Trust, and travel and accommodation expenses from the University of Miami; serving as a board member for Novartis Pharma; serving as a consultant for Vertex Pharmaceuticals Inc, Gilead Sciences Inc, and Inspire Pharmaceuticals Inc; receiving grants or grants pending from GlaxoSmithKline, Boehringer-Ingelheim, Vertex Pharmaceuticals Inc, and Insmed Inc; and receiving payment for lectures (including speakers bureau) from Novartis Pharma. Dr Byrnes reported receiving grant support from the New Zealand Health Research Council and the Faculty Research Development Fund (University of Auckland); and receiving travel support from the National Health and Medical Research Council (Australia). Dr Carlin reported receiving review activities fees from the Royal Children's Hospital Queensland. Dr Cooper reported serving as a board member for Pharmaxis Pty Ltd; and receiving grants or grants pending from Vertex Pharmaceuticals Inc, Inspire Pharmaceuticals Inc, and Gilead Sciences Inc. Dr Robertson reported serving as a consultant on advisory boards for Glaxo Seretide and Singulair; and receiving grants or grants pending from the National Health and Medical Research Council. Dr Tiddens reported serving as a consultant for Gilead Sciences Inc, Vertex Pharmaceuticals Inc, and Inspire Pharmaceuticals Inc; receiving grants or grants pending from Gilead Sciences Inc; and receiving payment for lectures from Roche. No other authors reported disclosures.; This study was supported by the National Health and Medical Research Council (grants 9937868 and 351541) and the Royal Children's Hospital Foundation, Australia. The tobramycin inhalation solution and delivery system used throughout the study was supplied by Pathogenesis Corporation, Chiron Corporation, and Novartis Pharmaceuticals Inc.; The National Health and Medical Research Council, the Royal Children's Hospital Foundation, Pathogenesis Corporation, Chiron Corporation, and Novartis Pharmaceuticals Inc had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Armstrong DS, 2005, PEDIATR PULM, V40, P500, DOI 10.1002/ppul.20294; Armstrong DS, 2002, AM J RESP CRIT CARE, V166, P983, DOI 10.1164/rccm.200204-269OC; Armstrong DS, 1996, PEDIATR PULM, V21, P267, DOI 10.1002/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.0.CO;2-K; Bell SC, 2008, CYSTIC FIBROSIS STAN; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brody AS, 2004, J PEDIATR-US, V145, P32, DOI 10.1016/j.jpeds.2004.02.038; Brody AS, 2005, AM J RESP CRIT CARE, V172, P1246, DOI 10.1164/rccm.200503-401PP; Crowley S, 2010, PEDIATR PULM, V45, P717, DOI 10.1002/ppul.21211; Cystic Fibrosis Foundation, 2009, PAT REG ANN DAT REP; de Jong PA, 2004, EUR RESPIR J, V23, P93, DOI 10.1183/09031936.03.00006603; Fortier MA, 2010, PEDIATR ANESTH, V20, P318, DOI 10.1111/j.1460-9592.2010.03263.x; Gaillard EA, 2003, EUR J RADIOL, V47, P215, DOI 10.1016/S0720-048X(02)00122-5; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Grimwood K, 2009, J CYST FIBROS, V8, P291, DOI 10.1016/j.jcf.2009.04.002; Hilliard TN, 2007, ARCH DIS CHILD, V92, P898, DOI 10.1136/adc.2006.105825; Lebecque P, 2006, J CYST FIBROS, V5, P237, DOI 10.1016/j.jcf.2006.04.001; Lee TG, 2009, EVID-BASED COMPL ALT, V6, P99, DOI 10.1093/ecam/nep054; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Lee TWR, 2004, PEDIATR PULM, V37, P104, DOI 10.1002/ppul.10401; Li ZH, 2005, JAMA-J AM MED ASSOC, V293, P581, DOI 10.1001/jama.293.5.581; Lillquist YP, 2011, J CYST FIBROS, V10, P175, DOI 10.1016/j.jcf.2011.01.002; Linnane B, 2008, PAEDIATR RESPIR REV, V9, P168, DOI 10.1016/j.prrv.2008.05.009; Loeve M, 2011, CHEST, V140, P178, DOI 10.1378/chest.10-1152; Nixon GM, 2001, J PEDIATR-US, V138, P699, DOI 10.1067/mpd.2001.112897; Paul K, 2004, AM J RESP CRIT CARE, V169, P719, DOI 10.1164/rccm.200307-959OC; Ratjen F, 2010, THORAX, V65, P286, DOI 10.1136/thx.2009.121657; Robinson TE, 2005, CHEST, V128, P2327, DOI 10.1378/chest.128.4.2327; Rosenfeld M, 1999, PEDIATR PULM, V28, P321, DOI 10.1002/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V; Schmid J, 2008, EUR RESPIR J, V32, P1583, DOI 10.1183/09031936.00099508; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; Sly PD, 2009, AM J RESP CRIT CARE, V180, P146, DOI 10.1164/rccm.200901-0069OC; Southern K W, 2004, Chron Respir Dis, V1, P205, DOI 10.1191/1479972304cd044rs; Stick SM, 2009, J PEDIATR-US, V155, P623, DOI 10.1016/j.jpeds.2009.05.005; Tiddens HAWM, 2006, CURR OPIN PULM MED, V12, P433, DOI 10.1097/01.mcp.0000245717.82009.ca; Tiddens HAWM, 2010, PEDIATR PULM, V45, P107, DOI 10.1002/ppul.21154; Tiddens HAWM, 2002, PEDIATR PULM, V34, P228, DOI 10.1002/ppul.10134; Treggiari MM, 2007, PEDIATR PULM, V42, P751, DOI 10.1002/ppul.20665; Wainwright CE, 2008, PEDIATR PULM, V43, P965, DOI 10.1002/ppul.20885; Wesley AW, 1996, NEW ZEAL MED J, V109, P140	40	154	156	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					163	171		10.1001/jama.2011.954	http://dx.doi.org/10.1001/jama.2011.954			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791CO	21750293				2022-12-28	WOS:000292639400023
J	Staples, MP; Kallmes, DF; Comstock, BA; Jarvik, JG; Osborne, RH; Heagerty, PJ; Buchbinder, R				Staples, Margaret P.; Kallmes, David F.; Comstock, Bryan A.; Jarvik, Jeffrey G.; Osborne, Richard H.; Heagerty, Patrick J.; Buchbinder, Rachelle			Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To determine whether vertebroplasty is more effective than placebo for patients with pain of recent onset (<= 6 weeks) or severe pain (score >= 8 on 0-10 numerical rating scale). Design Meta-analysis of combined individual patient level data. Setting Two multicentred randomised controlled trials of vertebroplasty; one based in Australia, the other in the United States. Participants 209 participants (Australian trial n=78, US trial n=131) with at least one radiographically confirmed vertebral compression fracture. 57 (27%) participants had pain of recent onset (vertebroplasty n=25, placebo n=32) and 99 (47%) had severe pain at baseline (vertebroplasty n=50, placebo n=49). Intervention Percutaneous vertebroplasty versus a placebo procedure. Main outcome measure Scores for pain (0-10 scale) and function (modified, 23 item Roland-Morris disability questionnaire) at one month. Results For participants with pain of recent onset, between group differences in mean change scores at one month for pain and disability were 0.1 (95% confidence interval -1.4 to 1.6) and 0.2 (-3.0 to 3.4), respectively. For participants with severe pain at baseline, between group differences for pain and disability scores at one month were 0.3 (-0.8 to 1.5) and 1.4 (-1.2 to 3.9), respectively. At one month those in the vertebroplasty group were more likely to be using opioids. Conclusions Individual patient data meta-analysis from two blinded trials of vertebroplasty, powered for subgroup analyses, failed to show an advantage of vertebroplasty over placebo for participants with recent onset fracture or severe pain. These results do not support the hypothesis that selected subgroups would benefit from vertebroplasty.	[Staples, Margaret P.; Buchbinder, Rachelle] Monash Univ, Cabrini Hosp, Dept Clin Epidemiol, Clayton, Vic 3800, Australia; [Staples, Margaret P.; Buchbinder, Rachelle] Monash Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med, Clayton, Vic 3800, Australia; [Kallmes, David F.] Mayo Clin, Coll Med, Dept Radiol, Rochester, MN USA; [Comstock, Bryan A.] Univ Washington, Ctr Biomed Stat, Dept Radiol, Seattle, WA 98195 USA; [Jarvik, Jeffrey G.] Univ Washington, Comparat Effectiveness Cost & Outcomes Res Ctr, Radiol & Neurol Surg, Seattle, WA 98195 USA; [Jarvik, Jeffrey G.] Univ Washington, Comparat Effectiveness Cost & Outcomes Res Ctr, Seattle, WA 98195 USA; [Osborne, Richard H.] Deakin Univ, Sch Hlth & Social Dev, Publ Hlth Innovat, Publ Hlth, Geelong, Vic 3217, Australia; [Osborne, Richard H.] Deakin Univ, Sch Hlth & Social Dev, Publ Hlth Innovat, Geelong, Vic 3217, Australia; [Heagerty, Patrick J.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Cabrini Health; Monash University; Monash University; Mayo Clinic; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Deakin University; Deakin University; University of Washington; University of Washington Seattle	Buchbinder, R (corresponding author), Cabrini Med Ctr, Suite 41,183 Wattletree Rd, Malvern, Vic 3144, Australia.	rachelle.buchbinder@monash.edu	Buchbinder, Rachelle/G-2952-2011; Osborne, Richard H/A-9447-2010; Jarvik, Jeffrey/AAL-4292-2021	Buchbinder, Rachelle/0000-0002-0597-0933; Osborne, Richard H/0000-0002-9081-2699; 	Australian National Health and Medical Research Council (NHMRC) population health career development award; NHMRC practitioner fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC) population health career development award(National Health and Medical Research Council (NHMRC) of Australia); NHMRC practitioner fellowship(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	RHO is supported in part by an Australian National Health and Medical Research Council (NHMRC) population health career development award and RB is supported in part by an NHMRC practitioner fellowship.	Baerlocher MO, 2010, RADIOLOGY, V255, P669, DOI 10.1148/radiol.10092107; Baerlocher MO, 2009, NEW ENGL J MED, V361, P2098; Baerlocher MO, 2009, J VASC INTERV RADIOL, V20, P1277, DOI 10.1016/j.jvir.2009.08.017; Bono CM, 2010, SPINE J, V10, P238, DOI 10.1016/j.spinee.2009.09.007; Brinjikji W, 2010, AM J NEURORADIOL, V31, P1631, DOI 10.3174/ajnr.A2145; Buchbinder R, 2010, SPINE J, V10, P241, DOI 10.1016/j.spinee.2010.01.001; Buchbinder R, 2010, MED J AUSTRALIA, V192, P338, DOI 10.5694/j.1326-5377.2010.tb03534.x; Buchbinder R, 2009, MED J AUSTRALIA, V191, P476, DOI 10.5694/j.1326-5377.2009.tb02906.x; Buchbinder R, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-156; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Carragee EJ, 2010, SPINE J, V10, P191, DOI 10.1016/j.spinee.2010.01.002; Clark W, 2009, NEW ENGL J MED, V361, P2097, DOI 10.1056/NEJMc096289; Clark WA, 2010, MED J AUSTRALIA, V192, P334, DOI 10.5694/j.1326-5377.2010.tb03533.x; Gangi A, 2010, CARDIOVASC INTER RAD, V33, P677, DOI 10.1007/s00270-010-9901-3; Gray LA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-126; Grotle M, 2004, SPINE, V29, pE492, DOI 10.1097/01.brs.0000143664.02702.0b; HUSKISSON EC, 1982, J RHEUMATOL, V9, P768; Kallmes D, 2009, AM J NEURORADIOL, V30, P1809, DOI 10.3174/ajnr.A1887; Kallmes DF, 2010, RADIOLOGY, V255, P675, DOI 10.1148/radiol.10100425; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Khosla A, 2010, RADIOLOGY, V257, P477, DOI 10.1148/radiol.10100237; Klazen CAH, 2010, LANCET, V376, P1085, DOI 10.1016/S0140-6736(10)60954-3; Koopman L, 2007, J CLIN EPIDEMIOL, V60, P1002, DOI 10.1016/j.jclinepi.2007.01.018; Munk PL, 2009, CAN ASSOC RADIOL J, V60, P170, DOI 10.1016/j.carj.2009.08.001; Psaty BM, 2010, JAMA-J AM MED ASSOC, V304, P793, DOI 10.1001/jama.2010.1161; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Stewart LA, 2002, EVAL HEALTH PROF, V25, P76, DOI 10.1177/0163278702025001006; Trout AT, 2005, AM J NEURORADIOL, V26, P2652; van Walraven C, 2010, J CLIN EPIDEMIOL, V63, P235, DOI 10.1016/j.jclinepi.2009.04.001; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	31	84	88	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 12	2011	343								d3952	10.1136/bmj.d3952	http://dx.doi.org/10.1136/bmj.d3952			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V41KU	21750078	Green Published, hybrid			2022-12-28	WOS:000209545900001
J	Kirby, T				Kirby, Tony			Profile Tien Yin Wong: tackling the rising burden of diabetic retinopathy	LANCET			English	Editorial Material												tony.kirby@lancet.com							0	0	0	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 9	2011	378	9786					118	118		10.1016/S0140-6736(11)61075-1	http://dx.doi.org/10.1016/S0140-6736(11)61075-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	795CJ	21742164	Bronze			2022-12-28	WOS:000292948800015
J	Gourdon, P; Liu, XY; Skjorringe, T; Morth, JP; Moller, LB; Pedersen, BP; Nissen, P				Gourdon, Pontus; Liu, Xiang-Yu; Skjorringe, Tina; Morth, J. Preben; Moller, Lisbeth Birk; Pedersen, Bjorn Panyella; Nissen, Poul			Crystal structure of a copper-transporting PIB-type ATPase	NATURE			English	Article							P-TYPE-ATPASE; MENKES DISEASE; METAL-BINDING; CANDIDATE GENE; ACTUATOR DOMAIN; PUMP; CU+; MECHANISM; SODIUM; ORGANIZATION	Heavy-metal homeostasis and detoxification is crucial for cell viability. P-type ATPases of the class IB (PIB) are essential in these processes, actively extruding heavy metals from the cytoplasm of cells. Here we present the structure of a PIB-ATPase, a Legionella pneumophila CopA Cu+-ATPase, in a copper-free form, as determined by X-ray crystallography at 3.2 angstrom resolution. The structure indicates a three-stage copper transport pathway involving several conserved residues. A PIB-specific transmembrane helix kinks at a double-glycine motif displaying an amphipathic helix that lines a putative copper entry point at the intracellular interface. Comparisons to Ca2+-ATPase suggest an ATPase-coupled copper release mechanism from the binding sites in the membrane via an extracellular exit site. The structure also provides a framework to analyse missense mutations in the human ATP7A and ATP7B proteins associated with Menkes' and Wilson's diseases.	[Skjorringe, Tina; Moller, Lisbeth Birk] Kennedy Ctr, Ctr Appl Human Mol Genet, DK-2600 Glostrup, Denmark; [Gourdon, Pontus; Liu, Xiang-Yu; Morth, J. Preben; Pedersen, Bjorn Panyella; Nissen, Poul] Aarhus Univ, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Liu, Xiang-Yu] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Aarhus University; Danmarks Grundforskningsfond; Peking University	Moller, LB (corresponding author), Kennedy Ctr, Ctr Appl Human Mol Genet, GI Landevej 7, DK-2600 Glostrup, Denmark.	lbm@kennedy.dk; pn@mb.au.dk	Nissen, Poul/D-5774-2014; Pedersen, Bjørn/H-4128-2017; Gourdon, Pontus/HCI-8898-2022; Gourdon, Pontus/E-1076-2014; Pedersen, Bjørn/AAT-2409-2021; Morth, Jens Preben/AAP-7834-2021; Morth, Jens Preben/G-4450-2013	Pedersen, Bjørn/0000-0001-7860-7230; Gourdon, Pontus/0000-0002-8631-3539; Pedersen, Bjørn/0000-0001-7860-7230; Morth, Jens Preben/0000-0003-4077-0192; Morth, Jens Preben/0000-0003-4077-0192; Nissen, Poul/0000-0003-0948-6628; Moller, Lisbeth/0000-0002-9524-4301	Danish Natural Science Research Council; Swedish Research Council; China Scholarship Council; Carlsberg Foundation; European Research Council; Novo Nordisk Foundation	Danish Natural Science Research Council(Danish Natural Science Research Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); China Scholarship Council(China Scholarship Council); Carlsberg Foundation(Carlsberg Foundation); European Research Council(European Research Council (ERC)European Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	We thank A. Pauluhn, C. Schulze-Briese,T. Tomizaki and V. Olieric (SLS), T. Ursby, M. Thunnissen, J. Unge and D. Haase (MAXLAB), and U. Muller, M. Weiss and K. Paithankar (BESSY) for assistance with synchrotron data collection. Support was provided by the Danscatt program of the Danish Natural Science Research Council. We also thank C. Buchrieser for supplying the L. pneumophila Philadelphia genome; X. D. Su for discussions, A. M. Nielsen for technical assistance and J. L. Karlsen for support on crystallographic computing. We are thankful to T. Deva and K. Faxen for preliminary functional analysis of the protein. P.G. was supported by the Swedish Research Council, X.-Y.L. by the China Scholarship Council and J.P.M. and B.P.P. by the Carlsberg Foundation. P.N. was supported by an advanced research grant (Biomemos) of the European Research Council and at earlier stages by a Hallas-Moller stipend of the Novo Nordisk Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Arnesano F, 2001, BIOCHEMISTRY-US, V40, P1528, DOI 10.1021/bi0014711; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Banci L, 2001, J BIOL CHEM, V276, P8415, DOI 10.1074/jbc.M008389200; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Banci L, 2009, BIOCHEM J, V422, P37, DOI 10.1042/BJ20090422; Boal AK, 2009, J AM CHEM SOC, V131, P14196, DOI 10.1021/ja906363t; Cariani L, 2004, ANAL BIOCHEM, V324, P79, DOI 10.1016/j.ab.2003.09.008; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chintalapati S, 2008, J MOL BIOL, V378, P581, DOI 10.1016/j.jmb.2008.01.094; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forbes JR, 1999, J BIOL CHEM, V274, P12408, DOI 10.1074/jbc.274.18.12408; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Gonzalez-Guerrero M, 2009, J BIOL CHEM, V284, P20804, DOI 10.1074/jbc.M109.016329; Gordon E, 2008, PROTEIN EXPRES PURIF, V62, P1, DOI 10.1016/j.pep.2008.07.005; Gourdon P, 2011, CRYST GROWTH DES, V11, P2098, DOI 10.1021/cg101360d; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Hatori Y, 2007, J BIOL CHEM, V282, P25213, DOI 10.1074/jbc.M703520200; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; Jones CE, 2003, J STRUCT BIOL, V143, P209, DOI 10.1016/j.jsb.2003.08.008; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim EH, 2009, FEMS MICROBIOL LETT, V301, P164, DOI 10.1111/j.1574-6968.2009.01813.x; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Leonhardt K, 2009, J BIOL CHEM, V284, P7793, DOI 10.1074/jbc.M805145200; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Moller AB, 2008, MOL PHYLOGENET EVOL, V46, P619, DOI 10.1016/j.ympev.2007.10.023; Morin I, 2009, FEBS J, V276, P4483, DOI 10.1111/j.1742-4658.2009.07155.x; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Pedersen BP, 2010, ACTA CRYSTALLOGR D, V66, P309, DOI 10.1107/S0907444909053244; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; POST RL, 1972, J BIOL CHEM, V247, P6530; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P9949, DOI 10.1021/bi0610045; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SILVER S, 1989, TRENDS BIOCHEM SCI, V14, P76, DOI 10.1016/0968-0004(89)90048-0; Solioz M, 2010, J BIOL INORG CHEM, V15, P3, DOI 10.1007/s00775-009-0588-3; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; TOYOSHIMA C, 1993, NATURE, V362, P469, DOI 10.1038/362469a0; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Tsuda T, 2009, EMBO J, V28, P1782, DOI 10.1038/emboj.2009.143; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Wu CC, 2008, STRUCTURE, V16, P976, DOI 10.1016/j.str.2008.02.025; Zheng ZQ, 2010, J NEUROCHEM, V114, P1630, DOI 10.1111/j.1471-4159.2010.06888.x	63	235	241	3	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					59	U74		10.1038/nature10191	http://dx.doi.org/10.1038/nature10191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21716286				2022-12-28	WOS:000292461300044
J	Radecki, RP; Sittig, DF				Radecki, Ryan P.; Sittig, Dean F.			Application of Electronic Health Records to the Joint Commission's 2011 National Patient Safety Goals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Radecki, Ryan P.] E Carolina Univ, Brody Sch Med, Dept Emergency Med, Greenville, NC 27834 USA; [Sittig, Dean F.] Univ Texas Hlth Sci Ctr, Houston, TX USA	University of North Carolina; East Carolina University; University of Texas System; University of Texas Health Science Center Houston	Radecki, RP (corresponding author), E Carolina Univ, Brody Sch Med, Dept Emergency Med, 2100 Stantonsburg Rd, Greenville, NC 27834 USA.	radecki@gmail.com	Sittig, Dean F./D-2471-2009	Sittig, Dean F./0000-0001-5811-8915; Radecki, Ryan/0000-0001-8590-6618	NATIONAL LIBRARY OF MEDICINE [R01LM006942] Funding Source: NIH RePORTER; NLM NIH HHS [R01-LM006942] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Evans RS, 2008, J AM MED INFORM ASSN, V15, P506, DOI 10.1197/jamia.M2721; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; Henneman PL, 2010, ANN EMERG MED, V55, P503, DOI 10.1016/j.annemergmed.2009.11.017; Mills PD, 2010, JT COMM J QUAL PATIE, V36, P87, DOI 10.1016/S1553-7250(10)36015-6; Peredo R, 2010, EUR J CLIN MICROBIOL, V29, P1173, DOI 10.1007/s10096-010-0971-6; Romano MJ, 2011, ARCH INTERN MED, V171, P897, DOI 10.1001/archinternmed.2010.527; Singh Hardeep, 2010, J Patient Saf, V6, P121, DOI 10.1097/PTS.0b013e3181ddf652; The Joint Commission, 2011, JOINT COMM 2011 NAT	9	18	18	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					92	93		10.1001/jama.2011.937	http://dx.doi.org/10.1001/jama.2011.937			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	21730246				2022-12-28	WOS:000292378700027
J	Tobias, M				Tobias, Martin			Global control of diabetes: information for action	LANCET			English	Editorial Material							MORTALITY		Minist Hlth, Wellington 6011, New Zealand		Tobias, M (corresponding author), Minist Hlth, Wellington 6011, New Zealand.	martin_tobias@moh.govt.nz						[Anonymous], 2011, LANCET, V377, P527; Barr ELM., 2006, AUSDIAB 2005 AUSTR D; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Organization WH, 2016, GLOBAL STATUS REPORT; TOBIAS MI, 2007, DIABETES SURVEILLANC; Webber J., 2009, Obesity and diabetes, P1, DOI 10.1002/9780470741474.ch1; *WHO, 2011, GLOB AL RESP INFL; World Health Organization, 2011, US GLYC HAEM HBA1C D	12	26	26	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 2	2011	378	9785					3	4		10.1016/S0140-6736(11)60604-1	http://dx.doi.org/10.1016/S0140-6736(11)60604-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791IU	21705073				2022-12-28	WOS:000292659700004
J	Ryan, ET; Madoff, LC; Ferraro, MJ				Ryan, Edward T.; Madoff, Lawrence C.; Ferraro, Mary Jane			A Man with Diarrhea after a Trip to the Dominican Republic Vibrio cholerae, serogroup O1 (toxigenic), serotype Ogawa, biotype El Tor.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIBIOTIC-TREATMENT; TRAVELERS DIARRHEA		[Ryan, Edward T.] Massachusetts Gen Hosp, Dept Infect Dis, Boston, MA 02114 USA; [Ferraro, Mary Jane] Massachusetts Gen Hosp, Dept Pathol & Microbiol, Boston, MA 02114 USA; [Ryan, Edward T.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Ferraro, Mary Jane] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Madoff, Lawrence C.] Massachusetts Dept Publ Hlth, Boston, MA USA; [Madoff, Lawrence C.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Department of Public Health; University of Massachusetts System; University of Massachusetts Worcester	Ryan, ET (corresponding author), Massachusetts Gen Hosp, Dept Infect Dis, Boston, MA 02114 USA.			Carpenter, Stephen/0000-0001-9879-327X				Anh Dang Duc, 2011, PLoS Negl Trop Dis, V5, pe1006, DOI 10.1371/journal.pntd.0001006; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; Clinical and Laboratory Standards Institute, 2010, METH ANT DIL DISK SU; DOMINICANA R, 2011, PROMED MAIL     0125; Harris JB, 2010, LANCET, V376, P1961, DOI 10.1016/S0140-6736(10)62172-1; Hartley DM, 2006, PLOS MED, V3, P63, DOI 10.1371/journal.pmed.0030007; Hill DR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1746; MHALU FS, 1979, LANCET, V1, P345; Nelson EJ, 2011, NEW ENGL J MED, V364, P5, DOI 10.1056/NEJMp1013771; Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204; Norman FF, 2008, CLIN INFECT DIS, V46, P1060, DOI 10.1086/529380; Reyburn R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000952; Ryan ET, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001003; Safa A, 2008, EMERG INFECT DIS, V14, P987, DOI 10.3201/eid1406.080129; Saha D, 2006, NEW ENGL J MED, V354, P2452, DOI 10.1056/NEJMoa054493; WHO, 2011, HLTH SAF DRINK WAT B; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601	17	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2011	364	26					2536	2541		10.1056/NEJMcpc1100928	http://dx.doi.org/10.1056/NEJMcpc1100928			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	785AM	21714651				2022-12-28	WOS:000292199800011
J	Song, Z; Safran, DG; Landon, BE; He, YL; Ellis, RP; Mechanic, RE; Day, MP; Chernew, ME				Song, Zirui; Safran, Dana Gelb; Landon, Bruce E.; He, Yulei; Ellis, Randall P.; Mechanic, Robert E.; Day, Matthew P.; Chernew, Michael E.			Health Care Spending and Quality in Year 1 of the Alternative Quality Contract	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACCOUNTABLE CARE; RISK ADJUSTMENT; MEDICARE; ORGANIZATIONS; INNOVATION; MASSACHUSETTS; PAYMENT; MODELS; REFORM; WILL	Background In 2009, Blue Cross Blue Shield of Massachusetts (BCBS) implemented a global payment system called the Alternative Quality Contract (AQC). Provider groups in the AQC system assume accountability for spending, similar to accountable care organizations that bear financial risk. Moreover, groups are eligible to receive bonuses for quality. Methods Seven provider organizations began 5-year contracts as part of the AQC system in 2009. We analyzed 2006-2009 claims for 380,142 enrollees whose primary care physicians (PCPs) were in the AQC system (intervention group) and for 1,351,446 enrollees whose PCPs were not in the system (control group). We used a propensity-weighted difference-in-differences approach, adjusting for age, sex, health status, and secular trends to isolate the treatment effect of the AQC in comparisons of spending and quality between the intervention group and the control group. Results Average spending increased for enrollees in both the intervention and control groups in 2009, but the increase was smaller for enrollees in the intervention group $15.51 (1.9%) less per quarter (P = 0.007). Savings derived largely from shifts in outpatient care toward facilities with lower fees; from lower expenditures for procedures, imaging, and testing; and from a reduction in spending for enrollees with the highest expected spending. The AQC system was associated with an improvement in performance on measures of the quality of the management of chronic conditions in adults (P < 0.001) and of pediatric care (P = 0.001), but not of adult preventive care. All AQC groups met 2009 budget targets and earned surpluses. Total BCBS payments to AQC groups, including bonuses for quality, are likely to have exceeded the estimated savings in year 1. Conclusions The AQC system was associated with a modest slowing of spending growth and improved quality of care in 2009. Savings were achieved through changes in referral patterns rather than through changes in utilization. The long-term effect of the AQC system on spending growth depends on future budget targets and providers' ability to further improve efficiencies in practice. (Funded by the Commonwealth Fund and others.)	[Song, Zirui; Landon, Bruce E.; He, Yulei; Chernew, Michael E.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Safran, Dana Gelb; Day, Matthew P.] Blue Cross & Blue Shield Massachusetts, Boston, MA USA; [Ellis, Randall P.] Boston Univ, Dept Econ, Boston, MA 02215 USA; [Song, Zirui] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Mechanic, Robert E.] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA USA	Harvard University; Harvard Medical School; Boston University; National Bureau of Economic Research; Brandeis University	Song, Z (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	zirui_song@hms.harvard.edu		He, Yulei/0000-0002-8451-5452	Commonwealth Fund; National Institute on Aging [F30-AG039175]; National Bureau of Economic Research [T32-AG000186]; Charles H. Hood Foundation; NATIONAL INSTITUTE ON AGING [T32AG000186, F30AG039175, R13AG011570] Funding Source: NIH RePORTER	Commonwealth Fund; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Bureau of Economic Research; Charles H. Hood Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by a grant from the Commonwealth Fund (to Dr. Chernew). Mr. Song is supported by a predoctoral M.D./Ph.D. National Research Service Award (F30-AG039175) from the National Institute on Aging and a predoctoral Fellowship in Aging and Health Economics (T32-AG000186) from the National Bureau of Economic Research. The analysis of pediatric quality measures was funded by a grant from the Charles H. Hood Foundation (to Dr. Chernew).	Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; [Anonymous], 2010, HLTH AFFAIRS    0727; Bebinger M, 2009, HEALTH AFFAIR, V28, P1373, DOI 10.1377/hlthaff.28.5.1373; Bodenheimer T, 2009, NEW ENGL J MED, V360, P2693, DOI 10.1056/NEJMp0902909; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Casella G., 2002, STAT INFERENCE, V2nd; Centers for Medicare and Medicaid Services, 2009, BER TYP SERV; Chernew ME, 2011, HEALTH AFFAIR, V30, P51, DOI 10.1377/hlthaff.2010.0980; Chernew ME, 2010, NEW ENGL J MED, V362, P1166, DOI 10.1056/NEJMp1002873; Chernew ME, 2009, HEALTH AFFAIR, V28, P1253, DOI 10.1377/hlthaff.28.5.1253; CMS HHS, 2011, FED REGISTER, V76, P19528; Devers K, 2009, CAN ACCOUNTABLE CARE; Ellis RP, 2007, J HEALTH ECON, V26, P25, DOI 10.1016/j.jhealeco.2006.06.004; Engelberg Center for Health Care Reform, 2009, BEND CURV EFF STEPS; Fisher ES, 2007, HEALTH AFFAIR, V26, pW44, DOI 10.1377/hlthaff.26.1.w44; Fisher ES, 2010, JAMA-J AM MED ASSOC, V304, P1715, DOI 10.1001/jama.2010.1513; Goroll AH, 2007, J GEN INTERN MED, V22, P410, DOI 10.1007/s11606-006-0083-2; Guterman S, 2010, HEALTH AFFAIR, V29, P1188, DOI 10.1377/hlthaff.2010.0442; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Kilo CM, 2010, HEALTH AFFAIR, V29, P773, DOI 10.1377/hlthaff.2010.0012; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; McClellan M, 2010, HEALTH AFFAIR, V29, P982, DOI 10.1377/hlthaff.2010.0194; Mechanic R, 2010, NEW ENGL J MED, V362, P772, DOI 10.1056/NEJMp1001013; Medicare Payment Advisory Commission, 2009, REP C IMPR INC MED P; Merrell K, 2010, HEALTH AFFAIR, V29, P852, DOI 10.1377/hlthaff.2009.0995; Miller HD, 2009, HEALTH AFFAIR, V28, P1418, DOI 10.1377/hlthaff.28.5.1418; Orszag PR, 2007, NEW ENGL J MED, V357, P1793, DOI 10.1056/NEJMp078190; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Rittenhouse DR, 2009, JAMA-J AM MED ASSOC, V301, P2038, DOI 10.1001/jama.2009.691; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Shortell SM, 2010, HEALTH AFFAIR, V29, P1293, DOI 10.1377/hlthaff.2010.0453; Shortell SM, 2010, JAMA-J AM MED ASSOC, V303, P1747, DOI 10.1001/jama.2010.575; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934	34	142	142	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2011	365	10					909	918		10.1056/NEJMsa1101416	http://dx.doi.org/10.1056/NEJMsa1101416			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816JX	21751900	Green Accepted			2022-12-28	WOS:000294595600007
J	Ekiert, DC; Friesen, RHE; Bhabha, G; Kwaks, T; Jongeneelen, M; Yu, WL; Ophorst, C; Cox, F; Korse, HJWM; Brandenburg, B; Vogels, R; Brakenhoff, JPJ; Kompier, R; Koldijk, MH; Cornelissen, LAHM; Poon, LLM; Peiris, M; Koudstaal, W; Wilson, IA; Goudsmit, J				Ekiert, Damian C.; Friesen, Robert H. E.; Bhabha, Gira; Kwaks, Ted; Jongeneelen, Mandy; Yu, Wenli; Ophorst, Carla; Cox, Freek; Korse, Hans J. W. M.; Brandenburg, Boerries; Vogels, Ronald; Brakenhoff, Just P. J.; Kompier, Ronald; Koldijk, Martin H.; Cornelissen, Lisette A. H. M.; Poon, Leo L. M.; Peiris, Malik; Koudstaal, Wouter; Wilson, Ian A.; Goudsmit, Jaap			A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses	SCIENCE			English	Article							MONOCLONAL-ANTIBODIES; HEMAGGLUTININ; PH; RECOGNITION; PEPTIDE; H5N1; HA2	Current flu vaccines provide only limited coverage against seasonal strains of influenza viruses. The identification of V(H)1-69 antibodies that broadly neutralize almost all influenza A group 1 viruses constituted a breakthrough in the influenza field. Here, we report the isolation and characterization of a human monoclonal antibody CR8020 with broad neutralizing activity against most group 2 viruses, including H3N2 and H7N7, which cause severe human infection. The crystal structure of Fab CR8020 with the 1968 pandemic H3 hemagglutinin (HA) reveals a highly conserved epitope in the HA stalk distinct from the epitope recognized by the V(H)1-69 group 1 antibodies. Thus, a cocktail of two antibodies may be sufficient to neutralize most influenza A subtypes and, hence, enable development of a universal flu vaccine and broad-spectrum antibody therapies.	[Friesen, Robert H. E.; Kwaks, Ted; Jongeneelen, Mandy; Ophorst, Carla; Cox, Freek; Korse, Hans J. W. M.; Brandenburg, Boerries; Vogels, Ronald; Brakenhoff, Just P. J.; Kompier, Ronald; Koldijk, Martin H.; Koudstaal, Wouter; Goudsmit, Jaap] Crucell Holland BV, NL-2301 CA Leiden, Netherlands; [Ekiert, Damian C.; Bhabha, Gira; Yu, Wenli; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Cornelissen, Lisette A. H. M.] Wageningen Univ, Cent Vet Inst, NL-8221 RA Lelystad, Netherlands; [Poon, Leo L. M.; Peiris, Malik] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Emerging Infect Dis, Pokfulam, Hong Kong, Peoples R China; [Poon, Leo L. M.; Peiris, Malik] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Johnson & Johnson; Scripps Research Institute; Wageningen University & Research; University of Hong Kong; University of Hong Kong; Scripps Research Institute	Koudstaal, W (corresponding author), Crucell Holland BV, Archimedesweg 4-6, NL-2301 CA Leiden, Netherlands.	wouter.koudstaal@crucell.com; wilson@scripps.edu	Poon, Leo/AAP-6887-2020; Poon, Leo Lit Man/C-4382-2009; Peiris, Joseph Sriyal Malik/C-4380-2009	Poon, Leo Lit Man/0000-0002-9101-7953; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Kwaks, Ted/0000-0003-1608-9372; Brandenburg, Boerries/0000-0002-5025-3802; Ekiert, Damian/0000-0002-2570-0404	National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services, USA [HHSN272200900060C]; University Grants Committee, Hong Kong [AoE/M-12/06]; NIH [GM080209]; Skaggs Institute; DOE Office of Biological and Environmental Research; NIH, National Center for Research Resources; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080209] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University Grants Committee, Hong Kong; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute; DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Tien and D. Marciano of the Robotics Core at the Joint Center for Structural Genomics for automated crystal screening; T. Doukov and the staff of the SSRL BL9-2 for beamline support; X. Dai and R. Stanfield for excellent assistance with data collection, processing, and analyses; R. Lerner, J. Paulson, and D. Burton for valuable comments and insightful discussion; E. Geelen, D. Spek, and V. Klaren for excellent assistance and advice; K. Hegmans, A. Lourbakos, J. Meijer, and A. Apetri and their teams for producing the mAbs and Fabs; C. Y. H. Leung for providing the A/WF/Hong Kong/MPA892/06 virus; E. de Boer-Luijtze and technicians in the groups of P. van Rossum and S. Riemersma for assistance with the animal experiments; E. Brown from Ottawa University, Canada for the mouse-adapted A/Hong Kong/1/68 strain; and A. Dingemans for critical review of the manuscript. This project has been funded in part by the National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services, USA, under contract HHSN272200900060C; the Area of Excellence Scheme of the University Grants Committee, Hong Kong (grant AoE/M-12/06); a predoctoral fellowship from the Achievement Rewards for College Scientists Foundation (D. C. E.); grant GM080209 from the NIH Molecular Evolution Training Program (D. C. E.); and the Skaggs Institute (I. A. W.). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the U.S. Department of Energy (DOE), Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Lightsource (SSRL) Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by NIH, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences. This is publication 20951 from the Scripps Research Institute. Coordinates and structure factors have been deposited in the Protein Data Bank (PDB code 3SDY). Nucleotide sequences for the CR8020 variable regions have been deposited in GenBank (accession nos. JN093122, JN093123). A patent application relating to antibody CR8020 has been filed (International Publication Number WO2010/130636). Sharing of materials will be subject to standard material transfer agreements.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Belongia E., 2008, Morbidity and Mortality Weekly Report, V57, P393; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Chen GL, 2009, NAT MED, V15, P1251, DOI 10.1038/nm1109-1251; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; Fleury D, 2000, PROTEINS, V40, P572; Hashem AM, 2010, BIOCHEM BIOPH RES CO, V403, P247, DOI 10.1016/j.bbrc.2010.11.030; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Lorieau JL, 2010, P NATL ACAD SCI USA, V107, P11341, DOI 10.1073/pnas.1006142107; Lowen Anice C., 2007, Infectious Disorders - Drug Targets, V7, P318; RUSS G, 1987, ACTA VIROL, V31, P374; Salzberg S, 2008, NATURE, V454, P160, DOI 10.1038/454160a; Skehel JJ, 2002, VACCINE, V20, pS51, DOI 10.1016/S0264-410X(02)00131-7; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Stropkovska A, 2009, ACTA VIROL, V53, P15, DOI 10.4149/av_2009_01_15; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Vareckova E, 2003, ARCH VIROL, V148, P469, DOI 10.1007/s00705-002-0932-1; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Wang TT, 2009, NAT STRUCT MOL BIOL, V16, P233, DOI 10.1038/nsmb.1574; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Xu R, 2011, J VIROL, V85, P5172, DOI 10.1128/JVI.02430-10; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350	37	631	714	3	173	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2011	333	6044					843	850		10.1126/science.1204839	http://dx.doi.org/10.1126/science.1204839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21737702	Green Accepted			2022-12-28	WOS:000293785400032
J	Tachiwana, H; Kagawa, W; Shiga, T; Osakabe, A; Miya, Y; Saito, K; Hayashi-Takanaka, Y; Oda, T; Sato, M; Park, SY; Kimura, H; Kurumizaka, H				Tachiwana, Hiroaki; Kagawa, Wataru; Shiga, Tatsuya; Osakabe, Akihisa; Miya, Yuta; Saito, Kengo; Hayashi-Takanaka, Yoko; Oda, Takashi; Sato, Mamoru; Park, Sam-Yong; Kimura, Hiroshi; Kurumizaka, Hitoshi			Crystal structure of the human centromeric nucleosome containing CENP-A	NATURE			English	Article							HISTONE H3; PROTEIN; DNA; FEATURES; VARIANT; CSE4	In eukaryotes, accurate chromosome segregation during mitosis and meiosis is coordinated by kinetochores, which are unique chromosomal sites for microtubule attachment(1,2). Centromeres specify the kinetochore formation sites on individual chromosomes, and are epigenetically marked by the assembly of nucleosomes containing the centromere-specific histone H3 variant, CENP-A(3-12). Although the underlying mechanism is unclear, centromere inheritance is probably dictated by the architecture of the centromeric nucleosome. Here we report the crystal structure of the human centromeric nucleosome containing CENP-A and its cognate alpha-satellite DNA derivative (147 base pairs). In the human CENP-A nucleosome, the DNA is wrapped around the histone octamer, consisting of two each of histones H2A, H2B, H4 and CENP-A, in a left-handed orientation. However, unlike the canonical H3 nucleosome, only the central 121 base pairs of the DNA are visible. The thirteen base pairs from both ends of the DNA are invisible in the crystal structure, and the alpha N helix of CENP-A is shorter than that of H3, which is known to be important for the orientation of the DNA ends in the canonical H3 nucleosome(13). A structural comparison of the CENP-A and H3 nucleosomes revealed that CENP-A contains two extra amino acid residues (Arg 80 and Gly 81) in the loop 1 region, which is completely exposed to the solvent. Mutations of the CENP-A loop 1 residues reduced CENP-A retention at the centromeres in human cells. Therefore, the CENP-A loop 1 may function in stabilizing the centromeric chromatin containing CENP-A, possibly by providing a binding site for trans-acting factors. The structure provides the first atomic-resolution picture of the centromere-specific nucleosome.	[Tachiwana, Hiroaki; Kagawa, Wataru; Shiga, Tatsuya; Osakabe, Akihisa; Miya, Yuta; Saito, Kengo; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, Tokyo 1628480, Japan; [Hayashi-Takanaka, Yoko; Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Oda, Takashi; Sato, Mamoru] Yokohama City Univ, Grad Sch Nanobiosci, Dept Supramol Biol, Div Macromol Crystallog, Yokohama, Kanagawa 2300045, Japan; [Park, Sam-Yong] Yokohama City Univ, Grad Sch Nanobiosci, Dept Supramol Biol, Prot Design Lab, Yokohama, Kanagawa 2300045, Japan	Waseda University; Osaka University; Yokohama City University; Yokohama City University	Kurumizaka, H (corresponding author), Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	kurumizaka@waseda.jp	Kimura, Hiroshi/B-9524-2015; Tachiwana, Hiroaki/AHB-3091-2022; Hayashi, Yoko/GPT-4159-2022	Kimura, Hiroshi/0000-0003-0854-083X; Tachiwana, Hiroaki/0000-0001-9227-7653; SAITO, Kengo/0000-0002-8714-6285; Osakabe, Akihisa/0000-0002-2526-3398; Kurumizaka, Hitoshi/0000-0001-7412-3722; Kagawa, Wataru/0000-0002-8801-6589; HAYASHI, Yoko/0000-0002-0556-6738	Japanese Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Waseda Research Institute for Science and Engineering; Grants-in-Aid for Scientific Research [23770008] Funding Source: KAKEN	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Waseda Research Institute for Science and Engineering; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the beamline scientists, N. Shimizu, Y. Kawano, M. Makino and T. Hikima, for their assistance with data collection at the BL41XU and BL45XU beamlines of SPring-8. We also thank R. Matsumoto for technical assistance, K. Yoda for anti-CENP-C, and T. Fukagawa and Y. Hiraoka for discussions. This work was supported in part by Grants-in-Aid from the Japanese Society for the Promotion of Science (JSPS), and the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. H.Ku. was also supported by the Waseda Research Institute for Science and Engineering.	Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Camahort R, 2009, MOL CELL, V35, P794, DOI 10.1016/j.molcel.2009.07.022; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Dalai Y, 2007, P NATL ACAD SCI USA, V104, P15974, DOI 10.1073/pnas.0707648104; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujisawa T, 2000, J APPL CRYSTALLOGR, V33, P797, DOI 10.1107/S002188980000131X; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; Glatter O., 1982, SMALL ANGLE XRAY SCA; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Kingston IJ, 2011, J BIOL CHEM, V286, P4021, DOI 10.1074/jbc.M110.189340; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Osakabe A, 2010, J BIOL CHEM, V285, P11913, DOI 10.1074/jbc.M109.083238; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Silva NCE, 2007, J MOL BIOL, V370, P555, DOI 10.1016/j.jmb.2007.04.064; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tachiwana H, 2008, NUCLEIC ACIDS RES, V36, P2208, DOI 10.1093/nar/gkn060; Tachiwana H, 2010, P NATL ACAD SCI USA, V107, P10454, DOI 10.1073/pnas.1003064107; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tanaka Y, 2005, J BIOL CHEM, V280, P41609, DOI 10.1074/jbc.M509666200; Tanaka Y, 2004, METHODS, V33, P3, DOI 10.1016/j.ymeth.2003.10.024; Tsunaka Y, 2005, NUCLEIC ACIDS RES, V33, P3424, DOI 10.1093/nar/gki663; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697	40	279	282	1	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2011	476	7359					232	U135		10.1038/nature10258	http://dx.doi.org/10.1038/nature10258			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21743476				2022-12-28	WOS:000293731900042
J	Hu, J; Xue, Y; Lee, S; Ha, Y				Hu, Jian; Xue, Yi; Lee, Sangwon; Ha, Ya			The crystal structure of GXGD membrane protease FlaK	NATURE			English	Article							SIGNAL PEPTIDE PEPTIDASE; GAMMA-SECRETASE; PSEUDOMONAS-AERUGINOSA; CATALYTIC PORE; II SECRETION; PRESENILIN; DOMAIN; IDENTIFICATION; CONFORMATION; TOPOLOGY	The GXGD proteases are polytopic membrane proteins with catalytic activities against membrane-spanning substrates that require a pair of aspartyl residues(1-4). Representative members of the family include preflagellin peptidase, type 4 prepilin peptidase, presenilin and signal peptide peptidase. Many GXGD proteases are important in medicine. For example, type 4 prepilin peptidase may contribute to bacterial pathogenesis(5-7), and mutations in presenilin are associated with Alzheimer's disease(8-10). As yet, there is no atomic-resolution structure in this protease family. Here we report the crystal structure of FlaK, a preflagellin peptidase from Methanococcus maripaludis, solved at 3.6 angstrom resolution. The structure contains six transmembrane helices. The GXGD motif and a short transmembrane helix, helix 4, are positioned at the centre, surrounded by other transmembrane helices. The crystal structure indicates that the protease must undergo conformational changes to bring the GXGD motif and a second essential aspartyl residue from transmembrane helix 1 into close proximity for catalysis. A comparison of the crystal structure with models of presenilin derived from biochemical analysis reveals three common transmembrane segments that are similarly arranged around the active site. This observation reinforces the idea that the prokaryotic and human proteases are evolutionarily related(11,12). The crystal structure presented here provides a framework for understanding the mechanism of the GXGD proteases, and may facilitate the rational design of inhibitors that target specific members of the family.	[Hu, Jian; Xue, Yi; Lee, Sangwon; Ha, Ya] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Ha, Y (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	ya.ha@yale.edu		Lee, Sangwon/0000-0002-9441-6546	US Department of Energy; National Institutes of Health; Ellison Medical Foundation; Yale's programme in Cellular Neuroscience, Neurodegeneration, and Repair (CNNR); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408, P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082839, R01GM101136] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Yale's programme in Cellular Neuroscience, Neurodegeneration, and Repair (CNNR); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Heroux, H. Robinson and A. Soares at NSLS, and J. Schuermann at APS NE-CAT for their help during data collection. X-ray diffraction data were measured at beamlines X25 and X29 at NSLS, and at 24-ID-C and 24-ID-E at APS. Financial support was principally from the US Department of Energy and from the National Institutes of Health. This work was supported by a New Scholar Award in Aging from the Ellison Medical Foundation (to Y.H.), a gift from the Neuroscience Education and Research Foundation (to Y.H.) and a pilot grant from Yale's programme in Cellular Neuroscience, Neurodegeneration, and Repair (CNNR) (to Y.H.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bardy SL, 2003, MOL MICROBIOL, V50, P1339, DOI 10.1046/j.1365-2958.2003.03758.x; Bardy SL, 2002, FEMS MICROBIOL LETT, V208, P53, DOI 10.1016/S0378-1097(01)00579-1; Bayley DP, 1999, J BACTERIOL, V181, P4146, DOI 10.1128/JB.181.14.4146-4153.1999; Bondar AN, 2009, STRUCTURE, V17, P395, DOI 10.1016/j.str.2008.12.017; Brouwers N, 2008, ANN MED, V40, P562, DOI 10.1080/07853890802186905; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; DAVIES DR, 1990, ANNU REV BIOPHYS BIO, V19, P189, DOI 10.1146/annurev.bb.19.060190.001201; Francetic O, 2007, J BACTERIOL, V189, P1783, DOI 10.1128/JB.01230-06; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Ha Y, 2009, SEMIN CELL DEV BIOL, V20, P240, DOI 10.1016/j.semcdb.2008.11.006; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jorissen E, 2010, CURR TOP DEV BIOL, V92, P201, DOI 10.1016/S0070-2153(10)92006-1; KABACK HR, 1966, P NATL ACAD SCI USA, V55, P920, DOI 10.1073/pnas.55.4.920; KALMOKOFF ML, 1990, BIOCHEM BIOPH RES CO, V167, P154, DOI 10.1016/0006-291X(90)91744-D; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; LaPointe CF, 2000, J BIOL CHEM, V275, P1502, DOI 10.1074/jbc.275.2.1502; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Lory S, 1997, GENE, V192, P117, DOI 10.1016/S0378-1119(96)00830-X; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Wang YC, 2007, J MOL BIOL, V374, P1104, DOI 10.1016/j.jmb.2007.10.014; Wang YC, 2007, P NATL ACAD SCI USA, V104, P2098, DOI 10.1073/pnas.0611080104; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	41	58	60	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2011	475	7357					528	U130		10.1038/nature10218	http://dx.doi.org/10.1038/nature10218			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21765428	Green Accepted			2022-12-28	WOS:000293167900047
J	Mackereth, CD; Madl, T; Bonnal, S; Simon, B; Zanier, K; Gasch, A; Rybin, V; Valcarcel, J; Sattler, M				Mackereth, Cameron D.; Madl, Tobias; Bonnal, Sophie; Simon, Bernd; Zanier, Katia; Gasch, Alexander; Rybin, Vladimir; Valcarcel, Juan; Sattler, Michael			Multi-domain conformational selection underlies pre-mRNA splicing regulation by U2AF	NATURE			English	Article							AUXILIARY FACTOR U2AF(65); POLYPYRIMIDINE TRACT; RECOGNITION; DYNAMICS; BINDING; RELAXATION; DOMAIN; RESTRAINTS; SEQUENCES; MECHANISM	Many cellular functions involve multi-domain proteins, which are composed of structurally independent modules connected by flexible linkers. Although it is often well understood how a given domain recognizes a cognate oligonucleotide or peptide motif, the dynamic interaction of multiple domains in the recognition of these ligands remains to be characterized. Here we have studied the molecular mechanisms of the recognition of the 3'-splice-site-associated polypyrimidine tract RNA by the large subunit of the human U2 snRNP auxiliary factor (U2AF65)(1-3) as a key early step in pre-mRNA splicing(4). We show that the tandem RNA recognition motif domains of U2AF65 adopt two remarkably distinct domain arrangements in the absence or presence of a strong (that is, high affinity) polypyrimidine tract. Recognition of sequence variations in the polypyrimidine tract RNA involves a population shift between these closed and open conformations. The equilibrium between the two conformations functions as a molecular rheostat that quantitatively correlates the natural variations in polypyrimidine tract nucleotide composition, length and functional strength to the efficiency to recruit U2 snRNP to the intron during spliceosome assembly(1,5-8). Mutations that shift the conformational equilibrium without directly affecting RNA binding modulate splicing activity accordingly. Similar mechanisms of cooperative multi-domain conformational selection may operate more generally in the recognition of degenerate nucleotide or amino acid motifs by multi-domain proteins(9,10).	[Mackereth, Cameron D.; Madl, Tobias; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Struct Biol, D-85764 Neuherberg, Germany; [Mackereth, Cameron D.] Univ Bordeaux, F-33607 Pessac, France; [Mackereth, Cameron D.] Inst Europe Chim & Biol, F-33607 Pessac, France; [Mackereth, Cameron D.; Simon, Bernd; Zanier, Katia; Gasch, Alexander; Rybin, Vladimir; Sattler, Michael] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Madl, Tobias; Sattler, Michael] Tech Univ Munich, Dept Chem, Munich Ctr Integrated Prot Sci, D-85747 Garching, Germany; [Bonnal, Sophie; Valcarcel, Juan] Univ Pompeu Fabra, Ctr Regulacio Genom, Barcelona 08003, Spain; [Valcarcel, Juan] Inst Catalana Recerca & Estudis Avancats, Barcelona 08003, Spain; [Madl, Tobias; Sattler, Michael] Tech Univ Munich, Chair Biomol NMR, Dept Chem, D-85747 Garching, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; UDICE-French Research Universities; Universite de Bordeaux; European Molecular Biology Laboratory (EMBL); Technical University of Munich; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA; Technical University of Munich	Sattler, M (corresponding author), Helmholtz Zentrum Munchen, Inst Struct Biol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	sattler@helmholtz-muenchen.de	Sattler, Michael/A-2407-2012; Madl, Tobias/B-1682-2012; Mackereth, Cameron D./F-7946-2013; Valcarcel, Juan/O-9814-2014	Sattler, Michael/0000-0002-1594-0527; Madl, Tobias/0000-0002-9725-5231; Mackereth, Cameron D./0000-0002-0776-7947; Valcarcel, Juan/0000-0001-5398-3571; Simon, Bernd/0000-0003-0164-5516	EMBO Long Term Fellowship; ICSN; Aquitaine regional government; Austrian Science Fund (FWF); EMBO; European Commission [226507]; EURASNET; AICR; Fundacion Marcelino Botin; ICREA Funding Source: Custom	EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); ICSN; Aquitaine regional government(Region Nouvelle-Aquitaine); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); EMBO(European Molecular Biology Organization (EMBO)); European Commission(European CommissionEuropean Commission Joint Research Centre); EURASNET; AICR; Fundacion Marcelino Botin; ICREA(ICREA)	We thank F. Gabel, M. Nilges, C. Griesinger, J. Muller and K. Scheffzek for discussions, and H. Tilgner for analysis of natural Py tract sequences. C. D. M. acknowledges support by EMBO Long Term Fellowship, ICSN and Aquitaine regional government. T. M. thanks the Austrian Science Fund (FWF) and EMBO for postdoctoral fellowships. We thank the EU NMR LSF in Frankfurt and the Bavarian NMR Centre (BNMRZ) in Munich for NMR measurement time. This work was supported by the European Commission, grants 3D Repertoire, FSG-V-RNA and NIM3 No. 226507 (M. S.), EURASNET, AICR and Fundacion Marcelino Botin (J.V.).	Banerjee H, 2003, RNA, V9, P88, DOI 10.1261/rna.2131603; Banerjee H, 2004, RNA, V10, P240, DOI 10.1261/rna.5153204; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUCKLE PE, 1993, BIOSENS BIOELECTRON, V8, P355, DOI 10.1016/0956-5663(93)80074-Y; Coolidge CJ, 1997, NUCLEIC ACIDS RES, V25, P888, DOI 10.1093/nar/25.4.888; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Guth S, 2001, MOL CELL BIOL, V21, P7673, DOI 10.1128/MCB.21.22.7673-7681.2001; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Ito T, 1999, EMBO J, V18, P4523, DOI 10.1093/emboj/18.16.4523; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Soares LMM, 2006, SCIENCE, V312, P1961, DOI 10.1126/science.1128659; NILGES M, 1995, J MOL BIOL, V245, P645, DOI 10.1006/jmbi.1994.0053; Ramos A, 1998, J AM CHEM SOC, V120, P10992, DOI 10.1021/ja982496e; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; ROSCIGNO RF, 1993, J BIOL CHEM, V268, P11222; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sickmier EA, 2006, MOL CELL, V23, P49, DOI 10.1016/j.molcel.2006.05.025; Simon B, 2010, ANGEW CHEM INT EDIT, V49, P1967, DOI 10.1002/anie.200906147; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; VALCARCEL J, 1997, MRNA FORMATION FUNCT, P31; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Yang DW, 1999, J BIOMOL NMR, V14, P333, DOI 10.1023/A:1008314803561; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0	36	156	156	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2011	475	7356					408	U174		10.1038/nature10171	http://dx.doi.org/10.1038/nature10171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21753750				2022-12-28	WOS:000292911200049
J	Jerjes, W; Upile, T				Jerjes, Waseem; Upile, Tahwinder			PERSONAL VIEW Use of medical titles by non-doctors can mislead patients	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jerjes, Waseem; Upile, Tahwinder] Chase Farm Hosp, London, England	University of London; University College London; Royal Free London NHS Foundation Trust	Jerjes, W (corresponding author), Chase Farm Hosp, London, England.	w.jerjes@ucl.ac.uk	Jerjes, Waseem/N-8538-2015	Jerjes, Waseem/0000-0002-6914-7401					0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 20	2011	343								d4241	10.1136/bmj.d4241	http://dx.doi.org/10.1136/bmj.d4241			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	797ZH	21775392	Green Submitted			2022-12-28	WOS:000293168700004
J	Tanser, F; Barnighausen, T; Hund, L; Garnett, GP; McGrath, N; Newell, ML				Tanser, Frank; Baernighausen, Till; Hund, Lauren; Garnett, Geoffrey P.; McGrath, Nuala; Newell, Marie-Louise			Effect of concurrent sexual partnerships on rate of new HIV infections in a high-prevalence, rural South African population: a cohort study	LANCET			English	Article							SUB-SAHARAN AFRICA; PUBLIC-HEALTH; COMMUNITY; DYNAMICS; LESSONS; EXPLAIN; SPREAD	Background Concurrent sexual partnerships are widely believed to be one of the main drivers of the HIV epidemic in sub-Saharan Africa. This view is supported by theoretical models predicting that increases in prevalence of concurrent partnerships could substantially increase the rate of spread of the disease. However, the effect of concurrent partnerships on HIV incidence has not been appropriately tested in a sub-Saharan African setting. Methods For this population-based cohort study, we used data from the Africa Centre demographic surveillance site in KwaZulu-Natal, South Africa, to try to find support for the concurrency hypothesis. We used a moving-window approach to construct estimates of the geographical variation in reported concurrent and lifetime partners in sexually active men aged 15-55 years (n=2153) across the study area. We then followed up 7284 HIV-negative women (>= 15 years of age) in the population and quantified the effect of the sexual behaviour profiles of men in the surrounding local community on a woman's hazard of HIV acquisition. Findings During 5 years' follow-up, 693 new female HIV infections occurred (incidence 3.60 cases per 100 person-years). We identified substantial intercommunity heterogeneity in the estimated point-prevalence of partnership concurrency (range 4.0-76.3%; mean 31.5%) and mean number of lifetime sexual partners (3.4-12.9; mean 6.3) in sexually active men in this population. After adjustment for individual-level sexual behaviour and demographic, socioeconomic, and environmental factors associated with HIV acquisition, mean lifetime number of partners of men in the immediate local community was predictive of hazard of HIV acquisition in women (adjusted hazard ratio [HR] 1.08, 95% CI 1.03-1.14, p=0.004), whereas a high prevalence of partnership concurrency in the same local community was not associated with any increase in risk of HIV acquisition (adjusted HR 1.02, 95% CI 0.95-1.09, p=0.556). Interpretation We find no evidence to suggest that concurrent partnerships are an important driver of HIV incidence in this typical high-prevalence rural African population. Our findings suggest that in similar hyperendemic sub-Saharan African settings, there is a need for straightforward, unambiguous messages aimed at the reduction of multiple partnerships, irrespective of whether those partnerships overlap in time.	[Tanser, Frank; Baernighausen, Till; McGrath, Nuala; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, ZA-3935 Mtubatuba, South Africa; [Baernighausen, Till] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Hund, Lauren] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Garnett, Geoffrey P.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [McGrath, Nuala] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Newell, Marie-Louise] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England	University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Tanser, F (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, ZA-3935 Mtubatuba, South Africa.	tanserf@africacentre.ac.za	Newell, Marie-Louise/AAE-8222-2019; Bärnighausen, Till/Y-2388-2019; Tanser, Frank/ABE-8326-2021; Garnett, Geoffrey P/A-9312-2008	Newell, Marie-Louise/0000-0002-1074-7699; McGrath, Nuala/0000-0002-1039-0159; Tanser, Frank/0000-0001-9797-0000	US National Institute of Child Health and Human Development; Wellcome Trust [WT083495MA]; National Institute of Child Health and Human Development [1R01-HD058482-01]; Wellcome Trust, UK [082384/Z/07/Z]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482] Funding Source: NIH RePORTER	US National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust, UK(Wellcome Trust); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	US National Institute of Child Health and Human Development; Wellcome Trust.; This research was supported by grant 1R01-HD058482-01 from the National Institute of Child Health and Human Development. Funding for the Africa Centre's Demographic Surveillance Information System and Population-based HIV Survey was received from the Wellcome Trust, UK (grant 082384/Z/07/Z). NM was supported by a Wellcome Trust fellowship (grant WT083495MA).	ANDERSON R M, 1991; Barnighausen T, 2009, AIDS RES HUM RETROV, V25, P405, DOI 10.1089/aid.2008.0211; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Barnighausen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003640; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Cleland J, 2004, SEX TRANSM INFECT, V80, P1, DOI 10.1136/sti.2004.013151; Epstein H, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2638; Ferguson NM, 2000, SEX TRANSM DIS, V27, P600, DOI 10.1097/00007435-200011000-00008; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Helleringer S, 2009, AIDS, V23, P1285, DOI 10.1097/QAD.0b013e32832aa85c; Hosegood V, 2009, DEMOGR RES, V20, P279, DOI 10.4054/DemRes.2009.20.13; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Lagarde E, 2001, AIDS, V15, P877, DOI 10.1097/00002030-200105040-00008; Lurie MN, 2010, AIDS BEHAV, V14, P34, DOI 10.1007/s10461-009-9640-0; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; MISHRA V, 2009, CONCURRENT SEXUAL PA; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014092; Morris M, 2010, AIDS BEHAV, V14, P31, DOI 10.1007/s10461-009-9639-6; Ng BE, 2011, COCHRANE DB SYST REV, V3; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Randolph W, 2004, ANNU REV PUBL HEALTH, V25, P419, DOI 10.1146/annurev.publhealth.25.101802.123046; Reniers G, 2010, AIDS, V24, P299, DOI 10.1097/QAD.0b013e328333af03; Roux AVD, 2005, J INFECT DIS, V191, pS25, DOI 10.1086/425288; Royston P, 2001, STATA J, V1, P1, DOI 10.1177/1536867X0100100101; Sawers L, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-34; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Shelton JD, 2007, LANCET, V370, P1809, DOI 10.1016/S0140-6736(07)61755-3; Shelton JD, 2010, LANCET, V375, P964, DOI 10.1016/S0140-6736(10)60416-3; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; *UNAIDS, 2008, 2008 REP GLOB AIDS E; *UNAIDS, 2008, STRAT CONS COMM MULT; UNAIDS Reference Group On Estimates Modelling & Projections, 2009, LANCET, V375, P621; *UNAIDS WHO, 2001, GUID US HIV TEST TEC; Waller L.A., 2004, APPL SPATIAL STAT PU; WATTS CH, 1992, MATH BIOSCI, V108, P89, DOI 10.1016/0025-5564(92)90006-I; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; *WORLD BANK, 2009, GLOB EC CRIS HIV PRE	39	123	124	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2011	378	9787					247	255		10.1016/S0140-6736(11)60779-4	http://dx.doi.org/10.1016/S0140-6736(11)60779-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798JD	21763937	Green Published, Green Accepted			2022-12-28	WOS:000293201100032
J	Melhuish, EC				Melhuish, Edward C.			Preschool Matters	SCIENCE			English	Editorial Material							EDUCATION		[Melhuish, Edward C.] Univ London, London WC1B 3RA, England; [Melhuish, Edward C.] Kyung Hee Univ, Seoul, South Korea	University of London; Kyung Hee University	Melhuish, EC (corresponding author), Univ London, London WC1B 3RA, England.	e.melhuish@bbk.ac.uk						2009 Results PISA, 2011, PISA 2009 RES, VII and IV; Aboud FE, 2006, EARLY CHILD RES Q, V21, P46, DOI 10.1016/j.ecresq.2006.01.008; BARNETT WS, 1992, J HUM RESOUR, V27, P279, DOI 10.2307/145736; Bauer PC, 2009, ECON LETT, V103, P87, DOI 10.1016/j.econlet.2009.01.032; Berlinski S, 2008, J PUBLIC ECON, V92, P1416, DOI 10.1016/j.jpubeco.2007.10.007; Berlinski S, 2009, J PUBLIC ECON, V93, P219, DOI 10.1016/j.jpubeco.2008.09.002; Bernanke B. S., 2011, COMMUNICATION   0302; Dumas C., 2010, 201007 U CERG PONT; Goodman A, 2005, FISC STUD, V26, P513, DOI 10.1111/j.1475-5890.2005.00022.x; Gormley WT, 2008, SCIENCE, V320, P1723, DOI 10.1126/science.1156019; Haskins R., 2010, INVESTING YOUNG CHIL; Havnes T., 2009, DISCUSSION PAPERS ST; Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898; Loeb S, 2007, ECON EDUC REV, V26, P52, DOI 10.1016/j.econedurev.2005.11.005; Magnuson KA, 2007, ECON EDUC REV, V26, P33, DOI 10.1016/j.econedurev.2005.09.008; McCain M., 1999, EARLY YEARS STUDY RE; Melhuish EC, 2008, SCIENCE, V321, P1161, DOI 10.1126/science.1158808; Montie JE, 2006, EARLY CHILD RES Q, V21, P313, DOI 10.1016/j.ecresq.2006.07.007; OECD, 2011, PISA 2009 RES, VII and IV; Pianta Robert C, 2009, Psychol Sci Public Interest, V10, P49, DOI 10.1177/1529100610381908; Reynolds AJ, 2011, SCIENCE, V333, P360, DOI 10.1126/science.1203618; Sammons P, 2008, INFLUENCES CHILDRENS; Shenglan L., 2006, EARLY CHILDHOOD CARE, P151; Vandell DL, 2010, CHILD DEV, V81, P737, DOI 10.1111/j.1467-8624.2010.01431.x; Zigler E, 2006, VISION FOR UNIVERSAL PRESCHOOL EDUCATION, P1, DOI 10.2277/ 0521612993	25	41	43	4	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2011	333	6040					299	300		10.1126/science.1209459	http://dx.doi.org/10.1126/science.1209459			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	792HF	21764739				2022-12-28	WOS:000292732000030
J	Yoshimatsu, K; Horiba, K; Kumigashira, H; Yoshida, T; Fujimori, A; Oshima, M				Yoshimatsu, K.; Horiba, K.; Kumigashira, H.; Yoshida, T.; Fujimori, A.; Oshima, M.			Metallic Quantum Well States in Artificial Structures of Strongly Correlated Oxide	SCIENCE			English	Article							THIN-FILMS; CA1-XSRXVO3; INSULATOR; MASS	The quantum confinement of strongly correlated electrons in artificial structures provides a platform for studying the behavior of correlated Fermi-liquid states in reduced dimensions. We report the creation and control of two-dimensional electron-liquid states in ultrathin films of SrVO(3) grown on Nb:SrTiO(3) substrates, which are artificial oxide structures that can be varied in thickness by single monolayers. Angle-resolved photoemission from the SrVO(3)/Nb:SrTiO(3) samples shows metallic quantum well states that are adequately described by the well-known phase-shift quantization rule. The observed quantum well states in SrVO(3) ultrathin films exhibit distinctive features-such as orbital-selective quantization originating from the anisotropic orbital character of the V 3d states and unusual band renormalization of the subbands near the Fermi level-that reflect complex interactions in the quantum well.	[Yoshimatsu, K.; Horiba, K.; Kumigashira, H.; Oshima, M.] Univ Tokyo, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; [Horiba, K.; Kumigashira, H.; Oshima, M.] Univ Tokyo, Synchrotron Radiat Res Org, Bunkyo Ku, Tokyo 1138656, Japan; [Kumigashira, H.] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan; [Yoshida, T.; Fujimori, A.] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Oshima, M.] JST, Bunkyo Ku, Tokyo 1138656, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; Japan Science & Technology Agency (JST)	Kumigashira, H (corresponding author), KEK, High Energy Accelerator Res Org, Inst Mat Struct Sci, 1-1 Oho, Tsukuba, Ibaraki 3050801, Japan.	kumigashira@sr.t.u-tokyo.ac.jp	Fujimori, Atsushi/U-1971-2019; Fujimori, Atsushi/G-5099-2014; Horiba, Koji/T-3803-2018; Yoshimatsu, Kohei/B-9300-2015	Fujimori, Atsushi/0000-0003-4876-0634; Horiba, Koji/0000-0002-1124-0451; Yoshimatsu, Kohei/0000-0001-9288-068X; KUMIGASHIRA, Hiroshi/0000-0003-4668-2695	Japan Society for the Promotion of Science (JSPS) [A19684010, S22224005]; JST; Grants-in-Aid for Scientific Research [22224005] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors are very grateful to I. Matsuda, S. Okamoto, and M. J. Rozenberg for useful discussions and K. Ono and A. Yagishita for their support in the experiment at the Photon Factory (PF), KEK. This work was supported by a Grant-in-Aid for Scientific Research (A19684010 and S22224005) from the Japan Society for the Promotion of Science (JSPS) and the JST PRESTO program. K.Y. acknowledges the financial support from JSPS for Young Scientists. This work at KEK-PF was done under the approval of the Program Advisory Committee (proposals 08S2-003 and 09S2-005) at the Institute of Materials Structure Science, KEK.	BRINKMAN WF, 1970, PHYS REV B, V2, P4342; Chiang TC, 2000, SURF SCI REP, V39, P181, DOI 10.1016/S0167-5729(00)00006-6; Georges A, 1996, REV MOD PHYS, V68, P13, DOI 10.1103/RevModPhys.68.13; Guo Y, 2004, SCIENCE, V306, P1915, DOI 10.1126/science.1105130; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Inoue IH, 1998, PHYS REV B, V58, P4372, DOI 10.1103/PhysRevB.58.4372; INOUE IH, 1995, PHYS REV LETT, V74, P2539, DOI 10.1103/PhysRevLett.74.2539; Kawakami RK, 1999, NATURE, V398, P132, DOI 10.1038/18178; Matsuda I, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.085327; Milun M, 2002, REP PROG PHYS, V65, P99, DOI 10.1088/0034-4885/65/2/201; Nekrasov IA, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.155112; Neupane M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.097001; Ohtomo A, 2002, NATURE, V419, P378, DOI 10.1038/nature00977; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Okamoto S, 2004, NATURE, V428, P630, DOI 10.1038/nature02450; Paggel JJ, 1999, SCIENCE, V283, P1709, DOI 10.1126/science.283.5408.1709; Pavarini E, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/188; Takizawa M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.235104; Yoshida T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146404; Yoshida T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.085119; Yoshimatsu K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.147601	21	115	115	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					319	322		10.1126/science.1205771	http://dx.doi.org/10.1126/science.1205771			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764742				2022-12-28	WOS:000292732000036
J	Losos, JB; Pringle, RM				Losos, Jonathan B.; Pringle, Robert M.			Competition, predation and natural selection in island lizards	NATURE			English	Letter							FOOD WEBS; SURVIVAL; PATTERNS; MARINE		[Losos, Jonathan B.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Pringle, Robert M.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Harvard University; Princeton University	Losos, JB (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	jlosos@oeb.harvard.edu						Calsbeek R, 2010, NATURE, V465, P613, DOI 10.1038/nature09020; Diaz-Uriarte R, 1999, P ROY SOC B-BIOL SCI, V266, P2457, DOI 10.1098/rspb.1999.0946; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Schoener TW, 2005, SCIENCE, V310, P1807, DOI 10.1126/science.1120165; SCHOENER TW, 1978, NATURE, V274, P685, DOI 10.1038/274685a0; SCHOENER TW, 1983, J ANIM ECOL, V52, P237, DOI 10.2307/4598; Spiller DA, 2010, ECOLOGY, V91, P1424, DOI 10.1890/09-0715.1	7	8	8	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					E1	E2		10.1038/nature10140	http://dx.doi.org/10.1038/nature10140			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753806				2022-12-28	WOS:000292690500011
J	Fry, AM; Perez, A; Finelli, L				Fry, Alicia M.; Perez, Alejandro; Finelli, Lyn			Use of Intravenous Neuraminidase Inhibitors During the 2009 Pandemic: Results From Population-Based Surveillance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							INFLUENZA		[Fry, Alicia M.; Perez, Alejandro; Finelli, Lyn] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Fry, AM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	afry@cdc.gov	Finelli, Lyn/AAK-2360-2020					[Anonymous], UPD INT REC US ANT M; [Anonymous], EM US AUTH PER 4 FAC; Birnkrant D, 2009, NEW ENGL J MED, V361, P2204, DOI 10.1056/NEJMp0910479; Dao CN, 2010, J INFECT DIS, V202, P881, DOI 10.1086/655904; Dawood FS, 2010, J PEDIATR-US, V157, P808, DOI 10.1016/j.jpeds.2010.05.012	5	7	7	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					160	162		10.1001/jama.2011.950	http://dx.doi.org/10.1001/jama.2011.950			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791CO	21750292				2022-12-28	WOS:000292639400019
J	Notta, F; Doulatov, S; Laurenti, E; Poeppl, A; Jurisica, I; Dick, JE				Notta, Faiyaz; Doulatov, Sergei; Laurenti, Elisa; Poeppl, Armando; Jurisica, Igor; Dick, John E.			Isolation of Single Human Hematopoietic Stem Cells Capable of Long-Term Multilineage Engraftment	SCIENCE			English	Article							CORD-BLOOD; PROGENITOR CELLS; MICE; RECONSTITUTION; PURIFICATION; POPULATION; RECIPIENTS; HIERARCHY; MAP	Lifelong blood cell production is dependent on rare hematopoietic stem cells (HSCs) to perpetually replenish mature cells via a series of lineage-restricted intermediates. Investigating the molecular state of HSCs is contingent on the ability to purify HSCs away from transiently engrafting cells. We demonstrated that human HSCs remain infrequent, using current purification strategies based on Thy1 (CD90) expression. By tracking the expression of several adhesion molecules in HSC-enriched subsets, we revealed CD49f as a specific HSC marker. Single CD49f(+) cells were highly efficient in generating long-term multilineage grafts, and the loss of CD49f expression identified transiently engrafting multipotent progenitors (MPPs). The demarcation of human HSCs and MPPs will enable the investigation of the molecular determinants of HSCs, with a goal of developing stem cell-based therapeutics.	[Notta, Faiyaz; Doulatov, Sergei; Laurenti, Elisa; Poeppl, Armando; Dick, John E.] Ontario Canc Inst, Campbell Family Inst Canc Res, Div Stem Cell & Dev Biol, Toronto, ON M4X 1K9, Canada; [Notta, Faiyaz; Doulatov, Sergei; Laurenti, Elisa; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Jurisica, Igor] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Jurisica, Igor] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Dick, JE (corresponding author), Toronto Med Discovery Tower,Room 8-301,101 Coll S, Toronto, ON M5G 1L7, Canada.	jdick@uhnres.utoronto.ca		Laurenti, Elisa/0000-0002-9917-9092; Dick, John/0000-0002-9527-8317	Canadian Institutes for Health Research (CIHR); Swiss National Science Foundation; Roche; Canadian Cancer Society; Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research with province of Ontario; Ontario Ministry of Health and Long Term Care (OMOHLTC)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche(Roche Holding); Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research with province of Ontario; Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	We thank K. Moore and the obstetrics unit of Trillium Hospital (Mississauga, Ontario) for providing CB, the Dick Lab and M. Cooper for critical manuscript review, C. Nostro from the Keller lab for assistance with immunofluorescence, and P. A. Penttila and the University Health Network/Sickkids flow cytometry facility. This work was supported by Canadian Institutes for Health Research (CIHR) studentships (F.N. and S.D.) and Swiss National Science Foundation and Roche fellowships (E.L.). Grants were received from the CIHR, Canadian Cancer Society, Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute, Ontario Institute for Cancer Research with funds from the province of Ontario, and a Canada Research Chair. This research was funded in part by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC. Microarray data are available online at the Gene Expression Omnibus Web page (accession code GSE29105). F.N., S.D., and J.E.D. designed the study; F.N., S.D., and A.P. performed experiments; E.L., S.D., and I.J. analyzed gene expression data; F.N. prepared the manuscript; S.D. and J.E.D. edited the manuscript; and J.E.D supervised the study.	Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; CRAIG W, 1993, J EXP MED, V177, P1331, DOI 10.1084/jem.177.5.1331; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Goren A, 2010, NAT METHODS, V7, P47, DOI [10.1038/NMETH.1404, 10.1038/nmeth.1404]; HAO QL, 1995, BLOOD, V86, P3745, DOI 10.1182/blood.V86.10.3745.bloodjournal86103745; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; MAYANI H, 1993, BLOOD, V82, P2664; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; McKenzie JL, 2007, BLOOD, V109, P543, DOI 10.1182/blood-2006-06-030270; Notta F, 2010, BLOOD, V115, P3704, DOI 10.1182/blood-2009-10-249326; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Ueno H, 2003, NAT IMMUNOL, V4, P457, DOI 10.1038/ni916	21	544	574	1	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					218	221		10.1126/science.1201219	http://dx.doi.org/10.1126/science.1201219			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21737740				2022-12-28	WOS:000292502700049
J	Weinstein, RS				Weinstein, Robert S.			Glucocorticoid-Induced Bone Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INDUCED OSTEOPOROSIS; POSTMENOPAUSAL WOMEN; VERTEBRAL FRACTURE; MINERAL DENSITY; DOUBLE-BLIND; ALENDRONATE; PREVENTION; APOPTOSIS; OSTEOCYTES; BISPHOSPHONATES	A 55-year-old woman with severe, persistent asthma requiring glucocorticoid therapy for the past 3 months presents for care. Her medications include albuterol, inhaled fluticasone with salmeterol, montelukast, and prednisone (at a dose of 10 mg per day). In the past, she received several intermittent courses of prednisone at a dose of 15 mg or more per day. Her weight is 45.5 kg (100 lb), and her height 157.5 cm (62 in.); the body-mass index (the weight in kilograms divided by the square of the height in meters) is 18. Scattered wheezing is heard during expiration. Findings on vertebral percussion and rib-cage compression are unremarkable. How should her case be evaluated and managed to minimize the risk of fractures?	[Weinstein, Robert S.] Univ Arkansas Med Sci, Div Endocrinol & Metab, Ctr Osteoporosis & Metab Bone Dis, Dept Internal Med, Little Rock, AR 72205 USA; [Weinstein, Robert S.] Univ Arkansas Med Sci, Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Weinstein, RS (corresponding author), Univ Arkansas Med Sci, Div Endocrinol & Metab, Ctr Osteoporosis & Metab Bone Dis, Dept Internal Med, 4301 W Markham St,Slot 587, Little Rock, AR 72205 USA.	weinsteinroberts@uams.edu			Veterans Affairs [I01BX000436] Funding Source: NIH RePORTER; BLRD VA [I01 BX000436] Funding Source: Medline; VA [5I01BX000436-07] Funding Source: Federal RePORTER	Veterans Affairs(US Department of Veterans Affairs); BLRD VA; VA(US Department of Veterans Affairs)		Adachi JD, 2001, ARTHRITIS RHEUM, V44, P202, DOI 10.1002/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W; Adler RA, 2008, OSTEOPOROSIS, VOLS I AND II, 3RD EDITION, P1135; Agarwala S, 2009, J BONE JOINT SURG BR, V91B, P1013, DOI 10.1302/0301-620X.91B8.21518; Angeli A, 2006, BONE, V39, P253, DOI 10.1016/j.bone.2006.02.005; [Anonymous], 2009, GUID PREV TREATM GLU; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Canalis E, 2007, OSTEOPOROSIS INT, V18, P1319, DOI 10.1007/s00198-007-0394-0; Cooper MS, 2002, J BONE MINER RES, V17, P979, DOI 10.1359/jbmr.2002.17.6.979; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Curtis JR, 2005, ARTHRITIS RHEUM-US, V52, P2485, DOI 10.1002/art.21194; Devogelaer J-P, 2006, OSTEOPOROSIS INT, V17, P8; Devogelaer JP, 2010, J RHEUMATOL, V37, P141, DOI 10.3899/jrheum.090411; Devogelaer JP, 2006, OSTEOPOROSIS INT, V17, P8, DOI 10.1007/s00198-005-2032-z; Dore RK, 2010, ANN RHEUM DIS, V69, P872, DOI 10.1136/ard.2009.112920; Emkey R, 2003, ARTHRITIS RHEUM, V48, P1102, DOI 10.1002/art.10861; Fleisch H, 2000, BISPHOSPHONATES BONE, P42; Grossman JM, 2010, ARTHRIT CARE RES, V62, P1515, DOI 10.1002/acr.20295; Jia D, 2006, ENDOCRINOLOGY, V147, P5592, DOI 10.1210/en.2006-0459; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; LAI KA, 2005, ARTHRITIS RHEUM, V87, P2155, DOI DOI 10.1002/ART.10861; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; LOCASCIO V, 1990, BONE MINER, V8, P39, DOI 10.1016/0169-6009(91)90139-Q; MANKIN HJ, 1992, NEW ENGL J MED, V326, P1473; Miller Paul D, 2008, Curr Osteoporos Rep, V6, P12, DOI 10.1007/s11914-008-0003-y; *NAT OST FDN, 2009, NAT OST FDN CLIN GUI, DOI DOI 10.1002/ACR.20295; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; Orwoll E, 2000, NEW ENGL J MED, V343, P604, DOI 10.1056/NEJM200008313430902; Pearce G, 1998, J CLIN ENDOCR METAB, V83, P801, DOI 10.1210/jc.83.3.801; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Reid DM, 2009, LANCET, V373, P1253, DOI 10.1016/S0140-6736(09)60250-6; Reid DM, 2000, J BONE MINER RES, V15, P1006, DOI 10.1359/jbmr.2000.15.6.1006; Rubin MR, 2002, J CLIN ENDOCR METAB, V87, P4033, DOI 10.1210/jc.2002-012101; Russcher H, 2005, J CLIN ENDOCR METAB, V90, P5804, DOI 10.1210/jc.2005-0646; Saag KG, 2007, NEW ENGL J MED, V357, P2028, DOI 10.1056/NEJMoa071408; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Steinbuch M, 2004, OSTEOPOROSIS INT, V15, P323, DOI 10.1007/s00198-003-1548-3; Syed MI, 2006, AM J NEURORADIOL, V27, P1938; Tatsuno I, 2009, J CLIN ENDOCR METAB, V94, P1671, DOI 10.1210/jc.2008-1578; Tauchmanova L, 2006, J CLIN ENDOCR METAB, V91, P1779, DOI 10.1210/jc.2005-0582; Thompson JM, 1997, CALCIFIED TISSUE INT, V61, P377, DOI 10.1007/s002239900351; Van Staa TP, 2003, ARTHRITIS RHEUM, V48, P3224, DOI 10.1002/art.11283; van Staa TP, 2001, J BONE MINER RES, V16, P581, DOI 10.1359/jbmr.2001.16.3.581; Weinstein RS, 2010, ENDOCRINOLOGY, V151, P2641, DOI 10.1210/en.2009-1488; Weinstein RS, 2010, AGING CELL, V9, P147, DOI 10.1111/j.1474-9726.2009.00545.x; Weinstein RS, 2009, NEW ENGL J MED, V360, P53, DOI 10.1056/NEJMoa0802633; Weinstein RS, 2002, J CLIN INVEST, V109, P1041, DOI 10.1172/JCI200214538; Weinstein RS, 2000, J CLIN ENDOCR METAB, V85, P2907, DOI 10.1210/jc.85.8.2907; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Weinstein RS, 2004, ENDOCRINOLOGY, V145, P1980, DOI 10.1210/en.2003-1133; Weinstein RS, 2008, PRIMER METABOLIC BON, P267, DOI DOI 10.1002/9780470623992.CH58	50	447	476	2	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					62	70		10.1056/NEJMcp1012926	http://dx.doi.org/10.1056/NEJMcp1012926			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788QL	21732837				2022-12-28	WOS:000292459400010
J	Brodaty, H				Brodaty, Henry			Antidepressant treatment in Alzheimer's disease	LANCET			English	Editorial Material							DEPRESSION; SERTRALINE		[Brodaty, Henry] Univ New S Wales, Brain & Ageing Res Program, Sydney, NSW 2052, Australia; [Brodaty, Henry] Univ New S Wales, Primary Dementia Collaborat Res Ctr, Sch Psychiat, Fac Med, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Brodaty, H (corresponding author), Univ New S Wales, Brain & Ageing Res Program, Sydney, NSW 2052, Australia.	h.brodaty@unsw.edu.au						Banerjee S, 2011, LANCET, V378, P403, DOI 10.1016/S0140-6736(11)60830-1; Graff MJL, 2007, J GERONTOL A-BIOL, V62, P1002, DOI 10.1093/gerona/62.9.1002; Joffe R, 1996, CAN J PSYCHIAT, V41, P613, DOI 10.1177/070674379604101002; Miller MD, 2007, INT J GERIATR PSYCH, V22, P101, DOI 10.1002/gps.1699; National Institute for Health and Clinical Excellence, 2009, DEPR TREATM MAN DEPR; Nelson JC, 2011, J AM GERIATR SOC, V59, P577, DOI 10.1111/j.1532-5415.2011.03355.x; Nelson JC, 2010, FOCUS, V8, P605; Pollock BG, 2007, AM J GERIAT PSYCHIAT, V15, P942, DOI 10.1097/JGP.0b013e3180cc1ff5; Prince M, 2009, WORLD ALZHEIMERS REP; Rosenberg PB, 2010, AM J GERIAT PSYCHIAT, V18, P136, DOI 10.1097/JGP.0b013e3181c796eb; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; Teri L, 1997, J GERONTOL B-PSYCHOL, V52, pP159, DOI 10.1093/geronb/52B.4.P159; Weintraub D, 2010, AM J GERIAT PSYCHIAT, V18, P332, DOI 10.1097/JGP.0b013e3181cc0333	13	14	14	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2011	378	9789					375	376		10.1016/S0140-6736(11)61031-3	http://dx.doi.org/10.1016/S0140-6736(11)61031-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XM	21764117				2022-12-28	WOS:000293615900004
J	Matsuura, M; Dwek, E; Meixner, M; Otsuka, M; Babler, B; Barlow, MJ; Roman-Duval, J; Engelbracht, C; Sandstrom, K; Lakicevic, M; van Loon, JT; Sonneborn, G; Clayton, GC; Long, KS; Lundqvist, P; Nozawa, T; Gordon, KD; Hony, S; Panuzzo, P; Okumura, K; Misselt, KA; Montiel, E; Sauvage, M				Matsuura, M.; Dwek, E.; Meixner, M.; Otsuka, M.; Babler, B.; Barlow, M. J.; Roman-Duval, J.; Engelbracht, C.; Sandstrom, K.; Lakicevic, M.; van Loon, J. Th; Sonneborn, G.; Clayton, G. C.; Long, K. S.; Lundqvist, P.; Nozawa, T.; Gordon, K. D.; Hony, S.; Panuzzo, P.; Okumura, K.; Misselt, K. A.; Montiel, E.; Sauvage, M.			Herschel Detects a Massive Dust Reservoir in Supernova 1987A	SCIENCE			English	Article							LARGE-MAGELLANIC-CLOUD; INNER CIRCUMSTELLAR RING; HUBBLE-SPACE-TELESCOPE; GALAXY EVOLUTION SAGE; SN 1987A; SPIRE INSTRUMENT; NEUTRINO BURST; SPITZER SURVEY; LINE EMISSION; MILKY-WAY	We report far-infrared and submillimeter observations of supernova 1987A, the star whose explosion was observed on 23 February 1987 in the Large Magellanic Cloud, a galaxy located 160,000 light years away. The observations reveal the presence of a population of cold dust grains radiating with a temperature of about 17 to 23 kelvin at a rate of about 220 times the luminosity of the Sun. The intensity and spectral energy distribution of the emission suggest a dust mass of about 0.4 to 0.7 times the mass of the Sun. The radiation must originate from the supernova ejecta and requires the efficient precipitation of all refractory material into dust. Our observations imply that supernovae can produce the large dust masses detected in young galaxies at very high redshifts.	[Matsuura, M.; Barlow, M. J.] UCL, Dept Phys & Astron, Astrophys Grp, London WC1E 6BT, England; [Matsuura, M.] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Dwek, E.; Sonneborn, G.] NASA, Goddard Space Flight Ctr, Observat Cosmol Lab, Greenbelt, MD 20771 USA; [Meixner, M.; Otsuka, M.; Roman-Duval, J.; Long, K. S.; Gordon, K. D.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Babler, B.] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; [Engelbracht, C.; Misselt, K. A.; Montiel, E.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Sandstrom, K.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Lakicevic, M.; van Loon, J. Th] Keele Univ, Lennard Jones Labs, Astrophys Grp, Keele ST5 5BG, Staffs, England; [Lakicevic, M.] European So Observ, D-85748 Garching, Germany; [Clayton, G. C.] Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA; [Lundqvist, P.] Stockholm Univ, AlbaNova Univ Ctr, Oskar Klein Ctr, Dept Astron, SE-10691 Stockholm, Sweden; [Nozawa, T.] Univ Tokyo, Inst Phys & Math Universe, Chiba 2778583, Japan; [Hony, S.; Panuzzo, P.; Okumura, K.; Sauvage, M.] Commissariat Energie Atom & Energies Alternat, Lab Astrophys Instrumentat & Modelisat, Irfu SAp, F-91191 Gif Sur Yvette, France	University of London; University College London; University of London; University College London; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Space Telescope Science Institute; University of Wisconsin System; University of Wisconsin Madison; University of Arizona; Max Planck Society; Keele University; European Southern Observatory; Louisiana State University System; Louisiana State University; Oskar Klein Centre; Stockholm University; University of Tokyo; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS)	Matsuura, M (corresponding author), UCL, Dept Phys & Astron, Astrophys Grp, Gower St, London WC1E 6BT, England.	mikako@star.ucl.ac.uk	Sandstrom, Karin M/J-7544-2016; Lakicevic, Masa/ABB-7280-2021; Dwek, Eli/C-3995-2012; Barlow, Michael J/A-5638-2009; Otsuka, Masaaki/AAP-4081-2021; Sonneborn, George/D-5255-2012	Sandstrom, Karin M/0000-0002-4378-8534; Lakicevic, Masa/0000-0002-8231-0963; Barlow, Michael J/0000-0002-3875-1171; Panuzzo, Pasquale/0000-0002-0016-8271; Otsuka, Masaaki/0000-0001-7076-0310; Nozawa, Takaya/0000-0002-6153-7915; Montiel, Edward/0000-0003-2553-4474; Dwek, Eli/0000-0001-8033-1181; Babler, Brian/0000-0002-6984-5752; Matsuura, Mikako/0000-0002-5529-5593; Roman-Duval, Julia/0000-0001-6326-7069; Clayton, Geoffrey/0000-0002-0141-7436; Gordon, Karl/0000-0001-5340-6774	NASA Herschel Science Center, JPL [1381522, 1381650]; ESA; PACS; SPIRE teams; Herschel Science Centre; NASA Herschel Science Center; University College London Institute of Origins; European Southern Observatory-Keele studentship; STFC [ST/G002827/1, ST/J000035/1, ST/G002355/1, PP/D000955/1, PP/F000057/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/F000057/1, ST/J000035/1, ST/G002827/1, ST/G002355/1, PP/D000955/1] Funding Source: researchfish; Grants-in-Aid for Scientific Research [22684004] Funding Source: KAKEN	NASA Herschel Science Center, JPL; ESA(European Space Agency); PACS; SPIRE teams; Herschel Science Centre; NASA Herschel Science Center; University College London Institute of Origins; European Southern Observatory-Keele studentship; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Herschel is a European Space Agency (ESA) space observatory with science instruments provided by European-led principal investigator consortia and with important participation from NASA. We acknowledge financial support from the NASA Herschel Science Center, JPL contracts 1381522 and 1381650. We acknowledge the contributions and support of the ESA, the PACS and SPIRE teams, the Herschel Science Centre, the NASA Herschel Science Center, and the PACS and SPIRE instrument control centers, without which none of this work would have been possible. We also thank the HERITAGE team for various inputs on the data reduction. M. M. appreciates many discussions and inputs from H. Hirashita, I. Sakon, R. Wesson, K. Nomoto, and B. M. Swinyard. M. M. acknowledges the award of a University College London Institute of Origins Fellowship, and M. L. acknowledges a European Southern Observatory-Keele studentship.	ARNETT D, 1989, ASTROPHYS J, V341, pL63, DOI 10.1086/185458; ARNETT WD, 1989, ANNU REV ASTRON ASTR, V27, P629, DOI 10.1146/annurev.aa.27.090189.003213; Bernard JP, 2008, ASTRON J, V136, P919, DOI 10.1088/0004-6256/136/3/919; BIONTA RM, 1987, PHYS REV LETT, V58, P1494, DOI 10.1103/PhysRevLett.58.1494; Bouchet P, 2006, ASTROPHYS J, V650, P212, DOI 10.1086/505929; BURROWS CJ, 1995, ASTROPHYS J, V452, P680, DOI 10.1086/176339; Burrows DN, 2000, ASTROPHYS J, V543, pL149, DOI 10.1086/317271; CHEVALIER RA, 1987, NATURE, V328, P44, DOI 10.1038/328044a0; Diolaiti E, 2000, ASTRON ASTROPHYS SUP, V147, P335, DOI 10.1051/aas:2000305; DOTANI T, 1987, NATURE, V330, P230, DOI 10.1038/330230a0; Dwek E, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/2/63; Dwek E, 2010, ASTROPHYS J, V722, P425, DOI 10.1088/0004-637X/722/1/425; France K, 2010, SCIENCE, V329, P1624, DOI 10.1126/science.1192134; Gordon KD, 2003, ASTROPHYS J, V594, P279, DOI 10.1086/376774; Griffin MJ, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014519; Groningsson P, 2008, ASTRON ASTROPHYS, V492, P481, DOI 10.1051/0004-6361:200810551; HIRATA K, 1987, PHYS REV LETT, V58, P1490, DOI 10.1103/PhysRevLett.58.1490; Jerkstrand A, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201015937; Jones AP, 1996, ASTROPHYS J, V469, P740, DOI 10.1086/177823; LAOR A, 1993, ASTROPHYS J, V402, P441, DOI 10.1086/172149; Larsson J, 2011, NATURE, V474, P484, DOI 10.1038/nature10090; LUCY LB, 1989, LECT NOTES PHYS, V350, P164; Maoz D, 2010, MON NOT R ASTRON SOC, V407, P1314, DOI 10.1111/j.1365-2966.2010.16988.x; Matsuura M, 2009, MON NOT R ASTRON SOC, V396, P918, DOI 10.1111/j.1365-2966.2009.14743.x; Mattila S, 2010, ASTROPHYS J, V717, P1140, DOI 10.1088/0004-637X/717/2/1140; MCCRAY R, 1993, ANNU REV ASTRON ASTR, V31, P175, DOI 10.1146/annurev.aa.31.090193.001135; Meixner M, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014662; Meixner M, 2006, ASTRON J, V132, P2268, DOI 10.1086/508185; Morgan HL, 2003, MON NOT R ASTRON SOC, V343, P427, DOI 10.1046/j.1365-8711.2003.06681.x; MOSELEY SH, 1989, ASTROPHYS J, V347, P1119, DOI 10.1086/168201; MOSELEY SH, 1989, NATURE, V340, P697, DOI 10.1038/340697a0; Nozawa T, 2006, ASTROPHYS J, V648, P435, DOI 10.1086/505639; *PACS, PACS OBS MAN; Panagia N, 2000, ASTROPHYS J, V539, P197, DOI 10.1086/309212; Pilbratt GL, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014759; Poglitsch A, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014535; Potter TM, 2009, ASTROPHYS J, V705, P261, DOI 10.1088/0004-637X/705/1/261; Racusin JL, 2009, ASTROPHYS J, V703, P1752, DOI 10.1088/0004-637X/703/2/1752; ROULEAU F, 1991, ASTROPHYS J, V377, P526, DOI 10.1086/170382; Semenov D, 2003, ASTRON ASTROPHYS, V410, P611, DOI 10.1051/0004-6361:20031279; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Srinivasan S, 2009, ASTRON J, V137, P4810, DOI 10.1088/0004-6256/137/6/4810; Sturm R, 2010, ASTRON ASTROPHYS, V515, DOI 10.1051/0004-6361/200913317; SUNYAEV R, 1987, NATURE, V330, P227, DOI 10.1038/330227a0; Swinyard BM, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014605; THIELEMANN FK, 1990, ASTROPHYS J, V349, P222, DOI 10.1086/168308; Weingartner JC, 2001, ASTROPHYS J, V548, P296, DOI 10.1086/318651; WHITELOCK PA, 1989, MNRAS, V240, P7; WOODEN DH, 1993, ASTROPHYS J SUPPL S, V88, P477, DOI 10.1086/191830; WOOSLEY SE, 1988, P ASTRON SOC AUST, V7, P355, DOI 10.1017/S1323358000022475; Zanardo G, 2010, ASTROPHYS J, V710, P1515, DOI 10.1088/0004-637X/710/2/1515; Zubko VG, 1996, MON NOT R ASTRON SOC, V282, P1321, DOI 10.1093/mnras/282.4.1321	52	260	262	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1258	1261		10.1126/science.1205983	http://dx.doi.org/10.1126/science.1205983			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21737700	Green Submitted			2022-12-28	WOS:000294406400045
J	Polak, JF; Pencina, MJ; Pencina, KM; O'Donnell, CJ; Wolf, PA; D'Agostino, RB				Polak, Joseph F.; Pencina, Michael J.; Pencina, Karol M.; O'Donnell, Christopher J.; Wolf, Philip A.; D'Agostino, Ralph B., Sr.			Carotid-Wall Intima-Media Thickness and Cardiovascular Events	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; ATHEROSCLEROSIS RISK; ARTERIAL-WALL; MYOCARDIAL-INFARCTION; FRAMINGHAM RISK; PREDICTION; STROKE; COMMUNITIES; POPULATION; PLAQUE	Background Intima-media thickness of the walls of the common carotid artery and internal carotid artery may add to the Framingham risk score for predicting cardiovascular events. Methods We measured the mean intima-media thickness of the common carotid artery and the maximum intima-media thickness of the internal carotid artery in 2965 members of the Framingham Offspring Study cohort. Cardiovascular-disease outcomes were evaluated for an average follow-up of 7.2 years. Multivariable Cox proportional-hazards models were generated for intima-media thickness and risk factors. We evaluated the reclassification of cardiovascular disease on the basis of the 8-year Framingham risk score category (low, intermediate, or high) after adding intima-media thickness values. Results A total of 296 participants had a cardiovascular event. The risk factors of the Framingham risk score predicted these events, with a C statistic of 0.748 (95% confidence interval [CI], 0.719 to 0.776). The adjusted hazard ratio for cardiovascular disease with a 1-SD increase in the mean intima-media thickness of the common carotid artery was 1.13 (95% CI, 1.02 to 1.24), with a nonsignificant change in the C statistic of 0.003 (95% CI, 0.000 to 0.007); the corresponding hazard ratio for the maximum intima-media thickness of the internal carotid artery was 1.21 (95% CI, 1.13 to 1.29), with a modest increase in the C statistic of 0.009 (95% CI, 0.003 to 0.016). The net reclassification index increased significantly after addition of intima-media thickness of the internal carotid artery (7.6%, P<0.001) but not intima-media thickness of the common carotid artery (0.0%, P = 0.99). With the presence of plaque, defined as intima-media thickness of the internal carotid artery of more than 1.5 mm, the net reclassification index was 7.3% (P = 0.01), with an increase in the C statistic of 0.014 (95% CI, 0.003 to 0.025). Conclusions The maximum internal and mean common carotid-artery intima-media thicknesses both predict cardiovascular outcomes, but only the maximum intima-media thickness of (and presence of plaque in) the internal carotid artery significantly (albeit modestly) improves the classification of risk of cardiovascular disease in the Framingham Offspring Study cohort.	[Polak, Joseph F.] Tufts Med Ctr, Dept Radiol, Boston, MA 02111 USA; [Pencina, Michael J.] Boston Univ, Dept Biostat, Boston, MA 02215 USA; [Pencina, Karol M.; D'Agostino, Ralph B., Sr.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Wolf, Philip A.] Boston Univ, Dept Med & Neurol, Boston, MA 02215 USA; [O'Donnell, Christopher J.] NHLBI, Div Intramural Res, Framingham, MA USA	Tufts Medical Center; Boston University; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Polak, JF (corresponding author), Tufts Med Ctr, Dept Radiol, 800 Washington St,Box 299, Boston, MA 02111 USA.	jpolak@tuftsmedicalcenter.org		Wolf, Philip/0000-0002-3628-301X; Pencina, Michael/0000-0001-5798-8855	National Heart, Lung, and Blood Institute [R01 HL069003, HL081352, N01-HC-25195]; Abbott; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081352, R01HL069003, ZIAHL006002] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Abbott(Abbott Laboratories); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Heart, Lung, and Blood Institute (R01 HL069003 and HL081352, to Dr. Polak) and its Framingham Heart Study (N01-HC-25195).; Dr. Pencina reports receiving fees for board membership from Abbott. No other potential conflict of interest relevant to this article was reported.	Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Dalager S, 2007, STROKE, V38, P2698, DOI 10.1161/STROKEAHA.107.486480; del Sol AI, 2001, STROKE, V32, P1532, DOI 10.1161/01.STR.32.7.1532; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; Greenland P, 2010, CIRCULATION, V122, P2748, DOI 10.1161/CIR.0b013e3182051bab; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Hodis HN, 1996, ANN INTERN MED, V124, P548, DOI 10.7326/0003-4819-124-6-199603150-00002; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; LI RL, 1994, STROKE, V25, P2377, DOI 10.1161/01.STR.25.12.2377; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; MCNAMARA JR, 1987, CLIN CHIM ACTA, V166, P1, DOI 10.1016/0009-8981(87)90188-4; NAGHAVI M, 2006, AM J CARDIOL, V98, P2, DOI DOI 10.1016/J.AMJCARD.2006.03.002; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; OLeary DH, 1996, STROKE, V27, P224, DOI 10.1161/01.STR.27.2.224; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399; POLAK JF, 1993, RADIOLOGY, V188, P363, DOI 10.1148/radiology.188.2.8327679; Polak JF, 2010, J ULTRAS MED, V29, P1759, DOI 10.7863/jum.2010.29.12.1759; Rosvall M, 2005, J INTERN MED, V257, P430, DOI 10.1111/j.1365-2796.2005.01485.x; Rundek T, 2008, NEUROLOGY, V70, P1200, DOI 10.1212/01.wnl.0000303969.63165.34; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P376; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Touboul PJ, 2005, STROKE, V36, P1741, DOI 10.1161/01.STR.0000174490.23495.57; Touboul PJ, 2004, CEREBROVASC DIS, V18, P346, DOI 10.1159/000081812; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; WARWICK GR, 1982, CLIN CHEM, V28, P1379; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; 2001, JAMA, V285, P2486	36	566	590	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2011	365	3					213	221		10.1056/NEJMoa1012592	http://dx.doi.org/10.1056/NEJMoa1012592			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794QI	21774709	Green Accepted, Bronze			2022-12-28	WOS:000292915500005
J	Husebo, BS; Ballard, C; Sandvik, R; Nilsen, OB; Aarsland, D				Husebo, Bettina S.; Ballard, Clive; Sandvik, Reidun; Nilsen, Odd Bjarte; Aarsland, Dag			Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AGITATION; RISPERIDONE; PREVALENCE; STATEMENT; PSYCHOSIS; SYMPTOMS; DISEASE; SCALE	Objective To determine whether a systematic approach to the treatment of pain can reduce agitation in people with moderate to severe dementia living in nursing homes. Design Cluster randomised controlled trial. Setting 60 clusters (single independent nursing home units) in 18 nursing homes within five municipalities of western Norway. Participants 352 residents with moderate to severe dementia and clinically significant behavioural disturbances randomised to a stepwise protocol for the treatment of pain for eight weeks with additional follow-up four weeks after the end of treatment (33 clusters; n=175) or to usual treatment (control, 27 clusters; n=177). Intervention Participants in the intervention group received individual daily treatment of pain for eight weeks according to the stepwise protocol, with paracetamol (acetaminophen), morphine, buprenorphine transdermal patch, or pregabaline. The control group received usual treatment and care. Main outcome measures Primary outcome measure was agitation (scores on Cohen-Mansfield agitation inventory). Secondary outcome measures were aggression (scores on neuropsychiatric inventory-nursing home version), pain (scores on mobilisation-observation-behaviour-intensity-dementia-2), activities of daily living, and cognition (mini-mental state examination). Results Agitation was significantly reduced in the intervention group compared with control group after eight weeks (repeated measures analysis of covariance adjusting for baseline score, P<0.001): the average reduction in scores for agitation was 17% (treatment effect estimate -7.0, 95% confidence interval -3.7 to -10.3). Treatment of pain was also significantly beneficial for the overall severity of neuropsychiatric symptoms (-9.0, -5.5 to -12.6) and pain (-1.3, -0.8 to -1.7), but the groups did not differ significantly for activities of daily living or cognition. Conclusion A systematic approach to the management of pain significantly reduced agitation in residents of nursing homes with moderate to severe dementia. Effective management of pain can play an important part in the treatment of agitation and could reduce the number of unnecessary prescriptions for psychotropic drugs in this population.	[Ballard, Clive] Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 1UL, England; [Husebo, Bettina S.; Sandvik, Reidun] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, N-5020 Bergen, Norway; [Nilsen, Odd Bjarte] Stavanger Univ Hosp, Dept Psychiat, N-4011 Stavanger, Norway; [Aarsland, Dag] Karolinska Inst, Dept Neurobiol, Care Sci & Soc, Alzheimer Dis Res Ctr, Stockholm, Sweden; [Aarsland, Dag] Stavanger Univ Hosp, Dept Psychiat, Stavanger, Norway; [Aarsland, Dag] Univ Oslo, Oslo, Norway	University of London; King's College London; University of Bergen; Stavanger University Hospital; Karolinska Institutet; Stavanger University Hospital; University of Oslo	Ballard, C (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, Wolfson Wing & Hodgkin Bldg,Guys Campus, London SE1 1UL, England.	clive.ballard@kcl.ac.uk	Husebø, Bettina Sandgathe/AFO-7402-2022; Husebo, Bettina Sandgathe/AFP-1656-2022	Husebo, Bettina Sandgathe/0000-0002-6037-2864; Ballard, Clive/0000-0003-0022-5632; Aarsland, Dag/0000-0001-6314-216X	Norwegian Research Council [189439]; University of Bergen [09/1568]; Kavli's Research Centre for Ageing and Dementia, Haraldsplass Diakonian Hospital, Bergen, Norway	Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Bergen; Kavli's Research Centre for Ageing and Dementia, Haraldsplass Diakonian Hospital, Bergen, Norway	This study was funded by the Norwegian Research Council (protocol code 189439), the University of Bergen (09/1568), and Kavli's Research Centre for Ageing and Dementia, Haraldsplass Diakonian Hospital, Bergen, Norway.	[Anonymous], 1998, J Am Geriatr Soc, V46, P635; Ballard C, 2009, AM J GERIAT PSYCHIAT, V17, P726, DOI 10.1097/JGP.0b013e3181b0f8c0; BARNERJEE S, 2009, USE ANTIPSYCHOTIC ME; Brodaty H, 2003, J CLIN PSYCHIAT, V64, P134, DOI 10.4088/JCP.v64n0205; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Chibnall JT, 2005, J AM GERIATR SOC, V53, P1921, DOI 10.1111/j.1532-5415.2005.53572.x; Cohen-Mansfield J, 2005, J PSYCHIATR RES, V39, P325, DOI 10.1016/j.jpsychires.2004.08.009; Cohen-Mansfield J, 2004, INT J GERIATR PSYCH, V19, P881, DOI 10.1002/gps.1171; Cohen-Mansfield J, 2007, J GERONTOL A-BIOL, V62, P908, DOI 10.1093/gerona/62.8.908; Cohen-Mansfield J, 2008, PAIN, V134, P16, DOI 10.1016/j.pain.2007.03.023; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dartigues JF, 2009, LANCET NEUROL, V8, P1082, DOI 10.1016/S1474-4422(09)70298-4; De Deyn PP, 1999, NEUROLOGY, V53, P946, DOI 10.1212/WNL.53.5.946; Deberdt WG, 2005, AM J GERIAT PSYCHIAT, V13, P722, DOI 10.1176/appi.ajgp.13.8.722; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Husebo BS, 2010, SCAND J CARING SCI, V24, P380, DOI 10.1111/j.1471-6712.2009.00710.x; Husebo BS, 2008, J AM MED DIR ASSOC, V9, P427, DOI 10.1016/j.jamda.2008.03.001; HUSEBO BS, 2011, INT J GERIATR PSYCHI; Kovach Christine R, 2006, Am J Alzheimers Dis Other Demen, V21, P147, DOI 10.1177/1533317506288949; Livingston G, 2005, AM J PSYCHIAT, V162, P1996, DOI 10.1176/appi.ajp.162.11.1996; Lyketsos CG, 2006, AM J GERIAT PSYCHIAT, V14, P561, DOI 10.1097/01.JGP.0000221334.65330.55; Mahoney AEJ, 2008, AM J ALZHEIMERS DIS, V23, P250, DOI 10.1177/1533317508317524; Manfredi PL, 2003, INT J GERIATR PSYCH, V18, P700, DOI 10.1002/gps.906; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; Rinaldi P, 2005, INT J GERIATR PSYCH, V20, P168, DOI 10.1002/gps.1267; Selbaek G, 2007, INT J GERIATR PSYCH, V22, P843, DOI 10.1002/gps.1749; Sheikh K, 1979, Int Rehabil Med, V1, P51; Testad I, 2007, INT J GERIATR PSYCH, V22, P916, DOI 10.1002/gps.1766; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123	29	278	282	3	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 17	2011	343								d4065	10.1136/bmj.d4065	http://dx.doi.org/10.1136/bmj.d4065			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	794OQ	21765198	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000292910200002
J	Isaacs, FJ; Carr, PA; Wang, HH; Lajoie, MJ; Sterling, B; Kraal, L; Tolonen, AC; Gianoulis, TA; Goodman, DB; Reppas, NB; Emig, CJ; Bang, D; Hwang, SJ; Jewett, MC; Jacobson, JM; Church, GM				Isaacs, Farren J.; Carr, Peter A.; Wang, Harris H.; Lajoie, Marc J.; Sterling, Bram; Kraal, Laurens; Tolonen, Andrew C.; Gianoulis, Tara A.; Goodman, Daniel B.; Reppas, Nikos B.; Emig, Christopher J.; Bang, Duhee; Hwang, Samuel J.; Jewett, Michael C.; Jacobson, Joseph M.; Church, George M.			Precise Manipulation of Chromosomes in Vivo Enables Genome-Wide Codon Replacement	SCIENCE			English	Article							ESCHERICHIA-COLI; GENETIC-CODE; AMINO-ACIDS; RECOMBINATION; CONSEQUENCES; EVOLUTION; CLONING; SYSTEM; REPAIR; CELL	We present genome engineering technologies that are capable of fundamentally reengineering genomes from the nucleotide to the megabase scale. We used multiplex automated genome engineering (MAGE) to site-specifically replace all 314 TAG stop codons with synonymous TAA codons in parallel across 32 Escherichia coli strains. This approach allowed us to measure individual recombination frequencies, confirm viability for each modification, and identify associated phenotypes. We developed hierarchical conjugative assembly genome engineering (CAGE) to merge these sets of codon modifications into genomes with 80 precise changes, which demonstrate that these synonymous codon substitutions can be combined into higher-order strains without synthetic lethal effects. Our methods treat the chromosome as both an editable and an evolvable template, permitting the exploration of vast genetic landscapes.	[Isaacs, Farren J.; Wang, Harris H.; Lajoie, Marc J.; Kraal, Laurens; Tolonen, Andrew C.; Gianoulis, Tara A.; Goodman, Daniel B.; Jewett, Michael C.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Carr, Peter A.; Sterling, Bram; Jacobson, Joseph M.] MIT, Ctr Bits & Atoms, Cambridge, MA 02139 USA; [Carr, Peter A.; Sterling, Bram; Jacobson, Joseph M.] MIT, Media Lab, Cambridge, MA 02139 USA; [Wang, Harris H.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA; [Wang, Harris H.; Goodman, Daniel B.] Harvard Mit Div Hlth Sci & Technol, Program Med Engn & Med Phys, Cambridge, MA 02139 USA; [Wang, Harris H.; Gianoulis, Tara A.; Church, George M.] Harvard Univ, Wyss Inst, Boston, MA 02115 USA; [Lajoie, Marc J.] Harvard Univ, Program Chem Biol, Cambridge, MA 02138 USA; [Reppas, Nikos B.] Jould Unltd, Cambridge, MA 02139 USA; [Emig, Christopher J.] Stanford Univ, Dept Bioengn, Palo Alto, CA 94305 USA; [Bang, Duhee] Yonsei Univ, Dept Chem, Seoul 120749, South Korea; [Hwang, Samuel J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Jewett, Michael C.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Jewett, Michael C.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard University; Harvard University; Stanford University; Yonsei University; Massachusetts Institute of Technology (MIT); Northwestern University; Northwestern University	Isaacs, FJ (corresponding author), Yale Univ, Syst Biol Inst, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	farren.isaacs@yale.edu; carr@mit.edu	Jewett, Michael C/E-3506-2010	Goodman, Daniel/0000-0003-3759-6883; Tolonen, Andrew/0000-0001-5907-4504; Jacobson, Joseph/0000-0002-1332-3197; church, george/0000-0001-6232-9969; Jewett, Michael/0000-0003-2948-6211	NSF (SynBERC, Center for Bits and Atoms, and Genes and Genomes Systems Cluster); U.S. Department of Energy; NSF; National Defense Science and Engineering Graduate Fellowship; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM081450, R00GM081450] Funding Source: NIH RePORTER	NSF (SynBERC, Center for Bits and Atoms, and Genes and Genomes Systems Cluster); U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); National Defense Science and Engineering Graduate Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Zhang for helpful discussions and extensive use of laboratory resources, R. Kolter for the JC411 strain, and members of the Church and Jacobson labs for helpful discussions. Supported by the NSF (SynBERC, Center for Bits and Atoms, and Genes and Genomes Systems Cluster), the U.S. Department of Energy, an NSF graduate fellowship (H. H. W.), a National Defense Science and Engineering Graduate Fellowship (M.J.L.), and an NIH K99/R00 award (M.C.J.).	Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Carr PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh160; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Cha R S, 1992, PCR Methods Appl, V2, P14; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.2434959100; DeVito JA, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1084; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Funchain P, 2000, GENETICS, V154, P959; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699; Hemm MR, 2010, J BACTERIOL, V192, P46, DOI 10.1128/JB.00872-09; IRWIN B, 1995, J BIOL CHEM, V270, P22801, DOI 10.1074/jbc.270.39.22801; Itaya M, 2005, P NATL ACAD SCI USA, V102, P15971, DOI 10.1073/pnas.0503868102; Jacinto-Loeza E, 2008, NUCLEIC ACIDS RES, V36, P4233, DOI 10.1093/nar/gkn395; Knight RD, 2001, NAT REV GENET, V2, P49, DOI 10.1038/35047500; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Masi M, 2007, J BACTERIOL, V189, P2667, DOI 10.1128/JB.01448-06; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mukai T, 2010, NUCLEIC ACIDS RES, V38, P8188, DOI 10.1093/nar/gkq707; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Oppenheim AB, 2004, VIROLOGY, V319, P185, DOI 10.1016/j.virol.2003.11.007; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; SMITH GR, 1991, CELL, V64, P19, DOI 10.1016/0092-8674(91)90205-D; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Young TS, 2010, J BIOL CHEM, V285, P11039, DOI 10.1074/jbc.R109.091306; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	35	394	438	7	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					348	353		10.1126/science.1205822	http://dx.doi.org/10.1126/science.1205822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764749	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000292732000045
J	Luo, AH; Tahsili-Fahadan, P; Wise, RA; Lupica, CR; Aston-Jones, G				Luo, Alice H.; Tahsili-Fahadan, Pouya; Wise, Roy A.; Lupica, Carl R.; Aston-Jones, Gary			Linking Context with Reward: A Functional Circuit from Hippocampal CA3 to Ventral Tegmental Area	SCIENCE			English	Article							DOPAMINE NEURONS; COCAINE-SEEKING; NUCLEUS; RAT; REPRESENTATIONS; STIMULATION; PROJECTIONS; AFFERENTS; RELAPSE; MEMORY	Reward-motivated behavior is strongly influenced by the learned significance of contextual stimuli in the environment. However, the neural pathways that mediate context-reward relations are not well understood. We have identified a circuit from area CA3 of dorsal hippocampus to ventral tegmental area (VTA) that uses lateral septum (LS) as a relay. Theta frequency stimulation of CA3 excited VTA dopamine (DA) neurons and inhibited non-DA neurons. DA neuron excitation was likely mediated by disinhibition because local antagonism of g-aminobutyric acid receptors blocked responses to CA3 stimulation. Inactivating components of the CA3-LS-VTA pathway blocked evoked responses in VTA and also reinstatement of cocaine-seeking by contextual stimuli. This transsynaptic link between hippocampus and VTA appears to be an important substrate by which environmental context regulates goal-directed behavior.	[Luo, Alice H.; Wise, Roy A.] Natl Inst Drug Abuse, Behav Neurosci Sect, Behav Neurosci Res Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Tahsili-Fahadan, Pouya; Aston-Jones, Gary] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Lupica, Carl R.] Natl Inst Drug Abuse, Electrophysiol Res Sect, Cellular Neurobiol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Luo, AH (corresponding author), Natl Inst Drug Abuse, Behav Neurosci Sect, Behav Neurosci Res Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA.	alice_luo@hotmail.com	Lupica, Carl/AAY-3193-2021; Wise, Roy A/A-6465-2012	Lupica, Carl/0000-0002-5375-3263; 	U.S. Public Health Service [R37-DA006214, F31-MH071093]; National Institute on Drug Abuse; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH071093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000471, ZIADA000588, R37DA006214, ZIADA000457] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Bingham and J. See for assistance with the initial anatomical experiments; R. Fallon, G. Sartor, L. Zhang, S. Mahler, K. Moussawi, R. Smith, and T. Smith for assistance with behavioral studies; C. Backman and W. Freed for use of their microscopy equipment; and C. Mejias-Aponte for his programming expertise and thoughtful comments. This work was supported by U.S. Public Health Service grant awards R37-DA006214 and F31-MH071093, and the National Institute on Drug Abuse Intramural Research Program. The anatomical data were gathered at the University of Pennsylvania.	Alvernhe A, 2008, J NEUROSCI, V28, P7324, DOI 10.1523/JNEUROSCI.1909-08.2008; Bossert JM, 2005, EUR J PHARMACOL, V526, P36, DOI 10.1016/j.ejphar.2005.09.030; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; CARD JP, 1993, J NEUROSCI, V13, P2515, DOI 10.1523/JNEUROSCI.13-06-02515.1993; DEFRANCE JF, 1973, EXP BRAIN RES, V17, P447; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Floresco SB, 2001, J NEUROSCI, V21, P4915, DOI 10.1523/JNEUROSCI.21-13-04915.2001; Fuchs RA, 2007, EUR J NEUROSCI, V26, P487, DOI 10.1111/j.1460-9568.2007.05674.x; Geisler S, 2005, J COMP NEUROL, V490, P270, DOI 10.1002/cne.20668; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Legault M, 2000, J NEUROSCI, V20, P1635; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Luo AH, 2009, EUR J NEUROSCI, V29, P748, DOI 10.1111/j.1460-9568.2008.06606.x; SWANSON LW, 1981, J NEUROSCI, V1, P548; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Vorel SR, 2001, SCIENCE, V292, P1175, DOI 10.1126/science.1058043	17	273	281	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					353	357		10.1126/science.1204622	http://dx.doi.org/10.1126/science.1204622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764750	Green Accepted			2022-12-28	WOS:000292732000046
J	Riordan, O; Warnke, L				Riordan, Oliver; Warnke, Lutz			Explosive Percolation Is Continuous	SCIENCE			English	Article							EMERGENCE; BIRTH	"Explosive percolation" is said to occur in an evolving network when a macroscopic connected component emerges in a number of steps that is much smaller than the system size. Recent predictions based on simulations suggested that certain Achlioptas processes (much-studied local modifications of the classical mean-field growth model of Erdos and Renyi) exhibit this phenomenon, undergoing a phase transition that is discontinuous in the scaling limit. We show that, in fact, all Achlioptas processes have continuous phase transitions, although related models in which the number of nodes sampled may grow with the network size can indeed exhibit explosive percolation.	[Riordan, Oliver; Warnke, Lutz] Univ Oxford, Math Inst, Oxford OX1 3LB, England	University of Oxford	Riordan, O (corresponding author), Univ Oxford, Math Inst, 24-29 St Giles, Oxford OX1 3LB, England.	riordan@maths.ox.ac.uk			Engineering and Physical Sciences Research Council	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	L.W.'s research was supported by an Engineering and Physical Sciences Research Council Research Studentship and a Scatcherd European Scholarship.	Achlioptas D, 2009, SCIENCE, V323, P1453, DOI 10.1126/science.1167782; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Azar Y, 1999, SIAM J COMPUT, V29, P180, DOI 10.1137/S0097539795288490; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Beveridge A, 2009, SIAM J DISCRETE MATH, V23, P993, DOI 10.1137/070684148; Bohmam T, 2006, COMB PROBAB COMPUT, V15, P489, DOI 10.1017/S0963548306007486; Bohman T, 2001, RANDOM STRUCT ALGOR, V19, P75, DOI 10.1002/rsa.1019; Bohman T, 2009, SCIENCE, V323, P1438, DOI 10.1126/science.1171297; Bollobas B, 2003, HANDBOOK OF GRAPHS AND NETWORKS: FROM THE GENOME TO THE INTERNET, P1; BOLLOBAS B, 1984, T AM MATH SOC, V286, P257, DOI 10.2307/1999405; Bollobas B., 2003, INTERNET MATH, V1, P1, DOI [DOI 10.1080/15427951.2004.10129080, 10.1080/15427951.2004.10129080]; Bollobas B, 2007, RANDOM STRUCT ALGOR, V31, P3, DOI 10.1002/rsa.20168; Cho YS, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.042102; Cho YS, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.135702; D'Souza RM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.195702; da Costa RA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.255701; ERDOS P, 1960, B INT STATIST INST, V38, P343; Friedman EJ, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.255701; JANSON S, 1993, RANDOM STRUCT ALGOR, V4, P233, DOI 10.1002/rsa.3240040303; Lloyd AL, 2001, SCIENCE, V292, P1316, DOI 10.1126/science.1061076; Luczak T., 1990, RANDOM STRUCT ALGOR, V1, P287, DOI DOI 10.1002/RSA.3240010305; Nagler J, 2011, NAT PHYS, V7, P265, DOI [10.1038/nphys1860, 10.1038/NPHYS1860]; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pittel B, 2005, J COMB THEORY B, V93, P127, DOI 10.1016/j.jctb.2004.09.005; Radicchi F, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036110; Radicchi F, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.168701; Riordan O, 2005, COMB PROBAB COMPUT, V14, P897, DOI 10.1017/S096354830500708X; Spencer J, 2007, COMBINATORICA, V27, P587, DOI 10.1007/s00493-007-2163-2; Ziff RM, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.051105	29	205	209	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2011	333	6040					322	324		10.1126/science.1206241	http://dx.doi.org/10.1126/science.1206241			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764743				2022-12-28	WOS:000292732000037
J	Gravitz, L				Gravitz, Lauren			DRUGS A tangled web of targets	NATURE			English	Editorial Material							ALZHEIMERS-DISEASE											Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0	5	62	64	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					S9	S11		10.1038/475S9a	http://dx.doi.org/10.1038/475S9a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791UA	21760583				2022-12-28	WOS:000292690500005
J	Maunz, P				Maunz, Peter			QUANTUM PHYSICS Gentle measurement	NATURE			English	Editorial Material							SINGLE-ATOM; JUMPS		Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA	Duke University	Maunz, P (corresponding author), Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA.	peter.maunz@duke.edu						BERGQUIST JC, 1986, PHYS REV LETT, V57, P1699, DOI 10.1103/PhysRevLett.57.1699; Bochmann J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.203601; Hope JJ, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.043822; ITANO WM, 1990, PHYS REV A, V41, P2295, DOI 10.1103/PhysRevA.41.2295; Jones KM, 2006, REV MOD PHYS, V78, P483, DOI 10.1103/RevModPhys.78.483; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Long R, 2003, PHILOS T R SOC A, V361, P1375, DOI 10.1098/rsta.2003.1207; SAUTER T, 1986, PHYS REV LETT, V57, P1696, DOI 10.1103/PhysRevLett.57.1696; Schlosshauer M, 2004, REV MOD PHYS, V76, P1267, DOI 10.1103/RevModPhys.76.1267; Simon C, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.110405; Volz J, 2011, NATURE, V475, P210, DOI 10.1038/nature10225; Von Neumann J., 1932, MATH GRUNDLAGEN QUAN, V1st	13	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					180	181		10.1038/475180a	http://dx.doi.org/10.1038/475180a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753845				2022-12-28	WOS:000292690500038
J	English, PM				English, Peter M.			DOCTORS AND TERRORISTS Doctors should not agree to identify potential terrorists	BRITISH MEDICAL JOURNAL			English	Letter												petermbenglish@gmail.com	English, Peter/E-1341-2014	English, Peter/0000-0001-6914-9127				Dyer C, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3627	1	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 13	2011	343								d4211	10.1136/bmj.d4211	http://dx.doi.org/10.1136/bmj.d4211			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794OE	21752854				2022-12-28	WOS:000292908900005
J	Gutermuth, J; Nadas, K; Zirbs, M; Seifert, F; Hein, R; Ring, J; Brockow, K				Gutermuth, Jan; Nadas, Korinna; Zirbs, Michael; Seifert, Florian; Hein, Ruediger; Ring, Johannes; Brockow, Knut			Papular-purpuric gloves and socks syndrome	LANCET			English	Editorial Material									[Gutermuth, Jan; Zirbs, Michael; Seifert, Florian; Hein, Ruediger; Ring, Johannes] Tech Univ Munich, Dept Dermatol & Allergy Biederstein, D-80802 Munich, Germany; [Nadas, Korinna] Tech Univ Munich, Inst Virol, D-80802 Munich, Germany; [Gutermuth, Jan; Brockow, Knut] Tech Univ Munich, Ctr Allergy & Environm ZAUM, Helmholtz Ctr, D-80802 Munich, Germany; [Gutermuth, Jan; Ring, Johannes] Christine Kuhne Ctr Allergy Res & Educ CK CARE, Davos, Switzerland	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Gutermuth, J (corresponding author), Tech Univ Munich, Dept Dermatol & Allergy Biederstein, Biedersteinerstr 29, D-80802 Munich, Germany.	jan.gutermuth@lrz.tum.de	Ring, Johannes/GLN-4341-2022; Gutermuth, Jan/D-9487-2011	Ring, Johannes/0000-0001-8236-3152; 				Fruhauf J, 2009, J AM ACAD DERMATOL, V60, P691, DOI 10.1016/j.jaad.2008.08.037; HARMS M, 1990, J AM ACAD DERMATOL, V23, P850, DOI 10.1016/0190-9622(90)70302-X; Segura-Saint-Gerons R, 2007, MED ORAL PATOL ORAL, V12, P4; van Roijen MM, 1999, HAUTARZT, V50, P280, DOI 10.1007/s001050050902; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840	5	16	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 9	2011	378	9786					198	198		10.1016/S0140-6736(11)60554-0	http://dx.doi.org/10.1016/S0140-6736(11)60554-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	795CJ	21742170				2022-12-28	WOS:000292948800036
J	Heckman, TM; Kauffmann, G				Heckman, Timothy M.; Kauffmann, Guinevere			The Coevolution of Galaxies and Supermassive Black Holes: A Local Perspective	SCIENCE			English	Review							ACTIVE GALACTIC NUCLEI; DIGITAL SKY SURVEY; STAR-FORMATION; ELLIPTIC GALAXIES; BULGE MASS; EVOLUTION; LUMINOSITY; GROWTH; MODEL; FEEDBACK	One of the most fascinating discoveries in the past decade was that galaxies typically contain a centrally located black hole with a mass that is millions or even billions of times that of the Sun. There is now compelling evidence that we cannot understand how galaxies formed and evolved without understanding the life cycles of these supermassive black holes (and vice versa). We summarize the current understanding of this coevolution of galaxies and supermassive black holes (based largely on observations of the local, present-day universe) and describe prospects for the future.	[Heckman, Timothy M.] Johns Hopkins Univ, Ctr Astrophys Sci, Dept Phys & Astron, Baltimore, MD 21218 USA; [Kauffmann, Guinevere] Max Planck Inst Astrophys, D-85741 Garching, Germany	Johns Hopkins University; Max Planck Society	Heckman, TM (corresponding author), Johns Hopkins Univ, Ctr Astrophys Sci, Dept Phys & Astron, Baltimore, MD 21218 USA.	heckman@pha.jhu.edu						Baldry IK, 2004, ASTROPHYS J, V600, P681, DOI 10.1086/380092; Best PN, 2006, MON NOT R ASTRON SOC, V368, pL67, DOI 10.1111/j.1745-3933.2006.00159.x; Brandt WN, 2005, ANNU REV ASTRON ASTR, V43, P827, DOI 10.1146/annurev.astro.43.051804.102213; Brown MJI, 2007, ASTROPHYS J, V654, P858, DOI 10.1086/509652; Churazov E, 2001, ASTROPHYS J, V554, P261, DOI 10.1086/321357; Ciotti L, 2007, ASTROPHYS J, V665, P1038, DOI 10.1086/519833; Cowie LL, 1996, ASTRON J, V112, P839, DOI 10.1086/118058; Croton DJ, 2006, MON NOT R ASTRON SOC, V365, P11, DOI 10.1111/j.1365-2966.2005.09675.x; Davies RI, 2007, ASTROPHYS J, V671, P1388, DOI 10.1086/523032; Faber SM, 2007, ASTROPHYS J, V665, P265, DOI 10.1086/519294; Ferrarese L, 2005, SPACE SCI REV, V116, P523, DOI 10.1007/s11214-005-3947-6; Genzel R, 2010, REV MOD PHYS, V82, DOI 10.1103/RevModPhys.82.3121; Ghez AM, 2008, ASTROPHYS J, V689, P1044, DOI 10.1086/592738; Greene JE, 2007, ASTROPHYS J, V667, P131, DOI 10.1086/520497; Gultekin K, 2009, ASTROPHYS J, V698, P198, DOI 10.1088/0004-637X/698/1/198; Haring N, 2004, ASTROPHYS J, V604, pL89, DOI 10.1086/383567; Heckman TM, 2004, ASTROPHYS J, V613, P109, DOI 10.1086/422872; HECKMAN TM, 1990, ASTROPHYS J SUPPL S, V74, P833, DOI 10.1086/191522; Ho LC, 2008, ANNU REV ASTRON ASTR, V46, P475, DOI 10.1146/annurev.astro.45.051806.110546; Hopkins PF, 2006, ASTROPHYS J SUPPL S, V163, P1, DOI 10.1086/499298; Kauffmann G, 2003, MON NOT R ASTRON SOC, V346, P1055, DOI 10.1111/j.1365-2966.2003.07154.x; Kauffmann G, 2000, MON NOT R ASTRON SOC, V311, P576, DOI 10.1046/j.1365-8711.2000.03077.x; Kauffmann G, 2007, ASTROPHYS J SUPPL S, V173, P357, DOI 10.1086/516647; Kauffmann G, 2009, MON NOT R ASTRON SOC, V397, P135, DOI 10.1111/j.1365-2966.2009.14960.x; Li C, 2008, MON NOT R ASTRON SOC, V385, P1915, DOI 10.1111/j.l365-2966.2008.13023.x; Marconi A, 2003, ASTROPHYS J, V589, pL21, DOI 10.1086/375804; Marconi A, 2004, MON NOT R ASTRON SOC, V351, P169, DOI 10.1111/j.1365-2966.2004.07765.x; McNamara BR, 2007, ANNU REV ASTRON ASTR, V45, P117, DOI 10.1146/annurev.astro.45.051806.110625; Netzer H, 2009, MON NOT R ASTRON SOC, V399, P1907, DOI 10.1111/j.1365-2966.2009.15434.x; Noeske KG, 2007, ASTROPHYS J, V660, pL47, DOI 10.1086/517927; Panter B, 2007, MON NOT R ASTRON SOC, V378, P1550, DOI 10.1111/j.1365-2966.2007.11909.x; Reichard TA, 2009, ASTROPHYS J, V691, P1005, DOI 10.1088/0004-637X/691/2/1005; Saintonge A., 2011, MON NOT R ASTRON SOC; Sanders DB, 1996, ANNU REV ASTRON ASTR, V34, P749, DOI 10.1146/annurev.astro.34.1.749; Schiminovich D, 2007, ASTROPHYS J SUPPL S, V173, P315, DOI 10.1086/524659; Springel V, 2005, MON NOT R ASTRON SOC, V361, P776, DOI 10.1111/j.1365-2966.2005.09238.x; Veilleux S, 2005, ANNU REV ASTRON ASTR, V43, P769, DOI 10.1146/annurev.astro.43.072103.150610; Wild V, 2010, MON NOT R ASTRON SOC, V405, P933, DOI 10.1111/j.1365-2966.2010.16536.x	38	15	15	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					182	185		10.1126/science.1200504	http://dx.doi.org/10.1126/science.1200504			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21737734	Green Submitted			2022-12-28	WOS:000292502700038
J	Cherkin, DC; Sherman, KJ; Kahn, J; Wellman, R; Cook, AJ; Johnson, E; Erro, J; Delaney, K; Deyo, RA				Cherkin, Daniel C.; Sherman, Karen J.; Kahn, Janet; Wellman, Robert; Cook, Andrea J.; Johnson, Eric; Erro, Janet; Delaney, Kristin; Deyo, Richard A.			A Comparison of the Effects of 2 Types of Massage and Usual Care on Chronic Low Back Pain A Randomized, Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article							NATIONAL-SURVEY; THERAPY	Background: Few studies have evaluated the effectiveness of massage for chronic low back pain. Objective: To compare the effectiveness of 2 types of massage and usual care for chronic back pain. Design: Parallel-group randomized, controlled trial. Randomization was computer-generated, with centralized allocation concealment. Participants were blinded to massage type but not to assignment to massage versus usual care. Massage therapists were unblinded. The study personnel who assessed outcomes were blinded to treatment assignment. (ClinicalTrials. gov registration number: NCT00371384) Setting: An integrated health care delivery system in the Seattle area. Patients: 401 persons 20 to 65 years of age with nonspecific chronic low back pain. Intervention: Structural massage (n = 132), relaxation massage (n = 136), or usual care (n = 133). Measurements: Roland Disability Questionnaire (RDQ) and symptom bothersomeness scores at 10 weeks (primary outcome) and at 26 and 52 weeks (secondary outcomes). Mean group differences of at least 2 points on the RDQ and at least 1.5 points on the symptom bothersomeness scale were considered clinically meaningful. Results: The massage groups had similar functional outcomes at 10 weeks. The adjusted mean RDQ score was 2.9 points (95% CI, 1.8 to 4.0 points) lower in the relaxation group and 2.5 points (CI, 1.4 to 3.5 points) lower in the structural massage group than in the usual care group, and adjusted mean symptom bothersomeness scores were 1.7 points (CI, 1.2 to 2.2 points) lower with relaxation massage and 1.4 points (CI, 0.8 to 1.9 points) lower with structural massage. The beneficial effects of relaxation massage on function (but not on symptom reduction) persisted at 52 weeks but were small. Limitation: Participants were not blinded to treatment. Conclusion: Massage therapy may be effective for treatment of chronic back pain, with benefits lasting at least 6 months. No clinically meaningful difference between relaxation and structural massage was observed in terms of relieving disability or symptoms.	[Cherkin, Daniel C.] Grp Hlth Res Inst, Seattle, WA 98101 USA; Univ Washington, Seattle, WA 98195 USA; Univ Vermont, Burlington, VT USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA	University of Washington; University of Washington Seattle; University of Vermont; Oregon Health & Science University	Cherkin, DC (corresponding author), Grp Hlth Res Inst, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.				National Center for Complementary and Alternative Medicine [R01 AT 001927]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT001927] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	Primary Funding Source: National Center for Complementary and Alternative Medicine.r Grant Support: By the NCCAM (grant R01 AT 001927).	Bombardier C, 2000, SPINE, V25, P3100, DOI 10.1097/00007632-200012150-00003; Cherkin Daniel C, 2002, J Am Board Fam Pract, V15, P463; Cherkin DC, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-96; Cherkin DC, 2001, ARCH INTERN MED, V161, P1081, DOI 10.1001/archinte.161.8.1081; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Field T, 2007, J BODYW MOV THER, V11, P141, DOI 10.1016/j.jbmt.2006.03.001; Furlan AD, 2009, SPINE, V34, P1669, DOI 10.1097/BRS.0b013e3181ad7bd6; Hagg O, 2003, EUR SPINE J, V12, P12, DOI 10.1007/s00586-002-0464-0; Hernandez-Reif M, 2001, INT J NEUROSCI, V106, P131, DOI 10.3109/00207450109149744; Kumnerddee Wipoo, 2009, J Med Assoc Thai, V92 Suppl 1, pS117; LI KH, 1991, J AM STAT ASSOC, V86, P1065, DOI 10.2307/2290525; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Little P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a884; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; Preyde M, 2000, CAN MED ASSOC J, V162, P1815; Riess PW, 1986, VITAL HLTH STAT; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wolsko PM, 2003, SPINE, V28, P292, DOI 10.1097/00007632-200302010-00018; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	22	82	85	0	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2011	155	1					1	+		10.7326/0003-4819-155-1-201107050-00002	http://dx.doi.org/10.7326/0003-4819-155-1-201107050-00002			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788MA	21727288				2022-12-28	WOS:000292447800001
J	Ruxin, J; Habinshuti, A				Ruxin, Josh; Habinshuti, Antoinette			Crowd control in Rwanda	NATURE			English	Editorial Material									[Ruxin, Josh] Columbia Univ, New York, NY 10027 USA	Columbia University	Ruxin, J (corresponding author), Columbia Univ, New York, NY 10027 USA.	joshruxin@columbia.edu							0	2	2	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2011	474	7353					572	573		10.1038/474572a	http://dx.doi.org/10.1038/474572a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	785CF	21720346	Bronze			2022-12-28	WOS:000292204300015
J	Hart, CL; Gruer, L; Watt, GCM				Hart, Carole L.; Gruer, Laurence; Watt, Graham C. M.			Cause specific mortality, social position, and obesity among women who had never smoked: 28 year cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LUNG-FUNCTION; BODY-MASS; SMOKING; MEN; DISEASE; HEALTH; RISK; INEQUALITIES; OVERWEIGHT; SCOTLAND	Objective To investigate the relations between causes of death, social position, and obesity in women who had never smoked. Design Prospective cohort study. Setting Renfrew and Paisley, Scotland. Participants 8353 women and 7049 men aged 45-64 were recruited to the Renfrew and Paisley Study in 1972-6. Of these, 3613 women had never smoked and were the focus of this study. They were categorised by occupational class (I and II, III non-manual, III manual, and IV and V) and body mass index groups (normal weight, overweight, moderately obese, and severely obese). Main outcome measures All cause and cause specific mortality during 28 years of follow-up by occupational class and body mass index, using Cox proportional hazards models adjusted for age and other confounders. Results The women in lower occupational classes who had never smoked were on average shorter and had poorer lung function and higher systolic blood pressure than women in the higher occupational classes. Overall, 43% (n=1555) were overweight, 14% (n=515) moderately obese, and 5% (n=194) severely obese. Obesity rates were higher in lower occupational classes and much higher in all occupational classes than in current smokers in the full cohort. Half the women died, 51% (n=916) from cardiovascular disease and 27% (n=487) from cancer. Relative to occupational class I and II, all cause mortality rates were more than a third higher in occupational classes III manual (relative rate 1.35, 95% confidence interval 1.16 to 1.57) and IV and V (1.34, 1.17 to 1.55) and largely explained by differences in obesity, systolic blood pressure, and lung function. Similar upward gradients were seen for cardiovascular disease and respiratory disease but not for cancer. Mortality rates were highest in severely obese women in the lowest occupational classes. Conclusions Women who had never smoked and were not obese had the lowest mortality rates, regardless of their social position. Where obesity is socially patterned as in this cohort, it may contribute to health inequalities and increase pressure on health and social services serving more disadvantaged populations.	[Hart, Carole L.; Watt, Graham C. M.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 8RZ, Lanark, Scotland; [Gruer, Laurence] NHS Hlth Scotland, Glasgow, Lanark, Scotland	University of Glasgow	Hart, CL (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 8RZ, Lanark, Scotland.	carole.hart@glasgow.ac.uk		Gruer, Laurence/0000-0002-1089-2896	NHS Health Scotland; University of Glasgow	NHS Health Scotland; University of Glasgow	This research was supported by NHS Health Scotland. CLH and LG were funded by NHS Health Scotland and GCMW by the University of Glasgow. They had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The researchers were independent of the funders. All decisions relating to the study were made by the authors alone. The views expressed in the paper may not reflect those of the funding organisations.	Aekplakorn Wichai, 2004, Journal of the Medical Association of Thailand, V87, P685; [Anonymous], 1965, LANCET, V1, P775; Cavelaars AEJM, 2000, BRIT MED J, V320, P1102, DOI 10.1136/bmj.320.7242.1102; Corbett J, 2009, SCOTTISH HLTH SURVEY; DALLOSSO HM, 1984, INT J OBESITY, V8, P365; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; General Register Office, 1966, CLASS OCC 1966, P1; Gruer L, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b480; Hart CL, 2005, INT J EPIDEMIOL, V34, P28, DOI 10.1093/ije/dyh348; Haslam D, 2006, BMJ-BRIT MED J, V333, P640, DOI 10.1136/bmj.333.7569.640; HAWTHORNE VM, 1995, SCOT MED J, V40, P102, DOI 10.1177/003693309504000402; Hole DJ, 1996, BRIT MED J, V313, P711; Hotchkiss JW, 2010, J EPIDEMIOL COMMUN H, V64, pA12, DOI 10.1136/jech.2010.120956.31; Huisman M, 2005, TOB CONTROL, V14, P106, DOI 10.1136/tc.2004.008573; Law MR, 1998, J EPIDEMIOL COMMUN H, V52, P344, DOI 10.1136/jech.52.6.344; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mannino DM, 2006, EUR RESPIR J, V27, P627, DOI 10.1183/09031936.06.00024605; Meyer HE, 2002, MED SCI SPORT EXER, V34, P1065, DOI 10.1097/00005768-200207000-00002; Nechuta SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000339; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Sabia S, 2010, AM J EPIDEMIOL, V172, P1415, DOI 10.1093/aje/kwq294; Singh PN, 1998, EPIDEMIOLOGY, V9, P246, DOI 10.1097/00001648-199805000-00007; Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; World Health Organization Commission on Social Inequalities in Health, 2007, ACH HLTH EQ ROOT CAU	26	19	19	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2011	342								d3785	10.1136/bmj.d3785	http://dx.doi.org/10.1136/bmj.d3785			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788PY	21712337	Green Submitted, Green Accepted, hybrid, Green Published			2022-12-28	WOS:000292458100003
J	Karim, SSA; Karim, QA				Karim, Salim S. Abdool; Karim, Quarraisha Abdool			Antiretroviral prophylaxis: a defining moment in HIV control	LANCET			English	Editorial Material							PREVENTION; INFECTION		[Karim, Salim S. Abdool] Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa CAPRISA, ZA-4013 Durban, South Africa; Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	University of Kwazulu Natal; Columbia University	Karim, SSA (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa CAPRISA, ZA-4013 Durban, South Africa.	karims1@ukzn.ac.za	Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Abdool/P-3117-2019; Abdool Karim, Quarraisha/GVS-1160-2022; Karim, Salim Safurdeen Abdool/N-5947-2013	Karim, Salim Abdool/0000-0002-4986-2133; Abdool Karim, Quarraisha/0000-0002-0985-477X; Karim, Salim Safurdeen Abdool/0000-0002-4986-2133	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068619, U01AI069469] Funding Source: NIH RePORTER; NIAID NIH HHS [UM1 AI068619, U01 AI069469, UM1 AI068619-07, U01 AI069469-06] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; FHI statement on the FEM-PrEP HIV Prevention Study, 2011, FHI STATEMENT FEM PR; Gilead Sciences Inc, 2011, GIL EXP ACC PROGR ME; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Karim SSA, 2011, NATURE, V474, P29, DOI 10.1038/474029a; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Siegfried N., 2009, COCHRANE DB SYST REV, V15	12	74	77	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2011	378	9809					E23	E25		10.1016/S0140-6736(11)61136-7	http://dx.doi.org/10.1016/S0140-6736(11)61136-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865EL	21771566	Green Submitted, Green Accepted			2022-12-28	WOS:000298293600002
J	Zamperetti, N; Bellomo, R; Piccinni, P; Ronco, C				Zamperetti, Nereo; Bellomo, Rinaldo; Piccinni, Pasquale; Ronco, Claudio			Reflections on transplantation waiting lists	LANCET			English	Editorial Material							DONATION; DEATH		[Zamperetti, Nereo; Piccinni, Pasquale] San Bortolo Hosp, Dept Anesthesia & Intens Care Med, I-36100 Vicenza, Italy; [Ronco, Claudio] San Bortolo Hosp, Dept Nephrol Dialysis & Transplantat, Int Renal Res Inst, I-36100 Vicenza, Italy; [Bellomo, Rinaldo] Dept Intens Care, Melbourne, Vic, Australia	ULSS 8 Berica; Ospedale San Bortolo di Vicenza; ULSS 8 Berica; Ospedale San Bortolo di Vicenza	Zamperetti, N (corresponding author), San Bortolo Hosp, Dept Anesthesia & Intens Care Med, Via Rodolfi 37, I-36100 Vicenza, Italy.	nereo.zamperetti@ulssvicenza.it		Ronco, Claudio/0000-0002-6697-4065				Beecher HK, 1968, JAMA-J AM MED ASSOC, V205, P85; Bentas W, 2008, NEPHROL DIAL TRANSPL, V23, P2043, DOI 10.1093/ndt/gfm912; Bernat JL, 2010, CRIT CARE MED, V38, P963, DOI 10.1097/CCM.0b013e3181c58916; Bernat JL, 2006, AM J TRANSPLANT, V6, P281, DOI 10.1111/j.1600-6143.2005.01194.x; *COUNC EUR NEWSL T, INT FIG DON TRANSPL; Devita Michael A., 1993, Kennedy Institute of Ethics Journal, V3, P113; Huang E, 2009, SEMIN NEPHROL, V29, P621, DOI 10.1016/j.semnephrol.2009.07.011; Kaplan RM, 2007, ANNU REV PUBL HEALTH, V28, P321, DOI 10.1146/annurev.publhealth.28.021406.144141; National Health Service (NHS), 2013, NHS BLOOD TRANSPL TR; *PRES CONS MIN, C STAT REG SED 23 SE; *PRES CONS MIN, C STAT REG SED 31 GE; STEIN R, 2008, WASHINGTON POST 0322; Transplantation Society of Australia and New Zealand, 2014, ORG TRANSPL DEC DON; *US HLTH RES SERV, 2010, ORG PROC TRANSPL NET; Zamperetti N, 2006, INTENS CARE MED, V32, P830, DOI 10.1007/s00134-006-0155-0	15	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 13	2011	378	9791					632	635		10.1016/S0140-6736(10)62343-4	http://dx.doi.org/10.1016/S0140-6736(10)62343-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	812UX	21752461				2022-12-28	WOS:000294319500035
J	Hadigan, C; Kottilil, S				Hadigan, Colleen; Kottilil, Shyamasundaran			Hepatitis C Virus Infection and Coinfection With Human Immunodeficiency Virus Challenges and Advancements in Management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACEBO-CONTROLLED TRIAL; ALPHA-2A PLUS RIBAVIRIN; CHRONIC HCV INFECTION; GENOTYPE 1 INFECTION; PEGINTERFERON ALPHA-2A; UNITED-STATES; DOUBLE-BLIND; PEGYLATED INTERFERON-ALPHA-2A; NONALCOHOLIC STEATOHEPATITIS; FIBROSIS PROGRESSION	Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) both emerged in the second half of the 20th century, and chronic infection with these agents is among the greatest challenges facing health care in the United States and worldwide. Despite tremendous advances in treatment and management of HIV and HCV, individuals with HIV/HCV coinfection experience a more complicated disease course and treatment. Recognition of the important role that host factors, such as IL28B genotype, have in response to HCV therapy and the emergence of new effective therapies for HCV are actively reshaping the standard of care. These advances may translate into more effective treatment and management of patients with chronic HCV and HIV coinfection in the years ahead.	[Hadigan, Colleen; Kottilil, Shyamasundaran] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hadigan, C (corresponding author), NIAID, Immunoregulat Lab, NIH, 10 Ctr Dr,Bldg 10,Room 11C103, Bethesda, MD 20892 USA.	hadiganc@niaid.nih.gov	Kottilil, Shyam/ABF-7605-2021		National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000390] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The National Institute of Allergy and Infectious Diseases Intramural Research Program funded preparation of the manuscript.	Alvarez D, 2006, J VIRAL HEPATITIS, V13, P683, DOI 10.1111/j.1365-2893.2006.00749.x; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bacon BR, 2009, HEPATOLOGY, V49, P1838, DOI 10.1002/hep.22871; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Beste LA, 2010, CLIN GASTROENTEROL H, V8, P972, DOI 10.1016/j.cgh.2010.07.012; Carrat F, 2004, JAMA-J AM MED ASSOC, V292, P2839, DOI 10.1001/jama.292.23.2839; Castera L, 2007, ALIMENT PHARM THER, V26, P1489, DOI 10.1111/j.1365-2036.2007.03533.x; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Davis KL, 2011, J CLIN GASTROENTEROL, V45, pE17, DOI 10.1097/MCG.0b013e3181e12c09; Dharancy S, 2005, GASTROENTEROLOGY, V128, P334, DOI 10.1053/j.gastro.2004.11.016; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; DIBISCEGLIE AM, 1989, NEW ENGL J MED, V321, P1506, DOI 10.1056/NEJM198911303212204; Diez-Quevedo C, 2011, J CLIN PSYCHIAT, V72, P522, DOI 10.4088/JCP.09m05282blu; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gaslightwala I, 2006, J HEPATOL, V44, P1026, DOI 10.1016/j.jhep.2006.02.009; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gebo KA, 2005, JAIDS-J ACQ IMM DEF, V40, P609, DOI 10.1097/01.qai.0000171727.55553.78; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Grant WC, 2005, HEPATOLOGY, V42, P1406, DOI 10.1002/hep.20941; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Jeffers LJ, 2004, HEPATOLOGY, V39, P1702, DOI 10.1002/hep.20212; Jensen DM, 2009, ANN INTERN MED, V150, P528, DOI 10.7326/0003-4819-150-8-200904210-00007; Khattab M, 2010, LIVER INT, V30, P447, DOI 10.1111/j.1478-3231.2009.02171.x; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; Kim KH, 2007, BIOCHEM BIOPH RES CO, V355, P883, DOI 10.1016/j.bbrc.2007.02.044; Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8; Lafeuillade A, 2001, LANCET, V357, P280, DOI 10.1016/S0140-6736(00)03618-7; Lai MY, 1996, GASTROENTEROLOGY, V111, P1307, DOI 10.1053/gast.1996.v111.pm8898645; Lempicki RA, 2006, J INFECT DIS, V193, P1172, DOI 10.1086/501365; Leutscher PDC, 2010, HEPATOLOGY, V52, P430, DOI 10.1002/hep.23699; Lin WY, 2011, J BIOL CHEM, V286, P2665, DOI 10.1074/jbc.M110.168286; Linas BP, 2011, J VIRAL HEPATITIS, V18, P506, DOI 10.1111/j.1365-2893.2010.01325.x; Lok A, 2010, 61 ANN M AM ASS STUD; Loko MA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-303; Lutchman G, 2007, HEPATOLOGY, V46, P424, DOI 10.1002/hep.21661; Machado MV, 2010, HEPATOLOGY, V52, P71, DOI 10.1002/hep.23619; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; Morasco BJ, 2010, PSYCHOSOMATICS, V51, P401, DOI 10.1176/appi.psy.51.5.401; Murphy AA, 2011, AIDS, V25, P1179, DOI 10.1097/QAD.0b013e3283471d53; Neri S, 2010, J CLIN GASTROENTEROL, V44, pE210, DOI 10.1097/MCG.0b013e3181d88af5; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Paula H, 2010, AM J GASTROENTEROL, V105, P1782, DOI 10.1038/ajg.2010.46; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poynard T, 2009, GASTROENTEROLOGY, V136, P1618, DOI 10.1053/j.gastro.2009.01.039; Rodriguez-Torres M, 2009, NEW ENGL J MED, V360, P257, DOI 10.1056/NEJMoa0805062; Rodriguez-Torres M, 2010, ANN HEPATOL, V9, pS123, DOI 10.1016/S1665-2681(19)31737-5; Rosenthal E, 2003, AIDS, V17, P1803, DOI 10.1097/00002030-200308150-00009; Rozenberg L, 2009, AIDS, V23, P2439, DOI 10.1097/QAD.0b013e32832ff1c0; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Seden K, 2010, J ANTIMICROB CHEMOTH, V65, P1079, DOI 10.1093/jac/dkq086; Sherman KE, 2010, JAIDS-J ACQ IMM DEF, V55, P597, DOI 10.1097/QAI.0b013e3181f6d916; Sterling RK, 2008, HEPATOLOGY, V47, P1118, DOI 10.1002/hep.22134; Sulkowski MS, 2007, AIDS, V21, P2209, DOI 10.1097/QAD.0b013e3282f10de9; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V288, P199, DOI 10.1001/jama.288.2.199; Sulkowski MS, 2005, AIDS, V19, P585, DOI 10.1097/01.aids.0000163935.99401.25; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Vachon MLC, 2011, J HEPATOL, V54, P41, DOI 10.1016/j.jhep.2010.06.025; van de Laar T, 2009, GASTROENTEROLOGY, V136, P1609, DOI 10.1053/j.gastro.2009.02.006; Zeuzem S, 2010, 61 ANN M AM ASS STUD	63	37	38	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2011	306	3					294	301		10.1001/jama.2011.975	http://dx.doi.org/10.1001/jama.2011.975			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794BS	21771990				2022-12-28	WOS:000292870500022
J	Ladabaum, U; Wang, G; Terdiman, J; Blanco, A; Kuppermann, M; Boland, CR; Ford, J; Elkin, E; Phillips, KA				Ladabaum, Uri; Wang, Grace; Terdiman, Jonathan; Blanco, Amie; Kuppermann, Miriam; Boland, C. Richard; Ford, James; Elkin, Elena; Phillips, Kathryn A.			Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							DNA-MISMATCH-REPAIR; SERVICES TASK-FORCE; REVISED BETHESDA GUIDELINES; GENETIC TESTING STRATEGIES; NONPOLYPOSIS COLON-CANCER; POPULATION-BASED COHORT; AT-RISK RELATIVES; MICROSATELLITE INSTABILITY; ENDOMETRIAL CANCER; RANDOMIZED-TRIAL	Background: Testing has been advocated for all persons with newly diagnosed colorectal cancer to identify families with the Lynch syndrome, an autosomal dominant cancer-predisposition syndrome that is a paradigm for personalized medicine. Objective: To estimate the effectiveness and cost-effectiveness of strategies to identify the Lynch syndrome, with attention to sex, age at screening, and differential effects for probands and relatives. Design: Markov model that incorporated risk for colorectal, endometrial, and ovarian cancers. Data Sources: Published literature. Target Population: All persons with newly diagnosed colorectal cancer and their relatives. Time Horizon: Lifetime. Perspective: Third-party payer. Intervention: Strategies based on clinical criteria, prediction algorithms, tumor testing, or up-front germline mutation testing, followed by tailored screening and risk-reducing surgery. Outcome Measures: Life-years, cancer cases and deaths, costs, and incremental cost-effectiveness ratios. Results of Base-Case Analysis: The benefit of all strategies accrued primarily to relatives with a mutation associated with the Lynch syndrome, particularly women, whose life expectancy could increase by approximately 4 years with hysterectomy and salpingo-oophorectomy and adherence to colorectal cancer screening recommendations. At current rates of germline testing, screening, and prophylactic surgery, the strategies reduced deaths from colorectal cancer by 7% to 42% and deaths from endometrial and ovarian cancer by 1% to 6%. Among tumor-testing strategies, immunohistochemistry followed by BRAF mutation testing was preferred, with an incremental cost-effectiveness ratio of $36 200 per life-year gained. Results of Sensitivity Analysis: The number of relatives tested per proband was a critical determinant of both effectiveness and cost-effectiveness, with testing of 3 to 4 relatives required for most strategies to meet a threshold of $50 000 per life-year gained. Immunohistochemistry followed by BRAF mutation testing was preferred in 59% of iterations in probabilistic sensitivity analysis at a threshold of $100 000 per life-year gained. Screening for the Lynch syndrome with immunohistochemistry followed by BRAF mutation testing only up to age 70 years cost $44 000 per incremental life-year gained compared with screening only up to age 60 years, and screening without an upper age limit cost $88 700 per incremental life-year gained compared with screening only up to age 70 years. Limitation: Other types of cancer, uncertain family pedigrees, and genetic variants of unknown significance were not considered. Conclusion: Widespread colorectal tumor testing to identify families with the Lynch syndrome could yield substantial benefits at acceptable costs, particularly for women with a mutation associated with the Lynch syndrome who begin regular screening and have risk-reducing surgery. The cost-effectiveness of such testing depends on the participation rate among relatives at risk for the Lynch syndrome.	[Ladabaum, Uri] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Redwood City, CA 94063 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Baylor Univ, Med Ctr, Dallas, TX USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Stanford University; University of California System; University of California San Francisco; Baylor University; Baylor University Medical Center; Memorial Sloan Kettering Cancer Center	Ladabaum, U (corresponding author), Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, 450 Broadway St,Pavil C,4th Floor,MC 6341, Redwood City, CA 94063 USA.	uri.ladabaum@stanford.edu		Ford, James/0000-0002-2513-7025	National Institutes of Health [NIH 1 P01 CA130818, R01 CA72851]; National Cancer Institute; NATIONAL CANCER INSTITUTE [P01CA130818, R01CA072851] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By grants NIH 1 P01 CA130818 and R01 CA72851 from the National Institutes of Health.r Grants/grants pending: National Cancer Institute.		0	255	260	0	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2					69	+		10.7326/0003-4819-155-2-201107190-00002	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-00002			26	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	793KW	21768580	Green Accepted			2022-12-28	WOS:000292822000013
J	Watts, G				Watts, Geoff			Peter John Iliff Obituary	LANCET			English	Biographical-Item												geoff@scileg.freeserve.co.uk						ILIFF PJ, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 16	2011	378	9787					222	222		10.1016/S0140-6736(11)61115-X	http://dx.doi.org/10.1016/S0140-6736(11)61115-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798JD	21770063				2022-12-28	WOS:000293201100017
J	Joo, W; Xu, GZ; Persky, NS; Smogorzewska, A; Rudge, DG; Buzovetsky, O; Elledge, SJ; Pavletich, NP				Joo, Woo; Xu, Guozhou; Persky, Nicole S.; Smogorzewska, Agata; Rudge, Derek G.; Buzovetsky, Olga; Elledge, Stephen J.; Pavletich, Nikola P.			Structure of the FANCI-FANCD2 Complex: Insights into the Fanconi Anemia DNA Repair Pathway	SCIENCE			English	Article							INTERSTRAND CROSS-LINK; PROTEIN; REPLICATION; FANCD2; IDENTIFICATION; SCREEN; BINDS; GENE	Fanconi anemia is a cancer predisposition syndrome caused by defects in the repair of DNA interstrand cross-links (ICLs). Central to this pathway is the Fanconi anemia I-Fanconi anemia D2 (FANCI-FANCD2) (ID) complex, which is activated by DNA damage-induced phosphorylation and monoubiquitination. The 3.4 angstrom crystal structure of the similar to 300 kilodalton ID complex reveals that monoubiquitination and regulatory phosphorylation sites map to the I-D interface, suggesting that they occur on monomeric proteins or an opened-up complex and that they may serve to stabilize I-D heterodimerization. The 7.8 angstrom electron-density map of FANCI-DNA crystals and in vitro data show that each protein has binding sites for both single-and double-stranded DNA, suggesting that the ID complex recognizes DNA structures that result from the encounter of replication forks with an ICL.	[Joo, Woo; Persky, Nicole S.; Rudge, Derek G.; Buzovetsky, Olga; Pavletich, Nikola P.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Xu, Guozhou] Cornell Univ, Sloan Kettering Div, Joan & Sanford I Weill Grad Sch Med Sci, New York, NY 10065 USA; [Persky, Nicole S.; Rudge, Derek G.; Buzovetsky, Olga; Elledge, Stephen J.; Pavletich, Nikola P.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Smogorzewska, Agata; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Dept Genet, Div Genet,Sch Med, Boston, MA 02115 USA; [Smogorzewska, Agata] Rockefeller Univ, Lab Genome Maintenance, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Rockefeller University	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pavletin@mskcc.org		Smogorzewska, Agata/0000-0001-6285-1562	NIH; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044664, R37GM044664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. King for mass spectroscopy analysis and the staff of the Advanced Photon Source Northeast Collaborative Access Team and National Synchrotron Light Source X29 beamlines for help with data collection. This work was supported by the NIH and the Howard Hughes Medical Institute. Coordinates and structure factors have been deposited with the Protein Data Bank (accession codes 3S51 for FANCI, 3S4W for FANCI-FANCD2, and 3S4Z for Y DNA-FANCI).	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ben-Yehoyada M, 2009, MOL CELL, V35, P704, DOI 10.1016/j.molcel.2009.08.014; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Dorsman JC, 2007, CELL ONCOL, V29, P211; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Longerich S, 2009, J BIOL CHEM, V284, P23182, DOI 10.1074/jbc.C109.038075; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Park WH, 2005, J BIOL CHEM, V280, P23593, DOI 10.1074/jbc.M503730200; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Shen X, 2009, MOL CELL, V35, P716, DOI 10.1016/j.molcel.2009.06.034; Shimamura A, 2002, BLOOD, V100, P4649, DOI 10.1182/blood-2002-05-1399; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108; Yuan FH, 2009, J BIOL CHEM, V284, P24443, DOI 10.1074/jbc.M109.016006	23	118	118	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					312	316		10.1126/science.1205805	http://dx.doi.org/10.1126/science.1205805			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764741	Green Accepted			2022-12-28	WOS:000292732000034
J	Buckholtz, NS				Buckholtz, Neil S.			PERSPECTIVE In search of biomarkers	NATURE			English	Editorial Material							ALZHEIMERS ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; RECOMMENDATIONS; DISEASE		NIA, Dementias Aging Branch, Div Neurosci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Buckholtz, NS (corresponding author), NIA, Dementias Aging Branch, Div Neurosci, Bethesda, MD 20892 USA.	buckholn@nia.nih.gov						Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003	3	16	16	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					S8	S8		10.1038/475S8a	http://dx.doi.org/10.1038/475S8a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21760582	Bronze			2022-12-28	WOS:000292690500004
J	Luther, S; Fenton, FH; Kornreich, BG; Squires, A; Bittihn, P; Hornung, D; Zabel, M; Flanders, J; Gladuli, A; Campoy, L; Cherry, EM; Luther, G; Hasenfuss, G; Krinsky, VI; Pumir, A; Gilmour, RF; Bodenschatz, E				Luther, Stefan; Fenton, Flavio H.; Kornreich, Bruce G.; Squires, Amgad; Bittihn, Philip; Hornung, Daniel; Zabel, Markus; Flanders, James; Gladuli, Andrea; Campoy, Luis; Cherry, Elizabeth M.; Luther, Gisa; Hasenfuss, Gerd; Krinsky, Valentin I.; Pumir, Alain; Gilmour, Robert F., Jr.; Bodenschatz, Eberhard			Low-energy control of electrical turbulence in the heart	NATURE			English	Article							CARDIAC TISSUE; SPIRAL WAVES; DEFIBRILLATION; FIBRILLATION; TERMINATION; FIELD; PROPAGATION; ACTIVATION; MECHANISMS; SHOCKS	Controlling the complex spatio-temporal dynamics underlying life-threatening cardiac arrhythmias such as fibrillation is extremely difficult, because of the nonlinear interaction of excitation waves in a heterogeneous anatomical substrate(1-4). In the absence of a better strategy, strong, globally resetting electrical shocks remain the only reliable treatment for cardiac fibrillation(5-7). Here we establish the relationship between the response of the tissue to an electric field and the spatial distribution of heterogeneities in the scale-free coronary vascular structure. We show that in response to a pulsed electric field, E, these heterogeneities serve as nucleation sites for the generation of intramural electrical waves with a source density rho(E) and a characteristic time, tau, for tissue depolarization that obeys the power law tau proportional to E-alpha. These intramural wave sources permit targeting of electrical turbulence near the cores of the vortices of electrical activity that drive complex fibrillatory dynamics. Weshow in vitro that simultaneous and direct access to multiple vortex cores results in rapid synchronization of cardiac tissue and therefore, efficient termination of fibrillation. Using this control strategy, we demonstrate low-energy termination of fibrillation in vivo. Our results give new insights into the mechanisms and dynamics underlying the control of spatio-temporal chaos in heterogeneous excitable media and provide new research perspectives towards alternative, life-saving low-energy defibrillation techniques.	[Luther, Stefan; Fenton, Flavio H.; Squires, Amgad; Bittihn, Philip; Hornung, Daniel; Cherry, Elizabeth M.; Luther, Gisa; Krinsky, Valentin I.; Bodenschatz, Eberhard] Max Planck Inst Dynam & Self Org, D-37077 Gottingen, Germany; [Luther, Stefan; Fenton, Flavio H.; Cherry, Elizabeth M.; Gilmour, Robert F., Jr.] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; [Luther, Stefan; Bittihn, Philip; Hornung, Daniel; Luther, Gisa; Bodenschatz, Eberhard] Georg August Univ, Inst Nonlinear Dynam, D-37077 Gottingen, Germany; [Luther, Stefan; Zabel, Markus; Hasenfuss, Gerd; Bodenschatz, Eberhard] Heart Res Ctr Gottingen HRCG, D-37075 Gottingen, Germany; [Kornreich, Bruce G.; Flanders, James; Gladuli, Andrea; Campoy, Luis] Cornell Univ, Dept Clin Sci, Ithaca, NY 14853 USA; [Squires, Amgad; Bodenschatz, Eberhard] Cornell Univ, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Zabel, Markus; Hasenfuss, Gerd] Univ Med Ctr UMG, Dept Cardiol & Pneumol, D-37075 Gottingen, Germany; [Cherry, Elizabeth M.] Rochester Inst Technol, Sch Math Sci, Rochester, NY 14623 USA; [Krinsky, Valentin I.] Inst Nonlineaire Nice, F-06560 Valbonne, France; [Pumir, Alain] Univ Lyon 1, Lab Phys, Ecole Normale Super Lyon, F-69007 Lyon, France; [Pumir, Alain] CNRS, F-69007 Lyon, France; [Bodenschatz, Eberhard] Cornell Univ, Dept Mech & Aerosp Engn, Ithaca, NY 14853 USA	Max Planck Society; Cornell University; University of Gottingen; Cornell University; Cornell University; Rochester Institute of Technology; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Cornell University	Luther, S (corresponding author), Max Planck Inst Dynam & Self Org, Fassberg 17, D-37077 Gottingen, Germany.	stefan.luther@ds.mpg.de; flavio.h.fenton@cornell.edu	Luther, Stefan/C-7226-2009; Squires, Amgad Andrew/E-7414-2010; Bittihn, Philip/E-2078-2011; Pumir, Alain/AAH-6566-2020	Bittihn, Philip/0000-0002-1276-9381; Bodenschatz, Eberhard/0000-0002-2901-0144; Hornung, Daniel/0000-0002-7846-6375	National Science Foundation (NSF) [0800793, 0926190]; National Institutes of Health (NIH) [HL075515-S04, HL075515, HL073644]; IFCPAR Project [3404-4]; German Ministry for Education and Research [FKZ 01EZ0905/6]; Kavli Institute for Theoretical Physics [NSFPHY05-51164]; Pittsburgh Supercomputing Center (NSF TeraGrid); Pittsburgh NMR Center for Biomedical Research [NIH P41-EB001977]; European Community [HEALTH-F2-2009-241526]; Max Planck Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073644, R01HL075515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001977] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IFCPAR Project; German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Kavli Institute for Theoretical Physics; Pittsburgh Supercomputing Center (NSF TeraGrid)(National Science Foundation (NSF)); Pittsburgh NMR Center for Biomedical Research; European Community(European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank M. L. Riccio and the Cornell University mu CT Facility for Imaging and Preclinical Research for performing the micro-CT scanning, and T. K. Hitchens for technical assistance with cardiac structural imaging. M. W. Enyeart and J. Boesch assisted with the experiments and N. F. Otani provided insights from computer simulations. G. Hooker conducted the statistical analysis. This work was supported by National Science Foundation (NSF) grants 0800793 (F.H.F. and E.M.C.) and 0926190 (F.H.F.); by National Institutes of Health (NIH) grants HL075515-S04 (F.H.F.), HL075515 (R.F.G.) and HL073644 (R.F.G. and E.B.); by IFCPAR Project no. 3404-4 (A.P.); by the German Ministry for Education and Research through FKZ 01EZ0905/6 (S.L., M.Z., E.B. and G.H.); by the Kavli Institute for Theoretical Physics through NSFPHY05-51164; by the Pittsburgh Supercomputing Center (NSF TeraGrid); by the Pittsburgh NMR Center for Biomedical Research (NIH P41-EB001977); by the European Community's Seventh Framework Programme FP7/2007-2013 agreement HEALTH-F2-2009-241526 (EUTrigTreat) and by the Max Planck Society.	BABBS CF, 1980, AM HEART J, V99, P734, DOI 10.1016/0002-8703(80)90623-7; BIKTASHEV VN, 1994, PHILOS T R SOC A, V347, P611, DOI 10.1098/rsta.1994.0070; Cherry EM, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/125016; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; Fast VG, 1998, CIRC RES, V82, P375, DOI 10.1161/01.RES.82.3.375; Fenton F, 1998, CHAOS, V8, P20, DOI 10.1063/1.166311; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Fenton FH, 2009, CIRCULATION, V120, P467, DOI 10.1161/CIRCULATIONAHA.108.825091; Gray RA, 2005, P NATL ACAD SCI USA, V102, P4672, DOI 10.1073/pnas.0407860102; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; Hooks DA, 2002, CIRC RES, V91, P331, DOI 10.1161/01.RES.0000031957.70034.89; Kassab GS, 2006, AM J PHYSIOL-HEART C, V290, pH894, DOI 10.1152/ajpheart.00579.2005; KIRCHHOF C, 1993, CIRCULATION, V88, P736, DOI 10.1161/01.CIR.88.2.736; Koster RW, 2004, AM HEART J, V147, DOI 10.1016/j.ahj.2003.10.049; Mackenzie D, 2004, SCIENCE, V303, P786, DOI 10.1126/science.303.5659.786; Maleckar MM, 2008, AM J PHYSIOL-HEART C, V295, pH1626, DOI 10.1152/ajpheart.00706.2008; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; PLONSEY R, 1982, BIOPHYS J, V39, P309, DOI 10.1016/S0006-3495(82)84521-9; Pumir A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.208101; Pumir A, 1999, J THEOR BIOL, V199, P311, DOI 10.1006/jtbi.1999.0957; Rappel WJ, 1999, PHYS REV LETT, V83, P456, DOI 10.1103/PhysRevLett.83.456; Ripplinger CM, 2006, AM J PHYSIOL-HEART C, V291, pH184, DOI 10.1152/ajpheart.01300.2005; ROTH BJ, 1986, IEEE T BIO-MED ENG, V33, P467, DOI 10.1109/TBME.1986.325804; Sakurai T, 2002, SCIENCE, V296, P2009, DOI 10.1126/science.1071265; Sambelashvili AT, 2004, AM J PHYSIOL-HEART C, V286, pH2183, DOI 10.1152/ajpheart.00637.2003; Santini M, 1999, J INTERV CARD ELECTR, V3, P45, DOI 10.1023/A:1009871422517; Takagi S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.058101; Trayanova N, 1998, J ELECTROCARDIOL, V31, P23, DOI 10.1016/S0022-0736(98)90274-6; Walcott GP, 2003, RESUSCITATION, V59, P59, DOI 10.1016/S0300-9572(03)00161-8; Witkowski FX, 1998, NATURE, V392, P78, DOI 10.1038/32170	30	219	222	3	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					235	U152		10.1038/nature10216	http://dx.doi.org/10.1038/nature10216			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753855	Green Accepted			2022-12-28	WOS:000292690500052
J	van Groenigen, KJ; Osenberg, CW; Hungate, BA				van Groenigen, Kees Jan; Osenberg, Craig W.; Hungate, Bruce A.			Increased soil emissions of potent greenhouse gases under increased atmospheric CO2	NATURE			English	Article							ELEVATED CO2; CARBON-DIOXIDE; NITROUS-OXIDE; METHANE; METAANALYSIS; WATER; DENITRIFICATION; QUESTIONS; WETLANDS; EUROPE	Increasing concentrations of atmospheric carbon dioxide (CO2) can affect biotic and abiotic conditions in soil, such as microbial activity and water content(1,2). In turn, these changes might be expected to alter the production and consumption of the important greenhouse gases nitrous oxide (N2O) and methane (CH4) (refs 2, 3). However, studies on fluxes of N2O and CH4 from soil under increased atmospheric CO2 have not been quantitatively synthesized. Here we show, using meta-analysis, that increased CO2 (ranging from 463 to 780 parts per million by volume) stimulates both N2O emissions from upland soils and CH4 emissions from rice paddies and natural wetlands. Because enhanced greenhouse-gas emissions add to the radiative forcing of terrestrial ecosystems, these emissions are expected to negate at least 16.6 per cent of the climate change mitigation potential previously predicted from an increase in the terrestrial carbon sink under increased atmospheric CO2 concentrations(4). Our results therefore suggest that the capacity of land ecosystems to slow climate warming has been overestimated.	[van Groenigen, Kees Jan; Hungate, Bruce A.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [van Groenigen, Kees Jan; Hungate, Bruce A.] No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86011 USA; [van Groenigen, Kees Jan] Trinity Coll Dublin, Sch Nat Sci, Dept Bot, Dublin 2, Ireland; [Osenberg, Craig W.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA	Northern Arizona University; Northern Arizona University; Trinity College Dublin; State University System of Florida; University of Florida	van Groenigen, KJ (corresponding author), No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA.	cjvangroenigen@nau.edu	Hungate, Bruce/F-8991-2011; van groenigen, kees jan/ABF-2075-2021; van Groenigen, Kees Jan/Q-7081-2018; Osenberg, Craig/M-9904-2013; van Groenigen, Kees Jan/B-3747-2012	Hungate, Bruce/0000-0002-7337-1887; van groenigen, kees jan/0000-0002-9165-3925; van Groenigen, Kees Jan/0000-0002-9165-3925; Osenberg, Craig/0000-0003-1918-7904	DOE-NICCR; NSF [DEB-0949460]; Irish Research Council for Science, Engineering and Technology; Marie Curie Actions under FP7	DOE-NICCR(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Marie Curie Actions under FP7	We thank S. A. Prior, G. B. Runion, F. Hagedorn, A. Niboyet, J. C. Blankinship, W. Cheng, T. Kanerva, R. S. Nowak, S. F. Zitzer, F. A. Dijkstra and J. P. Megonigal for sharing their data. Financial support for this study was provided by DOE-NICCR, NSF (DEB-0949460) and the Irish Research Council for Science, Engineering and Technology, co-funded by Marie Curie Actions under FP7.	Adams DC, 1997, ECOLOGY, V78, P1277, DOI 10.1890/0012-9658(1997)078[1277:RTFMAO]2.0.CO;2; ASELMANN I, 1989, J ATMOS CHEM, V8, P307, DOI 10.1007/BF00052709; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; GIFFORD RM, 1994, AUST J PLANT PHYSIOL, V21, P1, DOI 10.1071/PP9940001; Hedges L.V., 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.1890/0012-9658(1999)080[1150:TMAORR]2.0.CO;2; Holland EA, 2005, ECOL APPL, V15, P38, DOI 10.1890/03-5162; Hungate BA, 2009, GLOBAL CHANGE BIOL, V15, P2020, DOI 10.1111/j.1365-2486.2009.01866.x; Kammann C, 2008, SOIL BIOL BIOCHEM, V40, P2194, DOI 10.1016/j.soilbio.2008.04.012; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Matzner E, 2008, EUR J SOIL SCI, V59, P274, DOI 10.1111/j.1365-2389.2007.00992.x; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Osenberg CW, 1999, ECOLOGY, V80, P1105, DOI 10.2307/177058; Pendall E, 2004, NEW PHYTOL, V162, P311, DOI 10.1111/j.1469-8137.2004.01053.x; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Schulze ED, 2009, NAT GEOSCI, V2, P842, DOI 10.1038/ngeo686; Shindell DT, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021009; Smith KA, 2003, EUR J SOIL SCI, V54, P779, DOI 10.1046/j.1351-0754.2003.0567.x; SMITH MS, 1979, SOIL BIOL BIOCHEM, V11, P261, DOI 10.1016/0038-0717(79)90071-3; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Stehfest E, 2006, NUTR CYCL AGROECOSYS, V74, P207, DOI 10.1007/s10705-006-9000-7; Thornton PE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002868; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; WEIER KL, 1993, SOIL SCI SOC AM J, V57, P66, DOI 10.2136/sssaj1993.03615995005700010013x; WHITING GJ, 1993, NATURE, V364, P794, DOI 10.1038/364794a0; World Resources Institute, 2003, LAND AR CLASS EC TYP; Wullschleger SD, 2002, PLANT CELL ENVIRON, V25, P319, DOI 10.1046/j.1365-3040.2002.00796.x; Zak DR, 2000, NEW PHYTOL, V147, P201, DOI 10.1046/j.1469-8137.2000.00687.x	30	309	318	36	613	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					214	U121		10.1038/nature10176	http://dx.doi.org/10.1038/nature10176			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753852	Green Submitted			2022-12-28	WOS:000292690500047
J	Eyler, CE; Wu, QL; Yan, K; MacSwords, JM; Chandler-Militello, D; Misuraca, KL; Lathia, JD; Forrester, MT; Lee, J; Stamler, JS; Goldman, SA; Bredel, M; McLendon, RE; Sloan, AE; Hjelmeland, AB; Rich, JN				Eyler, Christine E.; Wu, Qiulian; Yan, Kenneth; MacSwords, Jennifer M.; Chandler-Militello, Devin; Misuraca, Katherine L.; Lathia, Justin D.; Forrester, Michael T.; Lee, Jeongwu; Stamler, Jonathan S.; Goldman, Steven A.; Bredel, Markus; McLendon, Roger E.; Sloan, Andrew E.; Hjelmeland, Anita B.; Rich, Jeremy N.			Glioma Stem Cell Proliferation and Tumor Growth Are Promoted by Nitric Oxide Synthase-2	CELL			English	Article							LYMPHOCYTIC-LEUKEMIA CELLS; HIGHLY SELECTIVE INHIBITOR; ACUTE MYELOID-LEUKEMIA; ISCHEMIC BRAIN-INJURY; MICE LACKING; IN-VIVO; HUMAN GLIOBLASTOMA; INITIATING CELLS; SEPTIC SHOCK; SELF-RENEWAL	Malignant gliomas are aggressive brain tumors with limited therapeutic options, and improvements in treatment require a deeper molecular understanding of this disease. As in other cancers, recent studies have identified highly tumorigenic subpopulations within malignant gliomas, known generally as cancer stem cells. Here, we demonstrate that glioma stem cells (GSCs) produce nitric oxide via elevated nitric oxide synthase-2 (NOS2) expression. GSCs depend on NOS2 activity for growth and tumorigenicity, distinguishing them from non-GSCs and normal neural progenitors. Gene expression profiling identified many NOS2-regulated genes, including the cell-cycle inhibitor cell division autoantigen-1 (CDA1). Further, high NOS2 expression correlates with decreased survival in human glioma patients, and NOS2 inhibition slows glioma growth in a murine intracranial model. These data provide insight into how GSCs are mechanistically distinct from their less tumorigenic counterparts and suggest that NOS2 inhibition may be an efficacious approach to treating this devastating disease.	[Eyler, Christine E.; Wu, Qiulian; Yan, Kenneth; MacSwords, Jennifer M.; Lathia, Justin D.; Lee, Jeongwu; Hjelmeland, Anita B.; Rich, Jeremy N.] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA; [Eyler, Christine E.; Misuraca, Katherine L.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Eyler, Christine E.] Duke Univ, Med Ctr, Med Scientist Training Program, Durham, NC 27710 USA; [McLendon, Roger E.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Chandler-Militello, Devin; Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Forrester, Michael T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Stamler, Jonathan S.] Case Western Reserve Univ, Sch Med, Inst Transformat Mol Med, Cleveland, OH 44106 USA; [Stamler, Jonathan S.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Neurol Surg, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Translat Neurosci, Cleveland, OH 44106 USA; [Rich, Jeremy N.] Case Western Reserve Univ, Sch Med, Cleveland Clin Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Bredel, Markus] Univ Alabama, Ctr Comprehens Canc, Dept Radiat Oncol, Birmingham, AL 35249 USA; [Bredel, Markus] Univ Freiburg, Neuroctr, Dept Neurosurg, D-79106 Freiburg, Germany; [Bredel, Markus] Univ Freiburg, Ctr Comprehens Canc, D-79106 Freiburg, Germany	Cleveland Clinic Foundation; Duke University; Duke University; Duke University; University of Rochester; Harvard University; Harvard Medical School; Massachusetts General Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; University Hospitals of Cleveland; University of Alabama System; University of Alabama Birmingham; University of Freiburg; University of Freiburg	Hjelmeland, AB (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA.	hjelmea@ccf.org; richj@ccf.org	Eyler, Christine E/A-2921-2010; Sloan, Andrew/AAE-9842-2020; Rich, Jeremy/AAM-1445-2021; Lathia, Justin/AHB-8296-2022	Stamler, Jonathan/0000-0002-6866-1572; Goldman, Steven/0000-0002-5498-4303	National Institutes of Health [F30NS063496, CA112958, CA116659, CA154130, CA151522, CA137443, NS063971, CA128269, CA101954, CA116257, CA142159, HL059130, HL091876,, HLO95463, CA108786, NS20023]; German Cancer Aid Grant Award [107714]; NATIONAL CANCER INSTITUTE [R01CA129958, P50CA108786, U01CA137443, UM1CA137443, R01CA151522, R42CA128269, R01CA154130, K08CA101954, F32CA142159, R01CA116257, R01CA116659] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059130, R01HL095463, R01HL091876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063971, R01NS075345, P50NS020023, F30NS063496, R01NS052534, R01NS054276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Cancer Aid Grant Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the sources of our funding, including National Institutes of Health grant F30NS063496 for C.E.E.; CA112958, CA116659, and CA154130 for J.N.R.; CA151522 for A.B.H.; CA137443, NS063971, CA128269, CA101954, and CA116257 for A.E.S.; CA142159 for J.D.L.; HL059130, HL091876, and HLO95463 for J.S.S.; and CA108786 and NS20023 for R.E.M. We also thank the Adelson Medical Research Foundation (S.A.G.), American Brain Tumor Association (J.D.L.), National Brain Tumor Society (A.B.H.), Ben and Catherine Ivy Foundation (A. E. S.), Damon Runyon Cancer Research Foundation (J.N.R.), German Cancer Aid Grant Award 107714 (M.B.), Goldhirsh Foundation (J.N.R.), James S. McDonnell Foundation (J.N.R. and S.A.G.), New York State Stem Cell Science Board (S. A. G.), Ohio Department of Development Tech 09-071 (A.E.S.), and Pediatric Brain Tumor Foundation of the United States (R.E.M.). We appreciate critical manuscript review by H. Suh; animal support provided by T. Myshrall, Y. Parker, and D. Lindner; M. Cook, B. Harvat, C. Shemo, and S. O'Bryant for flow cytometry assistance; D. Satterfield, L. Ehinger, J. Funkhouser, and J. Faison for technical assistance; the tissue provided by the Cleveland Clinic Foundation Tissue Procurement Service and S. Staugatis, R. Weil, and M. McGraw; and microarray analysis completed by P. Faber and W. Jones.	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Avontuur JAM, 1998, CRIT CARE MED, V26, P660, DOI 10.1097/00003246-199804000-00012; Bakshi A, 1998, J NEUROL SCI, V155, P196, DOI 10.1016/S0022-510X(97)00315-8; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brindicci C, 2009, CHEST, V135, P353, DOI 10.1378/chest.08-0964; Broadley KWR, 2011, STEM CELLS, V29, P452, DOI 10.1002/stem.582; Chai ZL, 2001, J BIOL CHEM, V276, P33665, DOI 10.1074/jbc.M007681200; Charles NA, 2010, CELL STEM CELL, V6, P6, DOI 10.1016/j.stem.2009.12.005; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; COBBS CS, 1995, CANCER RES, V55, P727; Dover AR, 2006, CLIN SCI, V111, P275, DOI 10.1042/CS20060104; Eissa NT, 1998, P NATL ACAD SCI USA, V95, P7625, DOI 10.1073/pnas.95.13.7625; Eissa NT, 1996, J BIOL CHEM, V271, P27184, DOI 10.1074/jbc.271.43.27184; Engels K, 2008, CANCER RES, V68, P5159, DOI 10.1158/0008-5472.CAN-08-0406; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Fetz V, 2009, INT J CANCER, V124, P2033, DOI 10.1002/ijc.24182; Forrester MT, 2011, BIOTECHNIQUES, V50, P41, DOI 10.2144/000113586; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698; Hausladen A, 1998, P NATL ACAD SCI USA, V95, P14100, DOI 10.1073/pnas.95.24.14100; Hochman JS, 2007, JAMA-J AM MED ASSOC, V297, P1657; Iadecola C, 1997, J NEUROSCI, V17, P9157; Kandalaft LE, 2008, CARCINOGENESIS, V29, P1282, DOI 10.1093/carcin/bgn087; Kashiwagi S, 2008, NAT MED, V14, P255, DOI 10.1038/nm1730; Keyoung HM, 2001, NAT BIOTECHNOL, V19, P843, DOI 10.1038/nbt0901-843; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Lam-Himlin D, 2006, NEUROCHEM INT, V49, P764, DOI 10.1016/j.neuint.2006.07.001; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Levesque MC, 2003, LEUKEMIA, V17, P442, DOI 10.1038/sj.leu.2402783; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lopez A, 2004, CRIT CARE MED, V32, P21, DOI 10.1097/01.CCM.0000105581.01815.C6; Luo CX, 2007, J NEUROCHEM, V103, P1872, DOI 10.1111/j.1471-4159.2007.04915.x; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Martinez-Diaz H, 2003, ARCH PATHOL LAB MED, V127, P1187; Nakatsubo N, 1998, FEBS LETT, V427, P263, DOI 10.1016/S0014-5793(98)00440-2; Perry A, 2009, BRAIN PATHOL, V19, P81, DOI 10.1111/j.1750-3639.2008.00167.x; Rai RM, 1998, P NATL ACAD SCI USA, V95, P13829, DOI 10.1073/pnas.95.23.13829; REBELLO SS, 2002, AAPS PHARMSCI, V4; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Singh D, 2007, AM J RESP CRIT CARE, V176, P988, DOI 10.1164/rccm.200704-588OC; Singh SK, 2003, CANCER RES, V63, P5821; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Strub A, 2006, MOL PHARMACOL, V69, P328, DOI 10.1124/mol.105.017087; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Thomsen LL, 1997, CANCER RES, V57, P3300; Tiscornia AC, 2004, LEUKEMIA, V18, P48, DOI 10.1038/sj.leu.2403169; Tu YG, 2007, J BIOL CHEM, V282, P11722, DOI 10.1074/jbc.M609623200; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0; Williams EL, 2005, BIOESSAYS, V27, P1228, DOI 10.1002/bies.20324; Yamaguchi S, 2002, BRIT J NEUROSURG, V16, P567; Yang DI, 2002, ANN NY ACAD SCI, V962, P8, DOI 10.1111/j.1749-6632.2002.tb04052.x; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zhao HX, 1998, BLOOD, V92, P1031; Zhao XR, 2000, BRAIN RES, V872, P215, DOI 10.1016/S0006-8993(00)02459-8	72	229	236	1	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					53	66		10.1016/j.cell.2011.06.006	http://dx.doi.org/10.1016/j.cell.2011.06.006			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729780	Bronze, Green Accepted			2022-12-28	WOS:000292539300006
J	Jeon, Y; Lee, JT				Jeon, Yesu; Lee, Jeannie T.			YY1 Tethers Xist RNA to the Inactive X Nucleation Center	CELL			English	Article							CHROMOSOME INACTIVATION; DOSAGE COMPENSATION; IN-VIVO; CELL-DIFFERENTIATION; BINDING PROTEIN; POLYMERASE-II; CTCF BINDING; POLYCOMB; GENE; MOUSE	The long noncoding Xist RNA inactivates one X chromosome in the female mammal. Current models posit that Xist induces silencing as it spreads along X and recruits Polycomb complexes. However, the mechanisms for Xist loading and spreading are currently unknown. Here, we define the nucleation center for Xist RNA and show that YY1 docks Xist particles onto the X chromosome. YY1 is a "bivalent'' protein, capable of binding both RNA and DNA through different sequence motifs. Xist's exclusive attachment to the inactive X is determined by an epigenetically regulated trio of YY1 sites as well as allelic origin. Specific YY1-to-RNA and YY1-to-DNA contacts are required to load Xist particles onto X. YY1 interacts with Xist RNA through Repeat C. We propose that YY1 acts as adaptor between regulatory RNA and chromatin targets.	[Jeon, Yesu; Lee, Jeannie T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Howard Hughes Med Inst,Dept Mol Biol, Boston, MA 02114 USA; [Jeon, Yesu; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Lee, JT (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Howard Hughes Med Inst,Dept Mol Biol, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu			Korean Research Foundation; MGH ECOR Fund; NIH [RO1-GM090278]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090278] Funding Source: NIH RePORTER	Korean Research Foundation(National Research Foundation of Korea); MGH ECOR Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	lWe thank K. Sarma, B. Del Rosario, and B. Payer for reading of the manuscript and all lab members for many helpful suggestions. We acknowledge K. Hochedlinger for Rosa26-M2rtTA mice, Y. Shi for His-YY1, and B. Del Rosario for purified His-GFP. This work was supported by a Korean Research Foundation grant and the MGH ECOR Fund to Y.J. and NIH RO1-GM090278 to J.T.L. J.T.L. is an Investigator of the Howard Hughes Medical Institute.	Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Bhadra MP, 2006, GENETICS, V174, P1151, DOI 10.1534/genetics.106.060541; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Chow JC, 2007, P NATL ACAD SCI USA, V104, P10104, DOI 10.1073/pnas.0610946104; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Clemson CM, 1998, J CELL BIOL, V142, P13, DOI 10.1083/jcb.142.1.13; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Do Kim J, 2006, GENOME RES, V16, P901, DOI 10.1101/gr.5091406; Do Kim J, 2009, NUCLEIC ACIDS RES, V37, P5656, DOI 10.1093/nar/gkp613; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Essien K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r131; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; HARIHARAN N, 1991, P NATL ACAD SCI USA, V88, P9799, DOI 10.1073/pnas.88.21.9799; HENDRICH BD, 1993, HUM MOL GENET, V2, P663, DOI 10.1093/hmg/2.6.663; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Johnston CM, 1998, CELL, V94, P809, DOI 10.1016/S0092-8674(00)81739-0; Jonkers I, 2008, MOL CELL BIOL, V28, P5583, DOI 10.1128/MCB.02269-07; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Laverty C, 2010, CURR OPIN GENET DEV, V20, P171, DOI 10.1016/j.gde.2010.01.007; Lee JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003749; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lee JT, 1999, P NATL ACAD SCI USA, V96, P3836, DOI 10.1073/pnas.96.7.3836; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Meyer BJ, 2010, CURR OPIN GENET DEV, V20, P179, DOI 10.1016/j.gde.2010.03.008; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; Park Y, 2003, MOL CELL, V11, P977, DOI 10.1016/S1097-2765(03)00147-3; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Pillet N, 1995, P NATL ACAD SCI USA, V92, P12515, DOI 10.1073/pnas.92.26.12515; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Pugacheva EM, 2005, HUM MOL GENET, V14, P953, DOI 10.1093/hmg/ddi089; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sado T, 2001, DEVELOPMENT, V128, P1275; Sarma Kavitha, 2010, Proc Natl Acad Sci U S A, V107, P22196, DOI 10.1073/pnas.1009785107; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Stavropoulos N, 2005, MOL CELL BIOL, V25, P2757, DOI 10.1128/MCB.25.7.2757-2769.2005; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Takahashi Y, 2000, GENE DEV, V14, P804; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2007, CURR OPIN GENET DEV, V17, P387, DOI 10.1016/j.gde.2007.08.001; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	70	361	393	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					119	133		10.1016/j.cell.2011.06.026	http://dx.doi.org/10.1016/j.cell.2011.06.026			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729784	Green Accepted, Bronze			2022-12-28	WOS:000292539300011
J	De Nicola, GM; Karreth, FA; Humpton, TJ; Gopinathan, A; Wei, C; Frese, K; Mangal, D; Yu, KH; Yeo, CJ; Calhoun, ES; Scrimieri, F; Winter, JM; Hruban, RH; Iacobuzio-Donahue, C; Kern, SE; Blair, IA; Tuveson, DA				De Nicola, Gina M.; Karreth, Florian A.; Humpton, Timothy J.; Gopinathan, Aarthi; Wei, Cong; Frese, Kristopher; Mangal, Dipti; Yu, Kenneth H.; Yeo, Charles J.; Calhoun, Eric S.; Scrimieri, Francesca; Winter, Jordan M.; Hruban, Ralph H.; Iacobuzio-Donahue, Christine; Kern, Scott E.; Blair, Ian A.; Tuveson, David A.			Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis	NATURE			English	Article							PANCREATIC-CANCER; HEME OXYGENASE-1; K-RAS; ACTIVATION; EXPRESSION; PATHWAY; INHIBITION; MUTATIONS; INDUCTION; ELEMENTS	Reactive oxygen species (ROS) are mutagenic and may thereby promote cancer(1). Normally, ROS levels are tightly controlled by an inducible antioxidant program that responds to cellular stressors and is predominantly regulated by the transcription factor Nrf2 (also known as Nfe212) and its repressor protein Keap1 (refs 2-5). In contrast to the acute physiological regulation of Nrf2, in neoplasia there is evidence for increased basal activation of Nrf2. Indeed, somatic mutations that disrupt the Nrf2-Keap1 interaction to stabilize Nrf2 and increase the constitutive transcription of Nrf2 target genes were recently identified, indicating that enhanced ROS detoxification and additional Nrf2 functions may in fact be pro-tumorigenic(6). Here, we investigated ROS metabolism in primary murine cells following the expression of endogenous oncogenic alleles of Kras, Braf and Myc, and found that ROS are actively suppressed by these oncogenes. K-Ras(G12D), B-Raf(V619E) and Myc(ERT2) each increased the transcription of Nrf2 to stably elevate the basal Nrf2, antioxidant program and thereby lower intracellular ROS and confer a more reduced intracellular environment. Oncogene-directed increased expression of Nrf2 is a new mechanism for the activation of the Nrf2 antioxidant program, and is evident in primary cells and tissues of mice expressing K-Ras(G12D) up and B-Raf(V619E), and in human pancreatic cancer. Furthermore, genetic targeting of the Nrf2 pathway impairs K-Ras(G12D)-induced proliferation and tumorigenesis in vivo. Thus, the Nrf2 antioxidant and cellular detoxification program represents a previously unappreciated mediator of oncogenesis.	[De Nicola, Gina M.; Karreth, Florian A.; Humpton, Timothy J.; Gopinathan, Aarthi; Frese, Kristopher; Tuveson, David A.] Cancer Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [De Nicola, Gina M.; Gopinathan, Aarthi] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Karreth, Florian A.] Univ Vienna, A-1030 Vienna, Austria; [Wei, Cong; Mangal, Dipti; Yu, Kenneth H.; Blair, Ian A.] Univ Penn, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA; [Yeo, Charles J.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Surg, Philadelphia, PA 19107 USA; [Calhoun, Eric S.] Alma Coll, Dept Biol, Alma, MI 48801 USA; [Scrimieri, Francesca; Hruban, Ralph H.; Iacobuzio-Donahue, Christine; Kern, Scott E.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21287 USA; [Winter, Jordan M.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Surg, Baltimore, MD 21287 USA; [Hruban, Ralph H.; Iacobuzio-Donahue, Christine; Kern, Scott E.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21287 USA	Cancer Research UK; CRUK Cambridge Institute; University of Pennsylvania; Pennsylvania Medicine; University of Vienna; University of Pennsylvania; Pennsylvania Medicine; Jefferson University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Tuveson, DA (corresponding author), Cancer Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.	david.tuveson@cancer.org.uk	Iacobuzio-Donahue, Christine/ABF-1295-2020; Humpton, Timothy/AAV-5501-2020	Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Humpton, Timothy/0000-0002-8030-9539; DeNicola, Gina/0000-0001-6611-6696; Wei, Cong/0000-0003-2310-9255	University of Cambridge; Cancer Research UK; The Li Ka Shing Foundation; Hutchison Whampoa Limited; NIHR Cambridge Biomedical Research Centre; NIH [CA101973, CA111294, CA084291, CA105490, CA62924, CA128920, CA106610]; Abramson Cancer Center of the University of Pennsylvania [IRG 78-002-26]; Emerald Foundation; Marjorie Kovler Fund; Ruth L. Kirschstein National Research Service Award [F32CA123887-01]; NATIONAL CANCER INSTITUTE [U01CA111294, R01CA128920, K08CA106610, R01CA101973, U01CA105490, U01CA084291, P50CA062924, F32CA123887] Funding Source: NIH RePORTER	University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); The Li Ka Shing Foundation; Hutchison Whampoa Limited; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abramson Cancer Center of the University of Pennsylvania; Emerald Foundation; Marjorie Kovler Fund; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Johnson for providing the Nrf2<SUP>-/-</SUP> mice; G. Evan, O. Sansom, C. Murtaugh, J.-J. Ventura and E. Wagner for MEFs; E Schmidt for Nrf2 antiserum; E. Jaffee,A. Maitra and A. Hors for human PDAcell lines; B. Haynes, S. Davies and N. Cook for human PDA tissue samples; C. Ross-Innes, K Holmes and J. Carroll for advice with the ChIP assay; and the ENCODE Consortium for ChIP-seq studies. We thank F. Connor, C. Martins arid other members of the Tuveson lab for assistance arid advice, and the animal carestaff and histology core at CRI. This research was supported by the University of Cambridge and Cancer Research UK, The Li Ka Shing Foundation and Hutchison Whampoa Limited, the NIHR Cambridge Biomedical Research Centre, arid the NIH (grants CA101973, CA111294, CA084291 and CA105490 to D.A.T.: CA62924 and CA128920 to S.E.K. and C.I.-D.; and CA106610 to C.I.-D.). Additional support was obtained from the Abramson Cancer Center of the University of Pennsylvania Pilot Grant IRG 78-002-26 (D.A.T.), Emerald Foundation (E.S.C.), the Marjorie Kovler Fund (S.E.K) and the Ruth L. Kirschstein National Research Service Award F32CA123887-01 (K.F) We regret that many primary references have been omitted due to space limitations.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cakir Y, 2005, ANTIOXID REDOX SIGN, V7, P726, DOI 10.1089/ars.2005.7.726; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; HAHN SA, 1995, CANCER RES, V55, P4670; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; He XQ, 2006, J BIOL CHEM, V281, P23620, DOI 10.1074/jbc.M604120200; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Karreth FA, 2009, MOL CELL, V36, P477, DOI 10.1016/j.molcel.2009.10.017; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Keum YS, 2006, CANCER RES, V66, P8804, DOI 10.1158/0008-5472.CAN-05-3513; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Park JH, 2008, P NATL ACAD SCI USA, V105, P6846, DOI 10.1073/pnas.0802776105; Rasband W., 2006, IMAGEJ; Recktenwald CV, 2008, CANCER RES, V68, P10086, DOI 10.1158/0008-5472.CAN-08-0360; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Sun CL, 2001, ONCOL REP, V8, P89; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suvorova ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006158; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Zhu PJ, 2008, RAPID COMMUN MASS SP, V22, P432, DOI 10.1002/rcm.3380	31	1443	1491	14	329	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					106	U128		10.1038/nature10189	http://dx.doi.org/10.1038/nature10189			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734707	Green Submitted, Green Accepted			2022-12-28	WOS:000292461300054
J	Sanchez-Lavega, A; del Rio-Gaztelurrutia, T; Hueso, R; Gomez-Forrellad, JM; Sanz-Requena, JF; Legarreta, J; Garcia-Melendo, E; Colas, F; Lecacheux, J; Fletcher, LN; Barrado-Navascues, D; Parker, D				Sanchez-Lavega, A.; del Rio-Gaztelurrutia, T.; Hueso, R.; Gomez-Forrellad, J. M.; Sanz-Requena, J. F.; Legarreta, J.; Garcia-Melendo, E.; Colas, F.; Lecacheux, J.; Fletcher, L. N.; Barrado-Navascues, D.; Parker, D.		Int Outer Planet Watch Team	Deep winds beneath Saturn's upper clouds from a seasonal long-lived planetary-scale storm	NATURE			English	Article							1990 EQUATORIAL DISTURBANCE; ZONAL WINDS; ATMOSPHERE; MODEL; JET	Convective storms occur regularly in Saturn's atmosphere(1-4). Huge storms known as Great White Spots, which are ten times larger than the regular storms, are rarer and occur about once per Saturnian year (29.5 Earth years). Current models propose that the outbreak of a Great White Spot is due to moist convection induced by water(5,6). However, the generation of the global disturbance and its effect on Saturn's permanent winds(1,7) have hitherto been unconstrained(8) by data, because there was insufficient spatial resolution and temporal sampling(9-11) to infer the dynamics of Saturn's weather layer (the layer in the troposphere where the cloud forms). Theoretically, it has been suggested that this phenomenon is seasonally controlled(5,9,10). Here we report observations of a storm at northern latitudes in the peak of a weak westward jet during the beginning of northern springtime, in accord with the seasonal cycle but earlier than expected. The storm head moved faster than the jet, was active during the two-month observation period, and triggered a planetary-scale disturbance that circled Saturn but did not significantly alter the ambient zonal winds. Numerical simulations of the phenomenon show that, as on Jupiter(12), Saturn's winds extend without decay deep down into the weather layer, at least to the water-cloud base at pressures of 10-12 bar, which is much deeper than solar radiation penetrates.	[Sanchez-Lavega, A.; del Rio-Gaztelurrutia, T.; Hueso, R.] Univ Basque Country, Escuela Tecn Super Ingn, Dept Fis Aplicada 1, Bilbao 48013, Spain; [Gomez-Forrellad, J. M.; Garcia-Melendo, E.] Esteve Duran Observ Fdn, Seva 08553, Spain; [Sanz-Requena, J. F.] Univ Europea Miguel de Cervantes, Valladolid 47012, Spain; [Legarreta, J.] Univ Basque Country, EUITI, Dept Ingn Sistemas & Automat, Bilbao 48012, Spain; [Garcia-Melendo, E.] Fac Ciencies, Inst Ciencies Espai CSIC IEEC, E-08193 Bellaterra, Spain; [Colas, F.] CNRS, UMR 8028, Observ Paris, Inst Mecan Celeste & Calculdes Ephemerides, F-75014 Paris, France; [Lecacheux, J.] LESIA, Observ Paris, F-92195 Meudon, France; [Fletcher, L. N.] Univ Oxford, Clarendon Lab, Dept Phys, Oxford OX1 3PU, England; [Barrado-Navascues, D.] MPIA CSIC, Ctr Astron Hispano Aleman, Observ Calar Alto, Almeria 04004, Spain; [Parker, D.] ALPO, Coral Gables, FL 33156 USA	University of Basque Country; Miguel de Cervantes European University (UEMC); University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; University of Oxford; Consejo Superior de Investigaciones Cientificas (CSIC)	Sanchez-Lavega, A (corresponding author), Univ Basque Country, Escuela Tecn Super Ingn, Dept Fis Aplicada 1, Alameda Urquijo S-N, Bilbao 48013, Spain.	agustin.sanchez@ehu.es	del Río Gaztelurrutia, Teresa/H-8831-2013; Garcia-Melendo, Enrique/AAH-5658-2020; Navascues, David Barrado/C-1439-2017; Fletcher, Leigh/D-6093-2011; Sanchez-Lavega, Agustin/Z-3639-2019; Hueso, Ricardo/Z-3277-2019	del Río Gaztelurrutia, Teresa/0000-0001-8552-226X; Navascues, David Barrado/0000-0002-5971-9242; Fletcher, Leigh/0000-0001-5834-9588; Hueso, Ricardo/0000-0003-0169-123X; Sanchez-Lavega, Agustin/0000-0001-7234-7634; Delcroix, Marc/0000-0002-9828-7390; Sanz Requena, Jose Francisco/0000-0003-3643-716X; Sanchez-Lavega, Agustin/0000-0001-7355-1522; LEGARRETA ETXAGIBEL, JON JOSU/0000-0001-6501-2705	Spanish MICIIN; FEDER; Gobierno Vasco; University of Oxford	Spanish MICIIN(Spanish Government); FEDER(European Commission); Gobierno Vasco(Basque Government); University of Oxford	A.S.-L., T.d.R.-G., R.H., J.L., J.M.G.-F., E.G.-M. and J.F.S.-R. are supported by the Spanish MICIIN, by FEDER and by Gobierno Vasco. We thank S. Perez-Hoyos for initial support of this study and M. Alises and A. Guijarro for taking the Calar Alto Observatory images (CAHA and MPG/CSIC). E.G.-M. used computing facilities at CESCA (Barcelona) supported by MICIIN. L.N.F. is supported by a Glasstone fellowship at the University of Oxford. The International Outer Planet Watch (IOPW) Team and other individual contributors listed in Supplementary Information provided most of the images used for tracking in this study; these images were complemented in some cases with images taken from contributors to the ALPO Japan (Association of Lunar and Planetary Observers) database (http://alpo-j.asahikawa-med.ac.jp/indexE.htm).	Acarreta JR, 1999, ICARUS, V137, P24, DOI 10.1006/icar.1998.6034; BARNET CD, 1992, ICARUS, V100, P499, DOI 10.1016/0019-1035(92)90113-L; BARNET CD, 1992, ICARUS, V98, P94, DOI 10.1016/0019-1035(92)90210-X; BEEBE RF, 1992, ICARUS, V95, P163, DOI 10.1016/0019-1035(92)90035-6; Choi DS, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003254; del Rio-Gaztelurrutia T, 2010, ICARUS, V209, P665, DOI 10.1016/j.icarus.2010.04.002; Dowling TE, 1998, ICARUS, V132, P221, DOI 10.1006/icar.1998.5917; Dyudina UA, 2007, ICARUS, V190, P545, DOI 10.1016/j.icarus.2007.03.035; Fischer G, 2007, ICARUS, V190, P528, DOI 10.1016/j.icarus.2007.04.002; Fletcher LN, 2010, ICARUS, V208, P337, DOI 10.1016/j.icarus.2010.01.022; Garcia-Melendo E, 2007, ICARUS, V191, P665, DOI 10.1016/j.icarus.2007.05.020; Hueso R, 2004, ICARUS, V172, P255, DOI 10.1016/j.icarus.2004.06.010; Hueso R, 2010, PLANET SPACE SCI, V58, P1152, DOI 10.1016/j.pss.2010.04.006; Li LM, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003631; Perez-Hoyos S, 2006, ICARUS, V180, P368, DOI 10.1016/j.icarus.2005.10.009; Perez-Hoyos S, 2005, ICARUS, V176, P155, DOI 10.1016/j.icarus.2005.01.014; Porco CC, 2005, SCIENCE, V307, P1243, DOI 10.1126/science.1107691; Read PL, 2009, PLANET SPACE SCI, V57, P1682, DOI 10.1016/j.pss.2009.03.004; Sanchez Lavega A., 1996, SCIENCE, V271, P631; SANCHEZ-LAVEGA A, 1982, ICARUS, V49, P1, DOI 10.1016/0019-1035(82)90052-5; Sanchez-Lavega A, 2000, ICARUS, V147, P405, DOI 10.1006/icar.2000.6449; Sanchez-Lavega A, 2008, NATURE, V451, P437, DOI 10.1038/nature06533; SANCHEZLAVEGA A, 1993, J GEOPHYS RES-PLANET, V98, P18857, DOI 10.1029/93JE01777; SANCHEZLAVEGA A, 1991, NATURE, V353, P397, DOI 10.1038/353397a0; SANCHEZLAVEGA A, 1987, ASTRON ASTROPHYS, V185, P315; Sayanagi KM, 2007, ICARUS, V187, P520, DOI 10.1016/j.icarus.2006.10.020; Seidelmann PK, 2007, CELEST MECH DYN ASTR, V98, P155, DOI 10.1007/s10569-007-9072-y; West RA, 2009, SATURN FROM CASSINI-HUYGENS, P161, DOI 10.1007/978-1-4020-9217-6_7	29	83	83	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					71	74		10.1038/nature10203	http://dx.doi.org/10.1038/nature10203			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734704	Green Submitted			2022-12-28	WOS:000292461300046
J	Bhutta, ZA; Labbok, M				Bhutta, Zulfiqar A.; Labbok, Miriam			Scaling up breastfeeding in developing countries	LANCET			English	Editorial Material							NEONATAL-MORTALITY; EFFICACY		[Bhutta, Zulfiqar A.] Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan; Univ N Carolina, Carolina Global Breastfeeding Inst, Dept Maternal & Child Hlth, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	Aga Khan University; University of North Carolina; University of North Carolina Chapel Hill	Bhutta, ZA (corresponding author), Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu		Labbok, Miriam/0000-0001-9515-3963				Abrahams SW, 2009, INT BREASTFEED J, V4, DOI 10.1186/1746-4358-4-11; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; Bhutta Z.A., 2010, GLOB HLTH WORKFORCE, V1, P61; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2011, LANCET, V377, P403, DOI 10.1016/S0140-6736(10)62274-X; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Chapman DJ, 2010, J HUM LACT, V26, P314, DOI 10.1177/0890334410369481; Declercq E, 2009, AM J PUBLIC HEALTH, V99, P929, DOI 10.2105/AJPH.2008.135236; Edmond KM, 2007, AM J CLIN NUTR, V86, P1126, DOI 10.1093/ajcn/86.4.1126; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Huffman SL, 2001, MIDWIFERY, V17, P80, DOI 10.1054/midw.2001.0253; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S24; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Tylleskar T, 2011, LANCET, V378, P420, DOI 10.1016/S0140-6736(11)60738-1	16	19	19	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2011	378	9789					378	380		10.1016/S0140-6736(11)60897-0	http://dx.doi.org/10.1016/S0140-6736(11)60897-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XM	21752460				2022-12-28	WOS:000293615900006
J	Shattock, RJ; Warren, M; McCormack, S; Hankins, CA				Shattock, Robin J.; Warren, Mitchell; McCormack, Sheena; Hankins, Catherine A.			Turning the Tide Against HIV	SCIENCE			English	Editorial Material							TRANSMISSION; PREVENTION		[Shattock, Robin J.; McCormack, Sheena] Univ London Imperial Coll Sci Technol & Med, London W2 1PG, England; [Warren, Mitchell] AVAC Global Advocacy HIV Prevent, New York, NY 10027 USA; [McCormack, Sheena] MRC, Clin Trials Unit, London NW1 2DA, England; [Hankins, Catherine A.] Joint United Nations Programme HIV AIDS, Programme Branch, Off Deputy Execut Director, CH-1211 Geneva, Switzerland	Imperial College London; Medical Research Council Clinical Trials Unit	Shattock, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, London W2 1PG, England.	r.shattock@imperial.ac.uk		Hankins, Catherine/0000-0002-1642-8592	MRC [MC_U122861322] Funding Source: UKRI; Medical Research Council [MC_U122861322] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; Excler JL, 2011, AIDS RES HUM RETROV, V27, P669, DOI [10.1089/aid.2010.0206, 10.1089/AID.2010.0206]; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Hecht R, 2010, LANCET, V376, P1254, DOI 10.1016/S0140-6736(10)61255-X; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keele BF, 2011, BLOOD, V118, P839, DOI 10.1182/blood-2010-12-325860; Kersh EN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019295; Matthews LT, 2010, AIDS, V24, P1975, DOI 10.1097/QAD.0b013e32833bedeb; Patterson K. P. H., 2010, 18 INT AIDS C VIENN, P18; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Roehr B., 2011, BRIT MED J, V342, pd2613; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; UNAIDS, 2011, AIDS 30 NAT CROSSR; van't Klooster G, 2008, 15 C RETR OPP INF CR; Whaley KJ, 2010, ANTIVIR RES, V88, pS55, DOI 10.1016/j.antiviral.2010.09.006	17	64	64	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					42	43		10.1126/science.1206399	http://dx.doi.org/10.1126/science.1206399			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	785UF	21719662				2022-12-28	WOS:000292255400037
J	You, JQ; Nori, F				You, J. Q.; Nori, Franco			Atomic physics and quantum optics using superconducting circuits	NATURE			English	Review							SINGLE MICROWAVE PHOTONS; JOSEPHSON PHASE QUBITS; MECHANICAL RESONATOR; ELECTRICAL CIRCUIT; PROCESS TOMOGRAPHY; BELLS-INEQUALITY; ARTIFICIAL-ATOM; GROUND-STATE; JUNCTION; GENERATION	Superconducting circuits based on Josephson junctions exhibit macroscopic quantum coherence and can behave like artificial atoms. Recent technological advances have made it possible to implement atomic-physics and quantum-optics experiments on a chip using these artificial atoms. This Review presents a brief overview of the progress achieved so far in this rapidly advancing field. We not only discuss phenomena analogous to those in atomic physics and quantum optics with natural atoms, but also highlight those not occurring in natural atoms. In addition, we summarize several prospective directions in this emerging interdisciplinary field.	[You, J. Q.] Fudan Univ, Dept Phys, State Key Lab Surface Phys, Key Lab Micro & Nano Photon Struct,Minist Educ, Shanghai 200433, Peoples R China; [You, J. Q.; Nori, Franco] RIKEN, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Nori, Franco] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA	Fudan University; RIKEN; University of Michigan System; University of Michigan	Nori, F (corresponding author), RIKEN, Adv Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	jqyou@fudan.edu.cn; fnori@riken.jp	Nori, Franco/B-1222-2009	Nori, Franco/0000-0003-3682-7432; You, Jian-Qiang/0000-0002-5823-549X	National Basic Research Program of China [2009CB929300]; National Natural Science Foundation of China [10625416]; ISTCP [2008DFA01930]; MOE of China [B06011]; National Science Foundation [0726909]; JSPS-RFBR [09-02-92114]; MEXT; Grants-in-Aid for Scientific Research [21102002] Funding Source: KAKEN	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ISTCP; MOE of China(Ministry of Education, China); National Science Foundation(National Science Foundation (NSF)); JSPS-RFBR(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceRussian Foundation for Basic Research (RFBR)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Ashhab for comments on the manuscript. J.Q.Y. acknowledges partial support from the National Basic Research Program of China (grant no. 2009CB929300), the National Natural Science Foundation of China (grant no. 10625416), the ISTCP (grant no. 2008DFA01930) and the MOE of China (grant no. B06011). F.N. acknowledges partial support from the Laboratory of Physical Sciences, National Security Agency, Army Research Office, DARPA, AFOSR, the National Science Foundation (grant no. 0726909), JSPS-RFBR (contract no. 09-02-92114), a Grant-in-Aid for Scientific Research (S), MEXT Kakenhi on Quantum Cybernetics, and the JSPS through its FIRST programme.	Abdumalikov AA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.193601; Ansmann M, 2009, NATURE, V461, P504, DOI 10.1038/nature08363; Ashhab S, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/2/023030; Ashhab S, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.042311; Astafiev O, 2007, NATURE, V449, P588, DOI 10.1038/nature06141; Astafiev O, 2010, SCIENCE, V327, P840, DOI 10.1126/science.1181918; Bertet P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.257002; Bialczak RC, 2010, NAT PHYS, V6, P409, DOI 10.1038/NPHYS1639; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Boulant N, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.014525; Chiorescu I, 2004, NATURE, V431, P159, DOI 10.1038/nature02831; Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; de Groot PC, 2010, NAT PHYS, V6, P763, DOI 10.1038/NPHYS1733; Deppe F, 2008, NAT PHYS, V4, P686, DOI 10.1038/nphys1016; Devoret M, 2007, ANN PHYS-BERLIN, V16, P767, DOI 10.1002/andp.200710261; DiCarlo L, 2010, NATURE, V467, P574, DOI 10.1038/nature09416; Dutton Z, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.104516; Filipp S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.200402; Forn-Diaz P, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.237001; Fragner A, 2008, SCIENCE, V322, P1357, DOI 10.1126/science.1164482; Friedman JR, 2000, NATURE, V406, P43, DOI 10.1038/35017505; Genovese M, 2005, PHYS REP, V413, P319, DOI 10.1016/j.physrep.2005.03.003; Gladchenko S, 2009, NAT PHYS, V5, P48, DOI [10.1038/nphys1151, 10.1038/NPHYS1151]; Grajcar M, 2008, NAT PHYS, V4, P612, DOI 10.1038/nphys1019; Grajcar M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035406; Harris SE, 1997, PHYS TODAY, V50, P36, DOI 10.1063/1.881806; Hauss J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.037003; Hofheinz M, 2008, NATURE, V454, P310, DOI 10.1038/nature07136; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; Houck AA, 2007, NATURE, V449, P328, DOI 10.1038/nature06126; Huang XMH, 2003, NATURE, V421, P496, DOI 10.1038/421496a; Ian H, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.063823; Il'ichev E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.097906; Ioffe LB, 2002, NATURE, V415, P503, DOI 10.1038/415503a; Johansson JR, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.147003; Johnson BR, 2010, NAT PHYS, V6, P663, DOI 10.1038/NPHYS1710; Katz N, 2006, SCIENCE, V312, P1498, DOI 10.1126/science.1126475; Kitaev A, 2006, ANN PHYS-NEW YORK, V321, P2, DOI 10.1016/j.aop.2005.10.005; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Kofman AG, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.104502; Law CK, 1996, PHYS REV LETT, V76, P1055, DOI 10.1103/PhysRevLett.76.1055; LEGGETT AJ, 1985, PHYS REV LETT, V54, P857, DOI 10.1103/PhysRevLett.54.857; Liu YX, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.014547; Liu YX, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.087001; Liu YX, 2004, EUROPHYS LETT, V67, P941, DOI 10.1209/epl/i2004-10144-3; Lupascu A, 2007, NAT PHYS, V3, P119, DOI 10.1038/nphys509; Makhlin Y, 2001, REV MOD PHYS, V73, P357, DOI 10.1103/RevModPhys.73.357; Marquardt F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093902; Martin I, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.125339; Meystre P., 2001, ATOM OPTICS; Murali KVRM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.087003; Naik A, 2006, NATURE, V443, P193, DOI 10.1038/nature05027; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Nataf P, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.023601; Nation PD, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.087004; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Neeley M, 2008, NAT PHYS, V4, P523, DOI 10.1038/nphys972; Neeley M, 2010, NATURE, V467, P570, DOI 10.1038/nature09418; Niemczyk T, 2010, NAT PHYS, V6, P772, DOI 10.1038/NPHYS1730; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Palacios-Laloy A, 2010, NAT PHYS, V6, P442, DOI 10.1038/NPHYS1641; Picot T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.040506; Rangelov AA, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.053403; Rocheleau T, 2010, NATURE, V463, P72, DOI 10.1038/nature08681; Rodrigues DA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.067204; Schoelkopf RJ, 2008, NATURE, V451, P664, DOI 10.1038/451664a; Scully M.O., 1997, QUANTUM OPT; Shen JT, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.213001; Shevchenko SN, 2010, PHYS REP, V492, P1, DOI 10.1016/j.physrep.2010.03.002; Siddiqi I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.207002; Sillanpaa MA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.193601; Sillanpaa MA, 2007, NATURE, V449, P438, DOI 10.1038/nature06124; Steffen M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.050502; Steffen M, 2006, SCIENCE, V313, P1423, DOI 10.1126/science.1130886; Steffen M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.100502; Valenzuela SO, 2006, SCIENCE, V314, P1589, DOI 10.1126/science.1134008; van der Wal CH, 2000, SCIENCE, V290, P773, DOI 10.1126/science.290.5492.773; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; Wallraff A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060501; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Wang H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.060401; Wang H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.240401; Wei LF, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.174513; Wei LF, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.113601; Wei LF, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.104516; Wilson CM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.257003; You JQ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.047001; You JQ, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.104516; You JQ, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.014505; You JQ, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.140515; You JQ, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.064509; You JQ, 2005, PHYS TODAY, V58, P42, DOI 10.1063/1.2155757; Yu Y, 2002, SCIENCE, V296, P889, DOI 10.1126/science.1069452; Zagoskin AM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.253602; Zhang P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.097204; Zhou L, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.063827; Zhou L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.100501; Zueco D, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.033846	100	935	948	6	272	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					589	597		10.1038/nature10122	http://dx.doi.org/10.1038/nature10122			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21720362	Green Submitted			2022-12-28	WOS:000292204300029
J	Dyer, C				Dyer, Clare			RESEARCH INTEGRITY The fraud squad	BRITISH MEDICAL JOURNAL			English	Editorial Material							RETRACTED ARTICLE. SEE; SCIENTIFIC FRAUD; PG 853		BMJ, London WC1H 9JR, England		Dyer, C (corresponding author), BMJ, London WC1H 9JR, England.	ClareDyer@aol.com						Academy of Medical Sciences, 2011, NEW PATHW REG GOV HL; Council of Canadian Academies, 2010, HON ACC TRUST FOST R; DEER B, 2011, BRIT MED J, V342, pD5347; Dyer C, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1492; Dyer C, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d833; *EUV, MEASL SURV REP 2010; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Farthing MJG, 2001, GUT, V48, P285, DOI 10.1136/gut.48.3.285; Ferriman A, 2000, BRIT MED J, V321, P1429, DOI 10.1136/bmj.321.7274.1429; Hawkes N, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2010; HM Treasury and Department for Business Innovation and Skills, 2011, PLAN GROWTH; LOCK S, 1995, BRIT MED J, V310, P1547, DOI 10.1136/bmj.310.6994.1547; Nimmo W, 2000, P R COLL PHYS EDI S7, V30, P2; PEARCE JM, 1994, BRIT J OBSTET GYNAEC, V101, P685; PEARCE JM, 1994, BRIT J OBSTET GYNAEC, V101, P716, DOI 10.1111/j.1471-0528.1994.tb13194.x; *PEOPL SCI POL, 2009, REV CURR UK ARR OV G; STANBROOK M, 2011, CMAJ            0509; 2010, ANESTHESIOLOGY N JUN; 2010, REPORT UK RES INTEGR; 2006, OFFICE RES INTEGRITY, V14	20	6	6	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 28	2011	342								d4017	10.1136/bmj.d4017	http://dx.doi.org/10.1136/bmj.d4017			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788PY	21712330				2022-12-28	WOS:000292458100017
J	Sarikaya, H				Sarikaya, Hakan			Hemifacial sweating after carotid artery dissection	LANCET			English	Editorial Material									Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Sarikaya, H (corresponding author), Univ Zurich Hosp, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland.	hakan.sarikaya@usz.ch							0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 13	2011	378	9791					606	606		10.1016/S0140-6736(11)61102-1	http://dx.doi.org/10.1016/S0140-6736(11)61102-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812UX	21764116	Green Accepted			2022-12-28	WOS:000294319500032
J	Samet, JM				Samet, Jonathan M.			The Clean Air Act and Health - A Clearer View from 2011	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Samet, Jonathan M.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Samet, Jonathan M.] Univ So Calif, USC Inst Global Hlth, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Samet, JM (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.							*ENV PROT AG, 2011, POL ASS REV SEC NAT; Health Effects Institute. (HEI), 2010, SPECIAL REPORT, V17, DOI DOI 10.1016/J.ENVINT.2019.104909; Krupnick A, 2002, ANNU REV PUBL HEALTH, V23, P427, DOI 10.1146/annurev.publhealth.23.100901.140516; Mauderly JL, 2010, INHAL TOXICOL, V22, P1, DOI 10.3109/08958371003793846; National Research Council, 2004, AIR QUAL MAN US	5	38	38	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2011	365	3					198	201		10.1056/NEJMp1103332	http://dx.doi.org/10.1056/NEJMp1103332			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	794QI	21732828				2022-12-28	WOS:000292915500003
J	Sekiya, S; Suzuki, A				Sekiya, Sayaka; Suzuki, Atsushi			Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors	NATURE			English	Article							HEPATIC PROGENITOR CELLS; CLONAL IDENTIFICATION; STEM-CELLS; IN-VIVO; LIVER; DIFFERENTIATION; CARDIOMYOCYTES; NORMALIZATION; EXPRESSION; NEURONS	The location and timing of cellular differentiation must be stringently controlled for proper organ formation. Normally, hepatocytes differentiate from hepatic progenitor cells to form the liver during development(1,2). However, previous studies have shown that the hepatic program can also be activated in non-hepatic lineage cells after exposure to particular stimuli or fusion with hepatocytes(3-9). These unexpected findings suggest that factors critical to hepatocyte differentiation exist and become activated to induce hepatocyte-specific properties in different cell types. Here, by screening the effects of twelve candidate factors, we identify three specific combinations of two transcription factors, comprising Hnf4 alpha plus Foxa1, Foxa2 or Foxa3, that can convert mouse embryonic and adult fibroblasts into cells that closely resemble hepatocytes in vitro. The induced hepatocyte-like (iHep) cells have multiple hepatocyte-specific features and reconstitute damaged hepatic tissues after transplantation. The generation of iHep cells may provide insights into the molecular nature of hepatocyte differentiation and potential therapies for liver diseases.	[Sekiya, Sayaka; Suzuki, Atsushi] Kyushu Univ, Div Organogenesis & Regenerat, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan; [Suzuki, Atsushi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Japan Science & Technology Agency (JST)	Suzuki, A (corresponding author), Kyushu Univ, Div Organogenesis & Regenerat, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	suzukicks@bioreg.kyushu-u.ac.jp		Suzuki, Atsushi/0000-0002-6347-5498	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	We thank A. Iwama, H. Miyoshi and R. M. Tanguay for sharing reagents, F. Costantini for providing the R26R<SUP>YFP</SUP> mice and E. Gunshima, A. Kaneyuki and H. Kuboyama for excellent technical assistance. This work was supported in part by the Program for Improvement of the Research Environment for Young Researchers from the Special Coordination Funds for Promoting Science and Technology commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, a Grant-in-Aid for Scientific Research from the MEXT of Japan and the Precursory Research for Embryonic Science and Technology Program of the Japan Science and Technology Agency.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kaneko S, 2001, HUM GENE THER, V12, P35, DOI 10.1089/104303401450942; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; REDDY JK, 1984, J CELL BIOL, V98, P2082, DOI 10.1083/jcb.98.6.2082; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SCARPELLI DG, 1981, P NATL ACAD SCI-BIOL, V78, P2577, DOI 10.1073/pnas.78.4.2577; SEGLEN PO, 1979, J TOXICOL ENV HEALTH, V5, P551, DOI 10.1080/15287397909529766; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suzuki A, 2000, HEPATOLOGY, V32, P1230, DOI 10.1053/jhep.2000.20349; Suzuki A, 2003, P NATL ACAD SCI USA, V100, P5034, DOI 10.1073/pnas.0936260100; Suzuki A, 2002, J CELL BIOL, V156, P173, DOI 10.1083/jcb.200108066; Suzuki A, 2003, DEVELOPMENT, V130, P2513, DOI 10.1242/dev.00459; Suzuki A, 2008, HEPATOLOGY, V48, P1964, DOI 10.1002/hep.22558; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Wang X, 2001, AM J PATHOL, V158, P571, DOI 10.1016/S0002-9440(10)63999-5; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	31	596	648	4	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					390	U148		10.1038/nature10263	http://dx.doi.org/10.1038/nature10263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21716291				2022-12-28	WOS:000292911200045
J	Robinson, JK; Bigby, M				Robinson, June K.; Bigby, Michael			Prevention of Melanoma With Regular Sunscreen Use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; SKIN; CELL		[Robinson, June K.] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA; [Bigby, Michael] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Bigby, Michael] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Northwestern University; Feinberg School of Medicine; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Robinson, JK (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Dermatol, 132 E Delaware Pl 5806, Chicago, IL 60611 USA.	june-robinson@northwestern.edu						[Anonymous], MEL SKIN CANC; Chang YM, 2009, INT J EPIDEMIOL, V38, P814, DOI 10.1093/ije/dyp166; Dennis LK, 2003, ANN INTERN MED, V139, P966, DOI 10.7326/0003-4819-139-12-200312160-00006; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; Green AC, 2011, J CLIN ONCOL, V29, P257, DOI 10.1200/JCO.2010.28.7078; Huncharek M, 2002, AM J PUBLIC HEALTH, V92, P1173, DOI 10.2105/AJPH.92.7.1173; IARC, 2001, IARC HDB CANC PREV, V5; *IARC, 1992, IARC MON EV CARC RIS, V55; Lin JS, 2011, ANN INTERN MED, V154, P190, DOI 10.7326/0003-4819-154-3-201102010-00009; van der Pols JC, 2006, CANCER EPIDEM BIOMAR, V15, P2546, DOI 10.1158/1055-9965.EPI-06-0352	10	10	10	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2011	306	3					302	303		10.1001/jama.2011.990	http://dx.doi.org/10.1001/jama.2011.990			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794BS	21712528				2022-12-28	WOS:000292870500023
J	Aung, K				Aung, KoKo			Review: Adding an ACE inhibitor or ARB to CCB therapy reduces CCB-associated edema in patients with hypertension	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ALISKIREN		Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Aung, K (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.		Aung, KoKo/I-1236-2019						0	0	0	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2							JC1-11	10.7326/0003-4819-155-2-201107190-02011	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	793KW	21768577				2022-12-28	WOS:000292822000010
J	Andrews, RC; Cooper, AR; Montgomery, AA; Norcross, AJ; Peters, TJ; Sharp, DJ; Jackson, N; Fitzsimons, K; Bright, J; Coulman, K; England, CY; Gorton, J; McLenaghan, A; Paxton, E; Polet, A; Thompson, C; Dayan, CM				Andrews, R. C.; Cooper, A. R.; Montgomery, A. A.; Norcross, A. J.; Peters, T. J.; Sharp, D. J.; Jackson, N.; Fitzsimons, K.; Bright, J.; Coulman, K.; England, C. Y.; Gorton, J.; McLenaghan, A.; Paxton, E.; Polet, A.; Thompson, C.; Dayan, C. M.			Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial	LANCET			English	Article							LIFE-STYLE; GLYCEMIC CONTROL; EXERCISE; THERAPY; RESISTANCE; WEIGHT; RISK; MANAGEMENT; OBESITY	Background Lifestyle changes soon after diagnosis might improve outcomes in patients with type 2 diabetes mellitus, but no large trials have compared interventions. We investigated the effects of diet and physical activity on blood pressure and glucose concentrations. Methods We did a randomised, controlled trial in southwest England in adults aged 30-80 years in whom type 2 diabetes had been diagnosed 5-8 months previously. Participants were assigned usual care (initial dietary consultation and follow-up every 6 months; control group), an intensive diet intervention (dietary consultation every 3 months with monthly nurse support), or the latter plus a pedometer-based activity programme, in a 2:5:5 ratio. The primary endpoint was improvement in glycated haemoglobin A(1c) (HbA(1c)) concentration and blood pressure at 6 months. Analysis was done by intention to treat. This study is registered, number ISRCTN92162869. Findings Of 593 eligible individuals, 99 were assigned usual care, 248 the diet regimen, and 246 diet plus activity. Outcome data were available for 587 (99%) and 579 (98%) participants at 6 and 12 months, respectively. At 6 months, glycaemic control had worsened in the control group (mean baseline HbA(1c) percentage 6.72, SD 1.02, and at 6 months 6.86, 1.02) but improved in the diet group (baseline-adjusted difference in percentage of HbA(1c) -0.28%, 95% CI -0.46 to -0.10; p=0.005) and diet plus activity group (-0.33%, -0.51 to -0.14; p<0.001). These differences persisted to 12 months, despite less use of diabetes drugs. Improvements were also seen in bodyweight and insulin resistance between the intervention and control groups. Blood pressure was similar in all groups. Interpretation An intensive diet intervention soon after diagnosis can improve glycaemic control. The addition of an activity intervention conferred no additional benefit.	[Andrews, R. C.; Norcross, A. J.; Peters, T. J.; Jackson, N.; Bright, J.; Coulman, K.; England, C. Y.; Gorton, J.; McLenaghan, A.; Paxton, E.; Polet, A.; Thompson, C.] Univ Bristol, Sch Clin Sci, Bristol BS1 3NY, Avon, England; [Cooper, A. R.] Univ Bristol, Sch Policy Studies, Ctr Exercise Nutr & Hlth Sci, Bristol BS1 3NY, Avon, England; [Montgomery, A. A.; Peters, T. J.; Sharp, D. J.] Univ Bristol, Sch Social & Community Med, Bristol BS1 3NY, Avon, England; [Fitzsimons, K.] Ctr Maternal & Child Enquiries, London, England; [Dayan, C. M.] Cardiff Univ, Sch Med, Ctr Endocrine & Diabet Sci, Cardiff, S Glam, Wales	University of Bristol; University of Bristol; University of Bristol; Cardiff University	Andrews, RC (corresponding author), Univ Bristol, Sch Clin Sci, Dorothy Hodgkin Bldg,Whitson St, Bristol BS1 3NY, Avon, England.	rob.andrews@bristol.ac.uk	Dayan, Colin/AAH-6242-2019; Cooper, Ashley/D-9956-2014	Dayan, Colin/0000-0002-6557-3462; Cooper, Ashley/0000-0001-8644-3870; England, Clare/0000-0003-0685-0690; Peters, Tim/0000-0003-2881-4180; andrews, robert/0000-0003-4939-1738; Montgomery, Alan/0000-0003-0450-1606; sharp, deborah/0000-0003-3071-9860	Diabetes UK; UK Department of Health; Sanofi-Aventis; GlaxoSmithKline; Medtronic Advisery; Novo Nordisk; Bristol-Myers Squibb; Medtronic; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [G0800800] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G0800800] Funding Source: researchfish	Diabetes UK(Diabetes UK); UK Department of Health; Sanofi-Aventis(Sanofi-Aventis); GlaxoSmithKline(GlaxoSmithKline); Medtronic Advisery(Medtronic); Novo Nordisk(Novo Nordisk); Bristol-Myers Squibb(Bristol-Myers Squibb); Medtronic(Medtronic); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Diabetes UK and the UK Department of Health.; RCA has received honoraria from GlaxoSmithKline, Novo Nordisk, Sanofi-Aventis, and Lilly, and travel expenses from Sanofi-Aventis. CMD has received consultancy fees from GlaxoSmithKline and Medtronic Advisery, speaker's fees from Novo Nordisk and Bristol-Myers Squibb, travel expenses from Medtronic, and is named on a patent held by Novartis. The other authors declare that they have no conflicts of interest.	Aschner P, 2010, DIABETES OBES METAB, V12, P252, DOI 10.1111/j.1463-1326.2009.01187.x; Avenell A, 2004, J HUM NUTR DIET, V17, P293, DOI 10.1111/j.1365-277X.2004.00530.x; BOGARDUS C, 1984, DIABETES, V33, P311, DOI 10.2337/diabetes.33.4.311; Boule NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218; Church TS, 2010, JAMA-J AM MED ASSOC, V304, P2253, DOI 10.1001/jama.2010.1710; Connor H, 2003, DIABETIC MED, V20, P786, DOI 10.1046/j.1464-5491.2003.01104.x; Dunstan DW, 2002, DIABETES CARE, V25, P1729, DOI 10.2337/diacare.25.10.1729; Food Standards Agency, 2001, BAL GOOD HLTH; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Joslin EP, 1959, TREATMENT DIABETES M; KLINE GM, 1987, MED SCI SPORT EXER, V19, P253; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Malpass A, 2009, PATIENT EDUC COUNS, V74, P258, DOI 10.1016/j.pec.2008.08.018; Miller WR, 1996, ADDICT BEHAV, V21, P835, DOI 10.1016/0306-4603(96)00044-5; Montgomery AA, 2000, BRIT MED J, V320, P686, DOI 10.1136/bmj.320.7236.686; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nield L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004097.pub4; Norris SL, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004096.pub2, 10.1002/14651858.CD004095.pub2, 10.1002/14651858.CD005270]; SALTIN B, 1979, DIABETES, V28, P30, DOI 10.2337/diab.28.1.S30; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Snowling NJ, 2006, DIABETES CARE, V29, P2518, DOI 10.2337/dc06-1317; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Thomas D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006296.pub2; United Kingdom Prospective Diabetes Study (UKPDS), 1995, BMJ-BRIT MED J, V310, P83, DOI DOI 10.1136/BMJ.310.6972.83; Wallace TM, 2002, DIABETIC MED, V19, P527, DOI 10.1046/j.1464-5491.2002.00745.x; WING RR, 1988, DIABETOLOGIA, V31, P902; Wycherley TP, 2008, DIABETES OBES METAB, V10, P1062, DOI 10.1111/j.1463-1326.2008.00863.x; YAMANOUCHI K, 1995, DIABETES CARE, V18, P775, DOI 10.2337/diacare.18.6.775; Zanuso S, 2010, ACTA DIABETOL, V47, P15, DOI 10.1007/s00592-009-0126-3	31	193	200	1	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2011	378	9786					129	139		10.1016/S0140-6736(11)60442-X	http://dx.doi.org/10.1016/S0140-6736(11)60442-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	795CJ	21705068				2022-12-28	WOS:000292948800029
J	Bonnet, RM; Bleeker, JAM				Bonnet, Roger-Maurice; Bleeker, Johan A. M.			A Dark Age for Space Astronomy?	SCIENCE			English	Editorial Material							SCIENTISTS; EUROPE; NASA		[Bonnet, Roger-Maurice] ISSI, CH-3012 Bern, Switzerland; [Bleeker, Johan A. M.] SRON Netherlands Inst Space Res, NL-3584 Utrecht, Netherlands; [Bleeker, Johan A. M.] Univ Utrecht, Astron Inst, NL-3508 Utrecht, Netherlands	Utrecht University	Bonnet, RM (corresponding author), ISSI, CH-3012 Bern, Switzerland.	rmbonnet@issibern.ch						Bhattacharjee Y, 2011, SCIENCE, V331, P1121, DOI 10.1126/science.331.6021.1121; BIGNAMI G, 2005, BR247 ESA; Billings L, 2010, NATURE, V467, P1028, DOI 10.1038/4671028a; Bode MF, 2008, ASTRONET INFRASTRUCT; BONNET RM, 1985, ESA SPECIAL PUBL, V1070; CLERY D, 1993, SCIENCE, V261, P540, DOI 10.1126/science.261.5121.540; DESELDING P, 2011, SPACE NEWS      0425; Lawler A, 2010, SCIENCE, V330, P1028, DOI 10.1126/science.330.6007.1028; National Research Council, 2010, NEW WORLDS NEW HOR A; Reich ES, 2011, NATURE, V471, P421, DOI 10.1038/471421a; UBERTINI P, 2011, V24 COSPAR WORK GROU	11	3	3	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					161	162		10.1126/science.1206409	http://dx.doi.org/10.1126/science.1206409			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	789GG	21737724				2022-12-28	WOS:000292502700028
J	Kabrhel, C; Varraso, R; Goldhaber, SZ; Rimm, E; Camargo, CA				Kabrhel, Christopher; Varraso, Raphaelle; Goldhaber, Samuel Z.; Rimm, Eric; Camargo, Carlos A., Jr.			Physical inactivity and idiopathic pulmonary embolism in women: prospective study	BRITISH MEDICAL JOURNAL			English	Article							DEEP-VEIN THROMBOSIS; CARDIOVASCULAR RISK-FACTORS; VENOUS-BLOOD FLOW; THROMBOEMBOLISM; EXERCISE; DISEASE; POPULATION; FIBRINOLYSIS; HEMOSTASIS; FIBRINOGEN	Objectives To determine the association between physical inactivity (that is, a sedentary lifestyle) and incident idiopathic pulmonary embolism. Design Prospective cohort study. Setting Nurses' Health Study. Participants 69 950 female nurses who completed biennial questionnaires from 1990 to 2008. Main outcome measures The primary outcome was idiopathic pulmonary embolism confirmed in medical records. Multivariable Cox proportional hazards models controlled for age, body mass index (BMI), energy intake, smoking, pack years, race, spouse's educational attainment, parity, menopause, non-aspirin non-steroidal anti-inflammatory drugs, warfarin, multivitamin supplements, hypertension, coronary heart disease, rheumatological disease, and dietary patterns. The primary exposure was physical inactivity, measured in hours of sitting each day. The secondary exposure was physical activity, measured in metabolic equivalents a day. Results Over the 18 year study period, there were 268 cases of incident idiopathic pulmonary embolism. There was an association between time of sitting and risk of idiopathic pulmonary embolism (41/104 720 v 16/14 565 cases in most inactive v least inactive in combined data; P<0.001 for trend). The risk of pulmonary embolism was more than twofold in women who spent the most time sitting compared with those who spent the least time sitting (multivariable hazard ratio 2.34, 95% confidence interval 1.30 to 4.20). There was no association between physical activity and pulmonary embolism (P=0.53 for trend). Conclusions Physical inactivity is associated with incident pulmonary embolism in women. Interventions that decrease time sitting could lower the risk of pulmonary embolism.	[Kabrhel, Christopher; Camargo, Carlos A., Jr.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Goldhaber, Samuel Z.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc,Dept Med, Boston, MA 02115 USA; [Varraso, Raphaelle] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Resp & Environm Epidemiol Team, F-94807 Villejuif, France; [Varraso, Raphaelle] Univ Paris 11, UMRS 1018, F-94807 Villejuif, France; [Rimm, Eric] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Rimm, Eric] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Rimm, Eric; Camargo, Carlos A., Jr.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kabrhel, C (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, Zero Emerson Pl,Suite 3B, Boston, MA 02114 USA.	ckabrhel@partners.org	Camargo, Carlos A./C-2145-2008; Varraso, Raphaelle/R-8740-2016	Camargo, Carlos A./0000-0002-5071-7654; Varraso, Raphaelle/0000-0002-3338-7825; Kabrhel, Christopher/0000-0002-8699-7176	National Institute on Aging, National Institutes of Health, Bethesda, MD [R21AG031079, P01CA87969, R01HL034594]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG031079] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Institute on Aging, National Institutes of Health, Bethesda, MD (R21AG031079, P01CA87969, and R01HL034594). The funding source had no role in design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript.	Arterburn DE, 2004, J AM GERIATR SOC, V52, P1907, DOI 10.1111/j.1532-5415.2004.52517.x; Bassett DR, 2010, MED SCI SPORT EXER, V42, P1819, DOI 10.1249/MSS.0b013e3181dc2e54; Centers for Disease Control and Prevention, 2007, US PHYS ACT STAT; Cushman M, 2004, JAMA-J AM MED ASSOC, V292, P1573, DOI 10.1001/jama.292.13.1573; El-Sayed MS, 2004, SPORTS MED, V34, P181, DOI 10.2165/00007256-200434030-00004; El-Sayed MS, 2000, MED SCI SPORT EXER, V32, P918; Eliasson M, 1996, INT J EPIDEMIOL, V25, P1182, DOI 10.1093/ije/25.6.1182; ElSayed MS, 1996, SPORTS MED, V22, P282, DOI 10.2165/00007256-199622050-00002; ElSayed MS, 1996, BLOOD COAGUL FIBRIN, V7, P484, DOI 10.1097/00001721-199606000-00009; Everett BM, 2009, J THROMB HAEMOST, V7, P588, DOI 10.1111/j.1538-7836.2009.03302.x; FOLSOM AR, 1991, ATHEROSCLEROSIS, V91, P191, DOI 10.1016/0021-9150(91)90167-2; Glynn RJ, 2005, AM J EPIDEMIOL, V162, P975, DOI 10.1093/aje/kwi309; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Goldhaber SZ, 1997, JAMA-J AM MED ASSOC, V277, P642, DOI 10.1001/jama.277.8.642; GOLDHABER SZ, 1983, AM J MED, V74, P1023, DOI 10.1016/0002-9343(83)90805-7; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Heit JA, 2005, J THROMB HAEMOST, V3, P1611, DOI 10.1111/j.1538-7836.2005.01415.x; Heit JA, 2003, CLIN CHEST MED, V24, P1, DOI 10.1016/S0272-5231(02)00077-1; Hitos K, 2007, J THROMB HAEMOST, V5, P1890, DOI 10.1111/j.1538-7836.2007.02664.x; Jackson AS, 2009, ARCH INTERN MED, V169, P1781, DOI 10.1001/archinternmed.2009.312; Kabrhel C, 2009, OBESITY, V17, P2040, DOI 10.1038/oby.2009.92; Kline JA, 2004, J THROMB HAEMOST, V2, P1247, DOI 10.1111/j.1538-7836.2004.00790.x; Kucher N, 2005, THROMB HAEMOSTASIS, V93, P494, DOI 10.1160/TH04-09-0587; Kurkciyan I, 2000, ARCH INTERN MED, V160, P1529, DOI 10.1001/archinte.160.10.1529; McNally MA, 1997, J BONE JOINT SURG AM, V79A, P1198, DOI 10.2106/00004623-199708000-00012; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Sochart DH, 1999, J BONE JOINT SURG BR, V81B, P700, DOI 10.1302/0301-620X.81B4.8909; STRATTON JR, 1991, CIRCULATION, V83, P1692, DOI 10.1161/01.CIR.83.5.1692; TROY LM, 1995, INT J OBESITY, V19, P570; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182; van Stralen KJ, 2007, J THROMB HAEMOST, V5, P2186, DOI 10.1111/j.1538-7836.2007.02732.x; van Stralen KJ, 2008, J AM GERIATR SOC, V56, P517, DOI 10.1111/j.1532-5415.2007.01588.x; van Stralen KJ, 2008, ARCH INTERN MED, V168, P21, DOI 10.1001/archinternmed.2007.5; Van Stralen KJ, 2005, J THROMB HAEMOST, V3, P2110, DOI 10.1111/j.1538-7836.2005.01482.x; Varraso R, 2007, AM J CLIN NUTR, V86, P488, DOI 10.1093/ajcn/86.2.488; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WILSON PWF, 1986, AM HEART J, V111, P1177, DOI 10.1016/0002-8703(86)90022-0; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	40	50	51	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 4	2011	343								d3867	10.1136/bmj.d3867	http://dx.doi.org/10.1136/bmj.d3867			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791RR	21727169	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000292682800005
J	Lee, MSY; Jago, JB; Garcia-Bellido, DC; Edgecombe, GD; Gehling, JG; Paterson, JR				Lee, Michael S. Y.; Jago, James B.; Garcia-Bellido, Diego C.; Edgecombe, Gregory D.; Gehling, James G.; Paterson, John R.			Modern optics in exceptionally preserved eyes of Early Cambrian arthropods from Australia	NATURE			English	Article							EMU BAY SHALE; SOUTH-AUSTRALIA; KANGAROO ISLAND; VISUAL-SYSTEM; LAGERSTATTE; TRILOBITES; EVOLUTION; TUZOIA	Despite the status of the eye as an "organ of extreme perfection"(1), theory suggests that complex eyes can evolve very rapidly(2). The fossil record has, until now, been inadequate in providing insight into the early evolution of eyes during the initial radiation of many animal groups known as the Cambrian explosion. This is surprising because Cambrian Burgess-Shale-type deposits are replete with exquisitely preserved animals, especially arthropods, that possess eyes(3-5). However, with the exception of biomineralized trilobite eyes, virtually nothing is known about the details of their optical design. Here we report exceptionally preserved fossil eyes from the Early Cambrian (similar to 515 million years ago) Emu Bay Shale of South Australia, revealing that some of the earliest arthropods possessed highly advanced compound eyes, each with over 3,000 large ommatidial lenses and a specialized 'bright zone'. These are the oldest non-biomineralized eyes known in such detail, with preservation quality exceeding that found in the Burgess Shale and Chengjiang deposits. Non-biomineralized eyes of similar complexity are otherwise unknown until about 85 million years later(6,7). The arrangement and size of the lenses indicate that these eyes belonged to an active predator that was capable of seeing in low light. The eyes are more complex than those known from contemporaneous trilobites and are as advanced as those of many living forms. They provide further evidence that the Cambrian explosion involved rapid innovation in fine-scale anatomy as well as gross morphology, and are consistent with the concept that the development of advanced vision helped to drive this great evolutionary event(8).	[Lee, Michael S. Y.; Jago, James B.; Gehling, James G.] S Australian Museum, Adelaide, SA 5000, Australia; [Lee, Michael S. Y.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Jago, James B.] Univ S Australia, Sch Nat & Built Environm, Mawson Lakes, SA 5095, Australia; [Garcia-Bellido, Diego C.] Inst Geociencias CSIC UCM, Inst Geol Econ, Dept Paleontol, Madrid 28040, Spain; [Edgecombe, Gregory D.] Nat Hist Museum, Dept Paleontol, London SW7 5BD, England; [Paterson, John R.] Univ New England, Sch Environm & Rural Sci, Div Earth Sci, Armidale, NSW 2351, Australia	University of Adelaide; University of South Australia; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UCM - Instituto de Geociencias (IGEO); CSIC-UCM - Instituto de Geologia Economica (IGE); Natural History Museum London; University of New England	Lee, MSY (corresponding author), S Australian Museum, Adelaide, SA 5000, Australia.	mike.lee@samuseum.sa.gov.au; jpater20@une.edu.au	Garcia-Bellido, Diego/AAF-9043-2021	Paterson, John/0000-0003-2947-3912; Garcia-Bellido, Diego/0000-0003-1922-9836; Edgecombe, Gregory/0000-0002-9591-8011; Jago, James/0000-0002-3059-1572	Australian Research Council [LP0774959]; South Australian Museum; Spanish Ministry of Science [RYC2007-00090, CGL2009-07073]; Beach Energy and Sealink Pty Ltd	Australian Research Council(Australian Research Council); South Australian Museum; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Beach Energy and Sealink Pty Ltd	We thank P. and C. Buck for access to and assistance at the fossil site; N. Schroeder, M. Gemmell, R. Atkinson, M. A. Binnie and numerous others (Supplementary Table 3) for help with excavations and curatorial assistance; A. Netting, P. Hudson and Adelaide Microscopy for imaging; D. Birch and G. Brock for SEM-EDS analysis; A. Baonza and J. F. de Celis for discussions on arthropod eye development; R. Fortey and A. Parker for comments and the Australian Research Council (grant LP0774959), South Australian Museum, Spanish Ministry of Science (RYC2007-00090 and grant CGL2009-07073), Beach Energy and Sealink Pty Ltd for funding.	[Anonymous], 1861, ORIGIN SPECIES MEANS; Briggs D.E.G., 1994, FOSSILS BURGESS SHAL; Briggs DEG, 1997, J PALEONTOL, V71, P22, DOI 10.1017/S0022336000038919; Clarkson E, 2006, ARTHROPOD STRUCT DEV, V35, P247, DOI 10.1016/j.asd.2006.08.002; Conway-Morris Simon., 1998, CRUCIBLE CREATION BU; Daley AC, 2009, SCIENCE, V323, P1597, DOI 10.1126/science.1169514; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Garcia-Bellido DC, 2009, PALAEONTOLOGY, V52, P1221, DOI 10.1111/j.1475-4983.2009.00914.x; Gehling JG, 2011, AUST J EARTH SCI, V58, P243, DOI 10.1080/08120099.2011.555487; Harzsch S, 2007, ORG DIVERS EVOL, V7, P20, DOI 10.1016/j.ode.2006.02.004; Harzsch S, 2006, ARTHROPOD STRUCT DEV, V35, P319, DOI 10.1016/j.asd.2006.08.009; Haug JT, 2009, PALAEONTOGR ABT A, V289, P1; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; Land MF, 2002, ANIMAL EYES; McCormick T, 1998, PALEOBIOLOGY, V24, P235; NILSSON DE, 1994, P ROY SOC B-BIOL SCI, V256, P53, DOI 10.1098/rspb.1994.0048; Oldham S, 2002, DEVELOPMENT, V129, P4103; Parker A., 2003, BLINK EYE CAUSE MOST; Parker AR, 2011, OPT LASER TECHNOL, V43, P323, DOI 10.1016/j.optlastec.2008.12.020; Paterson JR, 2010, PALAEONTOLOGY, V53, P377, DOI 10.1111/j.1475-4983.2010.00932.x; Plotnick RE, 2010, PALEOBIOLOGY, V36, P303, DOI 10.1666/08062.1; Ritchie A., 1985, Alcheringa, V9, P117, DOI 10.1080/03115518508618961; SCHOENEMANN B, 2010, LETHAIA         0930, DOI DOI 10.1111/J.1502-3931.2010.00239.X; Schoenemann B, 2008, ENTOMOL GEN, V31, P287; Snyder A. W., 1979, COMP PHYSL EVOLUTION, P225, DOI DOI 10.1007/978-3-642-66999-6_5; vanderBrugghen W, 1997, NATURE, V385, P589, DOI 10.1038/385589a0; Vannier J, 2007, J PALEONTOL, V81, P445, DOI 10.1666/pleo05070.1; Warrant E, 2006, INVERTEBRATE VISION, pXIX; WEHNER R, 1981, COMP PHYSL EVOLUTION, P287; ZHANG XG, 1990, PALAEONTOLOGY, V33, P911	30	58	60	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2011	474	7353					631	634		10.1038/nature10097	http://dx.doi.org/10.1038/nature10097			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21720369				2022-12-28	WOS:000292204300037
J	O'Brian, S; Onslow, M				O'Brian, Susan; Onslow, Mark			Clinical management of stuttering in children and adults	BRITISH MEDICAL JOURNAL			English	Review							LIDCOMBE PROGRAM; SOCIAL PHOBIA; TRIAL; ATTITUDES; IMPACT; INTERVENTION; ETIOLOGY; STAMMER; ONSET; AGE		[O'Brian, Susan; Onslow, Mark] Univ Sydney, Australian Stuttering Res Ctr, Lidcombe, NSW 2060, Australia	University of Sydney	Onslow, M (corresponding author), Univ Sydney, Australian Stuttering Res Ctr, Lidcombe, NSW 2060, Australia.	mark.onslow@sydney.edu.au		Onslow, Mark/0000-0003-2629-2390; O'Brian, Susan/0000-0002-0882-1909	University of Sydney	University of Sydney(University of Sydney)	Both authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: SO and MO have support from the University of Sydney for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Blumgart E, 2010, DEPRESS ANXIETY, V27, P687, DOI 10.1002/da.20657; Carey B, 2010, INT J LANG COMM DIS, V45, P108, DOI 10.3109/13682820902763944; Chang SE, 2008, NEUROIMAGE, V39, P1333, DOI 10.1016/j.neuroimage.2007.09.067; CONTURE EG, 1991, J SPEECH HEAR RES, V34, P1041, DOI 10.1044/jshr.3405.1041; Craig A, 2009, J FLUENCY DISORD, V34, P61, DOI 10.1016/j.jfludis.2009.05.002; Cream A, 2010, J SPEECH LANG HEAR R, V53, P887, DOI 10.1044/1092-4388(2009/09-0080); Cykowski MD, 2010, NEUROIMAGE, V52, P1495, DOI 10.1016/j.neuroimage.2010.05.011; Davis S, 2002, J CHILD PSYCHOL PSYC, V43, P939, DOI 10.1111/1469-7610.00093; DeCarle AJ, 1996, AM J PSYCHIAT, V153, P1367; DENIL LF, 1991, J SPEECH HEAR RES, V34, P60; Ezrati-Vinacour R, 2001, J SPEECH LANG HEAR R, V44, P368, DOI 10.1044/1092-4388(2001/030); Felsenfeld S, 2000, BEHAV GENET, V30, P359, DOI 10.1023/A:1002765620208; Hayhow R, 2002, J FLUENCY DISORD, V27, P1, DOI 10.1016/S0094-730X(01)00102-4; Hugh-Jones S, 1999, BRIT J EDUC PSYCHOL, V69, P141, DOI 10.1348/000709999157626; HURST MI, 1983, J FLUENCY DISORD, V8, P1, DOI 10.1016/0094-730X(83)90017-7; Iverach L, 2010, J SPEECH LANG HEAR R, V53, P1178, DOI 10.1044/1092-4388(2010/09-0166); Iverach L, 2009, J FLUENCY DISORD, V34, P173, DOI 10.1016/j.jfludis.2009.09.001; Iverach L, 2009, J ANXIETY DISORD, V23, P928, DOI 10.1016/j.janxdis.2009.06.003; Iverach L, 2009, J FLUENCY DISORD, V34, P29, DOI 10.1016/j.jfludis.2009.02.002; Jones M, 2005, BMJ-BRIT MED J, V331, P659, DOI 10.1136/bmj.38520.451840.E0; Kingston M, 2003, INT J LANG COMM DIS, V38, P165, DOI 10.1080/1368282031000062882; Klein JF, 2004, J FLUENCY DISORD, V29, P255, DOI 10.1016/j.jfludis.2004.08.001; Langevin M., 1998, CONT ISSUES COMMUNIC, V25, P8, DOI 10.1044/cicsd_25_S_8; Langevin M, 2009, J FLUENCY DISORD, V34, P72, DOI 10.1016/j.jfludis.2009.05.001; Langevin M, 2009, AM J SPEECH-LANG PAT, V18, P264, DOI 10.1044/1058-0360(2009/07-0087); Lattermann C, 2008, J FLUENCY DISORD, V33, P52, DOI 10.1016/j.jfludis.2007.12.002; Lewis C, 2008, AM J SPEECH-LANG PAT, V17, P139, DOI 10.1044/1058-0360(2008/014); Menzies RG, 2008, J SPEECH LANG HEAR R, V51, P1451, DOI 10.1044/1092-4388(2008/07-0070); Onslow M., HDB EVIDENC IN PRESS; Reilly S, 2009, PEDIATRICS, V123, P270, DOI 10.1542/peds.2007-3219; Sommer M, 2002, LANCET, V360, P380, DOI 10.1016/S0140-6736(02)09610-1; Stein MB, 1996, AM J PSYCHIAT, V153, P278; Yairi E, 1999, J SPEECH LANG HEAR R, V42, P1097, DOI 10.1044/jslhr.4205.1097; YAIRI E, 1983, J SPEECH HEAR DISORD, V48, P171, DOI 10.1044/jshd.4802.171	34	5	5	0	27	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 24	2011	342								d3742	10.1136/bmj.d3742	http://dx.doi.org/10.1136/bmj.d3742			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AW	21705407				2022-12-28	WOS:000292200800002
J	Wu, CL; Raja, SN				Wu, Christopher L.; Raja, Srinivasa N.			Treatment of acute postoperative pain	LANCET			English	Article							PATIENT-CONTROLLED ANALGESIA; GUIDED REGIONAL ANESTHESIA; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PERSISTENT POSTSURGICAL PAIN; OPIOID-INDUCED HYPERALGESIA; TOTAL KNEE ARTHROPLASTY; PERIPHERAL-NERVE BLOCK; EPIDURAL ANALGESIA; RECEPTOR ANTAGONISTS; EMERGENCY-DEPARTMENT	Although postoperative pain remains incompletely controlled in some settings, increased understanding of its mechanisms and the development of several therapeutic approaches have substantially improved pain control in past years. Advances in our understanding of the process of nociception have led to insight into gene-based pain therapy, the development of acute opioid-induced hyperalgesia, and persistent postsurgical pain. Use of specific analgesic techniques such as regional analgesia could improve patient outcomes. We also examine the development of new analgesic agents and treatment modalities and regimens for acute postoperative pain.	[Wu, Christopher L.; Raja, Srinivasa N.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Wu, Christopher L.; Raja, Srinivasa N.] Sch Med, Baltimore, MD USA	Johns Hopkins University	Wu, CL (corresponding author), Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA.	chwu@jhmi.edu	Wu, Christopher/AAH-5389-2020	Wu, Christopher/0000-0002-4484-0787; Yang, Shuman/0000-0002-9638-0890	Department of Anesthesiology and Critical Care Medicine of the Johns Hopkins University (Baltimore, MD, USA)	Department of Anesthesiology and Critical Care Medicine of the Johns Hopkins University (Baltimore, MD, USA)	This work was supported by the Department of Anesthesiology and Critical Care Medicine of the Johns Hopkins University (Baltimore, MD, USA).	Abrahams MS, 2009, BRIT J ANAESTH, V102, P408, DOI 10.1093/bja/aen384; Accardi MC, 2009, J BEHAV MED, V32, P328, DOI 10.1007/s10865-009-9207-6; Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Antonakakis JG, 2009, REGION ANESTH PAIN M, V34, P64, DOI 10.1016/AAP.0b013e3181933a53; Apfelbaum JL, 2003, ANESTH ANALG, V97, P534, DOI 10.1213/01.ANE.0000068822.10113.9E; Barrington MJ, 2009, REGION ANESTH PAIN M, V34, P534, DOI 10.1097/AAP.0b013e3181ae72e8; Becker G, 2009, LANCET, V373, P1198, DOI 10.1016/S0140-6736(09)60139-2; Benhamou D, 2008, PAIN, V136, P134, DOI 10.1016/j.pain.2007.06.028; Bjordal JM, 2003, EUR J PAIN, V7, P181, DOI 10.1016/S1090-3801(02)00098-8; Block BM, 2003, JAMA-J AM MED ASSOC, V290, P2455, DOI 10.1001/jama.290.18.2455; Brennan TJ, 2011, PAIN, V152, pS33, DOI 10.1016/j.pain.2010.11.005; Brennan TJ, 2005, ANESTHESIOLOGY, V103, P681, DOI 10.1097/00000542-200510000-00004; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; Brummett Chad M, 2009, J Opioid Manag, V5, P175; Buvanendran A, 2004, ANESTH ANALG, V99, P1453, DOI 10.1213/01.ANE.0000134806.61887.0D; Buvanendran A, 2003, JAMA-J AM MED ASSOC, V290, P2411, DOI 10.1001/jama.290.18.2411; Buvanendran A, 2010, ANESTH ANALG, V110, P199, DOI 10.1213/ANE.0b013e3181c4273a; Buvanendran A, 2009, CURR OPIN ANESTHESIO, V22, P588, DOI 10.1097/ACO.0b013e328330373a; Caraco Y, 2008, CLIN PHARMACOL THER, V83, P460, DOI 10.1038/sj.clpt.6100316; Carr DB, 1999, LANCET, V353, P2051, DOI 10.1016/S0140-6736(99)03313-9; Carstensen M, 2010, BRIT J ANAESTH, V104, P401, DOI 10.1093/bja/aeq041; Celerier E, 2000, ANESTHESIOLOGY, V92, P465, DOI 10.1097/00000542-200002000-00029; Cepeda M.S., 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004843.PUB2; Chu LF, 2008, CLIN J PAIN, V24, P479, DOI 10.1097/AJP.0b013e31816b2f43; Ciszkowski C, 2009, NEW ENGL J MED, V361, P827, DOI 10.1056/NEJMc0904266; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Eisenach JC, 2006, REGION ANESTH PAIN M, V31, P146, DOI 10.1016/j.rapm.2005.11.011; Fecho Karamarie, 2009, Ther Clin Risk Manag, V5, P961; Fischer HBJ, 2008, ANAESTHESIA, V63, P1105, DOI 10.1111/j.1365-2044.2008.05565.x; Fletcher D, 2008, PAIN, V137, P441, DOI 10.1016/j.pain.2008.02.026; Fortier MA, 2009, PEDIATRICS, V124, pE588, DOI 10.1542/peds.2008-3529; Frasco PE, 2005, ANESTH ANALG, V100, P162, DOI 10.1213/01.ANE.0000139354.26208.1C; Fredrickson MJ, 2010, ANAESTHESIA, V65, P608, DOI 10.1111/j.1365-2044.2009.06231.x; Freynet A, 2010, INTERACT CARDIOV TH, V10, P283, DOI 10.1510/icvts.2009.219576; Garcia-Quetglas E, 2007, PHARMACOL RES, V55, P122, DOI 10.1016/j.phrs.2006.11.003; Grant GJ, 2004, ANESTHESIOLOGY, V101, P133, DOI 10.1097/00000542-200407000-00021; Hinrichs-Rocker A, 2009, EUR J PAIN, V13, P719, DOI 10.1016/j.ejpain.2008.07.015; Horlocker TT, 2010, REGION ANESTH PAIN M, V35, P64, DOI 10.1097/AAP.0b013e3181c15c70; Hudcova J, 2006, COCHRANE DB SYST REV, DOI 10.1002/146518583.CD003348.pub2; Hurley RW, 2006, REGION ANESTH PAIN M, V31, P237, DOI 10.1016/j.rapm.2006.01.005; Ilfeld BM, 2010, PAIN, V150, P477, DOI 10.1016/j.pain.2010.05.028; Ip HYV, 2009, ANESTHESIOLOGY, V111, P657, DOI 10.1097/ALN.0b013e3181aae87a; Joly V, 2005, ANESTHESIOLOGY, V103, P147, DOI 10.1097/00000542-200507000-00022; Joshi GP, 2008, ANESTH ANALG, V107, P1026, DOI 10.1213/01.ane.0000333274.63501.ff; Katz J, 2009, EXPERT REV NEUROTHER, V9, P723, DOI 10.1586/ERN.09.20; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kehlet H, 2001, BRIT J ANAESTH, V87, P62, DOI 10.1093/bja/87.1.62; Kim SY, 2010, SURG ENDOSC, V24, P2776, DOI 10.1007/s00464-010-1045-7; Kim TJ, 2007, J PAIN, V8, P59, DOI 10.1016/j.jpain.2006.06.003; Kwekkeboom KL, 2006, J NURS SCHOLARSHIP, V38, P269, DOI 10.1111/j.1547-5069.2006.00113.x; Lavand'homme P, 2011, REGION ANESTH PAIN M, V36, P4, DOI 10.1097/AAP.0b013e31820305b8; Lee YS, 2006, CLIN PHARMACOL THER, V79, P407, DOI 10.1016/j.clpt.2006.01.013; Liu SS, 2007, ANESTH ANALG, V105, P789, DOI 10.1213/01.ane.0000278089.16848.1e; Liu SS, 2007, ANESTH ANALG, V104, P689, DOI 10.1213/01.ane.0000255040.71600.41; Liu SS, 2006, J AM COLL SURGEONS, V203, P914, DOI 10.1016/j.jamcollsurg.2006.08.007; Liu SS, 2010, REGION ANESTH PAIN M, V35, pS26, DOI 10.1097/AAP.0b013e3181d266f0; Liu SS, 2009, REGION ANESTH PAIN M, V34, P47, DOI 10.1097/AAP.0b013e3181933ec3; Liu SS, 2004, ANESTHESIOLOGY, V101, P153, DOI 10.1097/00000542-200407000-00024; Lotsch J, 2010, TRENDS PHARMACOL SCI, V31, P312, DOI 10.1016/j.tips.2010.04.002; Macrae WA, 2008, BRIT J ANAESTH, V101, P77, DOI 10.1093/bja/aen099; Manchikanti L, 2010, PAIN PHYSICIAN, V13, P401; Marcucci C, 2009, ANESTH ANALG, V108, P1996, DOI 10.1213/ane.0b013e3181a193f5; Mark TL, 2009, DRUG ALCOHOL DEPEN, V99, P345, DOI 10.1016/j.drugalcdep.2008.07.018; Marret E, 2008, BRIT J SURG, V95, P1331, DOI 10.1002/bjs.6375; Marret E, 2007, BRIT J SURG, V94, P665, DOI 10.1002/bjs.5825; Marret E, 2005, ANESTHESIOLOGY, V102, P1249, DOI 10.1097/00000542-200506000-00027; Marret E, 2009, ANESTHESIOLOGY, V111, P1279, DOI 10.1097/ALN.0b013e3181c14c3d; Martin TJ, 2005, ANESTHESIOLOGY, V103, P629, DOI 10.1097/00000542-200509000-00028; Minkowitz Harold S, 2010, J Opioid Manag, V6, P203; Mogil JS, 2009, PAIN, V146, P231, DOI 10.1016/j.pain.2009.07.023; Moore RA, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD007076.PUB2; Neal JM, 2010, REGION ANESTH PAIN M, V35, pS59, DOI 10.1097/AAP.0b013e3181ccbc96; Neal JM, 2010, REGION ANESTH PAIN M, V35, pS1, DOI 10.1097/AAP.0b013e3181d22fe0; Neal JM, 2009, REGION ANESTH PAIN M, V34, P134, DOI 10.1097/AAP.0b013e31819624eb; Nishimori M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005059.pub2; Oderda GM, 2007, ANN PHARMACOTHER, V41, P400, DOI 10.1345/aph.1H386; Ong CKS, 2010, ANESTH ANALG, V110, P1170, DOI 10.1213/ANE.0b013e3181cf9281; Padera R, 2008, ANESTHESIOLOGY, V108, P921, DOI 10.1097/ALN.0b013e31816c8a48; Park HJ, 2007, CLIN PHARMACOL THER, V81, P539, DOI 10.1038/sj.clpt.6100046; Peng PWH, 2010, BRIT J ANAESTH, V105, P155, DOI 10.1093/bja/aeq116; Peng PWH, 2007, PAIN RES MANAG, V12, P85, DOI 10.1155/2007/840572; Phillips DM, 2000, JAMA-J AM MED ASSOC, V284, P428, DOI 10.1001/jama.284.4.428; Popping DM, 2008, ARCH SURG-CHICAGO, V143, P990, DOI 10.1001/archsurg.143.10.990; Pogatzki EM, 2002, J NEUROPHYSIOL, V87, P721, DOI 10.1152/jn.00208.2001; Pogatzki-Zahn EM, 2007, BEST PRACT RES-CLIN, V21, P3, DOI 10.1016/j.bpa.2006.11.003; Remy C, 2005, BRIT J ANAESTH, V94, P505, DOI 10.1093/bja/aei085; Richman JM, 2006, ANESTH ANALG, V102, P248, DOI 10.1213/01.ANE.0000181289.09675.7D; Ritsema TS, 2007, ACAD EMERG MED, V14, P163, DOI 10.1197/j.aem.2006.08.015; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Singh JA, 2009, CLIN RHEUMATOL, V28, P1419, DOI 10.1007/s10067-009-1267-z; Sommer M, 2008, EUR J ANAESTH, V25, P267, DOI 10.1017/S0265021507003031; Sommer M, 2010, CLIN J PAIN, V26, P87, DOI 10.1097/AJP.0b013e3181b43d68; Somogyi AA, 2007, CLIN PHARMACOL THER, V81, P429, DOI 10.1038/sj.clpt.6100095; Sumida Shawn, 2009, J Opioid Manag, V5, P301; Sun Y, 2008, BRIT J ANAESTH, V101, P151, DOI 10.1093/bja/aen146; Usichenko TI, 2008, ANAESTHESIA, V63, P1343, DOI 10.1111/j.1365-2044.2008.05632.x; Vila H, 2005, ANESTH ANALG, V101, P474, DOI 10.1213/01.ANE.0000155970.45321.A8; Viscusi ER, 2006, ANESTH ANALG, V102, P188, DOI 10.1213/01.ane.0000183649.58483.77; Viscusi ER, 2004, JAMA-J AM MED ASSOC, V291, P1333, DOI 10.1001/jama.291.11.1333; Viscusi ER, 2005, ANESTHESIOLOGY, V102, P1014, DOI 10.1097/00000542-200505000-00022; Viscusi ER, 2009, ANESTH ANALG, V108, P1811, DOI 10.1213/ane.0b013e31819e0d3a; Walter C, 2009, PAIN, V146, P270, DOI 10.1016/j.pain.2009.07.013; Wang CF, 2009, ANESTH ANALG, V108, P1027, DOI 10.1213/ane.0b013e318193596a; Weiniger CF, 2010, EXPERT OPIN DRUG DEL, V7, P737, DOI 10.1517/17425241003767383; White PF, 2007, ANESTH ANALG, V105, P10, DOI 10.1213/01.ane.0000268392.05157.a8; Wijeysundera DN, 2008, LANCET, V372, P562, DOI 10.1016/S0140-6736(08)61121-6; Wu CL, 2005, ANESTHESIOLOGY, V103, P1079, DOI 10.1097/00000542-200511000-00023; Wu CL, 2004, REGION ANESTH PAIN M, V29, P525, DOI 10.1016/j.rapm.2004.07.002; Yeh YC, 2009, ANN PHARMACOTHER, V43, P1474, DOI 10.1345/aph.1M121; Zahn PK, 1998, PAIN, V74, P213, DOI 10.1016/S0304-3959(97)00181-4; Zaslansky R, 2010, EUR J EMERG MED, V17, P56, DOI 10.1097/MEJ.0b013e32832dbe69	111	334	367	0	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2011	377	9784					2215	2225		10.1016/S0140-6736(11)60245-6	http://dx.doi.org/10.1016/S0140-6736(11)60245-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	786XI	21704871				2022-12-28	WOS:000292340800034
J	Hinch, AG; Tandon, A; Patterson, N; Song, YL; Rohland, N; Palmer, CD; Chen, GK; Wang, K; Buxbaum, SG; Akylbekova, EL; Aldrich, MC; Ambrosone, CB; Amos, C; Bandera, EV; Berndt, SI; Bernstein, L; Blot, WJ; Bock, CH; Boerwinkle, E; Cai, QY; Caporaso, N; Casey, G; Cupples, LA; Deming, SL; Diver, WR; Divers, J; Fornage, M; Gillanders, EM; Glessner, J; Harris, CC; Hu, JJ; Ingles, SA; Isaacs, W; John, EM; Kao, WHL; Keating, B; Kittles, RA; Kolonel, LN; Larkin, E; Le Marchand, L; McNeill, LH; Millikan, RC; Murphy, A; Musani, S; Neslund-Dudas, C; Nyante, S; Papanicolaou, GJ; Press, MF; Psaty, BM; Reiner, AP; Rich, SS; Rodriguez-Gil, JL; Rotter, JI; Rybicki, BA; Schwartz, AG; Signorello, LB; Spitz, M; Strom, SS; Thun, MJ; Tucker, MA; Wang, ZM; Wiencke, JK; Witte, JS; Wrensch, M; Wu, XF; Yamamura, Y; Zanetti, KA; Zheng, W; Ziegler, RG; Zhu, XF; Redline, S; Hirschhorn, JN; Henderson, BE; Taylor, HA; Price, AL; Hakonarson, H; Chanock, SJ; Haiman, CA; Wilson, JG; Reich, D; Myers, SR				Hinch, Anjali G.; Tandon, Arti; Patterson, Nick; Song, Yunli; Rohland, Nadin; Palmer, Cameron D.; Chen, Gary K.; Wang, Kai; Buxbaum, Sarah G.; Akylbekova, Ermeg L.; Aldrich, Melinda C.; Ambrosone, Christine B.; Amos, Christopher; Bandera, Elisa V.; Berndt, Sonja I.; Bernstein, Leslie; Blot, William J.; Bock, Cathryn H.; Boerwinkle, Eric; Cai, Qiuyin; Caporaso, Neil; Casey, Graham; Cupples, L. Adrienne; Deming, Sandra L.; Diver, W. Ryan; Divers, Jasmin; Fornage, Myriam; Gillanders, Elizabeth M.; Glessner, Joseph; Harris, Curtis C.; Hu, Jennifer J.; Ingles, Sue A.; Isaacs, William; John, Esther M.; Kao, W. H. Linda; Keating, Brendan; Kittles, Rick A.; Kolonel, Laurence N.; Larkin, Emma; Le Marchand, Loic; McNeill, Lorna H.; Millikan, Robert C.; Murphy, Adam; Musani, Solomon; Neslund-Dudas, Christine; Nyante, Sarah; Papanicolaou, George J.; Press, Michael F.; Psaty, Bruce M.; Reiner, Alex P.; Rich, Stephen S.; Rodriguez-Gil, Jorge L.; Rotter, Jerome I.; Rybicki, Benjamin A.; Schwartz, Ann G.; Signorello, Lisa B.; Spitz, Margaret; Strom, Sara S.; Thun, Michael J.; Tucker, Margaret A.; Wang, Zhaoming; Wiencke, John K.; Witte, John S.; Wrensch, Margaret; Wu, Xifeng; Yamamura, Yuko; Zanetti, Krista A.; Zheng, Wei; Ziegler, Regina G.; Zhu, Xiaofeng; Redline, Susan; Hirschhorn, Joel N.; Henderson, Brian E.; Taylor, Herman A., Jr.; Price, Alkes L.; Hakonarson, Hakon; Chanock, Stephen J.; Haiman, Christopher A.; Wilson, James G.; Reich, David; Myers, Simon R.			The landscape of recombination in African Americans	NATURE			English	Article							HUMAN GENOME; MEIOTIC RECOMBINATION; MAP; HUMANS; PRDM9; POPULATIONS; SEQUENCE; HOTSPOTS; GENE; INSTABILITY	Recombination, together with mutation, gives rise to genetic variation in populations. Here we leverage the recent mixture of people of African and European ancestry in the Americas to build a genetic map measuring the probability of crossing over at each position in the genome, based on about 2.1 million crossovers in 30,000 unrelated African Americans. At intervals of more than three megabases it is nearly identical to a map built in Europeans. At finer scales it differs significantly, and we identify about 2,500 recombination hotspots that are active in people of West African ancestry but nearly inactive in Europeans. The probability of a crossover at these hotspots is almost fully controlled by the alleles an individual carries at PRDM9(P value <10(-245)). We identify a 17-base-pair DNA sequence motif that is enriched in these hotspots, and is an excellent match to the predicted binding target of PRDM9 alleles common in West Africans and rare in Europeans. Sites of this motif are predicted to be risk loci for disease-causing genomic rearrangements in individuals carrying these alleles. More generally, this map provides a resource for research in human genetic variation and evolution.	[Tandon, Arti; Patterson, Nick; Rohland, Nadin; Reich, David] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Hinch, Anjali G.; Myers, Simon R.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Tandon, Arti; Rohland, Nadin; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Song, Yunli; Myers, Simon R.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Palmer, Cameron D.; Hirschhorn, Joel N.] Broad Inst, Program Med & Populat Genet, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Palmer, Cameron D.; Hirschhorn, Joel N.] Childrens Hosp Boston, Div Endocrinol, Boston, MA 02115 USA; [Palmer, Cameron D.; Hirschhorn, Joel N.] Childrens Hosp Boston, Div Genet, Boston, MA 02115 USA; [Palmer, Cameron D.; Hirschhorn, Joel N.] Childrens Hosp Boston, Program Genom, Boston, MA 02115 USA; [Chen, Gary K.; Casey, Graham; Ingles, Sue A.; Press, Michael F.; Henderson, Brian E.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Chen, Gary K.; Casey, Graham; Ingles, Sue A.; Press, Michael F.; Henderson, Brian E.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90033 USA; [Wang, Kai] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Wang, Kai; Glessner, Joseph; Keating, Brendan; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Buxbaum, Sarah G.; Akylbekova, Ermeg L.] Jackson State Univ, Jackson Heart Study Coordinating Ctr, Jackson, MS 39213 USA; [Akylbekova, Ermeg L.; Musani, Solomon; Taylor, Herman A., Jr.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Aldrich, Melinda C.] Vanderbilt Univ, Sch Med, Dept Thorac Surg, Nashville, TN 37203 USA; [Aldrich, Melinda C.; Blot, William J.; Cai, Qiuyin; Deming, Sandra L.; Signorello, Lisa B.; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Div Epidemiol,Dept Med, Nashville, TN 37203 USA; [Aldrich, Melinda C.; Blot, William J.; Cai, Qiuyin; Deming, Sandra L.; Signorello, Lisa B.; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37203 USA; [Ambrosone, Christine B.] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Amos, Christopher; Spitz, Margaret; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Div Canc Prevent & Populat Sci, Houston, TX 77030 USA; [Bandera, Elisa V.] Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Berndt, Sonja I.; Caporaso, Neil; Tucker, Margaret A.; Ziegler, Regina G.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Bernstein, Leslie] City Hope Natl Med Ctr, Div Canc Etiol, Dept Populat Sci, Beckman Res Inst, Duarte, CA 91010 USA; [Blot, William J.; Signorello, Lisa B.] Int Epidemiol Inst, Rockville, MD 20850 USA; [Bock, Cathryn H.; Schwartz, Ann G.] Wayne State Univ Med, Karmanos Canc Inst, Detroit, MI 48201 USA; [Bock, Cathryn H.; Schwartz, Ann G.] Wayne State Univ Med, Dept Oncol, Detroit, MI 48201 USA; [Boerwinkle, Eric] Univ Texas Houston, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Houston, Div Epidemiol, Houston, TX 77030 USA; [Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Cupples, L. Adrienne] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; [Diver, W. Ryan; Thun, Michael J.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30303 USA; [Divers, Jasmin] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Fornage, Myriam; Gillanders, Elizabeth M.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Inst Mol Med, Houston, TX 77030 USA; [Fornage, Myriam; Gillanders, Elizabeth M.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol, Houston, TX 77030 USA; [Zanetti, Krista A.] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Harris, Curtis C.; Zanetti, Krista A.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Hu, Jennifer J.; Rodriguez-Gil, Jorge L.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Hu, Jennifer J.; Rodriguez-Gil, Jorge L.] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33136 USA; [Isaacs, William] Johns Hopkins Hosp & Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA; [John, Esther M.] Canc Prevent Inst Calif, Fremont, CA 94538 USA; [John, Esther M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [John, Esther M.] Stanford Canc Ctr, Stanford, CA 94305 USA; [Kao, W. H. Linda] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Kittles, Rick A.] Univ Illinois, Dept Med, Chicago, IL 60607 USA; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96813 USA; [Larkin, Emma] Vanderbilt Univ, Med Ctr, Div Allergy Pulm & Crit Care, Dept Med,Med Ctr E, Nashville, TN 37232 USA; [McNeill, Lorna H.] Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Div OVP Canc Prevent & Populat Sci, Houston, TX 77030 USA; [McNeill, Lorna H.] Univ Texas MD Anderson Canc Ctr, Ctr Community Implementat & Disseminat Res, Duncan Family Inst, Houston, TX 77030 USA; [Millikan, Robert C.; Nyante, Sarah] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Millikan, Robert C.; Nyante, Sarah] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Murphy, Adam] Northwestern Univ, Dept Urol, Chicago, IL 60611 USA; [Neslund-Dudas, Christine; Rybicki, Benjamin A.] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Papanicolaou, George J.] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Res Inst, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Seattle, WA 98101 USA; [Reiner, Alex P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Wang, Zhaoming] Natl Canc Inst Frederick, Core Genotype Facil, SAIC Frederick Inc, Frederick, MD 20877 USA; [Witte, John S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, Inst Human Genet, San Francisco, CA 94158 USA; [Witte, John S.] Univ Calif San Francisco, Dept Urol, Inst Human Genet, San Francisco, CA 94158 USA; [Zhu, Xiaofeng] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Redline, Susan] Brigham & Womens Hosp, Dept Med, Div Sleep Med, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Taylor, Herman A., Jr.] Jackson State Univ, Jackson, MS 39217 USA; [Taylor, Herman A., Jr.] Tougaloo Coll, Tougaloo, MS 39174 USA; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Harvard Medical School; University of Oxford; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Southern California; University of Southern California; University of Southern California; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Jackson State University; University of Mississippi; University of Mississippi Medical Center; Vanderbilt University; Vanderbilt University; Vanderbilt University; Roswell Park Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); City of Hope; Beckman Research Institute of City of Hope; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Boston University; Framingham Heart Study; American Cancer Society; Wake Forest University; Wake Forest Baptist Medical Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Miami; University of Miami; Johns Hopkins University; Johns Hopkins Medicine; Cancer Prevention Institute of California; Stanford University; Stanford Cancer Institute; Stanford University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Cancer Research Center of Hawaii; University of Hawaii System; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University; Henry Ford Health System; Henry Ford Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Washington; University of Washington Seattle; University of Virginia; Cedars Sinai Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Case Western Reserve University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Jackson State University; Tougaloo College; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania; University of Mississippi; University of Mississippi Medical Center	Reich, D (corresponding author), Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	reich@genetics.med.harvard.edu; myers@stats.ox.ac.uk	Zheng, Wei/O-3351-2013; Berndt, Sonja I/J-8423-2016; Rotter, Jerome/AAY-6598-2021; Tucker, Margaret A/B-4297-2015; zhang, weihua/GXV-1334-2022; Wang, Zhaoming/R-5527-2018; Buxbaum, Sarah G./E-1970-2013; Jorge L. Rodriguez-Gil, D.Phil/AAD-3523-2020; Rybicki, Benjamin/L-4614-2019; Diver, Ryan/AAG-3469-2019; Myers, Simon R/A-6792-2015; Bandera, Elisa V/M-4169-2014; Aldrich, Melinda/C-7783-2013; Zhu, Xiaofeng/O-6874-2019	Zheng, Wei/0000-0003-1226-070X; Wang, Zhaoming/0000-0001-7556-3869; Buxbaum, Sarah G./0000-0002-4886-3564; Jorge L. Rodriguez-Gil, D.Phil/0000-0002-1125-1281; Rybicki, Benjamin/0000-0003-3190-3467; Diver, Ryan/0000-0002-5418-9000; Myers, Simon R/0000-0002-2585-9626; Bandera, Elisa V/0000-0002-8789-2755; Glessner, Joseph/0000-0001-5131-2811; Nyante, Sarah/0000-0002-1770-5993; Rich, Stephen/0000-0003-3872-7793; Zhu, Xiaofeng/0000-0003-0037-411X; Cupples, L. Adrienne/0000-0003-0273-7965	Wellcome Trust; NIH [HL084107, GM091332]; National Heart, Lung and Blood Institute [HHSN268200960009C]; Children's Hospital of Philadelphia; Landenberger Foundation; Cotswold Foundation; DoD; Norris Foundation; MEC [CA63464, CA54281]; CARE [HD33175]; WCHS [CA100598]; DAMD [170100334, 17966071, W81XWH0710645, W81XWH0710203, W81XWH0610066]; Breast Cancer Research Foundation; SFBC [CA77305]; CBCS [CA58223, ES10126]; PLCO; NHBS [CA100374]; WFBC [R01-CA73629]; CPS-II (the American Cancer Society); LAAPC [99-00524V-10258, PC35139, DP000807]; MEC; MDA [CA68578, CA140388, ES007784]; GECAP [ES011126]; CaP Genes [CA88164]; IPCG [W81XWH0710122]; DCPC [GM08016]; SCCS [CA092447, CA68485]; University Cancer Foundation; Duncan Family institute; Center for Community; Implementation and Dissemination Research Core; Maryland Studies;  [CA1326792];  [CA148085];  [HG004726];  [CA060691];  [CA87895];  [PC35145];  [CA22453];  [ES06717];  [CA55769];  [CA127219];  [CA1116460S1];  [CA1116460];  [CA121197];  [CA141716];  [CA121197S2];  [CPRIT RP100443];  [CA148127];  [DAMD W81XWH0710645]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD033175] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA060691, R01CA073629, R01CA088164, R01CA063464, RC2CA148085, P50CA140388, R01CA092447, R01CA087895, R01CA121197, R37CA054281, R01CA141716, U19CA148127, U01CA063464, R01CA100374, R01CA054281, P50CA058223, R01CA127219, R01CA052689, R01CA055769, R01CA068578, R01CA077305, R01CA100598, P30CA068485, P30CA022453] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP000807] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065226, R01HL084107] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399, U01HG004168, U01HG004726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, R01ES011126, R01ES006717, P30ES007784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091332, S06GM008016] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Children's Hospital of Philadelphia; Landenberger Foundation; Cotswold Foundation; DoD(United States Department of Defense); Norris Foundation; MEC(European Commission); CARE; WCHS; DAMD; Breast Cancer Research Foundation; SFBC; CBCS; PLCO; NHBS; WFBC; CPS-II (the American Cancer Society)(American Cancer Society); LAAPC; MEC(European Commission); MDA(Muscular Dystrophy Association); GECAP; CaP Genes; IPCG; DCPC; SCCS; University Cancer Foundation; Duncan Family institute; Center for Community; Implementation and Dissemination Research Core; Maryland Studies; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the participants who donated DNA samples, to D. Altshuler, J. Buard, K. Bryc, J. Kovacs, B. de Massy, G. McVean, B. Pasaniuc and S. Sankararaman for conversations and critiques, and to A. Auton for facilitating analysis of the 1000 Genomes Project data. Analysis was supported by the Wellcome Trust and NIH grants HL084107 and GM091332. CARe was supported by a contract from the National Heart, Lung and Blood Institute (HHSN268200960009C) to create a phenotype and genotype database for dissemination to the biomedical research community. Eight parent studies contributed phenotypic data and DNA samples through the Broad Institute (N01-HC-65226): the Atherosclerosis Risk in Communities study (ARIC), the Cleveland Family Study (CFS), the Coronary Artery Risk Development in Young Adults study (CARDIA), the Jackson Heart Study (JHS), the Multi-Ethnic Study of Atherosclerosis (MESA) study, the Cardiovascular Health Study (CHS), the Framingham Heart Study (FHS) and the Sleep Heart Health Study (SHHS). Support for CARe also came from the individual research institutions, investigators, field staff and study participants. Individual funding information is available at http://public.nhlbi.nih.gov/GeneticsGenomics/home/care.aspx. All genome-wide genotyping of samples from the Children's Hospital of Pennsylvania (CHOP) was supported by an Institutional Development Award to the Center for Applied Genomics from the Children's Hospital of Philadelphia, a research award from the Landenberger Foundation and the Cotswold Foundation. We thank all study participants and the staff at the Center for Applied Genomics for performing the genotyping. The African American Breast Cancer Consortium (AABCC) was supported by a DoD Breast Cancer Research Program Era of Hope Scholar Award to C. A. H. and the Norris Foundation, and by grants to the component studies: MEC (CA63464, CA54281); CARE (HD33175); WCHS (CA100598, DAMD 170100334, Breast Cancer Research Foundation); SFBC (CA77305, DAMD 17966071); CBCS (CA58223, ES10126), PLCO (NCI Intramural Research Program); NHBS (CA100374); WFBC (R01-CA73629); and CPS-II (the American Cancer Society). The African American Prostate Cancer Consortium(AAPCC) was supported by grants CA63464, CA54281, CA1326792, CA148085 and HG004726, and by grants to the component studies: PLCO (NCI Intramural Research Program), LAAPC (Cancer Research Fund 99-00524V-10258), both MEC and LAAPC (PC35139, DP000807); MDA (CA68578, CA140388, ES007784, DAMD W81XWH0710645); GECAP (ES011126); CaP Genes (CA88164); IPCG (W81XWH0710122); DCPC (GM08016, DAMD W81XWH0710203, DAMD W81XWH0610066); and SCCS (CA092447, CA68485). The African American Lung Cancer Consortium(AALCC) was supported by grants CA060691, CA87895, PC35145 and CA22453, CA68578, CA140388, ES007784, ES06717, CA55769, CA127219, CA1116460S1, CA1116460, CA121197, CA141716, CA121197S2, CPRIT RP100443, CA148127, DAMD W81XWH0710645, University Cancer Foundation, Duncan Family institute, Center for Community, Implementation and Dissemination Research Core, and by grants to the component studies: PLCO and the Maryland Studies (NCI Intramural Research Program), LAAPC (Cancer Research Fund 99-00524V-10258), and both MEC and LAAPC (PC35139, DP000807).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; De Raedt T, 2006, NAT GENET, V38, P1419, DOI 10.1038/ng1920; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; GRIFFITHS RC, 1995, MATH BIOSCI, V127, P77, DOI 10.1016/0025-5564(94)00044-Z; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jorgenson E, 2005, AM J HUM GENET, V76, P276, DOI 10.1086/427926; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI 10.1016/j.ajhg.2007.09.022; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; WEITKAMP LR, 1974, CYTOGENET CELL GENET, V13, P179, DOI 10.1159/000130267	29	208	211	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2011	476	7359					170	U67		10.1038/nature10336	http://dx.doi.org/10.1038/nature10336			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21775986	Green Submitted, Green Accepted			2022-12-28	WOS:000293731900028
J	Lioy, DT; Garg, SK; Monaghan, CE; Raber, J; Foust, KD; Kaspar, BK; Hirrlinger, PG; Kirchhoff, F; Bissonnette, JM; Ballas, N; Mandel, G				Lioy, Daniel T.; Garg, Saurabh K.; Monaghan, Caitlin E.; Raber, Jacob; Foust, Kevin D.; Kaspar, Brian K.; Hirrlinger, Petra G.; Kirchhoff, Frank; Bissonnette, John M.; Ballas, Nurit; Mandel, Gail			A role for glia in the progression of Rett's syndrome	NATURE			English	Article							MECP2 DEFICIENCY; MOUSE MODEL; NEURONS; EXPRESSION; ASTROCYTES; ABNORMALITIES; DEFECTS; RELEASE	Rett's syndrome (RTT) is an X-chromosome-linked autism spectrum disorder caused by loss of function of the transcription factor methyl-CpG-binding protein 2 (MeCP2)(1). Although MeCP2 is expressed in most tissues(2), loss of MeCP2 expression results primarily in neurological symptoms(1,3,4). Earlier studies suggested the idea that RTT is due exclusively to loss of MeCP2 function in neurons(2,4-10). Although defective neurons clearly underlie the aberrant behaviours, we and others showed recently that the loss of MECP2 from glia negatively influences neurons in a non-cell-autonomous fashion(11-13). Here we show that in globally MeCP2-deficient mice, re-expression of Mecp2 preferentially in astrocytes significantly improved locomotion and anxiety levels, restored respiratory abnormalities to a normal pattern, and greatly prolonged lifespan compared to globally null mice. Furthermore, restoration of MeCP2 in the mutant astrocytes exerted a non-cell-autonomous positive effect on mutant neurons in vivo, restoring normal dendritic morphology and increasing levels of the excitatory glutamate transporter VGLUT1. Our study shows that glia, like neurons, are integral components of the neuropathology of RTT, and supports the targeting of glia as a strategy for improving the associated symptoms.	[Lioy, Daniel T.; Garg, Saurabh K.; Monaghan, Caitlin E.; Mandel, Gail] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Lioy, Daniel T.; Garg, Saurabh K.; Monaghan, Caitlin E.; Mandel, Gail] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Foust, Kevin D.; Kaspar, Brian K.] Ohio State Univ, Dept Pediat, Ctr Gene Therapy, Nationwide Childrens Hosp, Columbus, OH 43205 USA; [Hirrlinger, Petra G.] Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Kirchhoff, Frank] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Kirchhoff, Frank] Univ Saarland, Inst Pathol, D-37075 Homburg, Germany; [Bissonnette, John M.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97202 USA; [Bissonnette, John M.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97202 USA; [Ballas, Nurit] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Max Planck Society; Saarland University; Oregon Health & Science University; Oregon Health & Science University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Mandel, G (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.	mandelg@ohsu.edu	Kaspar, Brian/E-3349-2011; Kirchhoff, Frank/B-9335-2008	Kirchhoff, Frank/0000-0002-2324-2761; Monaghan, Caitlin/0000-0001-7055-3610	National Institutes of Health; International Rett Syndrome Foundation; Rett Syndrome Research Trust; Oregon Brain Institute; OHSU; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Rett Syndrome Foundation; Rett Syndrome Research Trust; Oregon Brain Institute; OHSU; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Brehm, R. H. Goodman, C. Bond, M. McGinley and C. Mandel-Brehm for discussions; P. Micha, J. Eng, S. Knopp and T. Shaffer for technical support; and M. Murtha for generating the CBA/CMV-MECP2 construct. ViraPur, LLC generated the AAV9 virus. The work was supported by grants from the National Institutes of Health (G. M. and N.B.), International Rett Syndrome Foundation (N.B. and J. M. B.), Rett Syndrome Research Trust (G. M. and B. K. K.), Oregon Brain Institute (D. T. L.), and OHSU Cell and Developmental Biology Training Program (D. T. L.). G. M. is an Investigator of the Howard Hughes Medical Institute.	Armstrong DD, 2005, J CHILD NEUROL, V20, P747, DOI 10.1177/08830738050200082401; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; BAUMAN ML, 1995, NEUROLOGY, V45, P1581, DOI 10.1212/WNL.45.8.1581; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Casper KB, 2007, GENESIS, V45, P292, DOI 10.1002/dvg.20287; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chow LML, 2008, TRANSGENIC RES, V17, P919, DOI 10.1007/s11248-008-9185-4; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; Samaco RC, 2009, P NATL ACAD SCI USA, V106, P21966, DOI 10.1073/pnas.0912257106; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009; Viemari JC, 2005, J NEUROSCI, V25, P11521, DOI 10.1523/JNEUROSCI.4373-05.2005; Weese-Mayer DE, 2006, PEDIATR RES, V60, P443, DOI 10.1203/01.pdr.0000238302.84552.d0	29	341	354	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2011	475	7357					497	U90		10.1038/nature10214	http://dx.doi.org/10.1038/nature10214			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21716289	Green Accepted			2022-12-28	WOS:000293167900040
J	Liu, C; Sage, JC; Miller, MR; Verhaak, RGW; Hippenmeyer, S; Vogel, H; Foreman, O; Bronson, RT; Nishiyama, A; Luo, LQ; Zong, H				Liu, Chong; Sage, Jonathan C.; Miller, Michael R.; Verhaak, Roel G. W.; Hippenmeyer, Simon; Vogel, Hannes; Foreman, Oded; Bronson, Roderick T.; Nishiyama, Akiko; Luo, Liqun; Zong, Hui			Mosaic Analysis with Double Markers Reveals Tumor Cell of Origin in Glioma	CELL			English	Article							NEURAL STEM-CELLS; INTEGRATED GENOMIC ANALYSIS; PROGENITOR CELLS; SUBVENTRICULAR ZONE; SUPPRESSOR GENE; WHITE-MATTER; HUMAN BRAIN; NG2 CELLS; GROWTH; GLIOBLASTOMA	Cancer cell of origin is difficult to identify by analyzing cells within terminal stage tumors, whose identity could be concealed by the acquired plasticity. Thus, an ideal approach to identify the cell of origin is to analyze proliferative abnormalities in distinct lineages prior to malignancy. Here, we use mosaic analysis with double markers (MADM) in mice to model gliomagenesis by initiating concurrent p53/Nf1 mutations sporadically in neural stem cells (NSCs). Surprisingly, MADM-based lineage tracing revealed significant aberrant growth prior to malignancy only in oligodendrocyte precursor cells (OPCs), but not in any other NSC-derived lineages or NSCs themselves. Upon tumor formation, phenotypic and transcriptome analyses of tumor cells revealed salient OPC features. Finally, introducing the same p53/Nf1 mutations directly into OPCs consistently led to gliomagenesis. Our findings suggest OPCs as the cell of origin in this model, even when initial mutations occur in NSCs, and highlight the importance of analyzing premalignant stages to identify the cancer cell of origin.	[Liu, Chong; Sage, Jonathan C.; Miller, Michael R.; Zong, Hui] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Verhaak, Roel G. W.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Hippenmeyer, Simon; Luo, Liqun] Stanford Univ, HHMI, Stanford, CA 94305 USA; [Hippenmeyer, Simon; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Vogel, Hannes] Stanford Univ, Sch Med, Dept Neuropathol, Stanford, CA 94305 USA; [Foreman, Oded] Jackson Lab, Sacramento, CA 95838 USA; [Bronson, Roderick T.] Tufts Cummings Sch Vet Med, Dept Biomed Sci, North Grafton, MA 01536 USA; [Nishiyama, Akiko] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA	University of Oregon; University of Texas System; UTMD Anderson Cancer Center; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Jackson Laboratory; University of Connecticut	Zong, H (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	hzong@uoregon.edu	Messier, Claude/A-2322-2008; Liu, Chong/J-4826-2014; Verhaak, Roel/ABE-7058-2020; Liu, Chong/G-3514-2011	Messier, Claude/0000-0002-4791-1763; Vogel, Otto Hannes/0000-0002-0960-3508; Liu, Chong/0000-0001-6578-5919; Luo, Liqun/0000-0001-5467-9264; Hippenmeyer, Simon/0000-0003-2279-1061	NIH [R55-CA136495, R01-CA136495]; NSF; European Molecular Biology Organization [ALTF 851-2005]; Human Frontier Science Program Organization [LT00805/2006-L]; Swiss National Science Foundation [PA00P3_124160]; Pew Charitable Trusts; NATIONAL CANCER INSTITUTE [R55CA136495, R01CA136495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program Organization(Human Frontier Science Program); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Pew Charitable Trusts; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Henner and M. Valle for technical support; J. Dugas for his help with the immunopanning method; and B. Bowerman, C. Doe, R. Galvao, W. Hong, M. Kohwi, M. Raff, R. Read, B. Tasic, X. Wu, and Y. Zhu for critical comments on the manuscript. This work is supported by NIH grants (R55-CA136495, R01-CA136495). M.R.M was supported by an NSF predoctoral fellowship. S.H. was supported by postdoctoral fellowships from the European Molecular Biology Organization (ALTF 851-2005), Human Frontier Science Program Organization (LT00805/2006-L), and Swiss National Science Foundation (PA00P3_124160). H.Z. is a Pew Scholar in Biomedical Sciences, supported by The Pew Charitable Trusts.	Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bennett MR, 2003, J NEUROSCI, V23, P7207, DOI 10.1523/JNEUROSCI.23-18-07207.2003; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Geha S, 2010, BRAIN PATHOL, V20, P399, DOI 10.1111/j.1750-3639.2009.00295.x; Genove G, 2005, NAT MED, V11, P450, DOI 10.1038/nm1208; Hippenmeyer S, 2010, NEURON, V68, P695, DOI 10.1016/j.neuron.2010.09.027; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Komitova M, 2009, J COMP NEUROL, V512, P702, DOI 10.1002/cne.21917; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Lee JS, 2010, HUM MOL GENET, V19, P4643, DOI 10.1093/hmg/ddq395; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Lindberg N, 2009, ONCOGENE, V28, P2266, DOI 10.1038/onc.2009.76; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; The WHO, 2020, CLASSIFICATION TUMOU; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	38	424	435	5	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 22	2011	146	2					209	221		10.1016/j.cell.2011.06.014	http://dx.doi.org/10.1016/j.cell.2011.06.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21737130	Bronze, Green Accepted			2022-12-28	WOS:000293013000005
J	Teufel, JD; Donner, T; Li, DL; Harlow, JW; Allman, MS; Cicak, K; Sirois, AJ; Whittaker, JD; Lehnert, KW; Simmonds, RW				Teufel, J. D.; Donner, T.; Li, Dale; Harlow, J. W.; Allman, M. S.; Cicak, K.; Sirois, A. J.; Whittaker, J. D.; Lehnert, K. W.; Simmonds, R. W.			Sideband cooling of micromechanical motion to the quantum ground state	NATURE			English	Article							MECHANICAL RESONATOR; BACK-ACTION; CAVITY; AMPLIFICATION; OSCILLATOR; TRANSDUCER; NOISE; LIMIT	The advent of laser cooling techniques revolutionized the study of many atomic-scale systems, fuelling progress towards quantum computing with trapped ions(1) and generating new states of matter with Bose-Einstein condensates(2). Analogous cooling techniques(3,4) can provide a general and flexible method of preparing macroscopic objects in their motional ground state. Cavity optomechanical or electromechanical systems achieve sideband cooling through the strong interaction between light and motion(5-15). However, entering the quantum regime-in which a system has less than a single quantum of motion-has been difficult because sideband cooling has not sufficiently overwhelmed the coupling of low-frequency mechanical systems to their hot environments. Here we demonstrate sideband cooling of an approximately 10-MHz micromechanical oscillator to the quantum ground state. This achievement required a large electromechanical interaction, which was obtained by embedding a micromechanical membrane into a superconducting microwave resonant circuit. To verify the cooling of the membrane motion to a phonon occupation of 0.34 +/- 0.05 phonons, we perform a near Heisenberg-limited position measurement(3) within (5.1 +/- 0.4)h/2 pi, where h is Planck's constant. Furthermore, our device exhibits strong coupling, allowing coherent exchange of microwave photons and mechanical phonons(16). Simultaneously achieving strong coupling, ground state preparation and efficient measurement sets the stage for rapid advances in the control and detection of non-classical states of motion(17,18), possibly even testing quantum theory itself in the unexplored region of larger size and mass(19). Because mechanical oscillators can couple to light of any frequency, they could also serve as a unique intermediary for transferring quantum information between microwave and optical domains(20).	[Teufel, J. D.; Li, Dale; Allman, M. S.; Cicak, K.; Sirois, A. J.; Whittaker, J. D.; Simmonds, R. W.] NIST, Boulder, CO 80305 USA; [Donner, T.; Harlow, J. W.; Lehnert, K. W.] Univ Colorado, JILA, Boulder, CO 80309 USA; [Donner, T.; Harlow, J. W.; Lehnert, K. W.] NIST, Boulder, CO 80309 USA; [Donner, T.; Harlow, J. W.; Allman, M. S.; Sirois, A. J.; Whittaker, J. D.; Lehnert, K. W.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder	Teufel, JD (corresponding author), NIST, Boulder, CO 80305 USA.	john.teufel@nist.gov	Teufel, John D/A-8898-2010; Allman, Michael/E-5922-2011; Lehnert, Konrad/B-7577-2009; Lehnert, Konrad W/O-7555-2019; Donner, Tobias/A-2845-2011	Teufel, John D/0000-0002-1873-9941; Lehnert, Konrad/0000-0002-0750-9649; Lehnert, Konrad W/0000-0002-0750-9649; Donner, Tobias/0000-0001-7016-587X; Whittaker, Jed/0000-0002-0456-3244; Simmonds, Raymond/0000-0003-2217-2965	NIST; DARPA; Deutsche Forschungsgemeinschft (DFG)	NIST(National Institute of Standards & Technology (NIST) - USA); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Deutsche Forschungsgemeinschft (DFG)(German Research Foundation (DFG))	We thank A. W. Sanders for taking the micrograph in Fig. 1 and the JILA instrument shop for fabrication and design of the cavity filter. This work was supported by NIST and the DARPA QuASAR programme. T. D. acknowledges support from the Deutsche Forschungsgemeinschft (DFG). This Letter is a contribution of the US government and not subject to copyright.	ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; BLAIR DG, 1995, PHYS REV LETT, V74, P1908, DOI 10.1103/PhysRevLett.74.1908; Bose S, 1997, PHYS REV A, V56, P4175, DOI 10.1103/PhysRevA.56.4175; Braginsky V. B., 1992, QUANTUM MEASUREMENT; BRAGINSKY VB, 1970, SOV PHYS JETP-USSR, V31, P829; Castellanos-Beltran MA, 2008, NAT PHYS, V4, P929, DOI 10.1038/nphys1090; Cicak K, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3304168; Clerk AA, 2010, REV MOD PHYS, V82, P1155, DOI 10.1103/RevModPhys.82.1155; Cuthbertson BD, 1996, REV SCI INSTRUM, V67, P2435, DOI 10.1063/1.1147193; DIEDRICH F, 1989, PHYS REV LETT, V62, P403, DOI 10.1103/PhysRevLett.62.403; Dobrindt JM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.263602; Groblacher S, 2009, NATURE, V460, P724, DOI 10.1038/nature08171; Groblacher S, 2009, NAT PHYS, V5, P485, DOI 10.1038/NPHYS1301; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; Kippenberg TJ, 2008, SCIENCE, V321, P1172, DOI 10.1126/science.1156032; Lin Q, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.103601; Mancini S, 1997, PHYS REV A, V55, P3042, DOI 10.1103/PhysRevA.55.3042; Marquardt F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093902; Marshall W, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.130401; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Park YS, 2009, NAT PHYS, V5, P489, DOI 10.1038/NPHYS1303; Regal CA, 2011, J PHYS CONF SER, V264, DOI 10.1088/1742-6596/264/1/012025; RIVIERE R, 2010, OPTOMECHANICAL SIDEB; Rocheleau T, 2010, NATURE, V463, P72, DOI 10.1038/nature08681; Schliesser A, 2009, NAT PHYS, V5, P509, DOI 10.1038/NPHYS1304; Teufel JD, 2011, NATURE, V471, P204, DOI 10.1038/nature09898; Teufel JD, 2009, NAT NANOTECHNOL, V4, P820, DOI [10.1038/NNANO.2009.343, 10.1038/nnano.2009.343]; Teufel JD, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.197203; Thompson JD, 2008, NATURE, V452, P72, DOI 10.1038/nature06715; Wilson-Rae I, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093901	30	1482	1495	9	329	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2011	475	7356					359	363		10.1038/nature10261	http://dx.doi.org/10.1038/nature10261			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21734657	Green Submitted			2022-12-28	WOS:000292911200038
J	Knohl, A; Veldkamp, E				Knohl, Alexander; Veldkamp, Edzo			GLOBAL CHANGE Indirect feedbacks to rising CO2	NATURE			English	Editorial Material							CARBON		[Knohl, Alexander] Univ Gottingen, Sect Bioclimatol, D-37077 Gottingen, Germany; [Veldkamp, Edzo] Univ Gottingen, Sect Soil Sci Trop & Subtrop Ecosyst, D-37077 Gottingen, Germany	University of Gottingen; University of Gottingen	Knohl, A (corresponding author), Univ Gottingen, Sect Bioclimatol, D-37077 Gottingen, Germany.	aknohl@uni-goettingen.de; eveldka@uni-goettingen.de	Knohl, Alexander/F-9453-2014; Veldkamp, Edzo/A-6660-2008	Knohl, Alexander/0000-0002-7615-8870; Veldkamp, Edzo/0000-0002-8318-8349				Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Hedin LO, 2009, ANNU REV ECOL EVOL S, V40, P613, DOI 10.1146/annurev.ecolsys.37.091305.110246; Hungate BA, 2009, GLOBAL CHANGE BIOL, V15, P2020, DOI 10.1111/j.1365-2486.2009.01866.x; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Thornton PE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002868; van Groenigen KJ, 2011, NATURE, V475, P214, DOI 10.1038/nature10176	8	17	22	3	88	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					177	178		10.1038/475177a	http://dx.doi.org/10.1038/475177a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753843				2022-12-28	WOS:000292690500036
J	Brockhurst, MA				Brockhurst, Michael A.			Sex, Death, and the Red Queen	SCIENCE			English	Editorial Material							PARASITE		Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England	University of Liverpool	Brockhurst, MA (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England.	michael.brockhurst@liv.ac.uk	Brockhurst, Michael A/A-6247-2009	Brockhurst, Michael/0000-0003-0362-820X				Bell G., 1982, MASTERPIECE NATURE; Buckling A, 2009, NATURE, V457, P824, DOI 10.1038/nature07892; Carroll L., 1871, LOOKING GLASS WHAT A; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; JAENIKE J, 1978, Evolutionary Theory, V3, P191; King KC, 2009, CURR BIOL, V19, P1438, DOI 10.1016/j.cub.2009.06.062; Lively CM, 2000, NATURE, V405, P679, DOI 10.1038/35015069; MAYNARD SMITH J., 1978, EVOLUTION SEX; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; Van Valen L., 1973, EVOL THEORY REV, V1, P1, DOI DOI 10.1038/344864A0	11	15	16	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					166	167		10.1126/science.1209420	http://dx.doi.org/10.1126/science.1209420			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	789GG	21737728				2022-12-28	WOS:000292502700032
J	Dunlop, JS				Dunlop, James S.			The Cosmic History of Star Formation	SCIENCE			English	Review							DIGITAL SKY SURVEY; LYMAN-BREAK GALAXIES; ULTRA-DEEP-FIELD; INFRARED LUMINOSITY FUNCTIONS; HIGH-REDSHIFT GALAXIES; UV-CONTINUUM SLOPE; TO 7 GALAXIES; FORMING GALAXIES; H-ALPHA; STELLAR POPULATIONS	Major advances in observational astronomy over the past 20 years have revolutionized our view of cosmic history, transforming our understanding of how the hot, smooth, early universe evolved into the complex and beautiful universe of stars and galaxies in which we now live. I describe how astronomers have used a range of complementary techniques to map out the rise and fall of star formation over 95% of cosmic time, back to the current observational frontier only similar to 500 million years after the Big Bang.	Univ Edinburgh, Royal Observ, Inst Astron, Edinburgh EH9 3HJ, Midlothian, Scotland	University of Edinburgh	Dunlop, JS (corresponding author), Univ Edinburgh, Royal Observ, Inst Astron, Edinburgh EH9 3HJ, Midlothian, Scotland.	jsd@roe.ac.uk			Royal Society; European Research Council; Science and Technology Facilities Council [ST/G001979/1] Funding Source: researchfish; STFC [ST/G001979/1] Funding Source: UKRI	Royal Society(Royal Society of London); European Research Council(European Research Council (ERC)European Commission); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The author acknowledges the support of the Royal Society through a Wolfson Research Merit award and the support of the European Research Council through the award of an Advanced Grant.	Bouwens RJ, 2010, ASTROPHYS J LETT, V708, pL69, DOI 10.1088/2041-8205/708/2/L69; Bouwens RJ, 2009, ASTROPHYS J, V705, P936, DOI 10.1088/0004-637X/705/1/936; Bouwens RJ, 2008, ASTROPHYS J, V686, P230, DOI 10.1086/590103; BRESSAN A, 1993, ASTRON ASTROPHYS SUP, V100, P647; BRUZUAL AG, 1993, APJ, V405, P538; Bunker AJ, 2010, MON NOT R ASTRON SOC, V409, P855, DOI 10.1111/j.1365-2966.2010.17350.x; Burgarella D, 2009, PUBL ASTRON SOC JPN, V61, P177, DOI 10.1093/pasj/61.2.177; Calzetti D, 1997, ASTRON J, V113, P162, DOI 10.1086/118242; Caputi KI, 2007, ASTROPHYS J, V660, P97, DOI 10.1086/512667; Caputi KI, 2006, MON NOT R ASTRON SOC, V366, P609, DOI 10.1111/j.1365-2966.2005.09887.x; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Charlot S, 2000, ASTROPHYS J, V539, P718, DOI 10.1086/309250; CHARY RR, 2011, ASTROPHYS J; Coelho P, 2005, ASTRON ASTROPHYS, V443, P735, DOI 10.1051/0004-6361:20053511; CONDON JJ, 1992, ANNU REV ASTRON ASTR, V30, P575, DOI 10.1146/annurev.aa.30.090192.003043; Conroy C, 2010, ASTROPHYS J, V712, P833, DOI 10.1088/0004-637X/712/2/833; Cowie LL, 1996, ASTRON J, V112, P839, DOI 10.1086/118058; Daddi E, 2007, ASTROPHYS J, V670, P156, DOI 10.1086/521818; Doherty M, 2006, MON NOT R ASTRON SOC, V370, P331, DOI 10.1111/j.1365-2966.2006.10484.x; Dunkley J, 2009, ASTROPHYS J, V701, P1804, DOI 10.1088/0004-637X/701/2/1804; DUNLOP JS, 2011, MON NOT R ASTRON SOC; Dunne L, 2003, MON NOT R ASTRON SOC, V341, P589, DOI 10.1046/j.1365-8711.2003.06440.x; Elbaz D, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014687; Finkelstein SL, 2010, ASTROPHYS J, V719, P1250, DOI 10.1088/0004-637X/719/2/1250; Fontana A, 2006, ASTRON ASTROPHYS, V459, P745, DOI 10.1051/0004-6361:20065475; Heavens A, 2004, NATURE, V428, P625, DOI 10.1038/nature02474; Heckman TM, 2011, SCIENCE, V333, P182, DOI 10.1126/science.1200504; Hopkins AM, 2003, ASTROPHYS J, V599, P971, DOI 10.1086/379608; Hopkins AM, 2006, ASTROPHYS J, V651, P142, DOI 10.1086/506610; Hughes DH, 1998, NATURE, V394, P241, DOI 10.1038/28328; Jimenez R, 2004, MON NOT R ASTRON SOC, V349, P240, DOI 10.1111/j.1365-2966.2004.07492.x; Kauffmann G, 2004, MON NOT R ASTRON SOC, V353, P713, DOI 10.1111/j.1365-2966.2004.08117.x; Kennicutt RC, 2009, ASTROPHYS J, V703, P1672, DOI 10.1088/0004-637X/703/2/1672; KENNICUTTJRC, 1998, NATURE, V36, P189; Kewley LJ, 2004, ASTRON J, V127, P2002, DOI 10.1086/382723; Le Floc'h E, 2005, ASTROPHYS J, V632, P169, DOI 10.1086/432789; Lilly SJ, 1996, ASTROPHYS J, V460, pL1, DOI 10.1086/309975; Madau P, 1996, MON NOT R ASTRON SOC, V283, P1388, DOI 10.1093/mnras/283.4.1388; Magdis GE, 2010, ASTROPHYS J, V714, P1740, DOI 10.1088/0004-637X/714/2/1740; Mathis H, 2006, MON NOT R ASTRON SOC, V365, P385, DOI 10.1111/j.1365-2966.2005.09790.x; McLure RJ, 2009, MON NOT R ASTRON SOC, V395, P2196, DOI 10.1111/j.1365-2966.2009.14677.x; Noeske KG, 2007, ASTROPHYS J, V660, pL47, DOI 10.1086/517927; Oesch PA, 2010, ASTROPHYS J LETT, V709, pL16, DOI 10.1088/2041-8205/709/1/L16; Ouchi M, 2010, ASTROPHYS J, V723, P869, DOI 10.1088/0004-637X/723/1/869; Panter B, 2007, MON NOT R ASTRON SOC, V378, P1550, DOI 10.1111/j.1365-2966.2007.11909.x; Panter B, 2008, MON NOT R ASTRON SOC, V391, P1117, DOI 10.1111/j.1365-2966.2008.13981.x; Reddy NA, 2005, ASTROPHYS J, V633, P748, DOI 10.1086/444588; Reddy NA, 2008, ASTROPHYS J SUPPL S, V175, P48, DOI 10.1086/521105; Reddy NA, 2009, ASTROPHYS J, V692, P778, DOI 10.1088/0004-637X/692/1/778; Robertson BE, 2010, NATURE, V468, P49, DOI 10.1038/nature09527; Ryan-Weber EV, 2009, MON NOT R ASTRON SOC, V395, P1476, DOI [10.1111/j.1365-2966.2009.14618.X, 10.1111/j.1365-2966.2009.14618.x]; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; Schaerer D, 2010, ASTRON ASTROPHYS, V515, DOI 10.1051/0004-6361/200913946; Sobral D, 2009, MON NOT R ASTRON SOC, V398, P75, DOI 10.1111/j.1365-2966.2009.15129.x; Steidel CC, 2003, ASTROPHYS J, V592, P728, DOI 10.1086/375772; Tanvir NR, 2009, NATURE, V461, P1254, DOI 10.1038/nature08459; Tojeiro R, 2009, ASTROPHYS J SUPPL S, V185, P1, DOI 10.1088/0067-0049/185/1/1; Tremonti CA, 2004, ASTROPHYS J, V613, P898, DOI 10.1086/423264; van Dokkum PG, 2010, NATURE, V468, P940, DOI 10.1038/nature09578; Weidner C, 2011, MON NOT R ASTRON SOC, V412, P979, DOI 10.1111/j.1365-2966.2010.17959.x; Wilkins SM, 2008, MON NOT R ASTRON SOC, V385, P687, DOI 10.1111/j.1365-2966.2008.12885.x; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513	64	6	6	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					178	181		10.1126/science.1200644	http://dx.doi.org/10.1126/science.1200644			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21737733				2022-12-28	WOS:000292502700037
J	Zheng, HM; Rivest, JB; Miller, TA; Sadtler, B; Lindenberg, A; Toney, MF; Wang, LW; Kisielowski, C; Alivisatos, AP				Zheng, Haimei; Rivest, Jessy B.; Miller, Timothy A.; Sadtler, Bryce; Lindenberg, Aaron; Toney, Michael F.; Wang, Lin-Wang; Kisielowski, Christian; Alivisatos, A. Paul			Observation of Transient Structural-Transformation Dynamics in a Cu2S Nanorod	SCIENCE			English	Article							TRANSMISSION-ELECTRON-MICROSCOPY; 1ST-ORDER TRANSITIONS; PHASE-TRANSFORMATION; NONVOLATILE; CHALCOCITE; PARTICLES; MEMORY	The study of first-order structural transformations has been of great interest to scientists in many disciplines. Expectations from phase-transition theory are that the system fluctuates between two equilibrium structures near the transition point and that the region of transition broadens in small crystals. We report the direct observation of structural fluctuations within a single nanocrystal using transmission electron microscopy. We observed trajectories of structural transformations in individual nanocrystals with atomic resolution, which reveal details of the fluctuation dynamics, including nucleation, phase propagation, and pinning of structural domains by defects. Such observations provide crucial insight for the understanding of microscopic pathways of phase transitions.	[Zheng, Haimei; Sadtler, Bryce; Wang, Lin-Wang; Kisielowski, Christian; Alivisatos, A. Paul] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Rivest, Jessy B.] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Miller, Timothy A.; Lindenberg, Aaron] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Sadtler, Bryce; Alivisatos, A. Paul] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Toney, Michael F.] Stanford Synchrotron Radiat Lab, Palo Alto, CA 94025 USA; [Kisielowski, Christian] Univ Calif Berkeley, Lawrence Berkeley Lab, Natl Ctr Electron Microcopy, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Stanford University; University of California System; University of California Berkeley; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zheng, HM (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.	hmzheng@lbl.gov; alivis@berkeley.edu	Alivisatos, Paul/N-8863-2015; Toney, Michael/ABD-5429-2021; wang, lin/GSE-3040-2022; Miller, Timothy/C-9128-2011	Alivisatos, Paul/0000-0001-6895-9048; Toney, Michael/0000-0002-7513-1166; Miller, Timothy/0000-0002-5585-7736; Zheng, Haimei/0000-0003-3813-4170; Sadtler, Bryce/0000-0003-4860-501X	Office of Science, Office of Basic Energy Sciences (BES), Materials Science and Engineering Division of the U.S. Department of Energy (DOE) [DE-AC02-05CH11231]	Office of Science, Office of Basic Energy Sciences (BES), Materials Science and Engineering Division of the U.S. Department of Energy (DOE)(United States Department of Energy (DOE))	We thank U. Dahmen at National Center for Electron Microscopy (NCEM) and E. Borrero and C. Dellago at University of Vienna for helpful discussions. The authors are grateful to the support of Helios Solar Energy Research Center (SERC) and NCEM, which are funded by the director of the Office of Science, Office of Basic Energy Sciences (BES), Materials Science and Engineering Division of the U.S. Department of Energy (DOE) under contract no. DE-AC02-05CH11231. TEM experiments were performed using TEAM0.5 microscope at NCEM. X-ray experiments were performed at the Stanford Synchrotron Radiation Laboratory, a DOE-BES user facility. J.B.R. was funded by a fellowship from Intel Corporation, and T.A.M. and A.L. were supported by the DOE BES Materials Sciences and Engineering Division. H.Z. conceived the work and performed the experiments; H.Z. and A.P.A. analyzed the data and wrote the paper; J.B.R. prepared nanorod samples, took ensemble x-ray data, and edited the paper; B.S. contributed to nanorod sample preparation and edited the paper; M.F.T., A.L., and T.A.M. provided x-ray analysis infrastructure; L.-W.W. provided theoretical calculation and edited the paper; and C.K. contributed to image analysis and edited the paper.	[Anonymous], 2002, THEORY TRANSFORMATIO; BUERGER MJ, 1963, SCIENCE, V141, P276, DOI 10.1126/science.141.3577.276; Chakrabarti D., 1983, J PHASE EQUILIB, V4, P254; CHALLA MSS, 1986, PHYS REV B, V34, P1841, DOI 10.1103/PhysRevB.34.1841; CHALLA MSS, 1990, PHASE TRANSIT, V24-6, P343, DOI 10.1080/01411599008210236; Egerton RF, 2004, MICRON, V35, P399, DOI 10.1016/j.micron.2004.02.003; Erni R, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.165443; EVANS HT, 1971, NATURE-PHYS SCI, V232, P69, DOI 10.1038/physci232069a0; Girit CO, 2009, SCIENCE, V323, P1705, DOI 10.1126/science.1166999; Glas F, 2008, J APPL PHYS, V104, DOI 10.1063/1.3009338; Guo QX, 2008, NANO LETT, V8, P972, DOI 10.1021/nl0731217; Jacobs K, 2001, SCIENCE, V293, P1803, DOI 10.1126/science.1063581; Lai SL, 1996, PHYS REV LETT, V77, P99, DOI 10.1103/PhysRevLett.77.99; Landau L.D, 2013, STAT PHYS; Lankhorst MHR, 2005, NAT MATER, V4, P347, DOI 10.1038/nmat1350; Lee SH, 2007, NAT NANOTECHNOL, V2, P626, DOI 10.1038/nnano.2007.291; Lentzen M, 2008, MICROSC MICROANAL, V14, P16, DOI 10.1017/S1431927608080045; POTTER RW, 1977, ECON GEOL, V72, P1524, DOI 10.2113/gsecongeo.72.8.1524; PUTNIS A, 1977, AM MINERAL, V62, P107; Reguer A, 2009, ULTRAMICROSCOPY, V110, P61, DOI 10.1016/j.ultramic.2009.09.006; Sadtler B, 2009, J AM CHEM SOC, V131, P5285, DOI 10.1021/ja809854q; Smith RF, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.065701; Stanley H.E., 1971, INTRO PHASE TRANSITI; VOTER AF, 1986, PHYS REV B, V34, P6819, DOI 10.1103/PhysRevB.34.6819; Wang ZW, 2010, P NATL ACAD SCI USA, V107, P17119, DOI 10.1073/pnas.1011224107; Wittenberg JS, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.125701; Yokota T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.265504	27	191	193	7	289	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					206	209		10.1126/science.1204713	http://dx.doi.org/10.1126/science.1204713			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21737738				2022-12-28	WOS:000292502700045
J	Perera, RM; Bardeesy, N				Perera, Rushika M.; Bardeesy, Nabeel			CANCER When antioxidants are bad	NATURE			English	Editorial Material							C-MYC		[Perera, Rushika M.] Massachusetts Gen Hosp, Inst Canc, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Perera, RM (corresponding author), Massachusetts Gen Hosp, Inst Canc, Boston, MA 02114 USA.	rperera@partners.org; bardeesy.nabeel@mgh.harvard.edu						De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111	10	56	59	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					43	44		10.1038/475043a	http://dx.doi.org/10.1038/475043a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734699				2022-12-28	WOS:000292461300039
J	Chang, HJ; Zuccotti, G				Chang, Huan J.; Zuccotti, Gianna			Frontal Headache	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AMEBIC MENINGOENCEPHALITIS; BALAMUTHIA-MANDRILLARIS; ENCEPHALITIS; SPECTRUM		[Zuccotti, Gianna] Partners Healthcare, Boston, MA USA	Partners Healthcare System		tina.chang@jama-archives.org						Silva RAE, 2010, ARCH NEUROL-CHICAGO, V67, P1516, DOI 10.1001/archneurol.2010.309; Cuevas P Mónica, 2006, Rev. chil. infectol., V23, P237; Deetz TR, 2003, CLIN INFECT DIS, V37, P1304, DOI 10.1086/379020; Deol I, 2000, SURG NEUROL, V53, P611, DOI 10.1016/S0090-3019(00)00232-9; FORONDA AS, 2005, INFECCOES AMEBAS VID, V2, P1461; Guarner J, 2007, MODERN PATHOL, V20, P1230, DOI 10.1038/modpathol.3800973; Jung SM, 2004, ARCH PATHOL LAB MED, V128, P466; Oddó B David, 2006, Rev. chil. infectol., V23, P232; Singh P, 2006, AM J NEURORADIOL, V27, P1217; 2008, JAMA-J AM MED ASSOC, V300, P2477, DOI DOI 10.1001/JAMA.300.21.2477	10	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2011	306	3					317	318		10.1001/jama.2011.994	http://dx.doi.org/10.1001/jama.2011.994			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794BS	21771997				2022-12-28	WOS:000292870500030
J	Smith, LK; Budd, JLS; Field, DJ; Draper, ES				Smith, Lucy K.; Budd, Judith L. S.; Field, David J.; Draper, Elizabeth S.			Socioeconomic inequalities in outcome of pregnancy and neonatal mortality associated with congenital anomalies: population based study	BRITISH MEDICAL JOURNAL			English	Article							PRENATAL-DIAGNOSIS; PAKISTANI WOMEN; TERMINATION; ATTITUDES; ENGLAND; EUROPE; RATES; OFFER; UK	Objectives To investigate socioeconomic inequalities in outcome of pregnancy and neonatal mortality associated with congenital anomalies. Design Retrospective population based registry study. Setting East Midlands and South Yorkshire regions of England (representing about 10% of births in England and Wales). Participants All registered cases of nine selected congenital anomalies with poor prognostic outcome audited as part of the United Kingdom's fetal anomaly screening programme with an end of pregnancy date between 1 January 1998 and 31 December 2007. Main outcome measures Socioeconomic variation in the risk of selected congenital anomalies; outcome of pregnancy; incidence of live birth and neonatal mortality over time. Deprivation measured with the index of multiple deprivation 2004 at super output area level. Results There were 1579 fetuses registered with one of the nine selected congenital anomalies. There was no evidence of variation in the overall risk of these anomalies with deprivation (rate ratio for the most deprived 10th with the least deprived 10th: 1.05, 95% confidence interval 0.89 to 1.23). The rate ratio varied with type of anomaly and maternal age (deprivation rate ratio adjusted for maternal age: 1.43 (1.17 to 1.74) for non-chromosomal anomalies; 0.85 (0.63 to 1.15) for chromosomal anomalies). Of the nine anomalies, 86% were detected in the antenatal period, and there was no evidence that this varied with deprivation (rate ratio 0.99, 0.84 to 1.17). The rate of termination after antenatal diagnosis of a congenital anomaly was lower in the most deprived areas compared with the least deprived areas (63% v 79%; rate ratio 0.80, 0.65 to 0.97). Consequently there were significant socioeconomic inequalities in the rate of live birth and neonatal mortality associated with the presence of any of these nine anomalies. Compared with the least deprived areas, the most deprived areas had a 61% higher rate of live births (1.61, 1.21 to 2.15) and a 98% higher neonatal mortality rate (1.98, 1.20 to 3.27) associated with a congenital anomaly. Conclusions Antenatal screening for congenital anomalies has reduced neonatal mortality through termination of pregnancy. Socioeconomic variation in decisions regarding termination of pregnancy after antenatal detection, however, has resulted in wide socioeconomic inequalities in liveborn infants with a congenital anomaly and subsequent neonatal mortality.	[Smith, Lucy K.; Budd, Judith L. S.; Field, David J.; Draper, Elizabeth S.] Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England	University of Leicester	Smith, LK (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England.	lks1@leicester.ac.uk	Smith, Lucy K/S-6593-2019; Draper, Elizabeth/S-6874-2019; Draper, Elizabeth S/I-6304-2018; Smith, Lucy K/I-6300-2018	Smith, Lucy K/0000-0001-9470-0793; Draper, Elizabeth/0000-0001-9340-8176; Draper, Elizabeth S/0000-0001-9340-8176; Smith, Lucy K/0000-0001-9470-0793	NIHR; UK Department of Health's National Institute of Health Research [RM62G0225]; National Institute for Health Research [RP-PG-0407-10029] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); UK Department of Health's National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank members of the NIHR programme grant team: Brad Manktelow, Elaine Boyle, and Julie Faulkes (University of Leicester) for helpful advice and comments throughout the study and Shona Golightly and Anna Springett (Centre for Maternal and Child Enquiries) for help with information on neonatal and infant deaths. We thank all NHS staff who notify cases to the EMSYCAR, Rosemary Pridding and Laura Berry for clerical support, and Martin Perkins for IT support.; This study was funded by UK Department of Health's National Institute of Health Research (RM62G0225). EMSYCAR is funded by the primary care trust in the areas covered by the register. The sponsors had no input in the design, the conduct, the analysis, or the interpretation of the study, and did not influence the manuscript preparation.	Ahmed S, 2006, PRENATAL DIAG, V26, P248, DOI 10.1002/pd.1391; Ahmed Shenaz, 2008, J Genet Couns, V17, P560, DOI 10.1007/s10897-008-9176-x; Alderdice F, 2008, PUBLIC HEALTH, V122, P42, DOI 10.1016/j.puhe.2007.05.004; Arif MO, 2008, PRENATAL DIAG, V28, P1149, DOI 10.1002/pd.2144; Davidson N, 2005, PAEDIATR PERINAT EP, V19, P50, DOI 10.1111/j.1365-3016.2004.00620.x; Dolk H, 2009, LANCET, V374, P378, DOI 10.1016/S0140-6736(09)61411-2; Gagnon A, 2009, J OBSTET GYNAECOL CA, V31, P875, DOI 10.1016/S1701-2163(16)34307-9; Garne E, 2005, ULTRASOUND OBST GYN, V25, P6, DOI 10.1002/uog.1784; Hewison J, 2007, PRENATAL DIAG, V27, P419, DOI 10.1002/pd.1701; Kirwan D, 2010, NHS FETAL ANOMALY SC; Liu SL, 2002, JAMA-J AM MED ASSOC, V287, P1561, DOI 10.1001/jama.287.12.1561; Lumley T, 2006, UW BIOSTATISTICS WOR; Neasham D, 2001, PAEDIATR PERINAT EP, V15, P364, DOI 10.1046/j.1365-3016.2001.0379a.x; Noble M, 2004, INDICES DEPRIVATION; Oakley Laura, 2009, Health Stat Q, P22; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Olesen C, 2009, SCAND J PUBLIC HEALT, V37, P246, DOI 10.1177/1403494808100938; Rauch ER, 2005, AM J OBSTET GYNECOL, V193, P1492, DOI 10.1016/j.ajog.2005.02.099; Rowe RE, 2004, PUBLIC HEALTH, V118, P177, DOI 10.1016/j.puhe.2003.08.004; Schechtman KB, 2002, OBSTET GYNECOL, V99, P216, DOI 10.1016/S0029-7844(01)01673-8; SMALLWOOD S, 2004, POPUL TRENDS, V20, P6; Smith LK, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6654; van der Pal-de Bruin KM, 2002, PRENATAL DIAG, V22, P966, DOI 10.1002/pd.442; Vrijheid M, 2000, ARCH DIS CHILD, V82, P349, DOI 10.1136/adc.82.5.349; Zeitlin J, 2008, PEDIATRICS, V121, pE936, DOI 10.1542/peds.2007-1620; Zyblewski SC, 2009, PEDIATR CARDIOL, V30, P1105, DOI 10.1007/s00246-009-9514-2	26	47	49	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2011	343								d4306	10.1136/bmj.d4306	http://dx.doi.org/10.1136/bmj.d4306			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797ZG	21771825	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000293168500010
J	Moller, K; Bein, T				Moeller, Karin; Bein, Thomas			Pores Within Pores-How to Craft Ordered Hierarchical Zeolites	SCIENCE			English	Editorial Material							MESOPOROUS ZEOLITES		[Moeller, Karin; Bein, Thomas] Univ Munich, Dept Chem, D-81377 Munich, Germany	University of Munich	Moller, K (corresponding author), Univ Munich, Dept Chem, Marchioninistr 15, D-81377 Munich, Germany.	karin.moeller@cup.uni-muenchen.de; bein@lmu.de	Möller, Karin/Q-6706-2017	Möller, Karin/0000-0002-2712-6610				Choi M, 2009, NATURE, V461, P246, DOI 10.1038/nature08288; Egeblad K, 2008, CHEM MATER, V20, P946, DOI 10.1021/cm702224p; Gu FN, 2010, CHEM MATER, V22, P2442, DOI 10.1021/cm903785r; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Martinez C, 2011, COORDIN CHEM REV, V255, P1558, DOI 10.1016/j.ccr.2011.03.014; Moller K, 2011, J AM CHEM SOC, V133, P5284, DOI 10.1021/ja108698s; Na K, 2011, SCIENCE, V333, P328, DOI 10.1126/science.1204452; Perez-Ramirez J, 2009, ADV FUNCT MATER, V19, P164, DOI 10.1002/adfm.200800871; Roth WJ, 2011, CATAL SCI TECHNOL, V1, P43, DOI 10.1039/c0cy00027b; Wang LF, 2010, MICROPOR MESOPOR MAT, V131, P58, DOI 10.1016/j.micromeso.2009.12.001; Yilmaz B, 2009, TOP CATAL, V52, P888, DOI 10.1007/s11244-009-9226-0	11	41	43	9	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					297	298		10.1126/science.1208528	http://dx.doi.org/10.1126/science.1208528			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764737				2022-12-28	WOS:000292732000028
J	Na, K; Jo, C; Kim, J; Cho, K; Jung, J; Seo, Y; Messinger, RJ; Chmelka, BF; Ryoo, R				Na, Kyungsu; Jo, Changbum; Kim, Jeongnam; Cho, Kanghee; Jung, Jinhwan; Seo, Yongbeom; Messinger, Robert J.; Chmelka, Bradley F.; Ryoo, Ryong			Directing Zeolite Structures into Hierarchically Nanoporous Architectures	SCIENCE			English	Article							MESOPOROUS MATERIALS; MOLECULAR-SIEVES; ACID SITES; NITROGEN; ADSORPTION; NANOSHEETS; MFI	Crystalline mesoporous molecular sieves have long been sought as solid acid catalysts for organic reactions involving large molecules. We synthesized a series of mesoporous molecular sieves that possess crystalline microporous walls with zeolitelike frameworks, extending the application of zeolites to the mesoporous range of 2 to 50 nanometers. Hexagonally ordered or disordered mesopores are generated by surfactant aggregates, whereas multiple cationic moieties in the surfactant head groups direct the crystallization of microporous aluminosilicate frameworks. The wall thicknesses, framework topologies, and mesopore sizes can be controlled with different surfactants. The molecular sieves are highly active as catalysts for various acid-catalyzed reactions of bulky molecular substrates, compared with conventional zeolites and ordered mesoporous amorphous materials.	[Na, Kyungsu; Jo, Changbum; Kim, Jeongnam; Cho, Kanghee; Jung, Jinhwan; Seo, Yongbeom; Ryoo, Ryong] Korea Adv Inst Sci & Technol, Dept Chem, Ctr Funct Nanomat, Taejon 305701, South Korea; [Na, Kyungsu; Jo, Changbum; Cho, Kanghee; Jung, Jinhwan; Seo, Yongbeom; Ryoo, Ryong] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol WCU, Taejon 305701, South Korea; [Messinger, Robert J.; Chmelka, Bradley F.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); University of California System; University of California Santa Barbara	Ryoo, R (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Ctr Funct Nanomat, Taejon 305701, South Korea.	rryoo@kaist.ac.kr	Ryoo, Ryong/B-1090-2009; Na, Kyungsu/AAQ-7708-2020; Messinger, Robert J./M-2471-2015; Na, Kyungsu/C-6210-2009	Messinger, Robert J./0000-0002-5537-3870; Ryoo, Ryong/0000-0003-0047-3329	National Honor Scientist Program [20100029665]; Ministry of Education, Science and Technology in Korea [R31-2010-000-10071-0]; U.S. NSF [CHE-0924654]; U.S. Department of Energy through the Institute of Multiscale Materials Studies at Los Alamos National Laboratory and Basic Energy Sciences [DE-FG02-03ER15467]; Warren and Katharine Schlinger Foundation; Central Facilities of the NSF [DMR-05-20415]; Division Of Materials Research [0843934] Funding Source: National Science Foundation	National Honor Scientist Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education, Science and Technology in Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); U.S. NSF(National Science Foundation (NSF)); U.S. Department of Energy through the Institute of Multiscale Materials Studies at Los Alamos National Laboratory and Basic Energy Sciences; Warren and Katharine Schlinger Foundation; Central Facilities of the NSF; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Honor Scientist Program (20100029665) and World Class University Program (R31-2010-000-10071-0) of the Ministry of Education, Science and Technology in Korea. The work at UCSB was supported by the U.S. NSF under grant CHE-0924654 and the U.S. Department of Energy through the Institute of Multiscale Materials Studies at Los Alamos National Laboratory and Basic Energy Sciences grant DE-FG02-03ER15467. R.J.M. is grateful to the Warren and Katharine Schlinger Foundation for a doctoral research fellowship. Solid-state NMR measurements were conducted using the Central Facilities of the NSF-supported UCSB Material Research Laboratory through grant DMR-05-20415. A patent has been filed by KAIST that claims new materials, preparation method, and catalytic applications thereof [10-2010-0064200, Korea, and PCT/KR2011/004128, Patent Cooperation Treaty (PCT)]. Author contributions: R. R. planned and supervised the project; K.N and R. R. wrote the manuscript; K.N., C.J., J.K., and J.J. synthesized surfactants and porous materials and performed XRD, SEM, and adsorption; K.N. performed catalytic investigations; K. C. performed TEM investigations; Y.S. analyzed acidity with <SUP>31</SUP>P NMR; and R.J.M. and B. F. C. performed 2D NMR investigations. B. F. C. (bradc@engineering.ucsb.edu) was responsible for the 2D NMR part. The authors declare that there are no competing financial interests. R. R., K.N., C.J., J.K., and J.J. are applicants for a patent related to this work. The patent deals with an invention of new materials and their synthesis method and applications. The patent was submitted to Korea on 5 July 2010 with application no. 10-2010-0064200 and submitted to PCT on 7 June 2011 with application no. PCT/KR2011/004128.	BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; BECK JS, 1994, CHEM MATER, V6, P1816, DOI 10.1021/cm00046a040; Choi M, 2006, NAT MATER, V5, P718, DOI 10.1038/nmat1705; Choi M, 2009, NATURE, V461, P246, DOI 10.1038/nature08288; Ciesla U, 1999, MICROPOR MESOPOR MAT, V27, P131, DOI 10.1016/S1387-1811(98)00249-2; Corma A, 1997, CHEM REV, V97, P2373, DOI 10.1021/cr960406n; Corma A, 2008, CHEM MATER, V20, P3218, DOI 10.1021/cm8002244; Cundy CS, 2003, CHEM REV, V103, P663, DOI 10.1021/cr020060i; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Egeblad K, 2008, CHEM MATER, V20, P946, DOI 10.1021/cm702224p; Fan W, 2008, NAT MATER, V7, P984, DOI 10.1038/nmat2302; HIGGINS JB, 1988, ZEOLITES, V8, P446, DOI 10.1016/S0144-2449(88)80219-7; Janicke MT, 1998, J AM CHEM SOC, V120, P6940, DOI 10.1021/ja972633s; Karlsson A, 1999, MICROPOR MESOPOR MAT, V27, P181, DOI 10.1016/S1387-1811(98)00252-2; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Liu Y, 2000, J AM CHEM SOC, V122, P8791, DOI 10.1021/ja001615z; LUNSFORD JH, 1985, J AM CHEM SOC, V107, P1540, DOI 10.1021/ja00292a015; Na K, 2010, J AM CHEM SOC, V132, P4169, DOI 10.1021/ja908382n; Perez-Ramirez J, 2008, CHEM SOC REV, V37, P2530, DOI 10.1039/b809030k; Ravikovitch PI, 1995, LANGMUIR, V11, P4765, DOI 10.1021/la00012a030; Rinaldi R, 2009, ENERG ENVIRON SCI, V2, P610, DOI 10.1039/b902668a; Ryoo R, 1999, J PHYS CHEM B, V103, P7743, DOI 10.1021/jp991673a; Ryoo R, 1996, J PHYS CHEM-US, V100, P17718, DOI 10.1021/jp9620835; SAITO A, 1995, MICROPOROUS MATER, V3, P543, DOI 10.1016/0927-6513(94)00064-3; Sheldon RA, 1999, APPL CATAL A-GEN, V189, P163, DOI 10.1016/S0926-860X(99)00274-4; Sun JL, 2009, NATURE, V458, P1154, DOI 10.1038/nature07957; Taguchi A, 2005, MICROPOR MESOPOR MAT, V77, P1, DOI 10.1016/j.micromeso.2004.06.030; VEGA AJ, 1988, J AM CHEM SOC, V110, P1049, DOI 10.1021/ja00212a008; WU EL, 1979, J PHYS CHEM-US, V83, P2777, DOI 10.1021/j100484a019; Zhang ZT, 2001, J AM CHEM SOC, V123, P5014, DOI 10.1021/ja004138t; Zhao Q, 2002, J PHYS CHEM B, V106, P4462, DOI 10.1021/jp015574k	31	668	693	39	1097	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2011	333	6040					328	332		10.1126/science.1204452	http://dx.doi.org/10.1126/science.1204452			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	792HF	21764745				2022-12-28	WOS:000292732000039
J	Chapman, S; Freeman, B				Chapman, Simon; Freeman, Becky			PUBLIC HEALTH From brand to bland-the demise of cigarette packaging	BRITISH MEDICAL JOURNAL			English	Editorial Material							TOBACCO PRODUCTS		[Chapman, Simon; Freeman, Becky] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney	Chapman, S (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	simon.chapman@sydney.edu.au	Chapman, Simon/D-4114-2009					*ALL AUSTR RET, 2011, PLAIN PACK IT JUST D; *BRIT AM TOB, VAN MED; *BRIT AM TOB AUSTR, 2011, DONT LET TAXP FOOT B; Canadian Cancer Society, 2010, CIG PACK HLTH WARN I; *CANC COUNC VICT Q, 2011, PLAIN PACK TOB PROD; Chapman S, 2003, TOB CONTROL, V12, P13; Durkin SJ, 2005, TOB CONTROL, V14, P429, DOI 10.1136/tc.2005.014167; Fong GT, 2004, NICOTINE TOB RES, V6, P341, DOI 10.1080/14622200412331320743; Freeman B, 2008, ADDICTION, V103, P580, DOI 10.1111/j.1360-0443.2008.02145.x; HOUSTON C, 2011, AGE             0529; *IMP TOB AUSTR, 2011, STOP THIS NANN STAT; McGrady B, 2004, WORLD TRADE REV, V3, P53; Parliament of Australia, 2011, TOB PLAIN PACK BILL; Voon T, 2011, IMPLICATIONS WTO LAW	14	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 13	2011	343								d4376	10.1136/bmj.d4376	http://dx.doi.org/10.1136/bmj.d4376			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	794OE	21752855				2022-12-28	WOS:000292908900006
J	McCartney, M				McCartney, Margaret			The scam of integrative medicine	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 13	2011	343								d4446	10.1136/bmj.d4446	http://dx.doi.org/10.1136/bmj.d4446			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	794OE	21752859				2022-12-28	WOS:000292908900017
J	Goetz, JG; Minguet, S; Navarro-Lerida, I; Lazcano, JJ; Samaniego, R; Calvo, E; Tello, M; Osteso-Ibanez, T; Pellinen, T; Echarri, A; Cerezo, A; Klein-Szanto, AJP; Garcia, R; Keely, PJ; Sanchez-Mateos, P; Cukierman, E; Del Pozo, MA				Goetz, Jacky G.; Minguet, Susana; Navarro-Lerida, Inmaculada; Jose Lazcano, Juan; Samaniego, Rafael; Calvo, Enrique; Tello, Marta; Osteso-Ibanez, Teresa; Pellinen, Teijo; Echarri, Asier; Cerezo, Ana; Klein-Szanto, Andres J. P.; Garcia, Ricardo; Keely, Patricia J.; Sanchez-Mateos, Paloma; Cukierman, Edna; Del Pozo, Miguel A.			Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis	CELL			English	Article							CELL-MIGRATION; RHO; CANCER; MORPHOGENESIS; FIBROBLASTS; PROGRESSION; EXPRESSION; DEFECTS; ABSENCE; GROWTH	Mechanotransduction is a key determinant of tissue homeostasis and tumor progression. It is driven by intercellular adhesions, cell contractility, and forces generated within the microenvironment and is dependent on extracellular matrix composition, organization, and compliance. We show that caveolin-1 (Cav1) favors cell elongation in three-dimensional cultures and promotes Rho- and force-dependent contraction, matrix alignment, and microenvironment stiffening through regulation of p190RhoGAP. In turn, microenvironment remodeling by Cav1 fibroblasts forces cell elongation. Cav1-deficient mice have disorganized stromal tissue architecture. Stroma associated with human carcinomas and melanoma metastases is enriched in Cav1-expressing carcinoma-associated fibroblasts (CAFs). Cav1 expression in breast CAFs correlates with low survival, and Cav1 depletion in CAFs decreases CAF contractility. Consistently, fibroblast expression of Cav1, through p190RhoGAP regulation, favors directional migration and invasiveness of carcinoma cells in vitro. In vivo, stromal Cav1 remodels peri- and intratumoral microenvironments to facilitate tumor invasion, correlating with increased metastatic potency. Thus, Cav1 modulates tissue responses through force-dependent architectural regulation of the microenvironment.	[Calvo, Enrique] CNIC, Prote Unit, Madrid 28029, Spain; [Samaniego, Rafael; Sanchez-Mateos, Paloma] Hosp Gen Univ Gregorio Maranon, Unidad Microscopi Confocal, Lab Inmunooncol, Madrid 28007, Spain; [Tello, Marta; Garcia, Ricardo] CSIC, Forcetool Grp, Inst Microelect Madrid, Tres Cantos 28760, Spain; [Keely, Patricia J.] Univ Wisconsin, Dept Pharmacol, Mol Biol Lab, Madison, WI 53706 USA; [Klein-Szanto, Andres J. P.; Cukierman, Edna] Canc Biol Program, Philadelphia, PA 19111 USA; [Goetz, Jacky G.; Minguet, Susana; Navarro-Lerida, Inmaculada; Jose Lazcano, Juan; Osteso-Ibanez, Teresa; Pellinen, Teijo; Echarri, Asier; Cerezo, Ana; Del Pozo, Miguel A.] CNIC, Integrin Signaling Lab, Dept Vasc Biol & Inflammat, Madrid 28029, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); General University Gregorio Maranon Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Microelectronica de Madrid (IMM); University of Wisconsin System; University of Wisconsin Madison; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Goetz, JG (corresponding author), Inst Genet & Mol & Cellular Biol, F-67404 Illkirch Graffenstaden, France.	jgoetz@igbmc.fr; madelpozo@cnic.es	Cukierman, Edna/A-3951-2013; Echarri, Asier/J-5333-2016; cukierman, edna/AAU-8932-2020; Cerezo, Ana/F-4403-2011; Garcia, Ricardo/B-3124-2013; Sanchez-Mateos, Paloma/E-8931-2013; Samaniego, Rafa/ABE-3558-2021; del Pozo, Miguel Angel/L-2861-2014; GOETZ, Jacky/AAT-1746-2021; Echarri, Asier/GZL-8132-2022; Osteso, Teresa/AAD-6364-2021	Echarri, Asier/0000-0002-7314-8087; cukierman, edna/0000-0002-1452-9576; Garcia, Ricardo/0000-0002-7115-1928; del Pozo, Miguel Angel/0000-0001-9077-391X; GOETZ, Jacky/0000-0003-2842-8116; Microelectronica de Madrid, Instituto de/0000-0003-4211-9045; Samaniego, Rafael/0000-0002-3081-7332; Minguet, Susana/0000-0001-8211-5538; Sanchez-Mateos, Paloma/0000-0001-6589-4445; Cerezo Montemayor, Ana/0000-0003-0275-0844; Osteso-Ibanez, Teresa/0000-0003-4247-8734; Navarro-Lerida, Inmaculada/0000-0001-9994-8069	MICINN (Spanish Ministry of Science and Innovation) [SAF2008-02100, RTICC RD06/0020/1033, CSD2009-00016, SAF2010-1602, MAT2009-08650, CSD2010-00024]; EMBO; European Heads of Research Councils; ESF; NIH/NCI [CA113451]; MICINN; Pro-CNIC Foundation; NATIONAL CANCER INSTITUTE [R01CA142833, R01CA114462, R01CA113451] Funding Source: NIH RePORTER	MICINN (Spanish Ministry of Science and Innovation)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EMBO(European Molecular Biology Organization (EMBO)); European Heads of Research Councils; ESF(European Commission); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Pro-CNIC Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Wethank J. Massague and R. Gomis for luciferase-expressing TCs; F. Sirotnak, M. Kolonin, and A. Schrum for E0771 cells; M. Morente, the CNIO Tumor Bank, and the Spanish National Tumor Bank Network for colon carcinoma TMA; the CNIC Viral Vector Unit for lentivirus; P. Martin and R. Mota for intravenous injection; I. Trevino for help with immunohistochemistry; K. Devarajan for breast TMA statistical analysis; V. Gupta, R. Castello-Cros, and D. Bassi for renal and breast CAF harvesting and immunohistochemistry; A. Alfranca for luciferase vector and advice; M. Montoya for advice on SHG and helpful discussion; F. Sanchez-Cabo for help with statistical analysis; A. U. for brainstorming; X. Bustelo, I.R. Nabi, G. Scita, and P.P. di Fiore for critical reading of the manuscript; and S. Bartlett for editing. This work was supported by grants from the MICINN (Spanish Ministry of Science and Innovation) to M.A.D.P. (SAF2008-02100, RTICC RD06/0020/1033, and CSD2009-00016), P.S.-M. (SAF2010-1602), and R.G. (MAT2009-08650 and CSD2010-00024); by EMBO Young Investigator Programme to M.A.D.P., and by the European Heads of Research Councils and the ESF through a European Young Investigator (EURYI) award to M.A.D.P.; and by NIH/NCI CA113451 and FCCC Kidney Keystone Program grants to E.C. J.G.G. and T.P. are CNIC postdoctoral fellows. S.M. and A.E. are Ramon y Cajal fellows. A.C. is a AECC (Spanish Association against Cancer) fellow. The CNIC is supported by the MICINN and the Pro-CNIC Foundation.	Amatangelo MD, 2005, AM J PATHOL, V167, P475, DOI 10.1016/S0002-9440(10)62991-4; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bustos RI, 2008, CURR BIOL, V18, P1606, DOI 10.1016/j.cub.2008.09.019; Cerezo A, 2009, MOL CELL BIOL, V29, P5046, DOI 10.1128/MCB.00315-09; Chang SH, 2009, AM J PATHOL, V175, P1768, DOI 10.2353/ajpath.2009.090171; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2009, SCIENCE, V324, P208, DOI 10.1126/science.1170107; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Gonzalez-Munoz E, 2009, ENDOCRINOLOGY, V150, P3493, DOI 10.1210/en.2008-1520; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Gratton JP, 2003, CANCER CELL, V4, P31, DOI 10.1016/S1535-6108(03)00168-5; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Mammoto A, 2007, J CELL SCI, V120, P456, DOI 10.1242/jcs.03353; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Razani B, 2001, J BIOL CHEM, V276, P38121; Ronnov-Jessen L, 2009, TRENDS MOL MED, V15, P5, DOI 10.1016/j.molmed.2008.11.001; Sloan EK, 2009, AM J PATHOL, V174, P2035, DOI 10.2353/ajpath.2009.080924; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Williams TM, 2006, AM J PATHOL, V169, P1784, DOI 10.2353/ajpath.2006.060590; Witkiewicz AK, 2008, CELL CYCLE, V7, P3021, DOI 10.4161/cc.7.19.6719; Witkiewicz AK, 2009, AM J PATHOL, V174, P2023, DOI 10.2353/ajpath.2009.080873; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yang G, 2008, EXP MOL PATHOL, V84, P131, DOI 10.1016/j.yexmp.2007.08.004; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	44	496	506	7	116	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 8	2011	146	1					148	163		10.1016/j.cell.2011.05.040	http://dx.doi.org/10.1016/j.cell.2011.05.040			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729786	Green Accepted, Bronze			2022-12-28	WOS:000292539300013
J	Lui, JH; Hansen, DV; Kriegstein, AR				Lui, Jan H.; Hansen, David V.; Kriegstein, Arnold R.			Development and Evolution of the Human Neocortex	CELL			English	Review							RADIAL GLIAL-CELLS; NEURAL STEM-CELLS; OUTER SUBVENTRICULAR ZONE; CEREBRAL CORTICAL SIZE; ALPHA-E-CATENIN; BETA-CATENIN; DEVELOPING MOUSE; VENTRICULAR ZONE; PROGENITOR-CELL; FETAL MONKEY	The size and surface area of the mammalian brain are thought to be critical determinants of intellectual ability. Recent studies show that development of the gyrated human neocortex involves a lineage of neural stem and transit-amplifying cells that forms the outer subventricular zone (OSVZ), a proliferative region outside the ventricular epithelium. We discuss how proliferation of cells within the OSVZ expands the neocortex by increasing neuron number and modifying the trajectory of migrating neurons. Relating these features to other mammalian species and known molecular regulators of the mouse neocortex suggests how this developmental process could have emerged in evolution.	[Lui, Jan H.; Hansen, David V.; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Lui, Jan H.; Hansen, David V.; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Lui, Jan H.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kriegstein, AR (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, 35 Med Ctr Way, San Francisco, CA 94143 USA.	kriegsteina@stemcell.ucsf.edu		Hansen, David/0000-0001-9679-7189	NIH-NINDS; Bernard Osher Foundation; California Institute for Regenerative Medicine Predoctoral Fellowship [TG2-01153]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075998, R01NS072630] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Bernard Osher Foundation; California Institute for Regenerative Medicine Predoctoral Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Arturo Alvarez-Buylla, David Rowitch, and Daniel Lim for their critical reading of the manuscript and insightful comments. We also thank Stephanie Redmond for helping make the initial observation of immature neurons in the OSVZ (Figure 2A). Artwork in Figures 1, 2, 4, 5, and 6 is by Kenneth X. Probst. Due to space limitations, we apologize that many primary and historical publications have not been cited. This work was supported by grants from the NIH-NINDS, the Bernard Osher Foundation, and a California Institute for Regenerative Medicine Predoctoral Fellowship for J.H.L. (TG2-01153). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the California Institute for Regenerative Medicine or any other agency of the State of California.	ALVAREZBUYLLA A, 1990, NEURON, V5, P101, DOI 10.1016/0896-6273(90)90038-H; ALVAREZBUYLLA A, 1988, J NEUROSCI, V8, P2707; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; AUSTIN CP, 1990, DEVELOPMENT, V110, P713; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Baala L, 2007, NAT GENET, V39, P454, DOI 10.1038/ng1993; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Bayatti N, 2008, CEREB CORTEX, V18, P1536, DOI 10.1093/cercor/bhm184; Bayer S.A., 1991, NEOCORTICAL DEV; Bentivoglio M, 1999, BRAIN RES BULL, V49, P305, DOI 10.1016/S0361-9230(99)00065-9; Borrell V, 2006, CEREB CORTEX, V16, P1571, DOI 10.1093/cercor/bhj094; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Campos LS, 2001, J NEUROSCI RES, V64, P590, DOI 10.1002/jnr.1111.abs; Chatzi C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000609; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chenn A, 2003, CEREB CORTEX, V13, P599, DOI 10.1093/cercor/13.6.599; Cheung AFP, 2007, J ANAT, V211, P164, DOI 10.1111/j.1469-7580.2007.00769.x; Cheung AFP, 2010, CEREB CORTEX, V20, P1071, DOI 10.1093/cercor/bhp168; CHOI BH, 1986, J NEUROPATH EXP NEUR, V45, P408, DOI 10.1097/00005072-198607000-00003; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fawcett D, 2002, BLOOM FAWCETT CONCIS; Fertuzinhos S, 2009, CEREB CORTEX, V19, P2196, DOI 10.1093/cercor/bhp009; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gal JS, 2006, J NEUROSCI, V26, P1045, DOI 10.1523/JNEUROSCI.4499-05.2006; GOFFINET AM, 1983, J COMP NEUROL, V215, P437, DOI 10.1002/cne.902150408; Gohlke JM, 2007, CEREB CORTEX, V17, P2433, DOI 10.1093/cercor/bhl151; Gould S. J., 1977, ONTOGENY PHYLOGENY; Gunhaga L, 2003, NAT NEUROSCI, V6, P701, DOI 10.1038/nn1068; Hansen DV, 2011, NEURON, V70, P645, DOI 10.1016/j.neuron.2011.05.006; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jakovcevski I, 2005, J NEUROSCI, V25, P10064, DOI 10.1523/JNEUROSCI.2324-05.2005; Jakovcevski I, 2011, CEREB CORTEX, V21, P1771, DOI 10.1093/cercor/bhq245; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Junghans D, 2005, DEV DYNAM, V233, P528, DOI 10.1002/dvdy.20365; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; LEVITT P, 1981, J NEUROSCI, V1, P27, DOI 10.1523/JNEUROSCI.01-01-00027.1981; Lien WH, 2008, J CELL SCI, V121, P1357, DOI 10.1242/jcs.020537; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Malatesta P, 2000, DEVELOPMENT, V127, P5253; MARINPADILLA M, 1992, J COMP NEUROL, V321, P223, DOI 10.1002/cne.903210205; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Mo ZC, 2008, CEREB CORTEX, V18, P1455, DOI 10.1093/cercor/bhm181; Mutch CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012376; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Ochiai W, 2009, MOL CELL NEUROSCI, V40, P225, DOI 10.1016/j.mcn.2008.10.007; Ohtsuka T, 2006, MOL CELL NEUROSCI, V31, P109, DOI 10.1016/j.mcn.2005.09.006; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Petanjek Z, 2009, CEREB CORTEX, V19, P249, DOI 10.1093/cercor/bhn078; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Puzzolo E, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-8; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Reid CB, 1997, DEVELOPMENT, V124, P2441; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Sahara S, 2009, NEURON, V63, P48, DOI 10.1016/j.neuron.2009.06.006; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; SMART IHM, 1986, J ANAT, V147, P27; SMART IHM, 1986, J ANAT, V146, P141; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Stancik EK, 2010, J NEUROSCI, V30, P7028, DOI 10.1523/JNEUROSCI.6131-09.2010; Stocker AM, 2009, DEV BIOL, V328, P66, DOI 10.1016/j.ydbio.2009.01.010; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; Torii M, 2009, NATURE, V461, P524, DOI 10.1038/nature08362; ULINSKI PS, 1974, J COMP NEUROL, V158, P243, DOI 10.1002/cne.901580303; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807; Ware ML, 1999, CEREB CORTEX, V9, P636, DOI 10.1093/cercor/9.6.636; Weimer JM, 2009, DEVELOPMENT, V136, P2965, DOI 10.1242/dev.036616; Weissman T, 2003, CEREB CORTEX, V13, P550, DOI 10.1093/cercor/13.6.550; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018; Yu XJ, 2011, J NEUROSCI, V31, P2413, DOI 10.1523/JNEUROSCI.5249-10.2011; Zecevic N, 2005, J COMP NEUROL, V491, P109, DOI 10.1002/cne.20714; Zecevic N, 2011, DEV NEUROBIOL, V71, P18, DOI 10.1002/dneu.20812; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	122	781	794	3	131	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 8	2011	146	1					18	36		10.1016/j.cell.2011.06.030	http://dx.doi.org/10.1016/j.cell.2011.06.030			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729779	Bronze, Green Accepted			2022-12-28	WOS:000292539300004
J	Green, WH; Schosser, RH				Green, W. Harris; Schosser, Robert Hill			Dermatologic Signs of Multiple Myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Green, W. Harris; Schosser, Robert Hill] E Carolina Univ, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Green, WH (corresponding author), E Carolina Univ, Greenville, NC 27858 USA.								0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					71	71		10.1056/NEJMicm1011176	http://dx.doi.org/10.1056/NEJMicm1011176			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788QL	21732838				2022-12-28	WOS:000292459400011
J	Howard, L; Salooja, N				Howard, Luke; Salooja, Nina			Outpatient management of pulmonary embolism	LANCET			English	Editorial Material							DEEP-VEIN THROMBOSIS		[Howard, Luke] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Natl Pulm Hypertens Serv, London W12 0HS, England; [Salooja, Nina] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Dept Haematol, London W12 0HS, England	Imperial College London; Imperial College London	Howard, L (corresponding author), Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Natl Pulm Hypertens Serv, London W12 0HS, England.	L.howard@imperial.ac.uk		Howard, Luke/0000-0003-2822-210X				Aujesky D, 2005, AM J RESP CRIT CARE, V172, P1041, DOI 10.1164/rccm.200506-862OC; Aujesky D, 2011, LANCET, V378, P41, DOI 10.1016/S0140-6736(11)60824-6; Dolovich LR, 2000, ARCH INTERN MED, V160, P181, DOI 10.1001/archinte.160.2.181; Heit JA, 1999, ARCH INTERN MED, V159, P445, DOI 10.1001/archinte.159.5.445; Jimenez D, 2010, AM J RESP CRIT CARE, V181, P983, DOI 10.1164/rccm.200908-1204OC; Otero R, 2010, THROMB RES, V126, pE1, DOI 10.1016/j.thromres.2009.09.026	6	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 2	2011	378	9785					5	6		10.1016/S0140-6736(11)60932-X	http://dx.doi.org/10.1016/S0140-6736(11)60932-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791IU	21703675				2022-12-28	WOS:000292659700005
J	Chowdhury, BA; Seymour, SM; Levenson, MS				Chowdhury, Badrul A.; Seymour, Sally M.; Levenson, Mark S.			Assessing the Safety of Adding LABAs to Inhaled Corticosteroids for Treating Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACTING BETA-AGONISTS		[Chowdhury, Badrul A.; Seymour, Sally M.] US FDA, Ctr Drug Evaluat & Res, Div Pulm Allergy & Rheumatol Prod, Off New Drugs, Silver Spring, MD USA; [Levenson, Mark S.] US FDA, Ctr Drug Evaluat & Res, Off Biostat, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Chowdhury, BA (corresponding author), US FDA, Ctr Drug Evaluat & Res, Div Pulm Allergy & Rheumatol Prod, Off New Drugs, Silver Spring, MD USA.							Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; Drazen JM, 2009, NEW ENGL J MED, V360, P1671, DOI 10.1056/NEJMe0902057; *FDA, 2010, MARCH 10 11 2010 JOI; Fleming TR, 2008, NEW ENGL J MED, V359, P1400, DOI 10.1056/NEJMe0807372; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15	5	84	87	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2011	364	26					2473	2475		10.1056/NEJMp1104375	http://dx.doi.org/10.1056/NEJMp1104375			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	785AM	21714647				2022-12-28	WOS:000292199800001
J	Pratsides, LAE; Nehme, J; Thursz, MR; Goldin, RD				Pratsides, Luke A. E.; Nehme, Jean; Thursz, Mark R.; Goldin, Robert D.			CASE REPORT Jaundiced after a party	BRITISH MEDICAL JOURNAL			English	Editorial Material							INDUCED LIVER-INJURY; FAILURE; MANAGEMENT; DRUGS		[Pratsides, Luke A. E.] Imperial Coll Sch Med, London, England; [Nehme, Jean] Imperial Coll Healthcare NHS Trust, London, England; [Thursz, Mark R.; Goldin, Robert D.] Univ London Imperial Coll Sci Technol & Med, Dept Gastroenterol & Hepatol, London, England	Imperial College London; Imperial College London; Imperial College London	Pratsides, LAE (corresponding author), Imperial Coll Sch Med, London, England.	luke.pratsides05@imperial.ac.uk		Thursz, Mark/0000-0002-8218-192X; Goldin, Robert/0000-0001-5184-4519				Bernal W, 2002, LANCET, V359, P558, DOI 10.1016/S0140-6736(02)07743-7; Biour M, 2000, GASTROEN CLIN BIOL, V24, P1052; Bjornsson E, 2010, ALIMENT PHARM THER, V32, P3, DOI 10.1111/j.1365-2036.2010.04320.x; DANAN G, 1993, J CLIN EPIDEMIOL, V46, P1323, DOI 10.1016/0895-4356(93)90101-6; Fidler H, 1996, J HEPATOL, V25, P563, DOI 10.1016/S0168-8278(96)80217-0; Jones AL, 1999, ALIMENT PHARM THER, V13, P129; *NHS BLOOD LIV TRA, 2009, PROT GUID AD UND DEC; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; SCHEUER PJ, 2006, LIVER BIOPSY INTERPR, P125; Tajiri K, 2008, WORLD J GASTROENTERO, V14, P6774, DOI 10.3748/wjg.14.6774	12	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 29	2011	342								d3441	10.1136/bmj.d3441	http://dx.doi.org/10.1136/bmj.d3441			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788PZ	21715452				2022-12-28	WOS:000292458200002
J	Shorvon, S; Tomson, T				Shorvon, Simon; Tomson, Torbjorn			Sudden unexpected death in epilepsy	LANCET			English	Article							TEMPORAL-LOBE EPILEPSY; VAGUS NERVE-STIMULATION; HEART-RATE-VARIABILITY; LOCALIZATION-RELATED EPILEPSY; REFRACTORY PARTIAL EPILEPSY; TERTIARY REFERRAL CENTER; POPULATION-BASED COHORT; UNEXPLAINED DEATH; RISK-FACTORS; ICTAL ASYSTOLE	Sudden unexpected death in epilepsy (SUDEP) refers to the sudden death of a seemingly healthy individual with epilepsy, usually occurring during, or immediately after, a tonic-clonic seizure. The frequency of SUDEP varies depending on the severity of the epilepsy, but overall the risk of sudden death is more than 20 times higher than that in the general population. Several different mechanisms probably exist, and most research has focused on seizure-related respiratory depression, cardiac arrhythmia, cerebral depression, and autonomic dysfunction. Data from a pooled analysis of risk factors indicate that the higher the frequency of tonic-clonic seizures, the higher the risk of SUDEP; furthermore, risk of SUDEP is also elevated in male patients, patients with long-duration epilepsy, and those on antiepileptic polytherapy. SUDEP usually occurs when the seizures are not witnessed and often at night. In this Seminar, we provide advice to clinicians on ways to minimise the risk of SUDEP, information to pass on to patients, and medicolegal aspects of these deaths.	[Shorvon, Simon] Natl Hosp Neurol & Neurosurg, UCL Inst Neurol, London WC1N 3BG, England; [Tomson, Torbjorn] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Tomson, Torbjorn] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Shorvon, S (corresponding author), Natl Hosp Neurol & Neurosurg, UCL Inst Neurol, Box 5, London WC1N 3BG, England.	s.shorvon@ion.ucl.ac.uk			Janssen Cilag; UCB Pharma; Eisai; GlaxoSmithKline; Janssen-Cilag Novartis; Sanofi-Aventis; Pfizer; Department of Health's National Institute for Health Research Biomedical Research Centres	Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); UCB Pharma(UCB Pharma SA); Eisai(Eisai Co Ltd); GlaxoSmithKline(GlaxoSmithKline); Janssen-Cilag Novartis; Sanofi-Aventis(Sanofi-Aventis); Pfizer(Pfizer); Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR))	SS has received consultancy fees from Janssen Cilag, UCB Pharma, and Eisai, and has received speaker's honoraria from GlaxoSmithKline, Janssen Cilag, and UCB Pharma. TT has received research grants from Eisai, GlaxoSmithKline, Janssen-Cilag Novartis, Sanofi-Aventis, Pfizer, and UCB Pharma. He has received speaker's honoraria from UCB Pharma and Eisai, and has received travel expenses from UCB Pharma.; The contribution by SS was partly undertaken at University College London Hospital, which received a proportion of funding from the Department of Health's National Institute for Health Research Biomedical Research Centres' funding scheme.	Adjei P, 2010, THESIS U COLL LONDON; Alldredge BK, 2001, NEW ENGL J MED, V345, P631, DOI 10.1056/NEJMoa002141; Amark P, 2007, EPILEPSIA, V48, P1023, DOI 10.1111/j.1528-1167.2007.01023.x; Annegers JF, 2000, EPILEPSIA, V41, P549, DOI 10.1111/j.1528-1157.2000.tb00208.x; [Anonymous], 2007, CURR DIAGN PATHOL; Ardesch JJ, 2007, CLIN NEUROL NEUROSUR, V109, P849, DOI 10.1016/j.clineuro.2007.07.024; Arshad A, 2008, PROG CARDIOVASC DIS, V50, P420, DOI 10.1016/j.pcad.2007.12.003; Aurlien D, 2007, ACTA NEUROL SCAND, V115, P199, DOI 10.1111/j.1600-0404.2006.00730.x; Bateman LM, 2010, EPILEPSIA, V51, P2211, DOI 10.1111/j.1528-1167.2010.02594.x; Bateman LM, 2010, EPILEPSIA, V51, P916, DOI 10.1111/j.1528-1167.2009.02513.x; Bateman LM, 2008, BRAIN, V131, P3239, DOI 10.1093/brain/awn277; Bell GS, 2010, J NEUROL NEUROSUR PS, V81, P716, DOI 10.1136/jnnp.2008.170837; Beran RG, 2006, LANCET NEUROL, V5, P464, DOI 10.1016/S1474-4422(06)70449-5; Beran RG, 2004, SEIZURE-EUR J EPILEP, V13, P523, DOI 10.1016/j.seizure.2003.12.008; Bird JM, 1997, EPILEPSIA, V38, pS52, DOI 10.1111/j.1528-1167.1997.tb06295.x; BIRNBACH CD, 1991, J EPILEPSY, V4, P11, DOI 10.1016/0896-6974(91)90116-Z; Brodie MJ, 2008, EPILEPSIA, V49, P99, DOI 10.1111/j.1528-1167.2008.01933.x; Cramer JA, 2002, EPILEPSY BEHAV, V3, P338, DOI 10.1016/S1525-5050(02)00037-9; DASHEIFF RM, 1991, J CLIN NEUROPHYSIOL, V8, P216, DOI 10.1097/00004691-199104000-00010; DASHEIFF RM, 1986, ARCH NEUROL-CHICAGO, V43, P194, DOI 10.1001/archneur.1986.00520020080028; Derby LE, 1996, EPILEPSIA, V37, P931, DOI 10.1111/j.1528-1157.1996.tb00529.x; Espinosa PS, 2009, NEUROLOGY, V72, P1702, DOI 10.1212/WNL.0b013e3181a55f90; Faught E, 2008, NEUROLOGY, V71, P1572, DOI 10.1212/01.wnl.0000319693.10338.b9; Ficker DM, 1998, NEUROLOGY, V51, P1270, DOI 10.1212/WNL.51.5.1270; GASTAUT H, 1957, LANCET, V2, P1018; George JR, 1998, J FORENSIC SCI, V43, P598; Glasscock E, 2010, J NEUROSCI, V30, P5167, DOI 10.1523/JNEUROSCI.5591-09.2010; Goldman AM, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000289; Hancox JC, 2000, LANCET, V356, P428, DOI 10.1016/S0140-6736(05)73573-X; Hennessy MJ, 1999, NEUROLOGY, V53, P1276, DOI 10.1212/WNL.53.6.1276; Hesdorffer DC, 2011, EPILEPSIA, V52, P1150, DOI 10.1111/j.1528-1167.2010.02952.x; Hindocha N, 2008, EPILEPSIA, V49, P360, DOI 10.1111/j.1528-1167.2007.01439_2.x; Hitiris N, 2007, EPILEPSY BEHAV, V10, P138, DOI 10.1016/j.yebeh.2006.11.010; Jehi Lara, 2010, Cleve Clin J Med, V77 Suppl 3, pS51, DOI 10.3949/ccjm.77.s3.09; JICK SS, 1992, PHARMACOEPIDEM DR S, V1, P59, DOI DOI 10.1002/PDS.2630010203; JOHNSTON SC, 1995, ANN NEUROL, V37, P531, DOI 10.1002/ana.410370416; Johnston SC, 1997, ANN NEUROL, V42, P588, DOI 10.1002/ana.410420409; Johnston SC, 1996, EPILEPSIA, V37, P428, DOI 10.1111/j.1528-1157.1996.tb00587.x; Kiely DG, 1996, CHEST, V109, P1215, DOI 10.1378/chest.109.5.1215; KLENERMAN P, 1993, J NEUROL NEUROSUR PS, V56, P149, DOI 10.1136/jnnp.56.2.149; Kloster R, 1999, J NEUROL NEUROSUR PS, V67, P439, DOI 10.1136/jnnp.67.4.439; Langan Y, 2005, NEUROLOGY, V64, P1131, DOI 10.1212/01.WNL.0000156352.61328.CB; Langan Y, 1998, SEIZURE-EUR J EPILEP, V7, P355, DOI 10.1016/S1059-1311(05)80002-0; Langan Y, 2000, J NEUROL NEUROSUR PS, V68, P211, DOI 10.1136/jnnp.68.2.211; Lathers CM, 2006, EPILEPSY BEHAV, V9, P236, DOI 10.1016/j.yebeh.2006.06.001; Lee HW, 1999, EPILEPSIA, V40, P1828, DOI 10.1111/j.1528-1157.1999.tb01606.x; Leestma JE, 1997, EPILEPSIA, V38, P47, DOI 10.1111/j.1528-1157.1997.tb01076.x; LEESTMA JE, 1984, EPILEPSIA, V25, P84, DOI 10.1111/j.1528-1157.1984.tb04159.x; LEESTMA JE, 1989, ANN NEUROL, V26, P195, DOI 10.1002/ana.410260203; Lhatoo SD, 2010, ANN NEUROL, V68, P787, DOI 10.1002/ana.22101; Lhatoo SD, 2001, ANN NEUROL, V49, P336; Lim ECH, 2000, J NEUROL NEUROSUR PS, V69, P557, DOI 10.1136/jnnp.69.4.557; LIP GYH, 1992, J ROY SOC MED, V85, P609; Malow BA, 2000, NEUROLOGY, V55, P1450, DOI 10.1212/WNL.55.10.1450; Malow BA, 2000, NEUROLOGY, V55, P1002, DOI 10.1212/WNL.55.7.1002; McKee JR, 2000, AM J MENT RETARD, V105, P229, DOI 10.1352/0895-8017(2000)105<0229:SUDIEI>2.0.CO;2; McLean BN, 2007, J NEUROL NEUROSUR PS, V78, P1395, DOI 10.1136/jnnp.2006.088492; Mohanraj R, 2006, LANCET NEUROL, V5, P481, DOI 10.1016/S1474-4422(06)70448-3; Monte CPJA, 2007, SEIZURE-EUR J EPILEP, V16, P1, DOI 10.1016/j.seizure.2006.10.002; Morton B, 2006, J NEUROL NEUROSUR PS, V77, P199, DOI 10.1136/jnnp.2005.066852; Nashef L, 1996, J NEUROL NEUROSUR PS, V60, P297, DOI 10.1136/jnnp.60.3.297; Nashef L, 1998, J NEUROL NEUROSUR PS, V64, P349, DOI 10.1136/jnnp.64.3.349; NASHEF L, 1995, J NEUROL NEUROSUR PS, V58, P462, DOI 10.1136/jnnp.58.4.462; NASHEF L, 1995, EPILEPSIA, V36, P1187, DOI 10.1111/j.1528-1157.1995.tb01061.x; Nashef L, 1997, EPILEPSIA, V38, pS6, DOI 10.1111/j.1528-1157.1997.tb06130.x; Natelson BH, 1998, ARCH NEUROL-CHICAGO, V55, P857, DOI 10.1001/archneur.55.6.857; National Highway Traffic Safety Administration, FAT AN REP SYST FARS; Nilsson L, 1999, LANCET, V353, P888, DOI 10.1016/S0140-6736(98)05114-9; Nilsson L, 2003, EPILEPSIA, V44, P575, DOI 10.1046/j.1528-1157.2003.03302.x; Nilsson L, 2001, EPILEPSIA, V42, P667, DOI 10.1046/j.1528-1157.2001.22000.x; Opeskin K, 2000, EPILEPSY RES, V40, P17, DOI 10.1016/S0920-1211(00)00098-X; Opeskin K, 2000, J CLIN NEUROSCI, V7, P34, DOI 10.1054/jocn.1999.0137; Opeskin K, 2003, SEIZURE-EUR J EPILEP, V12, P456, DOI 10.1016/S1059-1311(02)00352-7; Oppenheimer S, 2006, CLIN AUTON RES, V16, P6, DOI 10.1007/s10286-006-0276-0; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Persson H, 2005, NEUROLOGY, V65, P1021, DOI 10.1212/01.wnl.0000181368.50750.1c; Persson H, 2003, EPILEPSY RES, V57, P69, DOI 10.1016/j.eplepsyres.2003.10.012; Persson H, 2007, EPILEPSIA, V48, P917, DOI 10.1111/j.1528-1167.2006.00961.x; Racoosin JA, 2001, NEUROLOGY, V56, P514, DOI 10.1212/WNL.56.4.514; Rocamora R, 2003, EPILEPSIA, V44, P179, DOI 10.1046/j.1528-1157.2003.15101.x; Roche F, 2003, AM J CARDIOL, V91, P916, DOI 10.1016/S0002-9149(03)00040-7; Ronkainen E, 2005, J NEUROL NEUROSUR PS, V76, P1382, DOI 10.1136/jnnp.2004.053777; Rossetti AO, 2005, J NEUROL NEUROSUR PS, V76, P885, DOI 10.1136/jnnp.2004.051839; Rugg-Gunn FJ, 2004, LANCET, V364, P2212, DOI 10.1016/S0140-6736(04)17594-6; Ryvlin P, 2009, EPILEPSIA, V50, P223; Ryvlin P, 2009, EPILEPSIA, V50, P60; Salanova V, 2005, ACTA NEUROL SCAND, V111, P126, DOI 10.1111/j.1600-0404.2005.00371.x; Salanova V, 2002, EPILEPSIA, V43, P170, DOI 10.1046/j.1528-1157.2002.33800.x; Schnabel R, 2000, NEUROLOGY, V54, P903, DOI 10.1212/WNL.54.4.903; SCHOTT GD, 1977, BRIT MED J, V1, P1454, DOI 10.1136/bmj.1.6074.1454; Schraeder PL, 2006, EPILEPSY RES, V68, P137, DOI 10.1016/j.eplepsyres.2005.10.004; Schuele SU, 2007, NEUROLOGY, V69, P434, DOI 10.1212/01.wnl.0000266595.77885.7f; Schuele SU, 2008, EPILEPSIA, V49, P168, DOI 10.1111/j.1528-1167.2007.01330.x; Seyal M, 2009, EPILEPSIA, V50, P2557, DOI 10.1111/j.1528-1167.2009.02245.x; Shields LBE, 2002, AM J FOREN MED PATH, V23, P307, DOI 10.1097/00000433-200212000-00001; Shoja MM, 2007, CHILD NERV SYST, V23, P265, DOI 10.1007/s00381-006-0285-2; SIMON RP, 1984, NEUROLOGY, V34, P255, DOI 10.1212/WNL.34.2.255; So EL, 2000, EPILEPSIA, V41, P1494, DOI 10.1111/j.1528-1157.2000.tb00128.x; So NK, 2007, NEUROLOGY, V69, P423, DOI 10.1212/01.wnl.0000268698.04032.bc; Sperling MR, 2005, EPILEPSIA, V46, P49, DOI 10.1111/j.1528-1167.2005.00410.x; Sperling MR, 1999, ANN NEUROL, V46, P45, DOI 10.1002/1531-8249(199907)46:1<45::AID-ANA8>3.0.CO;2-I; Surges R, 2009, EPILEPSY RES, V87, P277, DOI 10.1016/j.eplepsyres.2009.08.008; Surges R, 2010, EPILEPSIA, V51, P738, DOI 10.1111/j.1528-1167.2010.02571.x; Tatum WO, 1999, NEUROLOGY, V52, P1267, DOI 10.1212/WNL.52.6.1267; Tellez-Zenteno JF, 2005, EPILEPSY RES, V65, P101, DOI 10.1016/j.eplepsyres.2005.05.004; TENNIS P, 1995, EPILEPSIA, V36, P29, DOI 10.1111/j.1528-1157.1995.tb01661.x; TERRENCE CF, 1975, NEUROLOGY, V25, P594, DOI 10.1212/WNL.25.6.594; TERRENCE CF, 1981, ANN NEUROL, V9, P458, DOI 10.1002/ana.410090508; Thomas P, 1996, EPILEPSIES, V8, P339; Timmings P L, 1993, Seizure, V2, P287, DOI 10.1016/S1059-1311(05)80142-6; Tomson T, 1998, EPILEPSY RES, V30, P77, DOI 10.1016/S0920-1211(97)00094-6; Tomson T, 2008, LANCET NEUROL, V7, P1021, DOI 10.1016/S1474-4422(08)70202-3; Tu E, 2011, BRAIN PATHOL, V21, P201, DOI 10.1111/j.1750-3639.2010.00438.x; Tupal S, 2006, EPILEPSIA, V47, P21, DOI 10.1111/j.1528-1167.2006.00365.x; Venit EL, 2004, EPILEPSIA, V45, P993, DOI 10.1111/j.0013-9580.2004.02304.x; Vlooswijk MCG, 2007, SEIZURE-EUR J EPILEP, V16, P153, DOI 10.1016/j.seizure.2006.11.002; Walczak TS, 2001, NEUROLOGY, V56, P519, DOI 10.1212/WNL.56.4.519; Williams J, 2006, J NEUROL NEUROSUR PS, V77, P481, DOI 10.1136/jnnp.2005.067777; Yuen AWC, 2007, EPILEPSY BEHAV, V10, P1, DOI 10.1016/j.yebeh.2006.09.004	119	285	296	0	56	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2011	378	9808					2028	2038		10.1016/S0140-6736(11)60176-1	http://dx.doi.org/10.1016/S0140-6736(11)60176-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863DY	21737136				2022-12-28	WOS:000298144200027
J	Wogelius, RA; Manning, PL; Barden, HE; Edwards, NP; Webb, SM; Sellers, WI; Taylor, KG; Larson, PL; Dodson, P; You, H; Da-Qing, L; Bergmann, U				Wogelius, R. A.; Manning, P. L.; Barden, H. E.; Edwards, N. P.; Webb, S. M.; Sellers, W. I.; Taylor, K. G.; Larson, P. L.; Dodson, P.; You, H.; Da-Qing, L.; Bergmann, U.			Trace Metals as Biomarkers for Eumelanin Pigment in the Fossil Record	SCIENCE			English	Article							MELANIN; COLOR; FEATHERS; MORPHOLOGY; CHEMISTRY; PRODUCTS; COPPER; EXAFS; BIRDS	Well-preserved fossils of pivotal early bird and nonavian theropod species have provided unequivocal evidence for feathers and/or downlike integuments. Recent studies have reconstructed color on the basis of melanosome structure; however, the chemistry of these proposed melanosomes has remained unknown. We applied synchrotron x-ray techniques to several fossil and extant organisms, including Confuciusornis sanctus, in order to map and characterize possible chemical residues of melanin pigments. Results show that trace metals, such as copper, are present in fossils as organometallic compounds most likely derived from original eumelanin. The distribution of these compounds provides a long-lived biomarker of melanin presence and density within a range of fossilized organisms. Metal zoning patterns may be preserved long after melanosome structures have been destroyed.	[Wogelius, R. A.; Manning, P. L.; Barden, H. E.; Edwards, N. P.; Larson, P. L.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; [Wogelius, R. A.; Manning, P. L.; Barden, H. E.; Edwards, N. P.] Univ Manchester, Williamson Res Ctr Mol Environm Sci, Manchester M13 9PL, Lancs, England; [Manning, P. L.; You, H.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Webb, S. M.] SSRL, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Sellers, W. I.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Taylor, K. G.] Manchester Metropolitan Univ, Sch Sci & Environm, Manchester M1 5GD, Lancs, England; [Larson, P. L.] Black Hills Inst Geol Res, Hill City, SD 57745 USA; [Dodson, P.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [You, H.] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; [Da-Qing, L.] Gansu Geol Museum, Lanzhou 730030, Gansu, Peoples R China; [Bergmann, U.] Linac Coherent Light Source, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA	University of Manchester; University of Manchester; University of Pennsylvania; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Manchester; Manchester Metropolitan University; University of Pennsylvania; Chinese Academy of Geological Sciences; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Wogelius, RA (corresponding author), Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England.	roy.wogelius@manchester.ac.uk	Wogelius, Roy/C-4917-2008; Manning, Phillip/F-9966-2011; Sellers, William Irvin/Q-3843-2019; Webb, Samuel M/D-4778-2009	Manning, Phillip/0000-0002-7161-6246; Sellers, William Irvin/0000-0002-2913-5406; Webb, Samuel M/0000-0003-1188-0464; Taylor, Kevin/0000-0001-7024-5001; Wogelius, Roy/0000-0002-5781-2152; You, Hai-Lu/0000-0003-2203-6461	Natural Environment Research Council	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Samples were provided by the Black Hills Institute Museum and the Museum fur Naturkunde, Humboldt University, Berlin. We thank D. Schwarz-Wings for making the Archaeopteryx sample available. We also thank Perkin-Elmer, M. George, K. Palmer, E. Kaxiras, V. Vishnyakov, and R. Morton for technical assistance and additional data, and D. Vaughan, G. Brown, and three reviewers for helpful comments on the manuscript. Portions of this research were carried out at SSRL, a national user facility operated by Stanford University on behalf of the U. S. Department of Energy, Office of Basic Energy Sciences. Funding was provided in part by a Natural Environment Research Council Envirosync grant and by an anonymous private donor. R. Hartley provided the artist's drawing of C. sanctus. Data described in this paper are presented within the SOM. R. A. W. wrote the manuscript, analyzed the data, and supervised or assisted in all analyses. P. L. M. cowrote the manuscript and assisted in all analyses. H. E. B., N.P.E., and W. I. S. assisted in all analyses and contributed to the manuscript. S. M. W. performed the EXAFS analyses. K. G. T. provided and supervised VP-FEG-SEM analyses. P. L. L. provided specimen access and identification and also assisted with all x-ray measurements. P. D. consulted on the manuscript, and along with H.Y. and L. D. assisted in field collection, preparation, and identification of samples. U. B. supervised the SRS-XRF program and assisted in manuscript preparation.	Bergmann U, 2010, P NATL ACAD SCI USA, V107, P9060, DOI 10.1073/pnas.1001569107; BOWNESS JM, 1952, BIOCHEM J, V51, P530, DOI 10.1042/bj0510530; Cheah SF, 2000, AM MINERAL, V85, P118, DOI 10.2138/am-2000-0113; Clarke JA, 2010, SCIENCE, V330, P954, DOI 10.1126/science.1193604; EDWARDS NP, P R SOC B, DOI DOI 10.1098/RSPB.2011.0135; Frenkel AI, 1999, J SYNCHROTRON RADIAT, V6, P653, DOI 10.1107/S0909049598015180; HELZ GR, 1993, GEOCHIM COSMOCHIM AC, V57, P15, DOI 10.1016/0016-7037(93)90464-8; Hill G. E., 2006, BIRD COLORATION, VI; Hou LH, 1999, NATURE, V399, P679, DOI 10.1038/21411; Katsikini M, 2009, J PHYS CONF SER, V190, DOI 10.1088/1742-6596/190/1/012204; Kaxiras E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218102; LARSSON BS, 1993, PIGM CELL RES, V6, P127, DOI 10.1111/j.1600-0749.1993.tb00591.x; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Liu Y, 2004, PIGM CELL RES, V17, P262, DOI 10.1111/j.1600-0749.2004.00140.x; Liu Y, 2003, PIGM CELL RES, V16, P72, DOI 10.1034/j.1600-0749.2003.00009.x; McGraw KJ, 2003, OIKOS, V102, P402; Niecke M, 1999, J ORNITHOL, V140, P355, DOI 10.1007/BF01651032; PALUMBO A, 1988, BIOCHIM BIOPHYS ACTA, V964, P193, DOI 10.1016/0304-4165(88)90166-3; RALPH CL, 1969, AM ZOOL, V9, P521; Simon JD, 2009, PIGM CELL MELANOMA R, V22, P563, DOI 10.1111/j.1755-148X.2009.00610.x; Stainsack J, 2003, INORG CHIM ACTA, V356, P243, DOI 10.1016/S0020-1693(03)00474-2; WILLIER B. H., 1940, PHYSIOLOGICAL ZOOLOGY, V13, P177; You HL, 2006, SCIENCE, V312, P1640, DOI 10.1126/science.1126377; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740	24	118	120	1	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1622	1626		10.1126/science.1205748	http://dx.doi.org/10.1126/science.1205748			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21719643				2022-12-28	WOS:000294900900041
J	Prochaska, JJ				Prochaska, Judith J.			Smoking and Mental Illness - Breaking the Link	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SCHIZOPHRENIA; CESSATION		Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Prochaska, JJ (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.		Prochaska, Judith J/I-4510-2013	Prochaska, Judith J/0000-0001-7925-326X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083684] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH083684] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Fiore MC, 2008, CLIN PRACTICE GUIDEL; Hall SM, 2009, ANNU REV CLIN PSYCHO, V5, P409, DOI 10.1146/annurev.clinpsy.032408.153614; McFall M, 2010, JAMA-J AM MED ASSOC, V304, P2485, DOI 10.1001/jama.2010.1769; Prochaska JJ, 2008, SCHIZOPHRENIA BULL, V34, P555, DOI 10.1093/schbul/sbm117; Tsoi DTY, 2010, BRIT J PSYCHIAT, V196, P346, DOI 10.1192/bjp.bp.109.066019	5	186	189	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2011	365	3					196	198		10.1056/NEJMp1105248	http://dx.doi.org/10.1056/NEJMp1105248			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794QI	21774707	Bronze, Green Accepted			2022-12-28	WOS:000292915500002
J	Mrazek, DA; Lerman, C				Mrazek, David A.; Lerman, Caryn			Facilitating Clinical Implementation of Pharmacogenomics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mrazek, David A.] Mayo Clin, Coll Med, Dept Psychiat, Rochester, MN 55905 USA; [Mrazek, David A.] Mayo Clin, Coll Med, Dept Pediat, Rochester, MN 55905 USA; [Lerman, Caryn] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Lerman, Caryn] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA	Mayo Clinic; Mayo Clinic; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Mrazek, DA (corresponding author), Mayo Clin, Coll Med, Dept Psychiat, 200 1st St SW, Rochester, MN 55905 USA.	mrazek.david@mayo.edu	Lerman, Caryn/AHC-5180-2022		NCI NIH HHS [P50 CA143187, P50-CA143187] Funding Source: Medline; NIDA NIH HHS [R01 DA017555, U01 DA020830, U01-DA020830] Funding Source: Medline; NIGMS NIH HHS [U19 GM061388, U19-GM61388] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA143187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM061388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA020830, R01DA017555] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Altman RB, 2011, CLIN PHARMACOL THER, V89, P348, DOI 10.1038/clpt.2010.310; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Kraemer HC, 2009, AM J PSYCHIAT, V166, P1222, DOI 10.1176/appi.ajp.2009.08121809; *NAT AC I MED, 2011, CLIN PRACT GUID WE C; Porcelli S, 2011, J PSYCHIATR NEUROSCI, V36, P87, DOI 10.1503/jpn.100059; Relling MV, 2011, CLIN PHARMACOL THER, V89, P464, DOI 10.1038/clpt.2010.279; Sallee FR, 2000, J CHILD ADOL PSYCHOP, V10, P27, DOI 10.1089/cap.2000.10.27; Shields AE, 2008, CLIN PHARMACOL THER, V83, P635, DOI 10.1038/clpt.2008.4; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Winner JG, 2010, ACAD PSYCHIATR, V34, P115, DOI 10.1176/appi.ap.34.2.115	10	49	49	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2011	306	3					304	305		10.1001/jama.2011.1010	http://dx.doi.org/10.1001/jama.2011.1010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794BS	21771991	Green Accepted			2022-12-28	WOS:000292870500024
J	Collette, BB; Carpenter, KE; Polidoro, BA; Juan-Jorda, MJ; Boustany, A; Die, DJ; Elfes, C; Fox, W; Graves, J; Harrison, LR; McManus, R; Minte-Vera, CV; Nelson, R; Restrepo, V; Schratwieser, J; Sun, CL; Amorim, A; Peres, MB; Canales, C; Cardenas, G; Chang, SK; Chiang, WC; Leite, ND; Harwell, H; Lessa, R; Fredou, FL; Oxenford, HA; Serra, R; Shao, KT; Sumaila, R; Wang, SP; Watson, R; Yanez, E				Collette, B. B.; Carpenter, K. E.; Polidoro, B. A.; Juan-Jorda, M. J.; Boustany, A.; Die, D. J.; Elfes, C.; Fox, W.; Graves, J.; Harrison, L. R.; McManus, R.; Minte-Vera, C. V.; Nelson, R.; Restrepo, V.; Schratwieser, J.; Sun, C. -L.; Amorim, A.; Brick Peres, M.; Canales, C.; Cardenas, G.; Chang, S. -K.; Chiang, W. -C.; de Oliveira Leite, N., Jr.; Harwell, H.; Lessa, R.; Fredou, F. L.; Oxenford, H. A.; Serra, R.; Shao, K. -T.; Sumaila, R.; Wang, S. -P.; Watson, R.; Yanez, E.			High Value and Long Life-Double Jeopardy for Tunas and Billfishes	SCIENCE			English	Editorial Material							EXTINCTION RISK; SIZE		[Collette, B. B.] NOAA, Natl Marine Fisheries Serv, Systemat Lab, Washington, DC 20230 USA; [Carpenter, K. E.; Polidoro, B. A.; Harwell, H.] Old Dominion Univ, Norfolk, VA 23529 USA; [Juan-Jorda, M. J.] Univ A Coruna, La Coruna, Spain; [Boustany, A.] Duke Univ, Nicholas Sch Environm, Durham, NC 27706 USA; [Die, D. J.] Univ Miami, Coral Gables, FL 33124 USA; [Graves, J.] Coll William & Mary, Virginia Inst Marine Sci, Williamsburg, VA 23187 USA; [Harrison, L. R.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Minte-Vera, C. V.] Univ Estadual Maringa, Maringa, Parana, Brazil; [Sun, C. -L.] Natl Taiwan Univ, Taipei, Taiwan; [Chang, S. -K.] Natl Sun Yat Sen Univ, Kaohsiung, Taiwan; [Lessa, R.; Fredou, F. L.] Univ Fed Rural Pernambuco, Recife, PE, Brazil; [Oxenford, H. A.] Univ W Indies, Ctr Resource Management & Environm Studies, Bridgetown, Barbados; [Shao, K. -T.] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Sumaila, R.; Watson, R.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Wang, S. -P.] Natl Taiwan Ocean Univ, Chilung, Taiwan; [Yanez, E.] Pontificia Univ Catolica Valparaiso, Valparaiso, Chile	National Oceanic Atmospheric Admin (NOAA) - USA; Old Dominion University; Universidade da Coruna; Duke University; University of Miami; William & Mary; Virginia Institute of Marine Science; Simon Fraser University; Universidade Estadual de Maringa; National Taiwan University; National Sun Yat Sen University; Universidade Federal Rural de Pernambuco (UFRPE); University West Indies Mona Jamaica; University of the West Indies Open Campus; Academia Sinica - Taiwan; University of British Columbia; National Taiwan Ocean University; Pontificia Universidad Catolica de Valparaiso	Collette, BB (corresponding author), NOAA, Natl Marine Fisheries Serv, Systemat Lab, Washington, DC 20230 USA.	collettb@si.edu	Watson, Reg A/F-4850-2012; Frédou, Flávia Lucena/I-3639-2012; CHIANG, WEICHUAN/S-8736-2018; Juan-Jordá, Maria José/B-4542-2019; Minte-Vera, Carolina/D-6326-2013; Collette, Bruce B./AAA-9532-2019; Canales, Cristian/AAU-2779-2020; LESSA, ROSANGELA PAULA TEIXEIRA/D-5043-2013; Harrison, Lucy/F-9494-2011; Sumaila, U. Rashid/ABE-6475-2020; Chang, Shui-Kai/B-5038-2010; Minte-Vera, Carolina V/A-5461-2017	Watson, Reg A/0000-0001-7201-8865; Frédou, Flávia Lucena/0000-0001-5492-7205; Juan-Jordá, Maria José/0000-0002-4586-2400; Chang, Shui-Kai/0000-0003-2929-1510; Minte-Vera, Carolina V/0000-0002-0537-1519; Lessa, Rosangela/0000-0002-9217-1215; Amorim, Alberto/0000-0002-1329-2634; Die, David/0000-0001-6504-8513; Canales, Cristian/0000-0002-4249-274X				Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Cullis-Suzuki S, 2010, MAR POLICY, V34, P1036, DOI 10.1016/j.marpol.2010.03.002; Cyranoski D, 2010, NATURE, V465, P280, DOI 10.1038/465280b; De Roos AM, 2002, P NATL ACAD SCI USA, V99, P12907, DOI 10.1073/pnas.192174199; Fromentin JM, 2010, SCIENCE, V327, P1325, DOI 10.1126/science.327.5971.1325-c; ICCAT, 2010, REP STAND COMM RES S; IUCN Standards and Petitions Subcommittee, 2014, GUID US IUCN RED LIS; Kitchell JF, 2006, B MAR SCI, V79, P669; Losada S, 2010, SCIENCE, V328, P1353, DOI 10.1126/science.328.5984.1353-a; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; MacKenzie BR, 2009, CONSERV LETT, V2, P25, DOI 10.1111/j.1755-263X.2008.00039.x; Majkowski J, 2007, GLOBAL FISHERY RESOU; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Sibert J, 2006, SCIENCE, V314, P1773, DOI 10.1126/science.1135347	15	203	207	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2011	333	6040					291	292		10.1126/science.1208730	http://dx.doi.org/10.1126/science.1208730			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21737699				2022-12-28	WOS:000292732000024
J	Carpenter, D; Kesselheim, AS; Joffe, S				Carpenter, Daniel; Kesselheim, Aaron S.; Joffe, Steven			Reputation and Precedent in the Bevacizumab Decision	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Carpenter, Daniel] Harvard Univ, Dept Govt, Cambridge, MA 02138 USA; [Kesselheim, Aaron S.; Joffe, Steven] Harvard Univ, Sch Med, Boston, MA USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Joffe, Steven] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Joffe, Steven] Childrens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital	Carpenter, D (corresponding author), Harvard Univ, Dept Govt, Cambridge, MA 02138 USA.		Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384				Carpenter D, 2010, PRINC STUD AM POLIT, P1; Mckee AE, 2010, ONCOLOGIST, V15, P13, DOI 10.1634/theoncologist.2010-S1-13; O'Shaughnessy J, 2010, J CLIN ONCOL S, V28, p15s; Ocana A, 2011, J CLIN ONCOL, V29, P254, DOI 10.1200/JCO.2010.32.0275	4	53	54	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2							e3	10.1056/nejmp1107201	http://dx.doi.org/10.1056/nejmp1107201			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791SP	21707383	Green Published			2022-12-28	WOS:000292685500006
J	Sarewitz, D				Sarewitz, Daniel			The dubious benefits of broader impact	NATURE			English	Editorial Material									[Sarewitz, Daniel] Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC 20009 USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC 20009 USA.	dsarewitz@gmail.com							0	19	19	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					141	141		10.1038/475141a	http://dx.doi.org/10.1038/475141a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791UA	21753811	Bronze			2022-12-28	WOS:000292690500016
J	Ziogas, A; Horick, NK; Kinney, AY; Lowery, JT; Domchek, SM; Isaacs, C; Griffin, CA; Moorman, PG; Edwards, KL; Hill, DA; Berg, JS; Tomlinson, GE; Anton-Culver, H; Strong, LC; Kasten, CH; Finkelstein, DM; Plon, SE				Ziogas, Argyrios; Horick, Nora K.; Kinney, Anita Y.; Lowery, Jan T.; Domchek, Susan M.; Isaacs, Claudine; Griffin, Constance A.; Moorman, Patricia G.; Edwards, Karen L.; Hill, Deirdre A.; Berg, Jonathan S.; Tomlinson, Gail E.; Anton-Culver, Hoda; Strong, Louise C.; Kasten, Carol H.; Finkelstein, Dianne M.; Plon, Sharon E.			Clinically Relevant Changes in Family History of Cancer Over Time	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BREAST-CANCER; COLORECTAL-CANCER; HIGH-RISK; INHERITANCE; ONSET; WOMEN	Context Knowledge of family cancer history is important for assessing cancer risk and guiding screening recommendations. Objective To quantify how often throughout adulthood clinically significant changes occur in cancer family history that would result in recommendations for earlier or intense screening. Design and Setting Descriptive study examining baseline and follow-up family history data from participants in the Cancer Genetics Network (CGN), a US national population-based cancer registry, between 1999 and 2009. Participants Adults with a personal history, family history, or both of cancer enrolled in the CGN through population-based cancer registries. Retrospective colorectal, breast, and prostate cancer screening-specific analyses included 9861, 2547, and 1817 participants, respectively; prospective analyses included 1533, 617, and 163 participants, respectively. Median follow-up was 8 years (range, 0-11 years). Screening-specific analyses excluded participants with the cancer of interest. Main Outcome Measures Percentage of individuals with clinically significant family histories and rate of change over 2 periods: (1) retrospectively, from birth until CGN enrollment and (2) prospectively, from enrollment to last follow-up. Results Retrospective analysis revealed that the percentages of participants who met criteria for high-risk screening based on family history at ages 30 and 50 years, respectively, were as follows: for colorectal cancer, 2.1% (95% confidence interval [CI], 1.8%-2.4%) and 7.1%(95% CI, 6.5%-7.6%); for breast cancer, 7.2%(95% CI, 6.1%-8.4%) and 11.4% (95% CI, 10.0%-12.8%); and for prostate cancer, 0.9%(95% CI, 0.5%-1.4%) and 2.0% (95% CI, 1.4%-2.7%). In prospective analysis, the numbers of participants who newly met criteria for high-risk screening based on family history per 100 persons followed up for 20 years were 2 (95% CI, 0-7) for colorectal cancer, 6 (95% CI, 2-13) for breast cancer, and 8 (95% CI, 3-16) for prostate cancer. The rate of change in cancer family history was similar for colorectal and breast cancer between the 2 analyses. Conclusion Clinically relevant family history of colorectal, breast, and prostate cancer that would result in recommendations for earlier or intense cancer screening increases between ages 30 and 50 years, although the absolute rate is low for prostate cancer. JAMA. 2011; 306(2): 172-178	[Ziogas, Argyrios; Anton-Culver, Hoda] Univ Calif Irvine, Irvine, CA 92717 USA; [Horick, Nora K.; Finkelstein, Dianne M.] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Finkelstein, Dianne M.] Harvard Univ, Boston, MA 02115 USA; [Kinney, Anita Y.] Huntsman Canc Inst, Salt Lake City, UT USA; [Kinney, Anita Y.] Univ Utah, Salt Lake City, UT USA; [Lowery, Jan T.] Univ Colorado, Aurora, CO USA; [Domchek, Susan M.] Univ Penn, Philadelphia, PA 19104 USA; [Isaacs, Claudine] Georgetown Univ, Washington, DC USA; [Griffin, Constance A.] Johns Hopkins Univ, Baltimore, MD USA; [Moorman, Patricia G.] Duke Univ, Med Ctr, Durham, NC USA; [Edwards, Karen L.] Univ Washington, Seattle, WA 98195 USA; [Hill, Deirdre A.] Univ New Mexico, Albuquerque, NM 87131 USA; [Berg, Jonathan S.] Univ N Carolina, Chapel Hill, NC USA; [Tomlinson, Gail E.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Tomlinson, Gail E.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Strong, Louise C.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Plon, Sharon E.] Baylor Coll Med, Houston, TX 77030 USA; [Kasten, Carol H.] NICHHD, NIH, Bethesda, MD 20892 USA	University of California System; University of California Irvine; Harvard University; Massachusetts General Hospital; Harvard University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Pennsylvania; Georgetown University; Johns Hopkins University; Duke University; University of Washington; University of Washington Seattle; University of New Mexico; University of North Carolina; University of North Carolina Chapel Hill; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Finkelstein, DM (corresponding author), 50 Staniford St,Ste 560, Boston, MA 02114 USA.	dfinkel-stein@partners.org	Tomlinson, Gail/AAR-9776-2020	Berg, Jonathan/0000-0003-2360-2664; Kinney, Anita/0000-0002-2996-9355	National Cancer Institute [U01CA078284, U24CA078134, U24CA078164, U24CA078156, U24CA078148, U24CA078146, U24CA078174, U24CA078157, U24CA078142, HHSN2612007440000C]; NATIONAL CANCER INSTITUTE [U24CA078134, U24CA078148, U24CA078174, U24CA078164, U24CA078157, U24CA078142, U24CA078156, U01CA078284, R01CA149051, U24CA078146] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The CGN is supported by grants U01CA078284, U24CA078134, U24CA078164, U24CA078156, U24CA078148, U24CA078146, U24CA078174, U24CA078157, and U24CA078142 and contract HHSN2612007440000C from the National Cancer Institute.	Acheson LS, 2000, GENET MED, V2, P180, DOI 10.1097/00125817-200005000-00004; Airewele G, 1998, J NATL CANCER I, V90, P543, DOI 10.1093/jnci/90.7.543; *AM CANC SOC, 2007, CANC FACTS FIG 2007; American Cancer Society, PROST CANC EARL DET; American Cancer Society, COL CANC EARL DET; Anton-Culver Hoda, 2003, Community Genet, V6, P171, DOI 10.1159/000078165; Bratt O, 2010, JNCI-J NATL CANCER I, V102, P1299; Burke W, 2009, AM J MED GENET A, V149A, P349, DOI 10.1002/ajmg.a.32643; BURT RW, 1995, ANNU REV MED, V46, P371; CLAUS EB, 1994, CANCER, V73, P643, DOI 10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; Hampel H, 2005, GASTROENTEROLOGY, V129, P415, DOI 10.1053/j.gastro.2005.05.011; Kuhl C, 2010, J CLIN ONCOL, V28, P1450, DOI 10.1200/JCO.2009.23.0839; Qureshi N, 2007, AHRQ PUBLICATION; Qureshi Nadeem, 2007, Evid Rep Technol Assess (Full Rep), P1; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Scheuner MT, 2010, GENET MED, V12, P726, DOI 10.1097/GIM.0b013e3181f30e9e; Sifri RD, 2002, J FAM PRACTICE, V51; Sweet KM, 2002, J CLIN ONCOL, V20, P528, DOI 10.1200/JCO.20.2.528; Tyler CV, 2006, J AM BOARD FAM MED, V19, P468, DOI 10.3122/jabfm.19.5.468; Warner E, 2008, ANN INTERN MED, V148, P671, DOI 10.7326/0003-4819-148-9-200805060-00007	21	36	37	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					172	178		10.1001/jama.2011.955	http://dx.doi.org/10.1001/jama.2011.955			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791CO	21750294	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000292639400024
J	Danaei, G; Finucane, MM; Lu, Y; Singh, GM; Cowan, MJ; Paciorek, CJ; Lin, JK; Farzadfar, F; Khang, YH; Stevens, GA; Rao, M; Ali, MK; Riley, LM; Robinson, CA; Ezzati, M				Danaei, Goodarz; Finucane, Mariel M.; Lu, Yuan; Singh, Gitanjali M.; Cowan, Melanie J.; Paciorek, Christopher J.; Lin, John K.; Farzadfar, Farshad; Khang, Young-Ho; Stevens, Gretchen A.; Rao, Mayuree; Ali, Mohammed K.; Riley, Leanne M.; Robinson, Carolyn A.; Ezzati, Majid		Global Burden Metab Risk Factors C	National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants	LANCET			English	Article							CARDIOVASCULAR RISK-FACTORS; BLOOD-GLUCOSE; SECULAR TRENDS; DISEASE; MORTALITY; POPULATION; HYPERGLYCEMIA; ASSOCIATION; HEMOGLOBIN; MANAGEMENT	Background Data for trends in glycaemia and diabetes prevalence are needed to understand the effects of diet and lifestyle within populations, assess the performance of interventions, and plan health services. No consistent and comparable global analysis of trends has been done. We estimated trends and their uncertainties in mean fasting plasma glucose (FPG) and diabetes prevalence for adults aged 25 years and older in 199 countries and territories. Methods We obtained data from health examination surveys and epidemiological studies (370 country-years and 2.7 million participants). We converted systematically between different glycaemic metrics. For each sex, we used a Bayesian hierarchical model to estimate mean FPG and its uncertainty by age, country, and year, accounting for whether a study was nationally, subnationally, or community representative. Findings In 2008, global age-standardised mean FPG was 5.50 mmol/L (95% uncertainty interval 5.37-5.63) for men and 5.42 mmol/L (5.29-5.54) for women, having risen by 0.07 mmol/L and 0.09 mmol/L per decade, respectively. Age-standardised adult diabetes prevalence was 9.8% (8-6-11.2) in men and 9.2% (8.0-10.5) in women in 2008, up from 8.3% (6.5-10.4) and 7.5% (5.8-9.6) in 1980. The number of people with diabetes increased from 153 (127-182) million in 1980, to 347 (314-382) million in 2008. We recorded almost no change in mean FPG in east and southeast Asia and central and eastern Europe. Oceania had the largest rise, and the highest mean FPG (6-09 mmol/L, 5.73-6.49 for men; 6.08 mmol/L, 5.72-6.46 for women) and diabetes prevalence (15.5%, 11.6-20.1 for men; and 15.9%, 12.1-20.5 for women) in 2008. Mean FPG and diabetes prevalence in 2008 were also high in south Asia, Latin America and the Caribbean, and central Asia, north Africa, and the Middle East. Mean FPG in 2008 was lowest in sub-Saharan Africa, east and southeast Asia, and high-income Asia-Pacific. In high-income subregions, western Europe had the smallest rise, 0.07 mmol/L per decade for men and 0.03 mmol/L per decade for women; North America had the largest rise, 0.18 mmol/L per decade for men and 0.14 mmol/L per decade for women. Interpretation Glycaemia and diabetes are rising globally, driven both by population growth and ageing and by increasing age-specific prevalences. Effective preventive interventions are needed, and health systems should prepare to detect and manage diabetes and its sequelae.	[Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Ctr Environm & Hlth, Dept Epidemiol & Biostat, Sch Publ Hlth, London W2 1PG, England; [Danaei, Goodarz] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Finucane, Mariel M.; Paciorek, Christopher J.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Lu, Yuan; Singh, Gitanjali M.; Lin, John K.; Farzadfar, Farshad] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Cowan, Melanie J.; Riley, Leanne M.] WHO, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland; [Stevens, Gretchen A.] WHO, Dept Hlth Stat & Informat, CH-1211 Geneva, Switzerland; [Paciorek, Christopher J.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Khang, Young-Ho] Univ Ulsan, Coll Med, Seoul, South Korea; [Ali, Mohammed K.] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Robinson, Carolyn A.] Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth, London W2 1PG, England	Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; World Health Organization; World Health Organization; University of California System; University of California Berkeley; University of Ulsan; Emory University; University of California System; University of California San Francisco; Imperial College London	Ezzati, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Environm & Hlth, Dept Epidemiol & Biostat, Sch Publ Hlth, Med Fac Bldg,St Marys Campus,Norfolk Pl, London W2 1PG, England.	majid.ezzati@imperial.ac.uk	Shi, Zumin/A-1093-2009; Rampal, Lekhraj/G-6117-2010; wang, YA XING/K-9671-2016; Colaus, PsyColaus/K-6607-2013; Chen, Chien-Jen/N-4723-2019; Castetbon, Katia/F-2686-2017; Lim, Stephen S/B-4055-2012; Danaei, Goodarz/B-6085-2008; Rampal, Sanjay/B-9691-2010; Cífková, Renata/O-5731-2017; Bovet, Pascal/F-4477-2011; Söderberg, Stefan/AAG-3881-2019; Castellano, Maurizio/C-1096-2011; Ali, Mohammed K/N-9833-2013; Miranda, J. Jaime/A-8482-2008; Bjerregaard, Peter/ABD-8894-2020; Lu, Yuan/D-4941-2015	Shi, Zumin/0000-0002-3099-3299; wang, YA XING/0000-0003-2749-7793; Rampal, Sanjay/0000-0002-0105-6407; Cífková, Renata/0000-0003-2765-3821; Bovet, Pascal/0000-0002-0242-4259; Söderberg, Stefan/0000-0001-9225-1306; Castellano, Maurizio/0000-0002-4569-2659; Miranda, J. Jaime/0000-0002-4738-5468; Bjerregaard, Peter/0000-0001-7153-8447; LIN, HSIEN-HO/0000-0002-7481-6016; Lin, John/0000-0003-2490-4453; Khang, Young-Ho/0000-0002-9585-8266; Woodward, Mark/0000-0001-9800-5296; Fall, Caroline/0000-0003-4402-5552; Ali, Mohammed/0000-0001-7266-2503; Lu, Yuan/0000-0001-5264-2169; Farzadfar, Farshad/0000-0001-8288-4046	Bill & Melinda Gates Foundation; WHO; MRC [MC_UP_A620_1016] Funding Source: UKRI; Medical Research Council [G0801056B, MC_UP_A620_1016] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); WHO(World Health Organization); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Bill & Melinda Gates Foundation and WHO.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Abubakari AR, 2009, PUBLIC HEALTH, V123, P602, DOI 10.1016/j.puhe.2009.07.009; Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Amos AF, 1997, DIABETIC MED, V14, pS7, DOI 10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO;2-I; [Anonymous], 1999, Diabetologia, V42, P647; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Berger B, 1999, DIABETES CARE, V22, P773, DOI 10.2337/diacare.22.5.773; Bjorkelund C, 2008, SCAND J PRIM HEALTH, V26, P140, DOI 10.1080/02813430802088403; Borch-Johnsen K, 1999, LANCET, V354, P617; Bovet P, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-34; Carstensen B, 2008, ANN CLIN BIOCHEM, V45, P140, DOI 10.1258/acb.2007.006212; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; Danaei Goodarz, 2009, Popul Health Metr, V7, P16, DOI 10.1186/1478-7954-7-16; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; Engelgau MM, 1997, DIABETES CARE, V20, P785, DOI 10.2337/diacare.20.5.785; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gakidou E, 2011, B WORLD HEALTH ORGAN, V89, P172, DOI 10.2471/BLT.10.080820; Gatling W, 1998, DIABETIC MED, V15, P1015, DOI 10.1002/(SICI)1096-9136(1998120)15:12<1015::AID-DIA719>3.0.CO;2-K; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gerstein HC, 1997, DIABETIC MED, V14, pS25, DOI 10.1002/(SICI)1096-9136(199708)14:3+<S25::AID-DIA441>3.3.CO;2-T; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; Lawes CMM, 2004, DIABETES CARE, V27, P2836; Lusignan Simon, 2005, BMC Fam Pract, V6, P13, DOI 10.1186/1471-2296-6-13; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; MCCANCE DR, 1994, BRIT MED J, V308, P1323, DOI 10.1136/bmj.308.6940.1323; Nagata M, 2010, NEPHROL DIAL TRANSPL, V25, P2557, DOI 10.1093/ndt/gfq062; Nakagami T, 2004, DIABETOLOGIA, V47, P385, DOI 10.1007/s00125-004-1334-6; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Sacks DB, 2002, CLIN CHEM, V48, P436; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Skyler JS, 2009, CIRCULATION, V119, P351, DOI 10.1161/CIRCULATIONAHA.108.191305; Venketasubramanian N, 1998, INT J EPIDEMIOL, V27, P15, DOI 10.1093/ije/27.1.15; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	43	2525	2614	4	444	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2011	378	9785					31	40		10.1016/S0140-6736(11)60679-X	http://dx.doi.org/10.1016/S0140-6736(11)60679-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791IU	21705069				2022-12-28	WOS:000292659700031
J	Heymsfield, AJ; Thompson, G; Morrison, H; Bansemer, A; Rasmussen, RM; Minnis, P; Wang, ZE; Zhang, DM				Heymsfield, Andrew J.; Thompson, Gregory; Morrison, Hugh; Bansemer, Aaron; Rasmussen, Roy M.; Minnis, Patrick; Wang, Zhien; Zhang, Damao			Formation and Spread of Aircraft-Induced Holes in Clouds	SCIENCE			English	Article							ICE PARTICLES	Hole-punch and canal clouds have been observed for more than 50 years, but the mechanisms of formation, development, duration, and thus the extent of their effect have largely been ignored. The holes have been associated with inadvertent seeding of clouds with ice particles generated by aircraft, produced through spontaneous freezing of cloud droplets in air cooled as it flows around aircraft propeller tips or over jet aircraft wings. Model simulations indicate that the growth of the ice particles can induce vertical motions with a duration of 1 hour or more, a process that expands the holes and canals in clouds. Global effects are minimal, but regionally near major airports, additional precipitation can be induced.	[Heymsfield, Andrew J.; Thompson, Gregory; Morrison, Hugh; Bansemer, Aaron; Rasmussen, Roy M.] NCAR, Boulder, CO 80301 USA; [Minnis, Patrick] NASA Langley Res Ctr, Hampton, VA 23681 USA; [Wang, Zhien; Zhang, Damao] Univ Wyoming, Dept Atmospher Sci, Laramie, WY 82071 USA	National Center Atmospheric Research (NCAR) - USA; National Aeronautics & Space Administration (NASA); NASA Langley Research Center; University of Wyoming	Heymsfield, AJ (corresponding author), NCAR, Boulder, CO 80301 USA.	heyms1@ncar.ucar.edu	Heymsfield, Andrew J/E-7340-2011; zhang, damao/A-2900-2016; Wang, Zhien/F-4857-2011; Minnis, Patrick/G-1902-2010; Wang, Zhien/AAN-2341-2020; Wang, Zhien/AAB-1528-2021	Heymsfield, Andrew J/0000-0003-4107-7533; zhang, damao/0000-0002-3518-292X; Wang, Zhien/0000-0003-3871-3834; Minnis, Patrick/0000-0002-4733-6148; Bansemer, Aaron/0000-0002-3714-1099	National Center for Atmospheric Research through NSF; National Center for Atmospheric Research through NASA [NNX07AQ85G, NNX10AN18G]; National Center for Atmospheric Research through FAA Aviation Climate Change Research Initiative	National Center for Atmospheric Research through NSF; National Center for Atmospheric Research through NASA; National Center for Atmospheric Research through FAA Aviation Climate Change Research Initiative	The authors wish to thank contributors to the data used in this study: N. Mirsky, N. Downs, E. Zrubek, M. Carmody, B. Skamarock, J. Tuttle, P. Kennedy, C. Velden, D. Spangenberg, and J. Robaidek. Editing by M. Miller and graphics with particular help from A. Norton, co-developer of VAPOR software, are greatly appreciated. This research was supported by the National Center for Atmospheric Research through NSF, through NASA from grants NNX07AQ85G and NNX10AN18G, and through the FAA Aviation Climate Change Research Initiative.	Appleman H., 1953, B AM METEOROL SOC, V34, P14, DOI [10.1175/1520-0477-34.1.14, DOI 10.1175/1520-0477-34.1.14]; Gierens K, 2009, J ATMOS SCI, V66, P217, DOI 10.1175/2008JAS2767.1; Heymsfield AJ, 2010, B AM METEOROL SOC, V91, P753, DOI 10.1175/2009BAMS2905.1; RANGNO AL, 1984, J CLIM APPL METEOROL, V23, P985, DOI 10.1175/1520-0450(1984)023<0985:FOOTPO>2.0.CO;2; RANGNO AL, 1983, J CLIM APPL METEOROL, V22, P214, DOI 10.1175/1520-0450(1983)022<0214:POIPIC>2.0.CO;2; Schumacher V. C., 1940, Z ANGEW METEOR, V57, P214; SEKHON RS, 1970, J ATMOS SCI, V27, P299, DOI 10.1175/1520-0469(1970)027<0299:SSSARR>2.0.CO;2; Skamarock WC, 2008, J COMPUT PHYS, V227, P3465, DOI 10.1016/j.jcp.2007.01.037; Thompson G, 2008, MON WEATHER REV, V136, P5095, DOI 10.1175/2008MWR2387.1; Woodley WL, 2003, J APPL METEOROL, V42, P640, DOI 10.1175/1520-0450(2003)042<0640:AIPAAR>2.0.CO;2; Zhang DM, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012143; 1968, WEATHERWISE, V21, P1; 1948, WEATHER, V3, P232	13	35	36	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					77	81		10.1126/science.1202851	http://dx.doi.org/10.1126/science.1202851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719676				2022-12-28	WOS:000292255400052
J	Tkalec, U; Ravnik, M; Copar, S; Zumer, S; Musevic, I				Tkalec, Uros; Ravnik, Miha; Copar, Simon; Zumer, Slobodan; Musevic, Igor			Reconfigurable Knots and Links in Chiral Nematic Colloids	SCIENCE			English	Article							CRYSTALS; DEFECTS; PHYSICS	Tying knots and linking microscopic loops of polymers, macromolecules, or defect lines in complex materials is a challenging task for material scientists. We demonstrate the knotting of microscopic topological defect lines in chiral nematic liquid-crystal colloids into knots and links of arbitrary complexity by using laser tweezers as a micromanipulation tool. All knots and links with up to six crossings, including the Hopf link, the Star of David, and the Borromean rings, are demonstrated, stabilizing colloidal particles into an unusual soft matter. The knots in chiral nematic colloids are classified by the quantized self-linking number, a direct measure of the geometric, or Berry's, phase. Forming arbitrary microscopic knots and links in chiral nematic colloids is a demonstration of how relevant the topology can be for the material engineering of soft matter.	[Tkalec, Uros; Zumer, Slobodan; Musevic, Igor] Jozef Stefan Inst, Dept Condensed Matter Phys, Ljubljana 1000, Slovenia; [Ravnik, Miha] Univ Oxford, Rudolf Peierls Ctr Theoret Phys, Oxford OX1 3NP, England; [Ravnik, Miha; Copar, Simon; Zumer, Slobodan; Musevic, Igor] Univ Ljubljana, Fac Math & Phys, Ljubljana 1000, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Oxford; University of Ljubljana	Tkalec, U (corresponding author), Max Planck Inst Dynam & Self Org, Bunsenstr 10, D-37073 Gottingen, Germany.	uros.tkalec@ijs.si; igor.musevic@ijs.si	Ravnik, Miha/F-3616-2011; Tkalec, Uroš/C-6386-2011; Tkalec, Uroš/GQI-1394-2022; Zumer, Slobodan/K-2840-2018	Ravnik, Miha/0000-0001-8883-9318; Tkalec, Uroš/0000-0003-0552-0518; Zumer, Slobodan/0000-0003-4872-9530	Slovenian Research Agency [P1-0099, PR-00182, J1-9728]; NAMASTE Center of Excellence; European Commission (EC)	Slovenian Research Agency(Slovenian Research Agency - Slovenia); NAMASTE Center of Excellence; European Commission (EC)(European CommissionEuropean Commission Joint Research Centre)	U. T. thanks S. Herminghaus, S. Kralj, and S. Vrtnik for discussions and kindly acknowledges support of the Max Planck Society. M. R. acknowledges support of the European Commission (EC) under the Marie Curie Program Active Liquid Crystal Colloids (ACTOIDS); content reflects only the authors' views and not the views of the EC. The research was funded by Slovenian Research Agency under the contracts P1-0099, PR-00182, and J1-9728 and in part by the NAMASTE Center of Excellence.	Adams C., 2004, KNOT BOOK; Araki T, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.127801; Bates A. D., 2005, DNA TOPOLOGY; BOULIGAND Y, 1974, J PHYS-PARIS, V35, P215, DOI 10.1051/jphys:01974003503021500; Cha J. C., 2011, KNOTINFO TABLE KNOT; Chichak KS, 2004, SCIENCE, V304, P1308, DOI 10.1126/science.1096914; Copar S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.177801; de Gennes P. G., 1993, PHYS LIQUID CRYSTALS; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Dennis MR, 2010, NAT PHYS, V6, P118, DOI 10.1038/NPHYS1504; Faddeev L, 1997, NATURE, V387, P58, DOI 10.1038/387058a0; Fukuda J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1250; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; Han DR, 2010, NAT NANOTECHNOL, V5, P712, DOI 10.1038/nnano.2010.193; Irwine W. T. M., 2008, NAT PHYS, V4, P716; Kauffman L. H., 2000, KNOTS PHYS, V3rd; Meluzzi D, 2010, ANNU REV BIOPHYS, V39, P349, DOI 10.1146/annurev.biophys.093008.131412; MERMIN ND, 1979, REV MOD PHYS, V51, P591, DOI 10.1103/RevModPhys.51.591; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; Musevic I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.187801; Musevic I, 2006, SCIENCE, V313, P954, DOI 10.1126/science.1129660; Nelson DR, 2004, NATURE, V430, P839, DOI 10.1038/430839a; Poulin P, 1997, SCIENCE, V275, P1770, DOI 10.1126/science.275.5307.1770; Prasolov V., 1997, KNOTS LINKS BRAIDS 3; Ravnik M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.247801; Raymer DM, 2007, P NATL ACAD SCI USA, V104, P16432, DOI 10.1073/pnas.0611320104; Sauvage, 1999, MOL CATENANES ROTAXA; Sharein R. G., 1998, THESIS U BRIT COLUMB; Stark H, 2001, PHYS REP, V351, P387, DOI 10.1016/S0370-1573(00)00144-7; WHITE JH, 1969, AM J MATH, V91, P693, DOI 10.2307/2373348; Wilczek F., 1988, GEOMETRIC PHASES PHY; Yada M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.185501	32	322	322	4	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					62	65		10.1126/science.1205705	http://dx.doi.org/10.1126/science.1205705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719671	Green Submitted			2022-12-28	WOS:000292255400047
J	Bonfoh, B; Raso, G; Kone, I; Dao, D; Girardin, O; Cisse, G; Zinsstag, J; Utzinger, J; Tanner, M				Bonfoh, Bassirou; Raso, Giovanna; Kone, Inza; Dao, Daouda; Girardin, Olivier; Cisse, Gualadio; Zinsstag, Jakob; Utzinger, Juerg; Tanner, Marcel			Research in a war zone	NATURE			English	Editorial Material							ARMED CONFLICT		[Bonfoh, Bassirou; Raso, Giovanna; Kone, Inza; Dao, Daouda] CSRS, Abidjan, Cote Ivoire; [Girardin, Olivier] Fondat Rurale Interjurassienne, Courtemelon, Switzerland; [Cisse, Gualadio; Zinsstag, Jakob; Utzinger, Juerg; Tanner, Marcel] Swiss Trop & Publ Hlth Inst, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute	Bonfoh, B (corresponding author), CSRS, Abidjan, Cote Ivoire.	bassirou.bonfoh@csrs.ci; marcel.tanner@unibas.ch	Cissé, Guéladio/U-7235-2018; Zinsstag, Jakob/A-8317-2008	Cissé, Guéladio/0000-0002-6286-976X; Zinsstag, Jakob/0000-0002-8899-6097; Kone, Inza/0000-0002-2940-2439				Betsi NA, 2006, AIDS CARE, V18, P356, DOI 10.1080/09540120500200856; Furst T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000513; Keiser J, 2010, CLIN INFECT DIS, V50, P1205, DOI 10.1086/651682; KFPE, 1998, GUID RES PARTN DEV C; Ouattara K, 2009, P NATL ACAD SCI USA, V106, P22026, DOI 10.1073/pnas.0908118106; TANNER M, 1994, ACTA TROP, V57, P153, DOI 10.1016/0001-706X(94)90006-X	6	40	41	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2011	474	7353					569	571		10.1038/474569a	http://dx.doi.org/10.1038/474569a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	785CF	21720345				2022-12-28	WOS:000292204300014
J	Frankel, N; Erezyilmaz, DF; McGregor, AP; Wang, S; Payre, F; Stern, DL				Frankel, Nicolas; Erezyilmaz, Deniz F.; McGregor, Alistair P.; Wang, Shu; Payre, Francois; Stern, David L.			Morphological evolution caused by many subtle-effect substitutions in regulatory DNA	NATURE			English	Article							DROSOPHILA-SECHELLIA; ADAPTIVE EVOLUTION; NATURAL-SELECTION; GENE; PERSPECTIVE; DIVERGENCE; UNDERLIES; EPISTASIS; SEQUENCE; ORIGIN	Morphology evolves often through changes in developmental genes, but the causal mutations, and their effects, remain largely unknown. The evolution of naked cuticle on larvae of Drosophila sechellia resulted from changes in five transcriptional enhancers of shavenbaby (svb), a transcript of the ovo locus that encodes a transcription factor that governs morphogenesis of microtrichiae, hereafter called 'trichomes'. Here we show that the function of one of these enhancers evolved through multiple single-nucleotide substitutions that altered both the timing and level of svb expression. The consequences of these nucleotide substitutions on larval morphology were quantified with a novel functional assay. We found that each substitution had a relatively small phenotypic effect, and that many nucleotide changes account for this large morphological difference. In addition, we observed that the substitutions had non-additive effects. These data provide unprecedented resolution of the phenotypic effects of substitutions and show how individual nucleotide changes in a transcriptional enhancer have caused morphological evolution.	[Frankel, Nicolas; Erezyilmaz, Deniz F.; Wang, Shu; Stern, David L.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Frankel, Nicolas; Erezyilmaz, Deniz F.; Wang, Shu; Stern, David L.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [McGregor, Alistair P.] Vet Med Univ Wien, Inst Populat Genet, A-1210 Vienna, Austria; [Payre, Francois] Univ Toulouse, F-31062 Toulouse, France; [Payre, Francois] Ctr Dev Biol, Ctr Natl Rech Sci, UMR5547, F-31062 Toulouse, France	Howard Hughes Medical Institute; Princeton University; Princeton University; University of Veterinary Medicine Vienna; Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Stern, DL (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA.	dstern@princeton.edu		PAYRE, Francois/0000-0002-8144-6711; Stern, David/0000-0002-1847-6483; McGregor, Alistair/0000-0002-2908-2420	Pew Charitable Trusts; Ruth L. Kirschstein National Research Service Award [F32 GM 83546-02]; Agence Nationale de la Recherche; NIH [GM063622-06A1]; NSF [IOS-0640339]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM083546, R01GM063622] Funding Source: NIH RePORTER	Pew Charitable Trusts; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Davis, P. Parikh and P. Valenti for assistance with cloning and the Drosophila Species Stock Center for fly stocks. This work was supported by the Pew Charitable Trusts Latin American Fellows Program in the Biomedical Sciences Fellowship to N.F., a Ruth L. Kirschstein National Research Service Award to D. F. E. (F32 GM 83546-02), Agence Nationale de la Recherche (Blanc 2008, Netoshape) to F. P., and NIH (GM063622-06A1) and NSF (IOS-0640339) grants to D.L.S.	Akam M, 1998, INT J DEV BIOL, V42, P445; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Baines JF, 2002, MOL BIOL EVOL, V19, P989, DOI 10.1093/oxfordjournals.molbev.a004179; Carroll S. B., 2001, DNA DIVERSITY MOL GE; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Casillas S, 2007, MOL BIOL EVOL, V24, P2222, DOI 10.1093/molbev/msm150; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chanut-Delalande H, 2006, PLOS BIOL, V4, P1549, DOI 10.1371/journal.pbio.0040290; Davidson EH, 2006, REG GEN GEN REG; Endo T, 1996, MOL BIOL EVOL, V13, P685, DOI 10.1093/oxfordjournals.molbev.a025629; Erezyilmaz DF, 2006, P NATL ACAD SCI USA, V103, P6925, DOI 10.1073/pnas.0509983103; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gerke J, 2009, SCIENCE, V323, P498, DOI 10.1126/science.1166426; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Haygood R, 2010, P NATL ACAD SCI USA, V107, P7853, DOI 10.1073/pnas.0911249107; HOWARD KR, 1990, DEVELOPMENT, V110, P1223; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Kliman RM, 2000, GENETICS, V156, P1913; Klingler M, 1996, DEV BIOL, V177, P73, DOI 10.1006/dbio.1996.0146; Legrand D, 2009, GENETICS, V182, P1197, DOI 10.1534/genetics.108.092080; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Monterio A, 2009, PLOS BIOL, V7, P209, DOI 10.1371/journal.pbio.1000037; Moses AM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-286; Nadeau NJ, 2010, TRENDS GENET, V26, P484, DOI 10.1016/j.tig.2010.08.004; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Orr HA, 1998, GENETICS, V149, P2099; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; Stern D. L., 2010, EVOLUTION DEV PREDIC; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; Swanson CI, 2010, DEV CELL, V18, P359, DOI 10.1016/j.devcel.2009.12.026; TAJIMA F, 1993, GENETICS, V135, P599; Weinreich DM, 2005, EVOLUTION, V59, P1165; Wilkins A.S., 2002, EVOLUTION DEV PATHWA; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052; Wittkopp PJ, 2006, HEREDITY, V97, P139, DOI 10.1038/sj.hdy.6800869; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896	44	141	142	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					598	603		10.1038/nature10200	http://dx.doi.org/10.1038/nature10200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21720363	Green Submitted, Green Accepted			2022-12-28	WOS:000292204300030
J	Hamann, K; Warneken, F; Greenberg, JR; Tomasello, M				Hamann, Katharina; Warneken, Felix; Greenberg, Julia R.; Tomasello, Michael			Collaboration encourages equal sharing in children but not in chimpanzees	NATURE			English	Article							DISTRIBUTIVE JUSTICE; COOPERATION; FAIRNESS; BEHAVIOR; EQUITY	Humans actively share resources with one another to a much greater degree than do other great apes, and much human sharing is governed by social norms of fairness and equity(1-3). When in receipt of a windfall of resources, human children begin showing tendencies towards equitable distribution with others at five to seven years of age(4-7). Arguably, however, the primordial situation for human sharing of resources is that which follows cooperative activities such as collaborative foraging, when several individuals must share the spoils of their joint efforts(8-10). Here we show that children of around three years of age share with others much more equitably in collaborative activities than they do in either windfall or parallel-work situations. By contrast, one of humans' two nearest primate relatives, chimpanzees (Pan troglodytes), 'share' (make food available to another individual) just as often whether they have collaborated with them or not. This species difference raises the possibility that humans' tendency to distribute resources equitably may have its evolutionary roots in the sharing of spoils after collaborative efforts.	[Hamann, Katharina; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, D-04103 Leipzig, Germany; [Warneken, Felix] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Greenberg, Julia R.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA	Max Planck Society; Harvard University; Michigan State University	Hamann, K (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Deutsch Pl 6, D-04103 Leipzig, Germany.	khamann@eva.mpg.de; warneken@wjh.harvard.edu			EC [215805]	EC(European CommissionEuropean Commission Joint Research Centre)	We thank all the children and day-care centres involved in this work for their cooperation, and we thank J. Dauksch, G. Duden, A. Gampe, I. Gavriliu, L. Hering, C. Markmann, M. Plotner, E. Rossi, A. Schrimpf, C. Weiske and the practical students at the Wolfgang Kohler Primate Research Center, Leipzig, for their help in recruiting children, data collection and behaviour coding. We also thank R. Pieszek and M. Ulrich for building the apparatuses, S. Tupke and M. Sureck for creating the figures, R. Mundry for statistical advice and the zookeepers at Leipzig Zoo for their assistance with the chimpanzees. This work received funding from the EC Seventh Framework Program (FP7/2007-2013) under grant agreement no. 215805.	Almas I, 2010, SCIENCE, V328, P1176, DOI 10.1126/science.1187300; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; Blake PR, 2010, EVOL HUM BEHAV, V31, P210, DOI 10.1016/j.evolhumbehav.2009.06.012; Boehm C, 1997, AM NAT, V150, pS100, DOI 10.1086/286052; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Damon W., 1977, SOCIAL WORLD CHILD; de Waal FBM, 2000, NATURE, V404, P563, DOI 10.1038/35007138; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Gilby IC, 2006, ANIM BEHAV, V71, P953, DOI 10.1016/j.anbehav.2005.09.009; Gummerum M, 2010, J ECON PSYCHOL, V31, P25, DOI 10.1016/j.joep.2009.09.002; Gurven M, 2004, BEHAV BRAIN SCI, V27, P543, DOI 10.1017/S0140525X04000123; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Hill K, 2002, HUM NATURE-INT BIOS, V13, P105, DOI 10.1007/s12110-002-1016-3; Hill K, 2009, EVOL ANTHROPOL, V18, P187, DOI 10.1002/evan.20224; Hirata S, 2007, PRIMATES, V48, P13, DOI 10.1007/s10329-006-0022-1; HOOK JG, 1979, PSYCHOL BULL, V86, P429, DOI 10.1037/0033-2909.86.3.429; Kienbaum J, 2009, EUR J DEV PSYCHOL, V6, P481, DOI 10.1080/17405620701497299; Kurzban R, 2001, PSYCHOL BULL, V127, P187, DOI 10.1037//0033-2909.127.2.187; LERNER MJ, 1974, J PERS SOC PSYCHOL, V29, P539, DOI 10.1037/h0036206; Marlowe FW, 2005, EVOL ANTHROPOL, V14, P54, DOI 10.1002/evan.20046; Melis AP, 2006, ANIM BEHAV, V72, P275, DOI 10.1016/j.anbehav.2005.09.018; Mitani JC, 2001, ANIM BEHAV, V61, P915, DOI 10.1006/anbe.2000.1681; Muller MN, 2005, ADV STUD BEHAV, V35, P275, DOI 10.1016/S0065-3454(05)35007-8; Rochat P, 2009, J CROSS CULT PSYCHOL, V40, P416, DOI 10.1177/0022022109332844; Sterelny K, 2007, PHILOS T R SOC B, V362, P719, DOI 10.1098/rstb.2006.2006; Thompson C, 1997, COGNITIVE DEV, V12, P199, DOI 10.1016/S0885-2014(97)90013-7; Tomasello M, 2009, WHY WE COOPERATE, P1; Warneken F, 2011, PSYCHOL SCI, V22, P267, DOI 10.1177/0956797610395392	30	215	222	2	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2011	476	7360					328	331		10.1038/nature10278	http://dx.doi.org/10.1038/nature10278			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	811JV	21775985				2022-12-28	WOS:000294206500037
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Press repeats journal's hype over acupuncture	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SHAM ACUPUNCTURE					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2011, DAILY MASH      0531; [Anonymous], 2011, DAILY TELEGRAPH 0530; [Anonymous], 2011, DAILY MIRROR    0505; Assefi NP, 2005, ANN INTERN MED, V143, P10, DOI 10.7326/0003-4819-143-1-200507050-00005; Moffet HH, 2009, J ALTERN COMPLEM MED, V15, P213, DOI 10.1089/acm.2008.0356; Paterson C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X572689; Tulder MW VA, 2000, COCHRANE DB SYST REV, V2	7	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 20	2011	343								d4606	10.1136/bmj.d4606	http://dx.doi.org/10.1136/bmj.d4606			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	797ZH	21775397				2022-12-28	WOS:000293168700013
J	McCartney, M				McCartney, Margaret			FROM THE FRONTLINE Doctors should stop supporting unethical screening	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020						0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 20	2011	343								d4592	10.1136/bmj.d4592	http://dx.doi.org/10.1136/bmj.d4592			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	797ZH	21775396				2022-12-28	WOS:000293168700011
J	Smith, BRK; Howlett, D				Smith, B. R. K.; Howlett, D.			A man with back pain	BRITISH MEDICAL JOURNAL			English	Editorial Material							VERTEBRAL OSTEOMYELITIS; DISCITIS		[Smith, B. R. K.; Howlett, D.] E Sussex Hosp Trust, Eastbourne Dist Gen Hosp, Eastbourne BN21 2UD, England		Smith, BRK (corresponding author), E Sussex Hosp Trust, Eastbourne Dist Gen Hosp, Eastbourne BN21 2UD, England.	brksmith@doctors.org.uk						Abou-Raya S, 2006, J INTERN MED, V260, P160, DOI 10.1111/j.1365-2796.2006.01675.x; Carragee EJ, 1997, J BONE JOINT SURG AM, V79A, P874, DOI 10.2106/00004623-199706000-00011; Chew FS, 2001, RADIOLOGY, V218, P211, DOI 10.1148/radiology.218.1.r01ja06211; Conaughty JM, 2006, SPINE, V31, pE830, DOI 10.1097/01.brs.0000241065.19723.13; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Dunbar JAT, 2010, CLIN RADIOL, V65, P974, DOI 10.1016/j.crad.2010.03.015; Eguchi Y, 2011, SPINE, V36, pE198, DOI 10.1097/BRS.0b013e3181d5ff05; Fouquet B, 1996, REV RHUM, V63, P24; Hatton M, 2002, QJM-INT J MED, V95, P189, DOI 10.1093/qjmed/95.3.189; JALLO GI, DISKITIS FOLLOW UP; KOCKJENSEN C, 1988, ACTA NEUROCHIR, V90, P42, DOI 10.1007/BF01541265; Walters R, 2006, EUR SPINE J, V15, P1397, DOI 10.1007/s00586-006-0144-6	12	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 20	2011	343								d4132	10.1136/bmj.d4132	http://dx.doi.org/10.1136/bmj.d4132			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797ZH	21775400				2022-12-28	WOS:000293168700003
J	Taniguchi, K; Maeda, R; Ando, T; Okumura, T; Nakazawa, N; Hatori, R; Nakamura, M; Hozumi, S; Fujiwara, H; Matsuno, K				Taniguchi, Kiichiro; Maeda, Reo; Ando, Tadashi; Okumura, Takashi; Nakazawa, Naotaka; Hatori, Ryo; Nakamura, Mitsutoshi; Hozumi, Shunya; Fujiwara, Hiroo; Matsuno, Kenji			Chirality in Planar Cell Shape Contributes to Left-Right Asymmetric Epithelial Morphogenesis	SCIENCE			English	Article							UNCONVENTIONAL MYOSIN; DROSOPHILA; DETERMINES; POLARITY; CADHERIN; AXIS	Some organs in animals display left-right (LR) asymmetry. To better understand LR asymmetric morphogenesis in Drosophila, we studied LR directional rotation of the hindgut epithelial tube. Hindgut epithelial cells adopt a LR asymmetric (chiral) cell shape within their plane, and we refer to this cell behavior as planar cell-shape chirality (PCC). Drosophila E-cadherin (DE-Cad) is distributed to cell boundaries with LR asymmetry, which is responsible for the PCC formation. Myosin ID switches the LR polarity found in PCC and in DE-Cad distribution, which coincides with the direction of rotation. An in silico simulation showed that PCC is sufficient to induce the directional rotation of this tissue. Thus, the intrinsic chirality of epithelial cells in vivo is an underlying mechanism for LR asymmetric tissue morphogenesis.	[Taniguchi, Kiichiro; Maeda, Reo; Ando, Tadashi; Okumura, Takashi; Nakazawa, Naotaka; Hatori, Ryo; Nakamura, Mitsutoshi; Hozumi, Shunya; Fujiwara, Hiroo; Matsuno, Kenji] Tokyo Univ Sci, Dept Biol Sci & Technol, Chiba 2788510, Japan; [Matsuno, Kenji] Tokyo Univ Sci, Res Inst Sci & Technol, Chiba 2788510, Japan	Tokyo University of Science; Tokyo University of Science	Taniguchi, K (corresponding author), Tokyo Univ Sci, Dept Biol Sci & Technol, 2641 Yamazaki, Chiba 2788510, Japan.	matsuno@rs.noda.tus.ac.jp	Taniguchi, Kiichiro/ACL-8906-2022; Hozumi, Shunya/Q-8610-2019	Taniguchi, Kiichiro/0000-0003-2321-7280; Nakamura, Mitsutoshi/0000-0001-7879-3176; Maeda, Reo/0000-0002-2727-3012; Hatori, Ryo/0000-0003-2224-5802; Nakazawa, Naotaka/0000-0002-8695-4344				CAMPOSORTEGA JA, 1987, EMBRYONIC DEV DROSOP; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Hashimoto M, 2010, NAT CELL BIOL, V12, P170, DOI 10.1038/ncb2020; Hozumi S, 2006, NATURE, V440, P798, DOI 10.1038/nature04625; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Pohl C, 2010, DEV CELL, V19, P402, DOI 10.1016/j.devcel.2010.08.014; Speder P, 2006, NATURE, V440, P803, DOI 10.1038/nature04623; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Xu JS, 2007, P NATL ACAD SCI USA, V104, P9296, DOI 10.1073/pnas.0703153104	11	130	130	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					339	341		10.1126/science.1200940	http://dx.doi.org/10.1126/science.1200940			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764746				2022-12-28	WOS:000292732000042
J	Lind, M; Bounias, I; Olsson, M; Gudbjornsdottir, S; Svensson, AM; Rosengren, A				Lind, Marcus; Bounias, Ioannis; Olsson, Marita; Gudbjornsdottir, Soffia; Svensson, Ann-Marie; Rosengren, Annika			Glycaemic control and incidence of heart failure in 20 985 patients with type 1 diabetes: an observational study	LANCET			English	Article							RISK-FACTORS; DISEASE; PREVALENCE; MORTALITY; REGISTER; SWEDEN; MEN	Background Poor glycaemic control is associated with microvascular and macrovascular complications in type 1 diabetes, but whether glycaemic control is associated with heart failure in such patients is not known. We aimed to assess this association in a large cohort of patients with type 1 diabetes identified from the Swedish national diabetes registry. Methods We identified all patients (aged >= 18 years) with type 1 diabetes and no known heart failure who were registered in the national diabetes registry between January, 1998, and December, 2003. These patients were followed up until hospital admission for heart failure, death, or end of follow-up on Dec 31, 2009. We calculated incidence categorised by glycated haemoglobin A(1c) (HbA(1c)) values, and we assessed the association between patients' characteristics, including HbA(1c), and heart failure. Findings In a cohort of 20 985 patients with mean age of 38.6 years (SD 13.3) at baseline, 635 patients (3%) were admitted to hospital with a primary or secondary diagnosis of heart failure during a median follow-up of 9.0 years (IQR 7.3-11.0), with an incidence of 3.38 events per 1000 patient-years (95% CI 3.12-3.65). Incidence increased monotonically with HbA(1c), with a range of 1.42-5.20 per 1000 patient-years between patients in the lowest (<6.5%) and highest (>= 10.5%) categories of HbA(1c). In a Cox regression analysis, with adjustment for age, sex, duration of diabetes, cardiovascular risk factors, and baseline or intervening acute myocardial infarction and other comorbidities, the hazard ratio for development of heart failure was 3.98 (95% CI 2.23-7.14) in patients with HbA(1c) of 10.5% or higher compared with a reference group of patients with HbA(1c) of less than 6.5%. Risk of heart failure increased with age and duration of diabetes. Other modifiable factors associated with increased risk of heart failure were smoking, high systolic blood pressure, and raised body-mass index. In a subgroup of 18 281 patients (87%) with data for blood lipids, higher HDL cholesterol was associated with lower risk of heart failure, but there was no association with LDL cholesterol. Interpretation The positive association between HbA(1c) and risk of heart failure in fairly young patients with type 1 diabetes indicates a potential for prevention of heart failure with improved glycaemic control.	[Lind, Marcus] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Emergency & Cardiovasc Med, Gothenburg, Sweden; [Lind, Marcus; Bounias, Ioannis] NU Hosp Org, Dept Med, Uddevalla, Sweden; [Olsson, Marita] Chalmers Univ Technol, Dept Math Sci, S-41296 Gothenburg, Sweden; [Gudbjornsdottir, Soffia] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Med, Dept Med, Gothenburg, Sweden; [Svensson, Ann-Marie] Ctr Registers Reg Vastra Gotaland, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; NU Hospital Group; Voestalpine AG; Chalmers University of Technology; Sahlgrenska University Hospital; University of Gothenburg	Lind, M (corresponding author), Uddevalla Cent Hosp, Dept Med, S-45180 Uddevalla, Sweden.	lind.marcus@telia.com	Lind, Marcus/AAI-6733-2021; Lind, Marcus/GRJ-4946-2022		AstzaZeneca; Novo Nordisk Scandinavia; Swedish Heart and Lung Foundation; Swedish Research Council; Abbot Scandinavia	AstzaZeneca; Novo Nordisk Scandinavia(Novo Nordisk); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Abbot Scandinavia	AstzaZeneca, Novo Nordisk Scandinavia, Swedish Heart and Lung Foundation, and Swedish Research Council.; M L has received honoraria or served as consultant for Bayer, Eli Lilly, Novartis, Novo Nordisk Scandinavia, Medtronic Pfizer, and Sanofi-Aventis; and has been a member of an advisory board for Novo Nordisk Scandinavia. ML's institution (NU-Hospital Organisation) has received grants from AstraZeneca and Novo Nordisk Scandinavia related to studies of risk factors and diabetic complications, which were not drug specific, and from Abbot Scandinavia for assessments of continuous glucose monitoring. All other authors declare that they have no conflicts of interest.	Asif M, 2000, P NATL ACAD SCI USA, V97, P2809, DOI 10.1073/pnas.040558497; Avendano GF, 1999, DIABETES, V48, P1443, DOI 10.2337/diabetes.48.7.1443; Bauters C, 2003, CARDIOVASC DIABETOL, V2, DOI 10.1186/1475-2840-2-1; CLELAND JG, 1995, EUR HEART J, V16, P741; Di Cori A, 2007, AM J CARDIOL, V99, P84, DOI 10.1016/j.amjcard.2006.07.063; Eeg-Olofsson K, 2010, DIABETES CARE, V33, P1640, DOI 10.2337/dc10-0398; FRASER GE, 1995, AM J CARDIOL, V75, P141, DOI 10.1016/S0002-9149(00)80063-6; Gul K, 2009, EUR J ECHOCARDIOGR, V10, P841, DOI 10.1093/ejechocard/jep086; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Ingelsson E, 2005, EUR J HEART FAIL, V7, P787, DOI 10.1016/j.ejheart.2004.12.007; Iribarren C, 2001, CIRCULATION, V103, P2668; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nichols GA, 2001, DIABETES CARE, V24, P1614, DOI 10.2337/diacare.24.9.1614; Rosen M, 2000, J INTERN MED, V248, P159, DOI 10.1046/j.1365-2796.2000.00716.x; Schaufelberger M, 2007, EUR HEART J, V28, P212, DOI 10.1093/eurheartj/ehl435; Shafazand M, 2009, EUR HEART J, V30, P671, DOI 10.1093/eurheartj/ehn541; Soedamah-Muthu SS, 2004, DIABETES CARE, V27, P530, DOI 10.2337/diacare.27.2.530; Steine K, 2007, EUR J HEART FAIL, V9, P1044, DOI 10.1016/j.ejheart.2007.07.013; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilhelmsen L, 2001, J INTERN MED, V249, P253, DOI 10.1046/j.1365-2796.2001.00801.x; Yazici D, 2013, ACTA DIABETOL, V50, P155, DOI 10.1007/s00592-010-0235-z	25	180	182	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2011	378	9786					140	146		10.1016/S0140-6736(11)60471-6	http://dx.doi.org/10.1016/S0140-6736(11)60471-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	795CJ	21705065				2022-12-28	WOS:000292948800030
J	Loewenberg, S				Loewenberg, Samuel			Profile Medha Munshi: tailoring diabetes care for older patients	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 9	2011	378	9786					119	119		10.1016/S0140-6736(11)61076-3	http://dx.doi.org/10.1016/S0140-6736(11)61076-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	795CJ	21742165	Bronze			2022-12-28	WOS:000292948800016
J	Cande, SC; Stegman, DR				Cande, Steven C.; Stegman, Dave R.			Indian and African plate motions driven by the push force of the Reunion plume head	NATURE			English	Article							FLOOD BASALTS; MELT PRODUCTION; DECCAN TRAPS; EVOLUTION; OCEAN; CONSTRAINTS; ATLANTIC; RIDGE; AGE; COLLISION	Mantle plumes are thought to play an important part in the Earth's tectonics, yet it has been difficult to isolate the effect that plumes have on plate motions. Here we analyse the plate motions involved in two apparently disparate events-the unusually rapid motion of India between 67 and 52 million years ago and a contemporaneous, transitory slowing of Africa's motion-and show that the events are coupled, with the common element being the position of the Indian and African plates relative to the location of the Reunion plume head. The synchroneity of these events suggests that they were both driven by the force of the Reunion plume head. The recognition of this plume force has substantial tectonic implications: the speed-up and slowdown of India, the possible cessation of convergence between Africa and Eurasia in the Palaeocene epoch and the enigmatic bends of the fracture zones on the Southwest Indian Ridge can all be attributed to the Reunion plume.	[Cande, Steven C.; Stegman, Dave R.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Cande, SC (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	scande@ucsd.edu	Stegman, Dave/F-5794-2010	Stegman, Dave/0000-0001-8012-6145	NSF [ANT-0944345]; Directorate For Geosciences [0944345] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank J. Stock for discussions. R. Gordon and D. Muller made comments on the manuscript. Funding was provided by NSF grant ANT-0944345 (to S.C.C.).	Acton G.D., 1999, INDIAN SUBCONTINENT, V44, P129; [Anonymous], 1999, SED BAS WOR; BARKER PF, 1979, GEOPHYS J ROY ASTR S, V59, P131, DOI 10.1111/j.1365-246X.1979.tb02556.x; BESSE J, 1988, J GEOPHYS RES-SOLID, V93, P11791, DOI 10.1029/JB093iB10p11791; Cande SC, 2010, GEOPHYS J INT, V183, P127, DOI 10.1111/j.1365-246X.2010.04737.x; Capitanio FA, 2009, EARTH PLANET SC LETT, V285, P210, DOI 10.1016/j.epsl.2009.06.019; Chenet AL, 2007, EARTH PLANET SC LETT, V263, P1, DOI 10.1016/j.epsl.2007.07.011; COURTILLOT V, 1986, EARTH PLANET SC LETT, V80, P361, DOI 10.1016/0012-821X(86)90118-4; DERCOURT J, 1986, TECTONOPHYSICS, V123, P241, DOI 10.1016/0040-1951(86)90199-X; Dewey J. F., 1989, ALPINE TECTONICS GEO, V45, P265, DOI DOI 10.1144/GSL.SP.1989.045.01.15; DUNCAN RA, 1991, REV GEOPHYS, V29, P31, DOI 10.1029/90RG02372; Dyment J., 1991, THESIS U L PASTEUR; FORSYTH D, 1975, GEOPHYS J ROY ASTR S, V43, P163, DOI 10.1111/j.1365-246X.1975.tb00631.x; GARZANTI E, 1987, GEODIN ACTA, V1, P297, DOI 10.1080/09853111.1987.11105147; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; HARPER JF, 1990, GEOPHYS J INT, V100, P423, DOI 10.1111/j.1365-246X.1990.tb00695.x; JURDY DM, 1984, J GEOPHYS RES, V89, P9927, DOI 10.1029/JB089iB12p09927; KLOOTWIJK CT, 1992, GEOLOGY, V20, P395, DOI 10.1130/0091-7613(1992)020<0395:AEIACP>2.3.CO;2; LARSON RL, 1991, GEOLOGY, V19, P547, DOI 10.1130/0091-7613(1991)019<0547:LPOEEF>2.3.CO;2; LIVERMORE RA, 1993, EARTH PLANET SC LETT, V117, P475, DOI 10.1016/0012-821X(93)90098-T; MCKENZIE D, 1971, GEOPHYS J ROY ASTR S, V24, P437, DOI 10.1111/j.1365-246X.1971.tb02190.x; McQuarrie N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017992; MOLNAR P, 1975, SCIENCE, V189, P419, DOI 10.1126/science.189.4201.419; Molnar P., 1988, BASIN RES, V1, P23, DOI DOI 10.1111/J.1365-2117.1988.TB00003.X; MORGAN JP, 1995, J GEOPHYS RES-SOL EA, V100, P12753, DOI 10.1029/95JB00041; MORGAN WJ, 1972, AM ASSOC PETR GEOL B, V56, P203; MULLER RD, 1993, GEOLOGY, V21, P275, DOI 10.1130/0091-7613(1993)021<0275:RPMRTT>2.3.CO;2; Nankivell A. P., 1997, THESIS U OXFORD; NORTON IO, 1979, J GEOPHYS RES, V84, P6803, DOI 10.1029/JB084iB12p06803; Pande K, 2002, P INDIAN AS-EARTH, V111, P115, DOI 10.1007/BF02981139; PATRIAT P, 1984, NATURE, V311, P615, DOI 10.1038/311615a0; Raymond C. A., 2000, GEOPHYS MONOGR SER, V121, P359; RICHARDS MA, 1989, SCIENCE, V246, P103, DOI 10.1126/science.246.4926.103; ROYER JY, 1989, J GEOPHYS RES-SOLID, V94, P13755, DOI 10.1029/JB094iB10p13755; ROYER JY, 1988, TECTONOPHYSICS, V155, P235, DOI 10.1016/0040-1951(88)90268-5; Sandwell DT, 1997, J GEOPHYS RES-SOL EA, V102, P10039, DOI 10.1029/96JB03223; SCLATER JG, 1974, GEOL SOC AM BULL, V85, P683, DOI 10.1130/0016-7606(1974)85<683:EOTECI>2.0.CO;2; Sharp WD, 2006, SCIENCE, V313, P1281, DOI 10.1126/science.1128489; Srivastava S. P., 1986, W N ATLANTIC REGION, VM, P379; Steinberger B, 2004, NATURE, V430, P167, DOI 10.1038/nature02660; Tarduno J, 2009, SCIENCE, V324, P50, DOI 10.1126/science.1161256; Tikku AA, 1999, J GEOPHYS RES-SOL EA, V104, P661, DOI 10.1029/1998JB900034; Tiwari VM, 2007, EARTH PLANET SC LETT, V264, P9, DOI 10.1016/j.epsl.2007.08.023; Torsvik TH, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000227; van Hinsbergen DJJ, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008051; VANDAMME D, 1991, REV GEOPHYS, V29, P159, DOI 10.1029/91RG00218; WHITE R, 1989, J GEOPHYS RES-SOLID, V94, P7685, DOI 10.1029/JB094iB06p07685; WHITE RS, 1993, PHILOS T ROY SOC A, V342, P137, DOI 10.1098/rsta.1993.0010; Whittaker JM, 2007, SCIENCE, V318, P83, DOI 10.1126/science.1143769	49	191	199	4	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					47	52		10.1038/nature10174	http://dx.doi.org/10.1038/nature10174			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734702				2022-12-28	WOS:000292461300042
J	Heath, I				Heath, Iona			LIFE AND DEATH Seeming virtuous on chronic diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Coll Gen Practitioners, London, England		Heath, I (corresponding author), Royal Coll Gen Practitioners, London, England.	iona.heath22@yahoo.co.uk							0	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2011	343								d4239	10.1136/bmj.d4239	http://dx.doi.org/10.1136/bmj.d4239			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SD	21734169				2022-12-28	WOS:000292684100009
J	Ourjoumtsev, A; Kubanek, A; Koch, M; Sames, C; Pinkse, PWH; Rempe, G; Murr, K				Ourjoumtsev, A.; Kubanek, A.; Koch, M.; Sames, C.; Pinkse, P. W. H.; Rempe, G.; Murr, K.			Observation of squeezed light from one atom excited with two photons	NATURE			English	Article							JAYNES-CUMMINGS MODEL; RESONANCE FLUORESCENCE; CAVITY; STATES; STATISTICS	Single quantum emitters such as atoms are well known as non-classical light sources with reduced noise in the intensity, capable of producing photons one by one at given times(1). However, the light field emitted by a single atom can exhibit much richer dynamics. A prominent example(2,3) is the predicted ability of a single atom to produce quadrature-squeezed light(4), which has fluctuations of amplitude or phase that are below the shot-noise level. However, such squeezing is much more difficult to observe than the emission of single photons(5). Squeezed beams have been generated using macroscopic and mesoscopic media down to a few tens of atoms(6), but despite experimental efforts(7-9), single-atom squeezing has so far escaped observation. Here we generate squeezed light with a single atom in a high-finesse optical resonator. The strong coupling of the atom to the cavity field induces a genuine quantum mechanical nonlinearity(10), which is several orders of magnitude larger than in typical macroscopic media(11-13). This produces observable quadrature squeezing(14-16), with an excitation beam containing on average only two photons per system lifetime. In sharp contrast to the emission of single photons(17), the squeezed light stems from the quantum coherence of photon pairs emitted from the system(18). The ability of a single atom to induce strong coherent interactions between propagating photons opens up new perspectives for photonic quantum logic with single emitters(19-24).	[Ourjoumtsev, A.; Kubanek, A.; Koch, M.; Sames, C.; Pinkse, P. W. H.; Rempe, G.; Murr, K.] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Ourjoumtsev, A.] Univ Paris 11, CNRS UMR 8501, Lab Charles Fabry, Inst Opt, F-91127 Palaiseau, France	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay	Ourjoumtsev, A (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	alexei.ourjoumtsev@institutoptique.fr; karim.murr@gmail.com	Kubanek, Alexander/AAT-9287-2020; Sames, Christian/A-3015-2013	Kubanek, Alexander/0000-0002-2417-1985; Ourjoumtsev, Alexei/0000-0003-4166-0518	Deutsche Forschungsgemeinschaft (Research Unit) [635]; European Union; Bavarian PhD programme of excellence (QCCC)	Deutsche Forschungsgemeinschaft (Research Unit)(German Research Foundation (DFG)); European Union(European Commission); Bavarian PhD programme of excellence (QCCC)	Support from the Deutsche Forschungsgemeinschaft (Research Unit 635), the European Union (IST project AQUTE, ITN network CCQED) and the Bavarian PhD programme of excellence (QCCC) is acknowledged.	Bishop LS, 2009, NAT PHYS, V5, P105, DOI 10.1038/NPHYS1154; Bozyigit D, 2011, NAT PHYS, V7, P154, DOI [10.1038/nphys1845, 10.1038/NPHYS1845]; CARMICHAEL HJ, 1985, PHYS REV LETT, V55, P2790, DOI 10.1103/PhysRevLett.55.2790; Carmichael HJ, 2008, STAT METHODS QUANTUM; Corney JF, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.023831; Dayan B, 2008, SCIENCE, V319, P1062, DOI 10.1126/science.1152261; Deleglise S, 2008, NATURE, V455, P510, DOI 10.1038/nature07288; Deppe F, 2008, NAT PHYS, V4, P686, DOI 10.1038/nphys1016; Drummond P. D., 2004, QUANTUM SQUEEZING; Foster GT, 2000, PHYS REV LETT, V85, P3149, DOI 10.1103/PhysRevLett.85.3149; Gehr R, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.203602; Gerber S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.183601; GRANGIER P, 2004, NEW J PHYS, V6, P163; GRANGIER P, 2004, NEW J PHYS, V6, P129; Grangier P., 2004, NEW J PHYS, V6, P85; Hoffges JT, 1997, OPT COMMUN, V133, P170, DOI 10.1016/S0030-4018(96)00621-9; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; KIMBLE HJ, 1977, PHYS REV LETT, V39, P691, DOI 10.1103/PhysRevLett.39.691; Kubanek A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.203602; Lambrecht A, 1996, EUROPHYS LETT, V36, P93, DOI 10.1209/epl/i1996-00192-1; MANDEL L, 1982, PHYS REV LETT, V49, P136, DOI 10.1103/PhysRevLett.49.136; McCormick CF, 2007, OPT LETT, V32, P178, DOI 10.1364/OL.32.000178; MEYSTRE P, 1982, PHYS LETT A, V89, P390, DOI 10.1016/0375-9601(82)90330-9; Rebic S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.150503; Schneebeli L, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.033843; Schuster I, 2008, NAT PHYS, V4, P382, DOI 10.1038/nphys940; SHORT R, 1983, PHYS REV LETT, V51, P384, DOI 10.1103/PhysRevLett.51.384; Stobinska M, 2010, OPT COMMUN, V283, P737, DOI 10.1016/j.optcom.2009.10.064; Vahlbruch H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.033602; VARADA GV, 1987, OPT COMMUN, V62, P328, DOI 10.1016/0030-4018(87)90299-9; Vogel W., 2006, QUANTUM OPT, V3rd; WALLS DF, 1981, PHYS REV LETT, V47, P709, DOI 10.1103/PhysRevLett.47.709	33	71	71	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2011	474	7353					623	626		10.1038/nature10170	http://dx.doi.org/10.1038/nature10170			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21720367	Green Submitted			2022-12-28	WOS:000292204300035
J	Hawe, P				Hawe, Penelope			PERSONAL VIEW We should publish the cost of each piece of research	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Calgary, Populat Hlth Intervent Res Ctr, Calgary, AB T2N 4ZE, Canada	University of Calgary	Hawe, P (corresponding author), Univ Calgary, Populat Hlth Intervent Res Ctr, Calgary, AB T2N 4ZE, Canada.	phawe@ucalgary.ca							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 29	2011	342								d4026	10.1136/bmj.d4026	http://dx.doi.org/10.1136/bmj.d4026			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788PZ	21715456	Green Submitted			2022-12-28	WOS:000292458200006
J	Jones, A; Bull, M; Vaidya, B				Jones, Angus; Bull, Matthew; Vaidya, Bijay			PICTURE QUIZ A woman with episodic headaches, sweating, and palpitations	BRITISH MEDICAL JOURNAL			English	Editorial Material							PHEOCHROMOCYTOMA; MANAGEMENT; DIAGNOSIS; THERAPY; TYPE-2		[Jones, Angus; Vaidya, Bijay] Royal Devon & Exeter Hosp, Dept Endocrinol, Exeter EX2 5DW, Devon, England; [Bull, Matthew] Royal Devon & Exeter Hosp, Dept Radiol, Exeter EX2 5DW, Devon, England	University of Exeter; University of Exeter	Vaidya, B (corresponding author), Royal Devon & Exeter Hosp, Dept Endocrinol, Exeter EX2 5DW, Devon, England.	bijay.vaidya@pms.ac.uk	bull, Matthew/AAD-2378-2019; Vaidya, Bijay/AAF-1947-2020	bull, Matthew/0000-0003-3693-0341; Vaidya, Bijay/0000-0002-2223-0494; Jones, Angus/0000-0002-0883-7599	National Institute for Health Research [ACF-2008-23-001] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		[Anonymous], 2007, GUID MAN THYR CANC; Brandi ML, 2001, J CLIN ENDOCR METAB, V86, P5658, DOI 10.1210/jc.86.12.5658; Brauckhoff M, 2004, WORLD J SURG, V28, P1305, DOI 10.1007/s00268-004-7637-4; Fraser WD, 2009, LANCET, V374, P145, DOI 10.1016/S0140-6736(09)60507-9; Frates MC, 2005, RADIOLOGY, V237, P794, DOI 10.1148/radiol.2373050220; Ilias I, 2004, J CLIN ENDOCR METAB, V89, P479, DOI 10.1210/jc.2003-031091; Kaltsas G, 2004, EUR J ENDOCRINOL, V151, P15, DOI 10.1530/eje.0.1510015; Lenders JWM, 2005, LANCET, V366, P665, DOI 10.1016/S0140-6736(05)67139-5; Lenders JWM, 2002, JAMA-J AM MED ASSOC, V287, P1427, DOI 10.1001/jama.287.11.1427; Marini F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-45; Pacak K, 2007, J CLIN ENDOCR METAB, V92, P4069, DOI 10.1210/jc.2007-1720; Rashidghamat Elham, 2010, BMJ, V340, pc1038, DOI 10.1136/bmj.c1038; Sakorafas GH, 2008, ENDOCR-RELAT CANCER, V15, P871, DOI 10.1677/ERC-08-0098; VANHEERDEN JA, 1990, WORLD J SURG, V14, P325, DOI 10.1007/BF01658516; Yeung MJ, 2008, ONCOLOGIST, V13, P105, DOI 10.1634/theoncologist.2007-0212	15	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 29	2011	342								d2977	10.1136/bmj.d2977	http://dx.doi.org/10.1136/bmj.d2977			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788PZ	21715464				2022-12-28	WOS:000292458200001
J	Doran, T; Kontopantelis, E; Valderas, JM; Campbell, S; Roland, M; Salisbury, C; Reeves, D				Doran, Tim; Kontopantelis, Evangelos; Valderas, Jose M.; Campbell, Stephen; Roland, Martin; Salisbury, Chris; Reeves, David			Effect of financial incentives on incentivised and non-incentivised clinical activities: longitudinal analysis of data from the UK Quality and Outcomes Framework	BRITISH MEDICAL JOURNAL			English	Article							PAY-FOR-PERFORMANCE; PRIMARY-CARE; HEALTH-CARE; OF-CARE; ENGLAND; IMPROVE; DISPARITIES; MANAGEMENT; PHYSICIANS; CONTRACT	Objective To investigate whether the incentive scheme for UK general practitioners led them to neglect activities not included in the scheme. Design Longitudinal analysis of achievement rates for 42 activities (23 included in incentive scheme, 19 not included) selected from 428 identified indicators of quality of care. Setting 148 general practices in England (653 500 patients). Main outcome measures Achievement rates projected from trends in the pre-incentive period (2000-1 to 2002-3) and actual rates in the first three years of the scheme (2004-5 to 2006-7). Results Achievement rates improved for most indicators in the pre-incentive period. There were significant increases in the rate of improvement in the first year of the incentive scheme (2004-5) for 22 of the 23 incentivised indicators. Achievement for these indicators reached a plateau after 2004-5, but quality of care in 2006-7 remained higher than that predicted by pre-incentive trends for 14 incentivised indicators. There was no overall effect on the rate of improvement for non-incentivised indicators in the first year of the scheme, but by 2006-7 achievement rates were significantly below those predicted by pre-incentive trends. Conclusions There were substantial improvements in quality for all indicators between 2001 and 2007. Improvements associated with financial incentives seem to have been achieved at the expense of small detrimental effects on aspects of care that were not incentivised.	[Doran, Tim; Kontopantelis, Evangelos; Campbell, Stephen; Reeves, David] Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England; [Valderas, Jose M.] Univ Oxford, NIHR Sch Primary Care Res, Dept Primary Hlth Care, Oxford OX3 7LF, England; [Roland, Martin] Univ Cambridge, Gen Practice & Primary Care Res Unit, Cambridge CB2 0SR, England; [Salisbury, Chris] Univ Bristol, Acad Unit Primary Hlth Care, Bristol BS8 2AA, Avon, England	University of Manchester; University of Oxford; University of Cambridge; University of Bristol	Doran, T (corresponding author), Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England.	tim.doran@manchester.ac.uk	Valderas, Jose M/G-7967-2014; Valderas, Jose M/Y-9814-2019; Kontopantelis, Evangelos/H-2966-2019; Salisbury, Chris/C-6724-2008; Reeves, David/H-6203-2014	Valderas, Jose M/0000-0002-9299-1555; Kontopantelis, Evangelos/0000-0001-6450-5815; Salisbury, Chris/0000-0002-4378-3960; Reeves, David/0000-0001-6377-6859; Campbell, Stephen/0000-0002-2328-4136; Roland, Martin/0000-0002-8533-3060	UK Department of Health; Commonwealth Fund	UK Department of Health; Commonwealth Fund	There was no direct funding for this study, but the National Primary Care Research and Development Centre receives core funding from the UK Department of Health. The views expressed are those of the authors and not necessarily those of the Department of Health. At the time of writing, TD was supported by a grant from the Commonwealth Fund as a Harkness Fellow in Health Care Policy and Practice.	Agency for Healthcare Research and Quality, AHRQ QUAL IND GUID P; Campbell SM, 1999, QUAL HEALTH CARE, V8, P6, DOI 10.1136/qshc.8.1.6; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Checkland K, 2008, SOCIOL HEALTH ILL, V30, P788, DOI 10.1111/j.1467-9566.2008.01081.x; *DEP HLTH, 2001, NAT SERV FRAM DIAB; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Department of Health, 1999, NAT SERV FRAM MENT H; Department of Health, 2004, NAT SERV FRAM REN SE; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Doran T, 2008, NEW ENGL J MED, V359, P274, DOI 10.1056/NEJMsa0800310; *GPRD, 2011, GPRD PRACT PAT POP; Heath I, 2004, BRIT J GEN PRACT, V54, P320; *INF CTR, 2011, ONL GP PRACT RES DAT; Institute for Clinical System Improvement, 2007, HLTH CAR GUID; *JOINT FORM COMM, 2007, BRIT NAT FORM; Lester H, 2006, BRIT J GEN PRACT, V56, P244; Marshall M, 2002, QUALITY INDICATORS G; MARSHALL M, 2004, 16 OECD HLTH PROM PR; McDonald R, 2007, BMJ-BRIT MED J, V334, P1357, DOI 10.1136/bmj.39238.890810.BE; McElduff P, 2004, QUAL SAF HEALTH CARE, V13, P191, DOI 10.1136/qshc.2003.007401; Millett C, 2007, PLOS MED, V4, P1087, DOI 10.1371/journal.pmed.0040191; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; *RAND, 2000, QUAL CAR ASS TOOLS; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; *SCOTT INT GUID NE, 2007, PUBL GUID; Steel N, 2007, BRIT J GEN PRACT, V57, P449; Tsai AC, 2005, AM J MANAG CARE, V11, P478; Vaghela P, 2009, DIABETES CARE, V32, P427, DOI 10.2337/dc08-1999; Winer B.J., 1962, STAT PRINCIPLES EXPT	30	161	162	0	23	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 28	2011	342								d3590	10.1136/bmj.d3590	http://dx.doi.org/10.1136/bmj.d3590			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788PY	21712336	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000292458100002
J	Kyrgidis, A; Tzellos, TG				Kyrgidis, Athanassios; Tzellos, Thrasivoulos-George			Safety and efficacy of zoledronic acid in multiple myeloma	LANCET			English	Letter							OSTEONECROSIS; JAW		[Kyrgidis, Athanassios] Aristotle Univ Thessaloniki, Dept Oral Maxillofacial Surg, Thessaloniki 54630, Greece; [Kyrgidis, Athanassios; Tzellos, Thrasivoulos-George] Aristotle Univ Thessaloniki, Dept Pharmacol, Thessaloniki 54630, Greece	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki	Kyrgidis, A (corresponding author), Aristotle Univ Thessaloniki, Dept Oral Maxillofacial Surg, Thessaloniki 54630, Greece.	kyrgidis@auth.gr		Tzellos, Thrasivoulos/0000-0003-2356-0847				Kyrgidis A, 2010, HIPPOKRATIA, V14, P13; Kyrgidis A, 2010, J CLIN ONCOL, V28, pE145, DOI 10.1200/JCO.2009.27.1809; Morgan GJ, 2010, LANCET, V376, P1989, DOI 10.1016/S0140-6736(10)62051-X; Weitzman R, 2007, CRIT REV ONCOL HEMAT, V62, P148, DOI 10.1016/j.critrevonc.2006.12.005	4	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2011	377	9784					2177	2178		10.1016/S0140-6736(11)60958-6	http://dx.doi.org/10.1016/S0140-6736(11)60958-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	786XI	21704864				2022-12-28	WOS:000292340800024
J	King, TE; Pardo, A; Selman, M				King, Talmadge E., Jr.; Pardo, Annie; Selman, Moises			Idiopathic pulmonary fibrosis	LANCET			English	Article							ALVEOLAR EPITHELIAL-CELLS; ENDOPLASMIC-RETICULUM STRESS; GENE-EXPRESSION PROFILES; PLACEBO-CONTROLLED TRIAL; LUNG FIBROBLASTS; MESENCHYMAL TRANSITION; INTERSTITIAL PNEUMONIA; ACUTE EXACERBATION; ARTERIAL-HYPERTENSION; OXIDATIVE STRESS	Idiopathic pulmonary fibrosis is a devastating, age-related lung disease of unknown cause that has few treatment options. This disease was once thought to be a chronic inflammatory process, but current evidence indicates that the fibrotic response is driven by abnormally activated alveolar epithelial cells (AECs). These cells produce mediators that induce the formation of fibroblast and myofibroblast foci through the proliferation of resident mesenchymal cells, attraction of circulating fibrocytes, and stimulation of the epithelial to mesenchymal transition. The fibroblast and myofibroblast foci secrete excessive amounts of extracellular matrix, mainly collagens, resulting in scarring and destruction of the lung architecture. The mechanisms that link idiopathic pulmonary fibrosis with ageing and aberrant epithelial activation are unknown; evidence suggests that the abnormal recapitulation of developmental pathways and epigenetic changes have a role. In this Seminar, we review recent data on the clinical course, therapeutic options, and underlying mechanisms thought to be involved in the pathogenesis of idiopathic pulmonary fibrosis.	[King, Talmadge E., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Pardo, Annie] Univ Nacl Autonoma Mexico, Fac Sci, Mexico City, DF, Mexico; [Selman, Moises] Inst Nacl Enfermedades Resp, Tlalpan, Mexico	University of California System; University of California San Francisco; Universidad Nacional Autonoma de Mexico	King, TE (corresponding author), Univ Calif San Francisco, Dept Med, 505 Parnassus Ave,Box 0120, San Francisco, CA 94143 USA.	tking@medicine.ucsf.edu	Franzeck, Fabian C/B-5055-2011		InterMune; Actelion; Gilead; ImmuneWorks; Genzyme; NIH	InterMune; Actelion; Gilead(Gilead Sciences); ImmuneWorks; Genzyme(Sanofi-AventisGenzyme Corporation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	TK's institution has received fees for consultancy work or for work on an advisory committee from InterMune, Actelion, Gilead, ImmuneWorks, and Genzyme, and has received grants from the NIH for the IPFnet study.	Alakhras M, 2007, CHEST, V131, P1448, DOI 10.1378/chest.06-2784; Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Andersson-Sjoland A, 2008, INT J BIOCHEM CELL B, V40, P2129, DOI 10.1016/j.biocel.2008.02.012; Armanios M, 2009, ANNU REV GENOM HUM G, V10, P45, DOI 10.1146/annurev-genom-082908-150046; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Bando M, 2008, RESPIROLOGY, V13, P263, DOI 10.1111/j.1440-1843.2007.01217.x; Bogatkevich GS, 2001, J BIOL CHEM, V276, P45184, DOI 10.1074/jbc.M106441200; Boon K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005134; Borensztajn K, 2008, TRENDS MOL MED, V14, P429, DOI 10.1016/j.molmed.2008.08.001; Bouros D, 2002, CHEST, V121, P1278, DOI 10.1378/chest.121.4.1278; Calabrese F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-14; Checa M, 2008, HUM GENET, V124, P465, DOI 10.1007/s00439-008-0571-z; Chen P, 2009, J CELL BIOCHEM, V108, P1233, DOI 10.1002/jcb.22363; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Coon DR, 2006, EXP MOL PATHOL, V80, P119, DOI 10.1016/j.yexmp.2005.12.003; Copley SJ, 2009, RADIOLOGY, V251, P566, DOI 10.1148/radiol.2512081242; Cosgrove GP, 2004, AM J RESP CRIT CARE, V170, P242, DOI 10.1164/rccm.200308-1151OC; Cottin V, 2010, EUR RESPIR J, V35, P105, DOI 10.1183/09031936.00038709; Coward WR, 2009, MOL CELL BIOL, V29, P4325, DOI 10.1128/MCB.01776-08; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Daniels CE, 2010, AM J RESP CRIT CARE, V181, P604, DOI 10.1164/rccm.200906-0964OC; Demedts M, 2005, NEW ENGL J MED, V353, P2229, DOI 10.1056/NEJMoa042976; Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0; Ebina M, 2004, AM J RESP CRIT CARE, V169, P1203, DOI 10.1164/rccm.200308-1111OC; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Fehrenbach H, 1998, CELL MOL BIOL, V44, P1147; Fell CD, 2007, CHEST, V131, P641, DOI 10.1378/chest.07-0057; Flaherty KR, 2004, AM J RESP CRIT CARE, V170, P904, DOI 10.1164/rccm.200402-147OC; Garcia-Alvarez J, 2006, SARCOIDOSIS VASC DIF, V23, P13; Germano D, 2009, AM J RESP CRIT CARE, V179, P939, DOI 10.1164/rccm.200809-1390OC; Ghofrani HA, 2002, LANCET, V360, P895, DOI 10.1016/S0140-6736(02)11024-5; Gilani SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008959; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; Gribbin J, 2009, RESP MED, V103, P927, DOI 10.1016/j.rmed.2008.11.001; Grutters JC, 2005, EUR RESPIR J, V25, P915, DOI 10.1183/09031936.05.00133404; Hamada K, 2007, CHEST, V131, P650, DOI 10.1378/chest.06-1466; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hironaka M, 1999, PATHOL INT, V49, P1060, DOI 10.1046/j.1440-1827.1999.00989.x; Hodgson U, 2006, AM J HUM GENET, V79, P149, DOI 10.1086/504639; Hodgson U, 2002, THORAX, V57, P338, DOI 10.1136/thorax.57.4.338; Imai K, 2005, EUR RESPIR J, V25, P250, DOI 10.1183/09031936.05.00023704; Jayachandran A, 2009, THORAX, V64, P1053, DOI 10.1136/thx.2009.121798; Kawasaki H, 2001, HUM PATHOL, V32, P1043, DOI 10.1053/hupa.2001.28246; Kelly BG, 2002, AM J RESP CRIT CARE, V166, P510, DOI 10.1164/rccm.2103058; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; King TE, 2011, AM J RESP CRIT CARE, V184, P92, DOI 10.1164/rccm.201011-1874OC; King TE, 2009, LANCET, V374, P222, DOI 10.1016/S0140-6736(09)60551-1; Kinnula VL, 2005, AM J RESP CRIT CARE, V172, P417, DOI 10.1164/rccm.200501-017PP; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Koli K, 2006, AM J PATHOL, V169, P61, DOI 10.2353/ajpath.2006.051263; Konishi K, 2009, AM J RESP CRIT CARE, V180, P167, DOI 10.1164/rccm.200810-1596OC; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Kubo H, 2005, CHEST, V128, P1475, DOI 10.1378/chest.128.3.1475; Kulasekaran P, 2009, AM J RESP CELL MOL, V41, P484, DOI 10.1165/rcmb.2008-0447OC; Lancaster LH, 2009, CHEST, V136, P772, DOI 10.1378/chest.08-2776; Lanceta J, 2010, EXP GERONTOL, V45, P269, DOI 10.1016/j.exger.2009.12.009; Larsson O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003220; Lawson WE, 2008, AM J PHYSIOL-LUNG C, V294, pL1119, DOI 10.1152/ajplung.00382.2007; Lee J, 2009, AM J PHYSIOL-LUNG C, V296, pL57, DOI 10.1152/ajplung.90411.2008; Lee JS, 2010, AM J MED, V123, P304, DOI 10.1016/j.amjmed.2009.07.033; Lettieri CJ, 2006, CHEST, V129, P746, DOI 10.1378/chest.129.3.746; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Maher TM, 2010, AM J RESP CRIT CARE, V182, P73, DOI 10.1164/rccm.200905-0674OC; Marmai C, 2011, AM J PHYSIOL-LUNG C, V301, pL71, DOI 10.1152/ajplung.00212.2010; McKeown S, 2009, EUR RESPIR J, V33, P77, DOI 10.1183/09031936.00060708; Mejia M, 2009, CHEST, V136, P10, DOI 10.1378/chest.08-2306; Moeller A, 2009, AM J RESP CRIT CARE, V179, P588, DOI 10.1164/rccm.200810-1534OC; Nadrous HF, 2005, CHEST, V128, P2393, DOI 10.1378/chest.128.4.2393; Nathan SD, 2010, RESP MED, V104, P1035, DOI 10.1016/j.rmed.2010.02.008; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Oshikawa K, 2000, RESP MED, V94, P1085, DOI 10.1053/rmed.2000.0917; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Pulkkinen V, 2010, FASEB J, V24, P1167, DOI 10.1096/fj.09-138545; Queisser MA, 2008, AM J RESP CELL MOL, V39, P337, DOI 10.1165/rcmb.2007-0244OC; Raghu G, 2004, NEW ENGL J MED, V350, P125, DOI 10.1056/NEJMoa030511; Raghu G, 2008, AM J RESP CRIT CARE, V178, P948, DOI 10.1164/rccm.200709-1446OC; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Sanders YY, 2008, AM J RESP CELL MOL, V39, P610, DOI 10.1165/rcmb.2007-0322OC; Savale L, 2009, AM J RESP CRIT CARE, V179, P566, DOI 10.1164/rccm.200809-1398OC; Scotton CJ, 2009, J CLIN INVEST, V119, P2550, DOI 10.1172/JCI33288; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Selman M, 2000, AM J PHYSIOL-LUNG C, V279, pL562, DOI 10.1152/ajplung.2000.279.3.L562; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; Selman M, 2010, SEMIN RESP CRIT CARE, V31, P607, DOI 10.1055/s-0030-1265901; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Silva CIS, 2007, J THORAC IMAG, V22, P221, DOI 10.1097/01.rti.0000213588.52343.13; Silva Denise Rossato, 2008, J. bras. pneumol., V34, P779, DOI 10.1590/S1806-37132008001000005; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; Song JW, 2011, EUR RESPIR J, V37, P356, DOI 10.1183/09031936.00159709; Song JW, 2009, CHEST, V136, P23, DOI 10.1378/chest.08-2572; Stewart GA, 2003, J PATHOL, V199, P488, DOI 10.1002/path.1295; Strieter RM, 2007, J CLIN INVEST, V117, P549, DOI 10.1172/JCI30562; Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132; Tang YW, 2003, J CLIN MICROBIOL, V41, P2633, DOI 10.1128/JCM.41.6.2633-2640.2003; Taniguchi H, 2010, EUR RESPIR J, V35, P821, DOI 10.1183/09031936.00005209; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Thabut G, 2009, ANN INTERN MED, V151, P767, DOI 10.7326/0003-4819-151-11-200912010-00004; Thannickal Victor J, 2006, Proc Am Thorac Soc, V3, P350, DOI 10.1513/pats.200601-001TK; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Tomioka H, 2007, RESPIROLOGY, V12, P700, DOI 10.1111/j.1440-1843.2007.01119.x; Travis W.D., 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Uematsu K, 2001, CANCER RES, V61, P8527; van den Blink B, 2010, PULM PHARMACOL THER, V23, P515, DOI 10.1016/j.pupt.2010.08.001; van Moorsel CHM, 2010, AM J RESP CRIT CARE, V182, P1419, DOI 10.1164/rccm.200906-0953OC; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Waghray M, 2005, FASEB J, V19, P854, DOI 10.1096/fj.04-2882fje; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Walters DM, 2008, ANTIOXID REDOX SIGN, V10, P321, DOI 10.1089/ars.2007.1901; Wang DC, 2010, MOL THER, V18, P625, DOI 10.1038/mt.2009.317; Wang RG, 1999, AM J PHYSIOL-LUNG C, V277, pL1158, DOI 10.1152/ajplung.1999.277.6.L1158; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Wang Y, 2009, AM J HUM GENET, V84, P52, DOI 10.1016/j.ajhg.2008.11.010; Weiss Daniel J, 2008, Proc Am Thorac Soc, V5, P637, DOI 10.1513/pats.200804-037DW; White ES, 2006, AM J RESP CRIT CARE, V173, P112, DOI 10.1164/rccm.200507-1058OC; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; Williams K, 2004, CHEST, V125, P2278, DOI 10.1378/chest.125.6.2278; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wootton SC, 2011, AM J RESP CRIT CARE, V183, P1698, DOI 10.1164/rccm.201010-1752OC; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Zhang YZ, 2011, NEW ENGL J MED, V364, P1576, DOI 10.1056/NEJMc1013504; Zisman DA, 2010, NEW ENGL J MED, V363, P620, DOI 10.1056/NEJMoa1002110; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	143	1252	1314	11	263	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2011	378	9807					1949	1961		10.1016/S0140-6736(11)60052-4	http://dx.doi.org/10.1016/S0140-6736(11)60052-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863AW	21719092				2022-12-28	WOS:000298136200029
J	Sparrow, B; Liu, J; Wegner, DM				Sparrow, Betsy; Liu, Jenny; Wegner, Daniel M.			Google Effects on Memory: Cognitive Consequences of Having Information at Our Fingertips	SCIENCE			English	Article							TRANSACTIVE MEMORY; WORDS	The advent of the Internet, with sophisticated algorithmic search engines, has made accessing information as easy as lifting a finger. No longer do we have to make costly efforts to find the things we want. We can "Google" the old classmate, find articles online, or look up the actor who was on the tip of our tongue. The results of four studies suggest that when faced with difficult questions, people are primed to think about computers and that when people expect to have future access to information, they have lower rates of recall of the information itself and enhanced recall instead for where to access it. The Internet has become a primary form of external or transactive memory, where information is stored collectively outside ourselves.	[Sparrow, Betsy] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Liu, Jenny] Univ Wisconsin Madison, Dept Psychol, Madison, WI 53706 USA; [Wegner, Daniel M.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Columbia University; University of Wisconsin System; University of Wisconsin Madison; Harvard University	Sparrow, B (corresponding author), Columbia Univ, Dept Psychol, 1190 Amsterdam Ave, New York, NY 10027 USA.	sparrow@psych.columbia.edu	Allstetter, William/AAP-9850-2021		Columbia University; NSF [BNS-0841746]	Columbia University; NSF(National Science Foundation (NSF))	We acknowledge the financial support of Columbia University to B.S. and NSF grant BNS-0841746 to D.M.W. Raw data are available from B.S.	[Anonymous], 2004, REALITY RES CHILDREN; Bjork R.A., 1972, CODING PROCESS HUM, P217; Carr N, 2008, ATLANTIC, V302, P56; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; HYDE TS, 1969, J EXP PSYCHOL, V82, P472, DOI 10.1037/h0028372; Peltokorpi V, 2008, REV GEN PSYCHOL, V12, P378, DOI 10.1037/1089-2680.12.4.378; Wegner DM, 1995, SOC COGNITION, V13, P319, DOI 10.1521/soco.1995.13.3.319; Wegner DM, 1986, THEORIES GROUP BEHAV, P185, DOI DOI 10.1007/978-1-4612-4634-3_9	8	490	517	22	437	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					776	778		10.1126/science.1207745	http://dx.doi.org/10.1126/science.1207745			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21764755				2022-12-28	WOS:000293512100049
J	Dolmans, GH; Werker, PM; Hennies, HC; Furniss, D; Festen, EA; Franke, L; Becker, K; van der Vlies, P; Wolffenbuttel, BH; Tinschert, S; Toliat, MR; Nothnagel, M; Franke, A; Klopp, N; Wichmann, HE; Nurnberg, P; Giele, H; Ophoff, RA; Wijmenga, C				Dolmans, Guido H.; Werker, Paul M.; Hennies, Hans C.; Furniss, Dominic; Festen, Eleonora A.; Franke, Lude; Becker, Kerstin; van der Vlies, Pieter; Wolffenbuttel, Bruce H.; Tinschert, Sigrid; Toliat, Mohammad R.; Nothnagel, Michael; Franke, Andre; Klopp, Norman; Wichmann, H-Erich; Nuernberg, Peter; Giele, Henk; Ophoff, Roel A.; Wijmenga, Cisca		Dutch Dupuytren Study Grp; German Dupuytren Study Grp; LifeLines Cohort Study; BSSH-GODD Consortium	Wnt Signaling and Dupuytren's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENETIC SUSCEPTIBILITY; CONTRACTURE; CATENIN; ASSOCIATION; VARIANTS	BACKGROUND Dupuytren's disease is a benign fibromatosis of the hands and fingers that leads to flexion contractures. We hypothesized that multiple genetic and environmental factors influence susceptibility to this disease and sought to identify susceptibility genes to better understand its pathogenesis. METHODS We conducted a genomewide association study of 960 Dutch persons with Dupuytren's disease and 3117 controls (the discovery set) to test for association between the disease and genetic markers. We tested the 35 single-nucleotide polymorphisms (SNPs) most strongly associated with Dupuytren's disease (P< 1x10-4) in the discovery set in three additional, independent case series comprising a total of 1365 affected persons and 8445 controls from Germany, the United Kingdom, and the Netherlands. RESULTS Initially, we observed a significant genomewide association between Dupuytren's disease and 8 SNPs at three loci. Tests of replication and joint analysis of all data from 2325 patients with Dupuytren's disease and 11,562 controls yielded an association with 11 SNPs from nine different loci (P< 5.0x10(-8)). Six of these loci contain genes known to be involved in the Wnt-signaling pathway: WNT4 (rs7524102) (P = 2.8x10(-9); odds ratio, 1.28), SFRP4 (rs16879765) (P = 5.6x10-39; odds ratio, 1.98), WNT2 (rs4730775) (P = 3.0x10(-8); odds ratio, 0.83), RSPO2 (rs611744) (P = 7.9x10(-15); odds ratio, 0.75), SULF1 (rs2912522) (P = 2.0x10(-13); odds ratio, 0.72), and WNT7B (rs6519955) (P = 3.2x10(-33); odds ratio, 1.54). CONCLUSIONS This study implicates nine different loci involved in genetic susceptibility to Dupuytren's disease. The fact that six of these nine loci harbor genes encoding proteins in the Wnt-signaling pathway suggests that aberrations in this pathway are key to the process of fibromatosis in Dupuytren's disease.	[Dolmans, Guido H.; Festen, Eleonora A.; Franke, Lude; van der Vlies, Pieter; Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Dolmans, Guido H.; Werker, Paul M.] Univ Med Ctr Groningen, Dept Plast Surg, NL-9700 RB Groningen, Netherlands; [Festen, Eleonora A.] Univ Med Ctr Groningen, Dept Gastroenterol, NL-9700 RB Groningen, Netherlands; [Wolffenbuttel, Bruce H.] Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 RB Groningen, Netherlands; Univ Groningen, Groningen, Netherlands; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Hennies, Hans C.; Becker, Kerstin; Toliat, Mohammad R.; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Div Dermatogenet, Cologne, Germany; [Hennies, Hans C.; Nuernberg, Peter] Univ Cologne, Ctr Mol Med, Cologne, Germany; [Tinschert, Sigrid] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Clin Genet, D-8027 Dresden, Germany; [Nothnagel, Michael] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Klopp, Norman; Wichmann, H-Erich] Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Furniss, Dominic; Giele, Henk] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Furniss, Dominic; Giele, Henk] John Radcliffe Hosp, Dept Plast & Reconstruct Surg, Oxford OX3 9DU, England; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Cologne; University of Cologne; Technische Universitat Dresden; University of Kiel; University of Kiel; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Oxford; University of Oxford; University of California System; University of California Los Angeles	Wijmenga, C (corresponding author), Univ Med Ctr Groningen, Dept Genet, POB 30001, NL-9700 RB Groningen, Netherlands.	ophoff@ucla.edu; cisca.wijmenga@med.umcg.nl	Wolffenbuttel, Bruce/A-8419-2011; Wichmann, Heinz Erich/AAA-5695-2022; Wijmenga, Cisca/AAE-7719-2019; Furniss, Dominic/AAH-4447-2019; Franke, Lude/P-7036-2016	Wolffenbuttel, Bruce/0000-0001-9262-6921; Wijmenga, Cisca/0000-0002-5635-1614; Nothnagel, Michael/0000-0001-8305-7114; Giele, Henk/0000-0003-2017-5193; Franke, Lude/0000-0002-5159-8802	University Medical Center Groningen; University of Groningen, the Netherlands; German Ministry of Education and Research through the German National Genome Research Network; German Research Foundation Cluster of Excellence Inflammation at Interfaces; Academy of Medical Sciences; Wellcome Trust; Oxford University [MRF/2009/HT/1932]; Netherlands Organization of Scientific Research [NWO 175.010.2007.006]; Dutch government; Ministries of Economic Affairs, Education, Culture and Science, and Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; Helmholtz Center Munich; German Research Center for Environmental Health; Munich Center of Health Sciences; WTCCC [076113, 085475]	University Medical Center Groningen; University of Groningen, the Netherlands(Netherlands Government); German Ministry of Education and Research through the German National Genome Research Network; German Research Foundation Cluster of Excellence Inflammation at Interfaces; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Wellcome Trust(Wellcome TrustEuropean Commission); Oxford University; Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch government; Ministries of Economic Affairs, Education, Culture and Science, and Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; Helmholtz Center Munich(Helmholtz Association); German Research Center for Environmental Health; Munich Center of Health Sciences; WTCCC	Supported by grants from the University Medical Center Groningen and the University of Groningen, the Netherlands, and in part by grants from the German Ministry of Education and Research through the German National Genome Research Network (NGFN-2 and NGFNplus) and the German Research Foundation Cluster of Excellence Inflammation at Interfaces; the Academy of Medical Sciences, Wellcome Trust Starter Grants for Clinical Lecturers, and the Oxford University Medical Research Fund (MRF/2009/HT/1932) (all to Dr. Furniss); data generated by the LifeLines Cohort Study, the KORA research platform, and the Wellcome Trust Case Control Consortium (WTCCC); a grant to the LifeLines Cohort Study from the Netherlands Organization of Scientific Research (NWO 175.010.2007.006); the Dutch government's Economic Structure Enhancing Fund; the Ministries of Economic Affairs, Education, Culture and Science, and Health, Welfare and Sports; the Northern Netherlands Collaboration of Provinces; the Province of Groningen; the Dutch Kidney Foundation; the Dutch Diabetes Research Foundation; the KORA research platform, initiated and financed by the Helmholtz Center Munich and the German Research Center for Environmental Health and supported by the Munich Center of Health Sciences as part of LMUinnovativ; and the WTCCC (awards 076113 and 085475).	Anthony Shawn G, 2008, Hand (N Y), V3, P87, DOI 10.1007/s11552-007-9076-9; Armstrong JR, 2000, J BONE JOINT SURG BR, V82B, P90, DOI 10.1302/0301-620X.82B1.9808; Bayat A, 2003, BRIT J PLAST SURG, V56, P328, DOI 10.1016/S0007-1226(03)00176-0; Bayat A, 2003, PLAST RECONSTR SURG, V111, P2133, DOI 10.1097/01.PRS.0000060531.98180.32; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; Bowley E, 2007, J SURG RES, V138, P141, DOI 10.1016/j.jss.2006.07.026; Burge P, 1999, HAND CLIN, V15, P63; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Degreef I, 2009, SCAND J PLAST RECONS, V43, P36, DOI 10.1080/02844310802489806; Dias JJ, 2006, J HAND SURG-BRIT EUR, V31B, P514, DOI 10.1016/j.jhsb.2006.05.005; Dubois PCA, 2010, NAT GENET, V42, P465, DOI 10.1038/ng0510-465; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Freeman SD, 2008, DEV BIOL, V320, P436, DOI 10.1016/j.ydbio.2008.05.554; Hindocha S, 2006, J HAND SURG-AM, V31A, P204, DOI 10.1016/j.jhsa.2005.09.018; Hindocha Sandip, 2009, Hand (N Y), V4, P256, DOI 10.1007/s11552-008-9160-9; Hu FZ, 2005, CLIN GENET, V68, P424, DOI 10.1111/j.1399-0004.2005.00504.x; Hurst LC, 2009, NEW ENGL J MED, V361, P968, DOI 10.1056/NEJMoa0810866; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Lam WL, 2010, J HAND SURG-EUR VOL, V35E, P312, DOI 10.1177/1753193410362848; Lee LC, 2006, J HAND SURG-AM, V31A, P211, DOI 10.1016/j.jhsa.2005.09.007; LUCK JV, 1959, J BONE JOINT SURG AM, V41, P635, DOI 10.2106/00004623-195941040-00008; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mosakhani N, 2010, MODERN PATHOL, V23, P1544, DOI 10.1038/modpathol.2010.146; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Ross DC, 1999, HAND CLIN, V15, P53; Sahota AP, 2009, EXP CELL RES, V315, P2752, DOI 10.1016/j.yexcr.2009.06.029; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Van Rijssen AL, 2006, J HAND SURG-BRIT EUR, V31B, P498, DOI 10.1016/j.jhsb.2006.03.174	32	140	140	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4					307	317		10.1056/NEJMoa1101029	http://dx.doi.org/10.1056/NEJMoa1101029			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798AJ	21732829	Bronze, Green Published			2022-12-28	WOS:000293172200009
J	Giesen, P; Smits, M; Huibers, L; Grol, R; Wensing, M				Giesen, Paul; Smits, Marleen; Huibers, Linda; Grol, Richard; Wensing, Michel			Quality of After-Hours Primary Care in the Netherlands: A Narrative Review	ANNALS OF INTERNAL MEDICINE			English	Review							OUT-OF-HOURS; RANDOMIZED CONTROLLED-TRIAL; PRIMARY MEDICAL-CARE; GENERAL-PRACTITIONERS; PATIENT SATISFACTION; HOURS SERVICE; TELEPHONE CONSULTATION; GP COOPERATIVES; HEALTH-CARE; EMERGENCY	Many Western countries are seeking an organizational model for after-hours primary care that is safe, efficient, and satisfactory for patients and health care professionals. Around the year 2000, Dutch primary care physicians (PCPs) reorganized their after-hours primary care and shifted from small rotation groups to large-scale PCP cooperatives. This article provides a narrative review of studies on a range of issues about after-hours primary care in the Netherlands, including experiences of health care professionals and patients, patient-safety incidents, adherence to practice guidelines, waiting times, and quality of telephone triage. Physicians expressed high satisfaction with PCP cooperatives; their workload decreased, and job satisfaction increased compared with the situation before the reorganization. In general, patients were also satisfied, but areas for improvement included telephone consultations, patient education, and distance to a pharmacy. A study identified patient-safety incidents in 2.4% of all contacts, of which most did not result in harm to patients. The average adherence to clinical guidelines by physicians was 77%, with lowest adherence scores for prescribing antibiotics and treatment in emergency cases. The average waiting time for home visits was 30 minutes. Seventy percent of patients with life-threatening problems were visited within the time target of 15 minutes. Telephone triage by nurses had positive effects on care efficiency by increasing the proportion of telephone consultations and decreasing the proportion of clinic consultations and home visits. The after-hours primary care system in the Netherlands might set an example for other countries struggling to find a good solution for the problems they encounter with after-hours primary care. Future developments in the Netherlands include integration and extensive collaboration with the accident and emergency departments of hospitals, in which PCPs take care of self-referring patients.	[Giesen, Paul; Smits, Marleen; Huibers, Linda; Grol, Richard; Wensing, Michel] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare IQ Healthcare, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Giesen, P (corresponding author), Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare IQ Healthcare, POB 9101,IQ Healthcare 114, NL-6500 HB Nijmegen, Netherlands.	p.giesen@iq.umcn.nl	Huibers, Linda/A-5974-2016; Wensing, Michel/H-8113-2014; Grol, Richard/C-8523-2013; Giesen, P.H.J./L-4325-2015; Smits, Marleen/I-4555-2015	Huibers, Linda/0000-0002-5048-3026; Wensing, Michel/0000-0001-6569-8137; Smits, Marleen/0000-0001-9073-5382					0	79	79	0	27	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2					108	113		10.7326/0003-4819-155-2-201107190-00006	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-00006			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	793KW	21768584				2022-12-28	WOS:000292822000017
J	Padian, NS; McCoy, SI; Karim, SSA; Hasen, N; Kim, J; Bartos, M; Katabira, E; Bertozzi, SM; Schwartlander, B; Cohen, MS				Padian, Nancy S.; McCoy, Sandra I.; Karim, Salim S. Abdool; Hasen, Nina; Kim, Julia; Bartos, Michael; Katabira, Elly; Bertozzi, Stefano M.; Schwartlaender, Bernhard; Cohen, Myron S.			HIV prevention transformed: the new prevention research agenda	LANCET			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; TO-CHILD TRANSMISSION; ADULT MALE CIRCUMCISION; RURAL SOUTH-AFRICA; ANTIRETROVIRAL THERAPY; SEXUAL-BEHAVIOR; DEVELOPING-COUNTRIES; HUMAN-PAPILLOMAVIRUS; CONTROLLED-TRIAL; RISK BEHAVIOR	We have entered a new era in HIV prevention whereby priorities have expanded from biomedical discovery to include implementation, effectiveness, and the effect of combination prevention at the population level. However, gaps in knowledge and implementation challenges remain. In this Review we analyse trends in the rapidly changing landscape of HIV prevention, and chart a new path for HIV prevention research that focuses on the implementation of effective and efficient combination prevention strategies to turn the tide on the HIV pandemic.	[Padian, Nancy S.; McCoy, Sandra I.] Univ Calif Berkeley, Inst Business & Econ Res, Berkeley, CA 94704 USA; [Padian, Nancy S.] Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94704 USA; [Padian, Nancy S.; Hasen, Nina] US Dept State, Off US Global AIDS Coordinator, Washington, DC 20520 USA; [Bertozzi, Stefano M.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Bertozzi, Stefano M.] Univ Washington, Seattle, WA 98195 USA; [Bertozzi, Stefano M.] INSP, Cuernavaca, Morelos, Mexico; [Karim, Salim S. Abdool] Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, Durban, South Africa; [Karim, Salim S. Abdool] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Kim, Julia] BDP, HIVAIDS Grp, UN Dev Programme, New York, NY USA; [Bartos, Michael; Schwartlaender, Bernhard] UNAIDS, Geneva, Switzerland; [Katabira, Elly] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Cohen, Myron S.] Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC USA; [Cohen, Myron S.] Univ N Carolina, Div Infect Dis, Chapel Hill, NC USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Bill & Melinda Gates Foundation; University of Washington; University of Washington Seattle; University of Kwazulu Natal; Columbia University; UNAIDS; Makerere University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	McCoy, SI (corresponding author), Univ Calif Berkeley, Inst Business & Econ Res, 1918 Univ Ave,Suite 3B, Berkeley, CA 94704 USA.	smccoy@berkeley.edu	Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Safurdeen Abdool/N-5947-2013; Karim, Salim Abdool/P-3117-2019	Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Karim, Salim Abdool/0000-0002-4986-2133; Bertozzi, Stefano M/0000-0002-1723-7085	Division of AIDS at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051794] Funding Source: NIH RePORTER	Division of AIDS at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MSC and SSAK thank the Division of AIDS at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health for their support.	Abbas UL, 2011, CURR OPIN HIV AIDS, V6, P114, DOI 10.1097/COH.0b013e328343ad7e; Angel JB, 2011, AIDS, V25, P731, DOI 10.1097/QAD.0b013e328344cea5; [Anonymous], 2007, MANUAL ESTIMATING NA; [Anonymous], UN ACC SCAL PRIOR HI; Auerbach J, 2009, HEALTH AFFAIR, V28, P1655, DOI 10.1377/hlthaff.28.6.1655; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; *AVAC GLOB ADV HIV, 2011, ONG PREEXP PROPH PRE; Baeten JM, 2010, AIDS, V24, P737, DOI 10.1097/QAD.0b013e32833616e0; BAIRD S, 2010, 18 INT AIDS C VIENN; Baird S, 2010, HEALTH ECON, V19, P55, DOI 10.1002/hec.1569; Barone MA, 2011, JAIDS-J ACQ IMM DEF, V57, pE7, DOI 10.1097/QAI.0b013e3182158967; Bateganya M. H., 2007, COCHRANE DB SYST REV, V17; BENGO JM, 2010, SITUATION ANAL MALE; BITEGA JP, 2011, 18 C RETR OPP INF BO; Branson BM, 2010, JAIDS-J ACQ IMM DEF, V55, pS102, DOI 10.1097/QAI.0b013e3181fbca44; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Cannon P, 2011, CURR OPIN HIV AIDS, V6, P74, DOI 10.1097/COH.0b013e32834122d7; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; *CLINICALTRIALS GO, 2011, THER INT PLUS IMM DE; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; COHEN J, 2010, SCIENCENOW      1123; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; CURRAN K, 2011, 18 C RETR OPP INF BO; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; *DEP HLTH HUM SERV, 2010, M DEL COLL HIV 1 CUR; *DEP HLTH HUM SERV, 2011, CTR HIV AIDS VACC IM; *DEP IND DEV, 2010, HRPC10 TACKL STRUCT; Dobard C., 2011, 18 C RETR OPP INF BO; *FAM HLTH INT, 2011, FHI STAT FEM PREP HI; Ferrari G, 2011, J VIROL, V85, P7029, DOI 10.1128/JVI.00171-11; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Ghys PD, 2010, SEX TRANSM INFECT, V86, pI1, DOI [10.1136/sti.2010.047852, 10.1136/sti.2010.044933]; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; *GOV KEN MIN PUBL, 2010, PROGR REP KEN VOL ME; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Green EC, 2006, AIDS BEHAV, V10, P335, DOI 10.1007/s10461-006-9073-y; Gregson S, 2007, PLOS MED, V4, P545, DOI 10.1371/journal.pmed.0040102; Gregson S, 2010, INT J EPIDEMIOL, V39, P1311, DOI 10.1093/ije/dyq055; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Haberer JE, 2010, AIDS BEHAV, V14, P1340, DOI 10.1007/s10461-010-9799-4; Hallett TB, 2011, SEX TRANSM INFECT, V87, P88, DOI 10.1136/sti.2010.043372; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; *HIV PREV TRIALS N, 2011, HPTN 052 RAND TRIAL; *HIV VACC MICR RES, 2010, ADV SCI TIM FISC CON; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Kagumire R, 2008, CAN MED ASSOC J, V179, P1119, DOI 10.1503/cmaj.081761; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Kim J, 2008, AIDS, V22, pS57, DOI 10.1097/01.aids.0000341777.78876.40; Kim J, 2009, B WORLD HEALTH ORGAN, V87, P824, DOI 10.2471/BLT.08.056580; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kohler H-P, 2010, CONDITIONAL CASH TRA; Koo DJ, 2006, AM J PUBLIC HEALTH, V96, P962, DOI 10.2105/AJPH.2006.089235; LETSELA L, 2009, SOUL CITY I HLTH DEV; Letvin NL, 2009, SCIENCE, V326, P1196, DOI 10.1126/science.1183278; Lurie MN, 2010, AIDS BEHAV, V14, P34, DOI 10.1007/s10461-009-9640-0; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Mahy M, 2010, SEX TRANSM INFECT, V86, pI48, DOI 10.1136/sti.2010.045989; Margolis DM, 2011, AIDS RES HUM RETROV, V27, P347, DOI 10.1089/aid.2011.0017; Mayer KH, 2010, AM J PUBLIC HEALTH, V100, P1867, DOI 10.2105/AJPH.2009.184796; McDaid LM, 2010, CURR OPIN HIV AIDS, V5, P311, DOI 10.1097/COH.0b013e32833a0b86; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; *MEAS DEM HLTH SUR, 2011, HIV AIDS SURV IND DA; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; MEDLIN C, 2008, POTENTIAL APPL CONDI; Mehta SD, 2009, J INFECT DIS, V200, P370, DOI 10.1086/600074; Mehta SD, 2009, AIDS, V23, P1557, DOI 10.1097/QAD.0b013e32832afe95; Merson M, 2008, LANCET, V372, P1805, DOI 10.1016/S0140-6736(08)61752-3; *MICR TRIAL NETW, 2011, MTN003; Mills E, 2008, HIV MED, V9, P332, DOI 10.1111/j.1468-1293.2008.00596.x; MOSES S, 1990, INT J EPIDEMIOL, V19, P693, DOI 10.1093/ije/19.3.693; MOSES S, 1994, SEX TRANSM DIS, V21, P201, DOI 10.1097/00007435-199407000-00004; *NAT I ALL INF DIS, 2011, TREAT HIV INF PEOPL; Novitsky V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010148; Oxman AD, 2010, LANCET, V375, P427, DOI 10.1016/S0140-6736(09)61251-4; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; Padian NS, 2011, JAIDS-J ACQ IMM DEF, V58, pE23, DOI 10.1097/QAI.0b013e318227af37; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; Paintsil E, 2009, CURR OPIN PEDIATR, V21, P94, DOI 10.1097/MOP.0b013e32831ec353; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Patterson K. P. H., 2010, 18 INT AIDS C VIENN, P18; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Peterson Leigh, 2007, PLoS Clin Trials, V2, pe27, DOI 10.1371/journal.pctr.0020027; Pinkerton SD, 2008, JAIDS-J ACQ IMM DEF, V47, P354, DOI 10.1097/QAI.0b013e318160d57e; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Prestage G, 2009, AIDS BEHAV, V13, P645, DOI 10.1007/s10461-009-9527-0; Pretorius C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013646; Pronyk PM, 2008, AIDS, V22, P1659, DOI 10.1097/QAD.0b013e328307a040; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Reynolds HW, 2008, SEX TRANSM INFECT, V84, pII49, DOI 10.1136/sti.2008.030049; Rhodes T, 2010, HARM REDUCTION EVIDE; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rohan LC, 2009, AAPS J, V11, P78, DOI 10.1208/s12248-009-9082-7; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; ROSEN S, 2011, 18 C RETR OPP INF BO; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Siliciano JD, 2010, CURR OPIN HIV AIDS, V5, P491, DOI 10.1097/COH.0b013e32833f206f; Smith K, 2011, CURR OPIN HIV AIDS, V6, P315, DOI 10.1097/COH.0b013e32834788e7; *SO AFR DEV COMM, 2006, EXP THINK TANK M HIV; Sobngwi-Tambekou J, 2009, SEX TRANSM INFECT, V85, P116, DOI 10.1136/sti.2008.032334; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; TENTHANI R, 2010, MALAWI RULES OUT CIR; Thornton RL, 2008, AM ECON REV, V98, P1829, DOI 10.1257/aer.98.5.1829; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; Tsague L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-753; UNAIDS, 2010, GLOB REP REP GLOB AI, P120; *US AG INT DEV, 2011, QUAL IMPR APPR RES P; VERNAZZA P, 2008, B SWISS PHYS    0130; Walensky RP, J ACQUIR IMMUNE DEFI, V56, P26; Wawer MJ, 2011, LANCET, V377, P209, DOI 10.1016/S0140-6736(10)61967-8; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; WHO, 2009, UN ACC SCAL PRIOR HI; WHO, 2022, ANT DRUGS TREAT PREG; *WHO, 2009, RAP ADV US ANT DRUGS; *WHO POP COUNC, 2009, HIV TEST TREATM PREV; *WHO UNICEF INT TA, 2007, GUID GLOB SCAL UP PR; *WORLD BANK, 2010, MAL TANZ RES SHOWS P; World Health Organisation, 2008, TASK SHIFT GLOB REC; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization, 2009, RAP ADV ANT THER HIV; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	136	197	199	0	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2011	378	9787					269	278		10.1016/S0140-6736(11)60877-5	http://dx.doi.org/10.1016/S0140-6736(11)60877-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798JD	21763938	Green Submitted, Green Accepted			2022-12-28	WOS:000293201100034
J	Li, HJ; Haurigot, V; Doyon, Y; Li, TJ; Wong, SNY; Bhagwat, AS; Malani, N; Anguela, XM; Sharma, R; Ivanciu, L; Murphy, SL; Finn, JD; Khazi, FR; Zhou, SZ; Paschon, DE; Rebar, EJ; Bushman, FD; Gregory, PD; Holmes, MC; High, KA				Li, Hojun; Haurigot, Virginia; Doyon, Yannick; Li, Tianjian; Wong, Sunnie Y.; Bhagwat, Anand S.; Malani, Nirav; Anguela, Xavier M.; Sharma, Rajiv; Ivanciu, Lacramiora; Murphy, Samuel L.; Finn, Jonathan D.; Khazi, Fayaz R.; Zhou, Shangzhen; Paschon, David E.; Rebar, Edward J.; Bushman, Frederic D.; Gregory, Philip D.; Holmes, Michael C.; High, Katherine A.			In vivo genome editing restores haemostasis in a mouse model of haemophilia	NATURE			English	Article							ZINC-FINGER NUCLEASES; LEBERS CONGENITAL AMAUROSIS; GENE-THERAPY; FACTOR-IX; CHIMERIC NUCLEASES; CELLS; TRANSDUCTION; VECTOR; DISRUPTION; DEFICIENCY	Editing of the human genome to correct disease-causing mutations is a promising approach for the treatment of genetic disorders. Genome editing improves on simple gene-replacement strategies by effecting in situ correction of a mutant gene, thus restoring normal gene function under the control of endogenous regulatory elements and reducing risks associated with random insertion into the genome. Gene-specific targeting has historically been limited to mouse embryonic stem cells. The development of zinc finger nucleases (ZFNs) has permitted efficient genome editing in transformed and primary cells that were previously thought to be intractable to such genetic manipulation(1). In vitro, ZFNs have been shown to promote efficient genome editing via homology-directed repair by inducing a site-specific double-strand break (DSB) at a target locus(2-4), but it is unclear whether ZFNs can induce DSBs and stimulate genome editing at a clinically meaningful level in vivo. Here we show that ZFNs are able to induce DSBs efficiently when delivered directly to mouse liver and that, when co-delivered with an appropriately designed gene-targeting vector, they can stimulate gene replacement through both homology-directed and homology-independent targeted gene insertion at the ZFN-specified locus. The level of gene targeting achieved was sufficient to correct the prolonged clotting times in a mouse model of haemophilia B, and remained persistent after induced liver regeneration. Thus, ZFN-driven gene correction can be achieved in vivo, raising the possibility of genome editing as a viable strategy for the treatment of genetic disease.	[Li, Hojun; Haurigot, Virginia; Bhagwat, Anand S.; Anguela, Xavier M.; Sharma, Rajiv; Ivanciu, Lacramiora; Murphy, Samuel L.; Finn, Jonathan D.; Khazi, Fayaz R.; Zhou, Shangzhen; High, Katherine A.] Childrens Hosp Philadelphia, CTRB 5000, Div Hematol, Philadelphia, PA 19104 USA; [Doyon, Yannick; Li, Tianjian; Wong, Sunnie Y.; Paschon, David E.; Rebar, Edward J.; Gregory, Philip D.; Holmes, Michael C.] Sangamo BioSci, Point Richmond Tech Ctr, Richmond, CA 94804 USA; [Malani, Nirav; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [High, Katherine A.] Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Sangamo Therapeutics, Inc.; University of Pennsylvania; Howard Hughes Medical Institute	High, KA (corresponding author), Childrens Hosp Philadelphia, CTRB 5000, Div Hematol, 3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	mholmes@sangamo.com; high@email.chop.edu	Anguela, Xavier M/D-3223-2013; High, Katherine A./AAB-9322-2020; Wilson, Matthew H/K-3193-2013; Anguela, Xavier/K-9594-2019; Huang, ZhiXin/H-5123-2017	Anguela, Xavier M/0000-0003-2430-8598; Anguela, Xavier/0000-0003-2430-8598; Huang, ZhiXin/0000-0003-0705-1970; Sharma, Rajiv/0000-0002-8147-5723; High, Katherine/0000-0002-0805-6223; Bushman, Frederic/0000-0003-4740-4056; Doyon, Yannick/0000-0002-3889-9563; Gregory, Philip/0000-0001-9249-2468; Haurigot, Virginia A./0000-0002-9772-2565	National Institutes of Health; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL064190, T32HL007150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Institutes of Health and the Howard Hughes Medical Institute.	Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Ayuso E, 2010, GENE THER, V17, P503, DOI 10.1038/gt.2009.157; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; GREEN PM, 2004, HAEMOPHILIA B MUTATI; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Li HJ, 2011, BLOOD, V117, P3311, DOI 10.1182/blood-2010-08-302729; Lin HF, 1997, BLOOD, V90, P3962, DOI 10.1182/blood.V90.10.3962; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Miao CH, 2000, MOL THER, V1, P522, DOI 10.1006/mthe.2000.0075; Miller DG, 2004, NAT GENET, V36, P767, DOI 10.1038/ng1380; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Nakai H, 2003, NAT GENET, V34, P297, DOI 10.1038/ng1179; Nakai H, 2001, J VIROL, V75, P6969, DOI 10.1128/JVI.75.15.6969-6976.2001; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; POLLAK ES, 2001, METABOLIC MOL BASES, P4393; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; THOMPSON AR, 1994, HUM GENET, V94, P299; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	30	394	480	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					217	U128		10.1038/nature10177	http://dx.doi.org/10.1038/nature10177			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21706032	Green Accepted			2022-12-28	WOS:000292690500048
J	Black, ME				Black, Mary E.			THE BIGGER PICTURE Choice: a tale of two hospitals	BRITISH MEDICAL JOURNAL			English	Editorial Material												drmaryblack@gmail.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 13	2011	343								d4421	10.1136/bmj.d4421	http://dx.doi.org/10.1136/bmj.d4421			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	794OE	21752858				2022-12-28	WOS:000292908900010
J	Goritz, C; Dias, DO; Tomilin, N; Barbacid, M; Shupliakov, O; Frisen, J				Goritz, Christian; Dias, David O.; Tomilin, Nikolay; Barbacid, Mariano; Shupliakov, Oleg; Frisen, Jonas			A Pericyte Origin of Spinal Cord Scar Tissue	SCIENCE			English	Article							BLOOD-BRAIN-BARRIER; COLLAGEN-PRODUCING CELLS; GLIAL SCAR; FIBROSIS; REGENERATION; FIBROBLASTS; MIGRATION; INJURY; REPAIR; MICE	There is limited regeneration of lost tissue after central nervous system injury, and the lesion is sealed with a scar. The role of the scar, which often is referred to as the glial scar because of its abundance of astrocytes, is complex and has been discussed for more than a century. Here we show that a specific pericyte subtype gives rise to scar-forming stromal cells, which outnumber astrocytes, in the injured spinal cord. Blocking the generation of progeny by this pericyte subtype results in failure to seal the injured tissue. The formation of connective tissue is common to many injuries and pathologies, and here we demonstrate a cellular origin of fibrosis.	[Goritz, Christian; Dias, David O.; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Tomilin, Nikolay; Shupliakov, Oleg] Karolinska Inst, Dept Neurosci, SE-17177 Stockholm, Sweden; [Barbacid, Mariano] Ctr Nacl Invest Oncol, Mol Oncol Programme, Madrid 28029, Spain	Karolinska Institutet; Karolinska Institutet	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Shupliakov, Oleg/R-9148-2016; Tomilin, Nikolay V/B-4676-2014; Göritz, Christian/AAK-5348-2021	Shupliakov, Oleg/0000-0001-5352-6848; Tomilin, Nikolay V/0000-0002-5581-3848; Göritz, Christian/0000-0003-0799-766X; Oliveira Dias, David/0000-0002-2144-6621	Swedish Research Council; Swedish Cancer Society; Tobias Stiftelsen; Hjarnfonden; Knut och Alice Wallenbergs Stiftelse; Swedish Agency for Innovation Systems; European Research Council [ERC-AG/250297-RAS AHEAD]; Foundation for Science and Technology, Portuguese government [SFRH/BD/63164/2009]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Tobias Stiftelsen; Hjarnfonden; Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Swedish Agency for Innovation Systems(Vinnova); European Research Council(European Research Council (ERC)European Commission); Foundation for Science and Technology, Portuguese government	We thank A. Simon and the Frisen and Shupliakov groups for valuable discussions. This study was supported by the Swedish Research Council, the Swedish Cancer Society, Tobias Stiftelsen, Hjarnfonden, Knut och Alice Wallenbergs Stiftelse, the Swedish Agency for Innovation Systems, and the European Research Council (ERC-AG/250297-RAS AHEAD). D. D. was supported by the Foundation for Science and Technology from the Portuguese government (SFRH/BD/63164/2009).	Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Camand E, 2004, EUR J NEUROSCI, V20, P1161, DOI 10.1111/j.1460-9568.2004.03558.x; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Dore-Duffy P, 2008, CURR PHARM DESIGN, V14, P1581, DOI 10.2174/138161208784705469; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; KRIKORIAN JG, 1981, EXP NEUROL, V72, P698, DOI 10.1016/0014-4886(81)90018-2; Krueger M, 2010, GLIA, V58, P1, DOI 10.1002/glia.20898; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; MATTHEWS MA, 1979, NEUROPATH APPL NEURO, V5, P161, DOI 10.1111/j.1365-2990.1979.tb00617.x; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Shearer MC, 2001, CELL TISSUE RES, V305, P267, DOI 10.1007/s004410100384; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Slezak M, 2007, GLIA, V55, P1565, DOI 10.1002/glia.20570; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sundberg C, 1996, LAB INVEST, V74, P452; WINDLE WF, 1950, J COMP NEUROL, V93, P241, DOI 10.1002/cne.900930206; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9	30	552	564	10	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					238	242		10.1126/science.1203165	http://dx.doi.org/10.1126/science.1203165			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21737741				2022-12-28	WOS:000292502700054
J	Heller, RC; Kang, S; Lam, WM; Chen, S; Chan, CS; Bell, SP				Heller, Ryan C.; Kang, Sukhyun; Lam, Wendy M.; Chen, Shuyan; Chan, Clara S.; Bell, Stephen P.			Eukaryotic Origin-Dependent DNA Replication In Vitro Reveals Sequential Action of DDK and S-CDK Kinases	CELL			English	Article							CHROMATIN ASSOCIATION; COMPLEX-FORMATION; MCM2-7 HELICASE; ATP-HYDROLYSIS; INITIATION; SLD3; CDC45; MCM10; GINS; PHOSPHORYLATION	Proper eukaryotic DNA replication requires temporal separation of helicase loading from helicase activation and replisome assembly. Using an in vitro assay for eukaryotic origin-dependent replication initiation, we investigated the control of these events. After helicase loading, we found that the Dbf4-dependent Cdc7 kinase (DDK) but not S phase cyclin-dependent kinase (S-CDK) is required for the initial origin recruitment of Sld3 and the Cdc45 helicase-activating protein. Likewise, in vivo, DDK drives early-firing-origin recruitment of Cdc45 before activation of S-CDK. After S-CDK activation, a second helicase-activating protein (GINS) and the remainder of the replisome are recruited to the origin. Finally, recruitment of lagging but not leading strand DNA polymerases depends on Mcm10 and DNA unwinding. Our studies identify distinct roles for DDK and S-CDK during helicase activation and support a model in which the leading strand DNA polymerase is recruited prior to origin DNA unwinding and RNA primer synthesis.	[Heller, Ryan C.; Kang, Sukhyun; Lam, Wendy M.; Chen, Shuyan; Chan, Clara S.; Bell, Stephen P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Bell, SP (corresponding author), MIT, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	spbell@mit.edu		Bell, Stephen/0000-0002-2876-610X; Kang, Sukhyun/0000-0002-7567-0231	NIH [GM52339]; Damon Runyon Cancer Research Foundation (DRG) [1959-07]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052339] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation (DRG); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Amon, I. Cheeseman, D. MacAlpine, and T. Takara for comments on the manuscript. Rfa1 antibodies were a gift from S. Brill. We thank R. Sinapius and J. Randell for reagents and K. Galani and H. Blitzblau for help with microarrays. This work was supported by NIH grant GM52339 (S.P.B.). S.P.B., S.C., and S.K. are Howard Hughes Medical Institute employees. R.C.H. was a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-# 1959-07).	Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Cadoret JC, 2010, CHROMOSOME RES, V18, P79, DOI 10.1007/s10577-009-9094-2; Cayrou C, 2010, CHROMOSOME RES, V18, P137, DOI 10.1007/s10577-009-9105-3; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Gambus A, 2011, J BIOL CHEM, V286, P11855, DOI 10.1074/jbc.M110.199521; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gregan J, 2003, MOL BIOL CELL, V14, P3876, DOI 10.1091/mbc.E03-02-0090; Homesley L, 2000, GENE DEV, V14, P913; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Jares P, 2000, GENE DEV, V14, P1528; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; LABIB K, 2010, GENE DEV, V24, P1028; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Nougarede R, 2000, MOL CELL BIOL, V20, P3795, DOI 10.1128/MCB.20.11.3795-3806.2000; Pasero P, 2002, METHOD ENZYMOL, V351, P184; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Sawyer SL, 2004, J MOL BIOL, V340, P195, DOI 10.1016/j.jmb.2004.04.066; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Seki T, 2000, P NATL ACAD SCI USA, V97, P14115, DOI 10.1073/pnas.97.26.14115; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Tsakraklides V, 2010, J BIOL CHEM, V285, P9437, DOI 10.1074/jbc.M109.072504; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Yabuuchi H, 2006, EMBO J, V25, P4663, DOI 10.1038/sj.emboj.7601347; Ying CY, 2005, EMBO J, V24, P4334, DOI 10.1038/sj.emboj.7600892; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	48	217	219	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 8	2011	146	1					80	91		10.1016/j.cell.2011.06.012	http://dx.doi.org/10.1016/j.cell.2011.06.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729781	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000292539300008
J	Qu, XH; Wen, JD; Lancaster, L; Noller, HF; Bustamante, C; Tinoco, I				Qu, Xiaohui; Wen, Jin-Der; Lancaster, Laura; Noller, Harry F.; Bustamante, Carlos; Tinoco, Ignacio, Jr.			The ribosome uses two active mechanisms to unwind messenger RNA during translation	NATURE			English	Article							SECONDARY STRUCTURE; SINGLE-MOLECULE; TRANSLOCATION; HELICASES; TIME; STABILITY; MOVEMENT; DYNAMICS; RECEPTOR	The ribosome translates the genetic information encoded in messenger RNA into protein. Folded structures in the coding region of an mRNA represent a kinetic barrier that lowers the peptide elongation rate, as the ribosome must disrupt structures it encounters in the mRNA at its entry site to allow translocation to the next codon. Such structures are exploited by the cell to create diverse strategies for translation regulation, such as programmed frameshifting(1,2), the modulation of protein expression levels-(3,4), ribosome localization(5) and co-translational protein folding(6). Although strand separation activity is inherent to the ribosome, requiring no exogenous helicases(7), its mechanism is still unknown. Here, using a single-molecule optical tweezers assay on mRNA hairpins, we find that the translation rate of identical codons at the decoding centre is greatly influenced by the GC content of folded structures at the mRNA entry site. Furthermore, force applied to the ends of the hairpin to favour its unfolding significantly speeds translation. Quantitative analysis of the force dependence of its helicase activity reveals that the ribosome, unlike previously studied helicases, uses two distinct active mechanisms to unwind mRNA structure: it destabilizes the helical junction at the mRNA entry site by biasing its thermal fluctuations towards the open state, increasing the probability of the ribosome translocating unhindered; and it mechanically pulls apart the mRNA single strands of the closed junction during the conformational changes that accompany ribosome translocation. The second of these mechanisms ensures a minimal basal rate of translation in the cell; specialized, mechanically stable structures are required to stall the ribosome temporarily(1,2). Our results establish a quantitative mechanical basis for understanding the mechanism of regulation of the elongation rate of translation by structured mRNAs.	[Qu, Xiaohui; Wen, Jin-Der; Bustamante, Carlos; Tinoco, Ignacio, Jr.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Qu, Xiaohui; Wen, Jin-Der; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Qu, Xiaohui; Wen, Jin-Der; Bustamante, Carlos] Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA; [Lancaster, Laura; Noller, Harry F.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Lancaster, Laura; Noller, Harry F.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Tinoco, I (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu; intinoco@lbl.gov	; Wen, Jin-Der/A-3159-2014	Qu, Xiaohui/0000-0001-7756-307X; Wen, Jin-Der/0000-0001-8317-4329; Bustamante, Carlos/0000-0002-2970-0073	National Institutes of Health; Human Frontiers Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM010840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank rnembers of the Tinoco and Bustamante labs for helpful discussions, especially S. B. Smith for his help with the optical tweezers, J. Moffitt for advice on data analysis arid C. Kaiser for suggestions. Our work was supported by grants from the National Institutes of Health (to IT., C.B. and H.F.N.) and the Human Frontiers Science Program (to I.T. and H.F.N).	Betterton MD, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011904; Chen G, 2009, P NATL ACAD SCI USA, V106, P12706, DOI 10.1073/pnas.0905046106; Cukras AR, 2003, MOL CELL, V12, P321, DOI 10.1016/S1097-2765(03)00275-2; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Giedroc DP, 2009, VIRUS RES, V139, P193, DOI 10.1016/j.virusres.2008.06.008; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Keller D, 2000, BIOPHYS J, V78, P541, DOI 10.1016/S0006-3495(00)76615-X; Kim S, 2010, J MOL BIOL, V395, P995, DOI 10.1016/j.jmb.2009.11.072; Lionnet T, 2007, P NATL ACAD SCI USA, V104, P19790, DOI 10.1073/pnas.0709793104; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Manosas M, 2010, NUCLEIC ACIDS RES, V38, P5518, DOI 10.1093/nar/gkq273; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Peske F, 2000, MOL CELL, V6, P501, DOI 10.1016/S1097-2765(00)00049-6; Rodnina MV, 2000, BIOL CHEM, V381, P377, DOI 10.1515/BC.2000.050; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Tinoco I, 2002, BIOPHYS CHEM, V101, P513, DOI 10.1016/S0301-4622(02)00177-1; Tinoco I, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025006; TSUCHIHASHI Z, 1991, NUCLEIC ACIDS RES, V19, P2457, DOI 10.1093/nar/19.9.2457; Uemura S, 2007, NATURE, V446, P454, DOI 10.1038/nature05625; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Young JC, 1996, EMBO J, V15, P172, DOI 10.1002/j.1460-2075.1996.tb00345.x; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	30	219	221	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					118	121		10.1038/nature10126	http://dx.doi.org/10.1038/nature10126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734708	Green Accepted			2022-12-28	WOS:000292461300057
J	Chiuve, SE; Fung, TT; Rexrode, KM; Spiegelman, D; Manson, JE; Stampfer, MJ; Albert, CM				Chiuve, Stephanie E.; Fung, Teresa T.; Rexrode, Kathryn M.; Spiegelman, Donna; Manson, JoAnn E.; Stampfer, Meir J.; Albert, Christine M.			Adherence to a Low-Risk, Healthy Lifestyle and Risk of Sudden Cardiac Death Among Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; POLYUNSATURATED FATTY-ACIDS; BODY-MASS INDEX; MEDITERRANEAN DIET; MYOCARDIAL-INFARCTION; PRIMARY PREVENTION; PROSPECTIVE COHORT; PHYSICAL-ACTIVITY; MORTALITY; TIME	Context Sudden cardiac death (SCD) accounts for more than half of all cardiac deaths; the majority of SCD events occur as the first manifestation of heart disease, especially among women. Primary preventive strategies are needed to reduce SCD incidence. Objective To estimate the degree to which adherence to a healthy lifestyle may lower the risk of SCD among women. Design, Setting, and Participants A prospective cohort study of 81 722 US women in the Nurses' Health Study from June 1984 to June 2010. Lifestyle factors were assessed via questionnaires every 2 to 4 years. A low-risk lifestyle was defined as not smoking, body mass index of less than 25, exercise duration of 30 minutes/day or longer, and top 40% of the alternate Mediterranean diet score, which emphasizes high intake of vegetables, fruits, nuts, legumes, whole grains, and fish and moderate intake of alcohol. Main Outcome Measure Sudden cardiac death (defined as death occurring within 1 hour after symptom onset without evidence of circulatory collapse). Results There were 321 cases of SCD during 26 years of follow-up. Women were a mean age of 72 years at the time of the SCD event. All 4 low-risk lifestyle factors were significantly and independently associated with a lower risk of SCD. The absolute risks of SCD were 22 cases/100 000 person-years among women with 0 low-risk factors, 17 cases/100 000 person-years with 1 low-risk factor, 18 cases/100 000 person-years with 2 low-risk factors, 13 cases/100 000 person-years with 3 low-risk factors, and 16 cases/100 000 person-years with 4 low-risk factors. Compared with women with 0 low-risk factors, the multivariable relative risk of SCD was 0.54 (95% confidence interval [CI], 0.34-0.86) for women with 1 low-risk factor, 0.41 (95% CI, 0.25-0.65) for 2 low-risk factors, 0.33 (95% CI, 0.20-0.54) for 3 low-risk factors, and 0.08 (95% CI, 0.03-0.23) for 4 low-risk factors. The proportion of SCD attributable to smoking, inactivity, overweight, and poor diet was 81%(95% CI, 52%-93%). Among women without clinically diagnosed coronary heart disease, the percentage of population attributable risk was 79% (95% CI, 40%-93%). Conclusion Adherence to a low-risk lifestyle is associated with a low risk of SCD.	[Chiuve, Stephanie E.; Albert, Christine M.] Brigham & Womens Hosp, Dept Med, Ctr Arrhythmia Prevent, Boston, MA 02115 USA; [Chiuve, Stephanie E.; Rexrode, Kathryn M.; Manson, JoAnn E.; Stampfer, Meir J.; Albert, Christine M.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Albert, Christine M.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Spiegelman, Donna; Stampfer, Meir J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Chiuve, Stephanie E.; Fung, Teresa T.; Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Chiuve, Stephanie E.; Fung, Teresa T.; Stampfer, Meir J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Spiegelman, Donna; Manson, JoAnn E.; Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Fung, Teresa T.] Simmons Coll, Dept Nutr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Simmons University	Chiuve, SE (corresponding author), 900 Commonwealth Ave, Boston, MA 02215 USA.	schiuve@hsph.harvard.edu	Rexrode, Kathryn M/I-1177-2018	Albert, Christine/0000-0002-2081-1121; Rexrode, Kathryn/0000-0003-3387-8429; Chiuve, Stephanie/0000-0002-3524-8917	National Institutes of Health [CA 87969, HL 034594]; American Heart Association [K99 HL097068]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL097068, R01HL034594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grants CA 87969 and HL 034594 from the National Institutes of Health. Dr Chiuve was supported in part by grant K99 HL097068 and a Clinical Research Program Award from the American Heart Association. Dr Albert was supported in part by an Established Investigator Award from the American Heart Association.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Ajani UA, 2004, ANN EPIDEMIOL, V14, P731, DOI 10.1016/j.annepidem.2003.10.008; Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Albert CM, 1999, CIRCULATION, V100, P944, DOI 10.1161/01.CIR.100.9.944; Albert CM, 2003, CIRCULATION, V107, P2096, DOI 10.1161/01.CIR.0000065223.21530.11; Albert CM, 2002, ARCH INTERN MED, V162, P1382, DOI 10.1001/archinte.162.12.1382; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Chugh SS, 2009, J AM COLL CARDIOL, V54, P2006, DOI 10.1016/j.jacc.2009.07.038; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P48, DOI 10.1093/oxfordjournals.aje.a114223; COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Ford ES, 2009, ARCH INTERN MED, V169, P1355, DOI 10.1001/archinternmed.2009.237; Forman JP, 2009, JAMA-J AM MED ASSOC, V302, P401, DOI 10.1001/jama.2009.1060; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Hildebrandt Mandy, 2006, BMC Med Res Methodol, V6, P32, DOI 10.1186/1471-2288-6-32; HINKLE LE, 1982, CIRCULATION, V65, P457, DOI 10.1161/01.CIR.65.3.457; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; KANNEL WB, 1975, CIRCULATION, V51, P606, DOI 10.1161/01.CIR.51.4.606; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Lemaitre RN, 1999, ARCH INTERN MED, V159, P686, DOI 10.1001/archinte.159.7.686; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; PETERS RW, 1995, J AM COLL CARDIOL, V26, P1287, DOI 10.1016/0735-1097(95)00328-2; Platz EA, 2000, CANCER CAUSE CONTROL, V11, P579, DOI 10.1023/A:1008999232442; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Roger VL, 2009, JAMA-J AM MED ASSOC, V302, P437, DOI 10.1001/jama.2009.1075; Schoenborn Charlotte A, 2010, Vital Health Stat 10, P1; SHEKELLE RB, 1982, AM J EPIDEMIOL, V115, P506, DOI 10.1093/oxfordjournals.aje.a113332; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; SISCOVICK DS, 1986, AM J EPIDEMIOL, V123, P490, DOI 10.1093/oxfordjournals.aje.a114265; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Stecker EC, 2006, J AM COLL CARDIOL, V47, P1161, DOI 10.1016/j.jacc.2005.11.045; United States Department of Health and Human Services, 2008 PHYS ACT GUID A; US Department of Agriculture, 1963, COMP FOODS RAW PROC, V8; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P303, DOI 10.1093/oxfordjournals.aje.a117252; WANNAMETHEE G, 1995, CIRCULATION, V91, P1749, DOI 10.1161/01.CIR.91.6.1749; Whang W, 2006, JAMA-J AM MED ASSOC, V295, P1399, DOI 10.1001/jama.295.12.1399; Willett WC, 2010, AM J CLIN NUTR, V91, P829, DOI 10.3945/ajcn.2010.29347; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	54	125	132	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					62	69		10.1001/jama.2011.907	http://dx.doi.org/10.1001/jama.2011.907			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	21730242	Green Accepted, Bronze			2022-12-28	WOS:000292378700021
J	Turok, N				Turok, Neil			Africa AIMS high	NATURE			English	Editorial Material									[Turok, Neil] Perimeter Inst Theoret Phys, Waterloo, ON, Canada	Perimeter Institute for Theoretical Physics	Turok, N (corresponding author), Perimeter Inst Theoret Phys, Waterloo, ON, Canada.	nturok@perimeterinstitute.ca							0	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2011	474	7353					567	569		10.1038/474567a	http://dx.doi.org/10.1038/474567a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	785CF	21720344	Bronze			2022-12-28	WOS:000292204300013
J	Isbister, GK; Fan, HW				Isbister, Geoffrey K.; Fan, Hui Wen			Spider bite	LANCET			English	Article							HEMOLYTIC-ANEMIA; PHONEUTRIA-NIGRIVENTER; LOXOSCELES-INTERMEDIA; CONTROLLED-TRIAL; CLINICAL PRESENTATION; MEDICAL IMPORTANCE; NEW-ZEALAND; BLACK; ENVENOMATION; LATRODECTISM	Spiders are a source of intrigue and fear, and several myths exist about their medical effects. Many people believe that bites from various spider species cause necrotic ulceration, despite evidence that most suspected cases of necrotic arachnidism are caused by something other than a spider bite. Latrodectism and loxoscelism are the most important clinical syndromes resulting from spider bite. Latrodectism results from bites by widow spiders (Latrodectus spp) and causes local, regional, or generalised pain associated with non-specific symptoms and autonomic effects. Loxoscelism is caused by Loxosceles spp, and the cutaneous form manifests as pain and erythema that can develop into a necrotic ulcer. Systemic loxoscelism is characterised by intravascular haemolysis and renal failure on occasion. Other important spiders include the Australian funnel-web spider (Atrax spp and Hadronyche spp) and the armed spider (Phoneutria spp) from Brazil. Antivenoms are an important treatment for spider envenomation but have been less successful than have those for snake envenomation, with concerns about their effectiveness for both latrodectism and loxoscelism.	[Isbister, Geoffrey K.] Univ Newcastle, Discipline Clin Pharmacol, Newcastle, NSW 2300, Australia; [Isbister, Geoffrey K.] Calvary Mater Newcastle, Dept Clin Toxicol & Pharmacol, Newcastle, NSW, Australia; [Fan, Hui Wen] Inst Butantan, Ctr Desenvolvimento Cultural, Sao Paulo, Brazil	University of Newcastle; Calvary Mater Newcastle Hospital; Instituto Butantan	Isbister, GK (corresponding author), Calvary Mater Newcastle, Edith St, Waratah, NSW 2298, Australia.	geoff.isbister@gmail.com	Isbister, Geoffrey K/G-8052-2015; Fan, Hui Wen/F-8649-2015; Fan, Hui Wen/C-3750-2019	Isbister, Geoffrey K/0000-0003-1519-7419; Fan, Hui Wen/0000-0002-8191-559X; 	NHMRC [ID605817]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We thank Felicity Prior for helping with the literature review and Rick Vetter for reviewing the report. GKI is supported by an NHMRC Clinical Career Development Award ID605817.	Afshari R, 2009, HUM EXP TOXICOL, V28, P697, DOI 10.1177/0960327109350668; Anderson P C, 1998, Mo Med, V95, P318; Antunes E, 2003, ANIMAIS PECONHENTOS, P150; ARTAZA O, 1982, REV MED CHILE, V110, P1101; Barbaro KC, 2010, TOXICON, V56, P972, DOI 10.1016/j.toxicon.2010.06.022; BARBARO KC, 1992, TOXICON, V30, P1117, DOI 10.1016/0041-0101(92)90057-C; BARRETT SM, 1994, ANN EMERG MED, V24, P21, DOI 10.1016/S0196-0644(94)70156-3; Brazilian Ministry of Health, 1998, MAN DIAGN TRAT AC AN, P181; Bucaretchi F, 2008, CLIN TOXICOL, V46, P885, DOI 10.1080/15563650802258524; Bucaretchi Fabio, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P17, DOI 10.1590/S0036-46652000000100003; Catalan A, 2009, REV MED CHILE, V137, P240, DOI /S0034-98872009000200008; Chaves-Moreira D, 2009, J CELL BIOCHEM, V107, P655, DOI 10.1002/jcb.22148; Chavez-Olortegui C, 2001, TOXICON, V39, P909, DOI 10.1016/S0041-0101(00)00218-X; CLARK RF, 1992, ANN EMERG MED, V21, P782, DOI 10.1016/S0196-0644(05)81021-2; Corzo G, 2003, CELL MOL LIFE SCI, V60, P2409, DOI 10.1007/s00018-003-3108-6; da Silva PH, 2004, TOXICON, V44, P693, DOI 10.1016/j.toxicon.2004.07.012; de Souza AL, 2008, TOXICON, V51, P151, DOI 10.1016/j.toxicon.2007.08.011; DeAsis C., 1934, American Journal of Tropical Medicine, VVol. 14, P33; Diochot S, 2007, TOXICON, V49, P271, DOI 10.1016/j.toxicon.2006.09.026; EICHNER ER, 1984, AM J CLIN PATHOL, V81, P683, DOI 10.1093/ajcp/81.5.683; Elbahlawan LM, 2005, PEDIATR EMERG CARE, V21, P177; Ellis Rodney M, 2005, Emerg Med Australas, V17, P152, DOI 10.1111/j.1742-6723.2005.00720.x; Escalante-Galindo P, 1999, Gac Med Mex, V135, P423; Garb JE, 2004, MOL PHYLOGENET EVOL, V31, P1127, DOI 10.1016/j.ympev.2003.10.012; Gomez HF, 1999, ACAD EMERG MED, V6, P1195, DOI 10.1111/j.1553-2712.1999.tb00133.x; Gomez MV, 2002, CELL MOL NEUROBIOL, V22, P579, DOI 10.1023/A:1021836403433; Graudins A, 2002, TOXICON, V40, P767, DOI 10.1016/S0041-0101(01)00280-X; Graudins A, 2002, TOXICON, V40, P259, DOI 10.1016/S0041-0101(01)00210-0; Grishin EV, 1998, TOXICON, V36, P1693, DOI 10.1016/S0041-0101(98)00162-7; Hoover NG, 2004, PEDIATRICS, V114, pE128, DOI 10.1542/peds.114.1.e128; Isbister GK, 2008, QJM-INT J MED, V101, P557, DOI 10.1093/qjmed/hcn048; Isbister GK, 2007, INTERN MED J, V37, P820, DOI 10.1111/j.1445-5994.2007.01513.x; Isbister GK, 2008, BRIT J CLIN PHARMACO, V65, P139, DOI 10.1111/j.1365-2125.2007.03004.x; Isbister GK, 2005, MED J AUSTRALIA, V182, P407, DOI 10.5694/j.1326-5377.2005.tb06760.x; Isbister GK, 2004, LANCET, V364, P549, DOI 10.1016/S0140-6736(04)16816-5; Isbister GK, 2004, TOXICON, V43, P477, DOI 10.1016/j.toxicon.2004.02.002; Isbister GK, 2004, TOXICON, V43, P133, DOI 10.1016/j.toxicon.2003.11.009; Isbister GK, 2004, MED J AUSTRALIA, V180, P225, DOI 10.5694/j.1326-5377.2004.tb05890.x; Isbister GK, 2004, INTERN MED J, V34, P38, DOI 10.1111/j.1444-0903.2004.00506.x; Isbister GK, 2003, J TOXICOL-CLIN TOXIC, V41, P809, DOI 10.1081/CLT-120025346; Isbister GK, 2003, MED J AUSTRALIA, V179, P88, DOI 10.5694/j.1326-5377.2003.tb05442.x; Isbister GK, 2003, J TOXICOL-CLIN TOXIC, V41, P291, DOI 10.1081/CLT-120021114; Isbister GK, 2002, QJM-INT J MED, V95, P723, DOI 10.1093/qjmed/95.11.723; Isbister GK, 2002, J TOXICOL-CLIN TOXIC, V40, P231, DOI 10.1081/CLT-120005493; KEY GF, 1981, AM J TROP MED HYG, V30, P273, DOI 10.4269/ajtmh.1981.30.273; Lane DR, 2004, CUTIS, V74, P341; Levi M, 2007, CRIT CARE MED, V35, P2191, DOI 10.1097/01.CCM.0000281468.94108.4B; Lira-da-Silva R M, 1995, Rev Soc Bras Med Trop, V28, P205, DOI 10.1590/S0037-86821995000300007; Lowry BP, 2001, ANN EMERG MED, V37, P161, DOI 10.1067/mem.2001.113031; Macchiavello A, 1937, REV CHIL HIST NAT, V41, P11; Macchiavello Atilio, 1947, PUERTO RICO JOUR PUBL HEALTH AND TROP MED, V22, P425; MÁLAQUE Ceila Maria Sant'Ana, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P139, DOI 10.1590/S0036-46652002000300005; Manriquez JJ, 2009, REV CHIL INFECTOL, V26, P420, DOI /S0716-10182009000600004; MARETIC Z, 1983, TOXICON, V21, P457, DOI 10.1016/0041-0101(83)90123-X; MARETIC Z., 1964, TOXICON, V2, P149, DOI 10.1016/0041-0101(64)90016-9; McDade J, 2010, J PEDIATR-US, V156, P155, DOI 10.1016/j.jpeds.2009.07.021; MINTON SA, 1964, PEDIATRICS, V33, P283; MULLER GJ, 1993, S AFR MED J, V83, P399; NANCE WE, 1961, AM J MED, V31, P801, DOI 10.1016/0002-9343(61)90164-4; Navarro-Silva MA, 2010, J ECON ENTOMOL, V103, P166, DOI 10.1603/EC09092; NEWLANDS G, 1990, S AFR MED J, V77, P92; Nicholson GM, 1998, PFLUG ARCH EUR J PHY, V436, P117, DOI 10.1007/s004240050612; Nicholson GM, 2004, TOXICON, V43, P587, DOI 10.1016/j.toxicon.2004.02.006; Nicholson GM, 2002, CLIN EXP PHARMACOL P, V29, P785, DOI 10.1046/j.1440-1681.2002.03741.x; Pauli I, 2006, TOXICON, V48, P123, DOI 10.1016/j.toxicon.2006.05.005; Pauli I, 2009, TOXICON, V53, P660, DOI 10.1016/j.toxicon.2009.01.033; PHILLIPS S, 1995, ANN EMERG MED, V25, P363, DOI 10.1016/S0196-0644(95)70296-2; PLATNICK NI, 2010, WORLD SPIDER CATALOG; Pneumatikos IA, 2003, ANN EMERG MED, V41, P158, DOI 10.1067/mem.2003.32; Pommier P, 2006, PRESSE MED, V35, P1825, DOI 10.1016/S0755-4982(06)74908-9; Quan D, 2009, AM J EMERG MED, V27, p759e1; Rash LD, 2002, TOXICON, V40, P225, DOI 10.1016/S0041-0101(01)00199-4; REES R, 1987, ANN EMERG MED, V16, P945, DOI 10.1016/S0196-0644(87)80738-2; REES RS, 1985, ANN SURG, V202, P659, DOI 10.1097/00000658-198511000-00020; RUSSELL FE, 1962, AM J MED SCI, V243, P159; Sari Ibrahim, 2008, Am J Emerg Med, V26, DOI 10.1016/j.ajem.2007.09.012; Schenone H, 2003, REV MED CHILE, V131, P437; SCHENONE H, 1970, AM J TROP MED HYG, V19, P564, DOI 10.4269/ajtmh.1970.19.564; SCHENONE H, 1989, REV INST MED TROP SP, V31, P403, DOI 10.1590/S0036-46651989000600007; Sezerino UM, 1998, T ROY SOC TROP MED H, V92, P546, DOI 10.1016/S0035-9203(98)90909-9; SOUTHCOTT RV, 1976, MED J AUSTRALIA, V1, P406, DOI 10.5694/j.1326-5377.1976.tb140704.x; STANFORD CF, 2007, CLIN TOXICOL, V45, P619; STILES AD, 1982, CLIN PEDIATR, V21, P174, DOI 10.1177/000992288202100308; Stoecker WV, 2006, J AM ACAD DERMATOL, V55, P888, DOI 10.1016/j.jaad.2006.04.065; SUTHERLAND SK, 1978, MED J AUSTRALIA, V2, P620, DOI 10.5694/j.1326-5377.1978.tb131783.x; Swanson DL, 2006, CLIN DERMATOL, V24, P213, DOI 10.1016/j.clindermatol.2005.11.006; Swanson DL, 2005, NEW ENGL J MED, V352, P700, DOI 10.1056/NEJMra041184; Tambourgi DV, 2010, TOXICON, V56, P1113, DOI 10.1016/j.toxicon.2010.01.021; Tambourgi DV, 1998, BIOCHEM BIOPH RES CO, V251, P366, DOI 10.1006/bbrc.1998.9474; Tambourgi DV, 2000, BLOOD, V95, P683, DOI 10.1182/blood.V95.2.683; TAYLOR EH, 1966, SOUTHERN MED J, V59, P1209, DOI 10.1097/00007611-196610000-00021; Trethewy Christopher E, 2003, Emerg Med (Fremantle), V15, P170, DOI 10.1046/j.1442-2026.2003.00435.x; Vetter RS, 2008, ANNU REV ENTOMOL, V53, P409, DOI 10.1146/annurev.ento.53.103106.093503; Vettera RS, 2003, TOXICON, V42, P413, DOI 10.1016/S0041-0101(03)00173-9; VORSE H, 1972, J PEDIATR-US, V80, P1035, DOI 10.1016/S0022-3476(72)80023-4; WARRELL DA, 1991, TOXICON, V29, P1263, DOI 10.1016/0041-0101(91)90198-Z; WIENER S, 1961, MED J AUSTRALIA, V2, P44, DOI 10.5694/j.1326-5377.1961.tb82566.x; WILLIAMS ST, 1995, AM J CLIN PATHOL, V104, P463; Wright SW, 1997, ANN EMERG MED, V30, P28, DOI 10.1016/S0196-0644(97)70106-9	99	138	145	0	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2011	378	9808					2039	2047		10.1016/S0140-6736(10)62230-1	http://dx.doi.org/10.1016/S0140-6736(10)62230-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863DY	21762981				2022-12-28	WOS:000298144200028
J	Hashiyama, K; Hayashi, Y; Kobayashi, S				Hashiyama, Kazuya; Hayashi, Yoshiki; Kobayashi, Satoru			Drosophila Sex lethal Gene Initiates Female Development in Germline Progenitors	SCIENCE			English	Article							INTERSTITIAL-CELLS; SOMATIC-CELLS; EXPRESSION; SXL; MELANOGASTER; TRANSCRIPTION; MECHANISMS; DIMORPHISM; PROTEINS; IDENTITY	Sex determination in the Drosophila germ line is regulated by both the sex of the surrounding soma and cell-autonomous cues. How primordial germ cells (PGCs) initiate sexual development via cell-autonomous mechanisms is unclear. Here, we demonstrate that, in Drosophila, the Sex lethal (Sxl) gene acts autonomously in PGCs to induce female development. Sxl is transiently expressed in PGCs during their migration to the gonads; this expression, which was detected only in XX PGCs, is necessary for PGCs to assume a female fate. Ectopic expression of Sxl in XY PGCs was sufficient to induce them to enter oogenesis and produce functional eggs when transplanted into an XX host. Our data provide powerful evidence that Sxl initiates female germline fate during sexual development.	[Hashiyama, Kazuya; Hayashi, Yoshiki; Kobayashi, Satoru] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Basic Biol, Higashiyama Ku, Okazaki, Aichi 4448787, Japan; [Hayashi, Yoshiki; Kobayashi, Satoru] Grad Univ Adv Studies, Dept Basic Biol, Sch Life Sci, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan	Kobayashi, S (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Basic Biol, Higashiyama Ku, Okazaki, Aichi 4448787, Japan.	skob@nibb.ac.jp		Hayashi, Yoshiki/0000-0002-8966-8730	Ministry of Education, Culture, Sports, Science and Technology (Japan); Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank the researchers who provided us with flies and antibodies and members of our laboratory for their valuable comments. We also thank the Drosophila Genetic Resource Center (Kyoto), the Bloomington and Vienna Drosophila RNAi Stock Centers, and the Developmental Studies Hybridoma Bank for fly stocks and antibodies. This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (Japan) to S. K. and a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science to K.H.	BERNSTEIN M, 1995, GENETICS, V139, P631; BOPP D, 1991, GENE DEV, V5, P403, DOI 10.1101/gad.5.3.403; Camara N, 2008, CURR TOP DEV BIOL, V83, P65, DOI 10.1016/S0070-2153(08)00403-1; CAMPBELL RD, 1985, J EXP ZOOL, V234, P451, DOI 10.1002/jez.1402340312; Casper A, 2006, DEVELOPMENT, V133, P2783, DOI 10.1242/dev.02415; Casper AL, 2009, DEVELOPMENT, V136, P3821, DOI 10.1242/dev.042374; DeFalco T, 2009, ANNU REV CELL DEV BI, V25, P457, DOI 10.1146/annurev.cellbio.042308.13350; Deshpande G, 1999, CELL, V99, P271, DOI 10.1016/S0092-8674(00)81658-X; Durcova-Hills G, 2008, CURR TOP DEV BIOL, V83, P185, DOI [10.1016/S0070-2153(08)00406-7, 10.1016/S0070-2153(09)00406-7]; Hashiyama K, 2009, GENE EXPR PATTERNS, V9, P50, DOI 10.1016/j.gep.2008.08.001; Hempel LU, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-113; Hempel LU, 2008, CURR TOP DEV BIOL, V83, P109, DOI 10.1016/S0070-2153(08)00404-3; Horabin JI, 2005, DEVELOPMENT, V132, P4801, DOI 10.1242/dev.02054; Huang L, 2005, DEV BIOL, V280, P407, DOI 10.1016/j.ydbio.2005.02.006; KEYES LN, 1992, CELL, V68, P933, DOI 10.1016/0092-8674(92)90036-C; LITTLEFIELD CL, 1984, DEV BIOL, V102, P426, DOI 10.1016/0012-1606(84)90207-0; MARSH JL, 1978, NATURE, V272, P249, DOI 10.1038/272249a0; Mattox W, 1996, GENETICS, V143, P303; Murray SM, 2010, CURR OPIN CELL BIOL, V22, P722, DOI 10.1016/j.ceb.2010.09.006; Oliver B, 2002, INT REV CYTOL, V219, P1; Penalva LOF, 2003, MICROBIOL MOL BIOL R, V67, P343, DOI 10.1128/MMBR.67.3.343-359.2003; Salz HK, 2010, FLY, V4, P60, DOI 10.4161/fly.4.1.11277; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; SCHUPBACH T, 1982, DEV BIOL, V89, P117, DOI 10.1016/0012-1606(82)90300-1; Shigenobu S, 2006, P NATL ACAD SCI USA, V103, P13728, DOI 10.1073/pnas.0603767103; STEINMANNZWICKY M, 1994, DEV GENET, V15, P265, DOI 10.1002/dvg.1020150308; STEINMANNZWICKY M, 1989, CELL, V57, P157, DOI 10.1016/0092-8674(89)90181-5; Van Doren M, 1998, CURR BIOL, V8, P243; Wawersik M, 2005, NATURE, V436, P563, DOI 10.1038/nature03849; Wawersik M, 2006, CELL CYCLE, V5, P1385, DOI 10.4161/cc.5.13.2905	30	44	46	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2011	333	6044					885	888		10.1126/science.1208146	http://dx.doi.org/10.1126/science.1208146			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21737698				2022-12-28	WOS:000293785400043
J	King, MS; Eisenberg, R; Newman, JH; Tolle, JJ; Harrell, FE; Nian, H; Ninan, M; Lambright, ES; Sheller, JR; Johnson, JE; Miller, RF				King, Matthew S.; Eisenberg, Rosana; Newman, John H.; Tolle, James J.; Harrell, Frank E., Jr.; Nian, Hui; Ninan, Mathew; Lambright, Eric S.; Sheller, James R.; Johnson, Joyce E.; Miller, Robert F.			Constrictive Bronchiolitis in Soldiers Returning from Iraq and Afghanistan	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GULF-WAR VETERANS; US MILITARY PERSONNEL; HEALTH-STATUS; PERSIAN-GULF; OBLITERANS; EXPOSURE; DYSPNEA	Background In this descriptive case series, 80 soldiers from Fort Campbell, Kentucky, with inhalational exposures during service in Iraq and Afghanistan were evaluated for dyspnea on exertion that prevented them from meeting the U. S. Army's standards for physical fitness. Methods The soldiers underwent extensive evaluation of their medical and exposure history, physical examination, pulmonary-function testing, and high-resolution computed tomography (CT). A total of 49 soldiers underwent thoracoscopic lung biopsy after noninvasive evaluation did not provide an explanation for their symptoms. Data on cardiopulmonary-exercise and pulmonary-function testing were compared with data obtained from historical military control subjects. Results Among the soldiers who were referred for evaluation, a history of inhalational exposure to a 2003 sulfur-mine fire in Iraq was common but not universal. Of the 49 soldiers who underwent lung biopsy, all biopsy samples were abnormal, with 38 soldiers having changes that were diagnostic of constrictive bronchiolitis. In the remaining 11 soldiers, diagnoses other than constrictive bronchiolitis that could explain the presenting dyspnea were established. All soldiers with constrictive bronchiolitis had normal results on chest radiography, but about one quarter were found to have mosaic air trapping or centrilobular nodules on chest CT. The results of pulmonary-function and cardiopulmonary-exercise testing were generally within normal population limits but were inferior to those of the military control subjects. Conclusions In 49 previously healthy soldiers with unexplained exertional dyspnea and diminished exercise tolerance after deployment, an analysis of biopsy samples showed diffuse constrictive bronchiolitis, which was possibly associated with inhalational exposure, in 38 soldiers.	[Miller, Robert F.] Vanderbilt Univ, Med Ctr, Dept Med, Med Ctr E 6134, Nashville, TN 37232 USA; [King, Matthew S.] Meharry Med Coll, Div Pulm & Crit Care Med, Nashville, TN 37208 USA; [Eisenberg, Rosana; Johnson, Joyce E.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Lambright, Eric S.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA; [Harrell, Frank E., Jr.; Nian, Hui] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA; [Ninan, Mathew] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA	Vanderbilt University; Meharry Medical College; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Tennessee System; University of Tennessee Health Science Center	Miller, RF (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Med Ctr E 6134, Nashville, TN 37232 USA.				National Center for Research Resources, National Institutes of Health [UL1-RR024975]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975, KL2RR024977, TL1RR024978] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported in part by a Clinical and Translational Science Award (UL1-RR024975) to Vanderbilt University Medical Center from the National Center for Research Resources, National Institutes of Health.	ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; BOSWELL RT, 1995, J OCCUP ENVIRON MED, V37, P850, DOI 10.1097/00043764-199507000-00015; BREATNACH E, 1982, CLIN RADIOL, V33, P657, DOI 10.1016/S0009-9260(82)80395-4; Coker WJ, 1999, BMJ-BRIT MED J, V318, P290, DOI 10.1136/bmj.318.7179.290; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; Devakonda A, 2010, CHEST, V137, P938, DOI 10.1378/chest.09-0800; de Mello GCF, 2010, RESPIRATION, V79, P322, DOI 10.1159/000235722; Kelsall HL, 2004, THORAX, V59, P897, DOI 10.1136/thx.2003.017103; Kreiss K, 2002, NEW ENGL J MED, V347, P330, DOI 10.1056/NEJMoa020300; Lee ES, 2000, RADIOLOGY, V216, P472, DOI 10.1148/radiology.216.2.r00au21472; MCLOUD TC, 1986, RADIOLOGY, V159, P1; Medinger AE, 1998, CHEST, V113, P612, DOI 10.1378/chest.113.3.612; Morris MJ, 2002, MIL MED, V167, P281; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Schwartz DA, 1997, JAMA-J AM MED ASSOC, V277, P238, DOI 10.1001/jama.277.3.238; SCHWARZ MI, 2003, INTERSTITIAL LUNG DI, P796; Shorr AF, 2004, JAMA-J AM MED ASSOC, V292, P2997, DOI 10.1001/jama.292.24.2997; Smith B, 2009, AM J EPIDEMIOL, V170, P1433, DOI 10.1093/aje/kwp287; Szema AM, 2008, J ALLERGY CLIN IMMUN, V121, pS230, DOI 10.1016/j.jaci.2007.12.909; Szema AM, 2010, ALLERGY ASTHMA PROC, V31, pE67, DOI 10.2500/aap.2010.31.3383; Tanaka N, 2004, J COMPUT ASSIST TOMO, V28, P351, DOI 10.1097/00004728-200405000-00009; Visscher Daniel W, 2006, Proc Am Thorac Soc, V3, P41, DOI 10.1513/pats.200512-124JH; WRIGHT JL, 1992, AM REV RESPIR DIS, V146, P240, DOI 10.1164/ajrccm/146.1.240; WRIGHT JL, 1984, HUM PATHOL, V15, P68, DOI 10.1016/S0046-8177(84)80332-9; ARMY PHYS FITNESS TE	25	165	167	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2011	365	3					222	230		10.1056/NEJMoa1101388	http://dx.doi.org/10.1056/NEJMoa1101388			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794QI	21774710	Green Accepted			2022-12-28	WOS:000292915500006
J	Payandeh, J; Scheuer, T; Zheng, N; Catterall, WA				Payandeh, Jian; Scheuer, Todd; Zheng, Ning; Catterall, William A.			The crystal structure of a voltage-gated sodium channel	NATURE			English	Article							MOLECULAR DETERMINANTS; IONIC SELECTIVITY; NA+ CHANNELS; LOCAL-ANESTHETICS; POTASSIUM CHANNEL; SKELETAL-MUSCLE; K+ SELECTIVITY; BLOCK; CA2+; PROTEINS	Voltage-gated sodium (Na-V) channels initiate electrical signalling in excitable cells and are the molecular targets for drugs and disease mutations, but the structural basis for their voltage-dependent activation, ion selectivity and drug block is unknown. Here we report the crystal structure of a voltage-gated Na+ channel from Arcobacter butzleri (NavAb) captured in a closed-pore conformation with four activated voltage sensors at 2.7 angstrom resolution. The arginine gating charges make multiple hydrophilic interactions within the voltage sensor, including unanticipated hydrogen bonds to the protein backbone. Comparisons to previous open-pore potassium channel structures indicate that the voltage-sensor domains and the S4-S5 linkers dilate the central pore by pivoting together around a hinge at the base of the pore module. The NavAb selectivity filter is short, similar to 4.6 angstrom wide, and water filled, with four acidic side chains surrounding the narrowest part of the ion conduction pathway. This unique structure presents a high-field-strength anionic coordination site, which confers Na+ selectivity through partial dehydration via direct interaction with glutamate side chains. Fenestrations in the sides of the pore module are unexpectedly penetrated by fatty acyl chains that extend into the central cavity, and these portals are large enough for the entry of small, hydrophobic pore-blocking drugs. This structure provides the template for understanding electrical signalling in excitable cells and the actions of drugs used for pain, epilepsy and cardiac arrhythmia at the atomic level.	[Payandeh, Jian; Scheuer, Todd; Zheng, Ning; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zheng, N (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	nzheng@uw.edu; wcatt@uw.edu	Tuluc, Petronel/C-2527-2011		Canadian Institutes of Health Research; National Institutes of Health [R01 NS15751, U01 NS058039]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015751, U01NS058039] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Hille for comments on a draft of the manuscript and members of the N.Z. and W.A.C. groups for their support throughout this project. We are grateful to investigators who provided genomic DNA and the beamline staff at the Advanced Light Source (BL8.2.1 and BL8.2.2) for their assistance during data collection. J.P. acknowledges support from a Canadian Institutes of Health Research fellowship and the encouragement of E. Payandeh. This work was supported by grants from the National Institutes of Health (R01 NS15751 and U01 NS058039 to W. A. C.) and by the Howard Hughes Medical Institute (N.Z.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alam A, 2009, NAT STRUCT MOL BIOL, V16, P35, DOI 10.1038/nsmb.1537; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bezanilla F, 2006, BIOL RES, V39, P425, DOI 10.4067/S0716-97602006000300005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; CATTERALL WA, 1987, TRENDS PHARMACOL SCI, V8, P57, DOI 10.1016/0165-6147(87)90011-3; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Chaptal V, 2010, J STRUCT BIOL, V171, P82, DOI 10.1016/j.jsb.2010.02.005; Chen XH, 1996, J GEN PHYSIOL, V108, P363, DOI 10.1085/jgp.108.5.363; Cronin CN, 2007, PROTEIN SCI, V16, P2023, DOI 10.1110/ps.072931407; CURTIS BM, 1986, BIOCHEMISTRY-US, V25, P3077, DOI 10.1021/bi00359a002; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; DELANO WL, 2002, PYMOLMOLECULAR VIEWE; Delmas P, 2005, NEURON, V47, P179, DOI 10.1016/j.neuron.2005.07.001; Doi M, 2001, ACTA CRYSTALLOGR D, V57, P628, DOI 10.1107/S0907444901002797; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EISENMAN G, 1983, J MEMBRANE BIOL, V76, P197, DOI 10.1007/BF01870364; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; Faham S, 2005, PROTEIN SCI, V14, P836, DOI 10.1110/ps.041167605; Faham S, 2002, J MOL BIOL, V316, P1, DOI 10.1006/jmbi.2001.5295; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; FELLER DJ, 1985, J BIOL CHEM, V260, P1542; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; HILLE B, 1975, J GEN PHYSIOL, V66, P535, DOI 10.1085/jgp.66.5.535; HILLE B, 1971, J GEN PHYSIOL, V58, P599, DOI 10.1085/jgp.58.6.599; HILLE B, 1972, J GEN PHYSIOL, V59, P637, DOI 10.1085/jgp.59.6.637; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jogini V, 2005, J MOL BIOL, V354, P272, DOI 10.1016/j.jmb.2005.09.031; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Koishi R, 2004, J BIOL CHEM, V279, P9532, DOI 10.1074/jbc.M313100200; Koth CMM, 2009, ADV PROTEIN CHEM STR, V76, P43, DOI 10.1016/S1876-1623(08)76002-4; Kuzmenkin A, 2004, J GEN PHYSIOL, V124, P349, DOI 10.1085/jgp.200409139; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MCCLESKEY EW, 1985, P NATL ACAD SCI USA, V82, P7149, DOI 10.1073/pnas.82.20.7149; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; MORELLO RS, 1984, J PHARMACOL EXP THER, V230, P156; NODA M, 1989, FEBS LETT, V259, P213, DOI 10.1016/0014-5793(89)81531-5; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Otwinowski Z, 1997, PROCESSING XRAY DIFF, V276; Petrek M, 2007, STRUCTURE, V15, P1357, DOI 10.1016/j.str.2007.10.007; Phillips K, 1997, J MOL BIOL, V273, P171, DOI 10.1006/jmbi.1997.1292; Ragsdale DS, 1996, P NATL ACAD SCI USA, V93, P9270, DOI 10.1073/pnas.93.17.9270; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Ryan DP, 2010, NEURON, V68, P282, DOI 10.1016/j.neuron.2010.10.008; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865; YU FH, 2004, SCI STKE; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zhao Y, 2004, P NATL ACAD SCI USA, V101, P17873, DOI 10.1073/pnas.0408270101; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3	66	1019	1039	15	483	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					353	U104		10.1038/nature10238	http://dx.doi.org/10.1038/nature10238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21743477	Green Accepted			2022-12-28	WOS:000292911200037
J	Pronovost, PJ; Goeschel, CA				Pronovost, Peter J.; Goeschel, Christine A.			Time to Take Health Delivery Research Seriously	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLOOD-STREAM INFECTIONS; QUALITY IMPROVEMENT; INTENSIVE-CARE; UNITED-STATES; PATIENT HARM; MORTALITY		[Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Pronovost, Peter J.; Goeschel, Christine A.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Qual & Safety Res Grp, Baltimore, MD 21205 USA; [Pronovost, Peter J.; Goeschel, Christine A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Pronovost, Peter J.; Goeschel, Christine A.] Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Pronovost, PJ (corresponding author), 1909 Thames St,2nd Floor, Baltimore, MD 21231 USA.	ppronovo@jhmi.edu	Goeschel, Christine/AAA-6783-2020					*CLIN GOV, LIST RES FOUND 18 47; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Lipitz-Snyderman A, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d219; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Newman-Toker DE, 2009, JAMA-J AM MED ASSOC, V301, P1060, DOI 10.1001/jama.2009.249; Pronovost PJ, 2011, HEALTH AFFAIR, V30, P628, DOI 10.1377/hlthaff.2011.0047; Pronovost PJ, 2011, CLIN INFECT DIS, V52, P507, DOI 10.1093/cid/ciq172; Pronovost PJ, 2010, AM J RESP CRIT CARE, V182, P1463, DOI 10.1164/rccm.201008-1255ED; Pronovost PJ, 2010, JAMA-J AM MED ASSOC, V304, P1721, DOI 10.1001/jama.2010.1542; Srinivasan A., 2011, Morbidity and Mortality Weekly Report, V60, P243	10	27	27	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2011	306	3					310	311		10.1001/jama.2011.1015	http://dx.doi.org/10.1001/jama.2011.1015			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794BS	21771994				2022-12-28	WOS:000292870500027
J	Chou, R				Chou, Roger			Review: Gabapentin reduces some types of chronic neuropathic pain more than placebo in adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.			Chou, Roger/0000-0001-9889-8610					0	5	5	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2							JC1-08	10.7326/0003-4819-155-2-201107190-02008	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	793KW	21768574				2022-12-28	WOS:000292822000007
J	Gutknecht, DR				Gutknecht, David R.			13-year renal outcomes varied in patients with type 1 diabetes and new-onset microalbuminuria	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Geisinger Med Ctr, Danville, PA 17822 USA	Geisinger Medical Center	Gutknecht, DR (corresponding author), Geisinger Med Ctr, Danville, PA 17822 USA.								0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2							JC1-13	10.7326/0003-4819-155-2-201107190-02013	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	793KW	21768579				2022-12-28	WOS:000292822000012
J	Jones, CU; Hunt, D; McGowan, DG; Amin, MB; Chetner, MP; Bruner, DW; Leibenhaut, MH; Husain, SM; Rotman, M; Souhami, L; Sandler, HM; Shipley, WU				Jones, Christopher U.; Hunt, Daniel; McGowan, David G.; Amin, Mahul B.; Chetner, Michael P.; Bruner, Deborah W.; Leibenhaut, Mark H.; Husain, Siraj M.; Rotman, Marvin; Souhami, Luis; Sandler, Howard M.; Shipley, William U.			Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOSE-ESCALATION TRIAL; ONCOLOGY GROUP RTOG; RADIATION-THERAPY; RADICAL PROSTATECTOMY; HORMONAL-THERAPY; FOLLOW-UP; SUPPRESSION; CARCINOMA; SURVIVAL; DISEASE	BACKGROUND It is not known whether short-term androgen-deprivation therapy (ADT) before and during radiotherapy improves cancer control and overall survival among patients with early, localized prostate adenocarcinoma. METHODS From 1994 through 2001, we randomly assigned 1979 eligible patients with stage T1b, T1c, T2a, or T2b prostate adenocarcinoma and a prostate-specific antigen (PSA) level of 20 ng per milliliter or less to radiotherapy alone (992 patients) or radiotherapy with 4 months of total androgen suppression starting 2 months before radiotherapy (radiotherapy plus short-term ADT, 987 patients). The primary end point was overall survival. Secondary end points included disease-specific mortality, distant metastases, biochemical failure (an increasing level of PSA), and the rate of positive findings on repeat prostate biopsy at 2 years. RESULTS The median follow-up period was 9.1 years. The 10-year rate of overall survival was 62% among patients receiving radiotherapy plus short-term ADT (the combined-therapy group), as compared with 57% among patients receiving radiotherapy alone (hazard ratio for death with radiotherapy alone, 1.17; P = 0.03). The addition of short-term ADT was associated with a decrease in the 10-year disease-specific mortality from 8% to 4% (hazard ratio for radiotherapy alone, 1.87; P = 0.001). Biochemical failure, distant metastases, and the rate of positive findings on repeat prostate biopsy at 2 years were significantly improved with radiotherapy plus short-term ADT. Acute and late radiation-induced toxic effects were similar in the two groups. The incidence of grade 3 or higher hormone-related toxic effects was less than 5%. Reanalysis according to risk showed reductions in overall and disease-specific mortality primarily among intermediate-risk patients, with no significant reductions among low-risk patients. CONCLUSIONS Among patients with stage T1b, T1c, T2a, or T2b prostate adenocarcinoma and a PSA level of 20 ng per milliliter or less, the use of short-term ADT for 4 months before and during radiotherapy was associated with significantly decreased disease-specific mortality and increased overall survival. According to post hoc risk analysis, the benefit was mainly seen in intermediate-risk, but not low-risk, men. (Funded by the National Cancer Institute; RTOG 94-08 ClinicalTrials.gov number, NCT00002597.)	[Jones, Christopher U.; Leibenhaut, Mark H.] Radiol Associates Sacramento, Sacramento, CA 95816 USA; [Hunt, Daniel] Univ Penn, Radiat Therapy Oncol Grp, Ctr Stat, Philadelphia, PA 19104 USA; [Bruner, Deborah W.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [McGowan, David G.] Cross Canc Inst, Dept Radiat Oncol, Edmonton, AB T6G 1Z2, Canada; [Chetner, Michael P.] Univ Alberta, Dept Surg, Div Urol, Edmonton, AB, Canada; [Husain, Siraj M.] Tom Baker Canc Clin, Dept Radiat Oncol, Calgary, AB, Canada; [Amin, Mahul B.] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Sandler, Howard M.] Cedars Sinai Med Ctr, Dept Radiat Oncol, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Rotman, Marvin] SUNY Hlth Sci Ctr, Dept Radiat Oncol, Brooklyn, NY 11203 USA; [Souhami, Luis] McGill Univ, Dept Radiat Oncol, Montreal, PQ H3A 2T5, Canada; [Shipley, William U.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA	Radiological Associates of Sacramento; Radiation Therapy Oncology Group (RTOG); University of Pennsylvania; University of Pennsylvania; University of Alberta; University of Alberta; Tom Baker Cancer Clinic; University of Calgary; Cedars Sinai Medical Center; Cedars Sinai Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; McGill University; Harvard University; Massachusetts General Hospital	Jones, CU (corresponding author), Radiol Associates Sacramento, 1500 Expo Pkwy, Sacramento, CA 95816 USA.	jonesc@radiological.com		Bruner, Deborah/0000-0002-5770-9948	National Cancer Institute [U10 CA21661, U10 CA37422, U10 CA32115]; Amgen; Ferring; GlaxoSmithKline; Eli Lilly; Calypso Medical; Varian; NATIONAL CANCER INSTITUTE [U10CA021661, U10CA032115, U10CA037422] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Amgen(Amgen); Ferring(Ferring Pharmaceuticals); GlaxoSmithKline(GlaxoSmithKline); Eli Lilly(Eli Lilly); Calypso Medical; Varian; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants (U10 CA21661, to the Radiation Therapy Oncology Group [RTOG]; U10 CA37422, to the Community Clinical Oncology Program; and U10 CA32115, to the RTOG Statistical Center) from the National Cancer Institute.; Dr. Chetner reports receiving lecture fees from and serving on the advisory boards of Amgen, Ferring, GlaxoSmithKline, and Eli Lilly and receiving fees for the development of educational presentations from Amgen and GlaxoSmithKline; and Dr. Sandler, consulting fees from Calypso Medical and Varian. No other potential conflict of interest relevant to this article was reported.	Al-Mamgani A, 2008, INT J RADIAT ONCOL, V72, P980, DOI 10.1016/j.ijrobp.2008.02.073; Beahrs O, 1992, AJCC CANC STAGING MA, V4th; Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502; Bolla M, 2009, NEW ENGL J MED, V360, P2516, DOI 10.1056/NEJMoa0810095; Bruner DW, 2011, J SEX MED, V8, P1228, DOI 10.1111/j.1743-6109.2010.02164.x; Bruner DW, 1997, ONCOL NEWS INT S3, V6, P22; Cooperberg MR, 2004, J UROLOGY, V171, P1393, DOI 10.1097/01.ju.0000107247.81471.06; COX DR, 1972, J R STAT SOC B, V34, P187; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; D'Amico AV, 2008, JAMA-J AM MED ASSOC, V299, P289, DOI 10.1001/jama.299.3.289; Dearnaley DP, 2007, LANCET ONCOL, V8, P475, DOI 10.1016/S1470-2045(07)70143-2; Debruyne FMJ, 2000, MOL UROL, V4, P251; Denham JW, 2005, LANCET ONCOL, V6, P841, DOI 10.1016/S1470-2045(05)70348-X; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GRIFFITHS K, 1994, SEMIN ONCOL, V21, P672; Horwitz EM, 2008, J CLIN ONCOL, V26, P2497, DOI 10.1200/JCO.2007.14.9021; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; KORN EL, 1992, STAT MED, V11, P813, DOI 10.1002/sim.4780110611; Kuban DA, 2008, INT J RADIAT ONCOL, V70, P67, DOI 10.1016/j.ijrobp.2007.06.054; Kupelian PA, 2004, INT J RADIAT ONCOL, V58, P25, DOI 10.1016/S0360-3016(03)00784-3; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Lawton CA, 2001, INT J RADIAT ONCOL, V49, P937, DOI 10.1016/S0360-3016(00)01516-9; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mohler JL, 2010, J NATL COMPR CANC NE, V8, P145, DOI 10.6004/jnccn.2010.0010; PILEPICH MV, 1995, UROLOGY, V45, P616, DOI 10.1016/S0090-4295(99)80053-3; Pilepich MV, 2005, INT J RADIAT ONCOL, V61, P1285, DOI 10.1016/j.ijrobp.2004.08.047; Potosky AL, 2000, JNCI-J NATL CANCER I, V92, P1582, DOI 10.1093/jnci/92.19.1582; Roach M, 2000, INT J RADIAT ONCOL, V47, P617, DOI 10.1016/S0360-3016(00)00577-0; Roach M, 1999, J UROLOGY, V161, P864, DOI 10.1016/S0022-5347(01)61793-2; Roach M, 2008, J CLIN ONCOL, V26, P585, DOI 10.1200/JCO.2007.13.9881; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; Saylor PJ, 2009, J UROLOGY, V181, P1998, DOI 10.1016/j.juro.2009.01.047; Soloway MS, 2002, J UROLOGY, V167, P112, DOI 10.1016/S0022-5347(05)65393-1; Waterhouse J, 1986, Oncol Nurs Forum, V13, P53; Yee DS, 2010, BJU INT, V105, P185, DOI 10.1111/j.1464-410X.2009.08698.x; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0; Zietman AL, 2004, J UROLOGY, V171, P210, DOI 10.1097/01.ju.0000100980.13364.a6; Zietman AL, 2010, J CLIN ONCOL, V28, P1106, DOI 10.1200/JCO.2009.25.8475	39	504	511	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2					107	118		10.1056/NEJMoa1012348	http://dx.doi.org/10.1056/NEJMoa1012348			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SP	21751904				2022-12-28	WOS:000292685500007
J	Li, F; Martienssen, R; Cande, WZ				Li, Fei; Martienssen, Rob; Cande, W. Zacheus			Coordination of DNA replication and histone modification by the Rik1-Dos2 complex	NATURE			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; POLYMERASE-EPSILON; RNA INTERFERENCE; S-PHASE; HETEROCHROMATIN FORMATION; CHROMOSOMAL REPLICATION; EPIGENETIC INHERITANCE; CELL-CYCLE; CHROMATIN	Histone modification marks have an important role in many chromatin processes(1,2). During DNA replication, both heterochromatin and euchromatin are disrupted ahead of the replication fork and are then reassembled into their original epigenetic states behind the fork(3,4). How histone marks are accurately inherited from generation to generation is still poorly understood. In fission yeast (Schizosaccharomyces pombe), RNA interference (RNAi)-mediated histone methylation is cell cycle regulated. Centromeric repeats are transiently transcribed in the S phase of the cell cycle and are processed into short interfering RNAs (siRNAs) by the complexes RITS (RNA-induced initiation of transcriptional gene silencing) and RDRC (RNA-directed RNA polymerase complex)(5-7). The small RNAs together with silencing factors-including Dos1 (also known as Clr8 and Raf1), Dos2 (also known as Clr7 and Raf2), Rik1 and Lid2-promote heterochromatic methylation of histone H3 at lysine 9 (H3K9) by a histone methyltransferase, Clr4 (refs 8-13). The methylation of H3K9 provides a binding site for Swi6, a structural and functional homologue of metazoan heterochromatin protein 1 (HP1)(14). Here we characterize a silencing complex in fission yeast that contains Dos2, Rik1, Mms19 and Cdc20 (the catalytic subunit of DNA polymerase-e). This complex regulates RNA polymerase II (RNA Pol II) activity in heterochromatin and is required for DNA replication and heterochromatin assembly. Our findings provide a molecular link between DNA replication and histone methylation, shedding light on how epigenetic marks are transmitted during each cell cycle.	[Li, Fei] NYU, Dept Biol, New York, NY 10003 USA; [Martienssen, Rob] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Cande, W. Zacheus] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	New York University; Cold Spring Harbor Laboratory; University of California System; University of California Berkeley	Li, F (corresponding author), NYU, Dept Biol, New York, NY 10003 USA.	fl43@nyu.edu		Li, Fei/0000-0002-1206-9684	National Institutes of Health [RO1GM076396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076396] Funding Source: NIH RePORTER; Direct For Biological Sciences [1025830] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. Allshire, P. Nurse, G. D'Urso and the Japan Yeast Genetic Resource Center for strains, E. Osborne and C. Hale for comments on the manuscript, Cold Spring Harbor Laboratory for mass spectrometry analysis, and members of the Cande and Li laboratories for their support and discussions. This work was supported by a grant from the National Institutes of Health (RO1GM076396) to W.Z.C. and R.M.	Allis C. D., 2006, EPIGENETICS; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; DUrso G, 1997, P NATL ACAD SCI USA, V94, P12491, DOI 10.1073/pnas.94.23.12491; Feng WY, 2001, MOL CELL BIOL, V21, P4495, DOI 10.1128/MCB.21.14.4495-4504.2001; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; Fuss J, 2002, J BIOL CHEM, V277, P8658, DOI 10.1074/jbc.M110615200; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Ito S, 2010, MOL CELL, V39, P632, DOI 10.1016/j.molcel.2010.07.029; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kirchmaier AL, 2001, SCIENCE, V291, P646, DOI 10.1126/science.291.5504.646; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lauder S, 1996, MOL CELL BIOL, V16, P6783; Li F, 2005, CURR BIOL, V15, P1448, DOI 10.1016/j.cub.2005.07.021; Li F, 2008, CELL, V135, P272, DOI 10.1016/j.cell.2008.08.036; Li YC, 2001, SCIENCE, V291, P650, DOI 10.1126/science.291.5504.650; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayama J, 2001, EMBO J, V20, P2857, DOI 10.1093/emboj/20.11.2857; Natsume T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002221; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; SMITH JG, 1995, MOL CELL BIOL, V15, P5165; Thon G, 2005, GENETICS, V171, P1583, DOI 10.1534/genetics.105.048298; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wallace J, 2005, CHROMOSOMA, V114, P389, DOI 10.1007/s00412-005-0024-6; White SA, 2008, CURR TOP MICROBIOL, V320, P157; Wu XY, 2001, J BIOL CHEM, V276, P23962, DOI 10.1074/jbc.M101041200; Yin HB, 2009, PLANT CELL, V21, P386, DOI 10.1105/tpc.108.061549	32	85	85	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					244	U2562		10.1038/nature10161	http://dx.doi.org/10.1038/nature10161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21725325	Green Submitted, Green Accepted			2022-12-28	WOS:000292690500054
J	Volz, J; Gehr, R; Dubois, G; Esteve, J; Reichel, J				Volz, Juergen; Gehr, Roger; Dubois, Guilhem; Esteve, Jerome; Reichel, Jakob			Measurement of the internal state of a single atom without energy exchange	NATURE			English	Article							QUANTUM; CAVITY	A measurement necessarily changes the quantum state being measured, a phenomenon known as back-action. Real measurements, however, almost always cause a much stronger back-action than is required by the laws of quantum mechanics. Quantum non-demolition measurements have been devised(1-6) that keep the additional back-action entirely within observables other than the one being measured. However, this back-action on other observables often imposes its own constraints. In particular, free-space optical detection methods for single atoms and ions (such as the shelving technique(7), a sensitive and well-developed method) inevitably require spontaneous scattering, even in the dispersive regime(8). This causes irreversible energy exchange (heating), which is a limitation in atom-based quantum information processing, where it obviates straightforward reuse of the qubit. No such energy exchange is required by quantum mechanics(9). Here we experimentally demonstrate optical detection of an atomic qubit with significantly less than one spontaneous scattering event. We measure the transmission and reflection of an optical cavity(10-13) containing the atom. In addition to the qubit detection itself, we quantitatively measure how much spontaneous scattering has occurred. This allows us to relate the information gained to the amount of spontaneous emission, and we obtain a detection error below 10 per cent while scattering less than 0.2 photons on average. Furthermore, we performa quantum Zeno-type experiment to quantify the measurement back-action, and find that every incident photon leads to an almost complete state collapse. Together, these results constitute a full experimental characterization of a quantum measurement in the 'energy exchange-free' regime below a single spontaneous emission event. Besides its fundamental interest, this approach could significantly simplify proposed neutral-atom quantum computation schemes(14), and may enable sensitive detection of molecules and atoms lacking closed transitions.	[Volz, Juergen; Gehr, Roger; Dubois, Guilhem; Esteve, Jerome; Reichel, Jakob] Univ Paris 06, CNRS, ENS, Lab Kastler Brossel, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Reichel, J (corresponding author), Univ Paris 06, CNRS, ENS, Lab Kastler Brossel, 24 Rue Lhomond, F-75005 Paris, France.	jakob.reichel@ens.fr	Esteve, Jerome/G-1084-2014; Reichel, Jakob/AAW-1107-2021; Volz, Jürgen/N-6457-2016	Esteve, Jerome/0000-0002-1556-8120; Reichel, Jakob/0000-0003-3420-4178; Volz, Jürgen/0000-0002-3174-2141	EU [247687]; Institut Francilien pour la Recherche sur les Atomes Froids (IFRAF); EURYI grant 'Integrated Quantum Devices'	EU(European Commission); Institut Francilien pour la Recherche sur les Atomes Froids (IFRAF); EURYI grant 'Integrated Quantum Devices'	This work was funded in part by the AQUTE Integrated Project of the EU (grant no. 247687), by the Institut Francilien pour la Recherche sur les Atomes Froids (IFRAF), and by the EURYI grant 'Integrated Quantum Devices'.	Bochmann J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.203601; Boozer AD, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.083602; Braginsky V. B., 1992, QUANTUM MEASUREMENT; Colombe Y, 2007, NATURE, V450, P272, DOI 10.1038/nature06331; Domokos P, 2003, J OPT SOC AM B, V20, P1098, DOI 10.1364/JOSAB.20.001098; Gehr R, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.203602; Gerber S, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/1/013032; Grangier P, 1998, NATURE, V396, P537, DOI 10.1038/25059; Haroche S., 2006, EXPLORING QUANTUM; Hechenblaikner G, 1998, PHYS REV A, V58, P3030, DOI 10.1103/PhysRevA.58.3030; Helstrom C. W, 1976, MATH SCI ENG SERIES, V123; Hope JJ, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.043822; Hume DB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.120502; Hunger D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/065038; Itano W. M., 2006, PERSPECTIVES QUANTUM; Jones KM, 2006, REV MOD PHYS, V78, P483, DOI 10.1103/RevModPhys.78.483; Khudaverdyan M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.123006; KWIAT P, 1995, PHYS REV LETT, V74, P4763, DOI 10.1103/PhysRevLett.74.4763; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; LUGIATO LA, 1984, PROG OPTICS, V21, P69, DOI 10.1016/S0079-6638(08)70122-7; Lupascu A, 2007, NAT PHYS, V3, P119, DOI 10.1038/nphys509; Maioli P, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett; Nogues G, 1999, NATURE, V400, P239, DOI 10.1038/22275; Puppe T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.013002	26	80	80	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					210	U117		10.1038/nature10225	http://dx.doi.org/10.1038/nature10225			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753851				2022-12-28	WOS:000292690500046
J	Wechsler, ME; Kelley, JM; Boyd, IOE; Dutile, S; Marigowda, G; Kirsch, I; Israel, E; Kaptchuk, TJ				Wechsler, Michael E.; Kelley, John M.; Boyd, Ingrid O. E.; Dutile, Stefanie; Marigowda, Gautham; Kirsch, Irving; Israel, Elliot; Kaptchuk, Ted J.			Active Albuterol or Placebo, Sham Acupuncture, or No Intervention in Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCEPTION; SUGGESTION; TRIALS; AIR	BACKGROUND In prospective experimental studies in patients with asthma, it is difficult to determine whether responses to placebo differ from the natural course of physiological changes that occur without any intervention. We compared the effects of a bronchodilator, two placebo interventions, and no intervention on outcomes in patients with asthma. METHODS In a double-blind, crossover pilot study, we randomly assigned 46 patients with asthma to active treatment with an albuterol inhaler, a placebo inhaler, sham acupuncture, or no intervention. Using a block design, we administered one each of these four interventions in random order during four sequential visits (3 to 7 days apart); this procedure was repeated in two more blocks of visits (for a total of 12 visits by each patient). At each visit, spirometry was performed repeatedly over a period of 2 hours. Maximum forced expiratory volume in 1 second (FEV1) was measured, and patients' self-reported improvement ratings were recorded. RESULTS Among the 39 patients who completed the study, albuterol resulted in a 20% increase in FEV1, as compared with approximately 7% with each of the other three interventions (P<0.001). However, patients' reports of improvement after the intervention did not differ significantly for the albuterol inhaler (50% improvement), placebo inhaler (45%), or sham acupuncture (46%), but the subjective improvement with all three of these interventions was significantly greater than that with the no-intervention control (21%) (P<0.001). CONCLUSIONS Although albuterol, but not the two placebo interventions, improved FEV1 in these patients with asthma, albuterol provided no incremental benefit with respect to the self-reported outcomes. Placebo effects can be clinically meaningful and can rival the effects of active medication in patients with asthma. However, from a clinical-management and research-design perspective, patient self-reports can be unreliable. An assessment of untreated responses in asthma may be essential in evaluating patient-reported outcomes. (Funded by the National Center for Complementary and Alternative Medicine.)	[Wechsler, Michael E.; Boyd, Ingrid O. E.; Dutile, Stefanie; Marigowda, Gautham; Israel, Elliot] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Wechsler, Michael E.; Kelley, John M.; Boyd, Ingrid O. E.; Dutile, Stefanie; Marigowda, Gautham; Kirsch, Irving; Israel, Elliot; Kaptchuk, Ted J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kelley, John M.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Kirsch, Irving; Kaptchuk, Ted J.] Beth Israel Deaconess Med Ctr, Program Placebo Studies, Boston, MA 02215 USA; [Kelley, John M.] Endicott Coll, Dept Psychol, Beverly, MA USA; [Kirsch, Irving] Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; University of Hull	Wechsler, ME (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA.	mwechsler@partners.org	Kirsch, Irving/P-9316-2019; Wechsler, Michael/AAC-5506-2019; Wechsler, Michael/B-3979-2013	Wechsler, Michael/0000-0003-3505-2946	National Center for Complementary and Alternative Medicine; National Center for Complementary and Alternative Medicine, National Institutes of Health [R21-AT002793-01, K24-AT004095]; GlaxoSmithKline; Merck; Schering-Plough; Asthmatx; Genentech; Sunovion; Cephalon; MedImmune; NKT Therapeutics; Boehringer Ingelheim; Novartis; AstraZeneca; Abbott; Amgen; Astellas Pharma US; BI Worldwide; Cowen; Gilead Sciences; Icagen; Johnson Johnson; newMentor; Ono Pharmaceutical; PDL BioPharma; Pulmatrix; Teva Pharmaceuticals; Ficksman and Conley; Prince, Lobel, Glovsky, and Tye; Campbell, Campbell, Edwards, and Conroy; Diedrich and Donohue; Sulloway and Hollis; Ryan Ryan Deluca; Aerovance; Biota; Ception; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT002793] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT004095] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary and Alternative Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Schering-Plough(Merck & CompanySchering Plough Corporation); Asthmatx; Genentech(Roche HoldingGenentech); Sunovion; Cephalon; MedImmune(AstraZenecaMedimmune); NKT Therapeutics; Boehringer Ingelheim(Boehringer Ingelheim); Novartis(Novartis); AstraZeneca(AstraZeneca); Abbott(Abbott Laboratories); Amgen(Amgen); Astellas Pharma US(Astellas Pharmaceuticals); BI Worldwide; Cowen; Gilead Sciences(Gilead Sciences); Icagen; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); newMentor; Ono Pharmaceutical; PDL BioPharma; Pulmatrix; Teva Pharmaceuticals(Teva Pharmaceutical Industries); Ficksman and Conley; Prince, Lobel, Glovsky, and Tye; Campbell, Campbell, Edwards, and Conroy; Diedrich and Donohue; Sulloway and Hollis; Ryan Ryan Deluca; Aerovance; Biota; Ception; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by the National Center for Complementary and Alternative Medicine.; Supported by grants (R21-AT002793-01 and K24-AT004095) from the National Center for Complementary and Alternative Medicine, National Institutes of Health.; Dr. Wechsler reports receiving fees for consulting and advisory-board membership from GlaxoSmithKline, Merck, Schering-Plough, Asthmatx, Genentech, Sunovion (formerly Sepracor), Cephalon, MedImmune, NKT Therapeutics, and Boehringer Ingelheim; lecture fees from Merck, Novartis, AstraZeneca, and GlaxoSmithKline; and grant support from GlaxoSmithKline and Asthmatx. Dr. Israel reports receiving fees for consulting and advisory-board membership from Abbott, Amgen, Astellas Pharma US, BI Worldwide, Cowen, Gilead Sciences, GlaxoSmithKline, Icagen, Johnson & Johnson, MedImmune, Merck, newMentor, NKT Therapeutics, Novartis, Ono Pharmaceutical, PDL BioPharma, Pulmatrix, Schering-Plough, Sunovion (formerly Sepracor), and Teva Pharmaceuticals; lecture fees from Merck; fees for expert testimony from Ficksman and Conley; Prince, Lobel, Glovsky, and Tye; Campbell, Campbell, Edwards, and Conroy; Diedrich and Donohue; Sulloway and Hollis; and Ryan Ryan Deluca; and grant support from Aerovance, Amgen, Biota, Ception, Genentech, Icagen, Johnson & Johnson, MedImmune, and Novartis. No other potential conflict of interest relevant to this article was reported.	Apter AJ, 1997, J ALLERGY CLIN IMMUN, V99, P605, DOI 10.1016/S0091-6749(97)70020-4; Beecher H. K., 1959, MEASUREMENT SUBJECTI; Benedetti F., 2020, PLACEBO EFFECTS, DOI [10.1093/oso/9780198843177.001.0001, DOI 10.1093/OSO/9780198843177.001.0001]; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BUTLER C, 1986, BRIT J CLIN PSYCHOL, V25, P173, DOI 10.1111/j.2044-8260.1986.tb00693.x; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Eisenberg L, 1977, Cult Med Psychiatry, V1, P9, DOI 10.1007/BF00114808; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; GODFREY S, 1973, J PSYCHOSOM RES, V17, P293, DOI 10.1016/0022-3999(73)90106-2; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; ISENBERG SA, 1992, J PSYCHOSOM RES, V36, P769, DOI 10.1016/0022-3999(92)90135-O; Jenkinson C, 1994, MEASURING HLTH MED O; Kaptchuk Ted, 2008, Nat Rev Drug Discov, V7, P554, DOI 10.1038/nrd2629; Kaptchuk TJ, 2008, CONTEMP CLIN TRIALS, V29, P587, DOI 10.1016/j.cct.2008.02.002; Kaptchuk TJ, 2011, PHILOS T R SOC B, V366, P1849, DOI 10.1098/rstb.2010.0385; Kaptchuk TJ, 1998, LANCET, V351, P1722, DOI 10.1016/S0140-6736(97)10111-8; Kemeny ME, 2007, J ALLERGY CLIN IMMUN, V119, P1375, DOI 10.1016/j.jaci.2007.03.016; KIKUCHI Y, 1994, NEW ENGL J MED, V330, P1329, DOI 10.1056/NEJM199405123301901; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; LUPARELLO T, 1968, PSYCHOSOM MED, V30, P819, DOI 10.1097/00006842-196811000-00002; Magadle R, 2002, CHEST, V121, P329, DOI 10.1378/chest.121.2.329; MAY O, 1988, EUR RESPIR J, V1, P527; MCCORMACK HM, 1988, PSYCHOL MED, V18, P1007, DOI 10.1017/S0033291700009934; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Sodergren SC, 1999, EXPECTANCIES SHAPE E, P333; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; Wise RA, 2009, J ALLERGY CLIN IMMUN, V124, P436, DOI 10.1016/j.jaci.2009.05.041; Zhang W, 2008, ANN RHEUM DIS, V67, P1716, DOI 10.1136/ard.2008.092015	28	224	229	0	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2					119	126		10.1056/NEJMoa1103319	http://dx.doi.org/10.1056/NEJMoa1103319			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SP	21751905	Bronze, Green Accepted			2022-12-28	WOS:000292685500008
J	Fidler, DP; Gostin, LO				Fidler, David P.; Gostin, Lawrence O.			The WHO Pandemic Influenza Preparedness Framework: A Milestone in Global Governance for Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Fidler, David P.] Indiana Univ, Maurer Sch Law, Bloomington, IN 47405 USA	Georgetown University; Indiana University System; Indiana University Bloomington	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], WHA645 WHO; CBD, 2011, NAG PROT ACC GEN RES; Fidler DP, 2008, EMERG INFECT DIS, V14, P88, DOI 10.3201/eid1401.070700; Fidler DP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000247; Holbrooke R, 2008, WASHINGTON POST 0810; Mack A., 2010, DOMESTIC INT IMPACTS; WHO, 2007, WHA6028 WHO; World Health Organization, DOC OP END WORK GROU; World Health Organization, DOC INT M PAND INFL; World Health Organization, 2011, PIPOEWG34 WHO	10	53	54	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					200	201		10.1001/jama.2011.960	http://dx.doi.org/10.1001/jama.2011.960			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791CO	21750298				2022-12-28	WOS:000292639400028
J	Appleby, J				Appleby, John			DATA BRIEFING Can we afford the NHS in future?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						*HM TREAS, 2011, HC836 HM TREAS; LANSLEY A, 2011, DAILY TELEGRAPH 0601; OECD, OECD HLTH DAT 2011 F	3	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 12	2011	343								d4321	10.1136/bmj.d4321	http://dx.doi.org/10.1136/bmj.d4321			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	794NX	21750075				2022-12-28	WOS:000292908200005
J	Kowey, PR				Kowey, Peter R.			The Silent Majority	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LIABILITY; REFORM		[Kowey, Peter R.] Main Line Hlth Syst, Lankenau Med Ctr, Wynnewood, PA USA; [Kowey, Peter R.] Main Line Hlth Syst, Inst Med Res, Wynnewood, PA USA; [Kowey, Peter R.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA	Lankenau Medical Center; Jefferson University	Kowey, PR (corresponding author), Main Line Hlth Syst, Lankenau Med Ctr, Wynnewood, PA USA.	koweyp@mlhs.org						Alpert JS, 2011, AM J MED, V124, P187, DOI 10.1016/j.amjmed.2010.10.010; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Dove JT, 2010, J AM COLL CARDIOL, V55, P2801, DOI 10.1016/j.jacc.2010.03.028; *GOV ACC OFF, 2003, MED MALPR IMPL RIS P; Mello MM, 2009, NEW ENGL J MED, V361, P1, DOI 10.1056/NEJMp0903765; Shanafelt TD, 2011, ARCH SURG-CHICAGO, V146, P54, DOI 10.1001/archsurg.2010.292; Tu JV, 1997, NEW ENGL J MED, V336, P1500, DOI 10.1056/NEJM199705223362106	7	2	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					18	19		10.1001/jama.2011.904	http://dx.doi.org/10.1001/jama.2011.904			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	21730231				2022-12-28	WOS:000292378700001
J	Aujesky, D; Roy, PM; Verschuren, F; Righini, M; Osterwalder, J; Egloff, M; Renaud, B; Verhamme, P; Stone, RA; Legal, C; Sanchez, O; Pugh, NA; N'gako, A; Cornuz, J; Hugii, O; Beer, HJ; Perrier, A; Fine, MJ; Yealy, DM				Aujesky, Drahomir; Roy, Pierre-Marie; Verschuren, Franck; Righini, Marc; Osterwalder, Joseph; Egloff, Michael; Renaud, Bertrand; Verhamme, Peter; Stone, Roslyn A.; Legal, Catherine; Sanchez, Olivier; Pugh, Nathan A.; N'gako, Alfred; Cornuz, Jacques; Hugii, Olivier; Beer, Hans-Juerg; Perrier, Arnaud; Fine, Michael J.; Yealy, Donald M.			Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial	LANCET			English	Article							MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; INTRAVENOUS UNFRACTIONATED HEPARIN; VENOUS THROMBOEMBOLIC DISEASE; CLINICAL PROGNOSTIC MODEL; LOW-RISK PATIENTS; EARLY DISCHARGE; ANTICOAGULANT-THERAPY; INITIAL TREATMENT; SEVERITY INDEX	Background Although practice guidelines recommend outpatient care for selected, haemodynamically stable patients with pulmonary embolism, most treatment is presently inpatient based. We aimed to assess non-inferiority of outpatient care compared with inpatient care. Methods We undertook an open-label, randomised non-inferiority trial at 19 emergency departments in Switzerland, France, Belgium, and the USA. We randomly assigned patients with acute, symptomatic pulmonary embolism and a low risk of death (pulmonary embolism severity index risk classes I or II) with a computer-generated randomisation sequence (blocks of 2-4) in a 1:1 ratio to initial outpatient (ie, discharged from hospital <= 24 h after randomisation) or inpatient treatment with subcutaneous enoxaparin (>= 5 days) followed by oral anticoagulation (>= 90 days). The primary outcome was symptomatic, recurrent venous thromboembolism within 90 days; safety outcomes included major bleeding within 14 or 90 days and mortality within 90 days. We used a non-inferiority margin of 4% for a difference between inpatient and outpatient groups. We included all enrolled patients in the primary analysis, excluding those lost to follow-up. This trial is registered with ClinicalTrials.gov, number NCT00425542. Findings Between February, 2007, and June, 2010, we enrolled 344 eligible patients. In the primary analysis, one (0.6%) of 171 outpatients developed recurrent venous thromboembolism within 90 days compared with none of 168 inpatients (95% upper confidence limit [UCL] 2-7%; p=0.011). Only one (0.6%) patient in each treatment group died within 90 days (95% UCL 2.1%; p=0.005), and two (1.2%) of 171 outpatients and no inpatients had major bleeding within 14 days (95% UCL 3.6%; p=0.031). By 90 days, three (1.8%) outpatients but no inpatients had developed major bleeding (95% UCL 4.5%; p=0.086). Mean length of stay was 0.5 days (SD 1.0) for outpatients and 3.9 days (SD 3.1) for inpatients. Interpretation In selected low-risk patients with pulmonary embolism, outpatient care can safely and effectively be used in place of inpatient care.	[Aujesky, Drahomir] Univ Hosp Bern, Univ Klin Allgemeine Innere Med, Inselspital, CH-3010 Bern, Switzerland; [Roy, Pierre-Marie] LUNAM Univ, Angers, France; [Roy, Pierre-Marie] Univ Angers, Angers, France; [Verschuren, Franck] Univ Louvain, Brussels, Belgium; [Righini, Marc; Perrier, Arnaud] Univ Geneva, Geneva, Switzerland; [Osterwalder, Joseph] Cantonal Hosp St Gallen, St Gallen, Switzerland; [Egloff, Michael; Beer, Hans-Juerg] Cantonal Hosp Baden, Baden, Switzerland; [Renaud, Bertrand; N'gako, Alfred] Univ Hosp Henri Mondor, Creteil, France; [Verhamme, Peter] Univ Louvain, Louvain, Belgium; [Fine, Michael J.] Univ Pittsburgh, VA Ctr Hlth Equity Res & Promot, VA Pittsburgh Healthcare Syst, Pittsburgh, PA 15260 USA; [Fine, Michael J.] Univ Pittsburgh, Div Gen Internal Med, Sch Med, Pittsburgh, PA 15260 USA; [Stone, Roslyn A.] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15260 USA; [Yealy, Donald M.] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA 15260 USA; [Legal, Catherine] Univ Argenteuil, Argenteuil, France; [Sanchez, Olivier] Hop Europeen Georges Pompidou, Paris, France; [Cornuz, Jacques; Hugii, Olivier] Univ Lausanne, Lausanne, Switzerland	University of Bern; University Hospital of Bern; Universite d'Angers; Universite Catholique Louvain; University of Geneva; Kantonsspital St. Gallen; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Lausanne	Aujesky, D (corresponding author), Univ Hosp Bern, Univ Klin Allgemeine Innere Med, Inselspital, CH-3010 Bern, Switzerland.	drahomir.aujesky@insel.ch	Roy, Pierre-Marie/AAA-7737-2022; Righini, Marc/AAX-8731-2020; Perrier, Arnaud/M-2263-2014; Hug, Balthasar L./G-1568-2010	Hugli, Olivier/0000-0003-2312-1625; Aujesky, Drahomir/0000-0002-3970-2670; Beer, Jurg Hans/0000-0002-7199-0406	Swiss National Science Foundation [3200B0-1121]; Programme Hospitalier de Recherche Clinique [21-03]; US National Heart, Lung, and Blood Institute [1R01HL085565-01A2]; GlaxoSmithKline; Sanofi-Aventis; Bayer; Biomerieux; Boehringer Ingelheim; Eli Lilly; LFB Biomedicaments; Daiichi-Sankyo; ThromboGenics; Leo; Pfizer; MSD; Menarini; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085565] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Programme Hospitalier de Recherche Clinique; US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); GlaxoSmithKline(GlaxoSmithKline); Sanofi-Aventis(Sanofi-Aventis); Bayer(Bayer AG); Biomerieux; Boehringer Ingelheim(Boehringer Ingelheim); Eli Lilly(Eli Lilly); LFB Biomedicaments; Daiichi-Sankyo(Daiichi Sankyo Company Limited); ThromboGenics; Leo(LEO Pharma); Pfizer(Pfizer); MSD; Menarini(Menarini Group); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Swiss National Science Foundation, Programme Hospitalier de Recherche Clinique, and the US National Heart, Lung, and Blood Institute. Sanofi-Aventis provided free drug supply in the participating European centres.; DA has received honoraria from Sanofi-Aventis and Bayer. PM R has received grants, honoraria, consultancy fees, and payments from GlaxoSmithKline, Sanofi-Aventis, Bayer, Biomerieux, Boehringer Ingelheim, Eli Lilly, and LFB Biomedicaments. PV has received grants, consultancy fees, and payments from Sanofi-Aventis, Bayer, Boehringer Ingelheim, Daiichi-Sankyo, ThromboGenics, Leo, and Pfizer. OH has received grants from Pfizer and MSD. HJB has received honoraria from Sariofi-Aventis, Bayer, Boehringer Ingelheim, Menarini, and GlaxoSmithKline.; This study was supported by grants from the Swiss National Science Foundation (3200B0-1121), the Programme Hospitalier de Recherche Clinique 2007 (21-03), and the US National Heart, Lung, and Blood Institute (1R01HL085565-01A2). Sanofi-Aventis provided free drug supply in the participating European centres. We thank Emmanuelle Le Moigne (Brest, France), David Elkharrat (Boulogne, France), Dominique Elkouri (Nantes, France), Mark Courtney (Chicago, IL, USA), Didier Honnart (Dijon, France), Jeannot Schmidt (Clermont-Ferrand, France), Jeffrey Kline (Charlotte, NC, USA), Yves Poitrineau (Thiers, France), and Bertrand Yersin (Lausanne, Switzerland).	Agterof MJ, 2010, J THROMB HAEMOST, V8, P1235, DOI 10.1111/j.1538-7836.2010.03831.x; Aujesky D, 2007, J INTERN MED, V261, P597, DOI 10.1111/j.1365-2796.2007.01785.x; Aujesky D, 2006, EUR HEART J, V27, P476, DOI 10.1093/eurheartj/ehi588; Aujesky D, 2006, ARCH INTERN MED, V166, P169, DOI 10.1001/archinte.166.2.169; Aujesky D, 2005, AM J RESP CRIT CARE, V172, P1041, DOI 10.1164/rccm.200506-862OC; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Beer JH, 2003, J THROMB HAEMOST, V1, P186, DOI 10.1046/j.1538-7836.2003.00005.x; Buller HR, 2007, NEW ENGL J MED, V357, P1094; Buller HR, 2004, ANN INTERN MED, V140, P867, DOI 10.7326/0003-4819-140-11-200406010-00007; Buller HR, 2003, NEW ENGL J MED, V349, P1695; Campbell IA, 2003, THORAX, V58, P470; Chan ISF, 2003, STAT METHODS MED RES, V12, P37, DOI 10.1191/0962280203sm314ra; Davies CWH, 2007, EUR RESPIR J, V30, P708, DOI 10.1183/09031936.00140506; Donze J, 2008, THROMB HAEMOSTASIS, V100, P943, DOI 10.1160/TH08-05-0285; Erkens PMG, 2010, J THROMB HAEMOST, V8, P2412, DOI 10.1111/j.1538-7836.2010.04041.x; Fiessinger JN, 2005, JAMA-J AM MED ASSOC, V293, P681, DOI 10.1001/jama.293.6.681; Fraga M, 2010, THROMB HAEMOSTASIS, V104, P1258, DOI 10.1160/TH10-07-0426; Heit JA, 1999, ARCH INTERN MED, V159, P445, DOI 10.1001/archinte.159.5.445; Janjua M, 2008, THROMB HAEMOSTASIS, V100, P756, DOI 10.1160/TH08-05-0319; Kaul S, 2006, ANN INTERN MED, V145, P62, DOI 10.7326/0003-4819-145-1-200607040-00011; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Koopman MMW, 1996, NEW ENGL J MED, V334, P682, DOI 10.1056/NEJM199603143341102; Kovacs MJ, 2010, J THROMB HAEMOST, V8, P2406, DOI 10.1111/j.1538-7836.2010.03981.x; Kovacs MJ, 2000, THROMB HAEMOSTASIS, V83, P209; Le Gal G, 2006, THROMB HAEMOSTASIS, V95, P963, DOI 10.1160/TH06-03-0158; Levine M, 1996, NEW ENGL J MED, V334, P677, DOI 10.1056/NEJM199603143341101; Merli G, 2001, ANN INTERN MED, V134, P191, DOI 10.7326/0003-4819-134-3-200102060-00009; OLSSON CG, 2006, MED SCI MONITOR, V12, pP19; Ong BS, 2005, MED J AUSTRALIA, V183, P239, DOI 10.5694/j.1326-5377.2005.tb07027.x; Otero R, 2010, THROMB RES, V126, pE1, DOI 10.1016/j.thromres.2009.09.026; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Siragusa S, 2005, ANN ONCOL, V16, P136, DOI 10.1093/annonc/mdi923; Snow V, 2007, ANN INTERN MED, V146, P204, DOI 10.7326/0003-4819-146-3-200702060-00149; Squizzato A, 2009, EUR RESPIR J, V33, P1148, DOI 10.1183/09031936.00133608; tenCate JW, 1997, NEW ENGL J MED, V337, P657; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; van Bladel ER, 2010, THROMB RES, V126, P481, DOI 10.1016/j.thromres.2010.08.019; Wells PS, 2005, ARCH INTERN MED, V165, P733, DOI 10.1001/archinte.165.7.733; Wells PS, 1998, ARCH INTERN MED, V158, P1809, DOI 10.1001/archinte.158.16.1809; ZONDAG W, 2010, BLOOD, V116, pLBA1	43	411	418	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 2	2011	378	9785					41	48		10.1016/S0140-6736(11)60824-6	http://dx.doi.org/10.1016/S0140-6736(11)60824-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791IU	21703676				2022-12-28	WOS:000292659700032
J	Kamien, RD				Kamien, Randall D.			Knot Your Simple Defect Lines?	SCIENCE			English	Editorial Material							KINETOPLAST DNA		Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA	University of Pennsylvania	Kamien, RD (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.	kamien@physics.upenn.edu		Kamien, Randall/0000-0003-1598-5626				Baas NA, 2009, EUR PHYS J-SPEC TOP, V178, P25, DOI 10.1140/epjst/e2010-01180-8; Dennis MR, 2010, NAT PHYS, V6, P118, DOI 10.1038/NPHYS1504; Shlomai J, 2004, CURR MOL MED, V4, P623, DOI 10.2174/1566524043360096; SIMPSON L, 1971, J MOL BIOL, V56, P443, DOI 10.1016/0022-2836(71)90394-9; Tkalec U, 2011, SCIENCE, V333, P62, DOI 10.1126/science.1205705	5	3	3	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					46	47		10.1126/science.1208526	http://dx.doi.org/10.1126/science.1208526			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719665				2022-12-28	WOS:000292255400040
J	Roediger, HL; McDermott, KB				Roediger, Henry L., III; McDermott, Kathleen B.			Remember When?	SCIENCE			English	Editorial Material							MEMORY		[Roediger, Henry L., III; McDermott, Kathleen B.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA	Washington University (WUSTL)	Roediger, HL (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	roediger@wustl.edu						Bartlett FC., 1995, REMEMBERING STUDY EX, V2nd edn; Edelson M, 2011, SCIENCE, V333, P108, DOI 10.1126/science.1203557; Loftus EF, 2005, LEARN MEMORY, V12, P361, DOI 10.1101/lm.94705; LOFTUS EF, 1978, J EXP PSYCHOL-HUM L, V4, P19, DOI 10.1037/0278-7393.4.1.19; Marsh EJ, 2004, APPL COGNITIVE PSYCH, V18, P491, DOI 10.1002/acp.1001; Meade ML, 2009, MEMORY, V17, P39, DOI 10.1080/09658210802524240; Rajaram S, 2010, PERSPECT PSYCHOL SCI, V5, P649, DOI 10.1177/1745691610388763; Roediger HL, 2001, PSYCHON B REV, V8, P365, DOI 10.3758/BF03196174; ROEDIGER HL, 2000, OXFORD HDB MEMORY, P149; Ross M., 2008, LEARNING MEMORY COMP, V2, P911; Weldon MS, 1997, J EXP PSYCHOL LEARN, V23, P1160, DOI 10.1037/0278-7393.23.5.1160; Weldon MS, 2001, PSYCHOL LEARN MOTIV, V40, P67	12	6	6	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					47	48		10.1126/science.1208565	http://dx.doi.org/10.1126/science.1208565			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	785UF	21719666				2022-12-28	WOS:000292255400041
J	Eastwood, DC; Floudas, D; Binder, M; Majcherczyk, A; Schneider, P; Aerts, A; Asiegbu, FO; Baker, SE; Barry, K; Bendiksby, M; Blumentritt, M; Coutinho, PM; Cullen, D; de Vries, RP; Gathman, A; Goodell, B; Henrissat, B; Ihrmark, K; Kauserud, H; Kohler, A; LaButti, K; Lapidus, A; Lavin, JL; Lee, YH; Lindquist, E; Lilly, W; Lucas, S; Morin, E; Murat, C; Oguiza, JA; Park, J; Pisabarro, AG; Riley, R; Rosling, A; Salamov, A; Schmidt, O; Schmutz, J; Skrede, I; Stenlid, J; Wiebenga, A; Xie, XF; Kues, U; Hibbett, DS; Hoffmeister, D; Hogberg, N; Martin, F; Grigoriev, IV; Watkinson, SC				Eastwood, Daniel C.; Floudas, Dimitrios; Binder, Manfred; Majcherczyk, Andrzej; Schneider, Patrick; Aerts, Andrea; Asiegbu, Fred O.; Baker, Scott E.; Barry, Kerrie; Bendiksby, Mika; Blumentritt, Melanie; Coutinho, Pedro M.; Cullen, Dan; de Vries, Ronald P.; Gathman, Allen; Goodell, Barry; Henrissat, Bernard; Ihrmark, Katarina; Kauserud, Havard; Kohler, Annegret; LaButti, Kurt; Lapidus, Alla; Lavin, Jose L.; Lee, Yong-Hwan; Lindquist, Erika; Lilly, Walt; Lucas, Susan; Morin, Emmanuelle; Murat, Claude; Oguiza, Jose A.; Park, Jongsun; Pisabarro, Antonio G.; Riley, Robert; Rosling, Anna; Salamov, Asaf; Schmidt, Olaf; Schmutz, Jeremy; Skrede, Inger; Stenlid, Jan; Wiebenga, Ad; Xie, Xinfeng; Kuees, Ursula; Hibbett, David S.; Hoffmeister, Dirk; Hogberg, Nils; Martin, Francis; Grigoriev, Igor V.; Watkinson, Sarah C.			The Plant Cell Wall-Decomposing Machinery Underlies the Functional Diversity of Forest Fungi	SCIENCE			English	Article							SERPULA-LACRYMANS; DECAY FUNGI; WOOD; GENOME; MECHANISMS; DIVERSIFICATION; CONVERSION; SYMBIOSIS; LITTER	Brown rot decay removes cellulose and hemicellulose from wood-residual lignin contributing up to 30% of forest soil carbon-and is derived from an ancestral white rot saprotrophy in which both lignin and cellulose are decomposed. Comparative and functional genomics of the "dry rot" fungus Serpula lacrymans, derived from forest ancestors, demonstrated that the evolution of both ectomycorrhizal biotrophy and brown rot saprotrophy were accompanied by reductions and losses in specific protein families, suggesting adaptation to an intercellular interaction with plant tissue. Transcriptome and proteome analysis also identified differences in wood decomposition in S. lacrymans relative to the brown rot Postia placenta. Furthermore, fungal nutritional mode diversification suggests that the boreal forest biome originated via genetic coevolution of above- and below-ground biota.	[Eastwood, Daniel C.] Univ Swansea, Coll Sci, Swansea SA2 8PP, W Glam, Wales; [Floudas, Dimitrios; Binder, Manfred; Hibbett, David S.] Clark Univ, Dept Biol, Worcester, MA 01610 USA; [Majcherczyk, Andrzej; Kuees, Ursula] Univ Gottingen, Busgen Inst, D-37077 Gottingen, Germany; [Schneider, Patrick; Hoffmeister, Dirk] Univ Jena, Hans Knoll Inst, D-07745 Jena, Germany; [Aerts, Andrea; Baker, Scott E.; LaButti, Kurt; Lapidus, Alla; Lindquist, Erika; Lucas, Susan; Riley, Robert; Salamov, Asaf; Schmutz, Jeremy; Grigoriev, Igor V.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Asiegbu, Fred O.] Univ Helsinki, Dept Forest Sci, FIN-00014 Helsinki, Finland; [Baker, Scott E.] Pacific NW Natl Lab, Richland, WA 99352 USA; [Bendiksby, Mika] Univ Oslo, Nat Hist Museum, NO-0138 Blindern, Norway; [Blumentritt, Melanie; Goodell, Barry; Xie, Xinfeng] Univ Maine, Orono, ME 04469 USA; [Coutinho, Pedro M.; Henrissat, Bernard] Univ Aix Marseille 1, UMR CNRS 6098, F-13288 Marseille 9, France; [Coutinho, Pedro M.; Henrissat, Bernard] Univ Aix Marseille 2, UMR CNRS 6098, F-13288 Marseille 9, France; [Cullen, Dan] Forest Prod Lab, Madison, WI 53726 USA; [de Vries, Ronald P.; Wiebenga, Ad] Royal Netherlands Acad Arts & Sci, Fungal Biodivers Ctr, Cent Bur Schimmelcultures, NL-3584 CT Utrecht, Netherlands; [Gathman, Allen; Lilly, Walt] SE Missouri State Univ, Dept Biol, Cape Girardeau, MO 63701 USA; [Goodell, Barry] Virginia Tech, Dept Wood Sci & Forest Prod, Blacksburg, VA 24061 USA; [Ihrmark, Katarina; Rosling, Anna; Stenlid, Jan; Hogberg, Nils] Swedish Univ Agr Sci, Dept Forest Mycol & Pathol, S-75007 Uppsala, Sweden; [Kauserud, Havard; Skrede, Inger] Univ Oslo, Dept Biol, NO-0316 Oslo, Norway; [Kohler, Annegret; Morin, Emmanuelle; Murat, Claude; Martin, Francis] Inst Natl Rech Agron INRA Nancy Univ, INRA Nancy, UMR 1136, F-54280 Champenoux, France; [Lavin, Jose L.; Oguiza, Jose A.; Pisabarro, Antonio G.] Univ Publ Navarra, Dept Agr Prod, Pamplona 31006, Spain; [Lee, Yong-Hwan; Park, Jongsun] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Schmidt, Olaf] Univ Hamburg, Dept Wood Biol, D-21031 Hamburg, Germany; [Watkinson, Sarah C.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	Swansea University; Clark University; University of Gottingen; Friedrich Schiller University of Jena; Hans Knoll Institute (HKI); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Helsinki; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Oslo; University of Maine System; University of Maine Orono; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; United States Department of Agriculture (USDA); United States Forest Service; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Virginia Polytechnic Institute & State University; Swedish University of Agricultural Sciences; University of Oslo; INRAE; Universite de Lorraine; Universidad Publica de Navarra; Seoul National University (SNU); University of Hamburg; University of Oxford	Eastwood, DC (corresponding author), Univ Swansea, Coll Sci, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	d.c.eastwood@swansea.ac.uk	Stenlid, Jan/K-5909-2019; Binder, Manfred/C-8571-2013; Kües, Ursula/B-8280-2008; Baker, Scott E/X-2065-2018; Riley, Robert/AAA-4531-2020; morin, emmanuelle/AAA-1246-2019; Schmutz, Jeremy/N-3173-2013; Majcherczyk, Andrzej/B-8267-2008; Henrissat, Bernard/J-2475-2012; de Vries, Ronald P./F-8125-2011; Kohler, Annegret/AAD-1876-2019; Goodell, Barry/CAI-6720-2022; Murat, Claude/AAA-5226-2020; Rosling, Anna/D-1984-2012; Oguiza, Jose A/K-5147-2014; JL, Lavín/J-7892-2013; Lapidus, Alla L/I-4348-2013; Cullen, Daniel/AAN-5484-2020; Pisabarro, Antonio G./K-3622-2014; Baker, Scott E./ABB-1635-2020; Barry, Kerrie Whitelaw/AAA-5500-2020	Kües, Ursula/0000-0001-9180-4079; Baker, Scott E/0000-0001-5085-3106; Riley, Robert/0000-0003-0224-0975; morin, emmanuelle/0000-0002-7268-972X; Schmutz, Jeremy/0000-0001-8062-9172; Majcherczyk, Andrzej/0000-0002-1616-6983; Henrissat, Bernard/0000-0002-3434-8588; de Vries, Ronald P./0000-0002-4363-1123; Goodell, Barry/0000-0002-7798-7419; Murat, Claude/0000-0003-0685-7307; JL, Lavín/0000-0003-0914-3211; Lapidus, Alla L/0000-0003-0427-8731; Pisabarro, Antonio G./0000-0001-6987-5794; Baker, Scott E./0000-0001-5085-3106; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Blumentritt, Melanie/0000-0003-2172-5599; Rosling, Anna/0000-0002-7003-5941; Park, Jongsun/0000-0003-0786-4701; Eastwood, Daniel/0000-0002-7015-0739; Stenlid, Jan/0000-0002-5344-2094; Skrede, Inger/0000-0002-1113-7403; Grigoriev, Igor/0000-0002-3136-8903; Asiegbu, Fred O/0000-0003-0223-7194	Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; NERC [NE/F01449X/1] Funding Source: UKRI; Natural Environment Research Council [NE/F01449X/1] Funding Source: researchfish	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	J. Schilling, University of Minnesota, and D. Barbara, University of Warwick, critically reviewed the manuscript; T. Marks designed graphics; and B. Wackler and M. Zomorrodi gave technical assistance. Assembly and annotations of S. lacrymans genomes are available at www.jgi.doe.gov/Serpula and DNA Data Bank of Japan/European Molecular Biology Laboratory/GenBank, accessions nos. AECQB00000000 and AEQC00000000. The complete microarray expression data set is available at the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) accession no. GSE27839. The work was conducted by the U.S. Department of Energy Joint Genome Institute and supported by the Office of Science of the U.S. Department of Energy under contract DE-AC02-05CH11231. Further financial support is acknowledged in the supporting online material on Science Online.	Arantes V, 2011, J IND MICROBIOL BIOT, V38, P541, DOI 10.1007/s10295-010-0798-2; Binder M, 2006, MYCOLOGIA, V98, P971, DOI 10.3852/mycologia.98.6.971; Binder M, 2010, MYCOLOGIA, V102, P865, DOI 10.3852/09-288; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Curling SF, 2002, INT BIODETER BIODEGR, V49, P13, DOI 10.1016/S0964-8305(01)00101-9; Eckert AJ, 2006, MOL PHYLOGENET EVOL, V40, P166, DOI 10.1016/j.ympev.2006.03.009; Eriksson K.-E., 1990, MICROBIAL ENZYMATIC; GILBERTSON RL, 1980, MYCOLOGIA, V72, P1, DOI 10.2307/3759417; Goodell B, 1997, J BIOTECHNOL, V53, P133, DOI 10.1016/S0168-1656(97)01681-7; Hibbett DS, 2001, SYST BIOL, V50, P215, DOI 10.1080/10635150151125879; Kauserud H, 2007, MOL ECOL, V16, P3350, DOI 10.1111/j.1365-294X.2007.03387.x; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Lindahl BO, 2002, PLANT SOIL, V242, P123, DOI 10.1023/A:1019650226585; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martin F, 2011, NEW PHYTOL, V190, P818, DOI 10.1111/j.1469-8137.2011.03688.x; MARTIN F, 2007, BIOL FUNGAL CELL MYC, V8, P291; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; NILSSON T, 1979, MYCOLOGIA, V71, P170, DOI 10.2307/3759230; NORTHUP RR, 1995, NATURE, V377, P227, DOI 10.1038/377227a0; Schmidt O, 2000, HOLZFORSCHUNG, V54, P221, DOI 10.1515/HF.2000.038; Schneider P, 2008, FUNGAL GENET BIOL, V45, P1487, DOI 10.1016/j.fgb.2008.08.009; Shimokawa T, 2004, HOLZFORSCHUNG, V58, P305, DOI 10.1515/HF.2004.047; Tlalka M, 2008, APPL ENVIRON MICROB, V74, P2700, DOI 10.1128/AEM.02765-07; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vasiliauskas R, 2007, NEW PHYTOL, V174, P441, DOI 10.1111/j.1469-8137.2007.02014.x; Wymelenberg AV, 2010, APPL ENVIRON MICROB, V76, P3599, DOI 10.1128/AEM.00058-10	28	386	408	7	470	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					762	765		10.1126/science.1205411	http://dx.doi.org/10.1126/science.1205411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21764756	Green Submitted			2022-12-28	WOS:000293512100045
J	Takahashi, S; Tupitsyn, IS; van Tol, J; Beedle, CC; Hendrickson, DN; Stamp, PCE				Takahashi, S.; Tupitsyn, I. S.; van Tol, J.; Beedle, C. C.; Hendrickson, D. N.; Stamp, P. C. E.			Decoherence in crystals of quantum molecular magnets	NATURE			English	Article							COHERENT DYNAMICS; ELECTRON; STATE; GRAVITY	Quantum decoherence is a central concept in physics. Applications such as quantum information processing depend on understanding it; there are even fundamental theories proposed that go beyond quantum mechanics(1-3), in which the breakdown of quantum theory would appear as an 'intrinsic' decoherence, mimicking the more familiar environmental decoherence processes(4). Such applications cannot be optimized, and such theories cannot be tested, until we have a firm handle on ordinary environmental decoherence processes. Here we show that the theory for insulating electronic spin systems can make accurate and testable predictions for environmental decoherence in molecular-based quantum magnets(5). Experiments on molecular magnets have successfully demonstrated quantum-coherent phenomena(6-8) but the decoherence processes that ultimately limit such behaviour were not well constrained. For molecular magnets, theory predicts three principal contributions to environmental decoherence: from phonons, from nuclear spins and from intermolecular dipolar interactions. We use high magnetic fields on single crystals of Fe-8 molecular magnets (in which the Fe ions are surrounded by organic ligands) to suppress dipolar and nuclear-spin decoherence. In these high-field experiments, we find that the decoherence time varies strongly as a function of temperature and magnetic field. The theoretical predictions are fully verified experimentally, and there are no other visible decoherence sources. In these high fields, we obtain a maximum decoherence quality-factor of 1.49 x 10(6); our investigation suggests that the environmental decoherence time can be extended up to about 500 microseconds, with a decoherence quality factor of similar to 6 x 10(7), by optimizing the temperature, magnetic field and nuclear isotopic concentrations.	[Takahashi, S.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Takahashi, S.] Univ Calif Santa Barbara, Inst Terahertz Sci & Technol, Santa Barbara, CA 93106 USA; [Takahashi, S.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Tupitsyn, I. S.; Stamp, P. C. E.] Univ British Columbia, Pacific Inst Theoret Phys, Vancouver, BC V6T 1Z1, Canada; [Tupitsyn, I. S.; Stamp, P. C. E.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [van Tol, J.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Beedle, C. C.; Hendrickson, D. N.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of Southern California; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of British Columbia; University of British Columbia; State University System of Florida; Florida State University; University of California System; University of California San Diego	Takahashi, S (corresponding author), Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA.	susumuta@usc.edu; stamp@phas.ubc.ca	Takahashi, Susumu/ABI-2675-2020; van Tol, Johan/G-4190-2011; Takahashi, Susumu/K-2616-2014	Takahashi, Susumu/0000-0002-1302-2845; van Tol, Johan/0000-0001-6972-2149; Takahashi, Susumu/0000-0002-1302-2845	NSF [DMR-0520481, DMR-0703925, DMR-0654118]; Keck Foundation; NSERC; CIFAR; PITP; John E. Fetzer Memorial Trust [D21-C62]; Center for Philosophy and the Natural Sciences, California State University, Sacramento; State of Florida; DOE	NSF(National Science Foundation (NSF)); Keck Foundation(W.M. Keck Foundation); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIFAR(Canadian Institute for Advanced Research (CIFAR)); PITP; John E. Fetzer Memorial Trust; Center for Philosophy and the Natural Sciences, California State University, Sacramento; State of Florida; DOE(United States Department of Energy (DOE))	This work was supported by the NSF (DMR-0520481, DMR-0703925), the Keck Foundation (S. T. and J.v.T.), NSERC, CIFAR, PITP, the John E. Fetzer Memorial Trust (grant D21-C62) and the Center for Philosophy and the Natural Sciences, California State University, Sacramento (I. S. T. and P. C. E. S.). The National High Magnetic Field Laboratory is supported by NSF Cooperative Agreement DMR-0654118, by the State of Florida, and by the DOE.	Barra AL, 2000, CHEM-EUR J, V6, P1608, DOI 10.1002/(SICI)1521-3765(20000502)6:9<1608::AID-CHEM1608>3.3.CO;2-#; Bertaina S, 2008, NATURE, V453, P203, DOI 10.1038/nature06962; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; Cuccoli A, 1999, EUR PHYS J B, V12, P39, DOI 10.1007/s100510050974; Gatteschi D, 2006, MESOSCOPIC PHYS NANO, P1; HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580; Hanson R, 2008, SCIENCE, V320, P352, DOI 10.1126/science.1155400; Hill S, 2002, INT J MOD PHYS B, V16, P3326, DOI 10.1142/S0217979202014322; Ladd TD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.107401; Leggett AJ, 2002, J PHYS-CONDENS MAT, V14, pR415, DOI 10.1088/0953-8984/14/15/201; LEGGETT AJ, 1987, REV MOD PHYS, V59, P1, DOI 10.1103/RevModPhys.59.1; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Morello A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.197202; Morello A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.207206; Morley GW, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2937630; Park K, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.014426; Penrose R, 1996, GEN RELAT GRAVIT, V28, P581, DOI 10.1007/BF02105068; Prokof'ev NV, 2000, REP PROG PHYS, V63, P669, DOI 10.1088/0034-4885/63/4/204; Schlegel C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.147203; Stamp PCE, 2006, STUD HIST PHILOS M P, V37, P467, DOI 10.1016/j.shpsb.2006.04.003; Stamp PCE, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.014401; 't Hooft G, 1999, CLASSICAL QUANT GRAV, V16, P3263, DOI 10.1088/0264-9381/16/10/316; Takahashi S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.087603; Takahashi S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.047601; Tupitsyn IS, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.132406; van Tol J, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1942533; WIEGHARDT K, 1984, ANGEW CHEM INT EDIT, V23, P77; Xu XD, 2009, NATURE, V459, P1105, DOI 10.1038/nature08120; Yao W, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195301	30	132	132	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2011	476	7358					76	79		10.1038/nature10314	http://dx.doi.org/10.1038/nature10314			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21775988	Green Submitted			2022-12-28	WOS:000293447300032
J	Glazener, C; Boachie, C; Buckley, B; Cochran, C; Dorey, G; Grant, A; Hagen, S; Kilonzo, M; McDonald, A; McPherson, G; Moore, K; Norrie, J; Ramsay, C; Vale, L; N'Dow, J				Glazener, Cathryn; Boachie, Charles; Buckley, Brian; Cochran, Claire; Dorey, Grace; Grant, Adrian; Hagen, Suzanne; Kilonzo, Mary; McDonald, Alison; McPherson, Gladys; Moore, Katherine; Norrie, John; Ramsay, Craig; Vale, Luke; N'Dow, James			Urinary incontinence in men after formal one-to-one pelvic-floor muscle training following radical prostatectomy or transurethral resection of the prostate (MAPS): two parallel randomised controlled trials	LANCET			English	Article							QUALITY-OF-LIFE; SURGICAL TREATMENTS; CONTINENCE; EXERCISES	Background Urinary incontinence is common immediately after prostate surgery. Men are often advised to do pelvic-floor exercises, but evidence to support this is inconclusive. Our aim was to establish if formal one-to-one pelvic floor muscle training reduces incontinence. Methods We undertook two randomised trials in men in the UK who were incontinent 6 weeks after radical prostatectomy (trial 1) or transurethral resection of the prostate (TURP; trial 2) to compare four sessions with a therapist over 3 months with standard care and lifestyle advice only. Randomisation was by remote computer allocation. Our primary endpoints, collected via postal questionnaires, were participants' reports of urinary incontinence and incremental cost per quality-adjusted life year (QALY) after 12 months. Group assignment was masked from outcome assessors, but this masking was not possible for participants or caregivers. We used intention-to-treat analyses to compare the primary outcome at 12 months. This study is registered, number ISRCTN87696430. Findings In the intervention group in trial 1, the rate of urinary incontinence at 12 months (148 [76%] of 196) was not significantly different from the control group (151 [77%] of 195; absolute risk difference [RD] -1.9%, 95% CI -10 to 6). In trial 2, the difference in the rate of urinary incontinence at 12 months (126 [65%] of 194) from the control group was not significant (125 [62%] of 203; RD 3.4%, 95% CI 6 to 13). Adjusting for minimisation factors or doing treatment-received analyses did not change these results in either trial. No adverse effects were reported. In both trials, the intervention resulted in higher mean costs per patient (180 pound and 209 pound respectively) but we did not identify evidence of an economically important difference in QALYs (0.002 [95% CI -0.027 to 0.023] and -0.00003 [-0.026 to 0.026]). Interpretation In settings where information about pelvic-floor exercise is widely available, one-to-one conservative physical therapy for men who are incontinent after prostate surgery is unlikely to be effective or cost effective. The high rates of persisting incontinence after 12 months suggest a substantial unrecognised and unmet need for management in these men.	[Glazener, Cathryn; Boachie, Charles; Cochran, Claire; McDonald, Alison; McPherson, Gladys; Ramsay, Craig] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; [Buckley, Brian] Bladder & Bowel Fdn, Kettering, England; [Dorey, Grace] Univ W England, Fac Hlth & Life Sci, Bristol BS16 1QY, Avon, England; [Grant, Adrian] Univ Aberdeen, Coll Life Sci & Med, Aberdeen AB25 2ZD, Scotland; [Hagen, Suzanne] Glasgow Caledonian Univ, Nursing Midwifery & Allied Hlth Profess Res Unit, Glasgow G4 0BA, Lanark, Scotland; [Kilonzo, Mary; Vale, Luke] Univ Aberdeen, Hlth Econ Res Unit, Aberdeen AB25 2ZD, Scotland; [Moore, Katherine] Univ Alberta, Fac Nursing, Edmonton, AB, Canada; [Norrie, John] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [N'Dow, James] Univ Aberdeen, Acad Urol Unit, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of West England; University of Aberdeen; Glasgow Caledonian University; University of Aberdeen; University of Alberta; University of Glasgow; University of Aberdeen	Glazener, C (corresponding author), Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland.	c.glazener@abdn.ac.uk	Ramsay, Craig/AAD-8249-2021	Ramsay, Craig/0000-0003-4043-7349; Kilonzo, Mary/0000-0002-3450-4536; Cochran, Claire/0000-0001-7349-7685; HAGEN, SUZANNE/0000-0002-9741-9160; Buckley, Brian/0000-0002-6007-9238; Vale, Luke/0000-0001-8574-8429	National Institute of Health Research, Health Technology Assessment (NIHR HTA) [03-14-03]; Chief Scientist Office of the Scottish Government Health Directorates; National Institute for Health Research [03/14/03] Funding Source: researchfish; Chief Scientist Office [NMAHP2, HERU2, HSRU1, HERU1] Funding Source: researchfish	National Institute of Health Research, Health Technology Assessment (NIHR HTA)(National Institute for Health Research (NIHR)); Chief Scientist Office of the Scottish Government Health Directorates; National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	The trial was funded by the National Institute of Health Research, Health Technology Assessment (NIHR HTA) Programme (project number 03-14-03) and will be published in full in Health Technology Assessment. HSRU, HERU, and NMAHP RU are funded by the Chief Scientist Office of the Scottish Government Health Directorates. However, the views expressed in this publication are those of the authors and not necessarily those of the funding bodies or the UK Department of Health. The authors accept full responsibility for the research. The MAPS study group thank all the men who willingly participated in the MAPS trial and completed their questionnaires, diaries, and attended heir therapy appointments. We also thank the staff at each of our centres for recruiting and motivating our participants. Thanks to the MAPS study office staff (Louise Campbell, Diane Collins, Janice Cruden, and Julie Murdoch) for administration of the trial.	Abrams P, 2006, J UROLOGY, V175, P1063, DOI 10.1016/S0022-5347(05)00348-4; Altman D, 2009, INCONTINENCE, P35; Armstrong N, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1288; *BANK ENGL, STAT INT DAT INT EXC; *DEP TRANSP, 1989, COBA 9 MAN; Department of Health, NHS REF COSTS 2008 2; Dorey G, 2009, PHYSIOTHERAPY, V95, P199, DOI 10.1016/j.physio.2009.03.003; Dumoulin C, 2010, COCHRANE DB SYST REV, V1; Floratos DL, 2002, BJU INT, V89, P714, DOI 10.1046/j.1464-410X.2002.02721.x; Frankel SJ, 1998, J CLIN EPIDEMIOL, V51, P677, DOI 10.1016/S0895-4356(98)00044-4; *HM REV CUST, EIM31240 EMPL US OWN; Hunter KF, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001843.pub3; Imamura M, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14400; Kind P., 1999, 172 U YORK YORK HLTH; Lourenco T, 2008, HEALTH TECHNOL ASSES, V12, P1; Lourenco Tania, 2008, BMJ, V337, pa449, DOI 10.1136/bmj.39575.517674.BE; Manassero F, 2007, NEUROUROL URODYNAM, V26, P985, DOI 10.1002/nau.20442; Moore KN, 2008, UROLOGY, V72, P1280, DOI 10.1016/j.urology.2007.12.034; Nagelkerke N, 2000, STAT MED, V19, P1849, DOI 10.1002/1097-0258(20000730)19:14<1849::AID-SIM506>3.0.CO;2-1; *NAT HLTH SERV SCO, 2009, SCOTT HLTH SERV COST; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Smith DP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4817; STASKIN D, 2009, 4 INT CONS INC REC I, P363; Van Kampen M, 1998, UROL INT, V60, P80, DOI 10.1159/000030216; Wallace SA, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001308.PUB2; White IR, 2005, STAT METHODS MED RES, V14, P327, DOI 10.1191/0962280205sm406oa; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	27	77	78	1	50	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2011	378	9788					328	337		10.1016/S0140-6736(11)60751-4	http://dx.doi.org/10.1016/S0140-6736(11)60751-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XL	21741700	Green Accepted, Green Submitted			2022-12-28	WOS:000293615800030
J	Nusinow, DA; Helfer, A; Hamilton, EE; King, JJ; Imaizumi, T; Schultz, TF; Farre, EM; Kay, SA				Nusinow, Dmitri A.; Helfer, Anne; Hamilton, Elizabeth E.; King, Jasmine J.; Imaizumi, Takato; Schultz, Thomas F.; Farre, Eva M.; Kay, Steve A.			The ELF4-ELF3-LUX complex links the circadian clock to diurnal control of hypocotyl growth	NATURE			English	Article							QUANTITATIVE-ANALYSIS; ARTIFICIAL MICRORNAS; FUNCTIONAL GENOMICS; PROTEIN; ELF3; TRANSCRIPTION; COMPONENT; ENCODES; TIME; COINCIDENCE	The circadian clock is required for adaptive responses to daily and seasonal changes in environmental conditions(1-3). Light and the circadian clock interact to consolidate the phase of hypocotyl cell elongation to peak at dawn under diurnal cycles in Arabidopsis thaliana(4-7). Here we identify a protein complex (called the evening complex)-composed of the proteins encoded by EARLY FLOWERING 3 (ELF3), ELF4 and the transcription-factor-encoding gene LUX ARRHYTHMO (LUX; also known as PHYTOCLOCK 1)-that directly regulates plant growth(8-12). ELF3 is both necessary and sufficient to form a complex between ELF4 and LUX, and the complex is diurnally regulated, peaking at dusk. ELF3, ELF4 and LUX are required for the proper expression of the growth-promoting transcription factors encoded by PHYTOCHROME INTERACTING FACTOR 4 (PIF4) and PIF5 (also known as PHYTOCHROME INTERACTING FACTOR 3-LIKE 6) under diurnal conditions(4,6,13). LUX targets the complex to the promoters of PIF4 and PIF5 in vivo. Mutations in PIF4 and/or PIF5 are epistatic to the loss of the ELF4-ELF3-LUX complex, suggesting that regulation of PIF4 and PIF5 is a crucial function of the complex. Therefore, the evening complex underlies the molecular basis for circadian gating of hypocotyl growth in the early evening.	[Nusinow, Dmitri A.; Helfer, Anne; Hamilton, Elizabeth E.; King, Jasmine J.; Imaizumi, Takato; Schultz, Thomas F.; Farre, Eva M.; Kay, Steve A.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Nusinow, Dmitri A.; Helfer, Anne; Hamilton, Elizabeth E.; King, Jasmine J.; Kay, Steve A.] Univ Calif San Diego, Ctr Chronobiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Kay, SA (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	skay@ucsd.edu	Kay, Steve A/F-6025-2011; Nusinow, Dmitri A/K-9129-2013	Kay, Steve A/0000-0002-0402-2878; Nusinow, Dmitri A/0000-0002-0497-1723; Schultz, Thomas/0000-0001-9694-9920; Farre, Eva M./0000-0003-1566-7572	University of California, San Diego; Chancellor's Undergraduate Research Scholarship; European Molecular Biology Organization [ALTF 236-2005]; National Science Foundation [IBN-0416762]; National Institutes of Health [NRSA GM083585, NRSA GM080930, R01 GM79712, R01 GM50006, GM67837]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079712, F32GM083585, R01GM067837, RC2GM092412, F32GM080930, R01GM056006, R01GM050006] Funding Source: NIH RePORTER	University of California, San Diego(University of California System); Chancellor's Undergraduate Research Scholarship; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	P. Y. Pongsawakul illustrated the model in Fig. 4c. We thank G. Breton, T. Hirota, J. Pruneda-Paz, D. Nagel, E. Kolmos and B. J. Cole for critical reading of the manuscript. We also thank J. Halverson, A. L. Quiroz and C. Valdivia for excellent technical assistance. pif4-101 pif5-1 seedlings were a generous gift from S. Lorrain and C. Fankhauser. F. Harmon originally identified the nature of the elf4-3 mutation and designed the dCAPS strategy. This work was supported by a University of California, San Diego, Chancellor's Undergraduate Research Scholarship (to J. J. K.), grants from the European Molecular Biology Organization (ALTF 236-2005 to A. H.), the National Science Foundation (IBN-0416762 to T. F. S.) and the National Institutes of Health (NRSA GM083585 to D.A.N., NRSA GM080930 to E. E. H., R01 GM79712 to T. I., and R01 GM50006 and GM67837 to S.A.K.).	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; de Montaigu A, 2010, TRENDS GENET, V26, P296, DOI 10.1016/j.tig.2010.04.003; Dixon LE, 2011, CURR BIOL, V21, P120, DOI 10.1016/j.cub.2010.12.013; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Harlow E., 1999, USING ANTIBODIES LAB; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; Hazen SP, 2005, PLANT PHYSIOL, V138, P990, DOI 10.1104/pp.105.061408; Helfer A, 2011, CURR BIOL, V21, P126, DOI 10.1016/j.cub.2010.12.021; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Hicks KA, 2001, PLANT CELL, V13, P1281, DOI 10.1105/tpc.13.6.1281; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Khanna R, 2003, PLANT PHYSIOL, V133, P1530, DOI 10.1104/pp.103.030007; Kikis EA, 2005, PLANT J, V44, P300, DOI 10.1111/j.1365-313X.2005.02531.x; Liu XL, 2001, PLANT CELL, V13, P1293, DOI 10.1105/tpc.13.6.1293; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Lorrain S, 2008, PLANT J, V53, P312, DOI 10.1111/j.1365-313X.2007.03341.x; Lu SX, 2009, PLANT PHYSIOL, V150, P834, DOI 10.1104/pp.108.133272; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Michael TP, 2008, PLOS BIOL, V6, P1887, DOI 10.1371/journal.pbio.0060225; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Niwa Y, 2009, PLANT CELL PHYSIOL, V50, P838, DOI 10.1093/pcp/pcp028; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Onai K, 2005, GENES CELLS, V10, P963, DOI 10.1111/j.1365-2443.2005.00892.x; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Para A, 2007, PLANT CELL, V19, P3462, DOI 10.1105/tpc.107.054775; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Rozen S, 2000, Methods Mol Biol, V132, P365; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Thines B, 2010, P NATL ACAD SCI USA, V107, P3257, DOI 10.1073/pnas.0911006107; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Yakir E, 2007, FEBS J, V274, P335, DOI 10.1111/j.1742-4658.2006.05616.x; Yu JW, 2008, MOL CELL, V32, P617, DOI 10.1016/j.molcel.2008.09.026; Zagotta MT, 1996, PLANT J, V10, P691, DOI 10.1046/j.1365-313X.1996.10040691.x	43	525	561	12	179	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					398	U161		10.1038/nature10182	http://dx.doi.org/10.1038/nature10182			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21753751	Green Accepted			2022-12-28	WOS:000292911200047
J	Stuber, GD; Sparta, DR; Stamatakis, AM; van Leeuwen, WA; Hardjoprajitno, JE; Cho, S; Tye, KM; Kempadoo, KA; Zhang, F; Deisseroth, K; Bonci, A				Stuber, Garret D.; Sparta, Dennis R.; Stamatakis, Alice M.; van Leeuwen, Wieke A.; Hardjoprajitno, Juanita E.; Cho, Saemi; Tye, Kay M.; Kempadoo, Kimberly A.; Zhang, Feng; Deisseroth, Karl; Bonci, Antonello			Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking	NATURE			English	Article							MIDBRAIN DOPAMINE NEURONS; BASOLATERAL AMYGDALA; COCAINE-SEEKING; BEHAVIOR; CORE; RELEASE; DISCONNECTION; INVOLVEMENT; MOTIVATION; INTERFACE	The basolateral amygdala (BLA) has a crucial role in emotional learning irrespective of valence(1-5,21-23). The BLA projection to the nucleus accumbens (NAc) is thought to modulate cue-triggered motivated behaviours(4,6,7,24,25), but our understanding of the interaction between these two brain regions has been limited by the inability to manipulate neural-circuit elements of this pathway selectively during behaviour. To circumvent this limitation, we used in vivo optogenetic stimulation or inhibition of glutamatergic fibres from the BLA to the NAc, coupled with intracranial pharmacology and ex vivo electrophysiology. Here we show that optical stimulation of the pathway from the BLA to the NAc in mice reinforces behavioural responding to earn additional optical stimulation of these synaptic inputs. Optical stimulation of these glutamatergic fibres required intra-NAc dopamine D1-type receptor signalling, but not D2-type receptor signalling. Brief optical inhibition of fibres from the BLA to the NAc reduced cue-evoked intake of sucrose, demonstrating an important role of this specific pathway in controlling naturally occurring reward-related behaviour. Moreover, although optical stimulation of glutamatergic fibres from the medial prefrontal cortex to the NAc also elicited reliable excitatory synaptic responses, optical self-stimulation behaviour was not observed by activation of this pathway. These data indicate that whereas the BLA is important for processing both positive and negative affect, the glutamatergic pathway from the BLA to the NAc, in conjunction with dopamine signalling in the NAc, promotes motivated behavioural responding. Thus, optogenetic manipulation of anatomically distinct synaptic inputs to the NAc reveals functionally distinct properties of these inputs in controlling reward-seeking behaviours.	[Stuber, Garret D.; Sparta, Dennis R.; Stamatakis, Alice M.] Univ N Carolina, UNC Neurosci Ctr, Dept Psychiat, Chapel Hill, NC 27599 USA; [Stuber, Garret D.; Sparta, Dennis R.; Stamatakis, Alice M.] Univ N Carolina, UNC Neurosci Ctr, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Stuber, Garret D.; Sparta, Dennis R.; van Leeuwen, Wieke A.; Hardjoprajitno, Juanita E.; Cho, Saemi; Tye, Kay M.; Kempadoo, Kimberly A.; Bonci, Antonello] Univ Calif San Francisco, Wheeler Ctr Neurobiol Drug Addict, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94608 USA; [Tye, Kay M.; Zhang, Feng; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Tye, Kay M.; Zhang, Feng; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Bonci, Antonello] NIDA, Intramural Res Program, Baltimore, MD 21224 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Stuber, GD (corresponding author), Univ N Carolina, UNC Neurosci Ctr, Dept Psychiat, Chapel Hill, NC 27599 USA.	gstuber@med.unc.edu	Stuber, Garret/E-1160-2011; Macrae, Rhiannon/AAX-1536-2020; , UNC Neuroscience Microscopy Core/AAE-8305-2022; Tye, Kay/J-6158-2013; Core, Vector/CAF-4832-2022	Tye, Kay/0000-0002-2435-0182; Stuber, Garret/0000-0003-1730-4855	NARSAD; ABMRF; Foundation of Hope; NIDA [DA029325]; Psychiatry Department at UNC Chapel Hill; State of California through the University of California at San Francisco;  [F32AA018610]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA018610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA029325, R01DA032750] Funding Source: NIH RePORTER	NARSAD(NARSAD); ABMRF; Foundation of Hope; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Psychiatry Department at UNC Chapel Hill; State of California through the University of California at San Francisco; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Phillips, V. Kharazia, A. Adamantidis and H.-C. Tsai for assistance and advice. We also thank V. Gukassyan and the UNC Neuroscience Center microscopy core facility. This study was supported by funds from NARSAD, ABMRF, The Foundation of Hope, and NIDA (DA029325), by startup funds provided by the Psychiatry Department at UNC Chapel Hill (G. D. S.) and by the State of California through the University of California at San Francisco (A. B.). D. R. S. was supported by F32AA018610.	Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Bromberg-Martin ES, 2009, NEURON, V63, P119, DOI 10.1016/j.neuron.2009.06.009; CADOR M, 1989, NEUROSCIENCE, V30, P77, DOI 10.1016/0306-4522(89)90354-0; Di Ciano P, 2004, J NEUROSCI, V24, P7167, DOI 10.1523/JNEUROSCI.1581-04.2004; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Floresco SB, 1998, EUR J NEUROSCI, V10, P1241, DOI 10.1046/j.1460-9568.1998.00133.x; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Jones JL, 2010, BIOL PSYCHIAT, V67, P737, DOI 10.1016/j.biopsych.2009.11.006; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McFarland K, 2003, J NEUROSCI, V23, P3531; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Setlow B, 2002, BEHAV NEUROSCI, V116, P267, DOI 10.1037//0735-7044.116.2.267; Shabel SJ, 2009, P NATL ACAD SCI USA, V106, P15031, DOI 10.1073/pnas.0905580106; Shiflett MW, 2010, EUR J NEUROSCI, V32, P1735, DOI 10.1111/j.1460-9568.2010.07439.x; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; WRIGHT CI, 1995, J COMP NEUROL, V361, P383, DOI 10.1002/cne.903610304; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	26	564	580	1	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2011	475	7356					377	U129		10.1038/nature10194	http://dx.doi.org/10.1038/nature10194			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21716290	Green Accepted, Green Submitted			2022-12-28	WOS:000292911200042
J	Hodge, JG; Brown, EF				Hodge, James G., Jr.; Brown, Erin Fuse			Assessing Liability for Health Care Entities That Insufficiently Prepare for Catastrophic Emergencies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hodge, James G., Jr.] Arizona State Univ, Sandra Day OConnor Coll Law, Ross Blakley Lib, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Hodge, JG (corresponding author), Arizona State Univ, Sandra Day OConnor Coll Law, Ross Blakley Lib, Room 318,POB 877906, Tempe, AZ 85287 USA.	james.hodge.1@asu.edu		Fuse Brown, Erin/0000-0002-6821-5345				FINK S, 2011, NY TIMES        0320; Maldin B, 2007, BIOSECUR BIOTERROR, V5, P43, DOI 10.1089/bsp.2006.0034; Niska R. W., 2011, NATL HLTH STAT REPOR, V37; The Joint Commission, 2005, SURG HOSP PROV SAF C; *U NC GILL SCH GLO, GOOD SAM ENT LIAB PR	5	18	18	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2011	306	3					308	309		10.1001/jama.2011.996	http://dx.doi.org/10.1001/jama.2011.996			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794BS	21771993				2022-12-28	WOS:000292870500026
J	Woloshin, S; Schwartz, LM				Woloshin, Steven; Schwartz, Lisa M.			Communicating Data About the Benefits and Harms of Treatment A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							RISK COMMUNICATION; INFORMATION; FORMATS	Background: Despite limited evidence, it is often asserted that natural frequencies (for example, 2 in 1000) are the best way to communicate absolute risks. Objective: To compare comprehension of treatment benefit and harm when absolute risks are presented as natural frequencies, percents, or both. Design: Parallel-group randomized trial with central allocation and masking of investigators to group assignment, conducted through an Internet survey in September 2009. (ClinicalTrials.gov registration number: NCT00950014) Setting: National sample of U. S. adults randomly selected from a professional survey firm's research panel of about 30 000 households. Participants: 2944 adults aged 18 years or older (all with complete follow-up). Intervention: Tables presenting absolute risks in 1 of 5 numeric formats: natural frequency (x in 1000), variable frequency (x in 100, x in 1000, or x in 10 000, as needed to keep the numerator >1), percent, percent plus natural frequency, or percent plus variable frequency. Measurements: Comprehension as assessed by 18 questions (primary outcome) and judgment of treatment benefit and harm. Results: The average number of comprehension questions answered correctly was lowest in the variable frequency group and highest in the percent group (13.1 vs. 13.8; difference, 0.7 [95% CI, 0.3 to 1.1]). The proportion of participants who "passed" the comprehension test (>= 13 correct answers) was lowest in the natural and variable frequency groups and highest in the percent group (68% vs. 73%; difference, 5 percentage points [CI, 0 to 10 percentage points]). The largest format effect was seen for the 2 questions about absolute differences: the proportion correct in the natural frequency versus percent groups was 43% versus 72% (P < 0.001) and 73% versus 87% (P < 0.001). Limitation: Even when data were presented in the percent format, one third of participants failed the comprehension test. Conclusion: Natural frequencies are not the best format for communicating the absolute benefits and harms of treatment. The more succinct percent format resulted in better comprehension: Comprehension was slightly better overall and notably better for absolute differences.	Vet Affairs Outcomes Grp, White River Jct, VT USA; Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA	Dartmouth College	Schwartz, LM (corresponding author), Dept Vet Affairs Med Ctr, Vet Affairs Outcomes Grp 111B, White River Jct, VT 05009 USA.				Attorney General Consumer and Prescriber Education grant program; Robert Wood Johnson Pioneer Program; National Cancer Institute	Attorney General Consumer and Prescriber Education grant program; Robert Wood Johnson Pioneer Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the Attorney General Consumer and Prescriber Education grant program, the Robert Wood Johnson Pioneer Program, and the National Cancer Institute.	Baker LC, 2003, VALIDITY SURVEY HLTH; Chang L, 2009, PUBLIC OPIN QUART, V73, P641, DOI 10.1093/poq/nfp075; Cuite CL, 2008, MED DECIS MAKING, V28, P377, DOI 10.1177/0272989X08315246; Elwyn G, 2006, BMJ-BRIT MED J, V333, P417, DOI 10.1136/bmj.38926.629329.AE; FISCHHOFF B, 2010, BEHAV FDN POLICY; GIGERENZER G, 1995, PSYCHOL REV, V102, P684, DOI 10.1037/0033-295X.102.4.684; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Girotto V, 2001, COGNITION, V78, P247, DOI 10.1016/S0010-0277(00)00133-5; Grimes DA, 1999, OBSTET GYNECOL, V93, P910, DOI 10.1016/S0029-7844(98)00567-5; KROTKI K, 2001, P 53 C INT STAT I 22; *MED HEALTHC PROD, 2005, GUID COMM RISKS BEN; Rosenbaum SE, 2010, J CLIN EPIDEMIOL, V63, P620, DOI 10.1016/j.jclinepi.2009.12.014; SCHUNEMANN HJ, 2009, COCHRANE HDB; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; Trevena LJ, 2006, J EVAL CLIN PRACT, V12, P13, DOI 10.1111/j.1365-2753.2005.00596.x; Visschers VHM, 2009, RISK ANAL, V29, P267, DOI 10.1111/j.1539-6924.2008.01137.x; Waters EA, 2006, J HEALTH COMMUN, V11, P167, DOI 10.1080/10810730500526695; Woloshin S, 2000, MED DECIS MAKING, V20, P298, DOI 10.1177/0272989X0002000306; Woloshin S, 2007, ANN INTERN MED, V146, P256, DOI 10.7326/0003-4819-146-4-200702200-00004; Yamagishi K, 1997, APPL COGNITIVE PSYCH, V11, P495, DOI 10.1002/(SICI)1099-0720(199712)11:6<495::AID-ACP481>3.0.CO;2-J; [No title captured]	22	89	90	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2					87	U70		10.7326/0003-4819-155-2-201107190-00004	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	793KW	21768582				2022-12-28	WOS:000292822000015
J	Cohen, CJ; Andrade-Villanueva, J; Clotet, B; Fourie, J; Johnson, MA; Ruxrungtham, K; Wu, H; Zorrilla, C; Crauwels, H; Rimsky, LT; Vanveggel, S; Boven, K				Cohen, Calvin J.; Andrade-Villanueva, Jaime; Clotet, Bonaventura; Fourie, Jan; Johnson, Margaret A.; Ruxrungtham, Kiat; Wu, Hao; Zorrilla, Carmen; Crauwels, Herta; Rimsky, Laurence T.; Vanveggel, Simon; Boven, Katia		THRIVE Study Grp	Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial	LANCET			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; COMBINATION THERAPY; PROTEASE-INHIBITOR; DAILY LAMIVUDINE; CYSTATIN-C; EMTRICITABINE; ZIDOVUDINE; TENOFOVIR; CREATININE; NEVIRAPINE	Background The non-nucleoside reverse transcriptase inhibitor (NNRTI), rilpivirine (TMC278; Tibotec Pharmaceuticals, County Cork, Ireland), had equivalent sustained efficacy to efavirenz in a phase 2b trial in treatment-naive patients infected with HIV-1, but fewer adverse events. We aimed to assess non-inferiority of rilpivirine to efavirenz in a phase 3 trial with common background nucleoside or nucleotide reverse transcriptase inhibitors (N[t]RTIs). Methods We undertook a 96-week, phase 3, randomised, double-blind, double-dummy, non-inferiority trial in 98 hospitals or medical centres in 21 countries. We enrolled adults (>= 18 years) not previously given antiretroviral therapy and with a screening plasma viral load of 5000 copies per mL or more and viral sensitivity to background N(t)RTIs. We randomly allocated patients (1:1) using a computer-generated interactive web-response system to receive oral rilpivirine 25 mg once daily or efavirenz 600 mg once daily; all patients received an investigator-selected regimen of background N(t)RTIs (tenofovir-disoproxil-fumarate plus emtricitabine, zidovudine plus lamivudine, or abacavir plus lamivudine). The primary outcome was non-inferiority (12% margin on logistic regression analysis) at 48 weeks in terms of confirmed response (viral load <50 copies per mL, defined by the intent-to-treat time to loss of virologic response [TLOVR] algorithm) in all patients who received at least one dose of study drug. This study is registered with ClinicalTrials.gov, number NCT00543725. Findings From May 22,2008, we screened 947 patients and enrolled 340 to each group. 86% of patients (291 of 340) who received at least one dose of rilpivirine responded, compared with 82% of patients (276 of 338) who received at least one dose of efavirenz (difference 3.5% [95% CI -1.7 to 8.8]; p(non-inferiority)<0.0001). Increases in CD4 cell counts were much the same between groups. 7% of patients (24 of 340) receiving rilpivirine had a virological failure compared with 5% of patients (18 of 338) receiving efavirenz. 4% of patients (15) in the rilpivirine group and 7% (25) in the efavirenz group discontinued treatment due to adverse events. Grade 2-4 treatment-related adverse events were less common with rilpivirine (16% [54 patients]) than they were with efavirenz (31% [104]; p<0.0001), as were rash and dizziness (p<0.0001 for both) and increases in lipid levels were significantly lower with rilpivirine than they were with efavirenz (p<0.0001). Interpretation Despite a slightly increased incidence of virological failures, a favourable safety profile and non-inferior efficacy compared with efavirenz means that rilpivirine could be a new treatment option for treatment-naive patients infected with HIV-1.	[Cohen, Calvin J.] Community Res Initiat New England, Boston, MA 02215 USA; [Andrade-Villanueva, Jaime] Univ Guadalajara, Hosp Civil Guadalajara, Ctr Univ Ciencias Salud, Guadalajara, Jalisco, Mexico; [Clotet, Bonaventura] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, E-08193 Barcelona, Spain; [Clotet, Bonaventura] Univ Autonoma Barcelona, IrsiCaixa Fdn, E-08193 Barcelona, Spain; [Fourie, Jan] Fourie Med Ctr, Dundee, Kwazulu Natal, South Africa; [Johnson, Margaret A.] Royal Free Hosp, London NW3 2QG, England; [Ruxrungtham, Kiat] Chulalongkorn Univ, Fac Med, HIV NAT, Thai Red Cross AIDS Res Ctr, Bangkok 10330, Thailand; [Ruxrungtham, Kiat] Chulalongkorn Univ, Fac Med, Dept Med, Bangkok 10330, Thailand; [Wu, Hao] Beijing Youan Hosp, Beijing, Peoples R China; [Zorrilla, Carmen] Univ Puerto Rico, Maternal Infant Studies Ctr, Rio Piedras, PR 00931 USA; [Crauwels, Herta; Rimsky, Laurence T.; Vanveggel, Simon] Tibotec, Beerse, Belgium; [Boven, Katia] Tibotec, Titusville, NJ USA	Universidad de Guadalajara; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Institut de Recerca de la Sida - IrsiCaixa; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University; Capital Medical University	Cohen, CJ (corresponding author), Community Res Initiat New England, Boston, MA 02215 USA.	ccohen@crine.org	; Andrade-Villanueva, Jaime Federico/GPK-6845-2022	Ruxrungtham, Kiat/0000-0001-7348-2352; Andrade-Villanueva, Jaime Federico/0000-0003-1948-655X	Tibotec; Gilead; Bristol-Myers Squibb; Merck, Sharp Dohme; Tobira; ViiV Healthcare; Boehringer Ingelheim; Tibotec Therapeutics; Abbott; GlaxoSmithKline; Janssen-Cilag; Pfizer; F Hoffmann-La Roche; National Science and Technology Development Agency; BIOTEC; Ministry of Science and Technology, Thailand; National Research University; Ratchadaphiseksomphot Endowment Fund [HR1161A]; Avexa; Advent	Tibotec; Gilead(Gilead Sciences); Bristol-Myers Squibb(Bristol-Myers Squibb); Merck, Sharp Dohme(Merck & Company); Tobira; ViiV Healthcare; Boehringer Ingelheim(Boehringer Ingelheim); Tibotec Therapeutics; Abbott(Abbott Laboratories); GlaxoSmithKline(GlaxoSmithKline); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); F Hoffmann-La Roche(Hoffmann-La Roche); National Science and Technology Development Agency; BIOTEC; Ministry of Science and Technology, Thailand; National Research University; Ratchadaphiseksomphot Endowment Fund; Avexa; Advent	CJC has received research funding from Tibotec, Gilead, Bristol-Myers Squibb, Merck, Sharp & Dohme, Tobira, and ViiV Healthcare; has received speakers' honoraria from Tibotec, Gilead, Bristol-Myers Squibb, and Merck, Sharp & Dohme; and is on advisory boards for Gilead, Tibotec, Merck, Sharp & Dohme, Abbott, Tobira, and Bristol-Myers Squibb. JA-V has received research grants or honoraria for participation in advisory boards or conferences from Boehringer Ingelheim, Bristol-Myers Squibb, Tibotec Therapeutics, Abbott, Merck, Sharp & Dohme, and ViiV Healthcare. BC has received research funding, consultancy fees, lecture sponsorships from, or has served on advisory boards for Abbott, Boehringer Ingelheim, Gilead, GlaxoSmithKline, ViiV Healthcare, Janssen-Cilag, Merck, Sharp & Dohme, and Pfizer. JF and HW declare no conflicts of interest. MAJ has received honoraria from Bristol-Myers Squibb, GlaxoSmithKline, Tibotec, ViiV Healthcare, Abbott, and Merck, Sharp & Dohme. KR has received consultancy fees, or honoraria, travel grants, or research grants from Tibotec, F Hoffmann-La Roche, Merck, Sharp & Dohme, Bristol-Myers Squibb, Gilead, Abbott, and GlaxoSmithKline; has received the Professional Researcher Strengthen Grant from the National Science and Technology Development Agency, BIOTEC, Ministry of Science and Technology, Thailand, the National Research University Project of CHE, and the Ratchadaphiseksomphot Endowment Fund (HR1161A). CZ has received grants or research support from Pfizer, Tibotec, Bristol-Myers Squibb, Avexa, and Advent, and received consultancy fees from Tibotec. HC, LTR, SV, and KB are all full time employees of Tibotec.	[Anonymous], 2002, CLIN CONS ACC TRAD A; [Anonymous], 2011, GUID US ANT AG HIV 1, P1; *BRIST MYERS SQUIB, 2010, FDA LAB SUST EF CAPS; *DAIDS, 2004, DIV AIDS DAIDS TABL; DeJesus E, 2004, CLIN INFECT DIS, V39, P1038, DOI 10.1086/424009; DeJesus E, 2004, CLIN INFECT DIS, V39, P411, DOI 10.1086/422143; Desmidt M, 2009, 12 EUR AIDS C COL GE; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Goebel F, 2006, AIDS, V20, P1721, DOI 10.1097/01.aids.0000242818.65215.bd; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; HODDER S, 2010, 48 ANN M INF DIS SOC; Hoek FJ, 2003, NEPHROL DIAL TRANSPL, V18, P2024, DOI 10.1093/ndt/gfg349; Johnson Victoria A, 2009, Top HIV Med, V17, P138; Laterza OF, 2002, CLIN CHEM, V48, P699; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LOZANO IS, 2003, ANTIVIR THER S, V8, P337; Manfredi R, 2004, JAIDS-J ACQ IMM DEF, V35, P492, DOI 10.1097/00126334-200404150-00007; Mbuagbaw LCE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004246.pub3; Menezes P, 2011, HIV MED, V12, P183, DOI 10.1111/j.1468-1293.2010.00867.x; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; Moyle GJ, 2005, JAIDS-J ACQ IMM DEF, V38, P417, DOI 10.1097/01.qai.0000147521.34369.c9; NELSON M, 2010, J INT AIDS SOC S4, V13, pP210; Perez-Molina Jose A, 2002, HIV Clin Trials, V3, P279, DOI 10.1310/3Q91-YT2D-BUT4-8HN6; PICCHIO G, 2010, 18 INT AIDS C VIENN; Pozniak AL, 2006, JAIDS-J ACQ IMM DEF, V43, P535; Pozniak AL, 2010, AIDS, V24, P55, DOI 10.1097/QAD.0b013e32833032ed; Pulido F, 2004, JAIDS-J ACQ IMM DEF, V35, P343, DOI 10.1097/00126334-200404010-00003; Rimsky L, 2010, 50 INT C ANT AG CHEM; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Tombuyzer L, 2009, ANTIVIR THER, V14, P103; van Leeuwen R, 2003, AIDS, V17, P987, DOI 10.1097/00002030-200305020-00007; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Wilkin A, 2010, 19 ANN CAN C HIV AID; 2011, FDA LABEL EDURANT RI	35	297	311	0	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2011	378	9787					229	237		10.1016/S0140-6736(11)60983-5	http://dx.doi.org/10.1016/S0140-6736(11)60983-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798JD	21763935				2022-12-28	WOS:000293201100030
J	Kralj, JM; Hochbaum, DR; Douglass, AD; Cohen, AE				Kralj, Joel M.; Hochbaum, Daniel R.; Douglass, Adam D.; Cohen, Adam E.			Electrical Spiking in Escherichia coli Probed with a Fluorescent Voltage-Indicating Protein	SCIENCE			English	Article							FLAGELLAR MOTOR; TRANSPORT; PHOTOTROPHY	Bacteria have many voltage-and ligand-gated ion channels, and population-level measurements indicate that membrane potential is important for bacterial survival. However, it has not been possible to probe voltage dynamics in an intact bacterium. Here we developed a method to reveal electrical spiking in Escherichia coli. To probe bacterial membrane potential, we engineered a voltage-sensitive fluorescent protein based on green-absorbing proteorhodopsin. Expression of the proteorhodopsin optical proton sensor (PROPS) in E. coli revealed electrical spiking at up to 1 hertz. Spiking was sensitive to chemical and physical perturbations and coincided with rapid efflux of a small-molecule fluorophore, suggesting that bacterial efflux machinery may be electrically regulated.	[Kralj, Joel M.; Cohen, Adam E.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Hochbaum, Daniel R.] Harvard Univ, Sch Engn & Appl Sci, Appl Phys Program, Cambridge, MA 02138 USA; [Douglass, Adam D.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Cohen, Adam E.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Harvard University	Cohen, AE (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	cohen@chemistry.harvard.edu		Hochbaum, Daniel/0000-0001-6220-6651	Harvard Center for Brain Science; Intelligence Community Postdoctoral Fellowship; National Science Foundation; Helen Hay Whitney Postdoctoral Fellowship; Charles A. King Trust	Harvard Center for Brain Science; Intelligence Community Postdoctoral Fellowship; National Science Foundation(National Science Foundation (NSF)); Helen Hay Whitney Postdoctoral Fellowship; Charles A. King Trust	We thank K. Rothschild for helpful discussions and for the GPR plasmid. We also thank H. Berg, R. Losick, J. Yuan, H. Inada, A. Garner, and D. Kahne for helpful discussions. G. Miesenbock provided the pHluorin plasmid. A. Fields, H. Bayraktar, V. Venkatachalam, and L. Bane helped with measurements. This work was supported by the Harvard Center for Brain Science, an Intelligence Community Postdoctoral Fellowship (J. M. K.), a National Science Foundation Graduate Fellowship (D. R. H.), a Helen Hay Whitney Postdoctoral Fellowship (A. D. D.), and a Charles A. King Trust Postdoctoral Fellowship (A. D. D). J. M. K., A. D. D., and A. E. C. have applied for a patent on PROPS as a sensor of membrane potential.	Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Bohnert JA, 2010, ANTIMICROB AGENTS CH, V54, P3770, DOI 10.1128/AAC.00620-10; Dioumaev AK, 2003, BIOCHEMISTRY-US, V42, P6582, DOI 10.1021/bi034253r; FUNG DC, 1995, NATURE, V375, P809, DOI 10.1038/375809a0; INGLEDEW WJ, 1984, MICROBIOL REV, V48, P222, DOI 10.1128/MMBR.48.3.222-271.1984; JOSHI AK, 1989, J BIOL CHEM, V264, P2126; Kolodner P, 1996, P NATL ACAD SCI USA, V93, P11618, DOI 10.1073/pnas.93.21.11618; Lo CJ, 2007, BIOPHYS J, V93, P294, DOI 10.1529/biophysj.106.095265; Martinac B, 2008, PHYSIOL REV, V88, P1449, DOI 10.1152/physrev.00005.2008; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; NOUMI T, 1987, FEBS LETT, V213, P381, DOI 10.1016/0014-5793(87)81526-0; Novo D, 1999, CYTOMETRY, V35, P55, DOI 10.1002/(SICI)1097-0320(19990101)35:1<55::AID-CYTO8>3.0.CO;2-2; Pucihar G., 2009, JOVE-J VIS EXP, V1659, DOI [10.3791/1659, DOI 10.3791/1659]; SPROTT GD, 1976, PHOTOCHEM PHOTOBIOL, V24, P21, DOI 10.1111/j.1751-1097.1976.tb06793.x; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365	16	228	235	5	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					345	348		10.1126/science.1204763	http://dx.doi.org/10.1126/science.1204763			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764748				2022-12-28	WOS:000292732000044
J	Sapolsky, RM				Sapolsky, Robert M.			Sympathy for the CEO	SCIENCE			English	Editorial Material							BEHAVIOR; STRESS; PHYSIOLOGY; PRIMATES		[Sapolsky, Robert M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Sapolsky, Robert M.] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA; [Sapolsky, Robert M.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Sapolsky, RM (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	sapolsky@stanford.edu						Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; Alberts SC, 1996, ANIM BEHAV, V51, P1269, DOI 10.1006/anbe.1996.0131; BRADY JV, 1958, J EXP ANAL BEHAV, V1, P69, DOI 10.1901/jeab.1958.1-69; CLARKE AS, 1995, AM J PRIMATOL, V37, P103, DOI 10.1002/ajp.1350370205; Gesquiere LR, 2011, SCIENCE, V333, P357, DOI 10.1126/science.1207120; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; MAROT M, 2005, SOCIAL DETERMINANTS; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SAPOLSKY RM, 1983, AM J PRIMATOL, V5, P365, DOI 10.1002/ajp.1350050406; Shively CA, 1997, BIOL PSYCHIAT, V41, P871, DOI 10.1016/S0006-3223(96)00185-0; WEISS JM, 1968, J COMP PHYSIOL PSYCH, V65, P251, DOI 10.1037/h0025562	11	9	9	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					293	294		10.1126/science.1209620	http://dx.doi.org/10.1126/science.1209620			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764734				2022-12-28	WOS:000292732000025
J	Park, JE; Heo, I; Tian, Y; Simanshu, DK; Chang, H; Jee, D; Patel, DJ; Kim, VN				Park, Jong-Eun; Heo, Inha; Tian, Yuan; Simanshu, Dhirendra K.; Chang, Hyeshik; Jee, David; Patel, Dinshaw J.; Kim, V. Narry			Dicer recognizes the 5 ' end of RNA for efficient and accurate processing	NATURE			English	Article							C-ELEGANS; MICRORNA BIOGENESIS; BINDING-PROTEIN; INTERFERENCE; DROSOPHILA; CELLS; MATURATION; URIDYLATION; MECHANISMS; PATHWAYS	A hallmark of RNA silencing is a class of approximately 22-nucleotide RNAs that are processed from double-stranded RNA precursors by Dicer. Accurate processing by Dicer is crucial for the functionality of microRNAs (miRNAs). The current model posits that Dicer selects cleavage sites by measuring a set distance from the 3' overhang of the double-stranded RNA terminus. Here we report that human Dicer anchors not only the 3' end but also the 5' end, with the cleavage site determined mainly by the distance (similar to 2 nucleotides) from the 5' end (5' counting rule). This cleavage requires a 5'-terminal phosphate group. Further, we identify a novel basic motif (5' pocket) in human Dicer that recognizes the 5'-phosphorylated end. The 5' counting rule and the 5' anchoring residues are conserved in Drosophila Dicer-1, but not in Giardia Dicer. Mutations in the 5' pocket reduce processing efficiency and alter cleavage sites in vitro. Consistently, miRNA biogenesis is perturbed in vivo when Dicer-null embryonic stem cells are replenished with the 5'-pocket mutant. Thus, 5'-end recognition by Dicer is important for precise and effective biogenesis of miRNAs. Insights from this study should also afford practical benefits to the design of small hairpin RNAs.	[Park, Jong-Eun; Heo, Inha; Chang, Hyeshik; Jee, David; Kim, V. Narry] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Tian, Yuan; Simanshu, Dhirendra K.; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Seoul National University (SNU); Memorial Sloan Kettering Cancer Center	Kim, VN (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	narrykim@snu.ac.kr	PARK, JONGEUN/AAG-9677-2019; Simanshu, Dhirendra/B-3361-2008	PARK, JONGEUN/0000-0002-1687-2423; Chang, Hyeshik/0000-0002-9812-8015; Simanshu, Dhirendra/0000-0002-9717-4618	National Research Foundation [2010000021, 20100020415]; Ministry of Education, Science and Technology; National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068776] Funding Source: NIH RePORTER	National Research Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to G. Hannon for Dicer-null mouse ES cells; J. Doudna for Giardia Dicer cDNA; and M. Siomi for Drosophila Dicer-1, Dicer-2, Loqs-PB and R2D2 constructs. We also thank the members of the V.N.K. laboratory, particularly C. Joo, M.-J. Yoon, K.-H. Yeom and A. Cho for discussions and technical help. The V.N.K. laboratory was supported by the Creative Research Initiatives Program (2010000021) and National Honor Scientist Program (20100020415) through the National Research Foundation and the BK21 Fellowships (J.-E.P. and H. C.) from the Ministry of Education, Science and Technology. Research in the D. J. P. laboratory was supported by the National Institutes of Health.	Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gunther T, 2006, MAGNESIUM RES, V19, P225; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han KH, 1996, NUCLEIC ACIDS RES, V24, P4362, DOI 10.1093/nar/24.21.4362; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Miyoshi K, 2010, RNA, V16, P506, DOI 10.1261/rna.1952110; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Serra MJ, 2002, RNA, V8, P307, DOI 10.1017/S1355838202024226; Silva J, 2004, ONCOGENE, V23, P8401, DOI 10.1038/sj.onc.1208176; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Wu HQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007566; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	41	335	353	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					201	U107		10.1038/nature10198	http://dx.doi.org/10.1038/nature10198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753850	Green Accepted			2022-12-28	WOS:000292690500044
J	Parent, F; Bachir, D; Inamo, J; Lionnet, F; Driss, F; Loko, G; Habibi, A; Bennani, S; Savale, L; Adnot, S; Maitre, B; Yaici, A; Hajji, L; O'Callaghan, DS; Clerson, P; Girot, R; Galacteros, F; Simonneau, G				Parent, Florence; Bachir, Dora; Inamo, Jocelyn; Lionnet, Francois; Driss, Francoise; Loko, Gylna; Habibi, Anoosha; Bennani, Soumiya; Savale, Laurent; Adnot, Serge; Maitre, Bernard; Yaici, Azzedine; Hajji, Leila; O'Callaghan, Dermot S.; Clerson, Pierre; Girot, Robert; Galacteros, Frederic; Simonneau, Gerald			A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMERICAN-SOCIETY; NONINVASIVE ESTIMATION; ARTERIAL-HYPERTENSION; EUROPEAN-ASSOCIATION; STANDARDS COMMITTEE; GUIDELINES; ECHOCARDIOGRAPHY; DIAGNOSIS; RECOMMENDATIONS; QUANTIFICATION	Background The prevalence and characteristics of pulmonary hypertension in adults with sickle cell disease have not been clearly established. Methods In this prospective study, we evaluated 398 outpatients with sickle cell disease (mean age, 34 years) at referral centers in France. All patients underwent Doppler echocardiography, with measurement of tricuspid-valve regurgitant jet velocity. Right heart catheterization was performed in 96 patients in whom pulmonary hypertension was suspected on the basis of a tricuspid regurgitant jet velocity of at least 2.5 m per second. Pulmonary hypertension was defined as a mean pulmonary arterial pressure of at least 25 mm Hg. Results The prevalence of a tricuspid regurgitant jet velocity of at least 2.5 m per second was 27%. In contrast, the prevalence of pulmonary hypertension as confirmed on catheterization was 6%. The positive predictive value of echocardiography for the detection of pulmonary hypertension was 25%. Among the 24 patients with confirmed pulmonary hypertension, the pulmonary-capillary wedge pressure was 15 mm Hg or less (indicating precapillary pulmonary hypertension) in 11 patients. Patients with confirmed pulmonary hypertension were older and had poorer functional capacity and higher levels of N-terminal pro-brain natriuretic peptide than other patients. In contrast, patients who had a tricuspid regurgitant jet velocity of at least 2.5 m per second without pulmonary hypertension and patients with a tricuspid regurgitant jet velocity of less than 2.5 m per second had similar clinical characteristics. Conclusions In this study of adults with sickle cell disease, the prevalence of pulmonary hypertension as confirmed on right heart catheterization was 6%. Echocardiographic evaluation alone had a low positive predictive value for pulmonary hypertension.	[Simonneau, Gerald] Univ Paris 11, Hop Antoine Beclere, AP HP, Serv Pneumol & Reanimat Resp, F-92140 Clamart, France; [Parent, Florence; Driss, Francoise; Yaici, Azzedine; O'Callaghan, Dermot S.; Simonneau, Gerald] Univ Paris 11, Le Kremlin Bicetre, France; [Parent, Florence; O'Callaghan, Dermot S.; Simonneau, Gerald] INSERM, U999, Clamart, France; [Savale, Laurent; Adnot, Serge; Maitre, Bernard] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Inamo, Jocelyn] Hop La Meynard, Fort De France, France; [Lionnet, Francois; Girot, Robert] Hop Tenon, F-75970 Paris, France; [Loko, Gylna] Hop Lamentin, Lamentin, France; [Clerson, Pierre] Orgametrie Biostat, Roubaix, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Martinique; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Martinique	Simonneau, G (corresponding author), Univ Paris 11, Hop Antoine Beclere, AP HP, Serv Pneumol & Reanimat Resp, 157 Rue Porte Trivaux, F-92140 Clamart, France.	gerald.simonneau@abc.aphp.fr	INAMO, Jocelyn/AGZ-1674-2022; Simonneau, Gerald/ABE-6614-2020; Savale, Laurent/AAJ-9781-2020	Maitre, Bernard/0000-0002-8061-1252; O'Callaghan, Dermot/0000-0002-0561-5800	French Ministry of Health; Assistance Publique-Hopitaux de Paris; Delegation for Clinical Research of the Assistance Publique-Hopitaux de Paris	French Ministry of Health; Assistance Publique-Hopitaux de Paris; Delegation for Clinical Research of the Assistance Publique-Hopitaux de Paris	Funded by the French Ministry of Health and Assistance Publique-Hopitaux de Paris; Supported by the French Ministry of Health and the Delegation for Clinical Research of the Assistance Publique-Hopitaux de Paris.	Anthi A, 2007, AM J RESP CRIT CARE, V175, P1272, DOI 10.1164/rccm.200610-1498OC; Ataga KI, 2006, BRIT J HAEMATOL, V134, P109, DOI 10.1111/j.1365-2141.2006.06110.x; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Barst RJ, 2004, J AM COLL CARDIOL, V43, p40S, DOI 10.1016/j.jacc.2004.02.032; BERGER M, 1985, J AM COLL CARDIOL, V6, P359, DOI 10.1016/S0735-1097(85)80172-8; Breiman L., 1984, CLASSIFICATION REGRE; Bunn HF, 2010, BLOOD, V116, P687, DOI 10.1182/blood-2010-02-268193; Castro O, 2003, BLOOD, V101, P1257, DOI 10.1182/blood-2002-03-0948; De Castro LM, 2008, AM J HEMATOL, V83, P19, DOI 10.1002/ajh.21058; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gordeuk VR, 2008, AM J HEMATOL, V83, P15, DOI 10.1002/ajh.21016; Hachulla E, 2005, ARTHRITIS RHEUM-US, V52, P3792, DOI 10.1002/art.21433; Haque AK, 2002, HUM PATHOL, V33, P1037, DOI 10.1053/hupa.2002.128059; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; KIRCHER BJ, 1990, AM J CARDIOL, V66, P493, DOI 10.1016/0002-9149(90)90711-9; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lanzarini L, 2002, AM HEART J, V144, P1087, DOI 10.1067/mhj.2002.126350; Lapa M, 2009, CIRCULATION, V119, P1518, DOI 10.1161/CIRCULATIONAHA.108.803221; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Saxena N, 2006, ECHOCARDIOGR-J CARD, V23, P750, DOI 10.1111/j.1540-8175.2006.00305.x; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Sitbon O, 2008, AM J RESP CRIT CARE, V177, P108, DOI 10.1164/rccm.200704-541OC; SUTTON LL, 1994, AM J CARDIOL, V74, P626, DOI 10.1016/0002-9149(94)90760-9	26	338	347	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					44	53		10.1056/NEJMoa1005565	http://dx.doi.org/10.1056/NEJMoa1005565			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788QL	21732836	Bronze, Green Published			2022-12-28	WOS:000292459400008
J	Shetty, P				Shetty, Priya			Exhibition Arabic roots of modern medicine	LANCET			English	Editorial Material												priya4876@gmail.com							0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 2	2011	378	9785					19	20		10.1016/S0140-6736(11)61004-0	http://dx.doi.org/10.1016/S0140-6736(11)61004-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	791IU	21739645	Bronze			2022-12-28	WOS:000292659700013
J	Stewardson, A; Pittet, D				Stewardson, Andrew; Pittet, Didier			The art of medicine Ignac Semmelweis-celebrating a flawed pioneer of patient safety	LANCET			English	Editorial Material									[Stewardson, Andrew; Pittet, Didier] Univ Hosp Geneva, Infect Control Programme, CH-1211 Geneva 14, Switzerland; [Stewardson, Andrew; Pittet, Didier] Univ Hosp Geneva, WHO Collaborating Ctr Patient Safety, CH-1211 Geneva 14, Switzerland; [Stewardson, Andrew; Pittet, Didier] Fac Med, CH-1211 Geneva 14, Switzerland	University of Geneva; University of Geneva; World Health Organization; University of Geneva	Pittet, D (corresponding author), Univ Hosp Geneva, Infect Control Programme, CH-1211 Geneva 14, Switzerland.	didier.pittet@hcuge.ch	Stewardson, Andrew/ABC-5208-2020	Stewardson, Andrew/0000-0001-6805-1224				Bjorneboe J, 1968, SEMMELWEIS; Celine, 1977, SEMMELWEIS; Nuland SB, 2003, DOCTORS PLAGUE GERMS; Pittet D, 2001, LANCET, P9; Semmelweis IF., 1861, AETIOLOGIE BEGRIFF P; WHO, 2009, WHO GUID HAND HYG HE	6	14	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2011	378	9785					22	23		10.1016/S0140-6736(11)61007-6	http://dx.doi.org/10.1016/S0140-6736(11)61007-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791IU	21739646				2022-12-28	WOS:000292659700016
J	Webster, PC				Webster, Paul Christopher			Richard Reznick: leading innovator of surgical education	LANCET			English	Biographical-Item																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 2	2011	378	9785					21	21		10.1016/S0140-6736(11)61006-4	http://dx.doi.org/10.1016/S0140-6736(11)61006-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791IU	21724026				2022-12-28	WOS:000292659700015
J	Roep, BO				Roep, Bart O.			New hope for immune intervention therapy in type 1 diabetes	LANCET			English	Editorial Material									Leiden Univ, Dept Immunohaematol & Blood Transfus, Med Ctr, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Roep, BO (corresponding author), Leiden Univ, Dept Immunohaematol & Blood Transfus, Med Ctr, NL-2300 RC Leiden, Netherlands.	boroep@lumc.nl	Roep, Bart/AAD-7609-2021					Gale EAM, 2002, NEW ENGL J MED, V346, P1740, DOI 10.1056/NEJM200205303462211; Kilpatrick ES, 2009, NAT REV ENDOCRINOL, V5, P537, DOI 10.1038/nrendo.2009.179; Matthews JB, 2010, CLIN EXP IMMUNOL, V160, P176, DOI 10.1111/j.1365-2249.2010.04153.x; Orban T, 2011, LANCET, V378, P412, DOI 10.1016/S0140-6736(11)60886-6; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Roep BO, 2010, NAT REV IMMUNOL, V10, P145, DOI 10.1038/nri2705; Staeva-Vieira T, 2007, CLIN EXP IMMUNOL, V148, P17, DOI 10.1111/j.1365-2249.2007.03328.x; TrialNet, TYP 1 DIAB; Wilson DM, 2011, DIABETES CARE, V34, P540, DOI 10.2337/dc10-1054	10	6	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2011	378	9789					376	378		10.1016/S0140-6736(11)60977-X	http://dx.doi.org/10.1016/S0140-6736(11)60977-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XM	21719097				2022-12-28	WOS:000293615900005
J	Tadmor, AD; Ottesen, EA; Leadbetter, JR; Phillips, R				Tadmor, Arbel D.; Ottesen, Elizabeth A.; Leadbetter, Jared R.; Phillips, Rob			Probing Individual Environmental Bacteria for Viruses by Using Microfluidic Digital PCR	SCIENCE			English	Article							DNA PACKAGING MOTOR; MICROBIAL COMMUNITIES; MOLECULAR ANALYSIS; SEQUENCE; DYNAMICS; TERMITE; ACETOGENESIS; DIVERSITY; SAMPLE; GUT	Viruses may very well be the most abundant biological entities on the planet. Yet neither metagenomic studies nor classical phage isolation techniques have shed much light on the identity of the hosts of most viruses. We used a microfluidic digital polymerase chain reaction (PCR) approach to physically link single bacterial cells harvested from a natural environment with a viral marker gene. When we implemented this technique on the microbial community residing in the termite hindgut, we found genus-wide infection patterns displaying remarkable intragenus selectivity. Viral marker allelic diversity revealed restricted mixing of alleles between hosts, indicating limited lateral gene transfer of these alleles despite host proximity. Our approach does not require culturing hosts or viruses and provides a method for examining virus-bacterium interactions in many environments.	[Tadmor, Arbel D.] CALTECH, Dept Biochem & Mol Biophys, Pasadena, CA 91125 USA; [Ottesen, Elizabeth A.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Leadbetter, Jared R.] CALTECH, Ronald & Maxine Linde Ctr Global Environm Sci, Pasadena, CA 91125 USA; [Phillips, Rob] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Phillips, Rob] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA	California Institute of Technology; Massachusetts Institute of Technology (MIT); California Institute of Technology; California Institute of Technology; California Institute of Technology	Tadmor, AD (corresponding author), CALTECH, Dept Biochem & Mol Biophys, Pasadena, CA 91125 USA.	arbel@caltech.edu; phillips@pboc.caltech.edu		Leadbetter, Jared/0000-0002-7033-0844	NIH [R01 GM085286-01S]; U.S. Department of Energy [DE-FG02-07ER64484]; NSF [EF-0523267, CMMI-0758343]; Davidow Family Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098465, R01GM085286] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000217] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Davidow Family Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We wish to thank D. Baltimore, S. Casjens, D. S. Fisher, R. W. Hendrix, H. J. Lee, M. Linden, E. G. Matson, R. Milo, V. J. Orphan, S. R. Quake, A. Z. Rosenthal, E. M. Rubin and colleagues at JGI, D. Z. Soghoian, N. D. Wolfe, D. Wu, X. Zhang, and the anonymous referees for their advice and feedback. We also wish to thank E. G. M. and A. Z. R for their assistance in collection of specimens and E. G. M. for ZAS genomic DNA. This project was supported by the NIH Director's Pioneer Award, NIH American Recovery and Reinvestment Act grant number R01 GM085286-01S, U.S. Department of Energy grant no. DE-FG02-07ER64484, and NSF grant nos. EF-0523267 and CMMI-0758343 and by the Davidow Family Research Fund. GenBank accession numbers are given in table S10.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; [Anonymous], 2000, GLOBAL CHANGE HUM HL, DOI [DOI 10.1023/A:1011519513354, 10.1023/A:1011519513354.]; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; CHAI S, 1992, J MOL BIOL, V224, P87, DOI 10.1016/0022-2836(92)90578-8; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; EPPLER K, 1991, VIROLOGY, V183, P519, DOI 10.1016/0042-6822(91)90981-G; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hongoh Y, 2003, FEMS MICROBIOL ECOL, V44, P231, DOI 10.1016/S0168-6496(03)00026-6; Hugenholtz P, 2002, GENOME BIOL, V3; Kristensen DM, 2010, TRENDS MICROBIOL, V18, P11, DOI 10.1016/j.tim.2009.11.003; Leadbetter JR, 1999, SCIENCE, V283, P686, DOI 10.1126/science.283.5402.686; Lilburn TC, 2001, SCIENCE, V292, P2495, DOI 10.1126/science.1060281; Lindell D, 2007, NATURE, V449, P83, DOI 10.1038/nature06130; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Mitchell MS, 2002, NUCLEIC ACIDS RES, V30, P4009, DOI 10.1093/nar/gkf524; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Moore SD, 2002, CURR BIOL, V12, pR96, DOI 10.1016/S0960-9822(02)00670-X; Ottesen EA, 2006, SCIENCE, V314, P1464, DOI 10.1126/science.1131370; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tholen A, 1997, FEMS MICROBIOL ECOL, V24, P137, DOI 10.1016/S0168-6496(97)00053-6; Thompson JR, 2004, APPL ENVIRON MICROB, V70, P4103, DOI 10.1128/AEM.70.7.4103-4110.2004; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Zare RN, 2010, ANNU REV BIOMED ENG, V12, P187, DOI 10.1146/annurev-bioeng-070909-105238	38	160	175	1	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					58	62		10.1126/science.1200758	http://dx.doi.org/10.1126/science.1200758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719670	Green Accepted			2022-12-28	WOS:000292255400046
J	Avrani, S; Wurtzel, O; Sharon, I; Sorek, R; Lindell, D				Avrani, Sarit; Wurtzel, Omri; Sharon, Itai; Sorek, Rotem; Lindell, Debbie			Genomic island variability facilitates Prochlorococcus-virus coexistence	NATURE			English	Article							PHAGE; EVOLUTION; BACTERIAL; ATLANTIC; ECOTYPES; COMMUNITIES; RESISTANCE; ELEMENTS	Prochlorococcus cyanobacteria are extremely abundant in the oceans, as are the viruses that infect them. How hosts and viruses coexist in nature remains unclear, although the presence of both susceptible and resistant cells may allow this coexistence. Combined whole-genome sequencing and PCR screening technology now enables us to investigate the effect of resistance on genome evolution and the genomic mechanisms behind the long-term coexistence of Prochlorococcus and their viruses. Here we present a genome analysis of 77 substrains selected for resistance to ten viruses, revealing mutations primarily in non-conserved, horizontally transferred genes that localize to a single hypervariable genomic island. Mutations affected viral attachment to the cell surface and imposed a fitness cost to the host, manifested by significantly lower growth rates or a previously unknown mechanism of more rapid infection by other viruses. The mutant genes are generally uncommon in nature yet some carry polymorphisms matching those found experimentally. These data are empirical evidence indicating that viral-attachment genes are preferentially located in genomic islands and that viruses are a selective pressure enhancing the diversity of both island genes and island gene content. This diversity emerges as a genomic mechanism that reduces the effective host population size for infection by a given virus, thus facilitating long-term coexistence between viruses and their hosts in nature.	[Avrani, Sarit; Sharon, Itai; Lindell, Debbie] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel; [Wurtzel, Omri; Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Technion Israel Institute of Technology; Weizmann Institute of Science	Lindell, D (corresponding author), Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel.	dlindell@tx.technion.ac.il	Wurtzel, Omri/AAG-3985-2019; Sharon, Itai/M-4472-2019	Wurtzel, Omri/0000-0002-6865-5914; Sharon, Itai/0000-0003-0705-2316; Lindell, Debbie/0000-0003-0612-4517	European Commission ERC [203406]; ISF [1504/06]; Technion Russell Berrie Nanotechnology Institute; ISF-FIRST [1615/09]; ERC; Azrieli fellowship	European Commission ERC(European CommissionEuropean Commission Joint Research CentreEuropean Research Council (ERC)); ISF(Israel Science Foundation); Technion Russell Berrie Nanotechnology Institute; ISF-FIRST; ERC(European Research Council (ERC)European Commission); Azrieli fellowship	We thank E. Zinser for the bacterial helper strain; I. Pekarsky for help with adsorption assays; I. Izhaki for advice on statistical analyses; O. Beja, Y. Mandel-Gutfreund, K. Kozek, U. Qimron and Lindell lab members for comments on the manuscript; and T. Dagan for coining the term 'susceptibility region'. Genome sequencing was carried out at the genome sequencing units at the Weizmann Institute of Science and the Technion - Israel Institute of Technology. This work was supported by a European Commission ERC Starting Grant (no. 203406), an ISF Morasha grant (no. 1504/06) and the Technion Russell Berrie Nanotechnology Institute (D. L.); and by an ISF-FIRST grant (no. 1615/09) and an ERC Starting Grant (R. S.). O. W. was supported by an Azrieli fellowship and D. L. is a Shillman fellow.	Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Bouman HA, 2006, SCIENCE, V312, P918, DOI 10.1126/science.1122692; Charlebois RL, 2004, GENOME RES, V14, P2469, DOI 10.1101/gr.3024704; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Comeau AM, 2005, CURR OPIN MICROBIOL, V8, P488, DOI 10.1016/j.mib.2005.06.004; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Dufresne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r90; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Langille MGI, 2010, NAT REV MICROBIOL, V8, P372, DOI 10.1038/nrmicro2350; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; Luria SE, 1943, GENETICS, V28, P491; Lythgoe KA, 2003, ECOL LETT, V6, P326, DOI 10.1046/j.1461-0248.2003.00433.x; Malmstrom RR, 2010, ISME J, V4, P1252, DOI 10.1038/ismej.2010.60; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Parsons YN, 2003, ARCH MICROBIOL, V179, P214, DOI 10.1007/s00203-003-0518-7; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Somova A G, 1966, Biull Eksp Biol Med, V31, P99; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Stoddard LI, 2007, APPL ENVIRON MICROB, V73, P5516, DOI 10.1128/AEM.00356-07; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Walker CB, 2009, ENVIRON MICROBIOL, V11, P2244, DOI 10.1111/j.1462-2920.2009.01946.x; WATERBURY JB, 1993, APPL ENVIRON MICROB, V59, P3393, DOI 10.1128/AEM.59.10.3393-3399.1993; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zwirglmaier K, 2007, ENVIRON MICROBIOL, V9, P1278, DOI 10.1111/j.1462-2920.2007.01246.x	34	192	197	5	90	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					604	608		10.1038/nature10172	http://dx.doi.org/10.1038/nature10172			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21720364				2022-12-28	WOS:000292204300031
J	Glick, S				Glick, Shimon			Rosalyn Sussman Yalow (1921-2011) OBITUARY	NATURE			English	Biographical-Item									[Glick, Shimon] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University	Glick, S (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel.	gshimon@bgu.ac.il							0	8	10	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2011	474	7353					580	580		10.1038/474580a	http://dx.doi.org/10.1038/474580a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21720355	Bronze			2022-12-28	WOS:000292204300022
J	Rasmussen, SGF; DeVree, BT; Zou, YZ; Kruse, AC; Chung, KY; Kobilka, TS; Thian, FS; Chae, PS; Pardon, E; Calinski, D; Mathiesen, JM; Shah, STA; Lyons, JA; Caffrey, M; Gellman, SH; Steyaert, J; Skiniotis, G; Weis, WI; Sunahara, RK; Kobilka, BK				Rasmussen, Soren G. F.; DeVree, Brian T.; Zou, Yaozhong; Kruse, Andrew C.; Chung, Ka Young; Kobilka, Tong Sun; Thian, Foon Sun; Chae, Pil Seok; Pardon, Els; Calinski, Diane; Mathiesen, Jesper M.; Shah, Syed T. A.; Lyons, Joseph A.; Caffrey, Martin; Gellman, Samuel H.; Steyaert, Jan; Skiniotis, Georgios; Weis, William I.; Sunahara, Roger K.; Kobilka, Brian K.			Crystal structure of the beta(2) adrenergic receptor-Gs protein complex	NATURE			English	Article							ADENYLATE-CYCLASE; BETA(2)-ADRENERGIC RECEPTOR; MEDIATED ACTIVATION; BINDING; CRYSTALLIZATION; RECONSTITUTION; INSIGHTS; AMINO	G protein-coupled receptors (GPCRs) are responsible for the majority of cellular responses to hormones and neurotransmitters as well as the senses of sight, olfaction and taste. The paradigm of GPCR signalling is the activation of a heterotrimeric GTP binding protein (G protein) by an agonist-occupied receptor. The beta(2) adrenergic receptor (beta(2)AR) activation of Gs, the stimulatory G protein for adenylyl cyclase, has long been a model system for GPCR signalling. Here we present the crystal structure of the active state ternary complex composed of agonist-occupied monomeric beta(2)AR and nucleotide-free Gs heterotrimer. The principal interactions between the beta(2)AR and Gs involve the amino-and carboxy-terminal a-helices of Gs, with conformational changes propagating to the nucleotide-binding pocket. The largest conformational changes in the beta(2)AR include a 14 angstrom outward movement at the cytoplasmic end of transmembrane segment 6 (TM6) and an alpha-helical extension of the cytoplasmic end of TM5. The most surprising observation is a major displacement of the alpha-helical domain of G alpha s relative to the Ras-like GTPase domain. This crystal structure represents the first high-resolution view of transmembrane signalling by a GPCR.	[Rasmussen, Soren G. F.; Zou, Yaozhong; Kruse, Andrew C.; Chung, Ka Young; Kobilka, Tong Sun; Thian, Foon Sun; Mathiesen, Jesper M.; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Dept Mol & Cellular Biol, Sch Med, Stanford, CA 94305 USA; [Rasmussen, Soren G. F.] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [DeVree, Brian T.; Calinski, Diane; Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Chae, Pil Seok; Gellman, Samuel H.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel, VIB, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Shah, Syed T. A.; Lyons, Joseph A.; Caffrey, Martin] Trinity Coll Dublin, Membrane Struct & Funct Biol Grp, Sch Med, Dublin 2, Ireland; [Shah, Syed T. A.; Lyons, Joseph A.; Caffrey, Martin] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; [Skiniotis, Georgios] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Skiniotis, Georgios] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Weis, William I.] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA	Stanford University; University of Copenhagen; University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Trinity College Dublin; Trinity College Dublin; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University	Kobilka, BK (corresponding author), Stanford Univ, Dept Mol & Cellular Biol, Sch Med, Stanford, CA 94305 USA.	sunahara@umich.edu; kobilka@stanford.edu	steyaert, jan/GQP-7811-2022; Steyaert, Jan/H-4662-2011; Lyons, Joseph/AAA-2528-2020; Chung, Ka Young/AAO-7984-2020; Shah, Syed Tasadaque Ali/AAB-4890-2021; Sunahara, Roger/AAJ-8667-2020; DeVree, Brian T/F-6205-2011; Weis, William I/G-1437-2011	Steyaert, Jan/0000-0002-3825-874X; Weis, William I/0000-0002-5583-6150; Kobilka, Brian/0000-0001-5958-3990; Chung, Ka Young/0000-0001-9038-9571; DeVree, Brian/0000-0003-0582-8125; Rasmussen, Soren/0000-0002-1853-1841; Caffrey, Martin/0000-0002-2931-4551; Skiniotis, Georgios/0000-0003-0238-7846	National Institutes of Health [NS028471, GM083118, GM56169, P01 GM75913, T32-GM008270, P60DK-20572, GM75915, P50GM073210, U54GM094599]; Science Foundation Ireland [07/IN.1/B1836]; FP7 COST Action [CM0902]; Mathers Foundation; Lundbeck Foundation; University of Michigan; Fund for Scientific Research of Flanders (FWO-Vlaanderen); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); Danish Council for Independent Research, Medical Sciences; Lundbeck Foundation [R37-2009-3457, R19-2008-2113] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073210, R01GM075915, U54GM094599, R01GM083118, R01GM056169, R01GM068603, T32GM008270, P01GM075913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); FP7 COST Action; Mathers Foundation; Lundbeck Foundation(Lundbeckfonden); University of Michigan(University of Michigan System); Fund for Scientific Research of Flanders (FWO-Vlaanderen)(FWO); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge support from National Institutes of Health Grants NS028471 (B. K. K.) and GM083118 (B. K. K. and R. K. S.), GM56169 (W. I. W.), P01 GM75913 (S. H. G), T32-GM008270 and P60DK-20572 (R. K. S.), GM75915, P50GM073210 and U54GM094599 (M. C.), Science Foundation Ireland (07/IN.1/B1836) and FP7 COST Action CM0902 (M. C.), the Mathers Foundation (B. K. K. and W. I. W.), the Lundbeck Foundation (Junior Group Leader Fellowship, S. G. F. R.), the University of Michigan Biomedical Sciences Scholars Program (R. K. S.), the Fund for Scientific Research of Flanders (FWO-Vlaanderen) and the Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB) (E. P. and J.S.), The Danish Council for Independent Research, Medical Sciences (J.M.M.). We thank D. Grayson and A. Coughlan for help with lipid synthesis.	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baltensperger K, 1996, J BIOL CHEM, V271, P1061, DOI 10.1074/jbc.271.2.1061; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; BRANDT DR, 1983, BIOCHEMISTRY-US, V22, P4357, DOI 10.1021/bi00288a002; Breitwieser GE, 2004, CIRC RES, V94, P17, DOI 10.1161/01.RES.0000110420.68526.19; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; CERIONE RA, 1984, BIOCHEMISTRY-US, V23, P4519, DOI 10.1021/bi00315a003; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; DELEAN A, 1980, J BIOL CHEM, V255, P7108; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; Domanska K, 2011, P NATL ACAD SCI USA, V108, P1314, DOI 10.1073/pnas.1008560108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Jastrzebska B, 2010, BIOCHEM J, V428, P1, DOI 10.1042/BJ20100270; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; MARKBY DW, 1993, SCIENCE, V262, P1895, DOI 10.1126/science.8266082; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Misquitta LV, 2004, STRUCTURE, V12, P2113, DOI 10.1016/j.str.2004.09.020; MORO O, 1993, J BIOL CHEM, V268, P22273; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; ROSS EM, 1977, J BIOL CHEM, V252, P5761; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Swaminath G, 2002, MOL PHARMACOL, V61, P65, DOI 10.1124/mol.61.1.65; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104	48	2132	2183	17	671	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2011	477	7366					549	U311		10.1038/nature10361	http://dx.doi.org/10.1038/nature10361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21772288	Green Accepted, Green Published			2022-12-28	WOS:000295320900031
J	Wherrett, DK; Bundy, B; Becker, DJ; DiMeglio, LA; Gitelman, SE; Goland, R; Gottlieb, PA; Greenbaum, CJ; Herold, KC; Marks, JB; Monzavi, R; Moran, A; Orban, T; Palmer, JP; Raskin, P; Rodriguez, H; Schatz, D; Wilson, DM; Krischer, JP; Skyler, JS				Wherrett, Diane K.; Bundy, Brian; Becker, Dorothy J.; DiMeglio, Linda A.; Gitelman, Stephen E.; Goland, Robin; Gottlieb, Peter A.; Greenbaum, Carla J.; Herold, Kevan C.; Marks, Jennifer B.; Monzavi, Roshanak; Moran, Antoinette; Orban, Tihamer; Palmer, Jerry P.; Raskin, Philip; Rodriguez, Henry; Schatz, Desmond; Wilson, Darrell M.; Krischer, Jeffrey P.; Skyler, Jay S.		Type 1 Diabet TrialNet GAD Study G	Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial	LANCET			English	Article							BETA-CELL FUNCTION; ORAL INSULIN; IMMUNOTHERAPY; PATHOGENESIS; PREVENT	Background Glutamic acid decarboxylase (GAD) is a major target of the autoimmune response that occurs in type 1 diabetes mellitus. In animal models of autoimmunity, treatment with a target antigen can modulate aggressive autoimmunity. We aimed to assess whether immunisation with GAD formulated with aluminum hydroxide (GAD-alum) would preserve insulin production in recent-onset type 1 diabetes. Methods Patients aged 3-45 years who had been diagnosed with type 1 diabetes for less than 100 days were enrolled from 15 sites in the USA and Canada, and randomly assigned to receive one of three treatments: three injections of 20 mu g GAD-alum, two injections of 20 mu g GAD-alum and one of alum, or 3 injections of alum. Injections were given subcutaneously at baseline, 4 weeks later, and 8 weeks after the second injection. The randomisation sequence was computer generated at the TrialNet coordinating centre. Patients and study personnel were masked to treatment assignment. The primary outcome was the baseline-adjusted geometric mean area under the curve (AUC) of serum C-peptide during the first 2 h of a 4-h mixed meal tolerance test at 1 year. Secondary outcomes included changes in glycated haemoglobin A(1c) (HbA(1c)) and insulin dose, and safety. Analysis included all randomised patients with known measurements. This trial is registered with ClinicalTrials.gov, number NCT00529399. Findings 145 patients were enrolled and treated with GAD-alum (n=48), GAD-alum plus alum (n=49), or alum (n=48). At 1 year, the 2-h AUC of C-peptide, adjusted for age, sex, and baseline C-peptide value, was 0.412 nmol/L (95% CI 0.349-0.478) in the GAD-alum group, 0.382 nmol/L (0.322-0.446) in the GAD-alum plus alum group, and 0.413 nmol/L (0.351-0.477) in the alum group. The ratio of the population mean of the adjusted geometric mean 2-h AUC of C-peptide was 0.998 (95% CI 0.779-1.22; p=0.98) for GAD-alum versus alum, and 0.926 (0.720-1.13; p=0.50) for GAD-alum plus alum versus alum. HbA(1c), insulin use, and the occurrence and severity of adverse events did not differ between groups. Interpretation Antigen-based immunotherapy therapy with two or three doses of subcutaneous GAD-alum across 4-12 weeks does not alter the course of loss of insulin secretion during 1 year in patients with recently diagnosed type 1 diabetes. Although antigen-based therapy is a highly desirable treatment and is effective in animal models, translation to human autoimmune disease remains a challenge.	[Marks, Jennifer B.; Skyler, Jay S.] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA; [Wherrett, Diane K.] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Bundy, Brian; Krischer, Jeffrey P.] Univ S Florida, Tampa, FL USA; [Becker, Dorothy J.] Univ Pittsburgh, Pittsburgh, PA USA; [DiMeglio, Linda A.; Rodriguez, Henry] Indiana Univ Sch Med, Indianapolis, IN USA; [Gitelman, Stephen E.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Goland, Robin] Columbia Univ, New York, NY USA; [Gottlieb, Peter A.] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Greenbaum, Carla J.] Benaroya Res Inst, Seattle, WA USA; [Herold, Kevan C.] Yale Univ, Sch Med, New Haven, CT USA; [Monzavi, Roshanak] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Moran, Antoinette] Univ Minnesota, Minneapolis, MN USA; [Orban, Tihamer] Joslin Diabet Ctr, Boston, MA 02215 USA; [Palmer, Jerry P.] Univ Washington, Sch Med, Seattle, WA USA; [Raskin, Philip] Univ Texas SW Med Sch, Dallas, TX USA; [Schatz, Desmond] Univ Florida, Gainesville, FL USA; [Wilson, Darrell M.] Stanford Univ, Stanford, CA 94305 USA	University of Miami; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); State University System of Florida; University of South Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indiana University System; Indiana University Bloomington; University of California System; University of California San Francisco; Columbia University; University of Colorado System; University of Colorado Anschutz Medical Campus; Benaroya Research Institute; Yale University; Children's Hospital Los Angeles; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Joslin Diabetes Center, Inc.; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas; State University System of Florida; University of Florida; Stanford University	Skyler, JS (corresponding author), Univ Miami, Miller Sch Med, Diabet Res Inst, POB 016960,D-110, Miami, FL 33136 USA.	jskyler@miami.edu	DiMeglio, Linda A./F-9277-2019; Krischer, Jeffrey P/I-5004-2012; Toledo, Frederico/G-9071-2013; Skyler, Jay S/F-4211-2016	DiMeglio, Linda A./0000-0002-8033-6078; Toledo, Frederico/0000-0002-6570-9948; Skyler, Jay/0000-0003-1136-8110	US National Institutes of Health; Eli Lilly; Medtronic; Diamyd; Tolerx; Bayhill Therapeutics; Macrogenics; Omni BioTherapeutics; Merck; Osiris Therapeutics; Aegera; Andromeda Biotech; Biodel; Boehringer Ingelheim; Calibra; CPEX; Generex; Hoffman-LaRoche; MannKind; Novo-Nordisk; Reata; Pfizer; Genentech; Halozyme; Intuity; Becton-Dickinson; MannKind Corporation; GlaxoSmithKline; Salutria Pharmaceuticals; Veroscience; Roche; Exsulin; NIH through the National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infections Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01 DK061010, U01 DK061016, U01 DK061034, U01 DK061036, U01 DK061040, U01 DK061041, U01 DK061042, U01 DK061055, U01 DK061058, U01 DK084565, U01 DK085453, U01 DK085461, U01 DK085463, U01 DK085466, U01 DK085499, U01 DK085505, U01 DK085509, HHSN267200800019C]; National Center for Research Resources [UL1 RR024131, UL1 RR024139, UL1 RR024153, UL1 RR024975, UL1 RR024982, UL1 RR025744, UL1 RR025761, UL1 RR025780, UL1 RR029890, UL1 RR031986, M01 RR00400]; Juvenile Diabetes Research Foundation International (JDRF); American Diabetes Association (ADA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000400, UL1RR025744, UL1RR029890, UL1RR024153, UL1RR024139, UL1RR025761, UL1RR031986, UL1RR024982, UL1RR024975, UL1RR024131, UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061040, U01DK061042, U01DK061058, UC4DK117009, U01DK061034, U01DK085453, U01DK085461, U01DK085499, U01DK085463, U01DK061036, U01DK061041, U01DK061010, U01DK085509, U01DK085466, U01DK061055, U01DK085505] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly(Eli Lilly); Medtronic(Medtronic); Diamyd; Tolerx; Bayhill Therapeutics; Macrogenics; Omni BioTherapeutics; Merck(Merck & Company); Osiris Therapeutics; Aegera; Andromeda Biotech; Biodel; Boehringer Ingelheim(Boehringer Ingelheim); Calibra; CPEX; Generex; Hoffman-LaRoche; MannKind; Novo-Nordisk(Novo Nordisk); Reata; Pfizer(Pfizer); Genentech(Roche HoldingGenentech); Halozyme; Intuity; Becton-Dickinson; MannKind Corporation; GlaxoSmithKline(GlaxoSmithKline); Salutria Pharmaceuticals; Veroscience; Roche(Roche Holding); Exsulin; NIH through the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infections Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); American Diabetes Association (ADA)(American Diabetes Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	US National Institutes of Health.; DKW reports receiving lecture fees from Eli Lilly and Medtronic. DJB reports receiving a grant from Diamyd. SEG reports serving on an advisory board for Genentech. RG reports receiving grants from Diamyd and Tolerx. PAG reports serving on advisory boards for Genentech, Eli Lilly, Sanofi-Aventis, and Tolerx; and reports receiving grants from Bayhill Therapeutics, Diamyd, Macrogenics, Omni BioTherapeutics, and Tolerx. CJG reports receiving grants from Bayhill Therapeutics, Diamyd, and Tolerx. JBM reports serving on an advisory board for Amgen. AM reports serving on an advisory board for Pfizer, and receiving grants from Tolerx, Merck, and Osiris Therapeutics. TO reports serving on the data safety monitoring board for Osiris Therapeutics, and being a founder of Orban Biotech. JPP reports being a consultant and receiving research grants and leading studies for Diamyd. PR reports serving on advisory boards for Amgen, AstraZeneca, MannKind, and Novo-Nordisk; serving on speakers bureaus for Merck and Novo-Nordisk; and receiving grants from Aegera, Andromeda Biotech, Bayhill Therapeutics, Biodel, Boehringer Ingelheim, Calibra, CPEX, Generex, Hoffman-LaRoche, MannKind, Novo-Nordisk, Osiris Therapeutics, and Reata. HR reports serving on an advisory board For Marcadia Biotech; serving as a consultant to Eli Lilly, Genentech, Bayer, EMD Serono, and Merck; being on the speakers bureau of Eli Lilly and Novo-Nordisk; and receiving grant support from Macrogenics and Eli Lilly. DS reports serving on advisory boards for Andromeda, Eli Lilly, GlaxoSmithKline, and Roche; giving a lecture supported by Pfizer; and receiving a grant from Diamyd. DMW reports serving on an advisory boards for DexCom and Genentech; and receiving grants support from Genentech, Diamyd, and Osiris Therapeutics. JSS reports serving on boards for Amylin Pharmaceuticals, DexCom, and Sanofi-Aventis; receiving grants from Bayhill Therapeutics, Halozyme, Intuity, and Osiris Therapeutics; receiving consultancy fees from Becton-Dickinson, Merck, MannKind Corporation, GlaxoSmithKline, Salutria Pharmaceuticals, Veroscience, Roche, and Exsulin; and receiving speakers' fees and payment for development of an educational presentation from Novo-Nordisk; and holds stock in Amylin Pharmaceuticals and Dexcom. BB, LAD, KCH, RM, and JPK declare that they have no conflicts of interest.; The sponsor of the trial was the Type 1 Diabetes TrialNet Study Group. The Type 1 Diabetes TrialNet Study Group is a clinical trials network funded by NIH through the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Allergy and Infections Diseases, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, via cooperative agreements (U01 DK061010, U01 DK061016, U01 DK061034, U01 DK061036, U01 DK061040, U01 DK061041, U01 DK061042, U01 DK061055, U01 DK061058, U01 DK084565, U01 DK085453, U01 DK085461, U01 DK085463, U01 DK085466, U01 DK085499, U01 DK085505, and U01 DK085509) and a contract (HHSN267200800019C); and through the National Center for Research Resources, via clinical translational science awards (UL1 RR024131, UL1 RR024139, UL1 RR024153, UL1 RR024975, UL1 RR024982, UL1 RR025744, UL1 RR025761, UL1 RR025780, UL1 RR029890, and UL1 RR031986) and a general clinical research center award (M01 RR00400). Trial Net also receives non-financial support from the Juvenile Diabetes Research Foundation International (JDRF) and the American Diabetes Association (ADA). The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of NIH, JDRF, or ADA. Diamyd Medical (Stockholm, Sweden) provided CAD-alum and placebo (alum), but had no involvement with the final study design, study conduct or management, data collection, data analysis, data interpretation, or writing of the report. There are no agreements concerning confidentiality of the data between Diamyd and the authors or the institutions named, in the credit lines. The authors did provide Diamyd Medical a copy of the original report before submission. Roche Diagnostics (Indianapolis, IN, USA) provided blood glucose monitoring metres and strips to research patients. No funds were paid for preparation of this report.	Achenbach P, 2008, CURR DIABETES REP, V8, P87, DOI 10.1007/s11892-008-0017-y; Agardh CD, 2005, J DIABETES COMPLICAT, V19, P238, DOI 10.1016/j.jdiacomp.2004.12.003; Agresti A., 1990, CATEGORICAL DATA ANA, pXV; *AM DIAB ASS, 2011, DIABETES CARE S1, V33, pS11; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; *CAN EUR RAND CONT, 1988, DIABETES, V37, P1574; Chaillous L, 2000, LANCET, V356, P545, DOI 10.1016/S0140-6736(00)02579-4; Choy EHS, 2001, ARTHRITIS RHEUM-US, V44, P1993, DOI 10.1002/1529-0131(200109)44:9<1993::AID-ART347>3.0.CO;2-A; COX DR, 1972, J R STAT SOC B, V34, P187; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; FEUTREN G, 1986, LANCET, V2, P119; Gottlieb PA, 2010, DIABETES CARE, V33, P826, DOI 10.2337/dc09-1349; Greenbaum CJ, 2008, DIABETES CARE, V31, P1966, DOI 10.2337/dc07-2451; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; Luo XR, 2010, IMMUNITY, V32, P488, DOI 10.1016/j.immuni.2010.04.002; Matthews JB, 2010, CLIN EXP IMMUNOL, V160, P176, DOI 10.1111/j.1365-2249.2010.04153.x; Orban T, 2011, LANCET, V378, P412, DOI 10.1016/S0140-6736(11)60886-6; Peakman M, 2010, DIABETES, V59, P2087, DOI 10.2337/db10-0630; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Pozzilli P, 2000, DIABETOLOGIA, V43, P1000, DOI 10.1007/s001250051482; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Skyler JS, 2011, DIABETES, V60, P1, DOI 10.2337/db10-1114; Skyler JS, 2008, ANN NY ACAD SCI, V1150, P190, DOI 10.1196/annals.1447.055; Skyler JS, 2005, DIABETES CARE, V28, P1630, DOI 10.2337/diacare.28.7.1630; SOLIMENA M, 1990, NEW ENGL J MED, V322, P1555, DOI 10.1056/NEJM199005313222202; Sosenko JM, 2004, DIABETES, V53, pA425; Steffes MW, 2003, DIABETES CARE, V26, P832, DOI 10.2337/diacare.26.3.832; Tian JD, 1996, NAT MED, V2, P1348, DOI 10.1038/nm1296-1348; Tisch R, 1998, DIABETES, V47, P894, DOI 10.2337/diabetes.47.6.894; Yamamoto K, 2007, EXPERT OPIN BIOL TH, V7, P359, DOI 10.1517/14712598.7.3.359; Ziegler AG, 2010, IMMUNITY, V32, P468, DOI 10.1016/j.immuni.2010.03.018	37	254	269	1	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2011	378	9788					319	327		10.1016/S0140-6736(11)60895-7	http://dx.doi.org/10.1016/S0140-6736(11)60895-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XL	21714999	Green Accepted			2022-12-28	WOS:000293615800029
J	Cobb, NK; Abrams, DB				Cobb, Nathan K.; Abrams, David B.			E-Cigarette or Drug-Delivery Device? Regulating Novel Nicotine Products	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cobb, Nathan K.; Abrams, David B.] Amer Legacy Fdn, Schroeder Inst Tobacco Res & Policy Studies, Washington, DC USA; [Cobb, Nathan K.] Georgetown Univ, Med Ctr, Div Pulm & Crit Care, Washington, DC 20007 USA; [Cobb, Nathan K.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Cobb, Nathan K.; Abrams, David B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA	Georgetown University; Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Cobb, NK (corresponding author), Amer Legacy Fdn, Schroeder Inst Tobacco Res & Policy Studies, Washington, DC USA.		Abrams, David B/AAY-7699-2020	Abrams, David B/0000-0002-0868-4350; Cobb, Nathan/0000-0003-4210-226X				Cobb NK, 2010, AM J PUBLIC HEALTH, V100, P2340, DOI 10.2105/AJPH.2010.199281; Deyton LR, 2011, REGULATION E CIGARET; Eissenberg T, 2010, TOB CONTROL, V19, P87, DOI 10.1136/tc.2009.033498; Rose JE, 2011, EXP CLIN PSYCHOPHARM, V19, pIII, DOI 10.1037/a0021869; Rose JE, 2010, EXP CLIN PSYCHOPHARM, V18, P385, DOI 10.1037/a0020834; Trtchounian A, 2010, NICOTINE TOB RES, V12, P905, DOI 10.1093/ntr/ntq114	6	120	123	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2011	365	3					193	195		10.1056/NEJMp1105249	http://dx.doi.org/10.1056/NEJMp1105249			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	794QI	21774706				2022-12-28	WOS:000292915500001
J	Sanders, RD; Pandharipande, PP; Davidson, AJ; Ma, DQ; Maze, M				Sanders, Robert D.; Pandharipande, Pratik P.; Davidson, Andrew J.; Ma, Daqing; Maze, Mervyn			Anticipating and managing postoperative delirium and cognitive decline in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CRITICALLY-ILL PATIENTS; CARDIAC-SURGERY; HIP FRACTURE; RISK-FACTORS; RANDOMIZED-TRIAL; ELDERLY-PATIENTS; CARE-UNIT; DEXMEDETOMIDINE; DYSFUNCTION; EMERGENCE		[Sanders, Robert D.; Ma, Daqing] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Magill Dept Anaesthet Intens Care & Pain Med, London SW10 9NH, England; [Sanders, Robert D.] Univ London Imperial Coll Sci Technol & Med, Dept Leucocyte Biol, London SW10 9NH, England; [Pandharipande, Pratik P.] VA TN Valley Hlth Care Syst, Anesthesiol Serv, Nashville, TN USA; [Pandharipande, Pratik P.] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Div Crit Care, Nashville, TN 37212 USA; [Davidson, Andrew J.] Royal Childrens Hosp, Dept Anaesthesia, Melbourne, Vic, Australia; [Davidson, Andrew J.] Murdoch Childrens Res Inst, Anaesthesia Res Grp, Melbourne, Vic, Australia; [Maze, Mervyn] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA	Imperial College London; Imperial College London; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of California System; University of California San Francisco	Sanders, RD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Magill Dept Anaesthet Intens Care & Pain Med, London SW10 9NH, England.	robert.sanders@imperial.ac.uk	Sanders, Robert/A-7844-2012	Pandharipande, Pratik/0000-0002-1389-8580; Sanders, Robert/0000-0003-0113-0328	Hospira, USA; Air Liquide, France; Air Products, USA; Medical Research Council [G0802353] Funding Source: researchfish; MRC [G0802353] Funding Source: UKRI	Hospira, USA; Air Liquide, France; Air Products, USA; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	All authors have completed the ICMJE disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; RDS has worked as a consultant for Air Liquide, France, and is a member of the Steering Committee of an Air Liquide sponsored clinical trial exploring the utility of xenon anaesthesia to prevent postoperative delirium. PPP has received funding from Hospira, USA, for clinical trials relating to the use of dexmedetomidine as a critical care sedative and honorariums from Hospira, USA, Orion Pharma, Finland, and Glaxo Smith Klein, United Kingdom. MM has received consultancy fees from Air Liquide, France, and Air Products, USA, regarding the clinical development of xenon and from Hospira and Orion regarding the clinical development of dexmedetomidine; no other relationships or activities that could appear to have influenced the	Avidan MS, 2011, J ALZHEIMER DIS; Baranov D, 2009, ANESTH ANALG, V108, P1627, DOI 10.1213/ane.0b013e318199dc72; Bruce AJ, 2007, INT PSYCHOGERIATR, V19, P197, DOI 10.1017/S104161020600425X; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Devlin JW, 2010, CRIT CARE MED, V38, P419, DOI 10.1097/CCM.0b013e3181b9e302; Evered L, 2011, ANESTH ANALG, V112, P1179, DOI 10.1213/ANE.0b013e318215217e; Fong TG, 2009, NEUROLOGY, V72, P1570, DOI 10.1212/WNL.0b013e3181a4129a; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Girard TD, 2010, CRIT CARE MED, V38, P428, DOI 10.1097/CCM.0b013e3181c58715; Hudetz JA, 2009, J CARDIOTHOR VASC AN, V23, P651, DOI 10.1053/j.jvca.2008.12.021; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Kalisvaart KJ, 2005, J AM GERIATR SOC, V53, P1658, DOI 10.1111/j.1532-5415.2005.53503.x; Koster S, 2009, ANN THORAC SURG, V87, P1469, DOI 10.1016/j.athoracsur.2009.02.080; Lepouse C, 2006, BRIT J ANAESTH, V96, P747, DOI 10.1093/bja/ael094; Leslie DL, 2008, ARCH INTERN MED, V168, P27, DOI 10.1001/archinternmed.2007.4; Lundstrom M, 2003, J AM GERIATR SOC, V51, P1002, DOI 10.1046/j.1365-2389.2003.51315.x; Maldonado JR, 2009, PSYCHOSOMATICS, V50, P206, DOI 10.1176/appi.psy.50.3.206; Marcantonio ER, 2001, J AM GERIATR SOC, V49, P516, DOI 10.1046/j.1532-5415.2001.49108.x; Mason SE, 2010, J ALZHEIMERS DIS, V22, pS67, DOI 10.3233/JAD-2010-101086; Morrison RS, 2003, J GERONTOL A-BIOL, V58, P76; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Prakanrattana U, 2007, ANAESTH INTENS CARE, V35, P714, DOI 10.1177/0310057X0703500509; Radtke FM, 2010, MINERVA ANESTESIOL, V76, P394; Reade MC, 2009, CRIT CARE, V13, DOI 10.1186/cc7890; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Robinson TN, 2009, ANN SURG, V249, P173, DOI 10.1097/SLA.0b013e31818e4776; Sanders RD, 2011, MED HYPOTHESES; Sieber FE, 2010, MAYO CLIN PROC, V85, P18, DOI 10.4065/mcp.2009.0469; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; Wan YJ, 2010, CRIT CARE MED, V38, P2190, DOI 10.1097/CCM.0b013e3181f17bcb; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Young J, 2007, BMJ-BRIT MED J, V334, P842, DOI 10.1136/bmj.39169.706574.AD; Young J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3704; Yu DH, 2010, CAN J ANESTH, V57, P843, DOI 10.1007/s12630-010-9338-9	34	85	88	4	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 20	2011	343								d4331	10.1136/bmj.d4331	http://dx.doi.org/10.1136/bmj.d4331			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797ZH	21775401				2022-12-28	WOS:000293168700005
J	Abrams, TE; Vaughan-Sarrazin, M; Fan, VS; Kaboli, PJ				Abrams, Thad E.; Vaughan-Sarrazin, Mary; Fan, Vincent S.; Kaboli, Peter J.			Geographic Isolation and the Risk for Chronic Obstructive Pulmonary Disease-Related Mortality	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; QUALITY-OF-LIFE; HOSPITAL MORTALITY; 30-DAY MORTALITY; FUEL COMBUSTION; HEART-FAILURE; BIOMASS SMOKE; HEALTH; VETERANS; CARE	Background: Little is known about the possible differences in outcomes between patients with chronic obstructive pulmonary disease (COPD) who live in rural areas and those who live in urban areas of the United States. Objective: To determine whether COPD-related mortality is higher in persons living in rural areas, and to assess whether hospital characteristics influence any observed associations. Design: Retrospective cohort study. Setting: 129 acute care Veterans Affairs hospitals. Patients: Hospitalized patients with a COPD exacerbation. Measurements: Patient rurality (primary exposure); 30-day mortality (primary outcome); and hospital volume and hospital rurality, defined as the mean proportion of hospital admissions coming from rural areas (secondary exposures). Results: 18 809 patients (71% of the study population) lived in urban areas, 5671 (21%) in rural areas, and 1919 (7%) in isolated rural areas. Mortality was increased in patients living in isolated rural areas compared with urban areas (5.0% vs. 3.8%; P = 0.002). The increase in mortality associated with living in an isolated rural area persisted after adjustment for patient characteristics and hospital rurality and volume (odds ratio [OR], 1.42 [95% CI, 1.07 to 1.89]; P = 0.016). Adjusted mortality did not seem to be higher in patients living in nonisolated rural areas (OR, 1.09 [CI, 0.90 to 1.32]; P = 0.47). Results were unchanged in analyses assessing the influence of an omitted confounder on estimates. Limitations: The study population was limited to mostly male inpatients who were veterans. Results were based on administrative data. Conclusion: Patients with COPD living in isolated rural areas of the United States seem to be at greater risk for COPD exacerbation-related mortality than those living in urban areas, independent of hospital rurality and volume. Mortality was not increased for patients living in nonisolated rural areas.	[Abrams, Thad E.] Iowa City Vet Affairs Healthcare Syst, Vet Rural Hlth Resource Center Cent Reg, Ctr Comprehens Access & Delivery Res & Evaluat, Iowa City Vet Affairs Med Ctr,Vet Hlth Adm Off Ru, Iowa City, IA 52246 USA; Univ Iowa, Iowa City, IA USA; Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; Univ Washington, Seattle, WA 98195 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Abrams, TE (corresponding author), Iowa City Vet Affairs Healthcare Syst, Vet Rural Hlth Resource Center Cent Reg, Ctr Comprehens Access & Delivery Res & Evaluat, Iowa City Vet Affairs Med Ctr,Vet Hlth Adm Off Ru, 601 Highway 6 W,Mailstop 152, Iowa City, IA 52246 USA.	Thad-Abrams@va.gov		Vaughan Sarrazin, Mary/0000-0001-8717-1061; Kaboli, Peter/0000-0003-0993-0952; abrams, thad/0000-0003-0510-7803	Veterans Health Administration Office of Rural Health; Veterans Rural Health Resource Center-Central Region; Health Services Research and Development Service through the Center for Comprehensive Access and Delivery Research and Evaluation at the Iowa City Veterans Affairs Healthcare System, U. S. Department of Veterans Affairs [HFP 04-149]	Veterans Health Administration Office of Rural Health; Veterans Rural Health Resource Center-Central Region; Health Services Research and Development Service through the Center for Comprehensive Access and Delivery Research and Evaluation at the Iowa City Veterans Affairs Healthcare System, U. S. Department of Veterans Affairs(US Department of Veterans Affairs)	By the Veterans Health Administration Office of Rural Health, Veterans Rural Health Resource Center-Central Region, and the Health Services Research and Development Service, through the Center for Comprehensive Access and Delivery Research and Evaluation at the Iowa City Veterans Affairs Healthcare System, U. S. Department of Veterans Affairs (grant HFP 04-149).		0	32	32	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2					80	+		10.7326/0003-4819-155-2-201107190-00003	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	793KW	21768581				2022-12-28	WOS:000292822000014
J	Aranganathan, S; Dharmarajan, R				Aranganathan, Shreedhar; Dharmarajan, Ramasubramanian			PICTURE QUIZ Ankle injury after a fall from a horse	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TOTAL DISLOCATION; FRACTURES; TALUS		[Aranganathan, Shreedhar] N Tees Hosp, Stockton On Tees TS19 8PE, England; [Dharmarajan, Ramasubramanian] N Cumbria Hosp NHS Trust, Carlisle, Cumbria, England	University Hospital of North Tees	Aranganathan, S (corresponding author), N Tees Hosp, Stockton On Tees TS19 8PE, England.	ashreedhar@gmail.com						Bucholz RW, 2009, ROCKWOOD GREENS FRAC, V1, P2267; Bucholz RW, 2009, ROCKWOOD GREENS FRAC, V1, P2252; DETENBEC.LC, 1969, J BONE JOINT SURG AM, VA 51, P283, DOI 10.2106/00004623-196951020-00007; Fleming J, 2009, J FOOT ANKLE SURG, V48, DOI [10.1053/j.jfas.2009.06.005, 10.1053/j.jfas.2009.01.015]; Haapamaki VV, 2004, AM J ROENTGENOL, V183, P615, DOI 10.2214/ajr.183.3.1830615; HAWKINS LG, 1970, J BONE JOINT SURG AM, VA 52, P991, DOI 10.2106/00004623-197052050-00013; Hoppenfeld S, 2003, SURG EXPOSURES ORTHO, P649; Last RJ, 2006, LASTS ANATOMY REGION, V3, P195; LEITNER B, 1955, J BONE JOINT SURG AM, V37, P89, DOI 10.2106/00004623-195537010-00010; PalomoTraver JM, 1997, J ORTHOP TRAUMA, V11, P45, DOI 10.1097/00005131-199701000-00014; Papanikolaou A, 2000, J FOOT ANKLE SURG, V8, P245; Pearce DH, 2005, RADIOGRAPHICS, V25, P399, DOI 10.1148/rg.252045709; Taymaz Asim, 2005, J Foot Ankle Surg, V44, P156, DOI 10.1053/j.jfas.2005.01.008; Tezval M, 2007, J ORTHOP TRAUMA, V21, P538, DOI 10.1097/BOT.0b013e318148c665; Wagner R, 2004, INJURY, V35, pB36, DOI 10.1016/j.injury.2004.07.010; Watson-Jones R, 1943, FRACTURES JOINT INJU, V2, P822	16	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2011	343								d2094	10.1136/bmj.d2094	http://dx.doi.org/10.1136/bmj.d2094			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797ZG	21771834				2022-12-28	WOS:000293168500004
J	Gandy, S				Gandy, Sam			PERSPECTIVE Prevention is better than cure	NATURE			English	Editorial Material							ALZHEIMERS-DISEASE; COMPOUND-B		[Gandy, Sam] Mt Sinai Sch Med, Alzheimers Dis Res Ctr, New York, NY 10029 USA; [Gandy, Sam] James J Peters VA Med Ctr, New York, NY USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Gandy, S (corresponding author), Mt Sinai Sch Med, Alzheimers Dis Res Ctr, New York, NY 10029 USA.	samuel.gandy@mssm.edu			NATIONAL INSTITUTE ON AGING [P50AG005138] Funding Source: NIH RePORTER; NIA NIH HHS [P50 AG005138] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Knight WD, 2011, BRAIN, V134, P293, DOI 10.1093/brain/awq310; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; TERRY RD, 1983, ANN NEUROL, V14, P497, DOI 10.1002/ana.410140502	7	30	31	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					S15	S15		10.1038/475S15a	http://dx.doi.org/10.1038/475S15a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791UA	21760576	Bronze, Green Accepted			2022-12-28	WOS:000292690500007
J	Kirkpatrick, I; McCabe, C				Kirkpatrick, Ian; McCabe, Christopher			A full blooded market system: at what cost to the NHS?	BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE		[Kirkpatrick, Ian] Univ Leeds, Sch Business, Leeds LS2 9JT, W Yorkshire, England; [McCabe, Christopher] Leeds Inst Hlth Sci, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Kirkpatrick, I (corresponding author), Univ Leeds, Sch Business, Leeds LS2 9JT, W Yorkshire, England.	I.Kirkpatrick@lubs.leeds.ac.uk	McCabe, Christopher/E-2051-2016; Kirkpatrick, Ian/AAB-2781-2020					[Anonymous], 2010, MIRROR MIRROR WALL P; CAMERON D, 2011, DAILY TELEGRAPH 0225; Davies P, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d491; DAVIS K, 2009, WHY HLTH REFORM MUST; Delamothe T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d408; Edwards N, 2005, BMJ-BRIT MED J, V331, P1464, DOI 10.1136/bmj.331.7530.1464; Greener I, 2009, POLICY POLIT, V37, P57, DOI 10.1332/030557309X395614; GUBB J, 2010, GOVT PLANS TRANSFER; House of Commons Health Committee, 2010, 4 HOUS COMM HLTH COM; Kahn JG, 2005, HEALTH AFFAIR, V24, P1629, DOI 10.1377/hlthaff.24.6.1629; MALBY R, 2011, HLTH SERVICE J  0518; Mannion R, 2011, BRIT MED BULL, V97, P7, DOI 10.1093/bmb/ldq042; Marini G, 2007, HEALTH POLICY, V83, P17, DOI 10.1016/j.healthpol.2006.11.007; Organisation for Economic Co-operation and Development, OECD HLTH DAT 2010 S; REINHARDT UE, 2008, NY TIMES        1121; The King's Fund, 2011, FUT LEAD MAN NHS; The King's Fund, 2010, MAN MAN AR THER NHS; Walshe K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3843; Watt N., 2011, GUARDIAN        0613; Woolhandler S, 2003, NEW ENGL J MED, V349, P768, DOI 10.1056/NEJMsa022033	20	1	1	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 13	2011	343								d3238	10.1136/bmj.d3238	http://dx.doi.org/10.1136/bmj.d3238			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	794OE	21752851				2022-12-28	WOS:000292908900002
J	Mays, N				Mays, Nicholas			Is there evidence that competition in healthcare is a good thing? No	BRITISH MEDICAL JOURNAL			English	Editorial Material									London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Mays, N (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England.	Nicholas.Mays@lshtm.ac.uk						BLOOM N, 2010, 201009 IMP COLL BUS; COOPER Z, EC J IN PRESS; Department of Health, 2011, GOV CHANG RESP NHS F; Gaynor, 2006, 12301 NBER; Gaynor M., 2010, DEATH MARKET POWER R; Gowrisankaran G, 2003, HEALTH SERV RES, V38, P1403, DOI 10.1111/j.1475-6773.2003.00185.x; PbR Data Assurance Framework 2007/08, 2008, PBR DAT ASS FRAM 200; SMITH P, 2009, OECD HLTH POLICY STU	8	11	11	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 5	2011	343								d4205	10.1136/bmj.d4205	http://dx.doi.org/10.1136/bmj.d4205			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791RV	21729996	Green Submitted			2022-12-28	WOS:000292683200005
J	Stevens, S				Stevens, Simon			Is there evidence that competition in healthcare is a good thing? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material									UnitedHlth Grp, Minnetonka, MN 55343 USA		Stevens, S (corresponding author), UnitedHlth Grp, 9900 Bren Rd E, Minnetonka, MN 55343 USA.	simon_l_stevens@uhc.com						Bloom N., 2010, 983 CTR EC PERF; Cooper Z., 2010, DOES HOSP COMPETITIO; Gaynor M., 2010, DEATH MARKET POWER R; Greaney TL, 2011, NEW ENGL J MED, V364, pE1, DOI 10.1056/NEJMp1013404; Mooney H, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3346; Pike C., 2010, COOPERATION COMPETIT, V1; Stensland J, 2010, HEALTH AFFAIR, V29, P1045, DOI 10.1377/hlthaff.2009.0599; The King's Fund, 2011, FUT LEAD MAN NHS; Timmins N, 2011, FINANCIAL TIMES 0509; *UN CTR HLTH REF M, 2009, 2 UN CTR HLTH REF MO; Vogt W.B., 2006, HAS HOSP CONSOLIDATI; Wise J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6809	12	5	5	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 5	2011	343								d4136	10.1136/bmj.d4136	http://dx.doi.org/10.1136/bmj.d4136			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791RV	21729995				2022-12-28	WOS:000292683200004
J	Edelson, M; Sharot, T; Dolan, RJ; Dudai, Y				Edelson, Micah; Sharot, Tali; Dolan, Raymond J.; Dudai, Yadin			Following the Crowd: Brain Substrates of Long-Term Memory Conformity	SCIENCE			English	Article							FALSE MEMORIES; AMYGDALA; COGNITION; PREDICTS; EMOTION; CORTEX; MONKEY	Human memory is strikingly susceptible to social influences, yet we know little about the underlying mechanisms. We examined how socially induced memory errors are generated in the brain by studying the memory of individuals exposed to recollections of others. Participants exhibited a strong tendency to conform to erroneous recollections of the group, producing both long-lasting and temporary errors, even when their initial memory was strong and accurate. Functional brain imaging revealed that social influence modified the neuronal representation of memory. Specifically, a particular brain signature of enhanced amygdala activity and enhanced amygdala-hippocampus connectivity predicted long-lasting but not temporary memory alterations. Our findings reveal how social manipulation can alter memory and extend the known functions of the amygdala to encompass socially mediated memory distortions.	[Edelson, Micah; Dudai, Yadin] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Sharot, Tali; Dolan, Raymond J.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England	Weizmann Institute of Science; University of London; University College London	Edelson, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	micah.edelson@weizmann.ac.il		Dolan, Ray/0000-0001-9356-761X; Edelson, Micah/0000-0001-6494-2871	Weizmann Institute-UK; British Academy; Wellcome Trust; Nella and Leon Benoziyo Center for Neurological Diseases	Weizmann Institute-UK; British Academy; Wellcome Trust(Wellcome TrustEuropean Commission); Nella and Leon Benoziyo Center for Neurological Diseases	M.E. was supported by a Weizmann Institute-UK Grant. T.S. is supported by a British Academy Postdoctoral Fellowship. R.J.D is supported by a Wellcome Trust Program Grant. Y.D. is supported by the Nella and Leon Benoziyo Center for Neurological Diseases. We thank A. Ben-Yakov, J. G. Edelson, T. Fitzgerald, O. Furman, S. Fleming, D. Levi, M. Guitart-Masip, A. Mendelsohn, U. Nili, A. Pine, J. S. Winston, and N. Wright for helpful comments and the support teams of the Norman and Helen Asher Center for Brain Imaging at the Weizmann Institute and the Imaging Neuroscience & Theoretical Neurobiology unit in the Wellcome Trust Center for Neuroimaging.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Aggleton JP., 2000, AMYGDALA FUNCTIONAL; ALLEN VL, 1965, ADV EXP SOC PSYCHOL, V2, P133; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Arndt J, 2010, J EXP PSYCHOL LEARN, V36, P66, DOI 10.1037/a0017394; Asch S. E., 1951, GROUPS LEADERSHIP ME, P39; Bartlett F. C., 1932, REMEMBERING; Bickart KC, 2011, NAT NEUROSCI, V14, P163, DOI 10.1038/nn.2724; Boyd R., 1988, P29; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dudai Y., 2002, MEMORY KEYWORDS CONC; Festinger L., 1957, THEOR COGNITIVE DIS, P99; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Howe ML, 2008, PSYCHOL BULL, V134, P768, DOI 10.1037/0033-2909.134.5.768; Klucharev V, 2009, NEURON, V61, P140, DOI 10.1016/j.neuron.2008.11.027; Kluver H, 1938, J PSYCHOL, V5, P33; Kuhl BA, 2007, NAT NEUROSCI, V10, P908, DOI 10.1038/nn1918; Levy BJ, 2002, TRENDS COGN SCI, V6, P299, DOI 10.1016/S1364-6613(02)01923-X; Loftus EF, 2005, LEARN MEMORY, V12, P361, DOI 10.1101/lm.94705; Meade ML, 2002, MEM COGNITION, V30, P995, DOI 10.3758/BF03194318; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P800, DOI 10.1162/0898929053747595; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Ochsner Kevin, 2006, SOC NEUROSCI-UK, P245; Okado Y, 2005, LEARN MEMORY, V12, P3, DOI 10.1101/lm.87605; Perkins HW, 2010, ADDICT BEHAV, V35, P866, DOI 10.1016/j.addbeh.2010.05.004; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; REYNA VF, 1995, LEARN INDIVID DIFFER, V7, P1, DOI 10.1016/1041-6080(95)90031-4; Reysen MB, 2005, MEMORY, V13, P87, DOI 10.1080/09658210344000602; Richardson MP, 2004, NAT NEUROSCI, V7, P278, DOI 10.1038/nn1190; Roediger HL, 2001, PSYCHON B REV, V8, P385, DOI 10.3758/BF03196177; Schacter D. L., 2001, 7 SINS MEMORY MIND F; Shaw JS, 1997, LAW HUMAN BEHAV, V21, P503, DOI 10.1023/A:1024875723399; Sherif M., 1936, PSYCHOL SOCIAL NORMS; Smith E.R., 2007, SOC PSYCHOL-GERMANY, V3rd Ed.; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Wright DB, 2009, CURR DIR PSYCHOL SCI, V18, P174, DOI 10.1111/j.1467-8721.2009.01631.x	42	128	138	6	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					108	111		10.1126/science.1203557	http://dx.doi.org/10.1126/science.1203557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	785UF	21719681	Green Published, Green Accepted			2022-12-28	WOS:000292255400061
J	Omori, T; Ando, K; Okano, M; Xu, X; Tanaka, Y; Ohnuma, I; Kainuma, R; Ishida, K				Omori, T.; Ando, K.; Okano, M.; Xu, X.; Tanaka, Y.; Ohnuma, I.; Kainuma, R.; Ishida, K.			Superelastic Effect in Polycrystalline Ferrous Alloys	SCIENCE			English	Article							SHAPE-MEMORY ALLOYS; MN-AL; THERMODYNAMIC CALCULATION; PHASE-EQUILIBRIA; TRANSFORMATION; BEHAVIOR; SYSTEM	In superelastic alloys, large deformation can revert to a memorized shape after removing the stress. However, the stress increases with increasing temperature, which limits the practical use over a wide temperature range. Polycrystalline Fe-Mn-Al-Ni shape memory alloys show a small temperature dependence of the superelastic stress because of a small transformation entropy change brought about by a magnetic contribution to the Gibbs energies. For one alloy composition, the superelastic stress varies by 0.53 megapascal/degrees C over a temperature range from -196 to 240 degrees C.	[Omori, T.; Ando, K.; Okano, M.; Xu, X.; Tanaka, Y.; Ohnuma, I.; Kainuma, R.; Ishida, K.] Tohoku Univ, Dept Mat Sci, Grad Sch Engn, Sendai, Miyagi 9808579, Japan	Tohoku University	Omori, T (corresponding author), Tohoku Univ, Dept Mat Sci, Grad Sch Engn, 6-6-02 Aoba Yama, Sendai, Miyagi 9808579, Japan.	omori@material.tohoku.ac.jp	OHNUMA, Ikuo/J-4253-2015; Kainuma, Ryosuke/I-6482-2013; Xiao, Xu/G-3923-2013; Omori, Toshihiro/A-4478-2017	Xiao, Xu/0000-0003-4301-2848; Omori, Toshihiro/0000-0001-9174-0239	Japan Society for the Promotion of Science; Tohoku University, Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [23686097, 11J04139] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tohoku University, Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors are grateful to K. R. A Ziebeck, Cavendish Laboratory, University of Cambridge, for help in critical reading. This work was supported by the Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science and by the Global Center of Excellence Program "Materials Integration (International Center of Education and Research), Tohoku University," Ministry of Education, Culture, Sports, Science, and Technology. A patent application has been filed on the materials, including the alloy presented herein.	Abbott A, 2001, NATURE, V414, P572, DOI 10.1038/414572b; ALCAZAR GAP, 1991, HYPERFINE INTERACT, V66, P221, DOI 10.1007/BF02395869; Ando K, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3266848; Dolce M, 2000, EARTHQUAKE ENG STRUC, V29, P945, DOI 10.1002/1096-9845(200007)29:7<945::AID-EQE958>3.0.CO;2-#; Duerig T.W., 1990, ENG ASPECTS SHAPE ME; GRAESSER EJ, 1991, J ENG MECH-ASCE, V117, P2590, DOI 10.1061/(ASCE)0733-9399(1991)117:11(2590); Hao S. M., 1984, METALL T A, V15, P1819; Kainuma R, 1998, J ALLOY COMPD, V269, P173, DOI 10.1016/S0925-8388(98)00127-3; Kainuma R, 2006, NATURE, V439, P957, DOI 10.1038/nature04493; Kakeshita T, 2002, MRS BULL, V27, P105, DOI 10.1557/mrs2002.45; Kim HY, 2004, MATER TRANS, V45, P2443, DOI 10.2320/matertrans.45.2443; Ma J, 2010, INT MATER REV, V55, P257, DOI 10.1179/095066010X12646898728363; MAGEE CL, 1972, ACTA METALL MATER, V20, P1031, DOI 10.1016/0001-6160(72)90137-X; MAKI T, 1984, SCRIPTA METALL MATER, V18, P1105, DOI 10.1016/0036-9748(84)90187-X; Maki T., 1998, SHAPE MEMORY MAT, P117; MULDAWER L, 1961, J CHEM PHYS, V35, P1904, DOI 10.1063/1.1732175; Olander A, 1932, J AM CHEM SOC, V54, P3819, DOI 10.1021/ja01349a004; Otsuka K, 1998, SHAPE MEMORY MAT, P1; Sutou Y, 2009, ACTA MATER, V57, P5759, DOI 10.1016/j.actamat.2009.08.011; Tanaka Y, 2010, SCIENCE, V327, P1488, DOI 10.1126/science.1183169; Tang W, 2000, METALL MATER TRANS A, V31, P2423, DOI 10.1007/s11661-000-0187-y; TONG HC, 1974, ACTA METALL MATER, V22, P887, DOI 10.1016/0001-6160(74)90055-8; Umino R, 2006, J PHASE EQUILIB DIFF, V27, P54, DOI 10.1361/105497106X92817; WOLLANTS P, 1979, Z METALLKD, V70, P113; YAN SS, 1985, SOLID STATE COMMUN, V54, P831, DOI 10.1016/0038-1098(85)90296-0; Zener C., 1955, J MET, V7, P619	26	263	268	20	252	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					68	71		10.1126/science.1202232	http://dx.doi.org/10.1126/science.1202232			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719673				2022-12-28	WOS:000292255400049
J	Thiele, P; Blair, S				Thiele, Pauline; Blair, Simon			A PATIENT'S JOURNEY Destined to die	BRITISH MEDICAL JOURNAL			English	Editorial Material												liam194@gmail.com							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 1	2011	343								d3625	10.1136/bmj.d3625	http://dx.doi.org/10.1136/bmj.d3625			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788QD	21724563	Bronze			2022-12-28	WOS:000292458600001
J	Casaer, MP; Mesotten, D; Hermans, G; Wouters, PJ; Schetz, M; Meyfroidt, G; Van Cromphaut, S; Ingels, C; Meersseman, P; Muller, J; Vlasselaers, D; Debaveye, Y; Desmet, L; Dubois, J; Van Assche, A; Vanderheyden, S; Wilmer, A; Van den Berghe, G				Casaer, Michael P.; Mesotten, Dieter; Hermans, Greet; Wouters, Pieter J.; Schetz, Miet; Meyfroidt, Geert; Van Cromphaut, Sophie; Ingels, Catherine; Meersseman, Philippe; Muller, Jan; Vlasselaers, Dirk; Debaveye, Yves; Desmet, Lars; Dubois, Jasperina; Van Assche, Aime; Vanderheyden, Simon; Wilmer, Alexander; Van den Berghe, Greet			Early versus Late Parenteral Nutrition in Critically Ill Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE INSULIN THERAPY; ENTERAL NUTRITION; ENERGY-BALANCE; AUTOPHAGY; GUIDELINES; SUPPORT; METAANALYSIS; DEFINITIONS; MULTICENTER; INFECTIONS	Background Controversy exists about the timing of the initiation of parenteral nutrition in critically ill adults in whom caloric targets cannot be met by enteral nutrition alone. Methods In this randomized, multicenter trial, we compared early initiation of parenteral nutrition (European guidelines) with late initiation (American and Canadian guidelines) in adults in the intensive care unit (ICU) to supplement insufficient enteral nutrition. In 2312 patients, parenteral nutrition was initiated within 48 hours after ICU admission (early-initiation group), whereas in 2328 patients, parenteral nutrition was not initiated before day 8 (late-initiation group). A protocol for the early initiation of enteral nutrition was applied to both groups, and insulin was infused to achieve normoglycemia. Results Patients in the late-initiation group had a relative increase of 6.3% in the likelihood of being discharged alive earlier from the ICU (hazard ratio, 1.06; 95% confidence interval [CI], 1.00 to 1.13; P = 0.04) and from the hospital (hazard ratio, 1.06; 95% CI, 1.00 to 1.13; P = 0.04), without evidence of decreased functional status at hospital discharge. Rates of death in the ICU and in the hospital and rates of survival at 90 days were similar in the two groups. Patients in the late-initiation group, as compared with the early-initiation group, had fewer ICU infections (22.8% vs. 26.2%, P = 0.008) and a lower incidence of cholestasis (P<0.001). The late-initiation group had a relative reduction of 9.7% in the proportion of patients requiring more than 2 days of mechanical ventilation (P = 0.006), a median reduction of 3 days in the duration of renal-replacement therapy (P = 0.008), and a mean reduction in health care costs of ss1,110 (about $1,600) (P = 0.04). Conclusions Late initiation of parenteral nutrition was associated with faster recovery and fewer complications, as compared with early initiation.	[Casaer, Michael P.; Mesotten, Dieter; Wouters, Pieter J.; Schetz, Miet; Meyfroidt, Geert; Van Cromphaut, Sophie; Ingels, Catherine; Muller, Jan; Vlasselaers, Dirk; Debaveye, Yves; Desmet, Lars; Vanderheyden, Simon; Van den Berghe, Greet] Catholic Univ Louvain, Dept Intens Care Med, Univ Hosp Leuven, B-3000 Louvain, Belgium; [Hermans, Greet; Meersseman, Philippe; Wilmer, Alexander] Catholic Univ Louvain, Med Intens Care Unit, Dept Internal Med, Univ Hosp, B-3000 Louvain, Belgium; [Dubois, Jasperina; Van Assche, Aime] Jessa Hosp, Dept Anesthesia, Hasselt, Belgium; [Dubois, Jasperina; Van Assche, Aime] Jessa Hosp, Dept Intens Care, Hasselt, Belgium	KU Leuven; University Hospital Leuven; Universite Catholique Louvain; Universite Catholique Louvain	Van den Berghe, G (corresponding author), Catholic Univ Louvain, Dept Intens Care Med, Univ Hosp Leuven, B-3000 Louvain, Belgium.	greet.vandenberghe@med.kuleuven.be	Casaer, Michael/Y-7131-2019; Wilmer, Alexander/H-7784-2018; Mesotten, Dieter/ABE-4176-2020; Hermans, Greet M/E-6234-2018; Van den Berghe, Greet/J-6788-2018; Hug, Balthasar L./G-1568-2010	Casaer, Michael/0000-0002-7087-0795; Wilmer, Alexander/0000-0002-4176-3608; Mesotten, Dieter/0000-0002-3258-4720; Hermans, Greet M/0000-0001-5340-1500; Van den Berghe, Greet/0000-0002-5320-1362; Meyfroidt, Geert/0000-0003-4259-3935	Flemish government; Catholic University of Leuven [GOA-2007/14]; Research Foundation Flanders, Belgium; University Hospitals Leuven, Belgium; Baxter Healthcare	Flemish government(European Commission); Catholic University of Leuven(KU Leuven); Research Foundation Flanders, Belgium(FWO); University Hospitals Leuven, Belgium; Baxter Healthcare	Funded by the Methusalem program of the Flemish government and others; EPaNIC ClinicalTrials.gov number, NCT00512122.; Supported by the Methusalem program of the Flemish government (with a grant through the Catholic University of Leuven to Dr. Van den Berghe), the Research Fund of the Catholic University of Leuven (GOA-2007/14, to Dr. Van den Berghe), the Research Foundation Flanders, Belgium (doctoral fellowship to Dr. Casaer and postdoctoral fellowship to Dr. Van Cromphaut), and the Clinical Research Fund of the University Hospitals Leuven, Belgium (doctoral fellowship to Dr. Ingels and postdoctoral fellowships to Drs. Mesotten and Hermans). In addition, the Catholic University of Leuven received an unconditional and nonrestrictive research grant for this trial from Baxter Healthcare.	Alberda Cathy, 2009, Intensive Care Med, V35, P1728, DOI 10.1007/s00134-009-1567-4; Alberda C, 2009, INTENS CARE MED, V35, P1728, DOI 10.1007/s00134-009-1567-4; Andersen PK, 2002, STAT METHODS MED RES, V11, P91, DOI 10.1191/0962280202SM276ra; Andrews PJD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1542; Barber JA, 1998, BRIT MED J, V317, P1195, DOI 10.1136/bmj.317.7167.1195; Barr J, 2004, CHEST, V125, P1446, DOI 10.1378/chest.125.4.1446; Biolo G, 2008, CRIT CARE MED, V36, P1768, DOI 10.1097/CCM.0b013e318174de32; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Braunschweig CL, 2001, AM J CLIN NUTR, V74, P534; Cahill NE, 2010, CRIT CARE MED, V38, P395, DOI 10.1097/CCM.0b013e3181c0263d; Casaer MP, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-21; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Debaveye Y, 2006, ANNU REV NUTR, V26, P513, DOI 10.1146/annurev.nutr.26.061505.111307; Dhaliwal R, 2004, INTENS CARE MED, V30, P1666, DOI 10.1007/s00134-004-2345-y; Doig GS, 2008, JAMA-J AM MED ASSOC, V300, P2731, DOI 10.1001/jama.2008.826; Dvir D, 2006, CLIN NUTR, V25, P37, DOI 10.1016/j.clnu.2005.10.010; Grau T, 2007, CRIT CARE, V11, DOI 10.1186/cc5670; Grau T, 2011, CRIT CARE MED, V39, P1263, DOI 10.1097/CCM.0b013e31820eb774; Griffiths RD, 1997, NUTRITION, V13, P752, DOI 10.1016/S0899-9007(97)83039-0; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P74, DOI 10.1177/014860710302700174; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; HORAN TC, 1992, AM J INFECT CONTROL, V20, P271, DOI 10.1016/S0196-6553(05)80201-9; Ibrahim EH, 2002, JPEN-PARENTER ENTER, V26, P174, DOI 10.1177/0148607102026003174; Jolliet P, 1998, INTENS CARE MED, V24, P848, DOI 10.1007/s001340050677; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kondrup J, 2003, CLIN NUTR, V22, P415, DOI 10.1016/S0261-5614(03)00098-0; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Langouche L, 2010, AM J RESP CRIT CARE, V182, P507, DOI 10.1164/rccm.200909-1395OC; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Martin CM, 2004, CAN MED ASSOC J, V170, P197, DOI 10.1503/cmaj.1040621; Martindale RG, 2009, CRIT CARE MED, V37, P1757, DOI 10.1097/CCM.0b013e3181a40116; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; McClave SA, 1998, JPEN-PARENTER ENTER, V22, P375, DOI 10.1177/0148607198022006375; Nasraway SA, 2006, CRIT CARE MED, V34, P964, DOI 10.1097/01.CCM.0000205758.18891.70; O'Brien JM, 2006, CRIT CARE MED, V34, P738, DOI 10.1097/01.CCM.0000202207.87891.FC; Peter JV, 2005, CRIT CARE MED, V33, P213, DOI 10.1097/01.CCM.0000150960.36228.C0; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Reid C, 2006, J HUM NUTR DIET, V19, P13, DOI 10.1111/j.1365-277X.2006.00661.x; Rubinson L, 2004, CRIT CARE MED, V32, P350, DOI 10.1097/01.CCM.0000089641.06306.68; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; Schetz M, 2008, J AM SOC NEPHROL, V19, P571, DOI 10.1681/ASN.2006101091; Simpson F, 2005, INTENS CARE MED, V31, P12, DOI 10.1007/s00134-004-2511-2; Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024; STREAT SJ, 1987, J TRAUMA, V27, P262, DOI 10.1097/00005373-198703000-00006; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vanhorebeek I, 2011, J CLIN ENDOCR METAB, V96, pE633, DOI 10.1210/jc.2010-2563; Villet S, 2005, CLIN NUTR, V24, P502, DOI 10.1016/j.clnu.2005.03.006; Vlasselaers D, 2009, LANCET, V373, P547, DOI 10.1016/S0140-6736(09)60044-1	52	959	1035	0	88	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2011	365	6					506	517		10.1056/NEJMoa1102662	http://dx.doi.org/10.1056/NEJMoa1102662			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805MW	21714640				2022-12-28	WOS:000293732100006
J	Wang, L; Gural, A; Sun, XJ; Zhao, XY; Perna, F; Huang, G; Hatlen, MA; Vu, L; Liu, F; Xu, HM; Asai, T; Xu, H; Deblasio, T; Menendez, S; Voza, F; Jiang, YW; Cole, PA; Zhang, JS; Melnick, A; Roeder, RG; Nimer, SD				Wang, Lan; Gural, Alexander; Sun, Xiao-Jian; Zhao, Xinyang; Perna, Fabiana; Huang, Gang; Hatlen, Megan A.; Vu, Ly; Liu, Fan; Xu, Haiming; Asai, Takashi; Xu, Hao; Deblasio, Tony; Menendez, Silvia; Voza, Francesca; Jiang, Yanwen; Cole, Philip A.; Zhang, Jinsong; Melnick, Ari; Roeder, Robert G.; Nimer, Stephen D.			The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation	SCIENCE			English	Article							HEMATOPOIETIC STEM-CELLS; FUSION PROTEIN; MYELOID-LEUKEMIA; DNA-BINDING; SELF-RENEWAL; T(8/21); DOMAIN; DIFFERENTIATION; TRANSCRIPTION; INHIBITOR	The chromosomal translocations found in acute myelogenous leukemia (AML) generate oncogenic fusion transcription factors with aberrant transcriptional regulatory properties. Although therapeutic targeting of most leukemia fusion proteins remains elusive, the posttranslational modifications that control their function could be targetable. We found that AML1-ETO, the fusion protein generated by the t(8;21) translocation, is acetylated by the transcriptional coactivator p300 in leukemia cells isolated from t(8;21) AML patients, and that this acetylation is essential for its self-renewal-promoting effects in human cord blood CD34(+) cells and its leukemogenicity in mouse models. Inhibition of p300 abrogates the acetylation of AML1-ETO and impairs its ability to promote leukemic transformation. Thus, lysine acetyltransferases represent a potential therapeutic target in AML.	[Wang, Lan; Gural, Alexander; Zhao, Xinyang; Perna, Fabiana; Huang, Gang; Hatlen, Megan A.; Vu, Ly; Liu, Fan; Xu, Haiming; Asai, Takashi; Xu, Hao; Deblasio, Tony; Menendez, Silvia; Voza, Francesca; Nimer, Stephen D.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Sun, Xiao-Jian; Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA; [Jiang, Yanwen; Melnick, Ari] Weill Cornell Med Coll, Dept Med, Div Hematol Oncol, New York, NY 10065 USA; [Cole, Philip A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Zhang, Jinsong] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University; Cornell University; Johns Hopkins University; University System of Ohio; University of Cincinnati	Nimer, SD (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY 10065 USA.	nimers@mskcc.org	Sun, Xiao-Jian/D-1560-2011; Xu, Haiming/A-2238-2014; Melnick, Ari/AAA-5763-2020	Sun, Xiao-Jian/0000-0001-8826-4614; Zhang, Jinsong/0000-0002-8798-7316; Zhao, Xinyang/0000-0001-6677-7072; Vu, Ly/0000-0002-1682-7702; Perna, Fabiana/0000-0002-3744-8672	Leukemia Lymphoma Society; Empire State Stem Cell Scholar award; Clinical Scholars award; Starr Foundation; NIH [GM62437]; Gabrielle's Angel Foundation; Acylin Therapeutics Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062437, R01GM062437] Funding Source: NIH RePORTER	Leukemia Lymphoma Society(Leukemia and Lymphoma Society); Empire State Stem Cell Scholar award; Clinical Scholars award; Starr Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Foundation; Acylin Therapeutics Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Nimer lab for thoughtful suggestions and comments; D. J. Meyers for the HAT inhibitors; E. Chuang for help with manuscript preparation; E. Dolezal for help with patient samples; K. Debeer for help with graphic design; M. E. Figueroa for help with data analysis; S. Pereira Mendez for technical assistance; and the MSKCC Animal Core Facility, Flow Cytometry Core Facility, and Anti-tumor Assessment Core Facility for their help. P.A.C. is a cofounder, paid consultant, and shareholder of Acylin Therapeutics Inc., which is developing p300 HAT inhibitors. P.A.C. and Johns Hopkins University hold a patent on HAT inhibitors that has been licensed to Acylin Therapeutics Inc. Supported by a Leukemia Lymphoma Society SCOR grant (S.D.N., R.G.R.), a Leukemia Lymphoma Society fellowship (L.W.), an Empire State Stem Cell Scholar award (L.W.), a Clinical Scholars award (F.L.), a Starr Foundation grant (X.-J.S., R.G.R., S.D.N.), NIH grant GM62437 (P.A.C.), and the Gabrielle's Angel Foundation. The microarray data have been submitted to the National Center for Biotechnology Information Gene Expression Omnibus (GEO) GSE28317.	Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; BREEMS DA, 1994, LEUKEMIA, V8, P1095; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Jankovic V, 2007, P NATL ACAD SCI USA, V104, P1260, DOI 10.1073/pnas.0607894104; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Klampfer L, 1996, P NATL ACAD SCI USA, V93, P14059, DOI 10.1073/pnas.93.24.14059; Kwok C, 2009, P NATL ACAD SCI USA, V106, P2853, DOI 10.1073/pnas.0810558106; Liu YZ, 2006, CANCER CELL, V9, P249, DOI 10.1016/j.ccr.2006.03.012; Mannari D, 2010, LEUKEMIA, V24, P891, DOI 10.1038/leu.2009.288; Minucci S, 2001, ONCOGENE, V20, P3110, DOI 10.1038/sj.onc.1204336; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Nimer SD, 2004, ONCOGENE, V23, P4249, DOI 10.1038/sj.onc.1207673; Okumura AJ, 2008, BLOOD, V112, P1392, DOI 10.1182/blood-2007-11-124735; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Park S, 2009, BLOOD, V113, P3558, DOI 10.1182/blood-2008-06-161307; Rhoades KL, 1996, P NATL ACAD SCI USA, V93, P11895, DOI 10.1073/pnas.93.21.11895; Vangala RK, 2003, BLOOD, V101, P270, DOI 10.1182/blood-2002-04-1288; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Wang L, 2007, CELL DEATH DIFFER, V14, P306, DOI 10.1038/sj.cdd.4401996; Wang L, 2009, BLOOD CELL MOL DIS, V43, P30, DOI 10.1016/j.bcmd.2009.03.005; Wildonger J, 2005, DEVELOPMENT, V132, P2263, DOI 10.1242/dev.01824; Wilson A, 2009, CURR OPIN GENET DEV, V19, P461, DOI 10.1016/j.gde.2009.08.005; Yamaguchi Y, 2004, J BIOL CHEM, V279, P15630, DOI 10.1074/jbc.M400355200; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443; Yan M, 2009, BLOOD, V113, P883, DOI 10.1182/blood-2008-04-153742; Zhang JS, 2004, SCIENCE, V305, P1286, DOI 10.1126/science.1097937; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608; Zheng YJ, 2005, J AM CHEM SOC, V127, P17182, DOI 10.1021/ja0558544	29	153	160	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					765	769		10.1126/science.1201662	http://dx.doi.org/10.1126/science.1201662			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21764752	Green Accepted			2022-12-28	WOS:000293512100046
J	Tan, YH; Luo, ZQ				Tan, Yunhao; Luo, Zhao-Qing			Legionella pneumophila SidD is a deAMPylase that modifies Rab1	NATURE			English	Article							EFFECTOR PROTEIN DRRA; AMPYLATION; SYSTEM; PHOSPHATASE; BINDING; FAMILY	Legionella pneumophila actively modulates host vesicle trafficking pathways to facilitate its intracellular replication with effectors translocated by the Dot/Icm type IV secretion system (T4SS)(1). The SidM/DrrA protein functions by locking the small GTPase Rab1 into an active form by its guanine nucleotide exchange factor (GEF) and AMPylation activity(2-4). Here we demonstrate that the L. pneumophila protein SidD preferably deAMPylates Rab1. We found that the deAMPylation activity of SidD could suppress the toxicity of SidM to yeast and is required to release Rab1 from bacterial phagosomes efficiently. A molecular mechanism for the temporal control of Rab1 activity in different phases of L. pneumophila infection is thus established. These observations indicate that AMPylation-mediated signal transduction is a reversible process regulated by specific enzymes.	[Tan, Yunhao; Luo, Zhao-Qing] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Luo, ZQ (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St, W Lafayette, IN 47907 USA.	luoz@purdue.edu	Tan, Yunhao/K-7442-2016; YAN, JING/J-7233-2015	Tan, Yunhao/0000-0002-5516-4980; Luo, Zhao-Qing/0000-0001-8890-6621	NIH-NIAID [R01AI069344, K02AI085403, R21AI092043]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069344, K02AI085403, R21AI092043] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Isberg for the antibody against SidM and A. Aronson and A. Tao for critical reading of the manuscript and for discussions. This work was supported by NIH-NIAID grants R01AI069344, K02AI085403 and R21AI092043 (Z.-Q.L).	Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Conover GM, 2003, MOL MICROBIOL, V48, P305, DOI 10.1046/j.1365-2958.2003.03400.x; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Fan HY, 1996, GENETICS, V142, P749; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; Kubori T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001216; Liu YC, 2008, P NATL ACAD SCI USA, V105, P9385, DOI 10.1073/pnas.0801055105; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Rantanen MK, 2007, FEBS J, V274, P3128, DOI 10.1111/j.1742-4658.2007.05845.x; Roy CR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.262pe14; Schlicker C, 2008, J MOL BIOL, V376, P570, DOI 10.1016/j.jmb.2007.11.097; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Shen XH, 2009, CELL MICROBIOL, V11, P911, DOI 10.1111/j.1462-5822.2009.01301.x; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	29	164	169	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2011	475	7357					506	U102		10.1038/nature10307	http://dx.doi.org/10.1038/nature10307			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21734656	Green Accepted			2022-12-28	WOS:000293167900042
J	Heaphy, CM; de Wilde, RF; Jiao, YC; Klein, AP; Edil, BH; Shi, CJ; Bettegowda, C; Rodriguez, FJ; Eberhart, CG; Hebbar, S; Offerhaus, GJ; McLendon, R; Rasheed, BA; He, YP; Yan, H; Bigner, DD; Oba-Shinjo, SM; Marie, SKN; Riggins, GJ; Kinzler, KW; Vogelstein, B; Hruban, RH; Maitra, A; Papadopoulos, N; Meeker, AK				Heaphy, Christopher M.; de Wilde, Roeland F.; Jiao, Yuchen; Klein, Alison P.; Edil, Barish H.; Shi, Chanjuan; Bettegowda, Chetan; Rodriguez, Fausto J.; Eberhart, Charles G.; Hebbar, Sachidanand; Offerhaus, G. Johan; McLendon, Roger; Rasheed, B. Ahmed; He, Yiping; Yan, Hai; Bigner, Darell D.; Oba-Shinjo, Sueli Mieko; Marie, Suely Kazue Nagahashi; Riggins, Gregory J.; Kinzler, Kenneth W.; Vogelstein, Bert; Hruban, Ralph H.; Maitra, Anirban; Papadopoulos, Nickolas; Meeker, Alan K.			Altered Telomeres in Tumors with ATRX and DAXX Mutations	SCIENCE			English	Article							CELLS; H3.3		[Heaphy, Christopher M.; de Wilde, Roeland F.; Klein, Alison P.; Rodriguez, Fausto J.; Eberhart, Charles G.; Hebbar, Sachidanand; Hruban, Ralph H.; Maitra, Anirban; Meeker, Alan K.] Johns Hopkins Med Inst, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine		npapado1@jhmi.edu; ameeker1@jhmi.edu	jiao, yuchen/H-6313-2011; Marie, Suely Kazue Nagahashi/D-1870-2012; Oba-Shinjo, Sueli M./C-4017-2012; Papadopoulos, Nickolas/K-7272-2012	Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Oba-Shinjo, Sueli M./0000-0002-1650-5973; Jiao, Yuchen/0000-0001-7917-8810; Heaphy, Christopher/0000-0003-4264-1810	Caring for Carcinoid Foundation; NATIONAL CANCER INSTITUTE [P50CA062924, R01CA113669, R01CA140316, P01CA134292, R37CA011898, R01CA121113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055089, P50NS020023] Funding Source: NIH RePORTER	Caring for Carcinoid Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	N.P., K.W.K., and B.V. are Founding Scientific Advisors of Personal Genome Diagnostics, Incorporated, a company focused on the identification of genetic alterations in human cancer for diagnostic and therapeutic purposes. N.P., K. W. K., and B. V. are members of the Scientific Advisory Board of Inostics, a company that is developing technologies for the molecular diagnosis of cancer. N.P., B. V., and K. W. K. also own stock in Inostics. The authors are entitled to a share of the royalties received by the university on sales of products related to genes described in this manuscript. The terms of these arrangements are being managed by the university in accordance with their conflict-of-interest policies. Johns Hopkins University has filed a patent application relating to the use of DAXX and ATRX mutations as diagnostic markers. Financial support came from the Caring for Carcinoid Foundation.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Elsaesser SJ, 2010, COLD SH Q B, V75, P27, DOI 10.1101/sqb.2010.75.008; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yeager TR, 1999, CANCER RES, V59, P4175	11	706	729	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					425	425		10.1126/science.1207313	http://dx.doi.org/10.1126/science.1207313			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21719641	Green Accepted			2022-12-28	WOS:000292959600036
J	Hessa, T; Sharma, A; Mariappan, M; Eshleman, HD; Gutierrez, E; Hegde, RS				Hessa, Tara; Sharma, Ajay; Mariappan, Malaiyalam; Eshleman, Heather D.; Gutierrez, Erik; Hegde, Ramanujan S.			Protein targeting and degradation are coupled for elimination of mislocalized proteins	NATURE			English	Article							SIGNAL RECOGNITION PARTICLE; CYTOSOLIC PRION PROTEIN; QUALITY-CONTROL PATHWAY; ENDOPLASMIC-RETICULUM; TRANSLOCATION CHANNEL; MEMBRANE; NEURODEGENERATION; ER; CONTRIBUTES; SEQUENCE	A substantial proportion of the genome encodes membrane proteins that are delivered to the endoplasmic reticulum by dedicated targeting pathways(1). Membrane proteins that fail targeting must be rapidly degraded to avoid aggregation and disruption of cytosolic protein homeostasis(2,3). The mechanisms of mislocalized protein (MLP) degradation are unknown. Here we reconstitute MLP degradation in vitro to identify factors involved in this pathway. We find that nascent membrane proteins tethered to ribosomes are not substrates for ubiquitination unless they are released into the cytosol. Their inappropriate release results in capture by the Bag6 complex, a recently identified ribosome-associating chaperone(4). Bag6-complex-mediated capture depends on the presence of unprocessed or non-inserted hydrophobic domains that distinguish MLPs from potential cytosolic proteins. A subset of these Bag6 complex 'clients' are transferred to TRC40 for insertion into the membrane, whereas the remainder are rapidly ubiquitinated. Depletion of the Bag6 complex selectively impairs the efficient ubiquitination of MLPs. Thus, by its presence on ribosomes that are synthesizing nascent membrane proteins, the Bag6 complex links targeting and ubiquitination pathways. We propose that such coupling allows the fast tracking of MLPs for degradation without futile engagement of the cytosolic folding machinery.	[Hessa, Tara; Sharma, Ajay; Mariappan, Malaiyalam; Eshleman, Heather D.; Gutierrez, Erik; Hegde, Ramanujan S.] NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Gutierrez, Erik] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University	Hegde, RS (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	hegde.science@gmail.com	mariappan, malaiyalam/K-9024-2012	Hegde, Ramanujan/0000-0001-8338-852X	National Institutes of Health; Wenner-Gren Foundations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008861, ZIAHD008860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Gren Foundations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are grateful to E. Whiteman and X. Li for carrying out the initial experiments for parts of this project, S. W. Kang, S. Shao, and Z. Zhang for discussions, P. Sengupta, J. Magadan, and C. Ott for constructs, J. Taunton and J. Garrison for cotransin, S. Shao for comments on the manuscript, and Y. Ye for discussions and sharing results before publication. This work was supported by the Intramural Research Program of the National Institutes of Health (R. S. H.) and a postdoctoral fellowship from The Wenner-Gren Foundations (T.H.).	Ashok A, 2008, MOL BIOL CELL, V19, P3463, DOI 10.1091/mbc.E08-01-0087; Berndt U, 2009, P NATL ACAD SCI USA, V106, P1398, DOI 10.1073/pnas.0808584106; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Chakrabarti O, 2009, CELL, V137, P1136, DOI 10.1016/j.cell.2009.03.042; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Emerman AB, 2010, MOL BIOL CELL, V21, P4325, DOI 10.1091/mbc.E10-09-0742; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Garrison JL, 2005, NATURE, V436, P285, DOI 10.1038/nature03821; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Kim SJ, 2002, MOL BIOL CELL, V13, P3775, DOI 10.1091/mbc.E02-05-0293; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; Lehner B, 2004, GENOMICS, V83, P153, DOI 10.1016/S0888-7543(03)00235-0; Levine CG, 2005, MOL BIOL CELL, V16, P279, DOI 10.1091/mbc.E04-06-0508; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Rane NS, 2010, J CELL BIOL, V188, P515, DOI 10.1083/jcb.200911115; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Sharma A, 2010, METHODS MOL BIOL, V619, P339, DOI 10.1007/978-1-60327-412-8_20; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0	38	175	176	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					394	U154		10.1038/nature10181	http://dx.doi.org/10.1038/nature10181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21743475	Green Accepted			2022-12-28	WOS:000292911200046
J	Canfield, SE				Canfield, Steven E.			Radical prostatectomy reduced mortality and disease progression over the long term more than watchful waiting in early prostate cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Texas Med Sch Houston, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Canfield, SE (corresponding author), Univ Texas Med Sch Houston, Houston, TX USA.								0	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2							JC1-02	10.7326/0003-4819-155-2-201107190-02002	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	793KW	21768568				2022-12-28	WOS:000292822000001
J	Gesquiere, LR; Learn, NH; Simao, MCM; Onyango, PO; Alberts, SC; Altmann, J				Gesquiere, Laurence R.; Learn, Niki H.; Simao, M. Carolina M.; Onyango, Patrick O.; Alberts, Susan C.; Altmann, Jeanne			Life at the Top: Rank and Stress in Wild Male Baboons	SCIENCE			English	Article							REPRODUCTIVE SUCCESS; DOMINANCE RANK; CORTISOL; INSTABILITY; HYPOTHESIS; PATTERNS; BEHAVIOR	In social hierarchies, dominant individuals experience reproductive and health benefits, but the costs of social dominance remain a topic of debate. Prevailing hypotheses predict that higher-ranking males experience higher testosterone and glucocorticoid (stress hormone) levels than lower-ranking males when hierarchies are unstable but not otherwise. In this long-term study of rank-related stress in a natural population of savannah baboons (Papio cynocephalus), high-ranking males had higher testosterone and lower glucocorticoid levels than other males, regardless of hierarchy stability. The singular exception was for the highest-ranking (alpha) males, who exhibited both high testosterone and high glucocorticoid levels. In particular, alpha males exhibited much higher stress hormone levels than second-ranking (beta) males, suggesting that being at the very top may be more costly than previously thought.	[Gesquiere, Laurence R.; Learn, Niki H.; Simao, M. Carolina M.; Onyango, Patrick O.; Altmann, Jeanne] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Alberts, Susan C.] Duke Univ, Dept Biol, Durham, NC USA; [Alberts, Susan C.; Altmann, Jeanne] Natl Museums Kenya, Inst Primate Res, Nairobi, Kenya; [Altmann, Jeanne] Univ Nairobi, Dept Vet Anat & Physiol, Nairobi 00100, Kenya	Princeton University; Duke University; University of Nairobi	Gesquiere, LR (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	lgesquie@princeton.edu	Onyango, Patrick/AGG-7442-2022		NSF [IOB-0322781, BCS-0323596]; NIH [R03 MH65294]; National Institute on Aging [P30 AG024361, P01 AG031719, R01-AG034513]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH065294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034513, P30AG024361, P01AG031719] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by NSF (grants IOB-0322781 and BCS-0323596), NIH (grant R03 MH65294), and National Institute on Aging (grants P30 AG024361, P01 AG031719, and R01-AG034513). Thanks to the Kenya Wildlife Services; Amboseli-Longido pastoralist communities; the Amboseli research team, particularly R. S. Mututua, S. Sayialel, J. K. Warutere, T. Wango, and V. K. Oudu; S. Mukherjee, G. Rodriguez, and J. Tung for advice on analysis; and J. Beehner, N. Goldman, C. Markham, J. Silk, and B. Singer for comments on previous drafts of this paper. All protocols were noninvasive and were approved in Kenya (Ministry of Education, Science, and Technology document 13/001/C351 Vol. II) and the United States (Princeton University Institutional Animal Care and Use Committee document 1689). Data are available in the Dryad database (http://dx.doi.org/10.5061/dryad.j850j).	Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; Alberts SC, 2003, ANIM BEHAV, V65, P821, DOI 10.1006/anbe.2003.2106; Alberts SC, 1996, ANIM BEHAV, V51, P1269, DOI 10.1006/anbe.1996.0131; Alberts SC, 2006, ANIM BEHAV, V72, P1177, DOI 10.1016/j.anbehav.2006.05.001; Bercovitch FB, 2002, ANNU REV ANTHROPOL, V31, P45, DOI 10.1146/annurev.anthro.31.040202.105553; Bergman TJ, 2005, ANIM BEHAV, V70, P703, DOI 10.1016/j.anbehav.2004.12.017; Cheney D. L., 2006, SPRINGER SERIES DEV, P147; Cheney DL, 2009, ADV STUD BEHAV, V39, P1, DOI 10.1016/S0065-3454(09)39001-4; Clutton-Brock T.H., 1988, P1; COWLISHAW G, 1991, ANIM BEHAV, V41, P1045, DOI 10.1016/S0003-3472(05)80642-6; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; Dixson A.F., 1998, PRIMATE SEXUALITY CO; ELLIS L, 1995, ETHOL SOCIOBIOL, V16, P257, DOI 10.1016/0162-3095(95)00050-U; Gesquiere LR, 2011, AM J PHYS ANTHROPOL, V144, P169, DOI 10.1002/ajpa.21374; HAUSFATER G, 1976, NATURE, V262, P688, DOI 10.1038/262688a0; Johnson S. E., 2006, SPRINGER SERIES DEV, P177; Rodriguez-Llanes JM, 2009, ANIM BEHAV, V78, P643, DOI 10.1016/j.anbehav.2009.06.012; MICHAEL RP, 1993, AM J PRIMATOL, V30, P213, DOI 10.1002/ajp.1350300306; Mills SC, 2009, AM NAT, V173, P475, DOI 10.1086/597222; Muehlenbein MP, 2006, AM J PHYS ANTHROPOL, V130, P546, DOI 10.1002/ajpa.20391; Muller MN, 2004, BEHAV ECOL SOCIOBIOL, V55, P332, DOI 10.1007/s00265-003-0713-1; Nelson R. J., 2005, INTRO BEHAV ENDOCRIN, P3; Pusey A, 1997, SCIENCE, V277, P828, DOI 10.1126/science.277.5327.828; RASMUSSEN KLR, 1985, BEHAV ECOL SOCIOBIOL, V17, P161; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SAPOLSKY RM, 1983, AM J PRIMATOL, V5, P365, DOI 10.1002/ajp.1350050406; SAPOLSKY RM, 1992, PSYCHONEUROENDOCRINO, V17, P701, DOI 10.1016/0306-4530(92)90029-7; Setchell JM, 2010, HORM BEHAV, V58, P720, DOI 10.1016/j.yhbeh.2010.07.004; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134	31	207	209	4	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2011	333	6040					357	360		10.1126/science.1207120	http://dx.doi.org/10.1126/science.1207120			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764751	Green Accepted			2022-12-28	WOS:000292732000047
J	Herbert, MR				Herbert, Martha R.			SHANK3, the Synapse, and Autism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Herbert, Martha R.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Herbert, Martha R.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Herbert, MR (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Huett A, 2009, EXP CELL RES, V315, P2001, DOI 10.1016/j.yexcr.2009.04.003; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965	5	37	38	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2					173	175		10.1056/NEJMcibr1104261	http://dx.doi.org/10.1056/NEJMcibr1104261			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SP	21751912				2022-12-28	WOS:000292685500017
J	Raj, L; Ide, T; Gurkar, AU; Foley, M; Schenone, M; Li, XY; Tolliday, NJ; Golub, TR; Carr, SA; Shamji, AF; Stern, AM; Mandinova, A; Schreiber, SL; Lee, SW				Raj, Lakshmi; Ide, Takao; Gurkar, Aditi U.; Foley, Michael; Schenone, Monica; Li, Xiaoyu; Tolliday, Nicola J.; Golub, Todd R.; Carr, Steven A.; Shamji, Alykhan F.; Stern, Andrew M.; Mandinova, Anna; Schreiber, Stuart L.; Lee, Sam W.			RETRACTED: Selective killing of cancer cells by a small molecule targeting the stress response to ROS (Retracted article. See vol. 561, pg. 420, 2018)	NATURE			English	Article; Retracted Publication							HUMAN TUMOR-CELLS; APOPTOSIS; GENE; MECHANISMS; INDUCTION; ONCOGENE; PROTEINS; ENZYMES; DEATH	Malignant transformation, driven by gain-of-function mutations in oncogenes and loss-of-function mutations in tumour suppressor genes, results in cell deregulation that is frequently associated with enhanced cellular stress (for example, oxidative, replicative, metabolic and proteotoxic stress, and DNA damage)(1). Adaptation to this stress phenotype is required for cancer cells to survive, and consequently cancer cells may become dependent upon non-oncogenes that do not ordinarily perform such a vital function in normal cells. Thus, targeting these non-oncogene dependencies in the context of a transformed genotype may result in a synthetic lethal interaction and the selective death of cancer cells(2). Here we used a cell-based small-molecule screening and quantitative proteomics approach that resulted in the unbiased identification of a small molecule that selectively kills cancer cells but not normal cells. Piperlongumine increases the level of reactive oxygen species (ROS) and apoptotic cell death in both cancer cells and normal cells engineered to have a cancer genotype, irrespective of p53 status, but it has little effect on either rapidly or slowly dividing primary normal cells. Significant antitumour effects are observed in piperlongumine-treated mouse xenograft tumour models, with no apparent toxicity in normal mice. Moreover, piperlongumine potently inhibits the growth of spontaneously formed malignant breast tumours and their associated metastases in mice. Our results demonstrate the ability of a small molecule to induce apoptosis selectively in cells that have a cancer genotype, by targeting a non-oncogene co-dependency acquired through the expression of the cancer genotype in response to transformation-induced oxidative stress(3-5).	[Raj, Lakshmi; Ide, Takao; Gurkar, Aditi U.; Mandinova, Anna; Lee, Sam W.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Raj, Lakshmi; Ide, Takao; Gurkar, Aditi U.; Mandinova, Anna; Lee, Sam W.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Foley, Michael; Schenone, Monica; Li, Xiaoyu; Tolliday, Nicola J.; Golub, Todd R.; Carr, Steven A.; Shamji, Alykhan F.; Stern, Andrew M.; Mandinova, Anna; Schreiber, Stuart L.; Lee, Sam W.] Broad Inst Harvard & MIT, Cambridge Ctr 7, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Lee, SW (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Bldg 149,13th St, Charlestown, MA 02129 USA.	amandinova@partners.org; stuart_schreiber@harvard.edu; swlee@partners.org	Carr, Steven A./AAH-8366-2019	Foley, Michael/0000-0003-1349-4698; Stern, Andrew/0000-0002-8437-2957	NIH [CA142805, CA127247, CA085681, CA080058]; National Cancer Institute's Initiative for Chemical Genetics [N01-CO-12400]; Cancer Target Discovery and Development Network [5 RC2 CA148399-02]; National Institutes of Health [RL1HG004671, RL1CA133834, RL1GM084437, UL1RR024924]; NATIONAL CANCER INSTITUTE [P01CA080058, R01CA085681, R01CA127247, RL1CA133834, R01CA142805, RC2CA148399] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024924] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RL1HG004671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084437] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute's Initiative for Chemical Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Target Discovery and Development Network; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Chu, L. Brown-Endres, E. Lerner and F. Neville for their help in preparing the manuscript, W. C. Hahn for BJ cell lines, V. Band for 76N cells, D. Beer for H1975 cells and K. Todorova, G. Wei, S. Ong, S. Norton and F. An for technical assistance. This project has been supported in part by grants CA142805, CA127247, CA085681 and CA080058 from NIH. This research was supported by the National Cancer Institute's Initiative for Chemical Genetics Contract (N01-CO-12400) and Cancer Target Discovery and Development Network grant (5 RC2 CA148399-02), as well as the National Institutes of Health Genomics Based Drug Discovery-Target ID Project Grant (RL1HG004671, which is administratively linked to National Institutes of Health Grants RL1CA133834, RL1GM084437 and UL1RR024924). S.L.S. is an Investigator with the Howard Hughes Medical Institute.	Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Bateman RL, 2008, J BIOL CHEM, V283, P35756, DOI 10.1074/jbc.M807125200; Bezerra DP, 2007, TOXICOL IN VITRO, V21, P1, DOI 10.1016/j.tiv.2006.07.007; Brown L, 2007, EMBO J, V26, P3410, DOI 10.1038/sj.emboj.7601779; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dinkova-Kostova AT, 2010, J BIOL CHEM, V285, P33747, DOI 10.1074/jbc.M110.163485; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Huang P, 2000, NATURE, V407, P390, DOI 10.1038/35030140; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Margolin AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007454; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Ralat LA, 2006, BIOCHEMISTRY-US, V45, P360, DOI 10.1021/bi0520737; Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Schramek D, 2011, NAT GENET, V43, P212, DOI 10.1038/ng.767; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Wang T, 2001, J BIOL CHEM, V276, P20999, DOI 10.1074/jbc.M101355200; Yap TA, 2011, CA-CANCER J CLIN, V61, P31, DOI 10.3322/caac.20095; Yue P, 2006, CANCER BIOL THER, V5, P492, DOI 10.4161/cbt.5.5.2565	27	828	876	2	349	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					231	234		10.1038/nature10167	http://dx.doi.org/10.1038/nature10167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753854	Green Accepted			2022-12-28	WOS:000292690500051
J	Stead, W				Stead, Wendy			The Gift of Perspective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Stead, Wendy] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care,Div Infect Dis, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Stead, W (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care,Div Infect Dis, Boston, MA 02215 USA.	wstead@bidmc.harvard.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					136	136		10.1001/jama.2011.914	http://dx.doi.org/10.1001/jama.2011.914			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791CO	21750284				2022-12-28	WOS:000292639400001
J	Heianza, Y; Hara, S; Arase, Y; Saito, K; Fujiwara, K; Tsuji, H; Kodama, S; Hsieh, SD; Mori, Y; Shimano, H; Yamada, N; Kosaka, K; Sone, H				Heianza, Yoriko; Hara, Shigeko; Arase, Yasuji; Saito, Kazumi; Fujiwara, Kazuya; Tsuji, Hiroshi; Kodama, Satoru; Hsieh, Shiun Dong; Mori, Yasumichi; Shimano, Hitoshi; Yamada, Nobuhiro; Kosaka, Kinori; Sone, Hirohito			HbA(1c) 5.7-6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study	LANCET			English	Article							GLYCATED HEMOGLOBIN; CARDIOVASCULAR RISK; INSULIN SENSITIVITY; CUT-POINTS; A1C; IMPACT; PREVALENCE; TOLERANCE; SECRETION; PEOPLE	Background The clinical relevance of the diagnostic criteria for prediabetes to prediction of progression to diabetes has been little studied. We aimed to compare the prevalence of prediabetes when assessed by the new glycated haemoglobin A(1c) (HbA(1c)) 5.7-6.4% criterion or by impaired fasting glucose, and assessed differences in progression rate to diabetes between these two criteria for prediabetes in a Japanese population. Methods Our longitudinal cohort study included 4670 men and 1571 women aged 24-82 years without diabetes at baseline (diabetes was defined as fasting plasma glucose >= 7.0 mmol/L, self-reported clinician-diagnosed diabetes, or HbA(1c) >= 6.5%) who attended Toranomon Hospital (Tokyo, Japan) for a routine health check between 1997 and 2003. Participants with a baseline diagnosis of prediabetes according to impaired fasting glucose (fasting plasma glucose 5.6-6.9 mmol/L) or HbA(1c) 5.7-6.4%, or both, were divided into four groups on the basis of baseline diagnosis of prediabetes. Rate of progression to diabetes was assessed annually. Findings Mean follow-up was 4.7 (SD 0.7) years. 412 (7%) of 6241 participants were diagnosed with prediabetes on the basis of the HbA(1c) 5.7-6.4% criterion. Screening by HbA(1c) alone missed 1270 (61%) of the 2092 prediabetic individuals diagnosed by a combination of impaired fasting glucose and HbA(1c) 5.7-6.4%. Overall cumulative probability of progression to diabetes did not differ significantly between participants with prediabetes discordantly diagnosed by either HbA(1c) or impaired fasting glucose alone (incidence was 7% for HbA(1c) alone [n=412 individuals and 30 incident cases] and 9% for impaired fasting glucose alone [n=1270,108 cases]; log-rank test, p=0.3317). Multivariate-adjusted hazard ratios for incident diabetes were 6.16 (95% CI 4.33-8.77) for those diagnosed with prediabetes by impaired fasting glucose alone and 6.00 (3.76-9.56) for diagnosis by HbA(1c) alone, and were substantially increased to 31.9 (22.6-45.0) for diagnosis by both impaired fasting glucose and HbA(1c) compared with normoglycaemic individuals. Interpretation Diagnosis of prediabetes by both the new HbA(1c) criterion and impaired fasting glucose identified individuals with an increased risk of progression to diabetes. Although the new HbA(1c) criterion identified fewer individuals at high risk than did impaired fasting glucose, the predictive value for progression to diabetes assessed by HbA(1c) 5.7-6.4% was similar to that assessed by impaired fasting glucose alone. The two tests used together could efficiently target people who are most likely to develop diabetes and allow for early intervention.	[Heianza, Yoriko; Hara, Shigeko; Arase, Yasuji; Saito, Kazumi; Tsuji, Hiroshi; Kodama, Satoru; Hsieh, Shiun Dong; Kosaka, Kinori; Sone, Hirohito] Toranomon Gen Hosp, Hlth Management Ctr, Tokyo 1058470, Japan; [Heianza, Yoriko; Saito, Kazumi; Fujiwara, Kazuya; Kodama, Satoru; Shimano, Hitoshi; Yamada, Nobuhiro; Sone, Hirohito] Univ Tsukuba, Inst Clin Med, Dept Internal Med, Ibaraki, Japan; [Hara, Shigeko; Arase, Yasuji; Tsuji, Hiroshi; Hsieh, Shiun Dong; Mori, Yasumichi; Kosaka, Kinori] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Tokyo 1058470, Japan	Toranomon Hospital; University of Tsukuba; Toranomon Hospital	Sone, H (corresponding author), Toranomon Gen Hosp, Hlth Management Ctr, Tokyo 1058470, Japan.	hsone@md.tsukuba.ac.jp	Shimano, Hitoshi/AAI-5648-2020; Sone, Hirohito/ABC-9346-2021; Shimano, Hitoshi/V-1761-2019; Heianza, Yoriko/M-5716-2017	Sone, Hirohito/0000-0003-1263-2817; Shimano, Hitoshi/0000-0002-5562-5572; Heianza, Yoriko/0000-0002-0957-9309	Japan Society for the Promotion of Science; Ministry of Health Labor and Welfare, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	Japan Society for the Promotion of Science; Ministry of Health Labor and Welfare, Japan.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Cederberg H, 2010, DIABETES CARE, V33, P2077, DOI 10.2337/dc10-0262; Chamnan P, 2011, DIABETES CARE, V34, P950, DOI 10.2337/dc09-2326; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Christensen DL, 2010, DIABETES CARE, V33, P580, DOI 10.2337/dc09-1843; Droumaguet C, 2006, DIABETES CARE, V29, P1619, DOI 10.2337/dc05-2525; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Harano T, 1999, Rinsho Byori, V47, P215; Heianza Y, 2011, DIABETOLOGIA, V54, P762, DOI 10.1007/s00125-010-2029-9; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lorenzo C, 2010, DIABETES CARE, V33, P2104, DOI 10.2337/dc10-0679; Mann DM, 2010, DIABETES CARE, V33, P2190, DOI 10.2337/dc10-0752; Mohan V, 2010, DIABETES CARE, V33, P515, DOI 10.2337/dc09-1694; Mostafa SA, 2010, DIABETES RES CLIN PR, V90, P100, DOI 10.1016/j.diabres.2010.06.008; Mukai N, 2009, DIABETES CARE, V32, P2288, DOI 10.2337/dc09-0896; Nakagami T, 2010, DIABETES RES CLIN PR, V87, P126, DOI 10.1016/j.diabres.2009.11.001; *NAT DIAB INF CLEA, SICKL CELL TRAIT OTH; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Nichols GA, 2007, DIABETES CARE, V30, P228, DOI 10.2337/dc06-1392; Olson DE, 2010, DIABETES CARE, V33, P2184, DOI 10.2337/dc10-0433; Seino Y., 2010, Journal of the Japan Diabetes Society, V53, P450, DOI 10.1111/j.2040-1124.2010.00074.x; Selvin E, 2011, DIABETES CARE, V34, P84, DOI 10.2337/dc10-1235; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; van 't Riet E, 2010, DIABETES CARE, V33, P61, DOI 10.2337/dc09-0677; Waki K, 2005, DIABETIC MED, V22, P323, DOI 10.1111/j.1464-5491.2004.01403.x; Wang WY, 2011, DIABETES CARE, V34, P363, DOI 10.2337/dc10-1680; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang XP, 2010, DIABETES CARE, V33, P1665, DOI 10.2337/dc09-1939	30	168	172	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2011	378	9786					147	155		10.1016/S0140-6736(11)60472-8	http://dx.doi.org/10.1016/S0140-6736(11)60472-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	795CJ	21705064				2022-12-28	WOS:000292948800031
J	Thorvaldsen, JL; Weaver, JR; Bartolomei, MS				Thorvaldsen, Joanne L.; Weaver, Jamie R.; Bartolomei, Marisa S.			A YY1 Bridge for X Inactivation	CELL			English	Editorial Material							CHROMOSOME; RNA; YIN-YANG-1		[Thorvaldsen, Joanne L.; Weaver, Jamie R.; Bartolomei, Marisa S.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Bartolomei, MS (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, 415 Curie Blvd, Philadelphia, PA 19104 USA.	bartolom@mail.med.upenn.edu						ARTHOLD S, 2011, HUM GENET, DOI DOI 10.1007/500439-011-1002-0; Belak ZR, 2008, BIOCHEM CELL BIOL, V86, P31, DOI [10.1139/O07-155, 10.1139/o07-155]; Beletskii A, 2001, P NATL ACAD SCI USA, V98, P9215, DOI 10.1073/pnas.161173098; Bellucci M, 2011, NAT METHODS, V8, P444, DOI 10.1038/nmeth.1611; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	10	8	16	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					11	13		10.1016/j.cell.2011.06.029	http://dx.doi.org/10.1016/j.cell.2011.06.029			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729777	Bronze			2022-12-28	WOS:000292539300002
J	Viviani, D; Charlet, A; van den Burg, E; Robinet, C; Hurni, N; Abatis, M; Magara, F; Stoop, R				Viviani, Daniele; Charlet, Alexandre; van den Burg, Erwin; Robinet, Camille; Hurni, Nicolas; Abatis, Marios; Magara, Fulvio; Stoop, Ron			Oxytocin Selectively Gates Fear Responses Through Distinct Outputs from the Central Amygdala	SCIENCE			English	Article							RAT CENTRAL NUCLEUS; CONDITIONED FEAR; NEURONS; POPULATIONS; BRAIN	Central amygdala (CeA) projections to hypothalamic and brain stem nuclei regulate the behavioral and physiological expression of fear, but it is unknown whether these different aspects of the fear response can be separately regulated by the CeA. We combined fluorescent retrograde tracing of CeA projections to nuclei that modulate fear-related freezing or cardiovascular responses with in vitro electrophysiological recordings and with in vivo monitoring of related behavioral and physiological parameters. CeA projections emerged from separate neuronal populations with different electrophysiological characteristics and different response properties to oxytocin. In vivo, oxytocin decreased freezing responses in fear-conditioned rats without affecting the cardiovascular response. Thus, neuropeptidergic signaling can modulate the CeA outputs through separate neuronal circuits and thereby individually steer the various aspects of the fear response.	[Viviani, Daniele; Charlet, Alexandre; van den Burg, Erwin; Robinet, Camille; Hurni, Nicolas; Abatis, Marios; Magara, Fulvio; Stoop, Ron] Univ Lausanne, Lausanne Univ Hosp Ctr, Dept Psychiat, Ctr Psychiat Neurosci, CH-1015 Lausanne, Switzerland; [Stoop, Ron] Univ Lausanne, Dept Physiol, CH-1015 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Stoop, R (corresponding author), Univ Lausanne, Lausanne Univ Hosp Ctr, Dept Psychiat, Ctr Psychiat Neurosci, CH-1015 Lausanne, Switzerland.	rstoop@unil.ch	Charlet, Alexandre/D-5179-2016	Charlet, Alexandre/0000-0003-4837-3706	Swiss National Science Foundation [3100A0-116462]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank E. Welker for outstanding scientific advice; H. Markram and R. Perin for expert help with multiple patch recordings; R. Daniel and D. Rainnie for feedback on the manuscript; and O. Bussard, V. Martin, N. Pochon and L. Bonsignore for technical support. Supported by Swiss National Science Foundation grant 3100A0-116462.	Bisetti A, 2006, NEUROSCIENCE, V142, P999, DOI 10.1016/j.neuroscience.2006.07.018; Bosch OJ, 2005, J NEUROSCI, V25, P6807, DOI 10.1523/JNEUROSCI.1342-05.2005; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Chieng BCH, 2006, J COMP NEUROL, V497, P910, DOI 10.1002/cne.21025; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; DAVIS M, 1992, P255; Day HEW, 1999, J COMP NEUROL, V413, P113; Dumont EC, 2002, EUR J NEUROSCI, V15, P545, DOI 10.1046/j.0953-816x.2001.01879.x; GOMEZ TMD, 1995, BRAIN RES, V689, P21, DOI 10.1016/0006-8993(95)00525-U; Gozzi A, 2010, NEURON, V67, P656, DOI 10.1016/j.neuron.2010.07.008; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Loewy AD., 1990, CENTRAL REGULATION A, P88; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Porges SW, 2003, ANN NY ACAD SCI, V1008, P31, DOI 10.1196/annals.1301.004; Rainville P, 2006, INT J PSYCHOPHYSIOL, V61, P5, DOI 10.1016/j.ijpsycho.2005.10.024; Sajdyk TJ, 2004, NEUROPEPTIDES, V38, P225, DOI 10.1016/j.npep.2004.05.006; Sansone Randy A, 2009, Psychiatry (Edgmont), V6, P33; SCHWABER JS, 1982, J NEUROSCI, V2, P1424, DOI 10.1523/jneurosci.02-10-01424.1982; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Vianna EPM, 2006, INT J PSYCHOPHYSIOL, V61, P70, DOI 10.1016/j.ijpsycho.2005.10.019; Waldherr M, 2007, P NATL ACAD SCI USA, V104, P16681, DOI 10.1073/pnas.0705860104; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	28	262	265	5	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					104	107		10.1126/science.1201043	http://dx.doi.org/10.1126/science.1201043			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719680				2022-12-28	WOS:000292255400060
J	Hrecka, K; Hao, CL; Gierszewska, M; Swanson, SK; Kesik-Brodacka, M; Srivastava, S; Florens, L; Washburn, MP; Skowronski, J				Hrecka, Kasia; Hao, Caili; Gierszewska, Magda; Swanson, Selene K.; Kesik-Brodacka, Malgorzata; Srivastava, Smita; Florens, Laurence; Washburn, Michael P.; Skowronski, Jacek			Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein	NATURE			English	Article							AICARDI-GOUTIERES SYNDROME; UBIQUITIN LIGASE; INNATE; GENE; ASSOCIATION; USURPS; CELLS	Macrophages and dendritic cells have key roles in viral infections, providing virus reservoirs that frequently resist antiviral therapies and linking innate virus detection to antiviral adaptive immune responses(1,2). Human immunodeficiency virus 1 (HIV-1) fails to transduce dendritic cells and has a reduced ability to transduce macrophages, due to an as yet uncharacterized mechanism that inhibits infection by interfering with efficient synthesis of viral complementary DNA(3,4). In contrast, HIV-2 and related simian immunodeficiency viruses (SIVsm/mac) transduce myeloid cells efficiently owing to their virion-associated Vpx accessory proteins, which counteract the restrictive mechanism(5,6). Here we show that the inhibition of HIV-1 infection in macrophages involves the cellular SAM domain HD domain-containing protein 1 (SAMHD1). Vpx relieves the inhibition of lentivirus infection in macrophages by loading SAMHD1 onto the CRL4(DCAF1) E3 ubiquitin ligase, leading to highly efficient proteasome-dependent degradation of the protein. Mutations in SAMHD1 cause Aicardi-Goutieres syndrome, a disease that produces a phenotype that mimics the effects of a congenital viral infection(7,8). Failure to dispose of endogenous nucleic acid debris in Aicardi-Goutieres syndrome results in inappropriate triggering of innate immune responses via cytosolic nucleic acids sensors(9,10). Thus, our findings show that macrophages are defended from HIV-1 infection by a mechanism that prevents an unwanted interferon response triggered by self nucleic acids, and uncover an intricate relationship between innate immune mechanisms that control response to self and to retroviral pathogens.	[Hrecka, Kasia; Hao, Caili; Kesik-Brodacka, Malgorzata; Skowronski, Jacek] Case Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Hrecka, Kasia; Gierszewska, Magda; Srivastava, Smita; Skowronski, Jacek] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Swanson, Selene K.; Florens, Laurence; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Dept Pathol & Lab Med, Med Ctr, Kansas City, KS 66160 USA	Case Western Reserve University; Cold Spring Harbor Laboratory; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Skowronski, J (corresponding author), Case Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	jacek.skowronski@case.edu	Kęsik-Brodacka, Małgorzata/ABG-7355-2021	Washburn, Michael/0000-0001-7568-2585; Florens, Laurence/0000-0002-9310-6650	NIH [R01 AI077459, R21 AI084694]; Case CFAR developmental funds; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077459, R21AI084694] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case CFAR developmental funds; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Karn, McDonald and Bernstein laboratories, C. Carlin, R. Asaad, M. Reuter and A. Valentin-Torres, for reagents and help at various stages of this project. We acknowledge the excellent assistance of C. Wang with fluorescence microscopy. We also thank M. Emerman and N. Manel for HIV-2 Rod proviral constructs, F. Kirchhoff for the SIVmac 239-GFP proviral clone, M. Lederman and D. McDonald for discussions, J. Karn and M. Greenberg for discussions and comments on the manuscript. We are grateful to L. Van Aelst and D. Littman for advice, discussions and critical reading of the manuscript. This work in the J. S. laboratory was supported by NIH grants R01 AI077459 and R21 AI084694 and by Case CFAR developmental funds. S. K. S., L. F. and M. P. W. are supported by The Stowers Institute for Medical Research.	Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Florens Laurence, 2006, V328, P159; GIBBS JS, 1995, J VIROL, V69, P2378, DOI 10.1128/JVI.69.4.2378-2383.1995; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; GUYADER M, 1989, EMBO J, V8, P1169, DOI 10.1002/j.1460-2075.1989.tb03488.x; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; HORTON R, 1994, VIROLOGY, V199, P453, DOI 10.1006/viro.1994.1144; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Kewalramani VN, 1996, VIROLOGY, V218, P159, DOI 10.1006/viro.1996.0176; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Pick E, 2007, MOL CELL BIOL, V27, P4708, DOI 10.1128/MCB.02432-06; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Yamashita M, 2009, J VIROL, V83, P9835, DOI 10.1128/JVI.01084-09; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; YU XF, 1991, J VIROL, V65, P5088, DOI 10.1128/JVI.65.9.5088-5091.1991; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	30	883	911	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					658	U137		10.1038/nature10195	http://dx.doi.org/10.1038/nature10195			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21720370	Green Accepted			2022-12-28	WOS:000292204300043
J	Tamura, Y; Itoh, K; Sesaki, H				Tamura, Yasushi; Itoh, Kie; Sesaki, Hiromi			SnapShot: Mitochondrial Dynamics	CELL			English	Editorial Material							FISSION; FUSION; MECHANISMS; MITOPHAGY		[Tamura, Yasushi; Itoh, Kie; Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Tamura, Y (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.		Yasushi, TAMURA/I-7122-2014; Tamura, Yasushi/H-8270-2017; Tamura, Yasushi/A-9997-2013	Tamura, Yasushi/0000-0002-8462-0607; 	NIGMS NIH HHS [R01 GM089853, GM89853, R01 GM089853-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089853] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Hoppins S, 2009, BBA-MOL CELL RES, V1793, P20, DOI 10.1016/j.bbamcr.2008.07.005; KAGEYAMA Y, 2011, CURR OPIN CELL BIOL; Kuroiwa T, 2010, P JPN ACAD B-PHYS, V86, P455, DOI 10.2183/pjab.86.455; McBride H, 2010, CURR BIOL, V20, pR274, DOI 10.1016/j.cub.2010.02.011; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Westermann B, 2010, SEMIN CELL DEV BIOL, V21, P542, DOI 10.1016/j.semcdb.2009.12.003; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	10	42	43	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7							1158.e1	10.1016/j.cell.2011.06.018	http://dx.doi.org/10.1016/j.cell.2011.06.018			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703455	Green Accepted, Bronze			2022-12-28	WOS:000292025700021
J	de Lau, W; Barker, N; Low, TY; Koo, BK; Li, VSW; Teunissen, H; Kujala, P; Haegebarth, A; Peters, PJ; van de Wetering, M; Stange, DE; van Es, JE; Guardavaccaro, D; Schasfoort, RBM; Mohri, Y; Nishimori, K; Mohammed, S; Heck, AJR; Clevers, H				de Lau, Wim; Barker, Nick; Low, Teck Y.; Koo, Bon-Kyoung; Li, Vivian S. W.; Teunissen, Hans; Kujala, Pekka; Haegebarth, Andrea; Peters, Peter J.; van de Wetering, Marc; Stange, Daniel E.; van Es, Johan E.; Guardavaccaro, Daniele; Schasfoort, Richard B. M.; Mohri, Yasuaki; Nishimori, Katsuhiko; Mohammed, Shabaz; Heck, Albert J. R.; Clevers, Hans			Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling	NATURE			English	Article							PANETH CELL-DIFFERENTIATION; STEM-CELLS; SMALL-INTESTINE; PEPTIDE IDENTIFICATION; HAIR FOLLICLE; REPORTER GENE; NULL MICE; IN-VITRO; EXPRESSION; R-SPONDIN1	The adult stem cell marker Lgr5 and its relative Lgr4 are often co-expressed in Wnt-driven proliferative compartments. We find that conditional deletion of both genes in the mouse gut impairs Wnt target gene expression and results in the rapid demise of intestinal crypts, thus phenocopying Wnt pathway inhibition. Mass spectrometry demonstrates that Lgr4 and Lgr5 associate with the Frizzled/Lrp Wnt receptor complex. Each of the four R-spondins, secreted Wnt pathway agonists, can bind to Lgr4, -5 and -6. In HEK293 cells, RSPO1 enhances canonical WNT signals initiated by WNT3A. Removal of LGR4 does not affect WNT3A signalling, but abrogates the RSPO1-mediated signal enhancement, a phenomenon rescued by re-expression of LGR4, -5 or -6. Genetic deletion of Lgr4/5 in mouse intestinal crypt cultures phenocopies withdrawal of Rspo1 and can be rescued by Wnt pathway activation. Lgr5 homologues are facultative Wnt receptor components that mediate Wnt signal enhancement by soluble R-spondin proteins. These results will guide future studies towards the application of R-spondins for regenerative purposes of tissues expressing Lgr5 homologues.	[de Lau, Wim; Barker, Nick; Koo, Bon-Kyoung; Li, Vivian S. W.; Teunissen, Hans; Haegebarth, Andrea; van de Wetering, Marc; Stange, Daniel E.; van Es, Johan E.; Guardavaccaro, Daniele; Clevers, Hans] Univ Med Ctr, NL-3584 CX Utrecht, Netherlands; [de Lau, Wim; Barker, Nick; Koo, Bon-Kyoung; Li, Vivian S. W.; Teunissen, Hans; Haegebarth, Andrea; van de Wetering, Marc; Stange, Daniel E.; van Es, Johan E.; Guardavaccaro, Daniele; Clevers, Hans] Hubrecht Inst, NL-3584 CX Utrecht, Netherlands; [Low, Teck Y.; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Low, Teck Y.; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Kujala, Pekka; Peters, Peter J.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Schasfoort, Richard B. M.] Univ Twente, Med Cell Biophys MIRA Inst, NL-7500 AE Enschede, Netherlands; [Mohri, Yasuaki; Nishimori, Katsuhiko] Tohoku Univ, Sendai, Miyagi 9818555, Japan	Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University; Netherlands Cancer Institute; University of Twente; Tohoku University	Clevers, H (corresponding author), Univ Med Ctr, NL-3584 CX Utrecht, Netherlands.	h.clevers@hubrecht.eu	Barker, Nick/A-5535-2011; Low, Teck Yew/Q-5946-2019; Heck, Albert/D-7098-2011; Barker, Nick/AAS-2774-2020; Stange, Daniel E/O-1837-2015; Barker, Nick/AAE-9833-2021; Mohammed, Shabaz/D-1042-2010; van+Es, Johan/ABD-5411-2021; Mohammed, Shabaz/AAY-6313-2020; Koo, Bon-Kyoung/V-5219-2017; Low, Teck Yew/J-4403-2014	Low, Teck Yew/0000-0001-7878-7534; Heck, Albert/0000-0002-2405-4404; Stange, Daniel E/0000-0003-4246-2230; Barker, Nick/0000-0003-3566-4475; Mohammed, Shabaz/0000-0003-2640-9560; Mohammed, Shabaz/0000-0003-2640-9560; Koo, Bon-Kyoung/0000-0002-4134-8033; Low, Teck Yew/0000-0001-7878-7534; Schasfoort, Richard/0000-0003-1601-3853; Guardavaccaro, Daniele/0000-0002-4517-1765; Li, Vivian/0000-0003-2041-0085				Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Flanagan CA, 2005, MOL PHARMACOL, V68, P1, DOI 10.1124/mol.105.014183; Frese CK, 2011, J PROTEOME RES, V10, P2377, DOI 10.1021/pr1011729; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kato S, 2007, FEBS LETT, V581, P4685, DOI 10.1016/j.febslet.2007.08.064; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Ng SS, 2009, J BIOL CHEM, V284, P35308, DOI 10.1074/jbc.M109.078261; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Raijmakers R, 2008, MOL CELL PROTEOMICS, V7, P1755, DOI 10.1074/mcp.M800093-MCP200; ROBINE S, 1993, J BIOL CHEM, V268, P11426; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Zhao JS, 2007, GASTROENTEROLOGY, V132, P1331, DOI 10.1053/j.gastro.2007.02.001	42	856	903	4	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2011	476	7360					293	U57		10.1038/nature10337	http://dx.doi.org/10.1038/nature10337			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21727895				2022-12-28	WOS:000294206500030
J	Grady, CA; McDonald, DR; Poppen, CF; Pritt, BS				Grady, Caroline A.; McDonald, Darren R.; Poppen, Carroll F.; Pritt, Bobbi S.			Dermacentor tick attached to tympanic membrane	LANCET			English	Editorial Material									[Pritt, Bobbi S.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Grady, Caroline A.] Mayo Clin, Dept Internal Med, Rochester, MN 55905 USA; [McDonald, Darren R.; Poppen, Carroll F.] Mayo Clin, Dept Otorhinolaryngol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Pritt, BS (corresponding author), Mayo Clin, Dept Lab Med & Pathol, 200 1st Ave SW,Hilton 4, Rochester, MN 55905 USA.	pritt.bobbi@mayo.edu		Pritt, Bobbi/0000-0003-0261-1326					0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 23	2011	378	9788					347	347		10.1016/S0140-6736(11)60981-1	http://dx.doi.org/10.1016/S0140-6736(11)60981-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XL	21723598	Bronze			2022-12-28	WOS:000293615800032
J	Mathieu, C; Gillard, P				Mathieu, Chantal; Gillard, Pieter			Arresting type 1 diabetes after diagnosis: GAD is not enough	LANCET			English	Editorial Material							BETA-CELL FUNCTION; DOUBLE-BLIND; THERAPY; CHILDREN; INSULIN; MICE		[Mathieu, Chantal] Catholic Univ Louvain, Univ Hosp Leuven, Lab Expt Med & Endocrinol, B-3000 Louvain, Belgium; Catholic Univ Louvain, Univ Hosp Leuven, Clin Expt Med & Endocrinol, B-3000 Louvain, Belgium	KU Leuven; University Hospital Leuven; Universite Catholique Louvain; KU Leuven; University Hospital Leuven; Universite Catholique Louvain	Mathieu, C (corresponding author), Catholic Univ Louvain, Univ Hosp Leuven, Lab Expt Med & Endocrinol, B-3000 Louvain, Belgium.	chantal.mathieu@uzleuven.be	Gillard, Pieter/AAA-9820-2020; Gillard, Pieter/GPX-1490-2022; Gillard, Pieter/AAY-1483-2020; mathieu, chantal/ABD-5505-2021	Gillard, Pieter/0000-0001-9111-4561; Gillard, Pieter/0000-0001-9111-4561; mathieu, chantal/0000-0002-4055-5233				Balasa B, 2001, CLIN IMMUNOL, V99, P241, DOI 10.1006/clim.2001.5012; Chatenoud L, 2010, NAT REV ENDOCRINOL, V6, P149, DOI 10.1038/nrendo.2009.275; *DIAB TRIALNET, TYP 1 DIAB TRIALNET; GlaxoSmithKline, GLAXOSMITHKLINE TOL; Gottlieb PA, 2010, DIABETES CARE, V33, P826, DOI 10.2337/dc09-1349; Greenbaum CJ, 2008, DIABETES CARE, V31, P1966, DOI 10.2337/dc07-2451; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Mastrandrea L, 2009, DIABETES CARE, V32, P1244, DOI 10.2337/dc09-0054; Matthews JB, 2010, CLIN EXP IMMUNOL, V160, P176, DOI 10.1111/j.1365-2249.2010.04153.x; Nanto-Salonen K, 2008, LANCET, V372, P1746, DOI 10.1016/S0140-6736(08)61309-4; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Roep BO, 2007, ANN NY ACAD SCI, V1103, P1, DOI 10.1196/annals.1394.018; Thayer TC, 2010, ENDOCRIN METAB CLIN, V39, P541, DOI 10.1016/j.ecl.2010.05.001; Vandemeulebroucke E, 2010, DIABETOLOGIA, V53, P36, DOI 10.1007/s00125-009-1569-3; Wherrett DK, 2011, LANCET, V378, P319, DOI 10.1016/S0140-6736(11)60895-7	15	10	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 23	2011	378	9788					291	292		10.1016/S0140-6736(11)60978-1	http://dx.doi.org/10.1016/S0140-6736(11)60978-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XL	21715000				2022-12-28	WOS:000293615800004
J	Avelino-Silva, VI; Avelino-Silva, T				Avelino-Silva, Vivian Iida; Avelino-Silva, Thiago			Evolution of a Jellyfish Sting	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Avelino-Silva, Vivian Iida; Avelino-Silva, Thiago] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil	Universidade de Sao Paulo	Avelino-Silva, VI (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.		Avelino-Silva, Vivian I/L-2640-2013; Avelino-Silva, Thiago J/J-8794-2013	Avelino-Silva, Vivian I/0000-0002-6660-3088; Avelino-Silva, Thiago J/0000-0001-9347-0519					0	4	6	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2011	365	3					251	251		10.1056/NEJMicm1009713	http://dx.doi.org/10.1056/NEJMicm1009713			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794QI	21774713				2022-12-28	WOS:000292915500009
J	Andolsek, KM				Andolsek, Kathryn M.			Review: Dopamine agonists are effective for the restless legs syndrome but may be discontinued due to adverse events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PRIMARY-CARE; DIAGNOSIS		Duke Univ, Sch Med, Duke Univ Hosp, Durham, NC 27706 USA	Duke University	Andolsek, KM (corresponding author), Duke Univ, Sch Med, Duke Univ Hosp, Durham, NC 27706 USA.		Andolsek, Kathryn/ABB-4457-2020; Andolsek, Kathryn/AAP-6370-2020	Andolsek, Kathryn/0000-0001-7994-3869					0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2							JC1-09	10.7326/0003-4819-155-2-201107190-02009	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	793KW	21768575				2022-12-28	WOS:000292822000008
J	Tang, N; Marshall, WF; McMahon, M; Metzger, RJ; Martin, GR				Tang, Nan; Marshall, Wallace F.; McMahon, Martin; Metzger, Ross J.; Martin, Gail R.			Control of Mitotic Spindle Angle by the RAS-Regulated ERK1/2 Pathway Determines Lung Tube Shape	SCIENCE			English	Article							PLANAR CELL POLARITY; ONCOGENIC K-RAS; BRANCHING MORPHOGENESIS; KIDNEY-DISEASE; SPROUTY GENES; MOUSE LUNG; IN-VIVO; ORIENTATION; DIVISION; PROGRESSION	During early lung development, airway tubes change shape. Tube length increases more than circumference as a large proportion of lung epithelial cells divide parallel to the airway longitudinal axis. We show that this bias is lost in mutants with increased extracellular signal-regulated kinase 1 (ERK1) and ERK2 activity, revealing a link between the ERK1/2 signaling pathway and the control of mitotic spindle orientation. Using a mathematical model, we demonstrate that change in airway shape can occur as a function of spindle angle distribution determined by ERK1/2 signaling, independent of effects on cell proliferation or cell size and shape. We identify sprouty genes, which encode negative regulators of fibroblast growth factor 10 (FGF10)-mediated RAS-regulated ERK1/2 signaling, as essential for controlling airway shape change during development through an effect on mitotic spindle orientation.	[Tang, Nan; Metzger, Ross J.; Martin, Gail R.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Marshall, Wallace F.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [McMahon, Martin] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94158 USA; [McMahon, Martin] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Metzger, RJ (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA.	ross.metzger@ucsf.edu; gail.r.martin@ucsf.edu	McMahon, Martin/L-3303-2013	McMahon, Martin/0000-0003-2812-1042; Tang, Nan/0000-0002-8284-3372	NIH [R01 CA131201, R01 GM077004, R01 CA78711, R01 DE17744, 5T32HL007185]; W. M. Keck Foundation; Sandler Foundation; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA078711, R01CA131261] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077004] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); Sandler Foundation; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. Licht and J. Zallen for insightful and helpful suggestions; B. Hann for technical advice; K. Thorn (Nikon Imaging Center at UCSF/QB3) for imaging assistance; and D. Hom, P. Ghatpande, C. Firkus, and E. Yu for technical assistance. We also thank members of the Martin, Metzger, and Marshall laboratories and M. Barna, P. Devine, U. Grieshammer, J. Jeong, O. Klein, M. Kumar, S. Luschnig, A. Mogilner, S. Rafelski, and S. Greenberg for helpful comments on the manuscript. This work was supported by NIH grants R01 CA131201 (to M.McM.), R01 GM077004 (to W. F. M), and R01 CA78711 and R01 DE17744 (to G. R. M.). W. F. M. was supported by the W. M. Keck Foundation; R. J. M. was supported by the UCSF Program for Breakthrough Biomedical Research, which is funded in part by the Sandler Foundation; N.T. was supported by an American Heart Association postdoctoral fellowship and NIH training grant 5T32HL007185.	Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Benazeraf B, 2010, NATURE, V466, P248, DOI 10.1038/nature09151; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Colvin JS, 2001, DEVELOPMENT, V128, P2095; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Gros J, 2010, CURR BIOL, V20, P1993, DOI 10.1016/j.cub.2010.09.063; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Huxley J. S., 1936, Nature London, V137, P780, DOI 10.1038/137780b0; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kieserman EK, 2009, J CELL SCI, V122, P2481, DOI 10.1242/jcs.042135; Klein OD, 2008, DEVELOPMENT, V135, P377, DOI 10.1242/dev.015081; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Liu Y, 2004, CURR BIOL, V14, P897, DOI 10.1016/j.cub.2004.05.020; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Minowada G, 1999, DEVELOPMENT, V126, P4465; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; WEIBEL ER, 1962, SCIENCE, V137, P577, DOI 10.1126/science.137.3530.577; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6	35	130	130	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					342	345		10.1126/science.1204831	http://dx.doi.org/10.1126/science.1204831			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764747	Green Accepted			2022-12-28	WOS:000292732000043
J	Lamont, T				Lamont, Tara			PATIENT SAFETY "Re-cognising" risks: from space shuttles to chest drains	BRITISH MEDICAL JOURNAL			English	Editorial Material							AGENCY											[Anonymous], 1997, CHALLENGER LAUNCH DE; Benning A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d195; Lamont T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c187; Lamont T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4489; Sokol Daniel K, 2008, World J Surg, V32, P942, DOI 10.1007/s00268-008-9471-6	5	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 13	2011	343								d4393	10.1136/bmj.d4393	http://dx.doi.org/10.1136/bmj.d4393			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	794OE	21752857				2022-12-28	WOS:000292908900008
J	Griffin, SJ; Borch-Johnsen, K; Davies, MJ; Khunti, K; Rutten, GEHM; Sandbaek, A; Sharp, SJ; Simmons, RK; van den Donk, M; Wareham, NJ; Lauritzen, T				Griffin, Simon J.; Borch-Johnsen, Knut; Davies, Melanie J.; Khunti, Kamlesh; Rutten, Guy E. H. M.; Sandbaek, Annelli; Sharp, Stephen J.; Simmons, Rebecca K.; van den Donk, Maureen; Wareham, Nicholas J.; Lauritzen, Torsten			Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial	LANCET			English	Article							CORONARY-HEART-DISEASE; COST-EFFECTIVENESS; MULTI-FACTORIAL; RISK; PEOPLE; INTERVENTION; MORTALITY; PROGRAM; GLUCOSE; SIMVASTATIN	Background Intensive treatment of multiple cardiovascular risk factors can halve mortality among people with established type 2 diabetes. We investigated the effect of early multifactorial treatment after diagnosis by screening. Methods In a pragmatic, cluster-randomised, parallel-group trial done in Denmark, the Netherlands, and the UK, 343 general practices were randomly assigned screening of registered patients aged 40-69 years without known diabetes followed by routine care of diabetes or screening followed by intensive treatment of multiple risk factors. The primary endpoint was first cardiovascular event, including cardiovascular mortality and morbidity, revascularisation, and non-traumatic amputation within 5 years. Patients and staff assessing outcomes were unaware of the practice's study group assignment. Analysis was done by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00237549. Findings Primary endpoint data were available for 3055 (99.9%) of 3057 screen-detected patients. The mean age was 60.3 (SD 6.9) years and the mean duration of follow-up was 5.3 (SD 1.6) years. Improvements in cardiovascular risk factors (HbA(1c) and cholesterol concentrations and blood pressure) were slightly but significantly better in the intensive treatment group. The incidence of first cardiovascular event was 7.2% (13.5 per 1000 person-years) in the intensive treatment group and 8.5% (15.9 per 1000 person-years) in the routine care group (hazard ratio 0.83, 95% CI 0.65-1.05), and of all-cause mortality 6.2% (11.6 per 1000 person-years) and 6.7% (12.5 per 1000 person-years; 0.91, 0.69-1.21), respectively. Interpretation An intervention to promote early intensive management of patients with type 2 diabetes was associated with a small, non-significant reduction in the incidence of cardiovascular events and death.	[Griffin, Simon J.; Sharp, Stephen J.; Simmons, Rebecca K.; Wareham, Nicholas J.] Addenbrookes Hosp, Inst Metab Sci, MRC, Epidemiol Unit, Cambridge CB2 0QQ, England; [Borch-Johnsen, Knut] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Borch-Johnsen, Knut] Univ So Denmark, Res Ctr Qual Hlth Care, Inst Publ Hlth, Odense, Denmark; [Borch-Johnsen, Knut; Sandbaek, Annelli; Lauritzen, Torsten] Aarhus Univ, Dept Gen Practice, Sch Publ Hlth, Aarhus, Denmark; [Davies, Melanie J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Khunti, Kamlesh] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Rutten, Guy E. H. M.; van den Donk, Maureen] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Steno Diabetes Center; University of Southern Denmark; Aarhus University; University of Leicester; University of Leicester; Utrecht University; Utrecht University Medical Center	Griffin, SJ (corresponding author), Addenbrookes Hosp, Inst Metab Sci, MRC, Epidemiol Unit, Box 285, Cambridge CB2 0QQ, England.	simon.griffin@mrc-epid.cam.ac.uk	Griffin, Simon J/K-3106-2013; /ABC-9527-2021	Griffin, Simon J/0000-0002-2157-4797; Davies, Melanie/0000-0002-9987-9371; Khunti, Kamlesh/0000-0003-2343-7099; Simmons, Rebecca/0000-0002-7726-8529	National Health Service Denmark; Danish Council for Strategic Research; Danish Research Foundation for General Practice; Danish Centre for Evaluation and Health Technology Assessment; Danish National Board of Health; Danish Medical Research Council; Aarhus University Research Foundation; Wellcome Trust [G061895]; UK Medical Research Council; UK NIHR; UK National Health Service RD; Julius Center for Health Sciences and Primary Care; University Medical Center; Utrecht; Novo Nordisk; Astra; Pfizer; GlaxoSmithKline; Servier; HemoCue; Merck; National Health Services, Copenhagen, Denmark; National Health Services, Aarhus, Denmark; National Health Services, Ringkobing, Denmark; National Health Services, Ribe, Denmark; National Health Services, South Jutland, Denmark; Novo Nordisk Foundation; National Board of Health; Novo Nordisk AS; Novo Nordisk Scandinavia AB; Novo Nordisk UK; ASTRA Denmark; Pfizer Denmark; GlaxoSmithKline Pharma Denmark; Servier Denmark; HemoCue Denmark; Medical Research Council [G0001164]; NIHR [08/116/300, RP-PG-0606-1259]; National Health Service; Department of Health [RP-PG-0606-1272]; ad hoc Support Sciences; MRC [G0501294, MC_U106179474, G0001164] Funding Source: UKRI; Medical Research Council [G0501294, MC_U106179474, MC_U106179471] Funding Source: researchfish; National Institute for Health Research [08/116/300, RP-PG-0606-1259] Funding Source: researchfish	National Health Service Denmark; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Research Foundation for General Practice; Danish Centre for Evaluation and Health Technology Assessment; Danish National Board of Health; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Aarhus University Research Foundation; Wellcome Trust(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK NIHR(National Institute for Health Research (NIHR)); UK National Health Service RD; Julius Center for Health Sciences and Primary Care; University Medical Center; Utrecht; Novo Nordisk(Novo Nordisk); Astra; Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); Servier(Servier); HemoCue; Merck(Merck & Company); National Health Services, Copenhagen, Denmark; National Health Services, Aarhus, Denmark; National Health Services, Ringkobing, Denmark; National Health Services, Ribe, Denmark; National Health Services, South Jutland, Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); National Board of Health; Novo Nordisk AS(Novo Nordisk); Novo Nordisk Scandinavia AB(Novo Nordisk); Novo Nordisk UK(Novo Nordisk); ASTRA Denmark; Pfizer Denmark(Pfizer); GlaxoSmithKline Pharma Denmark(GlaxoSmithKline); Servier Denmark; HemoCue Denmark; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); National Health Service; Department of Health; ad hoc Support Sciences; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	National Health Service Denmark, Danish Council for Strategic Research, Danish Research Foundation for General Practice, Danish Centre for Evaluation and Health Technology Assessment, Danish National Board of Health, Danish Medical Research Council, Aarhus University Research Foundation, Wellcome Trust, UK Medical Research Council, UK NIHR Health Technology Assessment Programme, UK National Health Service R&D, UK National Institute for Health Research, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, Novo Nordisk, Astra, Pfizer, GlaxoSmithKline, Servier, HemoCue, Merck.; We thank all patients, practice nurses, and family physicians for their contributions to the ADDITION-Europe study. We thank Ronald P Stolk, and Bruce H R Wolffenbuttel, University Medical Centre Groningen, University of Groningen, Netherlands, for participation on the steering committee that designed the study. ADDITION-Denmark was supported by the National Health Services in the counties of Copenhagen, Aarhus, Ringkobing, Ribe and South Jutland in Denmark, the Danish Council for Strategic Research, the Danish Research Foundation for General Practice, Novo Nordisk Foundation, the Danish Centre for Evaluation and Health Technology Assessment, the diabetes fund of the National Board of Health, the Danish Medical Research Council, and the Aarhus University Research Foundation. The trial has been given unrestricted grants from Novo Nordisk AS, Novo Nordisk Scandinavia AB, Novo Nordisk UK, ASTRA Denmark, Pfizer Denmark, GlaxoSmithKline Pharma Denmark, Servier Denmark, and HemoCue Denmark. Parts of the grants from Novo Nordisk Foundation, Danish Council for Strategic Research and Novo Nordisk were transferred to the other centres. We thank the Biochemistry Department at Steno Diabetes Centre for biochemical testing, and the following hospital departments for doing clinical assessments: Steno Diabetes Centre Research Laboratory, Esbjerg Hospital Diabetes Clinic, Holstebro Hospital Research department, Aabenraa Hospital Outpatient Clinic and Aarhus University Hospital Eye Department. ADDITION-Cambridge was supported by the Wellcome Trust (grant reference no: G061895), the Medical Research Council (grant reference no: G0001164), the NIHR Health Technology Assessment Programme (grant reference no: 08/116/300), National Health Service R&D support funding (including the Primary Care Research and Diabetes Research Networks), and the National Institute for Health Research under its Programme Grants for Applied Research scheme [RP-PG-0606-1259]. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the UK Department of Health. Bio-Rad provided equipment for haemoglobin A testing during the screening phase. We thank the Cambridge University Hospitals NHS Foundation Trust Department of Clinical Biochemistry and the NIHR Cambridge Biomedical Research Centre, Core Biochemical Assay Laboratory for carrying out the biochemical assays. ADDITION-Netherlands was supported by unrestricted grants from Novo Nordisk, Glaxo Smith Kline and Merck, and by the Julius Centre for Health Sciences and Primary Care, University Medical Centre, Utrecht. ADDITION-Leicester was supported by Department of Health and ad hoc Support Sciences, the NIHR Health Technology Assessment Programme (grant reference no: 08/116/300), National Health Service research and development support funding (including the Primary Care Research and Diabetes Research Network, and LNR CLAHRC) and the National Institute for Health Research. MJD and KK receive support from the Department of Health NIHR Programme Grant funding scheme [RP-PG-0606-1272). We thank the University Hospitals of Leicester NHS Trust Department of Clinical Biochemistry for carrying out biochemical assays. Permission to use the DTSQ questionnaire was granted by Professor Clare Bradley, Health Psychology Research, Royal Holloway University of London, Surrey, UK. These results were presented at the European Association for the Study of Diabetes (EASD) Annual Scientific Meeting, Stockholm, Sweden, Sept 20-24, 2010.	[Anonymous], 1995, Diabetes, V44, P1249; Bradley C., 1994, HDB PSYCHOL DIABETES, V1; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Collins R, 2003, LANCET, V361, P2005; Davies MJ, 2008, BMJ-BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Eborall HC, 2007, BMJ-BRIT MED J, V335, P486, DOI 10.1136/bmj.39303.723449.55; Echouffo-Tcheugui JB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-136; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gerstein HC, 2000, LANCET, V355, P253; Glumer C, 2006, DIABETOLOGIA, V49, P1536, DOI 10.1007/s00125-006-0248-x; Glumer C, 2004, DIABETES CARE, V27, P727, DOI 10.2337/diacare.27.3.727; Glumer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; IDF, 2009, IDF DIAB ATL; Janssen PGH, 2009, BRIT J GEN PRACT, V59, P43, DOI 10.3399/bjgp09X394851; Kahn R, 2010, LANCET, V375, P1365, DOI 10.1016/S0140-6736(09)62162-0; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; McIntosh A, 2001, CLIN GUIDELINES EVID; Olivarius ND, 2001, BMJ-BRIT MED J, V323, P970, DOI 10.1136/bmj.323.7319.970; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Royal College of General Practitioners in Denmark, 2004, TYP 2 DIAB GEN PRACT; Royal College of General Practitioners in Denmark, 1999, TYP 2 DIAB GEN PRACT; Ruige JB, 1997, DIABETES CARE, V20, P491, DOI 10.2337/diacare.20.4.491; Rutten G.E.H.M., 2006, HUIS WETEN, V49, P137; Rutten G.E.H.M., 1999, HUISARTS WET, V42, P67; Sandbaek A, 2008, DIABETOLOGIA, V51, P1127, DOI 10.1007/s00125-008-1013-0; Sargeant LA, 2010, DIABETIC MED, V27, P995, DOI 10.1111/j.1464-5491.2010.03056.x; Spijkerman AMW, 2002, EUR J CLIN INVEST, V32, P924, DOI 10.1046/j.1365-2362.2002.01090.x; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van den Donk M, 2010, QUAL LIFE RES, V19, P509, DOI 10.1007/s11136-010-9604-x; Wareham NJ, 2001, BMJ-BRIT MED J, V322, P986, DOI 10.1136/bmj.322.7292.986; Webb DR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-16; White IR, 2005, STAT MED, V24, P993, DOI 10.1002/sim.1981	41	325	330	0	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2011	378	9786					156	167		10.1016/S0140-6736(11)60698-3	http://dx.doi.org/10.1016/S0140-6736(11)60698-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	795CJ	21705063	Green Published, Green Submitted			2022-12-28	WOS:000292948800032
J	Alaynick, WA; Jessell, TM; Pfaff, SL				Alaynick, William A.; Jessell, Thomas M.; Pfaff, Samuel L.			Snapshot: Spinal Cord Development	CELL			English	Editorial Material							CIRCUITS; SPECIFICATION; NETWORKS		[Alaynick, William A.; Pfaff, Samuel L.] Salk Inst Biol Studies, HHMI, La Jolla, CA 92037 USA; [Jessell, Thomas M.] Columbia Univ, HHMI, New York, NY 10032 USA	Howard Hughes Medical Institute; Salk Institute; Columbia University; Howard Hughes Medical Institute	Alaynick, WA (corresponding author), Salk Inst Biol Studies, HHMI, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037116, R01NS054172, R37NS037116, P01NS031249] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS037116-05, R01 NS054172-02, R01 NS037116-08, R01 NS054172, R01 NS037116-04S1, R01 NS037116, P01 NS031249-15, R01 NS037116-10, P01 NS031249-14A1, R01 NS037116-03, R37 NS037116, R01 NS037116-09, P01 NS031249-18, R01 NS037116-07S1, R01 NS054172-01A2, R01 NS037116-04, R01 NS037116-08S1, R01 NS054172-05, P01 NS031249, R01 NS037116-07, R01 NS037116-06A1, R01 NS054172-04, P01 NS031249-17, P01 NS031249-16, R01 NS054172-03] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Jankowska E, 2001, J PHYSIOL-LONDON, V533, P31, DOI 10.1111/j.1469-7793.2001.0031b.x; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750	10	187	190	2	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					178	U19		10.1016/j.cell.2011.06.038	http://dx.doi.org/10.1016/j.cell.2011.06.038			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729788	Green Accepted, Bronze			2022-12-28	WOS:000292539300015
J	Avila, K; Moxey, D; de Lozar, A; Avila, M; Barkley, D; Hof, B				Avila, Kerstin; Moxey, David; de Lozar, Alberto; Avila, Marc; Barkley, Dwight; Hof, Bjorn			The Onset of Turbulence in Pipe Flow	SCIENCE			English	Article							COUPLED MAP LATTICES; PLANE COUETTE-FLOW; SPATIOTEMPORAL INTERMITTENCY; TRANSITION; STATES; PUFFS; LIFETIME; SLUGS	Shear flows undergo a sudden transition from laminar to turbulent motion as the velocity increases, and the onset of turbulence radically changes transport efficiency and mixing properties. Even for the well-studied case of pipe flow, it has not been possible to determine at what Reynolds number the motion will be either persistently turbulent or ultimately laminar. We show that in pipes, turbulence that is transient at low Reynolds numbers becomes sustained at a distinct critical point. Through extensive experiments and computer simulations, we were able to identify and characterize the processes ultimately responsible for sustaining turbulence. In contrast to the classical Landau-Ruelle-Takens view that turbulence arises from an increase in the temporal complexity of fluid motion, here, spatial proliferation of chaotic domains is the decisive process and intrinsic to the nature of fluid turbulence.	[Avila, Kerstin; de Lozar, Alberto; Avila, Marc; Hof, Bjorn] Max Planck Inst Dynam & Self Org, D-37073 Gottingen, Germany; [Moxey, David; Barkley, Dwight] Univ Warwick, Dept Math, Coventry CV4 7AL, W Midlands, England; [Barkley, Dwight] Univ Paris 07, Univ Paris 06, Ecole Super Phys & Chim Ind Ville Paris, CNRS,UMR 7636, F-75005 Paris, France	Max Planck Society; University of Warwick; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Universite Paris Cite	Avila, K (corresponding author), Max Planck Inst Dynam & Self Org, Bunsenstr 10, D-37073 Gottingen, Germany.	kavila@ds.mpg.de; bhof@ds.mpg.de	de Lozar, Alberto/A-4987-2010; Barkley, Dwight/F-8218-2014; Avila, Kerstin/E-8126-2013; Avila, Marc/A-1263-2009	Barkley, Dwight/0000-0003-4317-3705; Avila, Kerstin/0000-0002-7921-8234; Avila, Marc/0000-0001-5988-1090; Moxey, David/0000-0003-2186-8397	Deutsche Forschungsgemeinschaft [FOR 1182]; Max Planck Society; Engineering and Physical Sciences Research Council [EP/F017413/2]; Leverhulme Trust; Royal Society; Julich Supercomputing Centre [HGU16]; Grand Equipement National de Calcul Intensif-Institut du Developpement et des Ressources en Informatique Scientifique [2010-1119, 2011-1119]; International Max Planck Research School for the Physics of Biological and Complex Systems; Gottinger Graduate School for Neurosciences and Molecular Biosciences; EPSRC [EP/F017413/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F017413/1] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leverhulme Trust(Leverhulme Trust); Royal Society(Royal Society of London); Julich Supercomputing Centre; Grand Equipement National de Calcul Intensif-Institut du Developpement et des Ressources en Informatique Scientifique; International Max Planck Research School for the Physics of Biological and Complex Systems; Gottinger Graduate School for Neurosciences and Molecular Biosciences; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank A. P. Willis for sharing his hybrid spectral finite-difference code. We acknowledge the Deutsche Forschungsgemeinschaft (project FOR 1182), the Max Planck Society, and the Engineering and Physical Sciences Research Council (grant EP/F017413/2) for financial support. D. B. thanks the Leverhulme Trust and the Royal Society for their support. M.A. and B.H. acknowledge computing resources from GWDG (Gesellschaft fur wissenschaftliche Datenverarbeitung Gottingen) and the Julich Supercomputing Centre (grant HGU16), where DNS2 were performed. D.M. and D.B. acknowledge computing resources from the Centre for Scientific Computing, University of Warwick, and Grand Equipement National de Calcul Intensif-Institut du Developpement et des Ressources en Informatique Scientifique (grants 2010-1119 and 2011-1119), where DNS1 were performed. K.A. acknowledges support from the International Max Planck Research School for the Physics of Biological and Complex Systems and the Gottinger Graduate School for Neurosciences and Molecular Biosciences.	Avila M, 2010, J FLUID MECH, V646, P127, DOI 10.1017/S0022112009993296; Blackburn HM, 2004, J COMPUT PHYS, V197, P759, DOI 10.1016/j.jcp.2004.02.013; Bottin S, 1998, EUROPHYS LETT, V43, P171, DOI 10.1209/epl/i1998-00336-3; Bottin S, 1998, EUR PHYS J B, V6, P143, DOI 10.1007/s100510050536; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; CHATE H, 1988, PHYSICA D, V32, P409, DOI 10.1016/0167-2789(88)90065-6; DARBYSHIRE AG, 1995, J FLUID MECH, V289, P83, DOI 10.1017/S0022112095001248; De Lozar A, 2009, PHILOS T R SOC A, V367, P589, DOI 10.1098/rsta.2008.0199; Drazin PG, 2004, HYDRODYNAMIC STABILI; Eckhardt B, 2008, NONLINEARITY, V21, pT1, DOI 10.1088/0951-7715/21/1/T01; Eckhardt B, 2007, ANNU REV FLUID MECH, V39, P447, DOI 10.1146/annurev.fluid.39.050905.110308; Eckhardt B, 2009, PHILOS T R SOC A, V367, P449, DOI 10.1098/rsta.2008.0217; Faisst H, 2004, J FLUID MECH, V504, P343, DOI 10.1017/S0022112004008134; HARRIS TE, 1974, ANN PROBAB, V2, P969, DOI 10.1214/aop/1176996493; Hinrichsen H, 2000, ADV PHYS, V49, P815, DOI 10.1080/00018730050198152; Hof B, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.244502; Hof B, 2006, NATURE, V443, P59, DOI 10.1038/nature05089; Hof B, 2010, SCIENCE, V327, P1491, DOI 10.1126/science.1186091; Hof B, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.214501; KANEKO K, 1985, PROG THEOR PHYS, V74, P1033, DOI 10.1143/PTP.74.1033; Kuik DJ, 2010, J FLUID MECH, V645, P529, DOI 10.1017/S0022112009993065; Landau L., 1959, FLUID MECH, V225; Lawless J. F., 2003, STAT MODELS METHODS; Manneville P, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.025301; Meseguer A, 2003, J COMPUT PHYS, V186, P178, DOI 10.1016/S0021-9991(03)00029-9; Moxey D, 2010, P NATL ACAD SCI USA, V107, P8091, DOI 10.1073/pnas.0909560107; Nishi M, 2008, J FLUID MECH, V614, P425, DOI 10.1017/S0022112008003315; Peixinho J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.094501; POMEAU Y, 1986, PHYSICA D, V23, P3, DOI 10.1016/0167-2789(86)90104-1; Reynolds O., 1895, PHIL T ROY SOC LOND, V186, P123; Rolf J, 1998, PHYS REV E, V57, pR2503, DOI 10.1103/PhysRevE.57.R2503; Rotta J., 1956, ARCH APPL MECH, V24, P258; RUELLE D, 1971, COMMUN MATH PHYS, V20, P167, DOI 10.1007/BF01646553; Schneider TM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046310; Willis AP, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.014501; Willis AP, 2009, J FLUID MECH, V619, P213, DOI 10.1017/S0022112008004618; WYGNANSKI I, 1975, J FLUID MECH, V69, P283, DOI 10.1017/S0022112075001449; WYGNANSKI IJ, 1973, J FLUID MECH, V59, P281, DOI 10.1017/S0022112073001576	39	402	411	11	254	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					192	196		10.1126/science.1203223	http://dx.doi.org/10.1126/science.1203223			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21737736				2022-12-28	WOS:000292502700041
J	Cookson, MR				Cookson, Mark R.			A Feedforward Loop Links Gaucher and Parkinson's Diseases?	CELL			English	Editorial Material							ALPHA-SYNUCLEIN; GLUCOCEREBROSIDASE		NIA, Gene Express Unit, Neurogenet Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cookson, MR (corresponding author), NIA, Gene Express Unit, Neurogenet Lab, 35 Convent Dr, Bethesda, MD 20892 USA.	cookson@mail.nih.gov	Cookson, Mark/AAW-2516-2021	Cookson, Mark/0000-0002-1058-3831	NATIONAL INSTITUTE ON AGING [ZIAAG000939] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Choi JH, 2011, MOL GENET METAB, V104, P185, DOI 10.1016/j.ymgme.2011.06.008; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527; GWINN K, 2011, MOVEMENT DISORD, DOI DOI 10.1002/MDS.23776; Hardy J, 2010, NEURON, V68, P201, DOI 10.1016/j.neuron.2010.10.014; Li WX, 2004, J NEUROSCI, V24, P7400, DOI 10.1523/JNEUROSCI.1370-04.2004; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Velayati A, 2010, CURR NEUROL NEUROSCI, V10, P190, DOI 10.1007/s11910-010-0102-x; Yap TL, 2011, J BIOL CHEM, V286, P28080, DOI 10.1074/jbc.M111.237859	10	9	9	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 8	2011	146	1					9	11		10.1016/j.cell.2011.06.031	http://dx.doi.org/10.1016/j.cell.2011.06.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729776	Bronze			2022-12-28	WOS:000292539300001
J	Fischer, G; Kurth, WS; Gurnett, DA; Zarka, P; Dyudina, UA; Ingersoll, AP; Ewald, SP; Porco, CC; Wesley, A; Go, C; Delcroix, M				Fischer, G.; Kurth, W. S.; Gurnett, D. A.; Zarka, P.; Dyudina, U. A.; Ingersoll, A. P.; Ewald, S. P.; Porco, C. C.; Wesley, A.; Go, C.; Delcroix, M.			A giant thunderstorm on Saturn	NATURE			English	Article							CASSINI IMAGING SCIENCE; ATMOSPHERE; IONOSPHERE; VOYAGER-1; FEATURES; MOTIONS; RADIO; STORM; WATER; MODEL	Lightning discharges in Saturn's atmosphere emit radio waves(1) with intensities about 10,000 times stronger than those of their terrestrial counterparts(2). These radio waves are the characteristic features of lightning from thunderstorms on Saturn, which last for days to months(2). Convective storms about 2,000 kilometres in size have been observed in recent years at planetocentric latitude 35 degrees south(3-5) (corresponding to a planetographic latitude of 41 degrees south). Here we report observations of a giant thunderstorm at planetocentric latitude 35 degrees north that reached a latitudinal extension of 10,000 kilometres-comparable in size to a 'Great White Spot'(6,7)-about three weeks after it started in early December 2010. The visible plume consists of high-altitude clouds that overshoot the outermost ammonia cloud layer owing to strong vertical convection, as is typical for thunderstorms. The flash rates of this storm are about an order of magnitude higher than previous ones, and peak rates larger than ten per second were recorded. This main storm developed an elongated eastward tail with additional but weaker storm cells that wrapped around the whole planet by February 2011. Unlike storms on Earth, the total power of this storm is comparable to Saturn's total emitted power. The appearance of such storms in the northern hemisphere could be related to the change of seasons(7), given that Saturn experienced vernal equinox in August 2009.	[Fischer, G.] Austrian Acad Sci, Space Res Inst, A-8042 Graz, Austria; [Kurth, W. S.; Gurnett, D. A.] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; [Zarka, P.] Observ Paris, F-92195 Meudon, France; [Dyudina, U. A.; Ingersoll, A. P.; Ewald, S. P.] CALTECH, Pasadena, CA 91125 USA; [Porco, C. C.] Space Sci Inst, Cassini Imaging Cent Lab Operat, Boulder, CO 80301 USA; [Go, C.] Univ San Carlos, Dept Phys, Cebu 6000, Philippines; [Delcroix, M.] Soc Astron France, Commiss Observat Planetaires, F-31170 Tournefeuilee, France	Austrian Academy of Sciences; University of Iowa; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; California Institute of Technology; University of San Carlos	Fischer, G (corresponding author), Austrian Acad Sci, Space Res Inst, Schmiedlstr 6, A-8042 Graz, Austria.	georg.fischer@oeaw.ac.at	Kurth, William/AAA-7334-2019	Kurth, William/0000-0002-5471-6202; Delcroix, Marc/0000-0002-9828-7390	Austrian Science Fund (FWF); NASA/JPL	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NASA/JPL(National Aeronautics & Space Administration (NASA))	G.F. was supported by the Austrian Science Fund (FWF). Cassini research at the University of Iowa was funded by NASA/JPL. We thank A. Sanchez-Lavega for launching an alert on the webpage of the Planetary Virtual Observatory and Laboratory (http://www.pvol.ehu.es), and the amateur astronomers who subsequently observed the storm on Saturn, namely,T.Akutsu,T. Barry, J. Castella, D. Chang, D. Gray, J. B. Jovani, W. Kivits, T. Kumamori, F. J. Melillo, D. Parker, D. Peach, J. Phillips, J.-J. Poupeau, J. Sussenbach, K. Yunoki and S. Walker. S. Ghomizadeh and T. Ikemura were the first to observe the storm before the alert.	Atreya SK, 2010, IAU SYMP P SERIES, P130, DOI 10.1017/S1743921310007349; Baines KH, 2009, PLANET SPACE SCI, V57, P1650, DOI 10.1016/j.pss.2009.06.025; Christian HJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002347; CONNERNEY JEP, 1984, NATURE, V312, P136, DOI 10.1038/312136a0; Dyudina UA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043188; Dyudina UA, 2007, ICARUS, V190, P545, DOI 10.1016/j.icarus.2007.03.035; Fischer G, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2007JA012592; Fischer G, 2007, ICARUS, V190, P528, DOI 10.1016/j.icarus.2007.04.002; Fischer G, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016187; Fischer G, 2008, SPACE SCI REV, V137, P271, DOI 10.1007/s11214-008-9370-z; Gurnett DA, 2004, SPACE SCI REV, V114, P395, DOI 10.1007/s11214-004-1434-0; HANEL RA, 1983, ICARUS, V53, P262, DOI 10.1016/0019-1035(83)90147-1; Hueso R, 2004, ICARUS, V172, P255, DOI 10.1016/j.icarus.2004.06.010; HUNT GE, 1982, NATURE, V297, P132, DOI 10.1038/297132a0; INGERSOLL AP, 1984, SATURN, P195; KAISER ML, 1984, J GEOPHYS RES-SPACE, V89, P2371, DOI 10.1029/JA089iA04p02371; KAISER ML, 1983, NATURE, V303, P50, DOI 10.1038/303050a0; Li LM, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003631; Moore L, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027375; Perez-Hoyos S, 2006, ICARUS, V180, P368, DOI 10.1016/j.icarus.2005.10.009; Porco CC, 2004, SPACE SCI REV, V115, P363, DOI 10.1007/s11214-004-1456-7; Porco CC, 2005, SCIENCE, V307, P1243, DOI 10.1126/science.1107691; SANCHEZ-LAVEGA A, 1982, ICARUS, V49, P1, DOI 10.1016/0019-1035(82)90052-5; SANCHEZLAVEGA A, 1991, NATURE, V353, P397, DOI 10.1038/353397a0; SROMOVSKY LA, 1983, J GEOPHYS RES-SPACE, V88, P8650, DOI 10.1029/JA088iA11p08650; WARWICK JW, 1981, SCIENCE, V212, P239, DOI 10.1126/science.212.4491.239; ZARKA P, 1983, J GEOPHYS RES-SPACE, V88, P9007, DOI 10.1029/JA088iA11p09007	27	80	80	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					75	77		10.1038/nature10205	http://dx.doi.org/10.1038/nature10205			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734705				2022-12-28	WOS:000292461300047
J	Edwards, PP				Edwards, Peter P.			Electrons in Cement	SCIENCE			English	Editorial Material							AMMONIA SOLUTIONS; LIQUID-AMMONIA; SOLVENTS; ANIONS; METALS		Univ Oxford, Dept Chem, Oxford OX1 3QR, England	University of Oxford	Edwards, PP (corresponding author), Univ Oxford, Dept Chem, S Parks Rd, Oxford OX1 3QR, England.	peter.edwards@chem.ox.ac.uk						DENG ZH, 1994, J CHEM SOC FARADAY T, V90, P2009, DOI 10.1039/ft9949002009; Dye JL, 2009, ACCOUNTS CHEM RES, V42, P1564, DOI 10.1021/ar9000857; DYE JL, 1977, SCI AM, V237, P92, DOI 10.1038/scientificamerican0777-92; Edwards P., 1995, METAL NONMETAL TRANS; EDWARDS PP, 1982, ADV INORG CHEM RAD, V25, P135, DOI 10.1016/S0898-8838(08)60140-3; GIBSON GE, 1916, PHYS REV, V7, P33; Kim SW, 2011, SCIENCE, V333, P71, DOI 10.1126/science.1204394; Kraus CA, 1914, J AM CHEM SOC, V36, P864, DOI 10.1021/ja02182a010; Matsuishi S, 2003, SCIENCE, V301, P626, DOI 10.1126/science.1083842; Siefermann KR, 2011, ANGEW CHEM INT EDIT, V50, P5264, DOI 10.1002/anie.201006521; Thompson J. C., 1976, ELECT LIQUID AMMONIA; Zurek E, 2009, ANGEW CHEM INT EDIT, V48, P8198, DOI 10.1002/anie.200900373	12	14	15	4	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					49	50		10.1126/science.1207837	http://dx.doi.org/10.1126/science.1207837			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719667				2022-12-28	WOS:000292255400042
J	Rosenthal, PJ				Rosenthal, Philip J.			Lessons from Sickle Cell Disease in the Treatment and Control of Malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Rosenthal, PJ (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.							de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009	5	13	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2011	364	26					2549	2551		10.1056/NEJMcibr1105118	http://dx.doi.org/10.1056/NEJMcibr1105118			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	785AM	21714653				2022-12-28	WOS:000292199800015
J	Scheid, JF; Mouquet, H; Ueberheide, B; Diskin, R; Klein, F; Oliveira, TYK; Pietzsch, J; Fenyo, D; Abadir, A; Velinzon, K; Hurley, A; Myung, S; Boulad, F; Poignard, P; Burton, DR; Pereyra, F; Ho, DD; Walker, BD; Seaman, MS; Bjorkman, PJ; Chait, BT; Nussenzweig, MC				Scheid, Johannes F.; Mouquet, Hugo; Ueberheide, Beatrix; Diskin, Ron; Klein, Florian; Oliveira, Thiago Y. K.; Pietzsch, John; Fenyo, David; Abadir, Alexander; Velinzon, Klara; Hurley, Arlene; Myung, Sunnie; Boulad, Farid; Poignard, Pascal; Burton, Dennis R.; Pereyra, Florencia; Ho, David D.; Walker, Bruce D.; Seaman, Michael S.; Bjorkman, Pamela J.; Chait, Brian T.; Nussenzweig, Michel C.			Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; MEMORY B-CELLS; NEUTRALIZING ANTIBODIES; TYPE-1 GP120; ENVELOPE GLYCOPROTEIN; EPITOPE; RECEPTOR; GP41; INDIVIDUALS	Passive transfer of broadly neutralizing HIV antibodies can prevent infection, which suggests that vaccines that elicit such antibodies would be protective. Thus far, however, few broadly neutralizing HIV antibodies that occur naturally have been characterized. To determine whether these antibodies are part of a larger group of related molecules, we cloned 576 new HIV antibodies from four unrelated individuals. All four individuals produced expanded clones of potent broadly neutralizing CD4-binding-site antibodies that mimic binding to CD4. Despite extensive hypermutation, the new antibodies shared a consensus sequence of 68 immunoglobulin H (IgH) chain amino acids and arise independently from two related IgH genes. Comparison of the crystal structure of one of the antibodies to the broadly neutralizing antibody VRC01 revealed conservation of the contacts to the HIV spike.	[Scheid, Johannes F.; Mouquet, Hugo; Klein, Florian; Oliveira, Thiago Y. K.; Pietzsch, John; Abadir, Alexander; Velinzon, Klara; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Scheid, Johannes F.] Charite, D-10117 Berlin, Germany; [Ueberheide, Beatrix; Fenyo, David; Myung, Sunnie; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA; [Diskin, Ron; Bjorkman, Pamela J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Pietzsch, John] Free Univ Berlin, Dept Biol Chem & Pharm, D-14195 Berlin, Germany; [Hurley, Arlene] Rockefeller Univ, Rockefeller Univ Hosp, New York, NY 10065 USA; [Boulad, Farid] Mem Sloan Kettering Canc Ctr, Bone Marrow Transplant Serv, New York, NY 10065 USA; [Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Poignard, Pascal] Int AIDS Vaccine Initiat, New York, NY 10028 USA; [Burton, Dennis R.; Pereyra, Florencia; Walker, Bruce D.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA; [Pereyra, Florencia; Walker, Bruce D.] Massachusetts Gen Hosp, Partners AIDS Res Ctr, Charlestown, MA 02129 USA; [Pereyra, Florencia; Walker, Bruce D.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Ho, David D.; Walker, Bruce D.; Bjorkman, Pamela J.; Nussenzweig, Michel C.] Howard Hughes Med Inst, New York, NY 10065 USA; Aaron Diamond AIDS Res Ctr, New York, NY 10065 USA; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Rockefeller University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Rockefeller University; California Institute of Technology; Free University of Berlin; Rockefeller University; Memorial Sloan Kettering Cancer Center; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; International AIDS Vaccine Initiative; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@mail.rockefeller.edu	poignard, pascal/AAB-4613-2020; poignard, pascal/N-6678-2013; Oliveira, Thiago Y/ABF-5186-2020; Mouquet, Hugo/M-2750-2014; Oliveira, Thiago Y/HGA-3848-2022; Nussenzweig, Michel/AAE-7292-2019	Oliveira, Thiago Y/0000-0002-2654-0879; Mouquet, Hugo/0000-0002-4230-610X; Oliveira, Thiago Y/0000-0002-2654-0879; Ueberheide, Beatrix/0000-0003-2512-0204; Poignard, Pascal/0000-0002-0021-7192; Fenyo, David/0000-0001-5049-3825	NIH [P01 AI081677, RR00862, RR022220]; Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery/Comprehensive Antibody-Vaccine Immune Monitoring Consortium [38619s, 38660]; Gordon and Betty Moore Foundation; Stanford Synchrotron Radiation Lightsource; German Research Foundation (Deutsche Forschungsgemeinschaft) [KL 2389/1-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220, P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R01AI033292, P01AI081677] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery/Comprehensive Antibody-Vaccine Immune Monitoring Consortium; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Stanford Synchrotron Radiation Lightsource; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The data reported in this paper are tabulated in the supporting online material, and the coordinates for the 3BNC60 Fab as well as the antibody sequences have been deposited in the Protein Data Bank and the European Molecular Biology Laboratory-European Bioinformatics Institute database [accession codes: 3RPI (3BNC60 coordinates), HE584535 to HE584554 (antibody sequences)]. We thank the HIV-positive donors for their support. We thank M. Jankovic for discussions and help with cloning of HIV envelope constructs; R. Wyatt for the plasmid of YU2-gp140; J. Mascola for the plasmid of 2CC-core and YU2-gp120 mutants; and M. Connors for access to patient NIH45; C. Gaebler, M. Warncke, P. M. Marcovecchio, and H. Gao for help with protein expression; K. Moss for patient coordination. We thank F. McCutchan, G. Shaw, B. Hahn, J. Baalwa, D. Montefiori, F. Gao, M. Thomson, J. Overbaugh, R. Swanstrom, L. Morris, J. Kim, L. Zhang, D. Ellenberger, and C. Williamson for contributing the HIV-1 Envelope plasmids used in our neutralization panel. We thank M. Simek, F. Priddy, and all the study participants and research staff at each of the International AIDS Vaccine Initiative (IAVI) Protocol G project; clinical and site team members; and all of the Protocol G clinical investigators, specifically, G. Miiro, A. Pozniak, D. McPhee, O. Manigart, E. Karita, A. Inwoley, W. Jaoko, J. DeHovitz, L.-G. Bekker, P. Pitisuttithum, R. Paris, J. Serwanga, and S. Allen for samples from one broadly neutralizing serum donor from Protocol G. We thank L. Walker for providing data on the neutralizing specificity of the Protocol G donor. In connection with this work, M.C.N. and J. F. S. have a pending patent application with the U. S. Patent and Trademark Office, patent number U. S. 61/486,960, entitled "Human Immunodeficiency Virus Neutralizing Antibodies and Methods of Use Thereof." The reagents are available with a Materials Transfer Agreement. The work was supported by NIH grants P01 AI081677, RR00862, and RR022220, and by the Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery/Comprehensive Antibody-Vaccine Immune Monitoring Consortium, grant numbers 38619s and 38660. We thank the Molecular Observatory at Caltech (supported by the Gordon and Betty Moore Foundation) and the Stanford Synchrotron Radiation Lightsource. F. K. was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, KL 2389/1-1). M.C.N., P. J. B, and B. D. W. are Howard Hughes Medical Institute Investigators.	BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; MCCLURE MO, 1987, NATURE, V330, P487, DOI 10.1038/330487a0; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pietzsch J, 2010, J EXP MED, V207, P1995, DOI 10.1084/jem.20101176; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; THALI M, 1991, J VIROL, V65, P6188, DOI 10.1128/JVI.65.11.6188-6193.1991; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zwick MB, 2001, J VIROL, V75, P12198, DOI 10.1128/JVI.75.24.12198-12208.2001; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	36	848	929	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1633	1637		10.1126/science.1207227	http://dx.doi.org/10.1126/science.1207227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21764753	Green Accepted, Green Submitted			2022-12-28	WOS:000294900900044
J	Tse, D; Takeuchi, T; Kakeyama, M; Kajii, Y; Okuno, H; Tohyama, C; Bito, H; Morris, RGM				Tse, Dorothy; Takeuchi, Tomonori; Kakeyama, Masaki; Kajii, Yasushi; Okuno, Hiroyuki; Tohyama, Chiharu; Bito, Haruhiko; Morris, Richard G. M.			Schema-Dependent Gene Activation and Memory Encoding in Neocortex	SCIENCE			English	Article							LONG-TERM-MEMORY; SPATIAL MEMORY; ASSOCIATIVE MEMORY; EPISODIC MEMORY; RAT HIPPOCAMPUS; CONSOLIDATION; EXPRESSION; PLASTICITY; EXPERIENCE; NEURONS	When new learning occurs against the background of established prior knowledge, relevant new information can be assimilated into a schema and thereby expand the knowledge base. An animal model of this important component of memory consolidation reveals that systems memory consolidation can be very fast. In experiments with rats, we found that the hippocampal-dependent learning of new paired associates is associated with a striking up-regulation of immediate early genes in the prelimbic region of the medial prefrontal cortex, and that pharmacological interventions targeted at that area can prevent both new learning and the recall of remotely and even recently consolidated information. These findings challenge the concept of distinct fast (hippocampal) and slow (cortical) learning systems, and shed new light on the neural mechanisms of memory assimilation into schemas.	[Tse, Dorothy; Takeuchi, Tomonori; Morris, Richard G. M.] Univ Edinburgh, Ctr Cognit & Neural Syst, Edinburgh EH8 9JZ, Midlothian, Scotland; [Kakeyama, Masaki; Tohyama, Chiharu] Univ Tokyo, Grad Sch Med, Lab Environm Hlth Sci, Ctr Dis Biol & Integrat Med,Bunkyo Ku, Tokyo 1130033, Japan; [Kajii, Yasushi] Mitsubishi Tanabe Pharma Corp, Pharmacol Res Labs 1, Aoba Ku, Yokohama, Kanagawa 2270033, Japan; [Okuno, Hiroyuki; Bito, Haruhiko] Univ Tokyo, Grad Sch Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan	University of Edinburgh; University of Tokyo; Mitsubishi Tanabe Pharma Corporation; University of Tokyo	Morris, RGM (corresponding author), Univ Edinburgh, Ctr Cognit & Neural Syst, Edinburgh EH8 9JZ, Midlothian, Scotland.	r.g.m.morris@ed.ac.uk	Takeuchi, Tomonori/P-5988-2016; Bito, Haruhiko/A-8635-2008; Tohyama, Chiharu/AAI-5598-2020; Morris, Richard G M/C-9982-2013	Takeuchi, Tomonori/0000-0002-9981-4260; Tohyama, Chiharu/0000-0003-1061-6872; MORRIS, Richard G M/0000-0001-8661-1520; Bito, Haruhiko/0000-0001-6315-9594; OKUNO, HIROYUKI/0000-0001-6237-6503; Tse, Dorothy/0000-0003-2263-8139; Kakeyama, Masaki/0000-0001-9063-9673	Mitsubishi Tanabe Pharmaceutical Company; UK Medical Research Council; Uehara Foundation; Astellas Foundation; SRPBS-Ministry of Education, Culture, Sports, Science and Technology (MEXT); CREST-Japan Science and Technology Agency; Ministry of Health, Labour and Welfare of Japan; MRC [G0700447] Funding Source: UKRI; Medical Research Council [G0700447, G0700704B] Funding Source: researchfish	Mitsubishi Tanabe Pharmaceutical Company; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Uehara Foundation(Uehara Memorial Foundation); Astellas Foundation(Astellas Pharmaceuticals); SRPBS-Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST-Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from the Mitsubishi Tanabe Pharmaceutical Company, the UK Medical Research Council (R. G. M. M.), the Uehara and Astellas Foundations (T. T.), SRPBS-Ministry of Education, Culture, Sports, Science and Technology (MEXT) (C. T.), CREST-Japan Science and Technology Agency (H.O., H. B.), and grants-in-aid from MEXT (M. K., H.O., H. B.) and Ministry of Health, Labour and Welfare of Japan (M. K., H. B.). We thank B. Bontempi, S. Alaux-Cantin, M. Ginger, G. Poirier, P. Spooner, and J. Tulloch for technical advice, and S.-H. Wang for scientific discussion.	Barker GRI, 2008, J NEUROSCI, V28, P2837, DOI 10.1523/JNEUROSCI.4447-07.2008; Bartlett F. C., 1932, REMEMBERING; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bethus I, 2010, J NEUROSCI, V30, P1610, DOI 10.1523/JNEUROSCI.2721-09.2010; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bransford J., 1979, HUMAN COGNITION LEAR; Day M, 2003, NATURE, V424, P205, DOI 10.1038/nature01769; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dudai Y, 2000, BRAIN, PERCEPTION, MEMORY, P149; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Griffiths D, 1999, TRENDS COGN SCI, V3, P74, DOI 10.1016/S1364-6613(98)01272-8; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Harris JA, 1999, P NATL ACAD SCI USA, V96, P7587, DOI 10.1073/pnas.96.13.7587; Hasselmo ME, 2010, BEHAV BRAIN RES, V215, P261, DOI 10.1016/j.bbr.2009.12.010; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Komorowski RW, 2009, J NEUROSCI, V29, P9918, DOI 10.1523/JNEUROSCI.1378-09.2009; Kuhl BA, 2010, NAT NEUROSCI, V13, P501, DOI 10.1038/nn.2498; Laroche S, 2000, HIPPOCAMPUS, V10, P438; Lesburgueres E, 2011, SCIENCE, V331, P924, DOI 10.1126/science.1196164; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Miyashita T, 2009, J NEUROSCI, V29, P898, DOI 10.1523/JNEUROSCI.4588-08.2009; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Osada T, 2008, PHILOS T R SOC B, V363, P2187, DOI 10.1098/rstb.2008.2271; Restivo L, 2009, J NEUROSCI, V29, P8206, DOI 10.1523/JNEUROSCI.0966-09.2009; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Squire L. R., 1987, MEMORY BRAIN; STAUBLI U, 1989, BEHAV NEUROSCI, V103, P54, DOI 10.1037/0735-7044.103.1.54; Sweatt JD, 2003, MECH MEMORY; TEYLER TJ, 1986, BEHAV NEUROSCI, V100, P147, DOI 10.1037/0735-7044.100.2.147; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; van Kesteren MTR, 2010, J NEUROSCI, V30, P15888, DOI 10.1523/JNEUROSCI.2674-10.2010; van Kesteren MTR, 2010, P NATL ACAD SCI USA, V107, P7550, DOI 10.1073/pnas.0914892107; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; Winocur G, 2005, NAT NEUROSCI, V8, P273, DOI 10.1038/nn1401	44	363	366	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2011	333	6044					891	895		10.1126/science.1205274	http://dx.doi.org/10.1126/science.1205274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21737703				2022-12-28	WOS:000293785400045
J	Armstrong, JB; Schindler, DE				Armstrong, Jonathan B.; Schindler, Daniel E.			Excess digestive capacity in predators reflects a life of feast and famine	NATURE			English	Article							BIOENERGETICS MODEL; FISHES; RUN	A central challenge for predators is achieving positive energy balance when prey are spatially and temporally heterogeneous. Ecological heterogeneity produces evolutionary trade-offs in the physiological design of predators; this is because the ability to capitalize on pulses of food abundance requires high capacity for food-processing, yet maintaining such capacity imposes energetic costs that are taxing during periods of food scarcity(1,2). Recent advances in physiology show that when variation in foraging opportunities is predictable, animals may adjust energetic tradeoffs by rapidly modulating their digestive system to track variation in foraging opportunities(1). However, it is increasingly recognized that foraging opportunities for animals are unpredictable(3), which should favour animals that maintain a capacity for food-processing that exceeds average levels of consumption (loads)(2,4). Despite this basic principle of quantitative evolutionary design, estimates of digestive load: capacity ratios in wild animals are virtually nonexistent(1). Here we provide an extensive assessment of load: capacity ratios for the digestive systems of predators in the wild, compiling 639 estimates across 38 species of fish. We found that piscine predators typically maintain the physiological capacity to feed at daily rates 2-3 times higher than what they experience on average. A numerical simulation of the trade-off between food-processing capacity and metabolic cost suggests that the observed level of physiological opportunism is profitable only if predator-prey encounters, and thus predator energy budgets, are far more variable in nature than currently assumed.	[Armstrong, Jonathan B.; Schindler, Daniel E.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Armstrong, JB (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Box 355020, Seattle, WA 98195 USA.	Jonny99@uw.edu			Gordon and Betty Moore Foundation; US National Science Foundation; University of Washington School of Aquatic and Fishery Sciences; Directorate For Geosciences [1114918] Funding Source: National Science Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); US National Science Foundation(National Science Foundation (NSF)); University of Washington School of Aquatic and Fishery Sciences(University of Washington); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank T. Essington, R. Huey, T. Reed, A. Walters, V. Sturtevant and A. Armstrong for comments on this manuscript. We also thank the following people for contributing to this project: J. Kitchell, O. Jensen, E. Ward, D. Beauchamp, B. Chasco, A. Farrell, P. Bisson and J. Kershner. This work was supported by the Gordon and Betty Moore Foundation, the US National Science Foundation and the University of Washington School of Aquatic and Fishery Sciences.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1997, FISH BIOEN 3 0; Armstrong JB, 2010, ECOLOGY, V91, P1445, DOI 10.1890/09-0790.1; Arrington DA, 2002, ECOLOGY, V83, P2145, DOI 10.1890/0012-9658(2002)083[2145:HODFRO]2.0.CO;2; BEAUCHAMP DA, 1989, T AM FISH SOC, V118, P597, DOI 10.1577/1548-8659(1989)118<0597:COABMF>2.3.CO;2; BRECK JE, 1993, T AM FISH SOC, V122, P902, DOI 10.1577/1548-8659(1993)122<0902:FTAPFA>2.3.CO;2; Brodin Anders, 2007, P221; De Angelis D., 1992, INDIVIDUAL BASED MOD, DOI 10.1201/9781351073462; Diamond J, 2002, J PHYSIOL-LONDON, V542, P337, DOI 10.1113/jphysiol.2002.018366; Dupont-Prinet A, 2010, J EXP BIOL, V213, P1143, DOI 10.1242/jeb.037812; ELLIOTT JM, 1978, J ANIM ECOL, V47, P977, DOI 10.2307/3682; Essington TE, 2000, CAN J FISH AQUAT SCI, V57, P548, DOI 10.1139/cjfas-57-3-548; Farrell A. P., 2001, COMP BIOCH PHYSL A, V128, P549, DOI DOI 10.1016/S1095-6433(00)00335-4; GANS C, 1979, EVOLUTION, V33, P227, DOI 10.1111/j.1558-5646.1979.tb04677.x; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Huey RB, 2001, ECOLOGY, V82, P1; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Jeschke JM, 2007, OECOLOGIA, V152, P357, DOI 10.1007/s00442-006-0654-2; Kauffman MJ, 2007, ECOL LETT, V10, P690, DOI 10.1111/j.1461-0248.2007.01059.x; Kersten M, 1996, FUNCT ECOL, V10, P440, DOI 10.2307/2389936; KITCHELL JF, 1977, J FISH RES BOARD CAN, V34, P1922, DOI 10.1139/f77-258; KITCHELL JF, 1994, J FISH BIOL, V45, P209, DOI 10.1006/jfbi.1994.1224; Klaassen M, 1997, PHYSIOL ZOOL, V70, P125, DOI 10.1086/639556; Piersma T., 2011, FLEXIBLE PHENOTYPE; RICE JA, 1984, ECOLOGY, V65, P732, DOI 10.2307/1938045; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Schindler DE, 1997, ECOLOGY, V78, P1816; Scott D. W., 1992, MULTIVARIATE DENSITY, DOI 10.1002/9780470316849; SECOR SM, 1994, AM J PHYSIOL, V266, pG695, DOI 10.1152/ajpgi.1994.266.4.G695; Stevens ED, 2000, J FISH BIOL, V56, P191, DOI 10.1111/j.1095-8649.2000.tb02094.x; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; WEIBEL ER, 1991, P NATL ACAD SCI USA, V88, P10357, DOI 10.1073/pnas.88.22.10357; WEINER J, 1992, TRENDS ECOL EVOL, V7, P384, DOI 10.1016/0169-5347(92)90009-Z; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; [No title captured]	36	112	113	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2011	476	7358					84	+		10.1038/nature10240	http://dx.doi.org/10.1038/nature10240			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21734659				2022-12-28	WOS:000293447300034
J	Rosenthal, MB; Cutler, DM; Feder, J				Rosenthal, Meredith B.; Cutler, David M.; Feder, Judith			The ACO Rules - Striking the Balance between Participation and Transformative Potential	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenthal, Meredith B.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Cutler, David M.] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Feder, Judith] Georgetown Univ, Georgetown Publ Policy Inst, Washington, DC USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Georgetown University	Rosenthal, MB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.			Rosenthal, Meredith/0000-0003-3410-0184; Cutler, David/0000-0002-4949-8917				Berenson RA, 2010, AM J MANAG CARE, V16, P721; FISHER DW, 2011, MEDICARE SHARED SAVI	2	32	32	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4								10.1056/NEJMp1106012	http://dx.doi.org/10.1056/NEJMp1106012			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798AJ	21751898	Green Published, Green Submitted			2022-12-28	WOS:000293172200005
J	Eitel, I; von Knobelsdorff-Brenkenhoff, F; Bernhardt, P; Carbone, I; Muellerleile, K; Aldrovandi, A; Francone, M; Desch, S; Gutberlet, M; Strohm, O; Schuler, G; Schulz-Menger, J; Thiele, H; Friedrich, MG				Eitel, Ingo; von Knobelsdorff-Brenkenhoff, Florian; Bernhardt, Peter; Carbone, Iacopo; Muellerleile, Kai; Aldrovandi, Annachiara; Francone, Marco; Desch, Steffen; Gutberlet, Matthias; Strohm, Oliver; Schuler, Gerhard; Schulz-Menger, Jeanette; Thiele, Holger; Friedrich, Matthias G.			Clinical Characteristics and Cardiovascular Magnetic Resonance Findings in Stress (Takotsubo) Cardiomyopathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							APICAL BALLOONING SYNDROME; TAKO-TSUBO CARDIOMYOPATHY; LEFT-VENTRICULAR DYSFUNCTION; LATE GADOLINIUM ENHANCEMENT; TISSUE CHARACTERIZATION; INFARCT SIZE; INSIGHTS; MYOCARDITIS; PROFILE	Context Stress cardiomyopathy (SC) is a transient form of acute heart failure triggered by stressful events and associated with a distinctive left ventricular (LV) contraction pattern. Various aspects of its clinical profile have been described in small single-center populations, but larger, multicenter data sets have been lacking so far. Furthermore, it remains difficult to quickly establish diagnosis on admission. Objectives To comprehensively define the clinical spectrum and evolution of SC in a large population, including tissue characterization data from cardiovascular magnetic resonance (CMR) imaging; and to establish a set of CMR criteria suitable for diagnostic decision making in patients acutely presenting with suspected SC. Design, Setting, and Patients Prospective study conducted at 7 tertiary care centers in Europe and North America between January 2005 and October 2010 among 256 patients with SC assessed at the time of presentation as well as 1 to 6 months after the acute event. Main Outcome Measures Complete recovery of LV dysfunction. Results Eighty-one percent of patients (n=207) were postmenopausal women, 8% (n=20) were younger women (aged <= 50 years), and 11% (n=29) were men. A stressful trigger could be identified in 182 patients (71%). Cardiovascular magnetic resonance imaging data (available for 239 patients [93%]) revealed 4 distinct patterns of regional ventricular ballooning: apical (n=197 [82%]), biventricular (n=81 [34%]), midventricular (n=40 [17%]), and basal (n=2 [1%]). Left ventricular ejection fraction was reduced (48% [SD, 11%]; 95% confidence interval [CI], 47%-50%) in all patients. Stress cardiomyopathy was accurately identified by CMR using specific criteria: a typical pattern of LV dysfunction, myocardial edema, absence of significant necrosis/fibrosis, and markers for myocardial inflammation. Follow-up CMR imaging showed complete normalization of LV ejection fraction (66% [SD, 7%]; 95% CI, 64%-68%) and inflammatory markers in the absence of significant fibrosis in all patients. Conclusions The clinical profile of SC is considerably broader than reported previously. Cardiovascular magnetic resonance imaging at the time of initial clinical presentation may provide relevant functional and tissue information that might aid in the establishment of the diagnosis of SC.	[Eitel, Ingo; Desch, Steffen; Schuler, Gerhard; Thiele, Holger] Univ Leipzig, Ctr Heart, Dept Internal Med Cardiol, D-04289 Leipzig, Germany; [Gutberlet, Matthias] Univ Leipzig, Ctr Heart, Dept Diagnost & Intervent Radiol, D-04289 Leipzig, Germany; [Eitel, Ingo; Carbone, Iacopo; Strohm, Oliver; Friedrich, Matthias G.] Univ Calgary, Dept Cardiac Sci & Radiol, Stephenson Cardiovasc Magnet Resonance Ctr, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [von Knobelsdorff-Brenkenhoff, Florian; Schulz-Menger, Jeanette] Charite, Working Grp Cardiovasc Magnet Resonance, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [von Knobelsdorff-Brenkenhoff, Florian; Schulz-Menger, Jeanette] HELIOS Klinikum Berlin Buch, Dept Cardiol & Nephrol, Berlin, Germany; [Bernhardt, Peter] Univ Ulm, Dept Internal Med 2, D-7900 Ulm, Germany; [Carbone, Iacopo; Francone, Marco] Univ Rome, Dept Radiol Sci, Rome, Italy; [Muellerleile, Kai] Univ Hamburg Eppendorf, Ctr Cardiol & Cardiovasc Surg, Hamburg, Germany; [Aldrovandi, Annachiara] Univ Parma, Azienda Osped, Div Cardiol, Dept Heart & Lung, I-43100 Parma, Italy	Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Libin Cardiovascular Institute Of Alberta; University of Calgary; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helios Kliniken; Ulm University; Sapienza University Rome; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Parma; University Hospital of Parma	Eitel, I (corresponding author), Univ Leipzig, Ctr Heart, Dept Internal Med Cardiol, Strumpellstr 39, D-04289 Leipzig, Germany.	ingoeitel@gmx.de	Thiele, Holger/ABE-6792-2020; Gutberlet, Matthias/AAL-2699-2021; Francone, Marco/AAQ-5434-2020; Friedrich, Matthias/H-8474-2015; Francone, Marco/U-6761-2017	Thiele, Holger/0000-0002-0169-998X; Friedrich, Matthias/0000-0003-1204-5647; carbone, iacopo/0000-0003-3108-7527; Schulz-Menger, Jeanette/0000-0003-3100-1092; Francone, Marco/0000-0002-7906-3420; Gutberlet, Matthias/0000-0003-4879-0438	German Society of Cardiology	German Society of Cardiology	Dr Eitel is supported by a research grant from the German Society of Cardiology.	Abdel-Aty H, 2009, INT J CARDIOL, V132, P291, DOI 10.1016/j.ijcard.2007.08.102; Abraham J, 2009, J AM COLL CARDIOL, V53, P1320, DOI 10.1016/j.jacc.2009.02.020; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Athanasiadis A, 2006, CLIN RES CARDIOL, V95, P321, DOI 10.1007/s00392-006-0380-0; Bondarenko O, 2005, J CARDIOV MAGN RESON, V7, P481, DOI 10.1081/JCMR-200053623; Eitel I, 2008, EUR HEART J, V29, P2651, DOI 10.1093/eurheartj/ehn433; Eitel I, 2010, EUR RADIOL, V20, P422, DOI 10.1007/s00330-009-1549-5; Eshtehardi P, 2009, INT J CARDIOL, V135, P370, DOI 10.1016/j.ijcard.2008.03.088; Friedrich MG, 2008, JACC-CARDIOVASC IMAG, V1, P652, DOI 10.1016/j.jcmg.2008.07.011; Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007; Haghi D, 2006, EUR HEART J, V27, P2433, DOI 10.1093/eurheartj/ehl274; Haghi D, 2010, CLIN CARDIOL, V33, P307, DOI 10.1002/clc.20747; Heidary S, 2010, J AM COLL CARDIOL, V55, P2762, DOI 10.1016/j.jacc.2010.01.052; Hurst RT, 2006, J AM COLL CARDIOL, V48, P579, DOI 10.1016/j.jacc.2006.06.015; Hurst RT, 2010, JACC-CARDIOVASC IMAG, V3, P641, DOI 10.1016/j.jcmg.2010.01.009; Madhavan M, 2009, HEART, V95, P1436, DOI 10.1136/hrt.2009.170399; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008; Rolf A, 2009, EUR HEART J, V30, P1635, DOI 10.1093/eurheartj/ehp140; Rose JJ, 2010, REV CARDIOVASC MED, V11, P254, DOI 10.3909/ricm0544; Sharkey SW, 2010, J AM COLL CARDIOL, V55, P333, DOI 10.1016/j.jacc.2009.08.057; Singh NK, 2010, INT J CARDIOL, V141, P297, DOI 10.1016/j.ijcard.2008.12.043; Thiele H, 2006, J AM COLL CARDIOL, V47, P1641, DOI 10.1016/j.jacc.2005.11.065; Van de Walle SOA, 2006, MAYO CLIN PROC, V81, P1499, DOI 10.4065/81.11.1499; Watanabe H, 2005, JAMA-J AM MED ASSOC, V294, P305, DOI 10.1001/jama.294.3.305; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; Wu KC, 2008, J AM COLL CARDIOL, V51, P2414, DOI 10.1016/j.jacc.2008.03.018; Yoshida T, 2009, INT J CARDIOL, V134, pE73, DOI 10.1016/j.ijcard.2007.12.092	28	546	560	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2011	306	3					277	286		10.1001/jama.2011.992	http://dx.doi.org/10.1001/jama.2011.992			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794BS	21771988				2022-12-28	WOS:000292870500020
J	Rodriguez, LAG; Cea-Soriano, L; Martin-Merino, E; Johansson, S				Garcia Rodriguez, Luis A.; Cea-Soriano, Luca; Martin-Merino, Elisa; Johansson, Saga			Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SECONDARY PREVENTION; CORONARY; DISEASE; GUIDELINES; WITHDRAWAL; EVENTS	Objectives To evaluate the risk of myocardial infarction and death from coronary heart disease after discontinuation of low dose aspirin in primary care patients with a history of cardiovascular events. Design Nested case-control study. Setting The Health Improvement Network (THIN) database in the United Kingdom. Participants Individuals aged 50-84 with a first prescription for aspirin (75-300 mg/day) for secondary prevention of cardiovascular outcomes in 2000-7 (n=39 513). Main outcome measures Individuals were followed up for a mean of 3.2 years to identify cases of non-fatal myocardial infarction or death from coronary heart disease. A nested case-control analysis assessed the risk of these events in those who had stopped taking low dose aspirin compared with those who had continued treatment. Results There were 876 non-fatal myocardial infarctions and 346 deaths from coronary heart disease. Compared with current users, people who had recently stopped taking aspirin had a significantly increased risk of non-fatal myocardial infarction or death from coronary heart disease combined (rate ratio 1.43, 95% confidence interval 1.12 to 1.84) and non-fatal myocardial infarction alone (1.63, 1.23 to 2.14). There was no significant association between recently stopping low dose aspirin and the risk of death from coronary heart disease (1.07, 0.67 to 1.69). For every 1000 patients, over a period of one year there were about four more cases of non-fatal myocardial infarction among patients who discontinued treatment with low dose aspirin (recent discontinuers) compared with patients who continued treatment. Conclusions Individuals with a history of cardiovascular events who stop taking low dose aspirin are at increased risk of non-fatal myocardial infarction compared with those who continue treatment.	[Garcia Rodriguez, Luis A.; Cea-Soriano, Luca; Martin-Merino, Elisa] Spanish Ctr Pharmacoepidemiol Res CEIFE, Madrid 28004, Spain; [Johansson, Saga] AstraZeneca Res & Dev, Molndal, Sweden; [Johansson, Saga] Gothenburg Univ, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden	AstraZeneca; University of Gothenburg	Rodriguez, LAG (corresponding author), Spanish Ctr Pharmacoepidemiol Res CEIFE, Madrid 28004, Spain.	lagarcia@ceife.es	rodriguez, luis a garcia/B-1980-2010; Soriano, Lucia Cea/D-4380-2018	Soriano, Lucia Cea/0000-0002-7051-0730; Martin Merino, Elisa/0000-0002-3576-8605	AstraZeneca; AstraZeneca Research and Development Molndal	AstraZeneca(AstraZeneca); AstraZeneca Research and Development Molndal(AstraZeneca)	We thank Nesta Hughes and Catherine Hill, of Oxford PharmaGenesis, who provided writing support funded by AstraZeneca.; This study was funded by an unrestricted research grant from AstraZeneca Research and Development Molndal. The sponsors played no part in the design or conduct of the study.	ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bedson J, 2001, BRIT J GEN PRACT, V51, P1001; Biondi-Zoccai GGL, 2006, EUR HEART J, V27, P2667, DOI 10.1093/eurheartj/ehl334; Bjorklund L, 2009, INT J CLIN PRACT, V63, P468, DOI 10.1111/j.1742-1241.2008.01908.x; Campbell NC, 1998, BMJ-BRIT MED J, V316, P1430, DOI 10.1136/bmj.316.7142.1430; Collet JP, 2004, CIRCULATION, V110, P2361, DOI 10.1161/01.CIR.0000145171.89690.B4; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Ferrari E, 2005, J AM COLL CARDIOL, V45, P456, DOI 10.1016/j.jacc.2004.11.041; First Data Bank, 2010, MULTILEX PRIM CAR; Rodriguez LAG, 2009, CIRCULATION, V120, pS480; Rodriguez LAG, 2008, J AM COLL CARDIOL, V52, P1628, DOI 10.1016/j.jacc.2008.08.041; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Hoper S, 1998, FAM PRACT, V15, pS10; KROL WF, 1980, CIRCULATION, V62, P449; Lanas A, 2007, CURR MED RES OPIN, V23, P162, DOI 10.1185/030079907X162656; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Maulaz AB, 2005, ARCH NEUROL-CHICAGO, V62, P1217, DOI 10.1001/archneur.62.8.1217; Newby K, 2001, CIRCULATION, V103, P1727; Ng W, 2006, WORLD J GASTROENTERO, V12, P2923, DOI 10.3748/wjg.v12.i18.2923; PEARCE N, 1993, INT J EPIDEMIOL, V22, P1189, DOI 10.1093/ije/22.6.1189; Rodriguez LAG, 2004, CIRCULATION, V109, P3000, DOI 10.1161/01.CIR.0000132491.96623.04; Rothman K., 1998, MODERN EPIDEMIOLOGY; SLATTERY J, 1995, GUT, V37, P509, DOI 10.1136/gut.37.4.509; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; Stuart-Buttle C D, 1996, Proc AMIA Annu Fall Symp, P75; Sud A, 2005, ANN PHARMACOTHER, V39, P1792, DOI 10.1345/aph.1G249	27	92	95	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2011	343								d4094	10.1136/bmj.d4094	http://dx.doi.org/10.1136/bmj.d4094			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797ZG	21771831	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000293168500007
J	Lang, E				Lang, Eddy			Early treatment with tranexamic acid reduced bleeding death in patients with clinically important hemorrhage due to trauma	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calgary, Alberta Hlth Serv, Calgary, AB, Canada	Alberta Health Services (AHS); University of Calgary	Lang, E (corresponding author), Univ Calgary, Alberta Hlth Serv, Calgary, AB, Canada.		Lang, Eddy/AAS-2080-2020						0	1	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2							JC1-04	10.7326/0003-4819-155-2-201107190-02004	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	793KW	21768570				2022-12-28	WOS:000292822000003
J	Schrijvers, R; Desimmie, BA; Debyser, Z				Schrijvers, Rik; Desimmie, Belete Ayele; Debyser, Zeger			Rilpivirine: a step forward in tailored HIV treatment	LANCET			English	Editorial Material							EXPERIENCED HIV-1-INFECTED PATIENTS; PLACEBO-CONTROLLED TRIAL; REVERSE-TRANSCRIPTASE; TMC125 ETRAVIRINE; DOUBLE-BLIND; EFFICACY; SAFETY; EFAVIRENZ; THERAPY		[Schrijvers, Rik; Desimmie, Belete Ayele; Debyser, Zeger] Katholieke Univ Leuven, B-3000 Louvain, Belgium	KU Leuven	Debyser, Z (corresponding author), Katholieke Univ Leuven, B-3000 Louvain, Belgium.	zeger.debyser@med.kuleuven.be	debyser, zeger/H-1310-2013	debyser, zeger/0000-0002-3982-1565; Desimmie, Belete/0000-0002-1157-4224				Bacheler L, 2001, J VIROL, V75, P4999, DOI 10.1128/JVI.75.11.4999-5008.2001; Cohen C, 2010, 18 INT AIDS C VIENN; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; DEBYSER Z, 1991, P NATL ACAD SCI USA, V88, P1451, DOI 10.1073/pnas.88.4.1451; *DHHS PAN ANT GUID, 2011, GUID US ANT AG HIV I; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Lazzarin A, 2007, LANCET, V370, P39, DOI 10.1016/S0140-6736(07)61048-4; Madruga JV, 2007, LANCET, V370, P29, DOI 10.1016/S0140-6736(07)61047-2; Maggiolo F, 2009, J ANTIMICROB CHEMOTH, V64, P910, DOI 10.1093/jac/dkp334; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; Pozniak AL, 2010, AIDS, V24, P55, DOI 10.1097/QAD.0b013e32833032ed; RIMSKY L, 2010, 50 INT C ANT AG CHEM, pH1810; Rimsky L, 2011, 20 INT WORKSH HIV HE; U. S. Food and Drug Administration, 2011, APPR ED RILP NEW NNR; US Department of Health and Human Services Food and Drug Administration. Center for Drug Evaluation and Research (CDER), 2002, GUID IND ANT DRUGS U	16	17	18	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 16	2011	378	9787					201	203		10.1016/S0140-6736(11)60992-6	http://dx.doi.org/10.1016/S0140-6736(11)60992-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798JD	21763920				2022-12-28	WOS:000293201100004
J	Alwan, NA				Alwan, Nisreen A.			PERSONAL VIEW The killing of doctors in Iraq must stop	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Leeds, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Alwan, NA (corresponding author), Univ Leeds, Leeds LS2 9JT, W Yorkshire, England.	n.alwan@leeds.ac.uk	Alwan, Nisreen A./AFP-0662-2022	Alwan, Nisreen A./0000-0002-4134-8463					0	4	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 13	2011	343								d4467	10.1136/bmj.d4467	http://dx.doi.org/10.1136/bmj.d4467			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	794OE	21752860				2022-12-28	WOS:000292908900020
J	Roncato, C; Lefant, PY				Roncato, Christophe; Lefant, Pierre Yves			Thrombosis of the Inferior Vena Cava and Dilated Veins of the Trunk	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Roncato, Christophe; Lefant, Pierre Yves] Ctr Hosp St Louis La Rochelle, St Louis, France		Roncato, C (corresponding author), Ctr Hosp St Louis La Rochelle, St Louis, France.	christophe.roncato@ch-larochelle.fr		Roncato, Christophe/0000-0002-5627-2908					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2011	364	26					2535	2535		10.1056/NEJMicm1010652	http://dx.doi.org/10.1056/NEJMicm1010652			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	785AM	21714650				2022-12-28	WOS:000292199800009
J	Sherry, N; Hagopian, W; Ludvigsson, J; Jain, SM; Wahlen, J; Ferry, RJ; Bode, B; Aronoff, S; Holland, C; Carlin, D; King, KL; Wilder, RL; Pillemer, S; Bonvini, E; Johnson, S; Stein, KE; Koenig, S; Herold, KC; Daifotis, AG				Sherry, Nicole; Hagopian, William; Ludvigsson, Johnny; Jain, Sunil M.; Wahlen, Jack; Ferry, Robert J., Jr.; Bode, Bruce; Aronoff, Stephen; Holland, Christopher; Carlin, David; King, Karen L.; Wilder, Ronald L.; Pillemer, Stanley; Bonvini, Ezio; Johnson, Syd; Stein, Kathryn E.; Koenig, Scott; Herold, Kevan C.; Daifotis, Anastasia G.		Protege Trial Investigators	Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial	LANCET			English	Article							MONOCLONAL-ANTIBODY; INSULIN-SECRETION; IMMUNE THERAPY	Background Findings of small studies have suggested that short treatments with anti-CD3 monoclonal antibodies that are mutated to reduce Fc receptor binding preserve beta-cell function and decrease insulin needs in patients with recent-onset type 1 diabetes. In this phase 3 trial, we assessed the safety and efficacy of one such antibody, teplizumab. Methods In this 2-year trial, patients aged 8-35 years who had been diagnosed with type 1 diabetes for 12 weeks or fewer were enrolled and treated at 83 clinical centres in North America, Europe, Israel, and India. Participants were allocated (2:1:1:1 ratio) by an interactive telephone system, according to computer-generated block randomisation, to receive one of three regimens of teplizumab infusions (14-day full dose, 14-day low dose, or 6-day full dose) or placebo at baseline and at 26 weeks. The Protege study is still underway, and patients and study staff remain masked through to study closure. The primary composite outcome was the percentage of patients with insulin use of less than 0.5 U/kg per day and glycated haemoglobin A(1c) (HbA(1c)) of less than 6-5% at 1 year. Analyses included all patients who received at least one dose of study drug. This trial is registered with ClinicalTrials.gov, number NCT00385697. Findings 763 patients were screened, of whom 516 were randomised to receive 14-day full-dose teplizumab (n=209), 14-day low-dose teplizumab (n=102), 6-day full-dose teplizumab (n=106), or placebo (n=99). Two patients in the 14-day full-dose group and one patient in the placebo group did not start treatment, so 513 patients were eligible for efficacy analyses. The primary outcome did not differ between groups at 1 year: 19.8% (41/207) in the 14-day full-dose group; 13.7% (14/102) in the 14-day low-dose group; 20.8% (22/106) in the 6-day full-dose group; and 20.4% (20/98) in the placebo group. 5% (19/415) of patients in the teplizumab groups were not taking insulin at 1 year, compared with no patients in the placebo group at 1 year (p=0.03). Across the four study groups, similar proportions of patients had adverse events (414/417 [99%] in the teplizumab groups vs 98/99 [99%] in the placebo group) and serious adverse events (42/417 [10%] vs 9/99 [9%]). The most common clinical adverse event in the teplizumab groups was rash (220/417 [53%] vs 20/99 [20%] in the placebo group). Interpretation Findings of exploratory analyses suggest that future studies of immunotherapeutic intervention with teplizumab might have increased success in prevention of a decline in beta-cell function (measured by C-peptide) and provision of glycaemic control at reduced doses of insulin if they target patients early after diagnosis of diabetes and children.	[Sherry, Nicole] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Hagopian, William] NW Diabet Res Inst, Seattle, WA USA; [Ludvigsson, Johnny] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Pediat, Linkoping, Sweden; [Jain, Sunil M.] TOTALL Diabet Hormone Res Inst, Indore, Madhya Pradesh, India; [Wahlen, Jack] Endocrine Res Specialists, Ogden, UT USA; [Ferry, Robert J., Jr.] Le Bonheur Childrens Hosp, Div Pediat Endocrinol & Metab, Memphis, TN USA; [Ferry, Robert J., Jr.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Bode, Bruce] Atlanta Diabet Associates, Atlanta, GA USA; [Aronoff, Stephen] Res Inst Dallas, Dallas, TX USA; [Holland, Christopher; Carlin, David; King, Karen L.; Bonvini, Ezio; Johnson, Syd; Stein, Kathryn E.; Koenig, Scott; Daifotis, Anastasia G.] MacroGenics, Rockville, MD USA; [Wilder, Ronald L.] PAREXEL Int, Durham, NC USA; [Pillemer, Stanley] Amer Biopharma Corp, Gaithersburg, MD USA; [Herold, Kevan C.] Yale Univ, New Haven, CT USA	Harvard University; Massachusetts General Hospital; Linkoping University; University of Tennessee System; University of Tennessee Health Science Center; Parexel International; Yale University	Sherry, N (corresponding author), Massachusetts Gen Hosp Children, 175 Cambridge St,Room 537, Boston, MA 02114 USA.	nsherry@partners.org	Sahay, Rakesh Kumar/I-1336-2013; Vlasenko, Maryna V/I-2730-2018; Szalecki, Mieczyslaw/AAI-3112-2021; Ness, Kirsten K/N-2550-2018; Hanukoglu, Aaron/L-4892-2016; Ferry, Robert/ABC-5196-2021; Ludvigsson, Johnny/AAI-2051-2020; Ferry, Robert/O-6107-2016	Sahay, Rakesh Kumar/0000-0002-5471-0695; Szalecki, Mieczyslaw/0000-0002-2950-761X; Ness, Kirsten K/0000-0002-2084-1507; Hanukoglu, Aaron/0000-0003-1486-6641; Ferry, Robert/0000-0001-9228-3914; Ludvigsson, Johnny/0000-0003-1695-5234; Vlasenko, Maryna/0000-0003-3285-5727; Hancu, Nicolae/0000-0002-4688-5110; Sumnik, Zdenek/0000-0002-6462-6462	MacroGenics; Juvenile Diabetes Research Foundation; Eli Lilly; US National Institutes of Health [R21 HD059292, T35 DK007405]; Le Bonheur Foundation (Memphis TN, USA); Juvenile Diabetes Foundation [2008-502]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD059292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK007405] Funding Source: NIH RePORTER	MacroGenics; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Eli Lilly(Eli Lilly); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Le Bonheur Foundation (Memphis TN, USA); Juvenile Diabetes Foundation(Juvenile Diabetes Research Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding MacroGenics, the Juvenile Diabetes Research Foundation, and Eli Lilly.; CH, DC, KLK, EB, SJ, KES, SK, and AGD are employees of MacroGenics and potentially own shares or options in the company. NS, JL, SA, BB, JW, and RJF received research and travel support for this study from MacroGenics. JL has received advisory board support from Johnson & Johnson. RJF has received research support within the past 3 years from Tolerx (to study otelixizumab for recent-onset type 1 diabetes); unrelated research support from the US National Institutes of Health (grants R21 HD059292 and T35 DK007405), Gabrielle's Angel Foundation, Eli Lilly, Diamyd, Pfizer, and Novo Nordisk; and unrestricted research support from Le Bonheur Foundation (Memphis TN, USA). WH chairs the data safety and monitoring board for the BHT-3021-01 insulin plasmid trial (Bayhill Pharmaceuticals). KCH has received research support from MacroGenics, and support from the Juvenile Diabetes Foundation (grant 2008-502) for laboratory studies on patients' samples from Prot g. RLW is a former employee of MacroGenics and holds restricted stock in the company, and is now an employee of Parexel International, the lead contract research organisation that coordinated the Prot g trial globally. SA has received speaking honoraria from Eli Lilly. SP was formerly employed by MacroGenics and received stock options while employed there. SMJ declares that he has no conflicts of interest.	Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; BOLT S, 1993, EUR J IMMUNOL, V23, P403, DOI 10.1002/eji.1830230216; Chatenoud L, 2010, NAT REV ENDOCRINOL, V6, P149, DOI 10.1038/nrendo.2009.275; EvaluatePharma, IDFS 20 WORLD DIAB C; Gandhi GY, 2008, CLIN ENDOCRINOL, V69, P244, DOI 10.1111/j.1365-2265.2008.03179.x; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; HOLM S, 1979, SCAND J STAT, V6, P65; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Keymeulen B, 2010, DIABETOLOGIA, V53, P614, DOI 10.1007/s00125-009-1644-9; Keymeulen B, 2010, BLOOD, V115, P1145, DOI 10.1182/blood-2009-02-204875; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; Luo XR, 2010, IMMUNITY, V32, P488, DOI 10.1016/j.immuni.2010.04.002; PR Newswire, TOL GLAXOSMITHKLINE; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sherry NA, 2006, DIABETES, V55, P3238, DOI 10.2337/db05-1034; Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Steele C, 2004, DIABETES, V53, P426, DOI 10.2337/diabetes.53.2.426; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Xu DL, 2000, CELL IMMUNOL, V200, P16, DOI 10.1006/cimm.2000.1617	20	315	324	3	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2011	378	9790					487	497		10.1016/S0140-6736(11)60931-8	http://dx.doi.org/10.1016/S0140-6736(11)60931-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	809SO	21719095	Green Accepted			2022-12-28	WOS:000294077200028
J	Karim, SSA; Kashuba, ADM; Werner, L; Karim, QA				Karim, Salim S. Abdool; Kashuba, Angela D. M.; Werner, Lise; Karim, Quarraisha Abdool			Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women	LANCET			English	Editorial Material									[Karim, Salim S. Abdool; Werner, Lise; Karim, Quarraisha Abdool] Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, ZA-4013 Durban, Kwazulu Natal, South Africa; [Karim, Salim S. Abdool; Karim, Quarraisha Abdool] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Kashuba, Angela D. M.] Univ N Carolina, Div Pharmacotherapy & Expt Therapeut, Eshelman Sch Pharm, Chapel Hill, NC USA	University of Kwazulu Natal; Columbia University; University of North Carolina; University of North Carolina Chapel Hill	Karim, SSA (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, ZA-4013 Durban, Kwazulu Natal, South Africa.	karims1@ukzn.ac.za	Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Abdool/P-3117-2019; Abdool Karim, Quarraisha/GVS-1160-2022; Karim, Salim Safurdeen Abdool/N-5947-2013	Karim, Salim Abdool/0000-0002-4986-2133; Abdool Karim, Quarraisha/0000-0002-0985-477X; Karim, Salim Safurdeen Abdool/0000-0002-4986-2133	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, U01AI095031] Funding Source: NIH RePORTER; NIAID NIH HHS [U01 AI095031, P30 AI050410] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2011, FHI STAT FEM PREP HI; [Anonymous], 18 C RETR OPP INF BO; Dumond JB, 2007, AIDS, V21, P1899, DOI 10.1097/QAD.0b013e328270385a; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; HENDRIX C, 2011, 18 C OPP INF RETR BO; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2010, INDIAN J MED RES, V132, P656; Kashuba AD, 2010, 18 INT AIDS C VIENN; Patterson K. P. H., 2010, 18 INT AIDS C VIENN, P18; SCHWARTZ J, 2009, 5 IAS C HIV PATH TRE; UNAIDS, 2010, UNAIDS REP GLOB AIDS	11	179	179	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2011	378	9787					279	281		10.1016/S0140-6736(11)60878-7	http://dx.doi.org/10.1016/S0140-6736(11)60878-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798JD	21763939	Green Accepted, Green Submitted			2022-12-28	WOS:000293201100035
J	Alilain, WJ; Horn, KP; Hu, HM; Dick, TE; Silver, J				Alilain, Warren J.; Horn, Kevin P.; Hu, Hongmei; Dick, Thomas E.; Silver, Jerry			Functional regeneration of respiratory pathways after spinal cord injury	NATURE			English	Article							CROSSED PHRENIC PHENOMENON; INTERMITTENT HYPOXIA; AXONAL REGENERATION; PLASTICITY; RECOVERY; ABNORMALITIES; MOTONEURONS; AGONISTS; BRIDGES; GRAFTS	Spinal cord injuries often occur at the cervical level above the phrenic motor pools, which innervate the diaphragm. The effects of impaired breathing are a leading cause of death from spinal cord injuries, underscoring the importance of developing strategies to restore respiratory activity. Here we show that, after cervical spinal cord injury, the expression of chondroitin sulphate proteoglycans (CSPGs) associated with the perineuronal net (PNN) is upregulated around the phrenic motor neurons. Digestion of these potently inhibitory extracellular matrix molecules with chondroitinase ABC (denoted ChABC) could, by itself, promote the plasticity of tracts that were spared and restore limited activity to the paralysed diaphragm. However, when combined with a peripheral nerve autograft, ChABC treatment resulted in lengthy regeneration of serotonin-containing axons and other bulbospinal fibres and remarkable recovery of diaphragmatic function. After recovery and initial transection of the graft bridge, there was an unusual, overall increase in tonic electromyographic activity of the diaphragm, suggesting that considerable remodelling of the spinal cord circuitry occurs after regeneration. This increase was followed by complete elimination of the restored activity, proving that regeneration is crucial for the return of function. Overall, these experiments present a way to markedly restore the function of a single muscle after debilitating trauma to the central nervous system, through both promoting the plasticity of spared tracts and regenerating essential pathways.	[Alilain, Warren J.; Horn, Kevin P.; Hu, Hongmei; Dick, Thomas E.; Silver, Jerry] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Dick, Thomas E.] Case Western Reserve Univ, Sch Med, Div Pulm Crit Care & Sleep Med, Dept Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Silver, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, 2109 Adelbert Rd, Cleveland, OH 44106 USA.	wja4@case.edu; jxs10@case.edu			Christopher and Dana Reeve Foundation; International Spinal Research Trust; National Institute of Neurological Disorders and Stroke [NS25713, NS060767]; National Heart, Lung and Blood Institute [HL080318]; Brumagin Memorial Fund; Ellen Becker Neuroscience Regenerative Medicine Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS025713, R01NS025713, R01NS060767] Funding Source: NIH RePORTER; International Spinal Research Trust [STR106] Funding Source: researchfish	Christopher and Dana Reeve Foundation; International Spinal Research Trust; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Brumagin Memorial Fund; Ellen Becker Neuroscience Regenerative Medicine Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); International Spinal Research Trust	This project was funded by The Christopher and Dana Reeve Foundation (W.J.A.), the International Spinal Research Trust (W.J.A.), the National Institute of Neurological Disorders and Stroke, grants NS25713 and NS060767 (J.S.), and the National Heart, Lung and Blood Institute, grant HL080318 (T. E. D.). We offer special thanks to the Brumagin Memorial Fund (J.S.) and the Ellen Becker Neuroscience Regenerative Medicine Research Fund (J.S.). We also thank J. D. Houle and V. J. Tom for teaching us the peripheral nerve grafting technique.	Alilain WJ, 2008, J NEUROSCI, V28, P11862, DOI 10.1523/JNEUROSCI.3378-08.2008; Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Choi H, 2005, J NEUROSCI, V25, P4550, DOI 10.1523/JNEUROSCI.5135-04.2005; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Fuller DD, 2005, J NEUROTRAUM, V22, P203, DOI 10.1089/neu.2005.22.203; Fuller DD, 2003, J NEUROSCI, V23, P2993; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; GAUTHIER P, 1988, BRAIN RES, V438, P225, DOI 10.1016/0006-8993(88)91341-8; Gauthier P, 2002, J NEUROSCI RES, V70, P65, DOI 10.1002/jnr.10379; Golder FJ, 2005, J NEUROSCI, V25, P2925, DOI 10.1523/JNEUROSCI.0148-05.2005; Goshgarian HG, 2003, J APPL PHYSIOL, V94, P795, DOI 10.1152/japplphysiol.00847.2002; Hadley SD, 1999, EXP NEUROL, V160, P479, DOI 10.1006/exnr.1999.7240; Hayashi F, 2003, J APPL PHYSIOL, V94, P1421, DOI 10.1152/japplphysiol.00599.2002; Hodges MR, 2008, J NEUROSCI, V28, P2495, DOI 10.1523/JNEUROSCI.4729-07.2008; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Houle John D, 2009, J Vis Exp, DOI 10.3791/1324; Hunanyan AS, 2010, J NEUROSCI, V30, P7761, DOI 10.1523/JNEUROSCI.4659-09.2010; Lane MA, 2008, J COMP NEUROL, V511, P692, DOI 10.1002/cne.21864; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; McPhail LT, 2005, EUR J NEUROSCI, V21, P267, DOI 10.1111/j.1460-9568.2004.03837.x; MUNZ M, 1985, BRAIN RES, V340, P115, DOI 10.1016/0006-8993(85)90780-2; Nantwi KD, 1996, EXP NEUROL, V140, P53, DOI 10.1006/exnr.1996.0114; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Teng YD, 2003, J NEUROSCI, V23, P4182; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Yang LJS, 2006, P NATL ACAD SCI USA, V103, P11057, DOI 10.1073/pnas.0604613103; Zhou LJ, 2003, J NEUROSCI, V23, P1424, DOI 10.1523/JNEUROSCI.23-04-01424.2003	33	285	292	2	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					196	U95		10.1038/nature10199	http://dx.doi.org/10.1038/nature10199			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753849	Green Accepted			2022-12-28	WOS:000292690500043
J	Deweerdt, S				DeWeerdt, Sarah			PREVENTION Activity is the best medicine	NATURE			English	Editorial Material							COGNITIVE DECLINE; ALZHEIMER-DISEASE; PHYSICAL-ACTIVITY; OLDER-ADULTS; RISK; DEMENTIA; DIET											Barnes LL, 2004, NEUROLOGY, V63, P2322, DOI 10.1212/01.WNL.0000147473.04043.B3; Belleville S, 2011, BRAIN, V134, P1623, DOI 10.1093/brain/awr037; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Feart C, 2009, JAMA-J AM MED ASSOC, V302, P638, DOI 10.1001/jama.2009.1146; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Savica R, 2011, PSYCHIAT CLIN N AM, V34, P127, DOI 10.1016/j.psc.2010.11.006; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; Tangney CC, 2011, AM J CLIN NUTR, V93, P601, DOI 10.3945/ajcn.110.007369; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805	9	32	33	3	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					S16	S17		10.1038/475S16a	http://dx.doi.org/10.1038/475S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791UA	21760577	Bronze			2022-12-28	WOS:000292690500008
J	Gray, RA; Wikswo, JP				Gray, Richard A.; Wikswo, John P.			CARDIOVASCULAR DISEASE Several small shocks beat one big one	NATURE			English	Editorial Material							ATRIAL-FIBRILLATION; FIELD STIMULATION; VIRTUAL ELECTRODES; CARDIAC TISSUE; DEFIBRILLATION; MECHANISM; FEEDBACK; HEART; TIME		[Gray, Richard A.] US FDA, Off Sci & Engn Labs, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA; [Wikswo, John P.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Wikswo, John P.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA; [Wikswo, John P.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA	US Food & Drug Administration (FDA); Vanderbilt University; Vanderbilt University; Vanderbilt University	Gray, RA (corresponding author), US FDA, Off Sci & Engn Labs, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA.	richard.gray@fda.hhs.gov; john.wikswo@vanderbilt.edu	Gray, Richard/F-3916-2015	Gray, Richard/0000-0003-2798-6378				ALLESSIE M, 1991, CIRCULATION, V84, P1689, DOI 10.1161/01.CIR.84.4.1689; Bishop MJ, 2010, IEEE T BIO-MED ENG, V57, P2335, DOI 10.1109/TBME.2010.2051227; CARTEE LA, 1992, IEEE T BIO-MED ENG, V39, P76, DOI 10.1109/10.108130; DAVIDENKO JM, 1995, CIRC RES, V77, P1166, DOI 10.1161/01.RES.77.6.1166; Ditto WL, 2000, INT J BIFURCAT CHAOS, V10, P593, DOI 10.1142/S0218127400000402; Dosdall DJ, 2007, HEART RHYTHM, V4, pS51, DOI 10.1016/j.hrthm.2006.12.030; Fishler MG, 1998, J CARDIOVASC ELECTR, V9, P384, DOI 10.1111/j.1540-8167.1998.tb00926.x; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; Hosfeld VD, 2007, J BIOL PHYS, V33, P145, DOI 10.1007/s10867-007-9049-9; IDEKER RE, 1995, PACE, V18, P512, DOI 10.1111/j.1540-8159.1995.tb02562.x; Kok LC, 2004, CARDIOL CLIN, V22, P71, DOI 10.1016/S0733-8651(03)00113-9; Luther S, 2011, NATURE, V475, P235, DOI 10.1038/nature10216; Maleckar MM, 2008, AM J PHYSIOL-HEART C, V295, pH1626, DOI 10.1152/ajpheart.00706.2008; Pak HN, 2003, AM J PHYSIOL-HEART C, V285, pH2704, DOI 10.1152/ajpheart.00366.2003; Pumir A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.208101; Sobie EA, 1997, BIOPHYS J, V73, P1410, DOI 10.1016/S0006-3495(97)78173-6; TRAYANOVA NA, 1993, IEEE T BIO-MED ENG, V40, P899, DOI 10.1109/10.245611; Wikswo JP, 1995, BIOPHYS J, V69, P2195, DOI 10.1016/S0006-3495(95)80115-3	18	13	14	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					181	182		10.1038/475181a	http://dx.doi.org/10.1038/475181a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753846				2022-12-28	WOS:000292690500039
J	Jones, DA; DeVita, MA; Bellomo, R				Jones, Daryl A.; DeVita, Michael A.; Bellomo, Rinaldo			CURRENT CONCEPTS Rapid-Response Teams	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MEDICAL-EMERGENCY-TEAM; CARDIAC ARRESTS; ADVERSE EVENTS; CONSENSUS CONFERENCE; INTENSIVE-CARE; CODE RATES; MORTALITY; QUALITY; SYSTEM; NURSES		[Bellomo, Rinaldo] Austin Hosp, Intens Care Unit, Dept Intens Care, Melbourne, Vic 3084, Australia; [Jones, Daryl A.] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [DeVita, Michael A.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [DeVita, Michael A.] Univ Pittsburgh, Sch Med, Dept Internal Med, Pittsburgh, PA USA	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bellomo, R (corresponding author), Austin Hosp, Intens Care Unit, Dept Intens Care, Studley Rd, Melbourne, Vic 3084, Australia.	rinaldo.bellomo@austin.org.au		Bellomo, Rinaldo/0000-0002-1650-8939				Bagshaw SM, 2010, AM J CRIT CARE, V19, P74, DOI 10.4037/ajcc2009532; Bell MB, 2006, RESUSCITATION, V70, P66, DOI 10.1016/j.resuscitation.2005.11.011; Bellomo R, 2003, MED J AUSTRALIA, V179, P283, DOI 10.5694/j.1326-5377.2003.tb05548.x; Braithwaite RS, 2004, QUAL SAF HEALTH CARE, V13, P255, DOI 10.1136/qshc.2003.009324; BRENNAN TA, 1990, ANN INTERN MED, V112, P221, DOI 10.7326/0003-4819-112-3-221; Buist M, 2004, Crit Care Resusc, V6, P88; Buist MD, 1999, MED J AUSTRALIA, V171, P22, DOI 10.5694/j.1326-5377.1999.tb123492.x; Buist M, 2007, BMJ-BRIT MED J, V335, P1210, DOI 10.1136/bmj.39385.534236.47; Chan PS, 2008, JAMA-J AM MED ASSOC, V300, P2506, DOI 10.1001/jama.2008.715; Chan PS, 2010, ARCH INTERN MED, V170, P18, DOI 10.1001/archinternmed.2009.424; Chen J, 2009, CRIT CARE MED, V37, P148, DOI 10.1097/CCM.0b013e3181928ce3; Cretikos M, 2007, RESUSCITATION, V73, P62, DOI 10.1016/j.resuscitation.2006.08.020; Cretikos MA, 2008, MED J AUSTRALIA, V188, P657; Davis P., 2002, NEW ZEAL MED J, V115, P271; DeVita M, 2005, CRIT CARE, V9, P325, DOI 10.1186/cc3721; DeVita MA, 2005, QUAL SAF HEALTH CARE, V14, P326, DOI 10.1136/qshc.2004.011148; DeVita MA, 2006, MED EMERGENCY TEAMS, P91; DeVita MA, 2006, CRIT CARE MED, V34, P2463, DOI 10.1097/01.CCM.0000235743.38172.6E; DeVita MA, 2010, RESUSCITATION, V81, P375, DOI 10.1016/j.resuscitation.2009.12.008; Downey AW, 2008, CRIT CARE MED, V36, P477, DOI 10.1097/01.CCM.0000300277.41113.46; England K, 2008, CRIT CARE, V12, DOI 10.1186/cc6902; Foraida MI, 2003, J CRIT CARE, V18, P87, DOI 10.1053/jcrc.2003.50002; FRANKLIN C, 1994, CRIT CARE MED, V22, P244, DOI 10.1097/00003246-199402000-00014; Fresco C, 1999, AM HEART J, V138, P1058, DOI 10.1016/S0002-8703(99)70070-0; Gao HY, 2007, INTENS CARE MED, V33, P667, DOI 10.1007/s00134-007-0532-3; Harrison GA, 2005, RESUSCITATION, V65, P149, DOI 10.1016/j.resuscitation.2004.11.017; Hillman K, 2005, LANCET, V365, P2091; Hodgetts TJ, 2002, RESUSCITATION, V54, P115, DOI 10.1016/S0300-9572(02)00098-9; Jacques T, 2008, ANAESTH INTENS CARE, V36, P90, DOI 10.1177/0310057X0803600116; *JOINT COMM, 2009 NAT PAT SAF GOA; Jones D, 2006, QUAL SAF HEALTH CARE, V15, P427, DOI 10.1136/qshc.2005.016956; Jones D, 2005, CRIT CARE, V9, pR808, DOI 10.1186/cc3906; Jones D, 2007, RESUSCITATION, V74, P235, DOI 10.1016/j.resuscitation.2006.12.007; Jones D, 2006, CRIT CARE, V10, DOI 10.1186/cc4821; Jones D, 2009, CRIT CARE, V13, DOI 10.1186/cc7996; Jones Daryl A, 2007, Crit Care Resusc, V9, P151; Konrad D, 2010, INTENS CARE MED, V36, P100, DOI 10.1007/s00134-009-1634-x; Leuvan Chris H Van, 2008, Crit Care Resusc, V10, P111; Litvak E, 2010, JAMA-J AM MED ASSOC, V304, P1375, DOI 10.1001/jama.2010.1385; McGaughey J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005529; McQuillan P, 1998, BRIT MED J, V317, P631; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; SCHIMMEL EM, 1964, ANN INTERN MED, V60, P100, DOI 10.7326/0003-4819-60-1-100; Sebat F, 2007, CRIT CARE MED, V35, P2568, DOI 10.1097/01.CCM.0000287593.54658.89; Sharek PJ, 2007, JAMA-J AM MED ASSOC, V298, P2267, DOI 10.1001/jama.298.19.2267; Steel AC, 2008, JT COMM J QUAL PATIE, V34, P489, DOI 10.1016/S1553-7250(08)34062-8; Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003; Wilson RM, 1999, MED J AUSTRALIA, V170, P411, DOI 10.5694/j.1326-5377.1999.tb127814.x; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x; Winters BD, 2006, JAMA-J AM MED ASSOC, V296, P1645, DOI 10.1001/jama.296.13.1645	50	470	494	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2					139	146		10.1056/NEJMra0910926	http://dx.doi.org/10.1056/NEJMra0910926			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SP	21751906				2022-12-28	WOS:000292685500010
J	Tripodi, A; Mannucci, PM				Tripodi, Armando; Mannucci, Pier Mannuccio			MECHANISMS OF DISEASE The Coagulopathy of Chronic Liver Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RECOMBINANT FACTOR VIIA; PORTAL-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; COAGULATION DISORDERS; ACTIVATABLE FIBRINOLYSIS; HEPATIC FIBROGENESIS; CIRRHOTIC-PATIENTS; RISK-FACTORS; TRANSPLANTATION; GENERATION		[Tripodi, Armando; Mannucci, Pier Mannuccio] Univ Milan, Dept Internal Med, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ct, I-20122 Milan, Italy; [Mannucci, Pier Mannuccio] Ca Granda Maggiore Hosp Fdn, Sci Direct, IRCCS, Milan, Italy	University of Milan	Tripodi, A (corresponding author), Univ Milan, Dept Internal Med, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ct, Via Pace 9, I-20122 Milan, Italy.	armando.tripodi@unimi.it						Abe W, 2007, J HEPATOL, V46, P286, DOI 10.1016/j.jhep.2006.08.023; Aldawood A, 2011, THROMB J, V9, DOI 10.1186/1477-9560-9-1; Amitrano L, 2000, HEPATOLOGY, V31, P345, DOI 10.1002/hep.510310213; Anstee QM, 2008, J THROMB HAEMOST, V6, P1336, DOI 10.1111/j.1538-7836.2008.03015.x; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Bekker J, 2009, AM J TRANSPLANT, V9, P746, DOI 10.1111/j.1600-6143.2008.02541.x; BOKS AL, 1986, HEPATOLOGY, V6, P79, DOI 10.1002/hep.1840060115; Bosch J, 2004, GASTROENTEROLOGY, V127, P1123, DOI 10.1053/j.gastro.2004.07.015; Bosch J, 2008, HEPATOLOGY, V47, P1604, DOI 10.1002/hep.22216; Caldwell SH, 2006, HEPATOLOGY, V44, P1039, DOI 10.1002/hep.21303; Colucci M, 2003, HEPATOLOGY, V38, P230, DOI 10.1053/jhep.2003.50277; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Dabbagh O, 2010, CHEST, V137, P1145, DOI 10.1378/chest.09-2177; Dahlback B, 2004, INT J HEMATOL, V79, P109, DOI 10.1532/IJH97.03149; de Boer MT, 2005, DIGEST SURG, V22, P265, DOI 10.1159/000088056; de Franchis R, 2010, J HEPATOL, V53, P762, DOI 10.1016/j.jhep.2010.06.004; Delahousse B, 2010, THROMB HAEMOSTASIS, V104, P741, DOI 10.1160/TH10-01-0040; Diaz LK, 2001, NEW ENGL J MED, V344, P2030; EWE K, 1981, DIGEST DIS SCI, V26, P388, DOI 10.1007/BF01313579; Feys HB, 2007, BRIT J HAEMATOL, V138, P534, DOI 10.1111/j.1365-2141.2007.06688.x; Fiorucci S, 2004, HEPATOLOGY, V39, P365, DOI 10.1002/hep.20054; Franchini M, 2009, EUR J INTERN MED, V20, P562, DOI 10.1016/j.ejim.2009.05.004; Francoz C, 2005, GUT, V54, P691, DOI 10.1136/gut.2004.042796; Garcia-Tsao G, 2010, NEW ENGL J MED, V362, P823, DOI 10.1056/NEJMra0901512; Gatt A, 2010, J THROMB HAEMOST, V8, P1994, DOI 10.1111/j.1538-7836.2010.03937.x; Giannini EG, 2008, CURR OPIN HEMATOL, V15, P473, DOI 10.1097/MOH.0b013e32830a9746; Grabau CM, 2004, HEPATOLOGY, V40, P484, DOI 10.1002/hep.20317; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Hollestellel MJ, 2004, THROMB HAEMOSTASIS, V91, P267, DOI 10.1160/TH03-05-0310; Iannacone M, 2007, CLIN VACCINE IMMUNOL, V14, P1532, DOI 10.1128/CVI.00298-07; Kadayifci A, 2008, J HEPATOL, V49, P595, DOI 10.1016/j.jhep.2008.05.024; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; Lisman T, 2006, HEPATOLOGY, V44, P53, DOI 10.1002/hep.21231; Lisman T, 2001, GASTROENTEROLOGY, V121, P131, DOI 10.1053/gast.2001.25481; Lisman T, 2010, J HEPATOL, V52, P355, DOI 10.1016/j.jhep.2009.12.001; Lodge JPA, 2005, LIVER TRANSPLANT, V11, P973, DOI 10.1002/lt.20470; MCGILL DB, 1990, GASTROENTEROLOGY, V99, P1396, DOI 10.1016/0016-5085(90)91167-5; Montalto P, 2002, J HEPATOL, V37, P463, DOI 10.1016/S0168-8278(02)00208-8; Noris M, 1999, BLOOD, V94, P2569, DOI 10.1182/blood.V94.8.2569.420k13_2569_2574; Northup PG, 2006, AM J GASTROENTEROL, V101, P1524, DOI 10.1111/j.1572-0241.2006.00588.x; O'Donnell J, 2001, BRIT J HAEMATOL, V115, P687, DOI 10.1046/j.1365-2141.2001.03146.x; OKUDA K, 1985, GASTROENTEROLOGY, V89, P279, DOI 10.1016/0016-5085(85)90327-0; Planinsic RM, 2005, LIVER TRANSPLANT, V11, P895, DOI 10.1002/lt.20458; Ponziani FR, 2010, EXPERT OPIN PHARMACO, V11, P1479, DOI 10.1517/14656561003749264; Primignani M, 2010, DIGEST LIVER DIS, V42, P163, DOI 10.1016/j.dld.2009.08.003; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Saenko EL, 1999, J BIOL CHEM, V274, P37685, DOI 10.1074/jbc.274.53.37685; Saleh T, 2011, AM J MED, V124, P64, DOI 10.1016/j.amjmed.2010.08.014; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Segal JB, 2005, TRANSFUSION, V45, P1413, DOI 10.1111/j.1537-2995.2005.00546.x; Sogaard KK, 2009, AM J GASTROENTEROL, V104, P96, DOI 10.1038/ajg.2008.34; Terjung B, 2003, DIGESTION, V67, P138, DOI 10.1159/000071293; Tripod A, 2008, J THROMB HAEMOST, V6, P243, DOI 10.1111/j.1538-7836.2007.02827.x; Tripodi A, 2005, HEPATOLOGY, V41, P553, DOI 10.1002/hep.20569; Tripodi A, 2009, QUALITY LAB HEMOSTAS, P179; Tripodi A, 2006, HEPATOLOGY, V44, P440, DOI 10.1002/hep.21266; Tripodi A, 2011, CLIN GASTROENT-SER, P289, DOI 10.1007/978-1-60761-866-9_14; Tripodi A, 2010, HEPATOLOGY, V52, P249, DOI 10.1002/hep.23653; Tripodi A, 2009, GASTROENTEROLOGY, V137, P2105, DOI 10.1053/j.gastro.2009.08.045; Tripodi A, 2009, BRIT J HAEMATOL, V147, P77, DOI 10.1111/j.1365-2141.2009.07833.x; Valla DC, 2008, HEPATOLOGY, V47, P1384, DOI 10.1002/hep.22192; Da Rocha ECV, 2009, CLIN GASTROENTEROL H, V7, P988, DOI 10.1016/j.cgh.2009.04.019; WANLESS IR, 1995, HEPATOLOGY, V21, P1238, DOI 10.1002/hep.1840210505; Wright M, 2003, GUT, V52, P1206, DOI 10.1136/gut.52.8.1206; Zecchini R, 2010, J HEPATOL, V52, pS460, DOI 10.1016/S0168-8278(10)61187-7; Zocco MA, 2009, J HEPATOL, V51, P682, DOI 10.1016/j.jhep.2009.03.013	67	841	871	0	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2					147	156		10.1056/NEJMra1011170	http://dx.doi.org/10.1056/NEJMra1011170			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SP	21751907				2022-12-28	WOS:000292685500011
J	Coller, BS				Coller, Barry S.			Realigning Incentives to Achieve Health Care Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SINGLE-PAYER		Rockefeller Univ, Lab Blood & Vasc Biol, New York, NY 10065 USA	Rockefeller University	Coller, BS (corresponding author), Rockefeller Univ, Lab Blood & Vasc Biol, 1230 York Ave,Box 309, New York, NY 10065 USA.	barry.coller@rockefeller.edu						ENTHOVEN AC, 2005, HLTH AFF MILLWOOD S; Glied S, 2009, J HEALTH POLIT POLIC, V34, P593, DOI 10.1215/03616878-2009-017; Goldsmith J, 2011, HEALTH AFFAIR, V30, P32, DOI 10.1377/hlthaff.2010.0782; Haywood TT, 2011, NEW ENGL J MED, V364, DOI 10.1056/NEJMp1100950; HIATT HH, 1975, NEW ENGL J MED, V293, P235, DOI 10.1056/NEJM197507312930506; Marmor T, 2009, ANN INTERN MED, V150, P485, DOI 10.7326/0003-4819-150-7-200904070-00114; Oliver A, 2009, J HEALTH POLIT POLIC, V34, P509, DOI 10.1215/03616878-2009-013; Reinhardt UE, 2006, HEALTH AFFAIR, V25, P57, DOI 10.1377/hlthaff.25.1.57	8	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					204	205		10.1001/jama.2011.978	http://dx.doi.org/10.1001/jama.2011.978			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791CO	21750300				2022-12-28	WOS:000292639400030
J	Martinson, NA; Barnes, GL; Moulton, LH; Msandiwa, R; Hausler, H; Ram, M; McIntyre, JA; Gray, GE; Chaisson, RE				Martinson, Neil A.; Barnes, Grace L.; Moulton, Lawrence H.; Msandiwa, Reginah; Hausler, Harry; Ram, Malathi; McIntyre, James A.; Gray, Glenda E.; Chaisson, Richard E.			New Regimens to Prevent Tuberculosis in Adults with HIV Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOSE PHARMACOKINETICS; ISONIAZID PROPHYLAXIS; LATENT TUBERCULOSIS; THERAPY; RIFAPENTINE; RIFAMPICIN; TWICE	Background Treatment of latent tuberculosis in patients infected with the human immunodeficiency virus (HIV) is efficacious, but few patients around the world receive such treatment. We evaluated three new regimens for latent tuberculosis that may be more potent and durable than standard isoniazid treatment. Methods We randomly assigned South African adults with HIV infection and a positive tuberculin skin test who were not taking antiretroviral therapy to receive rifapentine (900 mg) plus isoniazid (900 mg) weekly for 12 weeks, rifampin (600 mg) plus isoniazid (900 mg) twice weekly for 12 weeks, isoniazid (300 mg) daily for up to 6 years (continuous isoniazid), or isoniazid (300 mg) daily for 6 months (control group). The primary end point was tuberculosis-free survival. Results The 1148 patients had a median age of 30 years and a median CD4 cell count of 484 per cubic millimeter. Incidence rates of active tuberculosis or death were 3.1 per 100 person-years in the rifapentine-isoniazid group, 2.9 per 100 person-years in the rifampin-isoniazid group, and 2.7 per 100 person-years in the continuous-isoniazid group, as compared with 3.6 per 100 person-years in the control group (P>0.05 for all comparisons). Serious adverse reactions were more common in the continuous-isoniazid group (18.4 per 100 person-years) than in the other treatment groups (8.7 to 15.4 per 100 person-years). Two of 58 isolates of Mycobacterium tuberculosis (3.4%) were found to have multidrug resistance. Conclusions On the basis of the expected rates of tuberculosis in this population of HIV-infected adults, all secondary prophylactic regimens were effective. Neither a 3-month course of intermittent rifapentine or rifampin with isoniazid nor continuous isoniazid was superior to 6 months of isoniazid.	[Martinson, Neil A.; Barnes, Grace L.; Chaisson, Richard E.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [Martinson, Neil A.; Barnes, Grace L.; Chaisson, Richard E.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD USA; [Moulton, Lawrence H.; Ram, Malathi] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Martinson, Neil A.; Msandiwa, Reginah; McIntyre, James A.; Gray, Glenda E.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Hausler, Harry] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Witwatersrand; University of the Western Cape	Chaisson, RE (corresponding author), Johns Hopkins Ctr TB Res, 1550 Orleans St,1M08, Baltimore, MD 21231 USA.	rchaiss@jhmi.edu	McIntyre, James/V-7115-2019; Trajman, Anete/C-7679-2016	Trajman, Anete/0000-0002-4000-4984; Moulton, Lawrence/0000-0001-7041-7387	National Institute of Allergy and Infectious Diseases and others; National Institute of Allergy and Infectious Diseases [AI048526, AI01637]; National Institutes of Health Fogarty International Center [D43 TW00001021S1, 5U2RTW007370]; U.S. Agency for International Development [GHS-A-00-03-00019-00]; Alere; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW000010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, R01AI048526, K24AI001637] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases and others(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); U.S. Agency for International Development(United States Agency for International Development (USAID)); Alere; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institute of Allergy and Infectious Diseases and others; ClinicalTrials.gov number, NCT00057122; Supported by grants from the National Institute of Allergy and Infectious Diseases (AI048526 and AI01637), the National Institutes of Health Fogarty International Center (D43 TW00001021S1 and 5U2RTW007370), and the U.S. Agency for International Development (GHS-A-00-03-00019-00).; Dr. Martinson reports receiving lecture fees from Alere. No other potential conflict of interest relevant to this article was reported.	Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P385; [Anonymous], 2011, GUID INT TUB CAS FIN; Balcells ME, 2006, EMERG INFECT DIS, V12, P744; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Boulle A, 2008, JAMA-J AM MED ASSOC, V300, P530, DOI 10.1001/jama.300.5.530; Bucher HC, 1999, AIDS, V13, P501, DOI 10.1097/00002030-199903110-00009; JI BH, 1993, AM REV RESPIR DIS, V148, P1541, DOI 10.1164/ajrccm/148.6_Pt_1.1541; Johnson JL, 2001, AIDS, V15, P2137, DOI 10.1097/00002030-200111090-00009; Kali PBN, 2006, JAIDS-J ACQ IMM DEF, V42, P379, DOI 10.1097/01.qai.0000218434.20404.9c; Keung A, 1999, INT J TUBERC LUNG D, V3, P437; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Langdon G, 2004, INT J TUBERC LUNG D, V8, P862; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; Miyazaki E, 1999, ANTIMICROB AGENTS CH, V43, P2126, DOI 10.1128/AAC.43.9.2126; Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC; Mosimaneotsile B, 2003, LANCET, V362, P1551, DOI 10.1016/S0140-6736(03)14745-9; Munseri PJ, 2008, INT J TUBERC LUNG D, V12, P1037; Mwinga A, 1998, AIDS, V12, P2447, DOI 10.1097/00002030-199818000-00014; PAPE JW, 1993, LANCET, V342, P268, DOI 10.1016/0140-6736(93)91817-6; Quigley MA, 2001, AIDS, V15, P215, DOI 10.1097/00002030-200101260-00011; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Schechter M, 2006, AM J RESP CRIT CARE, V173, P922, DOI 10.1164/rccm.200512-1953OC; Sterling TR, 2010, 41 UN WORLD LUNG HLT; Weiner M, 2004, AM J RESP CRIT CARE, V169, P1191, DOI 10.1164/rccm.200311-1612OC; Whalen CC, 1997, NEW ENGL J MED, V337, P801, DOI 10.1056/NEJM199709183371201; WHO, 2004, LESS LEARNT WORKSH 6; World Health Organization, 2008, JOINT WHO HIV AIDS T; World Health Organization, 2009, GLOB TUB CONTR EP ST; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	30	237	253	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					11	20		10.1056/NEJMoa1005136	http://dx.doi.org/10.1056/NEJMoa1005136			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788QL	21732833	Green Accepted			2022-12-28	WOS:000292459400005
J	Schmidt, M; Christiansen, CF; Mehnert, F; Rothman, KJ; Sorensen, HT				Schmidt, Morten; Christiansen, Christian F.; Mehnert, Frank; Rothman, Kenneth J.; Sorensen, Henrik Toft			Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CYCLOOXYGENASE-2 INHIBITORS; METAANALYSIS; COHORT; NSAIDS	Objectives To examine the risk of atrial fibrillation or flutter associated with use of non-selective non-steroidal anti-inflammatory drugs (NSAIDs) or selective cyclo-oxygenase (COX) 2 inhibitors. Design Population based case-control study using data from medical databases. Setting Northern Denmark (population 1.7 million). Participants 32 602 patients with a first inpatient or outpatient hospital diagnosis of atrial fibrillation or flutter between 1999 and 2008; 325 918 age matched and sex matched controls based on risk-set sampling. Main outcome measures Exposure to NSAID use at the time of admission (current use) or before (recent use). Current use was further classified as new use (first ever prescription redemption within 60 days before diagnosis date) or long term use. We used conditional logistic regression to compute odds ratios as unbiased estimates of the incidence rate ratios. Results 2925 cases (9%) and 21 871 controls (7%) were current users of either non-selective NSAIDs or COX 2 inhibitors. Compared with no use, the incidence rate ratio associating current drug use with atrial fibrillation or flutter was 1.33 (95% confidence interval 1.26 to 1.41) for non-selective NSAIDs and 1.50 (1.42 to 1.59) for COX 2 inhibitors. Adjustments for age, sex, and risk factors for atrial fibrillation or flutter reduced the incidence rate ratio to 1.17 (1.10 to 1.24) for non-selective NSAIDs and 1.27 (1.20 to 1.34) for COX 2 inhibitors. Among new users, the adjusted incidence rate ratio was 1.46 (1.33 to 1.62) for non-selective NSAIDs and 1.71 (1.56 to 1.88) for COX 2 inhibitors. Results for individual NSAIDs were similar. Conclusions Use of non-aspirin NSAIDs was associated with an increased risk of atrial fibrillation or flutter. Compared with non-users, the association was strongest for new users, with a 40-70% increase in relative risk (lowest for non-selective NSAIDs and highest for COX 2 inhibitors). Our study thus adds evidence that atrial fibrillation or flutter needs to be added to the cardiovascular risks to be considered when prescribing NSAIDs.	[Schmidt, Morten; Christiansen, Christian F.; Mehnert, Frank; Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus N, Denmark; [Rothman, Kenneth J.] Res Triangle Inst, RTI Hlth Solut, Res Triangle Pk, NC 27709 USA; [Rothman, Kenneth J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Aarhus University; Research Triangle Institute; Boston University	Schmidt, M (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus N, Denmark.	msc@dce.au.dk	Christiansen, Christian Fynbo/B-5870-2014; Sorensen, Henrik Toft/Z-6181-2019; Christiansen, Christian/ABE-9423-2021; Schmidt, Morten/F-5048-2013	Christiansen, Christian Fynbo/0000-0002-0727-953X; Sorensen, Henrik Toft/0000-0003-4299-7040; Christiansen, Christian/0000-0002-0727-953X; Schmidt, Morten/0000-0002-4935-4059; Rothman, Kenneth/0000-0003-2398-1705; Mehnert, Frank/0000-0001-7639-7356	Danish Medical Research Council [271-05-0511]; Clinical Epidemiological Research Foundation, Denmark; Danish Heart Association; Aarhus University; Department of Clinical Epidemiology collaborates within the EU	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Clinical Epidemiological Research Foundation, Denmark; Danish Heart Association; Aarhus University; Department of Clinical Epidemiology collaborates within the EU	The study was supported by the Danish Medical Research Council (grant 271-05-0511), the Clinical Epidemiological Research Foundation, Denmark, the Danish Heart Association, and an Aarhus University scholarship. Department of Clinical Epidemiology collaborates within the EU Seventh Framework Programme: Arrhythmogenic potential of drugs (ARITMO). None of the funding sources had a role in the study design, conduct, analysis, or reporting.	Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], GUIDELINES TREATMENT; Aw TJ, 2005, ARCH INTERN MED, V165, P490, DOI 10.1001/archinte.165.5.IOI50013; Badhwar N, 2008, J CARDIOVASC ELECTR, V19, P1151, DOI 10.1111/j.1540-8167.2008.01238.x; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Capone ML, 2007, PROSTAG OTH LIPID M, V82, P85, DOI 10.1016/j.prostaglandins.2006.05.019; Christiansen CF, 2009, ARCH INTERN MED, V169, P1677, DOI 10.1001/archinternmed.2009.297; Cryer B, 1998, AM J MED, V104, P413, DOI 10.1016/S0002-9343(98)00091-6; *DAN MED AG, REIMB MED; De Caterina R, 2010, ARCH INTERN MED, V170, P1450, DOI 10.1001/archinternmed.2010.305; Ehrenstein Vera, 2010, Clin Epidemiol, V2, P273, DOI 10.2147/CLEP.S13458; Engelmann MDM, 2005, EUR HEART J, V26, P2083, DOI 10.1093/eurheartj/ehi350; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Greenland S, 2000, AM J EPIDEMIOL, V151, P531; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Laine L, 2002, SEMIN ARTHRITIS RHEU, V32, P25, DOI 10.1053/sarh.2002.37217; Pedersen CB, 2006, DAN MED BULL, V53, P441; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Stevenson WG, 2004, NEW ENGL J MED, V351, P2437, DOI 10.1056/NEJMe048248; Thomsen RW, 2006, AM J GASTROENTEROL, V101, P2704, DOI 10.1111/j.1572-0241.2006.00825.x; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; van der Hooft CS, 2004, J AM COLL CARDIOL, V44, P2117, DOI 10.1016/j.jacc.2004.08.053; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396; Waldo AL, 2008, J AM COLL CARDIOL, V51, P779, DOI 10.1016/j.jacc.2007.08.066; Whelton A., 2001, AM J MED S1, V110, P33; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Zhang JJ, 2006, JAMA-J AM MED ASSOC, V296, P1619, DOI 10.1001/jama.296.13.jrv60015	30	81	88	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2011	343								d3450	10.1136/bmj.d3450	http://dx.doi.org/10.1136/bmj.d3450			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791RR	21727167	hybrid			2022-12-28	WOS:000292682800003
J	Young, JQ; Ranji, SR; Wachter, RM; Lee, CM; Niehaus, B; Auerbach, AD				Young, John Q.; Ranji, Sumant R.; Wachter, Robert M.; Lee, Connie M.; Niehaus, Brian; Auerbach, Andrew D.			"July Effect": Impact of the Academic Year-End Changeover on Patient Outcomes A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							INTENSIVE-CARE-UNIT; LENGTH-OF-STAY; SURGICAL EXPERIENCE; MEDICAL-EDUCATION; CARDIAC-SURGERY; MORTALITY; QUALITY; ERRORS; ADMISSION; RESIDENTS	Background: It is commonly believed that the quality of health care decreases during trainee changeovers at the end of the academic year. Purpose: To systematically review studies describing the effects of trainee changeover on patient outcomes. Data Sources: Electronic literature search of PubMed, Educational Research Information Center (ERIC), EMBASE, and the Cochrane Library for English-language studies published between 1989 and July 2010. Study Selection: Title and abstract review followed by full-text review to identify studies that assessed the effect of the changeover on patient outcomes and that used a control group or period as a comparator. Data Extraction: Using a standardized form, 2 authors independently abstracted data on outcomes, study setting and design, and statistical methods. Differences between reviewers were reconciled by consensus. Studies were then categorized according to methodological quality, sample size, and outcomes reported. Data Synthesis: Of the 39 included studies, 27 (69%) reported mortality, 19 (49%) reported efficiency (length of stay, duration of procedure, hospital charges), 23 (59%) reported morbidity, and 6 (15%) reported medical error outcomes; all studies focused on inpatient settings. Most studies were conducted in the United States. Thirteen (33%) were of higher quality. Studies with higher-quality designs and larger sample sizes more often showed increased mortality and decreased efficiency at time of changeover. Studies examining morbidity and medical error outcomes were of lower quality and produced inconsistent results. Limitations: The review was limited to English-language reports. No study focused on the effect of changeovers in ambulatory care settings. The definition of changeover, resident role in patient care, and supervision structure varied considerably among studies. Most studies did not control for time trends or level of supervision or use methods appropriate for hierarchical data. Conclusion: Mortality increases and efficiency decreases in hospitals because of year-end changeovers, although heterogeneity in the existing literature does not permit firm conclusions about the degree of risk posed, how changeover affects morbidity and rates of medical errors, or whether particular models are more or less problematic.	[Young, John Q.] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Young, JQ (corresponding author), Univ Calif San Francisco, Sch Med, Dept Psychiat, 401 Parnassus Ave,Box 0984-APC, San Francisco, CA 94143 USA.	jqyoung@lppi.ucsf.edu	Young, John Q./L-5916-2019	Young, John Q./0000-0003-2219-5657; Auerbach, Andrew/0000-0001-8440-0527	National Heart, Lung, and Blood Institute [K24HL098372]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL098372] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By grant K24HL098372 from the National Heart, Lung, and Blood Institute (Dr. Auerbach).	ABELSON MA, 1984, ACAD MANAGE REV, V9, P331, DOI 10.2307/258446; Alshekhlee A, 2009, J STROKE CEREBROVASC, V18, P232, DOI 10.1016/j.jstrokecerebrovasdis.2008.10.006; Anderson Kane L, 2009, Am J Orthop (Belle Mead NJ), V38, P606; Ayas NT, 2007, QUAL SAF HEALTH CARE, V16, P252, DOI 10.1136/qshc.2006.021162; AYLIN P, 1994, BRIT MED J, V309, P1690, DOI 10.1136/bmj.309.6970.1690; Bakaeen FG, 2009, ANN THORAC SURG, V88, P70, DOI 10.1016/j.athoracsur.2009.04.022; Banco SP, 2002, SPINE, V27, P962, DOI 10.1097/00007632-200205010-00016; Barry WA, 2003, J GEN INTERN MED, V18, P639, DOI 10.1046/j.1525-1497.2003.20605.x; Barzansky B, 2009, JAMA-J AM MED ASSOC, V302, P1349, DOI 10.1001/jama.2009.1324; BLUMBERG MS, 1990, JAMA-J AM MED ASSOC, V264, P573, DOI 10.1001/jama.1990.03450050031018; Borenstein SH, 2004, J SURG RES, V122, P162, DOI 10.1016/j.jss.2004.05.014; Bruckner TA, 2008, J PERINATOL, V28, P691, DOI 10.1038/jp.2008.72; BUCHWALD D, 1989, ARCH INTERN MED, V149, P765, DOI 10.1001/archinte.149.4.765; Caines LC, 2011, J GEN INTERN ME 0511; CARLEY K, 1992, ORGAN SCI, V3, P20, DOI 10.1287/orsc.3.1.20; Chan PS, 2010, ARCH INTERN MED, V170, P18, DOI 10.1001/archinternmed.2009.424; Chow KM, 2005, QJM-INT J MED, V98, P753, DOI 10.1093/qjmed/hci116; Claridge JA, 2001, SURGERY, V130, P346, DOI 10.1067/msy.2001.116670; Cosgrove CM, 2002, ANN ROY COLL SURG, V84, P344, DOI 10.1308/003588402760452691; Cunningham EJ, 2003, BRIT J NEUROSURG, V17, P124, DOI 10.1080/0268869031000108963; Dhaliwal AS, 2008, AM J SURG, V196, P720, DOI 10.1016/j.amjsurg.2008.07.005; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Englesbe MJ, 2007, ANN SURG, V246, P456, DOI 10.1097/SLA.0b013e31814855f2; Englesbe MJ, 2009, ANN SURG, V249, P871, DOI 10.1097/SLA.0b013e3181a501bd; ENQUSELASSIE F, 1993, INT J EPIDEMIOL, V22, P632, DOI 10.1093/ije/22.4.632; Finkielman JD, 2004, CRIT CARE MED, V32, P1161, DOI 10.1097/01.CCM.0000126151.56590.99; Ford AA, 2007, J PERINATOL, V27, P73, DOI 10.1038/sj.jp.7211635; Garcia S, 2009, SOUTH MED J, V102, P602, DOI 10.1097/SMJ.0b013e3181a2f8ca; Green Michael L, 2009, J Grad Med Educ, V1, P5, DOI 10.4300/01.01.0003; Haller G, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3974; Hartley KL, 2007, OPHTHAL SURG LAS IM, V38, P358, DOI 10.3928/15428877-20070901-01; Highstead RG, 2009, J TRAUMA, V67, P1087, DOI 10.1097/TA.0b013e3181b8441d; Huckman RS, 2005, NBER WORKING PAPER S; Inaba K, 2010, J TRAUMA, V68, P19, DOI 10.1097/TA.0b013e3181b88dfe; Jen MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007103; Kestle JRW, 2006, J NEUROSURG, V105, P165, DOI 10.3171/ped.2006.105.3.165; Krueger AB, 2004, J POLIT ECON, V112, P253, DOI 10.1086/381479; Lawton MT, 2005, NEUROSURGERY, V57, P9, DOI 10.1227/01.NEU.0000163082.20941.EF; Lesar TS, 1997, JAMA-J AM MED ASSOC, V277, P312, DOI 10.1001/jama.277.4.312; MARSHALL JB, 1995, GASTROINTEST ENDOSC, V42, P287, DOI 10.1016/S0016-5107(95)70123-0; Moher David, 2009, Open Med, V3, pe123; Myles TD, 2003, OBSTET GYNECOL, V102, P1080, DOI 10.1016/j.obstetgynecol.2003.08.001; Nuckols TK, 2009, NEW ENGL J MED, V360, P2202, DOI 10.1056/NEJMsa0810251; Nussbaum MS, 2002, SURGERY, V132, P670; Ornato JP, 1996, J AM COLL CARDIOL, V28, P1684, DOI 10.1016/S0735-1097(96)00411-1; Phillips DP, 2010, J GEN INTERN MED, V25, P774, DOI 10.1007/s11606-010-1356-3; Polanyi M., 1966, TACIT DIMENSION; Price J.L., 1977, STUDY TURNOVER; Prystowsky JB, 2002, SURGERY, V132, P663, DOI 10.1067/msy.2002.127550; Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576; Resnick AS, 2008, J SURG EDUC, V65, P243, DOI 10.1016/j.jsurg.2008.01.005; RICH EC, 1990, JAMA-J AM MED ASSOC, V263, P953; RICH EC, 1993, MED CARE, V31, P73, DOI 10.1097/00005650-199301000-00006; Schroeppel TJ, 2009, J AM COLL SURGEONS, V209, P378, DOI 10.1016/j.jamcollsurg.2009.05.026; Shuhaiber JH, 2008, ANN THORAC SURG, V86, P123, DOI 10.1016/j.athoracsur.2008.03.041; Shulkin D J, 1995, Am J Med Qual, V10, P14, DOI 10.1177/0885713X9501000104; Smith ER, 2006, J NEUROSURG, V105, P169, DOI 10.3171/ped.2006.105.3.169; Smith JP, 2002, AM J MED, V113, P288, DOI 10.1016/S0002-9343(02)01216-0; Soltau TD, 2008, PEDIATRICS, V122, pE1048, DOI 10.1542/peds.2008-0412; STAW BM, 1980, J OCCUP BEHAV, V1, P253; Sterkenburg A, 2010, ACAD MED, V85, P1408, DOI 10.1097/ACM.0b013e3181eab0ec; Stout CL, 2008, AM SURGEON, V74, P878; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Ten Cate O, 2010, MED TEACH, V32, P669, DOI 10.3109/0142159X.2010.500897; Turner PD, 2000, J GEN INTERN MED, V15, P23; Walling Hobart W, 2004, Mo Med, V101, P128; Yaghoubian A, 2010, J SURG EDUC, V67, P157, DOI 10.1016/j.jsurg.2010.04.003; Yeaton-Massey A, 2009, AM J OBSTET GYNECOL, V201, pS223, DOI 10.1016/j.ajog.2009.10.469; Young JQ, 2010, ACAD MED, V85, P1418, DOI 10.1097/ACM.0b013e3181eab8d0; Young JQ, 2009, JAMA-J AM MED ASSOC, V302, P1327, DOI 10.1001/jama.2009.1399	70	207	207	2	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 6	2011	155	5					309	U77		10.7326/0003-4819-155-5-201109060-00354	http://dx.doi.org/10.7326/0003-4819-155-5-201109060-00354			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815PX	21747093				2022-12-28	WOS:000294538900004
J	Anderson, PSL; Friedman, M; Brazeau, MD; Rayfield, EJ				Anderson, Philip S. L.; Friedman, Matt; Brazeau, Martin D.; Rayfield, Emily J.			Initial radiation of jaws demonstrated stability despite faunal and environmental change	NATURE			English	Article							MORPHOLOGICAL DISPARITY; FOSSIL RECORD; LABRID FISHES; MORPHOSPACE; MECHANICS; PATTERNS; OXYGEN	More than 99 per cent of the roughly 58,000 living vertebrate species have jaws(1). This major clade, whose members are collectively known as gnathostomes ('jawed mouths'), made its earliest definitive appearance in the Silurian period, 444-416 million years (Myr) ago, with both the origin of the modern (crown-group) radiation and the presumptive invasion of land occurring by the end of the Devonian period(2) (359 Myr ago). These events coincided with a major faunal shift that remains apparent today: the transition from Silurian ecosystems dominated by jawless fishes (agnathans) to younger assemblages composed almost exclusively of gnathostomes(2,3). This pattern has inspired several qualitative descriptions of the trophic radiation and ecological ascendance of the earliest jawed vertebrates(3-7). Here we present a quantitative analysis of functional variation in early gnathostome mandibular elements, placing constraints on our understanding of evolutionary patterns during this critical interval. We document an initial increase in functional disparity in the Silurian that stabilized by the first stage of the Devonian, before the occurrence of an Emsian (similar to 400 Myr ago) oxygenation event implicated in the trophic radiation of vertebrates(8). Subsequent taxonomic diversification during the Devonian did not result in increased functional variation; instead, new taxa revisited and elaborated on established mandibular designs. Devonian functional space is dominated by lobe-finned fishes and 'placoderms'; high disparity within the latter implies considerable trophic innovation among jaw-bearing stem gnathostomes. By contrast, the major groups of living vertebrates-ray-finned fishes and tetrapods-show surprisingly conservative mandibular morphologies with little indication of functional diversification or innovation. Devonian gnathostomes reached a point where they ceased to accrue further mandibular functional disparity before becoming taxonomic dominants relative to 'ostracoderm'-grade jawless fishes, providing a new perspective on classic adaptive hypotheses concerning this fundamental shift in vertebrate biodiversity.	[Anderson, Philip S. L.; Rayfield, Emily J.] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; [Friedman, Matt] Univ Oxford, Dept Earth Sci, Oxford OX1 3AN, England; [Brazeau, Martin D.] Humboldt Univ, Leibniz Inst Res Evolut & Biodivers, Museum Nat Kunde, D-10115 Berlin, Germany	University of Bristol; University of Oxford; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Anderson, PSL (corresponding author), Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England.	phil.anderson@bristol.ac.uk	Rayfield, Emily/F-5038-2010; Friedman, Matt/F-6991-2012; Brazeau, Martin D/B-6971-2009; Brazeau, Martin D/AAU-5390-2020	Rayfield, Emily/0000-0002-2618-750X; Brazeau, Martin D/0000-0001-6566-2820; Brazeau, Martin/0000-0002-0650-1282	Royal Society; Marie-Curie Actions fellowships; Fell Fund award; NERC [NE/G016623/1]; FQRNT; Natural Environment Research Council [NE/G016623/1] Funding Source: researchfish	Royal Society(Royal Society of London); Marie-Curie Actions fellowships; Fell Fund award; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); FQRNT(FQRNT); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank P. Donoghue, M. Rucklin and M. Ruta for discussions. This work was supported by Royal Society and Marie-Curie Actions fellowships, awarded to P. S. L. A.; a Fell Fund award to M. F.; NERC grant NE/G016623/1, awarded in part to E.J.R.; and a FQRNT postdoctoral fellowship, to M.D.B.	Alfaro ME, 2005, AM NAT, V165, pE140, DOI 10.1086/429564; Alfaro ME, 2004, EVOLUTION, V58, P495, DOI 10.1111/j.0014-3820.2004.tb01673.x; Anderson PSL, 2009, PALEOBIOLOGY, V35, P321, DOI 10.1666/0094-8373-35.3.321; BENTON MJ, 1993, FOSSIL RECORD, V2; CARROLL RL, 1988, VERTEBRATE PALEONTOL, V44; Ciampaglio CN, 2001, PALEOBIOLOGY, V27, P695, DOI 10.1666/0094-8373(2001)027<0695:DCIMOP>2.0.CO;2; COLBERT EH, 1991, EVOLUTION VERTEBRATE, V28; Copper P, 2002, PALAEOGEOGR PALAEOCL, V181, P27, DOI 10.1016/S0031-0182(01)00472-2; Dahl TW, 2010, P NATL ACAD SCI USA, V107, P17911, DOI 10.1073/pnas.1011287107; FOOTE M, 1994, PALEOBIOLOGY, V20, P320, DOI 10.1017/S009483730001280X; FOOTE M, 1993, PALEOBIOLOGY, V19, P403, DOI 10.1017/S0094837300014056; Ginter M., 2010, HDB PALEOICHTHYOLO D, V3D; HALSTEAD LB, 1969, PATTERN VERTEBRATE E, V26; Hulsey CD, 2002, P ROY SOC B-BIOL SCI, V269, P317, DOI 10.1098/rspb.2001.1874; Janvier P., 1993, P67; Janvier P., 1996, EARLY VERTEBRATES; Joachimski MM, 2009, EARTH PLANET SC LETT, V284, P599, DOI 10.1016/j.epsl.2009.05.028; Klug C, 2010, LETHAIA, V43, P465, DOI 10.1111/j.1502-3931.2009.00206.x; Markey MJ, 2007, P NATL ACAD SCI USA, V104, P7134, DOI 10.1073/pnas.0701706104; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Pough FH, 2009, VERTEBRATE LIFE, V8th; Qu Qing-Ming, 2010, Palaeoworld, V19, P146, DOI 10.1016/j.palwor.2009.11.003; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Royall R., 1997, STAT EVIDENCE LIKELI; SALLAN LC, 2010, P NATL ACAD SCI USA, V99, P8139; van Geldern R, 2006, PALAEOGEOGR PALAEOCL, V240, P47, DOI 10.1016/j.palaeo.2006.03.045; Wainwright PC, 2007, ANNU REV ECOL EVOL S, V38, P381, DOI 10.1146/annurev.ecolsys.38.091206.095706; Westneat MW, 2004, INTEGR COMP BIOL, V44, P378, DOI 10.1093/icb/44.5.378; Zhao Wen-Jin, 2010, Palaeoworld, V19, P4, DOI 10.1016/j.palwor.2009.11.007	29	97	100	1	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 11	2011	476	7359					206	209		10.1038/nature10207	http://dx.doi.org/10.1038/nature10207			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21734660				2022-12-28	WOS:000293731900036
J	Minemawari, H; Yamada, T; Matsui, H; Tsutsumi, J; Haas, S; Chiba, R; Kumai, R; Hasegawa, T				Minemawari, Hiromi; Yamada, Toshikazu; Matsui, Hiroyuki; Tsutsumi, Jun'ya; Haas, Simon; Chiba, Ryosuke; Kumai, Reiji; Hasegawa, Tatsuo			Inkjet printing of single-crystal films	NATURE			English	Article							HIGH-PERFORMANCE; TRANSISTOR; MOBILITY; POLYMER; TRANSPORT	The use of single crystals has been fundamental to the development of semiconductor microelectronics and solid-state science(1). Whether based on inorganic(2-5) or organic(6-8) materials, the devices that show the highest performance rely on single-crystal interfaces, with their nearly perfect translational symmetry and exceptionally high chemical purity. Attention has recently been focused on developing simple ways of producing electronic devices by means of printing technologies. 'Printed electronics' is being explored for the manufacture of large-area and flexible electronic devices by the patterned application of functional inks containing soluble or dispersed semiconducting materials(9-11). However, because of the strong self-organizing tendency of the deposited materials(12,13), the production of semiconducting thin films of high crystallinity (indispensable for realizing high carrier mobility) may be incompatible with conventional printing processes. Here we develop a method that combines the technique of antisolvent crystallization(14) with inkjet printing to produce organic semiconducting thin films of high crystallinity. Specifically, we show that mixing fine droplets of an antisolvent and a solution of an active semiconducting component within a confined area on an amorphous substrate can trigger the controlled formation of exceptionally uniform single-crystal or polycrystalline thin films that grow at the liquid-air interfaces. Using this approach, we have printed single crystals of the organic semiconductor 2,7-dioctyl[1] benzothieno[3,2-b][1] benzothiophene (C-8-BTBT) (ref. 15), yielding thin-film transistors with average carrier mobilities as high as 16.4 cm(2) V-1 s(-1). This printing technique constitutes a major step towards the use of high-performance single-crystal semiconductor devices for large-area and flexible electronics applications.	[Minemawari, Hiromi; Yamada, Toshikazu; Matsui, Hiroyuki; Tsutsumi, Jun'ya; Haas, Simon; Chiba, Ryosuke; Kumai, Reiji; Hasegawa, Tatsuo] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan; [Chiba, Ryosuke] Univ Tokyo, Dept Appl Phys, Hongo 1138656, Japan; [Kumai, Reiji] High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, CMRC, Tsukuba, Ibaraki 3050801, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; High Energy Accelerator Research Organization (KEK)	Hasegawa, T (corresponding author), Natl Inst Adv Ind Sci & Technol, AIST Tsukuba Cent 4, Tsukuba, Ibaraki 3058562, Japan.	t-hasegawa@aist.go.jp	Minemawari, Hiromi/K-9776-2018; Matsui, Hiroyuki/G-4616-2018; Kumai, Reiji/R-2453-2017; Hasegawa, Tatsuo/M-4775-2018; Yamada, Toshikazu/C-7533-2017; Tsutsumi, Jun'ya/O-6490-2016	Minemawari, Hiromi/0000-0003-3157-7905; Matsui, Hiroyuki/0000-0003-1956-9603; Kumai, Reiji/0000-0002-5320-0028; Hasegawa, Tatsuo/0000-0001-5187-7433; Yamada, Toshikazu/0000-0002-8322-2391; Tsutsumi, Jun'ya/0000-0002-0910-1188	New Energy and Industrial Technology Development Organization (NEDO); Japan Society for the Promotion of Science (JSPS)	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to Nippon Kayaku for providing C<INF>8</INF>-BTBT. We thank K. Takimiya and S. Horiuchi for discussions, H. Okamoto and H. Matsuzaki for help with optical measurements, K. Kobayashi for help with the X-ray measurements, and T. Iwadate for help with atomic-force microscopy and measurements of device characteristics. The synchrotron X-ray study was performed with the approval of the Photon Factory Program Advisory Committee (no. 2009S2-003). This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) through a Grant for Industrial Technology Research and also by the Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program).	Briseno AL, 2006, NATURE, V444, P913, DOI 10.1038/nature05427; Chen ZG, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3269930; De Poortere EP, 2002, APPL PHYS LETT, V80, P1583, DOI 10.1063/1.1456265; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; deMello AJ, 2006, NATURE, V442, P394, DOI 10.1038/nature05062; Ebata H, 2007, J AM CHEM SOC, V129, P15732, DOI 10.1021/ja074841i; Faltermeier D, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.125416; Hasegawa T, 2010, THIN SOLID FILMS, V518, P3988, DOI 10.1016/j.tsf.2009.11.024; Hiraoka M, 2007, ADV MATER, V19, P3248, DOI 10.1002/adma.200701162; Izawa T, 2008, ADV MATER, V20, P3388, DOI 10.1002/adma.200800799; Lim JA, 2009, ADV FUNCT MATER, V19, P1515, DOI 10.1002/adfm.200801135; Noh YY, 2007, NAT NANOTECHNOL, V2, P784, DOI 10.1038/nnano.2007.365; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Pope M., 1999, ELECT PROCESSES ORGA, V2nd ed., P59; Rivnay J, 2009, NAT MATER, V8, P952, DOI [10.1038/NMAT2570, 10.1038/nmat2570]; Sirringhaus H, 2000, SCIENCE, V290, P2123, DOI 10.1126/science.290.5499.2123; Sundar VC, 2004, SCIENCE, V303, P1644, DOI 10.1126/science.1094196; Takeya J, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2711393; TEAL GK, 1976, IEEE T ELECTRON DEV, V23, P621, DOI 10.1109/T-ED.1976.18464; Tsukazaki A, 2010, NAT MATER, V9, P889, DOI [10.1038/nmat2874, 10.1038/NMAT2874]; Tung H.H., 2009, CRYSTALLIZATION ORGA, P179; Uemura T, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.111501; Ulman A., 1991, INTRO ULTRATHIN ORGA; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Yan H, 2009, NATURE, V457, P679, DOI 10.1038/nature07727	26	1377	1402	28	1326	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					364	367		10.1038/nature10313	http://dx.doi.org/10.1038/nature10313			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21753752				2022-12-28	WOS:000292911200039
J	Ranu, H; Buyck, H; Willis, F; Madden, B				Ranu, Harpreet; Buyck, Hubertus; Willis, Fenella; Madden, Brendan			CASE REPORT Breathlessness and chest pain in a patient with sickle cell disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PULMONARY-HYPERTENSION; RISK-FACTORS; HEMOLYSIS; DEATH; HEMOGLOBINOPATHY; TRANSFUSION; MANAGEMENT; MORTALITY; PLATELET; OUTCOMES		[Ranu, Harpreet; Madden, Brendan] St George Hosp, Dept Cardiothorac Med, London SW17 0QT, England; [Buyck, Hubertus; Willis, Fenella] St George Hosp, Dept Haematol, London SW17 0QT, England	St Georges University London; St Georges University London	Ranu, H (corresponding author), St George Hosp, Dept Cardiothorac Med, London SW17 0QT, England.	harpreetranu@yahoo.com						Ataga KI, 2006, BRIT J HAEMATOL, V134, P109, DOI 10.1111/j.1365-2141.2006.06110.x; Castro O, 2003, BLOOD, V101, P1257, DOI 10.1182/blood-2002-03-0948; CASTRO O, 1994, BLOOD, V84, P643, DOI 10.1182/blood.V84.2.643.643; De Castro LM, 2008, AM J HEMATOL, V83, P19, DOI 10.1002/ajh.21058; EMRE U, 1995, J PEDIATR-US, V127, P901, DOI 10.1016/S0022-3476(95)70025-0; FEMIPEARSE D, 1970, J APPL PHYSIOL, V28, P574, DOI 10.1152/jappl.1970.28.5.574; Gladwin MT, 2008, NEW ENGL J MED, V359, P2254, DOI 10.1056/NEJMra0804411; Gladwin MT, 2000, LANCET, V355, P1476, DOI 10.1016/S0140-6736(00)02157-7; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Haque AK, 2002, HUM PATHOL, V33, P1037, DOI 10.1053/hupa.2002.128059; Inwald DP, 2000, BRIT J HAEMATOL, V111, P474, DOI 10.1046/j.1365-2141.2000.02353.x; Jeng MR, 2003, AM J HEMATOL, V74, P243, DOI 10.1002/ajh.10426; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Key NS, 1998, BLOOD, V91, P4216, DOI 10.1182/blood.V91.11.4216.411k15_4216_4223; Lee SP, 2006, ARTERIOSCL THROM VAS, V26, P1626, DOI 10.1161/01.ATV.0000220374.00602.a2; Little JA, 2009, EUR J HAEMATOL, V82, P315, DOI 10.1111/j.1600-0609.2009.01210.x; Machado RF, 2005, BRIT J HAEMATOL, V130, P445, DOI 10.1111/j.1365-2141.2005.05625.x; Melton CW, 2006, CLIN CHEST MED, V27, P487, DOI 10.1016/j.ccm.2006.04.001; MILLER GJ, 1971, THORAX, V26, P309, DOI 10.1136/thx.26.3.309; Minniti CP, 2009, BRIT J HAEMATOL, V147, P737, DOI 10.1111/j.1365-2141.2009.07906.x; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; National Heart Lung and Blood Institute, 2010, SLID THER PULM HYP S; Nifong TP, 2002, THER APHER, V6, P390, DOI 10.1046/j.1526-0968.2002.00425.x; Parent F, 2009, AM J RESP CRIT CARE, V179; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; POWARS D, 1988, MEDICINE, V67, P66, DOI 10.1097/00005792-198801000-00005; Ranu H, 2010, AM J RESP CRIT CARE, V181; Rees DC, 2003, BRIT J HAEMATOL, V120, P744, DOI 10.1046/j.1365-2141.2003.04193.x; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Santoli F, 1998, EUR RESPIR J, V12, P1124, DOI 10.1183/09031936.98.12051124; Sen N, 2009, LUNG, V187, P195, DOI 10.1007/s00408-009-9141-y; TAHHAN HR, 1994, TRANSFUSION, V34, P562, DOI 10.1046/j.1537-2995.1994.34794330008.x; Tomer A, 2001, J LAB CLIN MED, V137, P398, DOI 10.1067/mlc.2001.115450; Vichinsky EP, 2000, NEW ENGL J MED, V342, P1855, DOI 10.1056/NEJM200006223422502; Westerman MP, 1999, J LAB CLIN MED, V134, P352, DOI 10.1016/S0022-2143(99)90149-X; YOUNG RC, 1988, J NATL MED ASSOC, V80, P509	37	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 20	2011	343								d3797	10.1136/bmj.d3797	http://dx.doi.org/10.1136/bmj.d3797			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797ZH	21775406				2022-12-28	WOS:000293168700001
J	Arbabi, EM; Arshad, FA; Holden, K; Carrim, ZI				Arbabi, Esmaeil M.; Arshad, Faisal A.; Holden, Kate; Carrim, Zia I.			10-MINUTE CONSULTATION The Watery Eye	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Arbabi, Esmaeil M.; Carrim, Zia I.] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; [Arshad, Faisal A.] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; [Holden, Kate] Haxby & Wigginton Hlth Ctr, York, N Yorkshire, England	Saint James's University Hospital; University of Sheffield	Arbabi, EM (corresponding author), St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England.	esarbabi@gmail.com						Kanski J. K., 2007, CLIN OPHTHALMOLOGY S, P151; KUSHNER BJ, 1982, ARCH OPHTHALMOL-CHIC, V100, P597	2	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2011	343								d4029	10.1136/bmj.d4029	http://dx.doi.org/10.1136/bmj.d4029			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797ZG	21771824				2022-12-28	WOS:000293168500006
J	Bach, RG				Bach, Richard G.			CABG and PCI did not differ clinically for angina relief in severe CAD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Washington Univ, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Bach, RG (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.		Bach, Richard/AAI-2515-2021; Bach, Richard G/G-9764-2011						0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2							JC1-10	10.7326/0003-4819-155-2-201107190-02010	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	793KW	21768576				2022-12-28	WOS:000292822000009
J	Williams, R				Williams, Ruth			BIOMARKERS Warning signs	NATURE			English	Editorial Material							NEUROIMAGING INITIATIVE SUBJECTS; ALZHEIMERS-DISEASE											Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Reddy MM, 2011, CELL, V144, P132, DOI 10.1016/j.cell.2010.11.054; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Trojanowski JQ, 2010, ALZHEIMERS DEMENT, V6, P230, DOI 10.1016/j.jalz.2010.03.008	6	15	15	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					S5	S7		10.1038/475S5a	http://dx.doi.org/10.1038/475S5a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21760581	Bronze			2022-12-28	WOS:000292690500003
J	Murtagh, L; Ludwig, DS				Murtagh, Lindsey; Ludwig, David S.			State Intervention in Life-Threatening Childhood Obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BARIATRIC SURGERY; CHILDREN; ADOLESCENTS		[Ludwig, David S.] Childrens Hosp, Dept Med, Optimal Weight Life Program, Boston, MA 02115 USA; [Murtagh, Lindsey] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, Optimal Weight Life Program, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24DK082730] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		DePanfilis D, 2006, CHILD NEGLECT GUIDE; Murtagh L, 2007, J LAW MED ETHICS, V35, P497; Pinhas-Hamiel O, 2007, LANCET, V369, P1823, DOI 10.1016/S0140-6736(07)60821-6; Skelton JA, 2009, ACAD PEDIATR, V9, P322, DOI 10.1016/j.acap.2009.04.005; Treadwell JR, 2008, ANN SURG, V248, P763, DOI 10.1097/SLA.0b013e31818702f4; Varness T, 2009, PEDIATRICS, V123, P399, DOI 10.1542/peds.2008-0712; Viner RM, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3074; Wang YC, 2006, PEDIATRICS, V118, pE1721, DOI 10.1542/peds.2006-0682; Weiss R, 2010, NAT REV ENDOCRINOL, V6, P125, DOI 10.1038/nrendo.2010.1	9	33	34	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					206	207		10.1001/jama.2011.903	http://dx.doi.org/10.1001/jama.2011.903			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791CO	21750301				2022-12-28	WOS:000292639400031
J	Eckhardt, B				Eckhardt, Bruno			A Critical Point for Turbulence	SCIENCE			English	Editorial Material							PIPE-FLOW; TRANSITION; STATES		[Eckhardt, Bruno] Univ Marburg, Fachbereich Phys, D-35032 Marburg, Germany; [Eckhardt, Bruno] Delft Univ Technol, JM Burgersctr, NL-2628 CD Delft, Netherlands	Philipps University Marburg; Delft University of Technology	Eckhardt, B (corresponding author), Univ Marburg, Fachbereich Phys, D-35032 Marburg, Germany.	bruno.eckhardt@physik.uni-marburg.de	Eckhardt, Bruno/D-5948-2012	Eckhardt, Bruno/0000-0003-4050-3254				Avila K, 2011, SCIENCE, V333, P192, DOI 10.1126/science.1203223; Drazin PG, 2004, HYDRODYNAMIC STABILI; Eckhardt B, 2009, PHILOS T R SOC A, V367, P449, DOI 10.1098/rsta.2008.0217; Faisst H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.224502; Faisst H, 2004, J FLUID MECH, V504, P343, DOI 10.1017/S0022112004008134; Hinrichsen H, 2000, ADV PHYS, V49, P815, DOI 10.1080/00018730050198152; Hof B, 2004, SCIENCE, V305, P1594, DOI 10.1126/science.1100393; Hof B, 2006, NATURE, V443, P59, DOI 10.1038/nature05089; Manneville P, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.025301; Meseguer A, 2003, J COMPUT PHYS, V186, P178, DOI 10.1016/S0021-9991(03)00029-9; Moxey D, 2010, P NATL ACAD SCI USA, V107, P8091, DOI 10.1073/pnas.0909560107; Nishi M, 2008, J FLUID MECH, V614, P425, DOI 10.1017/S0022112008003315; Pringle CCT, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.074502; Rotta J., 1956, ING ARCH, V24, P258, DOI [10.1007/BF00536526, DOI 10.1007/BF00536526]; Wedin H, 2004, J FLUID MECH, V508, P333, DOI 10.1017/S0022112004009346	15	21	22	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2011	333	6039					165	166		10.1126/science.1208261	http://dx.doi.org/10.1126/science.1208261			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21737727				2022-12-28	WOS:000292502700031
J	Detsky, AS; Baerlocher, MO				Detsky, Allan S.; Baerlocher, Mark O.			Do Nice Patients Receive Better Care?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS		[Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada; [Baerlocher, Mark O.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California San Diego	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Room 429, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						Atzema CL, 2011, CAN MED ASSOC J, V183, P663, DOI 10.1503/cmaj.100685; AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401; Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; Cain DM, 2008, JAMA-J AM MED ASSOC, V299, P2893, DOI 10.1001/jama.299.24.2893; Chapman KR, 2001, CHEST, V119, P1691, DOI 10.1378/chest.119.6.1691; GORLIN R, 1983, NEW ENGL J MED, V308, P1059, DOI 10.1056/NEJM198305053081804; Hahn SR, 1996, J GEN INTERN MED, V11, P1, DOI 10.1007/BF02603477; LEVINSON W, 1993, MED CARE, V31, P285, DOI 10.1097/00005650-199304000-00001; Lutfey K, 2005, AM J SOCIOL, V110, P1326, DOI 10.1086/428914; Pomm HA, 2004, FAM MED, V36, P467	10	6	6	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					94	95		10.1001/jama.2011.883	http://dx.doi.org/10.1001/jama.2011.883			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	21730247				2022-12-28	WOS:000292378700028
J	Orban, T; Bundy, B; Becker, DJ; DiMeglio, LA; Gitelman, SE; Goland, R; Gottlieb, PA; Greenbaum, CJ; Marks, JB; Monzavi, R; Moran, A; Raskin, P; Rodriguez, H; Russell, WE; Schatz, D; Wherrett, D; Wilson, DM; Krischer, JP; Skyler, JS				Orban, Tihamer; Bundy, Brian; Becker, Dorothy J.; DiMeglio, Linda A.; Gitelman, Stephen E.; Goland, Robin; Gottlieb, Peter A.; Greenbaum, Carla J.; Marks, Jennifer B.; Monzavi, Roshanak; Moran, Antoinette; Raskin, Philip; Rodriguez, Henry; Russell, William E.; Schatz, Desmond; Wherrett, Diane; Wilson, Darrell M.; Krischer, Jeffrey P.; Skyler, Jay S.		Type 1 Diabet TrialNet Abatacept S	Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							BETA-CELL FUNCTION; MONOCLONAL-ANTIBODY; COSTIMULATION; ARTHRITIS; BLOCKADE	Background The immunopathogenesis of type 1 diabetes mellitus is associated with T-cell autoimmunity. To be fully active, immune T cells need a co-stimulatory signal in addition to the main antigen-driven signal. Abatacept modulates co-stimulation and prevents full T-cell activation. We evaluated the effect of abatacept in recent-onset type 1 diabetes. Methods In this multicentre, double-blind, randomised controlled trial, patients aged 6-45 years recently diagnosed with type 1 diabetes were randomly assigned (2:1) to receive abatacept (10 mg/kg, maximum 1000 mg per dose) or placebo infusions intravenously on days 1, 14, 28, and monthly for a total of 27 infusions over 2 years. Computer. generated permuted block randomisation was used, with a block size of 3 and stratified by participating site. Neither patients nor research personnel were aware of treatment assignments. The primary outcome was baseline-adjusted geometric mean 2-h area-under-the-curve (AUC) serum C-peptide concentration after a mixed-meal tolerance test at 2 years' follow-up. Analysis was by intention to treat for all patients for whom data were available. This trial is registered at ClinicalTrials.gov, NCT00505375. Findings 112 patients were assigned to treatment groups (77 abatacept, 35 placebo). Adjusted C-peptide AUC was 59% (95% CI 6.1-112) higher at 2 years with abatacept (n=73, 0.378 nmol/L) than with placebo (n=30, 0.238 nmol/L; p=0.0029). The difference between groups was present throughout the trial, with an estimated 9.6 months' delay (95% CI 3.47-15.6) in C-peptide reduction with abatacept. There were few infusion-related adverse events (36 reactions occurred in 17 [22%] patients on abatacept and 11 reactions in six [17%] on placebo). There was no increase in infections (32 (42%] patients on abatacept vs 15 [43%] on placebo) or neutropenia (seven [9%] vs five [14%]). Interpretation Co-stimulation modulation with abatacept slowed reduction in beta-cell function over 2 years. The beneficial effect suggests that T-cell activation still occurs around the time of clinical diagnosis of type 1 diabetes. Yet, despite continued administration of abatacept over 24 months, the decrease in beta-cell function with abatacept was parallel to that with placebo after 6 months of treatment, causing us to speculate that T-cell activation lessens with time. Further observation will establish whether the beneficial effect continues after cessation of abatacept infusions.	[Skyler, Jay S.] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA; [Orban, Tihamer] Joslin Diabet Ctr, Boston, MA 02215 USA; [Bundy, Brian; Krischer, Jeffrey P.] Univ S Florida, Tampa, FL USA; [Becker, Dorothy J.] Univ Pittsburgh, Pittsburgh, PA USA; [DiMeglio, Linda A.; Rodriguez, Henry] Indiana Univ Sch Med, Indianapolis, IN USA; [Gitelman, Stephen E.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Goland, Robin] Columbia Univ, New York, NY USA; [Gottlieb, Peter A.] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Greenbaum, Carla J.] Benaroya Res Inst, Seattle, WA USA; [Monzavi, Roshanak] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Moran, Antoinette] Univ Minnesota, Minneapolis, MN USA; [Raskin, Philip] Univ Texas SW Med Sch, Dallas, TX USA; [Russell, William E.] Vanderbilt Univ, Nashville, TN USA; [Schatz, Desmond] Univ Florida, Gainesville, FL USA; [Wherrett, Diane] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Wilson, Darrell M.] Stanford Univ, Stanford, CA 94305 USA	University of Miami; Harvard University; Joslin Diabetes Center, Inc.; State University System of Florida; University of South Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indiana University System; Indiana University Bloomington; University of California System; University of California San Francisco; Columbia University; University of Colorado System; University of Colorado Anschutz Medical Campus; Benaroya Research Institute; Children's Hospital Los Angeles; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; State University System of Florida; University of Florida; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Stanford University	Skyler, JS (corresponding author), Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA.	jskyler@miami.edu	Krischer, Jeffrey P/I-5004-2012; Skyler, Jay S/F-4211-2016; Moore, Daniel J/A-4924-2008; DiMeglio, Linda A./F-9277-2019; Moore, Daniel/V-6145-2019; Toledo, Frederico/G-9071-2013	Moore, Daniel J/0000-0002-6889-9345; DiMeglio, Linda A./0000-0002-8033-6078; Moore, Daniel/0000-0002-6889-9345; Toledo, Frederico/0000-0002-6570-9948; Skyler, Jay/0000-0003-1136-8110	National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01 DK061010, U01 DK061016, U01 DK061034, U01 DK061036, U01 DK061040, U01 DK061041, U01 DK061042, U01 DK061055, U01 DK061058, U01 DK084565, U01 DK085453, U01 DK085461, U01 DK085463, U01 DK085466, U01 DK085499, U01 DK085505, U01 DK085509, HHSN267200800019C]; National Center for Research Resources [UL1 RR024131, UL1 RR024139, UL1 RR024153, UL1 RR024975, UL1 RR024982, UL1 RR025744, UL1 RR025761, UL1 RR025780, UL1 RR029890, UL1 RR031986]; General Clinical Research Center [M01 RR00400]; Juvenile Diabetes Research Foundation International (JDRF); American Diabetes Association (ADA); Diamyd; Tolerx; Bayhill Therapeutics; Macrogenics; Omni Bio Therapeutics; Aegera; Andromeda Biotech; Biodel; Boehringer Ingelheim; Calibra; CPEX; Generex; Hoffman-LaRoche; Mann Kind; Novo-Nordisk; Osiris Therapeutics; Reata; Eli Lilly; Medtronic; Halozyme; Intuity; Becton-Dickinson; Merck; Mann Kind Corporation; GlaxoSmithKline; Salutria Pharmaceuticals; Veroscience; Roche; Exsulin; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780, UL1RR024982, UL1RR029890, UL1RR025761, UL1RR024975, M01RR000400, UL1RR024153, UL1RR024139, UL1RR031986, UL1RR025744, UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061058, U01DK061036, U01DK061034, U01DK085461, U01DK085505, U01DK085504, U01DK085509, U01DK061010, U01DK061041, U01DK061055, U01DK061040, U01DK085463, U01DK085453, UC4DK117009, U01DK061042, U01DK085499, U01DK085466] Funding Source: NIH RePORTER	National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); American Diabetes Association (ADA)(American Diabetes Association); Diamyd; Tolerx; Bayhill Therapeutics; Macrogenics; Omni Bio Therapeutics; Aegera; Andromeda Biotech; Biodel; Boehringer Ingelheim(Boehringer Ingelheim); Calibra; CPEX; Generex; Hoffman-LaRoche; Mann Kind; Novo-Nordisk(Novo Nordisk); Osiris Therapeutics; Reata; Eli Lilly(Eli Lilly); Medtronic(Medtronic); Halozyme; Intuity; Becton-Dickinson; Merck(Merck & Company); Mann Kind Corporation; GlaxoSmithKline(GlaxoSmithKline); Salutria Pharmaceuticals; Veroscience; Roche(Roche Holding); Exsulin; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	TO reports serving on a data safety monitoring board for Osiris Therapeutics and beings founder of Orban Biotech LLC. DJB reports receiving a grant from Diamyd. SEG reports serving on an advisory board for Genentech. RG reports receiving grants from Diamyd and Tolerx. PAG reports serving on advisory boards for Genentech, Eli Lilly, Sanofi-Aventis, and Tolerx, and reports receiving grants from Bayhill Therapeutics, Diamyd, Macrogenics, Omni Bio Therapeutics, and Tolerx. CJG reports receiving grants from Bayhill Therapeutics, Diamyd, and Tolerx. JBM reports serving on an advisory board for Amgen. AM reports serving on an advisory board for Pfizer and receiving grants from Tolerx, Merck, and Osiris Therapeutics. PR reports serving on advisory boards for Amgen, AstraZeneca, MannKind, and Novo-Nordisk, serving on speakers bureaus for Merck and Novo-Nordisk, and receiving grants from Aegera, Andromeda Biotech, Bayhill Therapeutics, Biodel, Boehringer Ingelheim, Calibra, CPEX, Generex, Hoffman-LaRoche, Mann Kind, Novo-Nordisk, Osiris Therapeutics, and Reata. HR reports serving on an advisory board for Marcadia Biotech, serving as a Consultant to Eli Lilly, Genentech, Bayer, EMD Serono, and Merck, being on the speakers bureau of Eli Lilly and Novo-Nordisk, and receiving grant support from Macrogenics and Eli Lilly. DS reports serving on advisory boards for Eli Lilly and GlaxoSmithKline and receiving a grant from Diamyd. DW reports receiving lecture fees from Eli Lilly and Medtronic. DMW reports serving on an advisory boards for DexCom and Genentech and receiving grants support from Genentech, Diamyd, and Osiris Therapeutics. JSS reports serving on boards for Amylin Pharmaceuticals, DexCom, and Sanofi-Aventis, receiving grants from Bayhill Therapeutics, Halozyme, Intuity, and Osiris Therapeutics, receiving consultancy fees from Becton-Dickinson, Merck, Mann Kind Corporation, GlaxoSmithKline, Salutria Pharmaceuticals, Veroscience, Roche, and Exsulin, and receiving speakers' fees and payment for development of an educational presentation from Novo-Nordisk and holds stock in Amylin Pharmaceuticals and Dexcom. BB, LADM, RM, WER, and JPK declare that they have no conflicts of interest.; The sponsor of the trial was the Type 1 Diabetes TrialNet Study Group. Type 1 Diabetes TrialNet Study Group is a clinical trials network funded by the National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Allergy and Infectious Diseases, and The Eunice Kennedy Shriver National Institute of Child Health and Human Development, through the cooperative agreements U01 DK061010, U01 DK061016, U01 DK061034, U01 DK061036, U01 DK061040, U01 DK061041, U01 DK061042, U01 DK061055, U01 DK061058, U01 DK084565, U01 DK085453, U01 DK085461, U01 DK085463, U01 DK085466, U01 DK085499, U01 DK085505, U01 DK085509, and a contract HHSN267200800019C; the National Center for Research Resources, through Clinical Translational Science Awards UL1 RR024131, UL1 RR024139, UL1 RR024153, UL1 RR024975, UL1 RR024982, UL1 RR025744, UL1 RR025761, UL1 RR025780, UL1 RR029890, UL1 RR031986, and General Clinical Research Center Award M01 RR00400; the Juvenile Diabetes Research Foundation International (JDRF); and the American Diabetes Association (ADA). The contents of this Article are solely the responsibility of the authors and do not necessarily represent the official views of the NIH, JDRF, or ADA. Bristol-Myers Squibb provided abatacept. Lifescan Division of Johnson and Johnson provided blood glucose monitoring meters and strips to participants.	Abrams JR, 1999, J CLIN INVEST, V103, P1243, DOI 10.1172/JCI5857; Agresti A., 1990, CATEGORICAL DATA ANA, pXV; *AM DIAB ASS, 2011, DIABETES CARE S1, V33, pS11; Bluestone JA, 2006, IMMUNITY, V24, P233, DOI 10.1016/j.immuni.2006.03.001; COX DR, 1972, J R STAT SOC B, V34, P187; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Genant HK, 2008, ANN RHEUM DIS, V67, P1084, DOI 10.1136/ard.2007.085084; Greenbaum CJ, 2008, DIABETES CARE, V31, P1966, DOI 10.2337/dc07-2451; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Keymeulen B, 2010, DIABETOLOGIA, V53, P614, DOI 10.1007/s00125-009-1644-9; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; Lo DJ, 2011, AM J TRANSPLANT, V11, P22, DOI 10.1111/j.1600-6143.2010.03317.x; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; Luo XR, 2010, IMMUNITY, V32, P488, DOI 10.1016/j.immuni.2010.04.002; Marelli-Berg FM, 2007, TRENDS IMMUNOL, V28, P267, DOI 10.1016/j.it.2007.04.008; Mease P, 2011, ARTHRITIS RHEUM-US, V63, P939, DOI 10.1002/art.30176; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Ruperto N, 2008, LANCET, V372, P383, DOI 10.1016/S0140-6736(08)60998-8; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Skyler JS, 2011, DIABETES, V60, P1, DOI 10.2337/db10-1114; Sosenko JM, 2004, DIABETES, V53, pA425; Steffes MW, 2003, DIABETES CARE, V26, P832, DOI 10.2337/diacare.26.3.832; Vincenti F, 2005, NEW ENGL J MED, V353, P770, DOI 10.1056/NEJMoa050085; von Herrath M, 2007, NAT REV IMMUNOL, V7, P988, DOI 10.1038/nri2192	27	382	397	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2011	378	9789					412	419		10.1016/S0140-6736(11)60886-6	http://dx.doi.org/10.1016/S0140-6736(11)60886-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XM	21719096	Green Accepted			2022-12-28	WOS:000293615900032
J	Portenoy, RK				Portenoy, Russell K.			Treatment of cancer pain	LANCET			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; QUALITY-OF-LIFE; CELL LUNG-CANCER; NEUROPATHIC PAIN; OPIOID ROTATION; PALLIATIVE CARE; ORAL METHADONE; MANAGEMENT; MORPHINE; RECOMMENDATIONS	In patients with active cancer, the management of chronic pain is an essential element in a comprehensive strategy for palliative care. This strategy emphasises multidimensional assessment and the coordinated use of treatments that together mitigate suffering and provide support to the patient and family. This review describes this framework, an approach to pain assessment, and widely accepted techniques to optimise the safety and effectiveness of opioid drugs and other treatments. The advances of recent decades suggest a future that includes increased evidence-based targeting of specific analgesic interventions within an individualised plan of care that is appropriate throughout the course of illness.	[Portenoy, Russell K.] Beth Israel Deaconess Med Ctr, Dept Pain Med & Palliat Care, New York, NY 10003 USA; [Portenoy, Russell K.] Albert Einstein Coll Med, New York, NY USA; [Portenoy, Russell K.] MJHS Hosp & Palliat Care, New York, NY USA	Harvard University; Beth Israel Deaconess Medical Center; Yeshiva University	Portenoy, RK (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pain Med & Palliat Care, New York, NY 10003 USA.	rporteno@chpnet.org			CNSBio; Covidien Mallinckrodt; Grupo Ferrer; King Pharmaceuticals; ProStrakan Pharmaceuticals; Purdue Pharrna; Abbott Laboratories; Ameritox; Archimedes Pharmaceuticals; Cephalon; Endo Pharmaceuticals; Forest Laboratories; GW Pharma; Meda Pharmaceuticals; Ortho-McNeil Janssen; Otsuka Pharma; Purdue Pharma; Tempur-Pedic Corp.	CNSBio; Covidien Mallinckrodt; Grupo Ferrer; King Pharmaceuticals; ProStrakan Pharmaceuticals; Purdue Pharrna; Abbott Laboratories(Abbott Laboratories); Ameritox; Archimedes Pharmaceuticals; Cephalon; Endo Pharmaceuticals; Forest Laboratories; GW Pharma; Meda Pharmaceuticals; Ortho-McNeil Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Otsuka Pharma(Otsuka Pharmaceutical); Purdue Pharma; Tempur-Pedic Corp.	I have received consultancy fees from CNSBio, Covidien Mallinckrodt, Grupo Ferrer, King Pharmaceuticals, ProStrakan Pharmaceuticals, and Purdue Pharrna, speakers' fees from Grupo Ferrer, and grants from Abbott Laboratories, Ameritox, Archimedes Pharmaceuticals, Cephalon, Covidien Mallinckrodt, Endo Pharmaceuticals, Forest Laboratories, GW Pharma, King Pharmaceuticals, Meda Pharmaceuticals, Ortho-McNeil Janssen, Otsuka Pharma, Purdue Pharma, and Tempur-Pedic Corp.	American Pain Society, 2008, PRINC AN US TREATM A; Bannister Kirsty, 2010, Curr Opin Support Palliat Care, V4, P1, DOI 10.1097/SPC.0b013e328335ddfe; Bardia A, 2006, J CLIN ONCOL, V24, P5457, DOI 10.1200/JCO.2006.08.3725; Becker G, 2007, J PAIN SYMPTOM MANAG, V34, P547, DOI 10.1016/j.jpainsymman.2006.12.018; Bennett GJ, 2010, ONCOLOGIST, V15, P9, DOI 10.1634/theoncologist.2009-S503; Brogan Shane, 2010, J Support Oncol, V8, P52; Bruera E, 2004, J CLIN ONCOL, V22, P185, DOI 10.1200/JCO.2004.03.172; Bryson John, 2006, Curr Oncol Rep, V8, P282, DOI 10.1007/s11912-006-0034-4; Caraceni A, 1999, PAIN, V82, P263, DOI 10.1016/S0304-3959(99)00073-1; Cassileth BR, 2010, ONCOLOGIST, V15, P19, DOI 10.1634/theoncologist.2009-S504; Chan FKL, 2008, AM J GASTROENTEROL, V103, P2908, DOI 10.1111/j.1572-0241.2008.02200.x; Chen YF, 2008, HEALTH TECHNOL ASSES, V12, P1, DOI 10.3310/hta12110; Cherny NI, 2010, ANN ONCOL, V21, P615, DOI 10.1093/annonc/mdp581; Chu LF, 2008, CLIN J PAIN, V24, P479, DOI 10.1097/AJP.0b013e31816b2f43; Coluzzi PH, 2001, PAIN, V91, P123, DOI 10.1016/S0304-3959(00)00427-9; Cormie PJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2154; Costa L, 2009, NAT CLIN PRACT ONCOL, V6, P163, DOI 10.1038/ncponc1323; Cruciani RA, 2005, J PAIN SYMPTOM MANAG, V29, P385, DOI 10.1016/j.jpainsymman.2004.06.012; De Lima MHAL, 2001, HEALTH POLICY, V56, P99, DOI 10.1016/S0168-8510(00)00130-5; Deandrea S, 2008, ANN ONCOL, V19, P1985, DOI 10.1093/annonc/mdn419; Dy SM, 2008, J CLIN ONCOL, V26, P3879, DOI 10.1200/JCO.2007.15.9517; Fainsinger RL, 2005, J PAIN SYMPTOM MANAG, V29, P224, DOI 10.1016/j.jpainsymman.2004.05.008; Falkmer U, 2003, ACTA ONCOL, V42, P620, DOI 10.1080/02841860310014895; Ferris FD, 2009, J CLIN ONCOL, V27, P3052, DOI 10.1200/JCO.2008.20.1558; Fine PG, 2009, J PAIN SYMPTOM MANAG, V38, P418, DOI 10.1016/j.jpainsymman.2009.06.002; Goudas LC, 2005, CANCER INVEST, V23, P182, DOI 10.1081/CNV-200050482; Green E, 2010, CLIN J PAIN, V26, P449, DOI 10.1097/AJP.0b013e3181dacd62; Grossman SA, 2000, ONCOLOGY-NY, V14, P135; Hjermstad Marianne J, 2009, Curr Opin Support Palliat Care, V3, P24, DOI 10.1097/SPC.0b013e3283260644; Holzer Peter, 2009, J Opioid Manag, V5, P145; Jimenez-Andrade JM, 2010, ANN NY ACAD SCI, V1198, P173, DOI 10.1111/j.1749-6632.2009.05429.x; Johnson C, 2010, EUR J CANCER, V46, P2242, DOI 10.1016/j.ejca.2010.04.014; Jost L, 2008, ANN ONCOL, V19, P119, DOI 10.1093/annonc/mdn108; Katz NP, 2007, CLIN J PAIN, V23, P103, DOI 10.1097/01.ajp.0000210953.86255.8f; Klepstad P, 2003, ACTA ANAESTH SCAND, V47, P725, DOI 10.1034/j.1399-6576.2003.00138.x; Knotkova H, 2009, J PAIN SYMPTOM MANAG, V38, P426, DOI 10.1016/j.jpainsymman.2009.06.001; Krakowski I, 2003, BRIT J CANCER, V89, pS67, DOI 10.1038/sj.bjc.6601086; Kwekkeboom KL, 2010, J PAIN SYMPTOM MANAG, V39, P126, DOI 10.1016/j.jpainsymman.2009.05.022; Lotsch J, 2009, PAIN, V144, P119, DOI 10.1016/j.pain.2009.03.023; Lussier D, 2010, OXFORD TXB PALLIATIV, P706; Maltoni M, 2005, SUPPORT CARE CANCER, V13, P888, DOI 10.1007/s00520-005-0807-6; McNicol E, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005180; Mercadante S, 2008, EUR J PAIN, V12, P1040, DOI 10.1016/j.ejpain.2008.01.013; Mercadante S, 2007, J PAIN SYMPTOM MANAG, V33, P217, DOI 10.1016/j.jpainsymman.2006.06.014; Modesto-Lowe V, 2010, J GEN INTERN MED, V25, P305, DOI 10.1007/s11606-009-1225-0; Moore RA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-73; O'Connor AB, 2009, AM J MED, V122, pS22, DOI 10.1016/j.amjmed.2009.04.007; Oldenmenger WH, 2009, EUR J CANCER, V45, P1370, DOI 10.1016/j.ejca.2009.01.007; Portenoy RK, 2011, SUBSTANCE ABUSE COMP, P695; Rhodin A, 2010, CLIN J PAIN, V26, P374, DOI 10.1097/AJP.0b013e3181d1059d; Sandoval JA, 2005, CLIN J PAIN, V21, P503, DOI 10.1097/01.ajp.0000146165.15529.50; Ferreira KAS, 2006, SUPPORT CARE CANCER, V14, P1086, DOI 10.1007/s00520-006-0086-x; Savage SR, 2003, J PAIN SYMPTOM MANAG, V26, P655, DOI 10.1016/S0885-3924(03)00219-7; Schneider JP, 2010, CNS DRUGS, V24, P805, DOI 10.2165/11584260-000000000-00000; Sloan Paul A, 2007, Curr Pain Headache Rep, V11, P283, DOI 10.1007/s11916-007-0205-5; Smith TJ, 2002, J CLIN ONCOL, V20, P4040, DOI 10.1200/JCO.2002.02.118; Stone P, 2011, PALLIATIVE MED, V25, P431, DOI 10.1177/0269216310380763; Tanvetyanon T, 2007, J THORAC ONCOL, V2, P1091, DOI 10.1097/JTO.0b013e31815cff64; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Trescot AM, 2010, J NATL COMPR CANC NE, V8, P1087, DOI 10.6004/jnccn.2010.0077; Walker JM, 2007, J CLIN SLEEP MED, V3, P455; Wilcock A, 2006, PALLIATIVE MED, V20, P661, DOI 10.1177/0269216306070755; World Health Organization, 1996, CANC PAIN REL; Zeppetella Giovambattista, 2009, Curr Opin Support Palliat Care, V3, P1, DOI 10.1097/SPC.0b013e3283260658	64	308	324	2	54	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2011	377	9784					2236	2247		10.1016/S0140-6736(11)60236-5	http://dx.doi.org/10.1016/S0140-6736(11)60236-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	786XI	21704873				2022-12-28	WOS:000292340800036
J	Shil, AB				Shil, Asit Baran			Wireless pulmonary artery haemodynamic monitoring	LANCET			English	Letter							HEART-FAILURE; TRIAL		USC Keck Sch Med, Los Angeles, CA 90015 USA	University of Southern California	Shil, AB (corresponding author), USC Keck Sch Med, Los Angeles, CA 90015 USA.	shil@usc.edu						Abraham WT, 2011, LANCET, V377, P658, DOI 10.1016/S0140-6736(11)60101-3; Al-Khadra AS, 1998, J AM COLL CARDIOL, V31, P419, DOI 10.1016/S0735-1097(97)00502-0; Cleland JGF, 2004, AM HEART J, V148, P157, DOI 10.1016/j.ahj.2004.03.010; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Tseng CH, 2011, EUR J CLIN INVEST, V41, P597, DOI 10.1111/j.1365-2362.2010.02447.x	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2011	377	9784					2176	2176		10.1016/S0140-6736(11)60955-0	http://dx.doi.org/10.1016/S0140-6736(11)60955-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	786XI	21704863				2022-12-28	WOS:000292340800021
J	Denham, BE				Denham, Bryan E.			Dietary Supplements-Regulatory Issues and Implications for Public Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Clemson Univ, Dept Commun Studies, Clemson, SC 29634 USA	Clemson University	Denham, BE (corresponding author), Clemson Univ, Dept Commun Studies, 412 Strode Tower, Clemson, SC 29634 USA.	bdenham@clemson.edu						Hill J.A., 2006, J FOOD L POL, V2, P361; *NAT CTR COMPL ALT, RES RES DIET HERB SU; US Food & Drug Administration, CURR GOOD MAN PRACT; *US GOV ACC OFF, 2009, PUBL US GOV ACC OFF; *US GOV ACC OFF, 2010, PUBL US GOV ACC OFF; *US GOV ACC OFF, 1993, PUBL US GOV ACC OFF	6	37	37	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2011	306	4					428	429		10.1001/jama.2011.982	http://dx.doi.org/10.1001/jama.2011.982			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797KL	21730229				2022-12-28	WOS:000293125800029
J	Kroshinsky, D; Stone, JH; Nazarian, RM				Kroshinsky, Daniela; Stone, John H.; Nazarian, Rosalynn M.			Case 22-2011: A 79-Year-Old Man with a Rash, Arthritis, and Ocular Erythema	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS; CUTANEOUS LEUKOCYTOCLASTIC VASCULITIS; VALVULAR HEART-DISEASE; JACCOUDS ARTHROPATHY; SCLERITIS; LESIONS; ANCA		[Kroshinsky, Daniela] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Stone, John H.] Massachusetts Gen Hosp, Dept Rheumatol, Boston, MA 02114 USA; [Nazarian, Rosalynn M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kroshinsky, Daniela] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Stone, John H.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Nazarian, Rosalynn M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kroshinsky, D (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA.		Kroshinsky, Daniela/AAM-4608-2020; Nazarian, Rosalynn/AFL-3176-2022	Kroshinsky, Daniela/0000-0002-4781-9676; Nazarian, Rosalynn/0000-0003-4003-7193				Amano H, 2008, LUPUS, V17, P837, DOI 10.1177/0961203308090113; Balsam L, 2008, AM J KIDNEY DIS, V52, P1168, DOI 10.1053/j.ajkd.2008.07.024; Barnadas MA, 2004, INT J DERMATOL, V43, P19, DOI 10.1111/j.1365-4632.2004.01714.x; BOOM B W, 1992, Journal of Dermatological Science, V3, P26, DOI 10.1016/0923-1811(92)90005-V; Carlson JA, 2006, AM J DERMATOPATH, V28, P486, DOI 10.1097/01.dad.0000246646.45651.a2; Carlson JA, 2010, HISTOPATHOLOGY, V56, P3, DOI 10.1111/j.1365-2559.2009.03443.x; Davis MDP, 2004, IMMUNOL ALLERGY CLIN, V24, P183, DOI 10.1016/j.iac.2004.01.007; Gupta S, 2009, INDIAN J DERMATOL VE, V75, P356, DOI 10.4103/0378-6323.53130; HARRIST TJ, 1979, HUM PATHOL, V10, P625, DOI 10.1016/S0046-8177(79)80109-4; Houser SL, 2002, CARDIOVASC PATHOL, V11, P210, DOI 10.1016/S1054-8807(02)00107-2; Jara Luis J, 2009, Curr Rheumatol Rep, V11, P410; Kano Y, 1998, ARCH DERMATOL, V134, P62, DOI 10.1001/archderm.134.1.62; Lamprecht P, 2003, CLIN EXP RHEUMATOL, V21, pS89; Okhravi N, 2005, SURV OPHTHALMOL, V50, P351, DOI 10.1016/j.survophthal.2005.04.001; RONDA N, 1994, CLIN EXP IMMUNOL, V95, P49; Russell JP, 2006, INT J DERMATOL, V45, P3, DOI 10.1111/j.1365-4632.2005.02898.x; Sheen YS, 2006, ARCH DERMATOL, V142, P879, DOI 10.1001/archderm.142.7.879; Thorne JE, 2002, AM J OPHTHALMOL, V134, P932, DOI 10.1016/S0002-9394(02)01814-7; Turesson C, 2009, CURR OPIN RHEUMATOL, V21, P35, DOI 10.1097/BOR.0b013e32831c5303; Wisnieski JJ, 2000, CURR OPIN RHEUMATOL, V12, P24, DOI 10.1097/00002281-200001000-00005; WISNIESKI JJ, 1995, MEDICINE, V74, P24, DOI 10.1097/00005792-199501000-00003	21	2	2	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2011	365	3					252	263		10.1056/NEJMcpc1100929	http://dx.doi.org/10.1056/NEJMcpc1100929			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794QI	21774714				2022-12-28	WOS:000292915500011
J	Urban, LE; McCrory, MA; Dallal, GE; Das, SK; Saltzman, E; Weber, JL; Roberts, SB				Urban, Lorien E.; McCrory, Megan A.; Dallal, Gerard E.; Das, Sai Krupa; Saltzman, Edward; Weber, Judith L.; Roberts, Susan B.			Accuracy of Stated Energy Contents of Restaurant Foods	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WEIGHT-LOSS; US ADULTS; CONSUMPTION; OBESITY; TRENDS; PREVALENCE; OVERWEIGHT; AMERICA; CHOICES; IMPACT	Context National recommendations for the prevention and treatment of obesity emphasize reducing energy intake. Foods purchased in restaurants provide approximately 35% of the daily energy intake in US individuals but the accuracy of the energy contents listed for these foods is unknown. Objective To examine the accuracy of stated energy contents of foods purchased in restaurants. Design and Setting A validated bomb calorimetry technique was used to measure dietary energy in food from 42 restaurants, comprising 269 total food items and 242 unique foods. The restaurants and foods were randomly selected from quick-serve and sit-down restaurants in Massachusetts, Arkansas, and Indiana between January and June 2010. Main Outcome Measure The difference between restaurant-stated and laboratory-measured energy contents, which were corrected for standard metabolizable energy conversion factors. Results The absolute stated energy contents were not significantly different from the absolute measured energy contents overall (difference of 10 kcal/portion; 95% confidence interval [CI], -15 to 34 kcal/portion; P =. 52); however, the stated energy contents of individual foods were variable relative to the measured energy contents. Of the 269 food items, 50 (19%) contained measured energy contents of at least 100 kcal/portion more than the stated energy contents. Of the 10% of foods with the highest excess energy in the initial sampling, 13 of 17 were available for a second sampling. In the first analysis, these foods contained average measured energy contents of 289 kcal/portion (95% CI, 186 to 392 kcal/portion) more than the stated energy contents; in the second analysis, these foods contained average measured energy contents of 258 kcal/portion (95% CI, 154 to 361 kcal/portion) more than the stated energy contents (P < .001 for each vs 0 kcal/portion difference). In addition, foods with lower stated energy contents contained higher measured energy contents than stated, while foods with higher stated energy contents contained lower measured energy contents (P < .001). Conclusions Stated energy contents of restaurant foods were accurate overall. However, there was substantial inaccuracy for some individual foods, with understated energy contents for those with lower energy contents.	[Roberts, Susan B.] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Energy Metab Lab, Boston, MA 02111 USA; [McCrory, Megan A.] Purdue Univ, Dept Foods & Nutr, Dept Psychol Sci, W Lafayette, IN 47907 USA; [McCrory, Megan A.] Purdue Univ, Ingest Behav Res Ctr, W Lafayette, IN 47907 USA; [Weber, Judith L.] Univ Arkansas Med Sci, Dept Pediat, Coll Med, Little Rock, AR 72205 USA	Tufts University; United States Department of Agriculture (USDA); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Arkansas System; University of Arkansas Medical Sciences	Roberts, SB (corresponding author), Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Energy Metab Lab, 711 Washington St, Boston, MA 02111 USA.	susan.roberts@tufts.edu			GSK Consumer Healthcare; US Department of Agriculture [58-1950-0-014]; Tufts University; Purdue University; Arkansas Children's Hospital Research Institute; Arkansas Biosciences Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069772] Funding Source: NIH RePORTER	GSK Consumer Healthcare; US Department of Agriculture(United States Department of Agriculture (USDA)); Tufts University; Purdue University; Arkansas Children's Hospital Research Institute; Arkansas Biosciences Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure ported that her institution received money from GSK Consumer Healthcare to conduct investigator-initiated research on dietary macronutrient composition interactions with orlistat effects on appetite and related variables; and money was paid to her institution (Department of Foods and Nutrition, Purdue University) for the corporate affiliates program in which interested parties, mostly food manufacturers or suppliers thereof, pay an annual fee to learn about recent research and discuss topical nutrition-related issues such as the 2010 Dietary Guidelines. No other authors reported disclosures.; This work was supported by the US Department of Agriculture agreement No. 58-1950-0-014 with Tufts University, by internal department research funds from Purdue University, and by the Arkansas Children's Hospital Research Institute and the Arkansas Biosciences Institute.	Ahuja JKC, 2008, J FOOD COMPOS ANAL, V21, pS119, DOI 10.1016/j.jfca.2007.05.005; Bowman SA, 2004, J AM COLL NUTR, V23, P163, DOI 10.1080/07315724.2004.10719357; Burke LE, 2011, J AM DIET ASSOC, V111, P92, DOI 10.1016/j.jada.2010.10.008; Butte NF, 2003, SCIENCE, V301; Duffey KJ, 2007, AM J CLIN NUTR, V85, P201, DOI 10.1093/ajcn/85.1.201; *EC RES SERV, DIET QUAL FOOD CONS; Economic Research Service, US PER CAP LOSS ADJ; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Hall KD, 2008, INT J OBESITY, V32, P573, DOI 10.1038/sj.ijo.0803720; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Jakicic JM, 2001, MED SCI SPORT EXER, V33, P2145, DOI 10.1097/00005768-200112000-00026; Johnson CM, 2010, ARCH INTERN MED, V170, P732, DOI 10.1001/archinternmed.2010.72; Kant AK, 2004, PREV MED, V38, P243, DOI 10.1016/j.ypmed.2003.10.004; Katan MB, 2010, JAMA-J AM MED ASSOC, V303, P65, DOI 10.1001/jama.2009.1912; Levene H, 1960, CONTRIBUTIONS PROBAB; Ludwig DS, 2009, JAMA-J AM MED ASSOC, V302, P434, DOI 10.1001/jama.2009.1045; McCrory MA, 1999, OBES RES, V7, P564, DOI 10.1002/j.1550-8528.1999.tb00715.x; Merrill AL, 1973, HDB USDA, V74; Natl. Cent. Health Stat, 2007, HLTH US 2007; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Pulos E, 2010, AM J PUBLIC HEALTH, V100, P1035, DOI 10.2105/AJPH.2009.174839; Roberto CA, 2010, AM J PUBLIC HEALTH, V100, P312, DOI 10.2105/AJPH.2009.160226; Root AD, 2004, INT J FOOD SCI NUTR, V55, P449, DOI 10.1080/09637480400010415; *SAS I INC, 2004, SAS STAT 9 1 US GUID, P4773; Technomic Information Services, 2008, DINN OCC CONS TREND; Urban LE, 2010, J AM DIET ASSOC, V110, P116, DOI 10.1016/j.jada.2009.10.003; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; *USDA, 2007, AW HOM PERC SEL NUTR; Wadden TA, 2003, ENDOCRIN METAB CLIN, V32, P981, DOI 10.1016/S0889-8529(03)00072-0; Wing R. R., 2002, Handbook of obesity treatment, P301; RESTAURANTS I MAGAZI	33	44	44	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2011	306	3					287	293		10.1001/jama.2011.993	http://dx.doi.org/10.1001/jama.2011.993			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794BS	21771989	Green Accepted, Bronze			2022-12-28	WOS:000292870500021
J	Garcia, DA				Garcia, David A.			Dalteparin did not differ from unfractionated heparin for reducing proximal DVT in critically ill patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ New Mexico, Albuquerque, NM 87131 USA	University of New Mexico	Garcia, DA (corresponding author), Univ New Mexico, Albuquerque, NM 87131 USA.								0	0	0	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2							JC1-07	10.7326/0003-4819-155-2-201107190-02007	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	793KW	21768573				2022-12-28	WOS:000292822000006
J	D'Agostino, RB				D'Agostino, Ralph B., Sr.			Changing End Points in Breast-Cancer Drug Approval - The Avastin Story	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PACLITAXEL		Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	Boston University	D'Agostino, RB (corresponding author), Boston Univ, Dept Math & Stat, Boston, MA 02215 USA.							*FDA ONC DRUG ADV, 2010, JUL 20 M; *FDA ONC DRUGS ADV, 2007, DEC 5 M; Muggia FM, 2000, J CLIN ONCOL, V18, P106, DOI 10.1200/JCO.2000.18.1.106; Panageas KS, 2007, J NATL CANCER I, V99, P428, DOI 10.1093/jnci/djk091; Sledge GW, 2003, J CLIN ONCOL, V21, P588, DOI 10.1200/JCO.2003.08.013	5	66	68	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2								10.1056/nejmp1106984	http://dx.doi.org/10.1056/nejmp1106984			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791SP	21707384				2022-12-28	WOS:000292685500005
J	Facciabene, A; Peng, XH; Hagemann, IS; Balint, K; Barchetti, A; Wang, LP; Gimotty, PA; Gilks, CB; Lal, P; Zhang, L; Coukos, G				Facciabene, Andrea; Peng, Xiaohui; Hagemann, Ian S.; Balint, Klara; Barchetti, Andrea; Wang, Li-Ping; Gimotty, Phyllis A.; Gilks, C. Blake; Lal, Priti; Zhang, Lin; Coukos, George			Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T-reg cells	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OVARIAN-CANCER; SUPPRESSOR-CELLS; DENDRITIC CELLS; IMMUNE THERAPY; B RECEPTOR; RECRUITMENT; CCR10; VEGF; EXPRESSION	Although immune mechanisms can suppress tumour growth(1,2), tumours establish potent, overlapping mechanisms that mediate immune evasion(3-6). Emerging evidence suggests a link between angiogenesis and the tolerance of tumours to immune mechanisms(7-10). Hypoxia, a condition that is known to drive angiogenesis in tumours, results in the release of damage-associated pattern molecules, which can trigger the rejection of tumours by the immune system(11). Thus, the counter-activation of tolerance mechanisms at the site of tumour hypoxia would be a crucial condition for maintaining the immunological escape of tumours. However, a direct link between tumour hypoxia and tolerance through the recruitment of regulatory cells has not been established. We proposed that tumour hypoxia induces the expression of chemotactic factors that promote tolerance. Here we show that tumour hypoxia promotes the recruitment of regulatory T (T-reg) cells through induction of expression of the chemokine CC-chemokine ligand 28 (CCL28), which, in turn, promotes tumour tolerance and angiogenesis. Thus, peripheral immune tolerance and angiogenesis programs are closely connected and cooperate to sustain tumour growth.	[Facciabene, Andrea; Peng, Xiaohui; Balint, Klara; Barchetti, Andrea; Zhang, Lin; Coukos, George] Univ Penn, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA; [Hagemann, Ian S.; Wang, Li-Ping; Lal, Priti] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Gimotty, Phyllis A.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Gilks, C. Blake] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of British Columbia	Coukos, G (corresponding author), Univ Penn, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA.	gcks@mail.med.upenn.edu	Balint, Klara/ABB-8816-2021; Coukos, George/ABG-7389-2020; Gimotty, Phyllis/GWZ-4136-2022; Hagemann, Ian/ABB-2854-2021; duan, hf/F-9166-2011; Zhang, Lin/K-8478-2012	Gimotty, Phyllis/0000-0002-3850-9799; Hagemann, Ian/0000-0002-3855-9745; Coukos, George/0000-0001-8813-7367	National Institutes of Health [R01-CA116779]; National Cancer Institute [P01-CA83638]; Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA116779, P50CA083638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant R01-CA116779; National Cancer Institute Ovarian SPORE grant P01-CA83638; and the Ovarian Cancer Research Fund. We thank M. Celeste Simon and S. Evans for generous help with the hypoxia studies; M. Feldman and the University of Pennsylvania Tumor Tissue & Biospecimen Bank for tumour processing; and G. Danet-Desnoyers and the University of Pennsylvania Xenograft Core Facility for NSG mice.	Ben-Shoshan J, 2008, EUR J IMMUNOL, V38, P2412, DOI 10.1002/eji.200838318; Bergeron M, 1999, NEUROSCIENCE, V89, P1357, DOI 10.1016/S0306-4522(98)00377-7; Bertozzi CC, 2006, IN VITRO CELL DEV-AN, V42, P58; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Buckanovich RJ, 2007, J CLIN ONCOL, V25, P852, DOI 10.1200/JCO.2006.08.8583; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Curiel TJ, 2004, CANCER RES, V64, P5535, DOI 10.1158/0008-5472.CAN-04-1272; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Daponte A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-335; Eksteen B, 2006, J IMMUNOL, V177, P593, DOI 10.4049/jimmunol.177.1.593; Elia L, 2007, CANCER GENE THER, V14, P201, DOI 10.1038/sj.cgt.7701004; Feng NG, 2006, J IMMUNOL, V176, P5749, DOI 10.4049/jimmunol.176.10.5749; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kandalaft LE, 2009, CLIN CANCER RES, V15, P4521, DOI 10.1158/1078-0432.CCR-08-0543; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Lazarus NH, 2003, J IMMUNOL, V170, P3799, DOI 10.4049/jimmunol.170.7.3799; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Lee YH, 1999, EUR J CANCER, V35, P1089, DOI 10.1016/S0959-8049(99)00073-8; Li B, 2006, CLIN CANCER RES, V12, P6808, DOI 10.1158/1078-0432.CCR-06-1558; Lotfi R, 2007, J IMMUNOTHER, V30, P16, DOI 10.1097/01.cji.0000211324.53396.f6; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Nagaraj S, 2007, ADV EXP MED BIOL, V601, P213; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Osada T, 2008, CANCER IMMUNOL IMMUN, V57, P1115, DOI 10.1007/s00262-007-0441-x; Pan JL, 2000, J IMMUNOL, V165, P2943, DOI 10.4049/jimmunol.165.6.2943; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Shimogai R, 2008, INT J GYNECOL CANCER, V18, P499, DOI 10.1111/j.1525-1438.2007.01055.x; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang L, 2002, AM J PATHOL, V161, P2295, DOI 10.1016/S0002-9440(10)64505-1; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	37	837	883	6	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					226	U141		10.1038/nature10169	http://dx.doi.org/10.1038/nature10169			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753853				2022-12-28	WOS:000292690500050
J	Poll, LW; Flake, P				Poll, Ludger Wilhelm; Flake, Peter			Imperforate Hymen with Hematocolpometra	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Poll, Ludger Wilhelm; Flake, Peter] Berufsgenossenschaftl Unfallklin Duisburg, Duisburg, Germany		Poll, LW (corresponding author), Berufsgenossenschaftl Unfallklin Duisburg, Duisburg, Germany.	lpoll@gmx.de							0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2					157	157		10.1056/NEJMicm1010082	http://dx.doi.org/10.1056/NEJMicm1010082			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SP	21751908				2022-12-28	WOS:000292685500012
J	Snyder, KA; Pearse, W				Snyder, Karrie Ann; Pearse, William			Discussing Fertility Preservation Options With Patients With Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Snyder, Karrie Ann] Northwestern Univ, Dept Sociol, Evanston, IL 60208 USA; [Pearse, William] Rosalind Franklin Univ, N Chicago, IL USA	Northwestern University; Rosalind Franklin University Medical & Science	Snyder, KA (corresponding author), Northwestern Univ, Dept Sociol, 1810 Chicago Ave, Evanston, IL 60208 USA.	karrie-snyder@northwestern.edu			NICHD NIH HHS [RL1 HD058296-04] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [RL1HD058296] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Kohler TS, 2011, J ASSIST REPROD GEN, V28, P269, DOI 10.1007/s10815-010-9504-6; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; Quinn Gwendolyn P, 2007, J Cancer Surviv, V1, P146, DOI 10.1007/s11764-007-0019-9; Quinn GP, 2009, J CLIN ONCOL, V27, P5952, DOI 10.1200/JCO.2009.23.0250; RIEKER PP, 1990, J CLIN ONCOL, V8, P347, DOI 10.1200/JCO.1990.8.2.347; Robertson JA, 2005, FERTIL STERIL, V83, P1622, DOI 10.1016/j.fertnstert.2005.03.013; Schover LR, 2002, J CLIN ONCOL, V20, P1890, DOI 10.1200/JCO.2002.07.174; SCHOVER LR, 2005, J NATL CANC I MONOGR, V34, P2, DOI DOI 10.1093/JNCIMONOGRAPHS/LGI010; Woodruff TK, 2010, CANCER TREAT RES, V156, P1, DOI 10.1007/978-1-4419-6518-9; Woodruff TK, 2007, CANC TREATMENT RES, V138	10	22	22	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					202	203		10.1001/jama.2011.973	http://dx.doi.org/10.1001/jama.2011.973			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791CO	21750299				2022-12-28	WOS:000292639400029
J	Amit, R; Garcia, HG; Phillips, R; Fraser, SE				Amit, Roee; Garcia, Hernan G.; Phillips, Rob; Fraser, Scott E.			Building Enhancers from the Ground Up: A Synthetic Biology Approach	CELL			English	Article							TET REPRESSOR; RNA-POLYMERASE; TRANSCRIPTIONAL REGULATION; THERMODYNAMIC ANALYSIS; GENE-REGULATION; TOGGLE SWITCH; IN-VIVO; EXPRESSION; PROMOTER; BINDING	A challenge of the synthetic biology approach is to use our understanding of a system to recreate a biological function with specific properties. We have applied this framework to bacterial enhancers, combining a driver, transcription factor binding sites, and a poised polymerase to create synthetic modular enhancers. Our findings suggest that enhancer-based transcriptional control depends critically and quantitatively on DNA looping, leading to complex regulatory effects when the enhancer cassettes contain additional transcription factor binding sites for TetR, a bacterial transcription factor. We show through a systematic interplay of experiment and thermodynamic modeling that the level of gene expression can be modulated to convert a variable inducer concentration input into discrete or step-like output expression levels. Finally, using a different DNA-binding protein (TraR), we show that the regulatory output is not a particular feature of the specific DNA-binding protein used for the enhancer but a general property of synthetic bacterial enhancers.	[Amit, Roee; Phillips, Rob; Fraser, Scott E.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Garcia, Hernan G.] CALTECH, Dept Phys, Pasadena, CA 91125 USA; [Amit, Roee; Phillips, Rob; Fraser, Scott E.] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Amit, R (corresponding author), Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel.	roeeamit@technion.ac.il	Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223; Garcia, Hernan G./0000-0002-5212-3649	NIH [ARRA R01 GM085286-01S, R01 GM085286, DP1 OD000217]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085286] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000217] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would especially like to thank Prof. Frances H. Arnold for providing lab space and the forum to conduct thorough discussions as this project was evolving. We would also like to thank Eric H. Davidson for important early discussions and Alex J. Ninfa for plasmids and strains. R.A. was supported by a NIH Ruth L. Kirschstein fellowship, a Caltech CBCD grant, and the NIH through award NIH ARRA R01 GM085286-01S. R.P. and H.G.G. gratefully acknowledge awards NIH ARRA R01 GM085286-01S, R01 GM085286, and the NIH Director's PIONEER Award DP1 OD000217.	Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Atkinson MR, 2002, MOL MICROBIOL, V46, P1247, DOI 10.1046/j.1365-2958.2002.03211.x; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Becker NA, 2005, J MOL BIOL, V349, P716, DOI 10.1016/j.jmb.2005.04.035; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Davidson E.H., 2006, REGULATORY GENOME; Davidson E. H., 2001, DEV EVOLUTION; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Garcia HG, 2011, P NATL ACAD SCI USA, V108, P12173, DOI 10.1073/pnas.1015616108; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hervas AB, 2009, J BACTERIOL, V191, P6123, DOI 10.1128/JB.00744-09; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; HILLEN W, 1984, J MOL BIOL, V172, P185, DOI 10.1016/S0022-2836(84)80037-6; Huo YX, 2006, MOL MICROBIOL, V59, P168, DOI 10.1111/j.1365-2958.2005.04943.x; JOUNG JK, 1993, P NATL ACAD SCI USA, V90, P3083, DOI 10.1073/pnas.90.7.3083; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; LAW SM, 1993, J MOL BIOL, V230, P161, DOI 10.1006/jmbi.1993.1133; Lederer T, 1995, ANAL BIOCHEM, V232, P190, DOI 10.1006/abio.1995.0006; Lederer T, 1996, BIOCHEMISTRY-US, V35, P7439, DOI 10.1021/bi952683e; LEE DH, 1989, P NATL ACAD SCI USA, V86, P476, DOI 10.1073/pnas.86.2.476; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; MAGASANIK B, 1993, J CELL BIOCHEM, V51, P34, DOI 10.1002/jcb.240510108; Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; Ninfa AJ, 2000, TRENDS MICROBIOL, V8, P172, DOI 10.1016/S0966-842X(00)01709-1; NINFA AJ, 1987, CELL, V50, P1039, DOI 10.1016/0092-8674(87)90170-X; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Phillips R., 2009, PHYS BIOL CELL; Qin YP, 2009, MOL MICROBIOL, V74, P330, DOI 10.1111/j.1365-2958.2009.06865.x; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rappas M, 2007, CURR OPIN STRUC BIOL, V17, P110, DOI 10.1016/j.sbi.2006.11.002; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Schulz A, 2000, J MOL BIOL, V300, P709, DOI 10.1006/jmbi.2000.3921; SU W, 1990, P NATL ACAD SCI USA, V87, P5504, DOI 10.1073/pnas.87.14.5504	38	40	40	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 8	2011	146	1					105	118		10.1016/j.cell.2011.06.024	http://dx.doi.org/10.1016/j.cell.2011.06.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729783	Green Accepted, Bronze			2022-12-28	WOS:000292539300010
J	Cruz, M; Coontz, R				Cruz, Maria; Coontz, Robert			A Universe of Galaxies	SCIENCE			English	Editorial Material														Cruz, Maria J./0000-0001-9111-182X					0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					169	169		10.1126/science.333.6039.169	http://dx.doi.org/10.1126/science.333.6039.169			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	789GG	21737729				2022-12-28	WOS:000292502700033
J	Maynard, AD				Maynard, Andrew D.			Don't define nanomaterials	NATURE			English	Editorial Material									Univ Michigan, Sch Publ Hlth, Risk Sci Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Maynard, AD (corresponding author), Univ Michigan, Sch Publ Hlth, Risk Sci Ctr, Ann Arbor, MI 48109 USA.	maynarda@umich.edu		Maynard, Andrew/0000-0003-2117-5128				Holdren J. P., 2011, POLICY PRINCIPLES US; Maynard AD, 2011, TOXICOL SCI, V120, pS109, DOI 10.1093/toxsci/kfq372	2	96	99	3	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					31	31		10.1038/475031a	http://dx.doi.org/10.1038/475031a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	788RE	21734686	Bronze			2022-12-28	WOS:000292461300014
J	Saso, S; Chatterjee, J; Georgiou, E; Ditri, AM; Smith, JR; Ghaem-Maghami, S				Saso, Srdjan; Chatterjee, Jayanta; Georgiou, Ektoras; Ditri, Anthony M.; Smith, J. Richard; Ghaem-Maghami, Sadaf			Endometrial cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Review							EXTERNAL-BEAM RADIOTHERAPY; MRC ASTEC; CARCINOMA; ULTRASOUND; MORBIDITY; DIAGNOSIS; ACCURACY; SURGERY; WOMEN; TRIAL		[Saso, Srdjan; Chatterjee, Jayanta] Univ London Imperial Coll Sci Technol & Med, Div Surg Oncol Reprod Biol & Anaesthet, Inst Reprod & Dev Biol, London W12 0NN, England; [Georgiou, Ektoras] Univ London Imperial Coll Sci Technol & Med, Dept Biosurg & Surg Technol, London W12 0NN, England; [Smith, J. Richard] Univ London Imperial Coll Sci Technol & Med, Queen Charlottes & Chelsea Hosp, W London Gynaecol Canc Ctr, London W12 0NN, England	Imperial College London; Imperial College London; Imperial College London	Saso, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Surg Oncol Reprod Biol & Anaesthet, Inst Reprod & Dev Biol, Hammersmith Hosp Campus, London W12 0NN, England.	srdjan.saso@imperial.ac.uk		Ghaem-Maghami, Sadaf/0000-0002-7369-5080; Georgiou, Ektoras/0000-0003-3884-3129				Abu-Rustum NR, 2011, INT J GYNECOL CANCER, V21, P511, DOI 10.1097/IGC.0b013e31820cc305; Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Ayhan A, 2002, INT J GYNECOL CANCER, V12, P448, DOI 10.1046/j.1525-1438.2002.t01-1-01133.x; Baekelandt MM, 2009, ANN ONCOL, V20, P29, DOI 10.1093/annonc/mdp120; Blake P, 2009, LANCET, V373, P137, DOI 10.1016/S0140-6736(08)61767-5; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P1132, DOI 10.1158/1055-9965.EPI-04-0871; Brown AK, 2007, GYNECOL ONCOL, V105, P55, DOI 10.1016/j.ygyno.2006.10.058; Butler J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c7407; Cancer Research UK, UT WOMB CANC STAT UK; Chan JK, 2007, GYNECOL ONCOL, V106, P282, DOI 10.1016/j.ygyno.2007.05.033; Clark TJ, 2002, BJOG-INT J OBSTET GY, V109, P313, DOI 10.1016/S1470-0328(02)01088-1; Clark TJ, 2002, JAMA-J AM MED ASSOC, V288, P1610, DOI 10.1001/jama.288.13.1610; Creasman WT, 2006, INT J GYNECOL OBSTET, V95, pS105, DOI 10.1016/S0020-7292(06)60031-3; Creasman W, 2009, INT J GYNECOL OBSTET, V105, P109, DOI 10.1016/j.ijgo.2009.02.010; CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8; de la Orden SG, 2008, J MINIM INVAS GYN, V15, P395, DOI 10.1016/j.jmig.2008.04.018; Emons G, 2009, J CANCER RES CLIN, V135, P1387, DOI 10.1007/s00432-009-0581-9; Gull B, 2003, AM J OBSTET GYNECOL, V188, P401, DOI 10.1067/mob.2003.154; Gupta JK, 2002, ACTA OBSTET GYN SCAN, V81, P799, DOI 10.1034/j.1600-0412.2001.810902.x; JICK SS, 1993, EPIDEMIOLOGY, V4, P20, DOI 10.1097/00001648-199301000-00005; Ju W, 2009, INT J GYNECOL CANCER, V19, P400, DOI 10.1111/IGC.0b013e3181a1caf8; Kinkel K, 1999, RADIOLOGY, V212, P711, DOI 10.1148/radiology.212.3.r99au29711; Kitchener H, 2009, LANCET, V373, P125, DOI 10.1016/S0140-6736(08)61766-3; Kitchener HC, 2007, DEWHURSTS TXB OBSTET; Kosary CiRL, 2007, NIH PUB, V07-6215; Lambrou NC, 2004, GYNECOL ONCOL, V93, P653, DOI 10.1016/j.ygyno.2004.03.015; Lin F, 2008, INT J GYNECOL CANCER, V18, P1315, DOI 10.1111/j.1525-1438.2007.01180.x; May K, 2010, COCHRANE DB SYST REV, V20; Mills AM, 2010, SEMIN DIAGN PATHOL, V27, P199, DOI 10.1053/j.semdp.2010.09.002; NHS Scotland, 2021, SCOTT REF GUID SUSP; Nout RA, 2010, LANCET, V375, P816, DOI 10.1016/S0140-6736(09)62163-2; *OFF NAT STAT, 2009, CANC REG STAT ENGL 2; Panici PB, 2008, JNCI-J NATL CANCER I, V100, P1707, DOI 10.1093/jnci/djn397; Sankaranarayanan R, 2006, BEST PRACT RES CL OB, V20, P207, DOI 10.1016/j.bpobgyn.2005.10.007; Smith-Bindman R, 1998, JAMA-J AM MED ASSOC, V280, P1510, DOI 10.1001/jama.280.17.1510	35	86	87	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2011	343								d3954	10.1136/bmj.d3954	http://dx.doi.org/10.1136/bmj.d3954			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SD	21734165				2022-12-28	WOS:000292684100003
J	Kim, SW; Shimoyama, T; Hosono, H				Kim, Sung Wng; Shimoyama, Terumasa; Hosono, Hideo			Solvated Electrons in High-Temperature Melts and Glasses of the Room-Temperature Stable Electride [Ca24Al28O64](4+).4e(-)	SCIENCE			English	Article							DYNAMICS	Solvated electrons in alkali metal-ammonia solutions have attracted attention as a prototype electronic conductor and chemical reducing agent for over a century. However, solvated electrons have not been realized in a high-temperature melt or glass of an oxide system to date. We demonstrated the formation of persistent solvated electrons in both a high-temperature melt and its glass by using the thermally stable electride [Ca24Al28O64](4+).4e(-)(C12A7:e(-)) and controlling the partial pressure of oxygen. The electrical and structural properties of the resulting melt and glass differ from those of the conventional C12A7:O2- oxide, exhibiting metallic and hopping conduction, respectively, and a glass transition temperature that is similar to 160 kelvin lower than that of C12A7:O2- glass. Solvated electrons reside in cage structures in C12A7:e(-) and form a diamagnetic paired state.	[Kim, Sung Wng; Hosono, Hideo] Tokyo Inst Technol, Frontier Res Ctr, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Shimoyama, Terumasa; Hosono, Hideo] Tokyo Inst Technol, Mat & Struct Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Kim, SW (corresponding author), Tokyo Inst Technol, Frontier Res Ctr, Midori Ku, POB S2-13,4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.		Hosono, Hideo/T-1845-2019; Hosono, HIdeo/J-3489-2013; Kim, Sung Wng/A-4747-2013	Hosono, HIdeo/0000-0001-9260-6728; Kim, Sung Wng/0000-0002-4802-5421	Japan Society for the Promotion of Science, Japan	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank K. Hayashi and T. Yoshizumi of Tokyo Institute of Technology for the help of iodometric titration. S. Matsuishi and S. Ito of Tokyo Institute of Technology are thanked for useful discussions. Help by T. Tomoda for Raman spectra measurements is acknowledged. This study was supported by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST), Japan Society for the Promotion of Science, Japan.	DENG ZH, 1992, PHYS REV LETT, V68, P2496, DOI 10.1103/PhysRevLett.68.2496; Dye JL, 2009, ACCOUNTS CHEM RES, V42, P1564, DOI 10.1021/ar9000857; Freyland W., 1995, METAL INSULATOR TRAN, P167; HALLSTEDT B, 1990, J AM CERAM SOC, V73, P15, DOI 10.1111/j.1151-2916.1990.tb05083.x; HOSONO H, 1990, J APPL PHYS, V67, P2840, DOI 10.1063/1.345453; Kajihara K, 2007, J PHYS CHEM C, V111, P14855, DOI 10.1021/jp074248n; Kim SW, 2007, NANO LETT, V7, P1138, DOI 10.1021/nl062717b; Kim SW, 2005, J AM CHEM SOC, V127, P1370, DOI 10.1021/ja043990n; Matsuishi S, 2003, SCIENCE, V301, P626, DOI 10.1126/science.1083842; MCMILLAN P, 1983, J NON-CRYST SOLIDS, V55, P221, DOI 10.1016/0022-3093(83)90672-5; McMillan PF, 1996, J NON-CRYST SOLIDS, V195, P261, DOI 10.1016/0022-3093(95)00536-6; MCNEAL NA, 1977, PHYS REV LETT, V38, P445, DOI 10.1103/PhysRevLett.38.445; Mei Q, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/24/245107; ONODA GY, 1970, J AM CERAM SOC, V53, P311, DOI 10.1111/j.1151-2916.1970.tb12114.x; Rawson H., 1967, INORGANIC GLASS FORM; Sushko PV, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.126401; Thompson J. C., 1976, ELECT LIQUID AMMONIA; Yoon SG, 2009, J NANOSCI NANOTECHNO, V9, P7345, DOI 10.1166/jnn.2009.1747; Yoshizumi T, 2010, J PHYS CHEM C, V114, P15354, DOI 10.1021/jp1054364	19	103	105	7	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					71	74		10.1126/science.1204394	http://dx.doi.org/10.1126/science.1204394			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719674				2022-12-28	WOS:000292255400050
J	Sim, MS; Bosak, T; Ono, S				Sim, Min Sub; Bosak, Tanja; Ono, Shuhei			Large Sulfur Isotope Fractionation Does Not Require Disproportionation	SCIENCE			English	Article							MICROBIAL SULFATE REDUCTION; ATMOSPHERIC OXYGEN; EVOLUTION; SEDIMENTS; OCEAN; BIOSPHERE; SULFIDE; BURIAL; CARBON; PYRITE	The composition of sulfur isotopes in sedimentary sulfides and sulfates traces the sulfur cycle throughout Earth's history. In particular, depletions of sulfur-34 ((34)S) in sulfide relative to sulfate exceeding 47 per mil (parts per thousand) often serve as a proxy for the disproportionation of intermediate sulfur species in addition to sulfate reduction. Here, we demonstrate that a pure, actively growing culture of a marine sulfate-reducing bacterium can deplete (34)S by up to 66 parts per thousand during sulfate reduction alone and in the absence of an extracellular oxidative sulfur cycle. Therefore, similar magnitudes of sulfur isotope fractionation in sedimentary rocks do not unambiguously record the presence of other sulfur-based metabolisms or the stepwise oxygenation of Earth's surface environment during the Proterozoic.	[Sim, Min Sub; Bosak, Tanja; Ono, Shuhei] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sim, MS (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	mssim@mit.edu		Sim, Min Sub/0000-0002-3491-9002	NASA Astrobiology Institute [NNA08CN84A]	NASA Astrobiology Institute	We thank W. Olszewski, K. Donovan, S. Templer, J. Seewald, S. Sylva, B. Weiss, L. Kump, J. Grabenstatter, B. Bannon, P. Hedman, and Y. J. Joo. This work was partially supported by NASA Astrobiology Institute (#NNA08CN84A).	Berner RA, 1998, SCIENCE, V282, P1426, DOI 10.1126/science.282.5393.1426; Brunner B, 2005, GEOCHIM COSMOCHIM AC, V69, P4759, DOI 10.1016/j.gca.2005.04.015; CANFIELD DE, 1994, SCIENCE, V266, P1973, DOI 10.1126/science.11540246; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; Canfield DE, 2010, GEOLOGY, V38, P415, DOI 10.1130/G30723.1; Canfield DE, 2009, P NATL ACAD SCI USA, V106, P8123, DOI 10.1073/pnas.0902037106; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; Farquhar J, 2003, GEOBIOLOGY, V1, P27, DOI 10.1046/j.1472-4669.2003.00007.x; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; GARRELS RM, 1981, P NATL ACAD SCI USA, V78, P4652, DOI 10.1073/pnas.78.8.4652; Hayes J.M., 1992, PROTEROZOIC BIOSPHER, P129; Hurtgen MT, 2005, GEOLOGY, V33, P41, DOI 10.1130/G20923.1; Johnston DT, 2007, GEOCHIM COSMOCHIM AC, V71, P3929, DOI 10.1016/j.gca.2007.05.008; Johnston DT, 2005, SCIENCE, V310, P1477, DOI 10.1126/science.1117824; JORGENSEN BB, 1990, SCIENCE, V249, P152, DOI 10.1126/science.249.4965.152; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; Kah LC, 2004, NATURE, V431, P834, DOI 10.1038/nature02974; Li XN, 2010, GEOCHIM COSMOCHIM AC, V74, P6764, DOI 10.1016/j.gca.2010.08.020; MOPPER K, 1980, MAR CHEM, V10, P55, DOI 10.1016/0304-4203(80)90058-4; NORTHROP DB, 1981, ANNU REV BIOCHEM, V50, P103, DOI 10.1146/annurev.bi.50.070181.000535; Otake T, 2008, CHEM GEOL, V249, P357, DOI 10.1016/j.chemgeo.2008.01.020; Parnell J, 2010, NATURE, V468, P290, DOI 10.1038/nature09538; PETERSON BJ, 1986, ECOLOGY, V67, P865, DOI 10.2307/1939809; REES CE, 1973, GEOCHIM COSMOCHIM AC, V37, P1141, DOI 10.1016/0016-7037(73)90052-5; ROSS GM, 1995, PRECAMBRIAN RES, V73, P71, DOI 10.1016/0301-9268(94)00072-Y; Rudnicki MD, 2001, GEOCHIM COSMOCHIM AC, V65, P777, DOI 10.1016/S0016-7037(00)00579-2; Sim MS, 2011, GEOCHIM COSMOCHIM AC, V75, P4244, DOI 10.1016/j.gca.2011.05.021; STAMS JM, 1983, ARCH MICROBIOL, V136, P54; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Wortmann UG, 2001, GEOLOGY, V29, P647, DOI 10.1130/0091-7613(2001)029<0647:HDBIES>2.0.CO;2; Wu NP, 2010, GEOCHIM COSMOCHIM AC, V74, P2053, DOI 10.1016/j.gca.2009.12.012; Zerkle AL, 2010, GEOCHIM COSMOCHIM AC, V74, P4953, DOI 10.1016/j.gca.2010.06.015	32	392	402	3	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					74	77		10.1126/science.1205103	http://dx.doi.org/10.1126/science.1205103			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719675				2022-12-28	WOS:000292255400051
J	Mele, C; Iatropoulos, P; Donadelli, R; Calabria, A; Maranta, R; Cassis, P; Buelli, S; Tomasoni, S; Piras, R; Krendel, M; Bettoni, S; Morigi, M; Delledonne, M; Pecoraro, C; Abbate, I; Capobianchi, MR; Hildebrandt, F; Otto, E; Schaefer, F; Macciardi, F; Ozaltin, F; Emre, S; Ibsirlioglu, T; Benigni, A; Remuzzi, G; Noris, M				Mele, Caterina; Iatropoulos, Paraskevas; Donadelli, Roberta; Calabria, Andrea; Maranta, Ramona; Cassis, Paola; Buelli, Simona; Tomasoni, Susanna; Piras, Rossella; Krendel, Mira; Bettoni, Serena; Morigi, Marina; Delledonne, Massimo; Pecoraro, Carmine; Abbate, Isabella; Capobianchi, Maria Rosaria; Hildebrandt, Friedhelm; Otto, Edgar; Schaefer, Franz; Macciardi, Fabio; Ozaltin, Fatih; Emre, Sevinc; Ibsirlioglu, Tulin; Benigni, Ariela; Remuzzi, Giuseppe; Noris, Marina		PodoNet Consortium	MYO1E Mutations and Childhood Familial Focal Segmental Glomerulosclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESISTANT NEPHROTIC SYNDROME; ACTIN CYTOSKELETON; GLOMERULAR PODOCYTES; GENE; DISEASES; PROTEIN; IDENTIFICATION; CYCLOSPORINE; ORGANIZATION; ENDOCYTOSIS	BACKGROUND Focal segmental glomerulosclerosis is a kidney disease that is manifested as the nephrotic syndrome. It is often resistant to glucocorticoid therapy and progresses to end-stage renal disease in 50 to 70% of patients. Genetic studies have shown that familial focal segmental glomerulosclerosis is a disease of the podocytes, which are major components of the glomerular filtration barrier. However, the molecular cause in over half the cases of primary focal segmental glomerulosclerosis is unknown, and effective treatments have been elusive. METHODS We performed whole-genome linkage analysis followed by high-throughput sequencing of the positive-linkage area in a family with autosomal recessive focal segmental glomerulosclerosis (index family) and sequenced a newly discovered gene in 52 unrelated patients with focal segmental glomerulosclerosis. Immunohistochemical studies were performed on human kidney-biopsy specimens and cultured podocytes. Expression studies in vitro were performed to characterize the functional consequences of the mutations identified. RESULTS We identified two mutations (A159P and Y695X) in MYO1E, which encodes a nonmuscle class I myosin, myosin 1E (Myo1E). The mutations in MYO1E segregated with focal segmental glomerulosclerosis in two independent pedigrees (the index family and Family 2). Patients were homozygous for the mutations and did not have a response to glucocorticoid therapy. Electron microscopy showed thickening and disorganization of the glomerular basement membrane. Normal expression of Myo1E was documented in control human kidney-biopsy specimens in vivo and in glomerular podocytes in vitro. Transfection studies revealed abnormal subcellular localization and function of the A159P-Myo1E mutant. The Y695X mutation causes loss of calmodulin binding and of the tail domains of Myo1E. CONCLUSIONS MYO1E mutations are associated with childhood-onset, glucocorticoid-resistant focal segmental glomerulosclerosis. Our data provide evidence of a role of Myo1E in podocyte function and the consequent integrity of the glomerular filtration barrier.	[Buelli, Simona; Tomasoni, Susanna; Morigi, Marina; Benigni, Ariela; Remuzzi, Giuseppe] Mario Negri Inst Pharmacol Res, Ctr Anna Maria Astori, I-24126 Bergamo, Italy; [Mele, Caterina; Iatropoulos, Paraskevas; Donadelli, Roberta; Maranta, Ramona; Cassis, Paola; Piras, Rossella; Bettoni, Serena; Remuzzi, Giuseppe; Noris, Marina] Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis Aldo & Cele Dacco Ranica, I-24126 Bergamo, Italy; [Remuzzi, Giuseppe] Osped Riuniti Bergamo, Unit Nephrol & Dialysis, I-24100 Bergamo, Italy; [Calabria, Andrea; Macciardi, Fabio] Univ Milan, Dept Med Surg & Dent, Milan, Italy; [Delledonne, Massimo] Univ Verona, Dept Biotechnol, Ctr Funct Genom, I-37100 Verona, Italy; [Pecoraro, Carmine] Santobono Hosp, Dept Nephrol & Dialysis, Naples, Italy; [Abbate, Isabella; Capobianchi, Maria Rosaria] Ist Nazl Malattie Infett Lazzaro Spallanzani, Virol Lab, Rome, Italy; [Krendel, Mira] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY USA; [Hildebrandt, Friedhelm; Otto, Edgar] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Hildebrandt, Friedhelm] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Schaefer, Franz] Ctr Pediat & Adolescent Med, Pediat Nephrol Div, Heidelberg, Germany; [Ozaltin, Fatih; Ibsirlioglu, Tulin] Hacettepe Univ, Fac Med, Dept Pediat Nephrol, TR-06100 Ankara, Turkey; [Emre, Sevinc] Istanbul Univ, Istanbul Fac Med, Dept Pediat Nephrol, Istanbul, Turkey	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Ospedali Riuniti di Bergamo; University of Milan; University of Verona; IRCCS Lazzaro Spallanzani; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Hacettepe University; Istanbul University	Remuzzi, G (corresponding author), Mario Negri Inst Pharmacol Res, Ctr Anna Maria Astori, Via Stezzano 87, I-24126 Bergamo, Italy.	giuseppe.remuzzi@marionegri.it	Ariela, Benigni/ABH-3492-2020; NORIS, MARINA/ABG-2219-2020; Bettoni, Serena/G-9469-2012; Buelli, Simona/AAB-1847-2020; Schaefer, Franz/G-4365-2010; Donadelli, Roberta/ABG-8930-2020; Tomasoni, Susanna/ABF-5747-2020; Mele, Caterina/ABF-3728-2020; Morigi, Marina/ABH-3131-2020; Piras, Rossella/AAZ-1122-2020; Abbate, Isabella/K-6434-2016; Delledonne, Massimo/O-8685-2017; Calabria, Andrea/AAA-3349-2019; Macciardi, Fabio/N-3768-2014; Remuzzi, Giuseppe/V-9766-2017	Ariela, Benigni/0000-0002-4721-5485; NORIS, MARINA/0000-0001-7651-5033; Buelli, Simona/0000-0002-2508-7793; Tomasoni, Susanna/0000-0002-7212-2512; Mele, Caterina/0000-0002-9536-3474; Morigi, Marina/0000-0001-8029-7382; Piras, Rossella/0000-0002-0218-0901; Calabria, Andrea/0000-0003-3515-3384; Macciardi, Fabio/0000-0003-0537-4266; Krendel, Mira/0000-0002-7008-9069; Otto, Edgar/0000-0002-2387-9973; Bettoni, Serena/0000-0002-7840-4596; Remuzzi, Giuseppe/0000-0002-6194-3446; Donadelli, Roberta/0000-0003-1472-1143; Capobianchi, Maria Rosaria/0000-0003-3465-0071; Iatropoulos, Paraskevas/0000-0001-9406-5734; Delledonne, Massimo/0000-0002-7100-4581	E-Rare program (PodoNet); Fondazione La Nuova Speranza Organizzazione Non Lucrativa di Utilita' Sociale (Onlus) (Milan); Fondazione Aiuti per la Ricerca sulle Malattie Rare Onlus (Bergamo, Italy); Fondazione ART per la Ricerca sui Trapianti Onlus (Milan); NephCure Foundation; National Institutes of Health [R01-DK076683, RC1-DK086542]; Fondazione ART per la Ricerca sui Trapianti Onlus; Scientific and Research Council of Turkey [108S417]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076683, RC1DK086542] Funding Source: NIH RePORTER	E-Rare program (PodoNet); Fondazione La Nuova Speranza Organizzazione Non Lucrativa di Utilita' Sociale (Onlus) (Milan); Fondazione Aiuti per la Ricerca sulle Malattie Rare Onlus (Bergamo, Italy); Fondazione ART per la Ricerca sui Trapianti Onlus (Milan); NephCure Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione ART per la Ricerca sui Trapianti Onlus; Scientific and Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported in part by grants from the E-Rare program (PodoNet), Fondazione La Nuova Speranza Organizzazione Non Lucrativa di Utilita' Sociale (Onlus) (Milan), Fondazione Aiuti per la Ricerca sulle Malattie Rare Onlus (Bergamo, Italy), Fondazione ART per la Ricerca sui Trapianti Onlus (Milan), and the NephCure Foundation; grants from the National Institutes of Health (R01-DK076683 and RC1-DK086542, to Dr. Hildebrandt); fellowships from Fondazione ART per la Ricerca sui Trapianti Onlus (to Drs. Piras and Mele); and a grant from the Scientific and Research Council of Turkey (108S417, to Dr. Ozaltin).	Adamek N, 2008, P NATL ACAD SCI USA, V105, P5710, DOI 10.1073/pnas.0710520105; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Barisoni L, 2007, CLIN J AM SOC NEPHRO, V2, P529, DOI 10.2215/CJN.04121206; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Braden GL, 2000, AM J KIDNEY DIS, V35, P878, DOI 10.1016/S0272-6386(00)70258-7; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Cattran DC, 1999, KIDNEY INT, V56, P2220, DOI 10.1046/j.1523-1755.1999.00778.x; Chiang CK, 2010, NAT REV NEPHROL, V6, P539, DOI 10.1038/nrneph.2010.103; D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024; DRENCKHAHN D, 1988, LAB INVEST, V59, P673; El Mezgueldi M, 2002, J BIOL CHEM, V277, P21514, DOI 10.1074/jbc.M200713200; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Filler G, 2003, AM J KIDNEY DIS, V42, P1107, DOI 10.1053/j.ajkd.2003.08.010; Forgacs E, 2009, J BIOL CHEM, V284, P2138, DOI 10.1074/jbc.M805530200; Friedrich C, 2006, AM J PHYSIOL-RENAL, V291, pF856, DOI 10.1152/ajprenal.00196.2005; Genin E, 1998, ANN HUM GENET, V62, P419, DOI 10.1046/j.1469-1809.1998.6250419.x; Genovese G, 2010, KIDNEY INT, V78, P698, DOI 10.1038/ki.2010.251; HAAS M, 1995, AM J KIDNEY DIS, V26, P740, DOI 10.1016/0272-6386(95)90437-9; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Kitiyakara C, 2004, AM J KIDNEY DIS, V44, P815, DOI 10.1016/S0272-6386(04)01081-9; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Krendel M, 2007, FEBS LETT, V581, P644, DOI 10.1016/j.febslet.2007.01.021; Krendel M, 2009, J AM SOC NEPHROL, V20, P86, DOI 10.1681/ASN.2007111172; Lowik MM, 2009, EUR J PEDIATR, V168, P1291, DOI 10.1007/s00431-009-1017-x; Machuca E, 2009, HUM MOL GENET, V18, pR185, DOI 10.1093/hmg/ddp328; Mathieson PW, 2008, NEW ENGL J MED, V359, P2492, DOI 10.1056/NEJMcibr0806881; Meyrier AY, 2009, KIDNEY INT, V76, P487, DOI 10.1038/ki.2009.204; Mucha B, 2006, PEDIATR RES, V59, P325, DOI 10.1203/01.pdr.0000196717.94518.f0; Nabet B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006491; Pollak MR, 2008, CURR OPIN NEPHROL HY, V17, P138, DOI 10.1097/MNH.0b013e3282f5dbe4; Roux AF, 2006, J MED GENET, V43, P763, DOI 10.1136/jmg.2006.041954; Singh N, 2009, AM J KIDNEY DIS, V54, P732, DOI 10.1053/j.ajkd.2009.06.023; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yu HYE, 2007, MOL BIOL CELL, V18, P4096, DOI 10.1091/mbc.E06-11-0993	40	167	172	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4					295	306		10.1056/NEJMoa1101273	http://dx.doi.org/10.1056/NEJMoa1101273			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798AJ	21756023	Green Accepted			2022-12-28	WOS:000293172200008
J	Wilke, RA; Dolan, ME				Wilke, Russell A.; Dolan, M. Eileen			Genetics and Variable Drug Response	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GENOTYPE		[Wilke, Russell A.] Vanderbilt Univ, Med Ctr, Oates Inst Expt Therapeut, Div Clin Pharmacol, Nashville, TN 37232 USA; [Wilke, Russell A.] Vanderbilt Univ, Dept Med, Div Gen Internal Med, Nashville, TN 37232 USA; [Dolan, M. Eileen] Univ Chicago, Dept Med, Comprehens Canc Res Ctr, Comm Clin Pharmacol & Pharmacogen, Chicago, IL 60637 USA	Vanderbilt University; Vanderbilt University; University of Chicago	Wilke, RA (corresponding author), Vanderbilt Univ, Med Ctr, Oates Inst Expt Therapeut, Div Clin Pharmacol, 23rd Ave S & Pierce Ave,550 RRB, Nashville, TN 37232 USA.	russell.a.wilke@vanderbilt.edu			NCI NIH HHS [CA136765, R01 CA136765, P50 CA125183] Funding Source: Medline; NHLBI NIH HHS [U01HL069757, U01 HL069757, U19 HL069757, U19HL065962, U19 HL065962] Funding Source: Medline; NIDDK NIH HHS [R01DK080007, R01 DK080007] Funding Source: Medline; NIGMS NIH HHS [U01GM61393, U01 GM061393] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA136765, P50CA125183] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069757, U19HL065962, U19HL069757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Epstein RS, 2010, J AM COLL CARDIOL, V55, P2804, DOI 10.1016/j.jacc.2010.03.009; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Relling MV, 2011, CLIN PHARMACOL THER, V89, P387, DOI 10.1038/clpt.2010.320; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; US Food and Drug Administration, TABL PHARM BIOM DRUG	10	41	41	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2011	306	3					306	307		10.1001/jama.2011.998	http://dx.doi.org/10.1001/jama.2011.998			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794BS	21771992	Green Accepted			2022-12-28	WOS:000292870500025
J	Hajdenberg, J				Hajdenberg, Julio			Review: Self-testing or self-management of oral anticoagulation reduces thromboembolic events and mortality more than usual care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									MD Anderson Canc Ctr Orlando, Orlando, FL USA	University of Texas System; UTMD Anderson Cancer Center	Hajdenberg, J (corresponding author), MD Anderson Canc Ctr Orlando, Orlando, FL USA.								0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2							JC1-06	10.7326/0003-4819-155-2-201107190-02006	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	793KW	21768572				2022-12-28	WOS:000292822000005
J	Kuhn, L; Susser, I; Stein, Z				Kuhn, Louise; Susser, Ida; Stein, Zena			Can further placebo-controlled trials of antiretroviral drugs to prevent sexual transmission of HIV be justified?	LANCET			English	Editorial Material									[Kuhn, Louise] Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, New York, NY 10032 USA; [Kuhn, Louise] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Susser, Ida] CUNY Hunter Coll, Dept Anthropol, New York, NY 10021 USA; [Susser, Ida] CUNY, Grad Ctr, New York, NY USA; [Susser, Ida] Columbia Univ, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Stein, Zena] New York State Psychiat Inst & Hosp, HIV Ctr Clin & Behav Studies, New York, NY 10032 USA	Columbia University; Columbia University; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Columbia University; New York State Psychiatry Institute	Kuhn, L (corresponding author), Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, New York, NY 10032 USA.	lk24@coloumbia.edu			NIMH NIH HHS [P30-MH433520] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Aldrovandi GM, 2010, J INFECT DIS, V202, pS366, DOI 10.1086/655972; *CDC, 1995, MMWR-MORBID MORTAL W, V44, P929; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; FHI, 2011, FHI IN ORD CLOS FEM; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Lurie P, 1999, LANCET, V353, P1878; Mofenson LM, 2010, ANTIVIR THER, V15, P537, DOI 10.3851/IMP1574; *NAT AIDS TREATM A, 2010, CONRAD FDA CONRAD CH; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Roland ME, 2007, CURR OPIN INFECT DIS, V20, P39, DOI 10.1097/QCO.0b013e328012c5e0; Stein Z., 2010, TRANSPARENCY ACCOUNT; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; UNICEF UNAIDS WHO & UNFPA, 2010, 5 UNICEF UNAIDS WHO; WILLIAMS BG, 2010, 18 INT AIDS C VIENN; Young TN, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002835.pub3	16	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2011	378	9787					285	287		10.1016/S0140-6736(11)60134-7	http://dx.doi.org/10.1016/S0140-6736(11)60134-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798JD	21763941				2022-12-28	WOS:000293201100037
J	Molina, JM; Cahn, P; Grinsztejn, B; Lazzarin, A; Mills, A; Saag, M; Supparatpinyo, K; Walmsley, S; Crauwels, H; Rimsky, LT; Vanveggel, S; Boven, K				Molina, Jean-Michel; Cahn, Pedro; Grinsztejn, Beatriz; Lazzarin, Adriano; Mills, Anthony; Saag, Michael; Supparatpinyo, Khuanchai; Walmsley, Sharon; Crauwels, Herta; Rimsky, Laurence T.; Vanveggel, Simon; Boven, Katia		ECHO Study Grp	Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial	LANCET			English	Article							ANTIRETROVIRAL THERAPY; COMBINATION THERAPY; PROTEASE-INHIBITOR; GUIDELINES; NEVIRAPINE; LAMIVUDINE; REGIMENS; EFFICACY; SAFETY	Background Efavirenz with tenofovir-disoproxil-fumarate and emtricitabine is a preferred antiretroviral regimen for treatment-naive patients infected with HIV-1. Rilpivirine, a new non-nucleoside reverse transcriptase inhibitor, has shown similar antiviral efficacy to efavirenz in a phase 2b trial with two nucleoside/nucleotide reverse transcriptase inhibitors. We aimed to assess the efficacy, safety, and tolerability of rilpivirine versus efavirenz, each combined with tenofovir-disoproxil-fumarate and emtricitabine. Methods We did a phase 3, randomised, double-blind, double-dummy, active-controlled trial, in patients infected with HIV-1 who were treatment-naive. The patients were aged 18 years or older with a plasma viral load at screening of 5000 copies per mL or greater, and viral sensitivity to all study drugs. Our trial was done at 112 sites across 21 countries. Patients were randomly assigned by a computer-generated interactive web response system to receive either once-daily 25 mg rilpivirine or once-daily 600 mg efavirenz, each with tenofovir-disoproxil-fumarate and emtricitabine. Our primary objective was to show non-inferiority (12% margin) of rilpivirine to efavirenz in terms of the percentage of patients with confirmed response (viral load <50 copies per mL intention-to-treat time-to-loss-of-virological-response [ITT-TLOVR] algorithm) at week 48. Our primary analysis was by intention-to-treat. We also used logistic regression to adjust for baseline viral load. This trial is registered with ClinicalTrials.gov, number NCT00540449. Findings 346 patients were randomly assigned to receive rilpivirine and 344 to receive efavirenz and received at least one dose of study drug, with 287 (83%) and 285 (83%) in the respective groups having a confirmed response at week 48. The point estimate from a logistic regression model for the percentage difference in response was -0.4 (95% CI -5.9 to 5.2), confirming non-inferiority with a 12% margin (primary endpoint). The incidence of virological failures was 13% (rilpivirine) versus 6% (efavirenz; 11% vs 4% by ITT-TLOVR). Grade 2-4 adverse events (55 [16%] on rilpivirine vs 108 [31%] on efavirenz, p<0.0001), discontinuations due to adverse events (eight [2%] on rilpivirine vs 27 [8%] on efavirenz), rash, dizziness, and abnormal dreams or nightmares were more common with efavirenz. Increases in plasma lipids were significantly lower with rilpivirine. Interpretation Rilpivirine showed non-inferior efficacy compared with efavirenz, with a higher virological-failure rate, but a more favourable safety and tolerability profile.	[Molina, Jean-Michel] St Louis Hosp, Dept Infect Dis, Paris 7, France; [Molina, Jean-Michel] Univ Paris Diderot, Paris, France; [Cahn, Pedro] Fdn Huesped, Buenos Aires, DF, Argentina; [Grinsztejn, Beatriz] Inst Pesquisa Clin Evandro Chagas Fiocruz, Rio De Janeiro, Brazil; [Lazzarin, Adriano] San Raffaele Univ, Milan, Italy; [Mills, Anthony] Anthony Mills MD Inc, Los Angeles, CA USA; [Saag, Michael] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL USA; [Supparatpinyo, Khuanchai] Chiang Mai Univ, Dept Med, Chiang Mai 50000, Thailand; [Walmsley, Sharon] Univ Hlth Network, Toronto, ON, Canada; [Crauwels, Herta; Rimsky, Laurence T.; Vanveggel, Simon] Tibotec BVBA, Beerse, Belgium; [Boven, Katia] Tibotec Inc, Titusville, NJ USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Fundacao Oswaldo Cruz; Vita-Salute San Raffaele University; University of Alabama System; University of Alabama Birmingham; Chiang Mai University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson USA	Molina, JM (corresponding author), St Louis Hosp, Dept Infect Dis, Paris 7, France.	jean-michel.molina@sls.aphp.fr	LAZZARIN, Adriano/K-3607-2018	LAZZARIN, Adriano/0000-0003-2551-7754; Mills, Anthony/0000-0002-6997-5581; Walmsley, Sharon/0000-0002-3959-5692	Abbott; Avexa; BI; Gilead; MSD; Tibotec; Janssen; GlaxoSmithKline (GSK); ViiV Healthcare; Pfizer; Pain Therapeutics; Tibotec/JJ; Vertex	Abbott(Abbott Laboratories); Avexa; BI; Gilead(Gilead Sciences); MSD; Tibotec; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); GlaxoSmithKline (GSK)(GlaxoSmithKline); ViiV Healthcare; Pfizer(Pfizer); Pain Therapeutics; Tibotec/JJ; Vertex(Vertex Pharmaceuticals)	J-MM has acted as a consultant, participated in advisory boards, has received speaker fees and has been an investigator for clinical trials for Tibotec, ViiV Healthcare, Gilead, Bristol-Myers Squibb (BMS), Abbott, Boehringer Ingelheim (BI), and Merck, Sharp &, Dohme (MSD). PC has received grant research support, advisory and speaker fees from Abbott, Avexa, BI, Gilead, MSD, Tibotec, Janssen, GlaxoSmithKline (GSK), and ViiV Healthcare. BC has participated in advisory boards, has received speaker fees and has been an investigator for clinical trials for Tibotec, BMS, ViiV Healthcare, and MSD. AL has acted as a consultant, participated in advisory boards, speaker bureaus and has been an investigator in for clinical trials for Abbott, BM S, BI, Gilead, MSD, Tibotec, Pfizer, ViiV Healthcare, GSK, and Roche. AM has served on advisory boards and speaker bureaus for Tibotec, GSK, BMS, Gilead, BI, MSD, and ViiV Healthcare, and has received research funding from Tibotec. MS has received consulting fees, research support, or both from BMS, BI, GSK, MSD, Pfizer, Pain Therapeutics, Tibotec/J&J, Vertex, and ViiV Healthcare. SW has received consultancy fees or lecture sponsorships from Abbott, BI, Gilead, MSD, ViiV Healthcare, and Tibotec. HC, LTR, SV, and KB are all full-time employees of Tibotec. KS declares no conflicts of interest.	Adams J, 2010, ANN PHARMACOTHER, V44, P157, DOI 10.1345/aph.1M359; *BRIST MYERS SQUIB, 2010, FDA LAB EF CAPS TABL; Buelens A, 2009, 12 EUR AIDS C COL GE; Clumeck N, 2008, HIV MED, V9, P65, DOI 10.1111/j.1468-1293.2007.00533.x; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; *CTR DRUG EV RES, 2002, GUID IND ANT DRUGS U; Desmidt M, 2009, 12 EUR AIDS C COL GE; DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, 2011, GUID US ANT AG HIV 1; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; HODDER S, 2010, 48 ANN M INF DIS SOC; HOETELMANS RM, 2005, 6 INT WORKSH CLIN PH; Johnson Victoria A, 2009, Top HIV Med, V17, P138; Laterza OF, 2002, CLIN CHEM, V48, P699; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LOZANO IS, 2003, ANTIVIR THER S, V8, P337; Manfredi R, 2004, JAIDS-J ACQ IMM DEF, V35, P492, DOI 10.1097/00126334-200404150-00007; Margot NA, 2006, ANTIMICROB AGENTS CH, V50, P4087, DOI 10.1128/AAC.00816-06; MATHIAS AA, 2010, 18 INT AIDS C VIENN; Mbuagbaw LCE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004246.pub3; National Institute of Allergy and infectious Diseases (NIAID) NUSNIoAaID, 2004, DIV AIDS TABL GRAD S; NELSON M, 2010, J INT AIDS SOC S4, V13, pP210; PEREZMOLINA JA, 2002, TRIALS, V3, P279; PICCHIO G, 2010, 18 INT AIDS C VIENN; Pozniak AL, 2010, AIDS, V24, P55, DOI 10.1097/QAD.0b013e32833032ed; Pulido F, 2004, JAIDS-J ACQ IMM DEF, V35, P343, DOI 10.1097/00126334-200404010-00003; Rimsky L, 2010, 50 INT C ANT AG CHEM; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; *TIB, 2011, FDA LAB RILP TABL; Tombuyzer L, 2009, ANTIVIR THER, V14, P103; van Leeuwen R, 2003, AIDS, V17, P987, DOI 10.1097/00002030-200305020-00007; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; VANVEGGEL S, 2009, 47 ANN M INF DIS SOC; Wilkin A, 2010, 19 ANN CAN C HIV AID	36	330	346	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2011	378	9787					238	246		10.1016/S0140-6736(11)60936-7	http://dx.doi.org/10.1016/S0140-6736(11)60936-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798JD	21763936				2022-12-28	WOS:000293201100031
J	Bustamante, CD; Burchard, EG; De La Vega, FM				Bustamante, Carlos D.; Burchard, Esteban Gonzalez; De La Vega, Francisco M.			Genomics for the world	NATURE			English	Editorial Material							ANCESTRY		[Bustamante, Carlos D.; De La Vega, Francisco M.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Burchard, Esteban Gonzalez] Univ Calif San Francisco, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco	Bustamante, CD (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	cdbustam@stanford.edu	De La Vega, Francisco/H-3832-2011	Bustamante, Carlos D./0000-0002-4187-7920	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229, U01HG005715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007546] Funding Source: NIH RePORTER; NHGRI NIH HHS [U01 HG005715, R01 HG003229] Funding Source: Medline; NIEHS NIH HHS [R01 ES015794] Funding Source: Medline; NIGMS NIH HHS [T32 GM007546] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acuna-Alonzo V, 2010, HUM MOL GENET, V19, P2877, DOI 10.1093/hmg/ddq173; Adeyemo A, 2010, PUBLIC HEALTH GENOMI, V13, P72, DOI 10.1159/000218711; [Anonymous], 2010, Nature, V467, P1026, DOI 10.1038/4671026a; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Kumar R, 2010, NEW ENGL J MED, V363, P321, DOI 10.1056/NEJMoa0907897; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Need AC, 2009, TRENDS GENET, V25, P489, DOI 10.1016/j.tig.2009.09.012; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Yang JJ, 2011, NAT GENET, V43, P237, DOI 10.1038/ng.763	10	365	368	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					163	165		10.1038/475163a	http://dx.doi.org/10.1038/475163a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791UA	21753830	Bronze, Green Accepted			2022-12-28	WOS:000292690500024
J	Langevin, F; Crossan, GP; Rosado, IV; Arends, MJ; Patel, KJ				Langevin, Frederic; Crossan, Gerry P.; Rosado, Ivan V.; Arends, Mark J.; Patel, Ketan J.			Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice	NATURE			English	Article							FETAL ALCOHOL SYNDROME; FANCONI-ANEMIA; DNA-ADDUCTS; CHILDHOOD LEUKEMIA; KNOCKOUT MICE; BONE-MARROW; ACETALDEHYDE; ETHANOL; CONSUMPTION; METABOLISM	Reactive aldehydes are common carcinogens. They are also by-products of several metabolic pathways and, without enzymatic catabolism, may accumulate and cause DNA damage. Ethanol, which is metabolished to acetaldehyde, is both carcinogenic and teratogenic in humans. Here we find that the Fanconi anaemia DNA repair pathway counteracts acetaldehyde-induced genotoxicity in mice. Our results show that the acetaldehyde-catabolising enzyme Aldh2 is essential for the development of Fancd2(-/-) embryos. Nevertheless, acetaldehyde-catabolism-competent mothers (Aldh2(+/-)) can support the development of double-mutant (Aldh2(-/-)Fancd2(-/-)) mice. However, these embryos are usually sensitive to ethanol exposure in utero, and ethanol consumption by postnatal double-deficient mice rapidly precipitates bone marrow failure. Lastly, Aldh2(-/-)Fancd2(-/-) mice spontaneously develop acute leukaemia. Acetaldehyde-mediated DNA damage may critically contribute to the genesis of fetal alcohol syndrome in fetuses, as well as to abnormal development, haematopoietic failure and cancer predisposition in Fanconi anaemia patients.	[Langevin, Frederic; Crossan, Gerry P.; Rosado, Ivan V.; Patel, Ketan J.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Arends, Mark J.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England; [Patel, Ketan J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England	MRC Laboratory Molecular Biology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Patel, KJ (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	kjp@mrc-lmb.cam.ac.uk	Rosado, Ivan/AAZ-9068-2020	Rosado, Ivan/0000-0001-7409-7341; Crossan, Gerry/0000-0002-7974-009X	Children's Leukaemia Trust; Fanconi Anaemia Research Fund; MRC [MC_U105178811] Funding Source: UKRI; Medical Research Council [MC_U105178811] Funding Source: researchfish	Children's Leukaemia Trust; Fanconi Anaemia Research Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Grompe for Fancd2 knockout mice, J. Sale and S. Takeda for DT40 strains, N. Sugimura and F. Gergely for comments on the manuscript. We are grateful to T. Langford, R. Berks, V. Smith, J. Wiles, C. Shepherd, M. Kidd, M. Brown, A. Mead, R. Pannell, J. Garaycoechea and A. Shortland for their assistance with animal experiments and husbandry. We thank N. Grant and P. Banks from the Visual Aids department for photographic images and W. Zhao of the Human Research Tissue Bank (NIHR Cambridge Biomedical Research Centre) for processing histology. F.L. and I.V.R. are funded by the Children's Leukaemia Trust and Fanconi Anaemia Research Fund, respectively. K.J.P. acknowledges M. Neuberger, N. McIntyre and C. Decal for support.	ABEL EL, 1991, ALCOHOL CLIN EXP RES, V15, P514, DOI 10.1111/j.1530-0277.1991.tb00553.x; Alpi A, 2007, MOL CELL BIOL, V27, P8421, DOI 10.1128/MCB.00504-07; Alter BP, 2005, ARCH OTOLARYNGOL, V131, P635, DOI 10.1001/archotol.131.7.635; Brooks PJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000050; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen L, 2007, CHEM RES TOXICOL, V20, P108, DOI 10.1021/tx060232x; Cheng G, 2003, CHEM RES TOXICOL, V16, P145, DOI 10.1021/tx025614r; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; Hazen SL, 1998, BIOCHEMISTRY-US, V37, P6864, DOI 10.1021/bi972449j; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; King G, 1998, J EXP ZOOL, V282, P12; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kunitoh S, 1997, J PHARMACOL EXP THER, V280, P527; Latino-Martel P, 2010, CANCER EPIDEM BIOMAR, V19, P1238, DOI 10.1158/1055-9965.EPI-09-1110; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; MacArthur AC, 2008, CANCER CAUSE CONTROL, V19, P283, DOI 10.1007/s10552-007-9091-8; Marc N, 2000, BIOCHEM GENET, V38, P297, DOI 10.1023/A:1002057000788; Marietta C, 2009, MUTAT RES-FUND MOL M, V664, P77, DOI 10.1016/j.mrfmmm.2009.03.011; Matsuda T, 2007, CARCINOGENESIS, V28, P2363, DOI 10.1093/carcin/bgm057; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; MEAGHER RC, 1982, NEW ENGL J MED, V307, P845, DOI 10.1056/NEJM198209303071402; MICHOT F, 1987, ACTA HAEMATOL-BASEL, V78, P252, DOI 10.1159/000205888; Nagayoshi H, 2009, MUTAT RES-GEN TOX EN, V673, P74, DOI 10.1016/j.mrgentox.2008.11.009; NAKAO S, 1991, AM J HEMATOL, V37, P120, DOI 10.1002/ajh.2830370210; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; O'Brien PJ, 2005, CRIT REV TOXICOL, V35, P609, DOI 10.1080/10408440591002183; OSHEA KS, 1979, J ANAT, V128, P65; Pappa A, 2003, BIOCHEM J, V376, P615, DOI 10.1042/BJ20030810; Parmar K, 2009, MUTAT RES-FUND MOL M, V668, P133, DOI 10.1016/j.mrfmmm.2009.03.015; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Perez-Miller S, 2010, NAT STRUCT MOL BIOL, V17, P159, DOI 10.1038/nsmb.1737; Ridpath JR, 2007, CANCER RES, V67, P11117, DOI 10.1158/0008-5472.CAN-07-3028; Riveros-Rosas H, 1997, ARCH MED RES, V28, P453; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Stein S, 2006, MUTAT RES-GEN TOX EN, V608, P1, DOI 10.1016/j.mrgentox.2006.01.009; SULIK KK, 1981, SCIENCE, V214, P936, DOI 10.1126/science.6795717; Vasiliou V, 2004, DRUG METAB REV, V36, P279, DOI 10.1081/DMR-120034001; VASILIOU V, 1989, COMP BIOCHEM PHYS C, V94, P671, DOI 10.1016/0742-8413(89)90130-8; Wang M, 2000, CHEM RES TOXICOL, V13, P1149, DOI 10.1021/tx000118t; WEBSTER WS, 1983, TERATOLOGY, V27, P231, DOI 10.1002/tera.1420270211; Yu HS, 2009, TOXICOL MECH METHOD, V19, P535, DOI 10.3109/15376510903401708	41	357	364	3	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					53	U67		10.1038/nature10192	http://dx.doi.org/10.1038/nature10192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734703				2022-12-28	WOS:000292461300043
J	Greenberg, M; Ridgely, MS				Greenberg, Michael; Ridgely, M. Susan			Clinical Decision Support and Malpractice Risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIAN ORDER ENTRY; SYSTEMS; ALERTS		[Greenberg, Michael] RAND Corp, RAND Inst Civil Justice, Pittsburgh, PA 15213 USA; [Greenberg, Michael; Ridgely, M. Susan] RAND Hlth, Pittsburgh, PA USA; [Greenberg, Michael] RAND Inst Civil Justice, Pittsburgh, PA USA	RAND Corporation; RAND Corporation	Greenberg, M (corresponding author), RAND Corp, RAND Inst Civil Justice, 4570 5th Ave, Pittsburgh, PA 15213 USA.	michaelg@rand.org						Aarts J, 2009, HEALTH AFFAIR, V28, P404, DOI 10.1377/hlthaff.28.2.404; Karsh BT, 2010, J AM MED INFORM ASSN, V17, P617, DOI 10.1136/jamia.2010.005637; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Kuperman GJ, 2007, J AM MED INFORM ASSN, V14, P29, DOI 10.1197/jamia.M2170; Spina JR, 2005, AM J MED QUAL, V20, P7, DOI 10.1177/1062860604273777; Van der Sijs H, 2006, J AM MED INFORM ASSN, V13, P138, DOI 10.1197/jamia.M1809; Wolfstadt JI, 2008, J GEN INTERN MED, V23, P451, DOI 10.1007/s11606-008-0504-5	7	24	24	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					90	91		10.1001/jama.2011.929	http://dx.doi.org/10.1001/jama.2011.929			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	787LV	21730245				2022-12-28	WOS:000292378700026
J	Tylleskar, T; Jackson, D; Meda, N; Engebretsen, IMS; Chopra, M; Diallo, AH; Doherty, T; Ekstrom, EC; Fadnes, LT; Goga, A; Kankasa, C; Klungsoyr, JI; Lombard, C; Nankabirwa, V; Nankunda, JK; Van de Perre, P; Sanders, D; Shanmugam, R; Sommerfelt, H; Wamani, H; Tumwine, JK				Tylleskar, Thorkild; Jackson, Debra; Meda, Nicolas; Engebretsen, Ingunn Marie S.; Chopra, Mickey; Diallo, Abdoulaye Hama; Doherty, Tanya; Ekstrom, Eva-Charlotte; Fadnes, Lars T.; Goga, Ameena; Kankasa, Chipepo; Klungsoyr, Jorn I.; Lombard, Carl; Nankabirwa, Victoria; Nankunda, Jolly K.; Van de Perre, Philippe; Sanders, David; Shanmugam, Rebecca; Sommerfelt, Halvor; Wamani, Henry; Tumwine, James K.		PROMISE-EBF Study Grp	Exclusive breastfeeding promotion by peer counsellors in sub-Saharan Africa (PROMISE-EBF): a cluster-randomised trial	LANCET			English	Article							HIV; GUIDELINES; EXPERIENCES; NUTRITION; EFFICACY; SUPPORT; COHORT	Background Exclusive breastfeeding (EBF) is reported to be a life-saving intervention in low-income settings. The effect of breastfeeding counselling by peer counsellors was assessed in Africa. Methods 24 communities in Burkina Faso, 24 in Uganda, and 34 in South Africa were assigned in a 1:1 ratio, by use of a computer-generated randomisation sequence, to the control or intervention clusters. In the intervention group, we scheduled one antenatal breastfeeding peer counselling visit and four post-delivery visits by trained peers. The data gathering team were masked to the intervention allocation. The primary outcomes were prevalance of EBF and diarrhoea reported by mothers for infants aged 12 weeks and 24 weeks. Country-specific prevalence ratios were adjusted for cluster effects and sites. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00397150. Findings 2579 mother infant pairs were assigned to the intervention or control clusters in Burkina Faso (n=392 and n=402, respectively), Uganda (n=396 and n=369, respectively), and South Africa (n=535 and 485, respectively). The EBF prevalences based on 24-h recall at 12 weeks in the intervention and control clusters were 310 (79%) of 392 and 139 (35%) of 402, respectively, in Burkina Faso (prevalence ratio 2.29, 95% CI 1.33-3.92); 323 (82%) of 396 and 161 (44%) of 369, respectively, in Uganda (1.89, 1.70-2.11); and 56 (10%) of 535 and 30 (6%) of 485, respectively, in South Africa (1.72, 1.12-2.63). The EBF prevalences based on 7-day recall in the intervention and control clusters were 300 (77%) and 94 (23%), respectively, in Burkina Faso (3.27, 2.13-5.03); 305 (77%) and 125 (34%), respectively, in Uganda (2.30, 2.00-2.65); and 41 (8%) and 19 (4%), respectively, in South Africa (1.98, 1.30-3.02). At 24 weeks, the prevalences based on 24-h recall were 286 (73%) in the intervention cluster and 88 (22%) in the control cluster in Burkina Faso (3.33, 1.74-6.38); 232 (59%) and 57 (15%), respectively, in Uganda (3.83, 2.97-4.95); and 12 (2%) and two (<1%), respectively, in South Africa (5.70, 1.33-24.26). The prevalences based on 7-day recall were 279 (71%) in the intervention cluster and 38 (9%) in the control cluster in Burkina Faso (7.53, 4.42-12.82); 203 (51%) and 41 (11%), respectively, in Uganda (4.66, 3.35-6.49); and ten (2%) and one (<1%), respectively, in South Africa (9.83, 1.40-69.14). Diarrhoea prevalence at age 12 weeks in the intervention and control clusters was 20 (5%) and 36 (9%), respectively, in Burkina Faso (0.57, 0.27-1.22); 39 (10%) and 32 (9%), respectively, in Uganda (1.13, 0.81-1.59); and 45 (8%) and 33 (7%), respectively, in South Africa (1.16, 0.78-1.75). The prevalence at age 24 weeks in the intervention and control clusters was 26 (7%) and 32 (8%), respectively, in Burkina Faso (0.83, 0.45-1.54); 52 (13%) and 59 (16%), respectively, in Uganda (0.82, 0.58-1.15); and 54 (10%) and 33 (7%), respectively, in South Africa (1.31, 0.89-1.93). Interpretation Low-intensity individual breastfeeding peer counselling is achievable and, although it does not affect the diarrhoea prevalence, can be used to effectively increase EBF prevalence in many sub-Saharan African settings.	[Tylleskar, Thorkild; Engebretsen, Ingunn Marie S.; Diallo, Abdoulaye Hama; Fadnes, Lars T.; Klungsoyr, Jorn I.; Nankabirwa, Victoria; Nankunda, Jolly K.; Sommerfelt, Halvor] Univ Bergen, Ctr Int Hlth, N-5020 Bergen, Norway; [Jackson, Debra; Doherty, Tanya; Sanders, David] Univ Western Cape, Sch Publ Hlth, ZA-7535 Bellville, South Africa; [Meda, Nicolas; Diallo, Abdoulaye Hama] Minist Hlth, Ctr MURAZ, Bobo Dioulasso, Burkina Faso; [Chopra, Mickey] UN Plaza, UNICEF, New York, NY USA; [Doherty, Tanya; Goga, Ameena; Lombard, Carl] MRC, Cape Town, South Africa; [Ekstrom, Eva-Charlotte] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Kankasa, Chipepo] Univ Zambia, Sch Med, Dept Paediat & Child Hlth, Lusaka, Zambia; [Nankabirwa, Victoria; Nankunda, Jolly K.; Tumwine, James K.] Makerere Univ, Coll Hlth Sci, Dept Paediat & Child Hlth, Kampala, Uganda; [Van de Perre, Philippe] INSERM, U1058, Montpellier, France; [Van de Perre, Philippe] Univ Montpellier I, Montpellier, France; [Van de Perre, Philippe] CHU Montpellier, Dept Bacteriol Virol, Montpellier, France; [Shanmugam, Rebecca] MRC, Durban, South Africa; [Sommerfelt, Halvor] Norwegian Inst Publ Hlth, Div Infect Dis Control, Oslo, Norway; [Wamani, Henry] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda	University of Bergen; University of the Western Cape; Centre Muraz; UNICEF; Uppsala University; University of Zambia; Makerere University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Norwegian Institute of Public Health (NIPH); Makerere University	Tylleskar, T (corresponding author), Univ Bergen, Ctr Int Hlth, POB 7800, N-5020 Bergen, Norway.	thorkild.tylleskar@cih.uib.no	Sommerfelt, Halvor/ABD-3552-2020; Engebretsen, Ingunn Marie S/N-5692-2017; Tylleskär, Thorkild/S-5529-2017; Jackson, Debra/D-2843-2009; Van de Perre, Philippe/B-9692-2008; Fadnes, Lars T/AAA-8691-2021; Nankunda, Jolly/AAS-4036-2020; Fadnes, Lars T/E-9086-2016	Sommerfelt, Halvor/0000-0002-5670-9786; Engebretsen, Ingunn Marie S/0000-0001-5852-3611; Tylleskär, Thorkild/0000-0003-4801-4324; Jackson, Debra/0000-0001-5252-5325; Van de Perre, Philippe/0000-0002-3912-0427; Fadnes, Lars T/0000-0001-8757-2092; Nankabirwa, Victoria/0000-0002-9952-8942; Jackson, Debra/0000-0003-3307-632X; Lombard, Carl/0000-0002-2136-6533	European Union [INCO-CT 2004-003660]; Research Council of Norway, Swedish International Development Cooperation Agency; Norwegian Programme for Development, Research and Education; Rockefeller Brothers Foundation; South African National Research Foundation	European Union(European Commission); Research Council of Norway, Swedish International Development Cooperation Agency(Research Council of Norway); Norwegian Programme for Development, Research and Education; Rockefeller Brothers Foundation; South African National Research Foundation(National Research Foundation - South Africa)	The study was funded by the European Union Sixth Framework International Cooperation Developing Countries (contract number INCO-CT 2004-003660); Research Council of Norway, Swedish International Development Cooperation Agency; Norwegian Programme for Development, Research and Education; Rockefeller Brothers Foundation; and the South African National Research Foundation. We thank the mothers and their families for their contributions to this study; representative study teams for their efforts; local health providers and administrative local councils for their cooperation; and Rajiv Bahl, WHO, for the assistance in planning the study and in the randomisation.	Aidam BA, 2005, J NUTR, V135, P1691, DOI 10.1093/jn/135.7.1691; Arifeen S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e67; Bahl R, 2005, B WORLD HEALTH ORGAN, V83, P418; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; Bhandari N, 2008, MATERN CHILD NUTR, V4, P5, DOI 10.1111/j.1740-8709.2007.00126.x; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bland RM, 2003, ARCH DIS CHILD, V88, P778, DOI 10.1136/adc.88.9.778; Chapman DJ, 2010, J HUM LACT, V26, P314, DOI 10.1177/0890334410369481; Coovadia HM, 2007, TROP MED INT HEALTH, V12, P1116, DOI 10.1111/j.1365-3156.2007.01895.x; Daniels K, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-6; Doherty T, 2007, AIDS, V21, P1791, DOI 10.1097/QAD.0b013e32827b1462; Doherty T, 2011, B WORLD HEALTH ORGAN, V89, P62, DOI 10.2471/BLT.10.079798; Engebretsen Ingunn Marie S, 2007, BMC Pediatr, V7, P10, DOI 10.1186/1471-2431-7-10; Engebretsen IM, 2010, INT BREASTFEED J, V5, DOI [10.1186/1746-4358-5-13, 10.1186/1746-4358-5-2]; Fjeld E, 2008, INT BREASTFEED J, V3, DOI 10.1186/1746-4358-3-26; Goga AE, 2009, JAIDS-J ACQ IMM DEF, V50, P521, DOI 10.1097/QAI.0b013e3181990620; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Hendricks MK, 2003, PUBLIC HEALTH NUTR, V6, P431, DOI 10.1079/PHN2003458; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; Jakobsen MS, 2008, ACTA PAEDIATR, V97, P68, DOI 10.1111/j.1651-2227.2007.00532.x; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Nankunda J, 2006, INT BREASTFEED J, V1, DOI 10.1186/1746-4358-1-19; Nankunda J, 2010, INT BREASTFEED J, V5, DOI 10.1186/1746-4358-5-16; Nankunda J, 2010, MATERN CHILD NUTR, V6, P53, DOI 10.1111/j.1740-8709.2009.00187.x; Nor B, 2009, J HUM LACT, V25, P427, DOI 10.1177/0890334409341050; PIWOZ EG, 2001, WHORHR0112 DEP CHILD; World Health Organization, 2008, INT COD MARK BREAST	30	180	188	1	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2011	378	9789					420	427		10.1016/S0140-6736(11)60738-1	http://dx.doi.org/10.1016/S0140-6736(11)60738-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XM	21752462	Green Submitted			2022-12-28	WOS:000293615900033
J	Ye, J				Ye, Jin			Protease Sets Site-1 on Lysosomes	SCIENCE			English	Editorial Material							BONE-FORMATION; CLEAVAGE; PATHWAY; SREBPS; CELLS; MICE		Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Ye, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	jin.ye@utsouthwestern.edu						Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Vincent MJ, 2003, J VIROL, V77, P8640, DOI 10.1128/JVI.77.16.8640-8649.2003; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7	13	4	4	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					50	51		10.1126/science.1209417	http://dx.doi.org/10.1126/science.1209417			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719668				2022-12-28	WOS:000292255400043
J	[Anonymous]				[Anonymous]			Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEMORRHAGE; CT	Objective To assess the effect of tranexamic acid (which reduces bleeding in surgical patients and reduces mortality due to bleeding in trauma patients) on intracranial haemorrhage in patients with traumatic brain injury. Methods A nested, randomised, placebo controlled trial. All investigators were masked to treatment allocation. All analyses were by intention to treat. Patients 270 adult trauma patients with, or at risk of, significant extracranial bleeding within 8 hours of injury, who also had traumatic brain injury. Interventions Patients randomly allocated to tranexamic acid (loading dose 1 g over 10 minutes, then infusion of 1 g over 8 hours) or matching placebo. Main outcome measures Intracranial haemorrhage growth (measured by computed tomography) between hospital admission and then 24-48 hours later, with adjustment for Glasgow coma score, age, time from injury to the scans, and initial haemorrhage volume. Results Of the 133 patients allocated to tranexamic acid and 137 allocated to placebo, 123 (92%) and 126 (92%) respectively provided information on the primary outcome. All patients provided information on clinical outcomes. The mean total haemorrhage growth was 5.9 ml (SD 26.8) and 8.1 mL (SD 29.2) in the tranexamic acid and placebo groups respectively (adjusted difference -3.8 mL (95% confidence interval -11.5 to 3.9)). New focal cerebral ischaemic lesions occurred in 6 (5%) patients in the tranexamic acid group versus 12 (9%) in the placebo group (adjusted odds ratio 0.51 (95% confidence interval 0.18 to 1.44)). There were 14 (11%) deaths in the tranexamic acid group and 24 (18%) in the placebo group (adjusted odds ratio 0.47 (0.21 to 1.04)). Conclusions This trial shows that neither moderate benefits nor moderate harmful effects of tranexamic acid in patients with traumatic brain injury can be excluded. However, the analysis provides grounds for further clinical trials evaluating the effect of tranexamic acid in this population.					IBIS, NEUROCRITICOS/C-1805-2016	Prieto-Merino, David/0000-0001-5001-0061; Al-Shahi Salman, Rustam/0000-0002-2108-9222	UK NIHR; Pfizer; BUPA Foundation; J P Moulton Charitable Foundation; UK Health Technology Assessment programme [06/303/20]; UK MRC; Scottish Funding Council through the SINAPSE Collaboration (Scottish Imaging Network, A Platform for Scientific Excellence); Scottish Funding Council; Medical Research Council [G108/613, G1002605] Funding Source: researchfish; National Institute for Health Research [09/102/01] Funding Source: researchfish; MRC [G108/613, G1002605] Funding Source: UKRI	UK NIHR(National Institute for Health Research (NIHR)); Pfizer(Pfizer); BUPA Foundation; J P Moulton Charitable Foundation; UK Health Technology Assessment programme(National Institute for Health Research (NIHR)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Funding Council through the SINAPSE Collaboration (Scottish Imaging Network, A Platform for Scientific Excellence); Scottish Funding Council; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The CRASH-2 study was funded by the UK NIHR Health Technology Assessment programme, Pfizer, BUPA Foundation, and J P Moulton Charitable Foundation. This sub-study was funded by the UK Health Technology Assessment programme (06/303/20). Rustam Al-Shahi Salman was funded by a UK MRC clinician scientist fellowship. Joanna Wardlaw was funded by the Scottish Funding Council through the SINAPSE Collaboration (Scottish Imaging Network, A Platform for Scientific Excellence).; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: the submitted work was funded by the UK Health Technology Assessment programme (06/303/20), Rustam Al-Shahi Salman was funded by a UK MRC clinician scientist fellowship, Joanna Wardlaw was funded by the Scottish Funding Council; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Baigent C, 2010, OXFORD TXB MED, P31; Bayir A, 2006, NEUROL INDIA, V54, P363, DOI 10.4103/0028-3886.28106; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Cordoba G, 2010, BMJ-BRIT MED J, V341, pc3920; Edwards P, 2005, LANCET, V365, P1957; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Henry DA, 2007, COCHRANE DB SYST REV, V17; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Perel P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007877.pub2; Perel P, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-72; PETERSEN OF, 1984, NEURORADIOLOGY, V26, P363, DOI 10.1007/BF00327488; Roos YB, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001245, DOI 10.1002/14651858.CD001245]; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Stein SC, 2007, INDIAN J MED RES, V125, P186; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; WARDLAW JM, 1994, AM J NEURORADIOL, V15, P1933	22	106	107	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2011	343								d3795	10.1136/bmj.d3795	http://dx.doi.org/10.1136/bmj.d3795			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788QD	21724564	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000292458600002
J	Bach, JF				Bach, Jean-Francois			Anti-CD3 antibodies for type 1 diabetes: beyond expectations	LANCET			English	Editorial Material							RECENT-ONSET; DOUBLE-BLIND; INSULIN; AUTOIMMUNITY; MELLITUS; TRIAL		[Bach, Jean-Francois] Hop Necker Enfants Malad, INSERM, U1013, F-75015 Paris, France; [Bach, Jean-Francois] Univ Paris 05, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Bach, JF (corresponding author), Univ Paris 05, Paris, France.	jean-francois.bach@academie-sciences.fr						CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134; FEUTREN G, 1986, LANCET, V2, P119; *GLAXOSMITHKLINE, 2011, GLAXOSMITHKLINE TOL; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Keymeulen B, 2010, DIABETOLOGIA, V53, P614, DOI 10.1007/s00125-009-1644-9; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; Raz I, 2001, LANCET, V358, P1749, DOI 10.1016/S0140-6736(01)06801-5; Sherry N, 2011, LANCET, V378, P487, DOI 10.1016/S0140-6736(11)60931-8; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Walter M, 2009, DIABETES CARE, V32, P2036, DOI 10.2337/dc09-0449	12	39	43	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 6	2011	378	9790					459	460		10.1016/S0140-6736(11)60980-X	http://dx.doi.org/10.1016/S0140-6736(11)60980-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	809SO	21719098				2022-12-28	WOS:000294077200004
J	Baicker, K; Chernew, ME				Baicker, Katherine; Chernew, Michael E.			The Economics of Financing Medicare	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Baicker, Katherine] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Chernew, Michael E.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Baicker, K (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.							Finkelstein A, 2007, Q J ECON, V122, P1, DOI 10.1162/qjec.122.1.1; *KAIS FAM FDN, 2011, MED SPEND FIN PRIM; ORSZAG PR, 2007, COMMUNICATION   0709; 2011, ANNUAL REPORT BOARDS	4	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4								10.1056/NEJMp1107671	http://dx.doi.org/10.1056/NEJMp1107671			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798AJ	21751901				2022-12-28	WOS:000293172200006
J	Soldner, F; Laganiere, J; Cheng, AW; Hockemeyer, D; Gao, Q; Alagappan, R; Khurana, V; Golbe, LI; Myers, RH; Lindquist, S; Zhang, L; Guschin, D; Fong, LK; Vu, BJ; Meng, XD; Urnov, FD; Rebar, EJ; Gregory, PD; Zhang, HS; Jaenisch, R				Soldner, Frank; Laganiere, Josee; Cheng, Albert W.; Hockemeyer, Dirk; Gao, Qing; Alagappan, Raaji; Khurana, Vikram; Golbe, Lawrence I.; Myers, Richard H.; Lindquist, Susan; Zhang, Lei; Guschin, Dmitry; Fong, Lauren K.; Vu, B. Joseph; Meng, Xiangdong; Urnov, Fyodor D.; Rebar, Edward J.; Gregory, Philip D.; Zhang, H. Steve; Jaenisch, Rudolf			Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations	CELL			English	Article							COPY NUMBER; HUMAN ESCS; GENOME; DISEASE; REPAIR; MODEL; OLIGODEOXYNUCLEOTIDES; PATHOGENESIS; GENES; IPSCS	Patient-specific induced pluripotent stem cells (iPSCs) derived from somatic cells provide a unique tool for the study of human disease, as well as a promising source for cell replacement therapies. One crucial limitation has been the inability to perform experiments under genetically defined conditions. This is particularly relevant for late age onset disorders in which in vitro phenotypes are predicted to be subtle and susceptible to significant effects of genetic background variations. By combining zinc finger nuclease (ZFN)-mediated genome editing and iPSC technology, we provide a generally applicable solution to this problem, generating sets of isogenic disease and control human pluripotent stem cells that differ exclusively at either of two susceptibility variants for Parkinson's disease by modifying the underlying point mutations in the a-synuclein gene. The robust capability to genetically correct disease-causing point mutations in patient-derived hiPSCs represents significant progress for basic biomedical research and an advance toward hiPSC-based cell replacement therapies.	[Soldner, Frank; Cheng, Albert W.; Hockemeyer, Dirk; Gao, Qing; Alagappan, Raaji; Khurana, Vikram; Lindquist, Susan; Jaenisch, Rudolf] Whitehead Inst, Cambridge, MA 02142 USA; [Lindquist, Susan; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA; [Cheng, Albert W.] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Laganiere, Josee; Zhang, Lei; Guschin, Dmitry; Fong, Lauren K.; Vu, B. Joseph; Meng, Xiangdong; Urnov, Fyodor D.; Rebar, Edward J.; Gregory, Philip D.; Zhang, H. Steve] Sangamo BioSci Inc, Pt Richmond Tech Ctr, Richmond, CA 94804 USA; [Khurana, Vikram] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Khurana, Vikram] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Myers, Richard H.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Golbe, Lawrence I.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurol, New Brunswick, NJ 08903 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Sangamo Therapeutics, Inc.; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Jaenisch, R (corresponding author), Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Guschin, Dmitry/U-3731-2019; Guschin, Dmitry/O-7594-2018	Guschin, Dmitry/0000-0002-4184-0001; Guschin, Dmitry/0000-0002-4184-0001; Myers, Richard/0000-0002-8365-2674; Cheng, Albert/0000-0003-2653-5743; Gregory, Philip/0000-0001-9249-2468; Laganiere, Josee/0000-0003-0775-3331; Hockemeyer, Dirk/0000-0002-5598-5092; Khurana, Vikram/0000-0002-4018-5527	NIH [R01-CA084198, R37-HD045022]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198, R37CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076843] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Ping Xu and Tenzin Lungjangwa for technical support and Jessica Dausman, Kibibi Ganz, Ruth Flannery, and Dongdong Fu for their help with animal husbandry and processing of teratomas. We would like to thank Tom Volkert and Jeong-Ah Kwon of the Whitehead Genome Technology Core for their help with the CNV analysis; Nicki Watson of the W.M. Keck Microscopy Facility for help with confocal microscopy; and Patti Wisniewski and Chad Araneo of the Whitehead Institute FACS facility for their help with cell sorting. We thank Gladys Dulay for construction of ZFN vectors and Elo Leung for computational analysis for the off-target study. We thank all of the members of the Jaenisch lab for helpful discussions and comments on the manuscript. R.J. was supported by NIH grants R01-CA084198 and R37-HD045022. This research was supported, in part, by a Collaborative Innovation Award from the Howard Hughes Medical Institute. R.J. is an adviser to Stemgent and a cofounder of Fate Therapeutics. D.H. is a Merck Fellow of the Life Sciences Research Foundation. J.L., L.K.F., L.Z., F.D.U., P.D.G., H.S.Z., D.J., B.J.V., X.M., and E.J.R. are full-time employees of Sangamo BioSciences, Inc.	Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Daley GQ, 2008, CELL, V132, P544, DOI 10.1016/j.cell.2008.02.009; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Golbe LI, 1996, ANN NEUROL, V40, P767, DOI 10.1002/ana.410400513; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Radecke F, 2006, MOL THER, V14, P798, DOI 10.1016/j.ymthe.2006.06.008; Radecke S, 2010, MOL THER, V18, P743, DOI 10.1038/mt.2009.304; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Schulz JB, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-5011-4; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Summers KM, 1996, HUM MUTAT, V7, P283; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Vogel G, 2010, SCIENCE, V330, P1172, DOI 10.1126/science.330.6008.1172; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	48	538	594	0	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 22	2011	146	2					318	331		10.1016/j.cell.2011.06.019	http://dx.doi.org/10.1016/j.cell.2011.06.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21757228	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000293013000013
J	Pastores, SM				Pastores, Stephen M.			Review: Intensive insulin therapy does not reduce mortality but increases severe hypoglycemia in hospitalized patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							GLYCEMIC CONTROL; METAANALYSIS		Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Pastores, SM (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.								0	3	5	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2							JC1-12	10.7326/0003-4819-155-2-201107190-02012	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	793KW	21768578				2022-12-28	WOS:000292822000011
J	Elbe, S				Elbe, Stefan			The art of medicine Should health professionals play the global health security card?	LANCET			English	Editorial Material									Univ Sussex, Sch Global Studies, Dept Int Relat, Brighton BN1 9SN, E Sussex, England	University of Sussex	Elbe, S (corresponding author), Univ Sussex, Sch Global Studies, Dept Int Relat, Brighton BN1 9SN, E Sussex, England.	s.elbe@sussex.ac.uk		Elbe, Stefan/0000-0002-5567-5262				Elbe S., 2010, SECURITY GLOBAL HLTH; Elbe Stefan., 2009, VIRUS ALERT SECURITY; Lakoff Andrew, 2008, BIOSECURITY INTERVEN; Price-Smith Andrew T., 2009, CONTAGION CHAOS DIS	4	13	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 16	2011	378	9787					220	221		10.1016/S0140-6736(11)61114-8	http://dx.doi.org/10.1016/S0140-6736(11)61114-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798JD	21770062	Bronze, Green Published			2022-12-28	WOS:000293201100016
J	Suffredini, AF; Munford, RS				Suffredini, Anthony F.; Munford, Robert S.			Novel Therapies for Septic Shock Over the Past 4 Decades	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACTIVATED PROTEIN-C; GRAM-NEGATIVE BACTEREMIA; ILL ADULT PATIENTS; SEVERE SEPSIS; SURVIVING SEPSIS; CAMPAIGN; EFFICACY; CARE; EPIDEMIOLOGY; INFLAMMATION	Infections that result in shock and organ failure are a major public health problem worldwide. Severe sepsis and septic shock affect patients of all ages and often complicate chronic diseases. They are the major causes of death in critical care units and contribute substantially to hospital inpatient costs. Translating the scientific advances of the last 4 decades into clinical practice has been challenging. Despite many attempts to develop new therapies, the basic elements of treatment have not changed since the 1960s. In this Grand Rounds, we summarize the results of the clinical trials conducted during the last 4 decades, discuss some lessons learned, and suggest possible directions for future investigation. JAMA. 2011;306(2):194-199 www.jama.com	[Suffredini, Anthony F.] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA; [Munford, Robert S.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Suffredini, AF (corresponding author), NIH, Dept Crit Care Med, Ctr Clin, Bldg 10,Rm 2C145, Bethesda, MD 20892 USA.	asuffredini@cc.nih.gov			Clinical Center, Intramural Research and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001138] Funding Source: NIH RePORTER	Clinical Center, Intramural Research and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Clinical Center, Intramural Research Program and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Abraham E, 2003, JAMA-J AM MED ASSOC, V290, P238, DOI 10.1001/jama.290.2.238; Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; ARISE, 2007, Crit Care Resusc, V9, P8; BARNETT JA, 1969, J AMER MED ASSOC, V209, P1514, DOI 10.1001/jama.209.10.1514; Barochia AV, 2010, CRIT CARE MED, V38, P668, DOI 10.1097/CCM.0b013e3181cb0ddf; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Centers for Disease Control and Prevention, 2010, MMWR-MORBID MORTAL W, V59, P1108; Eichacker PQ, 2007, INTENS CARE MED, V33, P396, DOI 10.1007/s00134-007-0556-8; Eichacker PQ, 2006, NEW ENGL J MED, V355, P1640, DOI 10.1056/NEJMp068197; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1197, DOI 10.1164/rccm.200204-302OC; Eli Lilly and Company, NCT00604214 E LILL C; Finfer S, 2010, CRIT CARE MED, V38, P683, DOI 10.1097/CCM.0b013e3181cc5302; GREENMAN RL, 1991, JAMA-J AM MED ASSOC, V266, P1097, DOI 10.1001/jama.266.8.1097; Hollenberg SM, 2011, AM J RESP CRIT CARE, V183, P847, DOI 10.1164/rccm.201006-0972CI; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Kavanagh BP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000094; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Kushner I, 1998, CYTOKINE GROWTH F R, V9, P191, DOI 10.1016/S1359-6101(98)00016-1; Levin M, 2000, LANCET, V356, P961, DOI 10.1016/S0140-6736(00)02712-4; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Marshall JC, 2008, J LEUKOCYTE BIOL, V83, P471, DOI 10.1189/jlb.0607380; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Minneci PC, 2009, CLIN MICROBIOL INFEC, V15, P308, DOI 10.1111/j.1469-0691.2009.02752.x; Monash University, AUSTR RES SEPS EV RA; Munford RS, 2006, ANNU REV PATHOL-MECH, V1, P467, DOI 10.1146/annurev.pathol.1.110304.100200; Munford RS, 2001, AM J RESP CRIT CARE, V163, P316, DOI 10.1164/ajrccm.163.2.2007102; Munford RS, 2010, MANDELL DOUGLAS BENN, P987; Nadel S, 2007, LANCET, V369, P836, DOI 10.1016/S0140-6736(07)60411-5; National Institute of General Medical Sciences, NCT00510835 NAT I GE; Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B; PERL TM, 1995, JAMA-J AM MED ASSOC, V274, P338, DOI 10.1001/jama.274.4.338; Quartin AA, 1997, JAMA-J AM MED ASSOC, V277, P1058, DOI 10.1001/jama.277.13.1058; Rowan K, 073747 NAT I HLTH RE; Singer M, 2004, LANCET, V364, P545, DOI 10.1016/S0140-6736(04)16815-3; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Sweeney DA, 2008, INTENS CARE MED, V34, P1955, DOI 10.1007/s00134-008-1274-6; Sweeney DA, 2009, CRIT CARE MED, V37, P327, DOI 10.1097/CCM.0b013e3181935102; Turgeon AF, 2007, ANN INTERN MED, V146, P193, DOI 10.7326/0003-4819-146-3-200702060-00009; University of Versailles, NCT00625209 U VERS; Warren HS, 2002, NEW ENGL J MED, V347, P1027, DOI 10.1056/NEJMsb020574; WEIL MH, 1958, ARCH INTERN MED, V101, P184, DOI 10.1001/archinte.1958.00260140016004; ZIEGLER EJ, 1982, NEW ENGL J MED, V307, P1225, DOI 10.1056/NEJM198211113072001; ZIEGLER EJ, 1991, NEW ENGL J MED, V324, P429, DOI 10.1056/NEJM199102143240701	49	64	70	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					194	199		10.1001/jama.2011.909	http://dx.doi.org/10.1001/jama.2011.909			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791CO	21750297				2022-12-28	WOS:000292639400027
J	Boyce, N				Boyce, Niall			The Lancet Technology: July, 2011	LANCET			English	Editorial Material												niall.boyce@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 9	2011	378	9786					117	117		10.1016/S0140-6736(11)61074-X	http://dx.doi.org/10.1016/S0140-6736(11)61074-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	795CJ	21748872				2022-12-28	WOS:000292948800014
J	Zimmet, P; Alberti, KGMM; Rubino, F; Dixon, JB				Zimmet, Paul; Alberti, K. George M. M.; Rubino, Francesco; Dixon, John B.			IDF's view of bariatric surgery in type 2 diabetes	LANCET			English	Editorial Material							RISK-FACTORS; ASSOCIATION; MORTALITY; MELLITUS; WEIGHT; TRENDS		[Zimmet, Paul; Dixon, John B.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Alberti, K. George M. M.] Univ London Imperial Coll Sci Technol & Med, London, England; [Rubino, Francesco] Weill Cornell Med Coll, New York, NY USA	Baker Heart and Diabetes Institute; Imperial College London; Cornell University	Zimmet, P (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia.	paul.zimmet@bakeridi.edu.au	Zimmet, Paul/H-7635-2013; Zimmet, Paul/O-8486-2019; Dixon, John B/A-5318-2011	Zimmet, Paul/0000-0003-0627-0776; Dixon, John B/0000-0001-5391-4082				[Anonymous], 1995, Diabetes, V44, P1249; Buchwald H, 2007, SURGERY, V142, P621, DOI 10.1016/j.surg.2007.07.018; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Colquitt J., 2009, COCHRANE DB SYST REV, V15, P1, DOI DOI 10.1002/14651858.CD003641.PUB3; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dixon JB, 2011, DIABETIC MED, V28, P628, DOI 10.1111/j.1464-5491.2011.03306.x; Dixon JB, 2003, ARCH INTERN MED, V163, P2058, DOI 10.1001/archinte.163.17.2058; Liebl A, 2002, DIABETOLOGIA, V45, pS23, DOI 10.1007/s00125-002-0863-0; Meijer RI, 2011, ARCH SURG-CHICAGO, V146, P744, DOI 10.1001/archsurg.2011.134; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Norris SL, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004096.pub2, 10.1002/14651858.CD004095.pub2, 10.1002/14651858.CD005270]; Office of Health Economics, 2010, SHEDD POUNDS OB MAN; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Welbourn R, 2011, UK NATL BARIATRIC SU	16	38	42	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2011	378	9786					108	110		10.1016/S0140-6736(11)61027-1	http://dx.doi.org/10.1016/S0140-6736(11)61027-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	795CJ	21742162				2022-12-28	WOS:000292948800008
J	Xiao, T; Staub, W; Robles, E; Gosse, NJ; Cole, GJ; Baier, H				Xiao, Tong; Staub, Wendy; Robles, Estuardo; Gosse, Nathan J.; Cole, Gregory J.; Baier, Herwig			Assembly of Lamina-Specific Neuronal Connections by Slit Bound to Type IV Collagen	CELL			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; AXON GUIDANCE; OPTIC TECTUM; ROBO RECEPTORS; RETINAL AXONS; RETINOTECTAL PROJECTION; EMBRYONIC ZEBRAFISH; BASEMENT-MEMBRANE; LATERAL POSITION; EXPRESSION	The mechanisms that generate specific neuronal connections in the brain are under intense investigation. In zebrafish, retinal ganglion cells project their axons into at least six layers within the neuropil of the midbrain tectum. Each axon elaborates a single, planar arbor in one of the target layers and forms synapses onto the dendrites of tectal neurons. We show that the laminar specificity of retinotectal connections does not depend on self-sorting interactions among RGC axons. Rather, tectum-derived Slit1, signaling through axonal Robo2, guides neurites to their target layer. Genetic and biochemical studies indicate that Slit binds to Dragnet (Col4a5), a type IV Collagen, which forms the basement membrane on the surface of the tectum. We further show that radial glial endfeet are required for the basement-membrane anchoring of Slit. We propose that Slit1 signaling, perhaps in the form of a superficial-to-deep gradient, presents laminar positional cues to ingrowing retinal axons.	[Xiao, Tong; Staub, Wendy; Robles, Estuardo; Gosse, Nathan J.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94158 USA; [Xiao, Tong; Staub, Wendy; Robles, Estuardo; Gosse, Nathan J.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Genet Program, San Francisco, CA 94158 USA; [Xiao, Tong; Staub, Wendy; Robles, Estuardo; Gosse, Nathan J.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Program Dev Biol, San Francisco, CA 94158 USA; [Cole, Gregory J.] N Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of North Carolina; North Carolina Central University	Baier, H (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18, D-82152 Martinsried, Germany.	herwig.baier@ucsf.edu		Robles, Estuardo/0000-0002-1202-2050	NIH [R01 EY013855, EY012406]; NATIONAL EYE INSTITUTE [R01EY013855, R01EY012406] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Hitoshi Okamoto, Marc Ekker, Chi-Bin Chien and members of our laboratory for reagents and fish lines. This work was funded by NIH R01 EY013855 and EY012406.	Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Baier H, 1996, DEVELOPMENT, V123, P415; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Campbell DS, 2007, NEURON, V55, P231, DOI 10.1016/j.neuron.2007.06.034; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Dalkic E, 2006, DEV GENES EVOL, V216, P555, DOI 10.1007/s00427-006-0070-y; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; Erskine L, 2000, J NEUROSCI, V20, P4975; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Ghanem N, 2003, GENOME RES, V13, P533, DOI 10.1101/gr.716103; Goodhill GJ, 2003, NEURAL COMPUT, V15, P549, DOI 10.1162/089976603321192077; Gosse NJ, 2008, NATURE, V452, P892, DOI 10.1038/nature06816; Halfter W, 1998, J COMP NEUROL, V397, P105, DOI 10.1002/(SICI)1096-9861(19980720)397:1<105::AID-CNE8>3.0.CO;2-4; Halfter W, 2002, J NEUROSCI, V22, P6029; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001743; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Hussain SA, 2006, J BIOL CHEM, V281, P39693, DOI 10.1074/jbc.M609384200; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Lee JS, 2001, DEV DYNAM, V221, P216, DOI 10.1002/dvdy.1136; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; Lemke G, 2005, ANNU REV CELL DEV BI, V21, P551, DOI 10.1146/annurev.cellbio.20.022403.093702; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; Nevin LM, 2011, DEVELOPMENT, V138, P2457, DOI 10.1242/dev.060335; Nevin LM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-126; Nevin LM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-36; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Poggi L, 2005, J CELL BIOL, V171, P991, DOI 10.1083/jcb.200509098; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244; Robles E, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00001; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Scott EK, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.013.2009; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Spitzweck B, 2010, CELL, V140, P409, DOI 10.1016/j.cell.2010.01.002; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Van Vactor D, 2006, CURR OPIN NEUROBIOL, V16, P40, DOI 10.1016/j.conb.2006.01.011; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; Xiao T, 2003, J NEUROSCI, V23, P4190; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Xiao T, 2007, NAT NEUROSCI, V10, P1529, DOI 10.1038/nn2002; YAMAGATA M, 1995, DEVELOPMENT, V121, P189; YAMAGATA M, 1995, DEVELOPMENT, V121, P3763; Yebra M, 2003, DEV CELL, V5, P695, DOI 10.1016/S1534-5807(03)00330-7; Yeo SY, 2004, MECH DEVELOP, V121, P315, DOI 10.1016/j.mod.2004.03.006; Yeo SY, 2001, DEV BIOL, V230, P1, DOI 10.1006/dbio.2000.0105	60	75	75	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					164	176		10.1016/j.cell.2011.06.016	http://dx.doi.org/10.1016/j.cell.2011.06.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729787	Green Accepted, Bronze			2022-12-28	WOS:000292539300014
J	Collins, PY; Patel, V; Joestl, SS; March, D; Insel, TR; Daar, AS				Collins, Pamela Y.; Patel, Vikram; Joestl, Sarah S.; March, Dana; Insel, Thomas R.; Daar, Abdallah S.		Sci Advisory Board; Executive Comm Grand Challenges Gl	Grand challenges in global mental health	NATURE			English	Editorial Material							PRIORITIES; DEMENTIA		[Collins, Pamela Y.; Joestl, Sarah S.; March, Dana] NIMH, Off Res Dispair & Global Mental Hlth, Bethesda, MD USA; [Patel, Vikram] London Sch Hyg & Trop Med UK, Ctr Global Mental Hlth, Sangath, Goa, India; [Daar, Abdallah S.] Univ Toronto, Toronto, ON, Canada; [Daar, Abdallah S.] McLaughlin Rotman Ctr Global Hlth, Toronto, ON, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Toronto; University of Toronto	Collins, PY (corresponding author), NIMH, Off Res Dispair & Global Mental Hlth, Bethesda, MD USA.	pamela.collins@nih.gov; a.daar@utoronto.ca	Collins, Pamela Y/AAD-9334-2022; Sahakian, Barbara/AAW-1198-2020; Kaaya, Sylvia/AAG-7064-2019; Stein, Dan/A-1752-2008; Hall, Wayne D/A-3283-2008; Durkin, Maureen/B-7834-2015; Bordin, Isabel A./O-7640-2015	Sahakian, Barbara/0000-0001-7352-1745; Kaaya, Sylvia/0000-0001-6732-3590; Stein, Dan/0000-0001-7218-7810; Hall, Wayne D/0000-0003-1984-0096; Bordin, Isabel A./0000-0002-3173-5419; Kapur, Shitij/0000-0002-2231-2924; Anderson, Warwick Peter/0000-0002-7130-3530; Patel, Vikram/0000-0003-1066-8584; Collins, Pamela Y./0000-0003-3956-448X; Walport, Mark/0000-0001-7220-5273	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], BR J PSYCHIAT; [Anonymous], ATL SUBST US; [Anonymous], 2004, COUNTR RES NEUR DIS; Beddington J, 2008, NATURE, V455, P1057, DOI 10.1038/4551057a; Bertolote J.M., 2002, SUICIDOLOGI, V7, P6, DOI [DOI 10.5617/SUICIDOLOGI.2330, 10.5617/suicidologi.2330]; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Sharan P, 2009, BRIT J PSYCHIAT, V195, P354, DOI 10.1192/bjp.bp.108.050187; Tomlinson M, 2009, B WORLD HEALTH ORGAN, V87, P438, DOI 10.2471/BLT.08.054353; Varmus H, 2003, SCIENCE, V302, P398, DOI 10.1126/science.1091769; Wimo A, 2010, ALZHEIMERS DEMENT, V6, P98, DOI 10.1016/j.jalz.2010.01.010; World Health Organization, 2008, GLOBAL BARDEN DIS 20; World Health Organization (WHO), 2005, MENT HLTH ATL	16	1227	1264	6	169	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					27	30		10.1038/475027a	http://dx.doi.org/10.1038/475027a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	788RE	21734685	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000292461300013
J	Le Breton, JC; Sharma, S; Saito, H; Yuasa, S; Jansen, R				Le Breton, Jean-Christophe; Sharma, Sandeep; Saito, Hidekazu; Yuasa, Shinji; Jansen, Ron			Thermal spin current from a ferromagnet to silicon by Seebeck spin tunnelling	NATURE			English	Article							METAL	Heat generation by electric current, which is ubiquitous in electronic devices and circuits, raises energy consumption and will become increasingly problematic in future generations of high-density electronics. The control and re-use of heat are therefore important topics for existing and emerging technologies, including spintronics. Recently it was reported that heat flow within a ferromagnet can produce a flow of spin angular momentum-a spin current-and an associated voltage(1). This spin Seebeck effect has been observed in metallic(1,2), insulating(3) and semiconductor ferromagnets(4) with temperature gradients across them. Here we describe and report the demonstration of Seebeck spin tunnelling-a distinctly different thermal spin flow, of purely interfacial nature-generated in a tunnel contact between electrodes of different temperatures when at least one of the electrodes is a ferromagnet. The Seebeck spin current is governed by the energy derivative of the tunnel spin polarization. By exploiting this in ferromagnet-oxide-silicon tunnel junctions, we observe thermal transfer of spins from the ferromagnet to the silicon without a net tunnel charge current. The induced spin accumulation scales linearly with heating power and changes sign when the temperature differential is reversed. This thermal spin current can be used by itself, or in combination with electrical spin injection, to increase device efficiency. The results highlight the engineering of heat transport in spintronic devices and facilitate the functional use of heat.	[Sharma, Sandeep; Saito, Hidekazu; Yuasa, Shinji; Jansen, Ron] Natl Inst Adv Ind Sci & Technol, Spintron Res Ctr, Tsukuba, Ibaraki 3058568, Japan; [Le Breton, Jean-Christophe; Sharma, Sandeep] Netherlands Fdn Fundamental Res Matter FOM, NL-3502 GA Utrecht, Netherlands; [Sharma, Sandeep] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	National Institute of Advanced Industrial Science & Technology (AIST); University of Groningen	Jansen, R (corresponding author), Natl Inst Adv Ind Sci & Technol, Spintron Res Ctr, Tsukuba, Ibaraki 3058568, Japan.	ron.jansen@aist.go.jp	Sharma, Sandeep/AAD-5241-2022; Jansen, Ron/K-8246-2018; Institute, Zernike/W-7033-2019; saito, hidekazu/K-1442-2018; Yuasa, Shinji/H-2804-2016	Jansen, Ron/0000-0003-2122-5244; saito, hidekazu/0000-0001-7520-0689; Yuasa, Shinji/0000-0003-1093-9057; Sharma, Sandeep/0000-0001-5475-1297	Netherlands Foundation for Fundamental Research on Matter (FOM)	Netherlands Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands))	We are grateful to S. P. Dash for help with the device fabrication and discussions, T. Yorozu for the finite-element calculations and A. Yamamoto for making the finite-element program available to us. This work was financially supported by the program "Controlling spin dynamics in magnetic nanostructures" of the Netherlands Foundation for Fundamental Research on Matter (FOM).	Adachi H, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3529944; Bauer GEW, 2010, SOLID STATE COMMUN, V150, P459, DOI 10.1016/j.ssc.2010.01.022; Chappert C, 2007, NAT MATER, V6, P813, DOI 10.1038/nmat2024; Dash S. P., 2011, SPIN PRECESSION DECO; Dash SP, 2009, NATURE, V462, P491, DOI 10.1038/nature08570; Fukushima A, 2005, JPN J APPL PHYS 2, V44, pL12, DOI 10.1143/JJAP.44.L12; Gravier L, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.052410; Hatami M, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.174426; Jansen R, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.241305; Jaworski CM, 2010, NAT MATER, V9, P898, DOI [10.1038/nmat2860, 10.1038/NMAT2860]; JOHNSON M, 1987, PHYS REV B, V35, P4959, DOI 10.1103/PhysRevB.35.4959; McCann E, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.134424; McCann E, 2004, J MAGN MAGN MATER, V268, P123, DOI 10.1016/S0304-8853(03)00485-2; Min BC, 2006, NAT MATER, V5, P817, DOI 10.1038/nmat1736; Nolas G. S., 2001, THERMOELECTRICS BASI; Park BG, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.217206; Sinova J, 2010, NAT MATER, V9, P880, DOI 10.1038/nmat2880; Slachter A, 2010, NAT PHYS, V6, P879, DOI [10.1038/NPHYS1767, 10.1038/nphys1767]; Slonczewski JC, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.054403; Uchida K, 2008, NATURE, V455, P778, DOI 10.1038/nature07321; Uchida K, 2010, NAT MATER, V9, P894, DOI [10.1038/NMAT2856, 10.1038/nmat2856]; Valenzuela SO, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.196601; Wang ZC, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.224419; Xiao J, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.214418; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323	25	199	201	3	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					82	85		10.1038/nature10224	http://dx.doi.org/10.1038/nature10224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21716285				2022-12-28	WOS:000292461300049
J	Joynt, KE; Harris, Y; Orav, EJ; Jha, AK				Joynt, Karen E.; Harris, Yael; Orav, E. John; Jha, Ashish K.			Quality of Care and Patient Outcomes in Critical Access Rural Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH INFORMATION-TECHNOLOGY; ACUTE MYOCARDIAL-INFARCTION; UNITED-STATES; US HOSPITALS; MORTALITY; ASSOCIATION; PERFORMANCE; RATES	Context Critical access hospitals (CAHs) play a crucial role in the US rural safety net. Current policy efforts have focused primarily on helping these small, isolated hospitals remain financially viable to ensure access for individuals living in rural areas in the United States; however, little is known about the quality of care they provide or the outcomes their patients achieve. Objectives To examine the quality of care and patient outcomes at CAHs and to understand why patterns of care might differ for CAHs vs non-CAHs. Design, Setting, and Patients A retrospective analysis in 4738 US hospitals of Medicare fee-for-service beneficiaries with acute myocardial infarction (AMI) (10 703 for CAHs vs 469 695 for non-CAHs), congestive heart failure (CHF) (52 927 for CAHs vs 958 790 for non-CAHs), and pneumonia (86 359 for CAHs vs 773 227 for non-CAHs) who were discharged in 2008-2009. Main Outcome Measures Clinical capabilities, performance on processes of care, and 30-day mortality rates, adjusted for age, sex, race, and medical comorbidities. Results Compared with other hospitals (n = 3470), 1268 CAHs (26.8%) were less likely to have intensive care units (380 [30.0%] vs 2581 [74.4%], P < .001), cardiac catheterization capabilities (6 [0.5%] vs 1654 [47.7%], P < .001), and at least basic electronic health records (80 [6.5%] vs 445 [13.9%], P < .001). The CAHs had lower performance on processes of care than non-CAHs for all 3 conditions examined (concordance with Hospital Quality Alliance process measures for AMI, 91.0% [95% CI, 89.7%-92.3%] vs 97.8% [95% CI, 97.7%-97.9%]; for CHF, 80.6% [95% CI, 79.2%-82.0%] vs 93.5% [95% CI, 93.3%-93.7%]; and for pneumonia, 89.3% [95% CI, 88.6%-90.0%] vs 93.7% [95% CI, 93.6%-93.9%]; P < .001 for each). Patients admitted to CAHs had higher 30-day mortality rates for each condition than those admitted to non-CAHs (for AMI: 23.5% vs 16.2%; adjusted odds ratio [OR], 1.70; 95% confidence interval [CI], 1.61-1.80; P < .001; for CHF: 13.4% vs 10.9%; adjusted OR, 1.28; 95% CI, 1.23-1.32; P < .001; and for pneumonia: 14.1% vs 12.1%; adjusted OR, 1.20; 95% CI, 1.16-1.24; P < .001). Conclusion Compared with non-CAHs, CAHs had fewer clinical capabilities, worse measured processes of care, and higher mortality rates for patients with AMI, CHF, or pneumonia.	[Joynt, Karen E.; Orav, E. John; Jha, Ashish K.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Joynt, Karen E.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Orav, E. John] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Jha, Ashish K.] Vet Affairs Boston Healthcare Syst, Boston, MA USA; [Harris, Yael] US Hlth Resources & Serv Adm, Dept Hlth & Human Serv, Rockville, MD 20857 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; United States Health Resources & Service Administration (HRSA)	Joynt, KE (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	kjoynt@partners.org			NHLBI NIH HHS [T32 HL007604, T32 HL007604-28] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007604] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ambardekar AV, 2010, AM J CARDIOL, V105, P139, DOI 10.1016/j.amjcard.2009.09.003; Audebert HJ, 2009, STROKE, V40, P902, DOI 10.1161/STROKEAHA.108.529255; Bahensky JA, J MED SYST; Baldwin LM, 2004, J RURAL HEALTH, V20, P99, DOI 10.1111/j.1748-0361.2004.tb00015.x; Casey M, 2006, CAH PARTICIPATION HO; Casey MM, 2004, J RURAL HEALTH, V20, P327, DOI 10.1111/j.1748-0361.2004.tb00046.x; Casey MM, 2010, 10 U MINN UPP MIDW R; Centers for Medicare and Medicaid Services, 2011, FED REGISTER, V76, P2454; Chan L, 2006, J RURAL HEALTH, V22, P140, DOI 10.1111/j.1748-0361.2006.00022.x; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Chukmaitov AS, 2009, MED CARE, V47, P466, DOI 10.1097/MLR.0b013e31818dcdf0; CMS Hospital Pay-for-Performance Workgroup, 2007, US DEP HLTH HUM SERV; Desai MM, 2009, 2009 MEASURES MAINTE; Funk LM, 2011, ANN SURG, V253, P912, DOI 10.1097/SLA.0b013e318213862f; Gamm LD, 2003, RURAL HLTH PEOPLE 20; Hartman L, 2007, J RURAL HEALTH, V23, P254, DOI 10.1111/j.1748-0361.2007.00098.x; Hines S, 2008, JT COMM J QUAL PATIE, V34, P326, DOI 10.1016/S1553-7250(08)34041-0; Institute of Medicine Committee on the Future of Rural Health Care Quality Board on Health Care Services., 2005, QUAL COLL FUT RUR HL; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; Jha AK, 2007, HEALTH AFFAIR, V26, P1104, DOI 10.1377/hlthaff.26.4.1104; Jha AK, 2009, NEW ENGL J MED, V361, P2637, DOI 10.1056/NEJMsa0904859; Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592; Joynt KE, 2011, CIRC-CARDIOVASC QUAL, V4, P53, DOI 10.1161/CIRCOUTCOMES.110.950964; KEELER EB, 1992, JAMA-J AM MED ASSOC, V268, P1709, DOI 10.1001/jama.268.13.1709; KRUMHOLZ HM, 2005, RISK ADJUSTMENT MODE; Li PX, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-245; Lutfiyya MN, 2007, INT J QUAL HEALTH C, V19, P141, DOI 10.1093/intqhc/mzm010; McCambridge M, 2010, ARCH INTERN MED, V170, P648, DOI 10.1001/archinternmed.2010.74; *MED PAYM ADV COMM, 2001, REP C MED RUR AM; Medicare Payment Advisory Commission, 2005, REP C ISS MOD MED PR; Moscovice I, 2000, J RURAL HEALTH, V16, P168, DOI 10.1111/j.1748-0361.2000.tb00451.x; Office of the National Coordinator for Health Information Technology, RECS SUPP CRIT ACC R; Pathman DE, 2006, HEALTH SERV RES, V41, P79, DOI 10.1111/j.1475-6773.2005.00454.x; Pope GC, 2011, EVALUATION CMS HCC R; Shea S, 2009, J AM MED INFORM ASSN, V16, P446, DOI 10.1197/jamia.M3157; Sheikh K, 2001, ARCH INTERN MED, V161, P737, DOI 10.1001/archinte.161.5.737; Stensland J, 2004, 44 U MINN RUR HLTH R; Sutton JP, 2005, PATTERNS POSTACUTE U; The Joint Commission, 2009, 2010 ORYX PERF MEAS; U.S. Department of Agriculture, MEAS RUR RUR URB COM; US Census Bureau, 2000, CENS 2000 SUMM FIL D; Wakefield DS, 2010, J AM MED INFORM ASSN, V17, P584, DOI 10.1136/jamia.2010.004267; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180	44	178	178	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					45	52		10.1001/jama.2011.902	http://dx.doi.org/10.1001/jama.2011.902			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	787LV	21730240	Green Accepted, Bronze			2022-12-28	WOS:000292378700019
J	Keown, P; Weich, S; Bhui, KS; Scott, J				Keown, Patrick; Weich, Scott; Bhui, Kamaldeep S.; Scott, Jan			Association between provision of mental illness beds and rate of involuntary admissions in the NHS in England 1988-2008: ecological study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; PSYCHIATRIC ADMISSION; HEALTH-CARE; SERVICES; TEAM	Objective To examine the rise in the rate of involuntary admissions for mental illness in England that has occurred as community alternatives to hospital admission have been introduced. Design Ecological analysis. Setting England, 1988-2008. Data source Publicly available data on provision of beds for people with mental illness in the National Health Service from Hospital Activity Statistics and involuntary admission rates from the NHS Information Centre. Main outcome measures Association between annual changes in provision of mental illness beds in the NHS and involuntary admission rates, using cross correlation. Partial correlation coefficients were calculated and regression analysis carried out for the time lag (interval) over which the largest association between these variables was identified. Results The rate of involuntary admissions per annum in the NHS increased by more than 60%, whereas the provision of mental illness beds decreased by more than 60% over the same period; these changes seemed to be synchronous. The strongest association between these variables was observed when a time lag of one year was introduced, with bed reductions preceding increases in involuntary admissions (cross correlation -0.60, 95% confidence interval -1.06 to -0.15). This association increased in magnitude when analyses were restricted to civil (non-forensic) involuntary admissions and non-secure mental illness beds. Conclusion The annual reduction in provision of mental illness beds was associated with the rate of involuntary admissions over the short to medium term, with the closure of two mental illness beds leading to one additional involuntary admission in the subsequent year. This study provides a method for predicting rates of involuntary admissions and what may happen in the future if bed closures continue.	[Keown, Patrick] Queen Elizabeth Hosp, Tranwell Unit, Gateshead NE10 9R, Tyne & Wear, England; [Keown, Patrick; Scott, Jan] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Weich, Scott] Warwick Med Sch, Hlth Sci Res Inst, Coventry, W Midlands, England; [Bhui, Kamaldeep S.] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London, England	Newcastle University - UK; University of Warwick; University of London; Queen Mary University London	Keown, P (corresponding author), Queen Elizabeth Hosp, Tranwell Unit, Gateshead NE10 9R, Tyne & Wear, England.	patrick.keown@ncl.ac.uk	Scott, Jan/F-2966-2010; Bhui, Kamaldeep/AAX-2576-2020	Scott, Jan/0000-0002-7203-8601; Bhui, Kamaldeep/0000-0002-9205-2144; Weich, Scott/0000-0002-7552-7697	SDO grant	SDO grant	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years. All authors are applicants for an SDO grant pending review to build on these analyses.	Bennewith O, 2010, BRIT J PSYCHIAT, V196, P75, DOI 10.1192/bjp.bp.109.068890; Bhui K, 2003, BRIT J PSYCHIAT, V182, P105, DOI 10.1192/bjp.182.2.105; Bindman J, 2002, SOC PSYCH PSYCH EPID, V37, P341, DOI 10.1007/s00127-002-0558-3; Craig TK, 2004, BMJ-BRIT MED J, V329, P1067, DOI 10.1136/bmj.38246.594873.7C; Davidge M., 1993, SURVEY ENGLISH MENTA; Dean C, 1993, BRIT MED J, V307, P642; Department of Health, 1988, IN PAT FORM DET HOSP; Department of Health, 2009, BED AV OCC; Glover G, 2006, BRIT J PSYCHIAT, V189, P441, DOI 10.1192/bjp.bp.105.020362; Information Centre (2009m), 2009, INP FORM DET HOSP ME; Johnson S, 2005, BRIT MED J, V331, P599, DOI 10.1136/bmj.38519.678148.8F; Keown P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1837; NHSX, 2022, EL PRESCR MED ADM ME; Priebe S, 2005, BMJ-BRIT MED J, V330, P123, DOI 10.1136/bmj.38296.611215.AE; Rethink, 2005, FUT PERF OUTL ALT PA; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; VELLEMAN PF, 1980, J AM STAT ASSOC, V75, P609, DOI 10.2307/2287657; Wall S, 1999, BRIT MED J, V318, P1520, DOI 10.1136/bmj.318.7197.1520; Weich S, 2008, BRIT MED J, V337, P970; Weich S, 2010, SOC PSYCHIAT PSYCHIA	20	80	81	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2011	343								d3736	10.1136/bmj.d3736	http://dx.doi.org/10.1136/bmj.d3736			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791RV	21729994	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000292683200001
J	Schousboe, JT; Kerlikowske, K; Loh, A; Cummings, SR				Schousboe, John T.; Kerlikowske, Karla; Loh, Andrew; Cummings, Steven R.			Personalizing Mammography by Breast Density and Other Risk Factors for Breast Cancer: Analysis of Health Benefits and Cost-Effectiveness	ANNALS OF INTERNAL MEDICINE			English	Article							CARCINOMA IN-SITU; NATURAL-HISTORY; FOLLOW-UP; MODEL; MORTALITY; WOMEN; STAGE; ACCURACY; THERAPY; STATES	Background: Current guidelines recommend mammography every 1 or 2 years starting at age 40 or 50 years, regardless of individual risk for breast cancer. Objective: To estimate the cost-effectiveness of mammography by age, breast density, history of breast biopsy, family history of breast cancer, and screening interval. Design: Markov microsimulation model. Data Sources: Surveillance, Epidemiology, and End Results program, Breast Cancer Surveillance Consortium, and the medical literature. Target Population: U. S. women aged 40 to 49, 50 to 59, 60 to 69, and 70 to 79 years with initial mammography at age 40 years and breast density of Breast Imaging Reporting and Data System (BI-RADS) categories 1 to 4. Time Horizon: Lifetime. Perspective: National health payer. Intervention: Mammography annually, biennially, or every 3 to 4 years or no mammography. Outcome Measures: Costs per quality-adjusted life-year (QALY) gained and number of women screened over 10 years to prevent 1 death from breast cancer. Results of Base-Case Analysis: Biennial mammography cost less than $100 000 per QALY gained for women aged 40 to 79 years with BI-RADS category 3 or 4 breast density or aged 50 to 69 years with category 2 density; women aged 60 to 79 years with category 1 density and either a family history of breast cancer or a previous breast biopsy; and all women aged 40 to 79 years with both a family history of breast cancer and a previous breast biopsy, regardless of breast density. Biennial mammography cost less than $50 000 per QALY gained for women aged 40 to 49 years with category 3 or 4 breast density and either a previous breast biopsy or a family history of breast cancer. Annual mammography was not cost-effective for any group, regardless of age or breast density. Results of Sensitivity Analysis: Mammography is expensive if the disutility of false-positive mammography results and the costs of detecting nonprogressive and nonlethal invasive cancer are considered. Limitation: Results are not applicable to carriers of BRCA1 or BRCA2 mutations. Conclusion: Mammography screening should be personalized on the basis of a woman's age, breast density, history of breast biopsy, family history of breast cancer, and beliefs about the potential benefit and harms of screening.	Pk Nicollet Hlth Serv, Minneapolis, MN USA; Univ Minnesota, Minneapolis, MN USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Calif Pacific Med Ctr, Res Inst, San Francisco Coordinating Ctr, San Francisco, CA USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; California Pacific Medical Center; California Pacific Medical Center Research Institute	Schousboe, JT (corresponding author), Pk Nicollet Inst, 3800 Pk Nicollet Blvd, Minneapolis, MN 55416 USA.	scho0600@umn.edu			Eli Lilly; Da Costa Family Foundation for Research in Breast Cancer Prevention of the California Pacific Medical Center; Breast Cancer Surveillance Consortium; National Cancer Institute BCSC [U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040]; NATIONAL CANCER INSTITUTE [U01CA063731, U01CA063736, U01CA069976, U01CA086076, U01CA070013, U01CA086082, U01CA070040, U01CA063740] Funding Source: NIH RePORTER	Eli Lilly(Eli Lilly); Da Costa Family Foundation for Research in Breast Cancer Prevention of the California Pacific Medical Center; Breast Cancer Surveillance Consortium; National Cancer Institute BCSC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Primary Funding Source: Eli Lilly, Da Costa Family Foundation for Research in Breast Cancer Prevention of the California Pacific Medical Center, and Breast Cancer Surveillance Consortium.r Grant Support: By an unrestricted grant from Eli Lilly and by the Da Costa Family Foundation for Research in Breast Cancer Prevention of the California Pacific Medical Center. Data collection for this work was supported by grants U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, and U01CA70040 from the National Cancer Institute BCSC. The collection of cancer incidence data used in this study was supported by several state public health departments and cancer registries throughout the United States; a full description of these sources can be found at http://breastscreening.cancer.gov/work/acknowledgement.html.	American Cancer Society, 2009, AM CANC SOC GUID EAR; Arias Elizabeth, 2006, Natl Vital Stat Rep, V54, P1; Arveux P, 2003, EUR J CANCER CARE, V12, P143, DOI 10.1046/j.1365-2354.2003.00373.x; Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00011; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Breast Cancer Surveillance Consortium, 2004, NIH PUBL; Brett J, 2005, PSYCHO-ONCOLOGY, V14, P917, DOI 10.1002/pon.904; Bureau of Labor Statistics, 2009, CONS PRIC IND DET RE, V2009; Burstrom K, 2006, HEALTH POLICY, V76, P359, DOI 10.1016/j.healthpol.2005.06.011; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Centers for Medicare & Medicaid Services, 2008, 2009 PHYS FEE SCHED; Chiu SYH, 2010, CANCER EPIDEM BIOMAR, V19, P1219, DOI 10.1158/1055-9965.EPI-09-1028; Ciatto S, 2005, BREAST, V14, P269, DOI 10.1016/j.breast.2004.12.004; EDDY DM, 1989, ANN INTERN MED, V111, P389, DOI 10.7326/0003-4819-111-5-389; Erbas B, 2006, BREAST CANCER RES TR, V97, P135, DOI 10.1007/s10549-005-9101-z; Ernster VL, 2000, ARCH INTERN MED, V160, P953, DOI 10.1001/archinte.160.7.953; Ernster VL, 2002, J NATL CANCER I, V94, P1546; Garuz R, 1997, EUR J PUBLIC HEALTH, V7, P68, DOI 10.1093/eurpub/7.1.68; Gotzsche PC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub2; HALL J, 1992, SOC SCI MED, V34, P993, DOI 10.1016/0277-9536(92)90130-I; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; KATTLOVE H, 1995, JAMA-J AM MED ASSOC, V273, P142, DOI 10.1001/jama.273.2.142; Kerlikowske K, 2003, JNCI-J NATL CANCER I, V95, P1692, DOI 10.1093/jnci/djg097; Kerlikowske K, 1998, J NATL CANCER I, V90, P1801, DOI 10.1093/jnci/90.23.1801; Kerlikowske K, 2007, J NATL CANCER I, V99, P386, DOI 10.1093/jnci/djk066; Lee CH, 2002, RADIOL CLIN N AM, V40, P395, DOI 10.1016/S0033-8389(01)00015-X; Lidgren M, 2007, QUAL LIFE RES, V16, P1073, DOI 10.1007/s11136-007-9202-8; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Olsen AH, 2009, BRIT J CANCER, V100, P1205, DOI 10.1038/sj.bjc.6604989; Plevritis SK, 2007, STAT MED, V26, P581, DOI 10.1002/sim.2550; Ries L MD, 2008, SEER CANC STAT REV 1; Sirovich BE, 1999, SURG CLIN N AM, V79, P961, DOI 10.1016/S0039-6109(05)70056-6; Surveillance Epidemiology and End Results (SEER) Program, 2007, RES DAT 1973 2005; Szeto KL, 1996, HEALTH POLICY, V38, P101, DOI 10.1016/0168-8510(96)00843-3; TAPLIN SH, 1995, J NATL CANCER I, V87, P417, DOI 10.1093/jnci/87.6.417; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Tosteson ANA, 2008, ANN INTERN MED, V148, P1, DOI 10.7326/0003-4819-148-1-200801010-00002; von Eschenbach AC, 2002, ONCOLOGIST, V7, P170, DOI 10.1634/theoncologist.7-3-170; Wang H, 2001, CANCER CAUSE CONTROL, V12, P39, DOI 10.1023/A:1008999403069; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311	45	231	235	0	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2011	155	1					10	+		10.7326/0003-4819-155-1-201107050-00003	http://dx.doi.org/10.7326/0003-4819-155-1-201107050-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788MA	21727289	Green Accepted			2022-12-28	WOS:000292447800002
J	Marschner, K; Kollmann, K; Schweizer, M; Braulke, T; Pohl, S				Marschner, Katrin; Kollmann, Katrin; Schweizer, Michaela; Braulke, Thomas; Pohl, Sandra			A Key Enzyme in the Biogenesis of Lysosomes Is a Protease That Regulates Cholesterol Metabolism	SCIENCE			English	Article							ELEMENT-BINDING PROTEINS; UDP-N-ACETYLGLUCOSAMINE; SITE-1 PROTEASE; CLEAVAGE; CELLS; SUBUNIT; GLCNAC-1-PHOSPHOTRANSFERASE; PHOSPHOTRANSFERASE; IDENTIFICATION; CONVERTASE	Mucolipidosis II is a severe lysosomal storage disorder caused by defects in the alpha and beta subunits of the hexameric N-acetylglucosamine-1-phosphotransferase complex essential for the formation of the mannose 6-phosphate targeting signal on lysosomal enzymes. Cleavage of the membrane-bound alpha/beta-subunit precursor by an unknown protease is required for catalytic activity. Here we found that the alpha/beta-subunit precursor is cleaved by the site-1 protease (S1P) that activates sterol regulatory element-binding proteins in response to cholesterol deprivation. S1P-deficient cells failed to activate the alpha/beta-subunit precursor and exhibited a mucolipidosis II-like phenotype. Thus, S1P functions in the biogenesis of lysosomes, and lipid-independent phenotypes of S1P deficiency may be caused by lysosomal dysfunction.	[Marschner, Katrin; Kollmann, Katrin; Braulke, Thomas; Pohl, Sandra] Univ Med Ctr Hamburg Eppendorf, Childrens Hosp, Dept Biochem, Hamburg, Germany; [Schweizer, Michaela] Univ Hamburg, Ctr Mol Neurobiol, Dept Electron Microscopy, D-2000 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg	Braulke, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Childrens Hosp, Dept Biochem, Hamburg, Germany.	braulke@uke.uni-hamburg.de	Pohl, Sandra/AAF-1943-2020; Braulke, Thomas/AAV-9121-2020	Braulke, Thomas/0000-0002-2336-8532; Pohl, Sandra/0000-0001-7409-7042	Deutsche Forschungsgemeinschaft [SFB877/B3, GRK1459]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank J. L. Goldstein for providing SRD-12B and CHO-7 cells. Lipoprotein-poor newborn calf serum and human LDL for selection of SRD-12B cells were provided by J. Heeren. We also thank J. Brand and C. Raithore for technical assistance. We are grateful to J. Bonifacino for critical reading of the manuscript and comments, and to K. Duncan for help in editing the manuscript. T. Braulke and S. Muller-Loennies hold a patent on the single-chain antibody fragment for the detection of M6P-containing proteins (International Patent no. PTC/EP2009/060224 and U.S./PTC Application no. 13/057,844). This work was supported by the Deutsche Forschungsgemeinschaft (SFB877/B3, GRK1459).	Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Elagoz A, 2002, J BIOL CHEM, V277, P11265, DOI 10.1074/jbc.M109011200; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; Kornfeld S., 2001, METABOLIC MOL BASES, P3421; Kudo M, 2006, J BIOL CHEM, V281, P11761, DOI 10.1074/jbc.M513717200; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; Mullerr-Loennies S, 2010, AM J PATHOL, V177, P240, DOI 10.2353/ajpath.2010.090954; Paik KH, 2005, HUM MUTAT, V26, P308, DOI 10.1002/humu.20205; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Pohl S, 2010, J BIOL CHEM, V285, P23936, DOI 10.1074/jbc.M110.129684; Rawson RB, 1998, J BIOL CHEM, V273, P28261, DOI 10.1074/jbc.273.43.28261; Rojek JM, 2008, J VIROL, V82, P6045, DOI 10.1128/JVI.02392-07; Rojek JM, 2010, J VIROL, V84, P573, DOI 10.1128/JVI.01697-09; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Saul RA, 2005, AM J MED GENET A, V135A, P328, DOI 10.1002/ajmg.a.30716; Schlombs K, 2003, P NATL ACAD SCI USA, V100, P14024, DOI 10.1073/pnas.2331794100; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; Stirling J, 2006, MOL BIOL CELL, V17, P413, DOI 10.1091/mbc.E05-06-0500; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; Walkley SU, 2009, BBA-MOL CELL RES, V1793, P726, DOI 10.1016/j.bbamcr.2008.11.014	25	99	107	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					87	90		10.1126/science.1205677	http://dx.doi.org/10.1126/science.1205677			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719679				2022-12-28	WOS:000292255400055
J	Iheanacho, I				Iheanacho, Ike			DRUG TALES AND OTHER STORIES Death of the silent witness: patients' reporting of adverse drug reactions	BRITISH MEDICAL JOURNAL			English	Editorial Material									Drug & Therapeut Bulletin, London, England		Iheanacho, I (corresponding author), Drug & Therapeut Bulletin, London, England.	iiheanacho@bmjgroup.com							0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 29	2011	342								d4042	10.1136/bmj.d4042	http://dx.doi.org/10.1136/bmj.d4042			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788PZ	21715457				2022-12-28	WOS:000292458200007
J	Chalmers, I; Haines, A				Chalmers, Iain; Haines, Andy			Commentary: Skilled forensic capacity needed to investigate allegations of research misconduct	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							STOKE CNEP SAGA; MMR SCARE		[Chalmers, Iain] James Lind Initiat, Oxford OX2 7LG, England; [Haines, Andy] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Chalmers, I (corresponding author), James Lind Initiat, Oxford OX2 7LG, England.	IChalmers@jameslindlibrary.org		Haines, Andy/0000-0002-8053-4605				Barrett J, 2008, FRAUD MISCONDUCT BIO, P260; DEER B, 2004, SUNDAY TIMES    0222; Deer B, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c7001; Gillman MA, 2011, LANCET, V377, P1403, DOI 10.1016/S0140-6736(11)60566-7; Godlee, 2011, BRIT MED J, V342, pd22, DOI [10.1136/bmj.d22, DOI 10.1136/BMJ.D22]; Gornall J, 2010, J ROY SOC MED, V103, P173, DOI 10.1258/jrsm.2010.10k011; Hey E, 2010, J ROY SOC MED, V103, P133, DOI 10.1258/jrsm.2010.09k045; Kennedy I, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d807; Marcovitch H, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d284; Modi N, 2011, ARCH DIS CHILD, V96, P500, DOI 10.1136/adc.2010.188243; Nimmo W, 2000, P R COLL PHYS EDI S7, V30, P2; OECD Global Science Forum, 2009, INV RES MISC ALL INT; Samuels MP, 1996, PEDIATRICS, V98, P1154; Stonier P, 2001, P R COLL PHYSICIANS, V31, P253; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wells F, 2010, J ROY SOC MED, V103, P352, DOI 10.1258/jrsm.2010.10k010; Wright T, 2010, J ROY SOC MED, V103, P277, DOI 10.1258/jrsm.2010.10k012	17	7	7	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2011	342								d3977	10.1136/bmj.d3977	http://dx.doi.org/10.1136/bmj.d3977			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788PY	21712329	Green Submitted			2022-12-28	WOS:000292458100014
J	Yli-Kyyny, T; Tamminen, I; Syri, J; Venesmaa, P; Kroger, H				Yli-Kyyny, Tero; Tamminen, Inari; Syri, Jukka; Venesmaa, Petri; Kroger, Heikki			Bilateral hip pain	LANCET			English	Editorial Material									[Yli-Kyyny, Tero; Tamminen, Inari; Syri, Jukka; Venesmaa, Petri; Kroger, Heikki] Kuopio Univ Hosp, Dept Orthoped Traumatol & Hand Surg, FIN-70211 Kuopio, Finland	Kuopio University Hospital	Yli-Kyyny, T (corresponding author), Kuopio Univ Hosp, Dept Orthoped Traumatol & Hand Surg, POB 1777, FIN-70211 Kuopio, Finland.	tero.yli-kyyny@kuh.fi						Ballas MT, 1998, AM FAM PHYSICIAN, V57, P267; Haney EM, 2008, CURR OPIN RHEUMATOL, V20, P423, DOI 10.1097/BOR.0b013e3283025eb0; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; TAMMINEN IS, 2010, J BONE MINER METAB; Yli-Kyyny TT, 2010, ORTHOPEDICS, V33, P867, DOI 10.3928/01477447-20101021-37	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2011	377	9784					2248	2248		10.1016/S0140-6736(11)60549-7	http://dx.doi.org/10.1016/S0140-6736(11)60549-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	786XI	21704874				2022-12-28	WOS:000292340800037
J	Mullin, S				Mullin, Sandra			Global anti-smoking campaigns urgently needed	LANCET			English	Editorial Material									World Lung Fdn, New York, NY 10006 USA		Mullin, S (corresponding author), World Lung Fdn, New York, NY 10006 USA.	smullin@worldlungfoundation.org						Chapman S, 1999, BRIT MED J, V318, P1508, DOI 10.1136/bmj.318.7197.1508b; Cotter Trish, 2008, N S W Public Health Bull, V19, P68, DOI 10.1071/NB07098; FCTC, 2003, WHO FRAM CONV TOB CO; MULLIN S, J HLTH COMM IN PRESS; MURUKUTLA N, 2011, TOB CONTROL; National Cancer Institute, 2008, ROL MED PROM RED TOB; Shafey O, 2009, TOBACCO ATLAS, V3, P37; Thrasher JF, 2011, AM J PUBLIC HEALTH, V101, P328, DOI 10.2105/AJPH.2009.189704; World Health Organization, 2011, REP GLOB TOB EP	9	4	4	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 10	2011	378	9795					970	971		10.1016/S0140-6736(11)61058-1	http://dx.doi.org/10.1016/S0140-6736(11)61058-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	824HO	21741699				2022-12-28	WOS:000295193200009
J	Pan, YD; Birdsey, RA; Fang, JY; Houghton, R; Kauppi, PE; Kurz, WA; Phillips, OL; Shvidenko, A; Lewis, SL; Canadell, JG; Ciais, P; Jackson, RB; Pacala, SW; McGuire, AD; Piao, SL; Rautiainen, A; Sitch, S; Hayes, D				Pan, Yude; Birdsey, Richard A.; Fang, Jingyun; Houghton, Richard; Kauppi, Pekka E.; Kurz, Werner A.; Phillips, Oliver L.; Shvidenko, Anatoly; Lewis, Simon L.; Canadell, Josep G.; Ciais, Philippe; Jackson, Robert B.; Pacala, Stephen W.; McGuire, A. David; Piao, Shilong; Rautiainen, Aapo; Sitch, Stephen; Hayes, Daniel			A Large and Persistent Carbon Sink in the World's Forests	SCIENCE			English	Article							TROPICAL FORESTS; UNITED-STATES; CO2 EMISSIONS; DROUGHT; LAND; SENSITIVITY; MANAGEMENT; ATMOSPHERE; INCREASE; BALANCE	The terrestrial carbon sink has been large in recent decades, but its size and location remain uncertain. Using forest inventory data and long-term ecosystem carbon studies, we estimate a total forest sink of 2.4 +/- 0.4 petagrams of carbon per year (Pg C year(-1)) globally for 1990 to 2007. We also estimate a source of 1.3 +/- 0.7 Pg C year(-1) from tropical land-use change, consisting of a gross tropical deforestation emission of 2.9 +/- 0.5 Pg C year(-1) partially compensated by a carbon sink in tropical forest regrowth of 1.6 +/- 0.5 Pg C year(-1). Together, the fluxes comprise a net global forest sink of 1.1 +/- 0.8 Pg C year(-1), with tropical estimates having the largest uncertainties. Our total forest sink estimate is equivalent in magnitude to the terrestrial sink deduced from fossil fuel emissions and land-use change sources minus ocean and atmospheric sinks.	[Pan, Yude; Birdsey, Richard A.] US Forest Serv, USDA, Newtown Sq, PA 19073 USA; [Fang, Jingyun; Piao, Shilong] Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China; [Fang, Jingyun] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing 100093, Peoples R China; [Houghton, Richard] Woods Hole Res Ctr, Falmouth, MA 02543 USA; [Kauppi, Pekka E.; Rautiainen, Aapo] Univ Helsinki, Helsinki, Finland; [Kurz, Werner A.] Nat Resources Canada, Canadian Forest Serv, Victoria, BC V8Z 1M5, Canada; [Phillips, Oliver L.; Lewis, Simon L.; Sitch, Stephen] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Shvidenko, Anatoly] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Canadell, Josep G.] Commonwealth Sci & Ind Res Org Marine & Atmospher, Global Carbon Project, Canberra, ACT, Australia; [Ciais, Philippe] Lab Sci Climat & Environm CEA UVSQ CNRS, Gif Sur Yvette, France; [Jackson, Robert B.] Duke Univ, Durham, NC 27708 USA; [Pacala, Stephen W.] Princeton Univ, Princeton, NJ 08544 USA; [McGuire, A. David] Univ Alaska, US Geol Survey, Alaska Cooperat Fish & Wildlife Res Unit, Fairbanks, AK 99775 USA; [Hayes, Daniel] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA	United States Department of Agriculture (USDA); United States Forest Service; Peking University; Chinese Academy of Sciences; Institute of Botany, CAS; Woods Hole Research Center; University of Helsinki; Natural Resources Canada; Canadian Forest Service; University of Leeds; International Institute for Applied Systems Analysis (IIASA); Commonwealth Scientific & Industrial Research Organisation (CSIRO); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Duke University; Princeton University; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; United States Department of Energy (DOE); Oak Ridge National Laboratory	Pan, YD (corresponding author), US Forest Serv, USDA, Newtown Sq, PA 19073 USA.	ypan@fs.fed.us	Sitch, Stephen A/F-8034-2015; Ciais, Philippe/A-6840-2011; Hayes, Daniel/B-8968-2012; Shvidenko, Anatoly/I-1505-2016; Noojipady, Praveen/B-2511-2010; Pan, Yude/F-6145-2015; Phillips, Oliver/A-1523-2011; Canadell, Pep/E-9419-2010	Sitch, Stephen A/0000-0003-1821-8561; Ciais, Philippe/0000-0001-8560-4943; Shvidenko, Anatoly/0000-0001-7640-2151; Phillips, Oliver/0000-0002-8993-6168; Canadell, Pep/0000-0002-8788-3218; Kurz, Werner/0000-0003-4576-7849; Rautiainen, Aapo/0000-0002-6885-215X; Jackson, Robert/0000-0001-8846-7147; Hayes, Daniel/0000-0002-3011-7934; Lewis, Simon/0000-0002-8066-6851	U.S. Forest Service, NASA [31021001]; National Basic Research Program of China on Global Change [2010CB50600]; Gordon and Betty Moore Foundation; Peking Univ.; Princeton Univ.; Natural Environment Research Council [NE/B503384/1, NE/D000300/1, NE/B504630/1] Funding Source: researchfish	U.S. Forest Service, NASA(United States Department of Agriculture (USDA)United States Forest ServiceNational Aeronautics & Space Administration (NASA)); National Basic Research Program of China on Global Change(National Basic Research Program of China); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Peking Univ.(Peking University); Princeton Univ.(Princeton University); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study is the major output of two workshops at Peking Univ. and Princeton Univ. Y.P., R.A.B., and J.F. were lead authors and workshop organizers; Y.P., R.A.B., J.F., R.H., P.E.K., W.A.K., O.L.P., A.S., and S.L.L. contributed primary data sets and analyses; J.G.C., P.C., R.B.J., and S.W.P. contributed noteworthy ideas to improve the study; A.D.M., S.P., A.R., S.S., and D.H. provided results of modeling or data analysis relevant to the study; and all authors contributed in writing, discussions, or comments. We thank K. McCullough for helping to make the map in Fig. 1 and C. Wayson for helping to develop a Monte-Carlo analysis. This work was supported in part by the U.S. Forest Service, NASA (grant 31021001), the National Basic Research Program of China on Global Change (2010CB50600), the Gordon and Betty Moore Foundation, Peking Univ., and Princeton Univ. This work is a contribution toward the Global Carbon Project's aim of fostering an international framework to study the global carbon cycle.	Birdsey R, 2006, J ENVIRON QUAL, V35, P1461, DOI 10.2134/jeq2005.0162; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Ciais P, 2008, NAT GEOSCI, V1, P425, DOI 10.1038/ngeo233; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; FAO, 2010, 163 FAO; Friedlingstein P, 2010, NAT GEOSCI, V3, P811, DOI 10.1038/ngeo1022; Gloor M, 2009, GLOBAL CHANGE BIOL, V15, P2418, DOI 10.1111/j.1365-2486.2009.01891.x; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Hooijer A, 2010, BIOGEOSCIENCES, V7, P1505, DOI 10.5194/bg-7-1505-2010; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Houghton RA, 2003, TELLUS B, V55, P378, DOI 10.1034/j.1600-0889.2003.01450.x; Intergovernamental Panel on Climate Change, 2006, IPCC GUID NAT GREENH; Kauppi PE, 2006, P NATL ACAD SCI USA, V103, P17574, DOI 10.1073/pnas.0608343103; Kauppi PE, 2010, FOREST ECOL MANAG, V259, P1239, DOI 10.1016/j.foreco.2009.07.044; Khatiwala S, 2009, NATURE, V462, P346, DOI 10.1038/nature08526; Kurz WA, 2008, P NATL ACAD SCI USA, V105, P1551, DOI 10.1073/pnas.0708133105; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lewis SL, 2009, ANNU REV ECOL EVOL S, V40, P529, DOI 10.1146/annurev.ecolsys.39.110707.173345; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; McGuire AD, 2009, ECOL MONOGR, V79, P523, DOI 10.1890/08-2025.1; Metsaranta JM, 2010, TELLUS B, V62, P719, DOI 10.1111/j.1600-0889.2010.00487.x; Nabuurs G. J., 2007, CLIMATE CHANGE 2007, P542; Pacala SW, 2001, SCIENCE, V292, P2316, DOI 10.1126/science.1057320; Page SE, 2011, GLOBAL CHANGE BIOL, V17, P798, DOI 10.1111/j.1365-2486.2010.02279.x; Pan Y, 2011, BIOGEOSCIENCES, V8, P715, DOI 10.5194/bg-8-715-2011; Pan YD, 2009, FOREST ECOL MANAG, V259, P151, DOI 10.1016/j.foreco.2009.09.049; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Sarmiento JL, 2010, BIOGEOSCIENCES, V7, P2351, DOI 10.5194/bg-7-2351-2010; Schulze ED, 2009, NAT GEOSCI, V2, P842, DOI 10.1038/ngeo686; Shvidenko A.Z., 2007, BASIC PROBLEMS TRANS, P5; Stinson G, 2011, GLOBAL CHANGE BIOL, V17, P2227, DOI 10.1111/j.1365-2486.2010.02369.x; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	37	3967	4321	328	3452	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					988	993		10.1126/science.1201609	http://dx.doi.org/10.1126/science.1201609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21764754	Green Submitted			2022-12-28	WOS:000294000400048
J	Yoo, AS; Sun, AX; Li, L; Shcheglovitov, A; Portmann, T; Li, YL; Lee-Messer, C; Dolmetsch, RE; Tsien, RW; Crabtree, GR				Yoo, Andrew S.; Sun, Alfred X.; Li, Li; Shcheglovitov, Aleksandr; Portmann, Thomas; Li, Yulong; Lee-Messer, Chris; Dolmetsch, Ricardo E.; Tsien, Richard W.; Crabtree, Gerald R.			MicroRNA-mediated conversion of human fibroblasts to neurons	NATURE			English	Article							CHROMATIN-REMODELING COMPLEXES; SUBVENTRICULAR ZONE; NEURAL DEVELOPMENT; GENE-EXPRESSION; MIR-124; REST; DIFFERENTIATION; NEUROGENESIS; NEOCORTEX; NETWORK	Neurogenic transcription factors and evolutionarily conserved signalling pathways have been found to be instrumental in the formation of neurons(1,2). However, the instructive role of microRNAs (miRNAs) in neurogenesis remains unexplored. We recently discovered that miR-9* and miR-124 instruct compositional changes of SWI/SNF-like BAF chromatin-remodelling complexes, a process important for neuronal differentiation and function(3-6). Nearing mitotic exit of neural progenitors, miR-9* and miR-124 repress the BAF53a subunit of the neural-progenitor (np)BAF chromatin-remodelling complex. After mitotic exit, BAF53a is replaced by BAF53b, and BAF45a by BAF45b and BAF45c, which are then incorporated into neuron-specific (n)BAF complexes essential for post-mitotic functions(4). Because miR-9/9* and miR-124 also control multiple genes regulating neuronal differentiation and function(5,7-13), we proposed that these miRNAs might contribute to neuronal fates. Here we show that expression of miR-9/9* and miR-124 (miR-9/9*-124) in human fibroblasts induces their conversion into neurons, a process facilitated by NEUROD2. Further addition of neurogenic transcription factors ASCL1 and MYT1L enhances the rate of conversion and the maturation of the converted neurons, whereas expression of these transcription factors alone without miR-9/9*-124 was ineffective. These studies indicate that the genetic circuitry involving miR-9/9*-124 can have an instructive role in neural fate determination.	[Yoo, Andrew S.; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Yoo, Andrew S.; Crabtree, Gerald R.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Yoo, Andrew S.; Crabtree, Gerald R.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Sun, Alfred X.] Stanford Univ, Program Canc Biol, Stanford, CA 94305 USA; [Li, Li; Li, Yulong; Tsien, Richard W.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Li, Li] Stanford Univ, Med Scientist Training Program, Stanford, CA 94305 USA; [Li, Li] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Shcheglovitov, Aleksandr; Portmann, Thomas; Dolmetsch, Ricardo E.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Lee-Messer, Chris] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	yooa@wustl.edu; crabtree@stanford.edu	Li, Li/B-9514-2015	Sun, Alfred Xuyang/0000-0002-7893-2006; Li, Li/0000-0001-6131-4394; Yoo, Andrew/0000-0002-0304-3247; Li, Yulong/0000-0002-9166-9919	Agency of Science, Technology and Research of Singapore (A*STAR); Stanford Medical Scientist Training Program; National Institutes of Mental Health (NIMH) [F30MH093125]; Frances B. Nelson predoctoral fellowship; CIRM; Swiss National Science Foundation SNSF [PA00P3_134196]; NIH [HD55391, AI060037, NS046789, NS24067, GM58234, MH064070]; Simon's Foundation; Simons Family Foundation; Mathers Family Foundation; Burnett Family Foundation; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH093125, R01MH064070, R56MH064070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067, R01NS046789, R37NS046789] Funding Source: NIH RePORTER	Agency of Science, Technology and Research of Singapore (A*STAR)(Agency for Science Technology & Research (A*STAR)); Stanford Medical Scientist Training Program; National Institutes of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Frances B. Nelson predoctoral fellowship; CIRM(California Institute for Regenerative Medicine); Swiss National Science Foundation SNSF(Swiss National Science Foundation (SNSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simon's Foundation; Simons Family Foundation; Mathers Family Foundation; Burnett Family Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank I. Graef and A. Cho for helpful suggestions and reagents, A. Kuo and W. Ho for technical help, and X. Bao and P. Khavari for their generous gift of reagents. A.S.Y. is a fellow of the Helen Hay Whitney Foundation. A. X. S. is funded by the Agency of Science, Technology and Research of Singapore (A*STAR). L. L. is supported by the Stanford Medical Scientist Training Program, National Institutes of Mental Health (NIMH) F30MH093125, and the Frances B. Nelson predoctoral fellowship. A. S. is supported by the CIRM post-doctoral fellowship. T. P. is supported by a Swiss National Science Foundation SNSF fellowship for advanced researchers (PA00P3_134196). R. E. D. is supported by the NIH Director's Award, and awards from the Simon's Foundation and the CIRM. R. E. D. is also grateful for funding from B. and F. Horowitz, M. McCafferey, B. and J. Packard, P. Kwan and K. Wang. R. W. T. is supported by grants from the Simons, Mathers and Burnett Family Foundations. This work was supported by grants from the Howard Hughes Medical Institute (G. R. C.) and the NIH (HD55391, AI060037 and NS046789 to G. R. C., and NS24067, GM58234 and MH064070 to R.W.T.).	Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Coolen M, 2009, CURR OPIN NEUROBIOL, V19, P461, DOI 10.1016/j.conb.2009.09.006; Hansen DV, 2011, NEURON, V70, P645, DOI 10.1016/j.neuron.2011.05.006; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; HO L, NATURE CELL IN PRESS; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Ince-Dunn G, 2006, NEURON, V49, P683, DOI 10.1016/j.neuron.2006.01.031; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Laneve P, 2010, NUCLEIC ACIDS RES, V38, P6895, DOI 10.1093/nar/gkq604; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lin CH, 2005, P NATL ACAD SCI USA, V102, P14877, DOI 10.1073/pnas.0506785102; Maiorano NA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-40; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; McCormick MB, 1996, MOL CELL BIOL, V16, P5792; Olson JM, 2001, DEV BIOL, V234, P174, DOI 10.1006/dbio.2001.0245; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Tang XQ, 2007, RNA, V13, P1803, DOI 10.1261/rna.498607; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139	27	693	742	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 11	2011	476	7359					228	U123		10.1038/nature10323	http://dx.doi.org/10.1038/nature10323			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21753754	Green Accepted			2022-12-28	WOS:000293731900041
J	Chen, SK; Badea, TC; Hattar, S				Chen, S. -K.; Badea, T. C.; Hattar, S.			Photoentrainment and pupillary light reflex are mediated by distinct populations of ipRGCs	NATURE			English	Article							RETINAL GANGLION-CELLS; MELANOPSIN; MORPHOLOGY; RESPONSES; PROJECTIONS; DIVERSITY	Intrinsically photosensitive retinal ganglion cells (ipRGCs) express the photopigment melanopsin and regulate a wide array of light-dependent physiological processes(1-11). Genetic ablation of ipRGCs eliminates circadian photoentrainment and severely disrupts the pupillary light reflex (PLR)(12,13). Here we show that ipRGCs consist of distinct subpopulations that differentially express the Brn3b transcription factor, and can be functionally distinguished. Brn3b-negative M1 ipRGCs innervate the suprachiasmatic nucleus (SCN) of the hypothalamus, whereas Brn3b-positive ipRGCs innervate all other known brain targets, including the olivary pre-tectal nucleus. Consistent with these innervation patterns, selective ablation of Brn3b-positive ipRGCs severely disrupts the PLR, but does not impair circadian photoentrainment. Thus, we find that molecularly distinct subpopulations of M1 ipRGCs, which are morphologically and electrophysiologically similar, innervate different brain regions to execute specific light-induced functions.	[Chen, S. -K.; Hattar, S.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Badea, T. C.] NEI, Retinal Circuit Dev & Genet Unit, N NRL, NIH, Bethesda, MD 20892 USA; [Hattar, S.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Johns Hopkins University	Hattar, S (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	tudor.badea@nih.gov; shattar@jhu.edu	Badea, Tudor Constantin/B-1654-2018; Hattar, Samer/W-6927-2019	Badea, Tudor Constantin/0000-0003-3086-6713; CHEN, SHIH-KUO/0000-0002-7921-1358	Johns Hopkins University Mouse Tri-Lab; National Institutes of Health [GM076430]; David and Lucile Packard Foundation; Alfred P. Sloan Foundation; NATIONAL EYE INSTITUTE [ZIAEY000504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076430] Funding Source: NIH RePORTER	Johns Hopkins University Mouse Tri-Lab; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Nathans for providing several animal lines (Brn3b<SUP>CKOAP</SUP>, R26<SUP>IAP</SUP> and Z/AP) that were crucial for the completion of this study. We thank J. L. Ecker, who created the inducible cre line (Opn4<SUP>CreERT2</SUP>) we used in this study. We thank Z. Yang in D. Zack's laboratory for providing the Brn3b<SUP>Z-dta</SUP> mouse line, which was generously provided by the original laboratory that created this line: W. Klein. We also thank R. Kuruvilla, H. Zhao, M. Halpern, A. P. Sampath and T. Schmidt for their careful reading of the manuscript and helpful suggestions and the Johns Hopkins University Mouse Tri-Lab for support. This work was supported by the National Institutes of Health grant GM076430 (S. H.), the David and Lucile Packard Foundation (S. H.), and the Alfred P. Sloan Foundation (S.H.).	Badea TC, 2003, J NEUROSCI, V23, P2314; Badea TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007859; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hannibal J, 2004, NEUROREPORT, V15, P2317, DOI 10.1097/00001756-200410250-00003; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Mu XQ, 2005, CURR BIOL, V15, P525, DOI 10.1016/j.cub.2005.01.043; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751	28	277	282	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2011	476	7358					92	+		10.1038/nature10206	http://dx.doi.org/10.1038/nature10206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21765429	Green Accepted			2022-12-28	WOS:000293447300036
J	Eyerich, S; Onken, AT; Weidinger, S; Franke, A; Nasorri, F; Pennino, D; Grosber, M; Pfab, F; Schmidt-Weber, CB; Mempel, M; Hein, R; Ring, J; Cavani, A; Eyerich, K				Eyerich, Stefanie; Onken, Anna T.; Weidinger, Stephan; Franke, Andre; Nasorri, Francesca; Pennino, Davide; Grosber, Martine; Pfab, Florian; Schmidt-Weber, Carsten B.; Mempel, Martin; Hein, Ruediger; Ring, Johannes; Cavani, Andrea; Eyerich, Kilian			Mutual Antagonism of T Cells Causing Psoriasis and Atopic Eczema	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PATCH TEST; DISEASE; MECHANISMS; EXPRESSION; IL-17	The simultaneous occurrence of psoriasis driven by type 1 helper T (Th1) cells and type 17 helper T (Th17) cells and atopic eczema dominated by type 2 helper T (Th2) cells is rare. Here, we describe three patients with co-occurring psoriasis and atopic eczema with an antagonistic course and distinct T-cell infiltrates in lesions from psoriasis and those from atopic eczema. Sensitized patients with psoriasis had a reaction to epicutaneous allergen challenge, with clinically and histologically verified eczema lesions containing a large number of allergen-reactive T cells. These findings support a causative role for T cells triggered by specific antigens in both psoriasis and atopic eczema.	[Onken, Anna T.; Grosber, Martine; Pfab, Florian; Hein, Ruediger; Ring, Johannes; Eyerich, Kilian] Tech Univ Munich, Dept Dermatol & Allergy, D-80802 Munich, Germany; [Eyerich, Stefanie; Pennino, Davide; Schmidt-Weber, Carsten B.] Tech Univ, Ctr Allergy & Environm ZAUM, Munich, Germany; [Eyerich, Stefanie; Pennino, Davide; Schmidt-Weber, Carsten B.] Helmholtz Ctr Munich, Munich, Germany; [Weidinger, Stephan] Univ Hosp Schleswig Holstein, Dept Dermatol Allergol & Venerol, Kiel, Germany; [Franke, Andre] Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, Kiel, Germany; [Mempel, Martin] Univ Med Gottingen, Dept Dermatol Venereol & Allergol, Gottingen, Germany; [Nasorri, Francesca; Cavani, Andrea] Ist Dermopat Immacolata, Expt Immunol Lab, Rome, Italy	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Gottingen; IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Eyerich, K (corresponding author), Tech Univ Munich, Dept Dermatol & Allergy, Biedersteiner Str 29, D-80802 Munich, Germany.	kilian.eyerich@lrz.tum.de	Schmidt-Weber, Carsten B./AAU-1621-2021; Ring, Johannes/GLN-4341-2022; Pennino, Davide/D-7519-2013; Weidinger, Stephan/C-8461-2011; Franke, Andre/B-2151-2010	Schmidt-Weber, Carsten B./0000-0002-3203-8084; Ring, Johannes/0000-0001-8236-3152; Pennino, Davide/0000-0002-5834-1049; Weidinger, Stephan/0000-0003-3944-252X; Franke, Andre/0000-0003-1530-5811	German Research Foundation [EY97/1-2, WE2678/4-1]; Kommission Klinische Forschung of the Klinikum Rechts der Isar Munich; Hochschulwissen-schaftsprogramm of the Technische Universitat Munich; Bayerische Forschungsstiftung; National Genome Research Network [01GS0809, 01GS0818]; Christine Kuhne Center of Allergy Research and Education	German Research Foundation(German Research Foundation (DFG)); Kommission Klinische Forschung of the Klinikum Rechts der Isar Munich; Hochschulwissen-schaftsprogramm of the Technische Universitat Munich; Bayerische Forschungsstiftung; National Genome Research Network; Christine Kuhne Center of Allergy Research and Education	Supported by the German Research Foundation and others.; Supported by grants from Deutsche Forschungsgemeinschaft (EY97/1-2 and WE2678/4-1), Kommission Klinische Forschung of the Klinikum Rechts der Isar Munich, Hochschulwissen-schaftsprogramm of the Technische Universitat Munich, Bayerische Forschungsstiftung, the National Genome Research Network (01GS0809 and 01GS0818), and the Christine Kuhne Center of Allergy Research and Education.	Albanesi C, 2007, J IMMUNOL, V179, P984, DOI 10.4049/jimmunol.179.2.984; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; DARSOW U, 1995, J ALLERGY CLIN IMMUN, V95, P677, DOI 10.1016/S0091-6749(95)70172-9; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Eyerich K, 2008, INT ARCH ALLERGY IMM, V145, P213, DOI 10.1159/000109290; Eyerich K, 2009, J ALLERGY CLIN IMMUN, V123, P59, DOI 10.1016/j.jaci.2008.10.031; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Ghoreschi K, 2003, NAT MED, V9, P40, DOI 10.1038/nm804; GREWE M, 1995, J INVEST DERMATOL, V105, P407, DOI 10.1111/1523-1747.ep12321078; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; Howell MD, 2009, J ALLERGY CLIN IMMUN, V124, pR7, DOI 10.1016/j.jaci.2009.07.012; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Pennino D, 2010, J IMMUNOL, V184, P4880, DOI 10.4049/jimmunol.0901767; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; Weiss G, 2002, J EUR ACAD DERMATOL, V16, P241, DOI 10.1046/j.1473-2165.2002.00406.x	18	142	147	5	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2011	365	3					231	238		10.1056/NEJMoa1104200	http://dx.doi.org/10.1056/NEJMoa1104200			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794QI	21774711	Green Published, Green Submitted			2022-12-28	WOS:000292915500007
J	Khodakaram, K; Barmano, N				Khodakaram, Kaveh; Barmano, Neshro			Uncommon reaction to a common prescription	LANCET			English	Editorial Material							METRONIDAZOLE-INDUCED ENCEPHALOPATHY; LESION		[Khodakaram, Kaveh] Cty Hosp Ryhov, Dept Surg, S-55185 Jonkoping, Sweden; [Barmano, Neshro] Cty Hosp Ryhov, Dept Internal Med, S-55185 Jonkoping, Sweden		Khodakaram, K (corresponding author), Cty Hosp Ryhov, Dept Surg, S-55185 Jonkoping, Sweden.	kaveh.khodakaram@lj.se						Bottenberg MM, 2011, J CLIN PHARMACOL, V51, P112, DOI 10.1177/0091270010362905; Kim E, 2007, AM J NEURORADIOL, V28, P1652, DOI 10.3174/ajnr.A0655; Lee SS, 2009, J COMPUT ASSIST TOMO, V33, P305, DOI 10.1097/RCT.0b013e31817e6f58; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Sharma P, 2009, AM J ROENTGENOL, V193, P879, DOI 10.2214/AJR.08.2257	5	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 16	2011	378	9787					288	288		10.1016/S0140-6736(11)60996-3	http://dx.doi.org/10.1016/S0140-6736(11)60996-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798JD	21763942				2022-12-28	WOS:000293201100038
J	Estes, JA; Terborgh, J; Brashares, JS; Power, ME; Berger, J; Bond, WJ; Carpenter, SR; Essington, TE; Holt, RD; Jackson, JBC; Marquis, RJ; Oksanen, L; Oksanen, T; Paine, RT; Pikitch, EK; Ripple, WJ; Sandin, SA; Scheffer, M; Schoener, TW; Shurin, JB; Sinclair, ARE; Soule, ME; Virtanen, R; Wardle, DA				Estes, James A.; Terborgh, John; Brashares, Justin S.; Power, Mary E.; Berger, Joel; Bond, William J.; Carpenter, Stephen R.; Essington, Timothy E.; Holt, Robert D.; Jackson, Jeremy B. C.; Marquis, Robert J.; Oksanen, Lauri; Oksanen, Tarja; Paine, Robert T.; Pikitch, Ellen K.; Ripple, William J.; Sandin, Stuart A.; Scheffer, Marten; Schoener, Thomas W.; Shurin, Jonathan B.; Sinclair, Anthony R. E.; Soule, Michael E.; Virtanen, Risto; Wardle, David A.			Trophic Downgrading of Planet Earth	SCIENCE			English	Review							SEA OTTERS; INTRODUCED PREDATORS; GROUND IMPACTS; TOP-DOWN; DYNAMICS; EXTINCTION; MASS; CASCADES; NUTRIENT; INVASION	Until recently, large apex consumers were ubiquitous across the globe and had been for millions of years. The loss of these animals may be humankind's most pervasive influence on nature. Although such losses are widely viewed as an ethical and aesthetic problem, recent research reveals extensive cascading effects of their disappearance in marine, terrestrial, and freshwater ecosystems worldwide. This empirical work supports long-standing theory about the role of top-down forcing in ecosystems but also highlights the unanticipated impacts of trophic cascades on processes as diverse as the dynamics of disease, wildfire, carbon sequestration, invasive species, and biogeochemical cycles. These findings emphasize the urgent need for interdisciplinary research to forecast the effects of trophic downgrading on process, function, and resilience in global ecosystems.	[Estes, James A.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA; [Terborgh, John] Duke Univ, Nicholas Sch Environm & Earth Sci, Ctr Trop Conservat, Durham, NC 27708 USA; [Brashares, Justin S.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Power, Mary E.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Berger, Joel] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Berger, Joel] Wildlife Conservat Soc, Bozeman, MT 59715 USA; [Bond, William J.] Univ Cape Town, Dept Bot, ZA-7701 Rondebosch, South Africa; [Carpenter, Stephen R.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Essington, Timothy E.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Holt, Robert D.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Jackson, Jeremy B. C.; Sandin, Stuart A.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Marquis, Robert J.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Oksanen, Lauri; Oksanen, Tarja] Univ Turku, Sect Ecol, Dept Biol, FI-20014 Turku, Finland; [Oksanen, Lauri] Finnmark Univ Coll, Dept Nat Sci, N-9509 Alta, Norway; [Oksanen, Tarja] Umea Univ, Dept Ecol & Environm Sci, SE-90087 Umea, Sweden; [Paine, Robert T.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Pikitch, Ellen K.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Ripple, William J.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Scheffer, Marten] Wageningen Univ, Dept Environm Sci, Aquat Ecol & Water Qual Management Grp, NL-6700 DD Wageningen, Netherlands; [Schoener, Thomas W.] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; [Schoener, Thomas W.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Shurin, Jonathan B.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Sinclair, Anthony R. E.] Univ British Columbia, Ctr Biodivers Res, Vancouver, BC V6T 1Z4, Canada; [Virtanen, Risto] Univ Oulu, Dept Biol, FI-90014 Oulu, Finland; [Wardle, David A.] Swedish Univ Agr Sci, Dept Forest Ecol & Management, Fac Forestry, SE-90183 Umea, Sweden	University of California System; University of California Santa Cruz; Duke University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Montana System; University of Montana; Wildlife Conservation Society; University of Cape Town; University of Wisconsin System; University of Wisconsin Madison; University of Washington; University of Washington Seattle; State University System of Florida; University of Florida; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Missouri System; University of Missouri Saint Louis; University of Turku; UiT The Arctic University of Tromso; Umea University; University of Washington; University of Washington Seattle; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Oregon State University; Wageningen University & Research; University of California System; University of California Davis; University of California System; University of California Davis; University of British Columbia; University of British Columbia; University of Oulu; Swedish University of Agricultural Sciences	Estes, JA (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA.	jestes@ucsc.edu	Ripple, William/ABE-9353-2020; Scheffer, Marten/C-1852-2012; Bond, William/AAY-7631-2020; Carpenter, Stephen/AAQ-6404-2020; Wardle, David A./F-6031-2011; Virtanen, Risto/G-1810-2010	Wardle, David A./0000-0002-0476-7335; Virtanen, Risto/0000-0002-8295-8217; Bond, William/0000-0002-3441-2084; Shurin, Jonathan/0000-0001-7870-1972	Institute for Ocean Conservation Science; Defenders of Wildlife; White Oak Plantation; NSF; Natural Sciences and Engineering Research Council of Canada; Nordforsk	Institute for Ocean Conservation Science; Defenders of Wildlife; White Oak Plantation; NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Nordforsk	Financial and logistic support provided by the Institute for Ocean Conservation Science, Defenders of Wildlife, and the White Oak Plantation; research support by the NSF (various U. S. authors), Natural Sciences and Engineering Research Council of Canada (A. R. E. S.), and Nordforsk (L.O., T.O., R. V.). C. Eisenberg, G. Mittelbach, J. Moore, D. Reznick, O. Schmitz, and T. Williams commented on the manuscript, and E. Smith assisted in manuscript preparation.	Anthony RG, 2008, ECOLOGY, V89, P2725, DOI 10.1890/07-1818.1; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Bartsch MR, 2005, J N AM BENTHOL SOC, V24, P168, DOI 10.1899/0887-3593(2005)024<0168:SEOPBF>2.0.CO;2; Berger J, 2001, ECOL APPL, V11, P947, DOI 10.2307/3061004; Beschta RL, 2006, EARTH SURF PROC LAND, V31, P1525, DOI 10.1002/esp.1362; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Bond William, 2010, P275; Brashares Justin S., 2010, P221; Cabascon C., 2007, FOREST ECOL MANAG, V253, P112; Carlsson NOL, 2009, FRONT ECOL ENVIRON, V7, P525, DOI 10.1890/080093; Carpenter SR, 2001, ECOL MONOGR, V71, P163, DOI 10.1890/0012-9615(2001)071[0163:TCNALP]2.0.CO;2; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; deRivera CE, 2005, ECOLOGY, V86, P3364, DOI 10.1890/05-0479; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; DUGGINS DO, 1989, SCIENCE, V245, P170, DOI 10.1126/science.245.4914.170; Dunham AE, 2008, OIKOS, V117, P571, DOI 10.1111/j.0030-1299.2008.16534.x; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Flannery T, 1994, FUTURE EATERS ECOLOG; Frank DA, 2008, OIKOS, V117, P1718, DOI 10.1111/j.1600-0706.2008.16846.x; FRETWELL SD, 1987, OIKOS, V50, P291, DOI 10.2307/3565489; Fukami T, 2006, ECOL LETT, V9, P1299, DOI 10.1111/j.1461-0248.2006.00983.x; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Gruner DS, 2004, ECOLOGY, V85, P3010, DOI 10.1890/04-0020; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Holdo RM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000210; IRONS DB, 1986, ECOLOGY, V67, P1460, DOI 10.2307/1939077; JANZEN DH, 1974, NAT HIST, V83, P48; Katz T, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003416; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lafferty KD, 2004, ECOL APPL, V14, P1566, DOI 10.1890/03-5088; Levine J. S., 1999, 991 UNEPDEIAEWTR; LEWONTIN RC, 1969, BROOKHAVEN SYM BIOL, P13; Markandya A, 2008, ECOL ECON, V67, P194, DOI 10.1016/j.ecolecon.2008.04.020; Mather T. H., 1984, IRRIGATION DRAINAGE; MCLAREN BE, 1994, SCIENCE, V266, P1555, DOI 10.1126/science.266.5190.1555; Montgomery DR, 1996, CAN J FISH AQUAT SCI, V53, P1061, DOI 10.1139/cjfas-53-5-1061; Moore JW, 2007, ECOLOGY, V88, P1278, DOI 10.1890/06-0782; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Naiman RJ, 1997, BIOSCIENCE, V47, P521, DOI 10.2307/1313120; Nicol S, 2010, FISH FISH, V11, P203, DOI 10.1111/j.1467-2979.2010.00356.x; Ostfeld RS, 2004, FRONT ECOL ENVIRON, V2, P13, DOI 10.1890/1540-9295(2004)002[0013:APGFYH]2.0.CO;2; Owen-Smith R.N., 1992, MEGAHERBIVORES INFLU; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; PAINE RT, 1980, J ANIM ECOL, V49, P667; Pershing AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012444; POWER ME, 1985, ECOLOGY, V66, P1448, DOI 10.2307/1938007; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Ray J. C., 2005, LARGE CARNIVORES CON; Reisewitz SE, 2006, OECOLOGIA, V146, P623, DOI 10.1007/s00442-005-0230-1; Ripple WJ, 2006, BIOL CONSERV, V133, P397, DOI 10.1016/j.biocon.2006.07.002; Ripple William J., 2010, P141; Ripple WJ, 2003, FOREST ECOL MANAG, V184, P299, DOI 10.1016/S0378-1127(03)00154-3; Roman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013255; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SAVIDGE JA, 1987, ECOLOGY, V68, P660, DOI 10.2307/1938471; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schindler DE, 1997, SCIENCE, V277, P248, DOI 10.1126/science.277.5323.248; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Schmitz OJ, 2005, OECOLOGIA, V145, P225, DOI 10.1007/s00442-005-0063-y; Schmitz OJ, 2010, ECOL LETT, V13, P1199, DOI 10.1111/j.1461-0248.2010.01511.x; Sinclair ARE, 2007, CONSERV BIOL, V21, P580, DOI 10.1111/j.1523-1739.2007.00699.x; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; Smith FA, 2010, SCIENCE, V330, P1216, DOI 10.1126/science.1194830; Smith FA, 2010, NAT GEOSCI, V3, P374, DOI 10.1038/ngeo877; Strong DR, 2010, ANNU REV ENV RESOUR, V35, P1, DOI 10.1146/annurev-environ-031809-133103; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Terborgh J., 2010, TROPHIC CASCADES PRE; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; ZIMOV SA, 1995, AM NAT, V146, P765, DOI 10.1086/285824	73	2397	2461	79	2567	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2011	333	6040					301	306		10.1126/science.1205106	http://dx.doi.org/10.1126/science.1205106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764740	Green Submitted			2022-12-28	WOS:000292732000031
J	Abbott, A				Abbott, Alison			DEMENTIA A problem for our age	NATURE			English	Editorial Material																			0	166	177	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					S2	S4		10.1038/475S2a	http://dx.doi.org/10.1038/475S2a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791UA	21760579	Bronze			2022-12-28	WOS:000292690500002
J	Eisenstein, M				Eisenstein, Michael			GENETICS Finding risk factors	NATURE			English	Editorial Material							ALZHEIMER-DISEASE; COMMON VARIANTS; CD2AP; EPHA1; CD33											Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Zhang J, 2008, AM J CLIN PATHOL, V129, P526, DOI 10.1309/W01Y0B808EMEH12L	8	46	47	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					S20	S22		10.1038/475S20a	http://dx.doi.org/10.1038/475S20a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791UA	21760580	Bronze			2022-12-28	WOS:000292690500010
J	Rowlett, P; McCartney, M; Mann, T; Hoare, G; Harriss, E; Parrondo, J; Bradshaw, NA; Collins, J; Linton, C				Rowlett, Peter; McCartney, Mark; Mann, Tony; Hoare, Graham; Harriss, Edmund; Parrondo, Juan; Bradshaw, Noel-Ann; Collins, Julia; Linton, Chris			The unplanned impact of mathematics	NATURE			English	Editorial Material									Univ Ulster, Newtownabbey, North Ireland; Univ Greenwich, London SE18 6PF, England; [Harriss, Edmund] Univ Arkansas, Fayetteville, AR 72701 USA; Univ Madrid, London, England; Univ Greenwich, London, England; [Rowlett, Peter] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Collins, Julia] Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland; [Linton, Chris] Univ Loughborough, Loughborough, Leics, England	Ulster University; University of Greenwich; University of Arkansas System; University of Arkansas Fayetteville; University of Greenwich; University of Birmingham; University of Edinburgh; Loughborough University	Rowlett, P (corresponding author), Univ Birmingham, Birmingham B15 2TT, W Midlands, England.		Rowlett, Peter/R-2612-2017; Parrondo, Juan MR/A-4228-2010	Rowlett, Peter/0000-0003-1917-7458; Parrondo, Juan MR/0000-0001-8525-3709					0	7	7	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					166	169		10.1038/475166a	http://dx.doi.org/10.1038/475166a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791UA	21753831	Bronze			2022-12-28	WOS:000292690500025
J	Schnabel, J				Schnabel, Jim			VACCINES Chasing the dream	NATURE			English	Editorial Material																		Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Goni F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013391; Hughes RAC, 2009, CLIN EXP IMMUNOL, V158, P34, DOI [10.1111/j.1365-2249.2009.04025.x, 10.1111/j.1365-2249.2009.04025.X]; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808	6	14	14	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					S18	S19		10.1038/475S18a	http://dx.doi.org/10.1038/475S18a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791UA	21760578				2022-12-28	WOS:000292690500009
J	Schnabel, J				Schnabel, Jim			AMYLOID Little proteins, big clues	NATURE			English	Editorial Material																			0	50	50	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					S12	S14		10.1038/475S12a	http://dx.doi.org/10.1038/475S12a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21760575	Bronze			2022-12-28	WOS:000292690500006
J	Hu, FB				Hu, Frank B.			Diet and exercise for new-onset type 2 diabetes?	LANCET			English	Editorial Material							LIFE-STYLE INTERVENTION; FOLLOW-UP; RISK-FACTORS; PREVENTION; COMPLICATIONS; WEIGHT		[Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu	Hu, Frank/C-1919-2013					Andrews RC, 2011, LANCET, V378, P129, DOI 10.1016/S0140-6736(11)60442-X; [Anonymous], 2011, DIAB ATL EP MORB; Aschner P, 2010, DIABETES OBES METAB, V12, P252, DOI 10.1111/j.1463-1326.2009.01187.x; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Church TS, 2010, JAMA-J AM MED ASSOC, V304, P2253, DOI 10.1001/jama.2010.1710; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Schulze MB, 2005, ANNU REV PUBL HEALTH, V26, P445, DOI 10.1146/annurev.publhealth.26.021304.144532; Snowling NJ, 2006, DIABETES CARE, V29, P2518, DOI 10.2337/dc06-1317; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334	12	11	12	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 9	2011	378	9786					101	102		10.1016/S0140-6736(11)60692-2	http://dx.doi.org/10.1016/S0140-6736(11)60692-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	795CJ	21705071				2022-12-28	WOS:000292948800004
J	van Rooij, R; Borbely, JS; Simonet, J; Hoogerland, MD; Eikema, KSE; Rozendaal, RA; Vassen, W				van Rooij, R.; Borbely, J. S.; Simonet, J.; Hoogerland, M. D.; Eikema, K. S. E.; Rozendaal, R. A.; Vassen, W.			Frequency Metrology in Quantum Degenerate Helium: Direct Measurement of the 2 S-3(1) -> 2 S-1(0) Transition	SCIENCE			English	Article							ATOMIC HELIUM; SPECTROSCOPY; SYSTEMS; RADIUS; ENERGY; SHIFTS; HE-3	Precision spectroscopy of simple atomic systems has refined our understanding of the fundamental laws of quantum physics. In particular, helium spectroscopy has played a crucial role in describing two-electron interactions, determining the fine-structure constant and extracting the size of the helium nucleus. Here we present a measurement of the doubly forbidden 1557-nanometer transition connecting the two metastable states of helium (the lowest energy triplet state 2 S-3(1) and first excited singlet state 2 S-1(0)), for which quantum electrodynamic and nuclear size effects are very strong. This transition is weaker by 14 orders of magnitude than the most predominantly measured transition in helium. Ultracold, submicrokelvin, fermionic He-3 and bosonic He-4 atoms are used to obtain a precision of 8 x 10(-12), providing a stringent test of two-electron quantum electrodynamic theory and of nuclear few-body theory.	[van Rooij, R.; Borbely, J. S.; Eikema, K. S. E.; Rozendaal, R. A.; Vassen, W.] LaserLaB Vrije Univ, NL-1081 HV Amsterdam, Netherlands; [Simonet, J.] Ecole Normale Super, Lab Kastler Brossel, F-75005 Paris, France; [Hoogerland, M. D.] Univ Auckland, Dept Phys, Auckland, New Zealand	Vrije Universiteit Amsterdam; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); University of Auckland	Vassen, W (corresponding author), LaserLaB Vrije Univ, De Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	w.vassen@vu.nl	Eikema, Kjeld/F-6271-2015	Eikema, Kjeld/0000-0002-2546-3584; Simonet, Juliette/0000-0002-4773-8542; Borbely, Joseph/0000-0001-8618-1145; van Rooij, Rob/0000-0001-8546-8283; Vassen, Wim/0000-0002-3785-4865	Dutch Foundation for Fundamental Research on Matter (FOM); EC; Netherlands Organization for Scientific Research (NWO)	Dutch Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); EC(European CommissionEuropean Commission Joint Research Centre); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work, as part of the European Science Foundation EuroQUAM Programme, was financially supported by the Dutch Foundation for Fundamental Research on Matter (FOM). J.S. acknowledges financial support from the EC's Seventh Framework Programme (LASERLAB-EUROPE). M.D.H. and K.S.E.E acknowledge financial support from the Netherlands Organization for Scientific Research (NWO). We would like to thank J. Bouma for technical support, and J. C. J. Koelemeij and K. A. H. van Leeuwen for fruitful discussions. We also thank G. W. F. Drake, K. Pachucki, and V. A. Yerokhin for sharing the calculated theoretical parameters detailed in SOM.	Borbely JS, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.060503; Dorrer C, 1997, PHYS REV LETT, V78, P3658, DOI 10.1103/PhysRevLett.78.3658; Dos Santos FP, 2001, PHYS REV LETT, V86, P3459, DOI 10.1103/PhysRevLett.86.3459; Drake GWF, 2008, CAN J PHYS, V86, P45, DOI 10.1139/P07-154; Drake GWF, 2005, CAN J PHYS, V83, P311, DOI 10.1139/P05-020; Eyler EE, 2008, EUR PHYS J D, V48, P43, DOI 10.1140/epjd/e2007-00289-y; Heisenberg W, 1926, Z PHYS, V39, P499, DOI 10.1007/BF01322090; Jeltes T, 2007, NATURE, V445, P402, DOI 10.1038/nature05513; Kandula DZ, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.063001; Kievsky A, 2008, J PHYS G NUCL PARTIC, V35, DOI 10.1088/0954-3899/35/6/063101; Killian TC, 1998, PHYS REV LETT, V81, P3807, DOI 10.1103/PhysRevLett.81.3807; Lach G, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.042510; LICHTEN W, 1991, PHYS REV A, V43, P1663, DOI 10.1103/PhysRevA.43.1663; McNamara JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.080404; Morton DC, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.034502; Morton DC, 2006, CAN J PHYS, V84, P83, DOI 10.1139/P06-009; Mueller P, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.133001; Pachucki K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070403; Pastor PC, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.023001; Robert A, 2001, SCIENCE, V292, P461, DOI 10.1126/science.1060622; ROSNER SD, 1970, PHYS REV A, V1, P571, DOI 10.1103/PhysRevA.1.571; SANSONETTI CJ, 1992, PHYS REV A, V45, pR1, DOI 10.1103/PhysRevA.45.R1; SHINER D, 1995, PHYS REV LETT, V74, P3553, DOI 10.1103/PhysRevLett.74.3553; Sick I, 2008, LECT NOTES PHYS, V745, P57, DOI 10.1007/978-3-540-75479-4_4; Sick I, 2008, PHYS REV C, V77, DOI 10.1103/PhysRevC.77.041302; Smiciklas M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.123001; Tychkov AS, 2006, PHYS REV A, V73, DOI 10.1103/PhysREvA.73.031603; van Leeuwen KAH, 2006, EUROPHYS LETT, V76, P409, DOI 10.1209/epl/i2006-10284-4; Yerokhin VA, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.022507; Zelevinsky T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.203001	30	98	99	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2011	333	6039					196	198		10.1126/science.1205163	http://dx.doi.org/10.1126/science.1205163			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21737737	Green Submitted			2022-12-28	WOS:000292502700042
J	Stuebe, AM				Stuebe, Alison M.			BECOMING A PHYSICIAN Level IV Evidence - Adverse Anecdote and Clinical Practice	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TERM		[Stuebe, Alison M.] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Chapel Hill, NC 27515 USA; [Stuebe, Alison M.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Maternal & Child Hlth, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Stuebe, AM (corresponding author), Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Chapel Hill, NC 27515 USA.							Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Hannah M, 1996, BRIT MED J, V312, P1433, DOI 10.1136/bmj.312.7044.1433; HANNAH ME, 1992, NEW ENGL J MED, V327, P368; HANNAH ME, 1992, NEW ENGL J MED, V326, P1587, DOI 10.1056/NEJM199206113262402; Hannah ME, 2000, OBSTET GYNECOL, V96, P533, DOI 10.1016/S0029-7844(00)00971-6; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825	6	12	13	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					8	9		10.1056/NEJMp1102632	http://dx.doi.org/10.1056/NEJMp1102632			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788QL	21732832				2022-12-28	WOS:000292459400004
J	van de Veerdonk, FL; Plantinga, TS; Hoischen, A; Smeekens, SP; Joosten, LAB; Gilissen, C; Arts, P; Rosentul, DC; Carmichael, AJ; Smits-van der Graaf, CAA; Kullberg, BJ; van der Meer, JWM; Lilic, D; Veltman, JA; Netea, MG				van de Veerdonk, Frank L.; Plantinga, Theo S.; Hoischen, Alexander; Smeekens, Sanne P.; Joosten, Leo A. B.; Gilissen, Christian; Arts, Peer; Rosentul, Diana C.; Carmichael, Andrew J.; Smits-van der Graaf, Chantal A. A.; Kullberg, Bart Jan; van der Meer, Jos W. M.; Lilic, Desa; Veltman, Joris A.; Netea, Mihai G.			STAT1 Mutations in Autosomal Dominant Chronic Mucocutaneous Candidiasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEFICIENCY; IMMUNITY; AUTOANTIBODIES; INFLAMMATION; RECOGNITION; CARCINOMA; ALBICANS; CELLS; IL-17	Background Chronic mucocutaneous candidiasis (CMC) is characterized by susceptibility to candida infection of skin, nails, and mucous membranes. Patients with recessive CMC and autoimmunity have mutations in the autoimmune regulator AIRE. The cause of autosomal dominant CMC is unknown. Methods We evaluated 14 patients from five families with autosomal dominant CMC. We incubated their peripheral-blood mononuclear cells with different combinations of stimuli to test the integrity of pathways that mediate immunity, which led to the selection of 100 genes that were most likely to contain the genetic defect. We used an array-based sequence-capture assay, followed by next-generation sequencing, to identify mutations. Results The mononuclear cells from the affected patients were characterized by poor production of interferon-gamma, interleukin-17, and interleukin-22, suggesting that the defect lay within the interleukin-12 receptor and interleukin-23 receptor signaling pathways. We identified heterozygous missense mutations in the DNA sequence encoding the coiled-coil (CC) domain of signal transducer and activator of transcription 1 (STAT1) in the patients. These mutations lead to defective responses in type 1 and type 17 helper T cells (Th1 and Th17). The interferon-gamma receptor pathway was intact in these patients. Conclusions Mutations in the CC domain of STAT1 underlie autosomal dominant CMC and lead to defective Th1 and Th17 responses, which may explain the increased susceptibility to fungal infection.	[van de Veerdonk, Frank L.; Plantinga, Theo S.; Smeekens, Sanne P.; Joosten, Leo A. B.; Rosentul, Diana C.; Smits-van der Graaf, Chantal A. A.; Kullberg, Bart Jan; van der Meer, Jos W. M.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6500 HB Nijmegen, Netherlands; [Hoischen, Alexander; Gilissen, Christian; Arts, Peer; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Smits-van der Graaf, Chantal A. A.] Radboud Univ Nijmegen, Med Ctr, Dept Pulm Dis, NL-6500 HB Nijmegen, Netherlands; [van de Veerdonk, Frank L.; Plantinga, Theo S.; Smeekens, Sanne P.; Joosten, Leo A. B.; Rosentul, Diana C.; Smits-van der Graaf, Chantal A. A.; Kullberg, Bart Jan; van der Meer, Jos W. M.; Netea, Mihai G.] Nijmegen Inst Infect Inflammat & Immun, Nijmegen, Netherlands; [Carmichael, Andrew J.] James Cook Univ Hosp, Dept Dermatol, Middlesbrough, Cleveland, England; [Lilic, Desa] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; James Cook University Hospital; Newcastle University - UK	van der Meer, JWM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.vandermeer@aig.umcn.nl	Smeekens, Sanne/AAZ-2061-2021; Joosten, Leo AB/H-3138-2015; Smeekens, Sanne/G-8307-2011; Gilissen, Christian/E-5246-2012; Hoischen, Alexander/AGF-7293-2022; Arts, Peer/Q-4139-2019; Hoischen, Alexander/D-1282-2013; Plantinga, Theo S./A-6895-2015; Veltman, Joris A/F-5128-2010; Smits-van der Graaf, Chantal/E-8652-2018; Netea, Mihai/N-5155-2014; van de Veerdonk, Frank L/C-7256-2008; van der Meer, Jos W.M./C-8521-2013; Kullberg, BJ/C-8520-2013	Smeekens, Sanne/0000-0002-7835-914X; Joosten, Leo AB/0000-0001-6166-9830; Smeekens, Sanne/0000-0002-7835-914X; Gilissen, Christian/0000-0003-1693-9699; Hoischen, Alexander/0000-0002-8072-4476; Arts, Peer/0000-0002-6742-6239; Hoischen, Alexander/0000-0002-8072-4476; Plantinga, Theo S./0000-0003-4990-6084; Veltman, Joris A/0000-0002-3218-8250; van de Veerdonk, Frank L/0000-0002-1121-4894; van der Meer, Jos W.M./0000-0001-5120-3690; Kullberg, BJ/0000-0002-6813-8167	Netherlands Organization for Scientific Research; Primary Immunodeficiency Association UK; European Union [Health-F5-2009-223143]; Aneuploidy Project [LSHG-CT-2006-37627]; Netherlands Organization for Health Research and Development (ZonMW) [917.66.36]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Primary Immunodeficiency Association UK; European Union(European Commission); Aneuploidy Project; Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	Supported by grants from the Netherlands Organization for Scientific Research (to Dr. Netea), the Primary Immunodeficiency Association UK (to Dr. Lilic), the Techgene Project funded by the European Union (Health-F5-2009-223143, to Drs. Veltman and Arts), the Aneuploidy Project (LSHG-CT-2006-37627, to Drs. Hoischen and Veltman), and the Netherlands Organization for Health Research and Development (ZonMW grant 917.66.36, to Dr. Veltman).	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Cetani F, 2001, J CLIN ENDOCR METAB, V86, P4747, DOI 10.1210/jc.86.10.4747; Chapgier A, 2006, PLOS GENET, V2, P1193, DOI 10.1371/journal.pgen.0020131; Chapgier A, 2006, J IMMUNOL, V176, P5078, DOI 10.4049/jimmunol.176.8.5078; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Hoshino A, 2006, BIOCHEM BIOPH RES CO, V346, P1062, DOI 10.1016/j.bbrc.2006.06.026; Kaganoi J, 2007, ANN SURG ONCOL, V14, P1405, DOI 10.1245/s10434-006-9274-7; Kimura HJ, 2009, ENDOCRINOLOGY, V150, P3409, DOI 10.1210/en.2008-1769; KIRKPATRICK CH, 1994, J AM ACAD DERMATOL, V31, pS14, DOI 10.1016/S0190-9622(08)81260-1; Koch D, 2009, CLIN EXP DERMATOL, V34, pE818, DOI 10.1111/j.1365-2230.2009.03561.x; Meloni A, 2008, J CLIN ENDOCR METAB, V93, P4389, DOI 10.1210/jc.2008-0935; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Ng WF, 2010, J ALLERGY CLIN IMMUN, V126, P1006, DOI 10.1016/j.jaci.2010.08.027; Park ES, 2000, MOL ENDOCRINOL, V14, P440, DOI 10.1210/me.14.3.440; Pfitzner E, 2004, CURR PHARM DESIGN, V10, P2839; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; van der Graaf CAA, 2003, NETH J MED, V61, P365; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Watanabe G, 2001, CANCER J, V7, P132; Xing JC, 2008, GENOMICS, V92, P452, DOI 10.1016/j.ygeno.2008.08.007; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102	31	441	446	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					54	61		10.1056/NEJMoa1100102	http://dx.doi.org/10.1056/NEJMoa1100102			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788QL	21714643				2022-12-28	WOS:000292459400009
J	Liebo, MJ; Israel, RL; Lillie, EO; Smith, MR; Rubenson, DS; Topol, EJ				Liebo, Max J.; Israel, Rachel L.; Lillie, Elizabeth O.; Smith, Michael R.; Rubenson, David S.; Topol, Eric J.			Is Pocket Mobile Echocardiography the Next-Generation Stethoscope? A Cross-sectional Comparison of Rapidly Acquired Images With Standard Transthoracic Echocardiography	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICAL-EXAMINATION; ULTRASOUND	Background: A pocket mobile echocardiography (PME) device is commercially available for clinical use, but public data documenting its accuracy compared with standard transthoracic echocardiography (TTE) are not available. Objective: To compare the accuracy of rapidly acquired PME images with those acquired by standard TTE. Design: Cross-sectional study. At the time of referral for TTE, ultrasonographers acquired PME images first in 5 minutes or less. Ultrasonographers were not blinded to the clinical indication for imaging or to the PME image results when obtaining standard TTE images. Two experienced echocardiographers and 2 cardiology fellows who were blinded to the indication for the study and TTE results but not to the device source interpreted the PME images. Setting: Scripps Clinic Torrey Pines and Scripps Green Hospital, La Jolla, California. Patients: Convenience sample of 97 patients consecutively referred for echocardiography. Measurements: Visualizability and accuracy (the sum of proportions of true-positive and true-negative readings and observer variability) for ejection fraction, wall-motion abnormalities, left ventricular end-diastolic dimension, inferior vena cava size, aortic and mitral valve pathology, and pericardial effusion. Results: Physician-readers could visualize some but not all echocardiographic measurements obtained with the PME device in every patient (highest proportions were for ejection fraction and left ventricular end-diastolic dimension [95% each]; the lowest proportion was for inferior vena cava size [75%]). Accuracy also varied by measurement (aortic valve was 96% [highest] and inferior vena cava size was 78% [lowest]) and decreased when nonvisualizability was accounted for (aortic valve was 91% and inferior vena cava size was 58%). Observer agreement was fair to moderate for some measurements among less-experienced readers. Limitation: The study was conducted at a single setting, there was no formal estimate of accuracy given the small convenience sample of patients, and few abnormal echocardiographic measurements occurred. Conclusion: The rapid acquisition of images by skilled ultrasonographers who use PME yields accurate assessments of ejection fraction and some but not all cardiac structures in many patients. Further testing of the device in larger patient cohorts with diverse cardiac abnormalities and with untrained clinicians obtaining and interpreting images is required before wide dissemination of its use can be recommended.	Scripps Clin, Scripps Translat Sci Inst, La Jolla, CA 92037 USA; W Wireless Hlth Inst, La Jolla, CA USA	Scripps Research Institute	Topol, EJ (corresponding author), 3344 N Torrey Pines Court, La Jolla, CA 92037 USA.	etopol@scripps.edu		Topol, Eric/0000-0002-1478-4729	National Institutes of Health [NIH/NCRR 5 UL1 RR025774]; Scripps Health; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scripps Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Primary Funding Source: National Institutes of Health.r Grant Support: In part by Scripps Health and by the National Institutes of Health (Clinical and Translational Science Award to Scripps Translational Science Institute; NIH/NCRR 5 UL1 RR025774).	Armstrong W.F., 2010, FEIGENBAUMS ECHOCARD, V7th ed.; Brennan JM, 2007, J AM SOC ECHOCARDIOG, V20, P857, DOI 10.1016/j.echo.2007.01.005; Cardim N, 2011, J AM SOC ECHOCARDIOG, V24, P117, DOI 10.1016/j.echo.2010.09.017; Fleiss J. L., 1981, WILEY SERIES PROBABI, V13, P212; Kimura BJ, 2008, JACC-CARDIOVASC IMAG, V1, P602, DOI 10.1016/j.jcmg.2008.06.004; Kobal SL, 2004, CHEST, V126, P693, DOI 10.1378/chest.126.3.693; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Popp RL, 1998, ACC CURR J REV, V7, P79; Reiser SL, 2009, TECHNOLOGICAL MED; Roelandt JRTC, 2003, HEART, V89, P971, DOI 10.1136/heart.89.9.971	10	105	108	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2011	155	1					33	+		10.7326/0003-4819-155-1-201107050-00005	http://dx.doi.org/10.7326/0003-4819-155-1-201107050-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788MA	21727291	Green Accepted			2022-12-28	WOS:000292447800004
J	Krupovic, M; Bamford, DH				Krupovic, Mart; Bamford, Dennis H.			Revealing Virus-Host Interplay	SCIENCE			English	Editorial Material							BACTERIA		[Krupovic, Mart] Inst Pasteur, Unite Biol Mol Gene Chez Extremophiles, F-75015 Paris, France; [Bamford, Dennis H.] Univ Helsinki, Dept Biosci, FIN-00014 Helsinki, Finland; [Bamford, Dennis H.] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Helsinki; University of Helsinki	Krupovic, M (corresponding author), Inst Pasteur, Unite Biol Mol Gene Chez Extremophiles, F-75015 Paris, France.	dennis.bamford@helsinki.fi	Krupovic, Mart/ABD-6255-2021; Krupovic, Mart/I-4209-2012	Krupovic, Mart/0000-0001-5486-0098; Krupovic, Mart/0000-0001-5486-0098; Bamford, Dennis/0000-0002-6438-8118				Allen EE, 2005, NAT REV MICROBIOL, V3, P489, DOI 10.1038/nrmicro1157; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Frada M, 2008, P NATL ACAD SCI USA, V105, P15944, DOI 10.1073/pnas.0807707105; Krupovic M, 2010, J MOL BIOL, V397, P144, DOI 10.1016/j.jmb.2010.01.037; Ottesen EA, 2006, SCIENCE, V314, P1464, DOI 10.1126/science.1131370; Prangishvili D, 2011, CURR OPIN MICROBIOL, V14, P315, DOI 10.1016/j.mib.2011.04.006; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tadmor AD, 2011, SCIENCE, V333, P58, DOI 10.1126/science.1200758; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Zare RN, 2010, ANNU REV BIOMED ENG, V12, P187, DOI 10.1146/annurev-bioeng-070909-105238	13	4	4	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					45	46		10.1126/science.1208557	http://dx.doi.org/10.1126/science.1208557			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719664				2022-12-28	WOS:000292255400039
J	Possemato, R; Marks, KM; Shaul, YD; Pacold, ME; Kim, D; Birsoy, K; Sethumadhavan, S; Woo, HK; Jang, HG; Jha, AK; Chen, WW; Barrett, FG; Stransky, N; Tsun, ZY; Cowley, GS; Barretina, J; Kalaany, NY; Hsu, PP; Ottina, K; Chan, AM; Yuan, B; Garraway, LA; Root, DE; Mino-Kenudson, M; Brachtel, EF; Driggers, EM; Sabatini, DM				Possemato, Richard; Marks, Kevin M.; Shaul, Yoav D.; Pacold, Michael E.; Kim, Dohoon; Birsoy, Kivanc; Sethumadhavan, Shalini; Woo, Hin-Koon; Jang, Hyun G.; Jha, Abhishek K.; Chen, Walter W.; Barrett, Francesca G.; Stransky, Nicolas; Tsun, Zhi-Yang; Cowley, Glenn S.; Barretina, Jordi; Kalaany, Nada Y.; Hsu, Peggy P.; Ottina, Kathleen; Chan, Albert M.; Yuan, Bingbing; Garraway, Levi A.; Root, David E.; Mino-Kenudson, Mari; Brachtel, Elena F.; Driggers, Edward M.; Sabatini, David M.			Functional genomics reveal that the serine synthesis pathway is essential in breast cancer	NATURE			English	Article							GENE-EXPRESSION SIGNATURE; NEOPLASTIC RAT-TISSUES; EMBRYONIC STEM-CELLS; XENOGRAFT MODEL; METABOLISM; IDENTIFICATION; DEHYDROGENASE; ACTIVATION; SCREEN; TUMORS	Cancer cells adapt their metabolic processes to drive macromolecular biosynthesis for rapid cell growth and proliferation(1,2). RNA interference (RNAi)-based loss-of-function screening has proven powerful for the identification of new and interesting cancer targets, and recent studies have used this technology in vivo to identify novel tumour suppressor genes(3). Here we developed a method for identifying novel cancer targets via negative-selection RNAi screening using a human breast cancer xenograft model at an orthotopic site in the mouse. Using this method, we screened a set of metabolic genes associated with aggressive breast cancer and stemness to identify those required for in vivo tumorigenesis. Among the genes identified, phosphoglycerate dehydrogenase (PHGDH) is in a genomic region of recurrent copy number gain in breast cancer and PHGDH protein levels are elevated in 70% of oestrogen receptor (ER)-negative breast cancers. PHGDH catalyses the first step in the serine biosynthesis pathway, and breast cancer cells with high PHGDH expression have increased serine synthesis flux. Suppression of PHGDH in cell lines with elevated PHGDH expression, but not in those without, causes a strong decrease in cell proliferation and a reduction in serine synthesis. We find that PHGDH suppression does not affect intracellular serine levels, but causes a drop in the levels of alpha-ketoglutarate, another output of the pathway and a tricarboxylic acid (TCA) cycle intermediate. In cells with high PHGDH expression, the serine synthesis pathway contributes approximately 50% of the total anaplerotic flux of glutamine into the TCA cycle. These results reveal that certain breast cancers are dependent on increased serine pathway flux caused by PHGDH overexpression and demonstrate the utility of in vivo negative-selection RNAi screens for finding potential anticancer targets.	[Possemato, Richard; Shaul, Yoav D.; Pacold, Michael E.; Kim, Dohoon; Birsoy, Kivanc; Chen, Walter W.; Barrett, Francesca G.; Tsun, Zhi-Yang; Kalaany, Nada Y.; Hsu, Peggy P.; Ottina, Kathleen; Chan, Albert M.; Yuan, Bingbing; Sabatini, David M.] Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Possemato, Richard; Shaul, Yoav D.; Pacold, Michael E.; Kim, Dohoon; Birsoy, Kivanc; Chen, Walter W.; Tsun, Zhi-Yang; Kalaany, Nada Y.; Hsu, Peggy P.; Ottina, Kathleen; Chan, Albert M.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Possemato, Richard; Shaul, Yoav D.; Pacold, Michael E.; Kim, Dohoon; Birsoy, Kivanc; Chen, Walter W.; Stransky, Nicolas; Cowley, Glenn S.; Barretina, Jordi; Kalaany, Nada Y.; Hsu, Peggy P.; Ottina, Kathleen; Chan, Albert M.; Garraway, Levi A.; Root, David E.; Sabatini, David M.] MIT, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Possemato, Richard; Shaul, Yoav D.; Pacold, Michael E.; Kim, Dohoon; Birsoy, Kivanc; Chen, Walter W.; Barrett, Francesca G.; Stransky, Nicolas; Tsun, Zhi-Yang; Cowley, Glenn S.; Barretina, Jordi; Kalaany, Nada Y.; Hsu, Peggy P.; Ottina, Kathleen; Chan, Albert M.; Garraway, Levi A.; Root, David E.; Sabatini, David M.] Broad Inst Harvard, Cambridge, MA 02142 USA; [Shaul, Yoav D.; Pacold, Michael E.; Kim, Dohoon; Birsoy, Kivanc; Chen, Walter W.; Tsun, Zhi-Yang; Kalaany, Nada Y.; Hsu, Peggy P.; Ottina, Kathleen; Chan, Albert M.; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Marks, Kevin M.; Sethumadhavan, Shalini; Woo, Hin-Koon; Jha, Abhishek K.; Driggers, Edward M.] Agios Pharmaceut, Cambridge, MA 02139 USA; [Pacold, Michael E.] Brigham & Womens Hosp, Harvard Radiat Oncol Program, Boston, MA 02114 USA; [Barretina, Jordi; Garraway, Levi A.] Dept Med Oncol, Boston, MA 02115 USA; [Barretina, Jordi; Garraway, Levi A.] Ctr Canc Genome Discovery, Dana Farber Canc Inst, Boston, MA 02115 USA; [Barretina, Jordi; Garraway, Levi A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Mino-Kenudson, Mari; Brachtel, Elena F.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Mino-Kenudson, Mari; Brachtel, Elena F.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Agios Pharmaceuticals; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sabatini, DM (corresponding author), Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	ravegnini, gloria/K-1330-2016; Shaul, Yoav/AAY-7011-2020; Barretina, Jordi/A-7192-2013	ravegnini, gloria/0000-0002-7774-402X; Kalaany, Nada/0000-0001-7489-1035; Barretina, Jordi/0000-0002-3478-4080; Possemato, Richard/0000-0002-2401-0030; Jha, Abhishek/0000-0001-9161-0450; Chen, Walter/0000-0002-7752-9581; /0000-0002-1446-7256	S. G. Komen for the Cure; Life Science Research Foundation; Keck Foundation; David H. Koch Institute for Integrative Cancer Research at MIT; Alexander and Margaret Stewart Trust; NIH [CA103866]; NATIONAL CANCER INSTITUTE [R01CA103866, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	S. G. Komen for the Cure; Life Science Research Foundation; Keck Foundation(W.M. Keck Foundation); David H. Koch Institute for Integrative Cancer Research at MIT; Alexander and Margaret Stewart Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the D. M. S. laboratory, M. Kwon, B. Luo and F. Reinhardt for assistance. This research is supported by fellowships from S. G. Komen for the Cure to R. P. and the Life Science Research Foundation to Y.D.S. and grants from the Keck Foundation, the David H. Koch Institute for Integrative Cancer Research at MIT, The Alexander and Margaret Stewart Trust Fund, and NIH Grant CA103866 to D. M. S. D. M. S. is an investigator of the Howard Hughes Medical Institute.	Achouri Y, 1997, BIOCHEM J, V323, P365, DOI 10.1042/bj3230365; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bric A, 2009, CANCER CELL, V16, P324, DOI 10.1016/j.ccr.2009.08.015; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; KNOX WE, 1969, ARCH BIOCHEM BIOPHYS, V132, P397, DOI 10.1016/0003-9861(69)90381-6; LUND K, 1985, ARCH BIOCHEM BIOPHYS, V237, P186, DOI 10.1016/0003-9861(85)90268-1; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; MILLER FR, 1993, J NATL CANCER I, V85, P1725, DOI 10.1093/jnci/85.21.1725; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; WALSH DA, 1965, BIOCHEMISTRY-US, V4, P1076, DOI 10.1021/bi00882a015; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701	26	1064	1097	5	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2011	476	7360					346	U119		10.1038/nature10350	http://dx.doi.org/10.1038/nature10350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21760589	Green Submitted, Bronze, Green Accepted, Green Published			2022-12-28	WOS:000294206500041
J	Wallack, AR				Wallack, Anya Rader			Single Payer Ahead - Cost Control and the Evolving Vermont Model	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Gover Hlth reform, Montpelier, VT USA		Wallack, AR (corresponding author), Gover Hlth reform, Montpelier, VT USA.								0	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					584	585		10.1056/NEJMp1104562	http://dx.doi.org/10.1056/NEJMp1104562			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808ER	21774704				2022-12-28	WOS:000293960500002
J	Li, H; Durbin, R				Li, Heng; Durbin, Richard			Inference of human population history from individual whole-genome sequences	NATURE			English	Article							ALLELE FREQUENCY-SPECTRUM; GENETIC DRIFT; NUCLEOTIDE; COALESCENT; DISPERSAL; REVEALS; MODEL; EAST	The history of human population size is important for understanding human evolution. Various studies(1-5) have found evidence for a founder event (bottleneck) in East Asian and European populations, associated with the human dispersal out-of-Africa event around 60 thousand years (kyr) ago. However, these studies have had to assume simplified demographic models with few parameters, and they do not provide a precise date for the start and stop times of the bottleneck. Here, with fewer assumptions on population size changes, we present a more detailed history of human population sizes between approximately ten thousand and a million years ago, using the pairwise sequentially Markovian coalescent model applied to the complete diploid genome sequences of a Chinese male (YH)(6), a Korean male (SJK)(7), three European individuals (J. C. Venter(8), NA12891 and NA12878 (ref. 9)) and two Yoruba males (NA18507 (ref. 10) and NA19239). We infer that European and Chinese populations had very similar population-size histories before 10-20 kyr ago. Both populations experienced a severe bottleneck 10-60 kyr ago, whereas African populations experienced a milder bottleneck from which they recovered earlier. All three populations have an elevated effective population size between 60 and 250 kyr ago, possibly due to population substructure(11). We also infer that the differentiation of genetically modern humans may have started as early as 100-120 kyr ago(12), but considerable genetic exchanges may still have occurred until 20-40 kyr ago.	[Li, Heng; Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Li, Heng] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Wellcome Trust Sanger Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Durbin, R (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	lh3@sanger.ac.uk; rd@sanger.ac.uk	Li, Heng/D-9344-2011; Durbin, Richard/AAE-7178-2019	Li, Heng/0000-0003-4874-2874; Durbin, Richard/0000-0002-9130-1006	Wellcome Trust [WT077192]	Wellcome Trust(Wellcome TrustEuropean Commission)	We are grateful to D. Bentley (Illumina) and J. Wang (Beijing Genomics Institute) for early access to the sequencing data. We thank A. Coghlan for the idea of bootstrapping, and N. Patterson, M. Przeworski, D. Reich, and members of the Durbin research group for discussions and critiques. This work was funded by Wellcome Trust grant WT077192.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Keinan A, 2009, NAT GENET, V41, P66, DOI 10.1038/ng.303; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McVean GAT, 2005, PHILOS T R SOC B, V360, P1387, DOI 10.1098/rstb.2005.1673; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; Nachman MW, 2000, GENETICS, V156, P297; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Wall JD, 2006, CURR OPIN GENET DEV, V16, P606, DOI 10.1016/j.gde.2006.09.006; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484	29	1221	1235	20	438	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2011	475	7357					493	U84		10.1038/nature10231	http://dx.doi.org/10.1038/nature10231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21753753	Green Accepted			2022-12-28	WOS:000293167900039
J	Swartz, R; Scheel, P				Swartz, Richard; Scheel, Paul			Retroperitoneal fibrosis: gaining traction on an enigma	LANCET			English	Editorial Material							MYCOPHENOLATE-MOFETIL TREATMENT; COMBINED PREDNISONE; THERAPY		[Swartz, Richard] Univ Michigan, Div Nephrol, Ann Arbor, MI 48109 USA; [Scheel, Paul] Johns Hopkins Med Inst, Baltimore, MD 21205 USA	University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Medicine	Swartz, R (corresponding author), Univ Michigan, Div Nephrol, Ann Arbor, MI 48109 USA.	rswartz@umich.edu						Adler S, 2008, RHEUMATOLOGY, V47, P1535, DOI 10.1093/rheumatology/ken291; Bourouma R, 1997, NEPHROL DIAL TRANSPL, V12, P2407, DOI 10.1093/ndt/12.11.2407; Kardar AH, 2002, J UROLOGY, V168, P550, DOI 10.1016/S0022-5347(05)64677-0; Marcolongo R, 2004, AM J MED, V116, P194, DOI 10.1016/j.amjmed.2003.08.033; Maturen KE, 2012, J THORAC IMAG, V27, pW35, DOI 10.1097/RTI.0b013e318213bcad; Scheel PJ, 2007, J UROLOGY, V178, P140, DOI 10.1016/j.juro.2007.03.057; Scheel PJ, 2011, ANN INTERN MED, V154, P31, DOI 10.7326/0003-4819-154-1-201101040-00005; Swartz RD, 2008, CLIN NEPHROL, V69, P260; Vaglio A, 2006, LANCET, V367, P241, DOI 10.1016/S0140-6736(06)68035-5; Vaglio A, 2011, LANCET, V378, P338, DOI 10.1016/S0140-6736(11)60934-3; van Bommel EFH, 2006, ANN INTERN MED, V144, P101, DOI 10.7326/0003-4819-144-2-200601170-00007; van Bommel EFH, 2007, AM J KIDNEY DIS, V49, P615, DOI 10.1053/j.ajkd.2007.02.268; Warnatz K, 2005, ANN RHEUM DIS, V64, P828, DOI 10.1136/ard.2004.029793	13	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2011	378	9788					294	296		10.1016/S0140-6736(11)60880-5	http://dx.doi.org/10.1016/S0140-6736(11)60880-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XL	21733569				2022-12-28	WOS:000293615800006
J	Montini, G; Tullus, K; Hewitt, I				Montini, Giovanni; Tullus, Kjell; Hewitt, Ian			MEDICAL PROGRESS Febrile Urinary Tract Infections in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CHRONIC-RENAL-FAILURE; SWEDISH REFLUX TRIAL; SEVERE VESICOURETERAL REFLUX; ACUTE PYELONEPHRITIS; ANTIBIOTIC-PROPHYLAXIS; VOIDING CYSTOURETHROGRAPHY; ANTENATAL DIAGNOSIS; ACID SCINTIGRAPHY; YOUNG-CHILDREN; CHILDHOOD		[Montini, Giovanni] Azienda Osped Univ StOrsola Malpighi, Dept Pediat, I-40138 Bologna, Italy; [Tullus, Kjell] Great Ormond St Hosp Sick Children, Dept Pediat Nephrol, London, England; [Hewitt, Ian] Princess Margaret Hosp Children, Perth, WA, Australia	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Western Australia	Montini, G (corresponding author), Azienda Osped Univ StOrsola Malpighi, Dept Pediat, Via Massarenti 11,Padigl 13, I-40138 Bologna, Italy.	giovanni.montini@aosp.bo.it	Tullus, Kjell/C-6589-2008; Montini, Giovanni/AAC-6612-2022	Montini, Giovanni/0000-0002-7350-4475	AstraZeneca	AstraZeneca(AstraZeneca)	Dr. Montini reports that his prior institution, Azienda Ospedaliera di Padova, has received grant support from AstraZeneca. No other potential conflict of interest relevant to this article was reported.	*AM AC PED COMM QU, 2000, PEDIATRICS, V105, P141; *AM UR ASS, CLIN GUID; American Academy of Pediatrics, 1999, PEDIATRICS, V103, P1052; [Anonymous], 1991, J R Coll Physicians Lond, V25, P36; Ardissino G, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e382; Bailey R R, 1973, Clin Nephrol, V1, P132; Benador D, 1997, LANCET, V349, P17, DOI 10.1016/S0140-6736(96)06126-0; Benador D, 2001, ARCH DIS CHILD, V84, P241, DOI 10.1136/adc.84.3.241; Bergman DA, 1999, PEDIATRICS, V103, P843; Bergman DA, 1999, PEDIATRICS, V104, P118; Bhide A, 2005, ULTRASOUND OBST GYN, V25, P489, DOI 10.1002/uog.1875; Bloomfield P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003772.pub2; Bosio M, 1998, PEDIATR RADIOL, V28, P250, DOI 10.1007/s002470050343; Brandstrom P, 2010, J UROLOGY, V184, P274, DOI 10.1016/j.juro.2010.01.055; Brandstrom P, 2010, J UROLOGY, V184, P286, DOI 10.1016/j.juro.2010.01.061; Brandstrom P, 2010, J UROLOGY, V184, P292, DOI 10.1016/j.juro.2010.01.060; Bricker L, 2000, HEALTH TECHNOL ASSES, V4, P1; BROYER M, 1993, PEDIATR NEPHROL, V7, P758, DOI 10.1007/BF01213347; Contopoulos-Ioannidis DG, 2004, PEDIATRICS, V114, pE111, DOI 10.1542/peds.114.1.e111; Coulthard MG, 2009, PEDIATR NEPHROL, V24, P227, DOI 10.1007/s00467-008-0911-1; Craig JC, 2010, NEW ENGL J MED, V362, P1250; Dai B, 2010, ARCH DIS CHILD, V95, P499, DOI 10.1136/adc.2009.173112; DELUCA FG, 1963, NEW ENGL J MED, V268, P75, DOI 10.1056/NEJM196301102680204; Doganis D, 2007, PEDIATRICS, V120, pE922, DOI 10.1542/peds.2006-2417; ELKHATIB M, 1994, CLIN NEPHROL, V41, P50; Esbjorner E, 1997, PEDIATR NEPHROL, V11, P438, DOI 10.1007/s004670050312; Faust WC, 2009, J UROLOGY, V181, P290, DOI 10.1016/j.juro.2008.09.039; Ferrara P, 2009, SCAND J UROL NEPHROL, V43, P47, DOI 10.1080/00365590802442086; FORBES GS, 1976, AM J ROENTGENOL, V127, P683, DOI 10.2214/ajr.127.4.683; Fouzas S, 2010, PEDIATRICS, V126, pE513, DOI 10.1542/peds.2009-3635; FRANCOIS P, 1995, ARCH PEDIATRIE, V2, P136, DOI 10.1016/0929-693X(96)89873-3; Garin EH, 2006, PEDIATRICS, V117, P626, DOI 10.1542/peds.2005-1362; Grattan-Smith JD, 2008, PEDIATR RADIOL, V38, pS83, DOI 10.1007/s00247-007-0668-x; Guay DRP, 2009, DRUGS, V69, P775, DOI 10.2165/00003495-200969070-00002; Hannson S, 2004, PEDIAT NEPHROLOGY, P1007; Hansson S, 2004, J UROLOGY, V172, P1071, DOI 10.1097/01.ju.0000135337.71154.60; HELLSTROM A, 1991, ARCH DIS CHILD, V66, P232, DOI 10.1136/adc.66.2.232; Hewitt IK, 2008, PEDIATRICS, V122, P486, DOI 10.1542/peds.2007-2894; Hiel JA, 2000, ARCH DIS CHILD, V82, P400; Hoberman A, 2003, NEW ENGL J MED, V348, P195, DOI 10.1056/NEJMoa021698; Hoberman A, 1999, PEDIATRICS, V104, P79, DOI 10.1542/peds.104.1.79; Hussein A, 2010, NEPHROL DIAL TRANSPL, V25, P779, DOI 10.1093/ndt/gfp532; JACOBSON SH, 1989, BMJ-BRIT MED J, V299, P703, DOI 10.1136/bmj.299.6701.703; Jakobsson B, 1997, ACTA PAEDIATR, V86, P803; Jantunen ME, 2001, PEDIATR INFECT DIS J, V20, P597, DOI 10.1097/00006454-200106000-00010; Jepson R. G., 2008, COCHRANE DB SYST REV, V2008, DOI DOI 10.1002/14651858.CD001321.PUB4; Jodal U, 2006, PEDIATR NEPHROL, V21, P785, DOI 10.1007/s00467-006-0063-0; Keren R, 2007, CURR OPIN PEDIATR, V19, P705, DOI 10.1097/MOP.0b013e3282f1dcd7; Keren R, 2008, PEDIATRICS, V122, P1409, DOI 10.1542/peds.2008-1285d; Koyle MA, 2010, J UROLOGY, V184, P285, DOI 10.1016/j.juro.2010.01.109; Lee HY, 2009, PEDIATR NEPHROL, V24, P2009, DOI 10.1007/s00467-009-1232-8; Lee MD, 2009, J PEDIATR-US, V154, P797, DOI 10.1016/j.jpeds.2008.12.045; LEVITT SB, 1981, PEDIATRICS, V67, P392; Levtchenko E, 2001, PEDIATR NEPHROL, V16, P878, DOI 10.1007/s004670100690; Li YH, 2002, RESP RES, V3, DOI 10.1186/rr173; Lim R, 2009, AM J ROENTGENOL, V192, P1197, DOI 10.2214/AJR.08.2187; Marild S, 1998, ACTA PAEDIATR, V87, P549, DOI 10.1080/08035259850158272; Marks SD, 2008, PEDIATR NEPHROL, V23, P9, DOI 10.1007/s00467-007-0552-9; Marra G, 2004, J PEDIATR-US, V144, P677, DOI 10.1016/j.jpeds.2004.01.043; Montini G, 2008, PEDIATRICS, V122, P1064, DOI 10.1542/peds.2007-3770; Montini G, 2007, BMJ-BRIT MED J, V335, P386, DOI 10.1136/bmj.39244.692442.55; Montini G, 2009, PEDIATRICS, V123, pE239, DOI 10.1542/peds.2008-1003; Montini G, 2009, PEDIATR NEPHROL, V24, P1605, DOI 10.1007/s00467-009-1213-y; *N AM PED REN TRIA, 2008, ANN REP N AM PED REN; NORMAND ICS, 1965, BMJ-BRIT MED J, V1, P1023, DOI 10.1136/bmj.1.5441.1023; Pennesi M, 2008, PEDIATRICS, V121, pE1489, DOI 10.1542/peds.2007-2652; PISTOR K, 1985, CLIN NEPHROL, V23, P278; Pohl HG, 1999, J UROLOGY, V162, P815, DOI 10.1097/00005392-199909010-00067; POLITANO VA, 1958, J UROLOGY, V79, P932, DOI 10.1016/S0022-5347(17)66369-9; Preda I, 2007, J PEDIATR-US, V151, P581, DOI 10.1016/j.jpeds.2007.05.008; Ragnarsdottir B, 2008, EUR J CLIN INVEST, V38, P12, DOI 10.1111/j.1365-2362.2008.02004.x; REUSS A, 1987, PEDIATR NEPHROL, V1, P546, DOI 10.1007/BF00849268; ROMERO R, 1985, AM J OBSTET GYNECOL, V151, P38, DOI 10.1016/0002-9378(85)90420-X; Roussey-Kesler G, 2008, J UROLOGY, V179, P674, DOI 10.1016/j.juro.2007.09.090; Royal Children's Hospital Melbourne, CLIN PRACT GUID; SAVAGE DCL, 1969, BRIT MED J, V3, P75, DOI 10.1136/bmj.3.5662.75; Sharifian M, 2008, PEDIATR NEPHROL, V23, P1511, DOI 10.1007/s00467-008-0864-4; SIDERAS P, 1995, ADV IMMUNOL, V59, P135, DOI 10.1016/S0065-2776(08)60631-8; Singh-Grewal D, 2005, ARCH DIS CHILD, V90, P853, DOI 10.1136/adc.2004.049353; SMELLIE JM, 1978, LANCET, V2, P175; Smellie JM, 2001, LANCET, V357, P1329, DOI 10.1016/S0140-6736(00)04520-7; Smith T, 1996, J NUCL MED, V37, P1336; STANSFELD JM, 1975, BRIT MED J, V3, P65, DOI 10.1136/bmj.3.5975.65; STEELE RE, 1963, NEW ENGL J MED, V269, P883, DOI 10.1056/NEJM196310242691702; Stefanidis CJ, 2007, PEDIATR NEPHROL, V22, P937, DOI 10.1007/s00467-006-0396-8; Tullus K, 1997, ACTA PAEDIATR, V86, P1198, DOI 10.1111/j.1651-2227.1997.tb14845.x; TULLUS K, 1991, J UROLOGY, V146, P1153, DOI 10.1016/S0022-5347(17)38029-1; Urinary tract infection in children, 2007, UR TRACT INF CHILDR; Vilaichone Aimon, 2001, Journal of the Medical Association of Thailand, V84, pS61; Wennerstrom M, 2000, ARCH PEDIAT ADOL MED, V154, P339, DOI 10.1001/archpedi.154.4.339; Wennerstrom M, 2000, J HYPERTENS, V18, P485, DOI 10.1097/00004872-200018040-00019; Wennerstrom M, 2000, J PEDIATR-US, V136, P30, DOI 10.1016/S0022-3476(00)90045-3; WHITE RHR, 1983, BRIT MED J, V287, P171; WILLIAMS GJ, 2001, COCHRANE DB SYST REV, V4; WISWELL TE, 1985, PEDIATRICS, V75, P901; Zamir G, 2004, ARCH DIS CHILD, V89, P466, DOI 10.1136/adc.2002.019182; ZHANG YY, 1995, NEW ZEAL MED J, V108, P142	97	176	198	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2011	365	3					239	250		10.1056/NEJMra1007755	http://dx.doi.org/10.1056/NEJMra1007755			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794QI	21774712				2022-12-28	WOS:000292915500008
J	Wollmann, P; Cui, S; Viswanathan, R; Berninghausen, O; Wells, MN; Moldt, M; Witte, G; Butryn, A; Wendler, P; Beckmann, R; Auble, DT; Hopfner, KP				Wollmann, Petra; Cui, Sheng; Viswanathan, Ramya; Berninghausen, Otto; Wells, Melissa N.; Moldt, Manuela; Witte, Gregor; Butryn, Agata; Wendler, Petra; Beckmann, Roland; Auble, David T.; Hopfner, Karl-Peter			Structure and mechanism of the Swi2/Snf2 remodeller Mot1 in complex with its substrate TBP	NATURE			English	Article							TATA-BINDING PROTEIN; RNA-POLYMERASE-II; PREINITIATION COMPLEX; DNA; TRANSCRIPTION; CHROMATIN; SOFTWARE; PROMOTER; SYSTEM; NC2	Swi2/Snf2-type ATPases regulate genome-associated processes such as transcription, replication and repair by catalysing the disruption, assembly or remodelling of nucleosomes or other protein-DNA complexes(1,2). It has been suggested that ATP-driven motor activity along DNA disrupts target protein-DNA interactions in the remodelling reaction(3-5). However, the complex and highly specific remodelling reactions are poorly understood, mostly because of a lack of high-resolution structural information about how remodellers bind to their substrate proteins. Mot1 (modifier of transcription 1 in Saccharomyces cerevisiae, denoted BTAF1 in humans) is a Swi2/Snf2 enzyme that specifically displaces the TATA box binding protein (TBP) from the promoter DNA and regulates transcription globally by generating a highly dynamic TBP pool in the cell(6,7). As a Swi2/Snf2 enzyme that functions as a single polypeptide and interacts with a relatively simple substrate, Mot1 offers an ideal system from which to gain a better understanding of this important enzyme family. To reveal how Mot1 specifically disrupts TBP-DNA complexes, we combined crystal and electron microscopy structures of Mot1-TBP from Encephalitozoon cuni-culi with biochemical studies. Here we show that Mot1 wraps around TBP and seems to act like a bottle opener: a spring-like array of 16 HEAT(huntingtin, elongation factor 3, protein phosphatase 2A and lipid kinase TOR) repeats grips the DNA-distal side of TBP via loop insertions, and the Swi2/Snf2 domain binds to upstream DNA, positioned to weaken the TBP-DNA interaction by DNA translocation. A 'latch' subsequently blocks the DNA-binding groove of TBP, acting as a chaperone to prevent DNA re-association and ensure efficient promoter clearance. This work shows how a remodelling enzyme can combine both motor and chaperone activities to achieve functional specificity using a conserved Swi2/Snf2 translocase.	[Wollmann, Petra; Cui, Sheng; Berninghausen, Otto; Moldt, Manuela; Witte, Gregor; Butryn, Agata; Wendler, Petra; Beckmann, Roland; Hopfner, Karl-Peter] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Wollmann, Petra; Witte, Gregor; Hopfner, Karl-Peter] Gene Ctr Munich, Munich Ctr Adv Photon, D-81377 Munich, Germany; [Viswanathan, Ramya; Wells, Melissa N.; Auble, David T.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Witte, Gregor; Beckmann, Roland; Hopfner, Karl-Peter] Gene Ctr Munich, Ctr Integrated Prot Sci, D-81377 Munich, Germany	University of Munich; University of Munich; University of Virginia; University of Munich	Hopfner, KP (corresponding author), Univ Munich, Dept Biochem, Feodor Lynen Str 25, D-81377 Munich, Germany.	auble@virginia.edu; hopfner@lmb.uni-muenchen.de	Sheng, CUI/M-6405-2013; Witte, Gregor/B-4635-2011; Cui, Sheng/AAQ-1721-2020; Wendler, Petra/C-9056-2014; Viswanathan, Ramya/L-5935-2019; Wendler, Petra/X-5799-2019; Hopfner, Karl-Peter/B-6864-2014	Sheng, CUI/0000-0001-6329-3582; Witte, Gregor/0000-0003-0313-0962; Wendler, Petra/0000-0002-8285-2199; Hopfner, Karl-Peter/0000-0002-4528-8357; Butryn, Agata/0000-0002-5227-4770	German Research Council [SFB 646, SFB/TR5]; Excellence Initiative (Center for Integrated Protein Science, Munich); DFG [WE4628/1]; NIH [GM55763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055763, T32GM008136] Funding Source: NIH RePORTER	German Research Council(German Research Foundation (DFG)); Excellence Initiative (Center for Integrated Protein Science, Munich); DFG(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Max-Planck Crystallization Facility Martinsried. We thank M. Lucas, A. Schele, C. Ungewickell, J. Goetzl and Y. Hiruma for help with experimentation. We thank J.-P. Armache and M. Turk for help with electron microscopy data. We are grateful to G. Miller and S. Hahn for advice. We thank the staff at the SLS and ESRF for help with data collection. We thank P. Cramer and members of the Hopfner and Auble laboratories for discussions and comments on the manuscript. This work was supported by the German Research Council (SFB 646 and SFB/TR5) and Excellence Initiative (Center for Integrated Protein Science, Munich) to K.-P. H. and R. B., by DFG grant WE4628/1 to P. Wendler and by NIH grant GM55763 to D.T.A.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Auble DT, 2009, TRENDS BIOCHEM SCI, V34, P49, DOI 10.1016/j.tibs.2008.10.008; AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Darst RP, 2003, J BIOL CHEM, V278, P13216, DOI 10.1074/jbc.M211445200; Darst RP, 2001, EMBO J, V20, P2028, DOI 10.1093/emboj/20.8.2028; Dasgupta A, 2002, P NATL ACAD SCI USA, V99, P2666, DOI 10.1073/pnas.052397899; de Graaf P, 2010, J CELL SCI, V123, P2663, DOI 10.1242/jcs.064097; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gangaraju VK, 2009, MOL CELL, V35, P58, DOI 10.1016/j.molcel.2009.05.013; Geisberg JV, 2004, MOL CELL, V14, P479, DOI 10.1016/j.molcel.2004.05.003; Gkikopoulos T, 2009, MOL CELL BIOL, V29, P4057, DOI 10.1128/MCB.00400-09; Hsu JY, 2008, GENE DEV, V22, P2353, DOI 10.1101/gad.1681808; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Klejman MP, 2004, MOL CELL BIOL, V24, P10072, DOI 10.1128/MCB.24.22.10072-10082.2004; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller G, 2006, NAT STRUCT MOL BIOL, V13, P603, DOI 10.1038/nsmb1117; Mohibullah N, 2008, GENE DEV, V22, P2994, DOI 10.1101/gad.1724408; Pereira LA, 2004, J BIOL CHEM, V279, P21802, DOI 10.1074/jbc.M313519200; Pereira LA, 2001, MOL CELL BIOL, V21, P7523, DOI 10.1128/MCB.21.21.7523-7534.2001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POON D, 1994, J BIOL CHEM, V269, P23135; Pugh BF, 2000, GENE, V255, P1, DOI 10.1016/S0378-1119(00)00288-2; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Schluesche P, 2007, NAT STRUCT MOL BIOL, V14, P1196, DOI 10.1038/nsmb1328; Sprouse RO, 2006, EMBO J, V25, P1492, DOI 10.1038/sj.emboj.7601050; TIMMERS HTM, 1992, P NATL ACAD SCI USA, V89, P8140, DOI 10.1073/pnas.89.17.8140; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; van Werven FJ, 2008, GENE DEV, V22, P2359, DOI 10.1101/gad.1682308; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004	44	56	56	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2011	475	7356					403	U168		10.1038/nature10215	http://dx.doi.org/10.1038/nature10215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21734658	Green Accepted			2022-12-28	WOS:000292911200048
J	Del Mastro, L; Boni, L; Michelotti, A; Gamucci, T; Olmeo, N; Gori, S; Giordano, M; Garrone, O; Pronzato, P; Bighin, C; Levaggi, A; Giraudi, S; Cresti, N; Magnolfi, E; Scotto, T; Vecchio, C; Venturini, M				Del Mastro, Lucia; Boni, Luca; Michelotti, Andrea; Gamucci, Teresa; Olmeo, Nina; Gori, Stefania; Giordano, Monica; Garrone, Ornella; Pronzato, Paolo; Bighin, Claudia; Levaggi, Alessia; Giraudi, Sara; Cresti, Nicola; Magnolfi, Emanuela; Scotto, Tiziana; Vecchio, Carlo; Venturini, Marco			Effect of the Gonadotropin-Releasing Hormone Analogue Triptorelin on the Occurrence of Chemotherapy-Induced Early Menopause in Premenopausal Women With Breast Cancer A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADJUVANT CHEMOTHERAPY; YOUNG-WOMEN; OVARIAN SUPPRESSION; AGE; FERTILITY; CYCLOPHOSPHAMIDE; AMENORRHEA; GOSERELIN; SURVIVAL; PRESERVATION	Context Premenopausal patients with breast cancer are at high risk of premature ovarian failure induced by systemic treatments, but no standard strategies for preventing this adverse effect are yet available. Objective To determine the effect of the temporary ovarian suppression obtained by administering the gonadotropin-releasing hormone analogue triptorelin during chemotherapy on the incidence of early menopause in young patients with breast cancer undergoing adjuvant or neoadjuvant chemotherapy. Design, Setting, and Patients The PROMISE-GIM6 (Prevention of Menopause Induced by Chemotherapy: A Study in Early Breast Cancer Patients-Gruppo Italiano Mammella 6) study, a parallel, randomized, open-label, phase 3 superiority trial, was conducted at 16 sites in Italy and enrolled 281 patients between October 2003 and January 2008. The patients were premenopausal women with stage I through III breast cancer who were candidates for adjuvant or neoadjuvant chemotherapy. Assuming a 60% rate of early menopause in the group treated with chemotherapy alone, it was estimated that 280 patients had to be enrolled to detect a 20% absolute reduction in early menopause in the group treated with chemotherapy plus triptorelin. The intention-to-treat analysis was performed by including all randomized patients and using imputed values for missing data. Interventions Before beginning chemotherapy, patients were randomly allocated to receive chemotherapy alone or combined with triptorelin. Triptorelin was administered intramuscularly at a dose of 3.75 mg at least 1 week before the start of chemotherapy and then every 4 weeks for the duration of chemotherapy. Main Outcome Measure Incidence of early menopause (defined as no resumption of menstrual activity and postmenopausal levels of follicle-stimulating hormone and estradiol 1 year after the last cycle of chemotherapy). Results The clinical and tumor characteristics of the 133 patients randomized to chemotherapy alone and the 148 patients randomized to chemotherapy plus triptorelin were similar. Twelve months after the last cycle of chemotherapy (last follow-up, August 18, 2009), the rate of early menopause was 25.9% in the chemotherapy-alone group and 8.9% in the chemotherapy plus triptorelin group, an absolute difference of -17% (95% confidence interval, -26% to -7.9%; P < .001). The odds ratio for treatment-related early menopause was 0.28 (95% confidence interval, 0.14 to 0.59; P < .001). Conclusion The use of triptorelin-induced temporary ovarian suppression during chemotherapy in premenopausal patients with early-stage breast cancer reduced the occurrence of chemotherapy-induced early menopause.	[Del Mastro, Lucia] Ist Nazl Ric Canc, SS Sviluppo Terapie Innovat, I-16132 Genoa, Italy; [Boni, Luca] Ctr Coordinamento Sperimentaz Clin AOU Careggi, Florence, Italy; [Boni, Luca] Ist Toscano Tumori, Florence, Italy; [Michelotti, Andrea; Cresti, Nicola] Univ Pisana, Azienda Osped, UO Oncol Med 1, Pisa, Italy; [Gamucci, Teresa; Magnolfi, Emanuela] Osped SS Trinita, SC Oncol Med, Sora, FR, Italy; [Olmeo, Nina; Scotto, Tiziana] Osped Civile, UO Oncol Med, Sassari, Italy; [Gori, Stefania] Osped S Maria Misericordia, SC Oncol Med, Perugia, Italy; [Giordano, Monica] Azienda Osped S Anna, Como, Italy; [Garrone, Ornella] Azienda Osped S Croce & Carle, SC Oncol Med, Cuneo, Italy; [Pronzato, Paolo; Bighin, Claudia; Levaggi, Alessia; Giraudi, Sara] Ist Nazl Ric Canc, SC Oncol Med A, I-16132 Genoa, Italy; [Vecchio, Carlo] Ist Nazl Ric Canc, SS Senol Chirurg, I-16132 Genoa, Italy; [Venturini, Marco] Osped Sacro Cuore, UO Oncol Med, Negrar, VR, Italy	University of Genoa; IRCCS AOU San Martino IST; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Hospital Santa Maria della Misericordia; Ospedale Sant'Anna di Como; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; IRCCS Sacro Cuore Don Calabria	Del Mastro, L (corresponding author), Ist Nazl Ric Canc, SS Sviluppo Terapie Innovat, Lgo R Benzi 10, I-16132 Genoa, Italy.	lucia.delmastro@istge.it	Levaggi, Alessia/AAB-9346-2019; Garrone, Ornella/AAC-5978-2022; Pronzato, Paolo/AAB-1455-2020; GORI, Stefania/N-8827-2016; Del Mastro, Lucia/J-6163-2016; GORI, Stefania/AAB-4802-2022; Boni, Luca/ABI-6243-2020; Garrone, Ornella/HHS-9402-2022	Garrone, Ornella/0000-0001-7359-5410; Pronzato, Paolo/0000-0001-8203-2564; GORI, Stefania/0000-0001-6320-405X; Del Mastro, Lucia/0000-0002-9546-5841; GORI, Stefania/0000-0001-6320-405X; Boni, Luca/0000-0003-2217-4047; Cresti, Nicola/0000-0002-0495-4472; Levaggi, Alessia/0000-0003-1007-9173; BIGHIN, Claudia/0000-0001-9956-0216	Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy; Associazione Italiana per la Ricerca sul Cancro, Italy; Associazione Italiana per la Ricerca sul Cancro; Ipsen	Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy; Associazione Italiana per la Ricerca sul Cancro, Italy(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ipsen(Ipsen)	This study was sponsored by the Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy, and partly supported by a grant from the Associazione Italiana per la Ricerca sul Cancro, Italy. The triptorelin used in the study was provided by Ipsen, Milan, Italy.; The Istituto Nazionale per la Ricerca sul Cancro, the Associazione Italiana per la Ricerca sul Cancro, and Ipsen had no role in the design or conduct of the study; the collection, analysis, or interpretation of the data; or the preparation, review, or approval of the manuscript.	ADAMI HO, 1986, NEW ENGL J MED, V315, P559, DOI 10.1056/NEJM198608283150906; Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Arriagada R, 2005, ANN ONCOL, V16, P389, DOI 10.1093/annonc/mdi085; ATAYA K, 1995, BIOL REPROD, V52, P365, DOI 10.1095/biolreprod52.2.365; Avis NE, 2004, PSYCHO-ONCOL, V13, P295, DOI 10.1002/pon.744; Badawy A, 2009, FERTIL STERIL, V91, P694, DOI 10.1016/j.fertnstert.2007.12.044; Bines J, 1996, J CLIN ONCOL, V14, P1718, DOI 10.1200/JCO.1996.14.5.1718; Blumenfeld Z, 2007, ONCOLOGIST, V12, P1044, DOI 10.1634/theoncologist.12-9-1044; BOKSER L, 1990, BRIT J CANCER, V61, P861, DOI 10.1038/bjc.1990.192; BROOKMEYER R, 1982, BIOMETRICS, V38, P29, DOI 10.2307/2530286; Del Mastro L, 2006, ANN ONCOL, V17, P74, DOI 10.1093/annonc/mdj029; DELAROCHEFORDIERE A, 1993, LANCET, V341, P1039, DOI 10.1016/0140-6736(93)92407-K; DelMastro L, 1997, BREAST CANCER RES TR, V43, P183, DOI 10.1023/A:1005792830054; Fornier MN, 2005, CANCER-AM CANCER SOC, V104, P1575, DOI 10.1002/cncr.21385; Gerber B, 2008, BREAST CANCER RES TR, V108, P1, DOI 10.1007/s10549-007-9572-1; Gerber B, 2011, J CLIN ONCOL, V29, P2334, DOI 10.1200/JCO.2010.32.5704; GOLDHIRSCH A, 1990, ANN ONCOL, V1, P30; Goodwin PJ, 1999, J CLIN ONCOL, V17, P2365, DOI 10.1200/JCO.1999.17.8.2365; ISMAILKHAN R, 2008, J CLIN ONCOL S, P26; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jonat W, 2002, J CLIN ONCOL, V20, P4628, DOI 10.1200/JCO.2002.05.042; Kim SS, 2010, CLIN OBSTET GYNECOL, V53, P740, DOI 10.1097/GRF.0b013e3181f96cb1; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; Leonard RC, 2010, J CLIN ONCOL S, V28, p15s; *NAT CANC I, COMM TOX CRIT VERS 2; Partridge AH, 2004, J CLIN ONCOL, V22, P4174, DOI 10.1200/jco.2004.01.159; Partridge A, 2007, EUR J CANCER, V43, P1646, DOI 10.1016/j.ejca.2007.04.006; Petrek JA, 2006, J CLIN ONCOL, V24, P1045, DOI 10.1200/JCO.2005.03.3969; RAVDIN PM, 1988, CANCER RES, V48, P1026; Recchia F, 2006, CANCER-AM CANCER SOC, V106, P514, DOI 10.1002/cncr.21646; Rivkin SE, 1996, J CLIN ONCOL, V14, P46, DOI 10.1200/JCO.1996.14.1.46; Schover LR, 2008, J CLIN ONCOL, V26, P753, DOI 10.1200/JCO.2007.14.1655; Swain SM, 2010, NEW ENGL J MED, V362, P2053, DOI 10.1056/NEJMoa0909638; Urruticoechea A, 2008, BREAST CANCER RES TR, V110, P411, DOI 10.1007/s10549-007-9745-y; *WHO, 1991, TECHN REP SER WHO, V670	35	277	284	1	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2011	306	3					269	276		10.1001/jama.2011.991	http://dx.doi.org/10.1001/jama.2011.991			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794BS	21771987				2022-12-28	WOS:000292870500019
J	Berkman, ND; Sheridan, SL; Donahue, KE; Halpern, DJ; Crotty, K				Berkman, Nancy D.; Sheridan, Stacey L.; Donahue, Katrina E.; Halpern, David J.; Crotty, Karen			Low Health Literacy and Health Outcomes: An Updated Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							QUALITY-OF-LIFE; HIV MEDICATION ADHERENCE; MANAGED CARE ENROLLEES; OLDER-ADULTS; RACIAL-DIFFERENCES; GLYCEMIC CONTROL; NUMERACY SKILLS; HEART-FAILURE; ANTIRETROVIRAL ADHERENCE; SCREENING MAMMOGRAPHY	Background: Approximately 80 million Americans have limited health literacy, which puts them at greater risk for poorer access to care and poorer health outcomes. Purpose: To update a 2004 systematic review and determine whether low health literacy is related to poorer use of health care, outcomes, costs, and disparities in health outcomes among persons of all ages. Data Sources: English-language articles identified through MEDLINE, CINAHL, PsycINFO, ERIC, and Cochrane Library databases and hand-searching (search dates for articles on health literacy, 2003 to 22 February 2011; for articles on numeracy, 1966 to 22 February 2011). Study Selection: Two reviewers independently selected studies that compared outcomes by differences in directly measured health literacy or numeracy levels. Data Extraction: One reviewer abstracted article information into evidence tables; a second reviewer checked information for accuracy. Two reviewers independently rated study quality by using predefined criteria, and the investigative team jointly graded the overall strength of evidence. Data Synthesis: 96 relevant good-or fair-quality studies in 111 articles were identified: 98 articles on health literacy, 22 on numeracy, and 9 on both. Low health literacy was consistently associated with more hospitalizations; greater use of emergency care; lower receipt of mammography screening and influenza vaccine; poorer ability to demonstrate taking medications appropriately; poorer ability to interpret labels and health messages; and, among elderly persons, poorer overall health status and higher mortality rates. Poor health literacy partially explains racial disparities in some outcomes. Reviewers could not reach firm conclusions about the relationship between numeracy and health outcomes because of few studies or inconsistent results among studies. Limitations: Searches were limited to articles published in English. No Medical Subject Heading terms exist for identifying relevant studies. No evidence concerning oral health literacy (speaking and listening skills) and outcomes was found. Conclusion: Low health literacy is associated with poorer health outcomes and poorer use of health care services.	[Berkman, Nancy D.] RTI Int, Div Hlth Serv & Social Policy Res, Program Hlth Care Qual & Outcomes, Res Triangle Pk, NC 27709 USA; Univ N Carolina, Chapel Hill, NC USA; Duke Univ, Durham, NC USA	Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; Duke University	Berkman, ND (corresponding author), RTI Int, Div Hlth Serv & Social Policy Res, Program Hlth Care Qual & Outcomes, POB 12194,3040 Cornwallis Rd, Res Triangle Pk, NC 27709 USA.	berkman@rti.org	Donahue, Katrina/E-7486-2012	Donahue, Katrina/0000-0003-4075-2875; Crotty, Karen/0000-0002-5633-5040; Halpern, David/0000-0002-2292-1017; Berkman, Nancy/0000-0003-3617-1082	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [HHSA-290-2007-10056-1]; Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was funded by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services (under contract HHSA-290-2007-10056-1).r Agency for Healthcare Research and Quality.		0	2375	2422	31	632	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2					97	+		10.7326/0003-4819-155-2-201107190-00005	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-00005			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	793KW	21768583				2022-12-28	WOS:000292822000016
J	Power, C; Rasko, JEJ				Power, Carl; Rasko, John E. J.			Will Cell Reprogramming Resolve the Embryonic Stem Cell Controversy? A Narrative Review	ANNALS OF INTERNAL MEDICINE			English	Review							HUMAN SOMATIC-CELLS; GERM-CELLS; DIRECTED DIFFERENTIATION; ETHICAL IMPLICATIONS; HUMAN FIBROBLASTS; NUCLEAR TRANSFER; DEFINED FACTORS; MORAL STATUS; PLURIPOTENCY; ADULT	In the past few years, relatively straightforward laboratory techniques have been developed to reprogram normal body cells to enter an embryonic stem cell-like state. Not only do these induced pluripotent stem cells hold great medical promise-perhaps greater than that of embryonic stem cells-but they also have escaped the ethical controversy in which the latter is mired. This article examines how cell reprogramming is likely to transform regenerative and reproductive medicine and highlights some of the medical, moral, and political hurdles that it faces. It also argues that induced pluripotent stem cells are more ethically problematic than most people believe and that cell reprogramming will not solve the stem cell controversy but complicate it further.	Univ Sydney, Centenary Inst, Sydney, NSW 2006, Australia; Royal Prince Alfred Hosp, Sydney, NSW, Australia	University of Sydney; Centenary Institute; University of Sydney	Rasko, JEJ (corresponding author), Centenary Inst, Locked Bag 6, Newtown, NSW 2042, Australia.	j.rasko@cenint.org	Rasko, John EJ/F-5754-2013	rasko, John/0000-0003-2975-807X					0	16	17	3	41	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2					114	121		10.7326/0003-4819-155-2-201107190-00007	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	793KW	21768585				2022-12-28	WOS:000292822000018
J	Padian, NS; Manian, S				Padian, Nancy S.; Manian, Shanthi			The concurrency debate: time to put it to rest	LANCET			English	Editorial Material							HIV; PREVENTION		[Padian, Nancy S.] US Dept State, Off US Global AIDS, Washington, DC 20520 USA; [Padian, Nancy S.] Univ Calif Berkeley, Dept Epidemiol, Berkeley, CA 94704 USA; [Manian, Shanthi] Univ Calif Berkeley, Inst Business & Econ Res, Berkeley, CA 94704 USA; [Padian, Nancy S.] Bill & Melinda Gates Fdn, Seattle, WA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Bill & Melinda Gates Foundation	Padian, NS (corresponding author), US Dept State, Off US Global AIDS, Washington, DC 20520 USA.	nancy.padian@gmail.com		Manian, Shanthi/0000-0002-0013-5138				Baumgartner JN, 2010, AIDS CARE, V22, P1153, DOI 10.1080/09540121003615095; Green EC, 2006, AIDS BEHAV, V10, P335, DOI 10.1007/s10461-006-9073-y; Lillie T, 2009, J HEALTH COMMUN, V14, P276, DOI 10.1080/10810730902805895; Lurie MN, 2010, AIDS BEHAV, V14, P17, DOI 10.1007/s10461-009-9583-5; Morris M, 2010, AIDS BEHAV, V14, P31, DOI 10.1007/s10461-009-9639-6; Shelton JD, 2009, LANCET, V374, P367, DOI 10.1016/S0140-6736(09)61399-4; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; *USAID, 2010, WORLD BANK DEB SER D	8	23	23	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 16	2011	378	9787					203	204		10.1016/S0140-6736(11)60974-4	http://dx.doi.org/10.1016/S0140-6736(11)60974-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798JD	21763921				2022-12-28	WOS:000293201100005
J	Samarasekera, U				Samarasekera, Udani			Bertrand Audoin: promoting a global strategy for IAS	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 16	2011	378	9787					218	218		10.1016/S0140-6736(11)61112-4	http://dx.doi.org/10.1016/S0140-6736(11)61112-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798JD	21763926				2022-12-28	WOS:000293201100014
J	Jones, SB; Simmons, B; Mastracchio, A; MacMillan, DWC				Jones, Spencer B.; Simmons, Bryon; Mastracchio, Anthony; MacMillan, David W. C.			Collective synthesis of natural products by means of organocascade catalysis	NATURE			English	Article							INDOLE ALKALOIDS; ASPIDOSPERMA ALKALOIDS; CASCADE CATALYSIS; (+)-ASPIDOSPERMIDINE; (-)-STRYCHNINE; DERIVATIVES; CYCLIZATION; KOPSININE; OXIDATION	Organic chemists are now able to synthesize small quantities of almost any known natural product, given sufficient time, resources and effort. However, translation of the academic successes in total synthesis to the large-scale construction of complex natural products and the development of large collections of biologically relevant molecules present significant challenges to synthetic chemists. Here we show that the application of two nature-inspired techniques, namely organocascade catalysis and collective natural product synthesis, can facilitate the preparation of useful quantities of a range of structurally diverse natural products from a common molecular scaffold. The power of this concept has been demonstrated through the expedient, asymmetric total syntheses of six well-known alkaloid natural products: strychnine, aspidospermidine, vincadifformine, akuammicine, kopsanone and kopsinine.	[Jones, Spencer B.; Simmons, Bryon; Mastracchio, Anthony; MacMillan, David W. C.] Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu			NIHGMS [R01 GM078201-05]; Bristol-Myers Squibb; Merck; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078201] Funding Source: NIH RePORTER	NIHGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Bristol-Myers Squibb(Bristol-Myers Squibb); Merck(Merck & Company); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was provided by NIHGMS (R01 GM078201-05) and gifts from Merck, Bristol-Myers Squibb and Abbott. S.B.J. and B. S. thank Bristol-Myers Squibb and Merck, respectively, for graduate fellowships.	ANET FAL, 1953, CHEM IND-LONDON, P245; Bandarage UK, 1999, TETRAHEDRON, V55, P9405, DOI 10.1016/S0040-4020(99)00513-X; Bonjoch J, 2000, CHEM REV, V100, P3455, DOI 10.1021/cr9902547; Cho HK, 2010, B KOREAN CHEM SOC, V31, P3382, DOI 10.5012/bkcs.2010.31.11.3382; COREY EJ, 1991, TETRAHEDRON LETT, V32, P7517, DOI 10.1016/0040-4039(91)80522-8; Dewick P. M., 2008, MED NATURAL PRODUCTS; GALLAGHER T, 1983, J AM CHEM SOC, V105, P2086, DOI 10.1021/ja00345a081; GATTA F, 1987, J HETEROCYCLIC CHEM, V24, P1183, DOI 10.1002/jhet.5570240449; Gnecco D, 2003, ARKIVOC, P185, DOI 10.3998/ark.5550190.0004.b19; Grondal C, 2010, NAT CHEM, V2, P167, DOI [10.1038/NCHEM.539, 10.1038/nchem.539]; Hajicek J, 2004, COLLECT CZECH CHEM C, V69, P1681, DOI 10.1135/cccc20041681; Huang Y, 2005, J AM CHEM SOC, V127, P15051, DOI 10.1021/ja055545d; Jeffery T, 1996, TETRAHEDRON, V52, P10113, DOI 10.1016/0040-4020(96)00547-9; Jones SB, 2009, J AM CHEM SOC, V131, P13606, DOI 10.1021/ja906472m; KNIGHT SD, 1993, J AM CHEM SOC, V115, P9293, DOI 10.1021/ja00073a057; Kobayashi S, 1999, TETRAHEDRON LETT, V40, P1519, DOI 10.1016/S0040-4039(98)02667-7; Kozmin SA, 2002, J AM CHEM SOC, V124, P4628, DOI 10.1021/ja017863s; KUEHNE ME, 1985, J ORG CHEM, V50, P4790, DOI 10.1021/jo00224a027; KUEHNE ME, 1995, SYNLETT, P557; Kuehne ME, 1998, J ORG CHEM, V63, P2172, DOI 10.1021/jo971838g; KUMP C, 1966, HELV CHIM ACTA, V49, P1237, DOI 10.1002/hlca.19660490403; MAGNUS P, 1985, J CHEM SOC CHEM COMM, P184, DOI 10.1039/c39850000184; Magnus P, 2000, TETRAHEDRON LETT, V41, P2077, DOI 10.1016/S0040-4039(00)00118-0; Marino JP, 2002, J AM CHEM SOC, V124, P13398, DOI 10.1021/ja026357f; Martin DBC, 2011, CHEM SCI, V2, P649, DOI 10.1039/c1sc00009h; Mori M, 2003, J AM CHEM SOC, V125, P9801, DOI 10.1021/ja029382u; Oestreich M., 2009, MIZOROKI HECK REACTI; OGAWA M, 1987, TETRAHEDRON LETT, V28, P3985, DOI 10.1016/S0040-4039(00)96438-4; PRASHAD M, 1995, SYNTHETIC COMMUN, V25, P95, DOI 10.1080/00397919508010793; Reed J. W, 2007, WAY SYNTHESIS EVOLUT; Simmons B, 2009, ANGEW CHEM INT EDIT, V48, P4349, DOI 10.1002/anie.200900220; Sirasani G, 2010, J ORG CHEM, V75, P3529, DOI 10.1021/jo100516g; Sole D, 2003, J ORG CHEM, V68, P5746, DOI 10.1021/jo034299q; Sole D, 1999, ANGEW CHEM INT EDIT, V38, P395, DOI 10.1002/(SICI)1521-3773(19990201)38:3<395::AID-ANIE395>3.0.CO;2-5; THOMAS PJ, 1978, J CHEM SOC P2, V11, P1130; Va P, 2010, J AM CHEM SOC, V132, P8489, DOI 10.1021/ja1027748; Walji AM, 2007, SYNLETT, P1477, DOI 10.1055/s-2007-980382; WENKERT E, 1988, J ORG CHEM, V53, P4875, DOI 10.1021/jo00255a044	38	532	534	7	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					183	188		10.1038/nature10232	http://dx.doi.org/10.1038/nature10232			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753848	Green Accepted			2022-12-28	WOS:000292690500041
J	Takahashi, H; Parmely, TJ; Sato, S; Tomomori-Sato, C; Banks, CAS; Kong, SE; Szutorisz, H; Swanson, SK; Martin-Brown, S; Washburn, MP; Florens, L; Seidel, CW; Lin, CQ; Smith, ER; Shilatifard, A; Conaway, RC; Conaway, JW				Takahashi, Hidehisa; Parmely, Tari J.; Sato, Shigeo; Tomomori-Sato, Chieri; Banks, Charles A. S.; Kong, Stephanie E.; Szutorisz, Henrietta; Swanson, Selene K.; Martin-Brown, Skylar; Washburn, Michael P.; Florens, Laurence; Seidel, Chris W.; Lin, Chengqi; Smith, Edwin R.; Shilatifard, Ali; Conaway, Ronald C.; Conaway, Joan W.			Human Mediator Subunit MED26 Functions as a Docking Site for Transcription Elongation Factors	CELL			English	Article							RNA-POLYMERASE-II; CARBOXYL-TERMINAL-DOMAIN; P-TEFB KINASE; HEAT-SHOCK; FACTOR ELL; HIV-1 TAT; COMPLEX; PROMOTER; ACTIVATION; BINDING	Promoter-proximal pausing by initiated RNA polymerase II (Pol II) and regulated release of paused polymerase into productive elongation has emerged as a major mechanism of transcription activation. Reactivation of paused Pol II correlates with recruitment of super-elongation complexes (SECs) containing ELL/EAF family members, P-TEFb, and other proteins, but the mechanism of their recruitment is an unanswered question. Here, we present evidence for a role of human Mediator subunit MED26 in this process. We identify in the conserved N-terminal domain of MED26 overlapping docking sites for SEC and a second ELL/EAF-containing complex, as well as general initiation factor TFIID. In addition, we present evidence consistent with the model that MED26 can function as a molecular switch that interacts first with TFIID in the Pol II initiation complex and then exchanges TFIID for complexes containing ELL/EAF and P-TEFb to facilitate transition of Pol II into the elongation stage of transcription.	[Takahashi, Hidehisa; Parmely, Tari J.; Sato, Shigeo; Tomomori-Sato, Chieri; Banks, Charles A. S.; Kong, Stephanie E.; Szutorisz, Henrietta; Swanson, Selene K.; Martin-Brown, Skylar; Washburn, Michael P.; Florens, Laurence; Seidel, Chris W.; Lin, Chengqi; Smith, Edwin R.; Shilatifard, Ali; Conaway, Ronald C.; Conaway, Joan W.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Conaway, Ronald C.; Conaway, Joan W.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Conaway, JW (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	jlc@stowers.org	Hidehisa, Takahashi/E-2175-2012	Washburn, Michael/0000-0001-7568-2585; Banks, Charles/0000-0002-0404-2940; Florens, Laurence/0000-0002-9310-6650; Tomomori-Sato, Chieri/0000-0002-2543-293X; Lin, Chengqi/0000-0002-2121-584X; Conaway, Joan/0000-0002-2786-0663	Stowers Institute; NIGMS, NIH [GM41628]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041628, R37GM041628] Funding Source: NIH RePORTER	Stowers Institute; NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Suganuma for helpful discussions, M. Thirman for a generous gift of the anti-EAF1 antibody, K. Zueckert-Gaudenz and A. Peak for help with microarray experiments, and M. Katt and V. Neubauer for tissue culture. C.L. is a PhD thesis student registered with the Open University. This work was supported by funds from the Stowers Institute and by Grant GM41628 from NIGMS, NIH to J.W.C. and R.C.C.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Balamotis MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.1164302; Banks CAS, 2007, J BIOL CHEM, V282, P5761, DOI 10.1074/jbc.M610393200; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Belakavadi M, 2010, MOL CELL BIOL, V30, P2437, DOI 10.1128/MCB.01541-09; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Booth V, 2000, J BIOL CHEM, V275, P31266, DOI 10.1074/jbc.M002595200; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Byun JS, 2009, P NATL ACAD SCI USA, V106, P19292, DOI 10.1073/pnas.0905469106; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Johnson KM, 2002, GENE DEV, V16, P1852, DOI 10.1101/gad.995702; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kim YK, 2002, MOL CELL BIOL, V22, P4622, DOI 10.1128/MCB.22.13.4622-4637.2002; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Lis JT, 2000, GENE DEV, V14, P792; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Martincic K, 2009, NAT IMMUNOL, V10, P1102, DOI 10.1038/ni.1786; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Montanuy I, 2008, J BIOL CHEM, V283, P7368, DOI 10.1074/jbc.M706243200; Mueller D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000249; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Park JM, 2001, MOL CELL, V8, P9, DOI 10.1016/S1097-2765(01)00296-9; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; SERIZAWA H, 1992, P NATL ACAD SCI USA, V89, P7476, DOI 10.1073/pnas.89.16.7476; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Shilatifard A, 1997, J BIOL CHEM, V272, P22355, DOI 10.1074/jbc.272.35.22355; Smith ER, 2008, P NATL ACAD SCI USA, V105, P8575, DOI 10.1073/pnas.0804379105; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Takahashi H, 2009, J BIOL CHEM, V284, P32405, DOI 10.1074/jbc.M109.017954; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032	61	234	247	2	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					92	104		10.1016/j.cell.2011.06.005	http://dx.doi.org/10.1016/j.cell.2011.06.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729782	Bronze, Green Accepted			2022-12-28	WOS:000292539300009
J	Tolstoy, E				Tolstoy, Eline			Galactic Paleontology	SCIENCE			English	Editorial Material							METAL-POOR STARS; DWARF SPHEROIDAL GALAXIES; CHEMICAL EVOLUTION; ABUNDANCES; SCULPTOR; SEXTANS; FORNAX; DRACO; MILKY	Individual low-mass stars have very long lives, comparable to the age of the universe, and can thus be used to probe ancient star formation. At present, such stars can be identified and studied only in the Milky Way and in the very closest of our neighboring galaxies, which are predominantly small dwarf galaxies. These nearby ancient stars are a fossil record that can provide detailed information about the physical processes that dominated the epoch of galaxy formation and subsequent evolution.	Observ Cote dAzur, Nice, France	UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur	Tolstoy, E (corresponding author), Observ Cote dAzur, Nice, France.							Aoki W, 2009, ASTRON ASTROPHYS, V502, P569, DOI 10.1051/0004-6361/200911959; Aparicio A, 2004, ASTRON J, V128, P1465, DOI 10.1086/382836; Battaglia G, 2008, ASTROPHYS J LETT, V681, pL13, DOI 10.1086/590179; Beers TC, 2005, ANNU REV ASTRON ASTR, V43, P531, DOI 10.1146/annurev.astro.42.053102.134057; Cohen JG, 2009, ASTROPHYS J, V701, P1053, DOI 10.1088/0004-637X/701/2/1053; de Boer TJL, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201016398; EDVARDSSON B, 1993, ASTRON ASTROPHYS, V275, P101; Frebel A, 2010, ASTROPHYS J, V708, P560, DOI 10.1088/0004-637X/708/1/560; Hidalgo SL, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/1/14; Kirby EN, 2008, ASTROPHYS J LETT, V685, pL43, DOI 10.1086/592432; Lanfranchi GA, 2007, ASTRON ASTROPHYS, V468, P927, DOI 10.1051/0004-6361:20066576; Letarte B, 2010, ASTRON ASTROPHYS, V523, DOI 10.1051/0004-6361/200913413; Mac Low MM, 1999, ASTROPHYS J, V513, P142, DOI 10.1086/306832; McWilliam A, 1997, ANNU REV ASTRON ASTR, V35, P503, DOI 10.1146/annurev.astro.35.1.503; Norris JE, 2008, ASTROPHYS J LETT, V689, pL113, DOI 10.1086/595962; Shetrone M, 2003, ASTRON J, V125, P684, DOI 10.1086/345966; Shetrone MD, 2001, ASTROPHYS J, V548, P592, DOI 10.1086/319022; Starkenburg E, 2010, ASTRON ASTROPHYS, V513, DOI 10.1051/0004-6361/200913759; Tafelmeyer M, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/201014733; Tinsley B. M., 1980, Fundamentals of Cosmic Physics, V5, P287; Tolstoy E, 2004, ASTROPHYS J, V617, pL119, DOI 10.1086/427388; Tolstoy E, 2009, ANNU REV ASTRON ASTR, V47, P371, DOI 10.1146/annurev-astro-082708-101650; Venn KA, 2004, ASTRON J, V128, P1177, DOI 10.1086/422734	26	7	7	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2011	333	6039					176	178		10.1126/science.1207392	http://dx.doi.org/10.1126/science.1207392			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21737732				2022-12-28	WOS:000292502700036
J	Froese, R				Froese, Rainer			Fishery reform slips through the net	NATURE			English	Editorial Material									Univ Kiel, Leibniz Inst Marine Sci, D-24098 Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel	Froese, R (corresponding author), Univ Kiel, Leibniz Inst Marine Sci, D-24098 Kiel, Germany.	rfroese@ifm-geomar.de	Froese, Rainer/C-9687-2009	Froese, Rainer/0000-0001-9745-636X					0	25	26	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					7	7		10.1038/475007a	http://dx.doi.org/10.1038/475007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	788RE	21734665	Green Accepted, Bronze			2022-12-28	WOS:000292461300004
J	Greene, JA; Kesselheim, AS				Greene, Jeremy A.; Kesselheim, Aaron S.			Why Do the Same Drugs Look Different? Pills, Trade Dress, and Public Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COLOR; PLACEBO; LITERACY		[Greene, Jeremy A.; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Greene, JA (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	greene@fas.harvard.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		[Anonymous], 2010, CBS 60 MINUTES  1229; Berman Adrienne, 2004, J Med Syst, V28, P9, DOI 10.1023/B:JOMS.0000021518.60670.10; Cardenas-Valladolid J, 2010, DRUG AGING, V27, P641, DOI 10.2165/11537320-000000000-00000; CARPENTER D, B HIST MED IN PRESS; Cutler C, 2011, BIOL BLOOD MARROW TR, V17, P285, DOI 10.1016/j.bbmt.2010.11.006; Davit BM, 2009, ANN PHARMACOTHER, V43, P1583, DOI 10.1345/aph.1M141; deCraen AJM, 1996, BRIT MED J, V313, P1624, DOI 10.1136/bmj.313.7072.1624; Donohue JM, 2007, NEW ENGL J MED, V357, P673, DOI 10.1056/NEJMsa070502; FACCHINETTI NJ, 1982, AM J PUBLIC HEALTH, V72, P468, DOI 10.2105/AJPH.72.5.468; Frank RG, 2007, NEW ENGL J MED, V357, P1993, DOI 10.1056/NEJMp078193; Fritsch David, 2006, INTELLECTUAL PROPERT, V47, P171; Generic Pharmaceutical Association, FACTS GLANC; Gray S, NHS EVIDENCE RESP; Greene Jeremy A., 2007, PRESCRIBING NUMBERS; Greenslit Nathan, 2002, Mol Interv, V2, P342, DOI 10.1124/mi.2.6.342; HARRINGTON A, 1997, PLACEBO EFFECT; Hellier Elizabeth, 2010, J Patient Saf, V6, P158; HORN CR, 1986, LANCET, V1, P165; HUSKISSON EC, 1974, BMJ-BRIT MED J, V4, P196, DOI 10.1136/bmj.4.5938.196; JACOBS KW, 1979, PERCEPT MOTOR SKILL, V49, P367, DOI 10.2466/pms.1979.49.2.367; Kenagy JW, 2001, AM J HEALTH-SYST PH, V58, P2033, DOI 10.1093/ajhp/58.21.2033; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Khan A, 2010, PSYCHOPHARMACOLOGY, V211, P113, DOI 10.1007/s00213-010-1874-z; Kirsche ML, 2005, DRUG STORE NEWS 0822; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Krieg M, 1967, BLACK MARKET MED; Lambert BL, 2005, DRUG SAFETY, V28, P495, DOI 10.2165/00002018-200528060-00003; Levinthal BR, 2008, J GEN INTERN MED, V23, P1172, DOI 10.1007/s11606-008-0612-2; LUCCHELLI PE, 1978, EUR J CLIN PHARMACOL, V13, P153, DOI 10.1007/BF00609760; Matheson Julia Anne, 2009, MED MARKET MEDIA, V44, P55; NEWMAN SJ, 1994, U CHICAGO LAW REV, V61, P1595, DOI 10.2307/1600127; Ngoh LN, 2009, J AM PHARM ASSOC, V49, pE132, DOI 10.1331/JAPhA.2009.07075; SabatU E., 2003, ADHERENCE LONG TERM; Schiff Gordon, 2004, J Med Syst, V28, P1, DOI 10.1023/B:JOMS.0000021517.51673.f3; Shrank WH, 2010, HEALTH AFFAIR, V29, P1383, DOI 10.1377/hlthaff.2009.0424; Stinson Nina, 1982, INDIANA LAW REV, V15, P733; Waber RL, 2008, JAMA-J AM MED ASSOC, V299, P1016, DOI 10.1001/jama.299.9.1016; Wolf MS, 2011, ARCH INTERN MED, V171, P300, DOI 10.1001/archinternmed.2011.39	38	55	55	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					83	89		10.1056/NEJMhle1101722	http://dx.doi.org/10.1056/NEJMhle1101722			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788QL	21732842				2022-12-28	WOS:000292459400016
J	Creten, C; van der Zwaan, S; Blankespoor, RJ; Maatkamp, A; Nicolai, J; van Os, J; Schieveld, JNM				Creten, Caroline; van der Zwaan, Sanne; Blankespoor, Roos J.; Maatkamp, Arjen; Nicolai, Joost; van Os, Jim; Schieveld, Jan N. M.			Late onset autism and anti-NMDA-receptor encephalitis	LANCET			English	Editorial Material									[Maatkamp, Arjen; Nicolai, Joost] Maastricht Univ, Dept Neurol, Med Ctr, NL-6202 AZ Maastricht, Netherlands; [Creten, Caroline; van der Zwaan, Sanne; Blankespoor, Roos J.; van Os, Jim; Schieveld, Jan N. M.] Maastricht Univ, Dept Psychiat, Med Ctr, NL-6202 AZ Maastricht, Netherlands	Maastricht University; Maastricht University	Schieveld, JNM (corresponding author), Maastricht Univ, Dept Psychiat & Psychol, Div Child & Adolescent Psychiat, Med Ctr, P Debyelaan 25,POB 5800, NL-6202 AZ Maastricht, Netherlands.	jan.schieveld@mumc.nl	Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/C-2113-2014; van Os, Jim/I-9496-2012; van Os, Jim/V-8884-2019	van Os, Jim/0000-0002-7245-1586; van Os, Jim/0000-0002-7245-1586				American Psychiatric Association, 2017, DIAGN STAT MAN MENT, V5th; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Kayser MS, 2010, AM J PSYCHIAT, V167, P1039, DOI 10.1176/appi.ajp.2010.09101547; Schieveld JNM, 2006, INT REV NEUROBIOL, V72, P195, DOI 10.1016/S0074-7742(05)72012-2; van Engeland H., 2008, RUTTERS CHILD ADOLES, P759	5	59	60	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 2	2011	378	9785					98	98		10.1016/S0140-6736(11)60548-5	http://dx.doi.org/10.1016/S0140-6736(11)60548-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791IU	21724038				2022-12-28	WOS:000292659700038
J	Johnson, N; Carran, S; Botner, J; Fontaine, K; Laxague, N; Nuetzel, P; Turnley, J; Tivnan, B				Johnson, Neil; Carran, Spencer; Botner, Joel; Fontaine, Kyle; Laxague, Nathan; Nuetzel, Philip; Turnley, Jessica; Tivnan, Brian			Pattern in Escalations in Insurgent and Terrorist Activity	SCIENCE			English	Article							LEARNING-CURVE	In military planning, it is important to be able to estimate not only the number of fatalities but how often attacks that result in fatalities will take place. We uncovered a simple dynamical pattern that may be used to estimate the escalation rate and timing of fatal attacks. The time difference between fatal attacks by insurgent groups within individual provinces in both Afghanistan and Iraq, and by terrorist groups operating worldwide, gives a potent indicator of the later pace of lethal activity.	[Johnson, Neil; Laxague, Nathan] Univ Miami, Dept Phys, Coral Gables, FL 33124 USA; [Carran, Spencer] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA; [Carran, Spencer] Univ Miami, Dept Math, Coral Gables, FL 33124 USA; [Botner, Joel] Univ Miami, Dept Comp Sci, Coral Gables, FL 33124 USA; [Fontaine, Kyle; Nuetzel, Philip] Univ Miami, Dept Int Studies, Coral Gables, FL 33124 USA; [Turnley, Jessica] Galisteo Consulting Grp, Albuquerque, NM 87110 USA; [Tivnan, Brian] Mitre Corp, Mclean, VA 22102 USA; [Tivnan, Brian] Univ Vermont, Ctr Complex Syst, Burlington, VT 05405 USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; MITRE Corporation; University of Vermont	Johnson, N (corresponding author), Univ Miami, Dept Phys, Coral Gables, FL 33124 USA.			Laxague, Nathan/0000-0002-0373-9236; Carran, Spencer/0000-0002-0554-6315	Joint IED Defeat Organization [N70465]; MITRE Corporation; Santa Fe Institute	Joint IED Defeat Organization; MITRE Corporation; Santa Fe Institute	The authors gratefully acknowledge support for this research from the Joint IED Defeat Organization, IDN# N70465, and from The MITRE Corporation and the Santa Fe Institute for their co-hosting of the "Mathematics of Terrorism" workshop. The views and conclusions contained in this paper are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of any of the above named organizations, to include the U.S. government. We also thank P. Dodds, C. Danforth and A. Clauset for broad discussions surrounding this topic, L. Amaral for discussions concerning non-Poissonian behavior, and the anonymous reviewers for suggestions.	ARGOTE L, 1990, SCIENCE, V247, P920, DOI 10.1126/science.247.4945.920; Belasco Amy, 2009, TROOP LEVELS AFGHAN; ben Avraham D., 2000, DIFFUSION REACTIONS; Bohannon J, 2011, SCIENCE, V331, P1256, DOI 10.1126/science.331.6022.1256; Bohorquez JC, 2009, NATURE, V462, P911, DOI 10.1038/nature08631; Clauset A, 2007, J CONFLICT RESOLUT, V51, P58, DOI 10.1177/0022002706296157; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Ducheneaut N., 2007, P CHI 2007 SPEC INT; DUTTON JM, 1984, ACAD MANAGE REV, V9, P235, DOI 10.2307/258437; Flynn MT, 2010, FIXING INTEL BLUEPRI; International Security Assistance Force, 2011, ISAF NUMB 2008 2010; Johnson DDP., 2009, J WASH ACAD SCI, V95, P89; Johnson N. F., 2003, FINANCIAL MARKET COM, P20; Kilcullen David, 2009, ACCIDENTAL GUERRILLA; Lim M, 2007, SCIENCE, V317, P1540, DOI 10.1126/science.1142734; Mottrie A, 2010, EUR UROL, V58, P127, DOI 10.1016/j.eururo.2010.03.045; RICHARDSON LF, 1948, J AM STAT ASSOC, V43, P523, DOI 10.2307/2280704; Robb J, 2007, BRAVE NEW WAR NEXT S; Rudnick J., 2010, ELEMENTS RANDOM WALK; Sagarin RD, 2010, NATURE, V465, P292, DOI 10.1038/465292a; SARASWAT SP, 1990, INFORM MANAGE, V19, P53, DOI 10.1016/0378-7206(90)90014-9	21	59	60	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					81	84		10.1126/science.1205068	http://dx.doi.org/10.1126/science.1205068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719677	Green Submitted			2022-12-28	WOS:000292255400053
J	Bern, C				Bern, Caryn			Antitrypanosomal Therapy for Chronic Chagas' Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRYPANOSOMA-CRUZI; ETIOLOGIC TREATMENT; HEART-DISEASE; BENZNIDAZOLE; NIFURTIMOX; INFECTION; DIAGNOSIS; TRIAL; CARDIOMYOPATHY; CHEMOTHERAPY	A 42-year-old woman presents to her physician with a letter stating that after she made a recent blood donation, a serologic test of her donated blood was positive for Chagas' disease. The patient was born in El Salvador and moved to the United States when she was 18 years of age. Her three children are 8, 13, and 16 years of age. Her medical history is remarkable only for a cholecystectomy 2 years earlier; she reports no cardiac or gastrointestinal symptoms. Her physical examination is unremarkable. Electrocardiography (ECG) shows sinus rhythm at a rate of 72 beats per minute and a complete right bundle-branch block. An echocardiogram shows mild left ventricular segmental wall-motion abnormalities, but a normal ejection fraction and left ventricular diameter. The patient is referred to an infectious-disease consultant, who recommends antitrypanosomal therapy.	Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Bern, C (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, 1600 Clifton Rd, Atlanta, GA 30333 USA.	cxb9@cdc.gov		Bern, Caryn/0000-0001-8195-7303				[Anonymous], [No title captured]; [Anonymous], 2002, WHO TECH REP SER, V905, P1; Basquiera AL, 2003, HEART, V89, P1186, DOI 10.1136/heart.89.10.1186; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Bern C, 2009, CLIN INFECT DIS, V49, pE52, DOI 10.1086/605091; Castro JA, 2006, HUM EXP TOXICOL, V25, P471, DOI 10.1191/0960327106het653oa; *CDCP, 2011, CHAG DIS RES HLTH PR; Coura J R, 1997, Rev Soc Bras Med Trop, V30, P139, DOI 10.1590/S0037-86821997000200009; Coura JR, 2002, MEM I OSWALDO CRUZ, V97, P3, DOI 10.1590/S0074-02762002000100001; de Oliveira RB, 1998, AM J GASTROENTEROL, V93, P884, DOI 10.1111/j.1572-0241.1998.270_r.x; deAndrade ALSS, 1996, LANCET, V348, P1407, DOI 10.1016/S0140-6736(96)04128-1; Diniz LD, 2010, ANTIMICROB AGENTS CH, V54, P2979, DOI 10.1128/AAC.01742-09; DOCAMPO R, 1990, CHEM-BIOL INTERACT, V73, P1, DOI 10.1016/0009-2797(90)90106-W; Engman DM, 2002, ACTA TROP, V81, P123, DOI 10.1016/S0001-706X(01)00202-9; Estani SS, 1998, AM J TROP MED HYG, V59, P526, DOI 10.4269/ajtmh.1998.59.526; Garcia S, 2005, ANTIMICROB AGENTS CH, V49, P1521, DOI 10.1128/AAC.49.4.1521-1528.2005; Gascon J, 2008, ENFERM INFEC MICR CL, V26, P99, DOI 10.1157/13115545; Jackson Y, 2010, CLIN INFECT DIS, V51, pE69, DOI 10.1086/656917; JUNCKERSTORFF R, 2010, KUCERS USE ANTIBIOTI, P2152; Junqueira ACV, 1996, T ROY SOC TROP MED H, V90, P129, DOI 10.1016/S0035-9203(96)90111-X; Koberle F., 1968, Advances in Parasitology, V6, P63, DOI 10.1016/S0065-308X(08)60472-8; MAGUIRE JH, 1987, CIRCULATION, V75, P1140, DOI 10.1161/01.CIR.75.6.1140; MAGUIRE JH, 1982, AM J TROP MED HYG, V31, P42, DOI 10.4269/ajtmh.1982.31.42; Marin-Neto JA, 2009, MEM I OSWALDO CRUZ, V104, P319, DOI 10.1590/S0074-02762009000900042; Marin-Neto JA, 2008, AM HEART J, V156, P37, DOI 10.1016/j.ahj.2008.04.001; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Ministerio da Saude. Secretaria de Vigilancia em Saude, 2005, Rev Soc Bras Med Trop, V38 Suppl 3, P7; MURRAY RJ, 2010, KUCERS USE ANTIBIOTI, P2155; Organizacion Panamericana de la Salud, 2006, OPSHDMCD42506; Perez-Molina JA, 2009, J ANTIMICROB CHEMOTH, V64, P1139, DOI 10.1093/jac/dkp357; Pinazo MJ, 2010, ANTIMICROB AGENTS CH, V54, P4896, DOI 10.1128/AAC.00537-10; Pinazo MJ, 2010, AM J TROP MED HYG, V82, P583, DOI 10.4269/ajtmh.2010.09-0620; Dias JCP, 2006, ANN INTERN MED, V144, P772, DOI 10.7326/0003-4819-144-10-200605160-00012; Rassi A, 2000, CLIN CARDIOL, V23, P883, DOI 10.1002/clc.4960231205; Rassi A., 2003, AM TRYPANOSOMIASIS, P117; Rassi A Jr, 2001, Arq Bras Cardiol, V76, P75; Rassi A, 2007, CIRCULATION, V115, P1101, DOI 10.1161/CIRCULATIONAHA.106.627265; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Sosa-Estani S, 2006, CURR OPIN INFECT DIS, V19, P583, DOI 10.1097/01.qco.0000247592.21295.a5; Sosa-Estani S, 2009, REV SOC BRAS MED TRO, V42, P484, DOI 10.1590/S0037-86822009000500002; Tarleton RL, 2007, PLOS MED, V4, P1852, DOI 10.1371/journal.pmed.0040332; Tarleton RL, 2003, TRENDS PARASITOL, V19, P447, DOI 10.1016/j.pt.2003.08.008; Urbina JA, 2003, TRENDS PARASITOL, V19, P495, DOI 10.1016/j.pt.2003.09.001; Urbina JA, 2010, ACTA TROP, V115, P55, DOI 10.1016/j.actatropica.2009.10.023; *US PHARM CONV, 1995, NIF; VILLAR JC, 2002, COCHRANE DB SYST REV; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; Viotti R, 2009, EXPERT REV ANTI-INFE, V7, P157, DOI 10.1586/14787210.7.2.157; WEGNER DHG, 1972, ARZNEI-FORSCHUNG, V22, P1635; WEGNER DHG, 1972, ARZNEI-FORSCHUNG, V22, P1624; Wincker P, 1997, PARASITOLOGY, V114, P367, DOI 10.1017/S0031182096008554; Zhang L, 1999, J INFECT DIS, V180, P480, DOI 10.1086/314889; 2010, DRUGS NEGLECTED DIS	53	190	195	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2011	364	26					2527	2534		10.1056/NEJMct1014204	http://dx.doi.org/10.1056/NEJMct1014204			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	785AM	21714649				2022-12-28	WOS:000292199800008
J	Spence, D				Spence, Des			FROM THE FRONTLINE The error of our ways	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 29	2011	342								d4082	10.1136/bmj.d4082	http://dx.doi.org/10.1136/bmj.d4082			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788PZ	21715459				2022-12-28	WOS:000292458200009
J	Dufour, C; Bacigalupo, A; Oneto, R; Socie, G; Tichelli, A; Passweg, JR; Risitano, AM; Schrezenmeier, H; Locasciulli, A; Aljurf, M; Marsh, JCW				Dufour, Carlo; Bacigalupo, Andrea; Oneto, Rosi; Socie, Gerard; Tichelli, Andre; Passweg, Jakob R.; Risitano, Antonio M.; Schrezenmeier, Hubert; Locasciulli, Anna; Aljurf, Mohammed; Marsh, Judith C. W.		Severe Aplastic Anaemia Working	Rabbit ATG for aplastic anaemia treatment: a backward step?	LANCET			English	Editorial Material							ANTITHYMOCYTE GLOBULIN; 1ST-LINE TREATMENT		[Dufour, Carlo] G Gaslini Childrens Hosp, Dept Haematol, Genoa, Italy; [Bacigalupo, Andrea; Oneto, Rosi] Azienda Osped Univ San Martino, Dept Haematol 2, Genoa, Italy; [Socie, Gerard] Hosp St Louis, Paris, France; [Socie, Gerard] Univ Paris 07, Paris, France; [Tichelli, Andre; Passweg, Jakob R.] Univ Basel Hosp, Dept Haematol, CH-4031 Basel, Switzerland; [Risitano, Antonio M.] Univ Naples Federico II, Dept Haematol, Naples, Italy; [Schrezenmeier, Hubert] German Red Cross Blood Transfus Serv, Inst Clin Transfus Med & Immunogenet, Ulm, Germany; [Schrezenmeier, Hubert] Univ Ulm, Ulm, Germany; [Locasciulli, Anna] Osped San Camillo, Dept Paediat Haematol, Rome, Italy; [Aljurf, Mohammed] King Faisal Specialist Hosp & Res Ctr, Bone Marrow Transplant Unit, Jeddah, Saudi Arabia; [Marsh, Judith C. W.] Kings Coll Hosp London, Dept Haematol Med, London, England; [Marsh, Judith C. W.] Kings Coll London, London WC2R 2LS, England	University of Genoa; IRCCS Istituto Giannina Gaslini; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Basel; University of Naples Federico II; Ulm University; Azienda Ospedaliera San Camillo-Forlanini; King Faisal Specialist Hospital & Research Center; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Dufour, C (corresponding author), G Gaslini Childrens Hosp, Dept Haematol, Genoa, Italy.	judith.marsh@nhs.net	Dufour, Carlo/AAB-1000-2021; passweg, jakob/AAG-3911-2020	Passweg, Jakob R/0000-0001-7092-3351				Afable MG, 2011, HAEMATOL-HEMATOL J, V96, P1269, DOI 10.3324/haematol.2011.042622; Atta EH, 2010, ANN HEMATOL, V89, P851, DOI 10.1007/s00277-010-0944-y; Bacigalupo A, 2010, HAEMATOL-HEMATOL J, V95, P976, DOI 10.3324/haematol.2009.018267; Garcia-Manero T, 2010, BLOOD S, V116, P2920; Halkes CJM, 2011, BONE MARROW TRANSPL, V46, pS373; Marsh J, 2011, 37 ANN M EUR GROUP B, P208; Marsh JC, 2011, BLOOD, V118, P2351, DOI 10.1182/blood-2010-12-327536; Marsh JCW, 2009, BRIT J HAEMATOL, V147, P43, DOI 10.1111/j.1365-2141.2009.07842.x; Risitano AM, 2010, BRIT J HAEMATOL, V148, P791, DOI 10.1111/j.1365-2141.2009.08027.x; Saracco P, 2011, BONE MARROW TRANSPL, V46, pS374; Scheinberg P, 2010, ASH ANN M ORL FL US; Tichelli A, 2011, BLOOD, V117, P4434, DOI 10.1182/blood-2010-08-304071; Vallejo C, 2009, ASH ANN M, V114, P3194	13	14	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 26	2011	378	9806					1831	1833		10.1016/S0140-6736(11)60817-9	http://dx.doi.org/10.1016/S0140-6736(11)60817-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857DQ	21737135				2022-12-28	WOS:000297695800011
J	Decramer, M				Decramer, Marc		European Resp Roadmap Initiative	The European Respiratory Roadmap	LANCET			English	Editorial Material									[Decramer, Marc; European Resp Roadmap Initiative] Katholieke Univ Leuven, Div Resp, B-3000 Louvain, Belgium	KU Leuven	Decramer, M (corresponding author), Katholieke Univ Leuven, Div Resp, B-3000 Louvain, Belgium.	Marc.Decramer@uzleuven.be		Nicod, Laurent P/0000-0002-0905-916X				[Anonymous], 2011, SMOK FREE LEG EU; Christensen CM, 2000, HARVARD BUS REV, V78, P102; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; *EUR COMM, 2009, SURV TOB AN REP; Gerkens S, 2010, HEALT SYST TRANSIT, V12, P1; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; K Neubauer, 2010, INVESTING EUROPES HL; Kamel N, 2008, EUR RESPIR J, V31, P924, DOI 10.1183/09031936.00033208; Kane RL, 2007, MED CARE, V45, P1195, DOI 10.1097/MLR.0b013e3181468ca3; La Parra D, 2008, AGEING SOC, V28, P85, DOI 10.1017/S0144686X07006563; Loddenkemper R, 2008, EUR RESPIR J, V32, P538, DOI 10.1183/09031936.00090908; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; World Health Organization, WORLD HLTH STAT 2008	13	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2011	378	9805					1765	1767		10.1016/S0140-6736(11)60619-3	http://dx.doi.org/10.1016/S0140-6736(11)60619-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851IS	21703674				2022-12-28	WOS:000297262300010
J	Baicker, K; Finkelstein, A				Baicker, Katherine; Finkelstein, Amy			The Effects of Medicaid Coverage - Learning from the Oregon Experiment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Baicker, Katherine] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Finkelstein, Amy] MIT, Dept Econ, Cambridge, MA 02139 USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT)	Baicker, K (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.				NIA NIH HHS [RC2 AG036631-01, R01 AG034151, RC2 AG036631, R01 AG034151-01A1] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [RC2AG036631, R01AG034151] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Finkelstein A, 2011, 17190 NBER; Institute of Medicine Committee on Health Insurance Status and Its Consequences, 2009, AM UN CRIS CONS HLTH; Levy H, 2008, ANNU REV PUBL HEALTH, V29, P399, DOI 10.1146/annurev.publhealth.28.021406.144042	3	94	94	2	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2011	365	8					683	685		10.1056/NEJMp1108222	http://dx.doi.org/10.1056/NEJMp1108222			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811JM	21774703	Green Accepted, Green Published			2022-12-28	WOS:000294205300002
J	Schroter, C; Kosma, K; Schultz, T				Schroeter, Christian; Kosma, Kyriaki; Schultz, Thomas			CRASY: Mass- or Electron-Correlated Rotational Alignment Spectroscopy	SCIENCE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; 2-DIMENSIONAL SPECTROSCOPY; COHERENCE SPECTROSCOPY; PROTON-TRANSFER; MOLECULES; CONSTANTS; NMR; FRAME	Rotational spectra have traditionally been measured without a concurrent means of differentiating the molecular constituents of the sample. Here, we present an all-optical multipulse experiment that allows the correlated measurement of rotational and mass or photoelectron spectra by combining Fourier transform rotational coherence spectroscopy with resonance-enhanced multiphoton ionization. We demonstrate the power of this method with the determination of ground-state rotational constants and fragmentation channels for 10 different isotopes in a natural carbon disulfide sample. Three of the reported rotational constants were previously inaccessible by conventional spectroscopic techniques.	[Schroeter, Christian; Kosma, Kyriaki; Schultz, Thomas] Max Born Inst, D-12489 Berlin, Germany	Max Born Institute for Nonlinear Optics & Short Term Spectroscopy	Schultz, T (corresponding author), Max Born Inst, Max Born Str 2A, D-12489 Berlin, Germany.	schultz@mbi-berlin.de	Schröter, Christian/I-7922-2013; Schultz, Thomas/C-2749-2009	Schultz, Thomas/0000-0001-6901-1814; Schroeter, Christian/0000-0001-6622-3723	Deutsche Forschungsgemeinschaft [SFB-450]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank F. Noack for support by providing the laser system in the femtosecond application laboratory of the Max-Born-Institut Berlin. Financial support by the Deutsche Forschungsgemeinschaft through SFB-450 is gratefully acknowledged.	AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450; Bisgaard CZ, 2009, SCIENCE, V323, P1464, DOI 10.1126/science.1169183; CAMPBELL EJ, 1981, J CHEM PHYS, V74, P829, DOI 10.1063/1.441158; Cheng CLC, 1996, J MOL SPECTROSC, V179, P205, DOI 10.1006/jmsp.1996.0198; CORCORAN TC, 1990, CHEM PHYS LETT, V170, P139, DOI 10.1016/0009-2614(90)87105-Z; David O, 2002, INT REV PHYS CHEM, V21, P499, DOI 10.1080/01442350210164287; De Lucia FC, 2010, J MOL SPECTROSC, V261, P1, DOI 10.1016/j.jms.2010.01.002; Dian BC, 2008, P NATL ACAD SCI USA, V105, P12696, DOI 10.1073/pnas.0800520105; ERNST RR, 1992, ANGEW CHEM INT EDIT, V31, P805, DOI 10.1002/anie.199208053; FELKER PM, 1992, J PHYS CHEM-US, V96, P7844, DOI 10.1021/j100199a005; Gador N, 2007, J PHYS CHEM A, V111, P11743, DOI 10.1021/jp076800e; GRANOVSKY AA, 2009, GAMES FIREFLY VERSIO; HERITAGE JP, 1975, PHYS REV LETT, V34, P1299, DOI 10.1103/PhysRevLett.34.1299; Hochstrasser RM, 2007, P NATL ACAD SCI USA, V104, P14190, DOI 10.1073/pnas.0704079104; Horneman VM, 2005, J MOL SPECTROSC, V234, P238, DOI 10.1016/j.jms.2005.09.011; HOULT DI, 1984, MAGNET RESON MED, V1, P339, DOI 10.1002/mrm.1910010305; Jonas DM, 2003, SCIENCE, V300, P1515, DOI 10.1126/science.1085687; Kumarappan V, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093006; Kummli DS, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2186642; Lide D.R., 2005, CRC HDB CHEM PHYS IN; Medvedev IR, 2010, OPT LETT, V35, P1533, DOI 10.1364/OL.35.001533; Meerts WL, 2006, PHYS SCRIPTA, V73, pC47, DOI 10.1088/0031-8949/73/1/N09; Petitprez D, 2004, CR PHYS, V5, P231, DOI 10.1016/j.crhy.2004.01.019; Riehn C, 2002, CHEM PHYS, V283, P297, DOI 10.1016/S0301-0104(02)00572-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Samoylova E, 2009, J PHYS CHEM A, V113, P8195, DOI 10.1021/jp903460b; Sanz ME, 2006, J AM CHEM SOC, V128, P3812, DOI 10.1021/ja058194b; Smith VR, 2010, PHYS CHEM CHEM PHYS, V12, P9632, DOI 10.1039/c003967e; Stapelfeldt H, 2003, REV MOD PHYS, V75, P543, DOI 10.1103/RevModPhys.75.543; Surin LA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.233401; Viftrup SS, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.023404; Viftrup SS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.143602; WILLIAMSON MP, 1985, J MOL BIOL, V182, P295, DOI 10.1016/0022-2836(85)90347-X	33	24	24	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					1011	1015		10.1126/science.1204352	http://dx.doi.org/10.1126/science.1204352			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21737701				2022-12-28	WOS:000294000400054
J	Chiu, WT; Chu, SF; Chang, CK; Lui, TN; Chiang, YH				Chiu, Wen-Ta; Chu, Shu-Fen; Chang, Cheng-Kuei; Lui, Tai-Ngar; Chiang, Yung-Hsiao			Implementation of a Motorcycle Helmet Law in Taiwan and Traffic Deaths Over 18 Years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Chiu, Wen-Ta; Lui, Tai-Ngar; Chiang, Yung-Hsiao] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Chu, Shu-Fen] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Chang, Cheng-Kuei] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University	Chiu, WT (corresponding author), Taipei Med Univ, Sch Med, Taipei, Taiwan.	ychiang@tmu.edu.tw						Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; *GOV TAIW DEP HLTH, 1991, STAT REP; Keng SH, 2005, ACCIDENT ANAL PREV, V37, P349, DOI 10.1016/j.aap.2004.09.006; *MIN INT GOV TAIW, 2000, POL POL REP; *MIN TRANSP COMM G, 1991, STAT REP; Tsai M C, 1999, Inj Prev, V5, P290	6	18	18	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2011	306	3					267	268		10.1001/jama.2011.989	http://dx.doi.org/10.1001/jama.2011.989			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794BS	21771985				2022-12-28	WOS:000292870500018
J	Wark, P				Wark, Peter			Tiotropium reduced exacerbations more than salmeterol in moderate-to-very severe COPD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia	University of Newcastle	Wark, P (corresponding author), Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia.		Wark, Peter/G-7037-2013	Wark, Peter/0000-0001-5676-6126					0	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2							JC1-03	10.7326/0003-4819-155-2-201107190-02003	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	793KW	21768569				2022-12-28	WOS:000292822000002
J	Imasaki, T; Calero, G; Cai, G; Tsai, KL; Yamada, K; Cardelli, F; Erdjument-Bromage, H; Tempst, P; Berger, I; Kornberg, GL; Asturias, FJ; Kornberg, RD; Takagi, Y				Imasaki, Tsuyoshi; Calero, Guillermo; Cai, Gang; Tsai, Kuang-Lei; Yamada, Kentaro; Cardelli, Francesco; Erdjument-Bromage, Hediye; Tempst, Paul; Berger, Imre; Kornberg, Guy Lorch; Asturias, Francisco J.; Kornberg, Roger D.; Takagi, Yuichiro			Architecture of the Mediator head module	NATURE			English	Article							RNA-POLYMERASE-II; REPEAT DOMAIN; COMPLEX; YEAST; PROTEIN; INITIATION; SUBUNIT; BINDING; SYSTEM; CTD	Mediator is a key regulator of eukaryotic transcription(1), connecting activators and repressors bound to regulatory DNA elements with RNA polymerase II1-4 (Pol II). In the yeast Saccharomyces cerevisiae, Mediator comprises 25 subunits with a total mass of more than one megadalton (refs 5, 6) and is organized into three modules, called head, middle/arm and tail(7-9). Our understanding of Mediator assembly and its role in regulating transcription has been impeded so far by limited structural information. Here we report the crystal structure of the essential Mediator head module (seven subunits, with a mass of 223 kilodaltons) at a resolution of 4.3 angstroms. Our structure reveals three distinct domains, with the integrity of the complex centred on a bundle of ten helices from five different head subunits. An intricate pattern of interactions within this helical bundle ensures the stable assembly of the head subunits and provides the binding sites for general transcription factors and Pol II. Our structural and functional data suggest that the head module juxtaposes transcription factor IIH and the carboxy-terminal domain of the largest subunit of Pol II, thereby facilitating phosphorylation of the carboxy-terminal domain of Pol II. Our results reveal architectural principles underlying the role of Mediator in the regulation of gene expression.	[Imasaki, Tsuyoshi; Yamada, Kentaro; Cardelli, Francesco; Takagi, Yuichiro] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Calero, Guillermo; Kornberg, Guy Lorch; Kornberg, Roger D.] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94350 USA; [Cai, Gang; Tsai, Kuang-Lei; Asturias, Francisco J.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; [Berger, Imre] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France	Indiana University System; Indiana University Bloomington; Stanford University; Scripps Research Institute; Memorial Sloan Kettering Cancer Center; European Molecular Biology Laboratory (EMBL)	Takagi, Y (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	ytakagi@iupui.edu	Cai, Gang/B-1103-2012; Cai, Gang/AAA-4439-2020	Cai, Gang/0000-0001-8622-3907; Cai, Gang/0000-0001-8622-3907; Tempst, Paul/0000-0002-6680-3987; Imasaki, Tsuyoshi/0000-0001-5462-1820; Berger, Imre/0000-0001-7518-9045; Erdjument-Bromage, Hediye/0000-0003-0224-3594	NCI [Y1-CO-1020]; NIGMS [Y1-GM-1104]; US National Science Foundation [MCB 0843026]; American Heart Association [0735395N]; Human Frontier Science Program; NIH [Y1-CO-1020, Y1-GM-1104, R01 GM67167, GM36659]; NCI Cancer Center [P30 CA08748]; European Commission; DOE [DE-AC02-06CH11357, DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067167, R37GM036659, R01GM036659] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Commission(European CommissionEuropean Commission Joint Research Centre); DOE(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Messerle for providing the Ta<INF>6</INF>Br<INF>14</INF> metal cluster, T. Hurley for reading the manuscript, M. Georgiadis for discussions, C. Kaplan for his advice on yeast genetics, T. Earnest for giving us beam time and L. Fabrizio for assisting with the N-terminal sequence analysis. We thank the CCP4 summer school, funded by the NCI (Y1-CO-1020), and NIGMS (Y1-GM-1104) for their assistance with the twinning data analysis. Y.T. thanks the instructors on 'The X-Ray Methods Course' at Cold Spring Harbor Laboratory. This work was supported by US National Science Foundation grant MCB 0843026 (Y.T.); the American Heart Association 0735395N (Y.T.); a Human Frontier Science Program long-term fellowship (T.I.); NIH grants R01 GM67167 (F.J.A.) and GM36659 (R.D.K.); NCI Cancer Center Support Grant P30 CA08748 (to the MSKCC Microchemistry and Proteomics Core Laboratory); and the European Commission Framework Program 7 projects INSTRUCT and P-CUBE (I.B.). X-ray data were collected at the GM/CA-CAT at the Advanced Photon Source, Argonne National Laboratory. GM/CA-CAT is funded by the NIH (Y1-CO-1020 and Y1-GM-1104) and the Advanced Photon Source is supported by the DOE (DE-AC02-06CH11357). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, supported by the DOE and the NIH, and at the Advanced Light Source, supported by the DOE (DE-AC02-05CH11231).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; Brignole EJ, 2009, NAT STRUCT MOL BIOL, V16, P190, DOI 10.1038/nsmb.1532; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P750, DOI 10.1107/S0907444997016247; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kang JS, 2001, J BIOL CHEM, V276, P42003, DOI 10.1074/jbc.M105961200; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KOLESKE AJ, 1992, CELL, V69, P883, DOI 10.1016/0092-8674(92)90298-Q; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NONET ML, 1989, GENETICS, V123, P715; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sogaard TMM, 2007, J BIOL CHEM, V282, P14113, DOI 10.1074/jbc.M701345200; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; STOFFLER G, 1983, ULTRASTRUCTURE MACRO, P409; Svejstrup JQ, 1997, P NATL ACAD SCI USA, V94, P6075, DOI 10.1073/pnas.94.12.6075; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Tempst Paul, 1994, Methods (Orlando), V6, P248, DOI 10.1006/meth.1994.1027; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; TISCHENDORF GW, 1974, MOL GEN GENET, V134, P187, DOI 10.1007/BF00267715	42	89	95	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					240	U45		10.1038/nature10162	http://dx.doi.org/10.1038/nature10162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21725323	Green Accepted			2022-12-28	WOS:000292690500053
J	Nolan, CJ; Damm, P; Prentki, M				Nolan, Christopher J.; Damm, Peter; Prentki, Marc			Type 2 diabetes across generations: from pathophysiology to prevention and management	LANCET			English	Article							IMPAIRED GLUCOSE-TOLERANCE; GENOME-WIDE ASSOCIATION; PANCREATIC BETA-CELL; VISCERAL ADIPOSE-TISSUE; INSULIN-RESISTANCE; METABOLIC SYNDROME; LIFE-STYLE; SUSCEPTIBILITY LOCI; MELLITUS; OBESITY	Type 2 diabetes is now a pandemic and shows no signs of abatement. In this Seminar we review the pathophysiology of this disorder, with particular attention to epidemiology, genetics, epigenetics, and molecular cell biology. Evidence is emerging that a substantial part of diabetes susceptibility is acquired early in life, probably owing to fetal or neonatal programming via epigenetic phenomena. Maternal and early childhood health might, therefore, be crucial to the development of effective prevention strategies. Diabetes develops because of inadequate islet beta-cell and adipose-tissue responses to chronic fuel excess, which results in so-called nutrient spillover, insulin resistance, and metabolic stress. The latter damages multiple organs. Insulin resistance, while forcing beta cells to work harder, might also have an important defensive role against nutrient-related toxic effects in tissues such as the heart. Reversal of ovemutrition, healing of the beta cells, and lessening of adipose tissue defects should be treatment priorities.	[Nolan, Christopher J.] Canberra Hosp, Dept Endocrinol, Canberra, ACT, Australia; [Nolan, Christopher J.] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Damm, Peter] Univ Copenhagen, Rigshosp, Fac Hlth Sci, Dept Obstet,Ctr Pregnant Women Diabet, DK-2100 Copenhagen, Denmark; [Prentki, Marc] Univ Montreal, CRCHUM, Montreal, PQ H3C 3J7, Canada; [Prentki, Marc] Univ Montreal, Montreal Diabet Res Ctr, Montreal, PQ H3C 3J7, Canada; [Prentki, Marc] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Prentki, Marc] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	Australian National University; Canberra Hospital; Australian National University; Rigshospitalet; University of Copenhagen; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Nolan, CJ (corresponding author), Canberrra Hosp, Dept Endocrinol, POB 11, Woden, ACT 2606, Australia.	christopher.nolan@anu.edu.au	Nolan, Christopher J/B-2026-2008	Nolan, Christopher J/0000-0002-6964-3819; Damm, Peter/0000-0002-2067-5246	Eli Lilly; GlaxoSmithKline; Merck Sharp Dhome; Norvartis; Servier; Novo Nordisk; Novo Nordisk Foundation	Eli Lilly(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Merck Sharp Dhome; Norvartis; Servier(Servier); Novo Nordisk(Novo Nordisk); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	CJN has received speaker's fees from Eli Lilly, GlaxoSmithKline, Merck Sharp Dhome, Norvartis, and Servier, and PD and CJN from Novo Nordisk. MP declares that he has no conflicts of interest.; We thank Viviane Delghingaro and Jee-Hye Kim for initial preparation of figures and Sharyn Wragg for her graphic design assistance. PD has received funding from Novo Nordisk and Novo Nordisk Foundation.	Ackermann RT, 2011, AM J PREV MED, V40, P11, DOI 10.1016/j.amepre.2010.09.022; Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Arroyo C, 2004, DIABETES CARE, V27, P129, DOI 10.2337/diacare.27.1.129; Aso Y, 2009, DIABETES RES CLIN PR, V85, P147, DOI 10.1016/j.diabres.2009.05.015; Astrup A, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00428.x; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Barrett H, 2010, BEST PRACT RES CL EN, V24, P527, DOI 10.1016/j.beem.2010.05.010; Berberoglu Z, 2010, CLIN ENDOCRINOL, V73, P305, DOI 10.1111/j.1365-2265.2010.03784.x; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chaillous L, 2010, DIABETES METAB, V36, P64, DOI 10.1016/j.diabet.2009.07.004; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006259; Clausen TD, 2005, DIABETES CARE, V28, P323, DOI 10.2337/diacare.28.2.323; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Colagiuri S, 2010, DIABETES OBES METAB, V12, P463, DOI 10.1111/j.1463-1326.2009.01182.x; Colagiuri S, 2011, DIABETES CARE, V34, P145, DOI 10.2337/dc10-1206; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Cundy T, 2000, DIABETIC MED, V17, P33, DOI 10.1046/j.1464-5491.2000.00215.x; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dabelea D, 2001, J PEDIATR ENDOCR MET, V14, P1085; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Delghingaro-Augusto V, 2009, DIABETOLOGIA, V52, P1122, DOI 10.1007/s00125-009-1317-8; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Dunstan DW, 2007, DIABETES CARE, V30, P516, DOI 10.2337/dc06-1996; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Espeland M, 2007, DIABETES CARE, V30, P1374; Franks PW, 2006, DIABETES, V55, P460, DOI 10.2337/diabetes.55.02.06.db05-0823; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gillman MW, 2010, DIABETES CARE, V33, P964, DOI 10.2337/dc09-1810; Guan HP, 2002, NAT MED, V8, P1122, DOI 10.1038/nm780; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hemminki K, 2010, DIABETES CARE, V33, P293, DOI 10.2337/dc09-0947; Herder C, 2011, EUR J CLIN INVEST, V41, P679, DOI 10.1111/j.1365-2362.2010.02454.x; Hochberg Z, 2011, ENDOCR REV, V32, P159, DOI 10.1210/er.2009-0039; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Hoy AJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE67, DOI 10.1152/ajpendo.90945.2008; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kawamori R, 2009, LANCET, V373, P1607, DOI 10.1016/S0140-6736(09)60222-1; Kelley DE, 2002, ANNU REV NUTR, V22, P325, DOI 10.1146/annurev.nutr.22.010402.102912; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lamontagne J, 2009, ENDOCRINOLOGY, V150, P3465, DOI 10.1210/en.2008-1557; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Larter CZ, 2010, J GASTROEN HEPATOL, V25, P672, DOI 10.1111/j.1440-1746.2010.06253.x; Lauenborg J, 2004, DIABETES CARE, V27, P1194, DOI 10.2337/diacare.27.5.1194; Lawrence JM, 2008, DIABETES CARE, V31, P899, DOI 10.2337/dc07-2345; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Liu LL, 2009, DIABETES CARE, V32, pS133, DOI 10.2337/dc09-S205; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Gonzalez ELM, 2009, J EPIDEMIOL COMMUN H, V63, P332, DOI 10.1136/jech.2008.080382; Mayer-Davis EJ, 2008, DIABETES CARE, V31, P470, DOI 10.2337/dc07-1321; Mayer-Davis EJ, 2009, DIABETES CARE, V32, pS112, DOI 10.2337/dc09-S203; McElduff A, 2005, DIABETES CARE, V28, P1260, DOI 10.2337/diacare.28.5.1260; McIntyre HD, 2009, CURR DIABETES REV, V5, P190, DOI 10.2174/157339909788920893; McTernan PG, 2002, DIABETES, V51, P1493, DOI 10.2337/diabetes.51.5.1493; Medici F, 1999, DIABETOLOGIA, V42, P146, DOI 10.1007/s001250051132; Meier JJ, 2007, DIABETOLOGIA, V50, P806, DOI 10.1007/s00125-007-0598-z; Meier JJ, 2010, DIABETES, V59, P1117, DOI 10.2337/db09-1899; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Misra A, 2010, J AM COLL NUTR, V29, p289S, DOI 10.1080/07315724.2010.10719844; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Natali A, 2006, DIABETOLOGIA, V49, P434, DOI 10.1007/s00125-006-0141-7; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; NATHAN PJ, 2010, CNS NEUROSCI THER, DOI DOI 10.1111/J.1755-5949.2010.00172.X; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; Nauck M, 2010, DIABETOLOGIA, V53, pS107; Nauck M, 2009, BEST PRACT RES CL EN, V23, P513, DOI 10.1016/j.beem.2009.03.002; Neu A, 2009, PEDIATR DIABETES, V10, P468, DOI 10.1111/j.1399-5448.2009.00528.x; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; Nolan CJ, 2006, DIABETOLOGIA, V49, P2120, DOI 10.1007/s00125-006-0305-5; Nolan CJ, 2008, TRENDS ENDOCRIN MET, V19, P285, DOI 10.1016/j.tem.2008.07.006; Nolan CJ, 2011, BEST PRACT RES CL OB, V25, P37, DOI 10.1016/j.bpobgyn.2010.10.004; Nolan CJ, 2010, J GASTROEN HEPATOL, V25, P1594, DOI 10.1111/j.1440-1746.2010.06473.x; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; ODEA K, 1991, MED J AUSTRALIA, V155, P258, DOI 10.5694/j.1326-5377.1991.tb142236.x; OSTBYE T, 1989, DIABETOLOGIA, V32, P585; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Pettitt DJ, 2008, DIABETES CARE, V31, P2126, DOI 10.2337/dc08-0769; PETTITT DJ, 1988, DIABETES, V37, P622, DOI 10.2337/diabetes.37.5.622; PIERCE M, 1995, DIABETIC MED, V12, P6, DOI 10.1111/j.1464-5491.1995.tb02054.x; Pinney SE, 2010, TRENDS ENDOCRIN MET, V21, P223, DOI 10.1016/j.tem.2009.10.002; Pinnick KE, 2011, P NUTR SOC, V70, P57, DOI 10.1017/S0029665110004015; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Poulsen P, 2009, DIABETES, V58, P1350, DOI 10.2337/db08-1714; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Rajpathak SN, 2009, BBA-GEN SUBJECTS, V1790, P671, DOI 10.1016/j.bbagen.2008.04.005; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Reinehr T, 2010, ARCH DIS CHILD, V95, P954, DOI 10.1136/adc.2010.187898; Reitman ML, 2000, TRENDS ENDOCRIN MET, V11, P410, DOI 10.1016/S1043-2760(00)00309-X; Renehan A, 2010, LANCET, V375, P2201, DOI 10.1016/S0140-6736(10)60706-4; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Samaras K, 2010, OBESITY, V18, P884, DOI 10.1038/oby.2009.443; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scheen AJ, 2007, DIABETES METAB, V33, P3, DOI 10.1016/j.diabet.2006.11.005; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Shah Pankaj, 2003, Curr Diab Rep, V3, P214, DOI 10.1007/s11892-003-0066-1; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Simmons RA, 2009, PEDIATR CLIN N AM, V56, P449, DOI 10.1016/j.pcl.2009.03.004; Sjoholm A, 2009, DIABETES OBES METAB, V11, P19, DOI 10.1111/j.1463-1326.2009.01074.x; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Succurro E, 2008, OBESITY, V16, P1881, DOI 10.1038/oby.2008.308; Suzuki K, 2010, ENDOCR J, V57, P359, DOI 10.1507/endocrj.K10E-077; TATTERSALL RB, 1975, DIABETES, V24, P452, DOI 10.2337/diabetes.24.5.452; Thorens B, 2008, INT J OBESITY, V32, pA62, DOI 10.1038/ijo.2008.208; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Unger RH, 2010, TRENDS ENDOCRIN MET, V21, P345, DOI 10.1016/j.tem.2010.01.009; van Tienen FHJ, 2011, INT J OBESITY, V35, P1154, DOI 10.1038/ijo.2010.275; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Walker GE, 2008, OBESITY, V16, P1983, DOI 10.1038/oby.2008.326; Walker KZ, 2010, J HUM NUTR DIET, V23, P344, DOI 10.1111/j.1365-277X.2010.01061.x; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Williams ED, 2010, DIABETOLOGIA, V53, P2538, DOI 10.1007/s00125-010-1888-4; World Health Organization, 2011, US GLYC HAEM HBA1C D; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zinman B, 2010, LANCET, V376, P103, DOI 10.1016/S0140-6736(10)60746-5; Zraika S, 2010, DIABETOLOGIA, V53, P1046, DOI 10.1007/s00125-010-1671-6	140	601	615	2	212	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2011	378	9786					169	181		10.1016/S0140-6736(11)60614-4	http://dx.doi.org/10.1016/S0140-6736(11)60614-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	795CJ	21705072	Green Submitted			2022-12-28	WOS:000292948800034
J	Cortellino, S; Xu, JF; Sannai, M; Moore, R; Caretti, E; Cigliano, A; Le Coz, M; Devarajan, K; Wessels, A; Soprano, D; Abramowitz, LK; Bartolomei, MS; Rambow, F; Bassi, MR; Bruno, T; Fanciulli, M; Renner, C; Klein-Szanto, AJ; Matsumoto, Y; Kobi, D; Davidson, I; Alberti, C; Larue, L; Bellacosa, A				Cortellino, Salvatore; Xu, Jinfei; Sannai, Mara; Moore, Robert; Caretti, Elena; Cigliano, Antonio; Le Coz, Madeleine; Devarajan, Karthik; Wessels, Andy; Soprano, Dianne; Abramowitz, Lara K.; Bartolomei, Marisa S.; Rambow, Florian; Bassi, Maria Rosaria; Bruno, Tiziana; Fanciulli, Maurizio; Renner, Catherine; Klein-Szanto, Andres J.; Matsumoto, Yoshihiro; Kobi, Dominique; Davidson, Irwin; Alberti, Christophe; Larue, Lionel; Bellacosa, Alfonso			Thymine DNA Glycosylase Is Essential for Active DNA Demethylation by Linked Deamination-Base Excision Repair	CELL			English	Article							MAMMALIAN DEVELOPMENT; EMBRYONIC LETHALITY; CANCER EPIGENETICS; PATERNAL GENOME; AID DEFICIENCY; METHYLATION; TRANSCRIPTION; 5-METHYLCYTOSINE; ACTIVATION; RECEPTORS	DNA methylation is a major epigenetic mechanism for gene silencing. Whereas methyltransferases mediate cytosine methylation, it is less clear how unmethylated regions in mammalian genomes are protected from de novo methylation and whether an active demethylating activity is involved. Here, we show that either knockout or catalytic inactivation of the DNA repair enzyme thymine DNA glycosylase (TDG) leads to embryonic lethality in mice. TDG is necessary for recruiting p300 to retinoic acid (RA)-regulated promoters, protection of CpG islands from hypermethylation, and active demethylation of tissue-specific developmentally and hormonally regulated promoters and enhancers. TDG interacts with the deaminase AID and the damage response protein GADD45a. These findings highlight a dual role for TDG in promoting proper epigenetic states during development and suggest a two-step mechanism for DNA demethylation in mammals, whereby 5-methylcytosine and 5-hydroxymethylcytosine are first deaminated by AID to thymine and 5-hydroxymethyluracil, respectively, followed by TDG-mediated thymine and 5-hydroxymethyluracil excision repair.	[Cortellino, Salvatore; Xu, Jinfei; Sannai, Mara; Moore, Robert; Caretti, Elena; Cigliano, Antonio; Le Coz, Madeleine; Bassi, Maria Rosaria; Bellacosa, Alfonso] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Cortellino, Salvatore; Xu, Jinfei; Sannai, Mara; Moore, Robert; Caretti, Elena; Cigliano, Antonio; Le Coz, Madeleine; Bassi, Maria Rosaria; Bellacosa, Alfonso] Fox Chase Canc Ctr, Epigenet & Progenitor Cells Keystone Program, Philadelphia, PA 19111 USA; [Devarajan, Karthik] Fox Chase Canc Ctr, Dept Biostat, Philadelphia, PA 19111 USA; [Renner, Catherine; Klein-Szanto, Andres J.] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Wessels, Andy] Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA; [Soprano, Dianne] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Abramowitz, Lara K.; Bartolomei, Marisa S.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Rambow, Florian; Alberti, Christophe; Larue, Lionel] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Rambow, Florian; Alberti, Christophe; Larue, Lionel] CNRS, INSERM, U1021, UMR3347, F-91405 Orsay, France; [Bruno, Tiziana; Fanciulli, Maurizio] Regina Elena Canc Ctr, I-00158 Rome, Italy; [Matsumoto, Yoshihiro] E Stroudsburg Univ, Dept Biol Sci, E Stroudsburg, PA 18301 USA; [Kobi, Dominique; Davidson, Irwin] CNRS INSERM ULP, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Medical University of South Carolina; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Pennsylvania State System of Higher Education (PASSHE); East Stroudsburg University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bellacosa, A (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA.	alfonso.bellacosa@fccc.edu	Larue, Lionel/F-7355-2013; bruno, tiziana/AAC-4913-2022; Cortellino, Salvatore/AAH-8857-2019; fanciulli, maurizio/ABH-6745-2020; Larue, Lionel/I-6532-2016; cigliano, antonio/J-1836-2015; Cigliano, Antonio/J-4660-2017; Cortellino, Salvatore/GPW-6929-2022	bruno, tiziana/0000-0003-0352-4523; Cigliano, Antonio/0000-0002-6408-3613; Bassi, Maria Rosaria/0000-0001-6736-6152; Davidson, Irwin/0000-0001-5533-1171; Matsumoto, Yoshihiro/0000-0001-6580-7188; CORTELLINO, Salvatore/0000-0001-8331-3800; Le Coz, Madeleine/0000-0003-4932-1342; rambow, florian/0000-0002-9727-8986	NIH [CA78412, CA06927, DK067558, T32GM008216]; Commonwealth of Pennsylvania; Italian Association for Cancer Research (AIRC); American-Italian Cancer Foundation; Epigenetics and Progenitor Cells Keystone Program Fellowship; NATIONAL CANCER INSTITUTE [P30CA006927, R29CA078412, R01CA078412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008216] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); American-Italian Cancer Foundation; Epigenetics and Progenitor Cells Keystone Program Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. F. De Angelis, H.-Y. Fan, R. Katz, O. Segatto, K. Zaret, and R. Zhang for critical reading of the manuscript; Drs. P. K. Cooper, F. Roegiers, and K. Soprano for comments and advice; G. Albergo, K. Brewer, C. Garnier, B. Lurie, and M. Oliver for mouse genotyping; Dr. Z.P. Zhang for help with CAT assays; Dr. J. Kulkosky, A. Kowalski, T. Stulkivska, and W. Schroeder for Crabp2 and Oct4 methylation analysis; Dr. M. Xu for the targeting plasmid (with permission from Dr. G. Martin); Dr. A.J. Furnace for recombinant GADD45a; Dr. K. Sugasawa for anti-TDG antibody; Drs. L. Bagella and P.L. Puri for p300 reporters; Drs. S. Peri and Y. Zhou for ingenuity pathway analysis; Dr. F. Alt for AID cDNA; Dr. N. Davidson for Apobec-1 cDNA; Dr. W. Cui for human Oct4::EGFP reporter; Drs. C. Niehrs and A. Schafer for advice on transfected plasmid recovery; Dr. J. Thorvaldsen for advice on bisulfite modification of PGC DNA; and R. Sonlin for secretarial assistance. We thank the following core facilities at the Fox Chase Cancer Center: Genotyping, Cell Culture, Transgenic and Knock-out, Laboratory Animal, and Fannie E. Rippel Biotechnology Facility. Y.M. would like to thank Dr. Alan Tomkinson for providing hospitality to conduct some of the experiments in his laboratory. This study was supported by NIH grants CA78412, CA06927, and DK067558; an appropriation from the Commonwealth of Pennsylvania to the Fox Chase Cancer Center; and the Italian Association for Cancer Research (AIRC). S.C. was supported, in part, by an American-Italian Cancer Foundation Post-Doctoral Research Fellowship. M.L.C. was supported by an Epigenetics and Progenitor Cells Keystone Program Fellowship. L.K.A. was supported by NIH training grant T32GM008216. A. B. would like to dedicate this article to the memory of his father Pancrazio who taught him the importance of hard work, perseverance and dedication.	Baker D, 2002, CHEM RES TOXICOL, V15, P33, DOI 10.1021/tx010113b; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Carrier F, 1999, MOL CELL BIOL, V19, P1673; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2003, P NATL ACAD SCI USA, V100, P15071, DOI 10.1073/pnas.2334585100; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; Howard JH, 2009, CANCER BIOL THER, V8, P94, DOI 10.4161/cbt.8.1.7469; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Kress C, 2006, P NATL ACAD SCI USA, V103, P11112, DOI 10.1073/pnas.0601793103; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li YQ, 2007, NUCLEIC ACIDS RES, V35, P390, DOI 10.1093/nar/gkl1052; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Missero C, 2001, J BIOL CHEM, V276, P33569, DOI 10.1074/jbc.M104963200; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Niehrs C, 2009, DIFFERENTIATION, V77, P1, DOI 10.1016/j.diff.2008.09.004; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Pantoja C, 2005, CANCER RES, V65, P26; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Reese KJ, 2006, CYTOGENET GENOME RES, V113, P153, DOI 10.1159/000090827; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Siegfried Z, 1997, CURR BIOL, V7, pR305, DOI 10.1016/S0960-9822(06)00144-8; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tanaka Y, 2000, MECH DEVELOP, V95, P133, DOI 10.1016/S0925-4773(00)00360-9; Thomassin H, 2001, EMBO J, V20, P1974, DOI 10.1093/emboj/20.8.1974; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Um S, 1998, J BIOL CHEM, V273, P20728, DOI 10.1074/jbc.273.33.20728; Vermot J, 2003, P NATL ACAD SCI USA, V100, P1763, DOI 10.1073/pnas.0437920100; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xu J, 2007, P NATL ACAD SCI USA, V104, P12377, DOI 10.1073/pnas.0704579104; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yi YW, 2000, BIOCHEM BIOPH RES CO, V272, P193; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597	62	582	612	3	135	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					67	79		10.1016/j.cell.2011.06.020	http://dx.doi.org/10.1016/j.cell.2011.06.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21722948	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000292539300007
J	Pfeffer, MA; Bowler, MB				Pfeffer, Marc A.; Bowler, Marianne B.			Access to Safety Data - Stockholders versus Prescribers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pfeffer, Marc A.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Pfeffer, Marc A.] Harvard Univ, Sch Med, Boston, MA USA; [Bowler, Marianne B.] US Dist Court, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Pfeffer, MA (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA.							BREYER STEPHEN, 2010, MAKING OUR DEMOCRACY; Curfman GD, 2006, NEW ENGL J MED, V354, P1193, DOI 10.1056/NEJMe068054; *FOOD DRUG ADM, SENT IN NAT STRAT MO	3	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					1	3		10.1056/NEJMp1104699	http://dx.doi.org/10.1056/NEJMp1104699			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788QL	21714642				2022-12-28	WOS:000292459400001
J	Chan, PS; Patel, MR; Klein, LW; Krone, RJ; Dehmer, GJ; Kennedy, K; Nallamothu, BK; Weaver, WD; Masoudi, FA; Rumsfeld, JS; Brindis, RG; Spertus, JA				Chan, Paul S.; Patel, Manesh R.; Klein, Lloyd W.; Krone, Ronald J.; Dehmer, Gregory J.; Kennedy, Kevin; Nallamothu, Brahmajee K.; Weaver, W. Douglas; Masoudi, Frederick A.; Rumsfeld, John S.; Brindis, Ralph G.; Spertus, John A.			Appropriateness of Percutaneous Coronary Intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL THERAPY; AD HOC; REVASCULARIZATION; ANGIOPLASTY; CRITERIA; DISEASE; PCI	Context Despite the widespread use of percutaneous coronary intervention (PCI), the appropriateness of these procedures in contemporary practice is unknown. Objective To assess the appropriateness of PCI in the United States. Design, Setting, and Patients Multicenter, prospective study of patients within the National Cardiovascular Data Registry undergoing PCI between July 1, 2009, and September 30, 2010, at 1091 US hospitals. The appropriateness of PCI was adjudicated using the appropriate use criteria for coronary revascularization. Results were stratified by whether the procedure was performed for an acute (ST-segment elevation myocardial infarction, non-ST-segment elevation myocardial infarction, or unstable angina with high-risk features) or nonacute indication. Main Outcome Measures Proportion of acute and nonacute PCIs classified as appropriate, uncertain, or inappropriate; extent of hospital-level variation in inappropriate procedures. Results Of 500 154 PCIs, 355 417 (71.1%) were for acute indications (ST-segment elevation myocardial infarction, 103 245 [20.6%]; non-ST-segment elevation myocardial infarction, 105 708 [21.1%]; high-risk unstable angina, 146 464 [29.3%]), and 144 737 (28.9%) for nonacute indications. For acute indications, 350 469 PCIs (98.6%) were classified as appropriate, 1055 (0.3%) as uncertain, and 3893 (1.1%) as inappropriate. For nonacute indications, 72 911 PCIs (50.4%) were classified as appropriate, 54 988 (38.0%) as uncertain, and 16 838 (11.6%) as inappropriate. The majority of inappropriate PCIs for nonacute indications were performed in patients with no angina (53.8%), low-risk ischemia on noninvasive stress testing (71.6%), or suboptimal (<= 1 medication) antianginal therapy (95.8%). Furthermore, although variation in the proportion of inappropriate PCI across hospitals was minimal for acute procedures, there was substantial hospital variation for nonacute procedures (median hospital rate for inappropriate PCI, 10.8%; interquartile range, 6.0%-16.7%). Conclusions In this large contemporary US cohort, nearly all acute PCIs were classified as appropriate. For nonacute indications, however, 12% were classified as inappropriate, with substantial variation across hospitals.	[Klein, Lloyd W.] Med Ctr, Chicago, IL USA; [Krone, Ronald J.] Washington Univ, Sch Med, St Louis, MO USA; [Dehmer, Gregory J.] Texas A&M Coll Med, Scott & White Healthcare, Temple, TX USA; [Nallamothu, Brahmajee K.] Vet Affairs Ann Arbor Hlth Serv Res, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Dev Ctr Excellence, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Weaver, W. Douglas] Henry Ford Hosp, Detroit, MI 48202 USA; [Masoudi, Frederick A.] Univ Colorado Denver, Aurora, CO USA; [Rumsfeld, John S.] Denver Vet Adm, Med Ctr, Denver, CO USA; [Brindis, Ralph G.] No Calif Kaiser Permanente, Oakland, CA USA; [Brindis, Ralph G.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Washington University (WUSTL); Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; Henry Ford Health System; Henry Ford Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Kaiser Permanente; University of California System; University of California San Francisco	Chan, PS (corresponding author), St Lukes Mid Amer Heart & Vasc Inst, 4401 Wornall Rd,5th Floor, Kansas City, MO 64111 USA.	pchan@cc-pc.com	Masoudi, Frederick/Q-7467-2019; Dehmer, Gregory/AAQ-9380-2021; Patel, Manesh/AAC-5385-2019; Spertus, John/ABD-3075-2021		National Heart, Lung, and Blood Institute (NHLBI) [K23HL102224]; American College of Cardiology (ACC); NCDR; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102224] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American College of Cardiology (ACC); NCDR; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Chan reported receiving support from a Career Development Grant Award (K23HL102224) from the National Heart, Lung, and Blood Institute (NHLBI) to examine the appropriateness of percutaneous coronary intervention in the United States. Dr Spertus reported having a contract from the American College of Cardiology (ACC) to analyze National Cardiovascular Data Registry (NCDR) data. Drs Brindis, Masoudi, and Rumsfeld reported receiving salary support from the ACC. No other authors reported disclosures.; The NCDR CathPCI Registry is an initiative of the ACC Foundation and the Society for Cardiovascular Angiography and Interventions. This study was supported by the NCDR.	Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Borden WB, 2011, JAMA-J AM MED ASSOC, V305, P1882, DOI 10.1001/jama.2011.601; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Cadet J, 2010, AHA ADJUSTS ANGIOPLA; Chan PS, 2011, J AM COLL CARDIOL, V57, P1546, DOI 10.1016/j.jacc.2010.10.050; Chan PS, 2009, ARCH INTERN MED, V169, P1265, DOI 10.1001/archinternmed.2009.196; Goldstein H., 2002, Understanding Statistics, V1, P223, DOI 10.1207/S15328031US0104_02; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Hannan EL, 2009, JACC-CARDIOVASC INTE, V2, P350, DOI 10.1016/j.jcin.2009.01.006; Hemingway H, 1999, J PUBLIC HEALTH MED, V21, P421, DOI 10.1093/pubmed/21.4.421; HILBORNE LH, 1993, JAMA-J AM MED ASSOC, V269, P761, DOI 10.1001/jama.269.6.761; Klein LW, 2009, J INVASIVE CARDIOL, V21, P558; Mahoney EM, 2010, CIRCULATION, V121, P71, DOI 10.1161/CIRCULATIONAHA.109.900704; Nallamothu BK, 2010, JAMA-J AM MED ASSOC, V304, P2059, DOI 10.1001/jama.2010.1509; Patel MR, 2009, J AM COLL CARDIOL, V53, P530, DOI 10.1016/j.jacc.2008.10.005; Rothberg MB, 2010, ANN INTERN MED, V153, P307, DOI 10.7326/0003-4819-153-5-201009070-00005; Weintraub WS, 1997, J AM COLL CARDIOL, V29, P459; Yim J, 2004, INT J CARDIOL, V95, P199, DOI 10.1016/j.ijcard.2003.03.028	18	282	294	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					53	61		10.1001/jama.2011.916	http://dx.doi.org/10.1001/jama.2011.916			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	21730241	Green Accepted			2022-12-28	WOS:000292378700020
J	Mortlock, DJ; Warren, SJ; Venemans, BP; Patel, M; Hewett, PC; McMahon, RG; Simpson, C; Theuns, T; Gonzales-Solares, EA; Adamson, A; Dye, S; Hambly, NC; Hirst, P; Irwin, MJ; Kuiper, E; Lawrence, A; Rottgering, HJA				Mortlock, Daniel J.; Warren, Stephen J.; Venemans, Bram P.; Patel, Mitesh; Hewett, Paul C.; McMahon, Richard G.; Simpson, Chris; Theuns, Tom; Gonzales-Solares, Eduardo A.; Adamson, Andy; Dye, Simon; Hambly, Nigel C.; Hirst, Paul; Irwin, Mike J.; Kuiper, Ernst; Lawrence, Andy; Rottgering, Huub J. A.			A luminous quasar at a redshift of z=7.085	NATURE			English	Article							DIGITAL SKY SURVEY; NEUTRAL HYDROGEN; BLACK-HOLES; Z-GREATER-THAN-6; REIONIZATION; Z-SIMILAR-TO-6; IONIZATION; DISCOVERY; EMISSION; UNIVERSE	The intergalactic medium was not completely reionized until approximately a billion years after the Big Bang, as revealed(1) by observations of quasars with redshifts of less than 6.5. It has been difficult to probe to higher redshifts, however, because quasars have historically been identified(2-4) in optical surveys, which are insensitive to sources at redshifts exceeding 6.5. Here we report observations of a quasar (ULASJ112001.48+064124.3) at a redshift of 7.085, which is 0.77 billion years after the Big Bang. ULASJ1120+0641 has a luminosity of 6.3 x 10(13)L(circle dot) and hosts a black hole with a mass of 2 x 10(9)M(circle dot) (where L(circle dot) and M(circle dot) are the luminosity and mass of the Sun). The measured radius of the ionized near zone around ULASJ1120+0641 is 1.9 megaparsecs, a factor of three smaller than is typical for quasars at redshifts between 6.0 and 6.4. The near-zone transmission profile is consistent with a Ly alpha d damping wing(5), suggesting that the neutral fraction of the intergalactic medium in front of ULASJ1120+0641 exceeded 0.1.	[Mortlock, Daniel J.; Warren, Stephen J.; Patel, Mitesh] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Astrophys Grp, London SW7 2AZ, England; [Venemans, Bram P.] European So Observ, D-85748 Garching, Germany; [Hewett, Paul C.; McMahon, Richard G.; Gonzales-Solares, Eduardo A.; Irwin, Mike J.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Simpson, Chris] Liverpool John Moores Univ, Astrophys Res Inst, Birkenhead CH41 1LD, Merseyside, England; [Theuns, Tom] Univ Durham, Inst Computat Cosmol, Dept Phys, Durham DH1 3LE, England; [Theuns, Tom] Univ Antwerp, B-2020 Antwerp, Belgium; [Adamson, Andy] Joint Astron Ctr, Hilo, HI 96720 USA; [Dye, Simon] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; [Hambly, Nigel C.; Lawrence, Andy] Univ Edinburgh, SUPA, Inst Astron, Royal Observ, Edinburgh EH9 3HJ, Midlothian, Scotland; [Hirst, Paul] Gemini Observ, Hilo, HI 96720 USA; [Kuiper, Ernst; Rottgering, Huub J. A.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands	Imperial College London; European Southern Observatory; University of Cambridge; Liverpool John Moores University; Durham University; University of Antwerp; University of Nottingham; University of Edinburgh; Leiden University; Leiden University - Excl LUMC	Mortlock, DJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Astrophys Grp, Prince Consort Rd, London SW7 2AZ, England.	mortlock@ic.ac.uk	Theuns, Tom/GXV-6618-2022; McMahon, Richard/G-4260-2012	Mortlock, Daniel/0000-0002-0041-3783; Theuns, Tom/0000-0002-3790-9520; McMahon, Richard/0000-0001-8447-8869; Dye, Simon/0000-0002-1318-8343; Warren, Stephen/0000-0003-1599-5402	University of London; STFC; Science and Technology Facilities Council [ST/H008519/1, ST/H004912/1, ST/H00243X/1, ST/H00047X/1, ST/G009465/1, PP/E001149/1, ST/F002289/1, ST/H004165/1, ST/H004211/1, ST/H001913/1, ST/H002391/1, ST/I001166/1, ST/I00162X/1, PP/C002229/1, ST/G001979/1, ST/G001901/1, ST/H000496/1, ST/H004157/1] Funding Source: researchfish; STFC [ST/H000496/1, ST/F002289/1, PP/E001149/1, ST/H004912/1, ST/G009465/1, ST/H004157/1, ST/H001913/1, ST/H002391/1, ST/H004165/1, ST/I001166/1, ST/H00047X/1, PP/C002229/1, ST/I00162X/1, ST/H008519/1, ST/G001979/1, ST/G001901/1, ST/H004211/1] Funding Source: UKRI	University of London; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	M.P. acknowledges support from the University of London's Perren Fund. P. C. H. and R.G.McM. acknowledge support from the STFC-funded Galaxy Formation and Evolution programme at the Institute of Astronomy. X. Fan and R. White supplied spectra of the SDSS quasars. M. Haehnelt provided insights into quasar near-zone physics. The staffs of the Joint Astronomy Centre, the Cambridge Astronomical Survey Unit and the Wide-Field Astronomy Unit, Edinburgh, all made vital contributions to the UKIDSS project. The support staff at the Gemini North Telescope, particularly K. Roth, provided assistance with the Gemini observations. This work is based in part on data obtained from UKIDSS, SDSS, the Liverpool Telescope, the Isaac Newton Telescope, the Gemini Observatory and the European Southern Observatory.	BECKER RH, 1995, ASTROPHYS J, V450, P559, DOI 10.1086/176166; Bolton JS, 2007, MON NOT R ASTRON SOC, V374, P493, DOI 10.1111/j.1365-2966.2006.11176.x; CALVERLEY AP, 2010, MON NOT R ASTRON SOC, V420, P1; Carilli CL, 2010, ASTROPHYS J, V714, P834, DOI 10.1088/0004-637X/714/1/834; Dunkley J, 2009, ASTROPHYS J SUPPL S, V180, P306, DOI 10.1088/0067-0049/180/2/306; Fan XH, 2001, ASTRON J, V122, P2833, DOI 10.1086/324111; Fan XH, 2003, ASTRON J, V125, P1649, DOI 10.1086/368246; Fan XH, 2006, ASTRON J, V132, P117, DOI 10.1086/504836; GUNN JE, 1965, ASTROPHYS J, V142, P1633, DOI 10.1086/148444; Haiman Z, 2002, ASTROPHYS J, V576, pL1, DOI 10.1086/343101; Haiman Z, 2010, AIP CONF PROC, V1294, P215, DOI 10.1063/1.3518857; Hewett PC, 2010, MON NOT R ASTRON SOC, V405, P2302, DOI 10.1111/j.1365-2966.2010.16648.x; Lawrence A, 2007, MON NOT R ASTRON SOC, V379, P1599, DOI 10.1111/j.1365-2966.2007.12040.x; Lehnert MD, 2010, NATURE, V467, P940, DOI 10.1038/nature09462; Miralda-Escude J, 1998, ASTROPHYS J, V501, P15, DOI 10.1086/305799; MORTLOCK DJ, MON NOT R A IN PRESS; Richards GT, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/5/167; Tanvir NR, 2009, NATURE, V461, P1254, DOI 10.1038/nature08459; Telfer RC, 2002, ASTROPHYS J, V565, P773, DOI 10.1086/324689; Vanzella E, 2011, ASTROPHYS J LETT, V730, DOI 10.1088/2041-8205/730/2/L35; Vestergaard M, 2009, ASTROPHYS J, V699, P800, DOI 10.1088/0004-637X/699/1/800; Volonteri M, 2006, ASTROPHYS J, V650, P669, DOI 10.1086/507444; White RL, 2003, ASTRON J, V126, P1, DOI 10.1086/375547; Willott CJ, 2007, ASTRON J, V134, P2435, DOI 10.1086/522962; Willott CJ, 2010, ASTRON J, V140, P546, DOI 10.1088/0004-6256/140/2/546; Willott CJ, 2010, ASTRON J, V139, P906, DOI 10.1088/0004-6256/139/3/906; Willott CJ, 2003, ASTROPHYS J, V587, pL15, DOI 10.1086/375126; Wyithe JSB, 2005, ASTROPHYS J, V628, P575, DOI 10.1086/430874; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513	30	1046	1052	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2011	474	7353					616	619		10.1038/nature10159	http://dx.doi.org/10.1038/nature10159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21720366	Green Submitted			2022-12-28	WOS:000292204300033
J	Wakabi, W				Wakabi, Wairagala			Profile Lul Riek: helping to improve public health in South Sudan	LANCET			English	Editorial Material																			0	1	1	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2011	377	9784					2171	2171		10.1016/S0140-6736(11)60949-5	http://dx.doi.org/10.1016/S0140-6736(11)60949-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	786XI	21704858	Bronze			2022-12-28	WOS:000292340800015
J	Mills, EJ; Bakanda, C; Birungi, J; Chan, K; Ford, N; Cooper, CL; Nachega, JB; Dybul, M; Hogg, RS				Mills, Edward J.; Bakanda, Celestin; Birungi, Josephine; Chan, Keith; Ford, Nathan; Cooper, Curtis L.; Nachega, Jean B.; Dybul, Mark; Hogg, Robert S.			Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda	ANNALS OF INTERNAL MEDICINE			English	Article							HIV-INFECTED INDIVIDUALS; SUB-SAHARAN AFRICA; FOLLOW-UP; IMMUNOLOGICAL OUTCOMES; SOUTHERN AFRICA; PATIENTS LOST; MEN MATTER; MORTALITY; CARE; TUBERCULOSIS	Background: Little is known about the effect of combination anti-retroviral therapy (cART) on life expectancy in sub-Saharan Africa. Objective: To estimate life expectancy of patients once they initiate cART in Uganda. Design: Prospective cohort study. Setting: Public sector HIV and AIDS disease-management program in Uganda. Patients: 22 315 eligible patients initiated cART during the study period, of whom 1943 were considered to have died. Measurements: All-cause mortality rates were calculated and abridged life tables were constructed and stratified by sex and baseline CD4 cell count status to estimate life expectancies for patients receiving cART. The average number of years remaining to be lived by patients who received cART at varying age categories was estimated. Results: After adjustment for loss to follow-up, crude mortality rates (deaths per 1000 person-years) ranged from 26.9 (95% CI, 25.4 to 28.5) in women to 43.9 (CI, 40.7 to 47.0) in men. For patients with a baseline CD4 cell count less than 0.050 X 10(9) cells/L, the mortality rate was 67.3 (CI, 62.1 to 72.9) deaths per 1000 person-years, whereas among persons with a baseline CD4 cell count of 0.250 X 10(9) cells/L or more, the mortality rate was 19.1 (CI, 16.0 to 22.7) deaths per 1000 person-years. Life expectancy at age 20 years for the overall cohort was 26.7 (CI, 25.0 to 28.4) additional years and at age 35 years was 27.9 (CI, 26.7 to 29.1) additional years. Life expectancy increased substantially with increasing baseline CD4 cell count. Similar trends are observed for older age groups. Limitations: A small (6.4%) proportion of patients were lost to follow-up, and it was imputed that 30% of these patients had died. Few patients with a CD4 cell count greater than 0.250 X 10(9) cells/L initiated cART. Conclusion: Ugandan patients receiving cART can expect an almost normal life expectancy, although there is considerable variability among subgroups of patients.	[Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6X1, Canada; AIDS Support Org, Kampala, Uganda; British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; Med Sans Frontieres, Geneva, Switzerland; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; Univ Stellenbosch, Cape Town, South Africa; Ottawa Hosp, Ottawa, ON, Canada; Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC USA	University of Ottawa; B.C. Centre for Excellence in HIV/AIDS; Doctors Without Borders; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cape Town; Stellenbosch University; University of Ottawa; Ottawa Hospital Research Institute; Simon Fraser University; Georgetown University	Mills, EJ (corresponding author), Univ Ottawa, Fac Hlth Sci, 43 Templeton, Ottawa, ON K1N 6X1, Canada.		Cooper, Curtis/M-9320-2019; Hogg, Robert S/B-2783-2012	Hogg, Robert S/0000-0003-3463-5488; Nachega, Jean/0000-0002-2862-4443	Canadian Institutes of Health Research; Canada Research Chair; National Institutes of Health; European Developing Country Clinical Trials Partnership	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Developing Country Clinical Trials Partnership	By the Canadian Institutes of Health Research. Dr. Mills is supported by a Canada Research Chair award. Dr. Nachega is supported by National Institutes of Health operating grants and the European Developing Country Clinical Trials Partnership Fellowship award. Dr. Hogg is a member of the Antiretroviral Cohort Collaboration, and he led the Antiretroviral Cohort Collaboration's high-income nation evaluation of life expectancy.	Allison P. D., 1995, SURVIVAL ANAL USING; Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; [Anonymous], 2011, WHO GLOB HLTH OBS 20; Bakanda C, 2011, INT J EPIDEMIOL; Bakanda C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019261; Bakanda C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016279; Bakanda C, 2011, AIDS, V25, P701, DOI 10.1097/QAD.0b013e3283437ed7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; CHIANG CL, 1972, J AM STAT ASSOC, V67, P538, DOI 10.2307/2284435; Chiang CL, 1968, LIFE TABLE ITS CONST, P189; Cooper CL, 2009, INT J INFECT DIS, V13, P302, DOI 10.1016/j.ijid.2008.06.042; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Eayres D, 2004, J EPIDEMIOL COMMUN H, V58, P243, DOI 10.1136/jech.2003.009654; Fang CT, 2007, QJM-INT J MED, V100, P97, DOI 10.1093/qjmed/hcl141; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Harries AD, 2006, LANCET, V367, P1817, DOI 10.1016/S0140-6736(06)68799-0; Hecht R, 2006, PLOS MED, V3, P1992, DOI 10.1371/journal.pmed.0030455; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Katabira Elly T., 2009, NATL ANTIRETROVIRAL; Kiboneka A, 2008, AIDS, V22, P2493, DOI 10.1097/QAD.0b013e328318f148; Kiboneka A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b201; Kuwane B, 2009, LANCET, V374, P1329, DOI 10.1016/S0140-6736(09)61823-7; Leisegang R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000189; Lima VD, 2007, AIDS, V21, P685, DOI 10.1097/QAD.0b013e32802ef30c; Madhavan S, 2009, POP STUD-J DEMOG, V63, P37, DOI 10.1080/00324720802592784; McGuire AL, 2005, HIV MED, V6, P57, DOI 10.1111/j.1468-1293.2005.00266.x; Mills EJ, 2011, AIDS, V25, P851, DOI 10.1097/QAD.0b013e32834564e9; Mills EJ, 2009, LANCET, V374, P275, DOI 10.1016/S0140-6736(09)61348-9; Muga R, 2007, AIDS, V21, P2521, DOI 10.1097/QAD.0b013e3282f1c933; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Mugyenyi P, 2009, LANCET, V374, P292, DOI 10.1016/S0140-6736(09)61365-9; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Rawat R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-316; ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143; Rosen S, 2007, PLOS MED, V8, P267; Tam LWY, 2007, HIV MED, V8, P267, DOI 10.1111/j.1468-1293.2007.00463.x; WHO, WHO ANT THER HIV INF; Williams T, 2011, CALCULATING LIFE EXP	43	297	306	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4					209	+		10.7326/0003-4819-155-4-201108160-00358	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-00358			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807KN	21768555				2022-12-28	WOS:000293896400001
J	Caiazzo, M; Dell'Anno, MT; Dvoretskova, E; Lazarevic, D; Taverna, S; Leo, D; Sotnikova, TD; Menegon, A; Roncaglia, P; Colciago, G; Russo, G; Carninci, P; Pezzoli, G; Gainetdinov, RR; Gustincich, S; Dityatev, A; Broccoli, V				Caiazzo, Massimiliano; Dell'Anno, Maria Teresa; Dvoretskova, Elena; Lazarevic, Dejan; Taverna, Stefano; Leo, Damiana; Sotnikova, Tatyana D.; Menegon, Andrea; Roncaglia, Paola; Colciago, Giorgia; Russo, Giovanni; Carninci, Piero; Pezzoli, Gianni; Gainetdinov, Raul R.; Gustincich, Stefano; Dityatev, Alexander; Broccoli, Vania			Direct generation of functional dopaminergic neurons from mouse and human fibroblasts	NATURE			English	Article							EMBRYONIC STEM-CELLS; EXPRESSION; TRANSPLANTATION	Transplantation of dopaminergic neurons can potentially improve the clinical outcome of Parkinson's disease, a neurological disorder resulting from degeneration of mesencephalic dopaminergic neurons(1,2). In particular, transplantation of embryonic-stem-cell-derived dopaminergic neurons has been shown to be efficient in restoring motor symptoms in conditions of dopamine deficiency(3,4). However, the use of pluripotent-derived cells might lead to the development of tumours if not properly controlled(5). Here we identified a minimal set of three transcription factors-Mash1 (also known as Ascl1), Nurr1 (also known as Nr4a2) and Lmx1a-that are able to generate directly functional dopaminergic neurons from mouse and human fibroblasts without reverting to a progenitor cell stage. Induced dopaminergic (iDA) cells release dopamine and show spontaneous electrical activity organized in regular spikes consistent with the pacemaker activity featured by brain dopaminergic neurons. The three factors were able to elicit dopaminergic neuronal conversion in prenatal and adult fibroblasts from healthy donors and Parkinson's disease patients. Direct generation of iDA cells from somatic cells might have significant implications for understanding critical processes for neuronal development, in vitro disease modelling and cell replacement therapies.	[Caiazzo, Massimiliano; Dell'Anno, Maria Teresa; Colciago, Giorgia; Broccoli, Vania] Ist Sci San Raffaele, Stem Cells & Neurogenesis Unit, Div Neurosci, I-20132 Milan, Italy; [Dvoretskova, Elena; Taverna, Stefano; Leo, Damiana; Sotnikova, Tatyana D.; Russo, Giovanni; Pezzoli, Gianni; Gainetdinov, Raul R.; Dityatev, Alexander] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy; [Lazarevic, Dejan] CBM Srl, I-34149 Trieste, Italy; [Lazarevic, Dejan; Roncaglia, Paola; Gustincich, Stefano] Int Sch Adv Studies SISSA, Neurobiol Sect, I-34136 Trieste, Italy; [Menegon, Andrea] Ist Sci San Raffaele, Expt Imaging Ctr, Adv Light & Electron Microscopy Bioimaging Ctr, I-20132 Milan, Italy; [Carninci, Piero] RIKEN Yokohama Inst, Omics Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; [Pezzoli, Gianni] Ist Clin Perfezionamento, Parkinson Inst, I-20126 Milan, Italy; [Gustincich, Stefano] Giovanni Armenise Harvard Fdn Lab, I-34136 Trieste, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Istituto Italiano di Tecnologia - IIT; International School for Advanced Studies (SISSA); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; RIKEN	Broccoli, V (corresponding author), Ist Sci San Raffaele, Stem Cells & Neurogenesis Unit, Div Neurosci, I-20132 Milan, Italy.	broccoli.vania@hsr.it	Broccoli, Vania/K-3464-2016; Gainetdinov, Raul R/G-5875-2011; Taverna, Stefano/AAN-1938-2020; menegon, andrea/AAN-3736-2020; Lazarevic, Dejan/AAN-1861-2020; Dityatev, Alexander/A-4034-2008; Carninci, Piero/K-1568-2014; Sotnikova, Tatyana D/T-9992-2017; Colciago, Giorgia/AAN-2698-2020; Caiazzo, Massimiliano/C-1722-2016	Broccoli, Vania/0000-0003-4050-0926; Gainetdinov, Raul R/0000-0003-2951-6038; Taverna, Stefano/0000-0003-1871-8662; menegon, andrea/0000-0002-2396-756X; Dityatev, Alexander/0000-0002-0472-0553; Carninci, Piero/0000-0001-7202-7243; Colciago, Giorgia/0000-0003-0476-8861; Caiazzo, Massimiliano/0000-0002-8975-3257; Gustincich, Stefano/0000-0002-2749-2514; lazarevic, dejan/0000-0003-4527-290X; Leo, Damiana/0000-0001-9219-5498; Roncaglia, Paola/0000-0002-2825-0621; Dell'Anno, Maria Teresa/0000-0003-1825-671X; Pezzoli, Gianni/0000-0003-4665-6710	Fondazione Grigioni per il Morbo di Parkinson [FGBRCVNI10310-001-V.B.]; Eranet Neuron; Cariplo Foundation; Ministry of Health; Italian Institute of Technology; Fondazione Telethon Funding Source: Custom	Fondazione Grigioni per il Morbo di Parkinson; Eranet Neuron; Cariplo Foundation(Fondazione Cariplo); Ministry of Health; Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); Fondazione Telethon(Fondazione Telethon)	We are thankful to D. Bonanomi, S.-L. Ang, S. El Mestikawy, M. P. Smidt, M. German and F. Valtorta for providing valuable antibodies. We thank A. Sessa and V. B. laboratory members for helpful discussion. M. Wernig is acknowledged for providing the iN-inducing lentiviral vectors. We are thankful to S. Nicolis for sharing Sox2<SUP>beta-geo</SUP> mice. L. Muzio, C. Laterza and G. Martino are acknowledged for the generation of Sox2<SUP>beta-geo</SUP> induced pluripotent stem cells. M. Bacigaluppi is acknowledged for advice on stereological countings. We thank the "Cell Line and DNA Biobank" (G. Gaslini Institute) and "Human Genetic Bank of Patients affected by Parkinson Disease and parkinsonism" (Parkinson Institute of Milan) of the Telethon Genetic Biobank Network for human fibroblast samples. This study was supported by the "Fondazione Grigioni per il Morbo di Parkinson" (grant no. FGBRCVNI10310-001-V.B.), Eranet Neuron (V. B.), Cariplo Foundation (V. B.), Ministry of Health (Giovani ricercatori Award) (V. B.) and Italian Institute of Technology (V.B., A.D., S.G., T.S., R.G.).	Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Ang SL, 2006, DEVELOPMENT, V133, P3499, DOI 10.1242/dev.02501; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; Broccoli V, 1999, NATURE, V401, P164, DOI 10.1038/43670; Colasante G, 2008, J NEUROSCI, V28, P10674, DOI 10.1523/JNEUROSCI.1283-08.2008; GRACE AA, 1984, J NEUROSCI, V4, P2866; GRACE AA, 1989, J NEUROSCI, V9, P3463; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Lindvall Olle, 2004, NeuroRx, V1, P382; Menegon A, 2006, J NEUROSCI, V26, P11670, DOI 10.1523/JNEUROSCI.3321-06.2006; Mundroff M. L., 2002, CURR PROTOC NEUROSCI; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Perlmann T, 2004, CELL TISSUE RES, V318, P45, DOI 10.1007/s00441-004-0974-7; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Politis M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000976; Pothos E, 1996, J NEUROCHEM, V66, P629; Pothos EN, 1998, J NEUROSCI, V18, P4106; Pruszak J., 2009, CURR PROTOC STEM CEL; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Simeone A, 2005, TRENDS NEUROSCI, V28, P62, DOI 10.1016/j.tins.2004.11.007; Sironi F, 2008, PARKINSONISM RELAT D, V14, P326, DOI 10.1016/j.parkreldis.2007.10.003; Sironi F, 2010, PARKINSONISM RELAT D, V16, P228, DOI 10.1016/j.parkreldis.2009.09.008; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Staal RGW, 2004, NAT NEUROSCI, V7, P341, DOI 10.1038/nn1205; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Zappone MV, 2000, DEVELOPMENT, V127, P2367	36	731	775	4	196	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2011	476	7359					224	U151		10.1038/nature10284	http://dx.doi.org/10.1038/nature10284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21725324				2022-12-28	WOS:000293731900040
J	Libman, H				Libman, Howard			Screening for HIV Infection A Healthy, "Low-Risk" 42-Year-Old Man	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; UNITED-STATES; CARE SETTINGS; COST-EFFECTIVENESS; HETEROSEXUAL TRANSMISSION; MEDICINE ASSOCIATION; CLINICAL-OUTCOMES; TYPE-1 INFECTION; PERSONS AWARE	Human immunodeficiency virus (HIV) infection meets many, if not all, of the established criteria that justify routine screening, and screening for HIV infection can be cost-effective depending on the population studied. In 2006, the Centers for Disease Control and Prevention recommended that HIV screening be included as part of routine care for most of the adult US population, but implementation of this policy has been slow. Mr Y is a 42-year-old man at relatively low risk of HIV infection who was offered testing by his primary care physician but declined it. He does not consider HIV infection to be a realistic possibility given his behavioral history and does not understand the purpose of being tested. The discussion that follows addresses the rationale for HIV screening, its potential benefits and risks, current testing options, and barriers to incorporating it into routine care. JAMA. 2011;306(6):637-644 www.jama.com	[Libman, Howard] Beth Israel Deaconess Med Ctr, Shapiro Clin Ctr, HIV Program Healthcare Associates, Boston, MA 02215 USA; [Libman, Howard] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Libman, H (corresponding author), Beth Israel Deaconess Med Ctr, Shapiro Clin Ctr, HIV Program Healthcare Associates, 330 Brookline Ave,Room 621A, Boston, MA 02215 USA.	hlibman@bidmc.harvard.edu						Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Anaya HD, 2008, J GEN INTERN MED, V23, P800, DOI 10.1007/s11606-008-0617-x; Bartlett JG, 2010, DIAGNOSTIC ASSAYS HI; Bartlett JG, 2008, JAMA-J AM MED ASSOC, V300, P945, DOI 10.1001/jama.300.8.945; Bashook PG, 2008, J GEN INTERN MED, V23, P367; Bernstein KT, 2008, ARCH INTERN MED, V168, P1458, DOI 10.1001/archinte.168.13.1458; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brooks L, 2009, SEX TRANSM DIS, V36, P127, DOI 10.1097/OLQ.0b013e318191701c; Burke RC, 2007, AIDS, V21, P1617, DOI 10.1097/QAD.0b013e32823f91ff; BUSCH MP, 1991, NEW ENGL J MED, V325, P1, DOI 10.1056/NEJM199107043250101; Campsmith ML, 2010, JAIDS-J ACQ IMM DEF, V53, P619, DOI 10.1097/QAI.0b013e3181bf1c45; Cassels S, 2009, AIDS, V23, P2497, DOI 10.1097/QAD.0b013e328330ed8a; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; *CDCP, 2009, DIAGN HIV INF AIDS U; Centers for Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P63; U.S. Public Health Service, 2001, MMWR Recomm Rep, V50, P1; Centers for Disease Control and Prevention, 2003, MMWR MORB MORTAL WKL, V52, P581; Centers for Disease Control and Prevention, 2009, RAP HIV TEST; Centers for Disease Control and Prevention, 2006, HIV TEST CHALL; Centers for Disease Control and Prevention, 2009, CONS REV GUID HIV CO; Centers for Disease Control and Prevention, ACT AIDS COMP; Centers for Disease Control (CDC), 1990, MMWR Morb Mortal Wkly Rep, V39, P380; Chou R, 2005, ANN INTERN MED, V143, P55, DOI 10.7326/0003-4819-143-1-200507050-00010; DEVINCENZI I, 1992, BRIT MED J, V304, P809; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Epstein RM, 1998, ANN INTERN MED, V128, P435, DOI 10.7326/0003-4819-128-6-199803150-00003; FARZADEGAN H, 1993, J INFECT DIS, V168, P327, DOI 10.1093/infdis/168.2.327; Frank AP, 1997, ARCH INTERN MED, V157, P309, DOI 10.1001/archinte.157.3.309; Gatty B, 2010, HIV SPECIALIST   SPR; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; HIV Prevention Trials Network, 2011, IN ANT TREATM PROT U; Holigrave DR, 2007, JAIDS-J ACQ IMM DEF, V44, P360, DOI 10.1097/QAI.0b013e31802ea4dd; Holtgrave DR, 2004, INT J STD AIDS, V15, P789, DOI 10.1258/0956462042563639; Home Access Health Corporation, HOM ACC HIV 1 TEST S; Johnson A. Satcher, 2010, Morbidity and Mortality Weekly Report, V59, P1550; Kaiser Family Foundation, 2006, SURV AM HIV AIDS; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Korthuis PT, 2011, AIDS EDUC PREV, V23, P70, DOI 10.1521/aeap.2011.23.3_supp.70; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; Mahajan AP, 2009, ANN INTERN MED, V150, P263, DOI 10.7326/0003-4819-150-4-200902170-00007; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Martin CA, 2002, CLIN DIAGN LAB IMMUN, V9, P187, DOI 10.1128/CDLI.9.1.187-189.2002; Mckinstry LA, 2007, SEX TRANSM DIS, V34, P796, DOI 10.1097/01.olq.000261726.56859.5a; National HIV/AIDS Clinicians' Consultation Center, 2011, COMP HIV STAT TEST L; Ostermann J, 2007, ARCH INTERN MED, V167, P2128, DOI 10.1001/archinte.167.19.2128; Paddock C, 2008, CDC RECOMMENDATIONS; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Qaseem A, 2009, ANN INTERN MED, V150, P125, DOI 10.7326/0003-4819-150-2-200901200-00300; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sanders GD, 2008, ANN INTERN MED, V148, P889, DOI 10.7326/0003-4819-148-12-200806170-00002; Siegel M, 2010, JAIDS-J ACQ IMM DEF, V55, P205, DOI 10.1097/QAI.0b013e3181e15bf4; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Sontag S., 1989, AIDS ITS METAPHORS; U.S. Preventive Services Task Force, 2005, SCREEN HIV; US Department of Health and Human Services, 2011, GUID US ANT AG HIV 1; US Department of Justice, QUEST ANSW ADA PERS; US Food and Drug Administration, 2010, ABB ARCH HIV AG AB C; US Food and Drug Administration, 2010, INSTI HIV 1 ANT TEST; Varghese B, 2002, SEX TRANSM DIS, V29, P38, DOI 10.1097/00007435-200201000-00007; Watensky RP, 2005, AM J MED, V118, P292, DOI 10.1016/j.amjmed.2004.07.055; Wenrich MD, 1997, J GEN INTERN MED, V12, P107, DOI 10.1046/j.1525-1497.1997.00015.x; West-Ojo T., 2010, Morbidity and Mortality Weekly Report, V59, P737; Wilson DP, 2010, SEX TRANSM DIS, V37, P13, DOI 10.1097/OLQ.0b013e3181b35549; World Health Organization, 1968, PRINC PRACT SCREEN D; World Health Organization, 2007, GUID PROV IN HIV TES; Zetola NM, 2007, JAMA-J AM MED ASSOC, V297, P1061, DOI 10.1001/jama.297.10.1061	71	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 10	2011	306	6					637	644		10.1001/jama.2011.1016	http://dx.doi.org/10.1001/jama.2011.1016			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	804XD	21730228				2022-12-28	WOS:000293687300025
J	Choi, JS; Kim, JS; Byun, IS; Lee, DH; Lee, MJ; Park, BH; Lee, C; Yoon, D; Cheong, H; Lee, KH; Son, YW; Park, JY; Salmeron, M				Choi, Jin Sik; Kim, Jin-Soo; Byun, Ik-Su; Lee, Duk Hyun; Lee, Mi Jung; Park, Bae Ho; Lee, Changgu; Yoon, Duhee; Cheong, Hyeonsik; Lee, Ki Ho; Son, Young-Woo; Park, Jeong Young; Salmeron, Miquel			Friction Anisotropy-Driven Domain Imaging on Exfoliated Monolayer Graphene	SCIENCE			English	Article								Graphene produced by exfoliation has not been able to provide an ideal graphene with performance comparable to that predicted by theory, and structural and/or electronic defects have been proposed as one cause of reduced performance. We report the observation of domains on exfoliated monolayer graphene that differ by their friction characteristics, as measured by friction force microscopy. Angle-dependent scanning revealed friction anisotropy with a periodicity of 180 on each friction domain. The friction anisotropy decreased as the applied load increased. We propose that the domains arise from ripple distortions that give rise to anisotropic friction in each domain as a result of the anisotropic puckering of the graphene.	[Choi, Jin Sik; Kim, Jin-Soo; Byun, Ik-Su; Lee, Duk Hyun; Lee, Mi Jung; Park, Bae Ho] Konkuk Univ, Div Quantum Phases & Devices, Dept Phys, Seoul 143701, South Korea; [Lee, Changgu] Sungkyunkwan Univ, Dept Mech Engn, Suwon 440746, South Korea; [Yoon, Duhee; Cheong, Hyeonsik] Sogang Univ, Dept Phys, Seoul 121742, South Korea; [Lee, Ki Ho; Son, Young-Woo] Korea Inst Adv Study, Seoul 130722, South Korea; [Park, Jeong Young] Korea Adv Inst Sci & Technol, Grad Sch Energy Environm Water & Sustainabil, NanoCentury KI, Taejon 305701, South Korea; [Salmeron, Miquel] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	Konkuk University; Sungkyunkwan University (SKKU); Sogang University; Korea Institute for Advanced Study (KIAS); Korea Advanced Institute of Science & Technology (KAIST); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Park, BH (corresponding author), Konkuk Univ, Div Quantum Phases & Devices, Dept Phys, Seoul 143701, South Korea.	baehpark@konkuk.ac.kr; jeongypark@kaist.ac.kr	son, Young-Woo/B-2566-2010; Park, Jeong Young/A-2999-2008; Park, Bae Ho/D-4840-2011; Cheong, Hyeonsik/D-7424-2012	Park, Jeong Young/0000-0002-8132-3076; Yoon, Duhee/0000-0002-9328-4350; Choi, Jin Sik/0000-0003-3027-5665; Cheong, Hyeonsik/0000-0002-2347-4044; Lee, Ki-Ho/0000-0003-3549-631X; Park, Bae Ho/0000-0003-0928-329X	Ministry of Education, Science, and Technology (National Research Laboratory) [2008-0060004]; Ministry of Education, Science, and Technology (World Class University) [R31-2008-000-10057-0, R31-2008-000-10055-0]; Ministry of Education, Science, and Technology [KRF-2008-314-C00111, KRF-2010-0005390, 2010-0015035, 2011-0014209, 2011-0017605]; Ministry of Education, Science, and Technology (Quantum Metamaterials Research Center) [R11-2008-053-03002-0]; Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, U.S. Department of Energy [DE-AC02-05CH11231]; Seoul Scholarship Foundation	Ministry of Education, Science, and Technology (National Research Laboratory)(Korea Science and Engineering FoundationMinistry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education, Science, and Technology (World Class University)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education, Science, and Technology (Quantum Metamaterials Research Center)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, U.S. Department of Energy(United States Department of Energy (DOE)); Seoul Scholarship Foundation	Supported by the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (National Research Laboratory program grant 2008-0060004; World Class University program grants R31-2008-000-10057-0 and R31-2008-000-10055-0; Basic Science Research program grants KRF-2008-314-C00111, KRF-2010-0005390, 2010-0015035, 2011-0014209, and 2011-0017605; and Quantum Metamaterials Research Center grant R11-2008-053-03002-0). M. B. S. was supported by the Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, U.S. Department of Energy, under contract DE-AC02-05CH11231. J.S.C. was supported by a Hi Seoul Science/Humanities Fellowship from the Seoul Scholarship Foundation.	Bao WZ, 2009, NAT NANOTECHNOL, V4, P562, DOI [10.1038/nnano.2009.191, 10.1038/NNANO.2009.191]; Carpick RW, 1999, TRIBOL LETT, V7, P79, DOI 10.1023/A:1019113218650; Dienwiebel M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126101; Fasolino A, 2007, NAT MATER, V6, P858, DOI 10.1038/nmat2011; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Filleter T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.086102; Grierson DS, 2005, J ADHES SCI TECHNOL, V19, P291, DOI 10.1163/1568561054352685; Hashimoto A, 2004, NATURE, V430, P870, DOI 10.1038/nature02817; Huang PY, 2011, NATURE, V469, P389, DOI 10.1038/nature09718; Lee C, 2010, SCIENCE, V328, P76, DOI 10.1126/science.1184167; Lee C, 2009, PHYS STATUS SOLIDI B, V246, P2562, DOI 10.1002/pssb.200982329; Lee H, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/32/325701; Liley M, 1998, SCIENCE, V280, P273, DOI 10.1126/science.280.5361.273; Lui CH, 2009, NATURE, V462, P339, DOI 10.1038/nature08569; Min K, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3534787; Morozov SV, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.016801; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Park JY, 2006, SCIENCE, V313, P186, DOI 10.1126/science.1125017; Park JY, 2005, SCIENCE, V309, P1354, DOI 10.1126/science.1113239; Sakhaee-Pour A, 2009, SOLID STATE COMMUN, V149, P91, DOI 10.1016/j.ssc.2008.09.050; Xu K, 2009, NANO LETT, V9, P4446, DOI 10.1021/nl902729p	21	243	250	10	312	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					607	610		10.1126/science.1207110	http://dx.doi.org/10.1126/science.1207110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21719640				2022-12-28	WOS:000293222400055
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING The pros and cons of generic drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@rti.org	Mendoza, Elvia/A-9361-2012	Kamerow, Douglas/0000-0001-7000-9957				Briesacher BA, 2009, AM J MANAG CARE, V15, P450; Emery J, 2010, BMJ; Ferner RE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2548; Greene JA, 2011, NEW ENGL J MED, V365, P83, DOI 10.1056/NEJMhle1101722; Hellier Elizabeth, 2010, J Patient Saf, V6, P158; Kaiser Family Foundation, 2010, US HLTH CAR COSTS; Mishori R, 2011, WASHINGTON POST 0712, pE1; Shrank WH, 2011, AM J MED, V124, P309, DOI 10.1016/j.amjmed.2010.11.020; Tanne JH, 2003, BRIT MED J, V327, P565, DOI 10.1136/bmj.327.7414.565	9	5	5	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 20	2011	343								d4584	10.1136/bmj.d4584	http://dx.doi.org/10.1136/bmj.d4584			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	797ZH	21775394				2022-12-28	WOS:000293168700009
J	Sokol, DK				Sokol, Daniel K.			ETHICS MAN The medical ethics of the battlefield	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Sokol, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	daniel.sokol@talk21.com						CHARLTON J, 1990, MILITARY QUOTATION B, P144; Kondro W, 2007, CAN MED ASSOC J, V177, P134, DOI 10.1503/cmaj.070852; PATTERSON K, TALK ME MY FATHER FR; US Department of Defence, 2004, EM WAR SURG	4	9	9	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 20	2011	343								d3877	10.1136/bmj.d3877	http://dx.doi.org/10.1136/bmj.d3877			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	797ZH	21775391				2022-12-28	WOS:000293168700002
J	Schouten, EJ; Jahn, A; Midiani, D; Makombe, SD; Mnthambala, A; Chirwa, Z; Harries, AD; van Oosterhout, JJ; Meguid, T; Ben-Smith, A; Zachariah, R; Lynen, L; Zolfo, M; Van Damme, W; Gilks, CF; Atun, R; Shawa, M; Chimbwandira, F				Schouten, Erik J.; Jahn, Andreas; Midiani, Dalitso; Makombe, Simon D.; Mnthambala, Austin; Chirwa, Zengani; Harries, Anthony D.; van Oosterhout, Joep J.; Meguid, Tarek; Ben-Smith, Anne; Zachariah, Rony; Lynen, Lutgarde; Zolfo, Maria; Van Damme, Wim; Gilks, Charles F.; Atun, Rifat; Shawa, Mary; Chimbwandira, Frank			Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; INITIATION; SETTINGS; AFRICA; COHORT		[Schouten, Erik J.; Jahn, Andreas; Midiani, Dalitso; Makombe, Simon D.; Mnthambala, Austin; Chirwa, Zengani; Chimbwandira, Frank] Minist Hlth, Dept HIV & AIDS, Lilongwe, Malawi; [Schouten, Erik J.] Management Sci Hlth, Lilongwe, Malawi; [Jahn, Andreas; Chirwa, Zengani] ITECH Malawi, Seattle, WA USA; [Jahn, Andreas; Chirwa, Zengani] Univ Washington, Seattle, WA 98195 USA; [Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London WC1, England; [van Oosterhout, Joep J.] Coll Med, Blantyre, Malawi; [Meguid, Tarek] Kamuzu Cent Hosp, Lilongwe, Malawi; [Ben-Smith, Anne] Maame Akua, Lilongwe, Malawi; [Zachariah, Rony] Med Sans Frontieres Operat Res Unit, Luxembourg, Luxembourg; [Lynen, Lutgarde; Zolfo, Maria; Van Damme, Wim] Inst Trop Med, B-2000 Antwerp, Belgium; [Gilks, Charles F.] UNAIDS, New Delhi, India; [Gilks, Charles F.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Sch Business, London, England; [Atun, Rifat] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Shawa, Mary] Off President & Cabinet, Lilongwe, Malawi	University of Washington; University of Washington Seattle; University of London; London School of Hygiene & Tropical Medicine; University of Malawi; Institute of Tropical Medicine (ITM); Imperial College London; Imperial College London	Schouten, EJ (corresponding author), Minist Hlth, Dept HIV & AIDS, POB 30377, Lilongwe, Malawi.	eschouten@msh.org	Atun, Rifat/AAH-5537-2021; Lynen, Lutgarde/A-1212-2014; Jahn, Andreas/ABB-7796-2020; Gilks, Charles/B-4184-2012; Lynen, Lutgarde/AAT-9180-2020; Van Damme, Wim/F-7404-2011; Zolfo, Maria/B-9787-2015	Lynen, Lutgarde/0000-0001-7183-4895; Jahn, Andreas/0000-0003-4645-1600; Gilks, Charles/0000-0002-8953-3123; Lynen, Lutgarde/0000-0001-7183-4895; Van Damme, Wim/0000-0002-6344-3007; Zolfo, Maria/0000-0001-9756-9380; Atun, Rifat/0000-0002-1531-5983; zachariah, rony/0000-0002-2915-9328				[Anonymous], 2009, LANCET, V373, P1352; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Ford N, 2010, AIDS, V24, P1461, DOI 10.1097/QAD.0b013e32833a2a14; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hargrove JW, 2010, AIDS, V24, pF11, DOI 10.1097/QAD.0b013e328335749d; Harries AD, 2006, LANCET, V367, P1870, DOI 10.1016/S0140-6736(06)68809-0; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; *MIN HLTH HIV UN M, ANT THER; Mofenson LM, 2010, CLIN INFECT DIS, V50, pS130, DOI 10.1086/651484; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; National Statistics Office and ORC Macro, 2005, MAL DEM HLTH SURV 20; Sutcliffe S, 2002, JAIDS-J ACQ IMM DEF, V31, P90, DOI 10.1097/00126334-200209010-00012; *UNAIDS, 09 AIDS EP UPD NOV 2; W.H. Organization, 2009, WORLD HLTH STAT 2009; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization, 2010, UN ACC SCAL PRIOR HI; CAMPAIGN ACCESS ESSE	22	193	193	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 16	2011	378	9787					282	284		10.1016/S0140-6736(10)62303-3	http://dx.doi.org/10.1016/S0140-6736(10)62303-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798JD	21763940				2022-12-28	WOS:000293201100036
J	Heinz, J; Idsardi, W				Heinz, Jeffrey; Idsardi, William			Sentence and Word Complexity	SCIENCE			English	Editorial Material							NATURAL-LANGUAGE; PHONOTACTICS		[Heinz, Jeffrey] Univ Delaware, Dept Linguist & Cognit Sci, Newark, DE 19716 USA; [Idsardi, William] Univ Maryland, Dept Linguist, College Pk, MD 20742 USA; [Idsardi, William] Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA	University of Delaware; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Heinz, J (corresponding author), Univ Delaware, Dept Linguist & Cognit Sci, 42 E Delaware Ave, Newark, DE 19716 USA.	heinz@udel.edu		Heinz, Jeffrey/0000-0002-5954-3195; Idsardi, William/0000-0003-4461-2685	NIDCD NIH HHS [7R01DC005660-07] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005660] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Applegate R.B., 2007, SAMALA ENGLISH DICT; Becerra-Bonache L, 2010, THEOR COMPUT SCI, V411, P2741, DOI 10.1016/j.tcs.2010.04.009; Belta C, 2007, IEEE ROBOT AUTOM MAG, V14, P61, DOI 10.1109/MRA.2007.339624; Berwick RC, 2011, TRENDS COGN SCI, V15, P113, DOI 10.1016/j.tics.2011.01.002; Chater N, 2007, J MATH PSYCHOL, V51, P135, DOI 10.1016/j.jmp.2006.10.002; De la Higuera Colin, 2010, GRAMMATICAL INFERENC; Folia V, 2010, LANG LEARN, V60, P188, DOI 10.1111/j.1467-9922.2010.00606.x; Gallistel C. R., 1990, ORG LEARNING; Halle M., 1978, LINGUISTIC THEORY PS; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hayes B, 2008, LINGUIST INQ, V39, P379, DOI 10.1162/ling.2008.39.3.379; Heinz J, 2010, LINGUIST INQ, V41, P623, DOI 10.1162/LING_a_00015; Kaplan R. M., 1994, Computational Linguistics, V20, P331; Lappin, 2011, LINGUISTIC NATIVISM; Meltzoff AN, 2009, SCIENCE, V325, P284, DOI 10.1126/science.1175626; Nowak MA, 2002, NATURE, V417, P611, DOI 10.1038/nature00771; Rose S, 2004, LANGUAGE, V80, P475, DOI 10.1353/lan.2004.0144; Sellers WI, 2004, J ANAT, V204, P343, DOI 10.1111/j.0021-8782.2004.00294.x; SHIEBER SM, 1985, LINGUIST PHILOS, V8, P333, DOI 10.1007/BF00630917; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Vapnik V., 1998, STAT LEARNING THEORY	21	37	38	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					295	297		10.1126/science.1210358	http://dx.doi.org/10.1126/science.1210358			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	792HF	21764736				2022-12-28	WOS:000292732000027
J	Jiang, Y; Zhang, YN; Cao, JX; Wu, RQ; Ho, W				Jiang, Ying; Zhang, Y. N.; Cao, J. X.; Wu, R. Q.; Ho, W.			Real-Space Imaging of Kondo Screening in a Two-Dimensional O-2 Lattice	SCIENCE			English	Article							HIDDEN ORDER; URU2SI2; SCALE	Kondo lattice systems can exhibit unusual many-body behaviors that result from the interplay between onsite Kondo screening and intersite coupling. We used scanning tunneling microscopy to image the Kondo resonance in a nonconventional Kondo lattice formed by self-assembled oxygen (O-2) molecules, which are paramagnetic, on the gold reconstructed surface [Au(110)-1x2]. The interplay between the intermolecular coupling for molecules adsorbed along chains and the onsite Kondo effect leads to the coexistence of both local and nonlocal Kondo screening at the atomic level. The latter provides evidence for collective deconfinement of magnetization induced in Au, whereas the former shows local "hybridization" between the Kondo clouds of nearest-neighbor O-2 molecules.	[Jiang, Ying; Zhang, Y. N.; Cao, J. X.; Wu, R. Q.; Ho, W.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Jiang, Ying] Peking Univ, Int Ctr Quantum Mat, Beijing 100871, Peoples R China; [Cao, J. X.] Xiangtan Univ, Dept Phys, Xiangtan 411105, Hunan, Peoples R China; [Ho, W.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; Peking University; Xiangtan University; University of California System; University of California Irvine	Ho, W (corresponding author), Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA.	wilsonho@uci.edu	Wu, R.Q./AAD-1067-2021; Jiang, Ying/D-3626-2014; Cao, Juexian/C-7345-2015; ZHANG, YANNING/AAE-2893-2020; Wu, Ruqian/C-1395-2013; ZHANG, YANNING/A-3316-2013	Wu, R.Q./0000-0002-6156-7874; Jiang, Ying/0000-0002-6887-5503; ZHANG, YANNING/0000-0002-3839-2965; Wu, Ruqian/0000-0002-6156-7874; 	National Science Foundation [DMR-0606520]; Department of Energy [DE-FG02-05ER46237]; Peking University; National Science Foundation of China	National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Peking University(Peking University); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by the National Science Foundation under grant DMR-0606520 (W. H.) and the Department of Energy under grant DE-FG02-05ER46237 (R. W.). Y. J. acknowledges support by the 985 Program of Peking University and the National Science Foundation of China. DFT calculations were performed on supercomputers at the National Energy Research Scientific Computing Center. We thank D. L. Mills, J. M. Lawrence, and W. Ji for enlightening discussions. The authors declare no competing financial interests.	Aynajian P, 2010, P NATL ACAD SCI USA, V107, P10383, DOI 10.1073/pnas.1005892107; Burdin S, 2000, PHYS REV LETT, V85, P1048, DOI 10.1103/PhysRevLett.85.1048; Coqblin B, 2006, PHILOS MAG, V86, P2567, DOI 10.1080/14786430500229349; Cronenwett SM, 1998, SCIENCE, V281, P540, DOI 10.1126/science.281.5376.540; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Goldhaber-Gordon D, 1998, NATURE, V391, P156, DOI 10.1038/34373; Hewson A C, 1993, KONDO PROBLEM HEAVY; Knorr N, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.096804; KONDO J, 1964, PROG THEOR PHYS, V32, P37, DOI 10.1143/PTP.32.37; Lin CY, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.156102; Madhavan V, 1998, SCIENCE, V280, P567, DOI 10.1126/science.280.5363.567; Nakatsuji S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.016401; Nakatsuji S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.106402; Ong TT, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.066405; Parks JJ, 2010, SCIENCE, V328, P1370, DOI 10.1126/science.1186874; Pauling L., 1960, NATURE CHEM BOND; Plihal M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.085404; Pruschke T, 2000, PHYS REV B, V61, P12799, DOI 10.1103/PhysRevB.61.12799; SCHLOTTMANN P, 1993, ADV PHYS, V42, P641, DOI 10.1080/00018739300101534; Schmidt AR, 2010, NATURE, V465, P570, DOI 10.1038/nature09073; Shishido H, 2010, SCIENCE, V327, P980, DOI 10.1126/science.1183376; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Ternes M, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/5/053001; von Lohneysen H, 2007, REV MOD PHYS, V79, P1015, DOI 10.1103/RevModPhys.79.1015; Wahl P, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.056601; Wolfle P, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.246401; Yang YF, 2008, NATURE, V454, P611, DOI 10.1038/nature07157	27	40	40	3	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					324	328		10.1126/science.1205785	http://dx.doi.org/10.1126/science.1205785			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764744				2022-12-28	WOS:000292732000038
J	Wisnivesky, JP; Smith, CB; Packer, S; Strauss, GM; Lurslurchachai, L; Federman, A; Halm, EA				Wisnivesky, Juan P.; Smith, Cardinale B.; Packer, Stuart; Strauss, Gary M.; Lurslurchachai, Linda; Federman, Alex; Halm, Ethan A.			Survival and risk of adverse events in older patients receiving postoperative adjuvant chemotherapy for resected stages II-IIIA lung cancer: observational cohort study	BRITISH MEDICAL JOURNAL			English	Article							VINORELBINE PLUS CISPLATIN; SEER-MEDICARE DATA; RADIATION-THERAPY; ELDERLY-PATIENTS; COMORBIDITY INDEX; POOLED ANALYSIS; METAANALYSIS; CLAIMS; RADIOTHERAPY; ONCOLOGISTS	Objective To compare the survival and risk of serious adverse events in older patients with stages II-IIIA non-small cell lung cancer treated with or without postoperative platinum based chemotherapy. Design Observational cohort study. Setting Cases of lung cancer in Surveillance Epidemiology and End Results registry linked to Medicare files, 1992-2005, and follow-up data to December 2007. Participants 3324 patients aged more than 65 years with resected stages II-IIIA lung cancer. Main outcome measures Primary outcome was overall survival and secondary outcome was the rate of serious adverse events among older patients treated with or without adjuvant chemotherapy. Results Overall, 21% (n=684) of patients received platinum based chemotherapy. Analyses adjusted, stratified, or matched by propensity scores showed that chemotherapy was associated with improved survival (hazard ratio range 0.78-0.81). The beneficial effect of chemotherapy was also observed among patients treated with radiation therapy (0.75-0.77) or without radiation therapy (0.74-0.77); however, chemotherapy was not beneficial for patients aged 80 or more (1.32-1.46). Adjuvant chemotherapy was associated with an increased odds of serious adverse events (odds ratio 2.0, 95% confidence interval 1.5 to 2.6). Conclusions Platinum based adjuvant chemotherapy is associated with reduced mortality and increased risk of serious adverse events in older patients with stages II-IIIA lung cancer. The magnitude of the benefit is similar to that observed in randomised controlled trials carried out among selected patients.	[Wisnivesky, Juan P.; Lurslurchachai, Linda; Federman, Alex] Mt Sinai Sch Med, Div Gen Internal Med, New York, NY 10029 USA; [Wisnivesky, Juan P.] Mt Sinai Sch Med, Div Pulm Crit Care & Sleep Med, New York, NY 10029 USA; [Smith, Cardinale B.; Packer, Stuart] Mt Sinai Sch Med, Div Hematol Oncol, Tisch Canc Inst, New York, NY 10029 USA; [Smith, Cardinale B.] Mt Sinai Sch Med, Brookdale Dept Geriatr, Div Hertzberg Palliat Care Inst, New York, NY 10029 USA; [Strauss, Gary M.] Tufts Med Ctr, Div Med Oncol, Boston, MA USA; [Halm, Ethan A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Halm, Ethan A.] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Tufts Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wisnivesky, JP (corresponding author), Mt Sinai Sch Med, Div Gen Internal Med, 1 Gustave L Levy Pl,Box 1087, New York, NY 10029 USA.	juan.wisnivesky@mssm.edu			National Cancer Institute [R01CA131348-02]; GlaxoSmithKline;  [R01CA131348-03S1]; NATIONAL CANCER INSTITUTE [R01CA131348] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); GlaxoSmithKline(GlaxoSmithKline); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Cancer Institute (R01CA131348-02). The funding source had no role in the study design, implementation, or the interpretation of the results. CBS was supported in part by a research supplement to promote diversity in health related research programme award (R01CA131348-03S1).; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; JPW has relationships with EHE International (member of research board), Novartis Pharmaceutical (lecture honorarium), and GlaxoSmithKline (chronic obstructive lung disease research grant) that might have an interest in the submitted work in the previous three years; CBS, GMS, EAH, AF, LL, and SP have no other relationships or activities that could appear to have influenced the submitted work.	Ando M, 2001, BRIT J CANCER, V85, P1634, DOI 10.1054/bjoc.2001.2162; Auperin A, 2010, LANCET, V375, P1267, DOI 10.1016/S0140-6736(10)60059-1; Balmer CE, 2001, PSYCHO-ONCOL, V10, P410, DOI 10.1002/pon.538; Blagden SP, 2003, BRIT J CANCER, V89, P1022, DOI 10.1038/sj.bjc.6601231; Brailer DJ, 1996, MED CARE, V34, P490, DOI 10.1097/00005650-199605000-00010; Chu DT, 2007, LUNG CANCER, V56, P433, DOI 10.1016/j.lungcan.2007.01.028; Cooper GS, 2002, MED CARE, V40, P43; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Du XLL, 2002, J CLIN ONCOL, V20, P4636, DOI 10.1200/JCO.2002.05.088; Earle CC, 2001, J CLIN ONCOL, V19, P1064, DOI 10.1200/JCO.2001.19.4.1064; Earle CC, 2000, CHEST, V117, P1239, DOI 10.1378/chest.117.5.1239; Fruh M, 2008, J CLIN ONCOL, V26, P3573, DOI 10.1200/JCO.2008.16.2727; Gridelli C, 2005, CHEST, V128, P947, DOI 10.1378/chest.128.2.947; Hamada C, 2005, J CLIN ONCOL, V23, P4999, DOI 10.1200/JCO.2005.09.017; Hirose T, 2005, INTERNAL MED, V44, P107, DOI 10.2169/internalmedicine.44.107; Hotta K, 2004, J CLIN ONCOL, V22, P3860, DOI 10.1200/JCO.2004.01.153; IEZZONI LI, 1994, MED CARE, V32, P700, DOI 10.1097/00005650-199407000-00004; Kalish R L, 1995, Am J Med Qual, V10, P48, DOI 10.1177/0885713X9501000108; Kates M, 2011, CHEST, V139, P491, DOI 10.1378/chest.09-2547; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; Klabunde CN, 2006, MED CARE, V44, P921, DOI 10.1097/01.mlr.0000223480.52713.b9; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; List MA, 2004, HEAD NECK-J SCI SPEC, V26, P163, DOI 10.1002/hed.10367; Maas KW, 2007, CURR OPIN PULM MED, V13, P297, DOI 10.1097/MCP.0b013e32819f834a; Morgensztern D, 2010, J THORAC ONCOL, V5, P29, DOI 10.1097/JTO.0b013e3181c5920c; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; *NAT CANC I, 1973, SURV EP END RES SEER; Pepe C, 2007, J CLIN ONCOL, V25, P1553, DOI 10.1200/JCO.2006.09.5570; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Pisters KMW, 2007, J CLIN ONCOL, V25, P5506, DOI 10.1200/JCO.2007.14.1226; POTOSKY AL, 1993, MED CARE, V31, P732; Ries LAG, SEER CANC STAT REV 1; Scagliotti GV, 2003, JNCI-J NATL CANCER I, V95, P1453, DOI 10.1093/jnci/djg059; Sedrakyan A, 2004, J THORAC CARDIOV SUR, V128, P414, DOI 10.1016/j.jtcvs.2004.04.027; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Tsevat J, 1998, JAMA-J AM MED ASSOC, V279, P371, DOI 10.1001/jama.279.5.371; Virnig BA, 2002, MED CARE, V40, P49; Waller D, 2004, EUR J CARDIO-THORAC, V26, P173, DOI 10.1016/j.ejcts.2004.03.041; Warren JL, 2002, MED CARE, V40, P3; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Wisnivesky JP, 2004, CHEST, V126, P761, DOI 10.1378/chest.126.3.761; Wisnivesky JP, 2010, AM J RESP CRIT CARE, V181, P264, DOI 10.1164/rccm.200907-1064OC; Yancik R, 1997, CANCER, V80, P1273, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1273::AID-CNCR13>3.0.CO;2-4; Yang P, 2005, CHEST, V128, P452, DOI 10.1378/chest.128.1.452	49	60	68	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 14	2011	343								d4013	10.1136/bmj.d4013	http://dx.doi.org/10.1136/bmj.d4013			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794OF	21757436	Green Published, hybrid			2022-12-28	WOS:000292909000001
J	Xu, X; Pan, SK; Cheng, SF; Zhang, B; Mu, DS; Ni, PX; Zhang, GY; Yang, S; Li, RQ; Wang, J; Orjeda, G; Guzman, F; Torres, M; Lozano, R; Ponce, O; Martinez, D; De la Cruz, G; Chakrabarti, SK; Patil, VU; Skryabin, KG; Kuznetsov, BB; Ravin, NV; Kolganova, TV; Beletsky, AV; Mardanov, AV; Di Genova, A; Bolser, DM; Martin, DMA; Li, GC; Yang, Y; Kuang, HH; Hu, Q; Xiong, XY; Bishop, GJ; Sagredo, B; Mejia, N; Zagorski, W; Gromadka, R; Gawor, J; Szczesny, P; Huang, SW; Zhang, ZH; Liang, CB; He, J; Li, Y; He, Y; Xu, JF; Zhang, YJ; Xie, BY; Du, YC; Qu, DY; Bonierbale, M; Ghislain, M; Herrera, MD; Giuliano, G; Pietrella, M; Perrotta, G; Facella, P; O'Brien, K; Feingold, SE; Barreiro, LE; Massa, GA; Diambra, L; Whitty, BR; Vaillancourt, B; Lin, HN; Massa, A; Geoffroy, M; Lundback, S; DellaPenna, D; Buell, CR; Sharma, SK; Marshall, DF; Waugh, R; Bryan, GJ; Destefanis, M; Nagy, I; Milbourne, D; Thomson, SJ; Fiers, M; Jacobs, JME; Nielsen, KL; Sonderkaer, M; Iovene, M; Torres, GA; Jiang, JM; Veilleux, RE; Bachem, CWB; de Boer, J; Borm, T; Kloosterman, B; van Eck, H; Datema, E; Hekkert, BTL; Goverse, A; van Ham, RCHJ; Visser, RGF				Xu, Xun; Pan, Shengkai; Cheng, Shifeng; Zhang, Bo; Mu, Desheng; Ni, Peixiang; Zhang, Gengyun; Yang, Shuang; Li, Ruiqiang; Wang, Jun; Orjeda, Gisella; Guzman, Frank; Torres, Michael; Lozano, Roberto; Ponce, Olga; Martinez, Diana; De la Cruz, German; Chakrabarti, S. K.; Patil, Virupaksh U.; Skryabin, Konstantin G.; Kuznetsov, Boris B.; Ravin, Nikolai V.; Kolganova, Tatjana V.; Beletsky, Alexey V.; Mardanov, Andrei V.; Di Genova, Alex; Bolser, Daniel M.; Martin, David M. A.; Li, Guangcun; Yang, Yu; Kuang, Hanhui; Hu, Qun; Xiong, Xingyao; Bishop, Gerard J.; Sagredo, Boris; Mejia, Nilo; Zagorski, Wlodzimierz; Gromadka, Robert; Gawor, Jan; Szczesny, Pawel; Huang, Sanwen; Zhang, Zhonghua; Liang, Chunbo; He, Jun; Li, Ying; He, Ying; Xu, Jianfei; Zhang, Youjun; Xie, Binyan; Du, Yongchen; Qu, Dongyu; Bonierbale, Merideth; Ghislain, Marc; del Rosario Herrera, Maria; Giuliano, Giovanni; Pietrella, Marco; Perrotta, Gaetano; Facella, Paolo; O'Brien, Kimberly; Feingold, Sergio E.; Barreiro, Leandro E.; Massa, Gabriela A.; Diambra, Luis; Whitty, Brett R.; Vaillancourt, Brieanne; Lin, Haining; Massa, AliciaN.; Geoffroy, Michael; Lundback, Steven; DellaPenna, Dean; Buell, C. Robin; Sharma, Sanjeev Kumar; Marshall, David F.; Waugh, Robbie; Bryan, Glenn J.; Destefanis, Marialaura; Nagy, Istvan; Milbourne, Dan; Thomson, Susan J.; Fiers, Mark; Jacobs, Jeanne M. E.; Nielsen, Kare L.; Sonderkaer, Mads; Iovene, Marina; Torres, Giovana A.; Jiang, Jiming; Veilleux, Richard E.; Bachem, Christian W. B.; de Boer, Jan; Borm, Theo; Kloosterman, Bjorn; van Eck, Herman; Datema, Erwin; Hekkert, Bas Te Lintel; Goverse, Aska; van Ham, Roeland C. H. J.; Visser, Richard G. F.		Potato Genome Sequencing Consortiu	Genome sequence and analysis of the tuber crop potato	NATURE			English	Article							EUKARYOTIC GENOMES; RESISTANCE GENES; IN-VITRO; RNA-SEQ; SOLANUM; TOOL; IDENTIFICATION; ELEMENTS; REVEALS; MAIZE	Potato (Solanum tuberosum L.) is the world's most important non-grain food crop and is central to global food security. It is clonally propagated, highly heterozygous, autotetraploid, and suffers acute inbreeding depression. Here we use a homozygous doubled-monoploid potato clone to sequence and assemble 86% of the 844-megabase genome. We predict 39,031 protein-coding genes and present evidence for at least two genome duplication events indicative of a palaeopolyploid origin. As the first genome sequence of an asterid, the potato genome reveals 2,642 genes specific to this large angiosperm clade. We also sequenced a heterozygous diploid clone and show that gene presence/absence variants and other potentially deleterious mutations occur frequently and are a likely cause of inbreeding depression. Gene family expansion, tissue-specific expression and recruitment of genes to new pathways contributed to the evolution of tuber development. The potato genome sequence provides a platform for genetic improvement of this vital crop.	[Huang, Sanwen; Zhang, Zhonghua; Liang, Chunbo; He, Jun; Li, Ying; He, Ying; Xu, Jianfei; Zhang, Youjun; Xie, Binyan; Du, Yongchen; Qu, Dongyu] Chinese Acad Agr Sci, Key Lab Hort Crops Genet Improvement, Sino Dutch Joint Lab Hort Genom, Inst Vegetables & Flowers,Minist Agr, Beijing 100081, Peoples R China; [Xu, Xun; Pan, Shengkai; Cheng, Shifeng; Zhang, Bo; Mu, Desheng; Ni, Peixiang; Zhang, Gengyun; Yang, Shuang; Li, Ruiqiang; Wang, Jun] Chinese Minist Agr, Key Lab Genom, BGI Shenzhen, Shenzhen 518083, Peoples R China; [Orjeda, Gisella; Guzman, Frank; Torres, Michael; Lozano, Roberto; Ponce, Olga; Martinez, Diana; De la Cruz, German] Cayetano Heredia Univ, Genom Res Unit, Lima 13, Peru; [Orjeda, Gisella; Guzman, Frank; Torres, Michael; Lozano, Roberto; Ponce, Olga; Martinez, Diana; De la Cruz, German] San Cristobal Huamanga Univ, Biotechnol & Plant Genet Lab, Ayacucho, Peru; [Chakrabarti, S. K.; Patil, Virupaksh U.] Cent Potato Res Inst, Shimla 171001, Himachal Prades, India; [Skryabin, Konstantin G.; Kuznetsov, Boris B.; Ravin, Nikolai V.; Kolganova, Tatjana V.; Beletsky, Alexey V.; Mardanov, Andrei V.] Ctr Bioengn RAS, Moscow 117312, Russia; [Di Genova, Alex] Univ Chile, UMI CNRS 2807, Ctr Genome Regulat, CGR CMM, Santiago, Chile; [Di Genova, Alex] Univ Chile, UMI CNRS 2807, Ctr Math Modeling, Santiago, Chile; [Bolser, Daniel M.; Martin, David M. A.] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland; [Li, Guangcun; Yang, Yu] Shandong Acad Agr Sci, High Technol Res Ctr, Jinan 250100, Peoples R China; [Kuang, Hanhui; Hu, Qun] Huazhong Agr Univ, Minist Educ, Coll Hort & Forestry, Dept Vegetable Crops,Key Lab Hort Biol, Wuhan 430070, Peoples R China; [Xiong, Xingyao] Hunan Agr Univ, Coll Hort & Landscape, Changsha 410128, Hunan, Peoples R China; [Bishop, Gerard J.] Univ London Imperial Coll Sci Technol & Med, Div Biol, London SW7 1AZ, England; [Sagredo, Boris; Mejia, Nilo] Inst Invest Agropecuarias, Sector Los Choapinos, Rengo 2940000, Region Libertad, Chile; [Zagorski, Wlodzimierz; Gromadka, Robert; Gawor, Jan; Szczesny, Pawel] PAS, DNA Sequencing & Oligonucleotides Synth Lab, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Bonierbale, Merideth; Ghislain, Marc; del Rosario Herrera, Maria] Int Potato Ctr, Lima 12, Peru; [Giuliano, Giovanni; Pietrella, Marco; Perrotta, Gaetano; Facella, Paolo] Italian Natl Agcy New Technol, Energy & Sustainable Dev ENEA, Casaccia Res Ctr, I-00123 Rome, Italy; [Giuliano, Giovanni; Pietrella, Marco; Perrotta, Gaetano; Facella, Paolo] Trisaia Res Ctr, I-75026 Rotondella, Matera, Italy; [O'Brien, Kimberly] J Craig Venter Inst, Rockville, MD 20850 USA; [Feingold, Sergio E.; Barreiro, Leandro E.; Massa, Gabriela A.] INTA, Estn Expt Agropecuaria Balcarce, Lab Agrobiotecnol, RA-7620 Balcarce, Argentina; [Diambra, Luis] Univ Nacl LaPlata, CREG, Lab Biol Sistemas, RA-1888 La Plata, Argentina; [Vaillancourt, Brieanne; Lin, Haining; Massa, AliciaN.; Geoffroy, Michael; Lundback, Steven; DellaPenna, Dean; Buell, C. Robin] Michigan State Univ, E Lansing, MI 48824 USA; [Sharma, Sanjeev Kumar; Marshall, David F.; Waugh, Robbie; Bryan, Glenn J.] Scottish Crop Res Inst, Genet Programme, Dundee DD2 5DA, Scotland; [Destefanis, Marialaura; Nagy, Istvan; Milbourne, Dan] Teagasc Crops Res Ctr, Oak Pk, Carlow, Ireland; [Thomson, Susan J.; Fiers, Mark; Jacobs, Jeanne M. E.] New Zealand Inst Plant & Food Res Ltd, Christchurch 8140, New Zealand; [Nielsen, Kare L.; Sonderkaer, Mads] Aalborg Univ, AAU, Dept Biotechnol Chem & Environm Engn, DK-9000 Aalborg, Denmark; [Iovene, Marina; Torres, Giovana A.; Jiang, Jiming] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Veilleux, Richard E.] Virginia Polytech Inst & State Univ, Dept Hort, Blacksburg, VA 24061 USA; [Bachem, Christian W. B.; de Boer, Jan; Borm, Theo; Kloosterman, Bjorn; Visser, Richard G. F.] Univ Wageningen & Res Ctr, Dept Plant Sci, Lab Plant Breeding, NL-6708 PB Wageningen, Netherlands; [Goverse, Aska; van Ham, Roeland C. H. J.; Visser, Richard G. F.] Ctr BioSyst Genom, NL-6708 PB Wageningen, Netherlands; [Goverse, Aska] Univ Wageningen & Res Ctr, Dept Plant Sci, Nematol Lab, NL-6708 PB Wageningen, Netherlands	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs; Beijing Genomics Institute (BGI); Ministry of Agriculture & Rural Affairs; Universidad Peruana Cayetano Heredia; Universidad Nacional De San Cristobal De Huamanga; Indian Council of Agricultural Research (ICAR); ICAR - Central Potato Research Institute; Research Center of Biotechnology RAS; Russian Academy of Sciences; Universidad de Chile; Universidad de Chile; University of Dundee; Shandong Academy of Agricultural Sciences; Huazhong Agricultural University; Hunan Agricultural University; Imperial College London; Instituto de Investigacion Agropecuaria (INIA); Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; CGIAR; International Potato Center (CIP); Italian National Agency New Technical Energy & Sustainable Economics Development; J. Craig Venter Institute; Instituto Nacional de Tecnologia Agropecuaria (INTA); National University of La Plata; Michigan State University; James Hutton Institute; Teagasc; New Zealand Institute for Plant & Food Research Ltd; Aalborg University; University of Wisconsin System; University of Wisconsin Madison; Virginia Polytechnic Institute & State University; Wageningen University & Research; Centre for BioSystems Genomics; Wageningen University & Research	Huang, SW (corresponding author), Chinese Acad Agr Sci, Key Lab Hort Crops Genet Improvement, Sino Dutch Joint Lab Hort Genom, Inst Vegetables & Flowers,Minist Agr, Beijing 100081, Peoples R China.	huangsanwen@caas.net.cn; buell@msu.edu; Richard.Visser@wur.nl	van Eck, Herman/C-5940-2008; Torres, Giovana/AAN-5637-2020; L, Diambra/F-6319-2015; Beletsky, Alexey/AAA-5366-2019; Giuliano, Giovanni/A-2701-2012; Visser, Richard GF/B-3423-2012; Jiang, Jiming/V-6060-2019; Marshall, David F/F-2471-2011; Kolganova, Tatyana/E-1587-2014; Guzman, Fanny fg/K-5592-2013; Fiers, Mark WEJ/E-6755-2010; Whitty, Brett/P-3231-2019; Sharma, Sanjeev Kumar/H-8147-2013; Massa, Gabriela/ABF-7533-2021; Ravin, Nikolai V/C-5907-2014; Martin, David/C-2984-2009; Mardanov, Andrey/S-2294-2016; He, Jun/ABC-9997-2021; Nielsen, Kåre Lehmann L/A-1181-2013; Iovene, Marina/J-5593-2015; Facella, Paolo/HHC-1895-2022; Wang, Jun/A-7261-2013; Jiang, Jiming/A-9614-2009; Bolser, Dan/AAE-3087-2019; Huang, Sanwen/ABE-9053-2020; Patil, Virupaksh/AAH-5133-2021; Torres, Giovana A/J-7989-2012; Pietrella, Marco/ABE-3613-2020; MARTINEZ, DIANA/P-2887-2018; Xu, Xun/AAI-6763-2020; Guzman, Frank L/H-1271-2014; Zhang, Youjun/AAY-7948-2020; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	van Eck, Herman/0000-0002-6530-0616; Torres, Giovana/0000-0002-3740-8689; L, Diambra/0000-0001-8052-4880; Beletsky, Alexey/0000-0002-7611-2354; Giuliano, Giovanni/0000-0002-2486-0510; Visser, Richard GF/0000-0002-0213-4016; Jiang, Jiming/0000-0002-6435-6140; Marshall, David F/0000-0001-9309-2570; Guzman, Fanny fg/0000-0003-1537-0904; Fiers, Mark WEJ/0000-0001-5694-2409; Whitty, Brett/0000-0001-5776-5424; Mardanov, Andrey/0000-0002-8245-8757; He, Jun/0000-0003-3733-0241; Nielsen, Kåre Lehmann L/0000-0002-5598-4401; Iovene, Marina/0000-0002-5992-8677; Facella, Paolo/0000-0001-9076-3754; Jiang, Jiming/0000-0002-6435-6140; Bolser, Dan/0000-0002-3991-0859; Huang, Sanwen/0000-0002-8547-5309; Torres, Giovana A/0000-0002-3740-8689; MARTINEZ, DIANA/0000-0003-1115-5967; Xu, Xun/0000-0002-5338-5173; Guzman, Frank L/0000-0002-5048-4213; Zhang, Youjun/0000-0003-3508-6695; Bachem, Christian/0000-0002-3077-6833; Milbourne, Dan/0000-0002-8323-6195; Martin, David/0000-0002-8732-204X; Ravin, Nikolai/0000-0002-1456-1832; Thomson, Susan/0000-0001-7127-9414; Sharma, Sanjeev Kumar/0000-0002-3273-0708; Bryan, Glenn/0000-0002-7752-5740; Szczesny, Pawel/0000-0001-8442-0157; Wang, Jun/0000-0002-8540-8931; Feingold, Sergio/0000-0002-7107-4651; Ponce, Olga Patricia/0000-0001-9454-5797; Chakrabarti, Swarup Kumar/0000-0001-5566-3264; Di Genova, Alex/0000-0002-3120-9283; zhang, zhonghua/0000-0002-1034-227X; Zhang, Bo/0000-0001-8890-8416; Sonderkaer, Mads/0000-0002-9309-7459; Orjeda, Gisella/0000-0003-3013-5523; Pietrella, Marco/0000-0002-8789-6860; Massa, Gabriela Alejandra/0000-0002-9028-1330; Lozano, Roberto/0000-0003-0760-4977; Wang, Jun/0000-0002-2113-5874; Vaillancourt, Brieanne/0000-0002-6795-5173; Jacobs, Jeanne/0000-0002-1047-1039; Buell, C Robin/0000-0002-6727-4677; Perrotta, Gaetano/0000-0003-2037-1063; Gromadka, Robert/0000-0002-9941-6692; Gawor, Jan/0000-0003-3800-2557	EU [APOPHYS EU-QLRT-2001-01849]; US Department of Agriculture National Institute of Food and Agriculture [2008-55300-04757, 2009-85606-05673]; "863'' National High Tech Research Development Program in China [2006AA100107]; "973'' National Key Basic Research Program in China [2006CB101904, 2007CB815703, 2007CB815705, 2009CB119000]; Board of Wageningen University and Research Centre; CAPES Brazilian Ministry of Education; Chinese Academy of Agricultural Sciences; Chinese Ministry of Agriculture; Chinese Ministry of Finance [1251610601001]; Chinese Ministry of Science and Technology [2007DFB30080]; China Postdoctoral Science Foundation [20070420446]; CONICET (Argentina); DAFF Research Stimulus Fund [07-567]; CONICYT-Chile [PBCT-PSD-03]; Danish Council for Strategic Research Programme Commission on Health, Food and Welfare [2101-07-0116]; Danish Council for Strategic Research Programme Commission on Strategic Growth Technologies [2106-07-0021]; FINCyT [099-FINCyT-EQUIP-2009, 076-FINCyT-PIN-2008]; Prestamo BID [1663/OC-PE]; Fund for Economic Structural Support (FES); HarvestPlus Challenge Program; Indian Council of Agricultural Research; INIA-Ministry of Agriculture of Chile; Instituto Nacional de Innovacion Agraria-Ministry of Agriculture of Peru; Instituto Nacional de Tecnologia Agropecuaria (INTA); Italian Ministry of Research (Special Fund for Basic Research); International Potato Center; LBMG of Center for Genome Regulation and Center for Mathematical Modeling; Universidad de Chile [UMI 2807 CNRS]; Ministry of Education and Science of Russia [02.552.11.7073]; National Nature Science Foundation of China [30671319, 30725008, 30890032, 30971995]; Natural Science Foundation of Shandong Province in China [Y2006D21]; Netherlands Technology Foundation (STW); Netherlands Genomics Initiative (NGI); Netherlands Ministries of Economic Affairs (EZ) and Agriculture (LNV); New Zealand Institute for Crop & Food Research Ltd Strategic Science Initiative; Perez Guerrero Fund; Peruvian Ministry of Agriculture-Technical Secretariat of coordination; CGIAR; Peruvian National Council of Science and Technology (CONCYTEC); Polish Ministry of Science and Higher Education [47/PGS/2006/01]; Programa Cooperativo para el Desarrollo Tecnologico Agroalimentario y Agroindustrial del Cono Sur (PROCISUR); Project Programa Bicentenario de Ciencia y Tecnologia - Conicyt; PBCT - Conicyt [PSD-03]; Russian Foundation for Basic Research [09-04-12275]; Secretaria de Ciencia y Tecnologia (SECyT) actual Ministerio de Ciencia y Tecnologia (MINCyT), Argentina; Shenzhen Municipal Government of China [CXB200903110066A, ZYC200903240077A, ZYC200903240076A]; Solexa project [272-07-0196]; Inter-American Council for Integral Development (FEMCIDI); Teagasc; Teagasc Walsh Fellowship Scheme; New Zealand Institute for Plant & Food Research Ltd; Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); Department for Environment, Food and Rural Affairs (DEFRA; Agriculture and Horticulture Development Board - Potato Council; UK Biotechnology and Biological Sciences Research Council [BB/F012640]; US National Science Foundation [DBI-0604907/DBI-0834044]; Virginia Agricultural Experiment Station USDA [135853]; Wellcome Trust [WT 083481]; BBSRC [BB/F012640/1, BB/F013280/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F013280/1, BB/F012640/1] Funding Source: researchfish	EU(European Commission); US Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); "863'' National High Tech Research Development Program in China(National High Technology Research and Development Program of China); "973'' National Key Basic Research Program in China(National Basic Research Program of China); Board of Wageningen University and Research Centre; CAPES Brazilian Ministry of Education(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Chinese Academy of Agricultural Sciences; Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); Chinese Ministry of Finance; Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); DAFF Research Stimulus Fund; CONICYT-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Danish Council for Strategic Research Programme Commission on Health, Food and Welfare; Danish Council for Strategic Research Programme Commission on Strategic Growth Technologies; FINCyT; Prestamo BID; Fund for Economic Structural Support (FES); HarvestPlus Challenge Program; Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR)); INIA-Ministry of Agriculture of Chile; Instituto Nacional de Innovacion Agraria-Ministry of Agriculture of Peru; Instituto Nacional de Tecnologia Agropecuaria (INTA); Italian Ministry of Research (Special Fund for Basic Research)(Ministry of Education, Universities and Research (MIUR)); International Potato Center(CGIAR); LBMG of Center for Genome Regulation and Center for Mathematical Modeling; Universidad de Chile; Ministry of Education and Science of Russia(Ministry of Education and Science, Russian Federation); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province in China(Natural Science Foundation of Shandong Province); Netherlands Technology Foundation (STW)(Technologiestichting STW); Netherlands Genomics Initiative (NGI); Netherlands Ministries of Economic Affairs (EZ) and Agriculture (LNV); New Zealand Institute for Crop & Food Research Ltd Strategic Science Initiative; Perez Guerrero Fund; Peruvian Ministry of Agriculture-Technical Secretariat of coordination; CGIAR(CGIAR); Peruvian National Council of Science and Technology (CONCYTEC); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Programa Cooperativo para el Desarrollo Tecnologico Agroalimentario y Agroindustrial del Cono Sur (PROCISUR); Project Programa Bicentenario de Ciencia y Tecnologia - Conicyt; PBCT - Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/PBCT); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Secretaria de Ciencia y Tecnologia (SECyT) actual Ministerio de Ciencia y Tecnologia (MINCyT), Argentina(Secretaria de Ciencia y Tecnologia (SECYT)); Shenzhen Municipal Government of China; Solexa project; Inter-American Council for Integral Development (FEMCIDI); Teagasc; Teagasc Walsh Fellowship Scheme; New Zealand Institute for Plant & Food Research Ltd; Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); Department for Environment, Food and Rural Affairs (DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); Agriculture and Horticulture Development Board - Potato Council; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); US National Science Foundation(National Science Foundation (NSF)); Virginia Agricultural Experiment Station USDA; Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We acknowledge the assistance of W. Amoros, B. Babinska, R. V. Baslerov, B. K. Bumazhkin, M. F. Carboni, T. Conner, J. Coombs, L. Daddiego, J. M. D'Ambrosio, G. Diretto, S. B. Divito, D. Douches, M. Filipiak, G. Gianese, R. Hutten, E. Jacobsen, E. Kalinska, S. Kamoun, D. Kells, H. Kossowska, L. Lopez, M. Magallanes-Lundback, T. Miranda, P. S. Naik, A. N. Panteleeva, D. Pattanayak, E. O. Patutina, M. Portantier, S. Rawat, R. Simon, B. P. Singh, B. Singh, W. Stiekema, M. V. Sukhacheva and C. Town in providing plant material, generating data, annotation, analyses, and discussions. We are indebted to additional faculty and staff of the BGI-Shenzhen, J Craig Venter Institute, and MSU Research Technology Support Facility who contributed to this project. Background and preliminary data were provided by the Centre for BioSystems Genomics (CBSG), EU-project (APOPHYS EU-QLRT-2001-01849) and US Department of Agriculture National Institute of Food and Agriculture SolCAP project (2008-55300-04757 and 2009-85606-05673). We acknowledge the funding made available by the "863'' National High Tech Research Development Program in China (2006AA100107), "973'' National Key Basic Research Program in China (2006CB101904, 2007CB815703, 2007CB815705, 2009CB119000), Board of Wageningen University and Research Centre, CAPES Brazilian Ministry of Education, Chinese Academy of Agricultural Sciences (seed grant to S. H.), Chinese Ministry of Agriculture (The "948'' Program), Chinese Ministry of Finance (1251610601001), Chinese Ministry of Science and Technology (2007DFB30080), China Postdoctoral Science Foundation (20070420446 to Z.Z.), CONICET (Argentina), DAFF Research Stimulus Fund (07-567), CONICYT-Chile (PBCT-PSD-03), Danish Council for Strategic Research Programme Commission on Health, Food and Welfare (2101-07-0116), Danish Council for Strategic Research Programme Commission on Strategic Growth Technologies (Grant 2106-07-0021), FINCyT ((099-FINCyT-EQUIP-2009)/(076-FINCyT-PIN-2008), Prestamo BID no. 1663/OC-PE, FONDAP and BASAL-CMM), Fund for Economic Structural Support (FES), HarvestPlus Challenge Program, Indian Council of Agricultural Research, INIA-Ministry of Agriculture of Chile, Instituto Nacional de Innovacion Agraria-Ministry of Agriculture of Peru, Instituto Nacional de Tecnologia Agropecuaria (INTA), Italian Ministry of Research (Special Fund for Basic Research), International Potato Center (CIP-CGIAR core funds), LBMG of Center for Genome Regulation and Center for Mathematical Modeling, Universidad de Chile (UMI 2807 CNRS), Ministry of Education and Science of Russia (contract 02.552.11.; 7073), National Nature Science Foundation of China (30671319, 30725008, 30890032, 30971995), Natural Science Foundation of Shandong Province in China (Y2006D21), Netherlands Technology Foundation (STW), Netherlands Genomics Initiative (NGI), Netherlands Ministries of Economic Affairs (EZ) and Agriculture (LNV), New Zealand Institute for Crop & Food Research Ltd Strategic Science Initiative, Perez Guerrero Fund, Peruvian Ministry of Agriculture-Technical Secretariat of coordination with the CGIAR, Peruvian National Council of Science and Technology (CONCYTEC), Polish Ministry of Science and Higher Education (47/PGS/2006/01), Programa Cooperativo para el Desarrollo Tecnologico Agroalimentario y Agroindustrial del Cono Sur (PROCISUR), Project Programa Bicentenario de Ciencia y Tecnologia - Conicyt, PBCT - Conicyt PSD-03, Russian Foundation for Basic Research (09-04-12275), Secretaria de Ciencia y Tecnologia (SECyT) actual Ministerio de Ciencia y Tecnologia (MINCyT),Argentina, Shenzhen Municipal Government of China (CXB200903110066A, ZYC200903240077A, ZYC200903240076A), Solexa project (272-07-0196), Special Multilateral Fund of the Inter-American Council for Integral Development (FEMCIDI), Teagasc, Teagasc Walsh Fellowship Scheme, The New Zealand Institute for Plant & Food Research Ltd Capability Fund, UK Potato Genome Sequencing grant (Scottish Government Rural and Environment Research and Analysis Directorate (RERAD), Department for Environment, Food and Rural Affairs (DEFRA), Agriculture and Horticulture Development Board - Potato Council), UK Biotechnology and Biological Sciences Research Council (Grant BB/F012640), US National Science Foundation Plant Genome Research Program (DBI-0604907/DBI-0834044), Virginia Agricultural Experiment Station USDA Hatch Funds (135853), and Wellcome Trust Strategic award (WT 083481).	Albach DC, 2001, SYST BOT, V26, P242; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Ballvora A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-112; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Borm T. J., 2008, THESIS WAGENINGEN U; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burlingame B, 2009, J FOOD COMPOS ANAL, V22, P494, DOI 10.1016/j.jfca.2009.09.001; Chaisson M, 2004, BIOINFORMATICS, V20, P2067, DOI 10.1093/bioinformatics/bth205; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chen N., 2004, CURR PROTOC BIOINFOR, V25, P4101; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Fettke J, 2010, NEW PHYTOL, V185, P663, DOI 10.1111/j.1469-8137.2009.03126.x; Glaczinski H, 2002, POTATO RES, V45, P163, DOI 10.1007/BF02736112; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Haynes FL, 1972, PROSPECTS POTATO DEV, P100; Hijmans RJ, 2001, AM J POTATO RES, V78, P403, DOI 10.1007/BF02896371; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiang ZS, 2008, GENOME RES, V18, P1362, DOI 10.1101/gr.078477.108; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kohler A, 2008, PLANT MOL BIOL, V66, P619, DOI 10.1007/s11103-008-9293-9; Kuang H, 2004, PLANT CELL, V16, P2870, DOI 10.1105/tpc.104.025502; Kuang HH, 2009, GENOME RES, V19, P42, DOI [10.1101/gr.07816.108, 10.1101/gr.078196.108]; Kuang HH, 2005, PLANT J, V44, P37, DOI 10.1111/j.1365-313X.2005.02506.x; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Paz MM, 1999, PLANT BREEDING, V118, P53, DOI 10.1046/j.1439-0523.1999.118001053.x; Peters SA, 2009, PLANT J, V58, P857, DOI 10.1111/j.1365-313X.2009.03822.x; Porter BW, 2009, MOL GENET GENOMICS, V281, P609, DOI 10.1007/s00438-009-0434-x; PRAT S, 1990, FEBS LETT, V268, P334, DOI 10.1016/0014-5793(90)81281-R; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sanseverino W, 2010, NUCLEIC ACIDS RES, V38, pD814, DOI 10.1093/nar/gkp978; Shannon JC, 1996, PLANT PHYSIOL, V110, P835, DOI 10.1104/pp.110.3.835; Simillion C, 2008, BIOINFORMATICS, V24, P127, DOI 10.1093/bioinformatics/btm449; Sonnewald U, 2001, TRENDS PLANT SCI, V6, P333, DOI 10.1016/S1360-1385(01)02020-9; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tang XM, 2009, CHROMOSOME RES, V17, P899, DOI 10.1007/s10577-009-9077-3; Tauberger E, 2000, PLANT J, V23, P43, DOI 10.1046/j.1365-313x.2000.00783.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van der Vossen E., 2010, WHOLE GENOME PROFILI; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; VanOoijen J. W., 2006, JOINMAP; Visser RGF, 2009, AM J POTATO RES, V86, P417, DOI 10.1007/s12230-009-9097-8; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928	57	1302	1433	21	574	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					189	U94		10.1038/nature10158	http://dx.doi.org/10.1038/nature10158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21743474	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000292690500042
J	Kandasamy, J; Jenkinson, MD; Mallucci, CL				Kandasamy, Jothy; Jenkinson, Michael D.; Mallucci, Conor L.			Contemporary management and recent advances in paediatric hydrocephalus	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ENDOSCOPIC 3RD VENTRICULOSTOMY; CEREBROSPINAL-FLUID SHUNTS; QUALITY-OF-LIFE; CLINICAL ARTICLE; CHILDHOOD HYDROCEPHALUS; RANDOMIZED-TRIAL; SPINA-BIFIDA; MULTICENTER; INSERTION; SURGERY		[Kandasamy, Jothy; Jenkinson, Michael D.; Mallucci, Conor L.] Walton Ctr Neurol & Neurosurg, Dept Neurosurg, Liverpool L9 7LJ, Merseyside, England; [Kandasamy, Jothy; Jenkinson, Michael D.; Mallucci, Conor L.] Royal Liverpool Alder Hey Childrens Hosp, Dept Neurosurg, Liverpool L12 2AP, Merseyside, England	Walton Centre; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital	Kandasamy, J (corresponding author), Walton Ctr Neurol & Neurosurg, Dept Neurosurg, Liverpool L9 7LJ, Merseyside, England.	jegajothy@hotmail.com		Mallucci, Conor/0000-0002-5509-0547; Jenkinson, Michael/0000-0003-4587-2139	Walton Centre for Neurology and Neurosurgery; Royal Liverpool Alder Hey Children's Hospital	Walton Centre for Neurology and Neurosurgery; Royal Liverpool Alder Hey Children's Hospital	The authors received support from the Walton Centre for Neurology and Neurosurgery and the Royal Liverpool Alder Hey Children's Hospital for the submitted work.	Adzick NS, 2011, NEW ENGL J MED, V364, P993, DOI 10.1056/NEJMoa1014379; Bayston R, 2001, NEUROSURG CLIN N AM, V12, P703, DOI 10.1016/S1042-3680(18)30027-5; Blount JP, 2004, NEUROSURGERY, V54, P1190, DOI 10.1227/01.NEU.0000119236.08000.49; Cochrane DD, 2002, EUR J PEDIATR SURG, V12, pS6; CUSIMANO MD, 1992, PEDIATR NEUROSURG, V17, P10, DOI 10.1159/000120558; Del Bigio MR, 2010, DEV DISABIL RES REV, V16, P16, DOI 10.1002/ddrr.94; Dennis M, 2007, J INT NEUROPSYCH SOC, V13, P312, DOI 10.1017/S1355617707070336; Drake JM, 1998, NEUROSURGERY, V43, P294, DOI 10.1097/00006123-199808000-00068; Farmer D, 2003, BRIT MED J, V326, P461, DOI 10.1136/bmj.326.7387.461; FERNELL E, 1990, ACTA PAEDIATR SCAND, V79, P1080, DOI 10.1111/j.1651-2227.1990.tb11387.x; Fraser JD, 2009, J LAPAROENDOSC ADV S, V19, P675, DOI 10.1089/lap.2009.0116; Hayhurst C, 2010, J NEUROSURG, V113, P1273, DOI 10.3171/2010.3.JNS091237; Hoppe-Hirsch E, 1998, CHILD NERV SYST, V14, P97, DOI 10.1007/s003810050186; Hunt GM, 2003, BRIT MED J, V326, P1365, DOI 10.1136/bmj.326.7403.1365; Javadpour M, 2003, BRIT J NEUROSURG, V17, P266, DOI 10.1080/0268869031000153215; Kandasamy J, 2011, CHILD NERV SYST, V27, P575, DOI 10.1007/s00381-010-1290-z; Kestle J, 2000, PEDIATR NEUROSURG, V33, P230, DOI 10.1159/000055960; Kestle JRW, 2003, J NEUROSURG, V98, P284, DOI 10.3171/jns.2003.98.2.0284; Kulkarni AV, 2010, CHILD NERV SYST, V26, P1711, DOI 10.1007/s00381-010-1195-x; Kulkarni AV, 2010, J NEUROSURG-PEDIATR, V6, P310, DOI 10.3171/2010.8.PEDS103; Kulkarni AV, 2010, J NEUROSURG-PEDIATR, V6, P11, DOI 10.3171/2010.3.PEDS09358; Kulkarni AV, 2010, CHILD NERV SYST, V26, P737, DOI 10.1007/s00381-010-1131-0; Pollack IF, 1999, NEUROSURGERY, V45, P1399, DOI 10.1097/00006123-199912000-00026; Richards HK, 2009, J NEUROSURG-PEDIATR, V4, P389, DOI 10.3171/2009.4.PEDS09210	24	7	7	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2011	343								d4191	10.1136/bmj.d4191	http://dx.doi.org/10.1136/bmj.d4191			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794OE	21752834				2022-12-28	WOS:000292908900004
J	McCartney, M				McCartney, Margaret			HEALTH MARKETING Waterlogged?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WATER; DRINK; RISK					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Bennett Jill A, 2004, J Gerontol Nurs, V30, P22; BIRCH LL, 1989, PHYSIOL BEHAV, V45, P387, DOI 10.1016/0031-9384(89)90145-5; Brander Nickie, 2003, Nurs Times, V99, P50; British Bottled Water Producers, WAT VIT STAT IND DAT; Hebert LA, 2003, AM J KIDNEY DIS, V41, P962, DOI 10.1016/S0272-6386(03)00193-8; *HYRDR HLTH, WE DONT DRINK EN WAT; Manz F, 2007, J AM COLL NUTR, V26, p535S, DOI 10.1080/07315724.2007.10719655; Muckelbauer R, 2009, PEDIATRICS, V123, pE661, DOI 10.1542/peds.2008-2186; Negoianu D, 2008, J AM SOC NEPHROL, V19, P1041, DOI 10.1681/ASN.2008030274; *NHS CHOIC, 8 TIPS HLTH LIV; Petraccia L, 2006, CLIN NUTR, V25, P377, DOI 10.1016/j.clnu.2005.10.002; Rogers PJ, 2001, APPETITE, V36, P57, DOI 10.1006/appe.2000.0374; Strippoli GFM, 2011, NEPHROLOGY, V16, P326, DOI 10.1111/j.1440-1797.2010.01415.x; Valtin H, 2002, AM J PHYSIOL-REG I, V283, pR993, DOI 10.1152/ajpregu.00365.2002; 2000, BBC NEWS        0427	15	15	16	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 12	2011	343								d4280	10.1136/bmj.d4280	http://dx.doi.org/10.1136/bmj.d4280			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	794NX	21750074				2022-12-28	WOS:000292908200004
J	Preiss, D; Sattar, N				Preiss, David; Sattar, Naveed			The case for diabetes screening: ADDITION-Europe	LANCET			English	Editorial Material							MELLITUS; TRIALS		[Preiss, David; Sattar, Naveed] Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland	University of Glasgow	Sattar, N (corresponding author), Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland.	naveed.sattar@glasgow.ac.uk		Preiss, David/0000-0003-3139-1836				Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Griffin SJ, 2011, LANCET, V378, P156, DOI 10.1016/S0140-6736(11)60698-3; Jarvinen TLN, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2175; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Preiss D, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.10.019; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Turnbull F, 2005, ARCH INTERN MED, V165, P1410; Ware JH, 2011, NEW ENGL J MED, V364, P1685, DOI 10.1056/NEJMp1103502	9	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2011	378	9786					106	108		10.1016/S0140-6736(11)60819-2	http://dx.doi.org/10.1016/S0140-6736(11)60819-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	795CJ	21705070				2022-12-28	WOS:000292948800007
J	Arner, P				Arner, Peter			Lipases in Cachexia	SCIENCE			English	Editorial Material							CANCER CACHEXIA; ADIPOSE-TISSUE; LIPOLYSIS; FAT		Karolinska Univ Hosp, Dept Med, Karolinska Inst, S-14186 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Arner, P (corresponding author), Karolinska Univ Hosp, Dept Med, Karolinska Inst, S-14186 Stockholm, Sweden.	peter.arner@ki.se		Arner, Peter/0000-0002-6208-6220				Agustsson T, 2007, CANCER RES, V67, P5531, DOI 10.1158/0008-5472.CAN-06-4585; Byerley LO, 2010, NUTR CANCER, V62, P484, DOI 10.1080/01635580903441220; Claus TH, 2005, J PHARMACOL EXP THER, V315, P1396, DOI 10.1124/jpet.105.086926; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Fouladiun M, 2005, CANCER-AM CANCER SOC, V103, P2189, DOI 10.1002/cncr.21013; KLEIN S, 1990, J CLIN INVEST, V86, P1403, DOI 10.1172/JCI114854; Lainscak M, 2009, INT J CARDIOL, V132, P303, DOI 10.1016/j.ijcard.2008.11.149; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Mracek T, 2011, BRIT J CANCER, V104, P441, DOI 10.1038/sj.bjc.6606083; Ryden M, 2008, CANCER-AM CANCER SOC, V113, P1695, DOI 10.1002/cncr.23802; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008	11	26	26	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					163	164		10.1126/science.1209418	http://dx.doi.org/10.1126/science.1209418			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21737725				2022-12-28	WOS:000292502700029
J	Shao, SC; Hegde, RS				Shao, Sichen; Hegde, Ramanujan S.			A Flip Turn for Membrane Protein Insertion	CELL			English	Editorial Material							EXIT TUNNEL; RIBOSOME; INTEGRATION; TOPOLOGY		[Shao, Sichen; Hegde, Ramanujan S.] NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Shao, Sichen] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University	Hegde, RS (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	hegde.science@gmail.com		Hegde, Ramanujan/0000-0001-8338-852X; Shao, Sichen/0000-0003-2679-5537	Intramural NIH HHS [ZIA HD008862-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008862] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Berndt U, 2009, P NATL ACAD SCI USA, V106, P1398, DOI 10.1073/pnas.0808584106; Cheng ZL, 2006, NAT STRUCT MOL BIOL, V13, P930, DOI 10.1038/nsmb1146; Devaraneni PK, 2011, CELL, V146, P134, DOI 10.1016/j.cell.2011.06.004; Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Pool MR, 2009, J CELL BIOL, V185, P889, DOI 10.1083/jcb.200807066; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063	10	6	6	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					13	15		10.1016/j.cell.2011.06.028	http://dx.doi.org/10.1016/j.cell.2011.06.028			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729778	Bronze, Green Accepted			2022-12-28	WOS:000292539300003
J	Madhi, SA; Nachman, S; Violari, A; Kim, S; Cotton, MF; Bobat, R; Jean-Philippe, P; McSherry, G; Mitchell, C				Madhi, Shabir A.; Nachman, Sharon; Violari, Avy; Kim, Soyeon; Cotton, Mark F.; Bobat, Raziya; Jean-Philippe, Patrick; McSherry, George; Mitchell, Charles		P1041 Study Team	Primary Isoniazid Prophylaxis against Tuberculosis in HIV-Exposed Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFECTION; COMMUNITY; TRANSMISSION; IMPACT; NEED	Background The dual epidemic of human immunodeficiency virus (HIV) and tuberculosis is a major cause of sickness and death in sub-Saharan Africa. We conducted a double-blind, randomized, placebo-controlled trial of preexposure isoniazid prophylaxis against tuberculosis in HIV-infected children and uninfected children exposed to HIV during the perinatal period. Methods We randomly assigned 548 HIV-infected and 804 HIV-uninfected infants (91 to 120 days of age) to isoniazid (10 to 20 mg per kilogram of body weight per day) or matching placebo for 96 weeks. All patients received bacille Calmette-Guerin (BCG) vaccination against tuberculosis within 30 days after birth. HIV-infected children had access to antiretroviral therapy. The primary outcome measures were tuberculosis disease and death in HIV-infected children and latent tuberculosis infection, tuberculosis disease, and death in HIV-uninfected children within 96 to 108 weeks after randomization. Results Antiretroviral therapy was initiated in 98.9% of HIV-infected children during the study. Among HIV-infected children, protocol-defined tuberculosis or death occurred in 52 children (19.0%) in the isoniazid group and 53 (19.3%) in the placebo group (P = 0.93). Among HIV-uninfected children, there was no significant difference in the combined incidence of tuberculosis infection, tuberculosis disease, or death between the isoniazid group (39 children, 10%) and the placebo group (45 children, 11%; P = 0.44). The rate of tuberculosis was 121 cases per 1000 child-years (95% confidence interval [CI], 95 to 153) among HIV-infected children as compared with 41 per 1000 child-years (95% CI, 31 to 52) among HIV-uninfected children. There were no significant differences in clinical or severe laboratory toxic effects between treatment groups. Conclusions Primary isoniazid prophylaxis did not improve tuberculosis-disease-free survival among HIV-infected children or tuberculosis-infection-free survival among HIV-uninfected children immunized with BCG vaccine. Despite access to antiretroviral therapy, the burden of tuberculosis remained high among HIV-infected children.	[Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn, Vaccine Preventable Dis & Med Res Council,Resp &, Johannesburg, South Africa; [Violari, Avy] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Cotton, Mark F.] Univ Stellenbosch, Cape Town, South Africa; [Bobat, Raziya] Univ KwaZulu Natal, Durban, South Africa; [Nachman, Sharon] SUNY Stony Brook, Dept Pediat, Stony Brook, NY 11794 USA; [Kim, Soyeon] Harvard Univ, Sch Publ Hlth, Dept Biostat, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Jean-Philippe, Patrick] Henry Jackson Fdn, Div Aids, Bethesda, MD USA; [McSherry, George] Penn State Univ, Coll Med, Hershey, PA USA; [Mitchell, Charles] Univ Miami, Miami, FL USA	National Research Foundation - South Africa; University of Witwatersrand; University of Witwatersrand; Stellenbosch University; University of Kwazulu Natal; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Harvard T.H. Chan School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Miami	Madhi, SA (corresponding author), Resp & Meningeal Pathogens Res Unit, POB 90753, ZA-2013 Bertsham, Gauteng, South Africa.	madhis@rmpru.co.za	Rivet, Catherine A/M-7978-2014; Cotton, Mark/AAQ-9936-2020	Cotton, Mark/0000-0003-2559-6034	National Institutes of Health; Secure the Future; NIAID [U01 AI068632]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health [AI068632]; Statistical and Data Analysis Center at the Harvard School of Public Health, under NIAID; Pediatric AIDS Clinical Trials Group [5 U01 AI41110]; IMPAACT Group [1 U01 AI068616]; NIAID; NICHD International and Domestic Pediatric and Maternal HIV Clinical Trials Network (NICHD) [N01-DK-9-001/HHSN267200-800001C]; Secure the Future Fund; Bristol-Myers Squibb; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069521, UM1AI068632, U01AI041110, U01AI068616, U01AI068632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Secure the Future; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Statistical and Data Analysis Center at the Harvard School of Public Health, under NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pediatric AIDS Clinical Trials Group; IMPAACT Group; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD International and Domestic Pediatric and Maternal HIV Clinical Trials Network (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Secure the Future Fund; Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institutes of Health and Secure the Future; Overall support for the International Maternal-Pediatric-Adolescent AIDS Clinical Trials (IMPAACT) Group was provided by grants from the NIAID (U01 AI068632), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Institute of Mental Health (AI068632). This work was supported by the Statistical and Data Analysis Center at the Harvard School of Public Health, under NIAID cooperative agreements with the Pediatric AIDS Clinical Trials Group (5 U01 AI41110) and the IMPAACT Group (1 U01 AI068616). Support of the sites was provided by NIAID and the NICHD International and Domestic Pediatric and Maternal HIV Clinical Trials Network (NICHD contract number N01-DK-9-001/HHSN267200-800001C). The study was also funded by a grant from the Secure the Future Fund, a philanthropy program sponsored by Bristol-Myers Squibb.	Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Ansari NA, 2003, PEDIATR INFECT DIS J, V22, P43, DOI 10.1097/00006454-200301000-00013; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Cotton MF, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-40; [DAIDS RSC], 2004, TOX TABL; Hesseling AC, 2009, CLIN INFECT DIS, V48, P108, DOI 10.1086/595012; HSU KHK, 1984, JAMA-J AM MED ASSOC, V251, P1283, DOI 10.1001/jama.251.10.1283; HSU KHK, 1974, JAMA-J AM MED ASSOC, V229, P528, DOI 10.1001/jama.229.5.528; Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018; Madhi SA, 2000, INT J TUBERC LUNG D, V4, P448; Madhi SA, 2000, CLIN INFECT DIS, V31, P170, DOI 10.1086/313925; Marais BJ, 2006, AM J RESP CRIT CARE, V173, P1078, DOI 10.1164/rccm.200511-1809SO; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Middelkoop K, 2008, CLIN INFECT DIS, V47, P349, DOI 10.1086/589750; Moore DP, 2010, PEDIATR INFECT DIS J, V29, P1099, DOI 10.1097/INF.0b013e3181eaefff; MOUNT FW, 1961, NEW ENGL J MED, V265, P713, DOI 10.1056/NEJM196110122651501; Nunn P, 2007, J INFECT DIS, V196, pS5, DOI 10.1086/518660; Smieja M, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001363; The South African National Tuberculosis Control Programme, 2004, PRACT GUID; Wood R, 2010, CLIN INFECT DIS, V51, P401, DOI 10.1086/655129; World Health Organization, 1999, MAN SEV MALN MAN PHY; Zar HJ, 2007, BRIT MED J, V334, P136, DOI 10.1136/bmj.39000.486400.55	22	107	110	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					21	31		10.1056/NEJMoa1011214	http://dx.doi.org/10.1056/NEJMoa1011214			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788QL	21732834	Green Accepted			2022-12-28	WOS:000292459400006
J	Komen, DJC; Van Doorn, MBA; Zeegelaar, JE				Komen, Danielle J. C.; Van Doorn, Martijn B. A.; Zeegelaar, Jim E.			A 22 year old man with acute genital oedema and a swollen ankle	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEREDITARY ANGIOEDEMA; C1 INHIBITOR; DANAZOL; PATIENT		[Komen, Danielle J. C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [Van Doorn, Martijn B. A.] Vrije Univ Amsterdam, Med Ctr, Dept Dermatol, Amsterdam, Netherlands; [Zeegelaar, Jim E.] Flevo Hosp, Dept Dermatol, Almere, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Komen, DJC (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands.	d.j.komen@amc.uva.nl	Hug, Balthasar L./G-1568-2010					Bork K, 2003, J AM DENT ASSOC, V134, P1088, DOI 10.14219/jada.archive.2003.0323; Bork K, 1999, LANCET, V353, P1066, DOI 10.1016/S0140-6736(99)00110-5; Bork K, 2011, INT ARCH ALLERGY IMM, V154, P81, DOI 10.1159/000319213; Bowen Tom, 2010, Allergy Asthma Clin Immunol, V6, P24, DOI 10.1186/1710-1492-6-24; BRANDES SB, 1994, UROLOGY, V44, P602, DOI 10.1016/S0090-4295(94)80071-5; Caballero T, 2006, J ALLERGY CLIN IMMUN, V117, P476, DOI 10.1016/j.jaci.2005.10.045; Choi G, 2007, TRANSFUSION, V47, P1028, DOI 10.1111/j.1537-2995.2007.01239.x; CICARDI M, 1991, J ALLERGY CLIN IMMUN, V87, P768, DOI 10.1016/0091-6749(91)90120-D; Cicardi M, 2010, NEW ENGL J MED, V363, P532, DOI 10.1056/NEJMoa0906393; Cicardi Marco, 2010, Allergy Asthma Clin Immunol, V6, P14, DOI 10.1186/1710-1492-6-14; Cicardi M, 2010, NEW ENGL J MED, V363, P523, DOI 10.1056/NEJMoa0905079; Crampon D, 1998, J HEPATOL, V29, P1035, DOI 10.1016/S0168-8278(98)80140-2; Erceg A, 2003, Ned Tijdschr Geneeskd, V147, P771; FISHER AA, 1987, CUTIS, V39, P281; Levy R, 2008, J ALLERGY CLIN IMMUN, V121, pS231; Longhurst Hilary J, 2010, Allergy Asthma Clin Immunol, V6, P22, DOI 10.1186/1710-1492-6-22; McCabe J, 2008, AM J HEALTH-SYST PH, V65, P420, DOI 10.2146/ajhp070299; Noble H, 2004, INT J STD AIDS, V15, P489, DOI 10.1258/0956462041211306; Nzeako UC, 2001, ARCH INTERN MED, V161, P2417, DOI 10.1001/archinte.161.20.2417; Pappalardo E, 2000, J ALLERGY CLIN IMMUN, V106, P1147, DOI 10.1067/mai.2000.110471; Roche O, 2005, ANN ALLERG ASTHMA IM, V94, P498, DOI 10.1016/S1081-1206(10)61121-0; Saw NK, 2005, POSTGRAD MED J, V81, P131, DOI 10.1136/pgmj.2003.018564; van Doorn MBA, 2005, J ALLERGY CLIN IMMUN, V116, P876, DOI 10.1016/j.jaci.2005.05.019; Van Sickels NJ, 2010, ORAL SURG ORAL MED O, V109, P168, DOI 10.1016/j.tripleo.2009.09.031; Vitrat-Hincky V, 2010, ALLERGY, V65, P1331, DOI 10.1111/j.1398-9995.2010.02368.x; WRIGHT RA, 1979, JAMA-J AM MED ASSOC, V241, P157, DOI 10.1001/jama.241.2.157; Zuraw BL, 2008, NEW ENGL J MED, V359, P1027, DOI 10.1056/NEJMcp0803977; Zuraw Bruce L, 2010, Allergy Asthma Clin Immunol, V6, P23, DOI 10.1186/1710-1492-6-23; Zuraw BL, 2009, ALLERGY ASTHMA PROC, V30, P487, DOI 10.2500/aap.2009.30.3277; ZURLO JJ, 1990, FERTIL STERIL, V54, P64	30	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2011	343								d3132	10.1136/bmj.d3132	http://dx.doi.org/10.1136/bmj.d3132			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SD	21734172				2022-12-28	WOS:000292684100002
J	Trivedi, NS; Libman, H				Trivedi, Neha S.; Libman, Howard			Update: A 39-Year-Old Man With HIV-Associated Lipodystrophy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material														Trivedi, Neha/0000-0003-1006-1408				Fuller J, 2008, JAMA-J AM MED ASSOC, V300, P1056, DOI 10.1001/jama.300.5.jrr80007	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					87	87		10.1001/jama.2011.938	http://dx.doi.org/10.1001/jama.2011.938			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	21730244				2022-12-28	WOS:000292378700024
J	Willeit, P; Willeit, J; Kloss-Brandstatter, A; Kronenberg, F; Kiechl, S				Willeit, Peter; Willeit, Johann; Kloss-Brandstaetter, Anita; Kronenberg, Florian; Kiechl, Stefan			Fifteen-Year Follow-up of Association Between Telomere Length and Incident Cancer and Cancer Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Willeit, Peter] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Willeit, Johann; Kiechl, Stefan] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria; [Kloss-Brandstaetter, Anita; Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Innsbruck, Austria	University of Cambridge; Medical University of Innsbruck; Medical University of Innsbruck	Willeit, P (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.	stefan.kiechl@i-med.ac.at	Kronenberg, Florian/B-1736-2008; Willeit, Peter/HCI-7091-2022	Kronenberg, Florian/0000-0003-2229-1120; Willeit, Peter/0000-0002-1866-7159; Kloss-Brandstatter, Anita/0000-0002-0873-6704	British Heart Foundation [RG/08/014/24067] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Houben JMJ, 2011, J GERONTOL A-BIOL, V66, P38, DOI 10.1093/gerona/glq164; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wood AM, 2009, STAT MED, V28, P1067, DOI 10.1002/sim.3530	6	74	75	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					42	44		10.1001/jama.2011.901	http://dx.doi.org/10.1001/jama.2011.901			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	21730239				2022-12-28	WOS:000292378700018
J	Lewiecki, EM				Lewiecki, E. Michael			Osteoporosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material													Merelli, Emanuela/H-6375-2016; Paoletti, Nicola/D-8120-2018; P. Lió, Pietro Lio/AAV-3358-2021; Lewiecki, E. Michael/B-3706-2018	Merelli, Emanuela/0000-0002-1321-4134; P. Lió, Pietro Lio/0000-0002-0540-5053; Lewiecki, E. Michael/0000-0003-2026-9587				Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; [Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1; Baim S, 2008, J CLIN DENSITOM, V11, P75, DOI 10.1016/j.jocd.2007.12.007; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Chesnut CH, 2000, AM J MED, V109, P267, DOI 10.1016/S0002-9343(00)00490-3; Chesnut CH, 2004, J BONE MINER RES, V19, P1241, DOI 10.1359/JBMR.040325; Clowes JA, 2004, J CLIN ENDOCR METAB, V89, P1117, DOI 10.1210/jc.2003-030501; Cranney A, 2002, ENDOCR REV, V23, P508, DOI 10.1210/er.2001-2002; Cranney A, 2002, ENDOCR REV, V23, P517, DOI 10.1210/er.2001-3002; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fuchs RK, 2001, J BONE MINER RES, V16, P148, DOI 10.1359/jbmr.2001.16.1.148; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; GRAZIANI G, 1995, NEPHROL DIAL TRANSPL, V10, P1376; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Kelley GA, 2000, J APPL PHYSIOL, V88, P1730, DOI 10.1152/jappl.2000.88.5.1730; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Lewiecki EM, 2010, J CLIN DENSITOM, V13, P335, DOI 10.1016/j.jocd.2010.06.005; Lewiecki EM, 2003, J CLIN DENSITOM, V6, P307, DOI 10.1385/JCD:6:4:307; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; MacKelvie KJ, 2002, J BONE MINER RES, V17, P834, DOI 10.1359/jbmr.2002.17.5.834; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; *NAT OST FDN, 2011, CLIN GUID PREV TREAT; National Committee for Quality Assurance, 2011, STAT HLTH CAR QUAL; National Osteoporosis Foundation, 2008, CLIN GUID PREV TREAT; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Qaseem A, 2008, ANN INTERN MED, V149, P404, DOI 10.7326/0003-4819-149-6-200809160-00007; Qaseem A, 2008, ANN INTERN MED, V148, P680, DOI 10.7326/0003-4819-148-9-200805060-00008; Quandt SA, 2005, MAYO CLIN PROC, V80, P343, DOI 10.4065/80.3.343; RECKER RR, 1992, JAMA-J AM MED ASSOC, V268, P2403, DOI 10.1001/jama.268.17.2403; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schousboe JT, 2005, J AM GERIATR SOC, V53, P1697, DOI 10.1111/j.1532-5415.2005.53504.x; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; SHEA B, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004526.PUB2; Tannenbaum C, 2002, J CLIN ENDOCR METAB, V87, P4431, DOI 10.1210/jc.2002-020275; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Watts Nelson B, 2010, Endocr Pract, V16, P1016; Wolff I, 1999, OSTEOPOROSIS INT, V9, P1, DOI 10.1007/s001980050109; World Health Organization Collaborating Centre for Metabolic Bone, 2010, FRAX WHO FRACT RISK	51	9	9	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2011	155	1							ITC1	10.7326/0003-4819-155-1-201107050-01001	http://dx.doi.org/10.7326/0003-4819-155-1-201107050-01001			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788MA	21727287				2022-12-28	WOS:000292447800013
J	Uzun, G; Mutluoglu, M				Uzun, Gunalp; Mutluoglu, Mesut			Dependent Rubor	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Uzun, Gunalp; Mutluoglu, Mesut] Haydarpasa Teaching Hosp, Gulhane Mil Med Acad, Istanbul, Turkey	Gulhane Military Medical Academy; Istanbul Haydarpasa Numune Training & Research Hospital; Istanbul Haydarpasa Sultan Abdulhamid Training & Research Hospital	Uzun, G (corresponding author), Haydarpasa Teaching Hosp, Gulhane Mil Med Acad, Istanbul, Turkey.	gunalpuzun@yahoo.com	Mutluoglu, Mesut/B-4451-2009; Uzun, Gunalp/C-2363-2009	Uzun, Gunalp/0000-0002-8717-6230; Mutluoglu, Mesut/0000-0002-1112-5779					0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2011	364	26					E56	E56		10.1056/NEJMicm1010160	http://dx.doi.org/10.1056/NEJMicm1010160			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	785AM	21714646				2022-12-28	WOS:000292199800010
J	Blendon, RJ; Benson, JM				Blendon, Robert J.; Benson, John M.			The Public's Views about Medicare and the Budget Deficit	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Blendon, Robert J.; Benson, John M.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Blendon, Robert J.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Blendon, RJ (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							[Anonymous], 2010, NY TIMES        1106; Binstock RH, 2006, GENERATIONS, V30, P24; Blendon RJ, 2008, NEW ENGL J MED, V359, P2050, DOI 10.1056/NEJMsr0807717; Campbell A. L., 2003, POLICIES MAKE CITIZE; U.S. Census Bureau, 2011 STAT ABSTR POP	5	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4								10.1056/NEJMp1107184	http://dx.doi.org/10.1056/NEJMp1107184			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798AJ	21751897				2022-12-28	WOS:000293172200007
J	Seeley, RJ; Sandoval, DA				Seeley, Randy J.; Sandoval, Darleen A.			NEUROSCIENCE Weight loss through smoking	NATURE			English	Editorial Material									[Seeley, Randy J.; Sandoval, Darleen A.] Univ Cincinnati, Metab Dis Inst, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati	Seeley, RJ (corresponding author), Univ Cincinnati, Metab Dis Inst, Cincinnati, OH 45237 USA.	randy.seeley@uc.edu		Seeley, Randy/0000-0002-3721-5625				Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Huang H, 2011, J NEUROPHYSIOL, V106, P1191, DOI 10.1152/jn.00740.2010; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106	6	28	30	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					176	177		10.1038/475176a	http://dx.doi.org/10.1038/475176a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753841				2022-12-28	WOS:000292690500035
J	Zukor, K; He, ZG				Zukor, Katherine; He, Zhigang			REGENERATIVE MEDICINE Drawing breath after spinal injury	NATURE			English	Editorial Material							CORD-INJURY; PLASTICITY; ELONGATION		[Zukor, Katherine; He, Zhigang] Childrens Hosp Boston, Kirby Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Zukor, K (corresponding author), Childrens Hosp Boston, Kirby Program Neurosci, Boston, MA 02115 USA.	katherine.zukor@childrens.harvard.edu; zhigang.he@childrens.harvard.edu						Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Goshgarian HG, 2003, J APPL PHYSIOL, V94, P795, DOI 10.1152/japplphysiol.00847.2002; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; RICHARDSON PM, 1982, BRAIN RES, V237, P147, DOI 10.1016/0006-8993(82)90563-7; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sun F, 2010, CURR OPIN NEUROBIOL, V20, P510, DOI 10.1016/j.conb.2010.03.013	13	4	6	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					178	179		10.1038/475178a	http://dx.doi.org/10.1038/475178a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21753842	Bronze			2022-12-28	WOS:000292690500037
J	Hampton, T				Hampton, Tracy			Data Mining Approach Shows Promise in Detecting Unexpected Drug Interactions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	5	5	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					144	144		10.1001/jama.2011.918	http://dx.doi.org/10.1001/jama.2011.918			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791CO	21750287				2022-12-28	WOS:000292639400004
J	Routen, AC				Routen, Ash C.			PERSONAL VIEW Should our children be sitting comfortably in school?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Worcester, Inst Sport & Exercise Sci, Worcester, Worcs, England	University of Worcester	Routen, AC (corresponding author), Univ Worcester, Inst Sport & Exercise Sci, Worcester, Worcs, England.	a.routen@worc.ac.uk		Routen, Ash/0000-0001-5651-4228					0	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 6	2011	343								d4273	10.1136/bmj.d4273	http://dx.doi.org/10.1136/bmj.d4273			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791SD	21734171				2022-12-28	WOS:000292684100011
J	Simon, A; Warszawski, J; Kariyawasam, D; Le Chenadec, J; Benhammou, V; Czernichow, P; Foissac, F; Laborde, K; Treluyer, JM; Firtion, G; Layouni, I; Munzer, M; Bavoux, F; Polak, M; Blanche, S				Simon, Albane; Warszawski, Josiane; Kariyawasam, Dulanjalee; Le Chenadec, Jerome; Benhammou, Valerie; Czernichow, Paul; Foissac, Frantz; Laborde, Kathleen; Treluyer, Jean-Marc; Firtion, Ghislaine; Layouni, Incs; Munzer, Martine; Bavoux, Francoise; Polak, Michel; Blanche, Stephane		ANRS French Perinatal Cohort Study	Association of Prenatal and Postnatal Exposure to Lopinavir-Ritonavir and Adrenal Dysfunction Among Uninfected Infants of HIV-Infected Mothers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PARTIAL ALDOSTERONE RESISTANCE; LOPINAVIR/RITONAVIR; PHARMACOKINETICS; INSUFFICIENCY; HYPERPLASIA; BIRTH; AGE; INHIBITORS; PREGNANCY; CHILDREN	Context Lopinavir-ritonavir is a human immunodeficiency virus 1 (HIV-1) protease inhibitor boosted by ritonavir, a cytochrome p450 inhibitor. A warning about its tolerance in premature newborns was recently released, and transient elevation of 17-hydroxyprogesterone (17OHP) was noted in 2 newborns treated with lopinavir-ritonavir in France. Objective To evaluate adrenal function in newborns postnatally treated with lopinavir-ritonavir. Design, Setting, and Participants Retrospective cross-sectional analysis of the database from the national screening for congenital adrenal hyperplasia (CAH) and the French Perinatal Cohort. Comparison of HIV-1-uninfected newborns postnatally treated with lopinavir-ritonavir and controls treated with standard zidovudine. Main Outcome Measures Plasma 17OHP and dehydroepiandrosterone-sulfate (DHEA-S) concentrations during the first week of treatment. Clinical and biological symptoms compatible with adrenal deficiency. Results Of 50 HIV-1-uninfected newborns who received lopinavir-ritonavir at birth for a median of 30 days (interquartile range [IQR], 25-33), 7 (14%) had elevated 17OHP levels greater than 16.5 ng/mL for term infants (>23.1 ng/mL for preterm) on days 1 to 6 vs 0 of 108 controls having elevated levels. The median 17OHP concentration for 42 term newborns treated with lopinavir-ritonavir was 9.9 ng/mL (IQR, 3.9-14.1 ng/mL) vs 3.7 ng/mL (IQR, 2.6-5.3 ng/mL) for 93 term controls (P < .001). The difference observed in median 17OHP values between treated newborns and controls was higher in children also exposed in utero (11.5 ng/mL vs 3.7 ng/mL; P < .001) than not exposed in utero (6.9 ng/mL vs 3.3 ng/mL; P =. 03). The median DHEA-S concentration among 18 term newborns treated with lopinavir-ritonavir was 9242 ng/mL (IQR, 1347-25 986 ng/mL) compared with 484 ng/mL (IQR, 218-1308 ng/mL) among 17 term controls (P < .001). The 17OHP and DHEA-S concentrations were positively correlated (r = 0.53; P =. 001). All term newborns treated with lopinavir-ritonavir were asymptomatic, although 3 premature newborns experienced life-threatening symptoms compatible with adrenal insufficiency, including hyponatremia and hyperkalemia with, in 1 case, cardiogenic shock. All symptoms resolved following completion of the lopinavir-ritonavir treatment. Conclusion Among newborn children of HIV-1-infected mothers exposed in utero to lopinavir-ritonavir, postnatal treatment with a lopinavir-ritonavir-based regimen, compared with a zidovudine-based regimen, was associated with transient adrenal dysfunction.	[Blanche, Stephane] Hop Necker Enfants Malad, AP HP, Unite Immunol Hematol Pediat, F-75015 Paris, France; [Simon, Albane; Kariyawasam, Dulanjalee; Polak, Michel] Assoc Francaise Depistage & Prevent Handicaps Enf, Unite Endocrinol Pediat, Paris, France; [Foissac, Frantz; Treluyer, Jean-Marc] Hop Necker Enfants Malad, AP HP, Paris Ctr, Unite Rech Clin, F-75015 Paris, France; [Laborde, Kathleen] Hop Necker Enfants Malad, AP HP, Lab Explorat Fonct, F-75015 Paris, France; [Polak, Michel] Hop Necker Enfants Malad, AP HP, INSERM, U845, F-75015 Paris, France; [Foissac, Frantz; Treluyer, Jean-Marc; Blanche, Stephane] EA 3620, Paris, France; [Simon, Albane; Kariyawasam, Dulanjalee; Polak, Michel] Univ Paris 05, Paris, France; [Warszawski, Josiane; Le Chenadec, Jerome; Benhammou, Valerie] Equipe VIH & IST, INSERM, CESP U1018, Le Kremlin Bicetre, France; [Warszawski, Josiane] Univ & Fac Med Paris Sud, Le Kremlin Bicetre, France; [Warszawski, Josiane] Hop Bicetre, AP HP, Serv Epidemiol & Sante Publ, Le Kremlin Bicetre, France; [Firtion, Ghislaine] Hop Cochin Port Royal, AP HP, Serv Neonatol, Creteil, France; [Layouni, Incs] Hop Intercommunal Creteil, Serv Neonatol, Creteil, France; [Munzer, Martine] Ctr Hosp Univ Reims, Serv Pediat, Reims, France; [Bavoux, Francoise] Hop Cochin St Vincent Paul, AP HP, Unite Pharmacovigilance Pediat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; CHU de Reims; Universite de Reims Champagne-Ardenne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Blanche, S (corresponding author), Hop Necker Enfants Malad, AP HP, Unite Immunol Hematol Pediat, 149 Rue Sevres, F-75015 Paris, France.	stephane.blanche@nck.aphp.fr	kariyawasam, dulanjalee/AAH-1867-2021; Foix-L'Hélias, Laurence/AAH-4933-2019; treluyer, Jean-Marc/F-8036-2010; Matheron, Sophie/D-7420-2017	Foix-L'Hélias, Laurence/0000-0002-5699-4839; Matheron, Sophie/0000-0001-7879-6553	Abbott Laboratories; Pfizer; IPSEN; Sandoz-SAS Laboratories	Abbott Laboratories(Abbott Laboratories); Pfizer(Pfizer); IPSEN(Ipsen); Sandoz-SAS Laboratories(Randox Laboratories)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Warszawski reported having obtained a research grant from Abbott Laboratories for another study concerning lopinavir-ritonavir in children. Dr Polak reported having received support for educational presentations and grant support from Pfizer, IPSEN, and Sandoz-SAS Laboratories. Dr Blanche reported having received support for travel to meetings from Abbott Laboratories and honoraria for lectures and for development of educational presentations from Astellas, Boehringer Ingelheim, GlaxoSmithKline, and Tibotec Laboratories. No other disclosures were reported.r This study was supported by the French Agence Nationale de Recherche sur le SIDA (ANRS) and Agence Francaise de Securite Sanitaire et des Produits de Sante (AFSSAPS).	[Anonymous], KAL LOP RIT LAB CHAN; [Anonymous], PRISE CHARGE MED PER; Beal B., 1992, NONMEM USERS GUIDE; Benhammou V, 2008, AIDS, V22, P2165, DOI 10.1097/QAD.0b013e328311d18b; BLANCHE S, 1989, NEW ENGL J MED, V320, P1643, DOI 10.1056/NEJM198906223202502; Bornstein SR, 2009, NEW ENGL J MED, V360, P2328, DOI 10.1056/NEJMra0804635; Cavarzere P, 2009, EUR J ENDOCRINOL, V161, P285, DOI 10.1530/EJE-09-0145; Chadwick EG, 2008, AIDS, V22, P249, DOI 10.1097/QAD.0b013e3282f2be1d; Chadwick EG, 2009, PEDIATR INFECT DIS J, V28, P215, DOI 10.1097/INF.0b013e31818cc053; Chiappini E, 2009, CLIN INFECT DIS, V49, P1618, DOI 10.1086/644774; Coovadia H, 2009, CURR OPIN HIV AIDS, V4, P319, DOI 10.1097/COH.0b013e32832a9a17; Croxtall JD, 2010, DRUGS, V70, P1885, DOI 10.2165/11204950-000000000-00000; DEPERETTI E, 1978, J CLIN ENDOCR METAB, V47, P572, DOI 10.1210/jcem-47-3-572; DHONDT JL, 1986, J INHERIT METAB DIS, V9, P147, DOI 10.1007/BF01800869; Fernandez EF, 2009, J PERINATOL, V29, pS44, DOI 10.1038/jp.2009.24; Foisy MM, 2008, HIV MED, V9, P389, DOI 10.1111/j.1468-1293.2008.00579.x; Forest MG., 2003, DIAGNOSTICS ENDOCRIN, V3, P372; Gingelmaier A, 2006, AIDS, V20, P1737, DOI 10.1097/01.aids.0000242820.67001.2c; Haile-Selassie H, HIV MED, DOI [10.1111/j.1468-1293.2010.00902, DOI 10.1111/J.1468-1293.2010.00902]; Jullien V, 2006, ANTIMICROB AGENTS CH, V50, P3548, DOI 10.1128/AAC.00943-05; Lopriore E, 2007, AIDS, V21, P2564, DOI 10.1097/QAD.0b013e3282f12060; Lyall E G, 2001, HIV Med, V2, P314, DOI 10.1046/j.1464-2662.2001.00082.x; Martinerie L, 2009, PEDIATR RES, V66, P323, DOI 10.1203/PDR.0b013e3181b1bbec; Martinerie L, 2009, ENDOCRINOLOGY, V150, P4414, DOI 10.1210/en.2008-1498; McArthur MA, 2009, PEDIATR INFECT DIS J, V28, P1127, DOI 10.1097/INF.0b013e3181acd17e; Neary N, 2010, CURR OPIN ENDOCRINOL, V17, P217, DOI 10.1097/MED.0b013e328338f608; Nielsen KN, 2011, 18 C RETR OPP INF CR; Ozturk IC, 2000, MOL DIAGN, V5, P47, DOI 10.2165/00066982-200005010-00011; Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, REC US ANT DRUGS PRE; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Urien S, 2011, BRIT J CLIN PHARMACO, V71, P956, DOI 10.1111/j.1365-2125.2011.03926.x; Watterberg Kristi L, 2004, Semin Neonatol, V9, P13, DOI 10.1016/j.siny.2003.08.003; White PC, 2009, NAT REV ENDOCRINOL, V5, P490, DOI 10.1038/nrendo.2009.148; Yeh RF, 2009, ANTIMICROB AGENTS CH, V53, P2367, DOI 10.1128/AAC.01523-08	34	62	62	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					70	78		10.1001/jama.2011.915	http://dx.doi.org/10.1001/jama.2011.915			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	21730243	Bronze			2022-12-28	WOS:000292378700022
J	Chow, EJ; Mueller, BA; Baker, KS; Cushing-Haugen, KL; Flowers, MED; Martin, PJ; Friedman, DL; Lee, SJ				Chow, Eric J.; Mueller, Beth A.; Baker, K. Scott; Cushing-Haugen, Kara L.; Flowers, Mary E. D.; Martin, Paul J.; Friedman, Debra L.; Lee, Stephanie J.			Cardiovascular Hospitalizations and Mortality Among Recipients of Hematopoietic Stem Cell Transplantation	ANNALS OF INTERNAL MEDICINE			English	Article							LONG-TERM SURVIVORS; BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; ADMINISTRATIVE DATA; EUROPEAN-GROUP; VASCULAR ENDOTHELIUM; METABOLIC SYNDROME; KIDNEY-DISEASE; HEART-FAILURE; UNITED-STATES	Background: Hematopoietic stem cell transplantation (HSCT) is increasingly used to treat multiple malignant and nonmalignant conditions. The risk for cardiovascular disease after the procedure has not been well-described. Objective: To compare rates and hazards of cardiovascular-related hospitalization and death among persons who were still alive at least 2 years after HSCT with those in a population-based sample. Design: Retrospective cohort study. Setting: Comprehensive cancer center. Patients: 1491 patients who had survived 2 years or longer after HSCT received between 1985 and 2006, and frequency-matched persons who were randomly selected from drivers' license files in the state of Washington. Measurements: Cardiovascular hospitalizations and death, as determined from statewide hospital discharge records and death registries in Washington. Results: Compared with the general population, transplant recipients experienced increased cardiovascular death (adjusted incidence rate difference, 3.6 per 1000 person-years [95% CI, 1.7 to 5.5]). Recipients also had an increased cumulative incidence of ischemic heart disease, cardiomyopathy or heart failure, stroke, vascular diseases, and rhythm disorders and an increased incidence of related conditions that predispose toward more serious cardiovascular disease (hypertension, renal disease, dyslipidemia, and diabetes). No consistent differences in hazards were observed after total-body irradiation or receipt of an allogeneic versus an autologous graft, aside from an increased rate of hypertension among recipients of allogeneic grafts. Disease relapse after transplantation was associated with an increased hazard of cardiovascular death (hazard ratio, 2.3 [CI, 1.1 to 4.8]). Limitation: All patients received HSCT at a single institution, and no information was available on pretransplantation treatment and lifestyle factors that may influence risk for cardiovascular disease. Conclusion: Increased rates of cardiovascular disease should be taken into account when caring for patients who have received HSCT. Future efforts should be directed toward improved screening and controlling of factors that predispose toward cardiovascular disease.	[Chow, Eric J.] Seattle Childrens Hosp, Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Seattle, WA 98195 USA; Vanderbilt Univ, Nashville, TN USA; Vanderbilt Ingram Canc Ctr, Nashville, TN USA	Fred Hutchinson Cancer Center; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Vanderbilt University; Vanderbilt University	Chow, EJ (corresponding author), Seattle Childrens Hosp, Fred Hutchinson Canc Res Ctr, POB 19024,M4-C308, Seattle, WA 98109 USA.	ericchow@u.washington.edu	Chow, Eric/GWV-1056-2022; Chow, Eric/AAU-8380-2021	Chow, Eric/0000-0001-7712-961X; Chow, Eric/0000-0001-7712-961X	American Society for Blood and Marrow Transplantation; Leukemia and Lymphoma Society; Seattle Children's Research Institute; NATIONAL CANCER INSTITUTE [U54CA091408] Funding Source: NIH RePORTER	American Society for Blood and Marrow Transplantation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Seattle Children's Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Primary Funding Source: The American Society for Blood and Marrow Transplantation, the Leukemia and Lymphoma Society, and the Seattle Children's Research Institute.	Annaloro C, 2008, BONE MARROW TRANSPL, V41, P797, DOI 10.1038/sj.bmt.1705972; Armenian SH, 2008, J CLIN ONCOL, V26, P5537, DOI 10.1200/JCO.2008.17.7428; Baker KS, 2007, BLOOD, V109, P1765, DOI 10.1182/blood-2006-05-022335; Bhatia S, 2005, BLOOD, V105, P4215, DOI 10.1182/blood-2005-01-0035; Bhatia S, 2007, BLOOD, V110, P3784, DOI 10.1182/blood-2007-03-082933; Biedermann BC, 2008, BEST PRACT RES CL HA, V21, P129, DOI 10.1016/j.beha.2008.02.003; Centers for Disease Control and Prevention, GROWTH CHARTS; Chao NJ, 2008, THOMAS HEMATOPOTETIC, P1257, DOI DOI 10.1016/J.BEHA.2008.02.002; Chow EJ, 2010, BIOL BLOOD MARROW TR, V16, P1674, DOI 10.1016/j.bbmt.2010.05.016; GIANNI L, 2008, BLOOD, V26, P3777; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Herman AA, 1997, PAEDIATR PERINAT EP, V11, P5, DOI 10.1046/j.1365-3016.11.s1.11.x; Hingorani S, 2007, BONE MARROW TRANSPL, V39, P223, DOI 10.1038/sj.bmt.1705573; Hoffmeister PA, 2004, J PEDIAT HEMATOL ONC, V26, P81, DOI 10.1097/00043426-200402000-00003; HOROWITZ MM, 2008, THOMAS HEMATOPOIETIC, P15; IVES DG, 2009, MED CARE, V57, P133; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Majhail NS, 2009, BONE MARROW TRANSPL, V43, P49, DOI 10.1038/bmt.2008.263; Martin PJ, 2010, J CLIN ONCOL, V28, P1011, DOI 10.1200/JCO.2009.25.6693; Meacham LR, 2010, CANCER EPIDEM BIOMAR, V19, P170, DOI 10.1158/1055-9965.EPI-09-0555; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; *OFF FIN MAN STAT, AG SEX RAC HISP OR; *OFF FIN MAN STAT, MIGR, DOI DOI 10.1016/J.ANNEPIDEM.2003.09.016; Powell H, 2001, J CLIN EPIDEMIOL, V54, P687, DOI 10.1016/S0895-4356(00)00364-4; Quan H, 2004, MED CARE, V42, P801, DOI 10.1097/01.mlr.0000132391.59713.0d; Rizzo JD, 2006, BIOL BLOOD MARROW TR, V12, P138, DOI 10.1016/j.bbmt.2005.09.012; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Saydah SH, 2004, ANN EPIDEMIOL, V14, P507, DOI 10.1016/j.annepidem.2003.09.016; Schmitz N, 2006, BLOOD, V108, P4288, DOI 10.1182/blood-2006-05-024042; Shankar SM, 2007, CANCER EPIDEM BIOMAR, V16, P834, DOI 10.1158/1055-9965.EPI-06-0714; Socie G, 2003, BLOOD, V101, P3373, DOI 10.1182/blood-2002-07-2231; SUN CL, 2010, CIRCULATION, V116, P3129; Taskinen M, 2000, LANCET, V356, P993, DOI 10.1016/S0140-6736(00)02717-3; Tichelli A, 2008, BEST PRACT RES CL HA, V21, P139, DOI 10.1016/j.beha.2008.02.002; Tichelli A, 2008, HAEMATOL-HEMATOL J, V93, P1203, DOI 10.3324/haematol.12949; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9	40	132	135	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2011	155	1					21	+		10.7326/0003-4819-155-1-201107050-00004	http://dx.doi.org/10.7326/0003-4819-155-1-201107050-00004			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788MA	21727290				2022-12-28	WOS:000292447800003
J	Pregler, JP; Crandall, CJ				Pregler, Janet P.; Crandall, Carolyn J.			Update in Women's Health: Evidence Published in 2010	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; CANCER-SOCIETY GUIDELINES; CARDIOVASCULAR-DISEASE; COST-EFFECTIVENESS; CERVICAL-CANCER; BREAST; FRACTURES; MUTATION; RISK; BISPHOSPHONATES		[Pregler, Janet P.; Crandall, Carolyn J.] Univ Calif Los Angeles, David Geffen Sch Med, Iris Cantor UCLA Womens Hlth Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Pregler, JP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Iris Cantor UCLA Womens Hlth Ctr, 100 UCLA Med Plaza,Suite 250, Los Angeles, CA 90095 USA.	japregler@mednet.ucla.edu		Pregler, Janet/0000-0001-9420-161X				Abrahamsen B, 2009, J BONE MINER RES, V24, P1095, DOI [10.1359/JBMR.081247, 10.1359/jbmr.081247]; Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; American College of Obstetricians and Gynecologists Committee on Gynecologic Practice, 2008, Obstet Gynecol, V112, P1189, DOI 10.1097/AOG.0b013e31818e8782; Anderson K, 2006, ANN INTERN MED, V144, P397, DOI 10.7326/0003-4819-144-6-200603210-00006; [Anonymous], 2009, Obstet Gynecol, V114, P1409, DOI 10.1097/AOG.0b013e3181c6f8a4; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Berg AO, 2005, ANN INTERN MED, V143, P355, DOI 10.7326/0003-4819-143-5-200509060-00011; Berg AO, 2003, AM FAM PHYSICIAN, V67, P1759; Bolland MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3691; Favus MJ, 2010, NEW ENGL J MED, V363, P2027, DOI 10.1056/NEJMct1004903; Institute of Medicine, 2010, DIET REF INT CALC VI; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Mosca L, 2007, J AM COLL CARDIOL, V49, P1230, DOI 10.1016/j.jacc.2007.02.020; National Osteoporosis Foundation, 2008, CLIN GUID PREV TREAT; Nichols MI, 2010, OBSTET GYNECOL, V116, P1252, DOI 10.1097/AOG.0b013e3181ff93d8; Plevritis SK, 2006, JAMA-J AM MED ASSOC, V295, P2374, DOI 10.1001/jama.295.20.2374; Qaseem A, 2008, ANN INTERN MED, V149, P404, DOI 10.7326/0003-4819-149-6-200809160-00007; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Shane E, 2010, NEW ENGL J MED, V362, P1825, DOI 10.1056/NEJMe1003064; Smith RA, 2009, CA-CANCER J CLIN, V59, P27, DOI 10.3322/caac.20008; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P346, DOI 10.1016/j.ajog.2007.07.047	23	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2011	155	1					52	+		10.7326/0003-4819-155-1-201107050-00341	http://dx.doi.org/10.7326/0003-4819-155-1-201107050-00341			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788MA	21727293				2022-12-28	WOS:000292447800006
J	Bennett, DA; Emberson, JR				Bennett, Derrick A.; Emberson, Jonathan R.			Text messaging in smoking cessation: the txt2stop trial	LANCET			English	Editorial Material							MORTALITY; PHONES		[Bennett, Derrick A.; Emberson, Jonathan R.] Univ Oxford, Nuffield Dept Clin Med, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Bennett, Derrick A.; Emberson, Jonathan R.] Univ Oxford, Nuffield Dept Clin Med, Epidemiol Studies Unit, Oxford OX3 7LF, England	University of Oxford; University of Oxford	Bennett, DA (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Clin Trial Serv Unit, Richard Doll Bldg, Oxford OX3 7LF, England.	derrick.bennett@ctsu.ox.ac.uk	, Bennett/O-7998-2019; Bennett, Derrick/AFL-9254-2022; Bennett, Derrick/AAH-1220-2022	Bennett, Derrick/0000-0002-9170-8447; Bennett, Derrick/0000-0002-9170-8447; Emberson, Jonathan/0000-0001-7792-9422				Allender S, 2009, TOB CONTROL, V18, P262, DOI 10.1136/tc.2008.026294; Cole-Lewis H, 2010, EPIDEMIOL REV, V32, P56, DOI 10.1093/epirev/mxq004; Collins R, 2001, LANCET, V357, P373, DOI 10.1016/S0140-6736(00)03651-5; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; Free C, 2011, LANCET, V378, P49, DOI 10.1016/S0140-6736(11)60701-0; Kaplan WA, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-9; Krishna S, 2009, TELEMED J E-HEALTH, V15, P231, DOI 10.1089/tmj.2008.0099; Mottillo S, 2009, EUR HEART J, V30, P718, DOI 10.1093/eurheartj/ehn552; Peto R, 1994, MORTALITY SMOKING DE; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; Warren CW, 2006, LANCET, V367, P749, DOI 10.1016/S0140-6736(06)68192-0; World Health Organization, 2009, WHO REP GLOB TOB EP	13	11	11	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2011	378	9785					6	7		10.1016/S0140-6736(11)60882-9	http://dx.doi.org/10.1016/S0140-6736(11)60882-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791IU	21722951				2022-12-28	WOS:000292659700006
J	Franke-Arnold, S; Gibson, G; Boyd, RW; Padgett, MJ				Franke-Arnold, Sonja; Gibson, Graham; Boyd, Robert W.; Padgett, Miles J.			Rotary Photon Drag Enhanced by a Slow-Light Medium	SCIENCE			English	Article							ORBITAL ANGULAR-MOMENTUM; ROTATING MEDIUM; AETHER DRAG; POLARIZATION; PROPAGATION	Transmission through a spinning window slightly rotates the polarization of the light, typically by a microradian. It has been predicted that the same mechanism should also rotate an image. Because this rotary photon drag has a contribution that is inversely proportional to the group velocity, the image rotation is expected to increase in a slow-light medium. Using a ruby window under conditions for coherent population oscillations, we induced an effective group index of about 1 million. The resulting rotation angle was large enough to be observed by the eye. This result shows that rotary photon drag applies to images as well as polarization. The possibility of switching between different rotation states may offer new opportunities for controlled image coding.	[Franke-Arnold, Sonja; Gibson, Graham; Padgett, Miles J.] Univ Glasgow, Sch Phys & Astron SUPA, Glasgow G12 8QQ, Lanark, Scotland; [Boyd, Robert W.] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; [Boyd, Robert W.] Univ Rochester, Inst Opt, Rochester, NY 14627 USA; [Boyd, Robert W.] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA	University of Glasgow; University of Ottawa; University of Rochester; University of Rochester	Franke-Arnold, S (corresponding author), Univ Glasgow, Sch Phys & Astron SUPA, Glasgow G12 8QQ, Lanark, Scotland.	sonja.franke-arnold@glasgow.ac.uk	Padgett, Miles J/B-7625-2008; Franke-Arnold, Sonja/C-6927-2009	Padgett, Miles J/0000-0001-6643-0618; Franke-Arnold, Sonja/0000-0002-2375-4206; Gibson, Graham/0000-0003-0051-8654	UK Engineering and Physical Sciences Research Council; Royal Society; Wolfson Foundation; European Commission [FP7-ICT-255914]; Defense Advanced Research Projects Agency (DARPA)-DSO Slow Light Program; Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense [HDTRA1-10-1-0025]	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); Wolfson Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Defense Advanced Research Projects Agency (DARPA)-DSO Slow Light Program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense(United States Department of DefenseDefense Threat Reduction Agency)	This work is supported by the UK Engineering and Physical Sciences Research Council. M.J.P. thanks the Royal Society and the Wolfson Foundation. We acknowledge the financial support of the Future and Emerging Technologies (FET) program for Research of the European Commission, under the FET Open grant agreement PHORBITECH number FP7-ICT-255914. R. W. B. acknowledges support from the Defense Advanced Research Projects Agency (DARPA)-DSO Slow Light Program and from the Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense (grant HDTRA1-10-1-0025). The enhancement of image rotation in a slow-light medium was proposed by S. F.-A. and R. W. B., based on the spinning window for image drag previously investigated by M.J.P. The theoretical analysis was devised by S. F. A. and R. B. and performed by S. F. A. The experiment was designed by G. G. and M.J.P. and performed by G. G. All authors contributed to the writing of the manuscript.	Allen L, 2007, J MOD OPTIC, V54, P487, DOI 10.1080/09500340600832709; ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; Bigelow MS, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.113903; Bigelow MS, 2003, SCIENCE, V301, P200, DOI 10.1126/science.1084429; Courtial J, 1998, PHYS REV LETT, V81, P4828, DOI 10.1103/PhysRevLett.81.4828; Fizeau M.H, 1860, PHILOS MAG, V19, P245; FIZEAU MH, 1859, ANN CHIM PHYS, V57, P385; Fresnel A., 1818, ANN CHIM PHYS, V9, P57; GARETZ BA, 1981, J OPT SOC AM, V71, P609, DOI 10.1364/JOSA.71.000609; Gotte JB, 2007, P ROY SOC A-MATH PHY, V463, P2185, DOI 10.1098/rspa.2007.1871; JONES RV, 1976, P ROY SOC LOND A MAT, V349, P423, DOI 10.1098/rspa.1976.0082; JONES RV, 1972, PROC R SOC LON SER-A, V328, P337, DOI 10.1098/rspa.1972.0081; Leach J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.153902; NIENHUIS G, 1992, PHYS REV A, V46, P7079, DOI 10.1103/PhysRevA.46.7079; Padgett M, 2006, OPT LETT, V31, P2205, DOI 10.1364/OL.31.002205; Piredda G, 2007, J EUR OPT SOC-RAPID, V2, DOI 10.2971/jeos.2007.07004; PLAYER MA, 1976, P ROY SOC LOND A MAT, V349, P441, DOI 10.1098/rspa.1976.0083; Schweinsberg A, 2006, EUROPHYS LETT, V73, P218, DOI 10.1209/epl/i2005-10371-0	18	77	78	3	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					65	67		10.1126/science.1203984	http://dx.doi.org/10.1126/science.1203984			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719672				2022-12-28	WOS:000292255400048
J	Murenzi, R				Murenzi, Romain			Give the new generation a chance	NATURE			English	Editorial Material									TWAS, Trieste, Italy		Murenzi, R (corresponding author), TWAS, Trieste, Italy.	edoffice@twas.org		Murenzi, Romain/0000-0003-4228-7516					0	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2011	474	7353					543	543		10.1038/474543a	http://dx.doi.org/10.1038/474543a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	785CF	21720323	Bronze			2022-12-28	WOS:000292204300004
J	Matson, CK; Murphy, MW; Sarver, AL; Griswold, MD; Bardwell, VJ; Zarkower, D				Matson, Clinton K.; Murphy, Mark W.; Sarver, Aaron L.; Griswold, Michael D.; Bardwell, Vivian J.; Zarkower, David			DMRT1 prevents female reprogramming in the postnatal mammalian testis	NATURE			English	Article							DM-DOMAIN GENE; SEX DETERMINATION; OVARIAN FAILURE; FOXL2; DIFFERENTIATION; EXPRESSION; MOUSE; SOX9	Sex in mammals is determined in the fetal gonad by the presence or absence of the Y chromosome gene Sry, which controls whether bipotential precursor cells differentiate into testicular Sertoli cells or ovarian granulosa cells(1). This pivotal decision in a single gonadal cell type ultimately controls sexual differentiation throughout the body. Sex determination can be viewed as a battle for primacy in the fetal gonad between a male regulatory gene network in which Sry activates Sox9 and a female network involving WNT/beta-catenin signalling(2). In females the primary sex-determining decision is not final: loss of the FOXL2 transcription factor in adult granulosa cells can reprogram granulosa cells into Sertoli cells(2). Here we show that sexual fate is also surprisingly labile in the testis: loss of the DMRT1 transcription factor(3) in mouse Sertoli cells, even in adults, activates Foxl2 and reprograms Sertoli cells into granulosa cells. In this environment, theca cells form, oestrogen is produced and germ cells appear feminized. Thus Dmrt1 is essential to maintain mammalian testis determination, and competing regulatory networks maintain gonadal sex long after the fetal choice between male and female. Dmrt1 and Foxl2 are conserved throughout vertebrates(4,5) and Dmrt1-related sexual regulators are conserved throughout metazoans(3). Antagonism between Dmrt1 and Foxl2 for control of gonadal sex may therefore extend beyond mammals. Reprogramming due to loss of Dmrt1 also may help explain the aetiology of human syndromes linked to DMRT1, including disorders of sexual differentiation(6) and testicular cancer(7).	[Matson, Clinton K.; Murphy, Mark W.; Bardwell, Vivian J.; Zarkower, David] Univ Minnesota, Ctr Dev Biol, Minneapolis, MN 55455 USA; [Matson, Clinton K.; Murphy, Mark W.; Bardwell, Vivian J.; Zarkower, David] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Matson, Clinton K.; Bardwell, Vivian J.; Zarkower, David] Univ Minnesota, Mol Cellular Dev Biol & Genet Grad Program, Minneapolis, MN 55455 USA; [Sarver, Aaron L.; Bardwell, Vivian J.; Zarkower, David] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Griswold, Michael D.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Washington State University	Zarkower, D (corresponding author), Univ Minnesota, Ctr Dev Biol, Minneapolis, MN 55455 USA.	bardw001@umn.edu; zarko001@umn.edu			NIH [GM59152]; Minnesota Medical Foundation; NSF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD010808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059152] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Medical Foundation; NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Treier for helpful discussion, K. Hatzi, A. Minkina, A. Peterson, the University of Minnesota Mouse Genetics Laboratory and C. Small for technical assistance, J. Dean, R. Veitia and K.-i. Morohashi for antibodies, D. Greenstein and A. M. Weber-Main for comments on the manuscript, C. Manivel for histology expertise, M. Steffes and D. Gabrielson for oestradiol analysis, and the University of Minnesota Supercomputing Institute for computational resources. This work was funded by the NIH (GM59152), the Minnesota Medical Foundation, and a predoctoral fellowship from the NSF (to C.K.M.).	Barrionuevo F, 2009, DEV BIOL, V327, P301, DOI 10.1016/j.ydbio.2008.12.011; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Chang H, 2008, DEVELOPMENT, V135, P1875, DOI 10.1242/dev.018572; Cocquet J, 2005, GENOMICS, V85, P531, DOI 10.1016/j.ygeno.2005.01.007; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Duggavathi R, 2008, GENE DEV, V22, P1871, DOI 10.1101/gad.472008; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fahrioglu U, 2007, SEX DEV, V1, P42, DOI 10.1159/000096238; Kim S, 2007, DEV BIOL, V307, P314, DOI 10.1016/j.ydbio.2007.04.046; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Loffler KA, 2003, ENDOCRINOLOGY, V144, P3237, DOI 10.1210/en.2002-0095; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Murphy MW, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-58; Murphy MW, 2010, P NATL ACAD SCI USA, V107, P13360, DOI 10.1073/pnas.1006243107; Orisaka M, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-9; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Raymond CS, 1999, DEV BIOL, V215, P208, DOI 10.1006/dbio.1999.9461; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Tannour-Louet M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015392; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yoshimoto S, 2008, P NATL ACAD SCI USA, V105, P2469, DOI 10.1073/pnas.0712244105	31	401	422	2	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2011	476	7358					101	+		10.1038/nature10239	http://dx.doi.org/10.1038/nature10239			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21775990	Green Accepted			2022-12-28	WOS:000293447300038
J	Viviani, S; Zinzani, PL; Rambaldi, A; Brusamolino, E; Levis, A; Bonfante, V; Vitolo, U; Pulsoni, A; Liberati, AM; Specchia, G; Valagussa, P; Rossi, A; Zaja, F; Pogliani, EM; Pregno, P; Gotti, M; Gallamini, A; Scalabrini, DR; Bonadonna, G; Gianni, AM				Viviani, Simonetta; Zinzani, Pier Luigi; Rambaldi, Alessandro; Brusamolino, Ercole; Levis, Alessandro; Bonfante, Valeria; Vitolo, Umberto; Pulsoni, Alessandro; Liberati, Anna Marina; Specchia, Giorgina; Valagussa, Pinuccia; Rossi, Andrea; Zaja, Francesco; Pogliani, Enrico M.; Pregno, Patrizia; Gotti, Manuel; Gallamini, Andrea; Scalabrini, Delia Rota; Bonadonna, Gianni; Gianni, Alessandro M.		Michelangelo Fdn; Grp Italiano Terapie Innovative Ne; Intergrp Italiano Linfomi	ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELL TRANSPLANT; CHEMOTHERAPY; DISEASE; IFOSFAMIDE; VINORELBINE; FERTILITY; STANDARD; REGIMEN; HYBRID; MOPP	Background BEACOPP, an intensified regimen consisting of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone, has been advocated as the new standard of treatment for advanced Hodgkin's lymphoma, in place of the combination of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD). Methods We randomly assigned 331 patients with previously untreated and unfavorable Hodgkin's lymphoma (stage IIB, III, or IV, or an international prognostic score of >= 3 on a scale of 0 to 7, with higher scores indicating increased risk), to receive either BEACOPP or ABVD, each followed by local radiotherapy when indicated. Patients with residual or progressive disease after the initial therapy were to be treated according to a state-of-the-art high-dose salvage program. The median follow-up period was 61 months. Results The 7-year rate of freedom from first progression was 85% among patients who had received initial treatment with BEACOPP and 73% among those who had received initial treatment with ABVD (P = 0.004), and the 7-year rate of event-free survival was 78% and 71%, respectively (P = 0.15). A total of 65 patients (20 in the BEACOPP group, and 45 in the ABVD group) went on to receive the intended high-dose salvage regimen. As of the cutoff date, 3 of the 20 patients in the BEACOPP group and 15 of the 45 in the ABVD group who had had progressive disease or relapse after the initial therapy were alive and free of disease. After completion of the overall planned treatment, including salvage therapy, the 7-year rate of freedom from a second progression was 88% in the BEACOPP group and 82% in the ABVD group (P = 0.12), and the 7-year rate of overall survival was 89% and 84%, respectively (P = 0.39). Severe adverse events occurred more frequently in the BEACOPP group than in the ABVD group. Conclusions Treatment with BEACOPP, as compared with ABVD, resulted in better initial tumor control, but the long-term clinical outcome did not differ significantly between the two regimens.	[Gianni, Alessandro M.] Univ Milan, Ist Nazl Tumori, Dept Med Oncol, I-20133 Milan, Italy; [Viviani, Simonetta; Valagussa, Pinuccia; Bonadonna, Gianni; Gianni, Alessandro M.] Milan Canc Inst, Milan, Italy; [Pogliani, Enrico M.] Univ Milano Bicocca, Milan, Italy; [Pulsoni, Alessandro] Univ Roma La Sapienza, Rome, Italy; [Zinzani, Pier Luigi] Univ Bologna, Bologna, Italy; [Rambaldi, Alessandro; Rossi, Andrea] Osped Riuniti Bergamo, I-24100 Bergamo, Italy; [Brusamolino, Ercole; Gotti, Manuel] Policlin San Matteo, I-27100 Pavia, Italy; [Levis, Alessandro] Azienda Osped SS Antonio & Biagio & Cesare Arrigo, Alessandria, Italy; [Vitolo, Umberto; Pregno, Patrizia] Azienda Osped Univ San Giovanni Battista, Turin, Italy; [Liberati, Anna Marina] Azienda Osped Santa Maria Terni, Terni, Italy; [Specchia, Giorgina] Azienda Osped Policlin Consorziale, Bari, Italy; [Zaja, Francesco] Policlin Univ, Udine, Italy; [Gallamini, Andrea] Osped Santa Croce & Carle, Cuneo, Italy; [Scalabrini, Delia Rota] Ist Ric & Cura Cancro, Candiolo, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan; University of Milano-Bicocca; Sapienza University Rome; University of Bologna; Ospedali Riuniti di Bergamo; IRCCS Fondazione San Matteo; Azienda Ospedaliera SS Antonio Biagio Cesare Arrigo; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; Hospital Santa Maria della Misericordia; IRCCS Fondazione del Piemonte per l'Oncologia	Gianni, AM (corresponding author), Univ Milan, Ist Nazl Tumori, Dept Med Oncol, Via Venezian 1, I-20133 Milan, Italy.	alessandro.gianni@unimi.it	Gotti, Manuel/K-9120-2016; Zinzani, Pier Luigi/J-9182-2016; Viviani, Siimonetta/AAA-5685-2021; Rambaldi, Alessandro/P-2603-2018; Liberati, Anna Marina/I-8834-2012; Rambaldi, Alessandro/M-6172-2019; Viviani, Simonetta/F-6919-2017; Italiana Linfomi, Fondazione/AAW-6910-2021; Liberati, Anna Marina/C-1925-2017; Specchia, Giorgina/K-3084-2016	Zinzani, Pier Luigi/0000-0002-2112-2651; Rambaldi, Alessandro/0000-0002-3739-7502; Rambaldi, Alessandro/0000-0002-3739-7502; Viviani, Simonetta/0000-0002-5014-9546; Italiana Linfomi, Fondazione/0000-0002-5918-8824; Zaja, Francesco/0000-0003-3995-8817; Specchia, Giorgina/0000-0002-2479-9529; Valagussa, Pinuccia/0000-0003-3590-7916; vitolo, umberto/0000-0001-7772-2747	Fondazione Michelangelo	Fondazione Michelangelo	Funded by Fondazione Michelangelo	Bartlett Nancy L, 2005, Hematology Am Soc Hematol Educ Program, P245; BONADONNA G, 1975, CANCER, V36, P252, DOI 10.1002/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO;2-7; Bonfante V, 1998, BRIT J HAEMATOL, V103, P533; CANELLOS GP, 1992, NEW ENGL J MED, V327, P1478, DOI 10.1056/NEJM199211193272102; Cheson, 2000, J CLIN ONCOL, V18, P2351; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Cheson Bruce D, 2007, Curr Hematol Malig Rep, V2, P161, DOI 10.1007/s11899-007-0022-2; Clavio M, 2005, ONCOL REP, V14, P933; Diehl V, 2003, NEW ENGL J MED, V348, P2386, DOI 10.1056/NEJMoa022473; Diehl V, 2009, J CLIN ONCOL, V27; DIEHL V, 2005, NEW ENGL J MED, V353, P744; Diehl V, 2007, TRANSFUS APHER SCI, V37, P37, DOI 10.1016/j.transci.2007.04.004; Duggan DB, 2003, J CLIN ONCOL, V21, P607, DOI 10.1200/JCO.2003.12.086; Engert A, 2009, J CLIN ONCOL, V27, P4548, DOI 10.1200/JCO.2008.19.8820; Federico M, 2009, J CLIN ONCOL, V27, P805, DOI 10.1200/JCO.2008.17.0910; Forrest DL, 2005, J CLIN ONCOL, V23, P7994, DOI 10.1200/JCO.2005.01.9083; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Horning Sandra J, 2007, Hematology Am Soc Hematol Educ Program, P197; Hoskin PJ, 2009, J CLIN ONCOL, V27, P5390, DOI 10.1200/JCO.2009.23.3239; Jantunen E, 2006, EUR J HAEMATOL, V76, P245, DOI 10.1111/j.1600-0609.2005.00605.x; Johnson PWM, 2005, J CLIN ONCOL, V23, P9208, DOI 10.1200/JCO.2005.03.2151; Jurczak W, 2009, HAEMATOL-HEMATOL J, V94, P35; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; MILLS W, 1995, J CLIN ONCOL, V13, P588, DOI 10.1200/JCO.1995.13.3.588; SANTORO A, 1987, J CLIN ONCOL, V5, P27, DOI 10.1200/JCO.1987.5.1.27; Santoro A, 2007, HAEMATOL-HEMATOL J, V92, P35, DOI 10.3324/haematol.10661; Sieniawski M, 2008, BLOOD, V111, P71, DOI 10.1182/blood-2007-02-073544	27	287	301	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2011	365	3					203	212		10.1056/NEJMoa1100340	http://dx.doi.org/10.1056/NEJMoa1100340			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794QI	21774708	Bronze			2022-12-28	WOS:000292915500004
J	Sheldon, T				Sheldon, Tony			MARKET REFORMS Is competition law bad for patients?	BRITISH MEDICAL JOURNAL			English	Editorial Material												tonysheldon5@cs.com						*NED MED, 2010, RICHTSN ZORGS	1	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 20	2011	343								d4495	10.1136/bmj.d4495	http://dx.doi.org/10.1136/bmj.d4495			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	797ZH	21775402				2022-12-28	WOS:000293168700007
J	Perry, JJ; Stiell, IG; Sivilotti, MLA; Bullard, MJ; Emond, M; Symington, C; Sutherland, J; Worster, A; Hohl, C; Lee, JS; Eisenhauer, MA; Mortensen, M; Mackey, D; Pauls, M; Lesiuk, H; Wells, GA				Perry, Jeffrey J.; Stiell, Ian G.; Sivilotti, Marco L. A.; Bullard, Michael J.; Emond, Marcel; Symington, Cheryl; Sutherland, Jane; Worster, Andrew; Hohl, Corinne; Lee, Jacques S.; Eisenhauer, Mary A.; Mortensen, Melodie; Mackey, Duncan; Pauls, Merril; Lesiuk, Howard; Wells, George A.			Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To measure the sensitivity of modern third generation computed tomography in emergency patients being evaluated for possible subarachnoid haemorrhage, especially when carried out within six hours of headache onset. Design Prospective cohort study. Setting 11 tertiary care emergency departments across Canada, 2000-9. Participants Neurologically intact adults with a new acute headache peaking in intensity within one hour of onset in whom a computed tomography was ordered by the treating physician to rule out subarachnoid haemorrhage. Main outcome measures Subarachnoid haemorrhage was defined by any of subarachnoid blood on computed tomography, xanthochromia in cerebrospinal fluid, or any red blood cells in final tube of cerebrospinal fluid collected with positive results on cerebral angiography. Results Of the 3132 patients enrolled (mean age 45.1, 2571 (82.1%) with worst headache ever), 240 had subarachnoid haemorrhage (7.7%). The sensitivity of computed tomography overall for subarachnoid haemorrhage was 92.9% (95% confidence interval 89.0% to 95.5%), the specificity was 100% (99.9% to 100%), the negative predictive value was 99.4% (99.1% to 99.6%), and the positive predictive value was 100% (98.3% to 100%). For the 953 patients scanned within six hours of headache onset, all 121 patients with subarachnoid haemorrhage were identified by computed tomography, yielding a sensitivity of 100% (97.0% to 100.0%), specificity of 100% (99.5% to 100%), negative predictive value of 100% (99.5% to 100%), and positive predictive value of 100% (96.9% to 100%). Conclusion Modern third generation computed tomography is extremely sensitive in identifying subarachnoid haemorrhage when it is carried out within six hours of headache onset and interpreted by a qualified radiologist.	[Perry, Jeffrey J.] Univ Ottawa, Dept Emergency Med, Clin Epidemiol Program, Emergency Med,Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Perry, Jeffrey J.] Univ Ottawa, Dept Emergency Med, Clin Epidemiol Program, Epidemiol & Community Med,Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Perry, Jeffrey J.; Stiell, Ian G.; Symington, Cheryl; Mortensen, Melodie] Univ Ottawa, Dept Emergency Med, Clin Epidemiol Program, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Stiell, Ian G.] Univ Ottawa, Dept Emergency Med, Clin Epidemiol Program, Ottawa Hosp Res Inst,Dept Emergency Med, Ottawa, ON, Canada; [Sivilotti, Marco L. A.] Queens Univ, Dept Emergency Med, Emergency Med, Kingston, ON, Canada; [Sivilotti, Marco L. A.] Queens Univ, Dept Emergency Med, Pharmacol & Toxicol, Kingston, ON, Canada; [Sivilotti, Marco L. A.] Queens Univ, Dept Pharmacol & Toxicol, Emergency Med, Kingston, ON K7L 3N6, Canada; [Sivilotti, Marco L. A.] Queens Univ, Dept Pharmacol & Toxicol, Pharmacol & Toxicol, Kingston, ON K7L 3N6, Canada; [Mackey, Duncan] Univ Alberta, Dept Emergency Med, Edmonton, AB, Canada; [Bullard, Michael J.] Univ Alberta, Dept Emergency Med, Emergency Med, Edmonton, AB, Canada; [Emond, Marcel] Univ Laval, Dept Emergency Med, Quebec City, PQ G1K 7P4, Canada; [Sutherland, Jane] Univ Ottawa, Clin Epidemiol Program, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Worster, Andrew] Univ British Columbia, Dept Emergency Med, Vancouver, BC V5Z 1M9, Canada; [Hohl, Corinne] McMaster Univ, Div Emergency Med, Hamilton, ON, Canada; [Lee, Jacques S.] Univ Toronto, Div Emergency Med, Toronto, ON, Canada; [Eisenhauer, Mary A.] Univ Western Ontario, Div Emergency Med, London, ON, Canada; [Pauls, Merril] Univ Manitoba, Dept Emergency Med, Winnipeg, MB, Canada; [Lesiuk, Howard] Univ Ottawa, Div Neurosurg, Clin Epidemiol Program, Ottawa Hosp Res Inst,Consulting Neurosurg, Ottawa, ON, Canada; [Wells, George A.] Univ Ottawa, Dept Epidemiol & Community Med, Clin Epidemiol Program, Ottawa Hosp Res Ins,Biostat & Epidemiol, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada; University of Alberta; University of Alberta; Laval University; University of Ottawa; Ottawa Hospital Research Institute; University of British Columbia; McMaster University; University of Toronto; Western University (University of Western Ontario); University of Manitoba; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Perry, JJ (corresponding author), Ottawa Hosp, Clin Epidemiol Unit, F647,1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.	jperry@ohri.ca	Emond, Marcel/G-5804-2014; Sivilotti, Marco L.A./AAR-8892-2020; Hohl, Corinne M/AAY-3325-2021; Lee, Jacques/CAF-4380-2022	Emond, Marcel/0000-0001-7158-8110; Sivilotti, Marco L.A./0000-0001-6641-1118; Hohl, Corinne M/0000-0002-9210-7838; Lee, Jacques/0000-0002-9143-6285; Perry, Jeffrey/0000-0003-2134-9597; Stiell, Ian/0000-0002-2583-6408	Canadian Institutes for Health Research [67107, 153742]; Ontario Ministry of Health and Long Term Care; Physician's Services Incorporated Foundation [01-39]; Canadian Institutes for Health Research; Ontario Ministry of Health; Vancouver Coastal Health Research Institute	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Physician's Services Incorporated Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health(Ministry of Health and Long-Term Care, Ontario); Vancouver Coastal Health Research Institute	The study was funded by the Canadian Institutes for Health Research (grants 67107, 153742), the Ontario Ministry of Health and Long Term Care, and the physicians of Ontario through the Physician's Services Incorporated Foundation (01-39). JJP is supported by a Canadian Institutes for Health Research new investigator award and was previously supported as a career scientist by the Ontario Ministry of Health. IGS is a distinguished professor and university health research chair, University of Ottawa. CH is supported by a mentored clinician scientist award from the Vancouver Coastal Health Research Institute.	ADAMS HP, 1983, NEUROLOGY, V33, P981, DOI 10.1212/WNL.33.8.981; Boesiger BM, 2005, J EMERG MED, V29, P23, DOI 10.1016/j.jemermed.2005.02.002; Brisman JL, 2006, NEW ENGL J MED, V355, P928, DOI 10.1056/NEJMra052760; Byyny RL, 2008, ANN EMERG MED, V51, P697, DOI 10.1016/j.annemergmed.2007.10.007; Cortnum S, 2010, NEUROSURGERY, V66, P900, DOI [10.1227/01.NEU.0000367722.66098.21, 10.1227/01. NEU.0000367722.66098.21]; Edlow JA, 2000, ANN EMERG MED, V36, P507, DOI 10.1067/mem.2000.109449; Edlow JA, 2002, ARCH PATHOL LAB MED, V126, P413; Edlow JA, 2000, NEW ENGL J MED, V342, P29, DOI 10.1056/NEJM200001063420106; Edlow JA, 2008, ANN EMERG MED, V52, P407, DOI 10.1016/j.annemergmed.2008.07.001; Gee CA, 2009, ANN EMERG MED, V54, pS12, DOI 10.1016/j.annemergmed.2009.06.057; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Lourenco AP, 2009, J EMERG MED, V36, P171, DOI 10.1016/j.jemermed.2007.10.066; MACDONALD A, 1988, J NEUROL NEUROSUR PS, V51, P342, DOI 10.1136/jnnp.51.3.342; Morgenstern LB, 1998, ANN EMERG MED, V32, P297; Perry JJ, 2006, STROKE, V37, P2467, DOI 10.1161/01.STR.0000240689.15109.47; Perry Jeffrey J, 2002, CJEM, V4, P333; Perry JJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5204; Perry JJ, 2009, CAN J EMERG MED, V11, P516; Saini S, 2004, RADIOLOGY, V233, P323, DOI 10.1148/radiol.2332030994; Sames TA, 1996, ACAD EMERG MED, V3, P16, DOI 10.1111/j.1553-2712.1996.tb03296.x; Schievink WI, 1997, NEW ENGL J MED, V336, P28, DOI 10.1056/NEJM199701023360106; Sidman R, 1996, ACAD EMERG MED, V3, P827, DOI 10.1111/j.1553-2712.1996.tb03526.x; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; TEASDALE G, 1974, LANCET, V2, P81; TSEMENTZIS SA, 1985, NEUROSURGERY, V17, P908, DOI 10.1227/00006123-198512000-00007; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; VANDERWEE N, 1995, J NEUROL NEUROSUR PS, V58, P357, DOI 10.1136/jnnp.58.3.357; VERMEULEN M, 1990, J NEUROL NEUROSUR PS, V53, P365, DOI 10.1136/jnnp.53.5.365; Vermeulen MJ, 2007, STROKE, V38, P1216, DOI 10.1161/01.STR.0000259661.05525.9a; WEIR B, 1994, CEPHALALGIA, V14, P79, DOI 10.1046/j.1468-2982.1994.1402079.x	30	194	196	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 18	2011	343								d4277	10.1136/bmj.d4277	http://dx.doi.org/10.1136/bmj.d4277			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V41KX	21768192	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000209546200001
J	Horne-Badovinac, S; Munro, E				Horne-Badovinac, Sally; Munro, Edwin			Tubular Transformations	SCIENCE			English	Editorial Material							PLANAR CELL POLARITY; UNCONVENTIONAL MYOSIN; DROSOPHILA; MORPHOGENESIS; ORGANS		[Horne-Badovinac, Sally] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Munro, Edwin] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Horne-Badovinac, S (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58th St, Chicago, IL 60637 USA.	shorne@uchicago.edu						Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Hozumi S, 2006, NATURE, V440, P798, DOI 10.1038/nature04625; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Matsuyama M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000427; Meilhac SM, 2004, J CELL BIOL, V164, P97, DOI 10.1083/jcb.200309160; Segalen M, 2009, SEMIN CELL DEV BIOL, V20, P972, DOI 10.1016/j.semcdb.2009.03.018; Song H, 2010, NATURE, V466, P378, DOI 10.1038/nature09129; Speder P, 2006, NATURE, V440, P803, DOI 10.1038/nature04623; Tang N, 2011, SCIENCE, V333, P342, DOI 10.1126/science.1204831; Taniguchi K, 2011, SCIENCE, V333, P339, DOI 10.1126/science.1200940	12	4	4	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					294	295		10.1126/science.1209687	http://dx.doi.org/10.1126/science.1209687			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764735				2022-12-28	WOS:000292732000026
J	Misra, A; Garg, S				Misra, Anoop; Garg, Satish			HbA(1c) and blood glucose for the diagnosis of diabetes	LANCET			English	Editorial Material							FASTING PLASMA-GLUCOSE; HEMOGLOBIN A1C; ADULTS; ASSOCIATION; MELLITUS; IRON		[Misra, Anoop] Fortis Hosp, Fortis C DOC Ctr Excellence Diabet Obes Metab Dis, New Delhi 110016, India; [Garg, Satish] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Misra, A (corresponding author), Fortis Hosp, Fortis C DOC Ctr Excellence Diabet Obes Metab Dis, New Delhi 110016, India.	anoopmisra@metabolicresearchindia.com						Agus MSD, 2010, PEDIATR DIABETES, V11, P450, DOI 10.1111/j.1399-5448.2009.00635.x; Araneta MRG, 2010, DIABETES CARE, V33, P2626, DOI 10.2337/dc10-0958; Bao YQ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2249; Cheng YJ, 2009, DIABETES CARE, V32, P2027, DOI 10.2337/dc09-0440; Getaneh A, 2011, ENDOCR PRACT, V17, P210, DOI 10.4158/EP10119.OR; Hanas R, 2010, CLIN CHEM, V56, P1362, DOI 10.1373/clinchem.2010.150540; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016/S0140-6736(11)60472-8; Kim C, 2010, DIABETES CARE, V33, P780, DOI 10.2337/dc09-0836; Lippi G, 2011, PEDIATR DIABETES, V12, P183, DOI 10.1111/j.1399-5448.2010.00684.x; Lipska KJ, 2010, J CLIN ENDOCR METAB, V95, P5289, DOI 10.1210/jc.2010-1171; Mann DM, 2010, DIABETES CARE, V33, P2190, DOI 10.2337/dc10-0752; Mitka M, 2009, JAMA-J AM MED ASSOC, V301, P1528, DOI 10.1001/jama.2009.479; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Ng JM, 2010, DIABETES CARE, V33, P2310, DOI 10.2337/dc10-0917; Ollerton RL, 1999, DIABETES CARE, V22, P394, DOI 10.2337/diacare.22.3.394; Olson DE, 2010, DIABETES CARE, V33, P2184, DOI 10.2337/dc10-0433; Sacks DB, 2002, CLIN CHEM, V48, P436	18	13	13	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2011	378	9786					104	106		10.1016/S0140-6736(11)60789-7	http://dx.doi.org/10.1016/S0140-6736(11)60789-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	795CJ	21705066				2022-12-28	WOS:000292948800006
J	Eyler, EE				Eyler, Edward E.			Precision, Not Power	SCIENCE			English	Editorial Material							HELIUM		Univ Connecticut, Dept Phys, Storrs, CT 06269 USA	University of Connecticut	Eyler, EE (corresponding author), Univ Connecticut, Dept Phys, Storrs, CT 06269 USA.	edward.eyler@uconn.edu						Alexander SA, 2008, INT J QUANTUM CHEM, V108, P2813, DOI 10.1002/qua.21805; Eyler EE, 2008, EUR PHYS J D, V48, P43, DOI 10.1140/epjd/e2007-00289-y; Kandula DZ, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.063001; Lach G, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.042510; *NIST, 2010, 78 NIST; OTTERMANN CR, 1985, NUCL PHYS A, V436, P688, DOI 10.1016/0375-9474(85)90554-8; Pachucki K, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.062516; van Rooij R, 2011, SCIENCE, V333, P196, DOI 10.1126/science.1205163	8	0	0	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					164	165		10.1126/science.1208276	http://dx.doi.org/10.1126/science.1208276			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21737726				2022-12-28	WOS:000292502700030
J	Bodenheimer, T				Bodenheimer, Thomas			Lessons from the Trenches - A High-Functioning Primary Care Clinic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, Sch Med, Dept Family & Community Med, Ctr Excellence Primary Care, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bodenheimer, T (corresponding author), Univ Calif San Francisco, Sch Med, Dept Family & Community Med, Ctr Excellence Primary Care, San Francisco, CA 94143 USA.							Bodenheimer T, 2007, BUILDING TEAMS PRI 2; Bodenheimer T., 2007, BUILDING TEAMS PRI 1; *CLIN FAM HLTH SER, DET CLIN CAR MOD; Murray M, 2000, Fam Pract Manag, V7, P45; Saultz JW, 2005, ANN FAM MED, V3, P159, DOI 10.1370/afm.285; Schectman G, 2005, AM J MED, V118, P393, DOI 10.1016/j.amjmed.2005.01.003	6	38	38	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					5	8		10.1056/NEJMp1104942	http://dx.doi.org/10.1056/NEJMp1104942			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788QL	21732831				2022-12-28	WOS:000292459400003
J	Robinson, NJ				Robinson, Nigel J.			STRUCTURAL BIOLOGY A platform for copper pumps	NATURE			English	Editorial Material							ATPASES		Univ Durham, Biophys Sci Inst, Dept Chem, Sch Biol & Biomed Sci, Durham DH1 3LE, England	Durham University	Robinson, NJ (corresponding author), Univ Durham, Biophys Sci Inst, Dept Chem, Sch Biol & Biomed Sci, Durham DH1 3LE, England.	nigel.robinson@durham.ac.uk	Robinson, Nigel J/J-6363-2012	Robinson, Nigel J/0000-0001-5586-1092	Biotechnology and Biological Sciences Research Council [BB/H011110/1, BB/H011110/2] Funding Source: Medline; BBSRC [BB/H011110/2, BB/H011110/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; DAVIES K, 1993, NATURE, V361, P98, DOI 10.1038/361098a0; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Gonzalez-Guerrero M, 2010, MOL MICROBIOL, V78, P1246, DOI 10.1111/j.1365-2958.2010.07402.x; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201	10	7	7	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					41	42		10.1038/475041a	http://dx.doi.org/10.1038/475041a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734698				2022-12-28	WOS:000292461300038
J	Usher-Smith, JA; Thompson, MJ; Sharp, SJ; Walter, FM				Usher-Smith, Juliet A.; Thompson, Matthew J.; Sharp, Stephen J.; Walter, Fiona M.			Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CLINICAL CHARACTERISTICS; LABORATORY CHARACTERISTICS; CONSENSUS STATEMENT; PARTIAL REMISSION; METABOLIC-CONTROL; TYPE-1; MELLITUS; ONSET; ADOLESCENTS; FREQUENCY	Objective To identify the factors associated with diabetic ketoacidosis at diagnosis of type 1 diabetes in children and young adults. Design Systematic review. Data sources PubMed, EMBASE, Web of Science, Scopus, and Cinahl and article reference lists. Study selection Cohort studies including unselected groups of children and young adults presenting with new onset type 1 diabetes that distinguished between those who presented in diabetic ketoacidosis and those who did not and included a measurement of either pH or bicarbonate in the definition of diabetic ketoacidosis. There were no restrictions on language of publication. Results 46 studies involving more than 24 000 children in 31 countries were included. Together they compared 23 different factors. Factors associated with increased risk were younger age (for <2 years old v older, odds ratio 3.41 (95% confidence interval 2.54 to 4.59), for <5 years v older, odds ratio 1.59 (1.38 to 1.84)), diagnostic error (odds ratio 3.35 (2.35 to 4.79)), ethnic minority, lack of health insurance in the US (odds ratio 3.20 (2.03 to 5.04)), lower body mass index, preceding infection (odds ratio 3.14 (0.94 to 10.47)), and delayed treatment (odds ratio 1.74 (1.10 to 2.77)). Protective factors were having a first degree relative with type 1 diabetes at the time of diagnosis (odds ratio 0.33 (0.08 to 1.26)), higher parental education (odds ratios 0.4 (0.20 to 0.79) and 0.64 (0.43 to 0.94) in two studies), and higher background incidence of type 1 diabetes (correlation coefficient -0.715). The mean duration of symptoms was similar between children presenting with or without diabetic ketoacidosis (16.5 days (standard error 6.2) and 17.1 days (6.0) respectively), and up to 38.8% (285/735) of children who presented with diabetic ketoacidosis had been seen at least once by a doctor before diagnosis. Conclusions Multiple factors affect the risk of developing diabetic ketoacidosis at the onset of type 1 diabetes in children and young adults, and there is potential time, scope, and opportunity to intervene between symptom onset and development of diabetic ketoacidosis for both parents and clinicians.	[Usher-Smith, Juliet A.; Walter, Fiona M.] Univ Cambridge, General Practice & Primary Care Res Unit, Cambridge CB2 0SR, England; [Thompson, Matthew J.] Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; [Sharp, Stephen J.] MRC, Epidemiol Unit, Inst Metab Sci, Cambridge CB2 0QQ, England	University of Cambridge; University of Oxford; University of Cambridge	Usher-Smith, JA (corresponding author), Univ Cambridge, General Practice & Primary Care Res Unit, Cambridge CB2 0SR, England.	jau20@cam.ac.uk	Walter, Fiona/F-3054-2014; Walter, Fiona/GYR-1347-2022	Walter, Fiona/0000-0002-7191-6476; Usher-Smith, Juliet/0000-0002-8501-2531	NIHR; National Institute for Health Research [ACF-2009-14-011] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	JAUS is supported by an NIHR academic clinical fellowship and FW by an NIHR clinical lectureship. MJT is funded by NIHR programme grant "Development and implementation of new diagnostic processes and technologies in primary care," and SJS is employed by the MRC.	Abdul-Rasoul M, 2006, PEDIATR DIABETES, V7, P101, DOI 10.1111/j.1399-543X.2006.00155.x; Abdul-Rasoul M, 2010, PEDIATR DIABETES, V11, P351, DOI 10.1111/j.1399-5448.2009.00600.x; Ali K, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d294; AlKhawari M, 1997, DIABETES RES CLIN PR, V35, P123; Alvi NS, 2001, ARCH DIS CHILD, V85, P60, DOI 10.1136/adc.85.1.60; [Anonymous], CRIT APPR SKILLS PRO; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Blanc N, 2003, ARCH PEDIATRIE, V10, P320, DOI 10.1016/S0929-693X(03)00033-2; Bober E, 2001, J PEDIATR ENDOCR MET, V14, P435; Bowden SA, 2008, PEDIATR DIABETES, V9, P197, DOI 10.1111/j.1399-5448.2008.00376.x; Brousseau DC, 2005, AMBUL PEDIATR, V5, P319, DOI 10.1367/A04-203R1.1; Bui H, 2010, J PEDIATR-US, V156, P472, DOI 10.1016/j.jpeds.2009.10.001; Castaner MF, 1996, DIABETES METAB, V22, P349; Charemska Dorota, 2003, Med Wieku Rozwoj, V7, P261; Dixon-Woods Mary, 2007, J Health Serv Res Policy, V12, P42, DOI 10.1258/135581907779497486; Dunger DB, 2004, PEDIATRICS, V113, P133; Edge JA, 1999, ARCH DIS CHILD, V81, P318, DOI 10.1136/adc.81.4.318; Green A, 2000, LANCET, V355, P873; HAMILTON DV, 1976, BRIT MED J, V2, P211, DOI 10.1136/bmj.2.6029.211; Hekkala A, 2007, DIABETES CARE, V30, P861, DOI 10.2337/dc06-2281; Hekkala A, 2010, DIABETES CARE, V33, P1500, DOI 10.2337/dc09-2344; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hober D, 2010, NAT REV ENDOCRINOL, V6, P279, DOI 10.1038/nrendo.2010.27; Hodgson MI, 2006, REV MED CHILE, V134, P1535; Kapellen TM, 2001, MONATSSCHR KINDERH, V149, P679, DOI 10.1007/s001120170122; Komulainen J, 1998, CLIN SCI, V94, P263, DOI 10.1042/cs0940263; Komulainen J, 1996, ARCH DIS CHILD, V75, P410, DOI 10.1136/adc.75.5.410; Komulainen J, 1999, DIABETES CARE, V22, P1950, DOI 10.2337/diacare.22.12.1950; Levy-Marchal C, 2001, DIABETOLOGIA, V44, pB75, DOI 10.1007/PL00002958; Mallare JT, 2003, CLIN PEDIATR, V42, P591, DOI 10.1177/000992280304200704; Maniatis AK, 2005, PEDIATR DIABETES, V6, P79, DOI 10.1111/j.1399-543X.2005.00096.x; Mayer-Davis EJ, 2009, DIABETES CARE, V32, pS112, DOI 10.2337/dc09-S203; Mlynarski Wojciech, 2003, Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw, V9, P23; Neu A, 2001, Pediatr Diabetes, V2, P147, DOI 10.1034/j.1399-5448.2001.20402.x; Neu Andreas, 2003, Pediatr Diabetes, V4, P77, DOI 10.1034/j.1399-5448.2003.00007.x; Newfield RS, 2009, PEDIATR DIABETES, V10, P310, DOI 10.1111/j.1399-5448.2008.00475.x; Olak-Bialon Boguslawa, 2007, Pediatr Endocrinol Diabetes Metab, V13, P85; OLEARY LA, 1991, DIABETES RES CLIN PR, V14, P183, DOI 10.1016/0168-8227(91)90019-A; Pawlowicz Malgorzata, 2008, Pediatr Endocrinol Diabetes Metab, V14, P7; Pawlowicz M, 2009, PEDIATR DIABETES, V10, P542, DOI 10.1111/j.1399-5448.2009.00516.x; PINKNEY JH, 1994, DIABETOLOGIA, V37, P70; Pocecco M, 1993, Pediatr Med Chir, V15, P489; Prisco F, 2006, PEDIATR DIABETES, V7, P223, DOI 10.1111/j.1399-5448.2006.00187.x; Quinn M, 2006, J PEDIATR-US, V148, P366, DOI 10.1016/j.jpeds.2005.10.029; RAYFIELD EJ, 1982, AM J MED, V72, P439, DOI 10.1016/0002-9343(82)90511-3; Rewers A, 2007, PED SOC M TOR; Roche EF, 2005, PEDIATR DIABETES, V6, P75, DOI 10.1111/j.1399-543X.2005.00110.x; Rosenbauer J, 2002, J PEDIATR ENDOCR MET, V15, P1137; Sadauskaite-Kuehne V, 2002, DIABETES RES CLIN PR, V55, P247, DOI 10.1016/S0168-8227(01)00328-X; SALMAN H, 1991, DIABETIC MED, V8, P176, DOI 10.1111/j.1464-5491.1991.tb01567.x; SALMAN H, 1991, ANN SAUDI MED, V11, P302, DOI 10.5144/0256-4947.1991.302; Samuelsson U, 2005, DIABETES RES CLIN PR, V68, P49, DOI 10.1016/j.diabres.2004.08.002; Savova R, 1996, DIABETES RES CLIN PR, V34, pS159, DOI 10.1016/S0168-8227(96)90024-8; Schober E, 2010, DIABETOLOGIA, V53, P1057, DOI 10.1007/s00125-010-1704-1; Sebastiani Annicchiarico L, 1992, Ann Ig, V4, P173; Smith CP, 1998, ACTA PAEDIATR, V87, P537, DOI 10.1080/08035259850158245; SOCHETT EB, 1987, DIABETOLOGIA, V30, P453, DOI 10.1007/BF00279611; Soliman Ashraf T., 1999, Indian Journal of Pediatrics, V66, P363, DOI 10.1007/BF02845526; Soliman AT, 1997, J TROP PEDIATRICS, V43, P128, DOI 10.1093/tropej/43.3.128; Sundaram PCB, 2009, ARCH DIS CHILD, V94, P151, DOI 10.1136/adc.2007.133405; Tahirovic H, 2007, J PEDIATR ENDOCR MET, V20, P1137; Tanaka S, 2009, DIABETES, V58, P2285, DOI 10.2337/db09-0091; Ting Wei-Hsin, 2007, Acta Paediatrica Taiwanica, V48, P119; Vanelli M, 1999, DIABETES CARE, V22, P7, DOI 10.2337/diacare.22.1.7; Vehik K, 2009, DIABETIC MED, V26, P961, DOI 10.1111/j.1464-5491.2009.02819.x; Veijola R, 1996, J CLIN INVEST, V98, P2489, DOI 10.1172/JCI119067; Weech-Maldonado R, 2001, HEALTH SERV RES, V36, P575; Wolfsdorf J, 2006, DIABETES CARE, V29, P1150, DOI 10.2337/dc06-9909; Wolfsdorf J, 2007, PEDIATR DIABETES, V8, P28, DOI 10.1111/j.1399-5448.2007.00224.x; Wolfsdorf J, 2009, PEDIATR DIABETES, V10, P118, DOI 10.1111/j.1399-5448.2009.00569.x; Xin Y, 2010, J PAEDIATR CHILD H, V46, P171, DOI 10.1111/j.1440-1754.2009.01657.x; Yang Z, 2006, PEDIATR DIABETES, V7, P146, DOI 10.1111/j.1399-543X.2006.00163.x	73	82	83	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2011	343								d4092	10.1136/bmj.d4092	http://dx.doi.org/10.1136/bmj.d4092			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SI	21737470	hybrid, Green Published			2022-12-28	WOS:000292684800003
J	Patel, K				Patel, Kinesh			STARTING OUT Time to get smart about IT	BRITISH MEDICAL JOURNAL			English	Editorial Material												kinesh_patel@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 6	2011	343								d4212	10.1136/bmj.d4212	http://dx.doi.org/10.1136/bmj.d4212			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SD	21734168				2022-12-28	WOS:000292684100008
J	Banerjee, S; Hellier, J; Dewey, M; Romeo, R; Ballard, C; Baldwin, R; Bentham, P; Fox, C; Holmes, C; Katona, C; Knapp, M; Lawton, C; Lindesay, J; Livingston, G; McCrae, N; Moniz-Cook, E; Murray, J; Nurock, S; Orrell, M; O'Brien, J; Poppe, M; Thomas, A; Walwyn, R; Wilson, K; Burns, A				Banerjee, Sube; Hellier, Jennifer; Dewey, Michael; Romeo, Renee; Ballard, Clive; Baldwin, Robert; Bentham, Peter; Fox, Chris; Holmes, Clive; Katona, Cornelius; Knapp, Martin; Lawton, Claire; Lindesay, James; Livingston, Gill; McCrae, Niall; Moniz-Cook, Esme; Murray, Joanna; Nurock, Shirley; Orrell, Martin; O'Brien, John; Poppe, Michaela; Thomas, Alan; Walwyn, Rebecca; Wilson, Kenneth; Burns, Alistair			Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial	LANCET			English	Article							ALZHEIMERS-DISEASE; DIAGNOSIS; INTERVENTION; EFFICACY; SERVICES; SAFETY; CARE	Background Depression is common in dementia but the evidence base for appropriate drug treatment is sparse and equivocal. We aimed to assess efficacy and safety of two of the most commonly prescribed drugs, sertraline and mirtazapine, compared with placebo. Methods We undertook the parallel-group, double-blind, placebo-controlled, Health Technology Assessment Study of the Use of Antidepressants for Depression in Dementia (HTA-SADD) trial in participants from old-age psychiatry services in nine centres in England. Participants were eligible if they had probable or possible Alzheimer's disease, depression (lasting >= 4 weeks), and a Cornell scale for depression in dementia (CSDD) score of 8 or more. Participants were ineligible if they were clinically critical (eg, suicide risk), contraindicated to study drugs, on antidepressants, in another trial, or had no carer. The clinical trials unit at Kings College London (UK) randomly allocated participants with a computer-generated block randomisation sequence, stratified by centre, with varying block sizes, in a 1:1:1 ratio to receive sertraline (target dose 150 mg per day), mirtazapine (45 mg), or placebo (control group), all with standard care. The primary outcome was reduction in depression (CSDD score) at 13 weeks (outcomes to 39 weeks were also assessed), assessed with a mixed linear-regression model adjusted for baseline CSDD, time, and treatment centre. This study is registered, number ISRCTN88882979 and EudraCT 2006-000105-38. Findings Decreases in depression scores at 13 weeks did not differ between 111 controls and 107 participants allocated to receive sertraline (mean difference 1.17, 95% CI -0.23 to 2.58; p=0.10) or mirtazapine (0.01, -1.37 to 1.38; p=0.99), or between participants in the mirtazapine and sertraline groups (1.16, -0.25 to 2.57; p=0.11); these findings persisted to 39 weeks. Fewer controls had adverse reactions (29 of 111 [26%]) than did participants in the sertraline group (46 of 107, 43%; p=0.010) or mirtazapine group (44 of 108, 41%; p=0.031), and fewer serious adverse events rated as severe (p=0.003). Five patients in every group died by week 39. Interpretation Because of the absence of benefit compared with placebo and increased risk of adverse events, the present practice of use of these antidepressants, with usual care, for first-line treatment of depression in Alzheimer's disease should be reconsidered.	[Banerjee, Sube] Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, Sect Mental Hlth & Ageing PO26, London SE5 8AF, England; [Hellier, Jennifer; Walwyn, Rebecca] Kings Coll London, Mental Hlth & Neurosci Clin Trials Unit, London SE5 8AF, England; [Ballard, Clive] Kings Coll London, Wolfson Ctr Age Related Dis, London SE5 8AF, England; [Baldwin, Robert; Burns, Alistair] Univ Manchester, Dept Community Based Med, Manchester, Lancs, England; [Bentham, Peter] Univ Birmingham, Dept Psychiat, Birmingham, W Midlands, England; [Fox, Chris] Univ E Anglia, Sch Med, Norwich NR4 7TJ, Norfolk, England; [Holmes, Clive] Univ Southampton, Clin Neurosci Div, Southampton, Hants, England; [Katona, Cornelius; Livingston, Gill; Orrell, Martin] UCL, Dept Mental Hlth Sci, London, England; [Lawton, Claire] Univ Cambridge, Dept Psychiat, Cambridge, England; [Lindesay, James] Univ Leicester, Dept Psychiat, Leicester, Leics, England; [Moniz-Cook, Esme] Hull York Med Sch, Inst Rehabil, Kingston Upon Hull, Yorks, England; [Nurock, Shirley] Alzheimers Soc, London, England; [O'Brien, John; Thomas, Alan] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wilson, Kenneth] Univ Liverpool, Dept Psychiat, Liverpool L69 3BX, Merseyside, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of Manchester; University of Birmingham; University of East Anglia; University of Southampton; University of London; University College London; University of Cambridge; University of Leicester; University of Hull; University of York - UK; Newcastle University - UK; University of Liverpool	Banerjee, S (corresponding author), Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, Sect Mental Hlth & Ageing PO26, De Crespigny Pk, London SE5 8AF, England.	sube.banerjee@kcl.ac.uk	Hellier, Jennifer M/I-4347-2012; Banerjee, Sube/E-3757-2010; Thomas, Alan J/G-4807-2011; Livingston, G/C-7081-2008; Romeo, Renee/E-3261-2010; Knapp, Martin RJ/G-3011-2011; Dewey, Michael E/E-2049-2010	Romeo, Renee/0000-0003-3871-9697; Dewey, Michael E/0000-0002-7522-3677; Moniz-Cook, Esme/0000-0002-7232-4632; Livingston, Gill/0000-0001-6741-5516; Katona, Cornelius/0000-0001-7451-0167; Orrell, Martin/0000-0002-1169-3530; Banerjee, Sube/0000-0002-8083-7649; Fox, Chris/0000-0001-9480-5704; Hellier, Jennifer/0000-0003-1760-3708; Knapp, Martin/0000-0003-1427-0215; Burns, Alistair/0000-0002-9837-0645; Ballard, Clive/0000-0003-0022-5632; Holmes, Clive/0000-0003-1999-6912; O'Brien, John/0000-0002-0837-5080	UK National Institute for Health Research (NIHR) [04/11/02]; National Institute for Health Research [04/11/02] Funding Source: researchfish	UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme (project number 04/11/02). The views and opinions expressed here are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, National Health Service, or the Department of Health. We thank all the participants and carers that gave their time to be part of this study; Georgina Charlesworth, Tom Dening, and David Wilkinson for invaluable scientific advice, support, and input into the project at key stages from planning onwards; Pfizer for their donation of the sertraline and sertraline placebo for this trial; members of the HTA-SADD data monitoring and ethics committee and the HTA-SADD trial steering committee (Peter Connelly [chair DMEC], Robin Jacoby [chair TSC], Rowan Harwood, Cornelius Kelly, Angela Clayton-Turner, Craig Ritchie, and Ed Juszczak); the Alzheimer's Society for providing patient and public involvement support into the study; the NIHR Mental Health Research Network (MHRN) and Dementia and Neurodegenerative Disease Research Network (DeNDRoN) for practical help; and referring clinicians in every area.	ALEXOPOULOS GS, 1988, BIOL PSYCHIAT, V23, P271, DOI 10.1016/0006-3223(88)90038-8; Bains J, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003944; Ballard CG, 1996, INT J GERIATR PSYCH, V11, P507, DOI 10.1002/(SICI)1099-1166(199606)11:6<507::AID-GPS337>3.0.CO;2-U; Banerjee S, 2007, INT J GERIATR PSYCH, V22, P782, DOI 10.1002/gps.1741; Banerjee S, 2009, INT J GERIATR PSYCH, V24, P748, DOI 10.1002/gps.2191; BURNS A, 1990, BRIT J PSYCHIAT, V157, P81, DOI 10.1192/bjp.157.1.81; BURNS A, 1991, INT J GERIATR PSYCH, V6, P371, DOI 10.1002/gps.930060607; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Department of Health, 2008, LIV WELL DEM NAT DEM; Eccles M, 1998, BMJ-BRIT MED J, V317, P802, DOI 10.1136/bmj.317.7161.802; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; GREENWALD BS, 1989, AM J PSYCHIAT, V146, P1472; Lyketsos CG, 2003, ARCH GEN PSYCHIAT, V60, P737, DOI 10.1001/archpsyc.60.7.737; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P1686, DOI 10.1176/appi.ajp.157.10.1686; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Modrego PJ, 2010, J ALZHEIMERS DIS, V21, P1077, DOI 10.3233/JAD-2010-100153; Mohs R, 2000, NEUROLOGY, V54, pA415; Moniz-Cook E, 2008, AGING MENT HEALTH, V12, P14, DOI 10.1080/13607860801919850; National Institute for Clinical Excellence and Social Care Institute for Excellence (England and Wales), 2006, DEM SUPP PEOPL DEM T; National Institute for Health and Clinical Excellence, 2009, DEPR TREATM MAN DEPR; Nelson JC, 2011, J AM GERIATR SOC, V59, P577, DOI 10.1111/j.1532-5415.2011.03355.x; NETTEN A, 1993, COSTING COMMUNITY CA; Olin JT, 2002, AM J GERIAT PSYCHIAT, V10, P125; Petracca G, 1996, J NEUROPSYCH CLIN N, V8, P270; Pinheiro J, 2001, MIXED EFFECTS MODELS; Prince M, 2009, WORLD ALZHEIMERS REP; REIFLER BV, 1989, AM J PSYCHIAT, V146, P45; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; Rosenberg PB, 2010, AM J GERIAT PSYCHIAT, V18, P136, DOI 10.1097/JGP.0b013e3181c796eb; Smith SC, 2005, PSYCHOL MED, V37, P737; Thompson S, 2007, CAN J PSYCHIAT, V52, P248, DOI 10.1177/070674370705200407; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weintraub D, 2010, AM J GERIAT PSYCHIAT, V18, P332, DOI 10.1097/JGP.0b013e3181cc0333; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wimo A, 2010, WORLD ALZHEIMERS REP; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	37	308	311	2	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2011	378	9789					403	411		10.1016/S0140-6736(11)60830-1	http://dx.doi.org/10.1016/S0140-6736(11)60830-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XM	21764118	Green Submitted			2022-12-28	WOS:000293615900031
J	Bejar, R; Stevenson, K; Abdel-Wahab, O; Galili, N; Nilsson, B; Garcia-Manero, G; Kantarjian, H; Raza, A; Levine, RL; Neuberg, D; Ebert, BL				Bejar, Rafael; Stevenson, Kristen; Abdel-Wahab, Omar; Galili, Naomi; Nilsson, Bjoern; Garcia-Manero, Guillermo; Kantarjian, Hagop; Raza, Azra; Levine, Ross L.; Neuberg, Donna; Ebert, Benjamin L.			Clinical Effect of Point Mutations in Myelodysplastic Syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROGNOSTIC SCORING SYSTEM; TP53 MUTATIONS; OF-FUNCTION; GENE; RISK; CBL; EPIDEMIOLOGY; LEUKEMIA; RUNX1; IDH1	BACKGROUND Myelodysplastic syndromes are clinically heterogeneous disorders characterized by clonal hematopoiesis, impaired differentiation, peripheral-blood cytopenias, and a risk of progression to acute myeloid leukemia. Somatic mutations may influence the clinical phenotype but are not included in current prognostic scoring systems. METHODS We used a combination of genomic approaches, including next-generation sequencing and mass spectrometry-based genotyping, to identify mutations in samples of bone marrow aspirate from 439 patients with myelodysplastic syndromes. We then examined whether the mutation status for each gene was associated with clinical variables, including specific cytopenias, the proportion of blasts, and overall survival. RESULTS We identified somatic mutations in 18 genes, including two, ETV6 and GNAS, that have not been reported to be mutated in patients with myelodysplastic syndromes. A total of 51% of all patients had at least one point mutation, including 52% of the patients with normal cytogenetics. Mutations in RUNX1, TP53, and NRAS were most strongly associated with severe thrombocytopenia (P < 0.001 for all comparisons) and an increased proportion of bone marrow blasts (P < 0.006 for all comparisons). In a multivariable Cox regression model, the presence of mutations in five genes retained independent prognostic significance: TP53 (hazard ratio for death from any cause, 2.48; 95% confidence interval [CI], 1.60 to 3.84), EZH2 (hazard ratio, 2.13; 95% CI, 1.36 to 3.33), ETV6 (hazard ratio, 2.04; 95% CI, 1.08 to 3.86), RUNX1 (hazard ratio, 1.47; 95% CI, 1.01 to 2.15), and ASXL1 (hazard ratio, 1.38; 95% CI, 1.00 to 1.89). CONCLUSIONS Somatic point mutations are common in myelodysplastic syndromes and are associated with specific clinical features. Mutations in TP53, EZH2, ETV6, RUNX1, and ASXL1 are predictors of poor overall survival in patients with myelodysplastic syndromes, independently of established risk factors. (Funded by the National Institutes of Health and others.)	[Bejar, Rafael; Nilsson, Bjoern; Ebert, Benjamin L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Bejar, Rafael; Nilsson, Bjoern; Ebert, Benjamin L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Bejar, Rafael; Ebert, Benjamin L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Stevenson, Kristen; Neuberg, Donna] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USA; [Galili, Naomi; Raza, Azra] Columbia Univ, New York Presbyterian Hosp, Med Ctr, Dept Hematol, New York, NY USA; [Garcia-Manero, Guillermo; Kantarjian, Hagop] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Columbia University; NewYork-Presbyterian Hospital; University of Texas System; UTMD Anderson Cancer Center	Ebert, BL (corresponding author), Brigham & Womens Hosp, Karp Res Bldg,CHRB 05-211,1 Blackfan Cir, Boston, MA 02115 USA.	bebert@partners.org	levine, ross/AAE-7658-2019	Bejar, Rafael/0000-0002-5603-4598; Abdel-Wahab, Omar/0000-0002-3907-6171	National Institutes of Health (NIH) [5R01 HL082945, P01 CA108631, T32 HL007623]; Starr Cancer Consortium; Burroughs-Wellcome Fund; Huber-Foster Fellowship; NATIONAL CANCER INSTITUTE [P01CA108631] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945, T32HL007623] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Huber-Foster Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Institutes of Health (NIH) (5R01 HL082945 and P01 CA108631), the Starr Cancer Consortium, and the Burroughs-Wellcome Fund (Career Awards for Medical Scientists) (all to Dr. Ebert) and a grant from the NIH (T32 HL007623) and a Huber-Foster Fellowship (both to Dr. Bejar).	Badalian-Very G, 2010, BLOOD, V116, P1919, DOI 10.1182/blood-2010-04-279083; Bejar R, 2011, J CLIN ONCOL, V29, P504, DOI 10.1200/JCO.2010.31.1175; Chen CY, 2007, BRIT J HAEMATOL, V139, P405, DOI 10.1111/j.1365-2141.2007.06811.x; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Fisher CL, 2010, BLOOD, V115, P38, DOI 10.1182/blood-2009-07-230698; Garcia-Manero G, 2008, LEUKEMIA, V22, P538, DOI 10.1038/sj.leu.2405070; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; Horiike S, 2003, LEUKEMIA LYMPHOMA, V44, P915, DOI 10.1080/1042819031000067620; Kalfa N, 2006, J UROLOGY, V176, P891, DOI 10.1016/j.juro.2006.04.023; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; KANEKO H, 1995, BLOOD, V85, P2189, DOI 10.1182/blood.V85.8.2189.bloodjournal8582189; Kita-Sasai Y, 2001, BRIT J HAEMATOL, V115, P309, DOI 10.1046/j.1365-2141.2001.03073.x; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kosmider O, 2010, LEUKEMIA, V24, P1094, DOI 10.1038/leu.2010.52; Kosmider O, 2009, BLOOD, V114, P3285, DOI 10.1182/blood-2009-04-215814; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Malcovati L, 2007, J CLIN ONCOL, V25, P3503, DOI 10.1200/JCO.2006.08.5696; Odero MD, 2002, GENE CHROMOSOME CANC, V35, P11, DOI 10.1002/gcc.10090; Padua RA, 1998, LEUKEMIA, V12, P887, DOI 10.1038/sj.leu.2401044; PAQUETTE RL, 1993, BLOOD, V82, P590, DOI 10.1182/blood.V82.2.590.bloodjournal822590; Pardanani A, 2010, LEUKEMIA, V24, P1370, DOI 10.1038/leu.2010.98; Pedersen-Bjergaard J, 2008, LEUKEMIA, V22, P240, DOI 10.1038/sj.leu.2405078; Rocquain J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-401; Rollison DE, 2008, BLOOD, V112, P45, DOI 10.1182/blood-2008-01-134858; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Sekeres MA, 2010, HEMATOL ONCOL CLIN N, V24, P287, DOI 10.1016/j.hoc.2010.02.011; Sekeres MA, 2008, JNCI-J NATL CANCER I, V100, DOI 10.1093/jnci/djn349; Silva FPG, 2008, LEUKEMIA, V22, P1639, DOI 10.1038/leu.2008.34; Smith AE, 2010, BLOOD, V116, P3923, DOI 10.1182/blood-2010-03-274704; Steensma DP, 2005, EUR J HAEMATOL, V74, P47, DOI 10.1111/j.1600-0609.2004.00363.x; SUAREZ HG, 1991, ONCOGENE, V6, P677; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	36	1130	1184	4	74	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2011	364	26					2496	2506		10.1056/NEJMoa1013343	http://dx.doi.org/10.1056/NEJMoa1013343			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	785AM	21714648	Green Accepted			2022-12-28	WOS:000292199800005
J	Ezratty, EJ; Stokes, N; Chai, S; Shah, AS; Williams, SE; Fuchs, E				Ezratty, Ellen J.; Stokes, Nicole; Chai, Sophia; Shah, Alok S.; Williams, Scott E.; Fuchs, Elaine			A Role for the Primary Cilium in Notch Signaling and Epidermal Differentiation during Skin Development	CELL			English	Article							HAIR FOLLICLE MORPHOGENESIS; INTRAFLAGELLAR TRANSPORT; TERMINAL DIFFERENTIATION; CONDITIONAL ABLATION; KIDNEY-DISEASE; KIF3A SUBUNIT; CELL-DIVISION; STEM-CELLS; KINESIN-II; HEDGEHOG	Ciliogenesis precedes lineage-determining signaling in skin development. To understand why, we performed shRNA-mediated knockdown of seven intraflagellar transport proteins (IFTs) and conditional ablation of Ift-88 and Kif3a during embryogenesis. In both cultured keratinocytes and embryonic epidermis, all of these eliminated cilia, and many (not Kif3a) caused hyperproliferation. Surprisingly and independent of proliferation, ciliary mutants displayed defects in Notch signaling and commitment of progenitors to differentiate. Notch receptors and Notch-processing enzymes colocalized with cilia in wild-type epidermal cells. Moreover, differentiation defects in ciliary mutants were cell autonomous and rescued by activated Notch (NICD). By contrast, Shh signaling was neither operative nor required for epidermal ciliogenesis, Notch signaling, or differentiation. Rather, Shh signaling defects in ciliary mutants occurred later, arresting hair follicle morphogenesis in the skin. These findings unveil temporally and spatially distinct functions for primary cilia at the nexus of signaling, proliferation, and differentiation.	[Ezratty, Ellen J.; Stokes, Nicole; Chai, Sophia; Shah, Alok S.; Williams, Scott E.; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Williams, Scott/0000-0001-9975-7334	National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR027883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank L. Goldstein (UCSD) for Kif3 fl/fl mice and Q. Zhang (University of Iowa) for Ift88 fl/fl mice; D. Oristan and L. Polak for their expertise and assistance in the mouse facility; A. North and the RU Bioimaging Resource Center for assistance with image acquisition; and M. Schober, D. Devenport, C. Luxenburg, M. Kadaja, and other Fuchs laboratory members for helpful discussions and critical reading of the manuscript. E.J.E. is a Jane Coffin Childs postdoctoral fellow, A. S. S. is a Marie Josee and Henry Kravis postdoctoral fellow, S. E. W. is an American Cancer Society postdoctoral fellow, and E. F. is an investigator in the Howard Hughes Medical Institute. This work was supported by a grant from the National Institutes of Health.	Baldari CT, 2010, CURR OPIN CELL BIOL, V22, P75, DOI 10.1016/j.ceb.2009.10.010; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Bershteyn M, 2010, DEV CELL, V19, P270, DOI 10.1016/j.devcel.2010.07.009; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chakrabarti A, 1998, CELL TISSUE RES, V293, P453, DOI 10.1007/s004410051137; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Croyle MJ, 2011, DEVELOPMENT, V138, P1675, DOI 10.1242/dev.060210; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; ELOFSSON R, 1984, J ULTRA MOL STRUCT R, V87, P212, DOI 10.1016/S0022-5320(84)80061-1; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; FUCHS E, 1992, P NATL ACAD SCI USA, V89, P6906, DOI 10.1073/pnas.89.15.6906; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Gao J, 2008, GENE DEV, V22, P2111, DOI 10.1101/gad.1689908; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gritli-Linde A, 2007, DEV CELL, V12, P99, DOI 10.1016/j.devcel.2006.12.006; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Haraguchi K, 2006, J BIOL CHEM, V281, P4094, DOI 10.1074/jbc.M507028200; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Jaulin F, 2010, J CELL BIOL, V190, P443, DOI 10.1083/jcb.201006044; Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137; KENNEDY JR, 1968, J ULTRA MOL STRUCT R, V22, P530, DOI 10.1016/S0022-5320(68)90039-7; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Lehman JM, 2009, J INVEST DERMATOL, V129, P438, DOI 10.1038/jid.2008.279; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lowell S, 2000, CURR BIOL, V10, P491, DOI 10.1016/S0960-9822(00)00451-6; Luxenburg C, 2011, NAT CELL BIOL, V13, P203, DOI 10.1038/ncb2163; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; Pan JM, 2007, CELL, V129, P1255, DOI 10.1016/j.cell.2007.06.018; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Santos N, 2010, DEV CELL, V19, P5, DOI 10.1016/j.devcel.2010.07.001; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Wang X, 2008, J CELL BIOL, V183, P37, DOI 10.1083/jcb.200804030; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744	60	216	221	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7					1129	1141		10.1016/j.cell.2011.05.030	http://dx.doi.org/10.1016/j.cell.2011.05.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703454	Bronze, Green Accepted			2022-12-28	WOS:000292025700018
J	Tanimoto, T; Matayoshi, T; Yagasaki, F; Takeuchi, K; Kami, M				Tanimoto, Tetsuya; Matayoshi, Tetsutaro; Yagasaki, Fumiharu; Takeuchi, Kengo; Kami, Masahiro			Safety and efficacy of zoledronic acid in multiple myeloma	LANCET			English	Letter									[Tanimoto, Tetsuya; Takeuchi, Kengo] Japanese Fdn Canc Res, Inst Canc, Koto Ward, Tokyo 1358550, Japan; [Matayoshi, Tetsutaro] Univ Ryukyus, Okinawa, Japan; [Yagasaki, Fumiharu] Saitama Med Univ, Int Med Ctr, Saitama, Japan; [Kami, Masahiro] Univ Tokyo, Inst Med Sci, Tokyo, Japan	Japanese Foundation for Cancer Research; University of the Ryukyus; Saitama Medical University; University of Tokyo	Tanimoto, T (corresponding author), Japanese Fdn Canc Res, Inst Canc, Koto Ward, Tokyo 1358550, Japan.	tetanimot@yahoo.co.jp	Takeuchi, Kengo/C-3614-2008	Takeuchi, Kengo/0000-0002-1599-5800; Matayoshi, Tetsutaro/0000-0002-3834-4269				Falanga A, 2009, J CLIN ONCOL, V27, P4848, DOI 10.1200/JCO.2009.22.8197; Lyman GH, 2007, J CLIN ONCOL, V25, P5490, DOI 10.1200/JCO.2007.14.1283; Lyman GH, 2009, J CLIN ONCOL, V27, P4821, DOI 10.1200/JCO.2009.22.3032; Morgan GJ, 2010, LANCET, V376, P1989, DOI 10.1016/S0140-6736(10)62051-X; Palumbo A, 2008, LEUKEMIA, V22, P414, DOI 10.1038/sj.leu.2405062	5	2	2	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2011	377	9784					2178	2178		10.1016/S0140-6736(11)60959-8	http://dx.doi.org/10.1016/S0140-6736(11)60959-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	786XI	21704866	Bronze			2022-12-28	WOS:000292340800025
J	Esplugues, E; Huber, S; Gagliani, N; Hauser, AE; Town, T; Wan, YSY; O'Connor, W; Rongvaux, A; Van Rooijen, N; Haberman, AM; Iwakura, Y; Kuchroo, VK; Kolls, JK; Bluestone, JA; Herold, KC; Flavell, RA				Esplugues, Enric; Huber, Samuel; Gagliani, Nicola; Hauser, Anja E.; Town, Terrence; Wan, Yisong Y.; O'Connor, William, Jr.; Rongvaux, Anthony; Van Rooijen, Nico; Haberman, Ann M.; Iwakura, Yoichiro; Kuchroo, Vijay K.; Kolls, Jay K.; Bluestone, Jeffrey A.; Herold, Kevan C.; Flavell, Richard A.			Control of T(H)17 cells occurs in the small intestine	NATURE			English	Article							GROWTH-FACTOR-BETA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-CELLS; TH17 CELLS; MONOCLONAL-ANTIBODY; T-H-17 CELLS; TGF-BETA; MICE; DIFFERENTIATION; INTERLEUKIN-10	Interleukin (IL)-17-producing T helper cells (T(H)17) are a recently identified CD4(+) T cell subset distinct from T helper type 1 (T(H)1) and T helper type 2 (T(H)2) cells(1). T(H)17 cells can drive antigen-specific autoimmune diseases and are considered the main population of pathogenic T cells driving experimental autoimmune encephalomyelitis (EAE)(2), the mouse model for multiple sclerosis. The factors that are needed for the generation of T(H)17 cells have been well characterized(3-6). However, where and how the immune system controls T(H)17 cells in vivo remains unclear. Here, by using a model of tolerance induced by CD3-specific antibody, a model of sepsis and influenza A viral infection (H1N1), we show that pro-inflammatory T(H)17 cells can be redirected to and controlled in the small intestine. T(H)17-specific IL-17A secretion induced expression of the chemokine CCL20 in the small intestine, facilitating the migration of these cells specifically to the small intestine via the CCR6/CCL20 axis. Moreover, we found that T(H)17 cells are controlled by two different mechanisms in the small intestine: first, they are eliminated via the intestinal lumen; second, pro-inflammatory T(H)17 cells simultaneously acquire a regulatory phenotype within vitro and in vivo immune-suppressive properties (rT(H)17). These results identify mechanisms limiting T(H)17 cell pathogenicity and implicate the gastrointestinal tract as a site for control of T(H)17 cells.	[Esplugues, Enric; Huber, Samuel; O'Connor, William, Jr.; Rongvaux, Anthony; Herold, Kevan C.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Esplugues, Enric; Hauser, Anja E.] German Rheumatism Res Ctr DRFZ, D-10117 Berlin, Germany; [Esplugues, Enric] Charite, D-10117 Berlin, Germany; [Huber, Samuel] Univ Klinikum Hamburg Eppendorf, Med Klin 1, D-20246 Hamburg, Germany; [Gagliani, Nicola] San Raffaele Diabet Res Inst HSR DRI, I-20132 Milan, Italy; [Town, Terrence] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Town, Terrence] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Town, Terrence] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90048 USA; [Wan, Yisong Y.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Van Rooijen, Nico] Vrije Univ Amsterdam, Fac Med, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands; [Haberman, Ann M.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo 1088639, Japan; [Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Kolls, Jay K.] LSU Hlth Sci Ctr, Dept Genet, New Orleans, LA 70112 USA; [Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Flavell, Richard A.] Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Vrije Universiteit Amsterdam; Yale University; University of Tokyo; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of California System; University of California San Francisco; Howard Hughes Medical Institute	Esplugues, E (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	enric.esplugues@yale.edu; richard.flavell@yale.edu	Esplugues, Enric/AAD-4245-2020; Wan, Yisong/ABE-1200-2021; Iwakura, Yoichiro/E-5457-2011; Kolls, Jay/AAH-1829-2019; Van Rooijen, Nico/Z-1578-2019	Wan, Yisong/0000-0003-4346-9717; Iwakura, Yoichiro/0000-0002-9934-5775; Kolls, Jay/0000-0001-5151-6304; Esplugues, Enric/0000-0002-9733-8707; Huber, Samuel/0000-0001-9325-8227; Esplugues, Enric/0000-0002-8130-0413; Hauser, Anja Erika/0000-0002-7725-9526; Gagliani, Nicola/0000-0001-8514-1395	National Multiple Sclerosis Society; DFG [HU 1714/1-1]; James Hudson Brown-Alexander B. Coxe Fellowship; Spanish Ministry of Science; Transgenic Core of the Yale DERC [DK45735]; JDRF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061271, R37HL079142, R21HL104601, R01HL062052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); DFG(German Research Foundation (DFG)); James Hudson Brown-Alexander B. Coxe Fellowship; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Transgenic Core of the Yale DERC; JDRF(Juvenile Diabetes Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank F. Manzo for expert administrative assistance, L. Evangelisti and C. Hughes for generating embryonic stem cells and chimaeric mice, respectively, J. Stein for initial screening of knock-in mice, T. Ferrandino for assistance with the mouse colony, E. Eynon and J. Alderman for managing the mouse program and A. Lin for assistance with Gene Array analysis. We also thank T. Taylor and G. Tokmoulina for expert help with the FACS sorting and D. Gonzalez for help with the multiphoton microscopy. We would like to thank J. P. Allison for providing the anti-CTLA-4 antibody, F. Waldron-Lynch and J. S. Pober for providing peripheral blood mononuclear cells, and the NIH Tetramer core facility for providing the tetramers. W.O. was supported by a fellowship from the National Multiple Sclerosis Society. S. H. was supported by the DFG (HU 1714/1-1) and by a James Hudson Brown-Alexander B. Coxe Fellowship. E. E. was supported by the Spanish Ministry of Science postdoctoral fellowship and by a James Hudson Brown-Alexander B. Coxe Fellowship. R. A. F. is an Investigator of the Howard Hughes Medical Institute. The generation of mice for this work was supported by the Transgenic Core of the Yale DERC DK45735 and some of the work supported by a Pilot project from DK45735. This work was also supported by the JDRF.	ALEGRE ML, 1995, J IMMUNOL, V155, P1544; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brown SJ, 2007, AM J GASTROENTEROL, V102, P2058, DOI 10.1111/j.1572-0241.2007.01343.x; Carpenter PA, 2000, J IMMUNOL, V165, P6205, DOI 10.4049/jimmunol.165.11.6205; Chatenoud L, 1997, J IMMUNOL, V158, P2947; Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Herold KC, 2009, CLIN IMMUNOL, V132, P166, DOI 10.1016/j.clim.2009.04.007; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kohm AP, 2005, J IMMUNOL, V174, P4525, DOI 10.4049/jimmunol.174.8.4525; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Merger M, 2002, GUT, V51, P155, DOI 10.1136/gut.51.2.155; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Ochi A, 1993, Semin Immunol, V5, P57, DOI 10.1006/smim.1993.1008; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Petitto JM, 2000, NEUROSCI LETT, V285, P66, DOI 10.1016/S0304-3940(00)00996-4; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rodriguez-Creixems M, 2008, MEDICINE, V87, P234, DOI 10.1097/MD.0b013e318182119b; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; SOOS JM, 1993, J NEUROIMMUNOL, V43, P39, DOI 10.1016/0165-5728(93)90073-8; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	33	459	475	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2011	475	7357					514	U114		10.1038/nature10228	http://dx.doi.org/10.1038/nature10228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21765430	Green Submitted, Green Accepted			2022-12-28	WOS:000293167900044
J	Vaglio, A; Palmisano, A; Alberici, F; Maggiore, U; Ferretti, S; Cobelli, R; Ferrozzi, F; Corradi, D; Salvarani, C; Buzio, C				Vaglio, Augusto; Palmisano, Alessandra; Alberici, Federico; Maggiore, Umberto; Ferretti, Stefania; Cobelli, Rocco; Ferrozzi, Francesco; Corradi, Domenico; Salvarani, Carlo; Buzio, Carlo			Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial	LANCET			English	Article							MYCOPHENOLATE-MOFETIL TREATMENT; CHRONIC PERIAORTITIS; RETROSPECTIVE ANALYSIS; THERAPY; DEXAMETHASONE; EXPRESSION; REGRESSION; REMISSION; FEATURES	Background Glucocorticoids are the mainstay of treatment of idiopathic retroperitoneal fibrosis, but they often have substantial toxic effects. Several reports have suggested tamoxifen as an alternative to glucocorticoids. We compared the efficacy of prednisone with that of tamoxifen in maintainance of remission in patients with idiopathic retroperitoneal fibrosis. Methods In this open-label, randomised controlled trial, we enrolled patients aged 18-85 years with newly diagnosed idiopathic retroperitoneal fibrosis at the Parma Hospital, Parma, Italy, between Oct 1, 2000, and June 30, 2006. After induction therapy with 1 mg/kg daily of prednisone for 1 month, the patients who achieved remission were randomly assigned to receive tapering prednisone (initial dose 0.5 mg/kg daily) for 8 months or tamoxifen (fixed dose 0.5 mg/kg daily) for 8 months. The sequence of randomisation (1:1), blocked in groups of two and four (with block size randomly selected), was generated by the trial statistician with a computer programme. After the end of treatment, the patients were followed up for an additional 18 months. Neither patients nor those giving interventions or analysing the data were masked to group assignment. The two radiologists who assessed CT and Mill scans were masked. The primary endpoint was the relapse rate by the end of treatment (month 8), which was analysed by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00440349. Findings After induction therapy, 36 of the 40 enrolled patients achieved remission and were randomly assigned to treatment (18 per group). One patient (6%) in the prednisone group and seven patients (39%) in the tamoxifen group relapsed by the end of treatment (difference -33% [95% CI -58 to -8, p=0.0408]. The difference in relapse rate between the groups was sustained after the additional 18-month follow-up: the 26-month estimated cumulative relapse probability was 17% with prednisone and 50% with tamoxifen (difference -33% [-62 to -3, p=0.0372]). Cushingoid changes and grade 2 hypercholesterolaemia were more common in the prednisone group than in the tamoxifen group (p=0.0116 and p=0.0408, respectively). Interpretation Prednisone is more effective in prevention of relapses than is tamoxifen in patients with idiopathic retroperitoneal fibrosis. Therefore, prednisone should be considered as first-line treatment for patients with newly diagnosed idiopathic retroperitoneal fibrosis.	[Vaglio, Augusto; Palmisano, Alessandra; Alberici, Federico; Maggiore, Umberto; Buzio, Carlo] Univ Hosp, Dept Clin Med Nephrol & Hlth Sci, Parma, Italy; [Ferretti, Stefania] Univ Hosp, Div Urol, Parma, Italy; [Cobelli, Rocco] Univ Hosp, Serv Radiol, Parma, Italy; [Corradi, Domenico] Univ Hosp, Dept Pathol & Lab Med, Sect Pathol, Parma, Italy; [Ferrozzi, Francesco] Figlie S Camillo Inst, Cremona, Italy; [Salvarani, Carlo] Arcispedale S Maria Nuova, Rheumatol Serv, Reggio Emilia, Italy	University of Parma; University Hospital of Parma; University of Parma; University Hospital of Parma; University of Parma; University Hospital of Parma; University of Parma; University Hospital of Parma; IRCCS Arcispedale S. Maria Nuova	Vaglio, A (corresponding author), Azienda Osped Univ Parma, Dipartimento Clin Med Nefrol & Sci Prevenz, I-43126 Parma, Italy.	augusto.vaglio@virgilio.it	Corradi, Domenico/O-1666-2015; Vaglio, Augusto/AHE-8117-2022; Alberici, Federico/AAC-5289-2022; Salvarani, Carlo/K-2431-2018	Corradi, Domenico/0000-0002-8836-4778; Vaglio, Augusto/0000-0002-3814-9172; Alberici, Federico/0000-0002-1686-5709; Salvarani, Carlo/0000-0001-5426-5133; Maggiore, Umberto/0000-0002-7468-9600; Ferretti, Stefania/0000-0002-2292-5632	Parma University Hospital	Parma University Hospital	Parma University Hospital.	Adler S, 2008, RHEUMATOLOGY, V47, P1535, DOI 10.1093/rheumatology/ken291; BAKER LRI, 1987, BRIT J UROL, V60, P497, DOI 10.1111/j.1464-410X.1987.tb05028.x; Boiardi L, 2011, RHEUMATOLOGY, V50, P1025, DOI 10.1093/rheumatology/keq416; Bourouma R, 1997, NEPHROL DIAL TRANSPL, V12, P2407, DOI 10.1093/ndt/12.11.2407; CLARK CP, 1991, SURGERY, V109, P502; Corradi D, 2007, KIDNEY INT, V72, P742, DOI 10.1038/sj.ki.5002427; Dedeoglu F, 2001, J RHEUMATOL, V28, P1693; Fry AC, 2008, NEPHRON CLIN PRACT, V108, pC213, DOI 10.1159/000119715; Greco P, 2005, CLIN INFECT DIS, V41, pE72, DOI 10.1086/433189; HIGGINS PM, 1988, BRIT J SURG, V75, P573, DOI 10.1002/bjs.1800750625; Jois RN, 2007, RHEUMATOLOGY, V46, P717, DOI 10.1093/rheumatology/kel417; Kardar AH, 2002, J UROLOGY, V168, P550, DOI 10.1016/S0022-5347(05)64677-0; Khosroshahi A, 2011, CURR OPIN RHEUMATOL, V23, P57, DOI 10.1097/BOR.0b013e3283418057; KOEP L, 1977, SURGERY, V81, P250; Kottra JJ, 1996, RADIOL CLIN N AM, V34, P1259; Kume H, 2001, SCAND J UROL NEPHROL, V35, P255; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Magrey MN, 2009, ARTHRIT RHEUM-ARTHR, V61, P674, DOI 10.1002/art.24461; Marcolongo R, 2004, AM J MED, V116, P194, DOI 10.1016/j.amjmed.2003.08.033; Martorana D, 2006, ARTHRIT RHEUM-ARTHR, V55, P126, DOI 10.1002/art.21698; Moroni G, 2006, NEPHROL DIAL TRANSPL, V21, P2485, DOI 10.1093/ndt/gfl228; National Cancer Institute National Institutes of Health, COMM TERM CRIT ADV E; Ozener C, 1997, NEPHROL DIAL TRANSPL, V12, P2166, DOI 10.1093/ndt/12.10.2166; Pierre S, 2002, CLIN NEPHROL, V57, P314; RAMSHAW AL, 1994, J CLIN PATHOL, V47, P721, DOI 10.1136/jcp.47.8.721; RAMSHAW AL, 1994, HISTOPATHOLOGY, V24, P23, DOI 10.1111/j.1365-2559.1994.tb01267.x; ROBBE IJ, 1984, BRIT J RADIOL, V57, P92, DOI 10.1259/0007-1285-57-673-92; Scheel PJ, 2007, J UROLOGY, V178, P140, DOI 10.1016/j.juro.2007.03.057; Scheel PJ, 2011, ANN INTERN MED, V154, P31, DOI 10.7326/0003-4819-154-1-201101040-00005; Scheel PJ, 2009, MEDICINE, V88, P202, DOI 10.1097/MD.0b013e3181afc439; SLAVIN J, 1994, GROWTH FACTORS, V11, P205, DOI 10.3109/08977199409046918; Smyrk TC, 2011, CURR OPIN RHEUMATOL, V23, P74, DOI 10.1097/BOR.0b013e328341347b; Swartz RD, 2008, CLIN NEPHROL, V69, P260; Tan MO, 2003, UROL INT, V71, P426, DOI 10.1159/000074099; Vaglio A, 2003, AM J MED, V114, P454, DOI 10.1016/S0002-9343(03)00056-1; Vaglio A, 2006, LANCET, V367, P241, DOI 10.1016/S0140-6736(06)68035-5; Vaglio A, 2005, CURR OPIN RHEUMATOL, V17, P34, DOI 10.1097/01.bor.0000145517.83972.40; Vaglio A, 2008, CIRCULATION, V118, pE511, DOI 10.1161/CIRCULATIONAHA.108.767467; Vaglio A, 2006, AUTOIMMUN REV, V5, P458, DOI 10.1016/j.autrev.2006.03.011; Vaglio A, 2011, CURR OPIN RHEUMATOL, V23, P1, DOI 10.1097/BOR.0b013e328341137d; van Bommel EFH, 2009, MEDICINE, V88, P193, DOI 10.1097/MD.0b013e3181afc420; van Bommel EFH, 2006, ANN INTERN MED, V144, P101, DOI 10.7326/0003-4819-144-2-200601170-00007; van Bommel EFH, 2007, AM J KIDNEY DIS, V49, P615, DOI 10.1053/j.ajkd.2007.02.268; Warnatz K, 2005, ANN RHEUM DIS, V64, P828, DOI 10.1136/ard.2004.029793; Wu WS, 2006, J INVEST DERMATOL, V126, P1264, DOI 10.1038/sj.jid.5700274; Zen Y, 2009, AM J SURG PATHOL, V33, P1833, DOI 10.1097/PAS.0b013e3181b72882	46	148	163	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2011	378	9788					338	346		10.1016/S0140-6736(11)60934-3	http://dx.doi.org/10.1016/S0140-6736(11)60934-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XL	21733570				2022-12-28	WOS:000293615800031
J	Redig, AJ				Redig, Amanda J.			The Patient's Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Redig, AJ (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	aredig@partners.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2011	306	3					247	248		10.1001/jama.2011.934	http://dx.doi.org/10.1001/jama.2011.934			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794BS	21771979				2022-12-28	WOS:000292870500001
J	[Anonymous]				[Anonymous]			HIV/AIDS and the road to Rome	LANCET			English	Editorial Material																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 16	2011	378	9787					199	199						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798JD	21763917				2022-12-28	WOS:000293201100001
J	Janson, S				Janson, Svante			Networking-Smoothly Does It	SCIENCE			English	Editorial Material							EMERGENCE		Uppsala Univ, Dept Math, S-75106 Uppsala, Sweden	Uppsala University	Janson, S (corresponding author), Uppsala Univ, Dept Math, S-75106 Uppsala, Sweden.	svante.janson@math.uu.se						Achlioptas D, 2009, SCIENCE, V323, P1453, DOI 10.1126/science.1167782; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bohman T, 2001, RANDOM STRUCT ALGOR, V19, P75, DOI 10.1002/rsa.1019; Bohman T, 2009, SCIENCE, V323, P1438, DOI 10.1126/science.1171297; da Costa RA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.255701; Durrett Richard, 2007, RANDOM GRAPH DYNAMIC; Erdos P., 1960, EVOLUTION RANDOM GRA, V5, P17; Riordan O, 2011, SCIENCE, V333, P322, DOI 10.1126/science.1206241; Spencer J, 2007, COMBINATORICA, V27, P587, DOI 10.1007/s00493-007-2163-2	9	4	4	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					298	299		10.1126/science.1208712	http://dx.doi.org/10.1126/science.1208712			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21764738				2022-12-28	WOS:000292732000029
J	Decker, SL				Decker, Sandra L.			Medicaid Payment Levels to Dentists and Access to Dental Care Among Children and Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Although Medicaid removes most financial barriers to receipt of dental care among children and adolescents, Medicaid recipients may not be able to access dental care if dentists decline to participate in Medicaid because of low payment levels or other reasons. Objective To describe the association between state Medicaid dental fees in 2 years (2000 and 2008) and children's receipt of dental care. Design, Setting, and Participants Data on Medicaid dental fees in 2000 and 2008 for 42 states plus the District of Columbia were merged with data from 33 657 children and adolescents (aged 2-17 years) in the National Health Interview Survey (NHIS) for the years 2000-2001 and 2008-2009. Logit models were used to estimate the probability that children and adolescents had seen a dentist in the past 6 months as a function of the Medicaid prophylaxis fee and control variables including age group, race, poverty status, and state and year effects. The effect of fees on children with Medicaid relative to a control group, privately insured counterparts, served to separate Medicaid's effect on access to care from any correlation between the Medicaid fee or changes in fees by state and other attributes of states. Main Outcome Measure Whether a child or adolescent had seen a dentist in the past 6 months. Results On average, Medicaid dental payment levels did not change significantly in inflation-adjusted terms between 2000 and 2008, although a difference existed for some states, including in 5 states plus the District of Columbia, where payments increased at least 50%. In 2008-2009, more children and adolescents covered by Medicaid (55%, 95% confidence interval [CI], 53%-57%) had seen a dentist in the past 6 months than did uninsured children (27%, 95% CI, 24%-30%), but fewer than children covered by private insurance (68%, 95% CI, 67%-70%). Changes in state Medicaid dental payment fees between 2000 and 2008 were positively associated with use of dental care among children and adolescents covered by Medicaid. For example, a $10 increase in the Medicaid prophylaxis payment level (from $ 20 to $30) was associated with a 3.92 percentage point (95% CI, 0.54-7.50) increase in the chance that a child or adolescent covered by Medicaid had seen a dentist. Conclusion Higher Medicaid payment levels to dentists were associated with higher rates of receipt of dental care among children and adolescents. JAMA. 2011;306(2):187-193 www.jama.com	Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Div Hlth Care Stat, Hyattsville, MD 20782 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Decker, SL (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Div Hlth Care Stat, 3311 Toledo Rd,Room 3316, Hyattsville, MD 20782 USA.	sdecker@cdc.gov						Agrawal D, 2005, PEDIATRICS, V116, P1612, DOI 10.1542/peds.2005-2269; American Dental Association (ADA), 2004, INCR ACC MED DENT SE; CMS, MED MED STAT SUPPL; Congressional Research Service, 2004, REP C MED REIMB POL; Decker SL., 2007, REV ECON HOUSEHOLD, V5, P95; Dye Bruce A, 2007, Vital Health Stat 11, P1; Dye BA, 2010, INT J PAEDIATR DENT, V20, P132, DOI 10.1111/j.1365-263X.2009.01029.x; Efron B., 1986, STAT SCI, V1, P54, DOI [10.1214/ss/1177013815, DOI 10.1214/SS/1177013815]; Ellis ER, 2009, MEDICAID ENROLLMENT; Gilbert GH, 2002, COMMUNITY DENT ORAL, V30, P352, DOI 10.1034/j.1600-0528.2002.00062.x; Holcomb WL, 2001, OBSTET GYNECOL, V98, P685, DOI 10.1016/S0029-7844(01)01488-0; Kaiser Commission on Medicaid and the Uninsured, 2010, FILL URG NEED IMPR C; Kaiser Commission on Medicaid and the Uninsured, 2010, KAIS COMM MED UN; Kushman J E, 1978, Inquiry, V15, P225; Martinez ME, 2010, HLTH INSURANCE COVER; Massey JT, 1989, VITAL HLTH STAT, V2, P1; Mayer ML, 2000, INQUIRY-J HEALTH CAR, V37, P33; Mengers J., 2001, COMP PHYS DENT FEES; MEYER BD, 1995, J BUS ECON STAT, V13, P151, DOI 10.2307/1392369; National Center for Health Statistics, NAT HLTH INT SURV SU; Nietert PJ, 2005, HEALTH SERV RES, V40, P1078, DOI 10.1111/j.1475-6773.2005.00405.x; Smith V., 2010, HOPING EC RECOVERY P; SMITH V, 2009, CHIP ENROLLMENT JUNE; US Department of Health and Human Services, 2000, OR HLTH AM REP SURG; [US Department of Labor Bureau of Labor Statistics], CONS PRIC IND US CIT; Zuckerman S, 2004, HEALTH AFFAIR, V23, pW374, DOI 10.1377/hlthaff.w4.374; Zuckerman S, 2009, MED PHYS DENT FEES C	27	81	81	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					187	193		10.1001/jama.2011.956	http://dx.doi.org/10.1001/jama.2011.956			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791CO	21750296	Bronze			2022-12-28	WOS:000292639400026
J	Opie, LH				Opie, Lionel H.			Glycaemia and heart failure in diabetes types 1 and 2	LANCET			English	Editorial Material							MELLITUS; CARDIOMYOPATHY; PROGRESSION; STEATOSIS		[Opie, Lionel H.] Univ Cape Town, Fac Hlth Sci, Dept Med, Hatter Cardiovasc Res Inst, ZA-7925 Cape Town, Western Cape, South Africa; [Opie, Lionel H.] Groote Schuur Hosp, ZA-7925 Cape Town, Western Cape, South Africa	University of Cape Town; University of Cape Town	Opie, LH (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Med, Hatter Cardiovasc Res Inst, ZA-7925 Cape Town, Western Cape, South Africa.	lionel.opie@uct.ac.za						Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Carugo S, 2001, J HYPERTENS, V19, P1675, DOI 10.1097/00004872-200109000-00021; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gross JL, 2011, ANN INTERN MED, V154, P672, DOI 10.7326/0003-4819-154-10-201105170-00007; Herrero P, 2006, J AM COLL CARDIOL, V47, P598, DOI 10.1016/j.jacc.2005.09.030; Katare R, 2011, CIRC RES, V108, P1238, DOI 10.1161/CIRCRESAHA.110.239111; Lind M, 2011, LANCET, V378, P140, DOI 10.1016/S0140-6736(11)60471-6; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Opie LH, 2011, HEART, V97, P6, DOI 10.1136/hrt.2010.214031; Rijzewijk LJ, 2008, J AM COLL CARDIOL, V52, P1793, DOI 10.1016/j.jacc.2008.07.062; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Yakubovich N, 2011, CIRCULATION, V123, P342, DOI 10.1161/CIRCULATIONAHA.110.948489; Yudkin JS, 2011, LANCET, V377, P1220, DOI 10.1016/S0140-6736(10)61112-9	15	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 9	2011	378	9786					103	104		10.1016/S0140-6736(11)60787-3	http://dx.doi.org/10.1016/S0140-6736(11)60787-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	795CJ	21705067				2022-12-28	WOS:000292948800005
J	Tahrani, AA; Bailey, CJ; Del Prato, S; Barnett, AH				Tahrani, Abd A.; Bailey, Clifford J.; Del Prato, Stefano; Barnett, Anthony H.			Management of type 2 diabetes: new and future developments in treatment	LANCET			English	Article							GLUCAGON-LIKE PEPTIDE-1; DIPEPTIDYL PEPTIDASE-4 INHIBITOR; INADEQUATE GLYCEMIC CONTROL; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; ALPHA-CELL DYSFUNCTION; DOUBLE-BLIND; INSULIN-RESISTANCE; BETA-CELL; BARIATRIC SURGERY; SMALL-MOLECULE	The increasing prevalence, variable pathogenesis, progressive natural history, and complications of type 2 diabetes emphasise the urgent need for new treatment strategies. Longacting (eg, once weekly) agonists of the glucagon-like-peptide-1 receptor are advanced in development, and they improve prandial insulin secretion, reduce excess glucagon production, and promote satiety. Trials of inhibitors of dipeptidyl peptidase 4, which enhance the effect of endogenous incretin hormones, are also nearing completion. Novel approaches to glycaemic regulation include use of inhibitors of the sodium glucose cotransporter 2, which increase renal glucose elimination, and inhibitors of 11 beta-hydroxysteroid dehydrogenase 1, which reduce the glucocorticoid effects in liver and fat. Insulin-releasing glucokinase activators and pancreatic-G-protein-coupled fatty-acid-receptor agonists, glucagon-receptor antagonists, and metabolic inhibitors of hepatic glucose output are being assessed. Early proof of principle has been shown for compounds that enhance and partly mimic insulin action and replicate some effects of bariatric surgery.	[Tahrani, Abd A.; Barnett, Anthony H.] Univ Birmingham, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England; [Tahrani, Abd A.; Barnett, Anthony H.] Heart England Natl Hlth Serv Fdn Trust, Dept Endocrinol & Diabet, Birmingham, W Midlands, England; [Barnett, Anthony H.] Heart England Natl Hlth Serv Fdn Trust, Biomed Res Ctr, Birmingham, W Midlands, England; [Bailey, Clifford J.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Del Prato, Stefano] Univ Pisa, Dept Endocrinol & Metab, Sect Metab Dis & Diabet, Pisa, Italy	University of Birmingham; Heart of England NHS Foundation Trust; Heart of England NHS Foundation Trust; Aston University; University of Pisa	Barnett, AH (corresponding author), Birmingham Heartlands Hosp, Ctr Diabet, Birmingham B9 5SS, W Midlands, England.	anthony.barnett@heartofengland.nhs.uk	Del+Prato, Stefano/AAC-9197-2021; Tahrani, Abd/C-6939-2014; Del Prato, Stefano/K-3405-2016	Tahrani, Abd/0000-0001-9037-1937; Del Prato, Stefano/0000-0002-5388-0270; Bailey, Clifford J/0000-0002-6998-6811	National Institute for Health Research; Sanofi-Aventis; Novo Nordisk UK Research Foundation; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; Merck Sharp Dohme; Novartis; Eli Lilly; Novo Nordisk; Roche; Servier; Takeda; Boehringer-Ingelheim; National Institute for Health Research [RTF/01/094] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Sanofi-Aventis(Sanofi-Aventis); Novo Nordisk UK Research Foundation; AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Merck Serono(Merck & Company); Merck Sharp Dohme(Merck & Company); Novartis(Novartis); Eli Lilly(Eli Lilly); Novo Nordisk(Novo Nordisk); Roche(Roche Holding); Servier(Servier); Takeda(Takeda Pharmaceutical Company Ltd); Boehringer-Ingelheim(Boehringer Ingelheim); National Institute for Health Research(National Institute for Health Research (NIHR))	AAT is a research training fellow supported by the National Institute for Health Research. The views expressed in this report are those of the author(s) and not necessarily those of the National Health Service, National Institute for Health Research, or the Department of Health. AAT has also won research grants from Sanofi-Aventis and Novo Nordisk UK Research Foundation. CJB has attended advisory board meetings of Bristol-Myers Squibb and AstraZeneca; undertaken ad-hoc consultancy for Bristol-Myers Squibb, AstraZeneca, Merck Sharp & Dohme, Novo Nordisk, GlaxoSmithKline, and Takeda; received research grants from AstraZeneca and Sanofi-Aventis; delivered continuing medical educational programmes sponsored by Bristol-Myers Squibb, AstraZeneca, GlaxoSmithKline, Merck Serono, and Merck Sharp & Dohme; and received travel or accommodation reimbursement from GlaxoSmithKline and Bristol-Myers Squibb. SDP has received honoraria for lectures and advisory work and research funding from Merck Sharp & Dohme, Novartis, GlaxoSmithKline, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, Novo Nordisk, Roche, and Sanofi-Aventis. AHB has received honoraria for lectures and advisory work, and research funding from Servier, Merck Sharp & Dohme, Novartis, Takeda, GlaxoSmithKline, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, Novo Nordisk, Roche, Boehringer-Ingelheim, and Sanofi-Aventis.	Abu-Hamdah R, 2009, J CLIN ENDOCR METAB, V94, P1843, DOI 10.1210/jc.2008-1296; Agius L, 2007, BEST PRACT RES CL EN, V21, P587, DOI 10.1016/j.beem.2007.09.001; [Anonymous], BR J DIABETES VASC D, DOI DOI 10.1177/1474651410377832; *AR, 2008, AR PHARM ANN APD668; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Bailey Clifford J, 2007, Diab Vasc Dis Res, V4, P20, DOI 10.3132/dvdr.2007.002; Bailey CJ, 2010, LANCET, V375, P2223, DOI 10.1016/S0140-6736(10)60407-2; Bailey CJ, 2009, CURR DIABETES REP, V9, P360, DOI 10.1007/s11892-009-0057-y; BARNETT AH, 1980, POSTGRAD MED J, V56, P11, DOI 10.1136/pgmj.56.651.11; BARNETT AH, 2010, LINAGLIPTIN MONOTHER, P823; Barnett AH, 2009, VASC HEALTH RISK MAN, V5, P141; Barnett AH, 2009, CLIN ENDOCRINOL, V70, P343, DOI 10.1111/j.1365-2265.2008.03396.x; Bates SH, 2005, CELL METAB, V1, P169, DOI 10.1016/j.cmet.2005.02.001; Best JH, 2009, DIABETIC MED, V26, P722, DOI 10.1111/j.1464-5491.2009.02752.x; Black C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004654.pub2; Bonadonna RC, 2010, J CLIN ENDOCR METAB, V95, P5028, DOI 10.1210/jc.2010-1041; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Bueter M, 2010, GASTROENTEROLOGY, V138, P1845, DOI 10.1053/j.gastro.2009.11.012; Burcelin R, 2008, DIABETES METAB, V34, pS49, DOI 10.1016/S1262-3636(08)73395-0; Buse JB, 2010, DIABETES CARE, V33, P1255, DOI 10.2337/dc09-1914; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Chao EC, 2010, NAT REV DRUG DISCOV, V9, P551, DOI 10.1038/nrd3180; Chen DS, 2007, P NATL ACAD SCI USA, V104, P943, DOI 10.1073/pnas.0610173104; CHEN M, 1988, J CLIN ENDOCR METAB, V67, P951, DOI 10.1210/jcem-67-5-951; Chiellini C, 2009, DIABETOLOGIA, V52, P1027, DOI 10.1007/s00125-009-1333-8; Christensen M, 2010, CURR DIABETES REP, V10, P124, DOI 10.1007/s11892-010-0102-x; Cincotta A H, 1999, Expert Opin Investig Drugs, V8, P1683, DOI 10.1517/13543784.8.10.1683; Claus TH, 2007, J ENDOCRINOL, V192, P371, DOI 10.1677/JOE-06-0018; Cooper MS, 2009, J CLIN ENDOCR METAB, V94, P4645, DOI 10.1210/jc.2009-1412; DEACON CF, 1995, J CLIN ENDOCR METAB, V80, P952, DOI 10.1210/jc.80.3.952; DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; DeFronzo RA, 2008, DIABETES CARE, V31, P2315, DOI 10.2337/dc08-1035; Del Prato S, 2004, HORM METAB RES, V36, P775, DOI 10.1055/s-2004-826163; DeMaria EJ, 2007, NEW ENGL J MED, V356, P2176, DOI 10.1056/NEJMct067019; DePaula AL, 2011, OBES SURG, V21, P668, DOI 10.1007/s11695-010-0232-x; Diamant M, 2010, LANCET, V375, P2234, DOI 10.1016/S0140-6736(10)60406-0; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Ehses Jan A., 2009, Archives of Physiology and Biochemistry, V115, P240, DOI 10.1080/13813450903025879; Ferrannini E, 2010, DIABETES CARE, V33, P2217, DOI 10.2337/dc10-0612; Flatt PR, 2009, CURR DRUG METAB, V10, P125, DOI 10.2174/138920009787522124; Floettmann E, 2010, TOXICOL PATHOL, V38, P393, DOI 10.1177/0192623310362707; Fonseca VA, 2010, DIABETES OBES METAB, V12, P384, DOI 10.1111/j.1463-1326.2009.01181.x; Froud T, 2008, TRANSPLANTATION, V86, P36, DOI 10.1097/TP.0b013e31817c4ab3; Garcia-Vicente S, 2007, DIABETES, V56, P486, DOI 10.2337/db06-0269; Gaziano JM, 2010, DIABETES CARE, V33, P1503, DOI 10.2337/dc09-2009; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gerich JE, 2010, DIABETIC MED, V27, P136, DOI 10.1111/j.1464-5491.2009.02894.x; Gloyn AL, 2003, HUM MUTAT, V22, P353, DOI 10.1002/humu.10277; GRAEFEMODY U, 2010, LINAGLIPTIN NOVEL DP, P822; Green BD, 2007, BEST PRACT RES CL EN, V21, P497, DOI 10.1016/j.beem.2007.09.003; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Heise T, 2009, DIABETES OBES METAB, V11, P786, DOI 10.1111/j.1463-1326.2009.01046.x; Henry RR, 2009, LANCET, V374, P126, DOI 10.1016/S0140-6736(09)60870-9; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Holt RIG, 2010, DIABETES OBES METAB, V12, P1048, DOI 10.1111/j.1463-1326.2010.01304.x; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Iwamoto K, 2009, ENDOCR J, V56, P951, DOI 10.1507/endocrj.K09E-147; Jones D, 2010, NAT REV DRUG DISCOV, V9, P668, DOI 10.1038/nrd3271; Jose B, 2010, PATIENT PREFER ADHER, V4, P313, DOI 10.2147/PPA.S7494; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kennedy R.L., 2010, THERAP ADV ENDOCRINO, V1, P165; Kim D, 2007, DIABETES CARE, V30, P1487, DOI 10.2337/dc06-2375; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Kodra JT, 2008, J MED CHEM, V51, P5387, DOI 10.1021/jm7015599; Koren S, 2007, BEST PRACT RES CL EN, V21, P621, DOI 10.1016/j.beem.2007.08.004; Kozian DH, 2010, HORM METAB RES, V42, P502, DOI 10.1055/s-0030-1249637; Krentz AJ, 2005, DRUGS, V65, P385, DOI 10.2165/00003495-200565030-00005; Kruger DF, 2004, DRUGS, V64, P1419, DOI 10.2165/00003495-200464130-00003; Lam CKL, 2009, PHYSIOLOGY, V24, P159, DOI 10.1152/physiol.00003.2009; Lau YY, 2009, AAPS J, V11, P700, DOI 10.1208/s12248-009-9150-z; LEWIN AJ, 2010, SAFETY EFFICACY LINA, P821; List JF, 2009, DIABETES CARE, V32, P650, DOI 10.2337/dc08-1863; Lupi R, 2007, DIABETES METAB, V33, P340, DOI 10.1016/j.diabet.2007.03.005; Madsen P, 2009, J MED CHEM, V52, P2989, DOI 10.1021/jm8016249; Manchem VP, 2001, DIABETES, V50, P824, DOI 10.2337/diabetes.50.4.824; Marchetti P, 2010, ADV EXP MED BIOL, V654, P501, DOI 10.1007/978-90-481-3271-3_22; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Mingrone G, 2009, DIABETOLOGIA, V52, P873, DOI 10.1007/s00125-009-1288-9; Miras AD, 2010, CURR OPIN GASTROEN, V26, P140, DOI 10.1097/MOG.0b013e328333e94a; Morgan SA, 2009, DIABETES, V58, P2506, DOI 10.2337/db09-0525; Mudaliar S, 2010, AM J MED, V123, pS19, DOI 10.1016/j.amjmed.2009.12.006; Mues C, 2009, HORM METAB RES, V41, P730, DOI 10.1055/s-0029-1225360; Mulder H, 2009, DIABETOLOGIA, V52, P1240, DOI 10.1007/s00125-009-1359-y; NAUCK M, 2010, DAPAGLIFLOZIN VS GLI, P241; Nauck MA, 2011, DIABETOLOGIA, V54, P10, DOI 10.1007/s00125-010-1896-4; Nauck MA, 2009, INT J CLIN PRACT, V63, P46, DOI 10.1111/j.1742-1241.2008.01933.x; Nauck MA, 2009, DIABETES CARE, V32, P1237, DOI 10.2337/dc08-1961; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Pal M, 2009, DRUG DISCOV TODAY, V14, P784, DOI 10.1016/j.drudis.2009.05.013; Philippe J, 2009, INT J CLIN PRACT, V63, P321, DOI 10.1111/j.1742-1241.2008.01980.x; Pocai A, 2009, DIABETES, V58, P2258, DOI 10.2337/db09-0278; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Pournaras DJ, 2009, WORLD J SURG, V33, P1983, DOI 10.1007/s00268-009-0080-9; Pratley RE, 2009, DIABETES OBES METAB, V11, P167, DOI 10.1111/j.1463-1326.2008.01016.x; Ratner R, 2010, DIABETIC MED, V27, P556, DOI 10.1111/j.1464-5491.2010.02990.x; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Ridderstrale M, 2009, MOL CELL ENDOCRINOL, V297, P10, DOI 10.1016/j.mce.2008.10.002; Rivera N, 2007, J PHARMACOL EXP THER, V321, P743, DOI 10.1124/jpet.106.115717; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Rosenstock J, 2009, DIABETES OBES METAB, V11, P1145, DOI 10.1111/j.1463-1326.2009.01124.x; Rosenstock J, 2010, DIABETES CARE, V33, P1516, DOI 10.2337/dc09-2315; Rosenstock J, 2009, DIABETES CARE, V32, P1880, DOI 10.2337/dc09-0366; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Santer R, 2010, CLIN J AM SOC NEPHRO, V5, P133, DOI 10.2215/CJN.04010609; Sanwald-Ducray P, 2010, CLIN PHARMACOL THER, V88, P197, DOI 10.1038/clpt.2009.259; Schouten R, 2010, ANN SURG, V251, P236, DOI 10.1097/SLA.0b013e3181bdfbff; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Stoffers DA, 2003, DIABETES, V52, P734, DOI 10.2337/diabetes.52.3.734; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Tahrani AA, 2010, PHARMACOL THERAPEUT, V125, P328, DOI 10.1016/j.pharmthera.2009.11.001; Taskinen MR, 2011, DIABETES OBES METAB, V13, P65, DOI 10.1111/j.1463-1326.2010.01326.x; Tomlinson JW, 2001, ENDOCRINOLOGY, V142, P1982, DOI 10.1210/en.142.5.1982; Trautmann M, 2009, DIABETOLOGIA, V52, pS286; Tsai HJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-68; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wilding JPH, 2009, DIABETES CARE, V32, P1656, DOI 10.2337/dc09-0517; WILDING JPH, 2010, EFFECT DAPAGLIFLOZIN, P871; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Wynne K, 2006, INT J OBESITY, V30, P1729, DOI 10.1038/sj.ijo.0803344; Yang CS, 2010, DIABETES, V59, P2435, DOI 10.2337/db10-0221; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zhang B, 1999, SCIENCE, V284, P974, DOI 10.1126/science.284.5416.974; Zhang L, 2010, DIABETES OBES METAB, V12, P510, DOI 10.1111/j.1463-1326.2010.01216.x	133	397	411	0	135	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2011	378	9786					182	197		10.1016/S0140-6736(11)60207-9	http://dx.doi.org/10.1016/S0140-6736(11)60207-9			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	795CJ	21705062				2022-12-28	WOS:000292948800035
J	Devaraneni, PK; Conti, B; Matsumura, Y; Yang, ZY; Johnson, AE; Skach, WR				Devaraneni, Prasanna K.; Conti, Brian; Matsumura, Yoshihiro; Yang, Zhongying; Johnson, Arthur E.; Skach, William R.			Stepwise Insertion and Inversion of a Type II Signal Anchor Sequence in the Ribosome-Sec61 Translocon Complex	CELL			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; ER MEMBRANE; PROTEIN TRANSLOCATION; TRANSMEMBRANE SEGMENTS; SECRETORY PROTEINS; TOPOGENESIS; RECOGNITION; INTEGRATION; REVEALS; CHANNEL	In eukaryotic cells, the ribosome-Sec61 translocon complex (RTC) establishes membrane protein topology by cotranslationally partitioning nascent polypeptides into the cytosol, ER lumen, and lipid bilayer. Using photocrosslinking, collisional quenching, cysteine accessibility, and protease protection, we show that a canonical type II signal anchor (SA) acquires its topology through four tightly coupled and mechanistically distinct steps: (1) head-first insertion into Sec61 alpha, (2) nascent chain accumulation within the RTC, (3) inversion from type I to type II topology, and (4) stable translocation of C-terminal flanking residues. Progression through each stage is induced by incremental increases in chain length and involves abrupt changes in the molecular environment of the SA. Importantly, type II SA inversion deviates from a type I SA at an unstable intermediate whose topology is controlled by dynamic interactions between the ribosome and translocon. Thus, the RTC coordinates SA topogenesis within a protected environment via sequential energetic transitions of the TM segment.	[Devaraneni, Prasanna K.; Conti, Brian; Matsumura, Yoshihiro; Yang, Zhongying; Skach, William R.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Johnson, Arthur E.] Texas A&M Univ, Texas A&M Univ Syst Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Oregon Health & Science University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Skach, WR (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.	skachw@ohsu.edu	Johnson, Arthur E/G-3457-2012	Matsumura, Yoshihiro/0000-0002-3108-0440	US National Institutes of Health [GM53457, DK51818, GM26494, GM083568, HL083808]; NSF [EF-0623664]; Robert A. Welch Foundation Chair [BE-0017]; Manpei Suzuki Diabetes Foundation; American Heart Association; Cystic Fibrosis Foundation Therapeutics Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL083808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053457, R01GM026494, F32GM083568] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Robert A. Welch Foundation Chair(The Welch Foundation); Manpei Suzuki Diabetes Foundation; American Heart Association(American Heart Association); Cystic Fibrosis Foundation Therapeutics Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. N. Alder for valuable assistance and advice with fluorescence quenching, K. Rusterholtz and B. Leighton for technical assistance, Drs. Soo Kim and Amardeep Khushoo for critically reading the manuscript, and Dr. R. Hegde for generously providing TRAM antisera. This work was supported by US National Institutes of Health grants GM53457 (W.R.S.), DK51818 (W.R.S.), GM26494 (A.E.J.), GM083568 (B.C.), HL083808 (B.C.), NSF grant EF-0623664 (A.E.J.), Robert A. Welch Foundation Chair grant BE-0017 (A.E.J.), the Manpei Suzuki Diabetes Foundation (Y.M.), the American Heart Association (W.R.S.), and the Cystic Fibrosis Foundation Therapeutics Inc. (W.R.S.).	Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Foster W, 2000, J BIOL CHEM, V275, P34157, DOI 10.1074/jbc.M000165200; Garrison JL, 2005, NATURE, V436, P285, DOI 10.1038/nature03821; Goder V, 1999, J CELL BIOL, V147, P257, DOI 10.1083/jcb.147.2.257; Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361; HEGDE K, 1996, CELL, V85, P217; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; HIGH S, 1993, J BIOL CHEM, V268, P26745; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; Ismail N, 2008, BIOCHEM J, V411, P495, DOI 10.1042/BJ20071597; Johnson AE, 2005, TRAFFIC, V6, P1078, DOI 10.1111/j.1600-0854.2005.00340.x; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Junne T, 2010, MOL BIOL CELL, V21, P1662, DOI 10.1091/mbc.E10-01-0060; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; Kida Y, 2007, J CELL BIOL, V179, P1441, DOI 10.1083/jcb.200707050; Kida Y, 2010, MOL BIOL CELL, V21, P418, DOI 10.1091/mbc.E09-08-0738; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Lu JL, 2005, BIOCHEMISTRY-US, V44, P8230, DOI 10.1021/bi050372q; MATLACK KES, 1995, J BIOL CHEM, V270, P6170, DOI 10.1074/jbc.270.11.6170; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; Pitonzo D, 2009, MOL BIOL CELL, V20, P685, DOI 10.1091/mbc.E08-09-0902; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Pool MR, 2009, J CELL BIOL, V185, P889, DOI 10.1083/jcb.200807066; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; ROTHMAN RE, 1988, J BIOL CHEM, V263, P10470; Rutkowski DT, 2001, P NATL ACAD SCI USA, V98, P7823, DOI 10.1073/pnas.141125098; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; SHAW AS, 1988, P NATL ACAD SCI USA, V85, P7592, DOI 10.1073/pnas.85.20.7592; Shibatani T, 2005, BIOCHEMISTRY-US, V44, P5982, DOI 10.1021/bi047328f; Skach WR, 2009, NAT STRUCT MOL BIOL, V16, P606, DOI 10.1038/nsmb.1600; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; THRIFT RN, 1991, J CELL BIOL, V112, P809, DOI 10.1083/jcb.112.5.809; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063	46	77	78	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					134	147		10.1016/j.cell.2011.06.004	http://dx.doi.org/10.1016/j.cell.2011.06.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729785	Bronze, Green Accepted			2022-12-28	WOS:000292539300012
J	Joenje, H				Joenje, Hans			METABOLISM Alcohol, DNA and disease	NATURE			English	Editorial Material							ACETALDEHYDE; OXYGEN; CELLS		[Joenje, Hans] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, NL-1081 BT Amsterdam, Netherlands; [Joenje, Hans] Vrije Univ Amsterdam Med Ctr, VUmc Inst Canc & Immunol, Canc Ctr Amsterdam, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Joenje, H (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, NL-1081 BT Amsterdam, Netherlands.	h.joenje@vumc.nl						Brooks PJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000050; Garcia CL, 2009, MUTAT RES-FUND MOL M, V662, P3, DOI 10.1016/j.mrfmmm.2008.11.008; JOENJE H, 1989, MUTAT RES, V219, P193, DOI 10.1016/0921-8734(89)90001-5; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Novitskiy G, 2006, ALCOHOL CLIN EXP RES, V30, P1429, DOI 10.1111/j.1530-0277.2006.00171.x; Ridpath JR, 2007, CANCER RES, V67, P11117, DOI 10.1158/0008-5472.CAN-07-3028; SULIK KK, 1981, SCIENCE, V214, P936, DOI 10.1126/science.6795717	8	18	19	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					45	46		10.1038/475045a	http://dx.doi.org/10.1038/475045a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734701				2022-12-28	WOS:000292461300041
J	Read, P				Read, Peter			SATURN Storm-clouds brooding on towering heights	NATURE			English	Editorial Material							MOIST CONVECTION; ATMOSPHERE		Univ Oxford, Dept Phys, Oxford OX1 3PU, England	University of Oxford	Read, P (corresponding author), Univ Oxford, Dept Phys, Oxford OX1 3PU, England.	p.read1@physics.ox.ac.uk	Read, Peter Leonard/AAS-2773-2020		Science and Technology Facilities Council [ST/I001948/1] Funding Source: researchfish	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Dyudina UA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043188; Dyudina UA, 2007, ICARUS, V190, P545, DOI 10.1016/j.icarus.2007.03.035; Fischer G, 2011, NATURE, V475, P75, DOI 10.1038/nature10205; Fletcher LN, 2011, SCIENCE, V332, P1413, DOI 10.1126/science.1204774; Hueso R, 2004, ICARUS, V172, P255, DOI 10.1016/j.icarus.2004.06.010; LEAR E, 1877, LAUGHABLE LYRICS; Sanchez-Lavega A, 2011, NATURE, V475, P71, DOI 10.1038/nature10203; SANCHEZLAVEGA A, 1993, J GEOPHYS RES-PLANET, V98, P18857, DOI 10.1029/93JE01777; SMITH BA, 1979, SCIENCE, V204, P951, DOI 10.1126/science.204.4396.951	11	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					44	45		10.1038/475044a	http://dx.doi.org/10.1038/475044a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734700				2022-12-28	WOS:000292461300040
J	Sung, CC; Lin, SH				Sung, Chih-Chien; Lin, Shih-Hua			Nonobstructive Hydronephrosis with Secondary Polycythemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sung, Chih-Chien; Lin, Shih-Hua] Triserv Gen Hosp, Taipei, Taiwan	Tri-Service General Hospital	Sung, CC (corresponding author), Triserv Gen Hosp, Taipei, Taiwan.								0	5	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					E1	E1		10.1056/NEJMicm1013847	http://dx.doi.org/10.1056/NEJMicm1013847			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788QL	21732830				2022-12-28	WOS:000292459400012
J	Dechartres, A; Boutron, I; Trinquart, L; Charles, P; Ravaud, P				Dechartres, Agnes; Boutron, Isabelle; Trinquart, Ludovic; Charles, Pierre; Ravaud, Philippe			Single-Center Trials Show Larger Treatment Effects Than Multicenter Trials: Evidence From a Meta-epidemiologic Study	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIALS; PERCUTANEOUS CORONARY INTERVENTION; OBSTRUCTIVE PULMONARY-DISEASE; PROTON PUMP INHIBITORS; PUBLICATION BIAS; CLINICAL-TRIALS; METHODOLOGICAL QUALITY; EMPIRICAL-EVIDENCE; METAANALYSIS; EFFICACY	Background: A recent study suggested that results of single-center trials are frequently contradicted when similar trials are performed in multicenter settings. Purpose: To perform a meta-epidemiologic study to evaluate whether estimates of treatment effect differ between single-center and multicenter randomized, controlled trials (RCTs). Data Sources: MEDLINE was searched via PubMed for meta-analyses of RCTs with binary outcomes that were published between August 2008 and January 2009 and in the first 6 months of 2010 in the 10 leading journals of each medical specialty. One issue of the Cochrane Database of Systematic Reviews was also searched. Study Selection: All individual RCTs included in the meta-analyses were selected. Data Extraction: Data were extracted and their quality was assessed by use of the risk of bias tool of the Cochrane Collaboration. Data Synthesis: The primary outcome was the ratio of odds ratios (ROR), used to quantify the difference in estimated intervention effect between single-center and multicenter RCTs. An ROR less than 1 would indicate larger estimates of the intervention effect in single-center trials. Sensitivity analyses were performed with adjustment for sample size, risk of bias within RCTs, and variance of the log odds ratio to take publication bias into account. Forty-eight meta-analyses were selected, including 421 RCTs (223 were single-center and 198 were multicenter). Single-center RCTs showed a larger intervention effect than did multicenter RCTs (combined ROR, 0.73 [95% CI, 0.64 to 0.83]), with low heterogeneity across individual meta-analyses (I-2 = 12.0%; P = 0.24). Adjustment for sample size yielded consistent results (ROR, 0.85 [CI, 0.74 to 0.97]), as did adjustment for risk of bias within RCTs, such as allocation concealment (ROR, 0.76 [CI, 0.67 to 0.86]), and variance of log odds ratio (ROR, 0.83 [CI, 0.72 to 0.96]). Limitation: Despite sensitivity analyses, meta-confounding cannot be fully excluded. Conclusion: Single-center RCTs showed larger treatment effects than did multicenter RCTs, a finding that was consistent in all sensitivity analyses. These results suggest that this item should be considered when the results of RCTs and meta-analyses are interpreted.	[Dechartres, Agnes] Hop Hotel Dieu, INSERM U738, Ctr Epidemiol Clin, F-75004 Paris, France; Hop Hotel Dieu, APHP, F-75004 Paris, France; Univ Paris 05, Fac Med, Paris, France; French Cochrane Ctr, Paris, France; Hop Foch, Suresnes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Hospital Foch	Dechartres, A (corresponding author), Hop Hotel Dieu, INSERM U738, Ctr Epidemiol Clin, 1 Pl Parvis Notre Dame, F-75004 Paris, France.	agnes.dechartres@htd.aphp.fr	Trinquart, Ludovic/H-4961-2019; ravaud, philippe/C-1694-2009	Trinquart, Ludovic/0000-0002-3028-4900; Boutron, Isabelle/0000-0002-5263-6241; Ravaud, Philippe/0000-0001-8264-9206	Delegation Interregionale a la Recherche Clinique (DIRC), Ile de France, Assistance Publique-Hopitaux de Paris (APHP)	Delegation Interregionale a la Recherche Clinique (DIRC), Ile de France, Assistance Publique-Hopitaux de Paris (APHP)	Primary Funding Source: Academic grant Recherche sur la Recherche from the Delegation Interregionale a la Recherche Clinique (DIRC), Ile de France, Assistance Publique-Hopitaux de Paris (APHP).	Bangalore S, 2008, LANCET, V372, P1962, DOI 10.1016/S0140-6736(08)61560-3; Baujat B, 2002, STAT MED, V21, P2641, DOI 10.1002/sim.1221; Bechtold ML, 2008, AM J GASTROENTEROL, V103, P2919, DOI 10.1111/j.1572-0241.2008.02108.x; Bellomo R, 2009, CRIT CARE MED, V37, P3114, DOI 10.1097/CCM.0b013e3181bc7bd5; BERLIN JA, 1989, J AM STAT ASSOC, V84, P381; Biau DJ, 2008, ANN SURG, V247, P892, DOI 10.1097/SLA.0b013e31816ffa99; Boutron I, 2003, JAMA-J AM MED ASSOC, V290, P1062, DOI 10.1001/jama.290.8.1062; Brandler E, 2010, ACAD EMERG MED, V17, P1, DOI 10.1111/j.1553-2712.2009.00625.x; Cennamo V, 2010, ENDOSCOPY, V42, P381, DOI 10.1055/s-0029-1243992; Chalmers I, 1995, SYSTEMATIC REV; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Cooper NAM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1130; Crescenzi G, 2008, ANESTHESIOLOGY, V109, P1063, DOI 10.1097/ALN.0b013e31818db18b; Cuijpers P, 2008, AM J PSYCHIAT, V165, P1272, DOI 10.1176/appi.ajp.2008.07091422; De Luca G, 2008, EUR HEART J, V29, P3002, DOI 10.1093/eurheartj/ehn389; DICKERSIN K, 1993, ANN NY ACAD SCI, V703, P135, DOI 10.1111/j.1749-6632.1993.tb26343.x; Drummond MB, 2008, JAMA-J AM MED ASSOC, V300, P2407, DOI 10.1001/jama.2008.717; El-Toukhy T, 2008, BJOG-INT J OBSTET GY, V115, P1203, DOI 10.1111/j.1471-0528.2008.01838.x; Fairchild A, 2008, J CLIN ONCOL, V26, P4001, DOI 10.1200/JCO.2007.15.3312; Falagas ME, 2008, LANCET INFECT DIS, V8, P543, DOI 10.1016/S1473-3099(08)70202-0; Fan T, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1841; Feller M, 2010, CLIN INFECT DIS, V50, P473, DOI 10.1086/649923; Fernandez-Guisasola J, 2010, ANAESTHESIA, V65, P379, DOI 10.1111/j.1365-2044.2010.06249.x; Friedman BW, 2008, ANN EMERG MED, V52, P705, DOI 10.1016/j.annemergmed.2008.05.036; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Ho KM, 2009, AM J KIDNEY DIS, V53, P33, DOI 10.1053/j.ajkd.2008.05.019; Horvath K, 2010, BMJ-BRIT MED J, V340, pc1395; Jones AE, 2008, CRIT CARE MED, V36, P2734, DOI 10.1097/CCM.0b013e318186f839; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kalyani RR, 2010, J AM GERIATR SOC, V58, P1299, DOI 10.1111/j.1532-5415.2010.02949.x; Karthikesalingam A, 2010, BRIT J SURG, V97, P4, DOI 10.1002/bjs.6902; Kasapis C, 2009, EUR HEART J, V30, P44, DOI 10.1093/eurheartj/ehn514; Kjaergard LL, 1999, HEPATOLOGY, V30, P1134, DOI 10.1002/hep.510300510; Kuriya B, 2010, ANN RHEUM DIS, V69, P1298, DOI 10.1136/ard.2009.118307; Laine L, 2009, CLIN GASTROENTEROL H, V7, P33, DOI 10.1016/j.cgh.2008.08.016; Lee KP, 2002, JAMA-J AM MED ASSOC, V287, P2805, DOI 10.1001/jama.287.21.2805; Lee M, 2010, STROKE, V41, P1205, DOI 10.1161/STROKEAHA.109.573410; Lee M, 2010, STROKE, V41, P932, DOI 10.1161/STROKEAHA.109.574335; Lin PC, 2010, CRIT CARE MED, V38, P1197, DOI 10.1097/CCM.0b013e3181d69ccf; Lourenco T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1662; Marik PE, 2010, CHEST, V137, P544, DOI 10.1378/chest.09-1737; Martin-Rendon E, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub2; Meier P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c467; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Mollon B, 2008, J BONE JOINT SURG AM, V90A, P2322, DOI 10.2106/JBJS.H.00111; Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2; Novara G, 2008, EUR UROL, V54, P740, DOI 10.1016/j.eururo.2008.06.080; Nuesch E, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3244; Pengel LHM, 2009, TRANSPL INT, V22, P377, DOI 10.1111/j.1432-2277.2008.00789.x; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Piscione F, 2010, HEART, V96, P588, DOI 10.1136/hrt.2009.183277; Prasad K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002244.pub3; Riddle MS, 2008, CLIN INFECT DIS, V47, P1007, DOI 10.1086/591703; Schneider MP, 2010, J AM COLL CARDIOL, V55, P2299, DOI 10.1016/j.jacc.2010.01.043; Schomig A, 2008, J AM COLL CARDIOL, V52, P894, DOI 10.1016/j.jacc.2008.05.051; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Siempos II, 2010, CRIT CARE MED, V38, P954, DOI 10.1097/CCM.0b013e3181c8fe4b; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Sud S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2327; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Tan JA, 2010, INTENS CARE MED, V36, P926, DOI 10.1007/s00134-010-1877-6; Tierney JF, 2005, INT J EPIDEMIOL, V34, P79, DOI 10.1093/ije/dyh300; Tsoi DTY, 2010, BRIT J PSYCHIAT, V196, P346, DOI 10.1192/bjp.bp.109.066019; Van Craen K, 2010, J AM GERIATR SOC, V58, P83, DOI 10.1111/j.1532-5415.2009.02621.x; van Rijen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006216.pub2; von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027; Wang CH, 2010, ARCH INTERN MED, V170, P751, DOI 10.1001/archinternmed.2010.100; Weng CL, 2010, ANN INTERN MED, V152, P590, DOI 10.7326/0003-4819-152-9-201005040-00009; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Ziakas PD, 2010, OBSTET GYNECOL, V115, P1256, DOI 10.1097/AOG.0b013e3181deba40	74	182	184	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2011	155	1					39	+		10.7326/0003-4819-155-1-201107050-00006	http://dx.doi.org/10.7326/0003-4819-155-1-201107050-00006			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788MA	21727292				2022-12-28	WOS:000292447800005
J	Long, DT; Raschle, M; Joukov, V; Walter, JC				Long, David T.; Raeschle, Markus; Joukov, Vladimir; Walter, Johannes C.			Mechanism of RAD51-Dependent DNA Interstrand Cross-Link Repair	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; FANCONI-ANEMIA; HOMOLOGOUS RECOMBINATION; JUNCTIONS; PROTEIN	DNA interstrand cross-links (ICLs) are toxic DNA lesions whose repair in S phase of eukaryotic cells is incompletely understood. In Xenopus egg extracts, ICL repair is initiated when two replication forks converge on the lesion. Dual incisions then create a DNA double-strand break (DSB) in one sister chromatid, whereas lesion bypass restores the other sister. We report that the broken sister chromatid is repaired via RAD51-dependent strand invasion into the regenerated sister. Recombination acts downstream of FANCI-FANCD2, yet RAD51 binds ICL-stalled replication forks independently of FANCI-FANCD2 and before DSB formation. Our results elucidate the functional link between the Fanconi anemia pathway and the recombination machinery during ICL repair. In addition, they demonstrate the complete repair of a DSB via homologous recombination in vitro.	[Long, David T.; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Raeschle, Markus] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Joukov, Vladimir] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Max Planck Society; Harvard University; Dana-Farber Cancer Institute	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu	Joukov, Vladimir/K-3525-2019	Walter, Johannes/0000-0002-4186-7570; Long, David/0000-0001-9232-0316	NIH [GM GM80676, HL098316]; Department of Defense Breast Cancer Research [W81XWH-04-1-0524]; American Cancer Society [PF-10-146-01-DMC]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080676] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research(United States Department of Defense); American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Costanzo for the BRC<SUP>WT</SUP> expression construct; T. V. Ho and O. Scharer for instruction on pICL preparation; P. Knipscheer for reagents and helpful discussions; and A. D'Andrea, K. J. Patel, R. Scully, and P. Knipscheer for critical reading of the manuscript. This work was supported by NIH grants GM GM80676 and HL098316 and a John and Virginia Kaneb award to J.C.W., Department of Defense Breast Cancer Research Program Award W81XWH-04-1-0524 to V. J., and American Cancer Society postdoctoral fellowship PF-10-146-01-DMC to D.T.L. M. R. made initial observation of X-arcs; V. J. generated x.l.RAD51 antibodies; D.T.L. and J.C.W. designed and analyzed experiments; D.T.L. performed experiments; and D.T.L. and J.C.W. prepared the manuscript.	Bzymek M, 2010, NATURE, V464, P937, DOI 10.1038/nature08868; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Deans AJ, 2009, MOL CELL, V36, P943, DOI 10.1016/j.molcel.2009.12.006; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Lambert S, 2007, DNA REPAIR, V6, P1042, DOI 10.1016/j.dnarep.2007.02.024; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Nakanishi K, 2011, NAT STRUCT MOL BIOL, V18, P500, DOI 10.1038/nsmb.2029; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Robinson NP, 2007, EMBO J, V26, P816, DOI 10.1038/sj.emboj.7601529; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Yamamoto K, 2003, MOL CELL BIOL, V23, P5421, DOI 10.1128/MCB.23.15.5421-5430.2003; Yang YG, 2005, CARCINOGENESIS, V26, P1731, DOI 10.1093/carcin/bgi134; Zhang NX, 2007, DNA REPAIR, V6, P1670, DOI 10.1016/j.dnarep.2007.06.002	17	165	165	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					84	87		10.1126/science.1204258	http://dx.doi.org/10.1126/science.1204258			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719678	Green Accepted			2022-12-28	WOS:000292255400054
J	Turk, DC; Wilson, HD; Cahana, A				Turk, Dennis C.; Wilson, Hilary D.; Cahana, Alex			Treatment of chronic non-cancer pain	LANCET			English	Article							LOW-BACK-PAIN; SPINAL-CORD STIMULATION; EPIDURAL STEROID INJECTIONS; SURGERY SYNDROME; PHARMACOLOGICAL-TREATMENT; UNITED-STATES; LUMBAR FUSION; DOUBLE-BLIND; PSYCHOLOGICAL INTERVENTIONS; FIBROMYALGIA SYNDROME	Chronic pain is a pervasive problem that affects the patient, their significant others, and society in many ways. The past decade has seen advances in our understanding of the mechanisms underlying pain and in the availability of technically advanced diagnostic procedures; however, the most notable therapeutic changes have not been the development of novel evidenced-based methods, but rather changing trends in applications and practices within the available clinical armamentarium. We provide a general overview of empirical evidence for the most commonly used interventions in the management of chronic non-cancer pain, including pharmacological, interventional, physical, psychological, rehabilitative, and alternative modalities. Overall, currently available treatments provide modest improvements in pain and minimum improvements in physical and emotional functioning. The quality of evidence is mediocre and has not improved substantially during the past decade. There is a crucial need for assessment of combination treatments, identification of indicators of treatment response, and assessment of the benefit of matching of treatments to patient characteristics.	[Turk, Dennis C.; Wilson, Hilary D.; Cahana, Alex] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Turk, DC (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.	turkdc@uw.edu			Endo Pharmaceuticals; Ortho-McNeill Janssen; National Institutes of Health	Endo Pharmaceuticals; Ortho-McNeill Janssen; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	DCT has received grants from Endo Pharmaceuticals, Ortho-McNeill Janssen, and the National Institutes of Health. He has served as a consultant to Endo Pharmaceuticals, Galderma, Pfizer, and Smith & Nephew; served on an advisory board for Eli Lilly and Pfizer; is a Special Government Employee of the US Food and Drug Administration (FDA), and serves as Co-chair of the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) and Associate Director of Analgesic Clinical Trials Innovations, Opportunities; and Networks (ACTION), a public-private partnership with the US FDA. HOW has received a grant from Ortho-McNeill Janssen. AC declares that he has no conflicts of interest.	[Anonymous], 2009, MED LETT DRUGS THER, V51, P61; Armon C, 2007, NEUROLOGY, V68, P723, DOI 10.1212/01.wnl.0000256734.34238.e7; Arnold LM, 2010, J RHEUMATOL, V37, P2578, DOI 10.3899/jrheum.100365; Arnold Lesley M, 2006, Curr Psychiatry Rep, V8, P241, DOI 10.1007/s11920-006-0030-2; Arnold LM, 2000, PSYCHOSOMATICS, V41, P104, DOI 10.1176/appi.psy.41.2.104; Attal N, 2006, EUR J NEUROL, V13, P1153, DOI 10.1111/j.1468-1331.2006.01511.x; Attal N, 2010, EUR J NEUROL, V17, P1113, DOI 10.1111/j.1468-1331.2010.02999.x; Bennett G, 2000, J PAIN SYMPTOM MANAG, V20, pS37, DOI 10.1016/S0885-3924(00)00202-5; Bennett RA, 2003, AM J MED, V114, P537, DOI 10.1016/S0002-9343(03)00116-5; Burckhardt CS, 2005, APS CLIN PRACTICE GU, V4; Carville SF, 2008, ANN RHEUM DIS, V67, P536, DOI 10.1136/ard.2007.071522; Cepeda MS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005522.pub2; Cheng HT, 2010, CURR PAIN HEADACHE R, V14, P213, DOI 10.1007/s11916-010-0111-0; Chou R, 2009, GUIDELINE MANAGEMENT; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Chou R, 2009, J PAIN, V10, P147, DOI 10.1016/j.jpain.2008.10.007; Chou R, 2009, SPINE, V34, P1078, DOI 10.1097/BRS.0b013e3181a103b1; Chou R, 2009, SPINE, V34, P1094, DOI 10.1097/BRS.0b013e3181a105fc; Chou R, 2009, SPINE, V34, P1066, DOI 10.1097/BRS.0b013e3181a1390d; Chu LF, 2008, CLIN J PAIN, V24, P479, DOI 10.1097/AJP.0b013e31816b2f43; Compton WM, 2006, DRUG ALCOHOL DEPEN, V81, P103, DOI 10.1016/j.drugalcdep.2005.05.009; Crofford LJ, 2005, ARTHRITIS RHEUM-US, V52, P1264, DOI 10.1002/art.20983; DeBerard MS, 2001, SPINE, V26, P738; Deyo RA, 2005, SPINE, V30, P1441, DOI 10.1097/01.brs.0000166503.37969.8a; Dixon KE, 2007, HEALTH PSYCHOL, V26, P241, DOI 10.1037/0278-6133.26.3.241; Duhmke R. M., 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003726; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; FLOR H, 1992, PAIN, V49, P221, DOI 10.1016/0304-3959(92)90145-2; Frey ME, 2009, PAIN PHYSICIAN, V12, P379; Friedly J, 2008, ARCH PHYS MED REHAB, V89, P1011, DOI 10.1016/j.apmr.2007.10.037; Fritzell P, 2001, SPINE, V26, P2521, DOI 10.1097/00007632-200112010-00002; Furlan AD, 2005, SPINE, V30, P944, DOI 10.1097/01.brs.0000158941.21571.01; Furlan AD, 2006, CAN MED ASSOC J, V174, P1589, DOI 10.1503/cmaj.051528; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Gendreau RM, 2005, J RHEUMATOL, V32, P1975; Gerber Helmut R, 2003, Best Pract Res Clin Anaesthesiol, V17, P429, DOI 10.1016/S1521-6896(03)00014-4; Gilron I, 2005, NEW ENGL J MED, V352, P1324, DOI 10.1056/NEJMoa042580; Gilron Ian, 2005, Expert Rev Neurother, V5, P823, DOI 10.1586/14737175.5.6.823; Gilron I, 2009, LANCET, V374, P1252, DOI 10.1016/S0140-6736(09)61081-3; Griffin Marie R., 2001, American Journal of Medicine, V110, p33S, DOI 10.1016/S0002-9343(00)00634-3; Guay David R P, 2009, Consult Pharm, V24, P833, DOI 10.4140/TCP.n.2009.833; Guggenheimer J, 2011, J AM DENT ASSOC, V142, P38, DOI 10.14219/jada.archive.2011.0026; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Guzman J, 2001, BMJ-BRIT MED J, V322, P1511, DOI 10.1136/bmj.322.7301.1511; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; Henschke N, 2010, COCHRANE DB SYST REV, V20; Hoffman BM, 2007, HEALTH PSYCHOL, V26, P1, DOI 10.1037/0278-6133.26.1.1; Hornberger J, 2008, CLIN J PAIN, V24, P244, DOI 10.1097/AJP.0b013e318160216a; Jensen M, 2006, J BEHAV MED, V29, P95, DOI 10.1007/s10865-005-9031-6; Johnson M, 2007, PAIN, V130, P157, DOI 10.1016/j.pain.2007.02.007; Kemler MA, 2000, NEW ENGL J MED, V343, P618, DOI 10.1056/NEJM200008313430904; Khadilkar A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003008.pub3; Klement A, 2008, SCHMERZ, V22, P283, DOI 10.1007/s00482-008-0673-5; Kroenke K, 2009, GEN HOSP PSYCHIAT, V31, P206, DOI 10.1016/j.genhosppsych.2008.12.006; Luijsterburg PAJ, 2007, EUR SPINE J, V16, P881, DOI 10.1007/s00586-007-0367-1; Manchikanti Kavita N, 2008, J Opioid Manag, V4, P271; Manchikanti L, 2008, PAIN PHYSICIAN, V11, pS63; Manchikanti Laxmaiah, 2004, Pain Physician, V7, P465; Manchikanti L, 2010, PAIN PHYSICIAN, V13, pE141; Manchikanti L, 2009, PAIN PHYSICIAN, V12, P699; Manheimer E, 2005, ANN INTERN MED, V142, P651, DOI 10.7326/0003-4819-142-8-200504190-00014; Maniadakis N, 2000, PAIN, V84, P95, DOI 10.1016/S0304-3959(99)00187-6; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Mason L, 2004, BMJ-BRIT MED J, V328, P995, DOI 10.1136/bmj.38040.607141.EE; Michna E, 2007, CLIN J PAIN, V23, P173, DOI 10.1097/AJP.0b013e31802b4f95; Montgomery GH, 2000, INT J CLIN EXP HYP, V48, P138, DOI 10.1080/00207140008410045; Morley S, 1999, PAIN, V80, P1, DOI 10.1016/S0304-3959(98)00255-3; NACHEMSON AL, 1992, CLIN ORTHOP RELAT R, P8; National Academy of Sciences, 2001, MUSCULOSKELETAL DISO; Noble M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006605.pub2; Nuesch E, 2009, COCHRANE DB SYST REV, V4; Oesch P, 2010, J REHABIL MED, V42, P193, DOI 10.2340/16501977-0524; Paulozzi LJ, 2007, INJURY PREV, V13, P130, DOI 10.1136/ip.2006.014357; Rathmell JP, 2006, REGION ANESTH PAIN M, V31, P346, DOI 10.1016/j.rapm.2006.03.004; Roelofs PDDM, 2008, COCHRANE DB SYST REV, V1; Russell IJ, 2000, JCR-J CLIN RHEUMATOL, V6, P250, DOI 10.1097/00124743-200010000-00004; Schmidtko A, 2010, LANCET, V375, P1569, DOI 10.1016/S0140-6736(10)60354-6; SCHONSTEIN E, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001822; See S, 2008, AM FAM PHYSICIAN, V78, P365; Singh G, 1999, J RHEUMATOL, V26, P18; Stein C, 2010, CURR OPIN ANESTHESIO, V23, P598, DOI 10.1097/ACO.0b013e32833c57a8; Tan G, 2007, J REHABIL RES DEV, V44, P195, DOI 10.1682/JRRD.2006.06.0063; Tan Toni, 2010, BMJ, V340, pc1079, DOI 10.1136/bmj.c1079; Taylor Rod S, 2006, J Pain Symptom Manage, V31, pS13, DOI 10.1016/j.jpainsymman.2005.12.010; Taylor RS, 2005, SPINE, V30, P152, DOI 10.1097/01.brs.0000149199.68381.fe; Thieme K, 2007, ARTHRIT RHEUM-ARTHR, V57, P830, DOI 10.1002/art.22778; Thomsen AB, 2002, EUR J PAIN-LONDON, V6, P341, DOI 10.1016/S1090-3801(02)00023-X; Turk DC, 2005, CLIN J PAIN, V21, P44, DOI 10.1097/00002508-200501000-00006; Turk DC, 2002, CLIN J PAIN, V18, P355, DOI 10.1097/00002508-200211000-00003; Turk DC, 2009, BONICAS MANAGEMENT P, V4th, P13; Turner JA, 2004, PAIN, V108, P137, DOI 10.1016/j.pain.2003.12.016; Turner JA, 2007, CLIN J PAIN, V23, P180, DOI 10.1097/01.ajp.0000210955.93878.44; van Tulder M, 2007, SPINE, V32, P1785, DOI 10.1097/BRS.0b013e3180b9ef49; van Tulder MW, 2006, EUR SPINE J, V15, pS82, DOI 10.1007/s00586-005-1049-5; Verdu B, 2008, DRUGS, V68, P2611, DOI 10.2165/0003495-200868180-00007; Verhaak PFM, 1998, PAIN, V77, P231, DOI 10.1016/S0304-3959(98)00117-1; Vo T, 2009, PAIN, V143, P169, DOI 10.1016/j.pain.2009.03.013; Wang MC, 2009, SPINE, V34, P955, DOI 10.1097/BRS.0b013e31819e2fd5; Witt CM, 2010, J PAIN, V11, P431, DOI 10.1016/j.jpain.2009.08.010	101	407	445	0	82	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2011	377	9784					2226	2235		10.1016/S0140-6736(11)60402-9	http://dx.doi.org/10.1016/S0140-6736(11)60402-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	786XI	21704872				2022-12-28	WOS:000292340800035
J	Cassidy, J				Cassidy, Jane			LOBBY WATCH Christian Medical Fellowship	BRITISH MEDICAL JOURNAL			English	Editorial Material												janecassi2@googlemail.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 20	2011	343								d4586	10.1136/bmj.d4586	http://dx.doi.org/10.1136/bmj.d4586			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	797ZH	21775395				2022-12-28	WOS:000293168700010
J	Nerella, N				Nerella, Nishant			Bolus and continuous/high- and low-dose diuretics had similar effects on symptoms and renal function in acute, decompensated HF	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Maimonides Hosp, Brooklyn, NY 11219 USA	Maimonides Medical Center	Nerella, N (corresponding author), Maimonides Hosp, Brooklyn, NY 11219 USA.								0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2011	155	2							JC1-05	10.7326/0003-4819-155-2-201107190-02005	http://dx.doi.org/10.7326/0003-4819-155-2-201107190-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	793KW	21768571				2022-12-28	WOS:000292822000004
J	Montaner, JSG				Montaner, Julio S. G.			Treatment as prevention-a double hat-trick	LANCET			English	Editorial Material							ACTIVE ANTIRETROVIRAL THERAPY; HIV TRANSMISSION; ACCESS; EPIDEMIC; STRATEGY; GROWTH; CURB		[Montaner, Julio S. G.] Univ British Columbia, Fac Med, Div Aids, Vancouver, BC, Canada; [Montaner, Julio S. G.] St Pauls Hosp, BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Montaner, Julio S. G.] Providence Healthcare, Vancouver, BC, Canada	University of British Columbia; B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan	Montaner, JSG (corresponding author), Univ British Columbia, Fac Med, Div Aids, Vancouver, BC, Canada.	jmontaner@cfenet.ubc.ca	Montaner, Julio/K-7621-2012		CIHR Funding Source: Medline; NIDA NIH HHS [1DP1DA026182-01, DP1 DA026182] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026182] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		[Anonymous], 2011, LANCET, V377, P1719, DOI 10.1016/S0140-6736(11)60713-7; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Kirk G, 2011, 18 C RETR OPP INF BO, P484; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; *NAT I ALL INF DIS, 2011, TREAT HIV INF PEOPL; *NAT I ALL INF DIS, 2011, HPTN 052 STUD PREV S; Sturt AS, 2010, COCHRANE DB SYST REV, V3; Volkow ND, 2010, JAMA-J AM MED ASSOC, V303, P1423, DOI 10.1001/jama.2010.421; Wagner BG, 2010, AIDS, V24, P775, DOI 10.1097/QAD.0b013e3283366782; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; 2011, INT TREATM PREV WORK	17	94	99	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 16	2011	378	9787					208	209		10.1016/S0140-6736(11)60821-0	http://dx.doi.org/10.1016/S0140-6736(11)60821-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798JD	21763923				2022-12-28	WOS:000293201100008
J	Bramante, RM; Rand, M				Bramante, Robert Matthew; Rand, Masha			Angioedema	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bramante, Robert Matthew; Rand, Masha] N Shore Univ Hosp, Manhasset, NY 11030 USA	Northwell Health; North Shore University Hospital	Bramante, RM (corresponding author), N Shore Univ Hosp, Manhasset, NY 11030 USA.	rbramante@nshs.edu							0	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2							e4	10.1056/NEJMicm1014034	http://dx.doi.org/10.1056/NEJMicm1014034			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SP	21751902				2022-12-28	WOS:000292685500013
J	Brody, H				Brody, Herb			ALZHEIMER'S DISEASE	NATURE			English	Editorial Material																			0	15	18	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					S1	S1		10.1038/475S1a	http://dx.doi.org/10.1038/475S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791UA	21760574	Bronze			2022-12-28	WOS:000292690500001
J	Li, Y; Yin, J; Cai, XY; Temkin-Greener, H; Mukamel, DB				Li, Yue; Yin, Jun; Cai, Xueya; Temkin-Greener, Helena; Mukamel, Dana B.			Association of Race and Sites of Care With Pressure Ulcers in High-Risk Nursing Home Residents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINIMUM DATA SET; PAY-FOR-PERFORMANCE; RACIAL DISPARITIES; QUALITY; MANAGEMENT; US; PREVALENCE; ADJUSTMENT; FACILITIES; VALIDITY	Context A variety of nursing home quality improvement programs have been implemented during the last decade but their implications for racial disparities on quality are unknown. Objectives To determine the longitudinal trend of racial disparities in pressure ulcer prevalence among high-risk, long-term nursing home residents and to assess whether persistent disparities are related to where residents received care. Design, Setting, and Participants Observational cohort study of pressure ulcer rates in 2.1 million white and 346 808 black residents of 12 473 certified nursing homes in the United States that used the nursing home resident assessment; Online Survey, Certification, and Reporting files; and Area Resource Files for 2003 through 2008. Nursing homes were categorized according to their proportions of black residents. Main Outcome Measures Risk-adjusted racial disparities between and within sites of care and risk-adjusted odds of pressure ulcers in stages 2 through 4 for black and white residents receiving care in different nursing home facilities. Results Pressure ulcer rates decreased overall from 2003 through 2008 but black residents of nursing homes showed persistently higher pressure ulcer rates than white residents. In 2003, the pressure ulcer rate was 16.8% (95% confidence interval [CI], 16.6%-17.0%) for black nursing home residents compared with 11.4% (95% CI, 11.3%-11.5%) for white residents; in 2008, the rate was 14.6% (95% CI, 14.4%-14.8%) compared with 9.6%(95% CI, 9.5%-9.7%), respectively (P>.05 for trend of disparities). In nursing homes with the highest percentages of black residents (>= 35%), both black residents (unadjusted rate of 15.5% [95% CI, 15.2%-15.8%] in 2008; adjusted odds ratio [AOR], 1.59 [95% CI, 1.52-1.67]) and white residents (unadjusted rate of 12.1% [95% CI, 11.8%12.4%]; AOR, 1.33 [95% CI, 1.26-1.40]) had higher rates of pressure ulcers than nursing homes serving primarily white residents (concentration of black residents <5%), in which white residents had an unadjusted rate of 8.8% (95% CI, 8.7%-8.9%). Conclusions From 2003 through 2008, the prevalence of pressure ulcers among high-risk nursing home residents was higher among black residents than among white residents. This disparity was in part related to the site of nursing home care. JAMA. 2011;306(2):179-186	[Li, Yue; Cai, Xueya] Univ Iowa, Div Gen Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Yin, Jun; Cai, Xueya] Univ Iowa, Dept Biostat, Iowa City, IA 52242 USA; [Li, Yue; Cai, Xueya] Iowa City VA Med Ctr, Ctr Comprehens Access & Delivery Res Evaluat, Iowa City, IA USA; [Temkin-Greener, Helena] Univ Rochester, Med Ctr, Dept Community & Prevent Med, Rochester, NY 14642 USA; [Mukamel, Dana B.] Univ Calif Irvine, Dept Med, Hlth Policy Res Inst, Irvine, CA 92717 USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Rochester; University of California System; University of California Irvine	Li, Y (corresponding author), Univ Iowa, Div Gen Internal Med, Carver Coll Med, 200 Hawkins Dr,Box C44-N GH, Iowa City, IA 52242 USA.	yue-li@uiowa.edu			National Institute on Aging [R01AG032264]; NATIONAL INSTITUTE ON AGING [R01AG032264] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by grant R01AG032264 from the National Institute on Aging.	*ABT ASS INC, 2006, QUAL MON MED GLOB PA; *ABT ASS INC, 2004, QUAL MEAS NAT PUBL R; Agency for Healthcare Research and Quality (AHRQ), 2009, NAT HEALTHC DISP REP; Allsworth JE, 2005, ETHNIC DIS, V15, P205; Baier Rosa R, 2003, J Am Med Dir Assoc, V4, P291, DOI 10.1016/S1525-8610(04)70387-4; Baumgarten M, 2004, J AM GERIATR SOC, V52, P1293, DOI 10.1111/j.1532-5415.2004.52358.x; Berlowitz DR, 1996, ANN INTERN MED, V124, P557, DOI 10.7326/0003-4819-124-6-199603150-00003; Berlowitz DR, 2001, J AM GERIATR SOC, V49, P872, DOI 10.1046/j.1532-5415.2001.49176.x; BERLOWITZ DR, 1993, IMPROVING CARE NURSI; Bernabei R, 1998, JAMA-J AM MED ASSOC, V279, P1877, DOI 10.1001/jama.279.23.1877; BRANDEIS GH, 1990, JAMA-J AM MED ASSOC, V264, P2905, DOI 10.1001/jama.264.22.2905; Cai SB, 2010, MED CARE, V48, P233, DOI 10.1097/MLR.0b013e3181ca2810; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Fennell ML, 2010, HEALTH AFFAIR, V29, P65, DOI 10.1377/hlthaff.2009.0003; *GEN ACC OFF, 2003, NURS HOM QUAL PREV S; Grabowski DC, 2003, J HEALTH ECON, V22, P1, DOI 10.1016/S0167-6296(02)00093-0; Harrington C, 2004, J HEALTH POLIT POLIC, V29, P43, DOI 10.1215/03616878-29-1-43; Harrington C, 2001, AM J PUBLIC HEALTH, V91, P1452, DOI 10.2105/AJPH.91.9.1452; Hsiao Cheng., 2003, ANAL PANEL DATA, VSecond; Institute of Medicine, IMPR QUAL CAR NURS H; Jones Adrienne L, 2009, Vital Health Stat 13, P1; Konetzka RT, 2009, MED CARE RES REV, V66, P491, DOI 10.1177/1077558709331813; Lapane KL, 2005, J AM GERIATR SOC, V53, P1077, DOI 10.1111/j.1532-5415.2005.53338_5.x; Lawton MP, 1998, J AM GERIATR SOC, V46, P736, DOI 10.1111/j.1532-5415.1998.tb03809.x; Li Y, 2010, AM J PUBLIC HEALTH, V100, pS256, DOI 10.2105/AJPH.2009.173468; Mor V, 2004, MED CARE, V42, P50, DOI 10.1097/01.mlr.0000120104.01232.5e; Mor V, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-20; Mor V, 2004, MILBANK Q, V82, P227, DOI 10.1111/j.0887-378X.2004.00309.x; Mor V, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-78; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Mukamel DB, 2008, HEALTH SERV RES, V43, P1244, DOI 10.1111/j.1475-6773.2007.00829.x; Mukamel DB, 2007, J GERONTOL B-PSYCHOL, V62, pS218, DOI 10.1093/geronb/62.4.S218; Rantz MJ, 2003, GERONTOLOGIST, V43, P248, DOI 10.1093/geront/43.2.248; Reddy M, 2008, JAMA-J AM MED ASSOC, V300, P2647, DOI 10.1001/jama.2008.778; Rollow W, 2006, ANN INTERN MED, V145, P342, DOI 10.7326/0003-4819-145-5-200609050-00134; Rosen Jules, 2006, Adv Skin Wound Care, V19, P262, DOI 10.1097/00129334-200606000-00011; Rosen J, 2006, J AM MED DIR ASSOC, V7, P141, DOI 10.1016/j.jamda.2005.08.003; Smith DB, 2007, HEALTH AFFAIR, V26, P1448, DOI 10.1377/hlthaff.26.5.1448; Stevenson DG, 2009, J AM GERIATR SOC, V57, P1678, DOI 10.1111/j.1532-5415.2009.02401.x; Werner R, 2010, HEALTH AFFAIR, V29, P1706, DOI 10.1377/hlthaff.2009.0556; Werner RM, 2010, MED CARE RES REV, V67, P364, DOI 10.1177/1077558709350885; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	42	70	70	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2011	306	2					179	186		10.1001/jama.2011.942	http://dx.doi.org/10.1001/jama.2011.942			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791CO	21750295	Green Accepted, Bronze			2022-12-28	WOS:000292639400025
J	Chandra, FA; Buzi, G; Doyle, JC				Chandra, Fiona A.; Buzi, Gentian; Doyle, John C.			Glycolytic Oscillations and Limits on Robust Efficiency	SCIENCE			English	Article							YEAST; LIMITATIONS	Both engineering and evolution are constrained by trade-offs between efficiency and robustness, but theory that formalizes this fact is limited. For a simple two-state model of glycolysis, we explicitly derive analytic equations for hard trade-offs between robustness and efficiency with oscillations as an inevitable side effect. The model describes how the trade-offs arise from individual parameters, including the interplay of feedback control with autocatalysis of network products necessary to power and catalyze intermediate reactions. We then use control theory to prove that the essential features of these hard trade-off "laws" are universal and fundamental, in that they depend minimally on the details of this system and generalize to the robust efficiency of any autocatalytic network. The theory also suggests worst-case conditions that are consistent with initial experiments.	[Chandra, Fiona A.] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA; [Buzi, Gentian; Doyle, John C.] CALTECH, Dept Control & Dynam Syst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Chandra, FA (corresponding author), CALTECH, Dept Bioengn, Pasadena, CA 91125 USA.	fiona@caltech.edu		/0000-0001-8370-3374	NIH [R01GM078992A]; Institute of Collaborative Biotechnologies from the U.S. Army Research Office [KK4102, DAAD19-03-D-0004]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Collaborative Biotechnologies from the U.S. Army Research Office	The authors thank H. El-Samad and J. Stewart-Ornstein at the University of California, San Francisco, for their laboratory space and assistance; N. Pierce (Ray Deshaies' lab) for the green fluorescent protein library; O. Venturelli (Richard Murray's lab) for her help; and M. Csete for helpful feedback. Microscopy was performed at the Nikon Imaging Center at UCSF. Experimental data are available in SOM. This work is supported by the NIH (award R01GM078992A) and Institute of Collaborative Biotechnologies from the U.S. Army Research Office (subaward KK4102, prime award DAAD19-03-D-0004).	Alderson DL, 2010, IEEE T SYST MAN CY A, V40, P839, DOI 10.1109/TSMCA.2010.2048027; Astrom K.J., 2008, FEEDBACK SYSTEMS INT; BETZ A, 1965, ARCH BIOCHEM BIOPHYS, V109, P585, DOI 10.1016/0003-9861(65)90404-2; Bier M, 1996, BIOPHYS CHEM, V62, P15, DOI 10.1016/S0301-4622(96)02195-3; Buzi G, 2011, AUTOMATICA, V47, P1123, DOI 10.1016/j.automatica.2011.02.040; Chernyak BV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P240, DOI 10.1007/s10541-005-0106-3; Doyle JC, 1992, FEEDBACK CONTROL THE; GHOSH A, 1964, BIOCHEM BIOPH RES CO, V16, P174, DOI 10.1016/0006-291X(64)90357-2; Goldbeter A., 1996, BIOCH OSCILLATIONS C; Hynne R, 2001, BIOPHYS CHEM, V94, P121; Iglesias PA., 2010, CONTROL THEORY SYSTE; Lander AD, 2004, PLOS BIOL, V2, P712, DOI 10.1371/journal.pbio.0020164; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Martins NC, 2007, IEEE T AUTOMAT CONTR, V52, P56, DOI 10.1109/TAC.2006.887898; Poulsen AK, 2007, BIOPHYS CHEM, V125, P275, DOI 10.1016/j.bpc.2006.08.009; Richard P, 2003, FEMS MICROBIOL REV, V27, P547, DOI 10.1016/S0168-6445(03)00065-2; RICHTER PH, 1981, SCIENCE, V211, P715, DOI 10.1126/science.6450447; Sandberg H, 2011, IEEE T AUTOMAT CONTR, V56, P293, DOI 10.1109/TAC.2010.2056450; SELKOV E, 1975, EUR J BIOCHEM, V59, P151, DOI 10.1111/j.1432-1033.1975.tb02436.x; Stahlberg A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-170; TERMONIA Y, 1981, P NATL ACAD SCI-BIOL, V78, P2952, DOI 10.1073/pnas.78.5.2952; Teusink B, 1996, BBA-BIOENERGETICS, V1275, P204, DOI 10.1016/0005-2728(96)00026-6	23	133	135	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2011	333	6039					187	192		10.1126/science.1200705	http://dx.doi.org/10.1126/science.1200705			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21737735	Green Submitted			2022-12-28	WOS:000292502700040
J	Baker, M				Baker, Monya			TECHNOLOGY FEATURE Inside the minds of mice and men	NATURE			English	Editorial Material							MOUSE; BEHAVIORS; DEFECTS											Abazyan B, 2010, BIOL PSYCHIAT, V68, P1172, DOI 10.1016/j.biopsych.2010.09.022; Bissonette GB, 2008, J NEUROSCI, V28, P11124, DOI 10.1523/JNEUROSCI.2820-08.2008; Bussey TJ, 2012, NEUROPHARMACOLOGY, V62, P1191, DOI 10.1016/j.neuropharm.2011.04.011; Goulding EH, 2008, P NATL ACAD SCI USA, V105, P20575, DOI 10.1073/pnas.0809053106; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Lutz C. M., J CLIN INVE IN PRESS; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Spencer CM, 2011, AUTISM RES, V4, P40, DOI 10.1002/aur.168; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Yang M, 2011, AUTISM RES, V4, P17, DOI 10.1002/aur.163	12	49	49	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					123	128		10.1038/475123a	http://dx.doi.org/10.1038/475123a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734709	Bronze			2022-12-28	WOS:000292461300061
J	Kruger, M; Schenk, M; Hommelhoff, P				Krueger, Michael; Schenk, Markus; Hommelhoff, Peter			Attosecond control of electrons emitted from a nanoscale metal tip	NATURE			English	Article							ABOVE-THRESHOLD IONIZATION; SPECTROSCOPY; DYNAMICS; PULSES; FIELDS; LIGHT	Attosecond science is based on steering electrons with the electric field of well controlled femtosecond laser pulses(1). It has led to the generation of extreme-ultraviolet pulses(2) with a duration of less than 100 attoseconds (ref. 3; 1 as = 10(-18) s), to the measurement of intramolecular dynamics (by diffraction of an electron taken from the molecule under scrutiny(4,5)) and to ultrafast electron holography(6). All these effects have been observed with atoms or molecules in the gas phase. Electrons liberated from solids by few-cycle laser pulses are also predicted(7,8) to show a strong light-phase sensitivity, but only very small effects have been observed(14). Here we report that the spectra of electrons undergoing photoemission from a nanometre-scale tungsten tip show a dependence on the carrier-envelope phase of the laser, with a current modulation of up to 100 per cent. Depending on the carrier-envelope phase, electrons are emitted either from a single sub-500-attosecond interval of the 6-femtosecond laser pulse, or from two such intervals; the latter case leads to spectral interference. We also show that coherent elastic re-scattering of liberated electrons takes place at the metal surface. Owing to field enhancement at the tip, a simple laser oscillator reaches the peak electric field strengths required for attosecond experiments at 100-megahertz repetition rates, rendering complex amplified laser systems dispensable. Practically, this work represents a simple, extremely sensitive carrier-envelope phase sensor, which could be shrunk in volume to about one cubic centimetre. Our results indicate that the attosecond techniques developed with (and for) atoms and molecules can also be used with solids. In particular, we foresee subfemtosecond, subnanometre probing of collective electron dynamics (such as plasmon polaritons(9)) in solid-state systems ranging in scale from mesoscopic solids to clusters and to single protruding atoms.	[Krueger, Michael; Schenk, Markus; Hommelhoff, Peter] Max Planck Inst Quantum Opt, Ultrafast Quantum Opt Grp, D-85748 Garching, Germany	Max Planck Society	Hommelhoff, P (corresponding author), Max Planck Inst Quantum Opt, Ultrafast Quantum Opt Grp, Hans Kopfermann Str 1, D-85748 Garching, Germany.	peter.hommelhoff@mpq.mpg.de	Hommelhoff, Peter/C-5121-2013; Krueger, Michael/K-4199-2019	Hommelhoff, Peter/0000-0003-4757-5410; Krueger, Michael/0000-0002-6188-9179	European Union	European Union(European Commission)	We thank M. Kling, C. Lemell, G. Wachter and B. Bergues for discussions, and J. Hoffrogge for reading the text before submission. This work has been supported in part by the European Union (FP7-IRG).	Aeschlimann M, 2007, NATURE, V446, P301, DOI 10.1038/nature05595; Antoine P, 1996, PHYS REV LETT, V77, P1234, DOI 10.1103/PhysRevLett.77.1234; Apolonski A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.073902; Baker S, 2006, SCIENCE, V312, P424, DOI 10.1126/science.1123904; Baltuska A, 2003, NATURE, V421, P611, DOI 10.1038/nature01414; Bormann R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.147601; Bucksbaum PH, 2007, SCIENCE, V317, P766, DOI 10.1126/science.1142135; Cavalieri AL, 2007, NATURE, V449, P1029, DOI 10.1038/nature06229; Corkum PB, 2007, NAT PHYS, V3, P381, DOI 10.1038/nphys620; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Faisal FHM, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.023412; Gazibegovic-Busuladzic A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.103004; Goulielmakis E, 2008, SCIENCE, V320, P1614, DOI 10.1126/science.1157846; Goulielmakis E, 2007, SCIENCE, V317, P769, DOI 10.1126/science.1142855; Hommelhoff P, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247402; Huismans Y, 2011, SCIENCE, V331, P61, DOI 10.1126/science.1198450; Kealhofer C., 2011, PHYS REV B UNPUB; Kim S, 2008, NATURE, V453, P757, DOI 10.1038/nature07012; Lemell C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.076403; Lindner F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.040401; Milosevic DB, 2006, J PHYS B-AT MOL OPT, V39, pR203, DOI 10.1088/0953-4075/39/14/R01; Niikura H, 2002, NATURE, V417, P917, DOI 10.1038/nature00787; Novotny L, 2011, NAT PHOTONICS, V5, P83, DOI [10.1038/nphoton.2010.237, 10.1038/NPHOTON.2010.237]; PAULUS GG, 1994, PHYS REV LETT, V72, P2851, DOI 10.1103/PhysRevLett.72.2851; Schenk M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.257601; Stockman MI, 2007, APPL PHYS A-MATER, V89, P247, DOI [10.1007/s00339-007-4105-7, 10.1007/s00339-007-41057]; Stockman MI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.137404; Yanagisawa H, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.257603; Yudin GL, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.013409; Zherebtsov S, 2011, NAT PHYS, V7, P656, DOI [10.1038/nphys1983, 10.1038/NPHYS1983]	30	452	458	6	260	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					78	81		10.1038/nature10196	http://dx.doi.org/10.1038/nature10196			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734706	Green Submitted			2022-12-28	WOS:000292461300048
J	Muller, RD				Mueller, R. Dietmar			EARTH SCIENCE Plate motion and mantle plumes	NATURE			English	Editorial Material									Univ Sydney, Sch Geosci, Sydney, NSW 2006, Australia	University of Sydney	Muller, RD (corresponding author), Univ Sydney, Sch Geosci, Sydney, NSW 2006, Australia.	dietmar.muller@sydney.edu.au	Müller, Dietmar/L-1200-2019	Müller, Dietmar/0000-0002-3334-5764				Armitage JJ, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003316; Cande SC, 2011, NATURE, V475, P47, DOI 10.1038/nature10174; Chenet AL, 2007, EARTH PLANET SC LETT, V263, P1, DOI 10.1016/j.epsl.2007.07.011; COFFIN MF, 1994, REV GEOPHYS, V32, P1, DOI 10.1029/93RG02508; Goes S, 2008, NATURE, V451, P981, DOI 10.1038/nature06691; Kumar P, 2007, NATURE, V449, P894, DOI 10.1038/nature06214; Schellart WP, 2007, NATURE, V446, P308, DOI 10.1038/nature05615; Stadler G, 2010, SCIENCE, V329, P1033, DOI 10.1126/science.1191223; Torsvik TH, 2010, NATURE, V466, P352, DOI 10.1038/nature09216; van Hinsbergen DJJ, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008051	10	9	12	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					40	41		10.1038/475040a	http://dx.doi.org/10.1038/475040a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734697				2022-12-28	WOS:000292461300037
J	Hackshaw, A; Kirkwood, A				Hackshaw, Allan; Kirkwood, Amy			Interpreting and reporting clinical trials with results of borderline significance	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHASE-III; RANDOMIZED-TRIAL; INTERVENTION; CANCER; CHEMOTHERAPY; THERAPY; ABSENCE	The quality of randomised clinical trials and how they are reported have improved over time, with clearer guidelines on conduct and statistical analysis.(1) Clinical trials often take several years, but interpreting the results at the end is arguably the most important activity because it influences whether a new intervention is recommended or not. Although researchers have become more familiar with medical statistics, the interpretation and reporting of results of borderline significance remains a problem. We examine the problem and recommend some solutions.	[Hackshaw, Allan; Kirkwood, Amy] UCL, Canc Res UK & UCL Canc Trials Ctr, London W1T 4TJ, England	Cancer Research UK; University of London; University College London	Hackshaw, A (corresponding author), UCL, Canc Res UK & UCL Canc Trials Ctr, London W1T 4TJ, England.	ah@ctc.ucl.ac.uk						Albain KS, 2009, LANCET, V374, P2055, DOI 10.1016/S0140-6736(09)61523-3; Alderson P, 2004, BMJ-BRIT MED J, V328, P476, DOI 10.1136/bmj.328.7438.476; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Bakitas M, 2009, JAMA-J AM MED ASSOC, V302, P741, DOI 10.1001/jama.2009.1198; Bhatt DL, 2009, NEW ENGL J MED, V361, P2330, DOI 10.1056/NEJMoa0908629; Cunningham D, 2009, J CLIN ONCOL, V27, P5513, DOI 10.1200/JCO.2009.24.2446; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Fidias PM, 2009, J CLIN ONCOL, V27, P591, DOI 10.1200/JCO.2008.17.1405; Gomes MF, 2009, LANCET, V373, P557, DOI 10.1016/S0140-6736(08)61734-1; Grau MV, 2009, J NATL CANCER I, V101, P267, DOI 10.1093/jnci/djn484; Haritoglou C, 2009, LANCET, V373, P1364, DOI 10.1016/S0140-6736(09)60218-X; Hess G, 2009, J CLIN ONCOL, V27, P3822, DOI 10.1200/JCO.2008.20.7977; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Lefebvre JL, 2009, JNCI-J NATL CANCER I, V101, P142, DOI 10.1093/jnci/djn460; Lowenberg B, 2009, NEW ENGL J MED, V361, P1235, DOI 10.1056/NEJMoa0901409; Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986; Moher D, 2001, ANN INTERN MED, V134, P657, DOI 10.7326/0003-4819-134-8-200104170-00011; Murphy AW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4220; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Paulussen M, 2008, J CLIN ONCOL, V26, P4385, DOI 10.1200/JCO.2008.16.5720; Peterson AV, 2009, JNCI-J NATL CANCER I, V101, P1378, DOI 10.1093/jnci/djp317; Plint AC, 2009, NEW ENGL J MED, V360, P2079, DOI 10.1056/NEJMoa0900544; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Roh MS, 2009, J CLIN ONCOL, V27, P5124, DOI 10.1200/JCO.2009.22.0467; Soligard T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2469; Stahl M, 2009, J CLIN ONCOL, V27, P851, DOI 10.1200/JCO.2008.17.0506; Stewart JSW, 2009, J CLIN ONCOL, V27, P1864, DOI 10.1200/JCO.2008.17.0530; Van Cutsem E, 2009, J CLIN ONCOL, V27, P3117, DOI 10.1200/JCO.2008.21.6663; Wheatley K, 2009, NEW ENGL J MED, V361, P1953, DOI 10.1056/NEJMoa0905368	30	63	63	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2011	343								d3340	10.1136/bmj.d3340	http://dx.doi.org/10.1136/bmj.d3340			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V41LK	21727163	Bronze			2022-12-28	WOS:000209547500001
J	Liljas, A; Ehrenberg, M; Aqvist, J				Liljas, Anders; Ehrenberg, Mans; Aqvist, Johan			Comment on "The Mechanism for Activation of GTP Hydrolysis on the Ribosome"	SCIENCE			English	Editorial Material													Aqvist, Johan/A-4360-2012						0	35	36	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					37	37		10.1126/science.1202472	http://dx.doi.org/10.1126/science.1202472			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719661				2022-12-28	WOS:000292255400026
J	van de Kamp, T; Vagovic, P; Baumbach, T; Riedel, A				van de Kamp, Thomas; Vagovic, Patrik; Baumbach, Tilo; Riedel, Alexander			A Biological Screw in a Beetle's Leg	SCIENCE			English	Article									[van de Kamp, Thomas; Riedel, Alexander] State Museum Nat Hist SMNK, D-76133 Karlsruhe, Germany; [van de Kamp, Thomas; Vagovic, Patrik; Baumbach, Tilo] Karlsruhe Inst Technol, ANKA Inst Synchrotron Radiat, D-76344 Eggenstein Leopoldshafen, Germany; [van de Kamp, Thomas] Univ Dusseldorf, Inst Zool 2, D-40225 Dusseldorf, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Heinrich Heine University Dusseldorf	Riedel, A (corresponding author), State Museum Nat Hist SMNK, D-76133 Karlsruhe, Germany.	riedel@smnk.de	Vagovic, Patrik/H-1193-2013; Baumbach, Tilo Gerd/K-5355-2013; van de Kamp, Thomas/G-1440-2016; Riedel, Alexander/V-2608-2019	van de Kamp, Thomas/0000-0001-7390-1318; Riedel, Alexander/0000-0002-8291-4425	German Research Foundation [RI 1817/3-1]	German Research Foundation(German Research Foundation (DFG))	We are grateful to F. Glaw encouraging us to prepare the initial manuscript, to S. Scharf for performing the segmentation of mu CT scans, and to D. Pelliccia for his assistance during the scans. M. Balke, O. Betz, and M. Spies kindly revised earlier drafts. The specimens examined are deposited at SMNK. The image data are stored at www. morphdbase. de?A_Riedel_20110523-M-4.1. This work was supported by grant RI 1817/3-1 from the German Research Foundation.	Betz O, 2007, J MICROSC-OXFORD, V227, P51, DOI 10.1111/j.1365-2818.2007.01785.x; Bogelsack G, 2000, THEOR BIOSCI, V119, P104, DOI 10.1078/1431-7613-00008; Chamorro-Lacayo ML, 2004, ZOOTAXA, P1; Frantsevich L, 2009, ARTHROPOD STRUCT DEV, V38, P16, DOI 10.1016/j.asd.2008.06.002; Larsen O., 1966, Opuscula Entomologica Suppl, V30, P1; Reuleaux F., 1900, LEHRBUCH KINEMATIK, V2, P723; Riedel A, 2010, ZOOL SCR, V39, P63, DOI 10.1111/j.1463-6409.2009.00404.x	7	39	40	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					52	52		10.1126/science.1204245	http://dx.doi.org/10.1126/science.1204245			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719669				2022-12-28	WOS:000292255400044
J	Latta, C; Haupt, F; Hanl, M; Weichselbaum, A; Claassen, M; Wuester, W; Fallahi, P; Faelt, S; Glazman, L; von Delft, J; Tureci, HE; Imamoglu, A				Latta, C.; Haupt, F.; Hanl, M.; Weichselbaum, A.; Claassen, M.; Wuester, W.; Fallahi, P.; Faelt, S.; Glazman, L.; von Delft, J.; Tuereci, H. E.; Imamoglu, A.			Quantum quench of Kondo correlations in optical absorption	NATURE			English	Article							STATES; DOTS	The interaction between a single confined spin and the spins of an electron reservoir leads to one of the most remarkable phenomena of many-body physics-the Kondo effect(1,2). Electronic transport measurements on single artificial atoms, or quantum dots, have made it possible to study the effect in great detail(3-5). Here we report optical measurements on a single semiconductor quantum dot tunnel-coupled to a degenerate electron gas which show that absorption of a single photon leads to an abrupt change in the system Hamiltonian and a quantum quench of Kondo correlations. By inferring the characteristic power-law exponents from the experimental absorption line shapes, we find a unique signature of the quench in the form of an Anderson orthogonality catastrophe(6,7), induced by a vanishing overlap between the initial and final many-body wavefunctions. We show that the power-law exponent that determines the degree of orthogonality can be tuned using an external magnetic field(8), which unequivocally demonstrates that the observed absorption line shape originates from Kondo correlations. Our experiments demonstrate that optical measurements on single artificial atoms offer new perspectives on many-body phenomena previously studied using transport spectroscopy only.	[Hanl, M.; Weichselbaum, A.; von Delft, J.] Univ Munich, Arnold Sommerfeld Ctr Theoret Phys, D-80333 Munich, Germany; [Latta, C.; Haupt, F.; Claassen, M.; Wuester, W.; Fallahi, P.; Faelt, S.; Tuereci, H. E.; Imamoglu, A.] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland; [Glazman, L.] Yale Univ, Sloane Phys Lab, New Haven, CT 06520 USA; [Tuereci, H. E.] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA	University of Munich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Yale University; Princeton University	Latta, C (corresponding author), ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	clatta@phys.ethz.ch; imamoglu@phys.ethz.ch	Weichselbaum, Andreas/I-8858-2012; fallahi, parisa/D-9157-2012	Weichselbaum, Andreas/0000-0002-5832-3908; Claassen, Martin/0000-0001-7580-0588; von Delft, Jan/0000-0002-8655-0999	Swiss NSF [200021-121757, PP00P2-123519/1]; ERC; DFG [SFB631, SFB-TR12, De730/3-2, De730/4-1]; Cluster of Excellence 'Nanosystems Initiative Munich'; NSF DMR [0906498]	Swiss NSF(Swiss National Science Foundation (SNSF)); ERC(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG)); Cluster of Excellence 'Nanosystems Initiative Munich'; NSF DMR(National Science Foundation (NSF))	This work was supported by Swiss NSF under grant no. 200021-121757 and an ERC Advanced Investigator Grant (A. I.). J.v.D. acknowledges support from the DFG (SFB631, SFB-TR12, De730/3-2, De730/4-1), the Cluster of Excellence 'Nanosystems Initiative Munich'. H. E. T. acknowledges support from the Swiss NSF under grant no. PP00P2-123519/1. L. G. acknowledges support from NSF DMR under grant no. 0906498.	ANDERSON PW, 1961, PHYS REV, V124, P41, DOI 10.1103/PhysRev.124.41; ANDERSON PW, 1967, PHYS REV LETT, V18, P1049, DOI 10.1103/PhysRevLett.18.1049; Atature M, 2006, SCIENCE, V312, P551, DOI 10.1126/science.1126074; Claassen M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.177403; Cronenwett SM, 1998, SCIENCE, V281, P540, DOI 10.1126/science.281.5376.540; Dalgarno PA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.176801; Dousse A, 2010, NATURE, V466, P217, DOI 10.1038/nature09148; Goldhaber-Gordon D, 1998, NATURE, V391, P156, DOI 10.1038/34373; Govorov AO, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.241307; GUNNARSSON O, 1983, PHYS REV B, V28, P4315, DOI 10.1103/PhysRevB.28.4315; Helmes RW, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.125301; Hilario LML, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.156802; Hogele A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.217401; Kikoin K, 2000, PHYS REV B, V62, P4647, DOI 10.1103/PhysRevB.62.4647; Kim D, 2011, NAT PHYS, V7, P223, DOI [10.1038/nphys1863, 10.1038/NPHYS1863]; Kleemans NAJM, 2010, NAT PHYS, V6, P534, DOI 10.1038/NPHYS1673; KONDO J, 1964, PROG THEOR PHYS, V32, P37, DOI 10.1143/PTP.32.37; Kouwenhoven L, 2001, PHYS WORLD, V14, P33; Latta C, 2009, NAT PHYS, V5, P758, DOI 10.1038/NPHYS1363; Mahan G., 2000, MANY PARTICLE PHYS, P612; Michler P, 2000, SCIENCE, V290, P2282, DOI 10.1126/science.290.5500.2282; Press D, 2008, NATURE, V456, P218, DOI 10.1038/nature07530; Shahbazyan TV, 2000, PHYS REV LETT, V84, P5896, DOI 10.1103/PhysRevLett.84.5896; Tureci HE, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.107402; van der Wiel WG, 2000, SCIENCE, V289, P2105, DOI 10.1126/science.289.5487.2105; Warburton RJ, 2000, NATURE, V405, P926, DOI 10.1038/35016030; Xu XD, 2009, NATURE, V459, P1105, DOI 10.1038/nature08120; Yilmaz ST, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.033601	28	86	86	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					627	630		10.1038/nature10204	http://dx.doi.org/10.1038/nature10204			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21720368	Green Submitted			2022-12-28	WOS:000292204300036
J	Metzl, JM				Metzl, Jonathan M.			The art of medicine "Why are the mentally ill still bearing arms?"	LANCET			English	Editorial Material									Vanderbilt Univ, Ctr Med Hlth & Soc, Nashville, TN 37235 USA	Vanderbilt University	Metzl, JM (corresponding author), Vanderbilt Univ, Ctr Med Hlth & Soc, 221 Kirkland Hall, Nashville, TN 37235 USA.	jonathan.metzl@vanderbilt.edu			Direct For Social, Behav & Economic Scie [1137717] Funding Source: National Science Foundation	Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))			0	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2011	377	9784					2172	2173		10.1016/S0140-6736(11)60950-1	http://dx.doi.org/10.1016/S0140-6736(11)60950-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	786XI	21714165				2022-12-28	WOS:000292340800016
J	Hiller, DA; Singh, V; Zhong, MH; Strobel, SA				Hiller, David A.; Singh, Vipender; Zhong, Minghong; Strobel, Scott A.			A two-step chemical mechanism for ribosome-catalysed peptide bond formation	NATURE			English	Article							TRANSITION-STATE; TRANSFERASE REACTION; TRANSFER-RNA; HYDRAZINOLYSIS; INTERMEDIATE; 2'-HYDROXYL; AMINOLYSIS; REVEALS; 2'-OH; WATER	The chemical step of natural protein synthesis, peptide bond formation, is catalysed by the large subunit of the ribosome. Crystal structures have shown that the active site for peptide bond formation is composed entirely of RNA(1). Recent work has focused on how an RNA active site is able to catalyse this fundamental biological reaction at a suitable rate for protein synthesis. On the basis of the absence of important ribosomal functional groups(2), lack of a dependence on pH(3), and the dominant contribution of entropy to catalysis(4), it has been suggested that the role of the ribosome is limited to bringing the substrates into close proximity. Alternatively, the importance of the 2'-hydroxyl of the peptidyl-transfer RNA(5) and a Bronsted coefficient near zero(6) have been taken as evidence that the ribosome coordinates a proton-transfer network. Here we report the transition state of peptide bond formation, based on analysis of the kinetic isotope effect at five positions within the reaction centre of a peptidyl-transfer RNA mimic. Our results indicate that in contrast to the uncatalysed reaction, formation of the tetrahedral intermediate and proton transfer from the nucleophilic nitrogen both occur in the rate-limiting step. Unlike in previous proposals, the reaction is not fully concerted; instead, breakdown of the tetrahedral intermediate occurs in a separate fast step. This suggests that in addition to substrate positioning, the ribosome is contributing to chemical catalysis by changing the rate-limiting transition state.	[Hiller, David A.; Singh, Vipender; Zhong, Minghong; Strobel, Scott A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Strobel, SA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	scott.strobel@yale.edu			NIH [GM54839]; Brown-Coxe fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054839] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brown-Coxe fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Klinman and D. Singleton for critical reading of the manuscript, and members of the S. A. S. laboratory for discussion. This work was supported by an NIH postdoctoral fellowship (D. A. H.), a Brown-Coxe fellowship (V. S.) and an NIH grant (GM54839).	Anisimov V, 1999, J MATH CHEM, V26, P75, DOI 10.1023/A:1019173509273; Bieling P, 2006, NAT STRUCT MOL BIOL, V13, P423, DOI 10.1038/nsmb1091; CLELAND WW, 1995, METHOD ENZYMOL, V249, P341; Dorner S, 2003, NUCLEIC ACIDS RES, V31, P6536, DOI 10.1093/nar/gkg842; Erlacher MD, 2005, NUCLEIC ACIDS RES, V33, P1618, DOI 10.1093/nar/gki308; Gawlita E, 2000, J AM CHEM SOC, V122, P11660, DOI 10.1021/ja001891d; Hiller DA, 2010, BIOCHEMISTRY-US, V49, P3868, DOI 10.1021/bi901458x; HOGG JL, 1980, J AM CHEM SOC, V102, P79, DOI 10.1021/ja00521a014; Huang KS, 2008, BIOCHEMISTRY-US, V47, P8822, DOI 10.1021/bi800299u; INWARD PW, 1965, J BIOL CHEM, V240, P1986; Kingery DA, 2008, CHEM BIOL, V15, P493, DOI 10.1016/j.chembiol.2008.04.005; Marlier JF, 1997, J AM CHEM SOC, V119, P8838, DOI 10.1021/ja970993+; MONRO RE, 1967, J MOL BIOL, V25, P347, DOI 10.1016/0022-2836(67)90146-5; OLEARY MH, 1979, J AM CHEM SOC, V101, P3300, DOI 10.1021/ja00506a027; Ranelov MA, 2010, J ORG CHEM, V75, P6782, DOI 10.1021/jo100886p; SATTERTH.AC, 1974, J AM CHEM SOC, V96, P7018, DOI 10.1021/ja00829a034; SAWYER CB, 1973, J AM CHEM SOC, V95, P7375, DOI 10.1021/ja00803a027; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Seila AC, 2005, BIOCHEMISTRY-US, V44, P4018, DOI 10.1021/bi047742f; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sievers A, 2004, P NATL ACAD SCI USA, V101, P7897, DOI 10.1073/pnas.0402488101; Singleton DA, 2000, J AM CHEM SOC, V122, P11035, DOI 10.1021/ja005519+; Unrau PJ, 2003, P NATL ACAD SCI USA, V100, P15393, DOI 10.1073/pnas.2433147100; Wallin G, 2010, P NATL ACAD SCI USA, V107, P1888, DOI 10.1073/pnas.0914192107; Wang QA, 2010, CHEM PHYS LETT, V501, P113, DOI 10.1016/j.cplett.2010.10.048; Zaher HS, 2011, EMBO J, V30, P2445, DOI 10.1038/emboj.2011.142; ZEEBERG B, 1973, J BIOL CHEM, V248, P5887; Zhong MH, 2006, ORG LETT, V8, P55, DOI 10.1021/ol052484f; Zhong MH, 2008, J ORG CHEM, V73, P603, DOI 10.1021/jo702070m	30	56	56	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2011	476	7359					236	U143		10.1038/nature10248	http://dx.doi.org/10.1038/nature10248			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21765427	Green Accepted			2022-12-28	WOS:000293731900043
J	Stefer, S; Reitz, S; Wang, F; Wild, K; Pang, YY; Schwarz, D; Bomke, J; Hein, C; Lohr, F; Bernhard, F; Denic, V; Dotsch, V; Sinning, I				Stefer, Susanne; Reitz, Simon; Wang, Fei; Wild, Klemens; Pang, Yin-Yuin; Schwarz, Daniel; Bomke, Joerg; Hein, Christopher; Loehr, Frank; Bernhard, Frank; Denic, Vladimir; Doetsch, Volker; Sinning, Irmgard			Structural Basis for Tail-Anchored Membrane Protein Biogenesis by the Get3-Receptor Complex	SCIENCE			English	Article							SIGNAL RECOGNITION PARTICLE; PHOSPHOLIPID-BILAYERS; ER MEMBRANE; INSERTION; GET3; TRANSLOCATION; MECHANISM; PATHWAY; BINDING	Tail-anchored (TA) proteins are involved in cellular processes including trafficking, degradation, and apoptosis. They contain a C-terminal membrane anchor and are posttranslationally delivered to the endoplasmic reticulum (ER) membrane by the Get3 adenosine triphosphatase interacting with the hetero-oligomeric Get1/2 receptor. We have determined crystal structures of Get3 in complex with the cytosolic domains of Get1 and Get2 in different functional states at 3.0, 3.2, and 4.6 angstrom resolution. The structural data, together with biochemical experiments, show that Get1 and Get2 use adjacent, partially overlapping binding sites and that both can bind simultaneously to Get3. Docking to the Get1/2 complex allows for conformational changes in Get3 that are required for TA protein insertion. These data suggest a molecular mechanism for nucleotide-regulated delivery of TA proteins.	[Wang, Fei; Denic, Vladimir] Harvard Univ, Dept Mol & Cellular Biol, Northwest Labs, Cambridge, MA 02138 USA; [Stefer, Susanne; Hein, Christopher; Loehr, Frank; Bernhard, Frank; Doetsch, Volker] Goethe Univ Frankfurt, Inst Biophys Chem, Ctr Biomol Magnet Resonance, D-60325 Frankfurt, Germany; [Reitz, Simon; Wild, Klemens; Pang, Yin-Yuin; Sinning, Irmgard] Univ Heidelberg, Biochem Ctr BZH, D-69120 Heidelberg, Germany; [Schwarz, Daniel; Bomke, Joerg] Merck KGaA, Merck Serono, Mol Interact & Biophys, D-64293 Darmstadt, Germany	Harvard University; Goethe University Frankfurt; Ruprecht Karls University Heidelberg; Merck KGaA; EMD Serono Inc.	Denic, V (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Northwest Labs, Cambridge, MA 02138 USA.	vdenic@mcb.harvard.edu; vdoetsch@em.uni-frankfurt.de; irmi.sinning@bzh.uni-heidelberg.de		Bernhard, Frank/0000-0002-4860-1783; Dotsch, Volker/0000-0001-5720-212X	Deutsche Forschungsgemeinschaft (DFG) [SFB 807, SFB 638]; Centre for Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence Frankfurt (Macromolecular Complexes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099943] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Centre for Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence Frankfurt (Macromolecular Complexes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	V.D. would like to thank M. Frech for his support of the project and acknowledges funding by the Deutsche Forschungsgemeinschaft (DFG) (SFB 807), the Centre for Biomolecular Magnetic Resonance (BMRZ), and the Cluster of Excellence Frankfurt (Macromolecular Complexes). I. S. thanks J. Kopp und C. Siegmann from the crystallization platform of the Biochemiezentrum and the Cluster of Excellence Heidelberg (CellNetworks), the European Synchrotron Radiation Facility for access to data collection, B. Dobberstein for generous support and stimulating discussions, and acknowledges funding by the DFG (SFB 638). Coordinates and structure factors have been deposited in the Research Collaboratory for Structural Bioinformatics Protein Data Bank (PDB) with accession nos. 3SJA, 3SJB, 3SJC, and 3SJD.	Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Colombo SF, 2009, J CELL SCI, V122, P2383, DOI 10.1242/jcs.049460; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Favaloro V, 2010, J CELL SCI, V123, P1522, DOI 10.1242/jcs.055970; High S, 2004, BIOCHEM SOC T, V32, P659, DOI 10.1042/BST0320659; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hu JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008061; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Meineke B, 2008, FEBS LETT, V582, P855, DOI 10.1016/j.febslet.2008.02.009; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Suloway CJM, 2009, P NATL ACAD SCI USA, V106, P14849, DOI 10.1073/pnas.0907522106; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Yamagata A, 2010, GENES CELLS, V15, P29, DOI 10.1111/j.1365-2443.2009.01362.x; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208	28	78	82	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2011	333	6043					758	762		10.1126/science.1207125	http://dx.doi.org/10.1126/science.1207125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21719644	Green Accepted			2022-12-28	WOS:000293512100044
J	Pope, PB; Smith, W; Denman, SE; Tringe, SG; Barry, K; Hugenholtz, P; McSweeney, CS; McHardy, AC; Morrison, M				Pope, P. B.; Smith, W.; Denman, S. E.; Tringe, S. G.; Barry, K.; Hugenholtz, P.; McSweeney, C. S.; McHardy, A. C.; Morrison, M.			Isolation of Succinivibrionaceae Implicated in Low Methane Emissions from Tammar Wallabies	SCIENCE			English	Article							ANAEROBIOSPIRILLUM-SUCCINICIPRODUCENS; MACROPUS-EUGENII; BOVINE RUMEN; FERMENTATION; FORESTOMACH; COMMUNITY; NITROGEN	The Tammar wallaby (Macropus eugenii) harbors unique gut bacteria and produces only one-fifth the amount of methane produced by ruminants per unit of digestible energy intake. We have isolated a dominant bacterial species (WG-1) from the wallaby microbiota affiliated with the family Succinivibrionaceae and implicated in lower methane emissions from starch-containing diets. This was achieved by using a partial reconstruction of the bacterium's metabolism from binned metagenomic data (nitrogen and carbohydrate utilization pathways and antibiotic resistance) to devise cultivation-based strategies that produced axenic WG-1 cultures. Pure-culture studies confirm that the bacterium is capnophilic and produces succinate, further explaining a microbiological basis for lower methane emissions from macropodids. This knowledge also provides new strategic targets for redirecting fermentation and reducing methane production in livestock.	[Pope, P. B.; Smith, W.; Denman, S. E.; McSweeney, C. S.; Morrison, M.] CSIRO Livestock Ind, Queensland Biosci Precinct, St Lucia, Qld 4067, Australia; [Pope, P. B.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Tringe, S. G.; Barry, K.; Hugenholtz, P.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Hugenholtz, P.] Australian Ctr Ecogenom, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Hugenholtz, P.] Australian Ctr Ecogenom, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [McHardy, A. C.] Max Planck Inst Informat, Max Planck Res Grp Computat Genom & Epidemiol, D-66123 Saarbrucken, Germany; [McHardy, A. C.] Univ Dusseldorf, Dept Algorithm Bioinformat, D-40225 Dusseldorf, Germany; [Morrison, M.] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Norwegian University of Life Sciences; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Queensland; University of Queensland; Max Planck Society; Heinrich Heine University Dusseldorf; University System of Ohio; Ohio State University	Morrison, M (corresponding author), CSIRO Livestock Ind, Queensland Biosci Precinct, St Lucia, Qld 4067, Australia.	mark.morrison@csiro.au	McHardy, Alice/ABF-2322-2020; Morrison, Mark/C-9707-2013; Hugenholtz, Philip/AAD-9138-2019; Denman, Stuart E/A-5823-2011; McHardy, Alice C/K-9377-2018; McSweeney, Chris S/C-3688-2012; Pope, Phillip/AAQ-2251-2021	McHardy, Alice/0000-0003-2370-3430; Morrison, Mark/0000-0001-9257-9133; Hugenholtz, Philip/0000-0001-5386-7925; Denman, Stuart E/0000-0002-9910-3709; McHardy, Alice C/0000-0003-2370-3430; Pope, Phillip/0000-0002-2067-4059; McSweeney, Chris/0000-0002-0114-5151	Commonwealth Scientific and Industrial Research Organisation's (CSIRO's) Office of the Chief Executive (OCE); U.S. Department of Energy-Joint Genome Institute Community Sequencing Program; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	Commonwealth Scientific and Industrial Research Organisation's (CSIRO's) Office of the Chief Executive (OCE); U.S. Department of Energy-Joint Genome Institute Community Sequencing Program; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	The Tammar wallaby project is partially supported by the Commonwealth Scientific and Industrial Research Organisation's (CSIRO's) Office of the Chief Executive (OCE) Science Leader and Transformational Biology Capability Platform grant programs (awarded to M. M.), a CSIRO OCE Postdoctoral Fellowship (awarded to P. B. P.), and the U.S. Department of Energy-Joint Genome Institute Community Sequencing Program. We are especially grateful for the support from L. Hinds (CSIRO Ecosystem Sciences), A.-D. Wright (University of Vermont), and P. Evans (CSIRO Livestock Industries), who assisted in sample collections. The work conducted by the U.S. Department of Energy-Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under contract no. DE-AC02-05CH11231. The whole-metagenome shotgun project and whole-genome shotgun project (for the WG-1 isolate) has been deposited at DDBJ/EMBL/GenBank under accession numbers ADGC00000000 and AFAK00000000, respectively. 16S rRNA gene sequences are deposited under accession numbers GQ358225 to GQ358517.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Evans PN, 2009, APPL ENVIRON MICROB, V75, P2598, DOI 10.1128/AEM.02436-08; Gagen EJ, 2010, APPL ENVIRON MICROB, V76, P7785, DOI 10.1128/AEM.01679-10; HAMLIN LJ, 1956, J BACTERIOL, V72, P548, DOI 10.1128/JB.72.4.548-554.1956; HUME ID, 1984, BIOSCIENCE, V34, P435, DOI 10.2307/1309633; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KEMPTON TJ, 1976, AUST J BIOL SCI, V29, P209, DOI 10.1071/BI9760209; KENNEDY PM, 1978, COMP BIOCHEM PHYS A, V61, P117, DOI 10.1016/0300-9629(78)90286-4; Lee PC, 1999, ENZYME MICROB TECH, V24, P549, DOI 10.1016/S0141-0229(98)00156-2; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; McKinlay JB, 2007, METAB ENG, V9, P177, DOI 10.1016/j.ymben.2006.10.006; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Ouwerkerk D, 2009, ANIM PROD SCI, V49, P1043, DOI 10.1071/EA08294; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; RUSSELL JB, 1989, APPL ENVIRON MICROB, V55, P1; Samuelov NS, 1999, APPL ENVIRON MICROB, V65, P2260; Tyson GW, 2005, APPL ENVIRON MICROB, V71, P6319, DOI 10.1128/AEM.71.10.6319-6324.2005; von Engelhardt W., 1978, Comparative Biochemistry and Physiology A, V60, P309, DOI 10.1016/0300-9629(78)90254-2	21	118	127	5	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					646	648		10.1126/science.1205760	http://dx.doi.org/10.1126/science.1205760			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21719642				2022-12-28	WOS:000293222400066
J	Chen, XW; Leischner, U; Rochefort, NL; Nelken, I; Konnerth, A				Chen, Xiaowei; Leischner, Ulrich; Rochefort, Nathalie L.; Nelken, Israel; Konnerth, Arthur			Functional mapping of single spines in cortical neurons in vivo	NATURE			English	Article							MOUSE AUDITORY-CORTEX; PYRAMIDAL NEURONS; DENDRITIC SPINES; FLUORESCENCE MICROSCOPY; VISUAL-CORTEX; ORGANIZATION; EXCITATION; DYNAMICS; SIGNALS; SPIKES	The individual functional properties and spatial arrangement of afferent synaptic inputs on dendrites have a critical role in the processing of information by neurons in the mammalian brain(1-4). Although recent work has identified visually-evoked local dendritic calcium signals in the rodent visual cortex(5), sensory-evoked signalling on the level of dendritic spines, corresponding to individual afferent excitatory synapses, remains unexplored(6). Here we used a new variant of high-resolution two-photon imaging(7) to detect sensory-evoked calcium transients in single dendritic spines of mouse cortical neurons in vivo. Calcium signals evoked by sound stimulation required the activation of NMDA (N-methyl-D-aspartate) receptors. Active spines are widely distributed on basal and apical dendrites and pure-tone stimulation at different frequencies revealed both narrowly and widely tuned spines. Notably, spines tuned for different frequencies were highly interspersed on the same dendrites: even neighbouring spines were mostly tuned to different frequencies. Thus, our results demonstrate that NMDA-receptor-dependent single-spine synaptic inputs to the same dendrite are highly heterogeneous. Furthermore, our study opens the way for in vivo mapping of functionally defined afferent sensory inputs with single-synapse resolution.	[Chen, Xiaowei; Leischner, Ulrich; Rochefort, Nathalie L.; Konnerth, Arthur] Tech Univ Munich, Inst Neurosci, D-80802 Munich, Germany; [Chen, Xiaowei; Leischner, Ulrich; Rochefort, Nathalie L.; Konnerth, Arthur] Tech Univ Munich, Ctr Integrated Prot Sci, D-80802 Munich, Germany; [Nelken, Israel] Hebrew Univ Jerusalem, Dept Neurobiol, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel; [Nelken, Israel] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, IL-91904 Jerusalem, Israel	Technical University of Munich; Technical University of Munich; University of Munich; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Konnerth, A (corresponding author), Tech Univ Munich, Inst Neurosci, Biedersteinerstr 29, D-80802 Munich, Germany.	arthur.konnerth@lrz.tum.de	Nelken, Israel/B-7753-2011; Leischner, Ulrich/H-9936-2012	Nelken, Israel/0000-0002-6645-107X; Rochefort, Nathalie/0000-0002-3498-6221; Leischner, Ulrich/0000-0001-7771-2135	Schiedel Foundation; German-Israeli Foundation (GIF) [1002/2008]; Deutsche Forschungsgemeinschaft [IRTG 1373]; Bundesministerium fur Bildung und Forschung (BMBF)	Schiedel Foundation; German-Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank J. Lou for technical assistance, D. Bayer, F. Bayer and W. Zeitz for building the scanning device, A. Fohr for software support and Y. Kovalchuk and H. Adelsberger for help during the initial experiments. This work was supported by the Schiedel Foundation, the German-Israeli Foundation (GIF grant 1002/2008 to I.N. and A. K.), the Deutsche Forschungsgemeinschaft (IRTG 1373) and the Bundesministerium fur Bildung und Forschung (BMBF) in the frame of ERA-NET NEURON. A. K. is a Carl-von-Linde senior fellow of the Institute for Advanced Study of the Technische Universitat Munchen.	Bandyopadhyay S, 2010, NAT NEUROSCI, V13, P361, DOI 10.1038/nn.2490; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; Bloodgood BL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000190; Branco T, 2010, CURR OPIN NEUROBIOL, V20, P494, DOI 10.1016/j.conb.2010.07.009; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Chadderton P, 2009, J NEUROSCI, V29, P14127, DOI 10.1523/JNEUROSCI.2061-09.2009; de Kock CPJ, 2008, J PHYSIOL-LONDON, V586, P3353, DOI 10.1113/jphysiol.2008.155580; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Donnert G, 2007, NAT METHODS, V4, P81, DOI 10.1038/NMETH986; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; GERIG JS, 1964, P IEEE, V52, P1753, DOI 10.1109/PROC.1964.3500; Holthoff K, 2004, J PHYSIOL-LONDON, V560, P27, DOI 10.1113/jphysiol.2004.072678; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Ji N, 2008, NAT METHODS, V5, P197, DOI 10.1038/NMETH.1175; Jia HB, 2011, NAT PROTOC, V6, P28, DOI 10.1038/nprot.2010.169; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kawaguchi Y, 2006, CEREB CORTEX, V16, P696, DOI 10.1093/cercor/bhj015; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Kremer Y, 2008, OPT EXPRESS, V16, P10066, DOI 10.1364/OE.16.010066; Larkum ME, 2008, CURR OPIN NEUROBIOL, V18, P321, DOI 10.1016/j.conb.2008.08.013; Lechleiter JD, 2002, BIOPHYS J, V83, P2292, DOI 10.1016/S0006-3495(02)73989-1; Linden JF, 2003, J NEUROPHYSIOL, V90, P2660, DOI 10.1152/jn.00751.2002; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Peters A., 1984, CEREBRAL CORTEX FUNC, P107, DOI [10.1007/978-3-662-03733-1_15, DOI 10.1007/978-3-662-03733-1_15]; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Roorda RD, 2004, J NEUROPHYSIOL, V92, P609, DOI 10.1152/jn.00087.2004; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Scholl B, 2010, NEURON, V65, P412, DOI 10.1016/j.neuron.2010.01.020; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Waters J, 2003, J NEUROSCI, V23, P8558; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; Wu GY, 2006, NEURON, V52, P705, DOI 10.1016/j.neuron.2006.10.009; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	43	262	268	3	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2011	475	7357					501	U97		10.1038/nature10193	http://dx.doi.org/10.1038/nature10193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21706031				2022-12-28	WOS:000293167900041
J	Shaw, AT; Forcione, DG; Digumarthy, SR; Iafrate, AJ				Shaw, Alice T.; Forcione, David G.; Digumarthy, Subba R.; Iafrate, A. John			Case 21-2011: A 31-Year-Old Man with ALK-Positive Adenocarcinoma of the Lung Adenocarcinoma of the lung (non-small-cell lung cancer), with anaplastic lymphoma kinase (ALK) gene rearrangement.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EML4-ALK FUSION GENE; PHASE-III; MUTATIONS; GEFITINIB; CHEMOTHERAPY; FEATURES; EGFR		[Shaw, Alice T.] Massachusetts Gen Hosp, Ctr Thorac Cancers, Boston, MA 02114 USA; [Forcione, David G.] Massachusetts Gen Hosp, Dept Gastroenterol, Boston, MA 02114 USA; [Digumarthy, Subba R.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Iafrate, A. John] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Shaw, Alice T.; Forcione, David G.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Digumarthy, Subba R.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Iafrate, A. John] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Shaw, AT (corresponding author), Massachusetts Gen Hosp, Ctr Thorac Cancers, Boston, MA 02114 USA.				Pfizer; Ariad; Chugai; Millennium; Abbott Molecular	Pfizer(Pfizer); Ariad; Chugai; Millennium(Takeda Pharmaceutical Company Ltd); Abbott Molecular	Dr. Shaw reports receiving consulting fees from Pfizer, Ariad, Chugai, and Millennium; and Dr. Iafrate, consulting fees from Pfizer and Abbott Molecular. No other potential conflict of interest relevant to this article was reported.	Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Inamura K, 2008, J THORAC ONCOL, V3, P13, DOI 10.1097/JTO.0b013e31815e8b60; Inamura K, 2009, MODERN PATHOL, V22, P508, DOI 10.1038/modpathol.2009.2; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kwak EL, 2011, NEW ENGL J MED, V364, P588; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; MORRIS SW, 1995, SCIENCE, V267, P316, DOI 10.1126/science.267.5196.316-b; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Sakairi Y, 2010, CLIN CANCER RES, V16, P4938, DOI 10.1158/1078-0432.CCR-10-0099; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Shaw AT, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.7606; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Takahashi T, 2010, ANN SURG ONCOL, V17, P889, DOI 10.1245/s10434-009-0808-7; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181; Zhang XC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-188	25	10	10	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2					158	167		10.1056/NEJMcpc1102202	http://dx.doi.org/10.1056/NEJMcpc1102202			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SP	21751909				2022-12-28	WOS:000292685500014
J	Tompkins, J				Tompkins, Joshua			Money for Nothing? The Problem of the Board-Exam Coaching Industry	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PERFORMANCE; COURSES; IMPACT		Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA	University of Southern California	Tompkins, J (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA.							Alcamo AM, 2010, ACAD MED, V85, pS45, DOI 10.1097/ACM.0b013e3181ed1cb9; Kaplan Medical, KAPLAN MED USMLE PRE; McGaghie WC, 2004, TEACH LEARN MED, V16, P202, DOI 10.1207/s15328015tlm1602_14; McGaghie WC, 2011, ACAD MED, V86, P48, DOI 10.1097/ACM.0b013e3181ffacdb; Werner LS, 2003, MED EDUC, V37, P527, DOI 10.1046/j.1365-2923.2003.01534.x	5	9	9	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2					104	105		10.1056/NEJMp1104500	http://dx.doi.org/10.1056/NEJMp1104500			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791SP	21751903				2022-12-28	WOS:000292685500004
J	Greene, JA				Greene, Jeremy A.			The art of medicine The substance of the brand	LANCET			English	Editorial Material									[Greene, Jeremy A.] Harvard Univ, Dept Hist Sci, Cambridge, MA 02139 USA; [Greene, Jeremy A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Cambridge, MA 02139 USA	Harvard University; Harvard University; Brigham & Women's Hospital	Greene, JA (corresponding author), Harvard Univ, Dept Hist Sci, Cambridge, MA 02139 USA.	jgreene2@partners.org	Mendoza, Elvia/A-9361-2012					*AMA, 1965, JAMA-J AM MED ASSOC, V194, P1311; Greene Jeremy A., 2007, PRESCRIBING NUMBERS; HEFFERREN JJ, 1962, JAMA-J AM MED ASSOC, V182, P1146; Stinson Nina, 1982, INDIANA LAW REV, V15, P733; SWEETNAM WP, 1964, PRACTITIONER, V192, P543	5	13	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 9	2011	378	9786					120	121		10.1016/S0140-6736(11)61077-5	http://dx.doi.org/10.1016/S0140-6736(11)61077-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	795CJ	21748873				2022-12-28	WOS:000292948800017
J	Morran, LT; Schmidt, OG; Gelarden, IA; Parrish, RC; Lively, CM				Morran, Levi T.; Schmidt, Olivia G.; Gelarden, Ian A.; Parrish, Raymond C., II; Lively, Curtis M.			Running with the Red Queen: Host-Parasite Coevolution Selects for Biparental Sex	SCIENCE			English	Article							INBREEDING DEPRESSION; SELF-FERTILIZATION; EVOLUTION; SNAIL; GENE	Most organisms reproduce through outcrossing, even though it comes with substantial costs. The Red Queen hypothesis proposes that selection from coevolving pathogens facilitates the persistence of outcrossing despite these costs. We used experimental coevolution to test the Red Queen hypothesis and found that coevolution with a bacterial pathogen (Serratia marcescens) resulted in significantly more outcrossing in mixed mating experimental populations of the nematode Caenorhabditis elegans. Furthermore, we found that coevolution with the pathogen rapidly drove obligately selfing populations to extinction, whereas outcrossing populations persisted through reciprocal coevolution. Thus, consistent with the Red Queen hypothesis, coevolving pathogens can select for biparental sex.	[Morran, Levi T.; Schmidt, Olivia G.; Gelarden, Ian A.; Parrish, Raymond C., II; Lively, Curtis M.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Morran, LT (corresponding author), Indiana Univ, Dept Biol, 1001 E 3rd St, Bloomington, IN 47405 USA.	lmorran@indiana.edu	Lively, Curtis M/A-8057-2011	Gelarden, Ian/0000-0002-7599-050X	Wissenschaftskolleg zu Berlin; NSF [DEB-0640639]; NIH [1F32GM096482-01]; NIH National Center for Research Resources (NCRR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096482] Funding Source: NIH RePORTER	Wissenschaftskolleg zu Berlin(Austrian Science Fund (FWF)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Hundley and R. Matteson for logistical assistance. We also thank F. Bashey, L. Delph, P. Phillips, M. Parmenter, the Lively and Hall laboratories, and two reviewers for helpful comments and discussion, as well as the Wissenschaftskolleg zu Berlin for a fellowship to C.M.L. during the preparation of the manuscript. Funding was provided by the NSF (DEB-0640639 to C.M.L) and the NIH (1F32GM096482-01 to L.T.M). Nematode strains were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). Data deposited at Dryad, 10.5061/dryad.c0q0h.	Agrawal AF, 2001, EVOLUTION, V55, P869, DOI 10.1554/0014-3820(2001)055[0869:PATEOS]2.0.CO;2; BELL G, 1982, MASTERPIECE NATURE E; BRENNER S, 1974, GENETICS, V77, P71; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Decaestecker E, 2007, NATURE, V450, P870, DOI 10.1038/nature06291; Fisher R.A., 1930, GENETICAL THEORY NAT; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; JAENIKE J, 1978, Evolutionary Theory, V3, P191; Jokela J, 2009, AM NAT, V174, pS43, DOI 10.1086/599080; King KC, 2009, CURR BIOL, V19, P1438, DOI 10.1016/j.cub.2009.06.062; Koskella B, 2009, EVOLUTION, V63, P2213, DOI 10.1111/j.1558-5646.2009.00711.x; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; LIVELY CM, 1990, NATURE, V344, P864, DOI 10.1038/344864a0; LIVELY CM, 1987, NATURE, V328, P519, DOI 10.1038/328519a0; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; MAYNARD SMITH J., 1978, EVOLUTION SEX; MILLER LM, 1988, CELL, V55, P167, DOI 10.1016/0092-8674(88)90019-0; Morran LT, 2009, NATURE, V462, P350, DOI 10.1038/nature08496; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; SCHEDL T, 1988, GENETICS, V119, P43; Schulte RD, 2010, P NATL ACAD SCI USA, V107, P7359, DOI 10.1073/pnas.1003113107; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Teotonio H, 2006, EVOLUTION, V60, P1300, DOI 10.1111/j.0014-3820.2006.tb01207.x; Van Valen L., 1973, EVOL THEORY REV, V1, P1, DOI DOI 10.1038/344864A0; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi	28	256	259	8	404	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2011	333	6039					216	218		10.1126/science.1206360	http://dx.doi.org/10.1126/science.1206360			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21737739	Green Accepted			2022-12-28	WOS:000292502700048
J	Morris, A; Grudberg, S; Levy, BD; Loscalzo, J				Morris, Alanna; Grudberg, Sarah; Levy, Bruce D.; Loscalzo, Joseph			A Sleeping Giant	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELL ARTERITIS; DOUBLE-BLIND; INVOLVEMENT; SERIES		[Levy, Bruce D.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, Dept Med, Harvard Inst Med Bldg,77 Ave Louis Pasteur,HIM855, Boston, MA 02115 USA.	blevy@partners.org	Loscalzo, Joseph/ABD-8980-2021					Bongartz T, 2006, CURR OPIN RHEUMATOL, V18, P10, DOI 10.1097/01.bor.0000197996.04709.4e; Chan CCK, 2001, BRIT J OPHTHALMOL, V85, P1061, DOI 10.1136/bjo.85.9.1061; Gonzalez-Gay MA, 2005, MEDICINE, V84, P277, DOI 10.1097/01.md.0000180043.19285.54; Hoffman GS, 2007, ANN INTERN MED, V146, P621, DOI 10.7326/0003-4819-146-9-200705010-00004; Jover JA, 2001, ANN INTERN MED, V134, P106, DOI 10.7326/0003-4819-134-2-200101160-00010; Levine SM, 2002, CURR OPIN RHEUMATOL, V14, P3, DOI 10.1097/00002281-200201000-00002; Lockhart Mark E, 2003, Radiology, V227, P512, DOI 10.1148/radiol.2272010487; Martinez-Taboada VM, 2008, ANN RHEUM DIS, V67, P625, DOI 10.1136/ard.2007.082115; Mazlumzadeh M, 2006, ARTHRITIS RHEUM, V54, P3310, DOI 10.1002/art.22163; Salvarani C, 2002, NEW ENGL J MED, V347, P261, DOI 10.1056/NEJMra011913; Salvarani C, 2001, ARTHRIT RHEUM-ARTHR, V45, P140, DOI 10.1002/1529-0131(200104)45:2<140::AID-ANR166>3.0.CO;2-2; Scola CJ, 2008, MEDICINE, V87, P45, DOI 10.1097/MD.0b013e3181646118	12	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					72	77		10.1056/NEJMcps0902041	http://dx.doi.org/10.1056/NEJMcps0902041			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788QL	21732839				2022-12-28	WOS:000292459400013
J	Yong, E				Yong, Ed			EMERGING DISEASES Disease trackers	BRITISH MEDICAL JOURNAL			English	Editorial Material												edyong209@googlemail.com						KARESH WB, 2005, EMERG INFECT DIS JUL	1	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 5	2011	343								d4117	10.1136/bmj.d4117	http://dx.doi.org/10.1136/bmj.d4117			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791RV	21729998				2022-12-28	WOS:000292683200003
J	Free, C; Knight, R; Robertson, S; Whittaker, R; Edwards, P; Zhou, WW; Rodgers, A; Cairns, J; Kenward, MG; Roberts, I				Free, Caroline; Knight, Rosemary; Robertson, Steven; Whittaker, Robyn; Edwards, Phil; Zhou, Weiwei; Rodgers, Anthony; Cairns, John; Kenward, Michael G.; Roberts, Ian			Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial	LANCET			English	Article							COTININE; NICOTINE; SMOKERS	Background Smoking cessation programmes delivered via mobile phone text messaging show increases in self-reported quitting in the short term. We assessed the effect of an automated smoking cessation programme delivered via mobile phone text messaging on continuous abstinence, which was biochemically verified at 6 months. Methods In this single-blind, randomised trial, undertaken in the UK, smokers willing to make a quit attempt were randomly allocated, using an independent telephone randomisation system, to a mobile phone text messaging smoking cessation programme (txt2stop), comprising motivational messages and behavioural-change support, or to a control group that received text messages unrelated to quitting. The system automatically generated intervention or control group texts according to the allocation. Outcome assessors were masked to treatment allocation. The primary outcome was self-reported continuous smoking abstinence, biochemically verified at 6 months. All analyses were by intention to treat. This study is registered, number ISRCTN 80978588. Findings We assessed 11914 participants for eligibility. 5800 participants were randomised, of whom 2915 smokers were allocated to the txt2stop intervention and 2885 were allocated to the control group; eight were excluded because they were randomised more than once. Primary outcome data were available for 5524 (95%) participants. Biochemically verified continuous abstinence at 6 months was significantly increased in the txt2stop group (10.7% txt2stop vs 4.9% control, relative risk [RR] 2-20, 95% CI 1.80-2.68; p<0.0001). Similar results were obtained when participants that were lost to follow-up were treated as smokers (268 [9%] of 2911 txt2stop vs 124 [4%] of 2881 control [RR 2.14, 95% CI 1.74-2-63; p<0.0001]), and when they were excluded (268 [10%] of 2735 txt2stop vs 124 [4%] of 2789 control [2.20,1.79-2-71; p<0.0001]). No significant heterogeneity was shown in any of the prespecified subgroups. Interpretation The txt2stop smoking cessation programme significantly improved smoking cessation rates at 6 months and should be considered for inclusion in smoking cessation services.	[Free, Caroline; Knight, Rosemary; Robertson, Steven; Edwards, Phil; Zhou, Weiwei; Cairns, John; Kenward, Michael G.; Roberts, Ian] Univ London London Sch Hyg & Trop Med, Clin Trials Res Unit, London WC1E 7HT, England; [Whittaker, Robyn] Univ Auckland, Clin Trials Res Unit, Auckland 1, New Zealand; [Rodgers, Anthony] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia	University of London; London School of Hygiene & Tropical Medicine; University of Auckland; George Institute for Global Health; University of Sydney	Free, C (corresponding author), Univ London London Sch Hyg & Trop Med, Clin Trials Res Unit, Keppel St, London WC1E 7HT, England.	caroline.free@lshtm.ac.uk	Cairns, John/AAD-1168-2020	Edwards, Phil/0000-0003-4431-8822; Rodgers, Anthony/0000-0003-1282-1896; Free, Caroline/0000-0003-1711-0006; Zhou, Weiwei/0000-0002-6136-9624	UK Medical Research Council, Primary Care Research Networks; The UK Medical Research Council; Cancer Research UK; The Primary Care Research Networks; MRC [G0601639] Funding Source: UKRI; Medical Research Council [G0601639] Funding Source: researchfish	UK Medical Research Council, Primary Care Research Networks(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); The Primary Care Research Networks; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UK Medical Research Council, Primary Care Research Networks.; The UK Medical Research Council, Cancer Research UK, and The Primary Care Research Networks funded the trial. We thank all the volunteers who took part in the trial, especially those who helped promote the study through supplying us with their personal stories; and all the GP practices, pharmacies, and smoking cessation services that displayed leaflets and posters, and promoted the trial.	Brendryen H, 2008, ADDICTION, V103, P478, DOI 10.1111/j.1360-0443.2007.02119.x; Brendryen H, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1005; Edwards P, 2002, BRIT MED J, V324, P1183, DOI 10.1136/bmj.324.7347.1183; Etter JF, 2000, AM J EPIDEMIOL, V151, P251; FEYERABEND C, 1990, J PHARM PHARMACOL, V42, P450, DOI 10.1111/j.2042-7158.1990.tb06592.x; FOULDS J, 1994, AM J PUBLIC HEALTH, V84, P1182, DOI 10.2105/AJPH.84.7.1182; Free C, 2009, TOB CONTROL, V18, P88, DOI 10.1136/tc.2008.026146; Free C, 2008, LANCET; Free Caroline, 2010, BMC Res Notes, V3, P250, DOI 10.1186/1756-0500-3-250; Haug S, 2009, NICOTINE TOB RES, V11, P915, DOI 10.1093/ntr/ntp084; International Telecommunications Union, WORLD 2010 ICT FACTS; JARVIS MJ, 1987, AM J PUBLIC HEALTH, V77, P1435, DOI 10.2105/AJPH.77.11.1435; Lader D, 2009, 40 OFF NAT STAT; Lancaster T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub2, 10.1002/14651858.CD001292.pub3]; Mallinckrodt CH, 2009, DRUG INF J, V43, P449, DOI 10.1177/009286150904300410; Michie S, 2011, ADDICT BEHAV, V36, P315, DOI 10.1016/j.addbeh.2010.11.016; Molenberghs G.K.M., 2007, MISSING DATA CLIN ST, P42; MURRAY RP, 1993, AM J PUBLIC HEALTH, V83, P1251, DOI 10.2105/AJPH.83.9.1251; Ofcom, CONS EXP TEL INT DIG; Rodgers A, 2005, TOB CONTROL, V14, P255, DOI 10.1136/tc.2005.011577; Rothman KJ, 2000, LANCET, V356, P1837, DOI 10.1016/S0140-6736(00)03244-X; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Stead L.F., 2003, COCHRANE DB SYST REV, V1; Stead LF, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001007.PUB2; Vollset SE, 2006, ANN INTERN MED, V144, P381, DOI 10.7326/0003-4819-144-6-200603210-00004; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x; Whittaker R, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006611.pub2, 10.1002/14651858.CD006611.pub3]; World Health Organization, 2009, WHO REP GLOB TOB EP	28	509	512	0	64	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2011	378	9785					49	55		10.1016/S0140-6736(11)60701-0	http://dx.doi.org/10.1016/S0140-6736(11)60701-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791IU	21722952	Green Published, Green Accepted			2022-12-28	WOS:000292659700033
J	Kriwacki, RW; Yoon, MK				Kriwacki, Richard W.; Yoon, Mi-Kyung			Fishing in the Nuclear Pore	SCIENCE			English	Editorial Material							MEMBRANE; PROTEINS; FLEXIBILITY; TRANSPORT; COMPLEX		[Kriwacki, Richard W.; Yoon, Mi-Kyung] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Kriwacki, RW (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	richard.kriwacki@stjude.org	Kriwacki, Richard/N-8154-2018	Kriwacki, Richard/0000-0002-9798-6018				Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Galea CA, 2008, J MOL BIOL, V376, P827, DOI 10.1016/j.jmb.2007.12.016; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Lusk CP, 2007, NAT REV MOL CELL BIO, V8, P414, DOI 10.1038/nrm2165; Meinema AC, 2011, SCIENCE, V333, P90, DOI 10.1126/science.1205741; Ohba T, 2004, J CELL BIOL, V167, P1051, DOI 10.1083/jcb.200409149; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201	12	4	4	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					44	45		10.1126/science.1208568	http://dx.doi.org/10.1126/science.1208568			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719663				2022-12-28	WOS:000292255400038
J	[Anonymous]				[Anonymous]			Global response to non-communicable disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR-DISEASE						Prabhakaran, Dorairaj/B-4147-2011; Miranda, J. Jaime/A-8482-2008; Niessen, Louis/F-6254-2015	Prabhakaran, Dorairaj/0000-0002-3172-834X; Miranda, J. Jaime/0000-0002-4738-5468; Niessen, Louis/0000-0002-8639-5191; Levitt, Naomi/0000-0001-6480-8066; Ghannem, Hassen/0000-0002-9417-6837				American Cancer Society, 2010, GLOB EC COST CANC; [Anonymous], 2005, PREV CHRON DIS VIT I; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; First Global Ministerial Conference on Healthy Lifestyles and Noncommunicable Disease Control, 2011, 1 GLOBAL MINISTERIAL; NCD Alliance, 2011, PROP OUTC DOC UN HIG; Nugent RA, 2010, 228 CTR GLOB DEV; Organization WH, 2016, GLOBAL STATUS REPORT; Rodgers A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019857; Smith R, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2796; SRIDHAR D, 2011, GETTING POLITICS RIG; Wald NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018742; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; WHO, 2010, WORLD MALARIA REPORT 2010, P1; *WHO, 2008, GLOB STRAT HARMF US; World Health Organization, 2011, PRIOR RES AG PREV CO; World Health Organization, 2008, ACT PLAN GLOB STRAT; World Health Organization, 2003, WHO FRAM CONV TOB CO; World Health Organization, 2004, GLOB STRAT DIET PHYS; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; GLOBAL ALLIANCE CHRO	20	21	22	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2011	342								d3823	10.1136/bmj.d3823	http://dx.doi.org/10.1136/bmj.d3823			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788QB	21724543				2022-12-28	WOS:000292458400002
J	Cohen, MS; Chen, YQ; McCauley, M; Gamble, T; Hosseinipour, MC; Kumarasamy, N; Hakim, JG; Kumwenda, J; Grinsztejn, B; Pilotto, JHS; Godbole, SV; Mehendale, S; Chariyalertsak, S; Santos, BR; Mayer, KH; Hoffman, IF; Eshleman, SH; Piwowar-Manning, E; Wang, L; Makhema, J; Mills, LA; de Bruyn, G; Sanne, I; Eron, J; Gallant, J; Havlir, D; Swindells, S; Ribaudo, H; Elharrar, V; Burns, D; Taha, ET; Nielsen-Saines, K; Celentano, D; Essex, M; Fleming, TR				Cohen, Myron S.; Chen, Ying Q.; McCauley, Marybeth; Gamble, Theresa; Hosseinipour, Mina C.; Kumarasamy, Nagalingeswaran; Hakim, James G.; Kumwenda, Johnstone; Grinsztejn, Beatriz; Pilotto, Jose H. S.; Godbole, Sheela V.; Mehendale, Sanjay; Chariyalertsak, Suwat; Santos, Breno R.; Mayer, Kenneth H.; Hoffman, Irving F.; Eshleman, Susan H.; Piwowar-Manning, Estelle; Wang, Lei; Makhema, Joseph; Mills, Lisa A.; de Bruyn, Guy; Sanne, Ian; Eron, Joseph; Gallant, Joel; Havlir, Diane; Swindells, Susan; Ribaudo, Heather; Elharrar, Vanessa; Burns, David; Taha, Taha E.; Nielsen-Saines, Karin; Celentano, David; Essex, Max; Fleming, Thomas R.		HPTN 052 Study Team	Prevention of HIV-1 Infection with Early Antiretroviral Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HETEROSEXUAL TRANSMISSION; HIV-1-INFECTED PATIENTS; MORTALITY; INITIATION; RETHINKING; RATES; RISK	Background Antiretroviral therapy that reduces viral replication could limit the transmission of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. Methods In nine countries, we enrolled 1763 couples in which one partner was HIV-1-positive and the other was HIV-1-negative; 54% of the subjects were from Africa, and 50% of infected partners were men. HIV-1-infected subjects with CD4 counts between 350 and 550 cells per cubic millimeter were randomly assigned in a 1: 1 ratio to receive antiretroviral therapy either immediately (early therapy) or after a decline in the CD4 count or the onset of HIV-1-related symptoms (delayed therapy). The primary prevention end point was linked HIV-1 transmission in HIV-1-negative partners. The primary clinical end point was the earliest occurrence of pulmonary tuberculosis, severe bacterial infection, a World Health Organization stage 4 event, or death. Results As of February 21, 2011, a total of 39 HIV-1 transmissions were observed (incidence rate, 1.2 per 100 person-years; 95% confidence interval [CI], 0.9 to 1.7); of these, 28 were virologically linked to the infected partner (incidence rate, 0.9 per 100 person-years, 95% CI, 0.6 to 1.3). Of the 28 linked transmissions, only 1 occurred in the early-therapy group (hazard ratio, 0.04; 95% CI, 0.01 to 0.27; P<0.001). Subjects receiving early therapy had fewer treatment end points (hazard ratio, 0.59; 95% CI, 0.40 to 0.88; P = 0.01). Conclusions The early initiation of antiretroviral therapy reduced rates of sexual transmission of HIV-1 and clinical events, indicating both personal and public health benefits from such therapy.	[Cohen, Myron S.] Univ N Carolina, Inst Global Hlth & Infect Dis, Sch Med, Chapel Hill, NC 27599 USA; [Chen, Ying Q.; Wang, Lei] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Fleming, Thomas R.] Univ Washington, Seattle, WA 98195 USA; [McCauley, Marybeth] Family Hlth Int, Arlington, VA USA; [McCauley, Marybeth] Family Hlth Int, Durham, NC USA; UNC Project, Lilongwe, Malawi; [Kumwenda, Johnstone] Johns Hopkins Project, Coll Med, Blantyre, Malawi; [Kumarasamy, Nagalingeswaran] YR Gaitonade Ctr AIDS Res & Educ, Chennai, Tamil Nadu, India; [Godbole, Sheela V.; Mehendale, Sanjay] Natl AIDS Res Inst, Pune, Maharashtra, India; [Hakim, James G.] Univ Zimbabwe, Harare, Zimbabwe; [Grinsztejn, Beatriz] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, BR-21045900 Rio De Janeiro, Brazil; [Pilotto, Jose H. S.] Fiocruz MS, Hosp Geral de Nova Iguacu, BR-21045900 Rio De Janeiro, Brazil; [Pilotto, Jose H. S.] Lab AIDS & Imunol Mol IOC Fiocurz, BR-21045900 Rio De Janeiro, Brazil; [Chariyalertsak, Suwat] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Santos, Breno R.] Hosp Nossa Senhora da Conceicao, Porto Alegre, RS, Brazil; [Mayer, Kenneth H.] Fenway Hlth, Boston, MA USA; [Ribaudo, Heather; Essex, Max] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Eshleman, Susan H.; Piwowar-Manning, Estelle; Gallant, Joel] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Taha, Taha E.; Celentano, David] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Makhema, Joseph] Botswana Harvard AIDS Inst, Gaborone, Botswana; [Mills, Lisa A.] Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Kenya Med Res Inst, CDC Res & Publ Hlth Collaborat HIV Res Branch, Kisumu, Kenya; [de Bruyn, Guy] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Sanne, Ian] Univ Witwatersrand, Dept Med, ZA-2001 Johannesburg, South Africa; [Havlir, Diane] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Swindells, Susan] Univ Nebraska Med Ctr, Omaha, NE USA; [Elharrar, Vanessa; Burns, David] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; [Nielsen-Saines, Karin] David Geffen UCLA Sch Med, Los Angeles, CA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Malawi; Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); University of Zimbabwe; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Chiang Mai University; Fenway Health; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Botswana-Harvard AIDS Institute Partnership; Kenya Medical Research Institute; University of Witwatersrand; University of Witwatersrand; University of California System; University of California San Francisco; University of Nebraska System; University of Nebraska Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cohen, MS (corresponding author), Univ N Carolina, Inst Global Hlth & Infect Dis, Sch Med, Suite 2115,Bioinformat Bldg,130 Mason Farm Rd,CB, Chapel Hill, NC 27599 USA.	mscohen@med.unc.edu	Khopkar-Kale, Priyanka S/K-4159-2017; Franzeck, Fabian C/B-5055-2011; Kumarasasmy, Nagalingeswaran/AAB-7348-2021; Calvet, GA/G-6959-2013; Godbole, Sheela/ABG-4942-2020; Godbole, Sheela/K-4177-2017; Azadbakht, Morteza/ABA-2569-2020; Pilotto, Jose Henrique/AAD-9773-2019; Hendrix, Craig W/G-4182-2014; Cardoso, Sandra W/D-7965-2015; Sanne, Ian/ABH-2231-2020; Moyo, Sikhulile/E-1464-2015; Choobkar, Saeed/AAA-3212-2020	Khopkar-Kale, Priyanka S/0000-0003-3276-3881; Calvet, GA/0000-0002-3545-5238; Azadbakht, Morteza/0000-0001-8103-3506; Pilotto, Jose Henrique/0000-0003-0521-8597; Hendrix, Craig W/0000-0002-5696-8665; Cardoso, Sandra W/0000-0001-5230-0003; Moyo, Sikhulile/0000-0003-3821-4592; Nyirenda, Mulinda/0000-0003-2037-7449; Kabudula, Chodziwadziwa/0000-0002-5867-0336; Sahay, Seema/0000-0001-6064-827X; Bollinger, Robert/0000-0002-6798-6834; de Bruyn, Guy/0000-0002-8028-4474; Taha, Taha/0000-0001-9814-4894; Chen, Ying Qing/0000-0002-2726-3391; Godbole, Sheela/0000-0001-6537-9064	National Institute of Allergy and Infectious Diseases; National Institute of Allergy and Infectious Diseases [UM1-AI068619, U01-AI068619, UM1-AI068613, U01-AI068613, UM1-AI068617, U01-AI068617]; Abbott Virology; Roche Diagnostics; Monogram Biosciences; Sanofi Pasteur; Merck; Bristol-Myers Squibb; GlaxoSmithKline; ViiV Healthcare; Gilead Sciences and Tibotec; Roche; Tibotec Therapeutics; Pfizer; Sangamo BioSciences; Koronis; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068617, P30AI027763, K24AI051982, UM1AI068613, U01AI068619, U01AI068613, P30AI050410, U01AI068617, UM1AI068619] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Abbott Virology; Roche Diagnostics; Monogram Biosciences; Sanofi Pasteur; Merck(Merck & Company); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); ViiV Healthcare; Gilead Sciences and Tibotec; Roche(Roche Holding); Tibotec Therapeutics; Pfizer(Pfizer); Sangamo BioSciences; Koronis; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institute of Allergy and Infectious Diseases and others; HPTN 052 ClinicalTrials.gov number, NCT00074581.); Supported by the HIV Prevention Trials Network (HPTN) and by grants (UM1-AI068619 and U01-AI068619; UM1-AI068613 and U01-AI068613, to the HPTN Network Laboratory; and UM1-AI068617 and U01-AI068617, to the HPTN Statistical and Data Management Center) from the National Institute of Allergy and Infectious Diseases. Study drugs were donated by Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV Healthcare, and Merck.; Dr. Hosseinipour reports receiving lecture fees from Abbott Virology; Dr. Eshleman, consulting fees from Roche Diagnostics, lecture fees and samples or laboratory reagents from Abbott Diagnostics and Celera Diagnostics, and lecture fees from Monogram Biosciences; Dr. Mills, grant support from GlaxoSmithKline; Dr. de Bruyn, travel support from Sanofi Pasteur; Dr. Eron, consulting fees and grant support from Merck, Bristol-Myers Squibb, GlaxoSmithKline, and ViiV Healthcare, consulting fees from Gilead Sciences and Tibotec, and lecture fees from Bristol-Myers Squibb and Roche; Dr. Gallant, consulting fees from Abbott Laboratories, Bristol-Myers Squibb, Gilead Sciences, Merck, Tibotec Therapeutics, ViiV Healthcare, GlaxoSmithKline, Pfizer, Sangamo BioSciences, and Koronis, grant support and travel support from Gilead Sciences, and lecture fees from Monogram Biosciences; Dr. Havlir, study drug from Abbott; and Dr. Swindells, consulting fees from Gilead Sciences and Abbott Diagnostics and grant support from Pfizer, GlaxoSmithKline, and Bristol- Myers Squibb. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2011, GUID INT TUB CAS FIN; Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Burns DN, 2010, CLIN INFECT DIS, V51, P725, DOI 10.1086/655889; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Cohen MS, 2010, CLIN INFECT DIS, V50, pS85, DOI 10.1086/651478; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dyer JR, 1998, J INFECT DIS, V177, P1742, DOI 10.1086/517436; Eshleman SH, J INFECT DI IN PRESS; Eyawo O, 2010, LANCET INFECT DIS, V10, P770, DOI 10.1016/S1473-3099(10)70189-4; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Lowrance D, 2007, JAIDS-J ACQ IMM DEF, V46, P56; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Novitsky V, 2011, AIDS            0418; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Ping LH, 1999, J VIROL, V73, P6271, DOI 10.1128/JVI.73.8.6271-6281.1999; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Smith K, 2011, CURR OPIN HIV AIDS, V6, P315, DOI 10.1097/COH.0b013e32834788e7; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	35	5682	5866	32	803	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2011	365	6					493	505		10.1056/NEJMoa1105243	http://dx.doi.org/10.1056/NEJMoa1105243			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805MW	27424812	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000293732100005
J	Cohen, MS; Chen, YQ; McCauley, M; Gamble, T; Hosseinipour, MC; Kumarasamy, N; Hakim, JG; Kumwenda, J; Grinsztejn, B; Pilotto, JHS; Godbole, SV; Chariyalertsak, S; Santos, BR; Mayer, KH; Hoffman, IF; Eshleman, SH; Piwowar-Manning, E; Cottle, L; Zhang, XC; Makhema, J; Mills, LA; Panchia, R; Faesen, S; Eron, J; Gallant, J; Havlir, D; Swindells, S; Elharrar, V; Burns, D; Taha, TE; Nielsen-Saines, K; Celentano, DD; Essex, M; Hudelson, SE; Redd, AD; Fleming, TR				Cohen, M. S.; Chen, Y. Q.; McCauley, M.; Gamble, T.; Hosseinipour, M. C.; Kumarasamy, N.; Hakim, J. G.; Kumwenda, J.; Grinsztejn, B.; Pilotto, J. H. S.; Godbole, S. V.; Chariyalertsak, S.; Santos, B. R.; Mayer, K. H.; Hoffman, I. F.; Eshleman, S. H.; Piwowar-Manning, E.; Cottle, L.; Zhang, X. C.; Makhema, J.; Mills, L. A.; Panchia, R.; Faesen, S.; Eron, J.; Gallant, J.; Havlir, D.; Swindells, S.; Elharrar, V.; Burns, D.; Taha, T. E.; Nielsen-Saines, K.; Celentano, D. D.; Essex, M.; Hudelson, S. E.; Redd, A. D.; Fleming, T. R.		HPTN 052 Study Team	Antiretroviral Therapy for the Prevention of HIV-1 Transmission	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED-TRIAL; VIRAL LOAD; HPTN 052; INFECTION	BACKGROUND An interim analysis of data from the HIV Prevention Trials Network (HPTN) 052 trial showed that antiretroviral therapy (ART) prevented more than 96% of genetically linked infections caused by human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. ART was then offered to all patients with HIV-1 infection (index participants). The study included more than 5 years of follow-up to assess the durability of such therapy for the prevention of HIV-1 transmission. METHODS We randomly assigned 1763 index participants to receive either early or delayed ART. In the early-ART group, 886 participants started therapy at enrollment (CD4+ count, 350 to 550 cells per cubic millimeter). In the delayed-ART group, 877 participants started therapy after two consecutive CD4+ counts fell below 250 cells per cubic millimeter or if an illness indicative of the acquired immunodeficiency syndrome (i.e., an AIDS-defining illness) developed. The primary study end point was the diagnosis of genetically linked HIV-1 infection in the previously HIV-1-negative partner in an intention-to-treat analysis. RESULTS Index participants were followed for 10,031 person-years; partners were followed for 8509 person-years. Among partners, 78 HIV-1 infections were observed during the trial (annual incidence, 0.9%; 95% confidence interval [CI], 0.7 to 1.1). Viral-linkage status was determined for 72 (92%) of the partner infections. Of these infections, 46 were linked (3 in the early-ART group and 43 in the delayed-ART group; incidence, 0.5%; 95% CI, 0.4 to 0.7) and 26 were unlinked (14 in the early-ART group and 12 in the delayed-ART group; incidence, 0.3%; 95% CI, 0.2 to 0.4). Early ART was associated with a 93% lower risk of linked partner infection than was delayed ART (hazard ratio, 0.07; 95% CI, 0.02 to 0.22). No linked infections were observed when HIV-1 infection was stably suppressed by ART in the index participant. CONCLUSIONS The early initiation of ART led to a sustained decrease in genetically linked HIV-1 infections in sexual partners. (Funded by the National Institute of Allergy and Infectious Diseases; HPTN 052 ClinicalTrials.gov number, NCT00074581.)	[Cohen, M. S.; Hosseinipour, M. C.; Hoffman, I. F.; Eron, J.] Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC USA; [Chen, Y. Q.; Zhang, X. C.] Fred Hutchinson Canc Res Ctr, Div Vaccine & Infect Dis, 1124 Columbia St, Seattle, WA 98104 USA; [Chen, Y. Q.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Cottle, L.] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, 1124 Columbia St, Seattle, WA 98104 USA; [Fleming, T. R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [McCauley, M.] FHI 360, Washington, DC USA; [Gamble, T.] FHI 360, Durham, NC USA; [Kumarasamy, N.] YR Gaitonde Ctr AIDS Res & Educ, Madras, Tamil Nadu, India; [Godbole, S. V.] Natl AIDS Res Inst, Pune, Maharashtra, India; [Hakim, J. G.] Univ Zimbabwe, Harare, Zimbabwe; [Kumwenda, J.] Johns Hopkins Project, Coll Med, Blantyre, Malawi; [Grinsztejn, B.] Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Pilotto, J. H. S.] Hosp Geral Nova Iguacu, Rio De Janeiro, Brazil; [Pilotto, J. H. S.] Fiocruz MS, IOC, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil; [Santos, B. R.] Hosp Nossa Senhora Conceicao GHC, Serv Infectol, Porto Alegre, RS, Brazil; [Chariyalertsak, S.] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai, Thailand; [Mayer, K. H.] Fenway Inst, Boston, MA USA; [Essex, M.] Harvard Sch Publ Hlth, Boston, MA USA; [Eshleman, S. H.; Piwowar-Manning, E.; Hudelson, S. E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Redd, A. D.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Taha, T. E.] Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Celentano, D. D.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Elharrar, V.; Burns, D.] NIAID, Div Aids, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Redd, A. D.] NIAID, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Makhema, J.] Botswana Harvard AIDS Inst, Gaborone, Botswana; [Mills, L. A.] Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent, KEMRI CDC Res & Publ Hlth Collaborat HIV Res Bran, Kisumu, Kenya; [Panchia, R.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Faesen, S.] Univ Witwatersrand, Clin HIV Res Unit, Dept Med, Fac Hlth Sci, Johannesburg, South Africa; [Gallant, J.] Southwest CARE Ctr, Santa Fe, NM USA; [Havlir, D.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Swindells, S.] Univ Nebraska Med Ctr, Omaha, NE USA; [Nielsen-Saines, K.] David Geffen UCLA Sch Med, Div Infect Dis, Los Angeles, CA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; FHI 360; Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); University of Zimbabwe; University of Malawi; Fundacao Oswaldo Cruz; Chiang Mai University; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Botswana-Harvard AIDS Institute Partnership; University of Witwatersrand; University of Witwatersrand; University of California System; University of California San Francisco; University of Nebraska System; University of Nebraska Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cohen, MS (corresponding author), Univ N Carolina, Inst Global Hlth & Infect Dis, Bioinformat Bldg,2nd Fl,130 Mason Farm Rd, Chapel Hill, NC 27599 USA.	mscohen@med.unc.edu	Khopkar-Kale, Priyanka S/K-4159-2017; Franzeck, Fabian C/B-5055-2011; Kumarasasmy, Nagalingeswaran/AAB-7348-2021; Calvet, GA/G-6959-2013; Godbole, Sheela/ABG-4942-2020; Godbole, Sheela/K-4177-2017; Azadbakht, Morteza/ABA-2569-2020; Pilotto, Jose Henrique/AAD-9773-2019; Hendrix, Craig W/G-4182-2014; Cardoso, Sandra W/D-7965-2015; Sanne, Ian/ABH-2231-2020; Moyo, Sikhulile/E-1464-2015; Choobkar, Saeed/AAA-3212-2020	Khopkar-Kale, Priyanka S/0000-0003-3276-3881; Calvet, GA/0000-0002-3545-5238; Azadbakht, Morteza/0000-0001-8103-3506; Pilotto, Jose Henrique/0000-0003-0521-8597; Hendrix, Craig W/0000-0002-5696-8665; Cardoso, Sandra W/0000-0001-5230-0003; Moyo, Sikhulile/0000-0003-3821-4592; Nyirenda, Mulinda/0000-0003-2037-7449; Kabudula, Chodziwadziwa/0000-0002-5867-0336; Sahay, Seema/0000-0001-6064-827X; Bollinger, Robert/0000-0002-6798-6834; de Bruyn, Guy/0000-0002-8028-4474; Taha, Taha/0000-0001-9814-4894; Chen, Ying Qing/0000-0002-2726-3391; Godbole, Sheela/0000-0001-6537-9064	National Institute of Allergy and Infectious Diseases [HPTN 052]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068617, P30AI027763, K24AI051982, UM1AI068613, U01AI068619, U01AI068613, P30AI050410, U01AI068617, UM1AI068619] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institute of Allergy and Infectious Diseases; HPTN 052 ClinicalTrials.gov number, NCT00074581.	Anglemyer A, 2013, COCHRANE DB SYST REV, V4; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; Boily MC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001250; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Chen YQ, 2012, CONTEMP CLIN TRIALS, V33, P1280, DOI 10.1016/j.cct.2012.07.007; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Cohen MS, 2012, CLIN TRIALS, V9, P340, DOI 10.1177/1740774512443594; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cori A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084511; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; El-Sadr WM, 2013, JAIDS-J ACQ IMM DEF, V63, pS115, DOI 10.1097/QAI.0b013e318299c3d9; Eshleman SH, 2011, J INFECT DIS, V204, P1918, DOI 10.1093/infdis/jir651; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; Hayes R, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-57; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Muessig KE, 2014, CURR HIV-AIDS REP, V11, P434, DOI 10.1007/s11904-014-0225-9; Ping LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071557; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Roberts T, 2016, CLIN INFECT DIS, V62, P1043, DOI 10.1093/cid/ciw001; Rodger A, 2016, JAMA; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Sturmer M, 2008, ANTIVIR THER, V13, P729; UNAIDS, 2020, PEOPL LIV HIV AD 10; UNAIDS, 2014, UND FAST TRACK ACC A; Vernazza PL, 2008, ANTIVIR THER, V13, P641; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2012, GUID OR PREEXP PROPH	29	5682	5866	32	803	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2016	375	9					830	839		10.1056/NEJMoa1600693	http://dx.doi.org/10.1056/NEJMoa1600693			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU9HA	27424812	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000382526000006
